<!DOCTYPE html SYSTEM "about:legacy-compat"><html lang="en" class="win-std-desktop-val"><head>
<META http-equiv="Content-Type" content="text/html">
<title>Source View: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241751/</title><meta name="robots" content="noindex,nofollow"><meta name="SortSite-IgnoreRule-Page" content="AccHtmlLinkTextReused,AccAdvancedReadingLevel,Section508-m-3,BugHtmlColgroup,BugIeCssMinMaxWidthHeight,ErrSpellingError,SeoBingTitleLength,SeoPage150k,UseGov5.1,UseGov9.2.3,UseGov10.11,UseGov11.7,UseGov14.3,UseGov17.4,UseGunningFog,W3cTitleTooLong"><link rel="icon" href="https://www-powermapper-com.azureedge.net/favicon.ico"><link rel="stylesheet" href="../Report/report-min-20200618.css"><script type="text/javascript" src="../Report/report-min-20210409.js"></script><!--[if lte IE 8]>
            <script>
                document.createElement('header');
                document.createElement('aside');
            </script>
            <![endif]--></head><body class="source"><a class="accessible" href="#content">Skip to Content</a><header><h1>
                        HTML Document
                    </h1><table><tr><th>
                        URL:
                    </th><td><a rel="nofollow" target="_top" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241751/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241751/</a></td></tr><tr><th>
                        HTTP Status:
                    </th><td>200 OK</td></tr><tr><th>
                        MIME Type:
                    </th><td>text/html </td></tr><tr><th>
                        Last Modified:
                    </th><td>Mon, 01 Jan 1601 00:00:00 GMT</td></tr><tr><th>
                        Download Time:
                    </th><td>5 seconds
                            </td></tr><tr><th>
                        Cookies:
                    </th><td> ncbi_sid=8A1AED4817306781_045  WebEnv=1TQwe1%408A1AED4817306  pmc.article.report= </td></tr><tr><th>
                        Size:
                    </th><td>2046 KB
                        </td></tr><tr><th>
                                Depth:
                            </th><td>4 clicks from home page
                            </td></tr><tr><th>
                                Charset:
                            </th><td>utf-8</td></tr><tr><th>
                                Forms:
                            </th><td>1 forms containing 2 controls
                            </td></tr><tr><th>
                        HTTP Headers:
                    </th><td><button class="chevron toggleChevron" data-toggleid="HttpHeaders"><img width="20" height="20" alt="View Headers" id="chevHttpHeaders" src="../Report/chevron-down.svg"></button>&nbsp;<span>14&nbsp;headers</span><div class="links" id="expand-HttpHeaders">Cache-Control: private<br>Connection: Keep-Alive<br>Content-Security-Policy: upgrade-insecure-requests<br>Date: Tue, 26 Oct 2021 18:05:47 GMT<br>Keep-Alive: timeout=1, max=10<br>NCBI-PHID: 8A1AC5371782FE310000000008240822.m_9<br>NCBI-SID: 8A1AED4817306781_0453SID<br>Referrer-Policy: origin-when-cross-origin<br>Server: Apache<br>Set-Cookie: pmc.article.report=; domain=.nih.gov; path=/; Max-Age=31536000<br>Strict-Transport-Security: max-age=31536000; includeSubDomains; preload<br>Transfer-Encoding: chunked<br>X-UA-Compatible: IE=Edge<br>X-XSS-Protection: 1; mode=block<br></div></td></tr><tr><th>
                        Links In:
                    </th><td><button class="chevron toggleChevron" data-toggleid="LinksIn"><img width="20" height="20" alt="View Links" id="chevLinksIn" src="../Report/chevron-down.svg"></button>&nbsp;<span>1&nbsp;pages</span><div class="links" id="expand-LinksIn"><a class="viewsource" rel="nofollow" target="_top" href="https://prod-www.papaandbarkleycbd.com/learn/what-is-the-role-of-the-endocannabinoid-system" data-pageid="357" data-line="0" data-col="0">https://prod-www.papaandbarkleycbd.com/learn/what-is-the-role-of-the-endocannabinoid-system</a><br></div></td></tr><tr><td>&nbsp;</td><td>&nbsp;</td></tr><tr class="middle"><th><img alt="OK" width="20" height="20" src="../Report/bench-better.svg">
                                Issues:
                            </th><td>
                                No issues found
                            </td></tr></table></header><main id="content" class="pre"><p><code>1</code><code>&lt;?xml version="1.0" encoding="utf-8"?&gt;</code></p><p><code>2</code><code>          </code></p><p><code>3</code><code>&lt;!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"&gt;</code></p><p><code>4</code><code>          </code></p><p><code>5</code><code>&lt;html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"&gt;</code></p><p><code>6</code><code>          </code></p><p><code>7</code><code>    </code></p><p><code>8</code><code>    &lt;head&gt;</code></p><p><code>9</code><code>&lt;meta http-equiv="Content-Type" content="text/html; charset=utf-8" /&gt;</code></p><p><code>10</code><code>          </code></p><p><code>11</code><code>        &lt;!-- AppResources meta begin --&gt;</code></p><p><code>12</code><code>          </code></p><p><code>13</code><code>        &lt;script type="text/javascript"&gt;</code></p><p><code>14</code><code>var ncbi_startTime = new Date();&lt;/script&gt;</code></p><p><code>15</code><code>          </code></p><p><code>16</code><code>        &lt;!-- AppResources meta end --&gt;</code></p><p><code>17</code><code>          </code></p><p><code>18</code><code>        </code></p><p><code>19</code><code>        &lt;!-- TemplateResources meta begin --&gt;</code></p><p><code>20</code><code>          </code></p><p><code>21</code><code>        &lt;meta name="paf_template" content="" /&gt;</code></p><p><code>22</code><code>          </code></p><p><code>23</code><code>          </code></p><p><code>24</code><code>        &lt;!-- TemplateResources meta end --&gt;</code></p><p><code>25</code><code>          </code></p><p><code>26</code><code>        </code></p><p><code>27</code><code>        &lt;!-- Logger begin --&gt;</code></p><p><code>28</code><code>          </code></p><p><code>29</code><code>        &lt;meta name="ncbi_db" content="pmc" /&gt;</code></p><p><code>30</code><code>&lt;meta name="ncbi_pdid" content="article" /&gt;</code></p><p><code>31</code><code>&lt;meta name="ncbi_acc" content="" /&gt;</code></p><p><code>32</code><code>&lt;meta name="ncbi_domain" content="nihpa" /&gt;</code></p><p><code>33</code><code>&lt;meta name="ncbi_report" content="record" /&gt;</code></p><p><code>34</code><code>&lt;meta name="ncbi_type" content="fulltext" /&gt;</code></p><p><code>35</code><code>&lt;meta name="ncbi_objectid" content="" /&gt;</code></p><p><code>36</code><code>&lt;meta name="ncbi_pcid" content="/articles/PMC2241751/" /&gt;</code></p><p><code>37</code><code>&lt;meta name="ncbi_app" content="pmc" /&gt;</code></p><p><code>38</code><code>          </code></p><p><code>39</code><code>        &lt;!-- Logger end --&gt;</code></p><p><code>40</code><code>          </code></p><p><code>41</code><code>        </code></p><p><code>42</code><code>        &lt;title&gt;</code></p><p><code>43</code><code>The Endocannabinoid System as an Emerging Target of Pharmacotherapy&lt;/title&gt;</code></p><p><code>44</code><code>          </code></p><p><code>45</code><code>        </code></p><p><code>46</code><code>        &lt;!-- AppResources external_resources begin --&gt;</code></p><p><code>47</code><code>          </code></p><p><code>48</code><code>        &lt;link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /&gt;</code></p><p><code>49</code><code>&lt;script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"&gt;</code></p><p><code>50</code><code>&lt;/script&gt;</code></p><p><code>51</code><code>          </code></p><p><code>52</code><code>          </code></p><p><code>53</code><code>        &lt;!-- AppResources external_resources end --&gt;</code></p><p><code>54</code><code>          </code></p><p><code>55</code><code>        </code></p><p><code>56</code><code>        &lt;!-- Page meta begin --&gt;</code></p><p><code>57</code><code>          </code></p><p><code>58</code><code>        &lt;meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /&gt;</code></p><p><code>59</code><code>&lt;link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241751/" /&gt;</code></p><p><code>60</code><code>&lt;link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /&gt;</code></p><p><code>61</code><code>&lt;meta name="citation_journal_title" content="Pharmacological reviews" /&gt;</code></p><p><code>62</code><code>&lt;meta name="citation_title" content="The Endocannabinoid System as an Emerging Target of Pharmacotherapy" /&gt;</code></p><p><code>63</code><code>&lt;meta name="citation_authors" content="PÁL PACHER, SÁNDOR BÁTKAI, GEORGE KUNOS" /&gt;</code></p><p><code>64</code><code>&lt;meta name="citation_date" content="September 2006" /&gt;</code></p><p><code>65</code><code>&lt;meta name="citation_issue" content="3" /&gt;</code></p><p><code>66</code><code>&lt;meta name="citation_volume" content="58" /&gt;</code></p><p><code>67</code><code>&lt;meta name="citation_firstpage" content="389" /&gt;</code></p><p><code>68</code><code>&lt;meta name="citation_doi" content="10.1124/pr.58.3.2" /&gt;</code></p><p><code>69</code><code>&lt;meta name="citation_abstract_html_url" content="/pmc/articles/PMC2241751/?report=abstract" /&gt;</code></p><p><code>70</code><code>&lt;meta name="citation_fulltext_html_url" content="/pmc/articles/PMC2241751/" /&gt;</code></p><p><code>71</code><code>&lt;meta name="citation_pmid" content="16968947" /&gt;</code></p><p><code>72</code><code>&lt;meta name="DC.Title" content="The Endocannabinoid System as an Emerging Target of Pharmacotherapy" /&gt;</code></p><p><code>73</code><code>&lt;meta name="DC.Type" content="Text" /&gt;</code></p><p><code>74</code><code>&lt;meta name="DC.Publisher" content="NIH Public Access" /&gt;</code></p><p><code>75</code><code>&lt;meta name="DC.Contributor" content="PÁL PACHER" /&gt;</code></p><p><code>76</code><code>&lt;meta name="DC.Contributor" content="SÁNDOR BÁTKAI" /&gt;</code></p><p><code>77</code><code>&lt;meta name="DC.Contributor" content="GEORGE KUNOS" /&gt;</code></p><p><code>78</code><code>&lt;meta name="DC.Date" content="2006 Sep" /&gt;</code></p><p><code>79</code><code>&lt;meta name="DC.Identifier" content="10.1124/pr.58.3.2" /&gt;</code></p><p><code>80</code><code>&lt;meta name="DC.Language" content="en" /&gt;</code></p><p><code>81</code><code>&lt;meta property="og:title" content="The Endocannabinoid System as an Emerging Target of Pharmacotherapy" /&gt;</code></p><p><code>82</code><code>&lt;meta property="og:type" content="article" /&gt;</code></p><p><code>83</code><code>&lt;meta property="og:description" content="The recent identification of cannabinoid receptors and their endogenous lipid ligands has triggered an exponential growth of studies exploring the endocannabinoid system and its regulatory functions in health and disease. Such studies have been greatly ..." /&gt;</code></p><p><code>84</code><code>&lt;meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241751/" /&gt;</code></p><p><code>85</code><code>&lt;meta property="og:site_name" content="PubMed Central (PMC)" /&gt;</code></p><p><code>86</code><code>&lt;meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png?_=0" /&gt;</code></p><p><code>87</code><code>&lt;meta name="twitter:card" content="summary" /&gt;</code></p><p><code>88</code><code>&lt;meta name="twitter:site" content="@ncbi" /&gt;</code></p><p><code>89</code><code>&lt;link rel="stylesheet" href="/corehtml/pmc/css/3.15.12/ncbi.min.css" type="text/css" data-apply="standalone" /&gt;</code></p><p><code>90</code><code>&lt;link rel="stylesheet" href="/corehtml/pmc/css/3.15.12/pmc.min.css" type="text/css" /&gt;</code></p><p><code>91</code><code>&lt;link rel="stylesheet" href="/corehtml/pmc/css/3.15.12/pmcrefs1.min.css" type="text/css" /&gt;</code></p><p><code>92</code><code>&lt;link rel="stylesheet" href="/corehtml/pmc/css/3.15.12/pmc_extras_prnt.min.css" type="text/css" media="print" /&gt;</code></p><p><code>93</code><code>&lt;style type="text/css"&gt;</code></p><p><code>94</code><code>.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}&lt;/style&gt;</code></p><p><code>95</code><code>&lt;style type="text/css"&gt;</code></p><p><code>96</code><code>.print-view{display:block}&lt;/style&gt;</code></p><p><code>97</code><code>&lt;script&gt;</code></p><p><code>98</code><code>          </code></p><p><code>99</code><code>				var isjq= typeof jQuery === "function"</code></p><p><code>100</code><code>			&lt;/script&gt;</code></p><p><code>101</code><code>&lt;script type="text/javascript"&gt;</code></p><p><code>102</code><code>if (!isjq){document.write('\x3Cscript type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"\x3E\x3C/script\x3E')}{document.write('\x3Cscript type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js"\x3E\x3C/script\x3E')}&lt;/script&gt;</code></p><p><code>103</code><code>&lt;script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.15.12"&gt;</code></p><p><code>104</code><code>//&lt;/script&gt;</code></p><p><code>105</code><code>&lt;script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.15.12"&gt;</code></p><p><code>106</code><code>//&lt;/script&gt;</code></p><p><code>107</code><code>&lt;script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.15.12"&gt;</code></p><p><code>108</code><code>//&lt;/script&gt;</code></p><p><code>109</code><code>&lt;meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'" /&gt;</code></p><p><code>110</code><code>&lt;script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js"&gt;</code></p><p><code>111</code><code>//&lt;/script&gt;</code></p><p><code>112</code><code>&lt;link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /&gt;</code></p><p><code>113</code><code>&lt;script type="text/javascript"&gt;</code></p><p><code>114</code><code>window.name="mainwindow";&lt;/script&gt;</code></p><p><code>115</code><code>&lt;style type="text/css"&gt;</code></p><p><code>116</code><code>          </code></p><p><code>117</code><code>        div.pmc_para_cit li.highlight,</code></p><p><code>118</code><code>        div.pmc_para_cit li.highlight .one_line_source</code></p><p><code>119</code><code>        { background: #E0E0E0; }</code></p><p><code>120</code><code>        a.bibr.highlight { background: #E0E0E0; } </code></p><p><code>121</code><code>      &lt;/style&gt;</code></p><p><code>122</code><code>&lt;meta name="cited_in_systematic_reviews" content="" /&gt;</code></p><p><code>123</code><code>&lt;link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2241751/pdf/nihms38123.pdf" /&gt;</code></p><p><code>124</code><code>          </code></p><p><code>125</code><code>          </code></p><p><code>126</code><code>        &lt;!-- Page meta end --&gt;</code></p><p><code>127</code><code>          </code></p><p><code>128</code><code>    &lt;link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /&gt;</code></p><p><code>129</code><code>&lt;meta name="ncbi_phid" content="8A1AC5371782FE310000000008240822.m_8" /&gt;</code></p><p><code>130</code><code>          </code></p><p><code>131</code><code>&lt;meta name='referrer' content='origin-when-cross-origin'/&gt;</code></p><p><code>132</code><code>&lt;link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4201310/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4200827/4200829/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /&gt;</code></p><p><code>133</code><code>&lt;link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4201310/css/3411343/3882866/4157116.css" media="print" /&gt;</code></p><p><code>134</code><code>&lt;/head&gt;</code></p><p><code>135</code><code>          </code></p><p><code>136</code><code>    &lt;body class="article"&gt;</code></p><p><code>137</code><code>          </code></p><p><code>138</code><code>        &lt;div class="grid"&gt;</code></p><p><code>139</code><code>          </code></p><p><code>140</code><code>            &lt;div class="col twelve_col nomargin shadow"&gt;</code></p><p><code>141</code><code>          </code></p><p><code>142</code><code>                &lt;!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet --&gt;</code></p><p><code>143</code><code>          </code></p><p><code>144</code><code>                &lt;div class="sysmessages"&gt;</code></p><p><code>145</code><code>          </code></p><p><code>146</code><code>                    &lt;noscript&gt;</code></p><p><code>147</code><code>          </code></p><p><code>148</code><code>	&lt;p class="nojs"&gt;</code></p><p><code>149</code><code>          </code></p><p><code>150</code><code>	&lt;strong&gt;</code></p><p><code>151</code><code>Warning:&lt;/strong&gt;</code></p><p><code>152</code><code>          </code></p><p><code>153</code><code>	The NCBI web site requires JavaScript to function. </code></p><p><code>154</code><code>	&lt;a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank"&gt;</code></p><p><code>155</code><code>more...&lt;/a&gt;</code></p><p><code>156</code><code>          </code></p><p><code>157</code><code>	&lt;/p&gt;</code></p><p><code>158</code><code>          </code></p><p><code>159</code><code>	&lt;/noscript&gt;</code></p><p><code>160</code><code>          </code></p><p><code>161</code><code>                &lt;/div&gt;</code></p><p><code>162</code><code>          </code></p><p><code>163</code><code>                &lt;!--/.sysmessage--&gt;</code></p><p><code>164</code><code>          </code></p><p><code>165</code><code>                &lt;div class="wrap"&gt;</code></p><p><code>166</code><code>          </code></p><p><code>167</code><code>                    &lt;div class="page"&gt;</code></p><p><code>168</code><code>          </code></p><p><code>169</code><code>                        &lt;div class="top"&gt;</code></p><p><code>170</code><code>          </code></p><p><code>171</code><code>                            &lt;div class="universal_header" id="universal_header"&gt;</code></p><p><code>172</code><code>&lt;ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"&gt;</code></p><p><code>173</code><code>&lt;li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"&gt;</code></p><p><code>174</code><code>&lt;a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"&gt;</code></p><p><code>175</code><code>&lt;span class="offscreen_noflow"&gt;</code></p><p><code>176</code><code>NCBI&lt;/span&gt;</code></p><p><code>177</code><code>&lt;img src="//static.pubmed.gov/portal/portal3rc.fcgi/4201310/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /&gt;</code></p><p><code>178</code><code>&lt;/a&gt;</code></p><p><code>179</code><code>&lt;/li&gt;</code></p><p><code>180</code><code>&lt;li class="offscreen_noflow ui-ncbimenu-item-skip access"&gt;</code></p><p><code>181</code><code>&lt;a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3"&gt;</code></p><p><code>182</code><code>Skip to main</code></p><p><code>183</code><code>                        content&lt;/a&gt;</code></p><p><code>184</code><code>&lt;/li&gt;</code></p><p><code>185</code><code>&lt;li class="offscreen_noflow ui-ncbimenu-item-skip access"&gt;</code></p><p><code>186</code><code>&lt;a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4"&gt;</code></p><p><code>187</code><code>Skip to</code></p><p><code>188</code><code>                        navigation&lt;/a&gt;</code></p><p><code>189</code><code>&lt;/li&gt;</code></p><p><code>190</code><code>&lt;li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"&gt;</code></p><p><code>191</code><code>&lt;a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources"&gt;</code></p><p><code>192</code><code>Resources&lt;/a&gt;</code></p><p><code>193</code><code>&lt;/li&gt;</code></p><p><code>194</code><code>&lt;li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"&gt;</code></p><p><code>195</code><code>&lt;a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto"&gt;</code></p><p><code>196</code><code>How To&lt;/a&gt;</code></p><p><code>197</code><code>&lt;/li&gt;</code></p><p><code>198</code><code>&lt;li class="offscreen_noflow ui-ncbimenu-item-skip access"&gt;</code></p><p><code>199</code><code>&lt;a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0"&gt;</code></p><p><code>200</code><code>About NCBI Accesskeys&lt;/a&gt;</code></p><p><code>201</code><code>&lt;/li&gt;</code></p><p><code>202</code><code>&lt;/ul&gt;</code></p><p><code>203</code><code>&lt;div class="myncbi"&gt;</code></p><p><code>204</code><code>&lt;span id="myncbiusername" style="display:none"&gt;</code></p><p><code>205</code><code>&lt;a href="/account/settings/" id="mnu" title="Edit account settings"&gt;</code></p><p><code>206</code><code>&lt;/a&gt;</code></p><p><code>207</code><code>&lt;/span&gt;</code></p><p><code>208</code><code>&lt;a accesskey="2" href="/myncbi/" id="myncbi" style="display:none"&gt;</code></p><p><code>209</code><code>My NCBI&lt;/a&gt;</code></p><p><code>210</code><code>&lt;a href="/account/" id="sign_in"&gt;</code></p><p><code>211</code><code>Sign in to NCBI&lt;/a&gt;</code></p><p><code>212</code><code>&lt;a href="/account/signout/" id="sign_out" style="display:none"&gt;</code></p><p><code>213</code><code>Sign Out&lt;/a&gt;</code></p><p><code>214</code><code>&lt;/div&gt;</code></p><p><code>215</code><code>&lt;/div&gt;</code></p><p><code>216</code><code>          </code></p><p><code>217</code><code>                            &lt;div class="header"&gt;</code></p><p><code>218</code><code>          </code></p><p><code>219</code><code>    &lt;div class="res_logo"&gt;</code></p><p><code>220</code><code>          </code></p><p><code>221</code><code>  &lt;h1 class="img_logo"&gt;</code></p><p><code>222</code><code>&lt;a href="/pmc/" class="pmc_logo offscreen"&gt;</code></p><p><code>223</code><code>PMC&lt;/a&gt;</code></p><p><code>224</code><code>&lt;/h1&gt;</code></p><p><code>225</code><code>          </code></p><p><code>226</code><code>  &lt;div class="NLMLogo"&gt;</code></p><p><code>227</code><code>          </code></p><p><code>228</code><code>    &lt;a href="https://www.nlm.nih.gov/" title="US National Library of Medicine"&gt;</code></p><p><code>229</code><code>US National Library of Medicine&lt;/a&gt;</code></p><p><code>230</code><code>          </code></p><p><code>231</code><code>    &lt;br /&gt;</code></p><p><code>232</code><code>          </code></p><p><code>233</code><code>    &lt;a href="https://www.nih.gov/" title="National Institutes of Health"&gt;</code></p><p><code>234</code><code>National Institutes of Health&lt;/a&gt;</code></p><p><code>235</code><code>          </code></p><p><code>236</code><code>  &lt;/div&gt;</code></p><p><code>237</code><code>          </code></p><p><code>238</code><code>&lt;/div&gt;</code></p><p><code>239</code><code>          </code></p><p><code>240</code><code>    &lt;div class="search"&gt;</code></p><p><code>241</code><code>&lt;form method="get" action="/pmc/"&gt;</code></p><p><code>242</code><code>&lt;div class="search_form"&gt;</code></p><p><code>243</code><code>&lt;label for="database" class="offscreen_noflow"&gt;</code></p><p><code>244</code><code>Search database&lt;/label&gt;</code></p><p><code>245</code><code>&lt;select id="database"&gt;</code></p><p><code>246</code><code>&lt;optgroup label="Recent"&gt;</code></p><p><code>247</code><code>&lt;option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete"&gt;</code></p><p><code>248</code><code>PMC&lt;/option&gt;</code></p><p><code>249</code><code>&lt;/optgroup&gt;</code></p><p><code>250</code><code>&lt;optgroup label="All"&gt;</code></p><p><code>251</code><code>&lt;option value="gquery"&gt;</code></p><p><code>252</code><code>All Databases&lt;/option&gt;</code></p><p><code>253</code><code>&lt;option value="assembly"&gt;</code></p><p><code>254</code><code>Assembly&lt;/option&gt;</code></p><p><code>255</code><code>&lt;option value="biocollections"&gt;</code></p><p><code>256</code><code>Biocollections&lt;/option&gt;</code></p><p><code>257</code><code>&lt;option value="bioproject"&gt;</code></p><p><code>258</code><code>BioProject&lt;/option&gt;</code></p><p><code>259</code><code>&lt;option value="biosample"&gt;</code></p><p><code>260</code><code>BioSample&lt;/option&gt;</code></p><p><code>261</code><code>&lt;option value="biosystems"&gt;</code></p><p><code>262</code><code>BioSystems&lt;/option&gt;</code></p><p><code>263</code><code>&lt;option value="books"&gt;</code></p><p><code>264</code><code>Books&lt;/option&gt;</code></p><p><code>265</code><code>&lt;option value="clinvar"&gt;</code></p><p><code>266</code><code>ClinVar&lt;/option&gt;</code></p><p><code>267</code><code>&lt;option value="cdd"&gt;</code></p><p><code>268</code><code>Conserved Domains&lt;/option&gt;</code></p><p><code>269</code><code>&lt;option value="gap"&gt;</code></p><p><code>270</code><code>dbGaP&lt;/option&gt;</code></p><p><code>271</code><code>&lt;option value="dbvar"&gt;</code></p><p><code>272</code><code>dbVar&lt;/option&gt;</code></p><p><code>273</code><code>&lt;option value="gene"&gt;</code></p><p><code>274</code><code>Gene&lt;/option&gt;</code></p><p><code>275</code><code>&lt;option value="genome"&gt;</code></p><p><code>276</code><code>Genome&lt;/option&gt;</code></p><p><code>277</code><code>&lt;option value="gds"&gt;</code></p><p><code>278</code><code>GEO DataSets&lt;/option&gt;</code></p><p><code>279</code><code>&lt;option value="geoprofiles"&gt;</code></p><p><code>280</code><code>GEO Profiles&lt;/option&gt;</code></p><p><code>281</code><code>&lt;option value="gtr"&gt;</code></p><p><code>282</code><code>GTR&lt;/option&gt;</code></p><p><code>283</code><code>&lt;option value="homologene"&gt;</code></p><p><code>284</code><code>HomoloGene&lt;/option&gt;</code></p><p><code>285</code><code>&lt;option value="ipg"&gt;</code></p><p><code>286</code><code>Identical Protein Groups&lt;/option&gt;</code></p><p><code>287</code><code>&lt;option value="medgen"&gt;</code></p><p><code>288</code><code>MedGen&lt;/option&gt;</code></p><p><code>289</code><code>&lt;option value="mesh"&gt;</code></p><p><code>290</code><code>MeSH&lt;/option&gt;</code></p><p><code>291</code><code>&lt;option value="ncbisearch"&gt;</code></p><p><code>292</code><code>NCBI Web Site&lt;/option&gt;</code></p><p><code>293</code><code>&lt;option value="nlmcatalog"&gt;</code></p><p><code>294</code><code>NLM Catalog&lt;/option&gt;</code></p><p><code>295</code><code>&lt;option value="nuccore"&gt;</code></p><p><code>296</code><code>Nucleotide&lt;/option&gt;</code></p><p><code>297</code><code>&lt;option value="omim"&gt;</code></p><p><code>298</code><code>OMIM&lt;/option&gt;</code></p><p><code>299</code><code>&lt;option value="pmc" data-ac_dict="pmc-search-autocomplete"&gt;</code></p><p><code>300</code><code>PMC&lt;/option&gt;</code></p><p><code>301</code><code>&lt;option value="popset"&gt;</code></p><p><code>302</code><code>PopSet&lt;/option&gt;</code></p><p><code>303</code><code>&lt;option value="protein"&gt;</code></p><p><code>304</code><code>Protein&lt;/option&gt;</code></p><p><code>305</code><code>&lt;option value="proteinclusters"&gt;</code></p><p><code>306</code><code>Protein Clusters&lt;/option&gt;</code></p><p><code>307</code><code>&lt;option value="protfam"&gt;</code></p><p><code>308</code><code>Protein Family Models&lt;/option&gt;</code></p><p><code>309</code><code>&lt;option value="pcassay"&gt;</code></p><p><code>310</code><code>PubChem BioAssay&lt;/option&gt;</code></p><p><code>311</code><code>&lt;option value="pccompound"&gt;</code></p><p><code>312</code><code>PubChem Compound&lt;/option&gt;</code></p><p><code>313</code><code>&lt;option value="pcsubstance"&gt;</code></p><p><code>314</code><code>PubChem Substance&lt;/option&gt;</code></p><p><code>315</code><code>&lt;option value="pubmed"&gt;</code></p><p><code>316</code><code>PubMed&lt;/option&gt;</code></p><p><code>317</code><code>&lt;option value="snp"&gt;</code></p><p><code>318</code><code>SNP&lt;/option&gt;</code></p><p><code>319</code><code>&lt;option value="sra"&gt;</code></p><p><code>320</code><code>SRA&lt;/option&gt;</code></p><p><code>321</code><code>&lt;option value="structure"&gt;</code></p><p><code>322</code><code>Structure&lt;/option&gt;</code></p><p><code>323</code><code>&lt;option value="taxonomy"&gt;</code></p><p><code>324</code><code>Taxonomy&lt;/option&gt;</code></p><p><code>325</code><code>&lt;option value="toolkit"&gt;</code></p><p><code>326</code><code>ToolKit&lt;/option&gt;</code></p><p><code>327</code><code>&lt;option value="toolkitall"&gt;</code></p><p><code>328</code><code>ToolKitAll&lt;/option&gt;</code></p><p><code>329</code><code>&lt;option value="toolkitbookgh"&gt;</code></p><p><code>330</code><code>ToolKitBookgh&lt;/option&gt;</code></p><p><code>331</code><code>&lt;/optgroup&gt;</code></p><p><code>332</code><code>&lt;/select&gt;</code></p><p><code>333</code><code>&lt;div class="nowrap"&gt;</code></p><p><code>334</code><code>&lt;label for="term" class="offscreen_noflow" accesskey="/"&gt;</code></p><p><code>335</code><code>Search term&lt;/label&gt;</code></p><p><code>336</code><code>&lt;div class="nowrap"&gt;</code></p><p><code>337</code><code>&lt;input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" /&gt;</code></p><p><code>338</code><code>&lt;/div&gt;</code></p><p><code>339</code><code>&lt;button id="search" type="submit" class="button_search nowrap" cmd="go"&gt;</code></p><p><code>340</code><code>Search&lt;/button&gt;</code></p><p><code>341</code><code>&lt;/div&gt;</code></p><p><code>342</code><code>&lt;/div&gt;</code></p><p><code>343</code><code>&lt;/form&gt;</code></p><p><code>344</code><code>&lt;ul class="searchlinks inline_list"&gt;</code></p><p><code>345</code><code>&lt;li&gt;</code></p><p><code>346</code><code>          </code></p><p><code>347</code><code>                        &lt;a href="/pmc/advanced/"&gt;</code></p><p><code>348</code><code>Advanced&lt;/a&gt;</code></p><p><code>349</code><code>          </code></p><p><code>350</code><code>                    &lt;/li&gt;</code></p><p><code>351</code><code>&lt;li&gt;</code></p><p><code>352</code><code>          </code></p><p><code>353</code><code>                        &lt;a href="/pmc/journals/"&gt;</code></p><p><code>354</code><code>Journal list&lt;/a&gt;</code></p><p><code>355</code><code>          </code></p><p><code>356</code><code>                    &lt;/li&gt;</code></p><p><code>357</code><code>&lt;li class="help"&gt;</code></p><p><code>358</code><code>          </code></p><p><code>359</code><code>                        &lt;a target="_blank" href="/books/NBK3825/"&gt;</code></p><p><code>360</code><code>Help&lt;/a&gt;</code></p><p><code>361</code><code>          </code></p><p><code>362</code><code>                    &lt;/li&gt;</code></p><p><code>363</code><code>&lt;/ul&gt;</code></p><p><code>364</code><code>&lt;/div&gt;</code></p><p><code>365</code><code>          </code></p><p><code>366</code><code>&lt;/div&gt;</code></p><p><code>367</code><code>          </code></p><p><code>368</code><code>          </code></p><p><code>369</code><code>                            </code></p><p><code>370</code><code>                            </code></p><p><code>371</code><code>                        &lt;!--&lt;component id="Page" label="headcontent"/&gt;</code></p><p><code>372</code><code>--&gt;</code></p><p><code>373</code><code>          </code></p><p><code>374</code><code>                            </code></p><p><code>375</code><code>                        &lt;/div&gt;</code></p><p><code>376</code><code>          </code></p><p><code>377</code><code>                        &lt;div class="content"&gt;</code></p><p><code>378</code><code>          </code></p><p><code>379</code><code>                            &lt;!-- site messages --&gt;</code></p><p><code>380</code><code>          </code></p><p><code>381</code><code>                            &lt;div class="ncbi-alerts pmc-labs-ad" id="pmc-labs-ad" role="region" aria-label="Alert" style="margin-bottom: 16px;"&gt;</code></p><p><code>382</code><code>&lt;div class="pmc-labs-ad-outer"&gt;</code></p><p><code>383</code><code>&lt;div class="pmc-labs-ad-inner"&gt;</code></p><p><code>384</code><code>&lt;p&gt;</code></p><p><code>385</code><code>Try out &lt;a href="https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC2241751/"&gt;</code></p><p><code>386</code><code>PMC Labs&lt;/a&gt;</code></p><p><code>387</code><code> and tell us what you think. &lt;a href="https://ncbiinsights.ncbi.nlm.nih.gov/2021/06/02/pmc-labs/" target="_blank"&gt;</code></p><p><code>388</code><code>Learn More&lt;/a&gt;</code></p><p><code>389</code><code>.&lt;/p&gt;</code></p><p><code>390</code><code>&lt;/div&gt;</code></p><p><code>391</code><code>&lt;/div&gt;</code></p><p><code>392</code><code>&lt;button type="button" class="close pmc-labs-ad-close" aria-controls="pmc-labs-ad" aria-label="Close Alert"&gt;</code></p><p><code>393</code><code>&lt;/button&gt;</code></p><p><code>394</code><code>&lt;/div&gt;</code></p><p><code>395</code><code>          </code></p><p><code>396</code><code>&lt;div class="container"&gt;</code></p><p><code>397</code><code>          </code></p><p><code>398</code><code>    &lt;div id="maincontent" class="content eight_col col"&gt;</code></p><p><code>399</code><code>          </code></p><p><code>400</code><code>          </code></p><p><code>401</code><code>        &lt;div class="navlink-box"&gt;</code></p><p><code>402</code><code>          </code></p><p><code>403</code><code>            &lt;ul class="page-breadcrumbs inline_list small"&gt;</code></p><p><code>404</code><code>&lt;li class="journal-list"&gt;</code></p><p><code>405</code><code>&lt;a href="/pmc/journals/" class="navlink"&gt;</code></p><p><code>406</code><code>Journal List&lt;/a&gt;</code></p><p><code>407</code><code>&lt;/li&gt;</code></p><p><code>408</code><code>&lt;li class="article-entrez-filter"&gt;</code></p><p><code>409</code><code>&lt;a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink"&gt;</code></p><p><code>410</code><code>HHS Author Manuscripts&lt;/a&gt;</code></p><p><code>411</code><code>&lt;/li&gt;</code></p><p><code>412</code><code>&lt;li class="accid"&gt;</code></p><p><code>413</code><code>PMC2241751&lt;/li&gt;</code></p><p><code>414</code><code>&lt;/ul&gt;</code></p><p><code>415</code><code>          </code></p><p><code>416</code><code>        &lt;/div&gt;</code></p><p><code>417</code><code>          </code></p><p><code>418</code><code>          </code></p><p><code>419</code><code>        &lt;!-- Journal banner --&gt;</code></p><p><code>420</code><code>          </code></p><p><code>421</code><code>        &lt;div class="pmc-page-banner whole_rhythm"&gt;</code></p><p><code>422</code><code>&lt;div&gt;</code></p><p><code>423</code><code>&lt;img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap" /&gt;</code></p><p><code>424</code><code>&lt;map id="logo-imagemap" name="logo-imagemap"&gt;</code></p><p><code>425</code><code>&lt;area target="_blank" rel="noopener noreferrer" shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" /&gt;</code></p><p><code>426</code><code>&lt;area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CBanner&amp;amp;TO=Publisher%7COther%7CN/A" /&gt;</code></p><p><code>427</code><code>&lt;area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CBanner&amp;amp;TO=Publisher%7COther%7CN/A" /&gt;</code></p><p><code>428</code><code>&lt;/map&gt;</code></p><p><code>429</code><code>&lt;/div&gt;</code></p><p><code>430</code><code> &lt;/div&gt;</code></p><p><code>431</code><code>          </code></p><p><code>432</code><code>        </code></p><p><code>433</code><code>        &lt;!--component id='MainPortlet' label='search-reference'/--&gt;</code></p><p><code>434</code><code>          </code></p><p><code>435</code><code>        </code></p><p><code>436</code><code>        &lt;!-- Book content --&gt;</code></p><p><code>437</code><code>          </code></p><p><code>438</code><code>        &lt;div class=""&gt;</code></p><p><code>439</code><code>          </code></p><p><code>440</code><code>            </code></p><p><code>441</code><code>        </code></p><p><code>442</code><code>            </code></p><p><code>443</code><code>            &lt;div id="mc" class=" article lit-style content pmc-wm slang-all page-box"&gt;</code></p><p><code>444</code><code>&lt;!--main-content--&gt;</code></p><p><code>445</code><code>&lt;div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"&gt;</code></p><p><code>446</code><code>&lt;div class="fm-sec half_rhythm no_top_margin"&gt;</code></p><p><code>447</code><code>&lt;div class="fm-flexbox"&gt;</code></p><p><code>448</code><code>&lt;div class="fm-citation"&gt;</code></p><p><code>449</code><code>&lt;div&gt;</code></p><p><code>450</code><code>&lt;span id="pmcmata"&gt;</code></p><p><code>451</code><code>Pharmacol Rev.&lt;/span&gt;</code></p><p><code>452</code><code> Author manuscript; available in PMC 2008 Feb 13.&lt;/div&gt;</code></p><p><code>453</code><code>&lt;div&gt;</code></p><p><code>454</code><code>&lt;/div&gt;</code></p><p><code>455</code><code>&lt;div class="final-form"&gt;</code></p><p><code>456</code><code>&lt;em&gt;</code></p><p><code>457</code><code>Published in final edited form as:&lt;/em&gt;</code></p><p><code>458</code><code>&lt;/div&gt;</code></p><p><code>459</code><code>&lt;div class="final-citation"&gt;</code></p><p><code>460</code><code>&lt;div class="fm-vol-iss-date"&gt;</code></p><p><code>461</code><code>&lt;a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=16968947" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CFront%20Matter&amp;amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access"&gt;</code></p><p><code>462</code><code>Pharmacol Rev. 2006 Sep; 58(3): 389–462. &lt;/a&gt;</code></p><p><code>463</code><code>&lt;/div&gt;</code></p><p><code>464</code><code> &lt;span class="doi"&gt;</code></p><p><code>465</code><code>&lt;span&gt;</code></p><p><code>466</code><code>doi: &lt;/span&gt;</code></p><p><code>467</code><code>&lt;a href="//dx.doi.org/10.1124%2Fpr.58.3.2" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CFront%20Matter&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI"&gt;</code></p><p><code>468</code><code>10.1124/pr.58.3.2&lt;/a&gt;</code></p><p><code>469</code><code>&lt;/span&gt;</code></p><p><code>470</code><code>&lt;/div&gt;</code></p><p><code>471</code><code>&lt;/div&gt;</code></p><p><code>472</code><code>&lt;div class="fm-ids"&gt;</code></p><p><code>473</code><code>&lt;div class="fm-citation-pmcid"&gt;</code></p><p><code>474</code><code>&lt;span class="fm-citation-ids-label"&gt;</code></p><p><code>475</code><code>PMCID: &lt;/span&gt;</code></p><p><code>476</code><code>&lt;span&gt;</code></p><p><code>477</code><code>PMC2241751&lt;/span&gt;</code></p><p><code>478</code><code>&lt;/div&gt;</code></p><p><code>479</code><code>&lt;div class="fm-citation-manuscriptid"&gt;</code></p><p><code>480</code><code>&lt;span class="fm-citation-ids-label"&gt;</code></p><p><code>481</code><code>NIHMSID: &lt;/span&gt;</code></p><p><code>482</code><code>&lt;span&gt;</code></p><p><code>483</code><code>NIHMS38123&lt;/span&gt;</code></p><p><code>484</code><code>&lt;/div&gt;</code></p><p><code>485</code><code>&lt;div class="fm-citation-pmid"&gt;</code></p><p><code>486</code><code>PMID: &lt;a href="/pubmed/16968947"&gt;</code></p><p><code>487</code><code>16968947&lt;/a&gt;</code></p><p><code>488</code><code>&lt;/div&gt;</code></p><p><code>489</code><code>&lt;/div&gt;</code></p><p><code>490</code><code>&lt;/div&gt;</code></p><p><code>491</code><code>&lt;h1 class="content-title"&gt;</code></p><p><code>492</code><code>The Endocannabinoid System as an Emerging Target of Pharmacotherapy&lt;/h1&gt;</code></p><p><code>493</code><code>&lt;div class="half_rhythm"&gt;</code></p><p><code>494</code><code>&lt;div class="contrib-group fm-author"&gt;</code></p><p><code>495</code><code>&lt;a href="/pubmed/?term=PACHER%20P%5BAuthor%5D&amp;amp;cauthor=true&amp;amp;cauthor_uid=16968947"&gt;</code></p><p><code>496</code><code>P&amp;#x000c1;L PACHER&lt;/a&gt;</code></p><p><code>497</code><code>, &lt;a href="/pubmed/?term=B%26%23x000c1%3BTKAI%20S%5BAuthor%5D&amp;amp;cauthor=true&amp;amp;cauthor_uid=16968947"&gt;</code></p><p><code>498</code><code>S&amp;#x000c1;NDOR B&amp;#x000c1;TKAI&lt;/a&gt;</code></p><p><code>499</code><code>, and  &lt;a href="/pubmed/?term=KUNOS%20G%5BAuthor%5D&amp;amp;cauthor=true&amp;amp;cauthor_uid=16968947"&gt;</code></p><p><code>500</code><code>GEORGE KUNOS&lt;/a&gt;</code></p><p><code>501</code><code>&lt;/div&gt;</code></p><p><code>502</code><code>&lt;div style="display:none" class="contrib-group aff-tip"&gt;</code></p><p><code>503</code><code>&lt;/div&gt;</code></p><p><code>504</code><code>&lt;/div&gt;</code></p><p><code>505</code><code>&lt;div class="fm-panel half_rhythm"&gt;</code></p><p><code>506</code><code>&lt;div class="togglers fm-copyright-license"&gt;</code></p><p><code>507</code><code>&lt;a href="#" class="pmctoggle" rid="idm139779474107280_ai"&gt;</code></p><p><code>508</code><code>Author information&lt;/a&gt;</code></p><p><code>509</code><code> &lt;a href="#" class="pmctoggle" rid="idm139779474107280_cpl"&gt;</code></p><p><code>510</code><code>Copyright and License information&lt;/a&gt;</code></p><p><code>511</code><code> &lt;a href="/pmc/about/disclaimer/" style="margin-left: 1em"&gt;</code></p><p><code>512</code><code>Disclaimer&lt;/a&gt;</code></p><p><code>513</code><code>&lt;/div&gt;</code></p><p><code>514</code><code>&lt;div class="fm-authors-info fm-panel hide half_rhythm" id="idm139779474107280_ai" style="display:none"&gt;</code></p><p><code>515</code><code>&lt;div class="fm-affl" lang="en" id="A1"&gt;</code></p><p><code>516</code><code>Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland&lt;/div&gt;</code></p><p><code>517</code><code>&lt;div id="FN1"&gt;</code></p><p><code>518</code><code>Address correspondence to: Dr. George Kunos, National Institutes of Health, NIAAA, Laboratory of Physiological Studies, 5625 Fishers Lane, Room 2S-24, Bethesda, MD 20892-9413. E-mail: &lt;a href="mailto:dev@null" data-email="vog.hin.liam@sonukg" class="oemail"&gt;</code></p><p><code>519</code><code>vog.hin.liam@sonukg&lt;/a&gt;</code></p><p><code>520</code><code>&lt;/div&gt;</code></p><p><code>521</code><code>&lt;div id="FN2"&gt;</code></p><p><code>522</code><code>P.P. and G.K. contributed equally to this work.&lt;/div&gt;</code></p><p><code>523</code><code>&lt;/div&gt;</code></p><p><code>524</code><code>&lt;div class="fm-article-notes fm-panel half_rhythm"&gt;</code></p><p><code>525</code><code>&lt;/div&gt;</code></p><p><code>526</code><code>&lt;div class="permissions fm-panel half_rhythm hide" id="idm139779474107280_cpl" style="display:none"&gt;</code></p><p><code>527</code><code>&lt;div class="fm-copyright half_rhythm"&gt;</code></p><p><code>528</code><code>&lt;a href="/pmc/about/copyright/"&gt;</code></p><p><code>529</code><code>Copyright notice&lt;/a&gt;</code></p><p><code>530</code><code> &lt;/div&gt;</code></p><p><code>531</code><code>&lt;/div&gt;</code></p><p><code>532</code><code>&lt;/div&gt;</code></p><p><code>533</code><code>&lt;div id="pmclinksbox" class="links-box whole_rhythm"&gt;</code></p><p><code>534</code><code>&lt;div class="fm-panel"&gt;</code></p><p><code>535</code><code>&lt;div&gt;</code></p><p><code>536</code><code>The publisher's final edited version of this article is available  at &lt;a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=16968947" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CFront%20Matter&amp;amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access"&gt;</code></p><p><code>537</code><code>Pharmacol Rev&lt;/a&gt;</code></p><p><code>538</code><code>&lt;/div&gt;</code></p><p><code>539</code><code>&lt;div&gt;</code></p><p><code>540</code><code>See other articles in PMC that &lt;a href="/pmc/articles/PMC2241751/citedby/"&gt;</code></p><p><code>541</code><code>cite&lt;/a&gt;</code></p><p><code>542</code><code> the published article.&lt;/div&gt;</code></p><p><code>543</code><code>&lt;/div&gt;</code></p><p><code>544</code><code>&lt;/div&gt;</code></p><p><code>545</code><code>&lt;/div&gt;</code></p><p><code>546</code><code>&lt;div class="sec"&gt;</code></p><p><code>547</code><code>&lt;/div&gt;</code></p><p><code>548</code><code>&lt;div id="idm139779474165312" lang="en" class="tsec sec"&gt;</code></p><p><code>549</code><code>&lt;h2 class="head no_bottom_margin" id="idm139779474165312title"&gt;</code></p><p><code>550</code><code>Abstract&lt;/h2&gt;</code></p><p><code>551</code><code>&lt;!--article-meta--&gt;</code></p><p><code>552</code><code>&lt;div&gt;</code></p><p><code>553</code><code>&lt;p id="P1" class="p p-first-last"&gt;</code></p><p><code>554</code><code>The recent identification of cannabinoid receptors and their endogenous lipid ligands has triggered an exponential growth of studies exploring the endocannabinoid system and its regulatory functions in health and disease. Such studies have been greatly facilitated by the introduction of selective cannabinoid receptor antagonists and inhibitors of endocannabinoid metabolism and transport, as well as mice deficient in cannabinoid receptors or the endocannabinoid-degrading enzyme fatty acid amidohydrolase. In the past decade, the endocannabinoid system has been implicated in a growing number of physiological functions, both in the central and peripheral nervous systems and in peripheral organs. More importantly, modulating the activity of the endocannabinoid system turned out to hold therapeutic promise in a wide range of disparate diseases and pathological conditions, ranging from mood and anxiety disorders, movement disorders such as Parkinson&amp;#x02019;s and Huntington&amp;#x02019;s disease, neuropathic pain, multiple sclerosis and spinal cord injury, to cancer, atherosclerosis, myocardial infarction, stroke, hypertension, glaucoma, obesity/metabolic syndrome, and osteoporosis, to name just a few. An impediment to the development of cannabinoid medications has been the socially unacceptable psychoactive properties of plant-derived or synthetic agonists, mediated by CB&lt;sub&gt;</code></p><p><code>555</code><code>1&lt;/sub&gt;</code></p><p><code>556</code><code> receptors. However, this problem does not arise when the therapeutic aim is achieved by treatment with a CB&lt;sub&gt;</code></p><p><code>557</code><code>1&lt;/sub&gt;</code></p><p><code>558</code><code> receptor antagonist, such as in obesity, and may also be absent when the action of endocannabinoids is enhanced indirectly through blocking their metabolism or transport. The use of selective CB&lt;sub&gt;</code></p><p><code>559</code><code>2&lt;/sub&gt;</code></p><p><code>560</code><code> receptor agonists, which lack psychoactive properties, could represent another promising avenue for certain conditions. The abuse potential of plant-derived cannabinoids may also be limited through the use of preparations with controlled composition and the careful selection of dose and route of administration. The growing number of preclinical studies and clinical trials with compounds that modulate the endocannabinoid system will probably result in novel therapeutic approaches in a number of diseases for which current treatments do not fully address the patients&amp;#x02019; need. Here, we provide a comprehensive overview on the current state of knowledge of the endocannabinoid system as a target of pharmacotherapy.&lt;/p&gt;</code></p><p><code>561</code><code>&lt;/div&gt;</code></p><p><code>562</code><code>&lt;/div&gt;</code></p><p><code>563</code><code>&lt;div id="S1" class="tsec sec"&gt;</code></p><p><code>564</code><code>&lt;h2 class="head no_bottom_margin" id="S1title"&gt;</code></p><p><code>565</code><code>I. Introduction&lt;/h2&gt;</code></p><p><code>566</code><code>&lt;p id="P2" class="p p-first-last"&gt;</code></p><p><code>567</code><code>Marijuana, or cannabis, is the most widely used illicit drug in Western societies and also the one with the longest recorded history of human use. The popularity of marijuana as a recreational drug is due to its ability to alter sensory perception and cause elation and euphoria, most vividly described by the 19th century French poet, Charles Baudelaire, in his book &lt;em&gt;</code></p><p><code>568</code><code>Les Paradis Artificiels&lt;/em&gt;</code></p><p><code>569</code><code> (&lt;a href="#R544" rid="R544" class=" bibr popnode"&gt;</code></p><p><code>570</code><code>Iversen, 2000&lt;/a&gt;</code></p><p><code>571</code><code>). However, the ability of extracts of the hemp plant (&lt;em&gt;</code></p><p><code>572</code><code>Cannabis sativa&lt;/em&gt;</code></p><p><code>573</code><code>) to cause a variety of medicinal effects unrelated to its psychoactive properties had been recognized as early as the third millennium BC, when Chinese texts described its usefulness in the relief of pain and cramps (&lt;a href="#R804" rid="R804" class=" bibr popnode"&gt;</code></p><p><code>574</code><code>Mechoulam, 1986&lt;/a&gt;</code></p><p><code>575</code><code>). In ancient India, the anxiety-relieving effect of bhang (the Indian term for marijuana ingested as food) had been recorded more than 3000 years ago. The use of cannabis or hashish as a psychoactive substance reached Europe and the Americas through the Arab world in the 19th century. During the same period, cannabis extracts had gained widespread use for medicinal purposes until 1937, when concern about the dangers of abuse led to the banning of marijuana for further medicinal use in the United States. The rather turbulent history of marijuana and the recent resurgence of interest in its medicinal properties have been the subject of excellent reviews (&lt;a href="#R804" rid="R804" class=" bibr popnode"&gt;</code></p><p><code>576</code><code>Mechoulam, 1986&lt;/a&gt;</code></p><p><code>577</code><code>; &lt;a href="#R544" rid="R544" class=" bibr popnode"&gt;</code></p><p><code>578</code><code>Iversen, 2000&lt;/a&gt;</code></p><p><code>579</code><code>; &lt;a href="#R271" rid="R271" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919791"&gt;</code></p><p><code>580</code><code>Di Marzo et al., 2004&lt;/a&gt;</code></p><p><code>581</code><code>; &lt;a href="#R527" rid="R527" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920329"&gt;</code></p><p><code>582</code><code>Howlett et al., 2004&lt;/a&gt;</code></p><p><code>583</code><code>; &lt;a href="#R957" rid="R957" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920256"&gt;</code></p><p><code>584</code><code>Pertwee, 2005a&lt;/a&gt;</code></p><p><code>585</code><code>; Piomelli, 2005; &lt;a href="#R277" rid="R277" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919252"&gt;</code></p><p><code>586</code><code>Di Marzo and Petrocellis, 2006&lt;/a&gt;</code></p><p><code>587</code><code>; &lt;a href="#R725" rid="R725" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920044"&gt;</code></p><p><code>588</code><code>Mackie, 2006&lt;/a&gt;</code></p><p><code>589</code><code>; &lt;a href="#R930" rid="R930" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919821"&gt;</code></p><p><code>590</code><code>Pagotto et al., 2006&lt;/a&gt;</code></p><p><code>591</code><code>). Added to this interest is the emergence of the endocannabinoid system, offering not only new insights into the mechanisms underlying the therapeutic actions of plant-derived phytocannabinoids but also novel molecular targets for pharmacotherapy. In this overview, we will briefly summarize current thoughts about the role of endocannabinoids in a given physiological or pathological process and then survey attempts to exploit this role for therapeutic gain.&lt;/p&gt;</code></p><p><code>592</code><code>&lt;/div&gt;</code></p><p><code>593</code><code>&lt;div id="S2" class="tsec sec"&gt;</code></p><p><code>594</code><code>&lt;h2 class="head no_bottom_margin" id="S2title"&gt;</code></p><p><code>595</code><code>II. The Pharmacology of Cannabinoids&lt;/h2&gt;</code></p><p><code>596</code><code>&lt;div id="S3" class="sec sec-first"&gt;</code></p><p><code>597</code><code>&lt;h3 id="S3title"&gt;</code></p><p><code>598</code><code>A. Cannabinoid Receptors and Ligands&lt;/h3&gt;</code></p><p><code>599</code><code>&lt;p id="P3" class="p p-first"&gt;</code></p><p><code>600</code><code>Up until the last two decades, marijuana research was a rather esoteric field, of interest to a small number of scientists. A contributory factor was the highly lipophilic nature of the biologically active ingredients, which led to the notion that marijuana elicits its effects nonspecifically by perturbing membrane lipids (&lt;a href="#R665" rid="R665" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919583"&gt;</code></p><p><code>601</code><code>Lawrence and Gill, 1975&lt;/a&gt;</code></p><p><code>602</code><code>). The first important breakthrough that ultimately led to a rejection of this concept was the identification by &lt;a href="#R361" rid="R361" class=" bibr popnode"&gt;</code></p><p><code>603</code><code>Gaoni and Mechoulam (1964)&lt;/a&gt;</code></p><p><code>604</code><code> of the correct chemical structure of the main psychoactive ingredient of marijuana, &amp;#x00394;&lt;sup&gt;</code></p><p><code>605</code><code>9&lt;/sup&gt;</code></p><p><code>606</code><code>-tetrahydrocannabinol (THC&lt;sup&gt;</code></p><p><code>607</code><code>&lt;a href="#FN3" rid="FN3" class=" fn"&gt;</code></p><p><code>608</code><code>1&lt;/a&gt;</code></p><p><code>609</code><code>&lt;/sup&gt;</code></p><p><code>610</code><code>), and the subsequent demonstration that bioactivity resides in the &lt;em&gt;</code></p><p><code>611</code><code>l&lt;/em&gt;</code></p><p><code>612</code><code>-stereoisomer of this compound (&lt;a href="#R808" rid="R808" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919930"&gt;</code></p><p><code>613</code><code>Mechoulam and Gaoni, 1967&lt;/a&gt;</code></p><p><code>614</code><code>), which is one of approximately 60 cannabinoids present in the plant (&lt;a href="#R265" rid="R265" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920370"&gt;</code></p><p><code>615</code><code>Dewey, 1986&lt;/a&gt;</code></p><p><code>616</code><code>). This discovery stimulated the generation of a whole range of synthetic analogs in the 1970s that included not only compounds structurally similar to phytocannabinoids (&lt;a href="/pmc/articles/PMC2241751/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"&gt;</code></p><p><code>617</code><code>&lt;span&gt;</code></p><p><code>618</code><code>Fig. 1A&lt;/span&gt;</code></p><p><code>619</code><code>&lt;/a&gt;</code></p><p><code>620</code><code>) but also analogs with different chemical structures, including classic and nonclassic cannabinoids and aminoalkylindoles (&lt;a href="/pmc/articles/PMC2241751/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"&gt;</code></p><p><code>621</code><code>&lt;span&gt;</code></p><p><code>622</code><code>Fig. 1B&lt;/span&gt;</code></p><p><code>623</code><code>&lt;/a&gt;</code></p><p><code>624</code><code>) (&lt;a href="#R526" rid="R526" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920214"&gt;</code></p><p><code>625</code><code>Howlett et al., 2002&lt;/a&gt;</code></p><p><code>626</code><code>), as well as the subsequently discovered endogenous arachidonic acid derivatives or endocannabinoids (&lt;a href="/pmc/articles/PMC2241751/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"&gt;</code></p><p><code>627</code><code>&lt;span&gt;</code></p><p><code>628</code><code>Fig. 1C&lt;/span&gt;</code></p><p><code>629</code><code>&lt;/a&gt;</code></p><p><code>630</code><code>), which are discussed in more detail below. Studies of the biological effects of THC and its synthetic analogs revealed strict structural selectivity (&lt;a href="#R517" rid="R517" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919073"&gt;</code></p><p><code>631</code><code>Hollister, 1974&lt;/a&gt;</code></p><p><code>632</code><code>) as well as stereo-selectivity (&lt;a href="#R570" rid="R570" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919500"&gt;</code></p><p><code>633</code><code>Jones et al., 1974&lt;/a&gt;</code></p><p><code>634</code><code>), telltale signs of drug-receptor interactions. Definitive evidence for the existence of specific cannabinoid receptors was followed soon by the demonstration of high-affinity, saturable, stereospecific binding sites for the synthetic cannabinoid agonist [&lt;sup&gt;</code></p><p><code>635</code><code>3&lt;/sup&gt;</code></p><p><code>636</code><code>H]CP-55,940 in mouse brain plasma membranes, which correlated with both the in vitro inhibition of adenylate cyclase and the in vivo analgesic effect of the compound (&lt;a href="#R263" rid="R263" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919261"&gt;</code></p><p><code>637</code><code>Devane et al., 1988&lt;/a&gt;</code></p><p><code>638</code><code>). The availability of a radioligand also allowed the mapping of cannabinoid receptors in the brain by receptor autoradiography (&lt;a href="#R485" rid="R485" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637197"&gt;</code></p><p><code>639</code><code>Herkenham et al., 1991b&lt;/a&gt;</code></p><p><code>640</code><code>). This mapping turned out to be of key importance in the subsequent identification of an orphan G protein-coupled receptor (GPCR) as the brain receptor for cannabinoids (&lt;a href="#R783" rid="R783" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919242"&gt;</code></p><p><code>641</code><code>Matsuda et al., 1990&lt;/a&gt;</code></p><p><code>642</code><code>), later named CB&lt;sub&gt;</code></p><p><code>643</code><code>1&lt;/sub&gt;</code></p><p><code>644</code><code> receptor, based on the overlapping regional distribution of the mRNA for this GPCR and [&lt;sup&gt;</code></p><p><code>645</code><code>3&lt;/sup&gt;</code></p><p><code>646</code><code>H]CP-55,940 binding sites. CB&lt;sub&gt;</code></p><p><code>647</code><code>1&lt;/sub&gt;</code></p><p><code>648</code><code> receptors are the most abundant receptors in the mammalian brain but are also present at much lower concentrations in a variety of peripheral tissues and cells. A second cannabinoid GPCR, CB&lt;sub&gt;</code></p><p><code>649</code><code>2&lt;/sub&gt;</code></p><p><code>650</code><code>, is expressed primarily in cells of the immune and hematopoietic systems (&lt;a href="#R863" rid="R863" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920079"&gt;</code></p><p><code>651</code><code>Munro et al., 1993&lt;/a&gt;</code></p><p><code>652</code><code>) but recently were found to be present in the brain (&lt;a href="#R1218" rid="R1218" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653472"&gt;</code></p><p><code>653</code><code>Van Sickle et al., 2005&lt;/a&gt;</code></p><p><code>654</code><code>; &lt;a href="#R411" rid="R411" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919949"&gt;</code></p><p><code>655</code><code>Gong et al., 2006&lt;/a&gt;</code></p><p><code>656</code><code>), in nonparenchymal cells of the cirrhotic liver (&lt;a href="#R577" rid="R577" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919100"&gt;</code></p><p><code>657</code><code>Julien et al., 2005&lt;/a&gt;</code></p><p><code>658</code><code>), in the endocrine pancreas (&lt;a href="#R576" rid="R576" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920217"&gt;</code></p><p><code>659</code><code>Juan-Pico et al., 2005&lt;/a&gt;</code></p><p><code>660</code><code>), and in bone (&lt;a href="#R587" rid="R587" class=" bibr popnode"&gt;</code></p><p><code>661</code><code>Karsak et al., 2004&lt;/a&gt;</code></p><p><code>662</code><code>; &lt;a href="#R537" rid="R537" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919031"&gt;</code></p><p><code>663</code><code>Idris et al., 2005&lt;/a&gt;</code></p><p><code>664</code><code>; &lt;a href="#R903" rid="R903" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920176"&gt;</code></p><p><code>665</code><code>Ofek et al., 2006&lt;/a&gt;</code></p><p><code>666</code><code>). Two splice variants of CB&lt;sub&gt;</code></p><p><code>667</code><code>1&lt;/sub&gt;</code></p><p><code>668</code><code> receptors have been also identified: CB&lt;sub&gt;</code></p><p><code>669</code><code>1A&lt;/sub&gt;</code></p><p><code>670</code><code>, which has an altered amino-terminal sequence (&lt;a href="#R1094" rid="R1094" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919414"&gt;</code></p><p><code>671</code><code>Shire et al., 1995&lt;/a&gt;</code></p><p><code>672</code><code>), and CB&lt;sub&gt;</code></p><p><code>673</code><code>1B&lt;/sub&gt;</code></p><p><code>674</code><code>, which has an in-frame deletion of 33 amino acids at the amino terminus (&lt;a href="#R1054" rid="R1054" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919546"&gt;</code></p><p><code>675</code><code>Ryberg et al., 2005&lt;/a&gt;</code></p><p><code>676</code><code>). The mRNAs of both splice variants are expressed at much lower levels than the CB&lt;sub&gt;</code></p><p><code>677</code><code>1&lt;/sub&gt;</code></p><p><code>678</code><code> mRNA and, although the receptors expressed from the cDNAs have unique pharmacology (&lt;a href="#R1054" rid="R1054" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919114"&gt;</code></p><p><code>679</code><code>Ryberg et al., 2005&lt;/a&gt;</code></p><p><code>680</code><code>), evidence for their natural expression has not been reported.&lt;/p&gt;</code></p><p><code>681</code><code>&lt;!--fig ft0--&gt;</code></p><p><code>682</code><code>&lt;!--fig mode=article f1--&gt;</code></p><p><code>683</code><code>&lt;div class="fig iconblock whole_rhythm" id="F1" co-legend-rid="lgnd_F1"&gt;</code></p><p><code>684</code><code>&lt;a href="/pmc/articles/PMC2241751/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"&gt;</code></p><p><code>685</code><code>&lt;!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--&gt;</code></p><p><code>686</code><code>&lt;div data-largeobj="" data-largeobj-link-rid="largeobj_idm139779462227120" class="figure"&gt;</code></p><p><code>687</code><code>&lt;img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms38123f1.jpg" title="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms38123f1.jpg" src="/pmc/articles/PMC2241751/bin/nihms38123f1.jpg" /&gt;</code></p><p><code>688</code><code>&lt;/div&gt;</code></p><p><code>689</code><code>&lt;div id="largeobj_idm139779462227120" class="largeobj-link align_right" style="display: none"&gt;</code></p><p><code>690</code><code>&lt;a target="object" rel="noopener" href="/pmc/articles/PMC2241751/figure/F1/?report=objectonly"&gt;</code></p><p><code>691</code><code>Open in a separate window&lt;/a&gt;</code></p><p><code>692</code><code>&lt;/div&gt;</code></p><p><code>693</code><code>&lt;/a&gt;</code></p><p><code>694</code><code>&lt;div class="icnblk_cntnt" id="lgnd_F1"&gt;</code></p><p><code>695</code><code>&lt;div&gt;</code></p><p><code>696</code><code>&lt;a class="figpopup" href="/pmc/articles/PMC2241751/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"&gt;</code></p><p><code>697</code><code>Fig. 1&lt;/a&gt;</code></p><p><code>698</code><code>&lt;/div&gt;</code></p><p><code>699</code><code>&lt;!--caption a7--&gt;</code></p><p><code>700</code><code>&lt;div class="caption"&gt;</code></p><p><code>701</code><code>&lt;p id="__p2"&gt;</code></p><p><code>702</code><code>The chemical structure and pharmacological activity of selected plant derived (A), synthetic (B), and endogenous cannabinoids (C).&lt;/p&gt;</code></p><p><code>703</code><code>&lt;/div&gt;</code></p><p><code>704</code><code>&lt;/div&gt;</code></p><p><code>705</code><code>&lt;/div&gt;</code></p><p><code>706</code><code>&lt;p id="P4"&gt;</code></p><p><code>707</code><code>An interesting twist on the steric selectivity of cannabinoid receptors has emerged through recent studies of the behaviorally inactive phytocannabinoid (&amp;#x02212;)-cannabidiol (CBD) and its synthetic analogs, which have negligible affinity for either CB&lt;sub&gt;</code></p><p><code>708</code><code>1&lt;/sub&gt;</code></p><p><code>709</code><code> or CB&lt;sub&gt;</code></p><p><code>710</code><code>2&lt;/sub&gt;</code></p><p><code>711</code><code> receptors. Paradoxically, some of the synthetic (+)-(+)-stereoisomers of these compounds were found to bind potently to both CB&lt;sub&gt;</code></p><p><code>712</code><code>1&lt;/sub&gt;</code></p><p><code>713</code><code> and CB&lt;sub&gt;</code></p><p><code>714</code><code>2&lt;/sub&gt;</code></p><p><code>715</code><code> receptors (&lt;a href="#R91" rid="R91" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920239"&gt;</code></p><p><code>716</code><code>Bisogno et al., 2001&lt;/a&gt;</code></p><p><code>717</code><code>) but to display only peripheral and not centrally mediated cannabinoid-like bioactivity, suggesting that they may act as antagonists rather than agonists at central, but not peripheral, CB&lt;sub&gt;</code></p><p><code>718</code><code>1&lt;/sub&gt;</code></p><p><code>719</code><code> receptors (&lt;a href="#R347" rid="R347" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653408"&gt;</code></p><p><code>720</code><code>Fride et al., 2005&lt;/a&gt;</code></p><p><code>721</code><code>).&lt;/p&gt;</code></p><p><code>722</code><code>&lt;p id="P5"&gt;</code></p><p><code>723</code><code>Another ligand that displays central versus peripheral selectivity is ajulemic acid, a metabolite of THC that was found to have potent anti-inflammatory and analgesic properties without any overt behavioral or psychoactive effects (&lt;a href="#R136" rid="R136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919276"&gt;</code></p><p><code>724</code><code>Burstein et al., 1992&lt;/a&gt;</code></p><p><code>725</code><code>; &lt;a href="#R290" rid="R290" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918899"&gt;</code></p><p><code>726</code><code>Dyson et al., 2005&lt;/a&gt;</code></p><p><code>727</code><code>; &lt;a href="#R838" rid="R838" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919841"&gt;</code></p><p><code>728</code><code>Mitchell et al., 2005&lt;/a&gt;</code></p><p><code>729</code><code>). Ajulemic acid was reported to bind to both CB&lt;sub&gt;</code></p><p><code>730</code><code>1&lt;/sub&gt;</code></p><p><code>731</code><code> and CB&lt;sub&gt;</code></p><p><code>732</code><code>2&lt;/sub&gt;</code></p><p><code>733</code><code> receptors with reasonably high affinity (&lt;em&gt;</code></p><p><code>734</code><code>K&lt;/em&gt;</code></p><p><code>735</code><code>&lt;sub&gt;</code></p><p><code>736</code><code>d&lt;/sub&gt;</code></p><p><code>737</code><code> 100&amp;#x02013;200 nM) but only to activate the latter (&lt;a href="#R1010" rid="R1010" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919538"&gt;</code></p><p><code>738</code><code>Rhee et al., 1997&lt;/a&gt;</code></p><p><code>739</code><code>), which may explain its unique and therapeutically attractive pharmacological profile. A more recent study indicated even higher affinities for CB&lt;sub&gt;</code></p><p><code>740</code><code>1&lt;/sub&gt;</code></p><p><code>741</code><code> (&lt;em&gt;</code></p><p><code>742</code><code>K&lt;/em&gt;</code></p><p><code>743</code><code>&lt;sub&gt;</code></p><p><code>744</code><code>i&lt;/sub&gt;</code></p><p><code>745</code><code> 6 nM) and CB&lt;sub&gt;</code></p><p><code>746</code><code>2&lt;/sub&gt;</code></p><p><code>747</code><code> receptors (&lt;em&gt;</code></p><p><code>748</code><code>K&lt;/em&gt;</code></p><p><code>749</code><code>&lt;sub&gt;</code></p><p><code>750</code><code>i&lt;/sub&gt;</code></p><p><code>751</code><code> 56 nM) and specified the role of CB&lt;sub&gt;</code></p><p><code>752</code><code>1&lt;/sub&gt;</code></p><p><code>753</code><code> in mediating its antihyperalgesic activity in neuropathic pain (&lt;a href="#R290" rid="R290" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919824"&gt;</code></p><p><code>754</code><code>Dyson et al., 2005&lt;/a&gt;</code></p><p><code>755</code><code>). This article also documented limited brain penetration of ajulemic acid compared with other cannabinoids, which may account for its favorable therapeutic profile. Ajulemic acid also binds to peroxisome proliferator-activated receptor &lt;em&gt;</code></p><p><code>756</code><code>&amp;#x003b3;&lt;/em&gt;</code></p><p><code>757</code><code> receptors with low (micromolar) affinity, which was proposed to account for its effect on adipocyte differentiation (&lt;a href="#R695" rid="R695" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920013"&gt;</code></p><p><code>758</code><code>Liu et al., 2003b&lt;/a&gt;</code></p><p><code>759</code><code>).&lt;/p&gt;</code></p><p><code>760</code><code>&lt;p id="P6"&gt;</code></p><p><code>761</code><code>Among the 60 or so cannabinoids present in marijuana, only THC is psychoactive. However, some of the other constituents, such as cannabidiol, have well-documented biological effects of potential therapeutic interest, such as antianxiety, anticonvulsive, antinausea, anti-inflammatory and antitumor properties (&lt;a href="#R813" rid="R813" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919228"&gt;</code></p><p><code>762</code><code>Mechoulam et al., 2002c&lt;/a&gt;</code></p><p><code>763</code><code>; &lt;a href="#R436" rid="R436" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919026"&gt;</code></p><p><code>764</code><code>Grotenhermen, 2004&lt;/a&gt;</code></p><p><code>765</code><code>; &lt;a href="#R1206" rid="R1206" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919632"&gt;</code></p><p><code>766</code><code>Vaccani et al., 2005&lt;/a&gt;</code></p><p><code>767</code><code>). Cannabidiol does not significantly interact with CB&lt;sub&gt;</code></p><p><code>768</code><code>1&lt;/sub&gt;</code></p><p><code>769</code><code> or CB&lt;sub&gt;</code></p><p><code>770</code><code>2&lt;/sub&gt;</code></p><p><code>771</code><code> receptors, and its actions have been attributed to inhibition of anandamide degradation or its antioxidant properties (&lt;a href="#R810" rid="R810" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919765"&gt;</code></p><p><code>772</code><code>Mechoulam and Hanus, 2002&lt;/a&gt;</code></p><p><code>773</code><code>; &lt;a href="#R813" rid="R813" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920048"&gt;</code></p><p><code>774</code><code>Mechoulam et al., 2002c&lt;/a&gt;</code></p><p><code>775</code><code>), or an interaction with as yet unidentified cannabinoid receptors (see below). Another marijuana constituent of potential therapeutic interest is tetrahydrocannabivarin (&lt;a href="#R751" rid="R751" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919983"&gt;</code></p><p><code>776</code><code>Markus, 1971&lt;/a&gt;</code></p><p><code>777</code><code>), which has recently been shown to have CB&lt;sub&gt;</code></p><p><code>778</code><code>1&lt;/sub&gt;</code></p><p><code>779</code><code> antagonist properties (&lt;a href="#R1177" rid="R1177" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919892"&gt;</code></p><p><code>780</code><code>Thomas et al., 2005&lt;/a&gt;</code></p><p><code>781</code><code>).&lt;/p&gt;</code></p><p><code>782</code><code>&lt;p id="P7"&gt;</code></p><p><code>783</code><code>In addition to CB&lt;sub&gt;</code></p><p><code>784</code><code>1&lt;/sub&gt;</code></p><p><code>785</code><code> and CB&lt;sub&gt;</code></p><p><code>786</code><code>2&lt;/sub&gt;</code></p><p><code>787</code><code> receptors, pharmacological evidence has been accumulating over the years to support the existence of one or more additional receptors for cannabinoids (reviewed in &lt;a href="#R57" rid="R57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919698"&gt;</code></p><p><code>788</code><code>Begg et al., 2005&lt;/a&gt;</code></p><p><code>789</code><code>). Two of these possibilities have been more extensively explored: an endothelial site involved in vasodilation and endothelial cell migration (&lt;a href="#R556" rid="R556" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919612"&gt;</code></p><p><code>790</code><code>J&amp;#x000e1;rai et al., 1999&lt;/a&gt;</code></p><p><code>791</code><code>; &lt;a href="#R56" rid="R56" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920173"&gt;</code></p><p><code>792</code><code>Begg et al., 2003&lt;/a&gt;</code></p><p><code>793</code><code>; &lt;a href="#R839" rid="R839" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919832"&gt;</code></p><p><code>794</code><code>Mo et al., 2004&lt;/a&gt;</code></p><p><code>795</code><code>), and a presynaptic site on glutamatergic terminals in the hippocampus mediating inhibition of glutamate release (&lt;a href="#R451" rid="R451" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653492"&gt;</code></p><p><code>796</code><code>H&amp;#x000e1;jos et al., 2001&lt;/a&gt;</code></p><p><code>797</code><code>). Responses elicited at both of these sites were reported to survive genetic ablation of CB&lt;sub&gt;</code></p><p><code>798</code><code>1&lt;/sub&gt;</code></p><p><code>799</code><code> receptors, yet be sensitive to inhibition by the CB&lt;sub&gt;</code></p><p><code>800</code><code>1&lt;/sub&gt;</code></p><p><code>801</code><code> antagonist SR141716 or by pertussis toxin but not by the CB&lt;sub&gt;</code></p><p><code>802</code><code>1&lt;/sub&gt;</code></p><p><code>803</code><code> antagonist AM251 (&lt;a href="#R556" rid="R556" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918840"&gt;</code></p><p><code>804</code><code>J&amp;#x000e1;rai et al., 1999&lt;/a&gt;</code></p><p><code>805</code><code>; &lt;a href="#R450" rid="R450" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919478"&gt;</code></p><p><code>806</code><code>H&amp;#x000e1;jos and Freund, 2002&lt;/a&gt;</code></p><p><code>807</code><code>; &lt;a href="#R505" rid="R505" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919740"&gt;</code></p><p><code>808</code><code>Ho and Hiley, 2003&lt;/a&gt;</code></p><p><code>809</code><code>; &lt;a href="#R904" rid="R904" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919521"&gt;</code></p><p><code>810</code><code>Offert&amp;#x000e1;ler et al., 2003&lt;/a&gt;</code></p><p><code>811</code><code>; &lt;a href="#R916" rid="R916" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653478"&gt;</code></p><p><code>812</code><code>O&amp;#x02019;Sullivan et al., 2004a&lt;/a&gt;</code></p><p><code>813</code><code>,&lt;a href="#R917" rid="R917" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653398"&gt;</code></p><p><code>814</code><code>b&lt;/a&gt;</code></p><p><code>815</code><code>). However, the two sites are apparently different. The aminoalkylindol WIN 55,212-2 was found to be an agonist and capsazepine an antagonist at the hippocampal (&lt;a href="#R450" rid="R450" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918786"&gt;</code></p><p><code>816</code><code>H&amp;#x000e1;jos and Freund, 2002&lt;/a&gt;</code></p><p><code>817</code><code>) but not at the endothelial receptor (&lt;a href="#R1251" rid="R1251" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919460"&gt;</code></p><p><code>818</code><code>Wagner et al., 1999&lt;/a&gt;</code></p><p><code>819</code><code>; &lt;a href="#R852" rid="R852" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653522"&gt;</code></p><p><code>820</code><code>Mukhopadhyay et al., 2002&lt;/a&gt;</code></p><p><code>821</code><code>). On the other hand, certain atypical cannabinoids with no affinity for CB&lt;sub&gt;</code></p><p><code>822</code><code>1&lt;/sub&gt;</code></p><p><code>823</code><code> or CB&lt;sub&gt;</code></p><p><code>824</code><code>2&lt;/sub&gt;</code></p><p><code>825</code><code> receptors behave as agonists (abnormal cannabidiol, O-1602) or antagonists at the endothelial receptor (cannabidiol, O-1918) but not at the hippocampal receptor (&lt;a href="#R57" rid="R57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919302"&gt;</code></p><p><code>826</code><code>Begg et al., 2005&lt;/a&gt;</code></p><p><code>827</code><code>). Arachidonoyl-L-serine, an endogenous lipid discovered in rat brain, has been found to be a vasodilator acting at the endothelial cannabinoid receptor (&lt;a href="#R834" rid="R834" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653383"&gt;</code></p><p><code>828</code><code>Milman et al., 2006&lt;/a&gt;</code></p><p><code>829</code><code>), although its activity at the hippocampal receptor has not yet been evaluated. The existence of this latter receptor has recently been called into question, as the ability of WIN 55,212-2 to suppress the same excitatory synapse as studied by &lt;a href="#R451" rid="R451" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653352"&gt;</code></p><p><code>830</code><code>H&amp;#x000e1;jos et al. (2001)&lt;/a&gt;</code></p><p><code>831</code><code> was found to be absent in two different strains of CB&lt;sub&gt;</code></p><p><code>832</code><code>1&lt;/sub&gt;</code></p><p><code>833</code><code> knockout mice, yet present in their respective wild-type controls (&lt;a href="#R1161" rid="R1161" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653392"&gt;</code></p><p><code>834</code><code>Takahashi and Castillo, 2006&lt;/a&gt;</code></p><p><code>835</code><code>). Atypical cannabinoid receptors with pharmacological properties similar to those of the endothelial receptor have been postulated to exist on microglia, where they mediate microglial migration (&lt;a href="#R1261" rid="R1261" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637228"&gt;</code></p><p><code>836</code><code>Walter et al., 2003&lt;/a&gt;</code></p><p><code>837</code><code>), and on neurons of the mouse vas deferens (&lt;a href="#R963" rid="R963" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918881"&gt;</code></p><p><code>838</code><code>Pertwee et al., 2002&lt;/a&gt;</code></p><p><code>839</code><code>, &lt;a href="#R959" rid="R959" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_539174732"&gt;</code></p><p><code>840</code><code>2005c&lt;/a&gt;</code></p><p><code>841</code><code>). Activation of this latter receptor by the CBD analog 7-OH-dimethylheptyl CBD, which is inactive at CB&lt;sub&gt;</code></p><p><code>842</code><code>1&lt;/sub&gt;</code></p><p><code>843</code><code>, CB&lt;sub&gt;</code></p><p><code>844</code><code>2&lt;/sub&gt;</code></p><p><code>845</code><code>, or transient receptor potential vanilloid type 1 (TRPV&lt;sub&gt;</code></p><p><code>846</code><code>1&lt;/sub&gt;</code></p><p><code>847</code><code>) receptors, inhibits electrically evoked contractions of the vas deferens, and the effect is selectively inhibited by CBD itself. A brain cannabinoid receptor distinct from CB&lt;sub&gt;</code></p><p><code>848</code><code>1&lt;/sub&gt;</code></p><p><code>849</code><code> was also indicated by the ability of anandamide and WIN 55,212-2, but not other agonists, to stimulate GTP&lt;em&gt;</code></p><p><code>850</code><code>&amp;#x003b3;&lt;/em&gt;</code></p><p><code>851</code><code>S binding in brain plasma membranes from CB&lt;sub&gt;</code></p><p><code>852</code><code>1&lt;/sub&gt;</code></p><p><code>853</code><code> knockout mice (&lt;a href="#R118" rid="R118" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919009"&gt;</code></p><p><code>854</code><code>Breivogel et al., 2001&lt;/a&gt;</code></p><p><code>855</code><code>).&lt;/p&gt;</code></p><p><code>856</code><code>&lt;p id="P8"&gt;</code></p><p><code>857</code><code>Of interest are recent findings reported in the patent literature that the orphan receptor GPR-55 (&lt;a href="#R1070" rid="R1070" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919361"&gt;</code></p><p><code>858</code><code>Sawzdargo et al., 1999&lt;/a&gt;</code></p><p><code>859</code><code>) recognizes a variety of cannabinoid ligands, but not WIN 55,212-2 (&lt;a href="#R124" rid="R124" class=" bibr popnode"&gt;</code></p><p><code>860</code><code>Brown and Wise, 2003&lt;/a&gt;</code></p><p><code>861</code><code>; &lt;a href="#R283" rid="R283" class=" bibr popnode"&gt;</code></p><p><code>862</code><code>Drmota et al., 2004&lt;/a&gt;</code></p><p><code>863</code><code>). However, GPR-55 is apparently not expressed in the vascular endothelium and is sensitive to HU-210 (&lt;a href="#R283" rid="R283" class=" bibr popnode"&gt;</code></p><p><code>864</code><code>Drmota et al., 2004&lt;/a&gt;</code></p><p><code>865</code><code>), a potent synthetic cannabinoid devoid of vasorelaxant properties (&lt;a href="#R1251" rid="R1251" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919665"&gt;</code></p><p><code>866</code><code>Wagner et al., 1999&lt;/a&gt;</code></p><p><code>867</code><code>). Furthermore, it couples to G&lt;sub&gt;</code></p><p><code>868</code><code>12&lt;/sub&gt;</code></p><p><code>869</code><code>/G&lt;sub&gt;</code></p><p><code>870</code><code>13&lt;/sub&gt;</code></p><p><code>871</code><code> and &lt;em&gt;</code></p><p><code>872</code><code>&amp;#x003c1;&lt;/em&gt;</code></p><p><code>873</code><code> kinase, which have been linked to vasoconstrictor rather than vasodilator responses. This suggests that GPR-55 is not the abnormal cannabidiol-sensitive endothelial receptor. Mice deficient in GPR-55 will help in defining the biological functions of this novel cannabinoid-sensitive receptor.&lt;/p&gt;</code></p><p><code>874</code><code>&lt;p id="P9"&gt;</code></p><p><code>875</code><code>Anandamide has been found to be an agonist ligand for the TRPV&lt;sub&gt;</code></p><p><code>876</code><code>1&lt;/sub&gt;</code></p><p><code>877</code><code> ion channel, although its affinity in the low micromolar range is lower than its affinity for CB&lt;sub&gt;</code></p><p><code>878</code><code>1&lt;/sub&gt;</code></p><p><code>879</code><code> receptors (reviewed by &lt;a href="#R1211" rid="R1211" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919661"&gt;</code></p><p><code>880</code><code>van der Stelt and Di Marzo, 2004&lt;/a&gt;</code></p><p><code>881</code><code>). An in vitro study in rat mesenteric arteries provided evidence that the endothelium-independent component of anandamide-induced vasodilation is mediated via activation of capsaicin-sensitive TRPV&lt;sub&gt;</code></p><p><code>882</code><code>1&lt;/sub&gt;</code></p><p><code>883</code><code> in sensory nerve terminals. This triggers the release of CGRP, which then dilates the artery by activation of calcitonin gene-related peptide receptors on the vascular smooth muscle (&lt;a href="#R1332" rid="R1332" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919283"&gt;</code></p><p><code>884</code><code>Zygmunt et al., 1999&lt;/a&gt;</code></p><p><code>885</code><code>). However, this mechanism does not contribute to the in vivo hypotensive action of anandamide, which is similar in wild-type and TRPV&lt;sub&gt;</code></p><p><code>886</code><code>1&lt;/sub&gt;</code></p><p><code>887</code><code>&lt;sup&gt;</code></p><p><code>888</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>889</code><code> mice (&lt;a href="#R921" rid="R921" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919717"&gt;</code></p><p><code>890</code><code>Pacher et al., 2004&lt;/a&gt;</code></p><p><code>891</code><code>).&lt;/p&gt;</code></p><p><code>892</code><code>&lt;p id="P10"&gt;</code></p><p><code>893</code><code>Both CB&lt;sub&gt;</code></p><p><code>894</code><code>1&lt;/sub&gt;</code></p><p><code>895</code><code> and CB&lt;sub&gt;</code></p><p><code>896</code><code>2&lt;/sub&gt;</code></p><p><code>897</code><code> receptors are G protein-coupled receptors. Surprisingly, they share little sequence homology, only 44% at the protein level or 68% in the transmembrane domains, which are thought to contain the binding sites for cannabinoids (&lt;a href="#R712" rid="R712" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653382"&gt;</code></p><p><code>898</code><code>Lutz, 2002&lt;/a&gt;</code></p><p><code>899</code><code>). Despite this, THC and most synthetic cannabinoids have similar affinities for the two receptors, and only recently did synthetic ligands that discriminate between CB&lt;sub&gt;</code></p><p><code>900</code><code>1&lt;/sub&gt;</code></p><p><code>901</code><code> and CB&lt;sub&gt;</code></p><p><code>902</code><code>2&lt;/sub&gt;</code></p><p><code>903</code><code> receptors emerge. These include agonists as well as antagonists, as listed in &lt;a href="/pmc/articles/PMC2241751/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"&gt;</code></p><p><code>904</code><code>&lt;span&gt;</code></p><p><code>905</code><code>Fig. 2&lt;/span&gt;</code></p><p><code>906</code><code>&lt;/a&gt;</code></p><p><code>907</code><code>. The development of potent and highly selective CB&lt;sub&gt;</code></p><p><code>908</code><code>1&lt;/sub&gt;</code></p><p><code>909</code><code> and CB&lt;sub&gt;</code></p><p><code>910</code><code>2&lt;/sub&gt;</code></p><p><code>911</code><code> receptor antagonists (&lt;a href="#R1019" rid="R1019" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919820"&gt;</code></p><p><code>912</code><code>Rinaldi-Carmona et al., 1994&lt;/a&gt;</code></p><p><code>913</code><code>, &lt;a href="#R1020" rid="R1020" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918969"&gt;</code></p><p><code>914</code><code>1998&lt;/a&gt;</code></p><p><code>915</code><code>) is particularly noteworthy as it provided critically important tools to explore the physiological functions of endocannabinoids. For example, as it will be discussed later in this review, the appetite-reducing effects of the CB&lt;sub&gt;</code></p><p><code>916</code><code>1&lt;/sub&gt;</code></p><p><code>917</code><code> antagonist SR141716 in various rodent models was the first sign to suggest that endocannabinoids may be tonically active orexigenic agents, representing the endogenous counterpart of the &amp;#x0201c;munchies&amp;#x0201d; caused by marijuana smoking.&lt;/p&gt;</code></p><p><code>918</code><code>&lt;!--fig ft0--&gt;</code></p><p><code>919</code><code>&lt;!--fig mode=article f1--&gt;</code></p><p><code>920</code><code>&lt;div class="fig iconblock whole_rhythm" id="F2" co-legend-rid="lgnd_F2"&gt;</code></p><p><code>921</code><code>&lt;a href="/pmc/articles/PMC2241751/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"&gt;</code></p><p><code>922</code><code>&lt;!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--&gt;</code></p><p><code>923</code><code>&lt;div data-largeobj="" data-largeobj-link-rid="largeobj_idm139779462223072" class="figure"&gt;</code></p><p><code>924</code><code>&lt;img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms38123f2.jpg" title="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms38123f2.jpg" src="/pmc/articles/PMC2241751/bin/nihms38123f2.jpg" /&gt;</code></p><p><code>925</code><code>&lt;/div&gt;</code></p><p><code>926</code><code>&lt;div id="largeobj_idm139779462223072" class="largeobj-link align_right" style="display: none"&gt;</code></p><p><code>927</code><code>&lt;a target="object" rel="noopener" href="/pmc/articles/PMC2241751/figure/F2/?report=objectonly"&gt;</code></p><p><code>928</code><code>Open in a separate window&lt;/a&gt;</code></p><p><code>929</code><code>&lt;/div&gt;</code></p><p><code>930</code><code>&lt;/a&gt;</code></p><p><code>931</code><code>&lt;div class="icnblk_cntnt" id="lgnd_F2"&gt;</code></p><p><code>932</code><code>&lt;div&gt;</code></p><p><code>933</code><code>&lt;a class="figpopup" href="/pmc/articles/PMC2241751/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"&gt;</code></p><p><code>934</code><code>Fig. 2&lt;/a&gt;</code></p><p><code>935</code><code>&lt;/div&gt;</code></p><p><code>936</code><code>&lt;!--caption a7--&gt;</code></p><p><code>937</code><code>&lt;div class="caption"&gt;</code></p><p><code>938</code><code>&lt;p id="__p3"&gt;</code></p><p><code>939</code><code>Selective agonists (A) and antagonists (B) of CB&lt;sub&gt;</code></p><p><code>940</code><code>1&lt;/sub&gt;</code></p><p><code>941</code><code> and CB&lt;sub&gt;</code></p><p><code>942</code><code>2&lt;/sub&gt;</code></p><p><code>943</code><code> receptors.&lt;/p&gt;</code></p><p><code>944</code><code>&lt;/div&gt;</code></p><p><code>945</code><code>&lt;/div&gt;</code></p><p><code>946</code><code>&lt;/div&gt;</code></p><p><code>947</code><code>&lt;p id="P11" class="p p-last"&gt;</code></p><p><code>948</code><code>However, these antagonists, as well as most of the other CB&lt;sub&gt;</code></p><p><code>949</code><code>1&lt;/sub&gt;</code></p><p><code>950</code><code> and CB&lt;sub&gt;</code></p><p><code>951</code><code>2&lt;/sub&gt;</code></p><p><code>952</code><code> antagonists developed to date, have inverse agonist properties (&lt;a href="#R110" rid="R110" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919591"&gt;</code></p><p><code>953</code><code>Bouaboula et al., 1997&lt;/a&gt;</code></p><p><code>954</code><code>, &lt;a href="#R109" rid="R109" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918738"&gt;</code></p><p><code>955</code><code>1999&lt;/a&gt;</code></p><p><code>956</code><code>), so their effects do not necessarily reflect reversal of the tonic action of an endocannabinoid. For this reason, the development of CB&lt;sub&gt;</code></p><p><code>957</code><code>1&lt;/sub&gt;</code></p><p><code>958</code><code> and CB&lt;sub&gt;</code></p><p><code>959</code><code>2&lt;/sub&gt;</code></p><p><code>960</code><code> receptor-deficient mouse strains (&lt;a href="#R668" rid="R668" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653486"&gt;</code></p><p><code>961</code><code>Ledent et al., 1999&lt;/a&gt;</code></p><p><code>962</code><code>; &lt;a href="#R1325" rid="R1325" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918955"&gt;</code></p><p><code>963</code><code>Zimmer et al., 1999&lt;/a&gt;</code></p><p><code>964</code><code>; &lt;a href="#R128" rid="R128" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919706"&gt;</code></p><p><code>965</code><code>Buckley et al., 2000&lt;/a&gt;</code></p><p><code>966</code><code>; &lt;a href="#R755" rid="R755" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919197"&gt;</code></p><p><code>967</code><code>Marsicano et al., 2002b&lt;/a&gt;</code></p><p><code>968</code><code>; &lt;a href="#R1024" rid="R1024" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920279"&gt;</code></p><p><code>969</code><code>Robbe et al., 2002&lt;/a&gt;</code></p><p><code>970</code><code>) was similarly important, as the use of these animals in combination with receptor antagonists can reinforce the putative regulatory roles of endocannabinoids. More recently, the development of conditional mutant mice that lack the expression of CB&lt;sub&gt;</code></p><p><code>971</code><code>1&lt;/sub&gt;</code></p><p><code>972</code><code> receptors only in certain types of neurons represents another milestone, as it allows linking of specific neuronal populations with a well-defined cannabinoid-modulated behavior (&lt;a href="#R753" rid="R753" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653378"&gt;</code></p><p><code>973</code><code>Marsicano et al., 2003&lt;/a&gt;</code></p><p><code>974</code><code>).&lt;/p&gt;</code></p><p><code>975</code><code>&lt;/div&gt;</code></p><p><code>976</code><code>&lt;div id="S4" class="sec"&gt;</code></p><p><code>977</code><code>&lt;h3 id="S4title"&gt;</code></p><p><code>978</code><code>B. Cannabinoid Receptor Signaling&lt;/h3&gt;</code></p><p><code>979</code><code>&lt;p id="P12" class="p p-first"&gt;</code></p><p><code>980</code><code>CB&lt;sub&gt;</code></p><p><code>981</code><code>1&lt;/sub&gt;</code></p><p><code>982</code><code> and CB&lt;sub&gt;</code></p><p><code>983</code><code>2&lt;/sub&gt;</code></p><p><code>984</code><code> receptors couple primarily to the G&lt;sub&gt;</code></p><p><code>985</code><code>i/o&lt;/sub&gt;</code></p><p><code>986</code><code> subtypes of G protein, and their signaling is remarkably complex. Although coupling to adenylate cyclase through G&lt;sub&gt;</code></p><p><code>987</code><code>i/o&lt;/sub&gt;</code></p><p><code>988</code><code> usually results in inhibition of cyclase activity through the release of G&lt;sub&gt;</code></p><p><code>989</code><code>i&lt;/sub&gt;</code></p><p><code>990</code><code>&lt;em&gt;</code></p><p><code>991</code><code>&lt;sub&gt;</code></p><p><code>992</code><code>&amp;#x003b1;&lt;/sub&gt;</code></p><p><code>993</code><code>&lt;/em&gt;</code></p><p><code>994</code><code> isoforms, cannabinoids can also stimulate isoforms 2, 4, or 7 of adenylate cyclase via the release of &lt;em&gt;</code></p><p><code>995</code><code>&amp;#x003b2;&amp;#x003b3;&lt;/em&gt;</code></p><p><code>996</code><code> subunits (&lt;a href="#R1009" rid="R1009" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920180"&gt;</code></p><p><code>997</code><code>Rhee et al., 1998&lt;/a&gt;</code></p><p><code>998</code><code>). Activation of adenylate cyclase also occurs when CB&lt;sub&gt;</code></p><p><code>999</code><code>1&lt;/sub&gt;</code></p><p><code>1000</code><code> and dopamine D&lt;sub&gt;</code></p><p><code>1001</code><code>2&lt;/sub&gt;</code></p><p><code>1002</code><code> receptors are simultaneously activated (&lt;a href="#R400" rid="R400" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637196"&gt;</code></p><p><code>1003</code><code>Glass and Felder, 1997&lt;/a&gt;</code></p><p><code>1004</code><code>), probably as a result of heterodimerization of these two types of receptors (&lt;a href="#R592" rid="R592" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919403"&gt;</code></p><p><code>1005</code><code>Kearn et al., 2005&lt;/a&gt;</code></p><p><code>1006</code><code>). Although direct evidence for the coupling of CB&lt;sub&gt;</code></p><p><code>1007</code><code>1&lt;/sub&gt;</code></p><p><code>1008</code><code> receptors to G&lt;sub&gt;</code></p><p><code>1009</code><code>q/11&lt;/sub&gt;</code></p><p><code>1010</code><code> had until recently been lacking (&lt;a href="#R525" rid="R525" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919955"&gt;</code></p><p><code>1011</code><code>Howlett, 2004&lt;/a&gt;</code></p><p><code>1012</code><code>), the agonist WIN 55,212-2, but not other cannabinoids, was recently reported to increase intracellular calcium in cultured hippocampal neurons and in human embryonic kidney 293 cells via coupling to G&lt;sub&gt;</code></p><p><code>1013</code><code>q/11&lt;/sub&gt;</code></p><p><code>1014</code><code> proteins (&lt;a href="#R661" rid="R661" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919355"&gt;</code></p><p><code>1015</code><code>Lauckner et al., 2005&lt;/a&gt;</code></p><p><code>1016</code><code>). Receptor dimerization may facilitate such coupling, which may account for CB&lt;sub&gt;</code></p><p><code>1017</code><code>1&lt;/sub&gt;</code></p><p><code>1018</code><code>-mediated mobilization of intracellular calcium in NG108-15 neuroblastoma glioma cells (&lt;a href="#R1148" rid="R1148" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919284"&gt;</code></p><p><code>1019</code><code>Sugiura et al., 1999&lt;/a&gt;</code></p><p><code>1020</code><code>). Cannabinoids can also inhibit different types of calcium channels (&lt;a href="#R727" rid="R727" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919735"&gt;</code></p><p><code>1021</code><code>Mackie and Hille, 1992&lt;/a&gt;</code></p><p><code>1022</code><code>; &lt;a href="#R372" rid="R372" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919232"&gt;</code></p><p><code>1023</code><code>Gebremedhin et al., 1999&lt;/a&gt;</code></p><p><code>1024</code><code>) and activate certain potassium channels (&lt;a href="#R728" rid="R728" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637207"&gt;</code></p><p><code>1025</code><code>Mackie et al., 1995&lt;/a&gt;</code></p><p><code>1026</code><code>) via G protein &lt;em&gt;</code></p><p><code>1027</code><code>&amp;#x003b2;&amp;#x003b3;&lt;/em&gt;</code></p><p><code>1028</code><code> subunits (&lt;a href="#R538" rid="R538" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919818"&gt;</code></p><p><code>1029</code><code>Ikeda, 1996&lt;/a&gt;</code></p><p><code>1030</code><code>). Cannabinoids can activate members of all three families of multifunctional mitogen-activated protein kinases, including p44/42 MAP kinase (&lt;a href="#R1275" rid="R1275" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918682"&gt;</code></p><p><code>1031</code><code>Wartmann et al., 1995&lt;/a&gt;</code></p><p><code>1032</code><code>; &lt;a href="#R244" rid="R244" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920260"&gt;</code></p><p><code>1033</code><code>Davis et al., 2003&lt;/a&gt;</code></p><p><code>1034</code><code>), p38 kinase (&lt;a href="#R694" rid="R694" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919445"&gt;</code></p><p><code>1035</code><code>Liu et al., 2000&lt;/a&gt;</code></p><p><code>1036</code><code>; &lt;a href="#R258" rid="R258" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919334"&gt;</code></p><p><code>1037</code><code>Derkinderen et al., 2001&lt;/a&gt;</code></p><p><code>1038</code><code>), and JUN-terminal kinase (&lt;a href="#R694" rid="R694" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920303"&gt;</code></p><p><code>1039</code><code>Liu et al., 2000&lt;/a&gt;</code></p><p><code>1040</code><code>; &lt;a href="#R1048" rid="R1048" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919648"&gt;</code></p><p><code>1041</code><code>Rueda et al., 2000&lt;/a&gt;</code></p><p><code>1042</code><code>) and activate the phosphatidylinositol-3-kinase pathway (&lt;a href="#R407" rid="R407" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653498"&gt;</code></p><p><code>1043</code><code>G&amp;#x000f3;mez Del Pulgar et al., 2002a&lt;/a&gt;</code></p><p><code>1044</code><code>). These effects could be via G protein activation (&lt;a href="#R356" rid="R356" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919585"&gt;</code></p><p><code>1045</code><code>Galve-Roperh et al., 2002&lt;/a&gt;</code></p><p><code>1046</code><code>; &lt;a href="#R244" rid="R244" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919760"&gt;</code></p><p><code>1047</code><code>Davis et al., 2003&lt;/a&gt;</code></p><p><code>1048</code><code>) or pathways independent of G proteins via other adaptor proteins (&lt;a href="#R1059" rid="R1059" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653431"&gt;</code></p><p><code>1049</code><code>S&amp;#x000e1;nchez et al., 2001b&lt;/a&gt;</code></p><p><code>1050</code><code>). Another G protein-independent pathway activated by cannabinoids involves G protein-coupled receptor kinase-3 and &lt;em&gt;</code></p><p><code>1051</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>1052</code><code>-arrestin-2, which are required for desensitization, but not for internalization, of CB&lt;sub&gt;</code></p><p><code>1053</code><code>1&lt;/sub&gt;</code></p><p><code>1054</code><code> receptors, and the related development of tolerance (&lt;a href="#R563" rid="R563" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637233"&gt;</code></p><p><code>1055</code><code>Jin et al., 1999&lt;/a&gt;</code></p><p><code>1056</code><code>). Cannabinoids can also regulate the activity of phosphatases, as ex-emplified the CB&lt;sub&gt;</code></p><p><code>1057</code><code>1&lt;/sub&gt;</code></p><p><code>1058</code><code>-mediated regulation of calcineurin (protein phosphatase 2b) (&lt;a href="#R152" rid="R152" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920097"&gt;</code></p><p><code>1059</code><code>Cannich et al., 2004&lt;/a&gt;</code></p><p><code>1060</code><code>) or the activation of mitogen-activated protein kinase phosphatase 1, which plays an important role in the anti-inflammatory action of anandamide (&lt;a href="#R293" rid="R293" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920232"&gt;</code></p><p><code>1061</code><code>Eljaschewitsch et al., 2006&lt;/a&gt;</code></p><p><code>1062</code><code>).&lt;/p&gt;</code></p><p><code>1063</code><code>&lt;p id="P13"&gt;</code></p><p><code>1064</code><code>Different structural classes of cannabinoid receptor agonists have the unique ability to activate different signaling cascades which, in turn, influences agonist efficacy. Using an in situ receptor/G protein reconstitution technique, CB&lt;sub&gt;</code></p><p><code>1065</code><code>1&lt;/sub&gt;</code></p><p><code>1066</code><code> receptors were found to efficiently couple and activate both G&lt;sub&gt;</code></p><p><code>1067</code><code>i&lt;/sub&gt;</code></p><p><code>1068</code><code> and G&lt;sub&gt;</code></p><p><code>1069</code><code>o&lt;/sub&gt;</code></p><p><code>1070</code><code>, whereas CB&lt;sub&gt;</code></p><p><code>1071</code><code>2&lt;/sub&gt;</code></p><p><code>1072</code><code> receptors only activated G&lt;sub&gt;</code></p><p><code>1073</code><code>o&lt;/sub&gt;</code></p><p><code>1074</code><code>. Furthermore, the efficacy of a given agonist was different whether CB&lt;sub&gt;</code></p><p><code>1075</code><code>1&lt;/sub&gt;</code></p><p><code>1076</code><code> receptors coupled to G&lt;sub&gt;</code></p><p><code>1077</code><code>i&lt;/sub&gt;</code></p><p><code>1078</code><code> or G&lt;sub&gt;</code></p><p><code>1079</code><code>o&lt;/sub&gt;</code></p><p><code>1080</code><code>, demonstrating agonist-selective G protein signaling (&lt;a href="#R401" rid="R401" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919694"&gt;</code></p><p><code>1081</code><code>Glass and Northup, 1999&lt;/a&gt;</code></p><p><code>1082</code><code>). &lt;a href="#R985" rid="R985" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920182"&gt;</code></p><p><code>1083</code><code>Prather et al. (2000)&lt;/a&gt;</code></p><p><code>1084</code><code> found that the aminoalkylindol agonist WIN 55,212-2 activated different G&lt;sub&gt;</code></p><p><code>1085</code><code>i&lt;/sub&gt;</code></p><p><code>1086</code><code>&lt;em&gt;</code></p><p><code>1087</code><code>&lt;sub&gt;</code></p><p><code>1088</code><code>&amp;#x003b1;&lt;/sub&gt;</code></p><p><code>1089</code><code>&lt;/em&gt;</code></p><p><code>1090</code><code> subunits with markedly different potencies. Even more striking is the recent finding that demonstrates cannabinoid agonist-selective activation of different G&lt;sub&gt;</code></p><p><code>1091</code><code>i&lt;/sub&gt;</code></p><p><code>1092</code><code>&lt;em&gt;</code></p><p><code>1093</code><code>&lt;sub&gt;</code></p><p><code>1094</code><code>&amp;#x003b1;&lt;/sub&gt;</code></p><p><code>1095</code><code>&lt;/em&gt;</code></p><p><code>1096</code><code> subunits (&lt;a href="#R853" rid="R853" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920309"&gt;</code></p><p><code>1097</code><code>Mukhopadhyay and Howlett, 2005&lt;/a&gt;</code></p><p><code>1098</code><code>). A possible practical implication of such findings is that unique therapeutic profiles may be achieved through the use of different agonists for the same receptor, and such profiles may differ from one target tissue to the other, depending on the pattern of G protein subunit expression.&lt;/p&gt;</code></p><p><code>1099</code><code>&lt;p id="P14"&gt;</code></p><p><code>1100</code><code>At least part of this agonist selectivity in G protein activation may be related to the existence of distinct binding sites on CB&lt;sub&gt;</code></p><p><code>1101</code><code>1&lt;/sub&gt;</code></p><p><code>1102</code><code> receptors for different classes of ligands, as documented by site-directed mutagenesis and molecular modeling studies (see &lt;a href="#R1006" rid="R1006" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919254"&gt;</code></p><p><code>1103</code><code>Reggio, 2003&lt;/a&gt;</code></p><p><code>1104</code><code>). These studies indicate that a K3.28A mutation in the third transmembrane domain caused a more than 1000-fold loss in affinity and loss of efficacy for anandamide and nonclassic cannabinoids, without affecting the affinity for WIN 55,212-2 (&lt;a href="#R1125" rid="R1125" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918846"&gt;</code></p><p><code>1105</code><code>Song and Bonner, 1996&lt;/a&gt;</code></p><p><code>1106</code><code>). In contrast, mutations at different sites in the third, fifth, and sixth transmembrane helices (F3.36A, W5.43A, and W6.48A) affected the binding of WIN 55,212-2 and SR141716, but not anandamide (&lt;a href="#R788" rid="R788" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918927"&gt;</code></p><p><code>1107</code><code>McAllister et al., 2003&lt;/a&gt;</code></p><p><code>1108</code><code>).&lt;/p&gt;</code></p><p><code>1109</code><code>&lt;p id="P15" class="p p-last"&gt;</code></p><p><code>1110</code><code>Another important feature of cannabinoid signaling in the brain is the lack of correlation between the density of CB&lt;sub&gt;</code></p><p><code>1111</code><code>1&lt;/sub&gt;</code></p><p><code>1112</code><code> receptors in a given brain region and the efficiency of receptor coupling, as determined by GTP&lt;em&gt;</code></p><p><code>1113</code><code>&amp;#x003b3;&lt;/em&gt;</code></p><p><code>1114</code><code>S binding (&lt;a href="#R119" rid="R119" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920225"&gt;</code></p><p><code>1115</code><code>Breivogel et al., 1997&lt;/a&gt;</code></p><p><code>1116</code><code>), which may explain why functionally important responses can be triggered in brain regions with very sparse CB&lt;sub&gt;</code></p><p><code>1117</code><code>1&lt;/sub&gt;</code></p><p><code>1118</code><code> receptor expression, such as the brainstem (&lt;a href="#R992" rid="R992" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653464"&gt;</code></p><p><code>1119</code><code>Rademacher et al., 2003&lt;/a&gt;</code></p><p><code>1120</code><code>) or the hypothalamus (&lt;a href="#R554" rid="R554" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919857"&gt;</code></p><p><code>1121</code><code>Jamshidi and Taylor, 2001&lt;/a&gt;</code></p><p><code>1122</code><code>). &lt;a href="#R1085" rid="R1085" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920174"&gt;</code></p><p><code>1123</code><code>Selley et al. (2001)&lt;/a&gt;</code></p><p><code>1124</code><code> have shown that the reduction in CB&lt;sub&gt;</code></p><p><code>1125</code><code>1&lt;/sub&gt;</code></p><p><code>1126</code><code> receptor density in CB&lt;sub&gt;</code></p><p><code>1127</code><code>1&lt;/sub&gt;</code></p><p><code>1128</code><code> heterozygote mice was compensated for by an increase in receptor/G protein coupling efficiency for some, but not other, agonists. Although the underlying mechanisms for such compensation are not clear, differences in the degree of receptor multimerization (&lt;a href="#R724" rid="R724" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918960"&gt;</code></p><p><code>1129</code><code>Mackie, 2005&lt;/a&gt;</code></p><p><code>1130</code><code>), or changes in signal amplification are possibilities. Recent observations indicate that a considerable proportion of the psychomotor effect of cannabinoids can be accounted for by a signaling cascade in striatal projection neurons involving protein kinase A-dependent phosphorylation of DARPP-32, achieved via modulation of dopamine D&lt;sub&gt;</code></p><p><code>1131</code><code>2&lt;/sub&gt;</code></p><p><code>1132</code><code> and adenosine A&lt;sub&gt;</code></p><p><code>1133</code><code>2A&lt;/sub&gt;</code></p><p><code>1134</code><code> transmission (&lt;a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637248"&gt;</code></p><p><code>1135</code><code>Andersson et al., 2005&lt;/a&gt;</code></p><p><code>1136</code><code>). This represents a unique form of amplification of CB&lt;sub&gt;</code></p><p><code>1137</code><code>1&lt;/sub&gt;</code></p><p><code>1138</code><code> signaling, as phosphorylation of DARPP-32 at Thr-34 amplifies downstream signaling via inhibition of protein phosphatase-1 (&lt;a href="#R429" rid="R429" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653379"&gt;</code></p><p><code>1139</code><code>Greengard, 2001&lt;/a&gt;</code></p><p><code>1140</code><code>). It would be interesting to test whether the efficiency of CB&lt;sub&gt;</code></p><p><code>1141</code><code>1&lt;/sub&gt;</code></p><p><code>1142</code><code> coupling to DARPP-32 is affected by cellular receptor density.&lt;/p&gt;</code></p><p><code>1143</code><code>&lt;/div&gt;</code></p><p><code>1144</code><code>&lt;div id="S5" class="sec sec-last"&gt;</code></p><p><code>1145</code><code>&lt;h3 id="S5title"&gt;</code></p><p><code>1146</code><code>C. Endocannabinoids&lt;/h3&gt;</code></p><p><code>1147</code><code>&lt;p id="P16" class="p p-first"&gt;</code></p><p><code>1148</code><code>The existence of specific receptors in mammalian cells that recognize a plant-derived substance rekindled the question raised two decades earlier, after brain receptors for morphine had been first described, i.e., is there an endogenous ligand? A positive answer was provided in 1992 by the report by Devane et al. describing the isolation from porcine brain of the lipid arachidonoyl ethanolamide, named anandamide, which bound to the brain cannabinoid receptor with reasonably high affinity and mimicked the behavioral actions of THC when injected into rodents (&lt;a href="#R264" rid="R264" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653365"&gt;</code></p><p><code>1149</code><code>Devane et al., 1992&lt;/a&gt;</code></p><p><code>1150</code><code>). Three years later a second endocannabinoid, 2-arachidonoylglycerol (2-AG), was discovered independently by &lt;a href="#R805" rid="R805" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919251"&gt;</code></p><p><code>1151</code><code>Mechoulam et al. (1995)&lt;/a&gt;</code></p><p><code>1152</code><code> and &lt;a href="#R1149" rid="R1149" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918891"&gt;</code></p><p><code>1153</code><code>Sugiura et al. (1995)&lt;/a&gt;</code></p><p><code>1154</code><code>. Since then, a number of related endogenous lipids with endocannabinoid-like activity have been reported (&lt;a href="/pmc/articles/PMC2241751/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"&gt;</code></p><p><code>1155</code><code>&lt;span&gt;</code></p><p><code>1156</code><code>Fig. 1c&lt;/span&gt;</code></p><p><code>1157</code><code>&lt;/a&gt;</code></p><p><code>1158</code><code>), but follow-up studies about biosynthesis, cellular transport, metabolism, and biological function have focused on anandamide and 2-AG, with much less information available about the other compounds with endocannabinoid-like properties. The biochemical aspects of endocannabinoids have been recently reviewed by &lt;a href="#R93" rid="R93" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919413"&gt;</code></p><p><code>1159</code><code>Bisogno et al. (2005)&lt;/a&gt;</code></p><p><code>1160</code><code>.&lt;/p&gt;</code></p><p><code>1161</code><code>&lt;p id="P17"&gt;</code></p><p><code>1162</code><code>Anandamide is a partial or full agonist of CB&lt;sub&gt;</code></p><p><code>1163</code><code>1&lt;/sub&gt;</code></p><p><code>1164</code><code> receptors, depending on the tissue and biological response measured. Although it also binds CB&lt;sub&gt;</code></p><p><code>1165</code><code>2&lt;/sub&gt;</code></p><p><code>1166</code><code> receptors, it has very low efficacy and may act as an antagonist (&lt;a href="#R412" rid="R412" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920318"&gt;</code></p><p><code>1167</code><code>Gonsiorek et al., 2000&lt;/a&gt;</code></p><p><code>1168</code><code>). The in vivo biosynthesis of anandamide (&lt;a href="/pmc/articles/PMC2241751/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"&gt;</code></p><p><code>1169</code><code>&lt;span&gt;</code></p><p><code>1170</code><code>Fig. 4&lt;/span&gt;</code></p><p><code>1171</code><code>&lt;/a&gt;</code></p><p><code>1172</code><code>) is believed to occur through the enzymatic hydrolysis catalyzed by a phospholipase D of a membrane lipid precursor, &lt;em&gt;</code></p><p><code>1173</code><code>N&lt;/em&gt;</code></p><p><code>1174</code><code>-arachidonoyl phosphatidylethanolamide (NAPE) (&lt;a href="#R1077" rid="R1077" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920342"&gt;</code></p><p><code>1175</code><code>Schmid et al., 1983&lt;/a&gt;</code></p><p><code>1176</code><code>), which itself is generated by the enzymatic transfer of arachidonic acid in the &lt;em&gt;</code></p><p><code>1177</code><code>sn&lt;/em&gt;</code></p><p><code>1178</code><code>-1 position in phosphatidylcholine to the amide group of PE (&lt;a href="#R273" rid="R273" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918767"&gt;</code></p><p><code>1179</code><code>Di Marzo et al., 1994&lt;/a&gt;</code></p><p><code>1180</code><code>; &lt;a href="#R143" rid="R143" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637238"&gt;</code></p><p><code>1181</code><code>Cadas et al., 1997&lt;/a&gt;</code></p><p><code>1182</code><code>). Although a specific transacylase for the latter reaction has not yet been identified, a NAPE-specific PLD has recently been cloned (&lt;a href="#R906" rid="R906" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919594"&gt;</code></p><p><code>1183</code><code>Okamoto et al., 2004&lt;/a&gt;</code></p><p><code>1184</code><code>). It is not yet known, however, whether NAPE-PLD is obligatory for the biosynthesis of anandamide, which could make it an attractive target of drug therapy when reduction of tissue anandamide would be of benefit. Indeed, there may be parallel pathways for the generation of anandamide from NAPE. A secretory PLA&lt;sub&gt;</code></p><p><code>1185</code><code>2&lt;/sub&gt;</code></p><p><code>1186</code><code> that can catalyze the hydrolysis of &lt;em&gt;</code></p><p><code>1187</code><code>N&lt;/em&gt;</code></p><p><code>1188</code><code>-acyl-PE to &lt;em&gt;</code></p><p><code>1189</code><code>N&lt;/em&gt;</code></p><p><code>1190</code><code>-acyl-lysoPE, which is then acted on by a lysoPLD to generate &lt;em&gt;</code></p><p><code>1191</code><code>N&lt;/em&gt;</code></p><p><code>1192</code><code>-acyl-ethanolamides, including anandamide, was recently identified in the stomach (&lt;a href="#R1153" rid="R1153" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918813"&gt;</code></p><p><code>1193</code><code>Sun et al., 2004&lt;/a&gt;</code></p><p><code>1194</code><code>). An alternative parallel pathway has been identified in our laboratory in RAW246.7 macrophages. This involves hydrolysis of NAPE to phosphoanandamide by a PLC, followed by dephosphorylation through a phosphatase (&lt;a href="#R696" rid="R696" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919286"&gt;</code></p><p><code>1195</code><code>Liu et al., 2006&lt;/a&gt;</code></p><p><code>1196</code><code>). This latter pathway rather than PLD is the target of regulation by bacterial endotoxin, which increases anandamide synthesis in macrophages (&lt;a href="#R1221" rid="R1221" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919307"&gt;</code></p><p><code>1197</code><code>Varga et al., 1998&lt;/a&gt;</code></p><p><code>1198</code><code>; &lt;a href="#R693" rid="R693" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920316"&gt;</code></p><p><code>1199</code><code>Liu et al., 2003a&lt;/a&gt;</code></p><p><code>1200</code><code>). The existence of this pathway may also account for the recent finding that anandamide tissue levels are unchanged in NAPE-PLD knockout compared with wild-type mice (&lt;a href="#R678" rid="R678" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920133"&gt;</code></p><p><code>1201</code><code>Leung et al., 2006&lt;/a&gt;</code></p><p><code>1202</code><code>).&lt;/p&gt;</code></p><p><code>1203</code><code>&lt;!--fig ft0--&gt;</code></p><p><code>1204</code><code>&lt;!--fig mode=article f1--&gt;</code></p><p><code>1205</code><code>&lt;div class="fig iconblock whole_rhythm" id="F4" co-legend-rid="lgnd_F4"&gt;</code></p><p><code>1206</code><code>&lt;a href="/pmc/articles/PMC2241751/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"&gt;</code></p><p><code>1207</code><code>&lt;!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--&gt;</code></p><p><code>1208</code><code>&lt;div data-largeobj="" data-largeobj-link-rid="largeobj_idm139779462215168" class="figure"&gt;</code></p><p><code>1209</code><code>&lt;a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;amp;p=PMC3&amp;amp;id=2241751_nihms38123f4.jpg" target="tileshopwindow" rel="noopener"&gt;</code></p><p><code>1210</code><code>&lt;div class="ts_bar small" title="Click on image to zoom"&gt;</code></p><p><code>1211</code><code>&lt;/div&gt;</code></p><p><code>1212</code><code>&lt;img loading="lazy" alt="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms38123f4.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2241751/bin/nihms38123f4.jpg" /&gt;</code></p><p><code>1213</code><code>&lt;/a&gt;</code></p><p><code>1214</code><code>&lt;/div&gt;</code></p><p><code>1215</code><code>&lt;div id="largeobj_idm139779462215168" class="largeobj-link align_right" style="display: none"&gt;</code></p><p><code>1216</code><code>&lt;a target="object" rel="noopener" href="/pmc/articles/PMC2241751/figure/F4/?report=objectonly"&gt;</code></p><p><code>1217</code><code>Open in a separate window&lt;/a&gt;</code></p><p><code>1218</code><code>&lt;/div&gt;</code></p><p><code>1219</code><code>&lt;/a&gt;</code></p><p><code>1220</code><code>&lt;div class="icnblk_cntnt" id="lgnd_F4"&gt;</code></p><p><code>1221</code><code>&lt;div&gt;</code></p><p><code>1222</code><code>&lt;a class="figpopup" href="/pmc/articles/PMC2241751/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"&gt;</code></p><p><code>1223</code><code>Fig. 4&lt;/a&gt;</code></p><p><code>1224</code><code>&lt;/div&gt;</code></p><p><code>1225</code><code>&lt;!--caption a7--&gt;</code></p><p><code>1226</code><code>&lt;div class="caption"&gt;</code></p><p><code>1227</code><code>&lt;p id="__p5"&gt;</code></p><p><code>1228</code><code>Schematic representation of the endocannabinoid system in pre- and postsynaptic neurons. The presynaptic terminal is located in the top, whereas the postsynaptic neuron is located in the bottom. EMT, endocannabinoid membrane transporter; MAGL, monoacylglyceride lipase; DAGL, DAG lipase; AEA, anandamide; NArPE, &lt;em&gt;</code></p><p><code>1229</code><code>N&lt;/em&gt;</code></p><p><code>1230</code><code>-arachidonyl phosphatidylethanolamine; NAT, &lt;em&gt;</code></p><p><code>1231</code><code>N&lt;/em&gt;</code></p><p><code>1232</code><code>-acyltransferase.&lt;/p&gt;</code></p><p><code>1233</code><code>&lt;/div&gt;</code></p><p><code>1234</code><code>&lt;/div&gt;</code></p><p><code>1235</code><code>&lt;/div&gt;</code></p><p><code>1236</code><code>&lt;p id="P18"&gt;</code></p><p><code>1237</code><code>2-AG is generated from diacylglycerol (DAG) by DAG lipase selective for the &lt;em&gt;</code></p><p><code>1238</code><code>sn&lt;/em&gt;</code></p><p><code>1239</code><code>-1 position (&lt;a href="/pmc/articles/PMC2241751/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"&gt;</code></p><p><code>1240</code><code>&lt;span&gt;</code></p><p><code>1241</code><code>Fig. 4&lt;/span&gt;</code></p><p><code>1242</code><code>&lt;/a&gt;</code></p><p><code>1243</code><code>). DAG, an intracellular second messenger that activates protein kinase C, can be generated from phosphoinositides by a phosphoinositide-specific PLC or from phosphatidic acid by phosphatidic acid phosphohydrolase (&lt;a href="#R93" rid="R93" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919142"&gt;</code></p><p><code>1244</code><code>Bisogno et al., 2005&lt;/a&gt;</code></p><p><code>1245</code><code>). Two DAG lipase isozymes, &lt;em&gt;</code></p><p><code>1246</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>1247</code><code> and &lt;em&gt;</code></p><p><code>1248</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>1249</code><code>, have been cloned (&lt;a href="#R92" rid="R92" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919967"&gt;</code></p><p><code>1250</code><code>Bisogno et al., 2003&lt;/a&gt;</code></p><p><code>1251</code><code>). In the adult brain they are localized in the postsynaptic plasma membrane, in line with their putative role in generating 2-AG involved in retrograde transmission.&lt;/p&gt;</code></p><p><code>1252</code><code>&lt;p id="P19"&gt;</code></p><p><code>1253</code><code>Basal levels of 2-AG in the brain are approximately 2 orders of magnitude higher than the levels of anandamide. Despite this, stimulus-induced release resulting in detectable extracellular levels could be demonstrated only for anandamide and not for 2-AG in an in vivo microdialysis study (&lt;a href="#R391" rid="R391" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919145"&gt;</code></p><p><code>1254</code><code>Giuffrida et al., 1999&lt;/a&gt;</code></p><p><code>1255</code><code>). This finding illustrates that, despite growing interest in endocannabinoids and their roles as retrograde neurotransmitters (&lt;a href="#R1295" rid="R1295" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653510"&gt;</code></p><p><code>1256</code><code>Wilson and Nicoll, 2002&lt;/a&gt;</code></p><p><code>1257</code><code>; Chevaleyre et al., 2006), the mechanism of their release is not well understood. Like prostanoids, endocannabinoids are not stored but generated on demand in response to a depolarization-induced rise in intracellular calcium or activation of various metabotropic receptors (&lt;a href="#R1223" rid="R1223" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637187"&gt;</code></p><p><code>1258</code><code>Varma et al., 2001&lt;/a&gt;</code></p><p><code>1259</code><code>; &lt;a href="#R605" rid="R605" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637222"&gt;</code></p><p><code>1260</code><code>Kim et al., 2002&lt;/a&gt;</code></p><p><code>1261</code><code>; &lt;a href="#R1300" rid="R1300" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918815"&gt;</code></p><p><code>1262</code><code>Witting et al., 2004&lt;/a&gt;</code></p><p><code>1263</code><code>; &lt;a href="#R266" rid="R266" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920359"&gt;</code></p><p><code>1264</code><code>Di et al., 2005a&lt;/a&gt;</code></p><p><code>1265</code><code>,&lt;a href="#R268" rid="R268" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920254"&gt;</code></p><p><code>1266</code><code>b&lt;/a&gt;</code></p><p><code>1267</code><code>). A putative membrane endocannabinoid transporter involved in the cellular uptake of endocannabinoids (see below) may also be involved in their release. This is suggested by the ability of a transport inhibitor to prevent the release of intracellularly applied anandamide (&lt;a href="#R718" rid="R718" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920248"&gt;</code></p><p><code>1268</code><code>Maccarrone et al., 2000a&lt;/a&gt;</code></p><p><code>1269</code><code>; &lt;a href="#R381" rid="R381" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918946"&gt;</code></p><p><code>1270</code><code>Gerdeman et al., 2002&lt;/a&gt;</code></p><p><code>1271</code><code>).&lt;/p&gt;</code></p><p><code>1272</code><code>&lt;p id="P20"&gt;</code></p><p><code>1273</code><code>Anandamide present in the extracellular space is accumulated by neurons and other cells by facilitated diffusion. This process is driven by its transmembrane concentration gradient, is saturable and temperature-dependent, and does not require ATP or sodium ions. Most importantly for the topic of the present review, anandamide uptake is selectively inhibited by a variety of structural analogs, which suggests the existence of a saturable cellular component involved in anandamide transport (&lt;a href="#R63" rid="R63" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653391"&gt;</code></p><p><code>1274</code><code>Beltramo et al., 1997&lt;/a&gt;</code></p><p><code>1275</code><code>; &lt;a href="#R94" rid="R94" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919341"&gt;</code></p><p><code>1276</code><code>Bisogno et al., 1997&lt;/a&gt;</code></p><p><code>1277</code><code>; &lt;a href="#R499" rid="R499" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919781"&gt;</code></p><p><code>1278</code><code>Hillard and Jarrahian, 2000&lt;/a&gt;</code></p><p><code>1279</code><code>; &lt;a href="#R718" rid="R718" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918739"&gt;</code></p><p><code>1280</code><code>Maccarrone et al., 2000a&lt;/a&gt;</code></p><p><code>1281</code><code>). However, a specific anandamide transporter protein has yet to be cloned, and it has been proposed that intracellular degradation of anandamide by fatty acid amide hydrolase (FAAH) is sufficient to account for anandamide uptake in long incubation periods (&lt;a href="#R393" rid="R393" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920148"&gt;</code></p><p><code>1282</code><code>Glaser et al., 2003&lt;/a&gt;</code></p><p><code>1283</code><code>). Studies with cells isolated from FAAH&lt;sup&gt;</code></p><p><code>1284</code><code>+/+&lt;/sup&gt;</code></p><p><code>1285</code><code> and FAAH&lt;sup&gt;</code></p><p><code>1286</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1287</code><code> mice did not resolve this issue, as the absence of FAAH was found not to affect anandamide uptake (&lt;a href="#R314" rid="R314" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918733"&gt;</code></p><p><code>1288</code><code>Fegley et al., 2004&lt;/a&gt;</code></p><p><code>1289</code><code>) or to reduce it substantially (&lt;a href="#R909" rid="R909" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919544"&gt;</code></p><p><code>1290</code><code>Ortega-Gutierrez et al., 2004&lt;/a&gt;</code></p><p><code>1291</code><code>), albeit under different experimental conditions. Nevertheless, a FAAH-independent component of anandamide uptake, inhibited by the compound UCM707, was detected in the latter study, supporting the notion of a protein other than FAAH being involved. This notion is also supported by the emergence of a number of synthetic transport inhibitors, the potencies of which to inhibit anandamide uptake does not correlate with their affinities for CB&lt;sub&gt;</code></p><p><code>1292</code><code>1&lt;/sub&gt;</code></p><p><code>1293</code><code>, CB&lt;sub&gt;</code></p><p><code>1294</code><code>2&lt;/sub&gt;</code></p><p><code>1295</code><code>, or TRPV&lt;sub&gt;</code></p><p><code>1296</code><code>1&lt;/sub&gt;</code></p><p><code>1297</code><code> receptors or their potencies to inhibit FAAH (&lt;a href="/pmc/articles/PMC2241751/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"&gt;</code></p><p><code>1298</code><code>&lt;span&gt;</code></p><p><code>1299</code><code>Fig. 3&lt;/span&gt;</code></p><p><code>1300</code><code>&lt;/a&gt;</code></p><p><code>1301</code><code>). However, in view of the important role of FAAH in generating the transmembrane concentration gradient for anandamide, the possibility that a noncatalytic region of FAAH or a FAAH-associated protein may act as anandamide transporter cannot be excluded. Interestingly, the elucidation of the crystal structure of FAAH revealed several channel-like regions in the enzyme, granting it simultaneous access to both the cytosolic and membrane domains (&lt;a href="#R112" rid="R112" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653459"&gt;</code></p><p><code>1302</code><code>Bracey et al., 2002&lt;/a&gt;</code></p><p><code>1303</code><code>). Against this possibility, however, is the recent report that the novel, high affinity anandamide transport inhibitor LY2318912 binds with similar &lt;em&gt;</code></p><p><code>1304</code><code>K&lt;/em&gt;</code></p><p><code>1305</code><code>&lt;sub&gt;</code></p><p><code>1306</code><code>d&lt;/sub&gt;</code></p><p><code>1307</code><code> and &lt;em&gt;</code></p><p><code>1308</code><code>b&lt;/em&gt;</code></p><p><code>1309</code><code>&lt;sub&gt;</code></p><p><code>1310</code><code>max&lt;/sub&gt;</code></p><p><code>1311</code><code> values to membranes from HeLa cells devoid of FAAH or transfected with FAAH, pointing to a binding site independent of the FAAH molecule (&lt;a href="#R848" rid="R848" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918872"&gt;</code></p><p><code>1312</code><code>Moore et al., 2005&lt;/a&gt;</code></p><p><code>1313</code><code>). Arguments for and against the existence of a bidirectional anandamide transporter have been recently reviewed (&lt;a href="#R500" rid="R500" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919864"&gt;</code></p><p><code>1314</code><code>Hillard and Jarrahian, 2003&lt;/a&gt;</code></p><p><code>1315</code><code>; &lt;a href="#R333" rid="R333" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919467"&gt;</code></p><p><code>1316</code><code>Fowler et al., 2004&lt;/a&gt;</code></p><p><code>1317</code><code>; &lt;a href="#R792" rid="R792" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919918"&gt;</code></p><p><code>1318</code><code>Mc-Farland and Barker, 2004&lt;/a&gt;</code></p><p><code>1319</code><code>; &lt;a href="#R394" rid="R394" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919404"&gt;</code></p><p><code>1320</code><code>Glaser et al., 2005&lt;/a&gt;</code></p><p><code>1321</code><code>).&lt;/p&gt;</code></p><p><code>1322</code><code>&lt;!--fig ft0--&gt;</code></p><p><code>1323</code><code>&lt;!--fig mode=article f1--&gt;</code></p><p><code>1324</code><code>&lt;div class="fig iconblock whole_rhythm" id="F3" co-legend-rid="lgnd_F3"&gt;</code></p><p><code>1325</code><code>&lt;a href="/pmc/articles/PMC2241751/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"&gt;</code></p><p><code>1326</code><code>&lt;!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--&gt;</code></p><p><code>1327</code><code>&lt;div data-largeobj="" data-largeobj-link-rid="largeobj_idm139779462219600" class="figure"&gt;</code></p><p><code>1328</code><code>&lt;a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;amp;p=PMC3&amp;amp;id=2241751_nihms38123f3.jpg" target="tileshopwindow" rel="noopener"&gt;</code></p><p><code>1329</code><code>&lt;div class="ts_bar small" title="Click on image to zoom"&gt;</code></p><p><code>1330</code><code>&lt;/div&gt;</code></p><p><code>1331</code><code>&lt;img loading="lazy" alt="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms38123f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2241751/bin/nihms38123f3.jpg" /&gt;</code></p><p><code>1332</code><code>&lt;/a&gt;</code></p><p><code>1333</code><code>&lt;/div&gt;</code></p><p><code>1334</code><code>&lt;div id="largeobj_idm139779462219600" class="largeobj-link align_right" style="display: none"&gt;</code></p><p><code>1335</code><code>&lt;a target="object" rel="noopener" href="/pmc/articles/PMC2241751/figure/F3/?report=objectonly"&gt;</code></p><p><code>1336</code><code>Open in a separate window&lt;/a&gt;</code></p><p><code>1337</code><code>&lt;/div&gt;</code></p><p><code>1338</code><code>&lt;/a&gt;</code></p><p><code>1339</code><code>&lt;div class="icnblk_cntnt" id="lgnd_F3"&gt;</code></p><p><code>1340</code><code>&lt;div&gt;</code></p><p><code>1341</code><code>&lt;a class="figpopup" href="/pmc/articles/PMC2241751/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"&gt;</code></p><p><code>1342</code><code>Fig. 3&lt;/a&gt;</code></p><p><code>1343</code><code>&lt;/div&gt;</code></p><p><code>1344</code><code>&lt;!--caption a7--&gt;</code></p><p><code>1345</code><code>&lt;div class="caption"&gt;</code></p><p><code>1346</code><code>&lt;p id="__p4"&gt;</code></p><p><code>1347</code><code>The structure and pharmacological specificity of inhibitors of FAAH and of endocannabinoid membrane transport.&lt;/p&gt;</code></p><p><code>1348</code><code>&lt;/div&gt;</code></p><p><code>1349</code><code>&lt;/div&gt;</code></p><p><code>1350</code><code>&lt;/div&gt;</code></p><p><code>1351</code><code>&lt;p id="P21"&gt;</code></p><p><code>1352</code><code>In some in vivo studies, treatment with transport inhibitors unmasked cannabinoid-like tonic effects on pain sensitivity, anxiety-like behaviors, locomotor activity, and muscle spasticity, which is an indication of the potential therapeutic usefulness of such compounds (&lt;a href="#R848" rid="R848" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919829"&gt;</code></p><p><code>1353</code><code>Moore et al., 2005&lt;/a&gt;</code></p><p><code>1354</code><code>; &lt;a href="#R108" rid="R108" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_393488956"&gt;</code></p><p><code>1355</code><code>Bortolato et al., 2006&lt;/a&gt;</code></p><p><code>1356</code><code>; &lt;a href="#R652" rid="R652" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919795"&gt;</code></p><p><code>1357</code><code>La Rana et al., 2006&lt;/a&gt;</code></p><p><code>1358</code><code>). Similar and more pronounced effects have been reported in response to treatment with FAAH inhibitors, as discussed below.&lt;/p&gt;</code></p><p><code>1359</code><code>&lt;p id="P22"&gt;</code></p><p><code>1360</code><code>In contrast to the unsettled status of anandamide transport and a putative transporter protein, the unique role of FAAH in the in vivo degradation of anandamide has been extensively documented (reviewed in &lt;a href="#R800" rid="R800" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919899"&gt;</code></p><p><code>1361</code><code>McKinney and Cravatt, 2005&lt;/a&gt;</code></p><p><code>1362</code><code>). Initial evidence for a membrane-associated enzyme in the liver that hydrolyzes &lt;em&gt;</code></p><p><code>1363</code><code>N&lt;/em&gt;</code></p><p><code>1364</code><code>-&lt;em&gt;</code></p><p><code>1365</code><code>N&lt;/em&gt;</code></p><p><code>1366</code><code>-acyl ethanolamides (&lt;a href="#R1078" rid="R1078" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919715"&gt;</code></p><p><code>1367</code><code>Schmid et al., 1985&lt;/a&gt;</code></p><p><code>1368</code><code>) was followed by the cloning of FAAH (&lt;a href="#R223" rid="R223" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920402"&gt;</code></p><p><code>1369</code><code>Cravatt et al., 1996&lt;/a&gt;</code></p><p><code>1370</code><code>) and the identification of its crystal structure in complex with an active site-directed inhibitor (&lt;a href="#R112" rid="R112" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653493"&gt;</code></p><p><code>1371</code><code>Bracey et al., 2002&lt;/a&gt;</code></p><p><code>1372</code><code>). The unique role of FAAH in terminating signaling by anandamide was indicated by the phenotype of FAAH knockout mice, which displayed 10 to 15 times elevated levels of anandamide across the brain, supersensitivity to the actions of exogenous anandamide, and the appearance of tonic signaling by endogenous anandamide, resulting in CB&lt;sub&gt;</code></p><p><code>1373</code><code>1&lt;/sub&gt;</code></p><p><code>1374</code><code> receptor-mediated hypoalgesia (&lt;a href="#R222" rid="R222" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920140"&gt;</code></p><p><code>1375</code><code>Cravatt et al., 2001&lt;/a&gt;</code></p><p><code>1376</code><code>; &lt;a href="#R688" rid="R688" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918720"&gt;</code></p><p><code>1377</code><code>Lichtman et al., 2004b&lt;/a&gt;</code></p><p><code>1378</code><code>), reduced anxiety (&lt;a href="#R589" rid="R589" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919905"&gt;</code></p><p><code>1379</code><code>Kathuria et al., 2003&lt;/a&gt;</code></p><p><code>1380</code><code>), antidepressant activity (Gobbi et al., 2006), and lowering of blood pressure in different models of experimental hypertension (&lt;a href="#R52" rid="R52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653377"&gt;</code></p><p><code>1381</code><code>B&amp;#x000e1;tkai et al., 2004b&lt;/a&gt;</code></p><p><code>1382</code><code>). &lt;a href="#R225" rid="R225" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920328"&gt;</code></p><p><code>1383</code><code>Cravatt et al. (2004)&lt;/a&gt;</code></p><p><code>1384</code><code> were able to resolve the relative roles of central versus peripheral fatty acid amides by generating mice deficient in FAAH in peripheral tissues only. These mice did not display the hypoalgesia observed in mice with global deficiency in FAAH, but had a similar anti-inflammatory phenotype, indicating that the latter was mediated by elevated fatty acid amides in peripheral tissues (&lt;a href="#R225" rid="R225" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919225"&gt;</code></p><p><code>1385</code><code>Cravatt et al., 2004&lt;/a&gt;</code></p><p><code>1386</code><code>). Interestingly, another amidohydrolase catalyzing the same reaction as FAAH but at acidic pH was recently identified and cloned (&lt;a href="#R1192" rid="R1192" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919415"&gt;</code></p><p><code>1387</code><code>Tsuboi et al., 2005&lt;/a&gt;</code></p><p><code>1388</code><code>). This lysosomal enzyme is structurally unrelated to FAAH and is widely distributed in tissues, with highest levels in the lung, and has been recently shown to contribute to the physiological degradation of anandamide in macrophages but not in the brain (&lt;a href="#R1154" rid="R1154" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919028"&gt;</code></p><p><code>1389</code><code>Sun et al., 2005&lt;/a&gt;</code></p><p><code>1390</code><code>).&lt;/p&gt;</code></p><p><code>1391</code><code>&lt;p id="P23"&gt;</code></p><p><code>1392</code><code>Although 2-AG is also hydrolyzed by FAAH under in vitro conditions (&lt;a href="#R417" rid="R417" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920092"&gt;</code></p><p><code>1393</code><code>Goparaju et al., 1998&lt;/a&gt;</code></p><p><code>1394</code><code>; &lt;a href="#R651" rid="R651" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920078"&gt;</code></p><p><code>1395</code><code>Lang et al., 1999&lt;/a&gt;</code></p><p><code>1396</code><code>), in vivo it is not a substrate of FAAH, as indicated by the unchanged brain levels of 2-AG in wild-type and FAAH&lt;sup&gt;</code></p><p><code>1397</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1398</code><code> mice (&lt;a href="#R914" rid="R914" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919986"&gt;</code></p><p><code>1399</code><code>Osei-Hyiaman et al., 2005a&lt;/a&gt;</code></p><p><code>1400</code><code>). 2-AG is hydrolyzed in vivo by a monoacylglyceride lipase (MGL) (&lt;a href="#R278" rid="R278" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919054"&gt;</code></p><p><code>1401</code><code>Dinh et al., 2002a&lt;/a&gt;</code></p><p><code>1402</code><code>,&lt;a href="#R279" rid="R279" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919691"&gt;</code></p><p><code>1403</code><code>b&lt;/a&gt;</code></p><p><code>1404</code><code>; &lt;a href="#R1055" rid="R1055" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919728"&gt;</code></p><p><code>1405</code><code>Saario et al., 2004&lt;/a&gt;</code></p><p><code>1406</code><code>). A study of the ultrastructural distribution of FAAH and MGL revealed that in the hippocampus, cerebellum, and amygdala, FAAH is located postsynaptically, whereas MGL is localized in presynaptic axon terminals, including terminals of GABAergic interneurons (&lt;a href="#R445" rid="R445" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920401"&gt;</code></p><p><code>1407</code><code>Gulyas et al., 2004&lt;/a&gt;</code></p><p><code>1408</code><code>). Correspondingly, functional studies in hippocampus indicate that depolarization-induced suppression of inhibition (DSI) is unaffected by pharmacological blockade of FAAH (&lt;a href="#R604" rid="R604" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920183"&gt;</code></p><p><code>1409</code><code>Kim and Alger, 2004&lt;/a&gt;</code></p><p><code>1410</code><code>), but it is potentiated by blocking MGL (&lt;a href="#R604" rid="R604" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919094"&gt;</code></p><p><code>1411</code><code>Kim and Alger, 2004&lt;/a&gt;</code></p><p><code>1412</code><code>; &lt;a href="#R734" rid="R734" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918817"&gt;</code></p><p><code>1413</code><code>Makara et al., 2005&lt;/a&gt;</code></p><p><code>1414</code><code>), in agreement with an earlier study implicating 2-AG rather than anandamide in synaptic plasticity in the hippocampus (&lt;a href="#R1139" rid="R1139" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919173"&gt;</code></p><p><code>1415</code><code>Stella et al., 1997&lt;/a&gt;</code></p><p><code>1416</code><code>). Further evidence supporting the role of 2-AG as the retrograde transmitter involved in synaptic plasticity is the preferential postsynaptic distribution of the major 2-AG biosynthetic enzyme, diacylglycerol lipase &lt;em&gt;</code></p><p><code>1417</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>1418</code><code>, in hippocampus and cerebellum (Katona et al., 2006; &lt;a href="#R1309" rid="R1309" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637198"&gt;</code></p><p><code>1419</code><code>Yoshida et al., 2006&lt;/a&gt;</code></p><p><code>1420</code><code>).&lt;/p&gt;</code></p><p><code>1421</code><code>&lt;p id="P24" class="p p-last"&gt;</code></p><p><code>1422</code><code>However, the behavioral consequences of DSI and its modulation remain unclear: selective knockout of CB&lt;sub&gt;</code></p><p><code>1423</code><code>1&lt;/sub&gt;</code></p><p><code>1424</code><code> receptors from GABAergic interneurons was found to abolish DSI and long-term depression (LTD) of inhibitory synapses, whereas the classic behavioral responses to THC remained unaffected in these animals (&lt;a href="#R844" rid="R844" class=" bibr popnode"&gt;</code></p><p><code>1425</code><code>Monory et al., 2005&lt;/a&gt;</code></p><p><code>1426</code><code>). Therefore, at this point it is difficult to predict the potential therapeutic usefulness of selective MGL inhibitors.&lt;/p&gt;</code></p><p><code>1427</code><code>&lt;/div&gt;</code></p><p><code>1428</code><code>&lt;/div&gt;</code></p><p><code>1429</code><code>&lt;div id="S6" class="tsec sec"&gt;</code></p><p><code>1430</code><code>&lt;h2 class="head no_bottom_margin" id="S6title"&gt;</code></p><p><code>1431</code><code>III. The Endocannabinoid System as Therapeutic Target in Pathophysiological Conditions&lt;/h2&gt;</code></p><p><code>1432</code><code>&lt;div id="S7" class="sec sec-first"&gt;</code></p><p><code>1433</code><code>&lt;h3 id="S7title"&gt;</code></p><p><code>1434</code><code>A. Diseases of Energy Metabolism&lt;/h3&gt;</code></p><p><code>1435</code><code>&lt;div id="S8" class="sec sec-first"&gt;</code></p><p><code>1436</code><code>&lt;p&gt;</code></p><p><code>1437</code><code>&lt;/p&gt;</code></p><p><code>1438</code><code>&lt;h4 id="S8title" class="inline"&gt;</code></p><p><code>1439</code><code>1. Endocannabinoids and Appetite Regulation &lt;/h4&gt;</code></p><p><code>1440</code><code>&lt;p id="P25" class="p p-first"&gt;</code></p><p><code>1441</code><code>It has been known since antiquity that use of cannabis in its various forms increases appetite, particularly for palatable foods, and can also result in significant weight gain (&lt;a href="#R281" rid="R281" class=" bibr popnode"&gt;</code></p><p><code>1442</code><code>Donovan, 1845&lt;/a&gt;</code></p><p><code>1443</code><code>; &lt;a href="#R75" rid="R75" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920106"&gt;</code></p><p><code>1444</code><code>Berry and Mechoulam, 2002&lt;/a&gt;</code></p><p><code>1445</code><code>). Following the identification of THC as the main psychoactive principle in marijuana, the appetite-promoting effect of smoked marijuana could be attributed to THC even before the identification of specific cannabinoid receptors (&lt;a href="#R516" rid="R516" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653497"&gt;</code></p><p><code>1446</code><code>Hollister, 1971&lt;/a&gt;</code></p><p><code>1447</code><code>; &lt;a href="#R428" rid="R428" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919296"&gt;</code></p><p><code>1448</code><code>Greenberg et al., 1976&lt;/a&gt;</code></p><p><code>1449</code><code>). Animal studies also documented the ability of THC to promote food intake, although consistent effects were only seen with relatively low doses (&lt;a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919079"&gt;</code></p><p><code>1450</code><code>Abel, 1975&lt;/a&gt;</code></p><p><code>1451</code><code>), most likely because the significant sedation and motor impairment seen with higher doses interferes with the animals&amp;#x02019; ability to initiate feeding. Variability in the observed changes in THC-induced food intake may also relate to the feeding state of the animal, the orexigenic effect being optimal in presatiated animals with low basal levels of food intake (&lt;a href="#R1289" rid="R1289" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919712"&gt;</code></p><p><code>1452</code><code>Williams et al., 1998&lt;/a&gt;</code></p><p><code>1453</code><code>). After the discovery of specific cannabinoid receptors and the introduction of selective antagonists, the increase in food intake caused by THC could be linked to CB&lt;sub&gt;</code></p><p><code>1454</code><code>1&lt;/sub&gt;</code></p><p><code>1455</code><code> receptors, as it was blocked by the selective CB&lt;sub&gt;</code></p><p><code>1456</code><code>1&lt;/sub&gt;</code></p><p><code>1457</code><code> antagonist SR141716, but not by the CB&lt;sub&gt;</code></p><p><code>1458</code><code>2&lt;/sub&gt;</code></p><p><code>1459</code><code> antagonist SR144528 (&lt;a href="#R1288" rid="R1288" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653415"&gt;</code></p><p><code>1460</code><code>Williams and Kirkham, 2002&lt;/a&gt;</code></p><p><code>1461</code><code>).&lt;/p&gt;</code></p><p><code>1462</code><code>&lt;p id="P26"&gt;</code></p><p><code>1463</code><code>The discovery of endocannabinoids has raised the question of their potential involvement in the physiological control of appetite and energy metabolism. This subject has been the topic of a number of recent reviews (&lt;a href="#R276" rid="R276" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919427"&gt;</code></p><p><code>1464</code><code>Di Marzo and Matias, 2005&lt;/a&gt;</code></p><p><code>1465</code><code>; &lt;a href="#R608" rid="R608" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920212"&gt;</code></p><p><code>1466</code><code>Kirkham, 2005&lt;/a&gt;</code></p><p><code>1467</code><code>; &lt;a href="#R1090" rid="R1090" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653409"&gt;</code></p><p><code>1468</code><code>Sharkey and Pittman, 2005&lt;/a&gt;</code></p><p><code>1469</code><code>; &lt;a href="#R930" rid="R930" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918895"&gt;</code></p><p><code>1470</code><code>Pagotto et al., 2006&lt;/a&gt;</code></p><p><code>1471</code><code>), and only a brief summary is provided here. The first indication of a role for endocannabinoids in appetite control was the documented ability of low doses of anandamide to increase food intake, when administered either systemically (&lt;a href="#R1287" rid="R1287" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919058"&gt;</code></p><p><code>1472</code><code>Williams and Kirkham, 1999&lt;/a&gt;</code></p><p><code>1473</code><code>; &lt;a href="#R468" rid="R468" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919608"&gt;</code></p><p><code>1474</code><code>Hao et al., 2000&lt;/a&gt;</code></p><p><code>1475</code><code>) or into the ventromedial hypothalamus (&lt;a href="#R554" rid="R554" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919138"&gt;</code></p><p><code>1476</code><code>Jamshidi and Taylor, 2001&lt;/a&gt;</code></p><p><code>1477</code><code>), and this effect could be attributed to stimulation of CB&lt;sub&gt;</code></p><p><code>1478</code><code>1&lt;/sub&gt;</code></p><p><code>1479</code><code> receptors (&lt;a href="#R1287" rid="R1287" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919446"&gt;</code></p><p><code>1480</code><code>Williams and Kirkham, 1999&lt;/a&gt;</code></p><p><code>1481</code><code>). Similar increases in food intake can be elicited by 2-AG administered systemically or into the nucleus accumbens shell region (&lt;a href="#R611" rid="R611" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919928"&gt;</code></p><p><code>1482</code><code>Kirkham et al., 2002&lt;/a&gt;</code></p><p><code>1483</code><code>) or into the lateral hypothalamus (&lt;a href="#R609" rid="R609" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653407"&gt;</code></p><p><code>1484</code><code>Kirkham and Williams, 2001a&lt;/a&gt;</code></p><p><code>1485</code><code>). Sites for the orexigenic actions of endocannabinoids in both the hypothalamus and the limbic forebrain suggest their involvement in both the homeostatic and hedonic control of eating (&lt;a href="#R471" rid="R471" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919984"&gt;</code></p><p><code>1486</code><code>Harrold and Williams, 2003&lt;/a&gt;</code></p><p><code>1487</code><code>; &lt;a href="#R1229" rid="R1229" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919018"&gt;</code></p><p><code>1488</code><code>Vickers and Kennett, 2005&lt;/a&gt;</code></p><p><code>1489</code><code>). Interestingly, endocannabinoid activation of hypothalamic centers, such as the paraventricular nucleus, may also occur indirectly via CB&lt;sub&gt;</code></p><p><code>1490</code><code>1&lt;/sub&gt;</code></p><p><code>1491</code><code> receptors on peripheral afferent nerve terminals (&lt;a href="#R410" rid="R410" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637239"&gt;</code></p><p><code>1492</code><code>Gomez et al., 2002&lt;/a&gt;</code></p><p><code>1493</code><code>), most likely located in the gastrointestinal tract. Such an &amp;#x0201c;indirect&amp;#x0201d; pathway is compatible with recent findings that CB&lt;sub&gt;</code></p><p><code>1494</code><code>1&lt;/sub&gt;</code></p><p><code>1495</code><code> mRNA is present in cholecystokinin-containing neurons in the nodose ganglion, where CB&lt;sub&gt;</code></p><p><code>1496</code><code>1&lt;/sub&gt;</code></p><p><code>1497</code><code> mRNA expression is up-regulated by fasting and down-regulated by refeeding (&lt;a href="#R131" rid="R131" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637199"&gt;</code></p><p><code>1498</code><code>Burdyga et al., 2004&lt;/a&gt;</code></p><p><code>1499</code><code>).&lt;/p&gt;</code></p><p><code>1500</code><code>&lt;p id="P27"&gt;</code></p><p><code>1501</code><code>Studies with antagonists provide more direct support for a regulatory function of endocannabinoids on feeding. Treatment of rats with SR141716 and the closely related CB&lt;sub&gt;</code></p><p><code>1502</code><code>1&lt;/sub&gt;</code></p><p><code>1503</code><code> antagonist AM251 reduced food intake under free-feeding (&lt;a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919477"&gt;</code></p><p><code>1504</code><code>Arnone et al., 1997&lt;/a&gt;</code></p><p><code>1505</code><code>; &lt;a href="#R194" rid="R194" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919744"&gt;</code></p><p><code>1506</code><code>Colombo et al., 1998a&lt;/a&gt;</code></p><p><code>1507</code><code>; &lt;a href="#R1108" rid="R1108" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920312"&gt;</code></p><p><code>1508</code><code>Simiand et al., 1998&lt;/a&gt;</code></p><p><code>1509</code><code>; &lt;a href="#R166" rid="R166" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918992"&gt;</code></p><p><code>1510</code><code>Chambers et al., 2003&lt;/a&gt;</code></p><p><code>1511</code><code>; &lt;a href="#R1091" rid="R1091" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919125"&gt;</code></p><p><code>1512</code><code>Shearman et al., 2003&lt;/a&gt;</code></p><p><code>1513</code><code>) or operant conditions (&lt;a href="#R339" rid="R339" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920266"&gt;</code></p><p><code>1514</code><code>Freedland et al., 2000&lt;/a&gt;</code></p><p><code>1515</code><code>; &lt;a href="#R801" rid="R801" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919199"&gt;</code></p><p><code>1516</code><code>McLaughlin et al., 2003&lt;/a&gt;</code></p><p><code>1517</code><code>), suggesting antagonism of the tonic orexigenic effect of an endocannabinoid. However, SR141716 and AM251 are inverse agonists (&lt;a href="#R386" rid="R386" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920003"&gt;</code></p><p><code>1518</code><code>Gifford and Ashby, 1996&lt;/a&gt;</code></p><p><code>1519</code><code>; &lt;a href="#R110" rid="R110" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918715"&gt;</code></p><p><code>1520</code><code>Bouaboula et al., 1997&lt;/a&gt;</code></p><p><code>1521</code><code>), which may be an alternative mechanism by which they reduce food intake.&lt;/p&gt;</code></p><p><code>1522</code><code>&lt;p id="P28"&gt;</code></p><p><code>1523</code><code>Definitive evidence for the involvement of endocannabinoids in the control of food intake has been provided through the use of CB&lt;sub&gt;</code></p><p><code>1524</code><code>1&lt;/sub&gt;</code></p><p><code>1525</code><code> receptor-deficient mice. In a study from our laboratory, food-deprived CB&lt;sub&gt;</code></p><p><code>1526</code><code>1&lt;/sub&gt;</code></p><p><code>1527</code><code> knockout mice were found to eat less than their wild-type littermates, and their food intake was unaffected by SR141716 treatment, whereas in wild-type mice SR141716 reduced food intake to the levels seen in the knockout mice (&lt;a href="#R274" rid="R274" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919952"&gt;</code></p><p><code>1528</code><code>Di Marzo et al., 2001b&lt;/a&gt;</code></p><p><code>1529</code><code>). Similar findings have been subsequently reported by others (&lt;a href="#R1286" rid="R1286" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919275"&gt;</code></p><p><code>1530</code><code>Wiley et al., 2005&lt;/a&gt;</code></p><p><code>1531</code><code>). This indicates that part of the hunger-induced increase in food intake is mediated by endocannabinoids acting at CB&lt;sub&gt;</code></p><p><code>1532</code><code>1&lt;/sub&gt;</code></p><p><code>1533</code><code> receptors. CB&lt;sub&gt;</code></p><p><code>1534</code><code>1&lt;/sub&gt;</code></p><p><code>1535</code><code> knockout mice are also resistant to overeating caused by neuropeptide Y (NPY) (&lt;a href="#R976" rid="R976" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919738"&gt;</code></p><p><code>1536</code><code>Poncelet et al., 2003&lt;/a&gt;</code></p><p><code>1537</code><code>), and SR141716 inhibits the hyperphagia of leptin-deficient mice even in the absence of temporary food deprivation (&lt;a href="#R274" rid="R274" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919753"&gt;</code></p><p><code>1538</code><code>Di Marzo et al., 2001b&lt;/a&gt;</code></p><p><code>1539</code><code>). This latter finding suggests that the absence of leptin results in increased endocannabinoid activity. Indeed, hypothalamic levels of endocannabinoids were elevated in leptin-deficient mice and rats and reduced after leptin treatment, suggesting that endocannabinoids are part of the leptin-regulated neural circuitry involved in appetite regulation (&lt;a href="#R274" rid="R274" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919803"&gt;</code></p><p><code>1540</code><code>Di Marzo et al., 2001b&lt;/a&gt;</code></p><p><code>1541</code><code>). Endogenous leptin may similarly suppress endocannabinoid levels, as indicated by our recent unpublished findings using mice with obesity induced by a high-fat diet, which have elevated plasma leptin levels proportional to their increased fat mass. Anandamide levels were significantly lower in the obese mice compared with their lean controls in the hypothalamus, limbic forebrain, and amygdala, with no difference in the cerebellum. Furthermore, there was a significant inverse correlation between plasma leptin levels and anandamide levels in the above three brain regions involved in appetite control but not in the cerebellum.&lt;/p&gt;</code></p><p><code>1542</code><code>&lt;p id="P29"&gt;</code></p><p><code>1543</code><code>A possible hypothalamic site for an interaction between leptin and endocannabinoids is the lateral hypothalamus, where CB&lt;sub&gt;</code></p><p><code>1544</code><code>1&lt;/sub&gt;</code></p><p><code>1545</code><code> receptors are present in orexin-and melanin-concentrating hormone (MCH)-containing neurons (&lt;a href="#R215" rid="R215" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919759"&gt;</code></p><p><code>1546</code><code>Cota et al., 2003&lt;/a&gt;</code></p><p><code>1547</code><code>), which also express functional leptin receptors (&lt;a href="#R531" rid="R531" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637234"&gt;</code></p><p><code>1548</code><code>H&amp;#x000fc;bschle et al., 2001&lt;/a&gt;</code></p><p><code>1549</code><code>; &lt;a href="#R540" rid="R540" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920373"&gt;</code></p><p><code>1550</code><code>Iqbal et al., 2001&lt;/a&gt;</code></p><p><code>1551</code><code>). These neurons project to dopaminergic neurons in the ventral tegmental area (&lt;a href="#R308" rid="R308" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920330"&gt;</code></p><p><code>1552</code><code>Fadel and Deutch, 2002&lt;/a&gt;</code></p><p><code>1553</code><code>), where they modulate the mesolimbic dopaminergic pathway involved in food reward. Thus, they could also represent a site of integration of hypothalamic and extrahypothalamic structures involved in the orexigenic effect of endocannabinoids. The MCH-containing neurons are tonically inhibited by GABAergic interneurons. &lt;a href="#R564" rid="R564" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918913"&gt;</code></p><p><code>1554</code><code>Jo et al. (2005)&lt;/a&gt;</code></p><p><code>1555</code><code> recently demonstrated that this inhibitory tone can be suppressed by the depolarization-induced release of endocannabinoids from the MCH neurons and their retrograde activation of presynaptic CB&lt;sub&gt;</code></p><p><code>1556</code><code>1&lt;/sub&gt;</code></p><p><code>1557</code><code> receptors on the GABAergic interneurons. The resulting increase in the activity of MCH neurons may contribute to the in vivo appetitive effect of endocannabinoids. Furthermore, this DSI could be blocked by leptin through inhibition of voltage-gated calcium channels in the MCH neurons, whereas it was increased 6-fold in leptin-deficient mice (&lt;a href="#R564" rid="R564" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919844"&gt;</code></p><p><code>1558</code><code>Jo et al., 2005&lt;/a&gt;</code></p><p><code>1559</code><code>), mirroring the changes in hypothalamic endocannabinoid content by leptin and leptin deficiency reported earlier (&lt;a href="#R274" rid="R274" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919268"&gt;</code></p><p><code>1560</code><code>Di Marzo et al., 2001b&lt;/a&gt;</code></p><p><code>1561</code><code>). Another hypothalamic site where a leptin/endocannabinoid interaction may occur is the paraventricular nucleus. At this site, glucocorticoids have been shown to induce endocannabinoid synthesis and endocannabinoid-induced suppression of synaptic excitation via a cAMP-dependent mechanism, and leptin was found to block these effects by a phosphodiesterase 3B-mediated decrease in intracellular cAMP (&lt;a href="#R736" rid="R736" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637237"&gt;</code></p><p><code>1562</code><code>Malcher-Lopes et al., 2006&lt;/a&gt;</code></p><p><code>1563</code><code>). These effects may underlie the orexigenic action of glucocorticoids.&lt;/p&gt;</code></p><p><code>1564</code><code>&lt;p id="P30"&gt;</code></p><p><code>1565</code><code>Another recent study indicates the importance of lateral hypothalamic orexin neurons in reward-seeking behavior in general (&lt;a href="#R469" rid="R469" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920031"&gt;</code></p><p><code>1566</code><code>Harris et al., 2005&lt;/a&gt;</code></p><p><code>1567</code><code>), suggesting that they may also be targets of the effects of endocannabinoids on drug reward (see section III. B.11.). Additionally, cannabinoids can increase the intake of palatable foods by acting at sites in the brainstem (&lt;a href="#R832" rid="R832" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918784"&gt;</code></p><p><code>1568</code><code>Miller et al., 2004&lt;/a&gt;</code></p><p><code>1569</code><code>), which also have reciprocal neural connections with forebrain limbic structures (&lt;a href="#R1065" rid="R1065" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918725"&gt;</code></p><p><code>1570</code><code>Saper, 2002&lt;/a&gt;</code></p><p><code>1571</code><code>). From a behavioral point of view, cannabinoids are involved in both the appetitive and consummatory aspects of feeding behavior (&lt;a href="#R169" rid="R169" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919847"&gt;</code></p><p><code>1572</code><code>Chaperon et al., 1998&lt;/a&gt;</code></p><p><code>1573</code><code>; &lt;a href="#R1182" rid="R1182" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919493"&gt;</code></p><p><code>1574</code><code>Thornton-Jones et al., 2005&lt;/a&gt;</code></p><p><code>1575</code><code>), in line with their multiple sites of action in the brain. Such multiple sites of action are also indicated by findings that in THC-naive rats, rimonabant suppressed food-maintained operant responses and metabolic activity in the limbic forebrain, measured by 2-deoxyglucose uptake, whereas in rats made tolerant to THC, an additional metabolic inhibition was detected in the hypothalamus (&lt;a href="#R341" rid="R341" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919630"&gt;</code></p><p><code>1576</code><code>Freedland et al., 2003&lt;/a&gt;</code></p><p><code>1577</code><code>). Exposure of rats to a palatable diet containing sucrose and condensed milk resulted in down-regulation of CB&lt;sub&gt;</code></p><p><code>1578</code><code>1&lt;/sub&gt;</code></p><p><code>1579</code><code> receptors in limbic structures involved in the hedonic aspects of feeding, but not in the hypothalamus (&lt;a href="#R470" rid="R470" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919175"&gt;</code></p><p><code>1580</code><code>Harrold et al., 2002&lt;/a&gt;</code></p><p><code>1581</code><code>). In the hypothalamus, the very low density of CB&lt;sub&gt;</code></p><p><code>1582</code><code>1&lt;/sub&gt;</code></p><p><code>1583</code><code> receptors is offset by their increased coupling (&lt;a href="#R119" rid="R119" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919162"&gt;</code></p><p><code>1584</code><code>Breivogel et al., 1997&lt;/a&gt;</code></p><p><code>1585</code><code>), which may be an alternative target of regulation (&lt;a href="#R46" rid="R46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919448"&gt;</code></p><p><code>1586</code><code>Basavarajappa and Hungund, 1999&lt;/a&gt;</code></p><p><code>1587</code><code>; &lt;a href="#R1267" rid="R1267" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920273"&gt;</code></p><p><code>1588</code><code>Wang et al., 2003&lt;/a&gt;</code></p><p><code>1589</code><code>) that needs to be explored.&lt;/p&gt;</code></p><p><code>1590</code><code>&lt;p id="P31"&gt;</code></p><p><code>1591</code><code>Within the appetitive neural circuitry, endocannabinoids have been shown to interact with both orexigenic factors such as endogenous opioids, NPY, orexins, and ghrelin, and anorexigenic factors including &lt;em&gt;</code></p><p><code>1592</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>1593</code><code>-melanocyte-stimulating hormone (&lt;em&gt;</code></p><p><code>1594</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>1595</code><code>-MSH), corticotropin-releasing hormone (CRH), and the peptide product of the cocaine and amphetamine-related transcript (CART). Inhibition of food intake by opioid &lt;em&gt;</code></p><p><code>1596</code><code>&amp;#x003bc;&lt;/em&gt;</code></p><p><code>1597</code><code> receptor antagonists and CB&lt;sub&gt;</code></p><p><code>1598</code><code>1&lt;/sub&gt;</code></p><p><code>1599</code><code> receptor antagonists is supra-additive (&lt;a href="#R610" rid="R610" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653416"&gt;</code></p><p><code>1600</code><code>Kirkham and Williams, 2001b&lt;/a&gt;</code></p><p><code>1601</code><code>; &lt;a href="#R1045" rid="R1045" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918783"&gt;</code></p><p><code>1602</code><code>Rowland et al., 2001&lt;/a&gt;</code></p><p><code>1603</code><code>; &lt;a href="#R176" rid="R176" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920006"&gt;</code></p><p><code>1604</code><code>Chen et al., 2004&lt;/a&gt;</code></p><p><code>1605</code><code>), suggesting a synergism between the endogenous opioid and cannabinoid systems in mediating the reinforcing effect of food (&lt;a href="#R1124" rid="R1124" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919622"&gt;</code></p><p><code>1606</code><code>Solinas and Goldberg, 2005&lt;/a&gt;</code></p><p><code>1607</code><code>). Indeed, CB&lt;sub&gt;</code></p><p><code>1608</code><code>1&lt;/sub&gt;</code></p><p><code>1609</code><code>-deficient mice fail to self-administer morphine (&lt;a href="#R668" rid="R668" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653401"&gt;</code></p><p><code>1610</code><code>Ledent et al., 1999&lt;/a&gt;</code></p><p><code>1611</code><code>; &lt;a href="#R212" rid="R212" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919512"&gt;</code></p><p><code>1612</code><code>Cossu et al., 2001&lt;/a&gt;</code></p><p><code>1613</code><code>) or to release dopamine in the nucleus accumbens in response to morphine (&lt;a href="#R771" rid="R771" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918898"&gt;</code></p><p><code>1614</code><code>Mascia et al., 1999&lt;/a&gt;</code></p><p><code>1615</code><code>), suggesting that the site of this synergism is in the mesolimbic dopaminergic pathway, which is involved in both drug and food reward (&lt;a href="#R667" rid="R667" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919044"&gt;</code></p><p><code>1616</code><code>Le Foll and Goldberg, 2005&lt;/a&gt;</code></p><p><code>1617</code><code>). The observation that SR141716 inhibits the orexigenic effect of morphine microinjected into the hypothalamic paraventricular nucleus but not the nucleus accumbens shell suggests additional interactions between the two systems, unrelated to the hedonic aspects of feeding (&lt;a href="#R1228" rid="R1228" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919263"&gt;</code></p><p><code>1618</code><code>Verty et al., 2003&lt;/a&gt;</code></p><p><code>1619</code><code>). A further intriguing parallel between the two systems is that opiate &lt;em&gt;</code></p><p><code>1620</code><code>&amp;#x003bc;&lt;/em&gt;</code></p><p><code>1621</code><code> receptor knockout mice, just as CB&lt;sub&gt;</code></p><p><code>1622</code><code>1&lt;/sub&gt;</code></p><p><code>1623</code><code>&lt;sup&gt;</code></p><p><code>1624</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1625</code><code> mice (see below), are resistant to diet-induced obesity (&lt;a href="#R1160" rid="R1160" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919110"&gt;</code></p><p><code>1626</code><code>Tabarin et al., 2005&lt;/a&gt;</code></p><p><code>1627</code><code>).&lt;/p&gt;</code></p><p><code>1628</code><code>&lt;p id="P32"&gt;</code></p><p><code>1629</code><code>As for interactions with NPY, the similar effectiveness of SR141716 to inhibit food intake in wild-type and NPY&lt;sup&gt;</code></p><p><code>1630</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1631</code><code> mice indicates that endocannabinoids are unlikely to be the primary compensatory factor that accounts for the lack of a lean phenotype in NPY&lt;sup&gt;</code></p><p><code>1632</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1633</code><code> mice (&lt;a href="#R274" rid="R274" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920252"&gt;</code></p><p><code>1634</code><code>Di Marzo et al., 2001b&lt;/a&gt;</code></p><p><code>1635</code><code>). However, anandamide was found to increase and AM251 to decrease depolarization-induced NPY release in rat hypothalamic explants, suggesting that NPY may contribute to the orexigenic effects of cannabinoids (&lt;a href="#R358" rid="R358" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919042"&gt;</code></p><p><code>1636</code><code>Gamber et al., 2005&lt;/a&gt;</code></p><p><code>1637</code><code>). A possible role of orexins in the appetitive effects of endocannabinoids is suggested by the finding that coexpression of the CB&lt;sub&gt;</code></p><p><code>1638</code><code>1&lt;/sub&gt;</code></p><p><code>1639</code><code> and orexin 1 receptors results in a marked potentiation of orexin A-induced signaling (&lt;a href="#R492" rid="R492" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920063"&gt;</code></p><p><code>1640</code><code>Hilairet et al., 2003&lt;/a&gt;</code></p><p><code>1641</code><code>). An important site of action of the orexigenic peptide ghrelin is the hypothalamic paraventricular nucleus, where its hyperphagic effect can be blocked by SR141716, suggesting that ghrelin may act via the release of endocannabinoids (&lt;a href="#R1193" rid="R1193" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919801"&gt;</code></p><p><code>1642</code><code>Tucci et al., 2004&lt;/a&gt;</code></p><p><code>1643</code><code>). Endocannabinoids, in turn, may be involved in ghrelin release, at least in the periphery, as suggested by an SR141716-induced decrease in plasma ghrelin levels in rats (&lt;a href="#R151" rid="R151" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920290"&gt;</code></p><p><code>1644</code><code>Cani et al., 2004&lt;/a&gt;</code></p><p><code>1645</code><code>).&lt;/p&gt;</code></p><p><code>1646</code><code>&lt;p id="P33" class="p p-last"&gt;</code></p><p><code>1647</code><code>The proopiomelanocortin-derived peptide &lt;em&gt;</code></p><p><code>1648</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>1649</code><code>-MSH acting at MC-4 melanocortin receptors is part of the leptin-regulated appetitive circuitry as a major anorectic mediator. The observations that SR141716 inhibits the feeding response induced by blocking MC-4 receptors, whereas &lt;em&gt;</code></p><p><code>1650</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>1651</code><code>-MSH does not affect THC-induced feeding, suggest that CB&lt;sub&gt;</code></p><p><code>1652</code><code>1&lt;/sub&gt;</code></p><p><code>1653</code><code> receptors are downstream from MC-4 receptors and have an obligatory role in &lt;em&gt;</code></p><p><code>1654</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>1655</code><code>-MSH effects on food intake (&lt;a href="#R1227" rid="R1227" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919845"&gt;</code></p><p><code>1656</code><code>Verty et al., 2004&lt;/a&gt;</code></p><p><code>1657</code><code>). The peptide product of CART is also a tonically active anorectic mediator (&lt;a href="#R628" rid="R628" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919748"&gt;</code></p><p><code>1658</code><code>Kristensen et al., 1998&lt;/a&gt;</code></p><p><code>1659</code><code>) and, unlike &lt;em&gt;</code></p><p><code>1660</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>1661</code><code>-MSH, may be a downstream mediator of the effect of endocannabinoids. Such an arrangement is suggested by the finding that SR141716 loses its ability to reduce food intake in CART&lt;sup&gt;</code></p><p><code>1662</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1663</code><code> mice (&lt;a href="#R914" rid="R914" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918766"&gt;</code></p><p><code>1664</code><code>Osei-Hyiaman et al., 2005a&lt;/a&gt;</code></p><p><code>1665</code><code>). Furthermore, mice deficient in FAAH have reduced levels of CART immunoreactivity in various hypothalamic and extrahypothalamic regions involved in appetite control, which is returned to normal levels by chronic SR141716 treatment (&lt;a href="#R914" rid="R914" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918785"&gt;</code></p><p><code>1666</code><code>Osei-Hyiaman et al., 2005a&lt;/a&gt;</code></p><p><code>1667</code><code>). These findings suggest that inhibition of CART release by CB&lt;sub&gt;</code></p><p><code>1668</code><code>1&lt;/sub&gt;</code></p><p><code>1669</code><code> activation may be involved in the orexigenic effect of anandamide. Finally, an interaction between endocannabinoids and CRH is indirectly suggested by coexpression of the mRNA for the CB&lt;sub&gt;</code></p><p><code>1670</code><code>1&lt;/sub&gt;</code></p><p><code>1671</code><code> receptor with the mRNA for CRH (&lt;a href="#R215" rid="R215" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920154"&gt;</code></p><p><code>1672</code><code>Cota et al., 2003&lt;/a&gt;</code></p><p><code>1673</code><code>) or the CRH type 1 receptor (&lt;a href="#R487" rid="R487" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918866"&gt;</code></p><p><code>1674</code><code>Hermann and Lutz, 2005&lt;/a&gt;</code></p><p><code>1675</code><code>).&lt;/p&gt;</code></p><p><code>1676</code><code>&lt;/div&gt;</code></p><p><code>1677</code><code>&lt;div id="S9" class="sec"&gt;</code></p><p><code>1678</code><code>&lt;p&gt;</code></p><p><code>1679</code><code>&lt;/p&gt;</code></p><p><code>1680</code><code>&lt;h4 id="S9title" class="inline"&gt;</code></p><p><code>1681</code><code>2. Endocannabinoids and Peripheral Energy Metabolism &lt;/h4&gt;</code></p><p><code>1682</code><code>&lt;p id="P34" class="p p-first"&gt;</code></p><p><code>1683</code><code>It is generally accepted that energy intake and utilization are regulated in a coordinated fashion, and factors involved in the central regulation of appetite may also affect peripheral energy metabolism (&lt;a href="#R1084" rid="R1084" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653437"&gt;</code></p><p><code>1684</code><code>Seeley and Woods, 2003&lt;/a&gt;</code></p><p><code>1685</code><code>). The first indirect indication that cannabinoids may affect energy homeostasis through a mechanism other than food intake came from a study of marijuana smokers tested in a hospital inpatient setting (&lt;a href="#R428" rid="R428" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919599"&gt;</code></p><p><code>1686</code><code>Greenberg et al., 1976&lt;/a&gt;</code></p><p><code>1687</code><code>). In this study, the marijuana-induced increase in caloric intake leveled off after a few days, whereas weight gain continued throughout the rest of the 21-day observation period, suggesting independent effects on appetite and peripheral energy metabolism. After the introduction of SR141716 as the first selective CB&lt;sub&gt;</code></p><p><code>1688</code><code>1&lt;/sub&gt;</code></p><p><code>1689</code><code> receptor antagonist (&lt;a href="#R1019" rid="R1019" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919499"&gt;</code></p><p><code>1690</code><code>Rinaldi-Carmona et al., 1994&lt;/a&gt;</code></p><p><code>1691</code><code>), a similar conclusion was reached in normal rats treated with SR141716 for 14 days. Tolerance to the anorectic effect of SR141716 developed within 5 days, whereas the reduction in body weight was maintained throughout the treatment period (&lt;a href="#R194" rid="R194" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919161"&gt;</code></p><p><code>1692</code><code>Colombo et al., 1998a&lt;/a&gt;</code></p><p><code>1693</code><code>). Later, similar observations were reported in mice with diet-induced obesity, in which food intake was reduced transiently whereas the reduction in body weight was maintained when the animals were chronically treated with SR141716 (&lt;a href="#R1000" rid="R1000" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653471"&gt;</code></p><p><code>1694</code><code>Ravinet Trillou et al., 2003&lt;/a&gt;</code></p><p><code>1695</code><code>) or AM251 (&lt;a href="#R493" rid="R493" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919633"&gt;</code></p><p><code>1696</code><code>Hildebrandt et al., 2003&lt;/a&gt;</code></p><p><code>1697</code><code>). These results suggested that factors other than appetite must be involved in the weight-reducing effect of CB&lt;sub&gt;</code></p><p><code>1698</code><code>1&lt;/sub&gt;</code></p><p><code>1699</code><code> antagonists.&lt;/p&gt;</code></p><p><code>1700</code><code>&lt;p id="P35"&gt;</code></p><p><code>1701</code><code>Peripheral targets of endocannabinoids include adipocytes, which express CB&lt;sub&gt;</code></p><p><code>1702</code><code>1&lt;/sub&gt;</code></p><p><code>1703</code><code> receptors (&lt;a href="#R67" rid="R67" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919093"&gt;</code></p><p><code>1704</code><code>Bensaid et al., 2003&lt;/a&gt;</code></p><p><code>1705</code><code>; &lt;a href="#R215" rid="R215" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919685"&gt;</code></p><p><code>1706</code><code>Cota et al., 2003&lt;/a&gt;</code></p><p><code>1707</code><code>). Stimulation of CB&lt;sub&gt;</code></p><p><code>1708</code><code>1&lt;/sub&gt;</code></p><p><code>1709</code><code> receptors on adipocytes can affect lipid metabolism through regulating the level of adiponectin production (&lt;a href="#R67" rid="R67" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920147"&gt;</code></p><p><code>1710</code><code>Bensaid et al., 2003&lt;/a&gt;</code></p><p><code>1711</code><code>), by increasing lipoprotein lipase activity (&lt;a href="#R215" rid="R215" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919396"&gt;</code></p><p><code>1712</code><code>Cota et al., 2003&lt;/a&gt;</code></p><p><code>1713</code><code>), or by inhibiting AMP-activated protein kinase (AMPK) (&lt;a href="#R620" rid="R620" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919982"&gt;</code></p><p><code>1714</code><code>Kola et al., 2005&lt;/a&gt;</code></p><p><code>1715</code><code>), which leads to increased lipogenesis and decrease in fatty acid &lt;em&gt;</code></p><p><code>1716</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>1717</code><code>-oxidation through reducing the phosphorylation and thus disinhibiting acetyl CoA carboxylase-1 (ACC1), the rate-limiting enzyme in fatty acid synthesis. The work by &lt;a href="#R215" rid="R215" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919490"&gt;</code></p><p><code>1718</code><code>Cota et al. (2003)&lt;/a&gt;</code></p><p><code>1719</code><code> provided the first clear evidence of peripheral metabolic targets of endocannabinoids in vivo in a mouse model of diet-induced obesity. By careful analysis of body composition, they were able to establish the lean phenotype of CB&lt;sub&gt;</code></p><p><code>1720</code><code>1&lt;/sub&gt;</code></p><p><code>1721</code><code>-deficient mice that had escaped earlier attention. Furthermore, the use of a pair-feeding paradigm revealed that hypophagia accounts for the lean phenotype only in young and not in adult animals, which clearly indicated the involvement of peripheral metabolic target(s) in the latter. The additional documentation of functional CB&lt;sub&gt;</code></p><p><code>1722</code><code>1&lt;/sub&gt;</code></p><p><code>1723</code><code> receptors in primary cultured adipocytes and their role in regulating lipogenesis provided one of the likely peripheral targets for the anabolic effects of endocannabinoids. The lean phenotype of CB&lt;sub&gt;</code></p><p><code>1724</code><code>1&lt;/sub&gt;</code></p><p><code>1725</code><code>&lt;sup&gt;</code></p><p><code>1726</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1727</code><code> mice in this study was more prominent in male than in female animals, which could suggest that endocannabinoid regulation of adiposity may be subject to modulation by sex hormones.&lt;/p&gt;</code></p><p><code>1728</code><code>&lt;p id="P36"&gt;</code></p><p><code>1729</code><code>Although earlier studies failed to detect CB&lt;sub&gt;</code></p><p><code>1730</code><code>1&lt;/sub&gt;</code></p><p><code>1731</code><code> receptors in the liver, more recently they have been identified in the mouse liver using a combination of methods including reverse transcription-polymerase chain reaction, in situ hybridization, immunohistochemistry, and Western blotting. In the same study, treatment of mice with the cannabinoid agonist HU-210 increased de novo lipogenesis and the expression of the transcription factor sterol regulatory element binding protein 1c (SREBP1c) as well as of its targets, ACC1 and fatty acid synthase (&lt;a href="#R915" rid="R915" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919045"&gt;</code></p><p><code>1732</code><code>Osei-Hyiaman et al., 2005b&lt;/a&gt;</code></p><p><code>1733</code><code>). The role of CB&lt;sub&gt;</code></p><p><code>1734</code><code>1&lt;/sub&gt;</code></p><p><code>1735</code><code> receptors in these effects was indicated by the ability of SR141716 to block them and by their absence in CB&lt;sub&gt;</code></p><p><code>1736</code><code>1&lt;/sub&gt;</code></p><p><code>1737</code><code> knockout mice (&lt;a href="#R915" rid="R915" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919294"&gt;</code></p><p><code>1738</code><code>Osei-Hyiaman et al., 2005b&lt;/a&gt;</code></p><p><code>1739</code><code>). The hepatic lipogenic pathway may be also directly activated through a cannabinoid-induced decrease in AMPK phosphorylation and activity in the liver (&lt;a href="#R620" rid="R620" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919799"&gt;</code></p><p><code>1740</code><code>Kola et al., 2005&lt;/a&gt;</code></p><p><code>1741</code><code>). CB&lt;sub&gt;</code></p><p><code>1742</code><code>1&lt;/sub&gt;</code></p><p><code>1743</code><code> receptors have been also detected in rat hepatocytes (&lt;a href="#R830" rid="R830" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919635"&gt;</code></p><p><code>1744</code><code>Michalopoulos et al., 2003&lt;/a&gt;</code></p><p><code>1745</code><code>), in whole mouse liver (&lt;a href="#R81" rid="R81" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919520"&gt;</code></p><p><code>1746</code><code>Biecker et al., 2004&lt;/a&gt;</code></p><p><code>1747</code><code>), and in rat and human hepatic stellate cells (&lt;a href="#R1103" rid="R1103" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920122"&gt;</code></p><p><code>1748</code><code>Siegmund et al., 2005&lt;/a&gt;</code></p><p><code>1749</code><code>; &lt;a href="#R1171" rid="R1171" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919574"&gt;</code></p><p><code>1750</code><code>Teixeira-Clerc et al., 2006&lt;/a&gt;</code></p><p><code>1751</code><code>).&lt;/p&gt;</code></p><p><code>1752</code><code>&lt;p id="P37"&gt;</code></p><p><code>1753</code><code>Fatty acid metabolism in hypothalamic neurons acts as a sensor of nutrient availability (&lt;a href="#R901" rid="R901" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920155"&gt;</code></p><p><code>1754</code><code>Obici et al., 2003&lt;/a&gt;</code></p><p><code>1755</code><code>), and its pharmacological modulation influences food intake (&lt;a href="#R603" rid="R603" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920331"&gt;</code></p><p><code>1756</code><code>Kim et al., 2004&lt;/a&gt;</code></p><p><code>1757</code><code>). CB&lt;sub&gt;</code></p><p><code>1758</code><code>1&lt;/sub&gt;</code></p><p><code>1759</code><code> activation was reported to increase &lt;em&gt;</code></p><p><code>1760</code><code>SREBP1c&lt;/em&gt;</code></p><p><code>1761</code><code> and &lt;em&gt;</code></p><p><code>1762</code><code>FAS&lt;/em&gt;</code></p><p><code>1763</code><code> gene expression in the hypothalamus, and the increased expression of these genes by fasting/refeeding (&lt;a href="#R953" rid="R953" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919881"&gt;</code></p><p><code>1764</code><code>Paulaskis and Sul, 1988&lt;/a&gt;</code></p><p><code>1765</code><code>) could be inhibited by SR141716 treatment at the beginning of the refeeding period, which also reduced food intake (&lt;a href="#R915" rid="R915" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918993"&gt;</code></p><p><code>1766</code><code>Osei-Hyiaman et al., 2005b&lt;/a&gt;</code></p><p><code>1767</code><code>). Although fatty acid synthesis was not measured directly in the hypothalamus, these findings suggest that the increase in food intake after fasting may involve a CB&lt;sub&gt;</code></p><p><code>1768</code><code>1&lt;/sub&gt;</code></p><p><code>1769</code><code>-mediated modulation of the fatty acid synthetic pathway. Modulation of AMPK activity by cannabinoids was documented not only in liver and adipose tissue but also in hypothalamus (&lt;a href="#R620" rid="R620" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919897"&gt;</code></p><p><code>1770</code><code>Kola et al., 2005&lt;/a&gt;</code></p><p><code>1771</code><code>), where it has been linked to appetite control (&lt;a href="#R837" rid="R837" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919877"&gt;</code></p><p><code>1772</code><code>Minokoshi et al., 2004&lt;/a&gt;</code></p><p><code>1773</code><code>). Thus, the AMPK/ACC1/FAS pathway may represent a common molecular pathway involved in both the central appetitive and the peripheral metabolic effects of endocannabinoids.&lt;/p&gt;</code></p><p><code>1774</code><code>&lt;p id="P38"&gt;</code></p><p><code>1775</code><code>Because total caloric intake is similar in wild-type and CB&lt;sub&gt;</code></p><p><code>1776</code><code>1&lt;/sub&gt;</code></p><p><code>1777</code><code>&lt;sup&gt;</code></p><p><code>1778</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1779</code><code> mice on a high-fat diet (&lt;a href="#R1001" rid="R1001" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653385"&gt;</code></p><p><code>1780</code><code>Ravinet Trillou et al., 2004&lt;/a&gt;</code></p><p><code>1781</code><code>; &lt;a href="#R915" rid="R915" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919787"&gt;</code></p><p><code>1782</code><code>Osei-Hyiaman et al., 2005b&lt;/a&gt;</code></p><p><code>1783</code><code>), the resistance of CB&lt;sub&gt;</code></p><p><code>1784</code><code>1&lt;/sub&gt;</code></p><p><code>1785</code><code>-deficient mice to diet-induced obesity must be associated with increased energy expenditure. Exposing wild-type C57BL6/J mice to a high-fat diet decreases energy expenditure, as documented by indirect calorimetry (&lt;a href="#R528" rid="R528" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920380"&gt;</code></p><p><code>1786</code><code>Hu et al., 2004&lt;/a&gt;</code></p><p><code>1787</code><code>), which may account for the increase in feed efficiency observed in such animals, whereas in CB&lt;sub&gt;</code></p><p><code>1788</code><code>1&lt;/sub&gt;</code></p><p><code>1789</code><code>&lt;sup&gt;</code></p><p><code>1790</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1791</code><code> mice feed efficiency was unaffected by a high-fat diet (&lt;a href="#R915" rid="R915" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919678"&gt;</code></p><p><code>1792</code><code>Osei-Hyiaman et al., 2005b&lt;/a&gt;</code></p><p><code>1793</code><code>). This suggests that the high-fat diet-induced decrease in energy expenditure is mediated by endocannabinoid activation of CB&lt;sub&gt;</code></p><p><code>1794</code><code>1&lt;/sub&gt;</code></p><p><code>1795</code><code> receptors. Accordingly, HU-210 treatment of wild-type mice decreased and SR141716 treatment increased the activity of carnitine palmitoyl transferase-1, the rate-limiting enzyme in fatty acid &lt;em&gt;</code></p><p><code>1796</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>1797</code><code>-oxidation (D. Osei-Hyiaman and G. Kunos, unpublished observations).&lt;/p&gt;</code></p><p><code>1798</code><code>&lt;p id="P39"&gt;</code></p><p><code>1799</code><code>One of the factors involved in this effect in vivo could be adiponectin, the adipocyte-derived hormone that promotes fatty acid &lt;em&gt;</code></p><p><code>1800</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>1801</code><code>-oxidation (&lt;a href="#R1304" rid="R1304" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920271"&gt;</code></p><p><code>1802</code><code>Yamauchi et al., 2002&lt;/a&gt;</code></p><p><code>1803</code><code>). Indeed, exposure to a high-fat diet resulted in a significant decline in plasma adiponectin in wild-type but not in CB&lt;sub&gt;</code></p><p><code>1804</code><code>1&lt;/sub&gt;</code></p><p><code>1805</code><code>&lt;sup&gt;</code></p><p><code>1806</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1807</code><code> mice (&lt;a href="#R914" rid="R914" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919172"&gt;</code></p><p><code>1808</code><code>Osei-Hyiaman et al., 2005a&lt;/a&gt;</code></p><p><code>1809</code><code>), and CB&lt;sub&gt;</code></p><p><code>1810</code><code>1&lt;/sub&gt;</code></p><p><code>1811</code><code> receptor activation in isolated adipocytes was found to suppress adiponectin expression (Perwitz et al., 2005; &lt;a href="#R780" rid="R780" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_393488951"&gt;</code></p><p><code>1812</code><code>Matias et al., 2006&lt;/a&gt;</code></p><p><code>1813</code><code>). Expression of the thermogenic uncoupling protein-1 was also down-regulated by CB&lt;sub&gt;</code></p><p><code>1814</code><code>1&lt;/sub&gt;</code></p><p><code>1815</code><code> activation, whereas the expression of the insulin-mimetic adipokine visfatin was increased (Perwitz et al., 2005). Conversely, rimonabant increases adiponectin secretion by adipocytes (&lt;a href="#R67" rid="R67" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919532"&gt;</code></p><p><code>1816</code><code>Bensaid et al., 2003&lt;/a&gt;</code></p><p><code>1817</code><code>) and adiponectin plasma levels in obese human subjects (&lt;a href="#R260" rid="R260" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919057"&gt;</code></p><p><code>1818</code><code>Despr&amp;#x000e9;s et al., 2005&lt;/a&gt;</code></p><p><code>1819</code><code>), which should lead to increased lipid &lt;em&gt;</code></p><p><code>1820</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>1821</code><code>-oxidation and thermogenesis in vivo. Chronic treatment of &lt;em&gt;</code></p><p><code>1822</code><code>ob&lt;/em&gt;</code></p><p><code>1823</code><code>/&lt;em&gt;</code></p><p><code>1824</code><code>ob&lt;/em&gt;</code></p><p><code>1825</code><code> mice with SR141716 increased thermogenesis, as indicated by increased oxygen consumption at a thermoneutral temperature measured by whole body calorimetry (&lt;a href="#R698" rid="R698" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653396"&gt;</code></p><p><code>1826</code><code>Liu et al., 2005&lt;/a&gt;</code></p><p><code>1827</code><code>). Glucose uptake, subsequently measured in the isolated soleus muscle of these animals, was significantly increased in the SR141716-pretreated group. A similar effect in humans may account for the increased glucose tolerance observed in obese patients treated with rimonabant (&lt;a href="#R1216" rid="R1216" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918922"&gt;</code></p><p><code>1828</code><code>Van Gaal et al., 2005&lt;/a&gt;</code></p><p><code>1829</code><code>). These observations could suggest the presence of CB&lt;sub&gt;</code></p><p><code>1830</code><code>1&lt;/sub&gt;</code></p><p><code>1831</code><code> receptors in skeletal muscle, which was recently documented (&lt;a href="#R930" rid="R930" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919224"&gt;</code></p><p><code>1832</code><code>Pagotto et al., 2006&lt;/a&gt;</code></p><p><code>1833</code><code>). Alternatively, increased glucose tolerance may be secondary to an effect of SR141716 on CB&lt;sub&gt;</code></p><p><code>1834</code><code>1&lt;/sub&gt;</code></p><p><code>1835</code><code> receptors in the liver. It has been proposed that increased lipid synthesis in the liver may produce insulin resistance in other tissues such as muscle (&lt;a href="#R793" rid="R793" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653454"&gt;</code></p><p><code>1836</code><code>McGarry, 1992&lt;/a&gt;</code></p><p><code>1837</code><code>), and CB&lt;sub&gt;</code></p><p><code>1838</code><code>1&lt;/sub&gt;</code></p><p><code>1839</code><code> receptor activation has been shown to contribute to the development of hepatic steatosis in diet-induced obesity (&lt;a href="#R915" rid="R915" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919380"&gt;</code></p><p><code>1840</code><code>Osei-Hyiaman et al., 2005b&lt;/a&gt;</code></p><p><code>1841</code><code>). Endocannabinoids may also influence insulin secretion directly in islet &lt;em&gt;</code></p><p><code>1842</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>1843</code><code>-cells via CB&lt;sub&gt;</code></p><p><code>1844</code><code>1&lt;/sub&gt;</code></p><p><code>1845</code><code> (&lt;a href="#R780" rid="R780" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_393488945"&gt;</code></p><p><code>1846</code><code>Matias et al., 2006&lt;/a&gt;</code></p><p><code>1847</code><code>) or CB&lt;sub&gt;</code></p><p><code>1848</code><code>2&lt;/sub&gt;</code></p><p><code>1849</code><code> receptors (&lt;a href="#R576" rid="R576" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919573"&gt;</code></p><p><code>1850</code><code>Juan-Pico et al., 2005&lt;/a&gt;</code></p><p><code>1851</code><code>).&lt;/p&gt;</code></p><p><code>1852</code><code>&lt;p id="P40" class="p p-last"&gt;</code></p><p><code>1853</code><code>The ability of rimonabant to increase energy expenditure may not be limited to an effect on adiponectin secretion, as indicated by an analysis of the effect of rimonabant treatment on gene expression profiles in lean and diet-induced obese mice as well as CB&lt;sub&gt;</code></p><p><code>1854</code><code>1&lt;/sub&gt;</code></p><p><code>1855</code><code>&lt;sup&gt;</code></p><p><code>1856</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1857</code><code> mice (&lt;a href="#R559" rid="R559" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919431"&gt;</code></p><p><code>1858</code><code>Jbilo et al., 2005&lt;/a&gt;</code></p><p><code>1859</code><code>). Rimonabant-induced decreases in body weight and adipose tissue mass in obese mice was accompanied by a near-complete reversal of obesity-induced changes in the expression of a wide range of genes. These included genes involved in adipocyte differentiation, lipolysis, generation of futile cycles, and glycolysis. These broad-based targets may underlie the ability of rimonabant to correct symptoms of the metabolic syndrome, as discussed below. They also raise the intriguing possibility that if a CB&lt;sub&gt;</code></p><p><code>1860</code><code>1&lt;/sub&gt;</code></p><p><code>1861</code><code> antagonist that does not cross the blood-brain barrier were available, it could be effective in the treatment of the metabolic syndrome without the risk of adverse CNS side effects (Horvath, 2006).&lt;/p&gt;</code></p><p><code>1862</code><code>&lt;/div&gt;</code></p><p><code>1863</code><code>&lt;div id="S10" class="sec"&gt;</code></p><p><code>1864</code><code>&lt;p&gt;</code></p><p><code>1865</code><code>&lt;/p&gt;</code></p><p><code>1866</code><code>&lt;h4 id="S10title" class="inline"&gt;</code></p><p><code>1867</code><code>3. Obesity and Associated Metabolic Abnormalities &lt;/h4&gt;</code></p><p><code>1868</code><code>&lt;p id="P41" class="p p-first"&gt;</code></p><p><code>1869</code><code>Genetic manipulation of the expression of endogenous proteins has been instrumental in uncovering their regulatory role in normal and pathological phenotypes. When CB&lt;sub&gt;</code></p><p><code>1870</code><code>1&lt;/sub&gt;</code></p><p><code>1871</code><code> knockout mice were first introduced, no change in body mass or feeding pattern had been noted (&lt;a href="#R668" rid="R668" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653501"&gt;</code></p><p><code>1872</code><code>Ledent et al., 1999&lt;/a&gt;</code></p><p><code>1873</code><code>; &lt;a href="#R1325" rid="R1325" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920339"&gt;</code></p><p><code>1874</code><code>Zimmer et al., 1999&lt;/a&gt;</code></p><p><code>1875</code><code>). However, in a subsequent study, CB&lt;sub&gt;</code></p><p><code>1876</code><code>1&lt;/sub&gt;</code></p><p><code>1877</code><code> knockout mice were found to have a life-long, small, but significant, weight deficit compared with their wild-type littermates, which could be attributed to a selective deficit in adipose tissue mass (&lt;a href="#R215" rid="R215" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920278"&gt;</code></p><p><code>1878</code><code>Cota et al., 2003&lt;/a&gt;</code></p><p><code>1879</code><code>) and was confirmed by others (&lt;a href="#R1001" rid="R1001" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653368"&gt;</code></p><p><code>1880</code><code>Ravinet Trillou et al., 2004&lt;/a&gt;</code></p><p><code>1881</code><code>; &lt;a href="#R915" rid="R915" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920177"&gt;</code></p><p><code>1882</code><code>Osei-Hyiaman et al., 2005b&lt;/a&gt;</code></p><p><code>1883</code><code>). Parallel to their decreased fat mass, CB&lt;sub&gt;</code></p><p><code>1884</code><code>1&lt;/sub&gt;</code></p><p><code>1885</code><code>&lt;sup&gt;</code></p><p><code>1886</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1887</code><code> mice have lower plasma leptin levels and an increased sensitivity to the anorectic effect of exogenous leptin (&lt;a href="#R1001" rid="R1001" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653394"&gt;</code></p><p><code>1888</code><code>Ravinet Trillou et al., 2004&lt;/a&gt;</code></p><p><code>1889</code><code>).&lt;/p&gt;</code></p><p><code>1890</code><code>&lt;p id="P42"&gt;</code></p><p><code>1891</code><code>The possibility that an increase in the activity of the endocannabinoid system may contribute to at least some forms of obesity was suggested by three sets of findings. First, CB&lt;sub&gt;</code></p><p><code>1892</code><code>1&lt;/sub&gt;</code></p><p><code>1893</code><code> antagonists were significantly more efficacious in reducing caloric intake and body weight in rodents with diet-induced or genetic obesity than in their respective lean controls (&lt;a href="#R274" rid="R274" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920222"&gt;</code></p><p><code>1894</code><code>Di Marzo et al., 2001b&lt;/a&gt;</code></p><p><code>1895</code><code>; &lt;a href="#R493" rid="R493" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918709"&gt;</code></p><p><code>1896</code><code>Hildebrandt et al., 2003&lt;/a&gt;</code></p><p><code>1897</code><code>; &lt;a href="#R1000" rid="R1000" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653488"&gt;</code></p><p><code>1898</code><code>Ravinet Trillouet et al., 2003&lt;/a&gt;</code></p><p><code>1899</code><code>; &lt;a href="#R1230" rid="R1230" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919210"&gt;</code></p><p><code>1900</code><code>Vickers et al., 2003&lt;/a&gt;</code></p><p><code>1901</code><code>).&lt;/p&gt;</code></p><p><code>1902</code><code>&lt;p id="P43"&gt;</code></p><p><code>1903</code><code>Second, CB&lt;sub&gt;</code></p><p><code>1904</code><code>1&lt;/sub&gt;</code></p><p><code>1905</code><code>&lt;sup&gt;</code></p><p><code>1906</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1907</code><code> mice are resistant to diet-induced obesity (&lt;a href="#R1001" rid="R1001" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653434"&gt;</code></p><p><code>1908</code><code>Ravinet Trillou et al., 2004&lt;/a&gt;</code></p><p><code>1909</code><code>; &lt;a href="#R915" rid="R915" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920043"&gt;</code></p><p><code>1910</code><code>Osei-Hyiaman et al., 2005b&lt;/a&gt;</code></p><p><code>1911</code><code>). In both of these studies, overall caloric intake was not different between wild-type compared with CB&lt;sub&gt;</code></p><p><code>1912</code><code>1&lt;/sub&gt;</code></p><p><code>1913</code><code>&lt;sup&gt;</code></p><p><code>1914</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1915</code><code> mice receiving the high-fat diet, suggesting that peripheral mechanisms play a dominant role in the control of body weight by CB&lt;sub&gt;</code></p><p><code>1916</code><code>1&lt;/sub&gt;</code></p><p><code>1917</code><code> receptors. CB&lt;sub&gt;</code></p><p><code>1918</code><code>1&lt;/sub&gt;</code></p><p><code>1919</code><code>&lt;sup&gt;</code></p><p><code>1920</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>1921</code><code> mice are also resistant to the metabolic changes that accompany diet-induced obesity in normal mice, including hypertriglyceridemia and elevated plasma leptin and insulin levels, indicative of leptin and insulin resistance, respectively (&lt;a href="#R1001" rid="R1001" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653402"&gt;</code></p><p><code>1922</code><code>Ravinet Trillou et al., 2004&lt;/a&gt;</code></p><p><code>1923</code><code>; &lt;a href="#R915" rid="R915" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920100"&gt;</code></p><p><code>1924</code><code>Osei-Hyiaman et al., 2005b&lt;/a&gt;</code></p><p><code>1925</code><code>). These metabolic changes, collectively defined by some as the &amp;#x0201c;metabolic syndrome&amp;#x0201d;, could also be reversed by SR141716 treatment (&lt;a href="#R1001" rid="R1001" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653376"&gt;</code></p><p><code>1926</code><code>Ravinet Trillou et al., 2004&lt;/a&gt;</code></p><p><code>1927</code><code>; &lt;a href="#R975" rid="R975" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653518"&gt;</code></p><p><code>1928</code><code>Poirier et al., 2005&lt;/a&gt;</code></p><p><code>1929</code><code>).&lt;/p&gt;</code></p><p><code>1930</code><code>&lt;p id="P44"&gt;</code></p><p><code>1931</code><code>As a third line of evidence, recent findings indicate that endocannabinoids and CB&lt;sub&gt;</code></p><p><code>1932</code><code>1&lt;/sub&gt;</code></p><p><code>1933</code><code> receptors are up-regulated in the liver and adipose tissue in various forms of experimental as well as in human obesity. In wild-type mice on a high-fat diet for 3 weeks, the basal rate of de novo hepatic fatty acid synthesis was markedly increased, and the increase was partially reversed by SR141716 treatment (&lt;a href="#R915" rid="R915" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920114"&gt;</code></p><p><code>1934</code><code>Osei-Hyiaman et al., 2005b&lt;/a&gt;</code></p><p><code>1935</code><code>). After 3 weeks of diet, the mice were not yet overweight but showed significant hepatic steatosis. Their hepatic content of anandamide was increased 3-fold, and the level of CB&lt;sub&gt;</code></p><p><code>1936</code><code>1&lt;/sub&gt;</code></p><p><code>1937</code><code> receptor protein in liver plasma membranes was also markedly increased (&lt;a href="#R915" rid="R915" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919159"&gt;</code></p><p><code>1938</code><code>Osei-Hyiaman et al., 2005b&lt;/a&gt;</code></p><p><code>1939</code><code>). These findings indicate that intake of a high-fat diet activates the hepatic endocannabinoid system, which contributes to increased lipogenesis and the subsequent development of hepatic steatosis and, ultimately, the development of obesity. Exposure of C57BL6/J mice to a high-fat diet has been reported to induce changes characteristic of the metabolic syndrome and also to rapidly induce the expression of SREBP1c and its downstream target lipogenic enzymes (&lt;a href="#R79" rid="R79" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919617"&gt;</code></p><p><code>1940</code><code>Biddinger et al., 2005&lt;/a&gt;</code></p><p><code>1941</code><code>). CB&lt;sub&gt;</code></p><p><code>1942</code><code>1&lt;/sub&gt;</code></p><p><code>1943</code><code> receptor knockout mice are resistant to these diet-induced changes, which indicates that endocannabinoids have a major role in mediating them (&lt;a href="#R915" rid="R915" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919592"&gt;</code></p><p><code>1944</code><code>Osei-Hyiaman et al., 2005b&lt;/a&gt;</code></p><p><code>1945</code><code>).&lt;/p&gt;</code></p><p><code>1946</code><code>&lt;p id="P45"&gt;</code></p><p><code>1947</code><code>An up-regulation of CB&lt;sub&gt;</code></p><p><code>1948</code><code>1&lt;/sub&gt;</code></p><p><code>1949</code><code> receptors has been also reported in adipose tissue of genetically obese compared with lean mice (&lt;a href="#R67" rid="R67" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920249"&gt;</code></p><p><code>1950</code><code>Bensaid et al., 2003&lt;/a&gt;</code></p><p><code>1951</code><code>), and elevated endocannabinoid levels have been detected in adipose tissue of obese compared with lean patients (&lt;a href="#R780" rid="R780" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_393488946"&gt;</code></p><p><code>1952</code><code>Matias et al., 2006&lt;/a&gt;</code></p><p><code>1953</code><code>). In a study involving 40 women (&lt;a href="#R302" rid="R302" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918957"&gt;</code></p><p><code>1954</code><code>Engeli et al., 2005&lt;/a&gt;</code></p><p><code>1955</code><code>), circulating levels of anandamide and 2-AG were significantly increased in 20 obese versus 20 lean subjects, and remained elevated after a 5% diet-induced weight reduction. Although these plasma levels were much too low to exert hormone-like activity, they probably originate from overflow from tissues and thus may reflect functionally relevant changes in endocannabinoid content at or near sites of action. In the same study, FAAH expression was markedly reduced in the adipose tissue of obese subjects and correlated negatively with circulating endocannabinoid levels. Furthermore, the expression of both CB&lt;sub&gt;</code></p><p><code>1956</code><code>1&lt;/sub&gt;</code></p><p><code>1957</code><code> and FAAH increased in mature adipocytes compared with preadipocytes. These findings suggest that the endocannabinoid system is activated in human obesity (&lt;a href="#R302" rid="R302" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919534"&gt;</code></p><p><code>1958</code><code>Engeli et al., 2005&lt;/a&gt;</code></p><p><code>1959</code><code>).&lt;/p&gt;</code></p><p><code>1960</code><code>&lt;p id="P46"&gt;</code></p><p><code>1961</code><code>A genetic missense polymorphism in the &lt;em&gt;</code></p><p><code>1962</code><code>FAAH&lt;/em&gt;</code></p><p><code>1963</code><code> gene predicting a proline to threonine substitution at position 129, which was reported to result in reduced cellular expression and activity of the enzyme (&lt;a href="#R179" rid="R179" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653487"&gt;</code></p><p><code>1964</code><code>Chiang et al., 2004&lt;/a&gt;</code></p><p><code>1965</code><code>), had been earlier found to be significantly associated with problem drug use (&lt;a href="#R1111" rid="R1111" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918901"&gt;</code></p><p><code>1966</code><code>Sipe et al., 2002&lt;/a&gt;</code></p><p><code>1967</code><code>). The same polymorphism has been linked to overweight and obesity in both Caucasian and African-American subjects (&lt;a href="#R1112" rid="R1112" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653503"&gt;</code></p><p><code>1968</code><code>Sipe et al., 2005&lt;/a&gt;</code></p><p><code>1969</code><code>). Interestingly, the elevated hepatic levels of anandamide in mice receiving a high-fat diet could be attributed to a decrease in FAAH activity (&lt;a href="#R915" rid="R915" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918838"&gt;</code></p><p><code>1970</code><code>Osei-Hyiaman et al., 2005b&lt;/a&gt;</code></p><p><code>1971</code><code>), suggesting that FAAH may play a key role in regulating endocannabinoid &amp;#x0201c;tone&amp;#x0201d; in both experimental and human obesity. Although this finding could suggest the targeting of FAAH in the treatment of eating/metabolic disorders, such an approach will be complicated by the fact that oleylethanolamide, an anorectic lipid that acts on the peroxisome proliferator-proliferator-activated receptor &lt;em&gt;</code></p><p><code>1972</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>1973</code><code> (PPAR&lt;em&gt;</code></p><p><code>1974</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>1975</code><code>) (&lt;a href="#R352" rid="R352" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919418"&gt;</code></p><p><code>1976</code><code>Fu et al., 2003&lt;/a&gt;</code></p><p><code>1977</code><code>), is also a substrate for FAAH. The opposing effects of elevated levels of both anandamide and oleylethanolamide after pharmacological blockade of FAAH may therefore result in no net change in appetite and energy metabolism.&lt;/p&gt;</code></p><p><code>1978</code><code>&lt;p id="P47"&gt;</code></p><p><code>1979</code><code>That increased endocannabinoid activity may also contribute to obesity and its metabolic consequences in humans was indicated by the highly promising results of recent clinical trials with rimonabant. As in the animal models of diet-induced obesity, rimonabant was effective both in reducing body weight and in reversing many of the associated metabolic abnormalities in obese subjects. In a multicenter, phase III study involving 1507 obese European subjects with a body mass index &amp;#x0003e;30 kg/m&lt;sup&gt;</code></p><p><code>1980</code><code>2&lt;/sup&gt;</code></p><p><code>1981</code><code> or a body mass index &amp;#x0003e;27 kg/m&lt;sup&gt;</code></p><p><code>1982</code><code>2&lt;/sup&gt;</code></p><p><code>1983</code><code> with dyslipidemia and moderate hypertension, rimonabant (20 mg/day) treatment for 1 year, combined with a moderately hypocaloric diet, not only reduced body weight but also reduced plasma triglycerides, increased HDL cholesterol, and decreased plasma insulin and insulin resistance (&lt;a href="#R1216" rid="R1216" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920282"&gt;</code></p><p><code>1984</code><code>Van Gaal et al., 2005&lt;/a&gt;</code></p><p><code>1985</code><code>). Blood pressure was not significantly affected. The parallel reduction in body weight and waist circumference suggested that the weight loss was predominantly due to loss of visceral fat, which is known to be a predisposing factor for the metabolic syndrome. Rimonabant was well tolerated, with mild to moderate nausea, diarrhea, and mood disorders occurring slightly more in the treatment group than in the placebo group (&lt;a href="#R1216" rid="R1216" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919099"&gt;</code></p><p><code>1986</code><code>Van Gaal et al., 2005&lt;/a&gt;</code></p><p><code>1987</code><code>).&lt;/p&gt;</code></p><p><code>1988</code><code>&lt;p id="P48"&gt;</code></p><p><code>1989</code><code>Essentially similar findings were reported in another large-scale, phase III study (RIO-North America) involving 3045 randomized, obese or overweight subjects. At the end of the 1st year, rimonabant-treated subjects were re-randomized to receive rimonabant or placebo, whereas the placebo group continued onto receive the placebo. During the 2nd year, rimonabant-treated patients retained the improvements achieved during the 1st year, whereas those who switched to placebo regained their original weight (&lt;a href="#R968" rid="R968" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653458"&gt;</code></p><p><code>1990</code><code>Pi-Sunyer et al., 2006&lt;/a&gt;</code></p><p><code>1991</code><code>).&lt;/p&gt;</code></p><p><code>1992</code><code>&lt;p id="P49"&gt;</code></p><p><code>1993</code><code>In a third study (RIO-Lipids) involving 1036 overweight/obese subjects, 20 mg/day rimonabant taken for 1 year significantly reduced body weight (&amp;#x02212;6.3 &amp;#x000b1; 0.5 kg), weight circumference (&amp;#x02212;5.7 &amp;#x000b1; 0.6 cm), and plasma triglycerides (&amp;#x02212;12.4 &amp;#x000b1; 3.2%), increased HDL cholesterol by 8.1 &amp;#x000b1; 1.5% and increased LDL particle size, improved glucose tolerance, and significantly elevated plasma adiponectin levels, resulting in a 50% decrease in the prevalence of the metabolic syndrome in the study population (&lt;a href="#R260" rid="R260" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918883"&gt;</code></p><p><code>1994</code><code>Despr&amp;#x000e9;s et al., 2005&lt;/a&gt;</code></p><p><code>1995</code><code>). In contrast with the other two studies, a statistically significant, small decrease in systolic and diastolic blood pressure was evident in the group receiving 20 mg of rimonabant, and the decrease was greater for patients with initial hypertension (blood pressure &amp;#x0003e;140/90 mm Hg). Although the reason for the lack of a blood pressure change in the other studies is not clear, the proportion of females was lower in RIO-Lipids (~60%) than in the other two studies where they represented ~80% of subjects. It is possible that a modest reduction in blood pressure by rimonabant occurs preferentially in males. The cumulative finding that blood pressure reduction, if present, is less than expected based on a similar level of weight reduction alone (&lt;a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653354"&gt;</code></p><p><code>1996</code><code>Appel et al., 2003&lt;/a&gt;</code></p><p><code>1997</code><code>), is noteworthy. As discussed in section D.1., rimonabant at an i.v. dose of 3 mg/kg causes a pressor response in anesthetized, hypertensive rats, which are supersensitive to the hypotensive effect of endogenous or exogenous anandamide (&lt;a href="#R51" rid="R51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653455"&gt;</code></p><p><code>1998</code><code>B&amp;#x000e1;tkai et al., 2004&lt;/a&gt;</code></p><p><code>1999</code><code>). Although the pressor effect is much smaller at lower doses of rimonabant comparable with the 20-mg oral dose used in humans or in the absence of anesthesia (S. B&amp;#x000e1;tkai, P. Pacher, and G. Kunos, unpublished observations), careful monitoring of blood pressure, particularly in the early stages of rimonabant treatment, may be advisable. A polymorphism in the &lt;em&gt;</code></p><p><code>2000</code><code>FAAH&lt;/em&gt;</code></p><p><code>2001</code><code> gene is associated with obesity (&lt;a href="#R1112" rid="R1112" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653444"&gt;</code></p><p><code>2002</code><code>Sipe et al., 2005&lt;/a&gt;</code></p><p><code>2003</code><code>), and because of the reduced enzyme activity resulting from this polymorphism, some of the affected individuals may have an elevated endocannabinoid tone, reversal of which by rimonabant could increase blood pressure.&lt;/p&gt;</code></p><p><code>2004</code><code>&lt;p id="P50"&gt;</code></p><p><code>2005</code><code>It is noteworthy that part of the rimonabant-induced improvements in the hormonal and lipid abnormalities in the three clinical studies appeared to be independent of weight reduction and, based on the preclinical findings discussed above, are most likely mediated via peripheral sites of action. An interesting alternative mechanism is suggested by the results of a recent meta-analysis of the effects of low carbohydrate, nonenergy-restricted diets on weight loss and cardiovascular risk factors (&lt;a href="#R896" rid="R896" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918774"&gt;</code></p><p><code>2006</code><code>Nordmann et al., 2006&lt;/a&gt;</code></p><p><code>2007</code><code>). Such diets were found to lead to significant weight loss for up to 1 year. Surprisingly, they were more favorable than low-fat diets in reducing plasma triglycerides and increasing HDL cholesterol levels, without a favorable effect on total or LDL cholesterol. The pattern of these metabolic changes is similar to that of those caused by 20 mg of rimonabant in the three clinical trials. Rimonabant has been shown to preferentially suppress the preference for sweet compared with normal (&lt;a href="#R1108" rid="R1108" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919943"&gt;</code></p><p><code>2008</code><code>Simiand et al., 1998&lt;/a&gt;</code></p><p><code>2009</code><code>) or high-fat reinforcers (&lt;a href="#R1271" rid="R1271" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920267"&gt;</code></p><p><code>2010</code><code>Ward and Dykstra, 2005&lt;/a&gt;</code></p><p><code>2011</code><code>) and can cause longer lasting suppression of intake of sweet compared with normal food (&lt;a href="#R384" rid="R384" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919898"&gt;</code></p><p><code>2012</code><code>Gessa et al., 2006&lt;/a&gt;</code></p><p><code>2013</code><code>). It is very possible that obese subjects treated with rimonabant unwittingly altered their diet by reducing carbohydrate intake, which may have contributed to the observed effects on triglycerides and HDL cholesterol. Detailed analyses of the effects of rimonabant on dietary habits are warranted.&lt;/p&gt;</code></p><p><code>2014</code><code>&lt;p id="P51" class="p p-last"&gt;</code></p><p><code>2015</code><code>Overall, the findings in these three large, multicenter clinical trials strongly support a pathogenic role of increased endocannabinoid activity in obesity and the associated metabolic abnormalities and highlight the unique therapeutic potential of CB&lt;sub&gt;</code></p><p><code>2016</code><code>1&lt;/sub&gt;</code></p><p><code>2017</code><code> blockade. Additional benefits may be gained by combination therapies. The efficacy of statins to preferentially lower LDL cholesterol may be effectively complemented by the ability of rimonabant to increase HDL cholesterol. In the case of insulin, the ability of rimonabant ability to increase insulin sensitivity could reduce the dose requirement for insulin in obese diabetic subjects and could also counteract the tendency of insulin treatment to cause weight gain. Nevertheless, further large-scale studies are warranted in view of the high nonadherence rate observed in the three clinical trials to date, which may have resulted in overestimation of the benefits of treatment (&lt;a href="#R1109" rid="R1109" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653405"&gt;</code></p><p><code>2018</code><code>Simons-Morton et al., 2006&lt;/a&gt;</code></p><p><code>2019</code><code>).&lt;/p&gt;</code></p><p><code>2020</code><code>&lt;/div&gt;</code></p><p><code>2021</code><code>&lt;div id="S11" class="sec sec-last"&gt;</code></p><p><code>2022</code><code>&lt;p&gt;</code></p><p><code>2023</code><code>&lt;/p&gt;</code></p><p><code>2024</code><code>&lt;h4 id="S11title" class="inline"&gt;</code></p><p><code>2025</code><code>4. Cachexia and Anorexia &lt;/h4&gt;</code></p><p><code>2026</code><code>&lt;p id="P52" class="p p-first"&gt;</code></p><p><code>2027</code><code>A negative energy balance resulting from decreased appetite and food intake and increased energy expenditure, leading to weight loss, can be the consequence of wasting diseases such as AIDS or metastatic cancer, or it could be associated with aging, chemotherapy of cancer, or neuropsychiatric conditions such as anorexia nervosa or various forms of dementia including Alzheimer&amp;#x02019;s disease. Although there is a growing body of evidence documenting the therapeutic effectiveness of synthetic THC or even smoked marijuana as appetite boosters in some of these conditions (&lt;a href="#R1005" rid="R1005" class=" bibr popnode"&gt;</code></p><p><code>2028</code><code>Regelson et al., 1976&lt;/a&gt;</code></p><p><code>2029</code><code>; &lt;a href="#R420" rid="R420" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920247"&gt;</code></p><p><code>2030</code><code>Gorter et al., 1992&lt;/a&gt;</code></p><p><code>2031</code><code>; &lt;a href="#R884" rid="R884" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919890"&gt;</code></p><p><code>2032</code><code>Nelson et al., 1994&lt;/a&gt;</code></p><p><code>2033</code><code>; &lt;a href="#R54" rid="R54" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919109"&gt;</code></p><p><code>2034</code><code>Beal et al., 1995&lt;/a&gt;</code></p><p><code>2035</code><code>, &lt;a href="#R55" rid="R55" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919369"&gt;</code></p><p><code>2036</code><code>1997&lt;/a&gt;</code></p><p><code>2037</code><code>; &lt;a href="#R1183" rid="R1183" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919091"&gt;</code></p><p><code>2038</code><code>Timpone et al., 1997&lt;/a&gt;</code></p><p><code>2039</code><code>) (&lt;a href="/pmc/articles/PMC2241751/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""&gt;</code></p><p><code>2040</code><code>&lt;span&gt;</code></p><p><code>2041</code><code>Table 1&lt;/span&gt;</code></p><p><code>2042</code><code>&lt;/a&gt;</code></p><p><code>2043</code><code>), there is only limited information on the potential involvement of the endocannabinoid system in their pathogenesis.&lt;/p&gt;</code></p><p><code>2044</code><code>&lt;!--table ft1--&gt;</code></p><p><code>2045</code><code>&lt;!--table-wrap mode="anchored" t5--&gt;</code></p><p><code>2046</code><code>&lt;div class="table-wrap anchored whole_rhythm" id="T1"&gt;</code></p><p><code>2047</code><code>&lt;h3&gt;</code></p><p><code>2048</code><code>TABLE 1&lt;/h3&gt;</code></p><p><code>2049</code><code>&lt;!--caption a7--&gt;</code></p><p><code>2050</code><code>&lt;div class="caption"&gt;</code></p><p><code>2051</code><code>&lt;p id="__p8"&gt;</code></p><p><code>2052</code><code>Clinical trials with cannabinoid-related medications in human disease&lt;/p&gt;</code></p><p><code>2053</code><code>&lt;/div&gt;</code></p><p><code>2054</code><code>&lt;div data-largeobj="" data-largeobj-link-rid="largeobj_idm139779462195728" class="xtable"&gt;</code></p><p><code>2055</code><code>&lt;table frame="hsides" rules="groups" class="rendered small default_table"&gt;</code></p><p><code>2056</code><code>&lt;thead&gt;</code></p><p><code>2057</code><code>&lt;tr&gt;</code></p><p><code>2058</code><code>&lt;th align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2059</code><code>Disease/Condition&lt;/th&gt;</code></p><p><code>2060</code><code>&lt;th align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2061</code><code>Sample Size, Design, Target Symptoms&lt;/th&gt;</code></p><p><code>2062</code><code>&lt;th align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2063</code><code>Compound (Dose)&lt;/th&gt;</code></p><p><code>2064</code><code>&lt;th align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2065</code><code>Parameters Studied&lt;/th&gt;</code></p><p><code>2066</code><code>&lt;th align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2067</code><code>Results&lt;/th&gt;</code></p><p><code>2068</code><code>&lt;th align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2069</code><code>Adverse Effects&lt;/th&gt;</code></p><p><code>2070</code><code>&lt;th align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2071</code><code>Reference&lt;/th&gt;</code></p><p><code>2072</code><code>&lt;/tr&gt;</code></p><p><code>2073</code><code>&lt;/thead&gt;</code></p><p><code>2074</code><code>&lt;tbody&gt;</code></p><p><code>2075</code><code>&lt;tr&gt;</code></p><p><code>2076</code><code>&lt;td colspan="7" align="left" rowspan="1"&gt;</code></p><p><code>2077</code><code>&lt;strong&gt;</code></p><p><code>2078</code><code>MS and SCI&lt;/strong&gt;</code></p><p><code>2079</code><code>&lt;/td&gt;</code></p><p><code>2080</code><code>&lt;/tr&gt;</code></p><p><code>2081</code><code>&lt;tr&gt;</code></p><p><code>2082</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2083</code><code>&amp;#x02003;MS&lt;/td&gt;</code></p><p><code>2084</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2085</code><code>Nine patients, DB, PL, spasticity&lt;/td&gt;</code></p><p><code>2086</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2087</code><code>THC (5- and 10-mg single-dose p.o.)&lt;/td&gt;</code></p><p><code>2088</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2089</code><code>EMG, clinical&lt;/td&gt;</code></p><p><code>2090</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2091</code><code>Improved spasticity score (objective)&lt;/td&gt;</code></p><p><code>2092</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2093</code><code>Minimal&lt;/td&gt;</code></p><p><code>2094</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2095</code><code>&lt;a href="#R966" rid="R966" class=" bibr popnode"&gt;</code></p><p><code>2096</code><code>Petro and Ellenberger (1981)&lt;/a&gt;</code></p><p><code>2097</code><code>&lt;/td&gt;</code></p><p><code>2098</code><code>&lt;/tr&gt;</code></p><p><code>2099</code><code>&lt;tr&gt;</code></p><p><code>2100</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2101</code><code>&amp;#x02003;MS&lt;/td&gt;</code></p><p><code>2102</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2103</code><code>Eight patients, SB, PL, tremor, ataxia&lt;/td&gt;</code></p><p><code>2104</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2105</code><code>THC (5 mg/6 h max three doses p.o.)&lt;/td&gt;</code></p><p><code>2106</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2107</code><code>Clinical&lt;/td&gt;</code></p><p><code>2108</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2109</code><code>Improved coordination and sense of well being, decreased tremor (subjective)&lt;/td&gt;</code></p><p><code>2110</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2111</code><code>Subjective &amp;#x0201c;high&amp;#x0201d; in all patients&lt;/td&gt;</code></p><p><code>2112</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2113</code><code>&lt;a href="#R187" rid="R187" class=" bibr popnode"&gt;</code></p><p><code>2114</code><code>Clifford (1983)&lt;/a&gt;</code></p><p><code>2115</code><code>&lt;/td&gt;</code></p><p><code>2116</code><code>&lt;/tr&gt;</code></p><p><code>2117</code><code>&lt;tr&gt;</code></p><p><code>2118</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2119</code><code>&amp;#x02003;MS&lt;/td&gt;</code></p><p><code>2120</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2121</code><code>13 patients, DB, PL, C, spasticity&lt;/td&gt;</code></p><p><code>2122</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2123</code><code>THC (2.5&amp;#x02013;15 mg daily for 5 days p.o.)&lt;/td&gt;</code></p><p><code>2124</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2125</code><code>Clinical, questionnaire&lt;/td&gt;</code></p><p><code>2126</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2127</code><code>Reduced spasticity (subjective); objective function tests not improved&lt;/td&gt;</code></p><p><code>2128</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2129</code><code>Common&lt;/td&gt;</code></p><p><code>2130</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2131</code><code>&lt;a href="#R1204" rid="R1204" class=" bibr popnode"&gt;</code></p><p><code>2132</code><code>Ungerleider et al. (1987)&lt;/a&gt;</code></p><p><code>2133</code><code>&lt;/td&gt;</code></p><p><code>2134</code><code>&lt;/tr&gt;</code></p><p><code>2135</code><code>&lt;tr&gt;</code></p><p><code>2136</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2137</code><code>&amp;#x02003;MS&lt;/td&gt;</code></p><p><code>2138</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2139</code><code>One patient, OL, spastic tetraparesis&lt;/td&gt;</code></p><p><code>2140</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2141</code><code>Cigarette smoke marijuana (one cigarette)&lt;/td&gt;</code></p><p><code>2142</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2143</code><code>Clinical, tremor recording, EMG&lt;/td&gt;</code></p><p><code>2144</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2145</code><code>Reduced ataxia and spasticity (objective)&lt;/td&gt;</code></p><p><code>2146</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2147</code><code>None&lt;/td&gt;</code></p><p><code>2148</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2149</code><code>&lt;a href="#R814" rid="R814" class=" bibr popnode"&gt;</code></p><p><code>2150</code><code>Meinck et al. (1989)&lt;/a&gt;</code></p><p><code>2151</code><code>&lt;/td&gt;</code></p><p><code>2152</code><code>&lt;/tr&gt;</code></p><p><code>2153</code><code>&lt;tr&gt;</code></p><p><code>2154</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2155</code><code>&amp;#x02003;MS&lt;/td&gt;</code></p><p><code>2156</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2157</code><code>10 patients, DB, C, spasticity&lt;/td&gt;</code></p><p><code>2158</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2159</code><code>Cigarette smoke marijuana (one cigarette; 1.54% THC)&lt;/td&gt;</code></p><p><code>2160</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2161</code><code>Dynamic posturography, objective balance&lt;/td&gt;</code></p><p><code>2162</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2163</code><code>Impaired posture and balance&lt;/td&gt;</code></p><p><code>2164</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2165</code><code>Subjective unpleasant &amp;#x0201c;high&amp;#x0201d; in all patients&lt;/td&gt;</code></p><p><code>2166</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2167</code><code>&lt;a href="#R427" rid="R427" class=" bibr popnode"&gt;</code></p><p><code>2168</code><code>Greenberg et al. (1994)&lt;/a&gt;</code></p><p><code>2169</code><code>&lt;/td&gt;</code></p><p><code>2170</code><code>&lt;/tr&gt;</code></p><p><code>2171</code><code>&lt;tr&gt;</code></p><p><code>2172</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2173</code><code>&amp;#x02003;MS&lt;/td&gt;</code></p><p><code>2174</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2175</code><code>One patient, DB, PL, C, spasticity&lt;/td&gt;</code></p><p><code>2176</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2177</code><code>Nabilone (1 mg/2 days for 16 wk p.o.)&lt;/td&gt;</code></p><p><code>2178</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2179</code><code>Visual analog scales&lt;/td&gt;</code></p><p><code>2180</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2181</code><code>Improved painful muscle spasms, mood and well being (subjective); reduced frequency of nocturia&lt;/td&gt;</code></p><p><code>2182</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2183</code><code>Mild sedation&lt;/td&gt;</code></p><p><code>2184</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2185</code><code>&lt;a href="#R770" rid="R770" class=" bibr popnode"&gt;</code></p><p><code>2186</code><code>Martyn et al. (1995)&lt;/a&gt;</code></p><p><code>2187</code><code>&lt;/td&gt;</code></p><p><code>2188</code><code>&lt;/tr&gt;</code></p><p><code>2189</code><code>&lt;tr&gt;</code></p><p><code>2190</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2191</code><code>&amp;#x02003;MS and SCI&lt;/td&gt;</code></p><p><code>2192</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2193</code><code>Two patients, OL, spasticity&lt;/td&gt;</code></p><p><code>2194</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2195</code><code>THC (10 or 15 mg p.o. or rectal)&lt;/td&gt;</code></p><p><code>2196</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2197</code><code>Clinical&lt;/td&gt;</code></p><p><code>2198</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2199</code><code>Improved walking ability and passive mobility, reduced rigidity, slight pain relief&lt;/td&gt;</code></p><p><code>2200</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2201</code><code>Temporal deterioration in ability to concentrate and in mood&lt;/td&gt;</code></p><p><code>2202</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2203</code><code>&lt;a href="#R120" rid="R120" class=" bibr popnode"&gt;</code></p><p><code>2204</code><code>Brenneisen et al. (1996)&lt;/a&gt;</code></p><p><code>2205</code><code>&lt;/td&gt;</code></p><p><code>2206</code><code>&lt;/tr&gt;</code></p><p><code>2207</code><code>&lt;tr&gt;</code></p><p><code>2208</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2209</code><code>&amp;#x02003;MS&lt;/td&gt;</code></p><p><code>2210</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2211</code><code>One patient, PL, nystagmus&lt;/td&gt;</code></p><p><code>2212</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2213</code><code>Cigarette smoke marijuana (inhaled)&lt;/td&gt;</code></p><p><code>2214</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2215</code><code>Eye movement recording&lt;/td&gt;</code></p><p><code>2216</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2217</code><code>Reduced nystagmus amplitude and improved visual acuity&lt;/td&gt;</code></p><p><code>2218</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2219</code><code>None&lt;/td&gt;</code></p><p><code>2220</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2221</code><code>&lt;a href="#R1079" rid="R1079" class=" bibr popnode"&gt;</code></p><p><code>2222</code><code>Schon et al. (1999)&lt;/a&gt;</code></p><p><code>2223</code><code>&lt;/td&gt;</code></p><p><code>2224</code><code>&lt;/tr&gt;</code></p><p><code>2225</code><code>&lt;tr&gt;</code></p><p><code>2226</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2227</code><code>&amp;#x02003;MS&lt;/td&gt;</code></p><p><code>2228</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2229</code><code>16 patients, DB, PL, C, spasticity&lt;/td&gt;</code></p><p><code>2230</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2231</code><code>Plant extract of THC (2.5&amp;#x02013;5 mg b.i.d. for 4 wk p.o.)&lt;/td&gt;</code></p><p><code>2232</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2233</code><code>Clinical, questionnaires, Ashworth score&lt;/td&gt;</code></p><p><code>2234</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2235</code><code>No improvement in Ashworth scale, worsening global impression&lt;/td&gt;</code></p><p><code>2236</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2237</code><code>41 adverse events in 16 patients during plant extract treatment&lt;/td&gt;</code></p><p><code>2238</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2239</code><code>&lt;a href="#R600" rid="R600" class=" bibr popnode"&gt;</code></p><p><code>2240</code><code>Killestein et al. (2002)&lt;/a&gt;</code></p><p><code>2241</code><code>&lt;/td&gt;</code></p><p><code>2242</code><code>&lt;/tr&gt;</code></p><p><code>2243</code><code>&lt;tr&gt;</code></p><p><code>2244</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2245</code><code>&amp;#x02003;MS and SCI&lt;/td&gt;</code></p><p><code>2246</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2247</code><code>24 patients, DB, PL, C, heterogeneous&lt;/td&gt;</code></p><p><code>2248</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2249</code><code>Plant extract of THC and CBD 1:1 (2.5&amp;#x02013;120 mg/day for 2 wk sublingual)&lt;/td&gt;</code></p><p><code>2250</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2251</code><code>Clinical, questionnaires&lt;/td&gt;</code></p><p><code>2252</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2253</code><code>Improvement of bladder control, muscle spasms, and spasticity and pain relief (subjective) but no in Ashworth scale&lt;/td&gt;</code></p><p><code>2254</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2255</code><code>4 dropouts due to adverse events&lt;/td&gt;</code></p><p><code>2256</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2257</code><code>&lt;a href="#R1245" rid="R1245" class=" bibr popnode"&gt;</code></p><p><code>2258</code><code>Wade et al. (2003)&lt;/a&gt;</code></p><p><code>2259</code><code>&lt;/td&gt;</code></p><p><code>2260</code><code>&lt;/tr&gt;</code></p><p><code>2261</code><code>&lt;tr&gt;</code></p><p><code>2262</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2263</code><code>&amp;#x02003;MS&lt;/td&gt;</code></p><p><code>2264</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2265</code><code>630 patients, DB, R, PL, spasticity&lt;/td&gt;</code></p><p><code>2266</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2267</code><code>Cannabis extract (Cannador: 2.5 mg &amp;#x00394;&lt;sup&gt;</code></p><p><code>2268</code><code>9&lt;/sup&gt;</code></p><p><code>2269</code><code>-THC + 1.25 mg CBD/capsule; Marinol: THC max 25 mg/day for 15 wk p.o.)&lt;/td&gt;</code></p><p><code>2270</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2271</code><code>Clinical, questionnaires Ashworth score, Rivermead Mobility Index&lt;/td&gt;</code></p><p><code>2272</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2273</code><code>No change in the Ashworthscore, but improvement in the patient-reported spasticity, pain, and sleep quality; unexpected reduction in hospital admission for relapse in the treatment groups; in 12-mo follow-up, THC improved muscle spasticity measured by the Ashworth scale and the Rivermead Mobility Index&lt;/td&gt;</code></p><p><code>2274</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2275</code><code>Minimal, similar to placebo&lt;/td&gt;</code></p><p><code>2276</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2277</code><code>&lt;a href="#R1312" rid="R1312" class=" bibr popnode"&gt;</code></p><p><code>2278</code><code>Zajicek et al. (2003&lt;/a&gt;</code></p><p><code>2279</code><code>, &lt;a href="#R1311" rid="R1311" class=" bibr popnode"&gt;</code></p><p><code>2280</code><code>2004)&lt;/a&gt;</code></p><p><code>2281</code><code>&lt;/td&gt;</code></p><p><code>2282</code><code>&lt;/tr&gt;</code></p><p><code>2283</code><code>&lt;tr&gt;</code></p><p><code>2284</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2285</code><code>&amp;#x02003;MS&lt;/td&gt;</code></p><p><code>2286</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2287</code><code>57 patients, DB, R, PL, C, spasticity, various&lt;/td&gt;</code></p><p><code>2288</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2289</code><code>Cannabis-based capsules (2.5 mg THC and 0.9 mg CBD; max dose 30 mg/day THC p.o.)&lt;/td&gt;</code></p><p><code>2290</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2291</code><code>Self-report of spasm frequency and symptoms, Ashworth Scale, Rivermead Mobility Index, 10-m timed walk&lt;/td&gt;</code></p><p><code>2292</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2293</code><code>Improved spasm frequency and mobility in the 37 patients who received at least 90% of their prescribed dose&lt;/td&gt;</code></p><p><code>2294</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2295</code><code>Minor adverse events were slightly more frequent in treated group&lt;/td&gt;</code></p><p><code>2296</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2297</code><code>&lt;a href="#R1215" rid="R1215" class=" bibr popnode"&gt;</code></p><p><code>2298</code><code>Vaney et al. (2004)&lt;/a&gt;</code></p><p><code>2299</code><code>&lt;/td&gt;</code></p><p><code>2300</code><code>&lt;/tr&gt;</code></p><p><code>2301</code><code>&lt;tr&gt;</code></p><p><code>2302</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2303</code><code>&amp;#x02003;MS&lt;/td&gt;</code></p><p><code>2304</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2305</code><code>14 patients, DB, PL, tremor&lt;/td&gt;</code></p><p><code>2306</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2307</code><code>Cannabis extract (Cannador: 2.5 mg &amp;#x00394;&lt;sup&gt;</code></p><p><code>2308</code><code>9&lt;/sup&gt;</code></p><p><code>2309</code><code>-THC + 1.25 mg CBD/capsule p.o. for 2 wk)&lt;/td&gt;</code></p><p><code>2310</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2311</code><code>Tremor index, measured using a validated tremor rating scale&lt;/td&gt;</code></p><p><code>2312</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2313</code><code>No effects on tremor&lt;/td&gt;</code></p><p><code>2314</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2315</code><code>Minimal&lt;/td&gt;</code></p><p><code>2316</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2317</code><code>&lt;a href="#R336" rid="R336" class=" bibr popnode"&gt;</code></p><p><code>2318</code><code>Fox et al. (2004)&lt;/a&gt;</code></p><p><code>2319</code><code>&lt;/td&gt;</code></p><p><code>2320</code><code>&lt;/tr&gt;</code></p><p><code>2321</code><code>&lt;tr&gt;</code></p><p><code>2322</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2323</code><code>&amp;#x02003;MS&lt;/td&gt;</code></p><p><code>2324</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2325</code><code>57 patients, DB, R, PL, C, spasticity, various&lt;/td&gt;</code></p><p><code>2326</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2327</code><code>Cannabis-based capsules (2.5 mg THC and 0.9 mg CBD; max dose 30 mg/day THC p.o.)&lt;/td&gt;</code></p><p><code>2328</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2329</code><code>Self-report of spasm frequency and symptoms, Ashworth Scale, Rivermead Mobility Index, 10-m timed walk&lt;/td&gt;</code></p><p><code>2330</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2331</code><code>Improved spasm frequency and mobility in the 37 patients who received at least 90% of their prescribed dose&lt;/td&gt;</code></p><p><code>2332</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2333</code><code>Minor adverse events were slightly more frequent in treated group&lt;/td&gt;</code></p><p><code>2334</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2335</code><code>&lt;a href="#R1215" rid="R1215" class=" bibr popnode"&gt;</code></p><p><code>2336</code><code>Vaney et al. (2004)&lt;/a&gt;</code></p><p><code>2337</code><code>&lt;/td&gt;</code></p><p><code>2338</code><code>&lt;/tr&gt;</code></p><p><code>2339</code><code>&lt;tr&gt;</code></p><p><code>2340</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2341</code><code>&amp;#x02003;MS&lt;/td&gt;</code></p><p><code>2342</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2343</code><code>14 patients, DB, PL, tremor&lt;/td&gt;</code></p><p><code>2344</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2345</code><code>Cannabis extract (Cannador: 2.5 mg &amp;#x00394;&lt;sup&gt;</code></p><p><code>2346</code><code>9&lt;/sup&gt;</code></p><p><code>2347</code><code>-THC + 1.25 mg CBD/capsule p.o. for 2 wk)&lt;/td&gt;</code></p><p><code>2348</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2349</code><code>Tremor index, measured using a validated tremor rating scale&lt;/td&gt;</code></p><p><code>2350</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2351</code><code>No effects on tremor&lt;/td&gt;</code></p><p><code>2352</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2353</code><code>Minimal&lt;/td&gt;</code></p><p><code>2354</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2355</code><code>&lt;a href="#R336" rid="R336" class=" bibr popnode"&gt;</code></p><p><code>2356</code><code>Fox et al. (2004)&lt;/a&gt;</code></p><p><code>2357</code><code>&lt;/td&gt;</code></p><p><code>2358</code><code>&lt;/tr&gt;</code></p><p><code>2359</code><code>&lt;tr&gt;</code></p><p><code>2360</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2361</code><code>&amp;#x02003;MS&lt;/td&gt;</code></p><p><code>2362</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2363</code><code>160 patients, DB, PL, R, M, VAS score for each patient&amp;#x02019;s most troublesome symptom&lt;/td&gt;</code></p><p><code>2364</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2365</code><code>GW-1000 (Sativex) delivered by oromucosal spray (2.7 mg &amp;#x00394;&lt;sup&gt;</code></p><p><code>2366</code><code>9&lt;/sup&gt;</code></p><p><code>2367</code><code>-THC and 2.5 mg CBD at each actuation)&lt;/td&gt;</code></p><p><code>2368</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2369</code><code>VAS score for each patient&amp;#x02019;s most troublesome symptom, Ashworth Scale&lt;/td&gt;</code></p><p><code>2370</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2371</code><code>No significant difference in the Ashworth scale, tremor, and pain at 6 wk between the Sativex and placebo groups; improved VAS scores for spasticity&lt;/td&gt;</code></p><p><code>2372</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2373</code><code>Minimal&lt;/td&gt;</code></p><p><code>2374</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2375</code><code>&lt;a href="#R1244" rid="R1244" class=" bibr popnode"&gt;</code></p><p><code>2376</code><code>Wade et al. (2004)&lt;/a&gt;</code></p><p><code>2377</code><code>&lt;/td&gt;</code></p><p><code>2378</code><code>&lt;/tr&gt;</code></p><p><code>2379</code><code>&lt;tr&gt;</code></p><p><code>2380</code><code>&lt;td colspan="7" align="left" rowspan="1"&gt;</code></p><p><code>2381</code><code>&lt;strong&gt;</code></p><p><code>2382</code><code>Pain (see also MS above)&lt;/strong&gt;</code></p><p><code>2383</code><code>&lt;/td&gt;</code></p><p><code>2384</code><code>&lt;/tr&gt;</code></p><p><code>2385</code><code>&lt;tr&gt;</code></p><p><code>2386</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2387</code><code>&amp;#x02003;Cancer&lt;/td&gt;</code></p><p><code>2388</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2389</code><code>10 patients, P, non-R, non-DB, pain&lt;/td&gt;</code></p><p><code>2390</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2391</code><code>THC (5, 10, 15, or 20 mg p.o.)&lt;/td&gt;</code></p><p><code>2392</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2393</code><code>Cancer-associated pain&lt;/td&gt;</code></p><p><code>2394</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2395</code><code>Superior to PL&lt;/td&gt;</code></p><p><code>2396</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2397</code><code>Common at higher doses&lt;/td&gt;</code></p><p><code>2398</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2399</code><code>&lt;a href="#R898" rid="R898" class=" bibr popnode"&gt;</code></p><p><code>2400</code><code>Noyes et al. (1975a)&lt;/a&gt;</code></p><p><code>2401</code><code>&lt;/td&gt;</code></p><p><code>2402</code><code>&lt;/tr&gt;</code></p><p><code>2403</code><code>&lt;tr&gt;</code></p><p><code>2404</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2405</code><code>&amp;#x02003;Cancer&lt;/td&gt;</code></p><p><code>2406</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2407</code><code>34 patients, P, non-R, C, pain&lt;/td&gt;</code></p><p><code>2408</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2409</code><code>THC (20 mg, codeine 120 mg p.o.)&lt;/td&gt;</code></p><p><code>2410</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2411</code><code>Cancer-associated pain&lt;/td&gt;</code></p><p><code>2412</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2413</code><code>Both superior to PL&lt;/td&gt;</code></p><p><code>2414</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2415</code><code>Common with THC&lt;/td&gt;</code></p><p><code>2416</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2417</code><code>&lt;a href="#R899" rid="R899" class=" bibr popnode"&gt;</code></p><p><code>2418</code><code>Noyes et al. (1975b)&lt;/a&gt;</code></p><p><code>2419</code><code>&lt;/td&gt;</code></p><p><code>2420</code><code>&lt;/tr&gt;</code></p><p><code>2421</code><code>&lt;tr&gt;</code></p><p><code>2422</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2423</code><code>&amp;#x02003;Cancer&lt;/td&gt;</code></p><p><code>2424</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2425</code><code>45 patients, DB, C, P, pain&lt;/td&gt;</code></p><p><code>2426</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2427</code><code>NIB (4 mg, codeine 50 mg, secobarbital 50 mg)&lt;/td&gt;</code></p><p><code>2428</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2429</code><code>Cancer associated pain&lt;/td&gt;</code></p><p><code>2430</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2431</code><code>NIB equal to codeine, superior to secobarbital and PL&lt;/td&gt;</code></p><p><code>2432</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2433</code><code>Common&lt;/td&gt;</code></p><p><code>2434</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2435</code><code>&lt;a href="#R1134" rid="R1134" class=" bibr popnode"&gt;</code></p><p><code>2436</code><code>Staquet et al. (1978)&lt;/a&gt;</code></p><p><code>2437</code><code>&lt;/td&gt;</code></p><p><code>2438</code><code>&lt;/tr&gt;</code></p><p><code>2439</code><code>&lt;tr&gt;</code></p><p><code>2440</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2441</code><code>&amp;#x02003;Dental extraction&lt;/td&gt;</code></p><p><code>2442</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2443</code><code>10 patients, DB, R, PL&lt;/td&gt;</code></p><p><code>2444</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2445</code><code>THC (0.022, 0044 mg, diazepam 0.157 mg/kg i.v.)&lt;/td&gt;</code></p><p><code>2446</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2447</code><code>Surgical pain&lt;/td&gt;</code></p><p><code>2448</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2449</code><code>THC superior to PL, inferior to diazepam&lt;/td&gt;</code></p><p><code>2450</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2451</code><code>Not discussed&lt;/td&gt;</code></p><p><code>2452</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2453</code><code>&lt;a href="#R993" rid="R993" class=" bibr popnode"&gt;</code></p><p><code>2454</code><code>Raft et al. (1977)&lt;/a&gt;</code></p><p><code>2455</code><code>&lt;/td&gt;</code></p><p><code>2456</code><code>&lt;/tr&gt;</code></p><p><code>2457</code><code>&lt;tr&gt;</code></p><p><code>2458</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2459</code><code>&amp;#x02003;FMF&lt;/td&gt;</code></p><p><code>2460</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2461</code><code>One patient, DB, R, C&lt;/td&gt;</code></p><p><code>2462</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2463</code><code>THC (50 mg daily p.o.)&lt;/td&gt;</code></p><p><code>2464</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2465</code><code>Gastrointestinal pain&lt;/td&gt;</code></p><p><code>2466</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2467</code><code>Superior to PL&lt;/td&gt;</code></p><p><code>2468</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2469</code><code>Not discussed&lt;/td&gt;</code></p><p><code>2470</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2471</code><code>&lt;a href="#R515" rid="R515" class=" bibr popnode"&gt;</code></p><p><code>2472</code><code>Holdcroft et al. (1997)&lt;/a&gt;</code></p><p><code>2473</code><code>&lt;/td&gt;</code></p><p><code>2474</code><code>&lt;/tr&gt;</code></p><p><code>2475</code><code>&lt;tr&gt;</code></p><p><code>2476</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2477</code><code>&amp;#x02003;MS&lt;/td&gt;</code></p><p><code>2478</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2479</code><code>One patient, OL, pain&lt;/td&gt;</code></p><p><code>2480</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2481</code><code>Nabilone (1 mg b.i.d. p.o.)&lt;/td&gt;</code></p><p><code>2482</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2483</code><code>Questionnaire, various&lt;/td&gt;</code></p><p><code>2484</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2485</code><code>Complete pain relief&lt;/td&gt;</code></p><p><code>2486</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2487</code><code>None&lt;/td&gt;</code></p><p><code>2488</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2489</code><code>&lt;a href="#R459" rid="R459" class=" bibr popnode"&gt;</code></p><p><code>2490</code><code>Hamann and di Vadi (1999)&lt;/a&gt;</code></p><p><code>2491</code><code>&lt;/td&gt;</code></p><p><code>2492</code><code>&lt;/tr&gt;</code></p><p><code>2493</code><code>&lt;tr&gt;</code></p><p><code>2494</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2495</code><code>&amp;#x02003;MS&lt;/td&gt;</code></p><p><code>2496</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2497</code><code>66 patients, DB, R, PL, pain, sleep disturbances&lt;/td&gt;</code></p><p><code>2498</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2499</code><code>Sativex delivered by oromucosal spray (2.7 mg &amp;#x00394;&lt;sup&gt;</code></p><p><code>2500</code><code>9&lt;/sup&gt;</code></p><p><code>2501</code><code>-THC and 2.5 mg CBD at each actuation)&lt;/td&gt;</code></p><p><code>2502</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2503</code><code>Pain, sleep disturbances, numerical rating scale&lt;/td&gt;</code></p><p><code>2504</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2505</code><code>Improved central neuropathic pain and sleep disturbances&lt;/td&gt;</code></p><p><code>2506</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2507</code><code>Minimal&lt;/td&gt;</code></p><p><code>2508</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2509</code><code>&lt;a href="#R1029" rid="R1029" class=" bibr popnode"&gt;</code></p><p><code>2510</code><code>Rog et al. (2005)&lt;/a&gt;</code></p><p><code>2511</code><code>&lt;/td&gt;</code></p><p><code>2512</code><code>&lt;/tr&gt;</code></p><p><code>2513</code><code>&lt;tr&gt;</code></p><p><code>2514</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2515</code><code>&amp;#x02003;Neuropathy of varying etiologies&lt;/td&gt;</code></p><p><code>2516</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2517</code><code>21 patients, DB, R, C, PL, pain&lt;/td&gt;</code></p><p><code>2518</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2519</code><code>Ajulemic acid (CT-3, IP-751: 4 or 10 mg p.o. two times daily)&lt;/td&gt;</code></p><p><code>2520</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2521</code><code>Neuropathic pain, VAS&lt;/td&gt;</code></p><p><code>2522</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2523</code><code>Significant reduction of chronic neuropathic pain&lt;/td&gt;</code></p><p><code>2524</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2525</code><code>Minimal&lt;/td&gt;</code></p><p><code>2526</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2527</code><code>&lt;a href="#R588" rid="R588" class=" bibr popnode"&gt;</code></p><p><code>2528</code><code>Karst et al. (2003)&lt;/a&gt;</code></p><p><code>2529</code><code>&lt;/td&gt;</code></p><p><code>2530</code><code>&lt;/tr&gt;</code></p><p><code>2531</code><code>&lt;tr&gt;</code></p><p><code>2532</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2533</code><code>&amp;#x02003;HIV&lt;/td&gt;</code></p><p><code>2534</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2535</code><code>523 patients, cross-sectional questionnaire study&lt;/td&gt;</code></p><p><code>2536</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2537</code><code>Cannabis&lt;/td&gt;</code></p><p><code>2538</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2539</code><code>Questionnaire, various&lt;/td&gt;</code></p><p><code>2540</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2541</code><code>In most patients who used cannabis to treat symptoms (143/523); reduction in muscle and neuropathic pain&lt;/td&gt;</code></p><p><code>2542</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2543</code><code>Not discussed&lt;/td&gt;</code></p><p><code>2544</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2545</code><code>&lt;a href="#R1301" rid="R1301" class=" bibr popnode"&gt;</code></p><p><code>2546</code><code>Woolridge et al. (2005)&lt;/a&gt;</code></p><p><code>2547</code><code>&lt;/td&gt;</code></p><p><code>2548</code><code>&lt;/tr&gt;</code></p><p><code>2549</code><code>&lt;tr&gt;</code></p><p><code>2550</code><code>&lt;td colspan="7" align="left" rowspan="1"&gt;</code></p><p><code>2551</code><code>&lt;strong&gt;</code></p><p><code>2552</code><code>Anorexia-cachexia in patients with cancer, HIV, or AIDS&lt;/strong&gt;</code></p><p><code>2553</code><code>&lt;/td&gt;</code></p><p><code>2554</code><code>&lt;/tr&gt;</code></p><p><code>2555</code><code>&lt;tr&gt;</code></p><p><code>2556</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2557</code><code>&amp;#x02003;Cancer&lt;/td&gt;</code></p><p><code>2558</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2559</code><code>54 patients, R, DB, weight&lt;/td&gt;</code></p><p><code>2560</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2561</code><code>THC (three doses of 0.1 mg/kg/day p.o.)&lt;/td&gt;</code></p><p><code>2562</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2563</code><code>Appetite, weight&lt;/td&gt;</code></p><p><code>2564</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2565</code><code>Improved appetite and increased weight&lt;/td&gt;</code></p><p><code>2566</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2567</code><code>Dizziness, sedation, confusion&lt;/td&gt;</code></p><p><code>2568</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2569</code><code>&lt;a href="#R1005" rid="R1005" class=" bibr popnode"&gt;</code></p><p><code>2570</code><code>Regelson et al. (1976)&lt;/a&gt;</code></p><p><code>2571</code><code>&lt;/td&gt;</code></p><p><code>2572</code><code>&lt;/tr&gt;</code></p><p><code>2573</code><code>&lt;tr&gt;</code></p><p><code>2574</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2575</code><code>&amp;#x02003;Cancer&lt;/td&gt;</code></p><p><code>2576</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2577</code><code>19 patients, OL, non-R, weight&lt;/td&gt;</code></p><p><code>2578</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2579</code><code>THC (three doses of 5 mg/day p.o.)&lt;/td&gt;</code></p><p><code>2580</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2581</code><code>Appetite, weight&lt;/td&gt;</code></p><p><code>2582</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2583</code><code>Improved appetite, trends for weight increase&lt;/td&gt;</code></p><p><code>2584</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2585</code><code>Common, but well-tolerated&lt;/td&gt;</code></p><p><code>2586</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2587</code><code>&lt;a href="#R884" rid="R884" class=" bibr popnode"&gt;</code></p><p><code>2588</code><code>Nelson et al. (1994)&lt;/a&gt;</code></p><p><code>2589</code><code>&lt;/td&gt;</code></p><p><code>2590</code><code>&lt;/tr&gt;</code></p><p><code>2591</code><code>&lt;tr&gt;</code></p><p><code>2592</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2593</code><code>&amp;#x02003;HIV/AIDS&lt;/td&gt;</code></p><p><code>2594</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2595</code><code>10 patients, non-R, weight&lt;/td&gt;</code></p><p><code>2596</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2597</code><code>THC (three doses of 2.5 mg/day p.o.)&lt;/td&gt;</code></p><p><code>2598</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2599</code><code>Weight&lt;/td&gt;</code></p><p><code>2600</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2601</code><code>Increased/stabilized weight&lt;/td&gt;</code></p><p><code>2602</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2603</code><code>Mild&lt;/td&gt;</code></p><p><code>2604</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2605</code><code>&lt;a href="#R420" rid="R420" class=" bibr popnode"&gt;</code></p><p><code>2606</code><code>Gorter et al. (1992)&lt;/a&gt;</code></p><p><code>2607</code><code>&lt;/td&gt;</code></p><p><code>2608</code><code>&lt;/tr&gt;</code></p><p><code>2609</code><code>&lt;tr&gt;</code></p><p><code>2610</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2611</code><code>&amp;#x02003;AIDS&lt;/td&gt;</code></p><p><code>2612</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2613</code><code>139 patients, R, PL, weight&lt;/td&gt;</code></p><p><code>2614</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2615</code><code>THC (two doses of 2.5 mg/day p.o.)&lt;/td&gt;</code></p><p><code>2616</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2617</code><code>VAS for hunger, weight&lt;/td&gt;</code></p><p><code>2618</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2619</code><code>Improved VAS for hunger but not weight&lt;/td&gt;</code></p><p><code>2620</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2621</code><code>Mild&lt;/td&gt;</code></p><p><code>2622</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2623</code><code>&lt;a href="#R54" rid="R54" class=" bibr popnode"&gt;</code></p><p><code>2624</code><code>Beal et al. (1995)&lt;/a&gt;</code></p><p><code>2625</code><code>&lt;/td&gt;</code></p><p><code>2626</code><code>&lt;/tr&gt;</code></p><p><code>2627</code><code>&lt;tr&gt;</code></p><p><code>2628</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2629</code><code>&amp;#x02003;AIDS&lt;/td&gt;</code></p><p><code>2630</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2631</code><code>94 patients, non-R, OL, weight&lt;/td&gt;</code></p><p><code>2632</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2633</code><code>THC (two doses of 2.5 mg/day p.o.)&lt;/td&gt;</code></p><p><code>2634</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2635</code><code>VAS for hunger, weight&lt;/td&gt;</code></p><p><code>2636</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2637</code><code>Improved VAS for hunger and weight (only for 1 month)&lt;/td&gt;</code></p><p><code>2638</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2639</code><code>Sedation, psychosis, dysphoria&lt;/td&gt;</code></p><p><code>2640</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2641</code><code>&lt;a href="#R55" rid="R55" class=" bibr popnode"&gt;</code></p><p><code>2642</code><code>Beal et al. (1997)&lt;/a&gt;</code></p><p><code>2643</code><code>&lt;/td&gt;</code></p><p><code>2644</code><code>&lt;/tr&gt;</code></p><p><code>2645</code><code>&lt;tr&gt;</code></p><p><code>2646</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2647</code><code>&amp;#x02003;AIDS&lt;/td&gt;</code></p><p><code>2648</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2649</code><code>52 patients, weight&lt;/td&gt;</code></p><p><code>2650</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2651</code><code>THC (two doses of 2.5 mg/day p.o. +/&amp;#x02212; Megace)&lt;/td&gt;</code></p><p><code>2652</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2653</code><code>VAS for hunger, weight&lt;/td&gt;</code></p><p><code>2654</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2655</code><code>Less effective than Megace&lt;/td&gt;</code></p><p><code>2656</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2657</code><code>Anxiety, euphoria, psychosis, confusion&lt;/td&gt;</code></p><p><code>2658</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2659</code><code>&lt;a href="#R1183" rid="R1183" class=" bibr popnode"&gt;</code></p><p><code>2660</code><code>Timpone et al. (1997)&lt;/a&gt;</code></p><p><code>2661</code><code>&lt;/td&gt;</code></p><p><code>2662</code><code>&lt;/tr&gt;</code></p><p><code>2663</code><code>&lt;tr&gt;</code></p><p><code>2664</code><code>&lt;td colspan="7" align="left" rowspan="1"&gt;</code></p><p><code>2665</code><code>&lt;strong&gt;</code></p><p><code>2666</code><code>Chemotherapy-induced nausea and vomiting&lt;/strong&gt;</code></p><p><code>2667</code><code>&lt;/td&gt;</code></p><p><code>2668</code><code>&lt;/tr&gt;</code></p><p><code>2669</code><code>&lt;tr&gt;</code></p><p><code>2670</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2671</code><code>&amp;#x02003;Chemotherapy-induced nausea and vomiting&lt;/td&gt;</code></p><p><code>2672</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2673</code><code>Review of 30 randomized trials involving 1366 patients, nausea, vomiting&lt;/td&gt;</code></p><p><code>2674</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2675</code><code>THC&lt;/td&gt;</code></p><p><code>2676</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2677</code><code>Nausea, vomiting&lt;/td&gt;</code></p><p><code>2678</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2679</code><code>Across all trials, cannabinoids were more effective than placebo&lt;/td&gt;</code></p><p><code>2680</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2681</code><code>Various&lt;/td&gt;</code></p><p><code>2682</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2683</code><code>&lt;a href="#R1186" rid="R1186" class=" bibr popnode"&gt;</code></p><p><code>2684</code><code>Tram&amp;#x000e8;r et al. (2001)&lt;/a&gt;</code></p><p><code>2685</code><code>&lt;/td&gt;</code></p><p><code>2686</code><code>&lt;/tr&gt;</code></p><p><code>2687</code><code>&lt;tr&gt;</code></p><p><code>2688</code><code>&lt;td colspan="7" align="left" rowspan="1"&gt;</code></p><p><code>2689</code><code>&lt;strong&gt;</code></p><p><code>2690</code><code>Traumatic brain injury&lt;/strong&gt;</code></p><p><code>2691</code><code>&lt;/td&gt;</code></p><p><code>2692</code><code>&lt;/tr&gt;</code></p><p><code>2693</code><code>&lt;tr&gt;</code></p><p><code>2694</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2695</code><code>&amp;#x02003;Closed head injury&lt;/td&gt;</code></p><p><code>2696</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2697</code><code>67 patients, R, DB, PL, phase II, M, neurological outcome&lt;/td&gt;</code></p><p><code>2698</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2699</code><code>HU-211 (dexanabinol: 48 or 150 mg i.v.)&lt;/td&gt;</code></p><p><code>2700</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2701</code><code>Intracranial, cerebral perfusion and blood pressure, Glasgow scale&lt;/td&gt;</code></p><p><code>2702</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2703</code><code>Better intracranial pressure/cerebral perfusion pressure control, trends towards better neurological outcome&lt;/td&gt;</code></p><p><code>2704</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2705</code><code>Similar in all groups, related to severe head trauma&lt;/td&gt;</code></p><p><code>2706</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2707</code><code>&lt;a href="#R618" rid="R618" class=" bibr popnode"&gt;</code></p><p><code>2708</code><code>Knoller et al. (2002)&lt;/a&gt;</code></p><p><code>2709</code><code>&lt;/td&gt;</code></p><p><code>2710</code><code>&lt;/tr&gt;</code></p><p><code>2711</code><code>&lt;tr&gt;</code></p><p><code>2712</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2713</code><code>&amp;#x02003;Traumatic brain injury&lt;/td&gt;</code></p><p><code>2714</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2715</code><code>861 patients, R, PL, phase III, M, neurological outcome&lt;/td&gt;</code></p><p><code>2716</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2717</code><code>HU-211 (dexanabinol: 150 mg i.v.)&lt;/td&gt;</code></p><p><code>2718</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2719</code><code>Extended Glasgow scale at 6 months&lt;/td&gt;</code></p><p><code>2720</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2721</code><code>No improvement&lt;/td&gt;</code></p><p><code>2722</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2723</code><code>Similar in all groups, related to severe head trauma&lt;/td&gt;</code></p><p><code>2724</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2725</code><code>&lt;a href="#R716" rid="R716" class=" bibr popnode"&gt;</code></p><p><code>2726</code><code>Maas et al. (2006)&lt;/a&gt;</code></p><p><code>2727</code><code>&lt;/td&gt;</code></p><p><code>2728</code><code>&lt;/tr&gt;</code></p><p><code>2729</code><code>&lt;tr&gt;</code></p><p><code>2730</code><code>&lt;td colspan="7" align="left" rowspan="1"&gt;</code></p><p><code>2731</code><code>&lt;strong&gt;</code></p><p><code>2732</code><code>Parkinson&amp;#x02019;s disease, levodopa-induced dyskinesia&lt;/strong&gt;</code></p><p><code>2733</code><code>&lt;/td&gt;</code></p><p><code>2734</code><code>&lt;/tr&gt;</code></p><p><code>2735</code><code>&lt;tr&gt;</code></p><p><code>2736</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2737</code><code>&amp;#x02003;Parkinson&amp;#x02019;s disease&lt;/td&gt;</code></p><p><code>2738</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2739</code><code>24 patients, R, DB, PL, motor disability&lt;/td&gt;</code></p><p><code>2740</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2741</code><code>SR141716 (0.3 mg/kg p.o.); antagonists of NK&lt;sub&gt;</code></p><p><code>2742</code><code>3&lt;/sub&gt;</code></p><p><code>2743</code><code> R (SR142801) and neurotensin receptors (SR48692)&lt;/td&gt;</code></p><p><code>2744</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2745</code><code>Motor symptoms and levodopa-induced dyskinesias after a single dose of levodopa&lt;/td&gt;</code></p><p><code>2746</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2747</code><code>No improvement in parkinsonian motor disability with any of drugs tested&lt;/td&gt;</code></p><p><code>2748</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2749</code><code>Minimal&lt;/td&gt;</code></p><p><code>2750</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2751</code><code>&lt;a href="#R828" rid="R828" class=" bibr popnode"&gt;</code></p><p><code>2752</code><code>Mesnage et al. (2004)&lt;/a&gt;</code></p><p><code>2753</code><code>&lt;/td&gt;</code></p><p><code>2754</code><code>&lt;/tr&gt;</code></p><p><code>2755</code><code>&lt;tr&gt;</code></p><p><code>2756</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2757</code><code>&amp;#x02003;Parkinson&amp;#x02019;s disease&lt;/td&gt;</code></p><p><code>2758</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2759</code><code>Seven patients, R, DB, PL, C, motor disability&lt;/td&gt;</code></p><p><code>2760</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2761</code><code>Nabilone&lt;/td&gt;</code></p><p><code>2762</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2763</code><code>Motor symptoms&lt;/td&gt;</code></p><p><code>2764</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2765</code><code>Reduces levodopa-induced dyskinesia in PD&lt;/td&gt;</code></p><p><code>2766</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2767</code><code>Minimal&lt;/td&gt;</code></p><p><code>2768</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2769</code><code>&lt;a href="#R1104" rid="R1104" class=" bibr popnode"&gt;</code></p><p><code>2770</code><code>Sieradzan et al. (2001)&lt;/a&gt;</code></p><p><code>2771</code><code>&lt;/td&gt;</code></p><p><code>2772</code><code>&lt;/tr&gt;</code></p><p><code>2773</code><code>&lt;tr&gt;</code></p><p><code>2774</code><code>&lt;td colspan="7" align="left" rowspan="1"&gt;</code></p><p><code>2775</code><code>&lt;strong&gt;</code></p><p><code>2776</code><code>Alzheimer&amp;#x02019;s disease, dementia&lt;/strong&gt;</code></p><p><code>2777</code><code>&lt;/td&gt;</code></p><p><code>2778</code><code>&lt;/tr&gt;</code></p><p><code>2779</code><code>&lt;tr&gt;</code></p><p><code>2780</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2781</code><code>&amp;#x02003;Alzheimer&amp;#x02019;s disease, dementia&lt;/td&gt;</code></p><p><code>2782</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2783</code><code>Six patients, OL, pilot, neuropsychiatric symptoms&lt;/td&gt;</code></p><p><code>2784</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2785</code><code>Dronabinol (2.5 mg/day for 2 wk)&lt;/td&gt;</code></p><p><code>2786</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2787</code><code>Neuropsychiatric Inventory score, subscores for agitation, aberrant motor, and nighttime behaviors&lt;/td&gt;</code></p><p><code>2788</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2789</code><code>Significant improvement in Neuropsychiatric Inventory total score, subscores for agitation, aberrant motor, and nighttime behaviors&lt;/td&gt;</code></p><p><code>2790</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2791</code><code>Minimal&lt;/td&gt;</code></p><p><code>2792</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2793</code><code>&lt;a href="#R1263" rid="R1263" class=" bibr popnode"&gt;</code></p><p><code>2794</code><code>Walther et al. (2006)&lt;/a&gt;</code></p><p><code>2795</code><code>&lt;/td&gt;</code></p><p><code>2796</code><code>&lt;/tr&gt;</code></p><p><code>2797</code><code>&lt;tr&gt;</code></p><p><code>2798</code><code>&lt;td colspan="7" align="left" rowspan="1"&gt;</code></p><p><code>2799</code><code>&lt;strong&gt;</code></p><p><code>2800</code><code>Primary dystonia&lt;/strong&gt;</code></p><p><code>2801</code><code>&lt;/td&gt;</code></p><p><code>2802</code><code>&lt;/tr&gt;</code></p><p><code>2803</code><code>&lt;tr&gt;</code></p><p><code>2804</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2805</code><code>&amp;#x02003;Primary dystonia&lt;/td&gt;</code></p><p><code>2806</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2807</code><code>15 patients, DB, R, PL, C, dystonia&lt;/td&gt;</code></p><p><code>2808</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2809</code><code>Nabilone (0.03 mg/kg)&lt;/td&gt;</code></p><p><code>2810</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2811</code><code>Motor symptoms&lt;/td&gt;</code></p><p><code>2812</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2813</code><code>No improvement&lt;/td&gt;</code></p><p><code>2814</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2815</code><code>Minimal&lt;/td&gt;</code></p><p><code>2816</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2817</code><code>&lt;a href="#R338" rid="R338" class=" bibr popnode"&gt;</code></p><p><code>2818</code><code>Fox et al. (2002b)&lt;/a&gt;</code></p><p><code>2819</code><code>&lt;/td&gt;</code></p><p><code>2820</code><code>&lt;/tr&gt;</code></p><p><code>2821</code><code>&lt;tr&gt;</code></p><p><code>2822</code><code>&lt;td colspan="7" align="left" rowspan="1"&gt;</code></p><p><code>2823</code><code>&lt;strong&gt;</code></p><p><code>2824</code><code>Tourette&amp;#x02019;s syndrome&lt;/strong&gt;</code></p><p><code>2825</code><code>&lt;/td&gt;</code></p><p><code>2826</code><code>&lt;/tr&gt;</code></p><p><code>2827</code><code>&lt;tr&gt;</code></p><p><code>2828</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2829</code><code>&amp;#x02003;Tourette&amp;#x02019;s syndrome&lt;/td&gt;</code></p><p><code>2830</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2831</code><code>12 patients, R, DB, PL, C, behavioral disorders&lt;/td&gt;</code></p><p><code>2832</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2833</code><code>THC (one dose of 5, 7.5, or 10 mg)&lt;/td&gt;</code></p><p><code>2834</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2835</code><code>Vocal and motor tics, various clinical scales&lt;/td&gt;</code></p><p><code>2836</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2837</code><code>Significant improvement of vocal and motor tics&lt;/td&gt;</code></p><p><code>2838</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2839</code><code>Minimal&lt;/td&gt;</code></p><p><code>2840</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2841</code><code>&lt;a href="#R860" rid="R860" class=" bibr popnode"&gt;</code></p><p><code>2842</code><code>M&amp;#x000fc;ller-Vahl et al. (2002)&lt;/a&gt;</code></p><p><code>2843</code><code>&lt;/td&gt;</code></p><p><code>2844</code><code>&lt;/tr&gt;</code></p><p><code>2845</code><code>&lt;tr&gt;</code></p><p><code>2846</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2847</code><code>&amp;#x02003;Tourette&amp;#x02019;s syndrome&lt;/td&gt;</code></p><p><code>2848</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2849</code><code>24 patients, R, DB, PL, behavioral disorders&lt;/td&gt;</code></p><p><code>2850</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2851</code><code>THC (5&amp;#x02013;10 mg)&lt;/td&gt;</code></p><p><code>2852</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2853</code><code>Vocal and motor tics, various clinical scales&lt;/td&gt;</code></p><p><code>2854</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2855</code><code>Significant improvement of vocal and motor tics&lt;/td&gt;</code></p><p><code>2856</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2857</code><code>Minimal&lt;/td&gt;</code></p><p><code>2858</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2859</code><code>&lt;a href="#R858" rid="R858" class=" bibr popnode"&gt;</code></p><p><code>2860</code><code>M&amp;#x000fc;ller-Vahl et al. (2003a)&lt;/a&gt;</code></p><p><code>2861</code><code>&lt;/td&gt;</code></p><p><code>2862</code><code>&lt;/tr&gt;</code></p><p><code>2863</code><code>&lt;tr&gt;</code></p><p><code>2864</code><code>&lt;td colspan="7" align="left" rowspan="1"&gt;</code></p><p><code>2865</code><code>&lt;strong&gt;</code></p><p><code>2866</code><code>Psychosis/schizophrenia/schizoaffective disorder&lt;/strong&gt;</code></p><p><code>2867</code><code>&lt;/td&gt;</code></p><p><code>2868</code><code>&lt;/tr&gt;</code></p><p><code>2869</code><code>&lt;tr&gt;</code></p><p><code>2870</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2871</code><code>&amp;#x02003;Schizophrenia/schizoaffective disorder&lt;/td&gt;</code></p><p><code>2872</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2873</code><code>481 patients, PL, DB, positive and negative symptoms&lt;/td&gt;</code></p><p><code>2874</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2875</code><code>SR141716; SR 142801 (NK&lt;sub&gt;</code></p><p><code>2876</code><code>3&lt;/sub&gt;</code></p><p><code>2877</code><code> R antagonist); SR46349B (5-HT&lt;sub&gt;</code></p><p><code>2878</code><code>2A/2C&lt;/sub&gt;</code></p><p><code>2879</code><code> R antagonist)&lt;/td&gt;</code></p><p><code>2880</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2881</code><code>Various symptom scales&lt;/td&gt;</code></p><p><code>2882</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2883</code><code>No improvement with CB&lt;sub&gt;</code></p><p><code>2884</code><code>1&lt;/sub&gt;</code></p><p><code>2885</code><code> antagonist, slight improvement with NK&lt;sub&gt;</code></p><p><code>2886</code><code>3&lt;/sub&gt;</code></p><p><code>2887</code><code> R and 5-HT&lt;sub&gt;</code></p><p><code>2888</code><code>2A/2C&lt;/sub&gt;</code></p><p><code>2889</code><code> R antagonist&lt;/td&gt;</code></p><p><code>2890</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2891</code><code>Minimal&lt;/td&gt;</code></p><p><code>2892</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2893</code><code>&lt;a href="#R821" rid="R821" class=" bibr popnode"&gt;</code></p><p><code>2894</code><code>Meltzer et al. (2004)&lt;/a&gt;</code></p><p><code>2895</code><code>&lt;/td&gt;</code></p><p><code>2896</code><code>&lt;/tr&gt;</code></p><p><code>2897</code><code>&lt;tr&gt;</code></p><p><code>2898</code><code>&lt;td colspan="7" align="left" rowspan="1"&gt;</code></p><p><code>2899</code><code>&lt;strong&gt;</code></p><p><code>2900</code><code>Obesity&lt;/strong&gt;</code></p><p><code>2901</code><code>&lt;/td&gt;</code></p><p><code>2902</code><code>&lt;/tr&gt;</code></p><p><code>2903</code><code>&lt;tr&gt;</code></p><p><code>2904</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2905</code><code>&amp;#x02003;Obesity, metabolic syndrome&lt;/td&gt;</code></p><p><code>2906</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2907</code><code>1507 patients, R, DB, PL, weight&lt;/td&gt;</code></p><p><code>2908</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2909</code><code>Rimonabant (5, 20 mg, 12 mo)&lt;/td&gt;</code></p><p><code>2910</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2911</code><code>Weight, WC, BP, lipids, insulin, glucose&lt;/td&gt;</code></p><p><code>2912</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2913</code><code>Weight and WC reduction, improved lipids, glucose tolerance, metabolic syndrome&lt;/td&gt;</code></p><p><code>2914</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2915</code><code>Mild (nausea, arthralgia, diarrhea)&lt;/td&gt;</code></p><p><code>2916</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2917</code><code>&lt;a href="#R1216" rid="R1216" class=" bibr popnode"&gt;</code></p><p><code>2918</code><code>Van Gaal et al. (2005)&lt;/a&gt;</code></p><p><code>2919</code><code>&lt;/td&gt;</code></p><p><code>2920</code><code>&lt;/tr&gt;</code></p><p><code>2921</code><code>&lt;tr&gt;</code></p><p><code>2922</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2923</code><code>&amp;#x02003;Obesity, metabolic syndrome&lt;/td&gt;</code></p><p><code>2924</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2925</code><code>1036 patients, R, DB, PL, weight&lt;/td&gt;</code></p><p><code>2926</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2927</code><code>Rimonabant (5, 20 mg, 12 m)&lt;/td&gt;</code></p><p><code>2928</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2929</code><code>Weight, waist c, lipids, glucose, insulin, leptin&lt;/td&gt;</code></p><p><code>2930</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2931</code><code>Weight and WC reduction, improved cardiovascular risk, reduced metabolic syndrome; decreased BP, increased plasma adiponectin&lt;/td&gt;</code></p><p><code>2932</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2933</code><code>Mild (nausea, anxiety, diarrhea, insomnia)&lt;/td&gt;</code></p><p><code>2934</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2935</code><code>&lt;a href="#R260" rid="R260" class=" bibr popnode"&gt;</code></p><p><code>2936</code><code>Despr&amp;#x000e9;s et al. (2005)&lt;/a&gt;</code></p><p><code>2937</code><code>&lt;/td&gt;</code></p><p><code>2938</code><code>&lt;/tr&gt;</code></p><p><code>2939</code><code>&lt;tr&gt;</code></p><p><code>2940</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2941</code><code>&amp;#x02003;Obesity, metabolic syndrome&lt;/td&gt;</code></p><p><code>2942</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2943</code><code>3045 patients, R, DB, PL, M, weight, cardiometabolic risk factors&lt;/td&gt;</code></p><p><code>2944</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2945</code><code>Rimonabant (5, 20 mg, 2 yr)&lt;/td&gt;</code></p><p><code>2946</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2947</code><code>Weight, WC, lipids, glucose, insulin, Leptin&lt;/td&gt;</code></p><p><code>2948</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2949</code><code>Weight and WC reduction, improved cardiovascular risk, reduced metabolic syndrome; weight regained in 2nd year with placebo&lt;/td&gt;</code></p><p><code>2950</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2951</code><code>Mild (nausea, anxiety, diarrhea, insomnia)&lt;/td&gt;</code></p><p><code>2952</code><code>&lt;td align="left" rowspan="1" colspan="1"&gt;</code></p><p><code>2953</code><code>&lt;a href="#R968" rid="R968" class=" bibr popnode"&gt;</code></p><p><code>2954</code><code>Pi-Sunyer et al. (2006)&lt;/a&gt;</code></p><p><code>2955</code><code>&lt;/td&gt;</code></p><p><code>2956</code><code>&lt;/tr&gt;</code></p><p><code>2957</code><code>&lt;/tbody&gt;</code></p><p><code>2958</code><code>&lt;/table&gt;</code></p><p><code>2959</code><code>&lt;/div&gt;</code></p><p><code>2960</code><code>&lt;div id="largeobj_idm139779462195728" class="largeobj-link align_right" style="display: none"&gt;</code></p><p><code>2961</code><code>&lt;a target="object" rel="noopener" href="/pmc/articles/PMC2241751/table/T1/?report=objectonly"&gt;</code></p><p><code>2962</code><code>Open in a separate window&lt;/a&gt;</code></p><p><code>2963</code><code>&lt;/div&gt;</code></p><p><code>2964</code><code>&lt;div class="tblwrap-foot"&gt;</code></p><p><code>2965</code><code>&lt;div id="TFN1"&gt;</code></p><p><code>2966</code><code>&lt;p id="__p9" class="p p-first-last"&gt;</code></p><p><code>2967</code><code>DB, double blind; PL, placebo-controlled; EMG, electromyography; SB, single blind; C, crossover; OL, open-label; max, maximum; R, randomized; M, multicenter; VAS, visual analog scale; P, prospective; PL, placebo; FMF, familial Mediterranean fever; NIB, nitrogen analog of THC; NK&lt;sub&gt;</code></p><p><code>2968</code><code>3&lt;/sub&gt;</code></p><p><code>2969</code><code> R, neurokinin 3 receptor; SR142801, (&lt;em&gt;</code></p><p><code>2970</code><code>R&lt;/em&gt;</code></p><p><code>2971</code><code>)-(&lt;em&gt;</code></p><p><code>2972</code><code>N&lt;/em&gt;</code></p><p><code>2973</code><code>)-[1-[3-[1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]propyl]-4-phenylpiperidin-4-yl]-&lt;em&gt;</code></p><p><code>2974</code><code>N&lt;/em&gt;</code></p><p><code>2975</code><code>-methylacetamide; SR48692, 2-[(1-(7-chloro-4-quinolinyl)-5-(2,6-dimethoxyphenyl)pyrazol-3-yl)carbonylamino]tricycle(3.3.1.1)decan-2-carboxylic acid}; SR463493B, 1(&lt;em&gt;</code></p><p><code>2976</code><code>Z&lt;/em&gt;</code></p><p><code>2977</code><code>)-[2-(dimethylamino)ethoxyimino]-1(2-fluorophenyl)-3-(4-hydroxyphenyl)-2(&lt;em&gt;</code></p><p><code>2978</code><code>E&lt;/em&gt;</code></p><p><code>2979</code><code>)-propene; 5-HT&lt;sub&gt;</code></p><p><code>2980</code><code>2A/2C&lt;/sub&gt;</code></p><p><code>2981</code><code> R, serotonin 2A/2C receptor, WC, waist circumference; BP, blood pressure.&lt;/p&gt;</code></p><p><code>2982</code><code>&lt;/div&gt;</code></p><p><code>2983</code><code>&lt;/div&gt;</code></p><p><code>2984</code><code>&lt;/div&gt;</code></p><p><code>2985</code><code>&lt;p id="P53"&gt;</code></p><p><code>2986</code><code>A few studies have reported the effectiveness of THC in stimulating appetite and weight gain in cancer patients, but these therapeutic effects have been more extensively documented in AIDS patients (reviewed by &lt;a href="#R607" rid="R607" class=" bibr popnode"&gt;</code></p><p><code>2987</code><code>Kirkham, 2004&lt;/a&gt;</code></p><p><code>2988</code><code>; &lt;a href="#R758" rid="R758" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920287"&gt;</code></p><p><code>2989</code><code>Martin and Wiley, 2004&lt;/a&gt;</code></p><p><code>2990</code><code>; &lt;a href="#R454" rid="R454" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920191"&gt;</code></p><p><code>2991</code><code>Hall et al., 2005&lt;/a&gt;</code></p><p><code>2992</code><code>) (see also &lt;a href="/pmc/articles/PMC2241751/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""&gt;</code></p><p><code>2993</code><code>&lt;span&gt;</code></p><p><code>2994</code><code>Table 1&lt;/span&gt;</code></p><p><code>2995</code><code>&lt;/a&gt;</code></p><p><code>2996</code><code>). Although concerns have been voiced about the potential immunosuppressive effect of cannabinoids in immunocompromised individuals (&lt;a href="#R613" rid="R613" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920269"&gt;</code></p><p><code>2997</code><code>Klein et al., 1998&lt;/a&gt;</code></p><p><code>2998</code><code>), repeated THC administration in a randomized, prospective, controlled trial was found to have few if any consistent effects on various immune functions in AIDS patients receiving antiviral treatment (&lt;a href="#R117" rid="R117" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918884"&gt;</code></p><p><code>2999</code><code>Bredt et al., 2002&lt;/a&gt;</code></p><p><code>3000</code><code>).&lt;/p&gt;</code></p><p><code>3001</code><code>&lt;p id="P54"&gt;</code></p><p><code>3002</code><code>Anorexia may also be associated with normal aging. A number of hormonal factors have been implicated in the loss of appetite in the elderly, including growth hormone, cholecystokinin, leptin, and various cytokines (&lt;a href="#R851" rid="R851" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920206"&gt;</code></p><p><code>3003</code><code>Morley, 2001&lt;/a&gt;</code></p><p><code>3004</code><code>). In a recent study in mice, an age-related decline in food and alcohol intake was accompanied by the loss of ability of the CB&lt;sub&gt;</code></p><p><code>3005</code><code>1&lt;/sub&gt;</code></p><p><code>3006</code><code> antagonist SR141716 to reduce food and alcohol intake and a decrease in CB&lt;sub&gt;</code></p><p><code>3007</code><code>1&lt;/sub&gt;</code></p><p><code>3008</code><code> receptor-stimulated GTP&lt;em&gt;</code></p><p><code>3009</code><code>&amp;#x003b3;&lt;/em&gt;</code></p><p><code>3010</code><code>S labeling in the limbic forebrain (&lt;a href="#R1267" rid="R1267" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919430"&gt;</code></p><p><code>3011</code><code>Wang et al., 2003&lt;/a&gt;</code></p><p><code>3012</code><code>). These findings suggest that, at least in this animal model, an age-dependent decrease in CB&lt;sub&gt;</code></p><p><code>3013</code><code>1&lt;/sub&gt;</code></p><p><code>3014</code><code> receptor signaling in the limbic forebrain may be related to the parallel decline in appetite for both food and alcohol. Anorexia can also accompany debilitating diseases such as Alzheimer&amp;#x02019;s disease, in which the effectiveness of THC to stimulate appetite has been documented (&lt;a href="#R1238" rid="R1238" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653446"&gt;</code></p><p><code>3015</code><code>Volicer et al., 1997&lt;/a&gt;</code></p><p><code>3016</code><code>). Anorexia nervosa is a psychiatric condition that occurs predominantly in younger women and is characterized by self-starvation, weight loss, and a disturbed body image. Plasma anandamide levels have been reported to increase in patients with restricting anorexia nervosa, which may be secondary to a marked decrease in plasma leptin levels in such patients (&lt;a href="#R845" rid="R845" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920075"&gt;</code></p><p><code>3017</code><code>Monteleone et al., 2002&lt;/a&gt;</code></p><p><code>3018</code><code>). Although the relationship between brain and plasma levels of anandamide is not clear, a parallel increase in anandamide in brain regions involved in reward may mediate the rewarding effect of self-starvation in anorexic patients (&lt;a href="#R846" rid="R846" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920364"&gt;</code></p><p><code>3019</code><code>Monteleone et al., 2005&lt;/a&gt;</code></p><p><code>3020</code><code>). A recent family-based study examined the possible association of a CB&lt;sub&gt;</code></p><p><code>3021</code><code>1&lt;/sub&gt;</code></p><p><code>3022</code><code> receptor gene polymorphism consisting of differences in a trinucleotide repeat with anorexia nervosa. Although no difference was found between parental alleles transmitted or not transmitted to the affected siblings, preferential transmission of different alleles could be established when the patients were subdivided into restricting and binging/purging subgroups (&lt;a href="#R1102" rid="R1102" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653432"&gt;</code></p><p><code>3023</code><code>Siegfried et al., 2004&lt;/a&gt;</code></p><p><code>3024</code><code>).&lt;/p&gt;</code></p><p><code>3025</code><code>&lt;p id="P55" class="p p-last"&gt;</code></p><p><code>3026</code><code>Endocannabinoids have been also implicated in a unique form of food intake: milk suckling in newborn animals. In an elegant series of studies, &lt;a href="#R347" rid="R347" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653456"&gt;</code></p><p><code>3027</code><code>Fride et al. (2005)&lt;/a&gt;</code></p><p><code>3028</code><code> have proposed a role for 2-AG in the brain to stimulate the suckling response in mouse pups. In their model, endogenous 2-AG in the pup&amp;#x02019;s brain initiated the suckling response via CB&lt;sub&gt;</code></p><p><code>3029</code><code>1&lt;/sub&gt;</code></p><p><code>3030</code><code> receptors, with continued suckling depending on milk-derived 2-AG (&lt;a href="#R346" rid="R346" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919189"&gt;</code></p><p><code>3031</code><code>Fride, 2004&lt;/a&gt;</code></p><p><code>3032</code><code>). As predicted by this model, treatment of pups with SR141716 inhibits suckling and leads to death due to failure to thrive, a condition analogous to a human condition known as nonorganic failure to thrive, in which an oral motor defect resulting in deficient suckling (&lt;a href="#R1007" rid="R1007" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919954"&gt;</code></p><p><code>3033</code><code>Reilly et al., 1999&lt;/a&gt;</code></p><p><code>3034</code><code>) is similar to the condition in mouse produced by pharmacological blockade or genetic ablation of CB&lt;sub&gt;</code></p><p><code>3035</code><code>1&lt;/sub&gt;</code></p><p><code>3036</code><code> (&lt;a href="#R347" rid="R347" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653422"&gt;</code></p><p><code>3037</code><code>Fride et al., 2005&lt;/a&gt;</code></p><p><code>3038</code><code>). The relatively high dose of SR141716 to inhibit suckling and its residual effectiveness in CB&lt;sub&gt;</code></p><p><code>3039</code><code>1&lt;/sub&gt;</code></p><p><code>3040</code><code> knockout mice suggested the additional involvement of a receptor distinct from CB&lt;sub&gt;</code></p><p><code>3041</code><code>1&lt;/sub&gt;</code></p><p><code>3042</code><code> or CB&lt;sub&gt;</code></p><p><code>3043</code><code>2&lt;/sub&gt;</code></p><p><code>3044</code><code> (&lt;a href="#R348" rid="R348" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919966"&gt;</code></p><p><code>3045</code><code>Fride et al., 2003&lt;/a&gt;</code></p><p><code>3046</code><code>).&lt;/p&gt;</code></p><p><code>3047</code><code>&lt;/div&gt;</code></p><p><code>3048</code><code>&lt;/div&gt;</code></p><p><code>3049</code><code>&lt;div id="S12" class="sec"&gt;</code></p><p><code>3050</code><code>&lt;h3 id="S12title"&gt;</code></p><p><code>3051</code><code>B. Pain and Inflammation&lt;/h3&gt;</code></p><p><code>3052</code><code>&lt;p id="P56" class="p p-first"&gt;</code></p><p><code>3053</code><code>One of the earliest uses of cannabis was to treat pain. Historical documents reveal the use of cannabis for surgical anesthesia in ancient China and to relieve pain of diverse origin in ancient Israel, Greece, Rome, and India (reviewed in &lt;a href="#R804" rid="R804" class=" bibr popnode"&gt;</code></p><p><code>3054</code><code>Mechoulam, 1986&lt;/a&gt;</code></p><p><code>3055</code><code>; &lt;a href="#R544" rid="R544" class=" bibr popnode"&gt;</code></p><p><code>3056</code><code>Iversen, 2000&lt;/a&gt;</code></p><p><code>3057</code><code>; &lt;a href="#R809" rid="R809" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918694"&gt;</code></p><p><code>3058</code><code>Mechoulam and Hanus, 2000&lt;/a&gt;</code></p><p><code>3059</code><code>). Numerous early studies have also demonstrated beneficial effects of cannabinoids in animal models of pain (reviewed in &lt;a href="#R1254" rid="R1254" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918770"&gt;</code></p><p><code>3060</code><code>Walker and Huang, 2002&lt;/a&gt;</code></p><p><code>3061</code><code>; &lt;a href="#R334" rid="R334" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653505"&gt;</code></p><p><code>3062</code><code>Fox and Bevan, 2005&lt;/a&gt;</code></p><p><code>3063</code><code>). In acute pain, anandamide, THC, cannabidiol, and synthetic cannabinoids such as CP55,940 and WIN 55,212-2 are effective against chemical (&lt;a href="#R1123" rid="R1123" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918852"&gt;</code></p><p><code>3064</code><code>Sofia et al., 1973&lt;/a&gt;</code></p><p><code>3065</code><code>; &lt;a href="#R330" rid="R330" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919061"&gt;</code></p><p><code>3066</code><code>Formukong et al., 1988&lt;/a&gt;</code></p><p><code>3067</code><code>; &lt;a href="#R148" rid="R148" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918991"&gt;</code></p><p><code>3068</code><code>Calignano et al., 1998&lt;/a&gt;</code></p><p><code>3069</code><code>; &lt;a href="#R213" rid="R213" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653494"&gt;</code></p><p><code>3070</code><code>Costa et al., 2004a&lt;/a&gt;</code></p><p><code>3071</code><code>,&lt;a href="#R214" rid="R214" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919618"&gt;</code></p><p><code>3072</code><code>b&lt;/a&gt;</code></p><p><code>3073</code><code>; &lt;a href="#R444" rid="R444" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919614"&gt;</code></p><p><code>3074</code><code>Guindon et al., 2006&lt;/a&gt;</code></p><p><code>3075</code><code>; &lt;a href="#R1202" rid="R1202" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920119"&gt;</code></p><p><code>3076</code><code>Ulugol et al., 2006&lt;/a&gt;</code></p><p><code>3077</code><code>), mechanical (&lt;a href="#R1123" rid="R1123" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919449"&gt;</code></p><p><code>3078</code><code>Sofia et al., 1973&lt;/a&gt;</code></p><p><code>3079</code><code>; &lt;a href="#R762" rid="R762" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637186"&gt;</code></p><p><code>3080</code><code>Martin et al., 1996&lt;/a&gt;</code></p><p><code>3081</code><code>; &lt;a href="#R1116" rid="R1116" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918912"&gt;</code></p><p><code>3082</code><code>Smith et al., 1998&lt;/a&gt;</code></p><p><code>3083</code><code>; &lt;a href="#R443" rid="R443" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919017"&gt;</code></p><p><code>3084</code><code>Guindon and Beaulieu, 2006&lt;/a&gt;</code></p><p><code>3085</code><code>), and thermal pain stimuli (&lt;a href="#R139" rid="R139" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653430"&gt;</code></p><p><code>3086</code><code>Buxbaum, 1972&lt;/a&gt;</code></p><p><code>3087</code><code>; &lt;a href="#R100" rid="R100" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919241"&gt;</code></p><p><code>3088</code><code>Bloom et al., 1977&lt;/a&gt;</code></p><p><code>3089</code><code>; &lt;a href="#R686" rid="R686" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919470"&gt;</code></p><p><code>3090</code><code>Lichtman and Martin, 1991a&lt;/a&gt;</code></p><p><code>3091</code><code>,&lt;a href="#R687" rid="R687" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919417"&gt;</code></p><p><code>3092</code><code>b&lt;/a&gt;</code></p><p><code>3093</code><code>; &lt;a href="#R349" rid="R349" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919127"&gt;</code></p><p><code>3094</code><code>Fride and Mechoulam, 1993&lt;/a&gt;</code></p><p><code>3095</code><code>; &lt;a href="#R443" rid="R443" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919542"&gt;</code></p><p><code>3096</code><code>Guindon and Beaulieu, 2006&lt;/a&gt;</code></p><p><code>3097</code><code>). Recent animal studies indicate that anandamide and cannabinoid ligands are also very effective against chronic pain of both neuropathic (&lt;a href="#R490" rid="R490" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919777"&gt;</code></p><p><code>3098</code><code>Herzberg et al., 1997&lt;/a&gt;</code></p><p><code>3099</code><code>; &lt;a href="#R121" rid="R121" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919588"&gt;</code></p><p><code>3100</code><code>Bridges et al., 2001&lt;/a&gt;</code></p><p><code>3101</code><code>; &lt;a href="#R335" rid="R335" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919035"&gt;</code></p><p><code>3102</code><code>Fox et al., 2001&lt;/a&gt;</code></p><p><code>3103</code><code>; &lt;a href="#R443" rid="R443" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920365"&gt;</code></p><p><code>3104</code><code>Guindon and Beaulieu, 2006&lt;/a&gt;</code></p><p><code>3105</code><code>) and inflammatory origin (&lt;a href="#R1190" rid="R1190" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919923"&gt;</code></p><p><code>3106</code><code>Tsou et al., 1996&lt;/a&gt;</code></p><p><code>3107</code><code>; &lt;a href="#R1012" rid="R1012" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920372"&gt;</code></p><p><code>3108</code><code>Richardson et al., 1998a&lt;/a&gt;</code></p><p><code>3109</code><code>,&lt;a href="#R1013" rid="R1013" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637220"&gt;</code></p><p><code>3110</code><code>b&lt;/a&gt;</code></p><p><code>3111</code><code>,&lt;a href="#R1014" rid="R1014" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919420"&gt;</code></p><p><code>3112</code><code>c&lt;/a&gt;</code></p><p><code>3113</code><code>; Li et al., 1999; &lt;a href="#R764" rid="R764" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919105"&gt;</code></p><p><code>3114</code><code>Martin et al., 1999b&lt;/a&gt;</code></p><p><code>3115</code><code>; &lt;a href="#R444" rid="R444" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919347"&gt;</code></p><p><code>3116</code><code>Guindon et al., 2006&lt;/a&gt;</code></p><p><code>3117</code><code>). Moreover, endocannabinoids and synthetic cannabinoids exert synergistic antinociceptive effects when combined with commonly used nonsteroid anti-inflammatory drugs, which may have utility in the pharmacotherapy of pain (&lt;a href="#R443" rid="R443" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920320"&gt;</code></p><p><code>3118</code><code>Guindon and Beaulieu, 2006&lt;/a&gt;</code></p><p><code>3119</code><code>; &lt;a href="#R444" rid="R444" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919381"&gt;</code></p><p><code>3120</code><code>Guindon et al., 2006&lt;/a&gt;</code></p><p><code>3121</code><code>; &lt;a href="#R1202" rid="R1202" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919219"&gt;</code></p><p><code>3122</code><code>Ulugol et al., 2006&lt;/a&gt;</code></p><p><code>3123</code><code>). Interestingly, a recent study has implicated the endocannabinoid system in the analgesic activity of paracetamol (acetaminophen), the most widely used painkiller (&lt;a href="#R918" rid="R918" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920228"&gt;</code></p><p><code>3124</code><code>Ottani et al., 2006&lt;/a&gt;</code></p><p><code>3125</code><code>), and there is also evidence for endocannabinoid involvement in the action of some general anesthetics, such as propofol (&lt;a href="#R948" rid="R948" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918790"&gt;</code></p><p><code>3126</code><code>Patel et al., 2003&lt;/a&gt;</code></p><p><code>3127</code><code>; &lt;a href="#R1073" rid="R1073" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919794"&gt;</code></p><p><code>3128</code><code>Schelling et al., 2006&lt;/a&gt;</code></p><p><code>3129</code><code>).&lt;/p&gt;</code></p><p><code>3130</code><code>&lt;p id="P57"&gt;</code></p><p><code>3131</code><code>Cannabinoids exert their antinociceptive effects by complex mechanisms involving effects on the central nervous system (&lt;a href="#R763" rid="R763" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919153"&gt;</code></p><p><code>3132</code><code>Martin et al., 1993&lt;/a&gt;</code></p><p><code>3133</code><code>; &lt;a href="#R511" rid="R511" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919852"&gt;</code></p><p><code>3134</code><code>Hohmann et al., 1995&lt;/a&gt;</code></p><p><code>3135</code><code>, &lt;a href="#R513" rid="R513" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653404"&gt;</code></p><p><code>3136</code><code>1998&lt;/a&gt;</code></p><p><code>3137</code><code>, &lt;a href="#R514" rid="R514" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920335"&gt;</code></p><p><code>3138</code><code>1999&lt;/a&gt;</code></p><p><code>3139</code><code>; &lt;a href="#R765" rid="R765" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920153"&gt;</code></p><p><code>3140</code><code>Martin et al., 1995&lt;/a&gt;</code></p><p><code>3141</code><code>, &lt;a href="#R762" rid="R762" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637210"&gt;</code></p><p><code>3142</code><code>1996&lt;/a&gt;</code></p><p><code>3143</code><code>, &lt;a href="#R766" rid="R766" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920208"&gt;</code></p><p><code>3144</code><code>1998&lt;/a&gt;</code></p><p><code>3145</code><code>, &lt;a href="#R761" rid="R761" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919865"&gt;</code></p><p><code>3146</code><code>1999a&lt;/a&gt;</code></p><p><code>3147</code><code>,&lt;a href="#R764" rid="R764" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919772"&gt;</code></p><p><code>3148</code><code>b&lt;/a&gt;</code></p><p><code>3149</code><code>; &lt;a href="#R1011" rid="R1011" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918966"&gt;</code></p><p><code>3150</code><code>Richardson et al., 1997&lt;/a&gt;</code></p><p><code>3151</code><code>, &lt;a href="#R1012" rid="R1012" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919390"&gt;</code></p><p><code>3152</code><code>1998a&lt;/a&gt;</code></p><p><code>3153</code><code>,&lt;a href="#R1013" rid="R1013" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637213"&gt;</code></p><p><code>3154</code><code>b&lt;/a&gt;</code></p><p><code>3155</code><code>; &lt;a href="#R823" rid="R823" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920060"&gt;</code></p><p><code>3156</code><code>Meng et al., 1998&lt;/a&gt;</code></p><p><code>3157</code><code>; &lt;a href="#R1146" rid="R1146" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919730"&gt;</code></p><p><code>3158</code><code>Strangman et al., 1998&lt;/a&gt;</code></p><p><code>3159</code><code>; &lt;a href="#R514" rid="R514" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919519"&gt;</code></p><p><code>3160</code><code>Hohmann and Walker, 1999&lt;/a&gt;</code></p><p><code>3161</code><code>; &lt;a href="#R335" rid="R335" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918718"&gt;</code></p><p><code>3162</code><code>Fox et al., 2001&lt;/a&gt;</code></p><p><code>3163</code><code>), spinal cord (&lt;a href="#R1303" rid="R1303" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919205"&gt;</code></p><p><code>3164</code><code>Yaksh, 1981&lt;/a&gt;</code></p><p><code>3165</code><code>; &lt;a href="#R686" rid="R686" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919686"&gt;</code></p><p><code>3166</code><code>Lichtman and Martin, 1991a&lt;/a&gt;</code></p><p><code>3167</code><code>,&lt;a href="#R687" rid="R687" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920102"&gt;</code></p><p><code>3168</code><code>b&lt;/a&gt;</code></p><p><code>3169</code><code>; &lt;a href="#R1280" rid="R1280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920091"&gt;</code></p><p><code>3170</code><code>Welch and Stevens, 1992&lt;/a&gt;</code></p><p><code>3171</code><code>; &lt;a href="#R1011" rid="R1011" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918800"&gt;</code></p><p><code>3172</code><code>Richardson et al., 1997&lt;/a&gt;</code></p><p><code>3173</code><code>, &lt;a href="#R1012" rid="R1012" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920368"&gt;</code></p><p><code>3174</code><code>1998a&lt;/a&gt;</code></p><p><code>3175</code><code>,&lt;a href="#R1013" rid="R1013" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637203"&gt;</code></p><p><code>3176</code><code>b&lt;/a&gt;</code></p><p><code>3177</code><code>; &lt;a href="#R513" rid="R513" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653355"&gt;</code></p><p><code>3178</code><code>Hohmann et al., 1998&lt;/a&gt;</code></p><p><code>3179</code><code>; &lt;a href="#R170" rid="R170" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920009"&gt;</code></p><p><code>3180</code><code>Chapman, 1999&lt;/a&gt;</code></p><p><code>3181</code><code>; &lt;a href="#R282" rid="R282" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918950"&gt;</code></p><p><code>3182</code><code>Drew et al., 2000&lt;/a&gt;</code></p><p><code>3183</code><code>; &lt;a href="#R873" rid="R873" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919170"&gt;</code></p><p><code>3184</code><code>Naderi et al., 2005&lt;/a&gt;</code></p><p><code>3185</code><code>; &lt;a href="#R1156" rid="R1156" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653470"&gt;</code></p><p><code>3186</code><code>Suplita et al., 2006&lt;/a&gt;</code></p><p><code>3187</code><code>), and peripheral sensory nerves (&lt;a href="#R148" rid="R148" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920113"&gt;</code></p><p><code>3188</code><code>Calignano et al., 1998&lt;/a&gt;</code></p><p><code>3189</code><code>; &lt;a href="#R1014" rid="R1014" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920077"&gt;</code></p><p><code>3190</code><code>Richardson et al., 1998c&lt;/a&gt;</code></p><p><code>3191</code><code>; &lt;a href="#R509" rid="R509" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919096"&gt;</code></p><p><code>3192</code><code>Hohmann and Herkenham, 1999&lt;/a&gt;</code></p><p><code>3193</code><code>; &lt;a href="#R335" rid="R335" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919317"&gt;</code></p><p><code>3194</code><code>Fox et al., 2001&lt;/a&gt;</code></p><p><code>3195</code><code>; &lt;a href="#R565" rid="R565" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920011"&gt;</code></p><p><code>3196</code><code>Johanek et al., 2001&lt;/a&gt;</code></p><p><code>3197</code><code>; &lt;a href="#R596" rid="R596" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920213"&gt;</code></p><p><code>3198</code><code>Kelly et al., 2003&lt;/a&gt;</code></p><p><code>3199</code><code>; &lt;a href="#R566" rid="R566" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919910"&gt;</code></p><p><code>3200</code><code>Johanek and Simone, 2004&lt;/a&gt;</code></p><p><code>3201</code><code>; &lt;a href="#R573" rid="R573" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918746"&gt;</code></p><p><code>3202</code><code>Jordt et al., 2004&lt;/a&gt;</code></p><p><code>3203</code><code>; &lt;a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_393488955"&gt;</code></p><p><code>3204</code><code>Amaya et al., 2006&lt;/a&gt;</code></p><p><code>3205</code><code>). This is consistent with the anatomical location of CB&lt;sub&gt;</code></p><p><code>3206</code><code>1&lt;/sub&gt;</code></p><p><code>3207</code><code> receptors in areas relevant to pain in the brain, spinal dorsal horn, dorsal root ganglia, and peripheral afferent neurons (&lt;a href="#R486" rid="R486" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919488"&gt;</code></p><p><code>3208</code><code>Herkenham et al., 1990&lt;/a&gt;</code></p><p><code>3209</code><code>, &lt;a href="#R484" rid="R484" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919257"&gt;</code></p><p><code>3210</code><code>1991a&lt;/a&gt;</code></p><p><code>3211</code><code>; &lt;a href="#R508" rid="R508" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920086"&gt;</code></p><p><code>3212</code><code>Hohmann and Herkenham, 1998&lt;/a&gt;</code></p><p><code>3213</code><code>, &lt;a href="#R509" rid="R509" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919088"&gt;</code></p><p><code>3214</code><code>1999&lt;/a&gt;</code></p><p><code>3215</code><code>; &lt;a href="#R506" rid="R506" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920021"&gt;</code></p><p><code>3216</code><code>Hohmann et al., 1999&lt;/a&gt;</code></p><p><code>3217</code><code>; &lt;a href="#R1062" rid="R1062" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653397"&gt;</code></p><p><code>3218</code><code>Sa&amp;#x000f1;udoPe&amp;#x000f1;a et al., 1999a&lt;/a&gt;</code></p><p><code>3219</code><code>).&lt;/p&gt;</code></p><p><code>3220</code><code>&lt;p id="P58"&gt;</code></p><p><code>3221</code><code>In addition to the role of CB&lt;sub&gt;</code></p><p><code>3222</code><code>1&lt;/sub&gt;</code></p><p><code>3223</code><code> receptors, there is recent evidence implicating CB&lt;sub&gt;</code></p><p><code>3224</code><code>2&lt;/sub&gt;</code></p><p><code>3225</code><code> receptors in the antihyperalgesic activity of cannabinoids in models of acute and chronic, neuropathic pain, especially of inflammatory origin (&lt;a href="#R148" rid="R148" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920369"&gt;</code></p><p><code>3226</code><code>Calignano et al., 1998&lt;/a&gt;</code></p><p><code>3227</code><code>; &lt;a href="#R467" rid="R467" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918873"&gt;</code></p><p><code>3228</code><code>Hanus et al., 1999&lt;/a&gt;</code></p><p><code>3229</code><code>; &lt;a href="#R735" rid="R735" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918932"&gt;</code></p><p><code>3230</code><code>Malan et al., 2001&lt;/a&gt;</code></p><p><code>3231</code><code>; &lt;a href="#R185" rid="R185" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919434"&gt;</code></p><p><code>3232</code><code>Clayton et al., 2002&lt;/a&gt;</code></p><p><code>3233</code><code>; &lt;a href="#R534" rid="R534" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919338"&gt;</code></p><p><code>3234</code><code>Ibrahim et al., 2003&lt;/a&gt;</code></p><p><code>3235</code><code>, &lt;a href="#R535" rid="R535" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920184"&gt;</code></p><p><code>3236</code><code>2005&lt;/a&gt;</code></p><p><code>3237</code><code>; &lt;a href="#R870" rid="R870" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920025"&gt;</code></p><p><code>3238</code><code>Nackley et al., 2003a&lt;/a&gt;</code></p><p><code>3239</code><code>,&lt;a href="#R871" rid="R871" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919808"&gt;</code></p><p><code>3240</code><code>b&lt;/a&gt;</code></p><p><code>3241</code><code>, &lt;a href="#R872" rid="R872" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919758"&gt;</code></p><p><code>3242</code><code>2004&lt;/a&gt;</code></p><p><code>3243</code><code>; &lt;a href="#R990" rid="R990" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919917"&gt;</code></p><p><code>3244</code><code>Quartilho et al., 2003&lt;/a&gt;</code></p><p><code>3245</code><code>; &lt;a href="#R296" rid="R296" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919683"&gt;</code></p><p><code>3246</code><code>Elmes et al., 2004&lt;/a&gt;</code></p><p><code>3247</code><code>; &lt;a href="#R507" rid="R507" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918832"&gt;</code></p><p><code>3248</code><code>Hohmann et al., 2004&lt;/a&gt;</code></p><p><code>3249</code><code>; &lt;a href="#R1083" rid="R1083" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918678"&gt;</code></p><p><code>3250</code><code>Scott et al., 2004&lt;/a&gt;</code></p><p><code>3251</code><code>; &lt;a href="#R1284" rid="R1284" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920398"&gt;</code></p><p><code>3252</code><code>Whiteside et al., 2005&lt;/a&gt;</code></p><p><code>3253</code><code>; &lt;a href="#R536" rid="R536" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920338"&gt;</code></p><p><code>3254</code><code>Ibrahim et al., 2006&lt;/a&gt;</code></p><p><code>3255</code><code>). Cannabinoid agonists may also release endogenous opioids, and a functional interplay between the endocannabinoid and opioid systems in modulating analgesic responses has been suggested by numerous studies (&lt;a href="#R988" rid="R988" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920089"&gt;</code></p><p><code>3256</code><code>Pugh et al., 1997&lt;/a&gt;</code></p><p><code>3257</code><code>; &lt;a href="#R746" rid="R746" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919870"&gt;</code></p><p><code>3258</code><code>Manzanares et al., 1999a&lt;/a&gt;</code></p><p><code>3259</code><code>,&lt;a href="#R747" rid="R747" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918911"&gt;</code></p><p><code>3260</code><code>b&lt;/a&gt;</code></p><p><code>3261</code><code>; &lt;a href="#R524" rid="R524" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918765"&gt;</code></p><p><code>3262</code><code>Houser et al., 2000&lt;/a&gt;</code></p><p><code>3263</code><code>; &lt;a href="#R535" rid="R535" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920281"&gt;</code></p><p><code>3264</code><code>Ibrahim et al., 2005&lt;/a&gt;</code></p><p><code>3265</code><code>; &lt;a href="#R1174" rid="R1174" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919901"&gt;</code></p><p><code>3266</code><code>Tham et al., 2005&lt;/a&gt;</code></p><p><code>3267</code><code>; &lt;a href="#R1232" rid="R1232" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918826"&gt;</code></p><p><code>3268</code><code>Vigano et al., 2005a&lt;/a&gt;</code></p><p><code>3269</code><code>,&lt;a href="#R1233" rid="R1233" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919476"&gt;</code></p><p><code>3270</code><code>b&lt;/a&gt;</code></p><p><code>3271</code><code>; &lt;a href="#R1290" rid="R1290" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919339"&gt;</code></p><p><code>3272</code><code>Williams et al., 2006&lt;/a&gt;</code></p><p><code>3273</code><code>).&lt;/p&gt;</code></p><p><code>3274</code><code>&lt;p id="P59"&gt;</code></p><p><code>3275</code><code>As discussed before, anandamide is also a ligand for TRPV&lt;sub&gt;</code></p><p><code>3276</code><code>1&lt;/sub&gt;</code></p><p><code>3277</code><code> receptors, albeit with an affinity lower than its affinity for CB&lt;sub&gt;</code></p><p><code>3278</code><code>1&lt;/sub&gt;</code></p><p><code>3279</code><code> receptors. The potential involvement of TRPV&lt;sub&gt;</code></p><p><code>3280</code><code>1&lt;/sub&gt;</code></p><p><code>3281</code><code> in the analgesic effect of endogenous anandamide has been raised by the findings that the analgesic response to microinjection of a FAAH antagonist into the periaqueductal gray of rats could be inhibited by a similar local microinjection of 6 nmol of capsazepine (&lt;a href="#R733" rid="R733" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919321"&gt;</code></p><p><code>3282</code><code>Maione et al., 2006&lt;/a&gt;</code></p><p><code>3283</code><code>). However, others reported that systemic administration of 10 mg/kg capsazepine, which blocked capsaicin-induced analgesia, failed to inhibit endocannabinoid-mediated, stress-induced analgesia, which could be enhanced by a FAAH inhibitor and completely blocked by the CB&lt;sub&gt;</code></p><p><code>3284</code><code>1&lt;/sub&gt;</code></p><p><code>3285</code><code> antagonist rimonabant (&lt;a href="#R1156" rid="R1156" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653433"&gt;</code></p><p><code>3286</code><code>Suplita et al., 2006&lt;/a&gt;</code></p><p><code>3287</code><code>).&lt;/p&gt;</code></p><p><code>3288</code><code>&lt;p id="P60"&gt;</code></p><p><code>3289</code><code>The analgesic response to exogenous cannabinoids suggested a role for the endocannabinoid system in regulating pain sensitivity, which has received experimental support (reviewed in &lt;a href="#R1255" rid="R1255" class=" bibr popnode"&gt;</code></p><p><code>3290</code><code>Walker et al., 2000&lt;/a&gt;</code></p><p><code>3291</code><code>, &lt;a href="#R1257" rid="R1257" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919104"&gt;</code></p><p><code>3292</code><code>2002&lt;/a&gt;</code></p><p><code>3293</code><code>; &lt;a href="#R225" rid="R225" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919014"&gt;</code></p><p><code>3294</code><code>Cravatt et al., 2004&lt;/a&gt;</code></p><p><code>3295</code><code>; &lt;a href="#R102" rid="R102" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919816"&gt;</code></p><p><code>3296</code><code>Boger et al., 2005&lt;/a&gt;</code></p><p><code>3297</code><code>). For example, &lt;a href="#R1256" rid="R1256" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918705"&gt;</code></p><p><code>3298</code><code>Walker et al. (1999)&lt;/a&gt;</code></p><p><code>3299</code><code> have demonstrated increased anandamide levels in some brain areas involved in nociception after peripheral nociceptive input in the rat. The functional role of endogenous anandamide was further supported by the predominantly CB&lt;sub&gt;</code></p><p><code>3300</code><code>1&lt;/sub&gt;</code></p><p><code>3301</code><code>-mediated analgesic response to FAAH or endocannabinoid transport inhibitors in animal models of acute and chronic pain (&lt;a href="#R685" rid="R685" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920012"&gt;</code></p><p><code>3302</code><code>Lichtman et al., 2004a&lt;/a&gt;</code></p><p><code>3303</code><code>; &lt;a href="#R168" rid="R168" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919113"&gt;</code></p><p><code>3304</code><code>Chang et al., 2006&lt;/a&gt;</code></p><p><code>3305</code><code>; &lt;a href="#R553" rid="R553" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920283"&gt;</code></p><p><code>3306</code><code>Jayamanne et al., 2006&lt;/a&gt;</code></p><p><code>3307</code><code>; &lt;a href="#R652" rid="R652" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920139"&gt;</code></p><p><code>3308</code><code>La Rana et al., 2006&lt;/a&gt;</code></p><p><code>3309</code><code>; &lt;a href="#R1156" rid="R1156" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653460"&gt;</code></p><p><code>3310</code><code>Suplita et al., 2006&lt;/a&gt;</code></p><p><code>3311</code><code>). Similarly, FAAH knockout mice had elevated brain levels of anandamide and displayed analgesic behavior in acute inflammatory, but not in chronic neuropathic models of pain (&lt;a href="#R688" rid="R688" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919779"&gt;</code></p><p><code>3312</code><code>Lichtman et al., 2004b&lt;/a&gt;</code></p><p><code>3313</code><code>). Formation of anandamide and 2-AG is also increased in response to stress in the periaqueductal gray matter, in which inhibition of endocannabinoid degradation was found to enhance stress-induced analgesia in a CB&lt;sub&gt;</code></p><p><code>3314</code><code>1&lt;/sub&gt;</code></p><p><code>3315</code><code> receptor-dependent manner (&lt;a href="#R512" rid="R512" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920024"&gt;</code></p><p><code>3316</code><code>Hohmann et al., 2005&lt;/a&gt;</code></p><p><code>3317</code><code>; &lt;a href="#R1156" rid="R1156" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653495"&gt;</code></p><p><code>3318</code><code>Suplita et al., 2006&lt;/a&gt;</code></p><p><code>3319</code><code>), confirming and extending an earlier finding that implicated CB&lt;sub&gt;</code></p><p><code>3320</code><code>1&lt;/sub&gt;</code></p><p><code>3321</code><code> receptors and endocannabinoids in stress-induced analgesia (&lt;a href="#R1209" rid="R1209" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920379"&gt;</code></p><p><code>3322</code><code>Valverde et al., 2000&lt;/a&gt;</code></p><p><code>3323</code><code>).&lt;/p&gt;</code></p><p><code>3324</code><code>&lt;p id="P61"&gt;</code></p><p><code>3325</code><code>In humans, the analgesic activity of THC and other cannabinoids is less clear-cut. There are numerous case reports on the beneficial effects of cannabis or synthetic derivatives of THC in pain associated with multiple sclerosis, cancer, neuropathies, and HIV infection (&lt;a href="#R898" rid="R898" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918829"&gt;</code></p><p><code>3326</code><code>Noyes et al., 1975a&lt;/a&gt;</code></p><p><code>3327</code><code>,&lt;a href="#R899" rid="R899" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653526"&gt;</code></p><p><code>3328</code><code>b&lt;/a&gt;</code></p><p><code>3329</code><code>; &lt;a href="#R770" rid="R770" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918990"&gt;</code></p><p><code>3330</code><code>Martyn et al., 1995&lt;/a&gt;</code></p><p><code>3331</code><code>; &lt;a href="#R204" rid="R204" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919747"&gt;</code></p><p><code>3332</code><code>Consroe et al., 1997&lt;/a&gt;</code></p><p><code>3333</code><code>; &lt;a href="#R459" rid="R459" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918858"&gt;</code></p><p><code>3334</code><code>Hamann and di Vadi, 1999&lt;/a&gt;</code></p><p><code>3335</code><code>; &lt;a href="#R1274" rid="R1274" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920151"&gt;</code></p><p><code>3336</code><code>Ware et al., 2003&lt;/a&gt;</code></p><p><code>3337</code><code>; &lt;a href="#R1047" rid="R1047" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919887"&gt;</code></p><p><code>3338</code><code>Rudich et al., 2003&lt;/a&gt;</code></p><p><code>3339</code><code>; &lt;a href="#R1272" rid="R1272" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653420"&gt;</code></p><p><code>3340</code><code>Ware and Beaulieu, 2005&lt;/a&gt;</code></p><p><code>3341</code><code>; &lt;a href="#R1273" rid="R1273" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919575"&gt;</code></p><p><code>3342</code><code>Ware et al., 2005&lt;/a&gt;</code></p><p><code>3343</code><code>; &lt;a href="#R71" rid="R71" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919301"&gt;</code></p><p><code>3344</code><code>Berlach et al., 2006&lt;/a&gt;</code></p><p><code>3345</code><code>; reviewed in &lt;a href="#R133" rid="R133" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919704"&gt;</code></p><p><code>3346</code><code>Burns and Ineck, 2006&lt;/a&gt;</code></p><p><code>3347</code><code>) (&lt;a href="/pmc/articles/PMC2241751/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""&gt;</code></p><p><code>3348</code><code>&lt;span&gt;</code></p><p><code>3349</code><code>Table 1&lt;/span&gt;</code></p><p><code>3350</code><code>&lt;/a&gt;</code></p><p><code>3351</code><code>). The results of randomized studies conducted before 1999 on the analgesic effect of orally administered synthetic cannabinoids in patients with postoperative, post-traumatic, cancer, or spastic pain had been subjected to a meta-analysis. The authors concluded that cannabinoids were not more effective than codeine in controlling pain, and their use was associated with numerous undesirable, dose-limiting CNS side effects (&lt;a href="#R150" rid="R150" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919077"&gt;</code></p><p><code>3352</code><code>Campbell et al., 2001&lt;/a&gt;</code></p><p><code>3353</code><code>).&lt;/p&gt;</code></p><p><code>3354</code><code>&lt;p id="P62"&gt;</code></p><p><code>3355</code><code>Recent clinical trials with THC or cannabis extracts containing a 1:1 mixture of THC and cannabidiol (Sativex, GW-1000) have provided mixed results. In a randomized, double-blind, placebo-controlled crossover study of 48 patients suffering from central neuropathic pain due to brachial plexus avulsion, oromucosally administered THC or Sativex was ineffective in reducing the pain severity score recorded during the last 7 days of treatment (&lt;a href="#R72" rid="R72" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918880"&gt;</code></p><p><code>3356</code><code>Berman et al., 2004&lt;/a&gt;</code></p><p><code>3357</code><code>). Similarly, oral THC (dronabinol) did not improve postoperative (&lt;a href="#R129" rid="R129" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919615"&gt;</code></p><p><code>3358</code><code>Buggy et al., 2003&lt;/a&gt;</code></p><p><code>3359</code><code>) and neuropathic pain (&lt;a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918869"&gt;</code></p><p><code>3360</code><code>Attal et al., 2004&lt;/a&gt;</code></p><p><code>3361</code><code>) in trials involving small numbers of patients. However, numerous lessons have been learned from these initial human studies on optimal trial design, dose and route of administration of cannabinoids, and more recent larger-scale studies allow reason for more optimism, as outlined below.&lt;/p&gt;</code></p><p><code>3362</code><code>&lt;p id="P63"&gt;</code></p><p><code>3363</code><code>THC or Sativex reduced neuropathic pain in patients with traumatic nerve injury or multiple sclerosis in randomized, double-blind, placebo-controlled, crossover trials (&lt;a href="#R1245" rid="R1245" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919817"&gt;</code></p><p><code>3364</code><code>Wade et al., 2003&lt;/a&gt;</code></p><p><code>3365</code><code>; &lt;a href="#R897" rid="R897" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918836"&gt;</code></p><p><code>3366</code><code>Notcutt et al., 2004&lt;/a&gt;</code></p><p><code>3367</code><code>). Modest, but clinically relevant analgesic effects were reported in 21 multiple sclerosis patients treated with dronabinol, in a randomized, controlled clinical trial (&lt;a href="#R1157" rid="R1157" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919004"&gt;</code></p><p><code>3368</code><code>Svendsen et al., 2004&lt;/a&gt;</code></p><p><code>3369</code><code>). Effective pain relief by orally administered cannabis extract or THC was also reported in a randomized, controlled, multicenter trial involving 611 multiple sclerosis patients (&lt;a href="#R1312" rid="R1312" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919253"&gt;</code></p><p><code>3370</code><code>Zajicek et al., 2003&lt;/a&gt;</code></p><p><code>3371</code><code>). Moreover, in a recent study of 66 multiple sclerosis patients, Sativex was effective in reducing central neuropathic pain (&lt;a href="#R1029" rid="R1029" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919606"&gt;</code></p><p><code>3372</code><code>Rog et al., 2005&lt;/a&gt;</code></p><p><code>3373</code><code>). A preview of as-yet-unpublished human studies gave an account of a significant benefit of Sativex over placebo in peripheral neuropathic pain characterized by allodynia, in central pain associated with multiple sclerosis, and in opiate-resistant, intractable pain due to cancer (&lt;a href="#R1050" rid="R1050" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920323"&gt;</code></p><p><code>3374</code><code>Russo, 2006&lt;/a&gt;</code></p><p><code>3375</code><code>). A multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis extract (Cannador) in patients with postoperative pain demonstrated significant dose-related improvements in rescue analgesia requirements and significant trends across the escalating dose groups for decreasing pain intensity (&lt;a href="#R519" rid="R519" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919968"&gt;</code></p><p><code>3376</code><code>Holdcroft et al. 2006&lt;/a&gt;</code></p><p><code>3377</code><code>). THC (Marinol) was found to suppress otherwise intractable cholestatic pruritus in a case report (&lt;a href="#R882" rid="R882" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920363"&gt;</code></p><p><code>3378</code><code>Neff et al., 2002&lt;/a&gt;</code></p><p><code>3379</code><code>). An analysis of pain questionnaires from 523 patients with HIV infections revealed that 90 to 94% of the subjects using cannabis experienced improvement in muscle and neuropathic pain (&lt;a href="#R1301" rid="R1301" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919206"&gt;</code></p><p><code>3380</code><code>Woolridge et al., 2005&lt;/a&gt;</code></p><p><code>3381</code><code>). The therapeutic potential of cannabinoids in pain associated with trigeminal neuralgia and migraine has also been the subject of several recent reviews (&lt;a href="#R683" rid="R683" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920241"&gt;</code></p><p><code>3382</code><code>Liang et al., 2004&lt;/a&gt;</code></p><p><code>3383</code><code>; &lt;a href="#R1051" rid="R1051" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919379"&gt;</code></p><p><code>3384</code><code>Russo, 2004&lt;/a&gt;</code></p><p><code>3385</code><code>, &lt;a href="#R1050" rid="R1050" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919106"&gt;</code></p><p><code>3386</code><code>2006&lt;/a&gt;</code></p><p><code>3387</code><code>). Preclinical studies (&lt;a href="#R137" rid="R137" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918714"&gt;</code></p><p><code>3388</code><code>Burstein et al., 1998&lt;/a&gt;</code></p><p><code>3389</code><code>, &lt;a href="#R138" rid="R138" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919198"&gt;</code></p><p><code>3390</code><code>2004&lt;/a&gt;</code></p><p><code>3391</code><code>; &lt;a href="#R135" rid="R135" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920169"&gt;</code></p><p><code>3392</code><code>Burstein, 2000&lt;/a&gt;</code></p><p><code>3393</code><code>, &lt;a href="#R134" rid="R134" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920016"&gt;</code></p><p><code>3394</code><code>2005&lt;/a&gt;</code></p><p><code>3395</code><code>; &lt;a href="#R290" rid="R290" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919700"&gt;</code></p><p><code>3396</code><code>Dyson et al., 2005&lt;/a&gt;</code></p><p><code>3397</code><code>; &lt;a href="#R838" rid="R838" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920020"&gt;</code></p><p><code>3398</code><code>Mitchell et al., 2005&lt;/a&gt;</code></p><p><code>3399</code><code>; &lt;a href="#R1056" rid="R1056" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919309"&gt;</code></p><p><code>3400</code><code>Salim et al., 2005&lt;/a&gt;</code></p><p><code>3401</code><code>) and a recent clinical trial of 24 patients with neuropathic pain of varying etiologies demonstrated that ajulemic acid, a major metabolite of THC with CB&lt;sub&gt;</code></p><p><code>3402</code><code>1&lt;/sub&gt;</code></p><p><code>3403</code><code> agonist activity, was effective in reducing pain without causing cannabinoid-like CNS side effects, the first evidence for the separability of the psychotropic and analgesic effects of a THC analog in humans (&lt;a href="#R588" rid="R588" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653508"&gt;</code></p><p><code>3404</code><code>Karst et al., 2003&lt;/a&gt;</code></p><p><code>3405</code><code>). Numerous additional human studies are ongoing to determine the effectiveness of THC or cannabis-based extracts against various forms of pain (reviewed in &lt;a href="#R1272" rid="R1272" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653468"&gt;</code></p><p><code>3406</code><code>Ware and Beaulieu, 2005&lt;/a&gt;</code></p><p><code>3407</code><code> reviewed in Ware and Beaulieu, 2006).&lt;/p&gt;</code></p><p><code>3408</code><code>&lt;p id="P64"&gt;</code></p><p><code>3409</code><code>Multiple lines of evidence support the important role of the cannabinoid signaling system in the modulation of immune function and inflammation (reviewed in &lt;a href="#R613" rid="R613" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919366"&gt;</code></p><p><code>3410</code><code>Klein et al., 1998&lt;/a&gt;</code></p><p><code>3411</code><code>, &lt;a href="#R615" rid="R615" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919904"&gt;</code></p><p><code>3412</code><code>2003&lt;/a&gt;</code></p><p><code>3413</code><code>; &lt;a href="#R1262" rid="R1262" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919239"&gt;</code></p><p><code>3414</code><code>Walter and Stella, 2004&lt;/a&gt;</code></p><p><code>3415</code><code>; &lt;a href="#R612" rid="R612" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919763"&gt;</code></p><p><code>3416</code><code>Klein, 2005&lt;/a&gt;</code></p><p><code>3417</code><code>). First, cannabinoid receptors are present on immune cells, where their expression is modulated by microbial antigens or other stimuli that induce immune activation. Second, stimulation of immune cells by bacterial toxins such as lipopolysaccharide (LPS) increases the cellular levels of endocannabinoids and their degrading enzyme(s). Third, cannabinoid agonists modulate immune function both in vitro and in vivo via cannabinoid receptor-dependent and -independent mechanisms.&lt;/p&gt;</code></p><p><code>3418</code><code>&lt;p id="P65" class="p p-last"&gt;</code></p><p><code>3419</code><code>The anti-inflammatory effects of cannabinoids are complex and may involve modulation of cytokine (e.g., TNF-&lt;em&gt;</code></p><p><code>3420</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>3421</code><code>, IL-12, IL-1, IL-6, and IL-10) and chemokine production (e.g., CCL2, CCL5, CXCL8, and CXCL10), modulation of adenosine signaling (&lt;a href="#R158" rid="R158" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919346"&gt;</code></p><p><code>3422</code><code>Carrier et al., 2006&lt;/a&gt;</code></p><p><code>3423</code><code>), expression of adhesion molecules (e.g., ICAM-1, P- intercellular adhesion molecule-1 and P-selectin), and the migration, proliferation, and apoptosis of inflammatory cells (reviewed in &lt;a href="#R613" rid="R613" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919357"&gt;</code></p><p><code>3424</code><code>Klein et al., 1998&lt;/a&gt;</code></p><p><code>3425</code><code>, &lt;a href="#R615" rid="R615" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920045"&gt;</code></p><p><code>3426</code><code>2003&lt;/a&gt;</code></p><p><code>3427</code><code>; &lt;a href="#R1262" rid="R1262" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919702"&gt;</code></p><p><code>3428</code><code>Walter and Stella, 2004&lt;/a&gt;</code></p><p><code>3429</code><code>; &lt;a href="#R612" rid="R612" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919377"&gt;</code></p><p><code>3430</code><code>Klein, 2005&lt;/a&gt;</code></p><p><code>3431</code><code>). To the extent that pain and inflammation accompany many of the disorders discussed in the rest of this review, cannabinoids would be expected to provide significant benefit due to their analgesic and anti-inflammatory properties.&lt;/p&gt;</code></p><p><code>3432</code><code>&lt;/div&gt;</code></p><p><code>3433</code><code>&lt;div id="S13" class="sec"&gt;</code></p><p><code>3434</code><code>&lt;h3 id="S13title"&gt;</code></p><p><code>3435</code><code>C. Central Nervous System Disorders&lt;/h3&gt;</code></p><p><code>3436</code><code>&lt;p id="P66" class="p p-first"&gt;</code></p><p><code>3437</code><code>The emerging role of the endocannabinoid system in a variety of CNS disorders should not come as a surprise given the very high level of expression of CB&lt;sub&gt;</code></p><p><code>3438</code><code>1&lt;/sub&gt;</code></p><p><code>3439</code><code> receptors in the brain. The particularly high density of CB&lt;sub&gt;</code></p><p><code>3440</code><code>1&lt;/sub&gt;</code></p><p><code>3441</code><code> receptors in the cortex, cerebellum, hippocampus, and basal ganglia had drawn early attention to diseases affecting movement, mood and anxiety disorders, and conditions related to altered brain reward mechanisms, as well as processes of memory and learning. The classic behavioral effects of marijuana also provided early clues about potential therapeutic targets, such as the control of pain or appetite. The role of the endocannabinoid system in the pathogenesis and treatment of specific CNS diseases is discussed below.&lt;/p&gt;</code></p><p><code>3442</code><code>&lt;div id="S14" class="sec"&gt;</code></p><p><code>3443</code><code>&lt;p&gt;</code></p><p><code>3444</code><code>&lt;/p&gt;</code></p><p><code>3445</code><code>&lt;h4 id="S14title" class="inline"&gt;</code></p><p><code>3446</code><code>1. Neurotoxicity and Neurotrauma &lt;/h4&gt;</code></p><p><code>3447</code><code>&lt;p id="P67" class="p p-first"&gt;</code></p><p><code>3448</code><code>The endocannabinoid system plays an important role in neuroprotection both in acute neuronal injury (e.g., traumatic brain injury, stroke, and epilepsy) and in chronic neurodegenerative disorders, such as multiple sclerosis, Parkinson&amp;#x02019;s disease, Huntington&amp;#x02019;s disease, amyotrophic lateral sclerosis, and Alzheimer&amp;#x02019;s disease (reviewed in &lt;a href="#R395" rid="R395" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918835"&gt;</code></p><p><code>3449</code><code>Glass, 2001&lt;/a&gt;</code></p><p><code>3450</code><code>; &lt;a href="#R811" rid="R811" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653400"&gt;</code></p><p><code>3451</code><code>Mechoulam et al., 2002a&lt;/a&gt;</code></p><p><code>3452</code><code>,&lt;a href="#R812" rid="R812" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918926"&gt;</code></p><p><code>3453</code><code>b&lt;/a&gt;</code></p><p><code>3454</code><code>; &lt;a href="#R438" rid="R438" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653475"&gt;</code></p><p><code>3455</code><code>Grundy, 2002&lt;/a&gt;</code></p><p><code>3456</code><code>; &lt;a href="#R230" rid="R230" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918998"&gt;</code></p><p><code>3457</code><code>Croxford, 2003&lt;/a&gt;</code></p><p><code>3458</code><code>; &lt;a href="#R284" rid="R284" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919001"&gt;</code></p><p><code>3459</code><code>Drysdale and Platt, 2003&lt;/a&gt;</code></p><p><code>3460</code><code>; &lt;a href="#R550" rid="R550" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918903"&gt;</code></p><p><code>3461</code><code>Jackson et al., 2005a&lt;/a&gt;</code></p><p><code>3462</code><code>; &lt;a href="#R997" rid="R997" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919351"&gt;</code></p><p><code>3463</code><code>Ramos et al., 2005&lt;/a&gt;</code></p><p><code>3464</code><code>). Although the underlying mechanisms are not fully understood, multiple cannabinoid receptor-dependent as well as receptor-independent processes have been implicated. These include, but are not limited to 1) modulation of excitatory glutamatergic transmissions and synaptic plasticity via presynaptic CB&lt;sub&gt;</code></p><p><code>3465</code><code>1&lt;/sub&gt;</code></p><p><code>3466</code><code> receptors (&lt;a href="#R842" rid="R842" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920251"&gt;</code></p><p><code>3467</code><code>Molina-Holgado et al., 1997&lt;/a&gt;</code></p><p><code>3468</code><code>; &lt;a href="#R752" rid="R752" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919108"&gt;</code></p><p><code>3469</code><code>Marsicano and Lutz, 1999&lt;/a&gt;</code></p><p><code>3470</code><code>; &lt;a href="#R381" rid="R381" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919217"&gt;</code></p><p><code>3471</code><code>Gerdeman et al., 2002&lt;/a&gt;</code></p><p><code>3472</code><code>; reviewed in &lt;a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920324"&gt;</code></p><p><code>3473</code><code>Alger, 2002&lt;/a&gt;</code></p><p><code>3474</code><code>; &lt;a href="#R1024" rid="R1024" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920381"&gt;</code></p><p><code>3475</code><code>Robbe et al., 2002&lt;/a&gt;</code></p><p><code>3476</code><code>; &lt;a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919078"&gt;</code></p><p><code>3477</code><code>Azad et al., 2003&lt;/a&gt;</code></p><p><code>3478</code><code>; &lt;a href="#R345" rid="R345" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919131"&gt;</code></p><p><code>3479</code><code>Freund et al., 2003&lt;/a&gt;</code></p><p><code>3480</code><code>; &lt;a href="#R379" rid="R379" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919805"&gt;</code></p><p><code>3481</code><code>Gerdeman and Lovinger, 2003&lt;/a&gt;</code></p><p><code>3482</code><code>; &lt;a href="#R972" rid="R972" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919496"&gt;</code></p><p><code>3483</code><code>Piomelli, 2003&lt;/a&gt;</code></p><p><code>3484</code><code>; &lt;a href="#R781" rid="R781" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920244"&gt;</code></p><p><code>3485</code><code>Mato et al., 2004&lt;/a&gt;</code></p><p><code>3486</code><code>), 2) modulation of immune responses and the release of inflammatory mediators by CB&lt;sub&gt;</code></p><p><code>3487</code><code>1&lt;/sub&gt;</code></p><p><code>3488</code><code>, CB&lt;sub&gt;</code></p><p><code>3489</code><code>2&lt;/sub&gt;</code></p><p><code>3490</code><code>, and non CB&lt;sub&gt;</code></p><p><code>3491</code><code>1&lt;/sub&gt;</code></p><p><code>3492</code><code>/CB&lt;sub&gt;</code></p><p><code>3493</code><code>2&lt;/sub&gt;</code></p><p><code>3494</code><code> receptors on neurons, astrocytes, microglia, macrophages, neutrophils and lymphocytes (&lt;a href="#R1276" rid="R1276" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919871"&gt;</code></p><p><code>3495</code><code>Watzl et al., 1991&lt;/a&gt;</code></p><p><code>3496</code><code>; &lt;a href="#R1320" rid="R1320" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918848"&gt;</code></p><p><code>3497</code><code>Zheng et al., 1992&lt;/a&gt;</code></p><p><code>3498</code><code>; &lt;a href="#R324" rid="R324" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919828"&gt;</code></p><p><code>3499</code><code>Fischer-Stenger et al., 1993&lt;/a&gt;</code></p><p><code>3500</code><code>; &lt;a href="#R140" rid="R140" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919406"&gt;</code></p><p><code>3501</code><code>Cabral and Fischer-Stenger, 1994&lt;/a&gt;</code></p><p><code>3502</code><code>; Kusher et al., 1994; &lt;a href="#R132" rid="R132" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919669"&gt;</code></p><p><code>3503</code><code>Burnette-Curley and Cabral, 1995&lt;/a&gt;</code></p><p><code>3504</code><code>; &lt;a href="#R142" rid="R142" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919497"&gt;</code></p><p><code>3505</code><code>Cabral et al., 1995&lt;/a&gt;</code></p><p><code>3506</code><code>; reviewed in &lt;a href="#R351" rid="R351" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920042"&gt;</code></p><p><code>3507</code><code>Friedman et al., 1995&lt;/a&gt;</code></p><p><code>3508</code><code>; &lt;a href="#R1321" rid="R1321" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919896"&gt;</code></p><p><code>3509</code><code>Zheng and Specter, 1996&lt;/a&gt;</code></p><p><code>3510</code><code>; &lt;a href="#R1095" rid="R1095" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920205"&gt;</code></p><p><code>3511</code><code>Shohami et al., 1997&lt;/a&gt;</code></p><p><code>3512</code><code>; &lt;a href="#R887" rid="R887" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918928"&gt;</code></p><p><code>3513</code><code>Newton et al., 1998&lt;/a&gt;</code></p><p><code>3514</code><code>; &lt;a href="#R1132" rid="R1132" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919192"&gt;</code></p><p><code>3515</code><code>Srivastava et al., 1998&lt;/a&gt;</code></p><p><code>3516</code><code>; &lt;a href="#R355" rid="R355" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918799"&gt;</code></p><p><code>3517</code><code>Gallily et al., 2000&lt;/a&gt;</code></p><p><code>3518</code><code>; &lt;a href="#R614" rid="R614" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919475"&gt;</code></p><p><code>3519</code><code>Klein et al., 2000a&lt;/a&gt;</code></p><p><code>3520</code><code>,&lt;a href="#R616" rid="R616" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919726"&gt;</code></p><p><code>3521</code><code>b&lt;/a&gt;</code></p><p><code>3522</code><code>, &lt;a href="#R615" rid="R615" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918727"&gt;</code></p><p><code>3523</code><code>2003&lt;/a&gt;</code></p><p><code>3524</code><code>; &lt;a href="#R1120" rid="R1120" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919697"&gt;</code></p><p><code>3525</code><code>Smith et al., 2000&lt;/a&gt;</code></p><p><code>3526</code><code>; &lt;a href="#R156" rid="R156" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919332"&gt;</code></p><p><code>3527</code><code>Carlisle et al., 2002&lt;/a&gt;</code></p><p><code>3528</code><code>; &lt;a href="#R382" rid="R382" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919486"&gt;</code></p><p><code>3529</code><code>Germain et al., 2002&lt;/a&gt;</code></p><p><code>3530</code><code>; &lt;a href="#R599" rid="R599" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918749"&gt;</code></p><p><code>3531</code><code>Killestein et al., 2003&lt;/a&gt;</code></p><p><code>3532</code><code>; &lt;a href="#R582" rid="R582" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920129"&gt;</code></p><p><code>3533</code><code>Kaplan et al., 2005&lt;/a&gt;</code></p><p><code>3534</code><code>; &lt;a href="#R996" rid="R996" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637235"&gt;</code></p><p><code>3535</code><code>Ramirez et al., 2005&lt;/a&gt;</code></p><p><code>3536</code><code>; reviewed in &lt;a href="#R351" rid="R351" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918760"&gt;</code></p><p><code>3537</code><code>Friedman et al., 1995&lt;/a&gt;</code></p><p><code>3538</code><code>; &lt;a href="#R1138" rid="R1138" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919365"&gt;</code></p><p><code>3539</code><code>Stella, 2004&lt;/a&gt;</code></p><p><code>3540</code><code>; &lt;a href="#R1262" rid="R1262" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920073"&gt;</code></p><p><code>3541</code><code>Walter and Stella, 2004&lt;/a&gt;</code></p><p><code>3542</code><code>; &lt;a href="#R210" rid="R210" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918983"&gt;</code></p><p><code>3543</code><code>Correa et al., 2005&lt;/a&gt;</code></p><p><code>3544</code><code>; &lt;a href="#R232" rid="R232" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919030"&gt;</code></p><p><code>3545</code><code>Croxford and Yamamura, 2005&lt;/a&gt;</code></p><p><code>3546</code><code>; &lt;a href="#R612" rid="R612" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920280"&gt;</code></p><p><code>3547</code><code>Klein, 2005&lt;/a&gt;</code></p><p><code>3548</code><code>;), 3) activation of cytoprotective signaling pathways (&lt;a href="#R431" rid="R431" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919003"&gt;</code></p><p><code>3549</code><code>Grigorenko et al., 2002&lt;/a&gt;</code></p><p><code>3550</code><code>), such as protein kinase B/Akt (&lt;a href="#R841" rid="R841" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637202"&gt;</code></p><p><code>3551</code><code>Molina-Holgado et al., 2002&lt;/a&gt;</code></p><p><code>3552</code><code>), protein kinase A (&lt;a href="#R606" rid="R606" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920272"&gt;</code></p><p><code>3553</code><code>Kim et al., 2005&lt;/a&gt;</code></p><p><code>3554</code><code>), or neurotrophic factors (&lt;a href="#R598" rid="R598" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919953"&gt;</code></p><p><code>3555</code><code>Khaspekov et al., 2004&lt;/a&gt;</code></p><p><code>3556</code><code>), 4) modulation of excitability and calcium homeostasis via effects on Ca&lt;sup&gt;</code></p><p><code>3557</code><code>2+&lt;/sup&gt;</code></p><p><code>3558</code><code>, K&lt;sup&gt;</code></p><p><code>3559</code><code>+&lt;/sup&gt;</code></p><p><code>3560</code><code>, and Na&lt;sup&gt;</code></p><p><code>3561</code><code>+&lt;/sup&gt;</code></p><p><code>3562</code><code> channels, &lt;em&gt;</code></p><p><code>3563</code><code>N&lt;/em&gt;</code></p><p><code>3564</code><code>-methyl D-aspartate (NMDA) receptors, gap junctions, and intracellular Ca&lt;sup&gt;</code></p><p><code>3565</code><code>2+&lt;/sup&gt;</code></p><p><code>3566</code><code> stores (&lt;a href="#R163" rid="R163" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919796"&gt;</code></p><p><code>3567</code><code>Caulfield and Brown, 1992&lt;/a&gt;</code></p><p><code>3568</code><code>; &lt;a href="#R727" rid="R727" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919371"&gt;</code></p><p><code>3569</code><code>Mackie and Hille, 1992&lt;/a&gt;</code></p><p><code>3570</code><code>; &lt;a href="#R726" rid="R726" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919660"&gt;</code></p><p><code>3571</code><code>Mackie et al., 1993&lt;/a&gt;</code></p><p><code>3572</code><code>; &lt;a href="#R874" rid="R874" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919029"&gt;</code></p><p><code>3573</code><code>Nadler et al., 1995&lt;/a&gt;</code></p><p><code>3574</code><code>; &lt;a href="#R1225" rid="R1225" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919187"&gt;</code></p><p><code>3575</code><code>Venance et al., 1995&lt;/a&gt;</code></p><p><code>3576</code><code>; &lt;a href="#R1095" rid="R1095" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918918"&gt;</code></p><p><code>3577</code><code>Shohami et al., 1997&lt;/a&gt;</code></p><p><code>3578</code><code>; &lt;a href="#R462" rid="R462" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920158"&gt;</code></p><p><code>3579</code><code>Hampson et al., 2000b&lt;/a&gt;</code></p><p><code>3580</code><code>; &lt;a href="#R920" rid="R920" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919611"&gt;</code></p><p><code>3581</code><code>Oz et al., 2000&lt;/a&gt;</code></p><p><code>3582</code><code>, &lt;a href="#R919" rid="R919" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920175"&gt;</code></p><p><code>3583</code><code>2004&lt;/a&gt;</code></p><p><code>3584</code><code>; &lt;a href="#R172" rid="R172" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653362"&gt;</code></p><p><code>3585</code><code>Chemin et al., 2001&lt;/a&gt;</code></p><p><code>3586</code><code>; &lt;a href="#R732" rid="R732" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653517"&gt;</code></p><p><code>3587</code><code>Maingret et al., 2001&lt;/a&gt;</code></p><p><code>3588</code><code>; &lt;a href="#R895" rid="R895" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919256"&gt;</code></p><p><code>3589</code><code>Nogueron et al., 2001&lt;/a&gt;</code></p><p><code>3590</code><code>; &lt;a href="#R1023" rid="R1023" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637223"&gt;</code></p><p><code>3591</code><code>Robbe et al., 2001&lt;/a&gt;</code></p><p><code>3592</code><code>; &lt;a href="#R1294" rid="R1294" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920132"&gt;</code></p><p><code>3593</code><code>Wilson and Nicoll, 2001&lt;/a&gt;</code></p><p><code>3594</code><code>; &lt;a href="#R1293" rid="R1293" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919168"&gt;</code></p><p><code>3595</code><code>Wilson et al., 2001&lt;/a&gt;</code></p><p><code>3596</code><code>; &lt;a href="#R891" rid="R891" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919277"&gt;</code></p><p><code>3597</code><code>Nicholson et al., 2003&lt;/a&gt;</code></p><p><code>3598</code><code>; &lt;a href="#R446" rid="R446" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920039"&gt;</code></p><p><code>3599</code><code>Guo and Ikeda, 2004&lt;/a&gt;</code></p><p><code>3600</code><code>; &lt;a href="#R256" rid="R256" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919024"&gt;</code></p><p><code>3601</code><code>del Carmen et al., 2005&lt;/a&gt;</code></p><p><code>3602</code><code>; &lt;a href="#R256" rid="R256" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919913"&gt;</code></p><p><code>3603</code><code>del Carmen Godino et al., 2005&lt;/a&gt;</code></p><p><code>3604</code><code>; &lt;a href="#R1323" rid="R1323" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919370"&gt;</code></p><p><code>3605</code><code>Zhuang et al., 2005&lt;/a&gt;</code></p><p><code>3606</code><code>), 5) antioxidant properties of cannabinoids (&lt;a href="#R305" rid="R305" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918744"&gt;</code></p><p><code>3607</code><code>Eshhar et al., 1995&lt;/a&gt;</code></p><p><code>3608</code><code>; &lt;a href="#R460" rid="R460" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919111"&gt;</code></p><p><code>3609</code><code>Hampson et al., 1998&lt;/a&gt;</code></p><p><code>3610</code><code>; &lt;a href="#R177" rid="R177" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920160"&gt;</code></p><p><code>3611</code><code>Chen and Buck, 2000&lt;/a&gt;</code></p><p><code>3612</code><code>; reviewed in &lt;a href="#R461" rid="R461" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919934"&gt;</code></p><p><code>3613</code><code>Hampson et al., 2000a&lt;/a&gt;</code></p><p><code>3614</code><code>; &lt;a href="#R754" rid="R754" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919399"&gt;</code></p><p><code>3615</code><code>Marsicano et al., 2002a&lt;/a&gt;</code></p><p><code>3616</code><code>), and 6) CB&lt;sub&gt;</code></p><p><code>3617</code><code>1&lt;/sub&gt;</code></p><p><code>3618</code><code> receptor-mediated hypothermia, possibly by reducing metabolic rate and oxygen demand (&lt;a href="#R671" rid="R671" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920056"&gt;</code></p><p><code>3619</code><code>Leker et al., 2003&lt;/a&gt;</code></p><p><code>3620</code><code>).&lt;/p&gt;</code></p><p><code>3621</code><code>&lt;p id="P68"&gt;</code></p><p><code>3622</code><code>Excitotoxicity, the toxic effects of an overactivation of glutamate receptors, and the resulting oxidative stress may contribute to the pathological processes eventually leading to cellular dysfunction or death in both acute and chronic forms of neurodegeneration (&lt;a href="#R220" rid="R220" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653461"&gt;</code></p><p><code>3623</code><code>Coyle and Puttfarcken, 1993&lt;/a&gt;</code></p><p><code>3624</code><code>; &lt;a href="#R802" rid="R802" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919676"&gt;</code></p><p><code>3625</code><code>McNamara, 1999&lt;/a&gt;</code></p><p><code>3626</code><code>; &lt;a href="#R713" rid="R713" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919443"&gt;</code></p><p><code>3627</code><code>Lutz, 2004&lt;/a&gt;</code></p><p><code>3628</code><code>). Dexanabinol (HU-211), a behaviorally inactive cannabinoid and noncompetitive antagonist of NMDA receptors, protects primary rat neuronal cultures against NMDA and glutamate exposure in vitro (&lt;a href="#R304" rid="R304" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918692"&gt;</code></p><p><code>3629</code><code>Eshhar et al., 1993&lt;/a&gt;</code></p><p><code>3630</code><code>; &lt;a href="#R875" rid="R875" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918914"&gt;</code></p><p><code>3631</code><code>Nadler et al., 1993a&lt;/a&gt;</code></p><p><code>3632</code><code>,&lt;a href="#R876" rid="R876" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919802"&gt;</code></p><p><code>3633</code><code>b&lt;/a&gt;</code></p><p><code>3634</code><code>). THC protects primary cultured neurons against kainate-mediated toxicity in a CB&lt;sub&gt;</code></p><p><code>3635</code><code>1&lt;/sub&gt;</code></p><p><code>3636</code><code>-dependent manner (&lt;a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918734"&gt;</code></p><p><code>3637</code><code>Abood et al., 2001&lt;/a&gt;</code></p><p><code>3638</code><code>), similar to protectin by WIN 55,212-2 against low extracellular magnesium-induced cell death (&lt;a href="#R1092" rid="R1092" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919319"&gt;</code></p><p><code>3639</code><code>Shen and Thayer, 1998&lt;/a&gt;</code></p><p><code>3640</code><code>). Palmitoylethanolamide also improves neuronal survival in a glutamate-induced cell death model (&lt;a href="#R1114" rid="R1114" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919363"&gt;</code></p><p><code>3641</code><code>Skaper et al., 1996&lt;/a&gt;</code></p><p><code>3642</code><code>). Intracerebral injection of NMDA in neonatal rats results in a 13-fold increase of cortical anandamide concentrations (&lt;a href="#R463" rid="R463" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919682"&gt;</code></p><p><code>3643</code><code>Hansen et al., 2001a&lt;/a&gt;</code></p><p><code>3644</code><code>,&lt;a href="#R464" rid="R464" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919807"&gt;</code></p><p><code>3645</code><code>b&lt;/a&gt;</code></p><p><code>3646</code><code>). Both THC and anandamide exerted CB&lt;sub&gt;</code></p><p><code>3647</code><code>1&lt;/sub&gt;</code></p><p><code>3648</code><code>-mediated neuroprotective effects in an ouabain-induced rat model of in vivo excitotoxicity (&lt;a href="#R1213" rid="R1213" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637189"&gt;</code></p><p><code>3649</code><code>van de Stelt et al., 2001a&lt;/a&gt;</code></p><p><code>3650</code><code>,&lt;a href="#R1214" rid="R1214" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637208"&gt;</code></p><p><code>3651</code><code>b&lt;/a&gt;</code></p><p><code>3652</code><code>). Anandamide and synthetic agonists of CB&lt;sub&gt;</code></p><p><code>3653</code><code>1&lt;/sub&gt;</code></p><p><code>3654</code><code> receptors also protected the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage in mice (&lt;a href="#R1099" rid="R1099" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919124"&gt;</code></p><p><code>3655</code><code>Shouman et al., 2006&lt;/a&gt;</code></p><p><code>3656</code><code>).&lt;/p&gt;</code></p><p><code>3657</code><code>&lt;p id="P69"&gt;</code></p><p><code>3658</code><code>Traumatic brain injury (TBI) is one of the leading causes of disability and mortality in young individuals (&lt;a href="#R520" rid="R520" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919547"&gt;</code></p><p><code>3659</code><code>Holm et al., 2005&lt;/a&gt;</code></p><p><code>3660</code><code>), yet the available therapy is very limited (&lt;a href="#R309" rid="R309" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919975"&gt;</code></p><p><code>3661</code><code>Faden, 2002&lt;/a&gt;</code></p><p><code>3662</code><code>; &lt;a href="#R715" rid="R715" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919624"&gt;</code></p><p><code>3663</code><code>Maas et al., 2004&lt;/a&gt;</code></p><p><code>3664</code><code>). TBI is characterized by cerebral edema, axonal and neuronal injury, increased permeability of the blood-brain barrier, and post-traumatic changes in cognitive and neurological functions (&lt;a href="#R53" rid="R53" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920277"&gt;</code></p><p><code>3665</code><code>Bayir et al., 2003&lt;/a&gt;</code></p><p><code>3666</code><code>). TBI can trigger glutamate-induced excitotoxicity, oxidative stress, release of inflammatory cytokines from brain-resident cells (microglia, neurons, and astrocytes), programmed cell death, and cortical blood flow dysregulation (reviewed in &lt;a href="#R1268" rid="R1268" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919909"&gt;</code></p><p><code>3667</code><code>Wang and Feuerstein, 2000&lt;/a&gt;</code></p><p><code>3668</code><code>; &lt;a href="#R376" rid="R376" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920349"&gt;</code></p><p><code>3669</code><code>Gentleman et al., 2004&lt;/a&gt;</code></p><p><code>3670</code><code>).&lt;/p&gt;</code></p><p><code>3671</code><code>&lt;p id="P70"&gt;</code></p><p><code>3672</code><code>The protective effect of cannabinoids in traumatic brain injury was first indicated in studies with the nonpsychotropic cannabinoid dexanabinol (HU-211) (&lt;a href="/pmc/articles/PMC2241751/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"&gt;</code></p><p><code>3673</code><code>&lt;span&gt;</code></p><p><code>3674</code><code>Fig. 1b&lt;/span&gt;</code></p><p><code>3675</code><code>&lt;/a&gt;</code></p><p><code>3676</code><code>). These studies have demonstrated reduced brain damage and improved motor and cognitive function in HU-211-treated animals in a rat model of TBI. The favorable effects of a single injection of HU-211 on learning and neurological deficits lasted up to 30 days and could be achieved within a therapeutic window of 6 h (&lt;a href="#R1097" rid="R1097" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918980"&gt;</code></p><p><code>3677</code><code>Shohami et al., 1993&lt;/a&gt;</code></p><p><code>3678</code><code>, &lt;a href="#R1096" rid="R1096" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919368"&gt;</code></p><p><code>3679</code><code>1995&lt;/a&gt;</code></p><p><code>3680</code><code>). Beneficial effects of HU-211 were also demonstrated in an axonal injury model (&lt;a href="#R1308" rid="R1308" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919557"&gt;</code></p><p><code>3681</code><code>Yoles et al., 1996&lt;/a&gt;</code></p><p><code>3682</code><code>; &lt;a href="#R1313" rid="R1313" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920235"&gt;</code></p><p><code>3683</code><code>Zalish and Lavie, 2003&lt;/a&gt;</code></p><p><code>3684</code><code>). These protective effects were attributed, at least in part, to NMDA receptor blockade, attenuation of Ca&lt;sup&gt;</code></p><p><code>3685</code><code>2+&lt;/sup&gt;</code></p><p><code>3686</code><code> influx and decreased TNF-&lt;em&gt;</code></p><p><code>3687</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>3688</code><code> levels (&lt;a href="#R874" rid="R874" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919605"&gt;</code></p><p><code>3689</code><code>Nadler et al., 1995&lt;/a&gt;</code></p><p><code>3690</code><code>; &lt;a href="#R1095" rid="R1095" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919386"&gt;</code></p><p><code>3691</code><code>Shohami et al., 1997&lt;/a&gt;</code></p><p><code>3692</code><code>; reviewed in &lt;a href="#R811" rid="R811" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653371"&gt;</code></p><p><code>3693</code><code>Mechoulam et al., 2002a&lt;/a&gt;</code></p><p><code>3694</code><code>,&lt;a href="#R812" rid="R812" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920146"&gt;</code></p><p><code>3695</code><code>b&lt;/a&gt;</code></p><p><code>3696</code><code>; &lt;a href="#R82" rid="R82" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920375"&gt;</code></p><p><code>3697</code><code>Biegon, 2004&lt;/a&gt;</code></p><p><code>3698</code><code>). In mice with closed head injury, brain levels of 2-AG increased, and exogenous 2-AG administered 1 h after the head injury reduced infarct size and improved neurological outcome (&lt;a href="#R933" rid="R933" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919195"&gt;</code></p><p><code>3699</code><code>Panikashvili et al., 2001&lt;/a&gt;</code></p><p><code>3700</code><code>). Neuroprotection by 2-AG was attributed to CB&lt;sub&gt;</code></p><p><code>3701</code><code>1&lt;/sub&gt;</code></p><p><code>3702</code><code> receptor-mediated inhibition of nuclear factor-&lt;em&gt;</code></p><p><code>3703</code><code>&amp;#x003ba;&lt;/em&gt;</code></p><p><code>3704</code><code>B and of the early expression of proinflammatory cytokines TNF-&lt;em&gt;</code></p><p><code>3705</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>3706</code><code>, IL-1&lt;em&gt;</code></p><p><code>3707</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>3708</code><code>, and IL-6 (&lt;a href="#R931" rid="R931" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919602"&gt;</code></p><p><code>3709</code><code>Panikashvili et al., 2005&lt;/a&gt;</code></p><p><code>3710</code><code>, &lt;a href="#R932" rid="R932" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920038"&gt;</code></p><p><code>3711</code><code>2006&lt;/a&gt;</code></p><p><code>3712</code><code>). In a rat model of TBI, BAY 38-7271, a CB&lt;sub&gt;</code></p><p><code>3713</code><code>1&lt;/sub&gt;</code></p><p><code>3714</code><code>/CB&lt;sub&gt;</code></p><p><code>3715</code><code>2&lt;/sub&gt;</code></p><p><code>3716</code><code> agonist with predominant action at CB&lt;sub&gt;</code></p><p><code>3717</code><code>1&lt;/sub&gt;</code></p><p><code>3718</code><code> receptors, caused a marked, 70% reduction in infarct volume when administered as a 4-h infusion immediately after induction of subdural hematoma, and even when it was applied with a 3-h delay, infarct volume was reduced by 59% (&lt;a href="#R784" rid="R784" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919739"&gt;</code></p><p><code>3719</code><code>Mauler et al., 2002&lt;/a&gt;</code></p><p><code>3720</code><code>).&lt;/p&gt;</code></p><p><code>3721</code><code>&lt;p id="P71" class="p p-last"&gt;</code></p><p><code>3722</code><code>A multicenter, double-blind, randomized, placebo-controlled phase II trial conducted in 67 patients with severe closed head injury found dexanabinol to be safe and well tolerated. The treated patients achieved significantly better intracranial pressure/cerebral perfusion pressure control without jeopardizing blood pressure, and a trend toward faster improvement and better neurological outcome was also observed (&lt;a href="#R618" rid="R618" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919466"&gt;</code></p><p><code>3723</code><code>Knoller et al., 2002&lt;/a&gt;</code></p><p><code>3724</code><code>). However, a double-blind, randomized, placebo-controlled phase III clinical trial of dexanabinol, conducted in 15 countries in 86 specialized centers and involving 861 patients failed to demonstrate any favorable effects (&lt;a href="#R716" rid="R716" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919337"&gt;</code></p><p><code>3725</code><code>Maas et al., 2006&lt;/a&gt;</code></p><p><code>3726</code><code>).&lt;/p&gt;</code></p><p><code>3727</code><code>&lt;/div&gt;</code></p><p><code>3728</code><code>&lt;div id="S15" class="sec"&gt;</code></p><p><code>3729</code><code>&lt;p&gt;</code></p><p><code>3730</code><code>&lt;/p&gt;</code></p><p><code>3731</code><code>&lt;h4 id="S15title" class="inline"&gt;</code></p><p><code>3732</code><code>2. Stroke &lt;/h4&gt;</code></p><p><code>3733</code><code>&lt;p id="P72" class="p p-first"&gt;</code></p><p><code>3734</code><code>Ischemic stroke is the most common form of stroke, mostly caused by a transient interruption of blood supply to the brain by thrombotic occlusion of blood vessels. It is an important cause of death and disability in industrialized countries, affecting up to 0.2% of the population each year (&lt;a href="#R617" rid="R617" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920362"&gt;</code></p><p><code>3735</code><code>Klijn and Hankey, 2003&lt;/a&gt;</code></p><p><code>3736</code><code>; &lt;a href="#R969" rid="R969" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919565"&gt;</code></p><p><code>3737</code><code>Pinto et al., 2004&lt;/a&gt;</code></p><p><code>3738</code><code>). One in six patients die in the 1st month after ischemic stroke, and half of the survivors are permanently disabled despite the best efforts to rehabilitate them and to prevent complications (&lt;a href="#R617" rid="R617" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920293"&gt;</code></p><p><code>3739</code><code>Klijn and Hankey, 2003&lt;/a&gt;</code></p><p><code>3740</code><code>).&lt;/p&gt;</code></p><p><code>3741</code><code>&lt;p id="P73"&gt;</code></p><p><code>3742</code><code>One of the first indications of the neuroprotective effect of cannabinoids came from the field of stroke research, using various in vitro and in vivo models of ischemic injury. Anandamide, 2-AG, and WIN 55,212-2 protected cultured cortical neurons against hypoxia and glucose deprivation (&lt;a href="#R877" rid="R877" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637217"&gt;</code></p><p><code>3743</code><code>Nagayama et al., 1999&lt;/a&gt;</code></p><p><code>3744</code><code>; &lt;a href="#R1110" rid="R1110" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919320"&gt;</code></p><p><code>3745</code><code>Sinor et al., 2000&lt;/a&gt;</code></p><p><code>3746</code><code>). The effects of various cannabinoid ligands were also investigated in in vivo models of global cerebral ischemia induced by two-vessel occlusion with hypotension or by four-vessel occlusion, or in focal ischemia induced by occlusion of the middle cerebral artery (MCAo), with or without reperfusion. Dexanabinol at doses of 2 to 10 mg/kg decreased infarct size and histological damage and improved neurological score in rat and gerbil models of both global and focal cerebral ischemia (&lt;a href="#R43" rid="R43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919922"&gt;</code></p><p><code>3747</code><code>Bar-Joseph et al., 1994&lt;/a&gt;</code></p><p><code>3748</code><code>; &lt;a href="#R1226" rid="R1226" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653381"&gt;</code></p><p><code>3749</code><code>Vered et al., 1994&lt;/a&gt;</code></p><p><code>3750</code><code> a,b; &lt;a href="#R60" rid="R60" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920306"&gt;</code></p><p><code>3751</code><code>Belayev et al., 1995a&lt;/a&gt;</code></p><p><code>3752</code><code>,&lt;a href="#R61" rid="R61" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920126"&gt;</code></p><p><code>3753</code><code>b&lt;/a&gt;</code></p><p><code>3754</code><code>,&lt;a href="#R62" rid="R62" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920391"&gt;</code></p><p><code>3755</code><code>c&lt;/a&gt;</code></p><p><code>3756</code><code>; &lt;a href="#R672" rid="R672" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919962"&gt;</code></p><p><code>3757</code><code>Leker et al., 1999&lt;/a&gt;</code></p><p><code>3758</code><code>; &lt;a href="#R662" rid="R662" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919894"&gt;</code></p><p><code>3759</code><code>Lavie et al., 2001&lt;/a&gt;</code></p><p><code>3760</code><code>; &lt;a href="#R1170" rid="R1170" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918708"&gt;</code></p><p><code>3761</code><code>Teichner et al., 2003&lt;/a&gt;</code></p><p><code>3762</code><code>). Importantly, this protective effect was observed even when the drug was administered 60 to 180 min after the insult (&lt;a href="#R1226" rid="R1226" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653418"&gt;</code></p><p><code>3763</code><code>Vered et al., 1994&lt;/a&gt;</code></p><p><code>3764</code><code>; &lt;a href="#R60" rid="R60" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918910"&gt;</code></p><p><code>3765</code><code>Belayev et al., 1995a&lt;/a&gt;</code></p><p><code>3766</code><code>,&lt;a href="#R61" rid="R61" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918807"&gt;</code></p><p><code>3767</code><code>b&lt;/a&gt;</code></p><p><code>3768</code><code>,&lt;a href="#R62" rid="R62" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919972"&gt;</code></p><p><code>3769</code><code>c&lt;/a&gt;</code></p><p><code>3770</code><code>; &lt;a href="#R672" rid="R672" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918854"&gt;</code></p><p><code>3771</code><code>Leker et al., 1999&lt;/a&gt;</code></p><p><code>3772</code><code>; &lt;a href="#R662" rid="R662" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920143"&gt;</code></p><p><code>3773</code><code>Lavie et al., 2001&lt;/a&gt;</code></p><p><code>3774</code><code>; &lt;a href="#R1170" rid="R1170" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919888"&gt;</code></p><p><code>3775</code><code>Teichner et al., 2003&lt;/a&gt;</code></p><p><code>3776</code><code>).&lt;/p&gt;</code></p><p><code>3777</code><code>&lt;p id="P74"&gt;</code></p><p><code>3778</code><code>WIN 55,212-2, at doses of 0.03 and 1 mg/kg but not 3 mg/kg decreased hippocampal neuronal loss after transient global cerebral ischemia in rats. It also reduced infarct size after permanent focal cerebral ischemia induced by MCAo, when given 40 min before 30 min after the occlusion, and these effects were prevented by SR141716 (&lt;a href="#R877" rid="R877" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637212"&gt;</code></p><p><code>3779</code><code>Nagayama et al., 1999&lt;/a&gt;</code></p><p><code>3780</code><code>). WIN 55,212-2 also protected cultured cerebral cortical neurons from in vitro hypoxia and glucose deprivation, but in contrast to the receptor-mediated neuroprotection observed in vivo, this in vitro effect was not stereoselective and was insensitive to CB&lt;sub&gt;</code></p><p><code>3781</code><code>1&lt;/sub&gt;</code></p><p><code>3782</code><code> and CB&lt;sub&gt;</code></p><p><code>3783</code><code>2&lt;/sub&gt;</code></p><p><code>3784</code><code> receptor antagonists (&lt;a href="#R877" rid="R877" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637211"&gt;</code></p><p><code>3785</code><code>Nagayama et al., 1999&lt;/a&gt;</code></p><p><code>3786</code><code>). BAY38-7271 also decreased infarct size in rats with permanent MCAo even when given intravenously 4 h after the occlusion (&lt;a href="#R784" rid="R784" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919566"&gt;</code></p><p><code>3787</code><code>Mauler et al., 2002&lt;/a&gt;</code></p><p><code>3788</code><code>). Similarly, HU-210 reduced infarct size by up to 77% and improved motor disability in a rat model of permanent MCAo (&lt;a href="#R671" rid="R671" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919684"&gt;</code></p><p><code>3789</code><code>Leker et al., 2003&lt;/a&gt;</code></p><p><code>3790</code><code>). The protective effect of HU-210 was partially reversed by pretreatment with SR141716, indicating CB&lt;sub&gt;</code></p><p><code>3791</code><code>1&lt;/sub&gt;</code></p><p><code>3792</code><code> receptor involvement. Surprisingly, all protection could be abolished by warming the animals to the body temperature of controls, indicating that CB&lt;sub&gt;</code></p><p><code>3793</code><code>1&lt;/sub&gt;</code></p><p><code>3794</code><code>-mediated hypothermia contributed to the neuroprotection (&lt;a href="#R671" rid="R671" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918730"&gt;</code></p><p><code>3795</code><code>Leker et al., 2003&lt;/a&gt;</code></p><p><code>3796</code><code>). Likewise, CB&lt;sub&gt;</code></p><p><code>3797</code><code>1&lt;/sub&gt;</code></p><p><code>3798</code><code>-mediated hypothermia was responsible for the neuroprotective effects of THC in a mouse transient MCAo model (&lt;a href="#R475" rid="R475" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919812"&gt;</code></p><p><code>3799</code><code>Hayakawa et al., 2004&lt;/a&gt;</code></p><p><code>3800</code><code>) and perhaps also in a rat model of global cerebral ischemia (&lt;a href="#R707" rid="R707" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920285"&gt;</code></p><p><code>3801</code><code>Louw et al., 2000&lt;/a&gt;</code></p><p><code>3802</code><code>). Consistent with these findings, CB&lt;sub&gt;</code></p><p><code>3803</code><code>1&lt;/sub&gt;</code></p><p><code>3804</code><code> knockout mice had increased mortality from permanent focal cerebral ischemia, increased infarct size, more severe neurological deficits after transient focal cerebral ischemia, and decreased cerebral blood flow in the ischemic penumbra during reperfusion, compared with wild type controls subjected to the same insult (&lt;a href="#R941" rid="R941" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637185"&gt;</code></p><p><code>3805</code><code>Parmentier-Batteur et al., 2002&lt;/a&gt;</code></p><p><code>3806</code><code>). NMDA neurotoxicity was also increased in CB&lt;sub&gt;</code></p><p><code>3807</code><code>1&lt;/sub&gt;</code></p><p><code>3808</code><code>&lt;sup&gt;</code></p><p><code>3809</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>3810</code><code> mice compared with wild-type littermates (&lt;a href="#R941" rid="R941" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637191"&gt;</code></p><p><code>3811</code><code>Parmentier-Batteur et al., 2002&lt;/a&gt;</code></p><p><code>3812</code><code>). Further evidence for a role of CB&lt;sub&gt;</code></p><p><code>3813</code><code>1&lt;/sub&gt;</code></p><p><code>3814</code><code> receptors is their increased expression on neurons in the arterial boundary zone of cortical infarction (&lt;a href="#R562" rid="R562" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919798"&gt;</code></p><p><code>3815</code><code>Jin et al., 2000&lt;/a&gt;</code></p><p><code>3816</code><code>). Finally, brain levels of endocannabinoids are increased during ischemic (&lt;a href="#R1075" rid="R1075" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920187"&gt;</code></p><p><code>3817</code><code>Schmid et al., 1995&lt;/a&gt;</code></p><p><code>3818</code><code>; &lt;a href="#R1072" rid="R1072" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919680"&gt;</code></p><p><code>3819</code><code>Schabitz et al., 2002&lt;/a&gt;</code></p><p><code>3820</code><code>; &lt;a href="#R69" rid="R69" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919191"&gt;</code></p><p><code>3821</code><code>Berger et al., 2004&lt;/a&gt;</code></p><p><code>3822</code><code>; &lt;a href="#R868" rid="R868" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919604"&gt;</code></p><p><code>3823</code><code>Muthian et al., 2004&lt;/a&gt;</code></p><p><code>3824</code><code>) and other types of brain injury (&lt;a href="#R1150" rid="R1150" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918685"&gt;</code></p><p><code>3825</code><code>Sugiura et al., 2000&lt;/a&gt;</code></p><p><code>3826</code><code>; &lt;a href="#R463" rid="R463" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918750"&gt;</code></p><p><code>3827</code><code>Hansen et al., 2001a&lt;/a&gt;</code></p><p><code>3828</code><code>,&lt;a href="#R464" rid="R464" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918755"&gt;</code></p><p><code>3829</code><code>b&lt;/a&gt;</code></p><p><code>3830</code><code>; &lt;a href="#R933" rid="R933" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919634"&gt;</code></p><p><code>3831</code><code>Panikashvili et al., 2001&lt;/a&gt;</code></p><p><code>3832</code><code>).&lt;/p&gt;</code></p><p><code>3833</code><code>&lt;p id="P75" class="p p-last"&gt;</code></p><p><code>3834</code><code>Other studies do not support the neuroprotective role of CB&lt;sub&gt;</code></p><p><code>3835</code><code>1&lt;/sub&gt;</code></p><p><code>3836</code><code> receptor activation. For example, CB&lt;sub&gt;</code></p><p><code>3837</code><code>1&lt;/sub&gt;</code></p><p><code>3838</code><code> antagonists by themselves had no effect on the outcome of injury, and in two recent reports, SR141716 and &lt;a id="__tag_814637250" class="tag_hotlink" href="/nuccore/LY320135" ref="/nuccore/LY320135"&gt;</code></p><p><code>3839</code><code>&lt;span class="tag-json" style="display:none"&gt;</code></p><p><code>3840</code><code>{"type":"entrez-nucleotide","attrs":{"text":"LY320135","term_id":"1257555575","term_text":"LY320135"}}&lt;/span&gt;</code></p><p><code>3841</code><code>LY320135&lt;/a&gt;</code></p><p><code>3842</code><code> were found to actually reduce infarct size and to improve neurological function in a rat model of MCAo (&lt;a href="#R69" rid="R69" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919509"&gt;</code></p><p><code>3843</code><code>Berger et al., 2004&lt;/a&gt;</code></p><p><code>3844</code><code>; &lt;a href="#R868" rid="R868" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919176"&gt;</code></p><p><code>3845</code><code>Muthian et al., 2004&lt;/a&gt;</code></p><p><code>3846</code><code>), whereas low doses of WIN 55,212-2 had no protective effect (&lt;a href="#R868" rid="R868" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918897"&gt;</code></p><p><code>3847</code><code>Muthian et al., 2004&lt;/a&gt;</code></p><p><code>3848</code><code>). Thus, it appears that both CB&lt;sub&gt;</code></p><p><code>3849</code><code>1&lt;/sub&gt;</code></p><p><code>3850</code><code> agonists and antagonists can be neuroprotective in cerebral ischemia. The reason for the opposite effects of pharmacological blockade versus genetic knockout of CB&lt;sub&gt;</code></p><p><code>3851</code><code>1&lt;/sub&gt;</code></p><p><code>3852</code><code> receptors is not clear and may be related to the CB&lt;sub&gt;</code></p><p><code>3853</code><code>1&lt;/sub&gt;</code></p><p><code>3854</code><code> receptor-independent effects of antagonists (&lt;a href="#R57" rid="R57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919688"&gt;</code></p><p><code>3855</code><code>Begg et al., 2005&lt;/a&gt;</code></p><p><code>3856</code><code>; &lt;a href="#R958" rid="R958" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918863"&gt;</code></p><p><code>3857</code><code>Pertwee, 2005b&lt;/a&gt;</code></p><p><code>3858</code><code>,&lt;a href="#R959" rid="R959" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_539174734"&gt;</code></p><p><code>3859</code><code>c&lt;/a&gt;</code></p><p><code>3860</code><code>). Clearly, evaluating the potential usefulness of cannabinoid ligands in the treatment of stroke warrants future studies.&lt;/p&gt;</code></p><p><code>3861</code><code>&lt;/div&gt;</code></p><p><code>3862</code><code>&lt;div id="S16" class="sec"&gt;</code></p><p><code>3863</code><code>&lt;p&gt;</code></p><p><code>3864</code><code>&lt;/p&gt;</code></p><p><code>3865</code><code>&lt;h4 id="S16title" class="inline"&gt;</code></p><p><code>3866</code><code>3. Multiple Sclerosis and Spinal Cord Injury &lt;/h4&gt;</code></p><p><code>3867</code><code>&lt;p id="P76" class="p p-first"&gt;</code></p><p><code>3868</code><code>Multiple sclerosis (MS) is a complex, immune-mediated, inflammatory disease of the white matter of the brain, which compromises impulse conduction due to the loss of the myelin sheath of neurons and the secondary axonal loss (&lt;a href="#R1128" rid="R1128" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919262"&gt;</code></p><p><code>3869</code><code>Sospedra and Martin, 2005&lt;/a&gt;</code></p><p><code>3870</code><code>). MS affects 2 to 5 million people worldwide and commonly presents with an unpredictable, relapsing-remitting course and a range of clinical symptoms depending on where the demyelination and axonal loss have occurred (&lt;a href="#R199" rid="R199" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919432"&gt;</code></p><p><code>3871</code><code>Compston and Coles, 2002&lt;/a&gt;</code></p><p><code>3872</code><code>). Some patients become disabled within a short period of time, whereas others can live their entire lives with only negligible or no disability. The symptoms of MS typically involve tremor, ataxia, visual loss, double vision, weakness or paralysis, difficulty in speaking, loss of bladder control and constipation, cognitive impairment, and painful muscle spasms. Muscle spasticity often leads to reduced mobility, considerable distress from pain, and interference with daily living activities. Spasticity, neuropathic and nociceptive pain, and some of the above symptoms are also common in spinal cord injury (SCI). Although there are numerous drugs available that target the immune system to slow down the progression of the disease, they are only moderately effective, and the treatment of MS remains mostly symptomatic and far from satisfactory (&lt;a href="#R601" rid="R601" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920204"&gt;</code></p><p><code>3873</code><code>Killestein and Polman, 2005&lt;/a&gt;</code></p><p><code>3874</code><code>).&lt;/p&gt;</code></p><p><code>3875</code><code>&lt;p id="P77"&gt;</code></p><p><code>3876</code><code>Cannabis had been used in ancient Greece, Rome, China, and India for relieving muscle cramps, spasm, and pain (reviewed in &lt;a href="#R804" rid="R804" class=" bibr popnode"&gt;</code></p><p><code>3877</code><code>Mechoulam, 1986&lt;/a&gt;</code></p><p><code>3878</code><code>, &lt;a href="#R806" rid="R806" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918925"&gt;</code></p><p><code>3879</code><code>Mechoulam et al., 1998&lt;/a&gt;</code></p><p><code>3880</code><code>; &lt;a href="#R809" rid="R809" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918844"&gt;</code></p><p><code>3881</code><code>Mechoulam and Hanus, 2000&lt;/a&gt;</code></p><p><code>3882</code><code>) and its therapeutic application in MS is a topic of recent lively debate (&lt;a href="#R438" rid="R438" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653519"&gt;</code></p><p><code>3883</code><code>Grundy, 2002&lt;/a&gt;</code></p><p><code>3884</code><code>; &lt;a href="#R956" rid="R956" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919056"&gt;</code></p><p><code>3885</code><code>Pertwee, 2002&lt;/a&gt;</code></p><p><code>3886</code><code>; &lt;a href="#R35" rid="R35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653421"&gt;</code></p><p><code>3887</code><code>Baker and Pryce, 2003&lt;/a&gt;</code></p><p><code>3888</code><code>; &lt;a href="#R230" rid="R230" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919204"&gt;</code></p><p><code>3889</code><code>Croxford, 2003&lt;/a&gt;</code></p><p><code>3890</code><code>; &lt;a href="#R602" rid="R602" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919701"&gt;</code></p><p><code>3891</code><code>Killestein et al., 2004&lt;/a&gt;</code></p><p><code>3892</code><code>; &lt;a href="#R1113" rid="R1113" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919342"&gt;</code></p><p><code>3893</code><code>Sirven and Berg, 2004&lt;/a&gt;</code></p><p><code>3894</code><code>; &lt;a href="#R550" rid="R550" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920103"&gt;</code></p><p><code>3895</code><code>Jackson et al., 2005a&lt;/a&gt;</code></p><p><code>3896</code><code>; &lt;a href="#R986" rid="R986" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918687"&gt;</code></p><p><code>3897</code><code>Pryce and Baker, 2005&lt;/a&gt;</code></p><p><code>3898</code><code>; &lt;a href="#R1025" rid="R1025" class=" bibr popnode"&gt;</code></p><p><code>3899</code><code>Robson, 2005&lt;/a&gt;</code></p><p><code>3900</code><code>; &lt;a href="#R1119" rid="R1119" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919711"&gt;</code></p><p><code>3901</code><code>Smith, 2005&lt;/a&gt;</code></p><p><code>3902</code><code>). &lt;a href="#R714" rid="R714" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919126"&gt;</code></p><p><code>3903</code><code>Lyman et al. (1989)&lt;/a&gt;</code></p><p><code>3904</code><code> examined the effects of parenteral THC in experimental autoimmune encephalomyelitis (EAE) in rats, a laboratory model of MS. THC treatment not only reduced CNS inflammation and improved neurological outcome but also improved survival compared with placebo. &amp;#x00394;&lt;sup&gt;</code></p><p><code>3905</code><code>8&lt;/sup&gt;</code></p><p><code>3906</code><code>-THC, a less psychotropic and more stable analog of THC, also reduced the severity and incidence of neurological deficits in rats with EAE (&lt;a href="#R1296" rid="R1296" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919032"&gt;</code></p><p><code>3907</code><code>Wirguin et al., 1994&lt;/a&gt;</code></p><p><code>3908</code><code>). The nonpsychotropic dexanabinol also suppressed inflammatory responses in the brain and spinal cord of rats with EAE and improved their neurological symptoms (&lt;a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919643"&gt;</code></p><p><code>3909</code><code>Achiron et al., 2000&lt;/a&gt;</code></p><p><code>3910</code><code>). Although CB&lt;sub&gt;</code></p><p><code>3911</code><code>1&lt;/sub&gt;</code></p><p><code>3912</code><code> receptor density is decreased in the striatum and cortex of EAE rats, this is compensated for by increased coupling to G protein-mediated signaling, ensuring the effectiveness of treatment with cannabinoid agonists (&lt;a href="#R74" rid="R74" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919258"&gt;</code></p><p><code>3913</code><code>Berrendero et al., 2001&lt;/a&gt;</code></p><p><code>3914</code><code>).&lt;/p&gt;</code></p><p><code>3915</code><code>&lt;p id="P78"&gt;</code></p><p><code>3916</code><code>In a mouse model of chronic relapsing EAE, intravenous administration of THC, WIN 55,212-2, JWH-133, or methanandamide reduced spasticity and tremor, whereas the same symptoms were exacerbated by treatment with either CB&lt;sub&gt;</code></p><p><code>3917</code><code>1&lt;/sub&gt;</code></p><p><code>3918</code><code> or CB&lt;sub&gt;</code></p><p><code>3919</code><code>2&lt;/sub&gt;</code></p><p><code>3920</code><code> antagonists (&lt;a href="#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920115"&gt;</code></p><p><code>3921</code><code>Baker et al., 2000&lt;/a&gt;</code></p><p><code>3922</code><code>). These mice with EAE had increased levels of anandamide, 2-AG, and palmitoylethanolamide (PEA) in areas associated with nerve damage (&lt;a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920112"&gt;</code></p><p><code>3923</code><code>Baker et al., 2001&lt;/a&gt;</code></p><p><code>3924</code><code>). Furthermore, spasticity could be relieved not only by administration of exogenous anandamide, 2-AG, or PEA but also by selective inhibitors of endocannabinoid transport or hydrolysis, which suggests tonic control of muscle tone by the endocannabinoid system in EAE (&lt;a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919102"&gt;</code></p><p><code>3925</code><code>Baker et al., 2001&lt;/a&gt;</code></p><p><code>3926</code><code>; &lt;a href="#R689" rid="R689" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919392"&gt;</code></p><p><code>3927</code><code>Ligresti et al., 2006a&lt;/a&gt;</code></p><p><code>3928</code><code>). Additional evidence for this has emerged through the use of CB&lt;sub&gt;</code></p><p><code>3929</code><code>1&lt;/sub&gt;</code></p><p><code>3930</code><code>-deficient mice, which tolerated inflammatory and excitotoxic insults poorly and developed substantial neurodegeneration after the induction of EAE (&lt;a href="#R987" rid="R987" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919358"&gt;</code></p><p><code>3931</code><code>Pryce et al., 2003&lt;/a&gt;</code></p><p><code>3932</code><code>). &lt;a href="#R551" rid="R551" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920299"&gt;</code></p><p><code>3933</code><code>Jackson et al. (2005b)&lt;/a&gt;</code></p><p><code>3934</code><code> reported that the absence of CB&lt;sub&gt;</code></p><p><code>3935</code><code>1&lt;/sub&gt;</code></p><p><code>3936</code><code> receptors was associated with increased caspase activation and a greater loss of myelin and axonal/neuronal proteins after the induction of chronic EAE. Interestingly, CB&lt;sub&gt;</code></p><p><code>3937</code><code>1&lt;/sub&gt;</code></p><p><code>3938</code><code> knockout mice had increased caspase 3 levels before the induction of EAE, suggesting a neuroprotective tone mediated by CB&lt;sub&gt;</code></p><p><code>3939</code><code>1&lt;/sub&gt;</code></p><p><code>3940</code><code> receptors (&lt;a href="#R550" rid="R550" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920211"&gt;</code></p><p><code>3941</code><code>Jackson et al., 2005a&lt;/a&gt;</code></p><p><code>3942</code><code>,&lt;a href="#R551" rid="R551" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920051"&gt;</code></p><p><code>3943</code><code>b&lt;/a&gt;</code></p><p><code>3944</code><code>). In mice with EAE, WIN 55,212-2 inhibited leukocyte/endothelial interactions via activation of CB&lt;sub&gt;</code></p><p><code>3945</code><code>2&lt;/sub&gt;</code></p><p><code>3946</code><code> receptors (&lt;a href="#R889" rid="R889" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919664"&gt;</code></p><p><code>3947</code><code>Ni et al., 2004&lt;/a&gt;</code></p><p><code>3948</code><code>). Interestingly, a recent study suggests that the high levels of IFN-&lt;em&gt;</code></p><p><code>3949</code><code>&amp;#x003b3;&lt;/em&gt;</code></p><p><code>3950</code><code> present in the CNS of mice with EAE can counteract endocannabinoid-mediated neuroprotection by disrupting P2X7 purinergic receptor signaling, a key step in endocannabinoid production by glia (&lt;a href="#R1299" rid="R1299" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919826"&gt;</code></p><p><code>3951</code><code>Witting et al., 2006&lt;/a&gt;</code></p><p><code>3952</code><code>).&lt;/p&gt;</code></p><p><code>3953</code><code>&lt;p id="P79"&gt;</code></p><p><code>3954</code><code>Another murine model of MS is Theiler&amp;#x02019;s murine encephalomyelitis virus-induced demyelinating disease. In mice with Theiler&amp;#x02019;s murine encephalomyelitis virus-induced demyelinating disease, treatment with WIN 55,212-2 slowed the progression of symptoms, down-regulated delayed-type hypersensitivity reactions and interferon-&lt;em&gt;</code></p><p><code>3955</code><code>&amp;#x003b3;&lt;/em&gt;</code></p><p><code>3956</code><code> production, and inhibited the expression of proinflammatory cytokines in the CNS (&lt;a href="#R231" rid="R231" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918686"&gt;</code></p><p><code>3957</code><code>Croxford and Miller, 2003&lt;/a&gt;</code></p><p><code>3958</code><code>). In another study using this model, treatment with WIN 55,212-2, ACEA, or JWH-015 caused long-lasting improvements in neurological deficits in the established disease and reduced microglial activation, abrogated major histocompatibility complex class II antigen expression, and decreased the number of CD4&lt;sup&gt;</code></p><p><code>3959</code><code>+&lt;/sup&gt;</code></p><p><code>3960</code><code> infiltrating T cells in the spinal cord. These changes were paralleled by extensive remyelination (&lt;a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637240"&gt;</code></p><p><code>3961</code><code>Arevalo-Martin et al., 2003&lt;/a&gt;</code></p><p><code>3962</code><code>). Treatment of Theiler&amp;#x02019;s murine encephalomyelitis virus-infected mice with the transport inhibitors OMDM1 and OMDM2 enhanced anandamide levels, down-regulated inflammatory responses in the spinal cord, and ameliorated motor symptoms (&lt;a href="#R829" rid="R829" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919921"&gt;</code></p><p><code>3963</code><code>Mestre et al., 2005&lt;/a&gt;</code></p><p><code>3964</code><code>), and similar findings were reported using the transport inhibitor UCM707 (&lt;a href="#R910" rid="R910" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919489"&gt;</code></p><p><code>3965</code><code>Ortega-Gutierrez et al., 2005&lt;/a&gt;</code></p><p><code>3966</code><code>). In these two studies, the treatments were also shown to reduce the surface expression of major histo-compatibility complex class II molecules, the production of the proinflammatory cytokines (TNF&lt;em&gt;</code></p><p><code>3967</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>3968</code><code>, IL-1&lt;em&gt;</code></p><p><code>3969</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>3970</code><code>, and IL-6), and the expression of inducible NO synthase.&lt;/p&gt;</code></p><p><code>3971</code><code>&lt;p id="P80"&gt;</code></p><p><code>3972</code><code>Consistent with the animal data, cannabinoids have shown promise in the treatment of MS in humans (&lt;a href="/pmc/articles/PMC2241751/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""&gt;</code></p><p><code>3973</code><code>&lt;span&gt;</code></p><p><code>3974</code><code>Table 1&lt;/span&gt;</code></p><p><code>3975</code><code>&lt;/a&gt;</code></p><p><code>3976</code><code>). A possible underlying mechanism is suggested by a recent study in which the endocannabinoid system was found to be highly activated during CNS inflammation in MS patients and to protect neurons from inflammatory damage by activating a negative feedback loop in microglial cells via CB&lt;sub&gt;</code></p><p><code>3977</code><code>1/2&lt;/sub&gt;</code></p><p><code>3978</code><code>-mediated epigenetic regulation of mitogen-activated protein kinase phosphatase 1 expression &lt;strong&gt;</code></p><p><code>3979</code><code>(&lt;/strong&gt;</code></p><p><code>3980</code><code>&lt;a href="#R293" rid="R293" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920014"&gt;</code></p><p><code>3981</code><code>Eljaschewitsch et al., 2006&lt;/a&gt;</code></p><p><code>3982</code><code>).&lt;/p&gt;</code></p><p><code>3983</code><code>&lt;p id="P81"&gt;</code></p><p><code>3984</code><code>There have been anecdotal reports of the effectiveness of marijuana smoking in relieving symptoms of MS and SPI (&lt;a href="#R433" rid="R433" class=" bibr popnode"&gt;</code></p><p><code>3985</code><code>Grinspoon and Bakalar, 1993&lt;/a&gt;</code></p><p><code>3986</code><code>, &lt;a href="#R434" rid="R434" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653476"&gt;</code></p><p><code>3987</code><code>1998&lt;/a&gt;</code></p><p><code>3988</code><code>), which were supported by the results of early open or single-blind observations with orally given THC or smoked marijuana, involving small numbers of patients (&lt;a href="#R289" rid="R289" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919721"&gt;</code></p><p><code>3989</code><code>Dunn and Davis, 1974&lt;/a&gt;</code></p><p><code>3990</code><code>; &lt;a href="#R965" rid="R965" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919709"&gt;</code></p><p><code>3991</code><code>Petro, 1980&lt;/a&gt;</code></p><p><code>3992</code><code>; &lt;a href="#R966" rid="R966" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919508"&gt;</code></p><p><code>3993</code><code>Petro and Ellenberger, 1981&lt;/a&gt;</code></p><p><code>3994</code><code>; &lt;a href="#R187" rid="R187" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919719"&gt;</code></p><p><code>3995</code><code>Clifford, 1983&lt;/a&gt;</code></p><p><code>3996</code><code>; &lt;a href="#R814" rid="R814" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919895"&gt;</code></p><p><code>3997</code><code>Meinck et al., 1989&lt;/a&gt;</code></p><p><code>3998</code><code>; &lt;a href="#R120" rid="R120" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920371"&gt;</code></p><p><code>3999</code><code>Brenneisen et al., 1996&lt;/a&gt;</code></p><p><code>4000</code><code>; &lt;a href="#R1079" rid="R1079" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919186"&gt;</code></p><p><code>4001</code><code>Schon et al., 1999&lt;/a&gt;</code></p><p><code>4002</code><code>). The most consistent finding was a subjective improvement in spasticity, although benefits for mobility, tremor, nystagmus, mood, and bladder control were also reported. In a double-blind crossover study of a single MS patient, nabilone treatment improved muscle spasms, nocturia, and general well-being (&lt;a href="#R770" rid="R770" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919328"&gt;</code></p><p><code>4003</code><code>Martyn, 1995&lt;/a&gt;</code></p><p><code>4004</code><code>). In contrast, &lt;a href="#R427" rid="R427" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919209"&gt;</code></p><p><code>4005</code><code>Greenberg et al. (1994)&lt;/a&gt;</code></p><p><code>4006</code><code> reported impairments of both balance and posture after a single dose of smoked cannabis in a placebo-controlled study of 10 MS patients and 10 normal subjects. In an anonymous survey of 112 MS patients who self-medicated with cannabis, 30 to 97% of the subjects reported relief from a wide variety of symptoms by smoking marijuana (&lt;a href="#R204" rid="R204" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918847"&gt;</code></p><p><code>4007</code><code>Consroe et al., 1997&lt;/a&gt;</code></p><p><code>4008</code><code>). These encouraging reports have triggered numerous larger, population-based clinical trials of cannabis-based medicines in MS, which have yielded mixed results.&lt;/p&gt;</code></p><p><code>4009</code><code>&lt;p id="P82"&gt;</code></p><p><code>4010</code><code>Using a randomized, double-blind, placebo-controlled, crossover design, &lt;a href="#R600" rid="R600" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920192"&gt;</code></p><p><code>4011</code><code>Killestein et al. (2002)&lt;/a&gt;</code></p><p><code>4012</code><code> have evaluated the effects of oral THC, two doses of 2.5 to 5 mg/day or a &lt;em&gt;</code></p><p><code>4013</code><code>Cannabis sativa&lt;/em&gt;</code></p><p><code>4014</code><code> plant extract administered over a 4-week period, in 16 MS patients with severe spasticity. Spasticity and disability, quantified using the objective Ashworth scale (&lt;a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919288"&gt;</code></p><p><code>4015</code><code>Ashworth, 1964&lt;/a&gt;</code></p><p><code>4016</code><code>) and the Expanded Disability Status Scale were not improved. However, a significant improvement in the subjective rating of spasm frequency and trends toward improved mobility were noted, with no effect on tremor, sleep quality, or lower urinary tract symptoms. Both THC and the plant extract worsened the patients&amp;#x02019; global impression of their conditions, with plant extracts causing more adverse side effects. It should be mentioned, however, that the dose of THC used was lower than that in subsequent studies with more positive outcome, and as was noted in an accompanying editorial (&lt;a href="#R1181" rid="R1181" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920085"&gt;</code></p><p><code>4017</code><code>Thompson and Baker, 2002&lt;/a&gt;</code></p><p><code>4018</code><code>), the study was not powered to detect efficacy.&lt;/p&gt;</code></p><p><code>4019</code><code>&lt;p id="P83"&gt;</code></p><p><code>4020</code><code>A large multicenter study involving 33 clinical centers and 660 MS patients in the United Kingdom and United States and supported by the UK Medical Council aimed to explore the effects of cannabis extract (Cannador) or synthetic THC (Marinol) versus placebo on spasticity, pain, tremor, bladder function, and cognitive function [Cannabinoids in Multiple Sclerosis (CAMS) study; &lt;a href="#R1312" rid="R1312" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920157"&gt;</code></p><p><code>4021</code><code>Zajicek et al., 2003&lt;/a&gt;</code></p><p><code>4022</code><code>, &lt;a href="#R1311" rid="R1311" class=" bibr popnode"&gt;</code></p><p><code>4023</code><code>2004&lt;/a&gt;</code></p><p><code>4024</code><code>]. There was no change in Ashworth score, tremor, irritability, depression, or tiredness after 15 weeks of treatment with Marinol or Cannador. However, there were significant improvements in patient-reported spasticity, pain, and sleep quality. Unexpectedly, there was also a reduction in hospital admissions for relapse in the two active treatment groups. Adverse side effects were generally minor and similar to those with placebo. Remarkably, in the 12-month follow-up of the original CAMS study of 657 patients, muscle spasticity measured by the Ashworth scale was significantly improved in the THC-treated group. The Rivermead Mobility Index was also improved, indicative of reduced disability. The effect of Cannador on tremor was also studied in a randomized, double-blind, placebo-controlled, crossover trial in 14 patients with MS. Consistent with an earlier report (&lt;a href="#R1312" rid="R1312" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920218"&gt;</code></p><p><code>4025</code><code>Zajicek et al., 2003&lt;/a&gt;</code></p><p><code>4026</code><code>), no significant therapeutic effects were noted (&lt;a href="#R336" rid="R336" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919103"&gt;</code></p><p><code>4027</code><code>Fox et al., 2004&lt;/a&gt;</code></p><p><code>4028</code><code>). In another study of similar design, administration of oral capsules containing 2.5 mg of &amp;#x00394;&lt;sup&gt;</code></p><p><code>4029</code><code>9&lt;/sup&gt;</code></p><p><code>4030</code><code>-THC plus 0.9 mg of CBD (maximal dose of 30 mg of &amp;#x00394;&lt;sup&gt;</code></p><p><code>4031</code><code>9&lt;/sup&gt;</code></p><p><code>4032</code><code>-THC/day) caused improvements in spasm frequency and mobility in 37 MS patients who received at least 90% of their prescribed dose (&lt;a href="#R1215" rid="R1215" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919082"&gt;</code></p><p><code>4033</code><code>Vaney et al., 2004&lt;/a&gt;</code></p><p><code>4034</code><code>).&lt;/p&gt;</code></p><p><code>4035</code><code>&lt;p id="P84"&gt;</code></p><p><code>4036</code><code>In a double-blind, placebo-controlled study involving 18 patients with MS, THC and CBD decreased self-reported spasticity and pain and improved bladder symptoms, whereas spasticity measured by the Ashworth scale was not significantly improved (&lt;a href="#R1245" rid="R1245" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918688"&gt;</code></p><p><code>4037</code><code>Wade et al., 2003&lt;/a&gt;</code></p><p><code>4038</code><code>). The therapeutic effect of Sativex delivered by oromucosal spray (2.7 mg of THC and 2.5 mg of CBD at each actuation) was evaluated in 160 outpatients with MS (&lt;a href="#R1118" rid="R1118" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653429"&gt;</code></p><p><code>4039</code><code>Smith, 2004&lt;/a&gt;</code></p><p><code>4040</code><code>). Patients were allowed to self-titrate the dose to achieve optimal effects, up to a maximal daily dose of 120 mg of THC and CBD. Efficacy was assessed by using a modified Ashworth scale to assess spasticity, whereas daily living, mobility, cognitive function, and tremor were quantified through the use of various scales and questionnaires (&lt;a href="#R1244" rid="R1244" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918939"&gt;</code></p><p><code>4041</code><code>Wade et al., 2004&lt;/a&gt;</code></p><p><code>4042</code><code>). There was no significant difference in the Ashworth scale, tremor, and pain at 6 weeks between the Sativex and placebo groups. However, visual analog scales showed significant improvement in patients whose primary symptom had been spasticity (&lt;a href="#R1244" rid="R1244" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919687"&gt;</code></p><p><code>4043</code><code>Wade et al., 2004&lt;/a&gt;</code></p><p><code>4044</code><code>). Sativex was well tolerated and effective against central neuropathic pain and sleep disturbances associated with MS in a randomized, controlled trial involving 66 patients (&lt;a href="#R1029" rid="R1029" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919065"&gt;</code></p><p><code>4045</code><code>Rog et al., 2005&lt;/a&gt;</code></p><p><code>4046</code><code>). Sativex was approved and launched in Canada in 2005 for the treatment of neuropathic pain associated with MS and is currently being investigated for various other therapeutic indications (&lt;a href="#R1051" rid="R1051" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918924"&gt;</code></p><p><code>4047</code><code>Russo, 2004&lt;/a&gt;</code></p><p><code>4048</code><code>, &lt;a href="#R1050" rid="R1050" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918857"&gt;</code></p><p><code>4049</code><code>2006&lt;/a&gt;</code></p><p><code>4050</code><code>).&lt;/p&gt;</code></p><p><code>4051</code><code>&lt;p id="P85"&gt;</code></p><p><code>4052</code><code>In a recent case report, a 46-year-old woman was diagnosed with MS after having entered treatment with the CB&lt;sub&gt;</code></p><p><code>4053</code><code>1&lt;/sub&gt;</code></p><p><code>4054</code><code> receptor antagonist rimonabant for obesity, and recovery to near normal was noted within weeks after discontinuation of the treatment (&lt;a href="#R1217" rid="R1217" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919211"&gt;</code></p><p><code>4055</code><code>van Oosten et al., 2004&lt;/a&gt;</code></p><p><code>4056</code><code>). This report, coupled with the more severe neurodegenerative process when MS is induced in CB&lt;sub&gt;</code></p><p><code>4057</code><code>1&lt;/sub&gt;</code></p><p><code>4058</code><code> knock-out mice or in mice treated with a CB&lt;sub&gt;</code></p><p><code>4059</code><code>1&lt;/sub&gt;</code></p><p><code>4060</code><code> receptor antagonist, could suggest that CB&lt;sub&gt;</code></p><p><code>4061</code><code>1&lt;/sub&gt;</code></p><p><code>4062</code><code> antagonism may exacerbate inflammatory demyelinating diseases in humans (&lt;a href="#R1217" rid="R1217" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918916"&gt;</code></p><p><code>4063</code><code>van Oosten et al., 2004&lt;/a&gt;</code></p><p><code>4064</code><code>). However, the occurrence of MS in this one patient may have been purely coincidental.&lt;/p&gt;</code></p><p><code>4065</code><code>&lt;p id="P86"&gt;</code></p><p><code>4066</code><code>Although the results of the above clinical studies (&lt;a href="/pmc/articles/PMC2241751/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""&gt;</code></p><p><code>4067</code><code>&lt;span&gt;</code></p><p><code>4068</code><code>Table 1&lt;/span&gt;</code></p><p><code>4069</code><code>&lt;/a&gt;</code></p><p><code>4070</code><code>) are somewhat equivocal, patients treated with cannabis experienced improvements in the most disturbing symptoms including pain and spasticity compared with those receiving placebo, without experiencing significant side effects. These studies also suggest that the Ashworth scale as a primary measure of spasticity in MS does not accurately assess the complex collection of symptoms associated with spasticity, which may be more accurately evaluated using subjective measures. Indeed, the use of the Ashworth scale as a primary measure of spasticity in MS has often being criticized, and many commonly used antispasticity medications have also failed to generate statistically significant improvements according to this scale (&lt;a href="#R502" rid="R502" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918861"&gt;</code></p><p><code>4071</code><code>Hinderer and Gupta, 1996&lt;/a&gt;</code></p><p><code>4072</code><code>; &lt;a href="#R1087" rid="R1087" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919041"&gt;</code></p><p><code>4073</code><code>Shakespeare et al., 2003&lt;/a&gt;</code></p><p><code>4074</code><code>). Accurate assessment of the clinical effectiveness of cannabinoids in MS may be complicated by the difficulty in achieving the most appropriate individual oral dose (&lt;a href="/pmc/articles/PMC2241751/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""&gt;</code></p><p><code>4075</code><code>&lt;span&gt;</code></p><p><code>4076</code><code>Table 1&lt;/span&gt;</code></p><p><code>4077</code><code>&lt;/a&gt;</code></p><p><code>4078</code><code>). Peak plasma concentrations and their timing vary greatly because of the low water solubility of cannabis components and the large variability in their absorption from the gastrointestinal tract. An additional disadvantage of oral administration is the hepatic first-pass effect. This can result in the formation of large quantities of the psychoactive metabolite 11-OH-THC, which may be responsible for some of the side effects observed (&lt;a href="/pmc/articles/PMC2241751/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""&gt;</code></p><p><code>4079</code><code>&lt;span&gt;</code></p><p><code>4080</code><code>Table 1&lt;/span&gt;</code></p><p><code>4081</code><code>&lt;/a&gt;</code></p><p><code>4082</code><code>). Delivery of cannabis-based extracts as an oromucosal spray may minimize these drawbacks and may allow patients to better optimize their individual daily dose by self-titration (&lt;a href="#R1050" rid="R1050" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920041"&gt;</code></p><p><code>4083</code><code>Russo, 2006&lt;/a&gt;</code></p><p><code>4084</code><code>).&lt;/p&gt;</code></p><p><code>4085</code><code>&lt;p id="P87" class="p p-last"&gt;</code></p><p><code>4086</code><code>In conclusion, controlled clinical trials with cannabinoids have demonstrated their efficacy in eliciting symptomatic improvements in MS patients. These results suggest that there is place for the use of cannabis in the treatment of MS, which should be confirmed in further larger-scale clinical trials.&lt;/p&gt;</code></p><p><code>4087</code><code>&lt;/div&gt;</code></p><p><code>4088</code><code>&lt;div id="S17" class="sec"&gt;</code></p><p><code>4089</code><code>&lt;p&gt;</code></p><p><code>4090</code><code>&lt;/p&gt;</code></p><p><code>4091</code><code>&lt;h4 id="S17title" class="inline"&gt;</code></p><p><code>4092</code><code>4. Movement Disorders (Basal Ganglia Disorders) &lt;/h4&gt;</code></p><p><code>4093</code><code>&lt;p id="P88" class="p p-first"&gt;</code></p><p><code>4094</code><code>Endocannabinoid involvement in the central regulation of motor functions and in movement disorders is based on multiple lines of evidence. First, CB&lt;sub&gt;</code></p><p><code>4095</code><code>1&lt;/sub&gt;</code></p><p><code>4096</code><code> receptors are highly expressed in the basal ganglia, especially in the substantia nigra and in the cerebellum (&lt;a href="#R486" rid="R486" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918801"&gt;</code></p><p><code>4097</code><code>Herkenham et al., 1990&lt;/a&gt;</code></p><p><code>4098</code><code>, &lt;a href="#R484" rid="R484" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918894"&gt;</code></p><p><code>4099</code><code>1991a&lt;/a&gt;</code></p><p><code>4100</code><code>,&lt;a href="#R485" rid="R485" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637229"&gt;</code></p><p><code>4101</code><code>b&lt;/a&gt;</code></p><p><code>4102</code><code>; &lt;a href="#R730" rid="R730" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919503"&gt;</code></p><p><code>4103</code><code>Mailleux and Vanderhaeghen, 1992&lt;/a&gt;</code></p><p><code>4104</code><code>; &lt;a href="#R1189" rid="R1189" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919367"&gt;</code></p><p><code>4105</code><code>Tsou et al., 1998&lt;/a&gt;</code></p><p><code>4106</code><code>; &lt;a href="#R510" rid="R510" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919926"&gt;</code></p><p><code>4107</code><code>Hohmann and Herkenham, 2000&lt;/a&gt;</code></p><p><code>4108</code><code>; &lt;a href="#R840" rid="R840" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919903"&gt;</code></p><p><code>4109</code><code>Moldrich and Wenger, 2000&lt;/a&gt;</code></p><p><code>4110</code><code>; &lt;a href="#R526" rid="R526" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919654"&gt;</code></p><p><code>4111</code><code>Howlett et al., 2002&lt;/a&gt;</code></p><p><code>4112</code><code>), areas involved in motor control. Second, endocannabinoids are also abundant in these brain regions (&lt;a href="#R89" rid="R89" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920400"&gt;</code></p><p><code>4113</code><code>Bisogno et al., 1999a&lt;/a&gt;</code></p><p><code>4114</code><code>; &lt;a href="#R275" rid="R275" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919220"&gt;</code></p><p><code>4115</code><code>Di Marzo et al., 2000&lt;/a&gt;</code></p><p><code>4116</code><code>). Third, endogenous, plant-derived, and synthetic cannabinoids have potent, mostly inhibitory, effects on motor activity (&lt;a href="#R227" rid="R227" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919869"&gt;</code></p><p><code>4117</code><code>Crawley et al., 1993&lt;/a&gt;</code></p><p><code>4118</code><code>; &lt;a href="#R349" rid="R349" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920348"&gt;</code></p><p><code>4119</code><code>Fride and Mechoulam, 1993&lt;/a&gt;</code></p><p><code>4120</code><code>; &lt;a href="#R1285" rid="R1285" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919886"&gt;</code></p><p><code>4121</code><code>Wickens and Pertwee, 1993&lt;/a&gt;</code></p><p><code>4122</code><code>; &lt;a href="#R1117" rid="R1117" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919245"&gt;</code></p><p><code>4123</code><code>Smith et al., 1994&lt;/a&gt;</code></p><p><code>4124</code><code>; &lt;a href="#R1033" rid="R1033" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919822"&gt;</code></p><p><code>4125</code><code>Romero et al., 1995a&lt;/a&gt;</code></p><p><code>4126</code><code>,&lt;a href="#R1034" rid="R1034" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919453"&gt;</code></p><p><code>4127</code><code>b&lt;/a&gt;</code></p><p><code>4128</code><code>, &lt;a href="#R1035" rid="R1035" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919246"&gt;</code></p><p><code>4129</code><code>2002b&lt;/a&gt;</code></p><p><code>4130</code><code>; reviewed in &lt;a href="#R1063" rid="R1063" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653359"&gt;</code></p><p><code>4131</code><code>Sa&amp;#x000f1;udo-Pe&amp;#x000f1; a et al., 1999b&lt;/a&gt;</code></p><p><code>4132</code><code>). Fourth, CB&lt;sub&gt;</code></p><p><code>4133</code><code>1&lt;/sub&gt;</code></p><p><code>4134</code><code> receptor and endocannabinoid levels are altered in the basal ganglia both in experimental models (&lt;a href="#R1318" rid="R1318" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919863"&gt;</code></p><p><code>4135</code><code>Zeng et al., 1999&lt;/a&gt;</code></p><p><code>4136</code><code>; &lt;a href="#R929" rid="R929" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918975"&gt;</code></p><p><code>4137</code><code>Page et al., 2000&lt;/a&gt;</code></p><p><code>4138</code><code>; &lt;a href="#R1032" rid="R1032" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920302"&gt;</code></p><p><code>4139</code><code>Romero et al., 2000&lt;/a&gt;</code></p><p><code>4140</code><code>; &lt;a href="#R655" rid="R655" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919010"&gt;</code></p><p><code>4141</code><code>Lastres-Becker et al., 2001a&lt;/a&gt;</code></p><p><code>4142</code><code>,&lt;a href="#R658" rid="R658" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919134"&gt;</code></p><p><code>4143</code><code>b&lt;/a&gt;</code></p><p><code>4144</code><code>, &lt;a href="#R654" rid="R654" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919171"&gt;</code></p><p><code>4145</code><code>2002a&lt;/a&gt;</code></p><p><code>4146</code><code>,&lt;a href="#R659" rid="R659" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919165"&gt;</code></p><p><code>4147</code><code>b&lt;/a&gt;</code></p><p><code>4148</code><code>; &lt;a href="#R415" rid="R415" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653474"&gt;</code></p><p><code>4149</code><code>Gonzalez et al., 2006&lt;/a&gt;</code></p><p><code>4150</code><code>) and human forms of movement disorders (&lt;a href="#R399" rid="R399" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918704"&gt;</code></p><p><code>4151</code><code>Glass et al., 1993&lt;/a&gt;</code></p><p><code>4152</code><code>, &lt;a href="#R398" rid="R398" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918681"&gt;</code></p><p><code>4153</code><code>2000&lt;/a&gt;</code></p><p><code>4154</code><code>, &lt;a href="#R402" rid="R402" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920053"&gt;</code></p><p><code>4155</code><code>2004&lt;/a&gt;</code></p><p><code>4156</code><code>; &lt;a href="#R655" rid="R655" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918909"&gt;</code></p><p><code>4157</code><code>Lastres-Becker et al., 2001a&lt;/a&gt;</code></p><p><code>4158</code><code>; reviewed in &lt;a href="#R1035" rid="R1035" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919157"&gt;</code></p><p><code>4159</code><code>Romero et al., 2002b&lt;/a&gt;</code></p><p><code>4160</code><code>). Fifth, the endocannabinoid system interacts with several neurotransmitter pathways at various levels of the basal ganglia circuitry (&lt;a href="#R396" rid="R396" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918806"&gt;</code></p><p><code>4161</code><code>Glass et al., 1997a&lt;/a&gt;</code></p><p><code>4162</code><code>; &lt;a href="#R831" rid="R831" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919146"&gt;</code></p><p><code>4163</code><code>Miller et al., 1998&lt;/a&gt;</code></p><p><code>4164</code><code>; &lt;a href="#R1064" rid="R1064" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919937"&gt;</code></p><p><code>4165</code><code>Sa&amp;#x000f1;udo-Pe&amp;#x000f1; a and Walker, 1998&lt;/a&gt;</code></p><p><code>4166</code><code>; &lt;a href="#R391" rid="R391" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919741"&gt;</code></p><p><code>4167</code><code>Giuffrida et al., 1999&lt;/a&gt;</code></p><p><code>4168</code><code>; &lt;a href="#R1027" rid="R1027" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919806"&gt;</code></p><p><code>4169</code><code>Rodriguez De Fonseca et al., 2001&lt;/a&gt;</code></p><p><code>4170</code><code>; &lt;a href="#R123" rid="R123" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919990"&gt;</code></p><p><code>4171</code><code>Brotchie, 2003&lt;/a&gt;</code></p><p><code>4172</code><code>; &lt;a href="#R1210" rid="R1210" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919672"&gt;</code></p><p><code>4173</code><code>van der Stelt and Di Marzo, 2003&lt;/a&gt;</code></p><p><code>4174</code><code>; &lt;a href="#R246" rid="R246" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919505"&gt;</code></p><p><code>4175</code><code>de Lago et al., 2004a&lt;/a&gt;</code></p><p><code>4176</code><code>).&lt;/p&gt;</code></p><p><code>4177</code><code>&lt;div id="S18" class="sec"&gt;</code></p><p><code>4178</code><code>&lt;p&gt;</code></p><p><code>4179</code><code>&lt;/p&gt;</code></p><p><code>4180</code><code>&lt;h5 id="S18title" class="inline"&gt;</code></p><p><code>4181</code><code>a. Parkinson&amp;#x02019;s disease and levodopa-induced dyskinesia &lt;/h5&gt;</code></p><p><code>4182</code><code>&lt;p id="P89" class="p p-first"&gt;</code></p><p><code>4183</code><code>Parkinson&amp;#x02019;s disease (PD) is the second most common neurodegenerative disease of adult onset, with incidence of 16 to 19/100,000 people worldwide (&lt;a href="#R1195" rid="R1195" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919577"&gt;</code></p><p><code>4184</code><code>Twelves et al., 2003&lt;/a&gt;</code></p><p><code>4185</code><code>). PD is caused by a severe loss of dopaminergic neurons in the substantia nigra pars reticulata (SNr), resulting in reduced dopamine levels and a loss of dopaminergic neurotransmission in the striatum, which interferes with motor function and coordination. Although excitotoxicity, oxidative stress, inflammation, mitochondrial dysfunction, and environmental and hereditary factors have all been implicated in the pathogenesis of PD, the exact cause of the loss of dopaminergic neurons remains elusive (&lt;a href="#R474" rid="R474" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920172"&gt;</code></p><p><code>4186</code><code>Hattori and Mizuno, 2004&lt;/a&gt;</code></p><p><code>4187</code><code>; &lt;a href="#R303" rid="R303" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919236"&gt;</code></p><p><code>4188</code><code>Eriksen et al., 2005&lt;/a&gt;</code></p><p><code>4189</code><code>). Clinically, PD is characterized by the classic triad of resting tremor, muscular rigidity, and bradykinesia/akinesia (slowness of movement or postural immobility). Current therapies include oral dopamine replacement via the dopamine precursor levodopa, anti-cholinergic agents, and monoamine oxidase B inhibitors (&lt;a href="#R522" rid="R522" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918875"&gt;</code></p><p><code>4190</code><code>Horn and Stern, 2004&lt;/a&gt;</code></p><p><code>4191</code><code>). Although dopamine replacement therapy can be effective in most patients by controlling the symptoms in the short term, their long-term use is associated with diminishing efficacy and severe side effects such as levodopa-induced dyskinesia (LID) (involuntary movements), which often lead to treatment discontinuation and severe disability.&lt;/p&gt;</code></p><p><code>4192</code><code>&lt;p id="P90"&gt;</code></p><p><code>4193</code><code>In PD, there are secondary abnormalities in nondopaminergic transmission within the basal ganglia that are thought to contribute to the inhibition of motor function. Inhibitory GABAergic transmission from the striatum to the external region of the globus pallidus (GPe) is increased, making the GPe hypoactive. This results in decreased GABAergic input from the GPe to the subthalamic nucleus which, together with increased activity of glutamatergic efferents to this nucleus, results in its hyperactivity. In turn, the hyperactive subthalamic nucleus increases the activity of the SNr and internal globus pallidus (GPi) through glutamatergic efferents. Because both the SNr and GPi provide inhibitory output to motor nuclei outside the basal ganglia (e.g., motor thalamus and brain stem locomotor regions), this mechanism is thought to contribute to the excessive motor inhibition in PD (&lt;a href="#R900" rid="R900" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918988"&gt;</code></p><p><code>4194</code><code>Obeso et al., 2000&lt;/a&gt;</code></p><p><code>4195</code><code>; &lt;a href="#R76" rid="R76" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920186"&gt;</code></p><p><code>4196</code><code>Bezard et al., 2001&lt;/a&gt;</code></p><p><code>4197</code><code>). In general, changes opposite to those described above are likely to be involved in LID. The final outcomes of the dysregulation of neuronal circuits are abnormal patterning, firing rate, and synchronization of basal ganglia outputs (&lt;a href="#R900" rid="R900" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920265"&gt;</code></p><p><code>4198</code><code>Obeso et al., 2000&lt;/a&gt;</code></p><p><code>4199</code><code>; &lt;a href="#R76" rid="R76" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920358"&gt;</code></p><p><code>4200</code><code>Bezard et al., 2001&lt;/a&gt;</code></p><p><code>4201</code><code>). Importantly, nondopaminergic mechanisms may counterbalance the loss of dopamine and are probably responsible for the lack of parkinsonian symptoms until the loss of &amp;#x0003e;80% of striatal dopamine. They may also attenuate the severity of symptoms once symptoms develop. As discussed below, the endocannabinoid system may play an important regulatory role in PD,PD and LID as well as in the compensatory mechanisms.&lt;/p&gt;</code></p><p><code>4202</code><code>&lt;p id="P91"&gt;</code></p><p><code>4203</code><code>Overactivity of endocannabinoid transmission, as reflected by increased tissue levels of endocannabinoids and CB&lt;sub&gt;</code></p><p><code>4204</code><code>1&lt;/sub&gt;</code></p><p><code>4205</code><code> receptors as well as decreased rates of endocannabinoid transport and degradation by FAAH, have been found in the basal ganglia in the 6-hydroxydopamine-lesioned or reserpine-treated rat models of PD (&lt;a href="#R731" rid="R731" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919593"&gt;</code></p><p><code>4206</code><code>Mailleux and Vanderhaeghen, 1993&lt;/a&gt;</code></p><p><code>4207</code><code>; &lt;a href="#R1032" rid="R1032" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919314"&gt;</code></p><p><code>4208</code><code>Romero et al., 2000&lt;/a&gt;</code></p><p><code>4209</code><code>; &lt;a href="#R439" rid="R439" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637231"&gt;</code></p><p><code>4210</code><code>Gubellini et al., 2002&lt;/a&gt;</code></p><p><code>4211</code><code>; &lt;a href="#R165" rid="R165" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919408"&gt;</code></p><p><code>4212</code><code>Centonze et al., 2005&lt;/a&gt;</code></p><p><code>4213</code><code>; &lt;a href="#R320" rid="R320" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919306"&gt;</code></p><p><code>4214</code><code>Fernandez-Espejo et al., 2005&lt;/a&gt;</code></p><p><code>4215</code><code>; &lt;a href="#R415" rid="R415" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653351"&gt;</code></p><p><code>4216</code><code>Gonzalez et al., 2006&lt;/a&gt;</code></p><p><code>4217</code><code>). In basal ganglia from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned marmosets, a primate model of PD, and in basal ganglia of PD patients, the density of striatal CB&lt;sub&gt;</code></p><p><code>4218</code><code>1&lt;/sub&gt;</code></p><p><code>4219</code><code> receptors and CB&lt;sub&gt;</code></p><p><code>4220</code><code>1&lt;/sub&gt;</code></p><p><code>4221</code><code> receptor-G-protein coupling were found to be increased (&lt;a href="#R655" rid="R655" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920050"&gt;</code></p><p><code>4222</code><code>Lastres-Becker et al., 2001a&lt;/a&gt;</code></p><p><code>4223</code><code>). The above changes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated marmosets and 6-hydroxydopamine-lesioned rats were reversible by chronic L-dopa treatment, which indicates that the similar changes observed in PD patients were unlikely to have been induced by the replacement therapy (&lt;a href="#R655" rid="R655" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919183"&gt;</code></p><p><code>4224</code><code>Lastres-Becker et al., 2001a&lt;/a&gt;</code></p><p><code>4225</code><code>; &lt;a href="#R721" rid="R721" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919343"&gt;</code></p><p><code>4226</code><code>Maccarrone et al., 2003&lt;/a&gt;</code></p><p><code>4227</code><code>). There is broad agreement that the endocannabinoid system becomes overactive in the basal ganglia in PD (reviewed in &lt;a href="#R123" rid="R123" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919597"&gt;</code></p><p><code>4228</code><code>Brotchie, 2003&lt;/a&gt;</code></p><p><code>4229</code><code>), although some studies report a reduction (&lt;a href="#R1107" rid="R1107" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919495"&gt;</code></p><p><code>4230</code><code>Silverdale et al., 2001&lt;/a&gt;</code></p><p><code>4231</code><code>) or no change in CB&lt;sub&gt;</code></p><p><code>4232</code><code>1&lt;/sub&gt;</code></p><p><code>4233</code><code> receptor expression (&lt;a href="#R484" rid="R484" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920164"&gt;</code></p><p><code>4234</code><code>Herkenham et al., 1991a&lt;/a&gt;</code></p><p><code>4235</code><code>) or a dependence on L-DOPA cotreatment of the increased CB&lt;sub&gt;</code></p><p><code>4236</code><code>1&lt;/sub&gt;</code></p><p><code>4237</code><code> receptor expression in the basal ganglia of animals with experimental PD (&lt;a href="#R1318" rid="R1318" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919095"&gt;</code></p><p><code>4238</code><code>Zeng et al., 1999&lt;/a&gt;</code></p><p><code>4239</code><code>).&lt;/p&gt;</code></p><p><code>4240</code><code>&lt;p id="P92"&gt;</code></p><p><code>4241</code><code>If the enhanced CB&lt;sub&gt;</code></p><p><code>4242</code><code>1&lt;/sub&gt;</code></p><p><code>4243</code><code> receptor signaling in the striatum is viewed as an attempt of the dopamine-deficient brain to normalize striatal function, the pharmacological amplification of this signaling might alleviate symptoms of PD, e.g., by reducing striatal glutamate release (&lt;a href="#R378" rid="R378" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919255"&gt;</code></p><p><code>4244</code><code>Gerdeman and Lovinger, 2001&lt;/a&gt;</code></p><p><code>4245</code><code>; &lt;a href="#R381" rid="R381" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919435"&gt;</code></p><p><code>4246</code><code>Gerdeman et al., 2002&lt;/a&gt;</code></p><p><code>4247</code><code>; &lt;a href="#R439" rid="R439" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637219"&gt;</code></p><p><code>4248</code><code>Gubellini et al., 2002&lt;/a&gt;</code></p><p><code>4249</code><code>). On the other hand, enhanced CB&lt;sub&gt;</code></p><p><code>4250</code><code>1&lt;/sub&gt;</code></p><p><code>4251</code><code> receptor signaling, if focused on the other part of the circuitry (e.g., GPe), can enhance GABA transmission, leading to inhibition of GPe and thereby contributing to the symptoms of PD. Likewise, CB&lt;sub&gt;</code></p><p><code>4252</code><code>1&lt;/sub&gt;</code></p><p><code>4253</code><code> antagonism could have either pro-parkinsonian effects, if it targets the striatum, or antiparkinsonian effects, if it targets the GPe. Accordingly, both agonists and antagonists might have therapeutic potential, both in PD and LID (reviewed in &lt;a href="#R123" rid="R123" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919693"&gt;</code></p><p><code>4254</code><code>Brotchie, 2003&lt;/a&gt;</code></p><p><code>4255</code><code>).&lt;/p&gt;</code></p><p><code>4256</code><code>&lt;p id="P93"&gt;</code></p><p><code>4257</code><code>Treatment with CB&lt;sub&gt;</code></p><p><code>4258</code><code>1&lt;/sub&gt;</code></p><p><code>4259</code><code> receptor agonists can decrease the tremor associated with overactivity of the subthalamic nucleus (&lt;a href="#R1061" rid="R1061" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918864"&gt;</code></p><p><code>4260</code><code>Sa&amp;#x000f1;udo-Pe&amp;#x000f1; a et al., 1998&lt;/a&gt;</code></p><p><code>4261</code><code>, &lt;a href="#R1063" rid="R1063" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653389"&gt;</code></p><p><code>4262</code><code>1999b&lt;/a&gt;</code></p><p><code>4263</code><code>), improve motor impairment seen with dopaminergic agonists (&lt;a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919036"&gt;</code></p><p><code>4264</code><code>Anderson et al., 1995&lt;/a&gt;</code></p><p><code>4265</code><code>; &lt;a href="#R744" rid="R744" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919118"&gt;</code></p><p><code>4266</code><code>Maneuf et al., 1997&lt;/a&gt;</code></p><p><code>4267</code><code>; &lt;a href="#R1061" rid="R1061" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919117"&gt;</code></p><p><code>4268</code><code>Sa&amp;#x000f1;udo-Pe&amp;#x000f1; a et al., 1998&lt;/a&gt;</code></p><p><code>4269</code><code>), protect against dopaminergic cell death (&lt;a href="#R660" rid="R660" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920284"&gt;</code></p><p><code>4270</code><code>Lastres-Becker et al., 2005&lt;/a&gt;</code></p><p><code>4271</code><code>), and delay or reduce the incidence of LID (&lt;a href="#R1104" rid="R1104" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919279"&gt;</code></p><p><code>4272</code><code>Sieradzan et al., 2001&lt;/a&gt;</code></p><p><code>4273</code><code>; &lt;a href="#R337" rid="R337" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919214"&gt;</code></p><p><code>4274</code><code>Fox et al., 2002a&lt;/a&gt;</code></p><p><code>4275</code><code>; &lt;a href="#R323" rid="R323" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919858"&gt;</code></p><p><code>4276</code><code>Ferrer et al., 2003&lt;/a&gt;</code></p><p><code>4277</code><code>; &lt;a href="#R387" rid="R387" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918700"&gt;</code></p><p><code>4278</code><code>Gilgun-Sherkiet et al., 2003&lt;/a&gt;</code></p><p><code>4279</code><code>). However, cannabinoid agonists are unlikely to be used for reducing bradykinesia in PD because of their hypokinetic profile both in primates and humans (&lt;a href="#R200" rid="R200" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919116"&gt;</code></p><p><code>4280</code><code>Consroe, 1998&lt;/a&gt;</code></p><p><code>4281</code><code>; &lt;a href="#R857" rid="R857" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653441"&gt;</code></p><p><code>4282</code><code>M&amp;#x000fc;ller-Vahl et al., 1999a&lt;/a&gt;</code></p><p><code>4283</code><code>; &lt;a href="#R1030" rid="R1030" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653515"&gt;</code></p><p><code>4284</code><code>Romero et al., 2002&lt;/a&gt;</code></p><p><code>4285</code><code>; &lt;a href="#R123" rid="R123" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919584"&gt;</code></p><p><code>4286</code><code>Brotchie, 2003&lt;/a&gt;</code></p><p><code>4287</code><code>; &lt;a href="#R230" rid="R230" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920074"&gt;</code></p><p><code>4288</code><code>Croxford, 2003&lt;/a&gt;</code></p><p><code>4289</code><code>; &lt;a href="#R231" rid="R231" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920070"&gt;</code></p><p><code>4290</code><code>Croxford and Miller, 2003&lt;/a&gt;</code></p><p><code>4291</code><code>).&lt;/p&gt;</code></p><p><code>4292</code><code>&lt;p id="P94"&gt;</code></p><p><code>4293</code><code>On the other hand, dysfunction of nigrostriatal dopaminergic neurons can be associated with overactivity of endocannabinoid transmission in the basal ganglia (see above). CB&lt;sub&gt;</code></p><p><code>4294</code><code>1&lt;/sub&gt;</code></p><p><code>4295</code><code> receptor antagonists may therefore be useful for alleviating the bradykinesia of PD or LID, because they attenuate CB&lt;sub&gt;</code></p><p><code>4296</code><code>1&lt;/sub&gt;</code></p><p><code>4297</code><code> signaling in GPe or GPi. (&lt;a href="#R731" rid="R731" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919974"&gt;</code></p><p><code>4298</code><code>Mailleux and Vanderhaeghen, 1993&lt;/a&gt;</code></p><p><code>4299</code><code>; &lt;a href="#R275" rid="R275" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919625"&gt;</code></p><p><code>4300</code><code>Di Marzo et al., 2000&lt;/a&gt;</code></p><p><code>4301</code><code>; &lt;a href="#R655" rid="R655" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918954"&gt;</code></p><p><code>4302</code><code>Lastres-Becker et al., 2001a&lt;/a&gt;</code></p><p><code>4303</code><code>,&lt;a href="#R658" rid="R658" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920238"&gt;</code></p><p><code>4304</code><code>b&lt;/a&gt;</code></p><p><code>4305</code><code>; &lt;a href="#R439" rid="R439" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637209"&gt;</code></p><p><code>4306</code><code>Gubellini et al., 2002&lt;/a&gt;</code></p><p><code>4307</code><code>; reviewed in &lt;a href="#R123" rid="R123" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919174"&gt;</code></p><p><code>4308</code><code>Brotchie, 2003&lt;/a&gt;</code></p><p><code>4309</code><code>; Fernandez-Espejo et al., reviewed in &lt;a href="#R123" rid="R123" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918724"&gt;</code></p><p><code>4310</code><code>Brotchie, 2003&lt;/a&gt;</code></p><p><code>4311</code><code>; 2005; &lt;a href="#R322" rid="R322" class=" bibr popnode"&gt;</code></p><p><code>4312</code><code>Fernandez-Ruiz and Gonzalez, 2005&lt;/a&gt;</code></p><p><code>4313</code><code>). Notwithstanding the above, studies using SR141716 in rat (&lt;a href="#R275" rid="R275" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918999"&gt;</code></p><p><code>4314</code><code>Di Marzo et al., 2000&lt;/a&gt;</code></p><p><code>4315</code><code>) and primate models of PD or LID (&lt;a href="#R827" rid="R827" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919856"&gt;</code></p><p><code>4316</code><code>Meschler et al., 2001&lt;/a&gt;</code></p><p><code>4317</code><code>; &lt;a href="#R1212" rid="R1212" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919340"&gt;</code></p><p><code>4318</code><code>van der Stelt et al., 2005&lt;/a&gt;</code></p><p><code>4319</code><code>) provided conflicting results. Rimonabant treatment also failed to influence dyskinesia in the first small-scale, randomized, double-blind, placebo-controlled human study (&lt;a href="#R828" rid="R828" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919793"&gt;</code></p><p><code>4320</code><code>Mesnage et al., 2004&lt;/a&gt;</code></p><p><code>4321</code><code>). However, the dose used in this human study was approximately 10-fold lower (0.3 mg/kg versus. 3 mg/kg), than in a recent primate study with positive outcome (&lt;a href="#R1212" rid="R1212" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919838"&gt;</code></p><p><code>4322</code><code>van der Stelt et al., 2005&lt;/a&gt;</code></p><p><code>4323</code><code>). As suggested by a recent report (&lt;a href="#R320" rid="R320" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920304"&gt;</code></p><p><code>4324</code><code>Fernandez-Espejo et al., 2005&lt;/a&gt;</code></p><p><code>4325</code><code>), it is also possible that CB&lt;sub&gt;</code></p><p><code>4326</code><code>1&lt;/sub&gt;</code></p><p><code>4327</code><code> receptor blockade is effective only at the very advanced stages of the disease. More recently, using Park-2 knockout mice, a genetic model of early PD, &lt;a href="#R414" rid="R414" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919561"&gt;</code></p><p><code>4328</code><code>Gonzalez et al. (2005)&lt;/a&gt;</code></p><p><code>4329</code><code> observed gender-dependent differences for both the levels of CB&lt;sub&gt;</code></p><p><code>4330</code><code>1&lt;/sub&gt;</code></p><p><code>4331</code><code> receptors and motor responses to agonists or antagonists, extending earlier data obtained in humans and in animal models of PD.&lt;/p&gt;</code></p><p><code>4332</code><code>&lt;p id="P95" class="p p-last"&gt;</code></p><p><code>4333</code><code>Taken together, although the above studies do not offer a complete understanding of the role of endocannabinoids and cannabinoid receptors in PD and LID, they support the notion that the endocannabinoid system plays an important role in movement disorders, including PD, and may provide the framework for novel therapeutic approaches in the future.&lt;/p&gt;</code></p><p><code>4334</code><code>&lt;/div&gt;</code></p><p><code>4335</code><code>&lt;div id="S19" class="sec"&gt;</code></p><p><code>4336</code><code>&lt;p&gt;</code></p><p><code>4337</code><code>&lt;/p&gt;</code></p><p><code>4338</code><code>&lt;h5 id="S19title" class="inline"&gt;</code></p><p><code>4339</code><code>b. Huntington&amp;#x02019;s disease &lt;/h5&gt;</code></p><p><code>4340</code><code>&lt;p id="P96" class="p p-first"&gt;</code></p><p><code>4341</code><code>Huntington&amp;#x02019;s disease (HD) is an inherited, autosomal dominant, progressive neuropsychiatric disorder of the midlife, caused by an unstable expansion of a trinucleotide polyglutamine repeat in the N-terminal domain of a protein termed huntingtin, which leads to degeneration of neurons in the basal ganglia and cortical regions. The disease is characterized by motor disturbances, such as chorea (involuntary movements) and dystonia, psychiatric symptoms, and dementia (&lt;a href="#R820" rid="R820" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918942"&gt;</code></p><p><code>4342</code><code>Melone et al., 2005&lt;/a&gt;</code></p><p><code>4343</code><code>). The prevalence of HD is similar to that of ALS (see below), but much lower than that of most of the other neurodegenerative illnesses discussed above or below. The therapy of HD is very limited and includes antidopaminergic drugs to reduce the hyperkinesias and antiglutamatergic agents to reduce excitotoxicity (&lt;a href="#R820" rid="R820" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919452"&gt;</code></p><p><code>4344</code><code>Melone et al., 2005&lt;/a&gt;</code></p><p><code>4345</code><code>).&lt;/p&gt;</code></p><p><code>4346</code><code>&lt;p id="P97"&gt;</code></p><p><code>4347</code><code>It has been clearly demonstrated, both in postmortem human tissue (&lt;a href="#R399" rid="R399" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920378"&gt;</code></p><p><code>4348</code><code>Glass et al., 1993&lt;/a&gt;</code></p><p><code>4349</code><code>, &lt;a href="#R398" rid="R398" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919710"&gt;</code></p><p><code>4350</code><code>2000&lt;/a&gt;</code></p><p><code>4351</code><code>; &lt;a href="#R1015" rid="R1015" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919322"&gt;</code></p><p><code>4352</code><code>Richfield and Herkenham, 1994&lt;/a&gt;</code></p><p><code>4353</code><code>) and in chemically induced and transgenic animal models (&lt;a href="#R257" rid="R257" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919388"&gt;</code></p><p><code>4354</code><code>Denovan-Wright and Robertson, 2000&lt;/a&gt;</code></p><p><code>4355</code><code>; &lt;a href="#R929" rid="R929" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920296"&gt;</code></p><p><code>4356</code><code>Page et al., 2000&lt;/a&gt;</code></p><p><code>4357</code><code>; &lt;a href="#R655" rid="R655" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919874"&gt;</code></p><p><code>4358</code><code>Lastres-Becker et al., 2001&lt;/a&gt;</code></p><p><code>4359</code><code>, &lt;a href="#R654" rid="R654" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919537"&gt;</code></p><p><code>4360</code><code>2002a&lt;/a&gt;</code></p><p><code>4361</code><code>,&lt;a href="#R659" rid="R659" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918811"&gt;</code></p><p><code>4362</code><code>b&lt;/a&gt;</code></p><p><code>4363</code><code>; &lt;a href="#R1105" rid="R1105" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919523"&gt;</code></p><p><code>4364</code><code>Sieradzan and Mann, 2001&lt;/a&gt;</code></p><p><code>4365</code><code>; &lt;a href="#R58" rid="R58" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919290"&gt;</code></p><p><code>4366</code><code>Behrens et al., 2002&lt;/a&gt;</code></p><p><code>4367</code><code>; &lt;a href="#R402" rid="R402" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920357"&gt;</code></p><p><code>4368</code><code>Glass et al., 2004&lt;/a&gt;</code></p><p><code>4369</code><code>; &lt;a href="#R790" rid="R790" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919971"&gt;</code></p><p><code>4370</code><code>McCaw et al., 2004&lt;/a&gt;</code></p><p><code>4371</code><code>) that a decrease in CB&lt;sub&gt;</code></p><p><code>4372</code><code>1&lt;/sub&gt;</code></p><p><code>4373</code><code> receptor level and signaling activity in the basal ganglia is one of the earliest changes in HD, preceding nerve loss and clinical symptoms. Furthermore, decreased levels of anandamide and 2-AG in the striatum and an increase of anandamide in the ventral mesencephalon, where the substantia nigra is located, have been documented in a rat model of HD (&lt;a href="#R655" rid="R655" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918878"&gt;</code></p><p><code>4374</code><code>Lastres-Becker et al., 2001&lt;/a&gt;</code></p><p><code>4375</code><code>). Thus, it appears that endocannabinoid signaling in the basal ganglia is hypofunctional in HD, which probably contributes to the hyperkinesia associated with the disease. These studies also suggest that the endocannabinoid system is involved in the pathogenesis and/or progression of HD, and cannabinoid agonists could be of significant therapeutic benefit in HD because of their anthyperkinetic and neuroprotective effects (reviewed in &lt;a href="#R657" rid="R657" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919745"&gt;</code></p><p><code>4376</code><code>Lastres-Becker et al., 2003b&lt;/a&gt;</code></p><p><code>4377</code><code>). A recent study identified a novel population of progenitor cells expressing CB&lt;sub&gt;</code></p><p><code>4378</code><code>1&lt;/sub&gt;</code></p><p><code>4379</code><code> receptors in the subependymal layer of the normal and Huntington&amp;#x02019;s diseased human brain. This finding raises the intriguing possibility that these cells could be a source of replacement of cells lost due to neurodegenerative disease (&lt;a href="#R236" rid="R236" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919313"&gt;</code></p><p><code>4380</code><code>Curtis et al., 2006&lt;/a&gt;</code></p><p><code>4381</code><code>).&lt;/p&gt;</code></p><p><code>4382</code><code>&lt;p id="P98"&gt;</code></p><p><code>4383</code><code>Indeed, data from animal models demonstrated that both CB&lt;sub&gt;</code></p><p><code>4384</code><code>1&lt;/sub&gt;</code></p><p><code>4385</code><code> agonists and inhibitors of endocannabinoid transport are able to reduce hyperkinesia (&lt;a href="#R659" rid="R659" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918707"&gt;</code></p><p><code>4386</code><code>Lastres-Becker et al., 2002b&lt;/a&gt;</code></p><p><code>4387</code><code>, &lt;a href="#R656" rid="R656" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919048"&gt;</code></p><p><code>4388</code><code>2003a&lt;/a&gt;</code></p><p><code>4389</code><code>). Interestingly, direct agonists of CB&lt;sub&gt;</code></p><p><code>4390</code><code>1&lt;/sub&gt;</code></p><p><code>4391</code><code> receptors, such as CP55,940, only produced a very modest effect compared with the anandamide transport inhibitor AM404, which also exhibits affinity for the VR&lt;sub&gt;</code></p><p><code>4392</code><code>1&lt;/sub&gt;</code></p><p><code>4393</code><code> receptor (&lt;a href="#R1331" rid="R1331" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919098"&gt;</code></p><p><code>4394</code><code>Zygmunt et al., 2000&lt;/a&gt;</code></p><p><code>4395</code><code>). This latter property of AM404 may account for its ability to reduce hyperkinesia (&lt;a href="#R659" rid="R659" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919312"&gt;</code></p><p><code>4396</code><code>Lastres-Becker et al., 2002b&lt;/a&gt;</code></p><p><code>4397</code><code>, &lt;a href="#R656" rid="R656" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918904"&gt;</code></p><p><code>4398</code><code>2003a&lt;/a&gt;</code></p><p><code>4399</code><code>), as other transport inhibitors such as VDM11 and AM374, which are not active at TRPV&lt;sub&gt;</code></p><p><code>4400</code><code>1&lt;/sub&gt;</code></p><p><code>4401</code><code> receptors, were devoid of antihyperkinetic effects in HD rats (&lt;a href="#R656" rid="R656" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920145"&gt;</code></p><p><code>4402</code><code>Lastres-Becker et al., 2003a&lt;/a&gt;</code></p><p><code>4403</code><code>), and the most potent transport inhibitor to date, UCM707, only produced a modest effect (&lt;a href="#R248" rid="R248" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919653"&gt;</code></p><p><code>4404</code><code>de Lago et al., 2002&lt;/a&gt;</code></p><p><code>4405</code><code>, &lt;a href="#R249" rid="R249" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919782"&gt;</code></p><p><code>4406</code><code>2004b&lt;/a&gt;</code></p><p><code>4407</code><code>, &lt;a href="#R247" rid="R247" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918782"&gt;</code></p><p><code>4408</code><code>2006&lt;/a&gt;</code></p><p><code>4409</code><code>). Arvanil, a hybrid endocannabinoid and vanilloid compound, was also reported to alleviate hyperkinesias in a rat model of HD (&lt;a href="#R250" rid="R250" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920276"&gt;</code></p><p><code>4410</code><code>de Lago et al., 2005&lt;/a&gt;</code></p><p><code>4411</code><code>). These results suggest that TRPV&lt;sub&gt;</code></p><p><code>4412</code><code>1&lt;/sub&gt;</code></p><p><code>4413</code><code> receptors alone, or in combination with CB&lt;sub&gt;</code></p><p><code>4414</code><code>1&lt;/sub&gt;</code></p><p><code>4415</code><code> receptors, might represent novel therapeutic targets in HD (reviewed in &lt;a href="#R657" rid="R657" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919734"&gt;</code></p><p><code>4416</code><code>Lastres-Becker et al., 2003b&lt;/a&gt;</code></p><p><code>4417</code><code>).&lt;/p&gt;</code></p><p><code>4418</code><code>&lt;p id="P99" class="p p-last"&gt;</code></p><p><code>4419</code><code>There have been few human trials on the effects of cannabinoid agonists in HD, and the results do not live up to the promise of the animal data. Small trials with the synthetic THC analog nabilone and with the nonpsychoactive cannabidiol showed no efficacy or even increased choreic movements in HD patients (&lt;a href="#R201" rid="R201" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919764"&gt;</code></p><p><code>4420</code><code>Consroe et al., 1991&lt;/a&gt;</code></p><p><code>4421</code><code>; &lt;a href="#R859" rid="R859" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653364"&gt;</code></p><p><code>4422</code><code>M&amp;#x000fc;ller-Vahl et al., 1999b&lt;/a&gt;</code></p><p><code>4423</code><code>). These negative results could be related to dosing issues, to the lack of TRPV&lt;sub&gt;</code></p><p><code>4424</code><code>1&lt;/sub&gt;</code></p><p><code>4425</code><code> receptor activity of the compounds tested, or to the advanced stage of the disease. Nevertheless, further studies are warranted to explore the therapeutic potential of cannabinoids in HD.&lt;/p&gt;</code></p><p><code>4426</code><code>&lt;/div&gt;</code></p><p><code>4427</code><code>&lt;div id="S20" class="sec sec-last"&gt;</code></p><p><code>4428</code><code>&lt;p&gt;</code></p><p><code>4429</code><code>&lt;/p&gt;</code></p><p><code>4430</code><code>&lt;h5 id="S20title" class="inline"&gt;</code></p><p><code>4431</code><code>c. Gilles de la Tourette&amp;#x02019;s syndrome, tardive dyskinesia, and dystonia &lt;/h5&gt;</code></p><p><code>4432</code><code>&lt;p id="P100" class="p p-first-last"&gt;</code></p><p><code>4433</code><code>Based on its ubiquitous presence in motor regions of the brain, the endocannabinoid system might be involved in other extrapyramidal disorders such as Gilles de la Tourette&amp;#x02019;s syndrome (TS), tardive dyskinesia, and dystonia. TS is a neurological syndrome that becomes evident in early childhood and is characterized by multiple motor and vocal tics lasting for more than 1 year. Plant-derived cannabinoids have been found to be effective in the treatment of tics and behavioral problems in TS (&lt;a href="#R855" rid="R855" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918776"&gt;</code></p><p><code>4434</code><code>M&amp;#x000fc;ller-Vahl et al., 1997&lt;/a&gt;</code></p><p><code>4435</code><code>, &lt;a href="#R856" rid="R856" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920305"&gt;</code></p><p><code>4436</code><code>1998&lt;/a&gt;</code></p><p><code>4437</code><code>, &lt;a href="#R861" rid="R861" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653451"&gt;</code></p><p><code>4438</code><code>1999c&lt;/a&gt;</code></p><p><code>4439</code><code>, &lt;a href="#R860" rid="R860" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920037"&gt;</code></p><p><code>4440</code><code>2002&lt;/a&gt;</code></p><p><code>4441</code><code>, &lt;a href="#R858" rid="R858" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653410"&gt;</code></p><p><code>4442</code><code>2003a&lt;/a&gt;</code></p><p><code>4443</code><code>,&lt;a href="#R862" rid="R862" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653380"&gt;</code></p><p><code>4444</code><code>M&amp;#x000fc;ller-Vahl et al., b&lt;/a&gt;</code></p><p><code>4445</code><code>; &lt;a href="#R854" rid="R854" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919587"&gt;</code></p><p><code>4446</code><code>M&amp;#x000fc;ller-Vahl, 2003&lt;/a&gt;</code></p><p><code>4447</code><code>). Beneficial effects of cannabinoids have been also reported in dystonia, both in animal models (&lt;a href="#R1016" rid="R1016" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919596"&gt;</code></p><p><code>4448</code><code>Richter and L&amp;#x000f6;scher, 1994&lt;/a&gt;</code></p><p><code>4449</code><code>, &lt;a href="#R1017" rid="R1017" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919752"&gt;</code></p><p><code>4450</code><code>2002&lt;/a&gt;</code></p><p><code>4451</code><code>) and in humans (&lt;a href="#R338" rid="R338" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919830"&gt;</code></p><p><code>4452</code><code>Fox et al., 2002b&lt;/a&gt;</code></p><p><code>4453</code><code>; &lt;a href="#R549" rid="R549" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919742"&gt;</code></p><p><code>4454</code><code>Jabusch et al., 2004&lt;/a&gt;</code></p><p><code>4455</code><code>). In addition, as described in the sections above, cannabinoids have potential in the management of the LID in PD and of the spasticity and tremor in MS. On the other hand, in patients chronically treated with neuroleptic drugs, a correlation between chronic cannabis use and the presence of tardive dyskinesia has been described previously (&lt;a href="#R1315" rid="R1315" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918706"&gt;</code></p><p><code>4456</code><code>Zaretsky et al., 1993&lt;/a&gt;</code></p><p><code>4457</code><code>).&lt;/p&gt;</code></p><p><code>4458</code><code>&lt;/div&gt;</code></p><p><code>4459</code><code>&lt;/div&gt;</code></p><p><code>4460</code><code>&lt;div id="S21" class="sec"&gt;</code></p><p><code>4461</code><code>&lt;p&gt;</code></p><p><code>4462</code><code>&lt;/p&gt;</code></p><p><code>4463</code><code>&lt;h4 id="S21title" class="inline"&gt;</code></p><p><code>4464</code><code>5. Amyotrophic Lateral Sclerosis &lt;/h4&gt;</code></p><p><code>4465</code><code>&lt;p id="P101" class="p p-first"&gt;</code></p><p><code>4466</code><code>ALS (also known as Lou Gehrig&amp;#x02019;s disease) is the most common adult-onset human motor neuron disease with a prevalence of 5 to 7/100,000. It is characterized by rapid, progressive degeneration of motor neurons in the brain and spinal cord, which ultimately leads to progressive weakness, paralysis, and premature death (&lt;a href="#R1044" rid="R1044" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919297"&gt;</code></p><p><code>4467</code><code>Rowland and Shneider, 2001&lt;/a&gt;</code></p><p><code>4468</code><code>). Although weak, patients are cognitively intact and thus are completely aware of their progressive disability. The disease strikes adults at any age, and most patients die within 3 to 5 years after the onset of symptoms. Although most cases of ALS are sporadic and are probably acquired, approximately 10% are familial, usually inherited in an autosomal dominant pattern. Despite a variety of putative underlying mechanisms, including oxidative stress, neuroinflammation, autoimmunity, a defect in neuronal glutamate transport and glutamate toxicity, neurofilament accumulation, exogenous factors (virusesor toxins), mitochondrial dysfunction, and mutations in the superoxide dismutase (&lt;em&gt;</code></p><p><code>4469</code><code>SOD1&lt;/em&gt;</code></p><p><code>4470</code><code>) gene, the pathogenesis of ALS is incompletely understood (&lt;a href="#R42" rid="R42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919282"&gt;</code></p><p><code>4471</code><code>Barnham et al., 2004&lt;/a&gt;</code></p><p><code>4472</code><code>). Tragically, available treatment options are limited and do not prevent disease progression and death (&lt;a href="#R1044" rid="R1044" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919940"&gt;</code></p><p><code>4473</code><code>Rowland and Shneider, 2001&lt;/a&gt;</code></p><p><code>4474</code><code>).&lt;/p&gt;</code></p><p><code>4475</code><code>&lt;p id="P102" class="p p-last"&gt;</code></p><p><code>4476</code><code>Based on the well-known protective effect of cannabinoids against oxidative cell damage and excitotoxicity (&lt;a href="#R460" rid="R460" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920298"&gt;</code></p><p><code>4477</code><code>Hampson et al., 1998&lt;/a&gt;</code></p><p><code>4478</code><code>; &lt;a href="#R1093" rid="R1093" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919559"&gt;</code></p><p><code>4479</code><code>Shen and Thayer, 1999&lt;/a&gt;</code></p><p><code>4480</code><code>; &lt;a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919052"&gt;</code></p><p><code>4481</code><code>Abood et al., 2001&lt;/a&gt;</code></p><p><code>4482</code><code>; &lt;a href="#R1213" rid="R1213" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637221"&gt;</code></p><p><code>4483</code><code>van der Stelt et al., 2001a&lt;/a&gt;</code></p><p><code>4484</code><code>), combined with their antispastic effect in MS, &lt;a href="#R159" rid="R159" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920134"&gt;</code></p><p><code>4485</code><code>Carter and Rosen (2001)&lt;/a&gt;</code></p><p><code>4486</code><code> have proposed the use of marijuana for the pharmacological management of ALS. Indeed, in a pilot study of the safety and tolerability of THC in ALS patients, symptomatic benefits were seen for spasticity, insomnia, and appetite (&lt;a href="#R373" rid="R373" class=" bibr popnode"&gt;</code></p><p><code>4487</code><code>Gelinas et al., 2002&lt;/a&gt;</code></p><p><code>4488</code><code>). Consistent with this clinical report, studies using transgenic mice expressing a mutant form of human SOD1 (hSOD1&lt;sup&gt;</code></p><p><code>4489</code><code>G93A&lt;/sup&gt;</code></p><p><code>4490</code><code> mice) as an experimental model of ALS have demonstrated that either THC or WIN55,212-2 administered after the onset of the disease or genetic ablation of FAAH delayed disease progression (&lt;a href="#R995" rid="R995" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918754"&gt;</code></p><p><code>4491</code><code>Raman et al., 2004&lt;/a&gt;</code></p><p><code>4492</code><code>; &lt;a href="#R87" rid="R87" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918997"&gt;</code></p><p><code>4493</code><code>Bilsland et al., 2006&lt;/a&gt;</code></p><p><code>4494</code><code>). Furthermore, THC potently reduced oxidative and excitotoxic damage in spinal cord cultures in vitro and prolonged survival in SOD1 mutant mice (&lt;a href="#R995" rid="R995" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918973"&gt;</code></p><p><code>4495</code><code>Raman et al., 2004&lt;/a&gt;</code></p><p><code>4496</code><code>). Surprisingly, neither WIN55,212-2 nor FAAH ablation affected the life span of SOD1(G93A) mice, whereas deletion of the CB&lt;sub&gt;</code></p><p><code>4497</code><code>1&lt;/sub&gt;</code></p><p><code>4498</code><code> receptor significantly extended life span without affecting the disease onset (&lt;a href="#R87" rid="R87" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919692"&gt;</code></p><p><code>4499</code><code>Bilsland et al., 2006&lt;/a&gt;</code></p><p><code>4500</code><code>). These results suggest that cannabinoids have significant neuroprotective effects in a mouse model of ALS but that these beneficial effects may be mediated by non-CB&lt;sub&gt;</code></p><p><code>4501</code><code>1&lt;/sub&gt;</code></p><p><code>4502</code><code> receptor mechanisms.&lt;/p&gt;</code></p><p><code>4503</code><code>&lt;/div&gt;</code></p><p><code>4504</code><code>&lt;div id="S22" class="sec"&gt;</code></p><p><code>4505</code><code>&lt;p&gt;</code></p><p><code>4506</code><code>&lt;/p&gt;</code></p><p><code>4507</code><code>&lt;h4 id="S22title" class="inline"&gt;</code></p><p><code>4508</code><code>6. Alzheimer&amp;#x02019;s Disease &lt;/h4&gt;</code></p><p><code>4509</code><code>&lt;p id="P103" class="p p-first"&gt;</code></p><p><code>4510</code><code>Alzheimer&amp;#x02019;s disease (AD) is a progressive neurodegenerative disorder that accounts for the vast majority of age-related dementia and is one of the most serious health problems in the industrialized world. The disease is characterized by the formation of neuritic plaques rich in &lt;em&gt;</code></p><p><code>4511</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>4512</code><code>-amyloid (A&lt;em&gt;</code></p><p><code>4513</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>4514</code><code>) peptide, neurofibrillary tangles rich in hyperphosphorylated &lt;em&gt;</code></p><p><code>4515</code><code>&amp;#x003c4;&lt;/em&gt;</code></p><p><code>4516</code><code> protein, gliosis, and a neuroinflammatory response involving astrocytes and microglia, inevitably leading to progressive global cognitive decline (&lt;a href="#R1279" rid="R1279" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918695"&gt;</code></p><p><code>4517</code><code>Weksler et al., 2005&lt;/a&gt;</code></p><p><code>4518</code><code>). These studies have engendered new perspectives on the possible role of the endocannabinoid system in neurodegenerative processes associated with inflammation (reviewed in &lt;a href="#R1262" rid="R1262" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919002"&gt;</code></p><p><code>4519</code><code>Walter and Stella, 2004&lt;/a&gt;</code></p><p><code>4520</code><code>), including those in AD (reviewed in &lt;a href="#R954" rid="R954" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918825"&gt;</code></p><p><code>4521</code><code>Pazos et al., 2004&lt;/a&gt;</code></p><p><code>4522</code><code>).&lt;/p&gt;</code></p><p><code>4523</code><code>&lt;p id="P104"&gt;</code></p><p><code>4524</code><code>In an in vitro cell culture model of AD, anandamide prevented A&lt;em&gt;</code></p><p><code>4525</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>4526</code><code>-induced neurotoxicity through CB&lt;sub&gt;</code></p><p><code>4527</code><code>1&lt;/sub&gt;</code></p><p><code>4528</code><code>-mediated activation of the mitogen-activated protein kinase pathway (&lt;a href="#R835" rid="R835" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919344"&gt;</code></p><p><code>4529</code><code>Milton, 2002&lt;/a&gt;</code></p><p><code>4530</code><code>). In rat microglia cells in culture, CB&lt;sub&gt;</code></p><p><code>4531</code><code>1&lt;/sub&gt;</code></p><p><code>4532</code><code> receptor stimulation also dose dependently inhibited the release of NO, which had been implicated in the neurotoxic effects of A&lt;em&gt;</code></p><p><code>4533</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>4534</code><code> peptide (&lt;a href="#R1253" rid="R1253" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919360"&gt;</code></p><p><code>4535</code><code>Waksman et al., 1999&lt;/a&gt;</code></p><p><code>4536</code><code>). In PC12 cells, protection against A&lt;em&gt;</code></p><p><code>4537</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>4538</code><code>-induced neurotoxicity was also observed with cannabidiol, which does not bind to CB&lt;sub&gt;</code></p><p><code>4539</code><code>1&lt;/sub&gt;</code></p><p><code>4540</code><code>/CB&lt;sub&gt;</code></p><p><code>4541</code><code>2&lt;/sub&gt;</code></p><p><code>4542</code><code> receptors (&lt;a href="#R543" rid="R543" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919964"&gt;</code></p><p><code>4543</code><code>Iuvone et al., 2004&lt;/a&gt;</code></p><p><code>4544</code><code>). Interestingly, CB&lt;sub&gt;</code></p><p><code>4545</code><code>1&lt;/sub&gt;</code></p><p><code>4546</code><code> receptor blockade by SR141716 improved the memory deficit induced by administration of A&lt;em&gt;</code></p><p><code>4547</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>4548</code><code> peptide in mice, presumably by increasing hippocampal acetylcholine levels (&lt;a href="#R785" rid="R785" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919951"&gt;</code></p><p><code>4549</code><code>Mazzola et al., 2003&lt;/a&gt;</code></p><p><code>4550</code><code>). However, analyses of brain tissue samples obtained from AD patients (&lt;a href="#R1282" rid="R1282" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919000"&gt;</code></p><p><code>4551</code><code>Westlake et al., 1994&lt;/a&gt;</code></p><p><code>4552</code><code>) or animal models of AD (&lt;a href="#R1031" rid="R1031" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919517"&gt;</code></p><p><code>4553</code><code>Romero et al., 1998&lt;/a&gt;</code></p><p><code>4554</code><code>; &lt;a href="#R64" rid="R64" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637195"&gt;</code></p><p><code>4555</code><code>Benito et al., 2003&lt;/a&gt;</code></p><p><code>4556</code><code>) indicate that CB&lt;sub&gt;</code></p><p><code>4557</code><code>1&lt;/sub&gt;</code></p><p><code>4558</code><code> receptors are not dramatically affected. In contrast, CB&lt;sub&gt;</code></p><p><code>4559</code><code>2&lt;/sub&gt;</code></p><p><code>4560</code><code> receptors and FAAH are overexpressed in microglia associated with neuritic plaques in the brain of AD patients (&lt;a href="#R64" rid="R64" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637194"&gt;</code></p><p><code>4561</code><code>Benito et al., 2003&lt;/a&gt;</code></p><p><code>4562</code><code>). Senile plaques in AD patients express both CB&lt;sub&gt;</code></p><p><code>4563</code><code>1&lt;/sub&gt;</code></p><p><code>4564</code><code> and CB&lt;sub&gt;</code></p><p><code>4565</code><code>2&lt;/sub&gt;</code></p><p><code>4566</code><code> receptors together with markers of microglial activation, and CB&lt;sub&gt;</code></p><p><code>4567</code><code>1&lt;/sub&gt;</code></p><p><code>4568</code><code>-positive neurons, present in high numbers in control cases, are greatly reduced in areas of microglial activation (&lt;a href="#R996" rid="R996" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637230"&gt;</code></p><p><code>4569</code><code>Ramirez et al., 2005&lt;/a&gt;</code></p><p><code>4570</code><code>). CB&lt;sub&gt;</code></p><p><code>4571</code><code>1&lt;/sub&gt;</code></p><p><code>4572</code><code> receptor protein levels and G protein coupling were also markedly decreased in AD brains, coupled with increased nitration of the CB&lt;sub&gt;</code></p><p><code>4573</code><code>1&lt;/sub&gt;</code></p><p><code>4574</code><code> and CB&lt;sub&gt;</code></p><p><code>4575</code><code>2&lt;/sub&gt;</code></p><p><code>4576</code><code> receptor proteins (&lt;a href="#R996" rid="R996" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637214"&gt;</code></p><p><code>4577</code><code>Ramirez et al., 2005&lt;/a&gt;</code></p><p><code>4578</code><code>). Intracerebroventricular administration of WIN 55,212-2 to rats prevented A&lt;em&gt;</code></p><p><code>4579</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>4580</code><code>-induced microglial activation, cognitive impairment and loss of neuronal markers. HU-210, WIN 55,212-2, and JWH-133 blocked A&lt;em&gt;</code></p><p><code>4581</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>4582</code><code>-induced activation of cultured microglial cells, as judged by mitochondrial activity, cell morphology and TNF-&lt;em&gt;</code></p><p><code>4583</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>4584</code><code> release, and these effects were independent of the antioxidant action of ligands. Furthermore, cannabinoids abrogated microglia-mediated neurotoxicity after addition of A&lt;em&gt;</code></p><p><code>4585</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>4586</code><code> to rat cortical cocultures (&lt;a href="#R996" rid="R996" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637215"&gt;</code></p><p><code>4587</code><code>Ramirez et al., 2005&lt;/a&gt;</code></p><p><code>4588</code><code>). Although there are no data available on the endocannabinoid content in AD brain tissue are available, increased levels have been reported in the brain after inflammatory events and in neurodegenerative disorders associated with inflammation (reviewed in &lt;a href="#R1262" rid="R1262" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919151"&gt;</code></p><p><code>4589</code><code>Walter and Stella, 2004&lt;/a&gt;</code></p><p><code>4590</code><code> and see also sections above).&lt;/p&gt;</code></p><p><code>4591</code><code>&lt;p id="P105" class="p p-last"&gt;</code></p><p><code>4592</code><code>Based on the above, one might hypothesize that A&lt;em&gt;</code></p><p><code>4593</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>4594</code><code> deposition induces the release of endocannabinoids from neurons and glia, which activate CB&lt;sub&gt;</code></p><p><code>4595</code><code>1&lt;/sub&gt;</code></p><p><code>4596</code><code>-mediated neuroprotective pathways and modulate the release of inflammatory mediators in microglia through CB&lt;sub&gt;</code></p><p><code>4597</code><code>2&lt;/sub&gt;</code></p><p><code>4598</code><code> receptors. If this hypothesis is confirmed by future studies, the beneficial effects of CB&lt;sub&gt;</code></p><p><code>4599</code><code>1&lt;/sub&gt;</code></p><p><code>4600</code><code>/CB&lt;sub&gt;</code></p><p><code>4601</code><code>2&lt;/sub&gt;</code></p><p><code>4602</code><code> agonists and FAAH antagonists in AD could be explored. Intriguingly, in a recent open-label pilot study of six patients in the late stages of dementia (five patients with AD and one patient with vascular dementia), treatment with 2.5 mg of dronabinol daily for 2 weeks significantly improved the Neuropsychiatric Inventory total score and the subscores for agitation and aberrant motor and nighttime behaviors (&lt;a href="#R1263" rid="R1263" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919185"&gt;</code></p><p><code>4603</code><code>Walther et al., 2006&lt;/a&gt;</code></p><p><code>4604</code><code>).&lt;/p&gt;</code></p><p><code>4605</code><code>&lt;/div&gt;</code></p><p><code>4606</code><code>&lt;div id="S23" class="sec"&gt;</code></p><p><code>4607</code><code>&lt;p&gt;</code></p><p><code>4608</code><code>&lt;/p&gt;</code></p><p><code>4609</code><code>&lt;h4 id="S23title" class="inline"&gt;</code></p><p><code>4610</code><code>7. Epilepsy &lt;/h4&gt;</code></p><p><code>4611</code><code>&lt;p id="P106" class="p p-first"&gt;</code></p><p><code>4612</code><code>If the balance between inhibitory and excitatory communications among neurons is disturbed, the intensity of excitatory transmission may exceed a certain threshold, leading to epileptic seizures. Stimulation of postsynaptic neurons is known to trigger the on-demand synthesis of endocannabinoids via an increase in intracellular calcium and/or stimulation of metabotropic receptors (reviewed in &lt;a href="#R972" rid="R972" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918842"&gt;</code></p><p><code>4613</code><code>Piomelli, 2003&lt;/a&gt;</code></p><p><code>4614</code><code>; &lt;a href="#R713" rid="R713" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919642"&gt;</code></p><p><code>4615</code><code>Lutz, 2004&lt;/a&gt;</code></p><p><code>4616</code><code>). Thereafter, endocannabinoids are released and reach presynaptic CB&lt;sub&gt;</code></p><p><code>4617</code><code>1&lt;/sub&gt;</code></p><p><code>4618</code><code> receptors retrogradely to modulate both inhibitory GABAergic and excitatory glutamatergic transmissions via multiple mechanisms (&lt;a href="#R752" rid="R752" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919528"&gt;</code></p><p><code>4619</code><code>Marsicano and Lutz, 1999&lt;/a&gt;</code></p><p><code>4620</code><code>; &lt;a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918902"&gt;</code></p><p><code>4621</code><code>Alger, 2002&lt;/a&gt;</code></p><p><code>4622</code><code>, &lt;a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918978"&gt;</code></p><p><code>4623</code><code>2004&lt;/a&gt;</code></p><p><code>4624</code><code>; &lt;a href="#R381" rid="R381" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919362"&gt;</code></p><p><code>4625</code><code>Gerdeman et al., 2002&lt;/a&gt;</code></p><p><code>4626</code><code>; &lt;a href="#R1024" rid="R1024" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918740"&gt;</code></p><p><code>4627</code><code>Robbe et al., 2002&lt;/a&gt;</code></p><p><code>4628</code><code>; &lt;a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919051"&gt;</code></p><p><code>4629</code><code>Azad et al., 2003&lt;/a&gt;</code></p><p><code>4630</code><code>; &lt;a href="#R345" rid="R345" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920390"&gt;</code></p><p><code>4631</code><code>Freund et al., 2003&lt;/a&gt;</code></p><p><code>4632</code><code>; &lt;a href="#R379" rid="R379" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919815"&gt;</code></p><p><code>4633</code><code>Gerdeman and Lovinger, 2003&lt;/a&gt;</code></p><p><code>4634</code><code>; &lt;a href="#R604" rid="R604" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920360"&gt;</code></p><p><code>4635</code><code>Kim and Alger, 2004&lt;/a&gt;</code></p><p><code>4636</code><code>; &lt;a href="#R542" rid="R542" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918979"&gt;</code></p><p><code>4637</code><code>Isokawa and Alger, 2005&lt;/a&gt;</code></p><p><code>4638</code><code>).&lt;/p&gt;</code></p><p><code>4639</code><code>&lt;p id="P107"&gt;</code></p><p><code>4640</code><code>Multiple pathways, eventually culminating in neuronal death, are triggered by excessive excitatory activity through a process known as excitotoxicity (&lt;a href="#R802" rid="R802" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919308"&gt;</code></p><p><code>4641</code><code>McNamara, 1999&lt;/a&gt;</code></p><p><code>4642</code><code>). Excitotoxicity is believed to contribute to the progression of numerous degenerative central nervous system disorders such as Parkinson&amp;#x02019;s disease, Alzheimer&amp;#x02019;s disease, and various forms of epilepsy. More than 1% of the human population is affected by epilepsy and the incidence is highest in elderly persons or during the first years of life (reviewed in &lt;a href="#R521" rid="R521" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919034"&gt;</code></p><p><code>4643</code><code>Holmes and Ben-Ari, 1998&lt;/a&gt;</code></p><p><code>4644</code><code>; &lt;a href="#R791" rid="R791" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919644"&gt;</code></p><p><code>4645</code><code>McCormick and Contreras, 2001&lt;/a&gt;</code></p><p><code>4646</code><code>). Epileptic syndromes are classified as generalized seizures, which affect the entire forebrain, or partial seizures, which occur within localized brain regions. Conventional antiepileptic treatment is not fully effective in ~30% of patients, therefore justifying the search for new targets (&lt;a href="#R653" rid="R653" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653439"&gt;</code></p><p><code>4647</code><code>LaRoche and Helmers, 2004&lt;/a&gt;</code></p><p><code>4648</code><code>).&lt;/p&gt;</code></p><p><code>4649</code><code>&lt;p id="P108"&gt;</code></p><p><code>4650</code><code>Cannabis has been used to treat epilepsy for centuries. Hashish was reported to cure the sick son of the chamberlain of the Caliphate Council in Baghdad by the medieval Arab writer Ibn al-Badri (&lt;a href="#R804" rid="R804" class=" bibr popnode"&gt;</code></p><p><code>4651</code><code>Mechoulam, 1986&lt;/a&gt;</code></p><p><code>4652</code><code>; &lt;a href="#R544" rid="R544" class=" bibr popnode"&gt;</code></p><p><code>4653</code><code>Iversen, 2000&lt;/a&gt;</code></p><p><code>4654</code><code>). Almost four centuries later, W. B. O&amp;#x02019;Shaughnessy, an Irish physician and scientist working at the Medical College of Calcutta, confirmed the benefit of hashish for treating pain, emesis, muscle spasms, and convulsions (reviewed in &lt;a href="#R585" rid="R585" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919724"&gt;</code></p><p><code>4655</code><code>Karler and Turkanis, 1981&lt;/a&gt;</code></p><p><code>4656</code><code>; &lt;a href="#R804" rid="R804" class=" bibr popnode"&gt;</code></p><p><code>4657</code><code>Mechoulam, 1986&lt;/a&gt;</code></p><p><code>4658</code><code>). The benefit of cannabis in epilepsy was also reported by a British neurologist (&lt;a href="#R1008" rid="R1008" class=" bibr popnode"&gt;</code></p><p><code>4659</code><code>Reynolds, 1890&lt;/a&gt;</code></p><p><code>4660</code><code>), but the medicinal use of cannabis was prohibited in the early 20th century in most countries.&lt;/p&gt;</code></p><p><code>4661</code><code>&lt;p id="P109"&gt;</code></p><p><code>4662</code><code>After the identification of the structure of THC (&lt;a href="#R361" rid="R361" class=" bibr popnode"&gt;</code></p><p><code>4663</code><code>Gaoni and Mechoulam, 1964&lt;/a&gt;</code></p><p><code>4664</code><code>), several groups investigated its antiepileptic effects (reviewed in &lt;a href="#R418" rid="R418" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918789"&gt;</code></p><p><code>4665</code><code>Gordon and Devinsky, 2001&lt;/a&gt;</code></p><p><code>4666</code><code>; &lt;a href="#R713" rid="R713" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919885"&gt;</code></p><p><code>4667</code><code>Lutz, 2004&lt;/a&gt;</code></p><p><code>4668</code><code>). THC was originally characterized as an anticonvulsant, but it has a variety of excitatory and depressant effects, ranging from convulsions to ataxia, depending on the dose, experimental model, and the animal species used (&lt;a href="#R585" rid="R585" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919788"&gt;</code></p><p><code>4669</code><code>Karler and Turkanis, 1981&lt;/a&gt;</code></p><p><code>4670</code><code>; reviewed in &lt;a href="#R418" rid="R418" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919773"&gt;</code></p><p><code>4671</code><code>Gordon and Devinsky, 2001&lt;/a&gt;</code></p><p><code>4672</code><code>; &lt;a href="#R713" rid="R713" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919426"&gt;</code></p><p><code>4673</code><code>Lutz, 2004&lt;/a&gt;</code></p><p><code>4674</code><code>). Further complicating the picture, animal studies also document a rebound effect to THC with enhanced CNS excitability and increased sensitivity to convulsions (&lt;a href="#R181" rid="R181" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920040"&gt;</code></p><p><code>4675</code><code>Chiu et al., 1979&lt;/a&gt;</code></p><p><code>4676</code><code>; &lt;a href="#R585" rid="R585" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920190"&gt;</code></p><p><code>4677</code><code>Karler and Turkanis, 1981&lt;/a&gt;</code></p><p><code>4678</code><code>; &lt;a href="#R584" rid="R584" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919194"&gt;</code></p><p><code>4679</code><code>Karler et al., 1986&lt;/a&gt;</code></p><p><code>4680</code><code>). This withdrawal hypersensitivity implies that in susceptible patients, the use of marijuana may be associated with withdrawal seizures (&lt;a href="#R585" rid="R585" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919976"&gt;</code></p><p><code>4681</code><code>Karler and Turkanis, 1981&lt;/a&gt;</code></p><p><code>4682</code><code>).&lt;/p&gt;</code></p><p><code>4683</code><code>&lt;p id="P110"&gt;</code></p><p><code>4684</code><code>Only case reports on the effects of THC in epileptic patients are currently available. Two reports described decreased seizure frequency after marijuana use (&lt;a href="#R206" rid="R206" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653353"&gt;</code></p><p><code>4685</code><code>Consroe et al., 1975&lt;/a&gt;</code></p><p><code>4686</code><code>; &lt;a href="#R295" rid="R295" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919813"&gt;</code></p><p><code>4687</code><code>Ellison et al., 1990&lt;/a&gt;</code></p><p><code>4688</code><code>) and an epidemiological study found that chronic marijuana use is protective against seizures (&lt;a href="#R888" rid="R888" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920274"&gt;</code></p><p><code>4689</code><code>Ng et al., 1990&lt;/a&gt;</code></p><p><code>4690</code><code>). According to a questionnaire completed by 215 epileptic patients using marijuana regularly, 7.4% experienced a reduction, 2.3% an increase, and 90.2% no change in seizure frequency (&lt;a href="#R418" rid="R418" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919732"&gt;</code></p><p><code>4691</code><code>Gordon and Devinsky, 2001&lt;/a&gt;</code></p><p><code>4692</code><code>). In contrast, marijuana smoking was associated with an increase in seizure frequency in another study (&lt;a href="#R593" rid="R593" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919271"&gt;</code></p><p><code>4693</code><code>Keeler and Reifler, 1967&lt;/a&gt;</code></p><p><code>4694</code><code>). Small-scale clinical studies have shown that the nonpsychotropic cannabidiol either reduced seizure frequency or had no significant effect on it (&lt;a href="#R235" rid="R235" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919364"&gt;</code></p><p><code>4695</code><code>Cunha et al., 1980&lt;/a&gt;</code></p><p><code>4696</code><code>; &lt;a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920163"&gt;</code></p><p><code>4697</code><code>Ames and Cridland, 1986&lt;/a&gt;</code></p><p><code>4698</code><code>; &lt;a href="#R418" rid="R418" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918699"&gt;</code></p><p><code>4699</code><code>Gordon and Devinsky, 2001&lt;/a&gt;</code></p><p><code>4700</code><code>).&lt;/p&gt;</code></p><p><code>4701</code><code>&lt;p id="P111"&gt;</code></p><p><code>4702</code><code>As in human studies, cannabinoids were found to exert both anti- and proconvulsive activity in animal models of epilepsy, largely depending on the stimulus applied to induce seizures (chemical, electrical, light, or fever) and the species used (&lt;a href="#R569" rid="R569" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920109"&gt;</code></p><p><code>4703</code><code>Johnson et al., 1975&lt;/a&gt;</code></p><p><code>4704</code><code>; &lt;a href="#R1172" rid="R1172" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918793"&gt;</code></p><p><code>4705</code><code>Ten Ham et al., 1975&lt;/a&gt;</code></p><p><code>4706</code><code>; &lt;a href="#R1242" rid="R1242" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918996"&gt;</code></p><p><code>4707</code><code>Wada et al., 1975a&lt;/a&gt;</code></p><p><code>4708</code><code>,&lt;a href="#R1243" rid="R1243" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920156"&gt;</code></p><p><code>4709</code><code>b&lt;/a&gt;</code></p><p><code>4710</code><code>; &lt;a href="#R209" rid="R209" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919412"&gt;</code></p><p><code>4711</code><code>Corcoran et al., 1978&lt;/a&gt;</code></p><p><code>4712</code><code>; &lt;a href="#R181" rid="R181" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920301"&gt;</code></p><p><code>4713</code><code>Chiu et al., 1979&lt;/a&gt;</code></p><p><code>4714</code><code>; &lt;a href="#R287" rid="R287" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919152"&gt;</code></p><p><code>4715</code><code>Duncan and Dagirmanjian, 1979&lt;/a&gt;</code></p><p><code>4716</code><code>; &lt;a href="#R326" rid="R326" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920125"&gt;</code></p><p><code>4717</code><code>Fish et al., 1981&lt;/a&gt;</code></p><p><code>4718</code><code>; &lt;a href="#R585" rid="R585" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920393"&gt;</code></p><p><code>4719</code><code>Karler and Turkanis, 1981&lt;/a&gt;</code></p><p><code>4720</code><code>; &lt;a href="#R190" rid="R190" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919834"&gt;</code></p><p><code>4721</code><code>Colasanti et al., 1982&lt;/a&gt;</code></p><p><code>4722</code><code>; &lt;a href="#R325" rid="R325" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919786"&gt;</code></p><p><code>4723</code><code>Fish and Consroe, 1983&lt;/a&gt;</code></p><p><code>4724</code><code>; &lt;a href="#R583" rid="R583" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919529"&gt;</code></p><p><code>4725</code><code>Karler et al., 1984&lt;/a&gt;</code></p><p><code>4726</code><code>, &lt;a href="#R584" rid="R584" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920007"&gt;</code></p><p><code>4727</code><code>1986&lt;/a&gt;</code></p><p><code>4728</code><code>; &lt;a href="#R203" rid="R203" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920027"&gt;</code></p><p><code>4729</code><code>Consroe and Mechoulam, 1987&lt;/a&gt;</code></p><p><code>4730</code><code>; &lt;a href="#R960" rid="R960" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919515"&gt;</code></p><p><code>4731</code><code>Pertwee et al., 1991&lt;/a&gt;</code></p><p><code>4732</code><code>; &lt;a href="#R476" rid="R476" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919524"&gt;</code></p><p><code>4733</code><code>Hayase et al., 2001a&lt;/a&gt;</code></p><p><code>4734</code><code>,&lt;a href="#R477" rid="R477" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920354"&gt;</code></p><p><code>4735</code><code>b&lt;/a&gt;</code></p><p><code>4736</code><code>; reviewed in &lt;a href="#R418" rid="R418" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918742"&gt;</code></p><p><code>4737</code><code>Gordon and Devinsky, 2001&lt;/a&gt;</code></p><p><code>4738</code><code>; &lt;a href="#R713" rid="R713" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918696"&gt;</code></p><p><code>4739</code><code>Lutz, 2004&lt;/a&gt;</code></p><p><code>4740</code><code>).&lt;/p&gt;</code></p><p><code>4741</code><code>&lt;p id="P112"&gt;</code></p><p><code>4742</code><code>Anandamide and its metabolically stable analog, O-1812, dose dependently inhibited electroshock-induced seizures in rats, and this effect was abolished by SR141716 (&lt;a href="#R1259" rid="R1259" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918900"&gt;</code></p><p><code>4743</code><code>Wallace et al., 2002&lt;/a&gt;</code></p><p><code>4744</code><code>). In a rat model of febrile seizures, the expression of presynaptic CB&lt;sub&gt;</code></p><p><code>4745</code><code>1&lt;/sub&gt;</code></p><p><code>4746</code><code> receptors in hippocampal GABAergic interneurons was increased (&lt;a href="#R175" rid="R175" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919703"&gt;</code></p><p><code>4747</code><code>Chen et al., 2003&lt;/a&gt;</code></p><p><code>4748</code><code>), and the CB&lt;sub&gt;</code></p><p><code>4749</code><code>1&lt;/sub&gt;</code></p><p><code>4750</code><code> receptor-mediated DSI was enhanced (&lt;a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920224"&gt;</code></p><p><code>4751</code><code>Alger, 2002&lt;/a&gt;</code></p><p><code>4752</code><code>), suggesting that the endogenous cannabinoid system is protective. Remarkably, in a rat model of pilocarpine-induced status epilepticus, CB&lt;sub&gt;</code></p><p><code>4753</code><code>1&lt;/sub&gt;</code></p><p><code>4754</code><code> receptor agonists were more effective in reducing seizure frequency than clinically used anticonvulsants, such as phenytoin or phenobarbital. Consistently, CB&lt;sub&gt;</code></p><p><code>4755</code><code>1&lt;/sub&gt;</code></p><p><code>4756</code><code> receptor blockade increased seizure frequency, and the seizure activity was associated with increased brain levels of CB&lt;sub&gt;</code></p><p><code>4757</code><code>1&lt;/sub&gt;</code></p><p><code>4758</code><code> receptors and 2-AG (&lt;a href="#R1258" rid="R1258" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919991"&gt;</code></p><p><code>4759</code><code>Wallace et al., 2003a&lt;/a&gt;</code></p><p><code>4760</code><code>).&lt;/p&gt;</code></p><p><code>4761</code><code>&lt;p id="P113"&gt;</code></p><p><code>4762</code><code>With use of the kainic acid-induced excitotoxic epileptiform seizure model in wild type and CB&lt;sub&gt;</code></p><p><code>4763</code><code>1&lt;/sub&gt;</code></p><p><code>4764</code><code> knockout mice, recent studies have established that the seizure-induced increase of intracellular calcium, a hallmark of epilepsy (&lt;a href="#R1004" rid="R1004" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919149"&gt;</code></p><p><code>4765</code><code>Raza et al., 2001&lt;/a&gt;</code></p><p><code>4766</code><code>), triggers the synthesis of anandamide, which activates CB&lt;sub&gt;</code></p><p><code>4767</code><code>1&lt;/sub&gt;</code></p><p><code>4768</code><code> receptors in glutamatergic neurons in the hippocampus and cerebral cortex (&lt;a href="#R753" rid="R753" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653361"&gt;</code></p><p><code>4769</code><code>Marsicano et al., 2003&lt;/a&gt;</code></p><p><code>4770</code><code>; &lt;a href="#R598" rid="R598" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919291"&gt;</code></p><p><code>4771</code><code>Khaspekov et al., 2004&lt;/a&gt;</code></p><p><code>4772</code><code>). Such &amp;#x0201c;on-demand&amp;#x0201d; activation of CB&lt;sub&gt;</code></p><p><code>4773</code><code>1&lt;/sub&gt;</code></p><p><code>4774</code><code> receptors was suggested to protect against excitotoxicity by various mechanisms, including inhibition of calcium channels and stimulation of potassium channels to decrease neuronal excitability and the activation of extracellular signal regulated kinases (&lt;a href="#R753" rid="R753" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653442"&gt;</code></p><p><code>4775</code><code>Marsicano et al., 2003&lt;/a&gt;</code></p><p><code>4776</code><code>; &lt;a href="#R598" rid="R598" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919936"&gt;</code></p><p><code>4777</code><code>Khaspekov et al., 2004&lt;/a&gt;</code></p><p><code>4778</code><code>). In contrast to these findings, FAAH knockout mice or mice treated with a CB&lt;sub&gt;</code></p><p><code>4779</code><code>1&lt;/sub&gt;</code></p><p><code>4780</code><code> agonist were found to have increased sensitivity to kainic acid-induced seizures (&lt;a href="#R186" rid="R186" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637224"&gt;</code></p><p><code>4781</code><code>Clement et al., 2003&lt;/a&gt;</code></p><p><code>4782</code><code>). The lack of protection in this latter study may be related to the nonselective activation of CB&lt;sub&gt;</code></p><p><code>4783</code><code>1&lt;/sub&gt;</code></p><p><code>4784</code><code> receptors on both inhibitory (proconvulsive effect) and excitatory neurons (anticonvulsive effect) and by the life-long rather than on-demand activation of CB&lt;sub&gt;</code></p><p><code>4785</code><code>1&lt;/sub&gt;</code></p><p><code>4786</code><code> receptors present in FAAH knockout animals.&lt;/p&gt;</code></p><p><code>4787</code><code>&lt;p id="P114" class="p p-last"&gt;</code></p><p><code>4788</code><code>In summary, the use of cannabinoids for the treatment of epilepsy is still controversial, although recent experimental studies provide some new insight. To date, there have been no large-scale, controlled clinical trials to examine the beneficial effects of cannabinoids in various forms of epilepsy. The potential use of the nonpsychotropic cannabidiol and of inhibitors of anandamide transport or degradation warrants further investigation.&lt;/p&gt;</code></p><p><code>4789</code><code>&lt;/div&gt;</code></p><p><code>4790</code><code>&lt;div id="S24" class="sec"&gt;</code></p><p><code>4791</code><code>&lt;p&gt;</code></p><p><code>4792</code><code>&lt;/p&gt;</code></p><p><code>4793</code><code>&lt;h4 id="S24title" class="inline"&gt;</code></p><p><code>4794</code><code>8. Mental Disorders &lt;/h4&gt;</code></p><p><code>4795</code><code>&lt;p id="P115" class="p p-first"&gt;</code></p><p><code>4796</code><code>The well-known psychotropic effects of cannabinoids and the distribution of cannabinoid receptors across important emotional circuits in the brain suggest that the endocannabinoid system may be involved in various psychiatric disorders such as schizophrenia and mood disorders (reviewed in &lt;a href="#R1210" rid="R1210" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919906"&gt;</code></p><p><code>4797</code><code>van der Stelt and Di Marzo, 2003&lt;/a&gt;</code></p><p><code>4798</code><code>; &lt;a href="#R455" rid="R455" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919572"&gt;</code></p><p><code>4799</code><code>Hall et al., 2004&lt;/a&gt;</code></p><p><code>4800</code><code>; &lt;a href="#R679" rid="R679" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919810"&gt;</code></p><p><code>4801</code><code>Leweke et al., 2004&lt;/a&gt;</code></p><p><code>4802</code><code>; &lt;a href="#R748" rid="R748" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920257"&gt;</code></p><p><code>4803</code><code>Manzanares et al., 2004&lt;/a&gt;</code></p><p><code>4804</code><code>; &lt;a href="#R1200" rid="R1200" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918828"&gt;</code></p><p><code>4805</code><code>Ujike and Morita, 2004&lt;/a&gt;</code></p><p><code>4806</code><code>; &lt;a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918958"&gt;</code></p><p><code>4807</code><code>Ashton et al., 2005&lt;/a&gt;</code></p><p><code>4808</code><code>; &lt;a href="#R359" rid="R359" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919656"&gt;</code></p><p><code>4809</code><code>Gambi et al., 2005&lt;/a&gt;</code></p><p><code>4810</code><code>; &lt;a href="#R1086" rid="R1086" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919988"&gt;</code></p><p><code>4811</code><code>Semple et al., 2005&lt;/a&gt;</code></p><p><code>4812</code><code>; &lt;a href="#R1234" rid="R1234" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919090"&gt;</code></p><p><code>4813</code><code>Vinod and Hungund, 2005&lt;/a&gt;</code></p><p><code>4814</code><code>).&lt;/p&gt;</code></p><p><code>4815</code><code>&lt;div id="S25" class="sec"&gt;</code></p><p><code>4816</code><code>&lt;p&gt;</code></p><p><code>4817</code><code>&lt;/p&gt;</code></p><p><code>4818</code><code>&lt;h5 id="S25title" class="inline"&gt;</code></p><p><code>4819</code><code>a. Schizophrenia &lt;/h5&gt;</code></p><p><code>4820</code><code>&lt;p id="P116" class="p p-first"&gt;</code></p><p><code>4821</code><code>Schizophrenia is the second most common mental disorder with a lifetime prevalence of approximately 0.2 to 2% worldwide (&lt;a href="#R40" rid="R40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920033"&gt;</code></p><p><code>4822</code><code>Ban, 2004&lt;/a&gt;</code></p><p><code>4823</code><code>). The disease usually begins in early adulthood or late adolescence and is characterized by psychotic episodes with positive symptoms including delusions and/or hallucinations, loose associations, and distortion of perception. The psychotic episodes are separated by periods with negative symptoms consisting of apathy, anhedonia, reduced social drive, loss of motivation, poverty of speech and thought, and blunting of affect. With disease progression, behavioral impairment can lead to complete social isolation. Although recent advances in the pharmacotherapy of schizophrenia produced great improvement in the clinical symptoms and the quality of life of patients, there is room for further improvements (&lt;a href="#R40" rid="R40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919481"&gt;</code></p><p><code>4824</code><code>Ban et al., 2004&lt;/a&gt;</code></p><p><code>4825</code><code>; &lt;a href="#R843" rid="R843" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919323"&gt;</code></p><p><code>4826</code><code>Moller, 2005&lt;/a&gt;</code></p><p><code>4827</code><code>).&lt;/p&gt;</code></p><p><code>4828</code><code>&lt;p id="P117"&gt;</code></p><p><code>4829</code><code>Numerous theories have been put forth regarding the etiology of schizophrenia, ranging from developmental or neurodegenerative processes, environmental factors, neurotransmitter abnormalities (dopamine or glutamate), and infectious or autoimmune processes, but also including the cannabinoid hypothesis (reviewed in &lt;a href="#R1173" rid="R1173" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919912"&gt;</code></p><p><code>4830</code><code>Thaker and Carpenter, 2001&lt;/a&gt;</code></p><p><code>4831</code><code>; &lt;a href="#R681" rid="R681" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920200"&gt;</code></p><p><code>4832</code><code>Lewis et al., 2005&lt;/a&gt;</code></p><p><code>4833</code><code>). It appears that hypoglutamatergic and hypodopaminergic transmission in the prefrontal cortex is involved in the negative symptoms, whereas hyperactivity of dopamine neurotransmission in the mesencephalic projections to the nucleus accumbens may underlie the positive symptoms (&lt;a href="#R1173" rid="R1173" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920088"&gt;</code></p><p><code>4834</code><code>Thaker and Carpenter, 2001&lt;/a&gt;</code></p><p><code>4835</code><code>; &lt;a href="#R681" rid="R681" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919331"&gt;</code></p><p><code>4836</code><code>Lewis et al., 2005&lt;/a&gt;</code></p><p><code>4837</code><code>).&lt;/p&gt;</code></p><p><code>4838</code><code>&lt;p id="P118"&gt;</code></p><p><code>4839</code><code>According to the endocannabinoid hypothesis of schizophrenia, overactivity of the endocannabinoid system may lead to a hyperdopaminergic and hypoglutamatergic state, which may underlie some of the symptoms (&lt;a href="#R301" rid="R301" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920268"&gt;</code></p><p><code>4840</code><code>Emrich et al., 1997&lt;/a&gt;</code></p><p><code>4841</code><code>, reviewed in &lt;a href="#R1200" rid="R1200" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919872"&gt;</code></p><p><code>4842</code><code>Ujike and Morita, 2004&lt;/a&gt;</code></p><p><code>4843</code><code>; &lt;a href="#R663" rid="R663" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_393488950"&gt;</code></p><p><code>4844</code><code>Laviolette and Grace, 2006&lt;/a&gt;</code></p><p><code>4845</code><code>). The endocannabinoid hypothesis is supported by multiple lines of evidence. First, the use of large amounts of cannabis and THC may produce psychotic symptoms in normal individuals, including delusions, hallucinations, and cognitive impairment, which resemble schizophrenia (&lt;a href="#R1130" rid="R1130" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920240"&gt;</code></p><p><code>4846</code><code>Spencer, 1971&lt;/a&gt;</code></p><p><code>4847</code><code>; &lt;a href="#R452" rid="R452" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919989"&gt;</code></p><p><code>4848</code><code>Halikas et al., 1972&lt;/a&gt;</code></p><p><code>4849</code><code>; &lt;a href="#R182" rid="R182" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919348"&gt;</code></p><p><code>4850</code><code>Chopra and Smith, 1974&lt;/a&gt;</code></p><p><code>4851</code><code>; &lt;a href="#R796" rid="R796" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919762"&gt;</code></p><p><code>4852</code><code>McGuire et al., 1994&lt;/a&gt;</code></p><p><code>4853</code><code>; &lt;a href="#R301" rid="R301" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919601"&gt;</code></p><p><code>4854</code><code>Emrich et al., 1997&lt;/a&gt;</code></p><p><code>4855</code><code>; &lt;a href="#R567" rid="R567" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920300"&gt;</code></p><p><code>4856</code><code>Johns, 2001&lt;/a&gt;</code></p><p><code>4857</code><code>; &lt;a href="#R286" rid="R286" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919939"&gt;</code></p><p><code>4858</code><code>D&amp;#x02019;Souza et al., 2004&lt;/a&gt;</code></p><p><code>4859</code><code>). Second, cannabis and THC may worsen psychotic symptoms in schizophrenic patients, contribute to poor outcome, increase the possibility of relapse, and decrease the effectiveness of antipsychotic drugs (&lt;a href="#R116" rid="R116" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918987"&gt;</code></p><p><code>4860</code><code>Breakey et al., 1974&lt;/a&gt;</code></p><p><code>4861</code><code>; &lt;a href="#R1188" rid="R1188" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919985"&gt;</code></p><p><code>4862</code><code>Treffert, 1978&lt;/a&gt;</code></p><p><code>4863</code><code>; &lt;a href="#R883" rid="R883" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919980"&gt;</code></p><p><code>4864</code><code>Negrete, 1989&lt;/a&gt;</code></p><p><code>4865</code><code>; &lt;a href="#R1194" rid="R1194" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920341"&gt;</code></p><p><code>4866</code><code>Turner and Tsuang, 1990&lt;/a&gt;</code></p><p><code>4867</code><code>; &lt;a href="#R692" rid="R692" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919059"&gt;</code></p><p><code>4868</code><code>Linszen et al., 1994&lt;/a&gt;</code></p><p><code>4869</code><code>; &lt;a href="#R768" rid="R768" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918792"&gt;</code></p><p><code>4870</code><code>Martinez-Arevalo et al., 1994&lt;/a&gt;</code></p><p><code>4871</code><code>; &lt;a href="#R1241" rid="R1241" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919419"&gt;</code></p><p><code>4872</code><code>Voruganti et al., 2001&lt;/a&gt;</code></p><p><code>4873</code><code>; &lt;a href="#R285" rid="R285" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920124"&gt;</code></p><p><code>4874</code><code>D&amp;#x02019;Souza et al., 2005&lt;/a&gt;</code></p><p><code>4875</code><code>). Third, the use of cannabis may precipitate the onset of schizophrenia in individuals susceptible to psychosis (&lt;a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919977"&gt;</code></p><p><code>4876</code><code>Andreasson et al., 1987&lt;/a&gt;</code></p><p><code>4877</code><code>; &lt;a href="#R833" rid="R833" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920405"&gt;</code></p><p><code>4878</code><code>Miller et al., 2001&lt;/a&gt;</code></p><p><code>4879</code><code>). Fourth, postmortem radioligand studies document increased CB&lt;sub&gt;</code></p><p><code>4880</code><code>1&lt;/sub&gt;</code></p><p><code>4881</code><code> receptor density in the dorsolateral and anterior cingular regions and subregions of the prefrontal cortex in schizophrenia (&lt;a href="#R245" rid="R245" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919670"&gt;</code></p><p><code>4882</code><code>Dean et al., 2001&lt;/a&gt;</code></p><p><code>4883</code><code>; &lt;a href="#R1317" rid="R1317" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919354"&gt;</code></p><p><code>4884</code><code>Zavitsanou et al., 2004&lt;/a&gt;</code></p><p><code>4885</code><code>; &lt;a href="#R886" rid="R886" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919849"&gt;</code></p><p><code>4886</code><code>Newell et al., 2006&lt;/a&gt;</code></p><p><code>4887</code><code>). Fifth, the levels of anandamide are increased in cerebrospinal fluid or blood from schizophrenic patients (&lt;a href="#R680" rid="R680" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919536"&gt;</code></p><p><code>4888</code><code>Leweke et al., 1999&lt;/a&gt;</code></p><p><code>4889</code><code>; &lt;a href="#R251" rid="R251" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920221"&gt;</code></p><p><code>4890</code><code>De Marchi et al., 2003&lt;/a&gt;</code></p><p><code>4891</code><code>; &lt;a href="#R390" rid="R390" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919087"&gt;</code></p><p><code>4892</code><code>Giuffrida et al., 2004&lt;/a&gt;</code></p><p><code>4893</code><code>). Sixth, treatment with neuroleptics appears to normalize the imbalance in endocannabinoid signaling in blood cells in schizophrenic patients (&lt;a href="#R251" rid="R251" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918931"&gt;</code></p><p><code>4894</code><code>De Marchi et al., 2003&lt;/a&gt;</code></p><p><code>4895</code><code>) and also decreases CB&lt;sub&gt;</code></p><p><code>4896</code><code>1&lt;/sub&gt;</code></p><p><code>4897</code><code> receptor binding in the rat nucleus accumbens (&lt;a href="#R1155" rid="R1155" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653525"&gt;</code></p><p><code>4898</code><code>Sundram et al., 2005&lt;/a&gt;</code></p><p><code>4899</code><code>). Last, the hebephrenic type of schizophrenia shows a strong association with polymorphisms in the &lt;em&gt;</code></p><p><code>4900</code><code>CNR1&lt;/em&gt;</code></p><p><code>4901</code><code> gene encoding CB&lt;sub&gt;</code></p><p><code>4902</code><code>1&lt;/sub&gt;</code></p><p><code>4903</code><code> receptors (&lt;a href="#R676" rid="R676" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918798"&gt;</code></p><p><code>4904</code><code>Leroy et al., 2001&lt;/a&gt;</code></p><p><code>4905</code><code>; &lt;a href="#R1201" rid="R1201" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919169"&gt;</code></p><p><code>4906</code><code>Ujike et al., 2002&lt;/a&gt;</code></p><p><code>4907</code><code>).&lt;/p&gt;</code></p><p><code>4908</code><code>&lt;p id="P119" class="p p-last"&gt;</code></p><p><code>4909</code><code>Taken together, the above evidence suggests that the endocannabinoid system may be a novel therapeutic target in schizophrenia. It is also tempting to speculate that CB&lt;sub&gt;</code></p><p><code>4910</code><code>1&lt;/sub&gt;</code></p><p><code>4911</code><code> antagonists may be beneficial against some, most likely the negative, symptoms of the disease. Some preclinical and clinical evidence also suggests that cannabidiol may have antipsychotic potential (reviewed in &lt;a href="#R1326" rid="R1326" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918850"&gt;</code></p><p><code>4912</code><code>Zuardi et al., 2006&lt;/a&gt;</code></p><p><code>4913</code><code>).&lt;/p&gt;</code></p><p><code>4914</code><code>&lt;/div&gt;</code></p><p><code>4915</code><code>&lt;div id="S26" class="sec sec-last"&gt;</code></p><p><code>4916</code><code>&lt;p&gt;</code></p><p><code>4917</code><code>&lt;/p&gt;</code></p><p><code>4918</code><code>&lt;h5 id="S26title" class="inline"&gt;</code></p><p><code>4919</code><code>b. Anxiety and depression &lt;/h5&gt;</code></p><p><code>4920</code><code>&lt;p id="P120" class="p p-first"&gt;</code></p><p><code>4921</code><code>Mood disorders such as generalized anxiety or panic disorder, major depressive disorder and bipolar disorder (manic depressive illness) are very common, often serious, and potentially life-threatening conditions. More than 20% of the adult population experiences a mood disorder at some point during their life. In up to 15% of individuals with major depressive disorder the cause of death is suicide. According to a World Health Organization forecast, by the year 2020 depression will become the second leading cause of premature death and disability worldwide (&lt;a href="#R926" rid="R926" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919927"&gt;</code></p><p><code>4922</code><code>Pacher and Kecskem&amp;#x000e9;ti, 2004&lt;/a&gt;</code></p><p><code>4923</code><code>). Although significant advances have been made in the treatment of mood disorders during the past decades, ~30% of the population do not respond to current therapies, and the search for novel pharmacological approaches continues (reviewed in &lt;a href="#R926" rid="R926" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919494"&gt;</code></p><p><code>4924</code><code>Pacher and Kecskem&amp;#x000e9;ti, 2004&lt;/a&gt;</code></p><p><code>4925</code><code>).&lt;/p&gt;</code></p><p><code>4926</code><code>&lt;p id="P121"&gt;</code></p><p><code>4927</code><code>Many of the psychological effects of cannabis and THC are biphasic and bidirectional, depending on mode of administration, dose, personality, time frame, degree of tolerance, and various other environmental and individual factors (&lt;a href="#R949" rid="R949" class=" bibr popnode"&gt;</code></p><p><code>4928</code><code>Paton and Pertwee, 1973&lt;/a&gt;</code></p><p><code>4929</code><code>; &lt;a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920229"&gt;</code></p><p><code>4930</code><code>Ashton et al., 1981&lt;/a&gt;</code></p><p><code>4931</code><code>, &lt;a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919244"&gt;</code></p><p><code>4932</code><code>2005&lt;/a&gt;</code></p><p><code>4933</code><code>; &lt;a href="#R1235" rid="R1235" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919996"&gt;</code></p><p><code>4934</code><code>Viveros et al., 2005&lt;/a&gt;</code></p><p><code>4935</code><code>). The acute effects in normal subjects can range from euphoria, relaxation, excitation, heightened perception, and increased motor activity to dysphoria, anxiety, sedation, perceptual distortion, and incoordination. THC, under certain conditions and at certain doses, exerts anxiolytic, antidepressant, and hypnotic effects in patients suffering from pain associated with cancer or multiple sclerosis and improves mood and general well-being in normal subjects (&lt;a href="#R1005" rid="R1005" class=" bibr popnode"&gt;</code></p><p><code>4936</code><code>Regelson et al., 1976&lt;/a&gt;</code></p><p><code>4937</code><code>; &lt;a href="#R403" rid="R403" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920057"&gt;</code></p><p><code>4938</code><code>Glass et al., 1980&lt;/a&gt;</code></p><p><code>4939</code><code>; &lt;a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919839"&gt;</code></p><p><code>4940</code><code>Ashton et al., 1981&lt;/a&gt;</code></p><p><code>4941</code><code>; &lt;a href="#R307" rid="R307" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920061"&gt;</code></p><p><code>4942</code><code>Fabre and McLendon, 1981&lt;/a&gt;</code></p><p><code>4943</code><code>; &lt;a href="#R539" rid="R539" class=" bibr popnode"&gt;</code></p><p><code>4944</code><code>Ilaria et al., 1981&lt;/a&gt;</code></p><p><code>4945</code><code>; &lt;a href="#R770" rid="R770" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918731"&gt;</code></p><p><code>4946</code><code>Martyn et al., 1995&lt;/a&gt;</code></p><p><code>4947</code><code>; &lt;a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919784"&gt;</code></p><p><code>4948</code><code>Ashton, 1999&lt;/a&gt;</code></p><p><code>4949</code><code>; &lt;a href="#R1245" rid="R1245" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919130"&gt;</code></p><p><code>4950</code><code>Wade et al., 2003&lt;/a&gt;</code></p><p><code>4951</code><code>). However, under different conditions and at higher doses, cannabis or THC can produce dysphoric reactions, anxiety, panic paranoia, and psychosis (&lt;a href="#R1130" rid="R1130" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919545"&gt;</code></p><p><code>4952</code><code>Spencer, 1971&lt;/a&gt;</code></p><p><code>4953</code><code>; &lt;a href="#R452" rid="R452" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920029"&gt;</code></p><p><code>4954</code><code>Halikas et al., 1972&lt;/a&gt;</code></p><p><code>4955</code><code>; &lt;a href="#R182" rid="R182" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920120"&gt;</code></p><p><code>4956</code><code>Chopra and Smith, 1974&lt;/a&gt;</code></p><p><code>4957</code><code>; &lt;a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920015"&gt;</code></p><p><code>4958</code><code>Ashton et al., 1981&lt;/a&gt;</code></p><p><code>4959</code><code>, &lt;a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918956"&gt;</code></p><p><code>4960</code><code>2005&lt;/a&gt;</code></p><p><code>4961</code><code>; &lt;a href="#R796" rid="R796" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920286"&gt;</code></p><p><code>4962</code><code>McGuire et al., 1994&lt;/a&gt;</code></p><p><code>4963</code><code>; &lt;a href="#R301" rid="R301" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918941"&gt;</code></p><p><code>4964</code><code>Emrich et al., 1997&lt;/a&gt;</code></p><p><code>4965</code><code>; &lt;a href="#R567" rid="R567" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919471"&gt;</code></p><p><code>4966</code><code>Johns, 2001&lt;/a&gt;</code></p><p><code>4967</code><code>; &lt;a href="#R952" rid="R952" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919123"&gt;</code></p><p><code>4968</code><code>Patton et al., 2002&lt;/a&gt;</code></p><p><code>4969</code><code>; &lt;a href="#R1185" rid="R1185" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919621"&gt;</code></p><p><code>4970</code><code>Tournier et al., 2003&lt;/a&gt;</code></p><p><code>4971</code><code>; &lt;a href="#R239" rid="R239" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920062"&gt;</code></p><p><code>4972</code><code>Dannon et al., 2004&lt;/a&gt;</code></p><p><code>4973</code><code>; &lt;a href="#R286" rid="R286" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919767"&gt;</code></p><p><code>4974</code><code>D&amp;#x02019;Souza et al., 2004&lt;/a&gt;</code></p><p><code>4975</code><code>; reviewed in &lt;a href="#R518" rid="R518" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918944"&gt;</code></p><p><code>4976</code><code>Hollister, 1986&lt;/a&gt;</code></p><p><code>4977</code><code>; &lt;a href="#R453" rid="R453" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920171"&gt;</code></p><p><code>4978</code><code>Hall and Solowij, 1998&lt;/a&gt;</code></p><p><code>4979</code><code>).&lt;/p&gt;</code></p><p><code>4980</code><code>&lt;p id="P122"&gt;</code></p><p><code>4981</code><code>CBD also possesses anxiolytic, antipsychotic and anticonvulsant properties, which are not mediated by classic cannabinoid receptors (&lt;a href="#R155" rid="R155" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920322"&gt;</code></p><p><code>4982</code><code>Carlini et al., 1975&lt;/a&gt;</code></p><p><code>4983</code><code>; &lt;a href="#R205" rid="R205" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920336"&gt;</code></p><p><code>4984</code><code>Consroe and Wolkin, 1977&lt;/a&gt;</code></p><p><code>4985</code><code>; &lt;a href="#R202" rid="R202" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919231"&gt;</code></p><p><code>4986</code><code>Consroe et al., 1981&lt;/a&gt;</code></p><p><code>4987</code><code>; &lt;a href="#R1328" rid="R1328" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918986"&gt;</code></p><p><code>4988</code><code>Zuardi et al., 1982&lt;/a&gt;</code></p><p><code>4989</code><code>, &lt;a href="#R1327" rid="R1327" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919714"&gt;</code></p><p><code>4990</code><code>1995&lt;/a&gt;</code></p><p><code>4991</code><code>, &lt;a href="#R1326" rid="R1326" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918810"&gt;</code></p><p><code>4992</code><code>2006&lt;/a&gt;</code></p><p><code>4993</code><code>; &lt;a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920150"&gt;</code></p><p><code>4994</code><code>Ames and Cridland, 1986&lt;/a&gt;</code></p><p><code>4995</code><code>; &lt;a href="#R757" rid="R757" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919527"&gt;</code></p><p><code>4996</code><code>Martin et al., 1987&lt;/a&gt;</code></p><p><code>4997</code><code>; &lt;a href="#R441" rid="R441" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920108"&gt;</code></p><p><code>4998</code><code>Guimaraes et al., 1990&lt;/a&gt;</code></p><p><code>4999</code><code>, &lt;a href="#R442" rid="R442" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919156"&gt;</code></p><p><code>5000</code><code>1994&lt;/a&gt;</code></p><p><code>5001</code><code>; reviewed in &lt;a href="#R813" rid="R813" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919101"&gt;</code></p><p><code>5002</code><code>Mechoulam et al., 2002c&lt;/a&gt;</code></p><p><code>5003</code><code>; &lt;a href="#R435" rid="R435" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919021"&gt;</code></p><p><code>5004</code><code>Grotenhermen, 2003&lt;/a&gt;</code></p><p><code>5005</code><code>; &lt;a href="#R703" rid="R703" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919400"&gt;</code></p><p><code>5006</code><code>Long et al., 2006&lt;/a&gt;</code></p><p><code>5007</code><code>). The mode of action of CBD is not completely understood; it may involve blockade of anandamide and serotonin reuptake (&lt;a href="#R91" rid="R91" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919627"&gt;</code></p><p><code>5008</code><code>Bisogno et al., 2001&lt;/a&gt;</code></p><p><code>5009</code><code>; &lt;a href="#R803" rid="R803" class=" bibr popnode"&gt;</code></p><p><code>5010</code><code>McPartland and Russo, 2001&lt;/a&gt;</code></p><p><code>5011</code><code>), inhibition of the enzymatic hydrolysis of anandamide (&lt;a href="#R811" rid="R811" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653469"&gt;</code></p><p><code>5012</code><code>Mechoulam et al., 2002&lt;/a&gt;</code></p><p><code>5013</code><code>), or an interaction with as yet unidentified receptors (&lt;a href="#R556" rid="R556" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919655"&gt;</code></p><p><code>5014</code><code>J&amp;#x000e1;rai et al., 1999&lt;/a&gt;</code></p><p><code>5015</code><code>; &lt;a href="#R963" rid="R963" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919250"&gt;</code></p><p><code>5016</code><code>Pertwee et al., 2002&lt;/a&gt;</code></p><p><code>5017</code><code>).&lt;/p&gt;</code></p><p><code>5018</code><code>&lt;p id="P123"&gt;</code></p><p><code>5019</code><code>Animal studies yielded further support to the biphasic and bidirectional effects of cannabinoids on anxiety, with low doses being anxiolytic and high doses being anxiogenic. Indeed, low doses of CP55,940 (&lt;a href="#R374" rid="R374" class=" bibr popnode"&gt;</code></p><p><code>5020</code><code>Genn et al., 2003&lt;/a&gt;</code></p><p><code>5021</code><code>; &lt;a href="#R749" rid="R749" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919350"&gt;</code></p><p><code>5022</code><code>Marco et al., 2004&lt;/a&gt;</code></p><p><code>5023</code><code>), nabilone (&lt;a href="#R907" rid="R907" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919555"&gt;</code></p><p><code>5024</code><code>Onaivi et al., 1990&lt;/a&gt;</code></p><p><code>5025</code><code>), and THC (&lt;a href="#R73" rid="R73" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918921"&gt;</code></p><p><code>5026</code><code>Berrendero and Maldonado, 2002&lt;/a&gt;</code></p><p><code>5027</code><code>) exerted anxiolytic-like effects in the light-dark crossing test and in the elevated plus-maze in adult rodents. Low-dose CP55,940 was also anxiolytic in other models of anxiety in adult, juvenile, or infant rodents (&lt;a href="#R1030" rid="R1030" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653499"&gt;</code></p><p><code>5028</code><code>Romero et al., 2002a&lt;/a&gt;</code></p><p><code>5029</code><code>; &lt;a href="#R105" rid="R105" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918745"&gt;</code></p><p><code>5030</code><code>Borcel et al., 2004&lt;/a&gt;</code></p><p><code>5031</code><code>; &lt;a href="#R375" rid="R375" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920035"&gt;</code></p><p><code>5032</code><code>Genn et al., 2004&lt;/a&gt;</code></p><p><code>5033</code><code>). In contrast, at medium to high doses, CP55,940 or HU-210 displayed anxiogenic effects in the same or other experimental paradigms in adult as well as in juvenile or infant animals (&lt;a href="#R794" rid="R794" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920135"&gt;</code></p><p><code>5034</code><code>McGregor et al., 1996a&lt;/a&gt;</code></p><p><code>5035</code><code>,&lt;a href="#R795" rid="R795" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919862"&gt;</code></p><p><code>5036</code><code>b&lt;/a&gt;</code></p><p><code>5037</code><code>; &lt;a href="#R1028" rid="R1028" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919823"&gt;</code></p><p><code>5038</code><code>Rodriguez de Fonseca et al., 1996&lt;/a&gt;</code></p><p><code>5039</code><code>; &lt;a href="#R392" rid="R392" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920067"&gt;</code></p><p><code>5040</code><code>Giuliani et al., 2000&lt;/a&gt;</code></p><p><code>5041</code><code>; &lt;a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920246"&gt;</code></p><p><code>5042</code><code>Arevalo et al., 2001&lt;/a&gt;</code></p><p><code>5043</code><code>; Marin et al., 2002; &lt;a href="#R103" rid="R103" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920195"&gt;</code></p><p><code>5044</code><code>Romero et al., 2002&lt;/a&gt;</code></p><p><code>5045</code><code>; &lt;a href="#R374" rid="R374" class=" bibr popnode"&gt;</code></p><p><code>5046</code><code>Genn et al., 2003&lt;/a&gt;</code></p><p><code>5047</code><code>;&lt;a href="#R374" rid="R374" class=" bibr popnode"&gt;</code></p><p><code>5048</code><code>2003&lt;/a&gt;</code></p><p><code>5049</code><code>;&lt;a href="#R375" rid="R375" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920095"&gt;</code></p><p><code>5050</code><code>2004&lt;/a&gt;</code></p><p><code>5051</code><code>; &lt;a href="#R749" rid="R749" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919882"&gt;</code></p><p><code>5052</code><code>Marin Marco et al., 2004&lt;/a&gt;</code></p><p><code>5053</code><code>). Although several hypotheses have been proposed to explain the biphasic effects of cannabinoids on anxiety, including distinct receptors (&lt;a href="#R457" rid="R457" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920194"&gt;</code></p><p><code>5054</code><code>Haller et al., 2004a&lt;/a&gt;</code></p><p><code>5055</code><code>,&lt;a href="#R458" rid="R458" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919628"&gt;</code></p><p><code>5056</code><code>b&lt;/a&gt;</code></p><p><code>5057</code><code>) or neuroanatomically separated CB&lt;sub&gt;</code></p><p><code>5058</code><code>1&lt;/sub&gt;</code></p><p><code>5059</code><code> receptors with a differential sensitivity to the anxiolytic versus anxiogenic effects of cannabinoids, these need to be confirmed in future studies (reviewed in &lt;a href="#R1235" rid="R1235" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919122"&gt;</code></p><p><code>5060</code><code>Viveros et al., 2005&lt;/a&gt;</code></p><p><code>5061</code><code>).&lt;/p&gt;</code></p><p><code>5062</code><code>&lt;p id="P124"&gt;</code></p><p><code>5063</code><code>The high level of CB&lt;sub&gt;</code></p><p><code>5064</code><code>1&lt;/sub&gt;</code></p><p><code>5065</code><code> receptors in the hippocampus, amygdala, and prefrontal and anterior cingular cortex, key regions in the regulation of anxiety, may suggest that the endocannabinoid system plays a role in the control of anxiety (&lt;a href="#R486" rid="R486" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920377"&gt;</code></p><p><code>5066</code><code>Herkenham et al., 1990&lt;/a&gt;</code></p><p><code>5067</code><code>, &lt;a href="#R484" rid="R484" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920005"&gt;</code></p><p><code>5068</code><code>1991a&lt;/a&gt;</code></p><p><code>5069</code><code>,&lt;a href="#R485" rid="R485" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637201"&gt;</code></p><p><code>5070</code><code>b&lt;/a&gt;</code></p><p><code>5071</code><code>; &lt;a href="#R397" rid="R397" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919960"&gt;</code></p><p><code>5072</code><code>Glass et al., 1997b&lt;/a&gt;</code></p><p><code>5073</code><code>; &lt;a href="#R590" rid="R590" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637193"&gt;</code></p><p><code>5074</code><code>Katona et al., 2001&lt;/a&gt;</code></p><p><code>5075</code><code>; &lt;a href="#R450" rid="R450" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918796"&gt;</code></p><p><code>5076</code><code>H&amp;#x000e1;jos and Freund, 2002&lt;/a&gt;</code></p><p><code>5077</code><code>; &lt;a href="#R1196" rid="R1196" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637190"&gt;</code></p><p><code>5078</code><code>Tzavara et al., 2003&lt;/a&gt;</code></p><p><code>5079</code><code>; &lt;a href="#R973" rid="R973" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919637"&gt;</code></p><p><code>5080</code><code>Pistis et al., 2004&lt;/a&gt;</code></p><p><code>5081</code><code>). Further support of this theory came from studies using CB&lt;sub&gt;</code></p><p><code>5082</code><code>1&lt;/sub&gt;</code></p><p><code>5083</code><code> receptor antagonists or CB&lt;sub&gt;</code></p><p><code>5084</code><code>1&lt;/sub&gt;</code></p><p><code>5085</code><code> receptor knockout mice. SR141716 produced anxiogenic effects in the elevated plus-maze and the defensive withdrawal tests in adult rats (&lt;a href="#R881" rid="R881" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919243"&gt;</code></p><p><code>5086</code><code>Navarro et al., 1997&lt;/a&gt;</code></p><p><code>5087</code><code>; &lt;a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919464"&gt;</code></p><p><code>5088</code><code>Arevalo et al., 2001&lt;/a&gt;</code></p><p><code>5089</code><code>). Furthermore, SR141716 not only reversed the anxiolytic effects of the CB&lt;sub&gt;</code></p><p><code>5090</code><code>1&lt;/sub&gt;</code></p><p><code>5091</code><code> agonist CP55,940 but also was anxiogenic in the ultrasonic vocalization test in rat pups when administered alone (&lt;a href="#R794" rid="R794" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919819"&gt;</code></p><p><code>5092</code><code>McGregor et al., 1996a&lt;/a&gt;</code></p><p><code>5093</code><code>). In contrast, &lt;a href="#R456" rid="R456" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919696"&gt;</code></p><p><code>5094</code><code>Haller et al. (2002)&lt;/a&gt;</code></p><p><code>5095</code><code> found SR141716 to be anxiolytic in the plus-maze in mice, but this effect was not mediated by CB&lt;sub&gt;</code></p><p><code>5096</code><code>1&lt;/sub&gt;</code></p><p><code>5097</code><code> receptors as indicated by its presence in CB&lt;sub&gt;</code></p><p><code>5098</code><code>1&lt;/sub&gt;</code></p><p><code>5099</code><code> knockout mice. Furthermore, another selective CB&lt;sub&gt;</code></p><p><code>5100</code><code>1&lt;/sub&gt;</code></p><p><code>5101</code><code> receptor antagonist, AM251, increased anxiety-like behavior in wild-type mice but had no effect in the knockouts, in support of a CB&lt;sub&gt;</code></p><p><code>5102</code><code>1&lt;/sub&gt;</code></p><p><code>5103</code><code> receptor-mediated anxiolysis. As discussed before, SR141716, but not AM251, also inhibits a CB&lt;sub&gt;</code></p><p><code>5104</code><code>1&lt;/sub&gt;</code></p><p><code>5105</code><code>-like receptor that mediates presynaptic inhibition of glutamate release in the hippocampus (&lt;a href="#R450" rid="R450" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918818"&gt;</code></p><p><code>5106</code><code>H&amp;#x000e1;jos and Freund, 2002&lt;/a&gt;</code></p><p><code>5107</code><code>). Thus, the findings of &lt;a href="#R456" rid="R456" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919549"&gt;</code></p><p><code>5108</code><code>Haller et al. (2002)&lt;/a&gt;</code></p><p><code>5109</code><code> could suggest that the anxiolytic effect of SR141716 is mediated by such a CB&lt;sub&gt;</code></p><p><code>5110</code><code>1&lt;/sub&gt;</code></p><p><code>5111</code><code>-like receptor, activation of which would be anxiogenic.&lt;/p&gt;</code></p><p><code>5112</code><code>&lt;p id="P125"&gt;</code></p><p><code>5113</code><code>CB&lt;sub&gt;</code></p><p><code>5114</code><code>1&lt;/sub&gt;</code></p><p><code>5115</code><code> knockout mice displayed increased anxiogenic responses in the light-dark box, plus-maze, and social interaction tests, an increased aggressive response in the resident-intruder test, and marked alterations in the hypothalamic-pituitary-adrenal (HPA) axis coupled with impaired action of known anxiolytic drugs such as buspiron and bromazepam (&lt;a href="#R456" rid="R456" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918879"&gt;</code></p><p><code>5116</code><code>Haller et al., 2002&lt;/a&gt;</code></p><p><code>5117</code><code>, &lt;a href="#R458" rid="R458" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919455"&gt;</code></p><p><code>5118</code><code>2004b&lt;/a&gt;</code></p><p><code>5119</code><code>; &lt;a href="#R760" rid="R760" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920250"&gt;</code></p><p><code>5120</code><code>Martin et al., 2002&lt;/a&gt;</code></p><p><code>5121</code><code>; &lt;a href="#R1205" rid="R1205" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918710"&gt;</code></p><p><code>5122</code><code>Urig&amp;#x000fc;en et al., 2004&lt;/a&gt;</code></p><p><code>5123</code><code>). However, &lt;a href="#R754" rid="R754" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920334"&gt;</code></p><p><code>5124</code><code>Marsicano et al. (2002)&lt;/a&gt;</code></p><p><code>5125</code><code> were unable to demonstrate anxiogenic-like response in CB&lt;sub&gt;</code></p><p><code>5126</code><code>1&lt;/sub&gt;</code></p><p><code>5127</code><code> knockout mice in the plus-maze. This may be related to differences in the genetic background of the CB&lt;sub&gt;</code></p><p><code>5128</code><code>1&lt;/sub&gt;</code></p><p><code>5129</code><code> knockout mice used and/or different experimental conditions. The importance of the latter is also indicated by the confounding effect of stress on anxiogenic behaviors and their modulation by endocannabinoids (&lt;a href="#R457" rid="R457" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919915"&gt;</code></p><p><code>5130</code><code>Haller et al., 2004a&lt;/a&gt;</code></p><p><code>5131</code><code>; &lt;a href="#R946" rid="R946" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919013"&gt;</code></p><p><code>5132</code><code>Patel et al., 2005&lt;/a&gt;</code></p><p><code>5133</code><code>). Stress-induced down-regulation of hippocampal endocannabinoid signaling may contribute to problems in behavioral flexibility and may play a role in the development of perseveratory and ruminatory behaviors in stress-related neuropsychiatric disorders (&lt;a href="#R497" rid="R497" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920292"&gt;</code></p><p><code>5134</code><code>Hill et al., 2005&lt;/a&gt;</code></p><p><code>5135</code><code>). Collectively, a majority of evidence supports a role for CB&lt;sub&gt;</code></p><p><code>5136</code><code>1&lt;/sub&gt;</code></p><p><code>5137</code><code> receptors in the control of emotional behavior and suggests the existence of an anxiolytic endocannabinoid tone. Facilitation of such a tone by inhibiting the degradation of endocannabinoids in vivo may be therapeutically exploited, as indicated by the reduced anxiety-like behavior and potent antidepressant-like effects in mice and rats treated with a FAAH or anandamide transport inhibitor and the blockade of this effect by SR141716 or AM281 (&lt;a href="#R589" rid="R589" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919425"&gt;</code></p><p><code>5138</code><code>Kathuria et al., 2003&lt;/a&gt;</code></p><p><code>5139</code><code>; &lt;a href="#R404" rid="R404" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919853"&gt;</code></p><p><code>5140</code><code>Gobbi et al., 2005&lt;/a&gt;</code></p><p><code>5141</code><code>; &lt;a href="#R108" rid="R108" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_393488954"&gt;</code></p><p><code>5142</code><code>Bortolato et al., 2006&lt;/a&gt;</code></p><p><code>5143</code><code>; &lt;a href="#R1053" rid="R1053" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919330"&gt;</code></p><p><code>5144</code><code>Rutkowska et al., 2006&lt;/a&gt;</code></p><p><code>5145</code><code>).&lt;/p&gt;</code></p><p><code>5146</code><code>&lt;p id="P126"&gt;</code></p><p><code>5147</code><code>The mechanisms responsible for the effects of cannabinoids on anxiety-related responses are complex and may involve modulation of numerous neurotransmitter systems. For example, stimulation of CB&lt;sub&gt;</code></p><p><code>5148</code><code>1&lt;/sub&gt;</code></p><p><code>5149</code><code> receptors in rodents activates the HPA axis through the release of CRH (&lt;a href="#R1277" rid="R1277" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919020"&gt;</code></p><p><code>5150</code><code>Weidenfeld et al., 1994&lt;/a&gt;</code></p><p><code>5151</code><code>; &lt;a href="#R1281" rid="R1281" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919754"&gt;</code></p><p><code>5152</code><code>Wenger et al., 1997&lt;/a&gt;</code></p><p><code>5153</code><code>; &lt;a href="#R767" rid="R767" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918773"&gt;</code></p><p><code>5154</code><code>Martin-Calderon et al., 1998&lt;/a&gt;</code></p><p><code>5155</code><code>; &lt;a href="#R746" rid="R746" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920032"&gt;</code></p><p><code>5156</code><code>Manzanares et al., 1999a&lt;/a&gt;</code></p><p><code>5157</code><code>; &lt;a href="#R749" rid="R749" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918713"&gt;</code></p><p><code>5158</code><code>Marco et al., 2004&lt;/a&gt;</code></p><p><code>5159</code><code>), which could account for the anxiogenic effects of high doses of cannabinoids (&lt;a href="#R1028" rid="R1028" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919040"&gt;</code></p><p><code>5160</code><code>Rodriguez de Fonseca et al., 1996&lt;/a&gt;</code></p><p><code>5161</code><code>; Marin et al., 2002). In contrast, there are also examples of negative modulation of HPA function by endocannabinoids (&lt;a href="#R267" rid="R267" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637232"&gt;</code></p><p><code>5162</code><code>Di et al., 2003&lt;/a&gt;</code></p><p><code>5163</code><code>; &lt;a href="#R947" rid="R947" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920179"&gt;</code></p><p><code>5164</code><code>Patel et al., 2004&lt;/a&gt;</code></p><p><code>5165</code><code>). Cannabinoids also modulate GABAergic transmission and the release of the peptide cholecystokinin, which may contribute to both anxiolytic and anxiogenic effects (&lt;a href="#R907" rid="R907" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919143"&gt;</code></p><p><code>5166</code><code>Onaivi et al., 1990&lt;/a&gt;</code></p><p><code>5167</code><code>; &lt;a href="#R591" rid="R591" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637192"&gt;</code></p><p><code>5168</code><code>Katona et al., 1999&lt;/a&gt;</code></p><p><code>5169</code><code>, &lt;a href="#R590" rid="R590" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637226"&gt;</code></p><p><code>5170</code><code>2001&lt;/a&gt;</code></p><p><code>5171</code><code>; &lt;a href="#R752" rid="R752" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919846"&gt;</code></p><p><code>5172</code><code>Marsicano and Lutz, 1999&lt;/a&gt;</code></p><p><code>5173</code><code>; &lt;a href="#R1191" rid="R1191" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919218"&gt;</code></p><p><code>5174</code><code>Tsou et al., 1999&lt;/a&gt;</code></p><p><code>5175</code><code>; &lt;a href="#R59" rid="R59" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919716"&gt;</code></p><p><code>5176</code><code>Beinfeld and Connolly, 2001&lt;/a&gt;</code></p><p><code>5177</code><code>; &lt;a href="#R1043" rid="R1043" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920203"&gt;</code></p><p><code>5178</code><code>Rotzinger and Vaccarino, 2003&lt;/a&gt;</code></p><p><code>5179</code><code>). Furthermore, cannabinoids enhance the release of endogenous opioids and a functional interplay between the endocannabinoid and opioid systems modulates analgesic responses and is involved in antidepressant-like effects and in various addiction-related processes (&lt;a href="#R988" rid="R988" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918717"&gt;</code></p><p><code>5180</code><code>Pugh et al., 1997&lt;/a&gt;</code></p><p><code>5181</code><code>; &lt;a href="#R747" rid="R747" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919428"&gt;</code></p><p><code>5182</code><code>Manzanares et al., 1999b&lt;/a&gt;</code></p><p><code>5183</code><code>; &lt;a href="#R524" rid="R524" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918908"&gt;</code></p><p><code>5184</code><code>Houser et al., 2000&lt;/a&gt;</code></p><p><code>5185</code><code>; &lt;a href="#R1324" rid="R1324" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637242"&gt;</code></p><p><code>5186</code><code>Zimmer et al., 2001&lt;/a&gt;</code></p><p><code>5187</code><code>; &lt;a href="#R385" rid="R385" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637227"&gt;</code></p><p><code>5188</code><code>Ghozland et al., 2002&lt;/a&gt;</code></p><p><code>5189</code><code>). From studies with THC and CP55,940, it appears that &lt;em&gt;</code></p><p><code>5190</code><code>&amp;#x003bc;&lt;/em&gt;</code></p><p><code>5191</code><code>- and &lt;em&gt;</code></p><p><code>5192</code><code>&amp;#x003b4;&lt;/em&gt;</code></p><p><code>5193</code><code>-opioid receptors mediate certain anxiolytic effects, whereas activation of &lt;em&gt;</code></p><p><code>5194</code><code>&amp;#x003ba;&lt;/em&gt;</code></p><p><code>5195</code><code>-opioid receptors leads to increased anxiety (&lt;a href="#R988" rid="R988" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919479"&gt;</code></p><p><code>5196</code><code>Pugh et al., 1997&lt;/a&gt;</code></p><p><code>5197</code><code>; &lt;a href="#R524" rid="R524" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918934"&gt;</code></p><p><code>5198</code><code>Houser et al., 2000&lt;/a&gt;</code></p><p><code>5199</code><code>; &lt;a href="#R1324" rid="R1324" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637218"&gt;</code></p><p><code>5200</code><code>Zimmer et al., 2001&lt;/a&gt;</code></p><p><code>5201</code><code>; &lt;a href="#R73" rid="R73" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920236"&gt;</code></p><p><code>5202</code><code>Berrendero and Maldonado, 2002&lt;/a&gt;</code></p><p><code>5203</code><code>; &lt;a href="#R385" rid="R385" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637216"&gt;</code></p><p><code>5204</code><code>Ghozland et al., 2002&lt;/a&gt;</code></p><p><code>5205</code><code>; &lt;a href="#R750" rid="R750" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919267"&gt;</code></p><p><code>5206</code><code>Marin et al., 2003&lt;/a&gt;</code></p><p><code>5207</code><code>). There are also interactions between the endocannabinoid and serotonergic systems (&lt;a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919616"&gt;</code></p><p><code>5208</code><code>Arevalo et al., 2001&lt;/a&gt;</code></p><p><code>5209</code><code>; &lt;a href="#R741" rid="R741" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919933"&gt;</code></p><p><code>5210</code><code>Malone and Taylor, 2001&lt;/a&gt;</code></p><p><code>5211</code><code>; &lt;a href="#R350" rid="R350" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919316"&gt;</code></p><p><code>5212</code><code>Fride and Shohami, 2002&lt;/a&gt;</code></p><p><code>5213</code><code>; &lt;a href="#R750" rid="R750" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919776"&gt;</code></p><p><code>5214</code><code>Marin et al., 2003&lt;/a&gt;</code></p><p><code>5215</code><code>; &lt;a href="#R749" rid="R749" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919891"&gt;</code></p><p><code>5216</code><code>Marco et al., 2004&lt;/a&gt;</code></p><p><code>5217</code><code>; &lt;a href="#R1135" rid="R1135" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920080"&gt;</code></p><p><code>5218</code><code>Steffens and Feuerstein, 2004&lt;/a&gt;</code></p><p><code>5219</code><code>; reviewed in &lt;a href="#R1235" rid="R1235" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919850"&gt;</code></p><p><code>5220</code><code>Viveros et al., 2005&lt;/a&gt;</code></p><p><code>5221</code><code>), although their role in anxiety-like behaviors has not been explored&lt;/p&gt;</code></p><p><code>5222</code><code>&lt;p id="P127"&gt;</code></p><p><code>5223</code><code>In contrast to earlier dogma, recent findings indicate that neurogenesis occurs in the adult brain. Furthermore, stress and depression decrease neurogenesis, particularly in the hippocampus, whereas electroconvulsive therapy and chronic treatment with conventional antidepressants increases this process (reviewed in &lt;a href="#R921" rid="R921" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920234"&gt;</code></p><p><code>5224</code><code>Pacher et al., 2004a&lt;/a&gt;</code></p><p><code>5225</code><code>). It has been recently demonstrated that the endocannabinoid system drives neural progenitor cell proliferation (&lt;a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920264"&gt;</code></p><p><code>5226</code><code>Aguado et al., 2005&lt;/a&gt;</code></p><p><code>5227</code><code>, &lt;a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637188"&gt;</code></p><p><code>5228</code><code>2006&lt;/a&gt;</code></p><p><code>5229</code><code>), and cannabinoids promote neurogenesis (&lt;a href="#R70" rid="R70" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919987"&gt;</code></p><p><code>5230</code><code>Berghuis et al., 2005&lt;/a&gt;</code></p><p><code>5231</code><code>; &lt;a href="#R560" rid="R560" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919237"&gt;</code></p><p><code>5232</code><code>Jiang et al., 2005&lt;/a&gt;</code></p><p><code>5233</code><code>). Furthermore, CB&lt;sub&gt;</code></p><p><code>5234</code><code>1&lt;/sub&gt;</code></p><p><code>5235</code><code> receptors appear to be required for neuronal survival in the hippocampus (&lt;a href="#R86" rid="R86" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919136"&gt;</code></p><p><code>5236</code><code>Bilkei-Gorzo et al., 2005&lt;/a&gt;</code></p><p><code>5237</code><code>). These findings are particularly exciting, as they raise the possibility of a role for endocannabinoids in antidepressive drug action. Indeed, CB&lt;sub&gt;</code></p><p><code>5238</code><code>1&lt;/sub&gt;</code></p><p><code>5239</code><code> receptor density in the hippocampus and hypothalamus is increased by chronic tricyclic antidepressant treatment (&lt;a href="#R496" rid="R496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_393488949"&gt;</code></p><p><code>5240</code><code>Hill et al., 2006&lt;/a&gt;</code></p><p><code>5241</code><code>), and the amplification of the actions of endocannabinoids by the FAAH inhibitor URB597 was found to produce antidepressant-like effects in the mouse tail-suspension and rat forced-swim tests, without eliciting reward-related effects indicative of addictive potential (&lt;a href="#R404" rid="R404" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919916"&gt;</code></p><p><code>5242</code><code>Gobbi et al., 2005&lt;/a&gt;</code></p><p><code>5243</code><code>). It should not be surprising, however, that based on the basis of the bimodal action of cannabinoids on mood and anxiety, a case could be made for the opposite, i.e., for the antidepressive potential of CB&lt;sub&gt;</code></p><p><code>5244</code><code>1&lt;/sub&gt;</code></p><p><code>5245</code><code> &lt;em&gt;</code></p><p><code>5246</code><code>antagonism&lt;/em&gt;</code></p><p><code>5247</code><code>. CB&lt;sub&gt;</code></p><p><code>5248</code><code>1&lt;/sub&gt;</code></p><p><code>5249</code><code> antagonists were reported to elicit antidepressant-like behavioral effects in rodents and can increase the synaptic concentration of biogenic amines, much like antidepressants do (reviewed in &lt;a href="#R1298" rid="R1298" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919855"&gt;</code></p><p><code>5250</code><code>Witkin et al., 2005&lt;/a&gt;</code></p><p><code>5251</code><code>). Thus, pharmacological modulation of the endocannabinoid system holds considerable promise in the treatment of both anxiety-related and mood disorders.&lt;/p&gt;</code></p><p><code>5252</code><code>&lt;p id="P128" class="p p-last"&gt;</code></p><p><code>5253</code><code>The results of a recent study implicated endocannabinoids and CB&lt;sub&gt;</code></p><p><code>5254</code><code>1&lt;/sub&gt;</code></p><p><code>5255</code><code> receptors in the extinction of aversive memories by demonstrating that CB&lt;sub&gt;</code></p><p><code>5256</code><code>1&lt;/sub&gt;</code></p><p><code>5257</code><code> knockout mice show impaired extinction in auditory fear-conditioning tests, and this could be mimicked in wild-type mice by treatment with SR141716 (&lt;a href="#R755" rid="R755" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919289"&gt;</code></p><p><code>5258</code><code>Marsicano et al., 2002b&lt;/a&gt;</code></p><p><code>5259</code><code>). These exciting findings raise the possibility that pharmacological amplification of CB&lt;sub&gt;</code></p><p><code>5260</code><code>1&lt;/sub&gt;</code></p><p><code>5261</code><code> signaling, for example, by FAAH inhibitors, may have therapeutic value in obsessive-compulsive disorder or post-traumatic shock syndrome.&lt;/p&gt;</code></p><p><code>5262</code><code>&lt;/div&gt;</code></p><p><code>5263</code><code>&lt;/div&gt;</code></p><p><code>5264</code><code>&lt;div id="S27" class="sec"&gt;</code></p><p><code>5265</code><code>&lt;p&gt;</code></p><p><code>5266</code><code>&lt;/p&gt;</code></p><p><code>5267</code><code>&lt;h4 id="S27title" class="inline"&gt;</code></p><p><code>5268</code><code>9. Insomnia &lt;/h4&gt;</code></p><p><code>5269</code><code>&lt;p id="P129" class="p p-first"&gt;</code></p><p><code>5270</code><code>Insomnia, the most common sleep disorder, is defined as difficulty with the initiation, maintenance, duration, or quality of sleep that results in the impairment of daytime functioning, despite adequate opportunity and circumstances for sleep (&lt;a href="#R1106" rid="R1106" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919919"&gt;</code></p><p><code>5271</code><code>Silber, 2005&lt;/a&gt;</code></p><p><code>5272</code><code>). The cause for insomnia is often not known, but frequently it may be a consequence of a chronic disease associated with pain or depression.&lt;/p&gt;</code></p><p><code>5273</code><code>&lt;p id="P130"&gt;</code></p><p><code>5274</code><code>Early studies documented the fact that marijuana and THC affect sleep patterns both in humans (&lt;a href="#R342" rid="R342" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653491"&gt;</code></p><p><code>5275</code><code>Freemon, 1972&lt;/a&gt;</code></p><p><code>5276</code><code>, &lt;a href="#R343" rid="R343" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919873"&gt;</code></p><p><code>5277</code><code>1982&lt;/a&gt;</code></p><p><code>5278</code><code>; &lt;a href="#R974" rid="R974" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919638"&gt;</code></p><p><code>5279</code><code>Pivik et al., 1972&lt;/a&gt;</code></p><p><code>5280</code><code>; &lt;a href="#R44" rid="R44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919422"&gt;</code></p><p><code>5281</code><code>Barratt et al., 1974&lt;/a&gt;</code></p><p><code>5282</code><code>; &lt;a href="#R318" rid="R318" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920196"&gt;</code></p><p><code>5283</code><code>Feinberg et al., 1975&lt;/a&gt;</code></p><p><code>5284</code><code>, &lt;a href="#R317" rid="R317" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919576"&gt;</code></p><p><code>5285</code><code>1976&lt;/a&gt;</code></p><p><code>5286</code><code>) and in experimental animals (&lt;a href="#R847" rid="R847" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919075"&gt;</code></p><p><code>5287</code><code>Monti, 1977&lt;/a&gt;</code></p><p><code>5288</code><code>; &lt;a href="#R130" rid="R130" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919652"&gt;</code></p><p><code>5289</code><code>Buonamici et al., 1982&lt;/a&gt;</code></p><p><code>5290</code><code>). More recently, &lt;a href="#R890" rid="R890" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919181"&gt;</code></p><p><code>5291</code><code>Nicholson et al. (2004)&lt;/a&gt;</code></p><p><code>5292</code><code> have studied the effects of cannabis extracts on nocturnal sleep, early-morning performance, memory, and sleepiness in a placebo-controlled, double-blind, crossover study in eight healthy volunteers. They found that 15 mg of THC was sedative, whereas 15 mg of CBD had alerting properties as it increased wake activity during sleep and counteracted the residual sedative activity of THC (&lt;a href="#R890" rid="R890" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920317"&gt;</code></p><p><code>5293</code><code>Nicholson et al., 2004&lt;/a&gt;</code></p><p><code>5294</code><code>).&lt;/p&gt;</code></p><p><code>5295</code><code>&lt;p id="P131"&gt;</code></p><p><code>5296</code><code>Anandamide was also found to modulate sleep by increasing slow-wave sleep two and rapid eye movement sleep in a CB&lt;sub&gt;</code></p><p><code>5297</code><code>1&lt;/sub&gt;</code></p><p><code>5298</code><code> receptor-dependent manner in rats (&lt;a href="#R867" rid="R867" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919603"&gt;</code></p><p><code>5299</code><code>Murillo-Rodriguez et al., 1998&lt;/a&gt;</code></p><p><code>5300</code><code>, &lt;a href="#R866" rid="R866" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919081"&gt;</code></p><p><code>5301</code><code>2001&lt;/a&gt;</code></p><p><code>5302</code><code>). Moreover, CB&lt;sub&gt;</code></p><p><code>5303</code><code>1&lt;/sub&gt;</code></p><p><code>5304</code><code> receptor expression in the pons of rats was modulated by the light/dark cycle and by sleep (&lt;a href="#R769" rid="R769" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919514"&gt;</code></p><p><code>5305</code><code>Martinez-Vargas et al., 2003&lt;/a&gt;</code></p><p><code>5306</code><code>), and endocannabinoids and CB&lt;sub&gt;</code></p><p><code>5307</code><code>1&lt;/sub&gt;</code></p><p><code>5308</code><code> receptors were also implicated in rapid eye movement sleep rebound (&lt;a href="#R878" rid="R878" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919920"&gt;</code></p><p><code>5309</code><code>Navarro et al., 2003&lt;/a&gt;</code></p><p><code>5310</code><code>). Interestingly, a recent study has demonstrated that anandamide not only induced sleep but also increased levels of the sleep-inducing substance adenosine in the basal forebrain, and both of these effects were blocked by SR141716 (&lt;a href="#R865" rid="R865" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918919"&gt;</code></p><p><code>5311</code><code>Murillo-Rodriguez et al., 2003&lt;/a&gt;</code></p><p><code>5312</code><code>).&lt;/p&gt;</code></p><p><code>5313</code><code>&lt;p id="P132"&gt;</code></p><p><code>5314</code><code>Oleamide is a fatty acid amide with a variety of in vitro effects, including inhibition of gap junction-mediated cell-cell communication (&lt;a href="#R101" rid="R101" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920347"&gt;</code></p><p><code>5315</code><code>Boger et al., 1998a&lt;/a&gt;</code></p><p><code>5316</code><code>,&lt;a href="#R103" rid="R103" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920394"&gt;</code></p><p><code>5317</code><code>b&lt;/a&gt;</code></p><p><code>5318</code><code>), modulation of 5-HT&lt;sub&gt;</code></p><p><code>5319</code><code>1&lt;/sub&gt;</code></p><p><code>5320</code><code>, 5-HT&lt;sub&gt;</code></p><p><code>5321</code><code>2A,C&lt;/sub&gt;</code></p><p><code>5322</code><code>, and 5-HT&lt;sub&gt;</code></p><p><code>5323</code><code>7&lt;/sub&gt;</code></p><p><code>5324</code><code> receptors (&lt;a href="#R1178" rid="R1178" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919690"&gt;</code></p><p><code>5325</code><code>Thomas et al., 1997&lt;/a&gt;</code></p><p><code>5326</code><code>, &lt;a href="#R1179" rid="R1179" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918994"&gt;</code></p><p><code>5327</code><code>1999&lt;/a&gt;</code></p><p><code>5328</code><code>; &lt;a href="#R478" rid="R478" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919025"&gt;</code></p><p><code>5329</code><code>Hedlund et al., 1999&lt;/a&gt;</code></p><p><code>5330</code><code>), and modulation of inhibitory ionotropic receptors such as the GABA&lt;sub&gt;</code></p><p><code>5331</code><code>A&lt;/sub&gt;</code></p><p><code>5332</code><code> receptor (&lt;a href="#R221" rid="R221" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920344"&gt;</code></p><p><code>5333</code><code>Coyne et al., 2002&lt;/a&gt;</code></p><p><code>5334</code><code>). Oleamide accumulates in the cerebrospinal fluid of sleep-deprived cats (&lt;a href="#R224" rid="R224" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653356"&gt;</code></p><p><code>5335</code><code>Cravatt et al., 1995&lt;/a&gt;</code></p><p><code>5336</code><code>) and rats (&lt;a href="#R49" rid="R49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919234"&gt;</code></p><p><code>5337</code><code>Basile et al., 1999&lt;/a&gt;</code></p><p><code>5338</code><code>) and induces sleep, an effect which could be blocked by SR141716 (&lt;a href="#R822" rid="R822" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919037"&gt;</code></p><p><code>5339</code><code>Mendelson and Basile, 1999&lt;/a&gt;</code></p><p><code>5340</code><code>). Initially, it was suggested that inhibition of anandamide degradation by FAAH rather than the activation of CB&lt;sub&gt;</code></p><p><code>5341</code><code>1&lt;/sub&gt;</code></p><p><code>5342</code><code> receptors was responsible for the sleep-inducing effect of oleamide (&lt;a href="#R106" rid="R106" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653512"&gt;</code></p><p><code>5343</code><code>Boring et al., 1996&lt;/a&gt;</code></p><p><code>5344</code><code>; &lt;a href="#R807" rid="R807" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920002"&gt;</code></p><p><code>5345</code><code>Mechoulam et al., 1997&lt;/a&gt;</code></p><p><code>5346</code><code>), but this is a matter of dispute (&lt;a href="#R331" rid="R331" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919569"&gt;</code></p><p><code>5347</code><code>Fowler, 2004&lt;/a&gt;</code></p><p><code>5348</code><code>; &lt;a href="#R669" rid="R669" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920367"&gt;</code></p><p><code>5349</code><code>Lees and Dougalis, 2004&lt;/a&gt;</code></p><p><code>5350</code><code>; &lt;a href="#R670" rid="R670" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920227"&gt;</code></p><p><code>5351</code><code>Leggett et al., 2004&lt;/a&gt;</code></p><p><code>5352</code><code>).&lt;/p&gt;</code></p><p><code>5353</code><code>&lt;p id="P133" class="p p-last"&gt;</code></p><p><code>5354</code><code>Although little is known about the role of the endocannabinoid system in the pathophysiology of sleep disorders, clinical studies uniformly report significantly improved sleep quality in patients taking cannabinoids for symptomatic treatment of multiple sclerosis, cancer, chronic pain, or intractable pruritus. Although psychotropic cannabinoids are unlikely to gain acceptance for the treatment of insomnia, FAAH inhibitors were shown to enhance certain endocannabinoid-mediated behaviors without evidence for addictive properties (&lt;a href="#R589" rid="R589" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920189"&gt;</code></p><p><code>5355</code><code>Kathuria et al., 2003&lt;/a&gt;</code></p><p><code>5356</code><code>). The sleep-inducing property of some potent FAAH inhibitors, such as the endogenous lipid 2-octyl &lt;em&gt;</code></p><p><code>5357</code><code>&amp;#x003b3;&lt;/em&gt;</code></p><p><code>5358</code><code>-bromoacetoacetate (&lt;a href="#R101" rid="R101" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919184"&gt;</code></p><p><code>5359</code><code>Boger et al., 1998a&lt;/a&gt;</code></p><p><code>5360</code><code>), could therefore be therapeutically exploited.&lt;/p&gt;</code></p><p><code>5361</code><code>&lt;/div&gt;</code></p><p><code>5362</code><code>&lt;div id="S28" class="sec"&gt;</code></p><p><code>5363</code><code>&lt;p&gt;</code></p><p><code>5364</code><code>&lt;/p&gt;</code></p><p><code>5365</code><code>&lt;h4 id="S28title" class="inline"&gt;</code></p><p><code>5366</code><code>10. Nausea and Emesis &lt;/h4&gt;</code></p><p><code>5367</code><code>&lt;p id="P134" class="p p-first"&gt;</code></p><p><code>5368</code><code>Nausea and vomiting can present as symptoms of a variety of diseases or as secondary consequences of chemotherapy or radiotherapy of cancer. It is for this latter indication that THC has gained acceptance as a highly efficacious therapeutic agent, often effective in cases resistant to other, more conventional, medications (reviewed by &lt;a href="#R758" rid="R758" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918868"&gt;</code></p><p><code>5369</code><code>Martin and Wiley, 2004&lt;/a&gt;</code></p><p><code>5370</code><code>; &lt;a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918743"&gt;</code></p><p><code>5371</code><code>Aapro, 2005&lt;/a&gt;</code></p><p><code>5372</code><code>; &lt;a href="#R454" rid="R454" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919402"&gt;</code></p><p><code>5373</code><code>Hall et al., 2005&lt;/a&gt;</code></p><p><code>5374</code><code>). Emesis is thought to involve activation of specific receptors on sensory nerve endings in the gut and also in brainstem regions including the medullary chemoreceptor trigger zone and the lateral reticular formation. Activation of 5-HT&lt;sub&gt;</code></p><p><code>5375</code><code>3&lt;/sub&gt;</code></p><p><code>5376</code><code> receptors appears to play a dominant role in acute emesis, whereas activation of NK&lt;sub&gt;</code></p><p><code>5377</code><code>1&lt;/sub&gt;</code></p><p><code>5378</code><code> (substance P) receptors is more important in the delayed emesis after chemotherapy, as indicated by the effectiveness of the respective receptor antagonists in controlling these different stages of the emetic response (&lt;a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918716"&gt;</code></p><p><code>5379</code><code>Aapro, 2005&lt;/a&gt;</code></p><p><code>5380</code><code>). Although the mechanism of the antiemetic action of cannabinoids is not quite clear, an interaction with 5-HT&lt;sub&gt;</code></p><p><code>5381</code><code>3&lt;/sub&gt;</code></p><p><code>5382</code><code> is suggested by the colocalization of CB&lt;sub&gt;</code></p><p><code>5383</code><code>1&lt;/sub&gt;</code></p><p><code>5384</code><code> and 5-HT&lt;sub&gt;</code></p><p><code>5385</code><code>3&lt;/sub&gt;</code></p><p><code>5386</code><code> receptors on GABAergic neurons where they have opposite effects on GABA release (&lt;a href="#R850" rid="R850" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920076"&gt;</code></p><p><code>5387</code><code>Morales et al., 2004&lt;/a&gt;</code></p><p><code>5388</code><code>). Also, cannabinoids may directly inhibit 5-HT&lt;sub&gt;</code></p><p><code>5389</code><code>3&lt;/sub&gt;</code></p><p><code>5390</code><code>-gated ion currents by a mechanism not involving CB&lt;sub&gt;</code></p><p><code>5391</code><code>1&lt;/sub&gt;</code></p><p><code>5392</code><code> receptors (&lt;a href="#R310" rid="R310" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919164"&gt;</code></p><p><code>5393</code><code>Fan, 1995&lt;/a&gt;</code></p><p><code>5394</code><code>; &lt;a href="#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920210"&gt;</code></p><p><code>5395</code><code>Barann et al., 2002&lt;/a&gt;</code></p><p><code>5396</code><code>). Such a CB&lt;sub&gt;</code></p><p><code>5397</code><code>1&lt;/sub&gt;</code></p><p><code>5398</code><code> receptor-independent effect is also suggested by the ability of cannabidiol, a natural constituent of marijuana which does not bind to the CB&lt;sub&gt;</code></p><p><code>5399</code><code>1&lt;/sub&gt;</code></p><p><code>5400</code><code> receptor, to reduce lithium-induced vomiting in the house musk shrew (&lt;a href="#R940" rid="R940" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920343"&gt;</code></p><p><code>5401</code><code>Parker et al., 2004&lt;/a&gt;</code></p><p><code>5402</code><code>). Nevertheless, the involvement of CB&lt;sub&gt;</code></p><p><code>5403</code><code>1&lt;/sub&gt;</code></p><p><code>5404</code><code> receptors is clearly indicated by the ability of SR141716 to reverse the effects of THC and synthetic agonists in suppressing vomiting caused by cisplatin (&lt;a href="#R242" rid="R242" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918831"&gt;</code></p><p><code>5405</code><code>Darmani, 2001b&lt;/a&gt;</code></p><p><code>5406</code><code>) or lithium chloride (&lt;a href="#R940" rid="R940" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918860"&gt;</code></p><p><code>5407</code><code>Parker et al., 2004&lt;/a&gt;</code></p><p><code>5408</code><code>), or by the ability of these agonist to reverse the emesis elicited by SR141716 in the least shrew (&lt;a href="#R241" rid="R241" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919022"&gt;</code></p><p><code>5409</code><code>Darmani, 2001a&lt;/a&gt;</code></p><p><code>5410</code><code>). These latter findings suggest that the emetic circuitry is tonically controlled by endocannabinoids.&lt;/p&gt;</code></p><p><code>5411</code><code>&lt;p id="P135" class="p p-last"&gt;</code></p><p><code>5412</code><code>In line with such a possibility, a recent human study found an association between chronic marijuana use, which probably results in desensitization of cannabinoid receptors, and cyclical hyperemesis: in the 19 subjects studied, the hyperemetic episodes subsided upon discontinuation of cannabis use and reappeared upon rechallenge with cannabis (&lt;a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918748"&gt;</code></p><p><code>5413</code><code>Allen et al., 2005&lt;/a&gt;</code></p><p><code>5414</code><code>). A meta-analysis of 30 randomized comparisons of cannabis (nabilone, dronabinol, or levonantradol) with placebo or standard antiemetics, involving a total of 1366 patients, concluded that cannabinoids are slightly more effective than conventional antiemetics, and the patients prefer them because of their mood enhancing and sedative effects. However, they were also more toxic, with dizziness, dysphoria, hallucinations, and paranoia being the most prominent undesirable side effects (&lt;a href="#R1186" rid="R1186" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653489"&gt;</code></p><p><code>5415</code><code>Tram&amp;#x000e9;r et al., 2001&lt;/a&gt;</code></p><p><code>5416</code><code>). This led to the recommendation to limit the use of cannabinoids as antiemetics to patients with chemotherapy-related sickness, in whom their mood-enhancing effects would be of added benefit.&lt;/p&gt;</code></p><p><code>5417</code><code>&lt;/div&gt;</code></p><p><code>5418</code><code>&lt;div id="S29" class="sec sec-last"&gt;</code></p><p><code>5419</code><code>&lt;p&gt;</code></p><p><code>5420</code><code>&lt;/p&gt;</code></p><p><code>5421</code><code>&lt;h4 id="S29title" class="inline"&gt;</code></p><p><code>5422</code><code>11. Drug Addiction and Alcohol Disorders &lt;/h4&gt;</code></p><p><code>5423</code><code>&lt;p id="P136" class="p p-first"&gt;</code></p><p><code>5424</code><code>The positive reinforcing effect of natural rewards, such as those derived from eating, drinking, work, or sexual activity, are mediated by the brain&amp;#x02019;s reward circuitry. Neuroanatomically, this circuitry consists of three series of coupled pathways. First-order neurons project from structures in the ventral limbic forebrain (orbitofrontal cortex and anterior cingulate area) to the mesencephalic ventral tegmental area (VTA) where they synapse onto dopaminergic neurons. These second-order neurons project primarily to neurons in the shell of the nucleus accumbens (nAc), but also to cortical areas and to the amygdala. Third-order neurons in the nAc, some of which are GABAergic, project to the ventral pallidum and other regions involved in mediating reward-related behaviors (recently reviewed by &lt;a href="#R711" rid="R711" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919158"&gt;</code></p><p><code>5425</code><code>Lupica et al., 2004&lt;/a&gt;</code></p><p><code>5426</code><code>; &lt;a href="#R367" rid="R367" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919959"&gt;</code></p><p><code>5427</code><code>Gardner, 2005&lt;/a&gt;</code></p><p><code>5428</code><code>). It is believed that addictive drugs activate or &amp;#x0201c;hijack&amp;#x0201d; the same pathway. Genetic vulnerability to drug addiction has been linked to a functional deficiency in the second-order dopaminergic neurons at their interface with third-order neurons in the nAc (&lt;a href="#R885" rid="R885" class=" bibr popnode"&gt;</code></p><p><code>5429</code><code>Nestler, 2003&lt;/a&gt;</code></p><p><code>5430</code><code>). In human subjects prone to addiction, a deficiency in D&lt;sub&gt;</code></p><p><code>5431</code><code>2&lt;/sub&gt;</code></p><p><code>5432</code><code> dopamine receptors in the nAc could be documented by brain imaging (&lt;a href="#R1240" rid="R1240" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918679"&gt;</code></p><p><code>5433</code><code>Volkow et al., 1997&lt;/a&gt;</code></p><p><code>5434</code><code>, &lt;a href="#R1239" rid="R1239" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918775"&gt;</code></p><p><code>5435</code><code>1999&lt;/a&gt;</code></p><p><code>5436</code><code>).&lt;/p&gt;</code></p><p><code>5437</code><code>&lt;p id="P137"&gt;</code></p><p><code>5438</code><code>A common denominator among different addictive drugs interacting with distinct receptors is their ability to activate the mesolimbic dopaminergic reward pathway and increase dopamine levels in the nAc, which is believed to be responsible for their addictive properties (&lt;a href="#R621" rid="R621" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919790"&gt;</code></p><p><code>5439</code><code>Koob, 1992&lt;/a&gt;</code></p><p><code>5440</code><code>; &lt;a href="#R1297" rid="R1297" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919970"&gt;</code></p><p><code>5441</code><code>Wise, 2004&lt;/a&gt;</code></p><p><code>5442</code><code>). Similar to other drugs of abuse, THC increases extracellular dopamine levels in the nAc via activation of CB&lt;sub&gt;</code></p><p><code>5443</code><code>1&lt;/sub&gt;</code></p><p><code>5444</code><code> receptors (&lt;a href="#R174" rid="R174" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919571"&gt;</code></p><p><code>5445</code><code>Chen et al., 1990&lt;/a&gt;</code></p><p><code>5446</code><code>; &lt;a href="#R1162" rid="R1162" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919247"&gt;</code></p><p><code>5447</code><code>Tanda et al., 1999&lt;/a&gt;</code></p><p><code>5448</code><code>) and also lowers the reward threshold for electrical brain stimulation (&lt;a href="#R368" rid="R368" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919631"&gt;</code></p><p><code>5449</code><code>Gardner et al., 1988&lt;/a&gt;</code></p><p><code>5450</code><code>), a phenomenon known to involve activation of the mesolimbic dopamine system. THC also increases the firing rate of the second-order VTA-nAc dopaminergic neurons via CB&lt;sub&gt;</code></p><p><code>5451</code><code>1&lt;/sub&gt;</code></p><p><code>5452</code><code> but not opiate receptors (&lt;a href="#R344" rid="R344" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920345"&gt;</code></p><p><code>5453</code><code>French, 1997&lt;/a&gt;</code></p><p><code>5454</code><code>), and withdrawal from THC increases corticotropin-releasing factor levels in the central nucleus of the amygdala (&lt;a href="#R1026" rid="R1026" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653452"&gt;</code></p><p><code>5455</code><code>Rodriguez de Fonseca et al., 1997&lt;/a&gt;</code></p><p><code>5456</code><code>), another hallmark of drugs of abuse (&lt;a href="#R622" rid="R622" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919641"&gt;</code></p><p><code>5457</code><code>Koob, 1996&lt;/a&gt;</code></p><p><code>5458</code><code>).&lt;/p&gt;</code></p><p><code>5459</code><code>&lt;p id="P138"&gt;</code></p><p><code>5460</code><code>THC and related synthetic cannabinoid agonists also fulfill the reward-related behavioral criteria for drugs of abuse: they support conditioned place preference (CPP) under appropriate conditions (&lt;a href="#R675" rid="R675" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920295"&gt;</code></p><p><code>5461</code><code>Lepore et al., 1995&lt;/a&gt;</code></p><p><code>5462</code><code>; &lt;a href="#R1208" rid="R1208" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918870"&gt;</code></p><p><code>5463</code><code>Valjent and Maldonado, 2000&lt;/a&gt;</code></p><p><code>5464</code><code>; &lt;a href="#R1314" rid="R1314" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637246"&gt;</code></p><p><code>5465</code><code>Zangen et al., 2006&lt;/a&gt;</code></p><p><code>5466</code><code>), they are self-administered intravenously or intracerebrally in a CB&lt;sub&gt;</code></p><p><code>5467</code><code>1&lt;/sub&gt;</code></p><p><code>5468</code><code> antagonist-sensitive manner (&lt;a href="#R756" rid="R756" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920193"&gt;</code></p><p><code>5469</code><code>Martellotta et al., 1998&lt;/a&gt;</code></p><p><code>5470</code><code>; &lt;a href="#R668" rid="R668" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653384"&gt;</code></p><p><code>5471</code><code>Ledent et al., 1999&lt;/a&gt;</code></p><p><code>5472</code><code>; &lt;a href="#R114" rid="R114" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653523"&gt;</code></p><p><code>5473</code><code>Braida et al., 2001&lt;/a&gt;</code></p><p><code>5474</code><code>; &lt;a href="#R1314" rid="R1314" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637236"&gt;</code></p><p><code>5475</code><code>Zangen et al., 2006&lt;/a&gt;</code></p><p><code>5476</code><code>), and they reinstate cocaine-or heroine-seeking behavior in rats previously extinguished from self-administration (&lt;a href="#R255" rid="R255" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920245"&gt;</code></p><p><code>5477</code><code>De Vries et al., 2001&lt;/a&gt;</code></p><p><code>5478</code><code>).&lt;/p&gt;</code></p><p><code>5479</code><code>&lt;p id="P139"&gt;</code></p><p><code>5480</code><code>An issue of intense interest is the location of the CB&lt;sub&gt;</code></p><p><code>5481</code><code>1&lt;/sub&gt;</code></p><p><code>5482</code><code> receptors mediating these effects. Similar to cannabinoids, opiates also increase the activity of dopaminergic neurons in the VTA. This effect has been shown to result from &lt;em&gt;</code></p><p><code>5483</code><code>&amp;#x003bc;&lt;/em&gt;</code></p><p><code>5484</code><code> receptor-mediated inhibition of GABA release from the terminals of inhibitory GABAergic interneurons, i.e., through a &amp;#x0201c;disinhibitory&amp;#x0201d; mechanism (&lt;a href="#R568" rid="R568" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637184"&gt;</code></p><p><code>5485</code><code>Johnson and North, 1992&lt;/a&gt;</code></p><p><code>5486</code><code>). A similar mechanism has been postulated for cannabinoids by &lt;a href="#R171" rid="R171" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919646"&gt;</code></p><p><code>5487</code><code>Cheer et al. (2000)&lt;/a&gt;</code></p><p><code>5488</code><code>, who reported that local application of the cannabinoid agonist HU-210 to brain slices containing the VTA increased dopaminergic neuronal activity, which could be blocked by the GABA&lt;sub&gt;</code></p><p><code>5489</code><code>A&lt;/sub&gt;</code></p><p><code>5490</code><code> antagonist bicuculline. In line with this, WIN 55,212-2 was found to suppress electrically evoked, but not muscimol-induced, inhibitory postsynaptic currents via CB&lt;sub&gt;</code></p><p><code>5491</code><code>1&lt;/sub&gt;</code></p><p><code>5492</code><code> receptors in brain slices containing the VTA (&lt;a href="#R1159" rid="R1159" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920374"&gt;</code></p><p><code>5493</code><code>Szabo et al., 2002&lt;/a&gt;</code></p><p><code>5494</code><code>). However, cannabinoids also inhibit glutamate release in the VTA, which would have an opposite effect on dopaminergic activity (&lt;a href="#R817" rid="R817" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637244"&gt;</code></p><p><code>5495</code><code>Melis et al., 2004a&lt;/a&gt;</code></p><p><code>5496</code><code>). There is evidence for additional sites of action, such as CB&lt;sub&gt;</code></p><p><code>5497</code><code>1&lt;/sub&gt;</code></p><p><code>5498</code><code> receptors on the terminals of GABAergic projection neurons that target GABA&lt;sub&gt;</code></p><p><code>5499</code><code>B&lt;/sub&gt;</code></p><p><code>5500</code><code> receptors on VTA dopamine neurons resulting in their disinhibition (&lt;a href="#R1018" rid="R1018" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_539174733"&gt;</code></p><p><code>5501</code><code>Riegel and Lupica, 2004&lt;/a&gt;</code></p><p><code>5502</code><code>). This pathway may be activated by ethanol, as indicated by the ability of the GABA&lt;sub&gt;</code></p><p><code>5503</code><code>B&lt;/sub&gt;</code></p><p><code>5504</code><code> agonist baclofen to antagonize the increase in ethanol drinking caused by WIN 55,212-2 treatment of alcohol-preferring rats (&lt;a href="#R198" rid="R198" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920170"&gt;</code></p><p><code>5505</code><code>Colombo et al., 2004&lt;/a&gt;</code></p><p><code>5506</code><code>). Activation of CB&lt;sub&gt;</code></p><p><code>5507</code><code>1&lt;/sub&gt;</code></p><p><code>5508</code><code> receptors on glutamatergic terminals in the nAc was reported to inhibit glutamate release onto GABAergic neurons in the nAc that project to the VTA, which may also result in disinhibition of VTA dopaminergic neurons (&lt;a href="#R1023" rid="R1023" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637206"&gt;</code></p><p><code>5509</code><code>Robbe et al., 2001&lt;/a&gt;</code></p><p><code>5510</code><code>). Indeed, both the VTA and the nAc may be sites of the rewarding effects of cannabinoids, as documented by the propensity of rats to self-administer THC into either site (&lt;a href="#R1314" rid="R1314" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637241"&gt;</code></p><p><code>5511</code><code>Zangen et al., 2006&lt;/a&gt;</code></p><p><code>5512</code><code>).&lt;/p&gt;</code></p><p><code>5513</code><code>&lt;p id="P140" class="p"&gt;</code></p><p><code>5514</code><code>Regardless of the exact location of presynaptic CB&lt;sub&gt;</code></p><p><code>5515</code><code>1&lt;/sub&gt;</code></p><p><code>5516</code><code> receptors, their natural activation occurs through retrograde transmission, with their endogenous ligands being released from postsynaptic cells (&lt;a href="#R627" rid="R627" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919043"&gt;</code></p><p><code>5517</code><code>Kreutzer and Regehr, 2001&lt;/a&gt;</code></p><p><code>5518</code><code>; &lt;a href="#R905" rid="R905" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919736"&gt;</code></p><p><code>5519</code><code>Ohno-Shosaku et al., 2001&lt;/a&gt;</code></p><p><code>5520</code><code>; &lt;a href="#R1294" rid="R1294" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918702"&gt;</code></p><p><code>5521</code><code>Wilson and Nicoll, 2001&lt;/a&gt;</code></p><p><code>5522</code><code>). This mechanism has also been implicated in LTD (&lt;a href="#R381" rid="R381" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918923"&gt;</code></p><p><code>5523</code><code>Gerdeman et al., 2002&lt;/a&gt;</code></p><p><code>5524</code><code>; &lt;a href="#R1024" rid="R1024" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919484"&gt;</code></p><p><code>5525</code><code>Robbe et al., 2002&lt;/a&gt;</code></p><p><code>5526</code><code>), a form of synaptic plasticity that can be initiated by drugs of abuse (&lt;a href="#R1180" rid="R1180" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653414"&gt;</code></p><p><code>5527</code><code>Thomas et al., 2001&lt;/a&gt;</code></p><p><code>5528</code><code>), and may be involved in certain features of compulsive drug use (&lt;a href="#R380" rid="R380" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919201"&gt;</code></p><p><code>5529</code><code>Gerdeman et al., 2003&lt;/a&gt;</code></p><p><code>5530</code><code>). A further indication that endocannabinoids may be involved in mechanisms of drug reward is findings that the neurochemical and behavioral responses to different classes of drugs of abuse can be inhibited by the CB&lt;sub&gt;</code></p><p><code>5531</code><code>1&lt;/sub&gt;</code></p><p><code>5532</code><code> receptor antagonists. These findings suggests that endocannabinoid activation of CB&lt;sub&gt;</code></p><p><code>5533</code><code>1&lt;/sub&gt;</code></p><p><code>5534</code><code> receptors in the mesolimbic reward pathway may be part of a &amp;#x0201c;common pathway&amp;#x0201d; of drug reward (reviewed in &lt;a href="#R254" rid="R254" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920165"&gt;</code></p><p><code>5535</code><code>De Vries and Schoffelmeer, 2005&lt;/a&gt;</code></p><p><code>5536</code><code>; &lt;a href="#R737" rid="R737" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653484"&gt;</code></p><p><code>5537</code><code>Maldonado et al., 2006&lt;/a&gt;</code></p><p><code>5538</code><code>). Examples of this are discussed below.&lt;/p&gt;</code></p><p><code>5539</code><code>&lt;div id="S30" class="sec"&gt;</code></p><p><code>5540</code><code>&lt;p&gt;</code></p><p><code>5541</code><code>&lt;/p&gt;</code></p><p><code>5542</code><code>&lt;h5 id="S30title" class="inline"&gt;</code></p><p><code>5543</code><code>a. Opiates &lt;/h5&gt;</code></p><p><code>5544</code><code>&lt;p id="P141" class="p p-first"&gt;</code></p><p><code>5545</code><code>There is a large body of evidence indicating a reciprocal relationship between the endocannabinoid and endogenous opioid systems in drug dependence (recently reviewed by &lt;a href="#R312" rid="R312" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919097"&gt;</code></p><p><code>5546</code><code>Fattore et al., 2005&lt;/a&gt;</code></p><p><code>5547</code><code>; &lt;a href="#R1232" rid="R1232" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919046"&gt;</code></p><p><code>5548</code><code>Vigano et al., 2005a&lt;/a&gt;</code></p><p><code>5549</code><code>,&lt;a href="#R1233" rid="R1233" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920000"&gt;</code></p><p><code>5550</code><code>b&lt;/a&gt;</code></p><p><code>5551</code><code>). This fact is not surprising, given that opioids and cannabinoids have a similar pharmacological profile at both the behavioral level (e.g., analgesia, hypothermia, catalepsy, and motor impairment) and cellular/molecular levels (both CB&lt;sub&gt;</code></p><p><code>5552</code><code>1&lt;/sub&gt;</code></p><p><code>5553</code><code> and opiate &lt;em&gt;</code></p><p><code>5554</code><code>&amp;#x003bc;&lt;/em&gt;</code></p><p><code>5555</code><code> receptors are predominantly presynaptic, they are coupled to and share the same pool of G&lt;sub&gt;</code></p><p><code>5556</code><code>i&lt;/sub&gt;</code></p><p><code>5557</code><code>/G&lt;sub&gt;</code></p><p><code>5558</code><code>o&lt;/sub&gt;</code></p><p><code>5559</code><code> proteins, and have an overlapping brain distribution). There are numerous examples for opioid or cannabinoid reward-related effects being inhibited by both CB&lt;sub&gt;</code></p><p><code>5560</code><code>1&lt;/sub&gt;</code></p><p><code>5561</code><code> and opiate &lt;em&gt;</code></p><p><code>5562</code><code>&amp;#x003bc;&lt;/em&gt;</code></p><p><code>5563</code><code> antagonists (&lt;a href="#R312" rid="R312" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918874"&gt;</code></p><p><code>5564</code><code>Fattore et al., 2005&lt;/a&gt;</code></p><p><code>5565</code><code>; &lt;a href="#R367" rid="R367" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919373"&gt;</code></p><p><code>5566</code><code>Gardner, 2005&lt;/a&gt;</code></p><p><code>5567</code><code>; &lt;a href="#R1232" rid="R1232" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919675"&gt;</code></p><p><code>5568</code><code>Vigano et al., 2005a&lt;/a&gt;</code></p><p><code>5569</code><code>,&lt;a href="#R1233" rid="R1233" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919394"&gt;</code></p><p><code>5570</code><code>b&lt;/a&gt;</code></p><p><code>5571</code><code>). The mechanisms underlying these reciprocal interactions are not clear, but they may involve heterodimerization of CB&lt;sub&gt;</code></p><p><code>5572</code><code>1&lt;/sub&gt;</code></p><p><code>5573</code><code> and &lt;em&gt;</code></p><p><code>5574</code><code>&amp;#x003bc;&lt;/em&gt;</code></p><p><code>5575</code><code> opiate receptors, depletion of shared G protein pools and/or utilization of common postreceptor signaling pathways. In addition, the opiate/cannabinoid synergism observed in nAc/striatal neurons appears to require adenosine and A2a receptor signaling (&lt;a href="#R1305" rid="R1305" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920319"&gt;</code></p><p><code>5576</code><code>Yao et al., 2006&lt;/a&gt;</code></p><p><code>5577</code><code>).&lt;/p&gt;</code></p><p><code>5578</code><code>&lt;p id="P142" class="p p-last"&gt;</code></p><p><code>5579</code><code>Here we will only review evidence that pertains to the potential involvement of endocannabinoids in the addictive, reward-related actions of opioids. Such evidence is based on the ability of pharmacological or genetic ablation of CB&lt;sub&gt;</code></p><p><code>5580</code><code>1&lt;/sub&gt;</code></p><p><code>5581</code><code> receptors to prevent or inhibit opioid effects. CB&lt;sub&gt;</code></p><p><code>5582</code><code>1&lt;/sub&gt;</code></p><p><code>5583</code><code> knockout mice were reported to be unable to acquire morphine self-administration (&lt;a href="#R668" rid="R668" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653357"&gt;</code></p><p><code>5584</code><code>Ledent et al., 1999&lt;/a&gt;</code></p><p><code>5585</code><code>; &lt;a href="#R212" rid="R212" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920216"&gt;</code></p><p><code>5586</code><code>Cossu et al., 2001&lt;/a&gt;</code></p><p><code>5587</code><code>), to have reduced morphine withdrawal symptoms (&lt;a href="#R668" rid="R668" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653490"&gt;</code></p><p><code>5588</code><code>Ledent et al., 1999&lt;/a&gt;</code></p><p><code>5589</code><code>), and not to develop CPP for morphine (&lt;a href="#R759" rid="R759" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919866"&gt;</code></p><p><code>5590</code><code>Martin et al., 2000&lt;/a&gt;</code></p><p><code>5591</code><code>). A possible neurochemical correlate of these changes is the lack of morphine-induced dopamine release in the nucleus accumbens of CB&lt;sub&gt;</code></p><p><code>5592</code><code>1&lt;/sub&gt;</code></p><p><code>5593</code><code> receptor knockout mice (&lt;a href="#R771" rid="R771" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920259"&gt;</code></p><p><code>5594</code><code>Mascia et al., 1999&lt;/a&gt;</code></p><p><code>5595</code><code>), although more recently CB&lt;sub&gt;</code></p><p><code>5596</code><code>1&lt;/sub&gt;</code></p><p><code>5597</code><code> blockade was found to reverse the morphine-induced decrease in ventropallidal GABA overflow without affecting the morphine-induced increase in dopamine release in the nAc (&lt;a href="#R144" rid="R144" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919554"&gt;</code></p><p><code>5598</code><code>Caill&amp;#x000e9; and Parsons, 2006&lt;/a&gt;</code></p><p><code>5599</code><code>). Treatment of wild-type mice and rats with a CB&lt;sub&gt;</code></p><p><code>5600</code><code>1&lt;/sub&gt;</code></p><p><code>5601</code><code> antagonist elicits similar phenotypes (&lt;a href="#R1046" rid="R1046" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920105"&gt;</code></p><p><code>5602</code><code>Rubino et al., 2000&lt;/a&gt;</code></p><p><code>5603</code><code>; &lt;a href="#R774" rid="R774" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918917"&gt;</code></p><p><code>5604</code><code>Mas-Nieto et al., 2001&lt;/a&gt;</code></p><p><code>5605</code><code>; &lt;a href="#R880" rid="R880" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637243"&gt;</code></p><p><code>5606</code><code>Navarro et al., 2001&lt;/a&gt;</code></p><p><code>5607</code><code>, &lt;a href="#R879" rid="R879" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919140"&gt;</code></p><p><code>5608</code><code>2004&lt;/a&gt;</code></p><p><code>5609</code><code>). These observations raise the therapeutic potential of chronic treatment with a CB&lt;sub&gt;</code></p><p><code>5610</code><code>1&lt;/sub&gt;</code></p><p><code>5611</code><code> receptor antagonist in preventing or reversing the development of opiate dependence.&lt;/p&gt;</code></p><p><code>5612</code><code>&lt;/div&gt;</code></p><p><code>5613</code><code>&lt;div id="S31" class="sec"&gt;</code></p><p><code>5614</code><code>&lt;p&gt;</code></p><p><code>5615</code><code>&lt;/p&gt;</code></p><p><code>5616</code><code>&lt;h5 id="S31title" class="inline"&gt;</code></p><p><code>5617</code><code>b. Nicotine &lt;/h5&gt;</code></p><p><code>5618</code><code>&lt;p id="P143" class="p p-first-last"&gt;</code></p><p><code>5619</code><code>Nicotine is the main neuroactive component in tobacco smoke and is responsible for its addictive properties. Nicotine&amp;#x02019;s rewarding effects are mediated by the same mesolimbic dopaminergic pathway that is involved in the rewarding effects of many other addictive drugs (&lt;a href="#R977" rid="R977" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919613"&gt;</code></p><p><code>5620</code><code>Pontieri et al., 1996&lt;/a&gt;</code></p><p><code>5621</code><code>). Therefore, it should not be unexpected that there is a positive synergism between nicotine and THC in paradigms used to reveal reinforcing effects (&lt;a href="#R1208" rid="R1208" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919492"&gt;</code></p><p><code>5622</code><code>Valjent and Maldonado, 2000&lt;/a&gt;</code></p><p><code>5623</code><code>). A role of endocannabinoids in the rewarding effects of nicotine is indicated by the absence of nicotine-induced CPP in CB&lt;sub&gt;</code></p><p><code>5624</code><code>1&lt;/sub&gt;</code></p><p><code>5625</code><code> knockout mice (&lt;a href="#R161" rid="R161" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919421"&gt;</code></p><p><code>5626</code><code>Castane et al., 2002&lt;/a&gt;</code></p><p><code>5627</code><code>), although the acquisition of nicotine self-administration was not affected by the absence of CB&lt;sub&gt;</code></p><p><code>5628</code><code>1&lt;/sub&gt;</code></p><p><code>5629</code><code> receptors in another study using an acute reinforcement paradigm (&lt;a href="#R212" rid="R212" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920326"&gt;</code></p><p><code>5630</code><code>Cossu et al., 2001&lt;/a&gt;</code></p><p><code>5631</code><code>). On the other hand, SR141716 was reported to decrease nicotine operant self-administration (&lt;a href="#R189" rid="R189" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918968"&gt;</code></p><p><code>5632</code><code>Cohen et al., 2002&lt;/a&gt;</code></p><p><code>5633</code><code>) and nicotine-induced CPP in rats (&lt;a href="#R666" rid="R666" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919071"&gt;</code></p><p><code>5634</code><code>Le Foll and Goldberg, 2004&lt;/a&gt;</code></p><p><code>5635</code><code>; Forget et al., 2006) and also to inhibit nicotine-induced dopamine release in the nucleus accumbens shell (&lt;a href="#R189" rid="R189" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919893"&gt;</code></p><p><code>5636</code><code>Cohen et al., 2002&lt;/a&gt;</code></p><p><code>5637</code><code>). SR141716 also inhibited nicotine self-administration sustained by nicotine-associated cues in the absence of nicotine itself (&lt;a href="#R188" rid="R188" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920082"&gt;</code></p><p><code>5638</code><code>Cohen et al., 2005&lt;/a&gt;</code></p><p><code>5639</code><code>), and chronic exposure to nicotine was reported to induce endocannabinoid release (&lt;a href="#R413" rid="R413" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920107"&gt;</code></p><p><code>5640</code><code>Gonzalez et al., 2002&lt;/a&gt;</code></p><p><code>5641</code><code>). Furthermore, SR141716 abolished the anxiolytic effects of low-dose nicotine in mice and potentiated its anxiogenic effects at higher doses (&lt;a href="#R38" rid="R38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919154"&gt;</code></p><p><code>5642</code><code>Balerio et al., 2006&lt;/a&gt;</code></p><p><code>5643</code><code>). Together, these findings justified testing rimonabant in clinical trials to promote smoking abstinence. Indeed, the results of a recent multicenter phase III clinical trial in the United States indicate that a 10-week treatment of smokers with a daily oral dose of 20 mg of rimonabant with a follow-up period of 42 weeks doubled the odds of quitting smoking, was well tolerated, and also reduced the post-cessation weight gain by &amp;#x0003e;80% (&lt;a href="#R238" rid="R238" class=" bibr popnode"&gt;</code></p><p><code>5644</code><code>Dale and Anthenelli, 2004&lt;/a&gt;</code></p><p><code>5645</code><code>).&lt;/p&gt;</code></p><p><code>5646</code><code>&lt;/div&gt;</code></p><p><code>5647</code><code>&lt;div id="S32" class="sec"&gt;</code></p><p><code>5648</code><code>&lt;p&gt;</code></p><p><code>5649</code><code>&lt;/p&gt;</code></p><p><code>5650</code><code>&lt;h5 id="S32title" class="inline"&gt;</code></p><p><code>5651</code><code>c. Cocaine &lt;/h5&gt;</code></p><p><code>5652</code><code>&lt;p id="P144" class="p p-first"&gt;</code></p><p><code>5653</code><code>Unlike THC, opiates and nicotine, cocaine does not increase the activity of dopaminergic neurons in the VTA but elevates synaptic levels of dopamine in the nAc by blocking dopamine reuptake at the dopamine transporter (&lt;a href="#R389" rid="R389" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918777"&gt;</code></p><p><code>5654</code><code>Giros et al., 1996&lt;/a&gt;</code></p><p><code>5655</code><code>). Therefore it is not surprising that cocaine-induced increases in dopamine in the nAc were found to be unaffected by genetic ablation of CB&lt;sub&gt;</code></p><p><code>5656</code><code>1&lt;/sub&gt;</code></p><p><code>5657</code><code> receptors (&lt;a href="#R1127" rid="R1127" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919667"&gt;</code></p><p><code>5658</code><code>Soria et al., 2005&lt;/a&gt;</code></p><p><code>5659</code><code>). Accordingly, CB&lt;sub&gt;</code></p><p><code>5660</code><code>1&lt;/sub&gt;</code></p><p><code>5661</code><code> receptors do not appear to participate in the acute rewarding properties of cocaine, as indicated by the preserved acute cocaine self-administration and cocaine-induced CPP in CB&lt;sub&gt;</code></p><p><code>5662</code><code>1&lt;/sub&gt;</code></p><p><code>5663</code><code> knockout mice (&lt;a href="#R759" rid="R759" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920376"&gt;</code></p><p><code>5664</code><code>Martin et al., 2000&lt;/a&gt;</code></p><p><code>5665</code><code>; &lt;a href="#R212" rid="R212" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919084"&gt;</code></p><p><code>5666</code><code>Cossu et al., 2001&lt;/a&gt;</code></p><p><code>5667</code><code>; &lt;a href="#R677" rid="R677" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920023"&gt;</code></p><p><code>5668</code><code>Lesscher et al., 2005&lt;/a&gt;</code></p><p><code>5669</code><code>; &lt;a href="#R1127" rid="R1127" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919578"&gt;</code></p><p><code>5670</code><code>Soria et al., 2005&lt;/a&gt;</code></p><p><code>5671</code><code>) or in mice treated with SR141716 (&lt;a href="#R1163" rid="R1163" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919792"&gt;</code></p><p><code>5672</code><code>Tanda et al., 2000&lt;/a&gt;</code></p><p><code>5673</code><code>; &lt;a href="#R255" rid="R255" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920353"&gt;</code></p><p><code>5674</code><code>De Vries et al., 2001&lt;/a&gt;</code></p><p><code>5675</code><code>; &lt;a href="#R144" rid="R144" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919833"&gt;</code></p><p><code>5676</code><code>Caill&amp;#x000e9; and Parsons, 2006&lt;/a&gt;</code></p><p><code>5677</code><code>). SR141716 treatment also did not affect the threshold-lowering effect of cocaine in the intracranial self-stimulation paradigm, although treatment with WIN 55,212-2 was able to achieve this, suggesting that CB&lt;sub&gt;</code></p><p><code>5678</code><code>1&lt;/sub&gt;</code></p><p><code>5679</code><code> receptor stimulation might inhibit the reinforcing properties of cocaine (&lt;a href="#R313" rid="R313" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919956"&gt;</code></p><p><code>5680</code><code>Fattore et al., 1999&lt;/a&gt;</code></p><p><code>5681</code><code>; &lt;a href="#R1237" rid="R1237" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918948"&gt;</code></p><p><code>5682</code><code>Vlachou et al., 2003&lt;/a&gt;</code></p><p><code>5683</code><code>).&lt;/p&gt;</code></p><p><code>5684</code><code>&lt;p id="P145" class="p p-last"&gt;</code></p><p><code>5685</code><code>Other studies indicate, however, that endocannabinoid activation of CB&lt;sub&gt;</code></p><p><code>5686</code><code>1&lt;/sub&gt;</code></p><p><code>5687</code><code> receptors may mediate the reinforcing effects of cocaine. SR141716 treatment decreased the sensitivity of rats to the reinforcing effects of cocaine in an intracranial self-stimulation paradigm (&lt;a href="#R259" rid="R259" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653399"&gt;</code></p><p><code>5688</code><code>Deroche-Gamonet et al., 2001&lt;/a&gt;</code></p><p><code>5689</code><code>). The ability to acquire operant self-administration of cocaine was reduced in CB&lt;sub&gt;</code></p><p><code>5690</code><code>1&lt;/sub&gt;</code></p><p><code>5691</code><code> knockout mice or in SR141716-treated wild-type mice, which also displayed a reduced maximal effort to obtain cocaine infusion in a progressive ratio schedule, compared with untreated wild-type mice (&lt;a href="#R759" rid="R759" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919842"&gt;</code></p><p><code>5692</code><code>Martin et al., 2000&lt;/a&gt;</code></p><p><code>5693</code><code>; &lt;a href="#R1127" rid="R1127" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919270"&gt;</code></p><p><code>5694</code><code>Soria et al., 2005&lt;/a&gt;</code></p><p><code>5695</code><code>). Furthermore, prior use of cannabis was found to enhance the &amp;#x0201c;high&amp;#x0201d; elicited by subsequent use of cocaine in humans (&lt;a href="#R327" rid="R327" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918981"&gt;</code></p><p><code>5696</code><code>Foltin et al., 1993&lt;/a&gt;</code></p><p><code>5697</code><code>; &lt;a href="#R709" rid="R709" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918930"&gt;</code></p><p><code>5698</code><code>Lukas et al., 1994&lt;/a&gt;</code></p><p><code>5699</code><code>) and also to hasten relapse in abstinent former cocaine users (&lt;a href="#R1002" rid="R1002" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918989"&gt;</code></p><p><code>5700</code><code>Rawson et al., 1986&lt;/a&gt;</code></p><p><code>5701</code><code>). Furthermore, a recent genetic study found an association between an (AAT)n triplet repeat polymorphism in the &lt;em&gt;</code></p><p><code>5702</code><code>CNR1&lt;/em&gt;</code></p><p><code>5703</code><code> gene encoding the CB&lt;sub&gt;</code></p><p><code>5704</code><code>1&lt;/sub&gt;</code></p><p><code>5705</code><code> receptor with cocaine addiction in an African-Caribbean population (&lt;a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653423"&gt;</code></p><p><code>5706</code><code>Ballon et al., 2006&lt;/a&gt;</code></p><p><code>5707</code><code>). Treatment with HU-210 promoted reinstatement of cocaine-seeking behavior in rats, whereas treatment with SR141716 prevented reinstatement (&lt;a href="#R255" rid="R255" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919055"&gt;</code></p><p><code>5708</code><code>De Vries et al., 2001&lt;/a&gt;</code></p><p><code>5709</code><code>). Thus, the endocannabinoid system may be involved in the acquisition and consolidation of cocaine addiction as well as in relapse, through mechanisms other than an effect on the cocaine-induced increase in dopaminergic transmission in the nAc. These latter studies also predict the possible effectiveness of rimonabant in the treatment of cocaine addiction.&lt;/p&gt;</code></p><p><code>5710</code><code>&lt;/div&gt;</code></p><p><code>5711</code><code>&lt;div id="S33" class="sec"&gt;</code></p><p><code>5712</code><code>&lt;p&gt;</code></p><p><code>5713</code><code>&lt;/p&gt;</code></p><p><code>5714</code><code>&lt;h5 id="S33title" class="inline"&gt;</code></p><p><code>5715</code><code>d. Alcohol &lt;/h5&gt;</code></p><p><code>5716</code><code>&lt;p id="P146" class="p p-first"&gt;</code></p><p><code>5717</code><code>Several lines of evidence indicate the involvement of the endocannabinoid system in alcohol drinking behavior (recently reviewed by &lt;a href="#R197" rid="R197" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919069"&gt;</code></p><p><code>5718</code><code>Colombo et al., 2005&lt;/a&gt;</code></p><p><code>5719</code><code>). Chronic alcohol intake increases endocannabinoid levels in the limbic forebrain (&lt;a href="#R413" rid="R413" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919016"&gt;</code></p><p><code>5720</code><code>Gonzalez et al., 2002&lt;/a&gt;</code></p><p><code>5721</code><code>) and decreases CB&lt;sub&gt;</code></p><p><code>5722</code><code>1&lt;/sub&gt;</code></p><p><code>5723</code><code> receptor binding and signaling (&lt;a href="#R47" rid="R47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653435"&gt;</code></p><p><code>5724</code><code>Basavarajappa and Hungund, 2002&lt;/a&gt;</code></p><p><code>5725</code><code>). Studies in the late 1990s indicated the effectiveness of SR141716 in reducing voluntary ethanol intake in rodent models of ethanol drinking (&lt;a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918984"&gt;</code></p><p><code>5726</code><code>Arnone et al., 1997&lt;/a&gt;</code></p><p><code>5727</code><code>; &lt;a href="#R195" rid="R195" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919318"&gt;</code></p><p><code>5728</code><code>Colombo et al., 1998b&lt;/a&gt;</code></p><p><code>5729</code><code>; &lt;a href="#R340" rid="R340" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919409"&gt;</code></p><p><code>5730</code><code>Freedland et al., 2001&lt;/a&gt;</code></p><p><code>5731</code><code>), whereas cannabinoid agonists promoted drinking (&lt;a href="#R354" rid="R354" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918856"&gt;</code></p><p><code>5732</code><code>Gallate et al., 1999&lt;/a&gt;</code></p><p><code>5733</code><code>; &lt;a href="#R196" rid="R196" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920083"&gt;</code></p><p><code>5734</code><code>Colombo et al., 2002&lt;/a&gt;</code></p><p><code>5735</code><code>). Operant self-administration of ethanol and relapse to drinking are also inhibited by SR141716 (&lt;a href="#R183" rid="R183" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920311"&gt;</code></p><p><code>5736</code><code>Cippitelli et al., 2005&lt;/a&gt;</code></p><p><code>5737</code><code>; &lt;a href="#R291" rid="R291" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919387"&gt;</code></p><p><code>5738</code><code>Economidou et al., 2006&lt;/a&gt;</code></p><p><code>5739</code><code>) and potentiated by chronic exposure to a cannabinoid agonist (&lt;a href="#R704" rid="R704" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637200"&gt;</code></p><p><code>5740</code><code>Lopez-Moreno et al., 2005&lt;/a&gt;</code></p><p><code>5741</code><code>).&lt;/p&gt;</code></p><p><code>5742</code><code>&lt;p id="P147"&gt;</code></p><p><code>5743</code><code>The possible role of the endocannabinoid system in ethanol preference was further indicated by observations of reduced voluntary ethanol drinking in CB&lt;sub&gt;</code></p><p><code>5744</code><code>1&lt;/sub&gt;</code></p><p><code>5745</code><code> knockout compared with wild-type mice (&lt;a href="#R533" rid="R533" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918736"&gt;</code></p><p><code>5746</code><code>Hungund et al., 2003&lt;/a&gt;</code></p><p><code>5747</code><code>; &lt;a href="#R976" rid="R976" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918952"&gt;</code></p><p><code>5748</code><code>Poncelet et al., 2003&lt;/a&gt;</code></p><p><code>5749</code><code>; &lt;a href="#R1267" rid="R1267" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919375"&gt;</code></p><p><code>5750</code><code>Wang et al., 2003&lt;/a&gt;</code></p><p><code>5751</code><code>; &lt;a href="#R647" rid="R647" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919457"&gt;</code></p><p><code>5752</code><code>Lallemand and de Witte, 2004&lt;/a&gt;</code></p><p><code>5753</code><code>; &lt;a href="#R869" rid="R869" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919516"&gt;</code></p><p><code>5754</code><code>Naassila et al., 2004&lt;/a&gt;</code></p><p><code>5755</code><code>; &lt;a href="#R1175" rid="R1175" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920242"&gt;</code></p><p><code>5756</code><code>Thanos et al., 2005&lt;/a&gt;</code></p><p><code>5757</code><code>), although no difference was noted in one study (&lt;a href="#R991" rid="R991" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637204"&gt;</code></p><p><code>5758</code><code>Racz et al., 2003&lt;/a&gt;</code></p><p><code>5759</code><code>). Sensitivity to alcohol is inversely related to the chance of becoming an alcoholic among humans (&lt;a href="#R1080" rid="R1080" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920382"&gt;</code></p><p><code>5760</code><code>Schuckit, 1997&lt;/a&gt;</code></p><p><code>5761</code><code>), and the same inverse relationship was noted in CB&lt;sub&gt;</code></p><p><code>5762</code><code>1&lt;/sub&gt;</code></p><p><code>5763</code><code> knockout mice and their wild-type littermates (&lt;a href="#R869" rid="R869" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920263"&gt;</code></p><p><code>5764</code><code>Naassila et al., 2004&lt;/a&gt;</code></p><p><code>5765</code><code>). The reduced voluntary ethanol intake in CB&lt;sub&gt;</code></p><p><code>5766</code><code>1&lt;/sub&gt;</code></p><p><code>5767</code><code> knockout mice was associated with reduced alcohol-induced CPP (&lt;a href="#R523" rid="R523" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918822"&gt;</code></p><p><code>5768</code><code>Houchi et al., 2004&lt;/a&gt;</code></p><p><code>5769</code><code>; &lt;a href="#R1175" rid="R1175" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919474"&gt;</code></p><p><code>5770</code><code>Thanos et al., 2005&lt;/a&gt;</code></p><p><code>5771</code><code>), a further indication of the role of CB&lt;sub&gt;</code></p><p><code>5772</code><code>1&lt;/sub&gt;</code></p><p><code>5773</code><code> receptors in the rewarding effects of alcohol.&lt;/p&gt;</code></p><p><code>5774</code><code>&lt;p id="P148"&gt;</code></p><p><code>5775</code><code>Similar to cannabinoids and other drugs of abuse, alcohol intake can also result in increased dopamine release in the nAc (&lt;a href="#R1278" rid="R1278" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919293"&gt;</code></p><p><code>5776</code><code>Weiss et al., 1993&lt;/a&gt;</code></p><p><code>5777</code><code>; &lt;a href="#R149" rid="R149" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919659"&gt;</code></p><p><code>5778</code><code>Campbell and McBride, 1995&lt;/a&gt;</code></p><p><code>5779</code><code>). The reported absence of such release in CB&lt;sub&gt;</code></p><p><code>5780</code><code>1&lt;/sub&gt;</code></p><p><code>5781</code><code> knockout mice and the ability of SR141716 to block ethanol-induced dopamine release in wild-type mice further suggest the involvement of endocannabinoids in the reinforcing effects of ethanol. However, the brain site where ethanol-induced endocannabinoid release and CB&lt;sub&gt;</code></p><p><code>5782</code><code>1&lt;/sub&gt;</code></p><p><code>5783</code><code> receptor activation occur is not yet known. The recent observation that microinjection of SR141716 into the prefrontal cortex of alcohol-preferring AA rats inhibited ethanol self-administration suggests that this region may be one of the sites involved (&lt;a href="#R465" rid="R465" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_393488953"&gt;</code></p><p><code>5784</code><code>Hansson et al., 2006&lt;/a&gt;</code></p><p><code>5785</code><code>). In the same study, FAAH activity and CB&lt;sub&gt;</code></p><p><code>5786</code><code>1&lt;/sub&gt;</code></p><p><code>5787</code><code> signaling were both reduced in the same brain region of AA rats compared with their nonpreferring ANA counterparts, and microinjection of the FAAH inhibitor URB597 increased ethanol self-administration (&lt;a href="#R465" rid="R465" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_393488947"&gt;</code></p><p><code>5788</code><code>Hansson et al., 2006&lt;/a&gt;</code></p><p><code>5789</code><code>). Analogous findings in female FAAH knockout mice are their increased voluntary ethanol intake and decreased alcohol sensitivity (&lt;a href="#R48" rid="R48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919679"&gt;</code></p><p><code>5790</code><code>Basavarajappa et al., 2006&lt;/a&gt;</code></p><p><code>5791</code><code>). These findings suggest that increased anandamide tone secondary to decreased FAAH activity in the prefrontal cortex may be causally linked to high alcohol preference. Such a scenario would be compatible with evidence for an association between problem drug and alcohol use and a missense mutation in the human FAAH gene (&lt;a href="#R1111" rid="R1111" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918906"&gt;</code></p><p><code>5792</code><code>Sipe et al., 2002&lt;/a&gt;</code></p><p><code>5793</code><code>).&lt;/p&gt;</code></p><p><code>5794</code><code>&lt;p id="P149" class="p p-last"&gt;</code></p><p><code>5795</code><code>A number of mediators have been implicated in the control of appetite for both food and alcohol. In the case of endocannabinoids, the regulation is &amp;#x0201c;unidirectional&amp;#x0201d;, i.e., endocannabinoids promote both food intake (see section III.A.3.) and alcohol drinking. Because both food intake and alcohol drinking activate the brain reward pathways, one might postulate that the role of endocannabinoids in promoting drinking behavior would be most prominent in the type of alcoholics who drink for the rewarding effects of alcohol, such as young binge-drinkers. The high alcohol preference of C57BL6 mice and the role of the endocannabinoid system mediating it were found to be age-dependent (&lt;a href="#R1267" rid="R1267" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920397"&gt;</code></p><p><code>5796</code><code>Wang et al., 2003&lt;/a&gt;</code></p><p><code>5797</code><code>), which is compatible with such a possibility. In contrast, the effects of NPY and CRH on food intake and ethanol consumption are bidirectional: NPY increases food intake (&lt;a href="#R184" rid="R184" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920152"&gt;</code></p><p><code>5798</code><code>Clark et al., 1984&lt;/a&gt;</code></p><p><code>5799</code><code>) but reduces ethanol consumption (&lt;a href="#R1176" rid="R1176" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918834"&gt;</code></p><p><code>5800</code><code>Thiele et al., 1998&lt;/a&gt;</code></p><p><code>5801</code><code>), whereas CRH is anoretic (&lt;a href="#R122" rid="R122" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918778"&gt;</code></p><p><code>5802</code><code>Britton et al., 1982&lt;/a&gt;</code></p><p><code>5803</code><code>) but promotes ethanol drinking (&lt;a href="#R377" rid="R377" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919582"&gt;</code></p><p><code>5804</code><code>George et al., 1990&lt;/a&gt;</code></p><p><code>5805</code><code>). The effects of NPY and CRH on alcohol preference correlate with their effects on anxiety-like behaviors, NPY being anxiolytic (&lt;a href="#R479" rid="R479" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919485"&gt;</code></p><p><code>5806</code><code>Heilig et al., 1989&lt;/a&gt;</code></p><p><code>5807</code><code>) and CRH being anxiogenic (&lt;a href="#R623" rid="R623" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920142"&gt;</code></p><p><code>5808</code><code>Koob and Thatcher-Britton, 1985&lt;/a&gt;</code></p><p><code>5809</code><code>). We would predict that CB&lt;sub&gt;</code></p><p><code>5810</code><code>1&lt;/sub&gt;</code></p><p><code>5811</code><code> antagonists will be more effective in reducing the drive to drink in younger people who drink for the rewarding effects of alcohol, whereas CRH antagonists or NPY agonists would be more effective in older, chronic alcoholics who more likely drink to suppress the negative affect and anxiety of alcohol withdrawal. This hypothesis may be tested by appropriately designed clinical trials. Studies to test the safety and efficacy of rimonabant in the treatment of alcoholism and alcohol abuse are currently underway at the National Institute on Alcohol Abuse and Alcoholism.&lt;/p&gt;</code></p><p><code>5812</code><code>&lt;/div&gt;</code></p><p><code>5813</code><code>&lt;div id="S34" class="sec sec-last"&gt;</code></p><p><code>5814</code><code>&lt;p&gt;</code></p><p><code>5815</code><code>&lt;/p&gt;</code></p><p><code>5816</code><code>&lt;h5 id="S34title" class="inline"&gt;</code></p><p><code>5817</code><code>e. Psychostimulants &lt;/h5&gt;</code></p><p><code>5818</code><code>&lt;p id="P150" class="p p-first-last"&gt;</code></p><p><code>5819</code><code>3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) is a psychostimulant abused for its euphorigenic and stimulant properties, and it is often used in combination with marijuana. Intracerebral self-administration of MDMA was found to be reduced in the presence of the cannabinoid agonist CP55,940 and increased after treatment with SR141716. These findings were interpreted to indicate synergism between the reinforcing effects of cannabinoids and MDMA and a reduction in the motivational value of MDMA by CB&lt;sub&gt;</code></p><p><code>5820</code><code>1&lt;/sub&gt;</code></p><p><code>5821</code><code> blockade (&lt;a href="#R115" rid="R115" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919374"&gt;</code></p><p><code>5822</code><code>Braida and Sala, 2002&lt;/a&gt;</code></p><p><code>5823</code><code>). In another study, the authors found that SR141716 blocked MDMA-induced CPP (&lt;a href="#R113" rid="R113" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919326"&gt;</code></p><p><code>5824</code><code>Braida et al., 2005&lt;/a&gt;</code></p><p><code>5825</code><code>). Amphetamine-induced long-term synaptic depression in the amygdala could be blocked by the CB&lt;sub&gt;</code></p><p><code>5826</code><code>1&lt;/sub&gt;</code></p><p><code>5827</code><code> antagonist AM251, mimicked by the agonist WIN 55,212-2, and occluded by the transport inhibitor AM404, suggesting that amphetamine-induced LTD and related behavioral effects may be mediated via endocannabinoid release (&lt;a href="#R530" rid="R530" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637205"&gt;</code></p><p><code>5828</code><code>Huang et al., 2003&lt;/a&gt;</code></p><p><code>5829</code><code>). Together, these findings suggest that CB&lt;sub&gt;</code></p><p><code>5830</code><code>1&lt;/sub&gt;</code></p><p><code>5831</code><code> antagonists may be of value in the treatment of addiction to psychostimulants, including amphetamine and MDMA.&lt;/p&gt;</code></p><p><code>5832</code><code>&lt;/div&gt;</code></p><p><code>5833</code><code>&lt;/div&gt;</code></p><p><code>5834</code><code>&lt;/div&gt;</code></p><p><code>5835</code><code>&lt;div id="S35" class="sec"&gt;</code></p><p><code>5836</code><code>&lt;h3 id="S35title"&gt;</code></p><p><code>5837</code><code>D. Cardiovascular and Respiratory Disorders&lt;/h3&gt;</code></p><p><code>5838</code><code>&lt;p id="P151" class="p p-first"&gt;</code></p><p><code>5839</code><code>Besides their well known neurobehavioral and immunological actions, cannabinoids and their endogenous and synthetic analogs exert important cardiovascular effects. The underlying mechanisms are complex, involving direct effects on the vasculature (&lt;a href="#R372" rid="R372" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919295"&gt;</code></p><p><code>5840</code><code>Gebremedhin et al., 1999&lt;/a&gt;</code></p><p><code>5841</code><code>; &lt;a href="#R556" rid="R556" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920069"&gt;</code></p><p><code>5842</code><code>J&amp;#x000e1;rai et al., 1999&lt;/a&gt;</code></p><p><code>5843</code><code>; &lt;a href="#R1249" rid="R1249" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920389"&gt;</code></p><p><code>5844</code><code>Wagner et al., 2001b&lt;/a&gt;</code></p><p><code>5845</code><code>; &lt;a href="#R1246" rid="R1246" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920159"&gt;</code></p><p><code>5846</code><code>Wagner et al., 2005&lt;/a&gt;</code></p><p><code>5847</code><code>) and myocardium (&lt;a href="#R104" rid="R104" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918933"&gt;</code></p><p><code>5848</code><code>Bonz et al., 2003&lt;/a&gt;</code></p><p><code>5849</code><code>; &lt;a href="#R773" rid="R773" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920055"&gt;</code></p><p><code>5850</code><code>Maslov et al., 2004&lt;/a&gt;</code></p><p><code>5851</code><code>; &lt;a href="#R1141" rid="R1141" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918982"&gt;</code></p><p><code>5852</code><code>Sterin-Borda et al., 2005&lt;/a&gt;</code></p><p><code>5853</code><code>), as well as modulation of autonomic outflow through sites of action in the central (&lt;a href="#R893" rid="R893" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919411"&gt;</code></p><p><code>5854</code><code>Niederhoffer and Szabo, 2000&lt;/a&gt;</code></p><p><code>5855</code><code>; &lt;a href="#R967" rid="R967" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918943"&gt;</code></p><p><code>5856</code><code>Pfitzer et al., 2004&lt;/a&gt;</code></p><p><code>5857</code><code>) and the peripheral nervous systems (&lt;a href="#R541" rid="R541" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919671"&gt;</code></p><p><code>5858</code><code>Ishac et al., 1996&lt;/a&gt;</code></p><p><code>5859</code><code>; &lt;a href="#R739" rid="R739" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653449"&gt;</code></p><p><code>5860</code><code>Malinowska et al., 1997&lt;/a&gt;</code></p><p><code>5861</code><code>; &lt;a href="#R1158" rid="R1158" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918779"&gt;</code></p><p><code>5862</code><code>Szabo et al., 2001&lt;/a&gt;</code></p><p><code>5863</code><code>; &lt;a href="#R892" rid="R892" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653513"&gt;</code></p><p><code>5864</code><code>Niederhoffer et al., 2003&lt;/a&gt;</code></p><p><code>5865</code><code>). As for endogenous cannabinoids, their effects are also complicated by their rapid metabolism, which liberates arachidonic acid that can be further metabolized into vasoactive prostanoids (reviewed in &lt;a href="#R806" rid="R806" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919978"&gt;</code></p><p><code>5866</code><code>Mechoulam et al., 1998&lt;/a&gt;</code></p><p><code>5867</code><code>; &lt;a href="#R637" rid="R637" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919965"&gt;</code></p><p><code>5868</code><code>Kunos et al., 2000&lt;/a&gt;</code></p><p><code>5869</code><code>; &lt;a href="#R998" rid="R998" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918756"&gt;</code></p><p><code>5870</code><code>Randall et al., 2002&lt;/a&gt;</code></p><p><code>5871</code><code>; &lt;a href="#R994" rid="R994" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919461"&gt;</code></p><p><code>5872</code><code>Ralevic et al., 2002&lt;/a&gt;</code></p><p><code>5873</code><code>).&lt;/p&gt;</code></p><p><code>5874</code><code>&lt;p id="P152"&gt;</code></p><p><code>5875</code><code>Studies to date indicate that CB&lt;sub&gt;</code></p><p><code>5876</code><code>1&lt;/sub&gt;</code></p><p><code>5877</code><code> receptors are much more important than CB&lt;sub&gt;</code></p><p><code>5878</code><code>2&lt;/sub&gt;</code></p><p><code>5879</code><code> receptors in cardiovascular regulation, the latter so far being implicated only in ischemic preconditioning and ischemia/reperfusion (I/R) injury of the myocardium (see below). CB&lt;sub&gt;</code></p><p><code>5880</code><code>1&lt;/sub&gt;</code></p><p><code>5881</code><code> receptors have been detected in the human, rat, and mouse myocardium where they mediate negative inotropy (&lt;a href="#R104" rid="R104" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919012"&gt;</code></p><p><code>5882</code><code>Bonz et al., 2003&lt;/a&gt;</code></p><p><code>5883</code><code>; &lt;a href="#R52" rid="R52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653520"&gt;</code></p><p><code>5884</code><code>B&amp;#x000e1;tkai et al., 2004b&lt;/a&gt;</code></p><p><code>5885</code><code>; &lt;a href="#R921" rid="R921" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919266"&gt;</code></p><p><code>5886</code><code>Pacher et al., 2004&lt;/a&gt;</code></p><p><code>5887</code><code>, &lt;a href="#R926" rid="R926" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918805"&gt;</code></p><p><code>5888</code><code>b&lt;/a&gt;</code></p><p><code>5889</code><code>, &lt;a href="#R922" rid="R922" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918791"&gt;</code></p><p><code>5890</code><code>2005a&lt;/a&gt;</code></p><p><code>5891</code><code>,&lt;a href="#R923" rid="R923" class=" bibr popnode"&gt;</code></p><p><code>5892</code><code>b&lt;/a&gt;</code></p><p><code>5893</code><code>,&lt;a href="#R925" rid="R925" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653438"&gt;</code></p><p><code>5894</code><code>d&lt;/a&gt;</code></p><p><code>5895</code><code>; &lt;a href="#R302" rid="R302" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919141"&gt;</code></p><p><code>5896</code><code>Engeli et al., 2005&lt;/a&gt;</code></p><p><code>5897</code><code>; &lt;a href="#R1246" rid="R1246" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918936"&gt;</code></p><p><code>5898</code><code>Wagner et al., 2005&lt;/a&gt;</code></p><p><code>5899</code><code>) and also in vascular tissues (&lt;a href="#R372" rid="R372" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919771"&gt;</code></p><p><code>5900</code><code>Gebremedhin et al., 1999&lt;/a&gt;</code></p><p><code>5901</code><code>; &lt;a href="#R694" rid="R694" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920308"&gt;</code></p><p><code>5902</code><code>Liu et al., 2000&lt;/a&gt;</code></p><p><code>5903</code><code>), where their activation leads to vasodilation, and both of these effects appear to be involved in the hypotensive effect of anandamide (&lt;a href="#R1247" rid="R1247" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919089"&gt;</code></p><p><code>5904</code><code>Wagner et al., 2001a&lt;/a&gt;</code></p><p><code>5905</code><code>,&lt;a href="#R1249" rid="R1249" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919651"&gt;</code></p><p><code>5906</code><code>b&lt;/a&gt;</code></p><p><code>5907</code><code>; &lt;a href="#R51" rid="R51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653419"&gt;</code></p><p><code>5908</code><code>B&amp;#x000e1;tkai et al., 2004a&lt;/a&gt;</code></p><p><code>5909</code><code>,&lt;a href="#R52" rid="R52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653360"&gt;</code></p><p><code>5910</code><code>b&lt;/a&gt;</code></p><p><code>5911</code><code>; &lt;a href="#R921" rid="R921" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920072"&gt;</code></p><p><code>5912</code><code>Pacher et al., 2004&lt;/a&gt;</code></p><p><code>5913</code><code>, &lt;a href="#R926" rid="R926" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919076"&gt;</code></p><p><code>5914</code><code>b&lt;/a&gt;</code></p><p><code>5915</code><code>, &lt;a href="#R922" rid="R922" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919636"&gt;</code></p><p><code>5916</code><code>2005a&lt;/a&gt;</code></p><p><code>5917</code><code>,&lt;a href="#R923" rid="R923" class=" bibr popnode"&gt;</code></p><p><code>5918</code><code>b&lt;/a&gt;</code></p><p><code>5919</code><code>,&lt;a href="#R925" rid="R925" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653511"&gt;</code></p><p><code>5920</code><code>d&lt;/a&gt;</code></p><p><code>5921</code><code>) in anesthetized rodents. Sympathetic nerve terminals contain presynaptic CB&lt;sub&gt;</code></p><p><code>5922</code><code>1&lt;/sub&gt;</code></p><p><code>5923</code><code> receptors, stimulation of which inhibits norepinephrine release (&lt;a href="#R541" rid="R541" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919391"&gt;</code></p><p><code>5924</code><code>Ishac et al., 1996&lt;/a&gt;</code></p><p><code>5925</code><code>), which contributes to the bradycardic effects of anandamide in vivo (&lt;a href="#R1249" rid="R1249" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919843"&gt;</code></p><p><code>5926</code><code>Wagner et al., 2001b&lt;/a&gt;</code></p><p><code>5927</code><code>). Anandamide-induced cardiovascular depressor effects are devoid of a centrally mediated component (&lt;a href="#R1220" rid="R1220" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919677"&gt;</code></p><p><code>5928</code><code>Varga et al., 1996&lt;/a&gt;</code></p><p><code>5929</code><code>), in contrast to the effects of certain synthetic cannabinoids, which cause centrally mediated sympathoexcitation (&lt;a href="#R893" rid="R893" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919063"&gt;</code></p><p><code>5930</code><code>Niederhoffer and Szabo, 2000&lt;/a&gt;</code></p><p><code>5931</code><code>; &lt;a href="#R363" rid="R363" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920355"&gt;</code></p><p><code>5932</code><code>Gardiner et al., 2001&lt;/a&gt;</code></p><p><code>5933</code><code>, &lt;a href="#R365" rid="R365" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919451"&gt;</code></p><p><code>5934</code><code>2002b&lt;/a&gt;</code></p><p><code>5935</code><code>).&lt;/p&gt;</code></p><p><code>5936</code><code>&lt;p id="P153"&gt;</code></p><p><code>5937</code><code>The vasorelaxant effect of endocannabinoids and synthetic cannabinoids in vitro are complex and display tissue and interspecies differences. They may involve CB&lt;sub&gt;</code></p><p><code>5938</code><code>1&lt;/sub&gt;</code></p><p><code>5939</code><code> and TRPV&lt;sub&gt;</code></p><p><code>5940</code><code>1&lt;/sub&gt;</code></p><p><code>5941</code><code> receptor- and NO-mediated or NO-independent mechanisms and also as yet undefined endothelial site(s) of action. A detailed discussion of these in vitro vasodilatory effects can be found in recent reviews (&lt;a href="#R498" rid="R498" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919797"&gt;</code></p><p><code>5942</code><code>Hillard, 2000&lt;/a&gt;</code></p><p><code>5943</code><code>; &lt;a href="#R637" rid="R637" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920275"&gt;</code></p><p><code>5944</code><code>Kunos et al., 2000&lt;/a&gt;</code></p><p><code>5945</code><code>, &lt;a href="#R636" rid="R636" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919336"&gt;</code></p><p><code>5946</code><code>2002&lt;/a&gt;</code></p><p><code>5947</code><code>; &lt;a href="#R994" rid="R994" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919167"&gt;</code></p><p><code>5948</code><code>Ralevic et al., 2002&lt;/a&gt;</code></p><p><code>5949</code><code>; &lt;a href="#R998" rid="R998" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918703"&gt;</code></p><p><code>5950</code><code>Randall et al., 2002&lt;/a&gt;</code></p><p><code>5951</code><code>, &lt;a href="#R999" rid="R999" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919925"&gt;</code></p><p><code>5952</code><code>2004&lt;/a&gt;</code></p><p><code>5953</code><code>; &lt;a href="#R57" rid="R57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920289"&gt;</code></p><p><code>5954</code><code>Begg et al., 2005&lt;/a&gt;</code></p><p><code>5955</code><code>; &lt;a href="#R922" rid="R922" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920202"&gt;</code></p><p><code>5956</code><code>Pacher et al., 2005a&lt;/a&gt;</code></p><p><code>5957</code><code>,&lt;a href="#R923" rid="R923" class=" bibr popnode"&gt;</code></p><p><code>5958</code><code>b&lt;/a&gt;</code></p><p><code>5959</code><code>) and is beyond the scope of this review.&lt;/p&gt;</code></p><p><code>5960</code><code>&lt;p id="P154"&gt;</code></p><p><code>5961</code><code>Compared with the growing body of information on the vascular effects of cannabinoids, less is known about cannabinoid-induced direct cardiac effects. Anandamide, &lt;em&gt;</code></p><p><code>5962</code><code>R&lt;/em&gt;</code></p><p><code>5963</code><code>-methanandamide, and HU-210 dose dependently decrease contractile performance in isolated, electrically paced human atrial muscle, an effect blocked by the potent CB&lt;sub&gt;</code></p><p><code>5964</code><code>1&lt;/sub&gt;</code></p><p><code>5965</code><code> antagonist AM251, whereas the involvement of CB&lt;sub&gt;</code></p><p><code>5966</code><code>2&lt;/sub&gt;</code></p><p><code>5967</code><code> receptors, NO, or prostanoids could be excluded (&lt;a href="#R104" rid="R104" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918712"&gt;</code></p><p><code>5968</code><code>Bonz et al., 2003&lt;/a&gt;</code></p><p><code>5969</code><code>). HU-210 also decreased left ventricular developed pressure in isolated perfused rat hearts through CB&lt;sub&gt;</code></p><p><code>5970</code><code>1&lt;/sub&gt;</code></p><p><code>5971</code><code> receptor activation (&lt;a href="#R773" rid="R773" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919372"&gt;</code></p><p><code>5972</code><code>Maslov et al., 2004&lt;/a&gt;</code></p><p><code>5973</code><code>; &lt;a href="#R630" rid="R630" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918920"&gt;</code></p><p><code>5974</code><code>Krylatov et al., 2005&lt;/a&gt;</code></p><p><code>5975</code><code>). Another study using isolated, perfused, rat Langendorff heart preparations to study the effects of anandamide, &lt;em&gt;</code></p><p><code>5976</code><code>R&lt;/em&gt;</code></p><p><code>5977</code><code>-methanandamide, and palmitoylethanolamide on coronary perfusion pressure and left ventricular developed pressure suggested the involvement of a cardiac site of action distinct from CB&lt;sub&gt;</code></p><p><code>5978</code><code>1&lt;/sub&gt;</code></p><p><code>5979</code><code> and CB&lt;sub&gt;</code></p><p><code>5980</code><code>2&lt;/sub&gt;</code></p><p><code>5981</code><code> receptors (&lt;a href="#R328" rid="R328" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919120"&gt;</code></p><p><code>5982</code><code>Ford et al., 2002&lt;/a&gt;</code></p><p><code>5983</code><code>).&lt;/p&gt;</code></p><p><code>5984</code><code>&lt;p id="P155"&gt;</code></p><p><code>5985</code><code>Several studies have examined the in vivo hemodynamic effects of endocannabinoids and their synthetic analogs in rodents (recently reviewed in &lt;a href="#R57" rid="R57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919027"&gt;</code></p><p><code>5986</code><code>Begg et al., 2005&lt;/a&gt;</code></p><p><code>5987</code><code>; &lt;a href="#R922" rid="R922" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919292"&gt;</code></p><p><code>5988</code><code>Pacher et al., 2005a&lt;/a&gt;</code></p><p><code>5989</code><code>,&lt;a href="#R923" rid="R923" class=" bibr popnode"&gt;</code></p><p><code>5990</code><code>b&lt;/a&gt;</code></p><p><code>5991</code><code>). Intravenous administration of anandamide causes a triphasic blood pressure response in anesthetized mice and rats, in which a prolonged hypotensive effect (phase III) is preceded by a transient, vagally mediated, fall in heart rate, cardiac and contractility, and blood pressure and an increase in total peripheral resistance (phase I) followed by a brief, pressor response (phase II) associated with increased cardiac contractility (&lt;a href="#R1219" rid="R1219" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918762"&gt;</code></p><p><code>5992</code><code>Varga et al., 1995&lt;/a&gt;</code></p><p><code>5993</code><code>; &lt;a href="#R646" rid="R646" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919548"&gt;</code></p><p><code>5994</code><code>Lake et al., 1997b&lt;/a&gt;</code></p><p><code>5995</code><code>; &lt;a href="#R921" rid="R921" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920346"&gt;</code></p><p><code>5996</code><code>Pacher et al., 2004&lt;/a&gt;</code></p><p><code>5997</code><code>, &lt;a href="#R926" rid="R926" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918809"&gt;</code></p><p><code>5998</code><code>b&lt;/a&gt;</code></p><p><code>5999</code><code>, &lt;a href="#R925" rid="R925" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653412"&gt;</code></p><p><code>6000</code><code>2005d&lt;/a&gt;</code></p><p><code>6001</code><code>). Inhibition of the phase I bradycardic response by TRPV&lt;sub&gt;</code></p><p><code>6002</code><code>1&lt;/sub&gt;</code></p><p><code>6003</code><code> receptor antagonists in rats (&lt;a href="#R740" rid="R740" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653466"&gt;</code></p><p><code>6004</code><code>Malinowska et al., 2001&lt;/a&gt;</code></p><p><code>6005</code><code>) and the absence of both phase I and phase II responses in TRPV&lt;sub&gt;</code></p><p><code>6006</code><code>1&lt;/sub&gt;</code></p><p><code>6007</code><code>&lt;sup&gt;</code></p><p><code>6008</code><code>&amp;#x02212;/&amp;#x02212;&lt;/sup&gt;</code></p><p><code>6009</code><code> mice (&lt;a href="#R921" rid="R921" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919780"&gt;</code></p><p><code>6010</code><code>Pacher et al., 2004&lt;/a&gt;</code></p><p><code>6011</code><code>) imply that these components are mediated by TRPV&lt;sub&gt;</code></p><p><code>6012</code><code>1&lt;/sub&gt;</code></p><p><code>6013</code><code> receptors. Additional central and vascular mechanisms may also be involved in the brief pressor response (phase II) in anesthetized rats (&lt;a href="#R640" rid="R640" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919107"&gt;</code></p><p><code>6014</code><code>Kwolek et al., 2005&lt;/a&gt;</code></p><p><code>6015</code><code>). The third, prolonged hypotensive phase (phase III) is characterized by marked decreased cardiac contractility and slightly decreased total peripheral resistance, and it lasts up to 10 min in anesthetized mice (&lt;a href="#R926" rid="R926" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920383"&gt;</code></p><p><code>6016</code><code>Pacher et al., 2004b&lt;/a&gt;</code></p><p><code>6017</code><code>, &lt;a href="#R925" rid="R925" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653387"&gt;</code></p><p><code>6018</code><code>2005d&lt;/a&gt;</code></p><p><code>6019</code><code>), similar to the hypotensive effect previously described in anesthetized but not conscious rats (&lt;a href="#R1137" rid="R1137" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918797"&gt;</code></p><p><code>6020</code><code>Stein et al., 1996&lt;/a&gt;</code></p><p><code>6021</code><code>; &lt;a href="#R1220" rid="R1220" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919851"&gt;</code></p><p><code>6022</code><code>Varga et al., 1996&lt;/a&gt;</code></p><p><code>6023</code><code>; &lt;a href="#R645" rid="R645" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653467"&gt;</code></p><p><code>6024</code><code>Lake et al., 1997a&lt;/a&gt;</code></p><p><code>6025</code><code>,&lt;a href="#R646" rid="R646" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919274"&gt;</code></p><p><code>6026</code><code>b&lt;/a&gt;</code></p><p><code>6027</code><code>; &lt;a href="#R364" rid="R364" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920004"&gt;</code></p><p><code>6028</code><code>Gardiner et al., 2002a&lt;/a&gt;</code></p><p><code>6029</code><code>; &lt;a href="#R52" rid="R52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653403"&gt;</code></p><p><code>6030</code><code>B&amp;#x000e1;tkai et al., 2004b&lt;/a&gt;</code></p><p><code>6031</code><code>) and also observed with synthetic cannabinoids (&lt;a href="#R1231" rid="R1231" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920118"&gt;</code></p><p><code>6032</code><code>Vidrio et al., 1996&lt;/a&gt;</code></p><p><code>6033</code><code>; &lt;a href="#R645" rid="R645" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653390"&gt;</code></p><p><code>6034</code><code>Lake et al., 1997a&lt;/a&gt;</code></p><p><code>6035</code><code>; &lt;a href="#R925" rid="R925" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653480"&gt;</code></p><p><code>6036</code><code>Pacher et al., 2005d&lt;/a&gt;</code></p><p><code>6037</code><code>).&lt;/p&gt;</code></p><p><code>6038</code><code>&lt;p id="P156" class="p"&gt;</code></p><p><code>6039</code><code>The anandamide-induced phase III hypotension and decreased cardiac contractility, as well as similar hemodynamic responses to synthetic cannabinoids, are mediated by CB&lt;sub&gt;</code></p><p><code>6040</code><code>1&lt;/sub&gt;</code></p><p><code>6041</code><code> receptors. First, these effects are prevented or reversed by selective CB&lt;sub&gt;</code></p><p><code>6042</code><code>1&lt;/sub&gt;</code></p><p><code>6043</code><code> antagonists both in normal rodents (&lt;a href="#R1219" rid="R1219" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919498"&gt;</code></p><p><code>6044</code><code>Varga et al., 1995&lt;/a&gt;</code></p><p><code>6045</code><code>, &lt;a href="#R1220" rid="R1220" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918735"&gt;</code></p><p><code>6046</code><code>1996&lt;/a&gt;</code></p><p><code>6047</code><code>; &lt;a href="#R147" rid="R147" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919564"&gt;</code></p><p><code>6048</code><code>Calignano et al., 1997&lt;/a&gt;</code></p><p><code>6049</code><code>; &lt;a href="#R921" rid="R921" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918935"&gt;</code></p><p><code>6050</code><code>Pacher et al., 2004&lt;/a&gt;</code></p><p><code>6051</code><code>, &lt;a href="#R926" rid="R926" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919884"&gt;</code></p><p><code>6052</code><code>b&lt;/a&gt;</code></p><p><code>6053</code><code>, &lt;a href="#R922" rid="R922" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920026"&gt;</code></p><p><code>6054</code><code>2005a&lt;/a&gt;</code></p><p><code>6055</code><code>,&lt;a href="#R925" rid="R925" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653406"&gt;</code></p><p><code>6056</code><code>d&lt;/a&gt;</code></p><p><code>6057</code><code>) and in mice lacking FAAH, which exhibit increased sensitivity to hypotensive and cardiodepressant effects of anandamide (&lt;a href="#R925" rid="R925" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653363"&gt;</code></p><p><code>6058</code><code>Pacher et al., 2005d&lt;/a&gt;</code></p><p><code>6059</code><code>). Second, there is a positive correlation between the concentrations of various cannabinoid agonists in producing half-maximal hypotensive and bradycardic responses (EC&lt;sub&gt;</code></p><p><code>6060</code><code>50&lt;/sub&gt;</code></p><p><code>6061</code><code>) and in their affinity constants for binding to CB&lt;sub&gt;</code></p><p><code>6062</code><code>1&lt;/sub&gt;</code></p><p><code>6063</code><code> receptors in the brain (&lt;a href="#R645" rid="R645" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653440"&gt;</code></p><p><code>6064</code><code>Lake et al., 1997a&lt;/a&gt;</code></p><p><code>6065</code><code>). Third, cannabinoid-induced hypotension and bradycardia are absent in mice lacking the CB&lt;sub&gt;</code></p><p><code>6066</code><code>1&lt;/sub&gt;</code></p><p><code>6067</code><code> receptor (&lt;a href="#R556" rid="R556" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920181"&gt;</code></p><p><code>6068</code><code>J&amp;#x000e1;rai et al., 1999&lt;/a&gt;</code></p><p><code>6069</code><code>; &lt;a href="#R668" rid="R668" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653463"&gt;</code></p><p><code>6070</code><code>Ledent et al., 1999&lt;/a&gt;</code></p><p><code>6071</code><code>). The involvement of the endocannabinoid system in various cardiovascular disorders is reviewed below.&lt;/p&gt;</code></p><p><code>6072</code><code>&lt;div id="S36" class="sec"&gt;</code></p><p><code>6073</code><code>&lt;p&gt;</code></p><p><code>6074</code><code>&lt;/p&gt;</code></p><p><code>6075</code><code>&lt;h4 id="S36title" class="inline"&gt;</code></p><p><code>6076</code><code>1. Hypertension &lt;/h4&gt;</code></p><p><code>6077</code><code>&lt;p id="P157" class="p p-first"&gt;</code></p><p><code>6078</code><code>Chronic use of cannabis in humans as well as both acute and prolonged administration of THC to experimental animals elicits a long-lasting decrease in blood pressure and heart rate (&lt;a href="#R1039" rid="R1039" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653481"&gt;</code></p><p><code>6079</code><code>Rosenkratz and Braude, 1974&lt;/a&gt;</code></p><p><code>6080</code><code>; &lt;a href="#R65" rid="R65" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920297"&gt;</code></p><p><code>6081</code><code>Benowitz and Jones, 1975&lt;/a&gt;</code></p><p><code>6082</code><code>), whereas the acute effect of smoking cannabis usually increases heart rate with no consistent change in blood pressure (&lt;a href="#R581" rid="R581" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919995"&gt;</code></p><p><code>6083</code><code>Kanakis et al., 1976&lt;/a&gt;</code></p><p><code>6084</code><code>). In a recent study conducted in 63 male cannabis smokers, 22% of subjects experienced symptomatic hypotension, which could be reversed by the administration of 30 or 90 mg but not lower doses of rimonabant, indicating that CB&lt;sub&gt;</code></p><p><code>6085</code><code>1&lt;/sub&gt;</code></p><p><code>6086</code><code> receptors mediate the hypotensive effect of cannabis smoking in humans (&lt;a href="#R419" rid="R419" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918893"&gt;</code></p><p><code>6087</code><code>Gorelick et al., 2006&lt;/a&gt;</code></p><p><code>6088</code><code>).&lt;/p&gt;</code></p><p><code>6089</code><code>&lt;p id="P158"&gt;</code></p><p><code>6090</code><code>More than three decades ago, several studies explored the potential use of cannabinoids to treat hypertension (&lt;a href="#R88" rid="R88" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919783"&gt;</code></p><p><code>6091</code><code>Birmingham, 1973&lt;/a&gt;</code></p><p><code>6092</code><code>; &lt;a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653521"&gt;</code></p><p><code>6093</code><code>Archer, 1974&lt;/a&gt;</code></p><p><code>6094</code><code>; &lt;a href="#R1222" rid="R1222" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918827"&gt;</code></p><p><code>6095</code><code>Varma and Goldbaum, 1975&lt;/a&gt;</code></p><p><code>6096</code><code>; &lt;a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918787"&gt;</code></p><p><code>6097</code><code>Adams et al., 1977&lt;/a&gt;</code></p><p><code>6098</code><code>; &lt;a href="#R226" rid="R226" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919880"&gt;</code></p><p><code>6099</code><code>Crawford and Merritt, 1979&lt;/a&gt;</code></p><p><code>6100</code><code>; &lt;a href="#R1316" rid="R1316" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919942"&gt;</code></p><p><code>6101</code><code>Zaugg and Kyncl, 1983&lt;/a&gt;</code></p><p><code>6102</code><code>). Unfortunately, the initial high anticipation was tempered by a report of the development of rapid tolerance to the hypotensive and bradycardic effects of THC (&lt;a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918711"&gt;</code></p><p><code>6103</code><code>Adams et al., 1976&lt;/a&gt;</code></p><p><code>6104</code><code>) and by the failure to separate the cardiovascular and neurobehavioral effects of cannabinoids. Albeit a later study in spontaneously hypertensive rats (SHR) demonstrated no tolerance to the same effects during a 10-day treatment period (&lt;a href="#R625" rid="R625" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918690"&gt;</code></p><p><code>6105</code><code>Kosersky, 1978&lt;/a&gt;</code></p><p><code>6106</code><code>), interest in this issue had vanished for the next two decades.&lt;/p&gt;</code></p><p><code>6107</code><code>&lt;p id="P159"&gt;</code></p><p><code>6108</code><code>As with many other effects of marijuana, the discovery of endocannabinoids has focused attention on their possible role in cardiovascular regulation. Studies with SR141716 indicated that the hypotensive/bradycardic effects of exogenous anandamide, THC, and potent synthetic cannabinoids are mediated by CB&lt;sub&gt;</code></p><p><code>6109</code><code>1&lt;/sub&gt;</code></p><p><code>6110</code><code> receptors (&lt;a href="#R1219" rid="R1219" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919424"&gt;</code></p><p><code>6111</code><code>Varga et al., 1995&lt;/a&gt;</code></p><p><code>6112</code><code>; &lt;a href="#R645" rid="R645" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653477"&gt;</code></p><p><code>6113</code><code>Lake et al., 1997a&lt;/a&gt;</code></p><p><code>6114</code><code>). CB&lt;sub&gt;</code></p><p><code>6115</code><code>1&lt;/sub&gt;</code></p><p><code>6116</code><code> receptor knockout mice have normal blood pressure (&lt;a href="#R556" rid="R556" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920199"&gt;</code></p><p><code>6117</code><code>J&amp;#x000e1;rai et al., 1999&lt;/a&gt;</code></p><p><code>6118</code><code>; &lt;a href="#R668" rid="R668" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653425"&gt;</code></p><p><code>6119</code><code>Ledent et al., 1999&lt;/a&gt;</code></p><p><code>6120</code><code>) and the blood pressure of normotensive mice and rats is unaffected or slightly reduced by CB&lt;sub&gt;</code></p><p><code>6121</code><code>1&lt;/sub&gt;</code></p><p><code>6122</code><code> antagonists (&lt;a href="#R1219" rid="R1219" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919645"&gt;</code></p><p><code>6123</code><code>Varga et al., 1995&lt;/a&gt;</code></p><p><code>6124</code><code>; &lt;a href="#R645" rid="R645" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653374"&gt;</code></p><p><code>6125</code><code>Lake et al., 1997a&lt;/a&gt;</code></p><p><code>6126</code><code>;Varga B&amp;#x000e1;tkai et al., 2004b). In anesthetized rats, anandamide elicits only a modest and short-lasting hypotensive response (&lt;a href="#R1219" rid="R1219" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920392"&gt;</code></p><p><code>6127</code><code>Varga et al., 1995&lt;/a&gt;</code></p><p><code>6128</code><code>; &lt;a href="#R645" rid="R645" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653482"&gt;</code></p><p><code>6129</code><code>Lake et al., 1997a&lt;/a&gt;</code></p><p><code>6130</code><code>), whereas in conscious normotensive rats it has no hypotensive effect at all (&lt;a href="#R1137" rid="R1137" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920315"&gt;</code></p><p><code>6131</code><code>Stein et al., 1996&lt;/a&gt;</code></p><p><code>6132</code><code>; &lt;a href="#R646" rid="R646" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919969"&gt;</code></p><p><code>6133</code><code>Lake et al., 1997b&lt;/a&gt;</code></p><p><code>6134</code><code>; &lt;a href="#R364" rid="R364" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919562"&gt;</code></p><p><code>6135</code><code>Gardiner et al., 2002&lt;/a&gt;</code></p><p><code>6136</code><code>). Furthermore, inhibitors of anandamide transport or FAAH do not lower blood pressure in normotensive animals (&lt;a href="#R147" rid="R147" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920356"&gt;</code></p><p><code>6137</code><code>Calignano et al., 1997&lt;/a&gt;</code></p><p><code>6138</code><code>; &lt;a href="#R52" rid="R52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653436"&gt;</code></p><p><code>6139</code><code>B&amp;#x000e1;tkai et al., 2004b&lt;/a&gt;</code></p><p><code>6140</code><code>), and mice deficient in FAAH have normal baseline hemodynamic characteristics and baroreceptor reflex function (&lt;a href="#R925" rid="R925" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653395"&gt;</code></p><p><code>6141</code><code>Pacher et al., 2005d&lt;/a&gt;</code></p><p><code>6142</code><code>). As pointed out by a recent editorial (&lt;a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653427"&gt;</code></p><p><code>6143</code><code>Awumey et al., 2005&lt;/a&gt;</code></p><p><code>6144</code><code>), these observations indicate a lack of involvement of endogenous cannabinoids in cardiovascular regulation under normal conditions.&lt;/p&gt;</code></p><p><code>6145</code><code>&lt;p id="P160"&gt;</code></p><p><code>6146</code><code>In contrast, a number of observations indicate that endocannabinoids &lt;em&gt;</code></p><p><code>6147</code><code>are&lt;/em&gt;</code></p><p><code>6148</code><code> involved in cardiovascular regulation in hypertension. Both THC (&lt;a href="#R625" rid="R625" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920036"&gt;</code></p><p><code>6149</code><code>Kosersky, 1978&lt;/a&gt;</code></p><p><code>6150</code><code>) and anandamide (&lt;a href="#R646" rid="R646" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918752"&gt;</code></p><p><code>6151</code><code>Lake et al., 1997b&lt;/a&gt;</code></p><p><code>6152</code><code>, &lt;a href="#R52" rid="R52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653424"&gt;</code></p><p><code>6153</code><code>B&amp;#x000e1;tkai et al., 2004b&lt;/a&gt;</code></p><p><code>6154</code><code>) induce larger and longer lasting hypotension in anesthetized SHR compared with normotensive controls, and the hypotensive effect of anandamide is preserved in conscious SHR (&lt;a href="#R646" rid="R646" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919552"&gt;</code></p><p><code>6155</code><code>Lake et al., 1997b&lt;/a&gt;</code></p><p><code>6156</code><code>). Interestingly, inhalation of THC also resulted in a greater and longer lasting decrease of arterial blood pressure in hypertensive compared with normotensive individuals (&lt;a href="#R226" rid="R226" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920350"&gt;</code></p><p><code>6157</code><code>Crawford and Merritt, 1979&lt;/a&gt;</code></p><p><code>6158</code><code>). By using a sophisticated pressure-volume analysis system, the hemodynamic effects of cannabinoid agonists and antagonists were evaluated in three different models of experimental hypertension (&lt;a href="#R52" rid="R52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653462"&gt;</code></p><p><code>6159</code><code>B&amp;#x000e1;tkai et al., 2004b&lt;/a&gt;</code></p><p><code>6160</code><code>). In anesthetized SHR, the CB&lt;sub&gt;</code></p><p><code>6161</code><code>1&lt;/sub&gt;</code></p><p><code>6162</code><code> antagonists AM251 and SR141716 both caused marked and sustained further increases in blood pressure and cardiac contractility (&lt;a href="/pmc/articles/PMC2241751/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"&gt;</code></p><p><code>6163</code><code>&lt;span&gt;</code></p><p><code>6164</code><code>Fig. 5&lt;/span&gt;</code></p><p><code>6165</code><code>&lt;/a&gt;</code></p><p><code>6166</code><code>). Conversely, preventing the degradation or uptake of endogenous anandamide by treatment with the FAAH inhibitor URB597 or the transport inhibitor OMDM2 reduced blood pressure, cardiac contractility, and vascular resistance to levels observed in normotensive controls, and these effects were prevented by pretreatment with a CB&lt;sub&gt;</code></p><p><code>6167</code><code>1&lt;/sub&gt;</code></p><p><code>6168</code><code> antagonist. Similar effects were seen in Dahl salt-sensitive rats and rats with angiotensin II-induced hypertension, whereas in the respective normotensive controls the same parameters remained unaffected by any of these treatments (&lt;a href="#R52" rid="R52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653369"&gt;</code></p><p><code>6169</code><code>B&amp;#x000e1;tkai et al., 2004b&lt;/a&gt;</code></p><p><code>6170</code><code>) (&lt;a href="/pmc/articles/PMC2241751/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"&gt;</code></p><p><code>6171</code><code>&lt;span&gt;</code></p><p><code>6172</code><code>Fig. 5&lt;/span&gt;</code></p><p><code>6173</code><code>&lt;/a&gt;</code></p><p><code>6174</code><code>). Anandamide and HU-210 induced more pronounced and longer lasting hypotension in SHR than in WKY rats. Unexpectedly, decreased cardiac contractility rather than a reduction in peripheral resistance was primarily responsible for the antihypertensive effect of anandamide, which was fully prevented by CB&lt;sub&gt;</code></p><p><code>6175</code><code>1&lt;/sub&gt;</code></p><p><code>6176</code><code> antagonists, but was unaffected by the TRPV&lt;sub&gt;</code></p><p><code>6177</code><code>1&lt;/sub&gt;</code></p><p><code>6178</code><code> antagonist capsazepine. In the same study, the expression of CB&lt;sub&gt;</code></p><p><code>6179</code><code>1&lt;/sub&gt;</code></p><p><code>6180</code><code> receptors was found to be increased in the myocardium and the aortic endothelium of SHR compared with WKY rats.&lt;/p&gt;</code></p><p><code>6181</code><code>&lt;!--fig ft0--&gt;</code></p><p><code>6182</code><code>&lt;!--fig mode=article f1--&gt;</code></p><p><code>6183</code><code>&lt;div class="fig iconblock whole_rhythm" id="F5" co-legend-rid="lgnd_F5"&gt;</code></p><p><code>6184</code><code>&lt;a href="/pmc/articles/PMC2241751/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"&gt;</code></p><p><code>6185</code><code>&lt;!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--&gt;</code></p><p><code>6186</code><code>&lt;div data-largeobj="" data-largeobj-link-rid="largeobj_idm139779462208928" class="figure"&gt;</code></p><p><code>6187</code><code>&lt;img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms38123f5.jpg" title="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms38123f5.jpg" src="/pmc/articles/PMC2241751/bin/nihms38123f5.jpg" /&gt;</code></p><p><code>6188</code><code>&lt;/div&gt;</code></p><p><code>6189</code><code>&lt;div id="largeobj_idm139779462208928" class="largeobj-link align_right" style="display: none"&gt;</code></p><p><code>6190</code><code>&lt;a target="object" rel="noopener" href="/pmc/articles/PMC2241751/figure/F5/?report=objectonly"&gt;</code></p><p><code>6191</code><code>Open in a separate window&lt;/a&gt;</code></p><p><code>6192</code><code>&lt;/div&gt;</code></p><p><code>6193</code><code>&lt;/a&gt;</code></p><p><code>6194</code><code>&lt;div class="icnblk_cntnt" id="lgnd_F5"&gt;</code></p><p><code>6195</code><code>&lt;div&gt;</code></p><p><code>6196</code><code>&lt;a class="figpopup" href="/pmc/articles/PMC2241751/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"&gt;</code></p><p><code>6197</code><code>Fig. 5&lt;/a&gt;</code></p><p><code>6198</code><code>&lt;/div&gt;</code></p><p><code>6199</code><code>&lt;!--caption a7--&gt;</code></p><p><code>6200</code><code>&lt;div class="caption"&gt;</code></p><p><code>6201</code><code>&lt;p id="__p6"&gt;</code></p><p><code>6202</code><code>Effects of anandamide, URB597, SR141716, and AM251 on left ventricular (LV) function in normotensive and spontaneously hypertensive rats. Representative left ventricular pressure-volume (PV) loops from WKY rats (a, d, and g) and SHR (b, c, e, f, h, and i) before (black) and after (red) treatment with indicated agents or their combinations. A leftward shift of PV loops and an increase in amplitude (pressure) indicate increased LV contractility, whereas a rightward shift and decrease in amplitude indicate decreased LV function. Experiments were repeated in three more animals in each treatment group with similar results. AEA, anandamide. Reproduced with permission from &lt;a href="#R51" rid="R51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653465"&gt;</code></p><p><code>6203</code><code>B&amp;#x000e1;tkai et al. (2004)&lt;/a&gt;</code></p><p><code>6204</code><code> &lt;em&gt;</code></p><p><code>6205</code><code>Circulation&lt;/em&gt;</code></p><p><code>6206</code><code> &lt;strong&gt;</code></p><p><code>6207</code><code>110:&lt;/strong&gt;</code></p><p><code>6208</code><code>1996&amp;#x02013;2002; &amp;#x000a9; Lippincott Williams and Wilkins.&lt;/p&gt;</code></p><p><code>6209</code><code>&lt;/div&gt;</code></p><p><code>6210</code><code>&lt;/div&gt;</code></p><p><code>6211</code><code>&lt;/div&gt;</code></p><p><code>6212</code><code>&lt;p id="P161"&gt;</code></p><p><code>6213</code><code>These findings point to the existence of an endocannabinoid tone in hypertension that limits the elevation of blood pressure and cardiac contractile performance through tonic activation of cardiac and probably vascular CB&lt;sub&gt;</code></p><p><code>6214</code><code>1&lt;/sub&gt;</code></p><p><code>6215</code><code>. A possible underlying mechanism is the observed up-regulation of cardiac and vascular CB&lt;sub&gt;</code></p><p><code>6216</code><code>1&lt;/sub&gt;</code></p><p><code>6217</code><code> in SHR compared with their normotensive controls, although increased coupling of these CB&lt;sub&gt;</code></p><p><code>6218</code><code>1&lt;/sub&gt;</code></p><p><code>6219</code><code> receptors may also contribute to the augmented sensitivity to the cardiovascular effects of anandamide (&lt;a href="#R52" rid="R52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653386"&gt;</code></p><p><code>6220</code><code>B&amp;#x000e1;tkai et al., 2004b&lt;/a&gt;</code></p><p><code>6221</code><code>). A proposed alternative mechanism would involve up-regulation of vascular TRPV&lt;sub&gt;</code></p><p><code>6222</code><code>1&lt;/sub&gt;</code></p><p><code>6223</code><code> receptors in hypertension, based on the reported ability of capsazepine to partially inhibit the hypotensive effect of anandamide and &lt;em&gt;</code></p><p><code>6224</code><code>R&lt;/em&gt;</code></p><p><code>6225</code><code>-methanandamide in hypertensive but not in normotensive rats (&lt;a href="#R682" rid="R682" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918698"&gt;</code></p><p><code>6226</code><code>Li et al., 2003&lt;/a&gt;</code></p><p><code>6227</code><code>; &lt;a href="#R1269" rid="R1269" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919349"&gt;</code></p><p><code>6228</code><code>Wang et al., 2005&lt;/a&gt;</code></p><p><code>6229</code><code>). However, capsazepine is known to have nonspecific effects even at low concentrations (&lt;a href="#R1003" rid="R1003" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637225"&gt;</code></p><p><code>6230</code><code>Ray et al., 2003&lt;/a&gt;</code></p><p><code>6231</code><code>), and up-regulation of TRPV&lt;sub&gt;</code></p><p><code>6232</code><code>1&lt;/sub&gt;</code></p><p><code>6233</code><code> cannot account either for the increased hypotensive potency of HU-210 (&lt;a href="#R52" rid="R52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653411"&gt;</code></p><p><code>6234</code><code>B&amp;#x000e1;tkai et al., 2004b&lt;/a&gt;</code></p><p><code>6235</code><code>), which is not a ligand for TRPV&lt;sub&gt;</code></p><p><code>6236</code><code>1&lt;/sub&gt;</code></p><p><code>6237</code><code> receptors (&lt;a href="#R1332" rid="R1332" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919658"&gt;</code></p><p><code>6238</code><code>Zygmunt et al., 1999&lt;/a&gt;</code></p><p><code>6239</code><code>), or for the dominant cardiac component in the hypotensive effect of exogenous or endogenous anandamide (&lt;a href="#R52" rid="R52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653502"&gt;</code></p><p><code>6240</code><code>B&amp;#x000e1;tkai et al., 2004b&lt;/a&gt;</code></p><p><code>6241</code><code>). Also, physiological concentrations of endogenous anandamide are at least an order of magnitude lower than the micromolar concentrations required to activate TRPV&lt;sub&gt;</code></p><p><code>6242</code><code>1&lt;/sub&gt;</code></p><p><code>6243</code><code> receptors.&lt;/p&gt;</code></p><p><code>6244</code><code>&lt;p id="P162" class="p p-last"&gt;</code></p><p><code>6245</code><code>A practical implication of these findings is that enhancing endocannabinoid tone by blocking the enzymatic degradation or cellular uptake of anandamide could be a novel therapeutic approach in the treatment of hypertension. Such a strategy has a number of desirable features: 1) unlike the generalized activation of CB&lt;sub&gt;</code></p><p><code>6246</code><code>1&lt;/sub&gt;</code></p><p><code>6247</code><code> receptors by direct acting agonists, inhibition of FAAH causes a more restricted profile of cannabinoid-like effects with no indication of psychoactivity (&lt;a href="#R589" rid="R589" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919705"&gt;</code></p><p><code>6248</code><code>Kathuria et al., 2003&lt;/a&gt;</code></p><p><code>6249</code><code>; &lt;a href="#R404" rid="R404" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918763"&gt;</code></p><p><code>6250</code><code>Gobbi et al., 2005&lt;/a&gt;</code></p><p><code>6251</code><code>), probably related to the discrete distribution of FAAH in the brain; 2) FAAH or transport inhibitors have no hemodynamic effects under normotensive conditions, which predicts the absence of postural hypotension or other side effects; and 3) having a major effect on the inappropriately increased cardiac contractility, such treatment may be effective in reversing the cardiac hypertrophy that usually accompanies chronic hypertension.&lt;/p&gt;</code></p><p><code>6252</code><code>&lt;/div&gt;</code></p><p><code>6253</code><code>&lt;div id="S37" class="sec"&gt;</code></p><p><code>6254</code><code>&lt;p&gt;</code></p><p><code>6255</code><code>&lt;/p&gt;</code></p><p><code>6256</code><code>&lt;h4 id="S37title" class="inline"&gt;</code></p><p><code>6257</code><code>2. Circulatory Shock &lt;/h4&gt;</code></p><p><code>6258</code><code>&lt;p id="P163" class="p p-first"&gt;</code></p><p><code>6259</code><code>The profound hypotension that can be elicited through pharmacological activation of CB&lt;sub&gt;</code></p><p><code>6260</code><code>1&lt;/sub&gt;</code></p><p><code>6261</code><code> receptors (&lt;a href="#R645" rid="R645" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653516"&gt;</code></p><p><code>6262</code><code>Lake et al., 1997a&lt;/a&gt;</code></p><p><code>6263</code><code>) triggered numerous studies to investigate the role of the endocannabinoid system in the hypotension associated with various forms of shock, including hemorrhagic (&lt;a href="#R1250" rid="R1250" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920008"&gt;</code></p><p><code>6264</code><code>Wagner et al., 1997&lt;/a&gt;</code></p><p><code>6265</code><code>; &lt;a href="#R145" rid="R145" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919958"&gt;</code></p><p><code>6266</code><code>Cainazzo et al., 2002&lt;/a&gt;</code></p><p><code>6267</code><code>), endotoxic (&lt;a href="#R1221" rid="R1221" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919932"&gt;</code></p><p><code>6268</code><code>Varga et al., 1998&lt;/a&gt;</code></p><p><code>6269</code><code>; &lt;a href="#R1270" rid="R1270" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920010"&gt;</code></p><p><code>6270</code><code>Wang et al., 2001&lt;/a&gt;</code></p><p><code>6271</code><code>; &lt;a href="#R693" rid="R693" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920340"&gt;</code></p><p><code>6272</code><code>Liu et al., 2003a&lt;/a&gt;</code></p><p><code>6273</code><code>; &lt;a href="#R51" rid="R51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653524"&gt;</code></p><p><code>6274</code><code>B&amp;#x000e1;tkai et al., 2004a&lt;/a&gt;</code></p><p><code>6275</code><code>; &lt;a href="#R366" rid="R366" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653426"&gt;</code></p><p><code>6276</code><code>Gardiner et al., 2005&lt;/a&gt;</code></p><p><code>6277</code><code>; &lt;a href="#R578" rid="R578" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920366"&gt;</code></p><p><code>6278</code><code>Kadoi et al., 2005&lt;/a&gt;</code></p><p><code>6279</code><code>), and cardiogenic shock (&lt;a href="#R1247" rid="R1247" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919836"&gt;</code></p><p><code>6280</code><code>Wagner et al., 2001a&lt;/a&gt;</code></p><p><code>6281</code><code>, &lt;a href="#R1248" rid="R1248" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920001"&gt;</code></p><p><code>6282</code><code>2003&lt;/a&gt;</code></p><p><code>6283</code><code>), and the shock associated with necrotizing pancreatitis (&lt;a href="#R782" rid="R782" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919811"&gt;</code></p><p><code>6284</code><code>Matsuda et al., 2005&lt;/a&gt;</code></p><p><code>6285</code><code>). Initial studies demonstrated that the putative CB&lt;sub&gt;</code></p><p><code>6286</code><code>1&lt;/sub&gt;</code></p><p><code>6287</code><code> receptor antagonist SR141716 prevented or reversed the hypotension associated with hemorrhagic, endotoxic, and cardiogenic shock (&lt;a href="#R1250" rid="R1250" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920022"&gt;</code></p><p><code>6288</code><code>Wagner et al., 1997&lt;/a&gt;</code></p><p><code>6289</code><code>, &lt;a href="#R1247" rid="R1247" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919212"&gt;</code></p><p><code>6290</code><code>2001a&lt;/a&gt;</code></p><p><code>6291</code><code>,&lt;a href="#R1249" rid="R1249" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918812"&gt;</code></p><p><code>6292</code><code>b&lt;/a&gt;</code></p><p><code>6293</code><code>; &lt;a href="#R1221" rid="R1221" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920384"&gt;</code></p><p><code>6294</code><code>Varga et al., 1998&lt;/a&gt;</code></p><p><code>6295</code><code>). Likewise, SR141716 reversed the hypotension associated with advanced liver cirrhosis (&lt;a href="#R50" rid="R50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918819"&gt;</code></p><p><code>6296</code><code>B&amp;#x000e1;tkai et al., 2001&lt;/a&gt;</code></p><p><code>6297</code><code>; &lt;a href="#R1036" rid="R1036" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919876"&gt;</code></p><p><code>6298</code><code>Ros et al., 2002&lt;/a&gt;</code></p><p><code>6299</code><code>), which is possibly secondary to the endotoxemia frequently found in patients with late-stage cirrhosis (&lt;a href="#R710" rid="R710" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919222"&gt;</code></p><p><code>6300</code><code>Lumsden et al., 1988&lt;/a&gt;</code></p><p><code>6301</code><code>). Observations that circulating macrophages and platelets from endotoxemic or cirrhotic animals or humans had elevated levels of endocannabinoids and, when isolated and injected into normal rats, these cells elicited SR141716-sensitive hypotension also pointed toward the involvement of CB&lt;sub&gt;</code></p><p><code>6302</code><code>1&lt;/sub&gt;</code></p><p><code>6303</code><code> receptors in many of these conditions (&lt;a href="#R1250" rid="R1250" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919180"&gt;</code></p><p><code>6304</code><code>Wagner et al., 1997&lt;/a&gt;</code></p><p><code>6305</code><code>; &lt;a href="#R1221" rid="R1221" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920090"&gt;</code></p><p><code>6306</code><code>Varga et al., 1998&lt;/a&gt;</code></p><p><code>6307</code><code>; &lt;a href="#R50" rid="R50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920262"&gt;</code></p><p><code>6308</code><code>B&amp;#x000e1;tkai et al., 2001&lt;/a&gt;</code></p><p><code>6309</code><code>; &lt;a href="#R720" rid="R720" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919483"&gt;</code></p><p><code>6310</code><code>Maccarrone et al., 2001&lt;/a&gt;</code></p><p><code>6311</code><code>, &lt;a href="#R717" rid="R717" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919389"&gt;</code></p><p><code>6312</code><code>2002&lt;/a&gt;</code></p><p><code>6313</code><code>; &lt;a href="#R1036" rid="R1036" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919405"&gt;</code></p><p><code>6314</code><code>Ros et al., 2002&lt;/a&gt;</code></p><p><code>6315</code><code>; &lt;a href="#R693" rid="R693" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918781"&gt;</code></p><p><code>6316</code><code>Liu et al., 2003a&lt;/a&gt;</code></p><p><code>6317</code><code>).&lt;/p&gt;</code></p><p><code>6318</code><code>&lt;p id="P164"&gt;</code></p><p><code>6319</code><code>Several recent reports demonstrated that anandamide and some atypical cannabinoids can cause both cardiodepressant and vasodilatory effects via as-yet-undefined receptors sensitive to inhibition by SR141716 but not by AM251 (&lt;a href="#R556" rid="R556" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919444"&gt;</code></p><p><code>6320</code><code>J&amp;#x000e1;rai et al., 1999&lt;/a&gt;</code></p><p><code>6321</code><code>; &lt;a href="#R328" rid="R328" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919941"&gt;</code></p><p><code>6322</code><code>Ford et al., 2002&lt;/a&gt;</code></p><p><code>6323</code><code>; &lt;a href="#R505" rid="R505" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919751"&gt;</code></p><p><code>6324</code><code>Ho and Hiley, 2003&lt;/a&gt;</code></p><p><code>6325</code><code>; &lt;a href="#R917" rid="R917" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653417"&gt;</code></p><p><code>6326</code><code>O&amp;#x02019;Sullivan et al., 2004b&lt;/a&gt;</code></p><p><code>6327</code><code>), a selective CB&lt;sub&gt;</code></p><p><code>6328</code><code>1&lt;/sub&gt;</code></p><p><code>6329</code><code> antagonist equipotent with SR141716 (&lt;a href="#R371" rid="R371" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653375"&gt;</code></p><p><code>6330</code><code>Gatley et al., 1997&lt;/a&gt;</code></p><p><code>6331</code><code>). A recent study compared the effects of SR141716 and AM251 in rats on the acute hypotensive effect of bacterial endotoxin (LPS) administered as an intravenous bolus. Hypotension in this model is fully attributable to the decreased cardiac contractility, whereas peripheral vascular resistance is increased, indicating vasoconstriction (&lt;a href="#R78" rid="R78" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919155"&gt;</code></p><p><code>6332</code><code>Biber et al., 1988&lt;/a&gt;</code></p><p><code>6333</code><code>; &lt;a href="#R178" rid="R178" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653413"&gt;</code></p><p><code>6334</code><code>Cheng et al., 2003&lt;/a&gt;</code></p><p><code>6335</code><code>). Using this model, the cardiodepressant and hypotensive effects of LPS were inhibited by SR141716 but not by AM251. Furthermore, LPS induced SR141716-sensitive hypotension in wild-type mice and in mice deficient in CB&lt;sub&gt;</code></p><p><code>6336</code><code>1&lt;/sub&gt;</code></p><p><code>6337</code><code> or both CB&lt;sub&gt;</code></p><p><code>6338</code><code>1&lt;/sub&gt;</code></p><p><code>6339</code><code> and CB&lt;sub&gt;</code></p><p><code>6340</code><code>2&lt;/sub&gt;</code></p><p><code>6341</code><code> receptors, suggesting that receptors distinct from CB&lt;sub&gt;</code></p><p><code>6342</code><code>1&lt;/sub&gt;</code></p><p><code>6343</code><code> or CB&lt;sub&gt;</code></p><p><code>6344</code><code>2&lt;/sub&gt;</code></p><p><code>6345</code><code> are primarily responsible for the observed hypotension (&lt;a href="#R51" rid="R51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653443"&gt;</code></p><p><code>6346</code><code>B&amp;#x000e1;tkai et al., 2004a&lt;/a&gt;</code></p><p><code>6347</code><code>). Interestingly, another recent study has demonstrated that the CB&lt;sub&gt;</code></p><p><code>6348</code><code>1&lt;/sub&gt;</code></p><p><code>6349</code><code>-selective cannabinoid antagonist AM281 prevented the hemodynamic changes induced by acute LPS injection in rats (&lt;a href="#R578" rid="R578" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919695"&gt;</code></p><p><code>6350</code><code>Kadoi et al., 2005a&lt;/a&gt;</code></p><p><code>6351</code><code>). Other results indicate that endocannabinoids may also contribute to endotoxin-induced hypotension indirectly, through CB&lt;sub&gt;</code></p><p><code>6352</code><code>1&lt;/sub&gt;</code></p><p><code>6353</code><code>-mediated prejunctional inhibition of sympathoexcitation (&lt;a href="#R406" rid="R406" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919560"&gt;</code></p><p><code>6354</code><code>Godlewski et al., 2004&lt;/a&gt;</code></p><p><code>6355</code><code>). In a different shock model in which continuous infusion of LPS in conscious rats causes marked peripheral vasodilatation and increased cardiac output, AM251 attenuated the tachycardic and hind quarter vasodilator effects of LPS. This result was attributed to modulation of &lt;em&gt;</code></p><p><code>6356</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>6357</code><code>-adrenergic vasodilation, rather than suppression of a direct vasodilator effect by endocannabinoids (&lt;a href="#R366" rid="R366" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653358"&gt;</code></p><p><code>6358</code><code>Gardiner et al., 2005&lt;/a&gt;</code></p><p><code>6359</code><code>). Interestingly, in a recent study, &lt;a href="#R782" rid="R782" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919707"&gt;</code></p><p><code>6360</code><code>Matsuda et al. (2005)&lt;/a&gt;</code></p><p><code>6361</code><code> demonstrated that AM251 improved mean arterial pressure and survival rate in models of severe acute necrotizing pancreatitis without affecting inflammatory changes, which suggests the involvement of cardiac or vascular CB&lt;sub&gt;</code></p><p><code>6362</code><code>1&lt;/sub&gt;</code></p><p><code>6363</code><code> receptors in the hypotension associated with this condition.&lt;/p&gt;</code></p><p><code>6364</code><code>&lt;p id="P165"&gt;</code></p><p><code>6365</code><code>In hemorrhagic, cardiogenic, and endotoxic shock, the cannabinoid agonists HU-210, WIN 55,212-2, and THC improved endothelial function and/or survival (&lt;a href="#R1250" rid="R1250" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919491"&gt;</code></p><p><code>6366</code><code>Wagner et al., 1997&lt;/a&gt;</code></p><p><code>6367</code><code>, &lt;a href="#R1247" rid="R1247" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919854"&gt;</code></p><p><code>6368</code><code>2001a&lt;/a&gt;</code></p><p><code>6369</code><code>, &lt;a href="#R1248" rid="R1248" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919746"&gt;</code></p><p><code>6370</code><code>2003&lt;/a&gt;</code></p><p><code>6371</code><code>; &lt;a href="#R1221" rid="R1221" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920136"&gt;</code></p><p><code>6372</code><code>Varga et al., 1998&lt;/a&gt;</code></p><p><code>6373</code><code>; &lt;a href="#R1120" rid="R1120" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919315"&gt;</code></p><p><code>6374</code><code>Smith et al., 2000&lt;/a&gt;</code></p><p><code>6375</code><code>, &lt;a href="#R1121" rid="R1121" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918701"&gt;</code></p><p><code>6376</code><code>2001&lt;/a&gt;</code></p><p><code>6377</code><code>). Surprisingly, the use of cannabinoid receptor antagonists, including SR141716, AM281, AM251, and SR144528, also leads to survival benefits in endotoxic and septic shock or necrotizing pancreatitis (&lt;a href="#R1221" rid="R1221" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920321"&gt;</code></p><p><code>6378</code><code>Varga et al., 1998&lt;/a&gt;</code></p><p><code>6379</code><code>; &lt;a href="#R1120" rid="R1120" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920388"&gt;</code></p><p><code>6380</code><code>Smith et al., 2000&lt;/a&gt;</code></p><p><code>6381</code><code>, &lt;a href="#R1121" rid="R1121" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919128"&gt;</code></p><p><code>6382</code><code>2001&lt;/a&gt;</code></p><p><code>6383</code><code>; &lt;a href="#R145" rid="R145" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919725"&gt;</code></p><p><code>6384</code><code>Cainazzo et al., 2002&lt;/a&gt;</code></p><p><code>6385</code><code>; &lt;a href="#R578" rid="R578" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919227"&gt;</code></p><p><code>6386</code><code>Kadoi et al., 2005a&lt;/a&gt;</code></p><p><code>6387</code><code>,&lt;a href="#R579" rid="R579" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920065"&gt;</code></p><p><code>6388</code><code>b&lt;/a&gt;</code></p><p><code>6389</code><code>; &lt;a href="#R782" rid="R782" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919963"&gt;</code></p><p><code>6390</code><code>Matsuda et al., 2005&lt;/a&gt;</code></p><p><code>6391</code><code>). In contrast, CB&lt;sub&gt;</code></p><p><code>6392</code><code>1&lt;/sub&gt;</code></p><p><code>6393</code><code> receptor blockade increased mortality in hemorrhagic (&lt;a href="#R1250" rid="R1250" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919188"&gt;</code></p><p><code>6394</code><code>Wagner et al., 1997&lt;/a&gt;</code></p><p><code>6395</code><code>) and cardiogenic shock (&lt;a href="#R1247" rid="R1247" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919074"&gt;</code></p><p><code>6396</code><code>Wagner et al., 2001a&lt;/a&gt;</code></p><p><code>6397</code><code>, &lt;a href="#R1248" rid="R1248" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919647"&gt;</code></p><p><code>6398</code><code>2003&lt;/a&gt;</code></p><p><code>6399</code><code>), despite the increase in blood pressure. In these latter conditions, endocannabinoid-mediated vasodilation may have survival value through improving tissue oxygenation by counteracting the excessive sympathetic vasoconstriction triggered by hemorrhage or myocardial infarction, and this would be removed by CB&lt;sub&gt;</code></p><p><code>6400</code><code>1&lt;/sub&gt;</code></p><p><code>6401</code><code> blockade. In contrast, CB&lt;sub&gt;</code></p><p><code>6402</code><code>1&lt;/sub&gt;</code></p><p><code>6403</code><code> blockade may improve survival in endotoxic shock by preventing the primary hypotensive response to LPS (reviewed in &lt;a href="#R637" rid="R637" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918859"&gt;</code></p><p><code>6404</code><code>Kunos et al., 2000&lt;/a&gt;</code></p><p><code>6405</code><code>; &lt;a href="#R494" rid="R494" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919033"&gt;</code></p><p><code>6406</code><code>Hiley and Ford, 2003&lt;/a&gt;</code></p><p><code>6407</code><code>, &lt;a href="#R495" rid="R495" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918965"&gt;</code></p><p><code>6408</code><code>2004&lt;/a&gt;</code></p><p><code>6409</code><code>; &lt;a href="#R922" rid="R922" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919650"&gt;</code></p><p><code>6410</code><code>Pacher et al., 2005a&lt;/a&gt;</code></p><p><code>6411</code><code>,&lt;a href="#R924" rid="R924" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919182"&gt;</code></p><p><code>6412</code><code>c&lt;/a&gt;</code></p><p><code>6413</code><code>).&lt;/p&gt;</code></p><p><code>6414</code><code>&lt;p id="P166"&gt;</code></p><p><code>6415</code><code>It should also be kept in mind that in most of the above conditions, hemodynamic changes are triggered by overwhelming inflammatory reaction, increased oxidative stress, and activation of downstream effector pathways, eventually leading to cardiovascular dysfunction and failure (reviewed in &lt;a href="#R306" rid="R306" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919359"&gt;</code></p><p><code>6416</code><code>Evgenov and Liaudet, 2005&lt;/a&gt;</code></p><p><code>6417</code><code>; &lt;a href="#R928" rid="R928" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919563"&gt;</code></p><p><code>6418</code><code>Pacher et al., 2005e&lt;/a&gt;</code></p><p><code>6419</code><code>). Therefore, the well known immune-modulatory, anti-inflammatory, and antioxidant effects of cannabinoids should not be overlooked in these conditions. Indeed, endocannabinoids and synthetic cannabinoid agonists decrease inflammatory cytokine release in endotoxin-stimulated cells and in endotoxin-challenged animals (reviewed in &lt;a href="#R1262" rid="R1262" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918970"&gt;</code></p><p><code>6420</code><code>Walter and Stella, 2004&lt;/a&gt;</code></p><p><code>6421</code><code>; &lt;a href="#R612" rid="R612" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920270"&gt;</code></p><p><code>6422</code><code>Klein et al., 2005&lt;/a&gt;</code></p><p><code>6423</code><code>). Surprisingly, SR141716 and the CB&lt;sub&gt;</code></p><p><code>6424</code><code>2&lt;/sub&gt;</code></p><p><code>6425</code><code> antagonist SR144528 were also reported to have anti-inflammatory effects (&lt;a href="#R1120" rid="R1120" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919731"&gt;</code></p><p><code>6426</code><code>Smith et al., 2000&lt;/a&gt;</code></p><p><code>6427</code><code>, &lt;a href="#R1121" rid="R1121" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920117"&gt;</code></p><p><code>6428</code><code>2001&lt;/a&gt;</code></p><p><code>6429</code><code>), which may be attributed to their inverse agonist properties or to CB&lt;sub&gt;</code></p><p><code>6430</code><code>1/2&lt;/sub&gt;</code></p><p><code>6431</code><code> receptor-independent mechanisms (reviewed in &lt;a href="#R57" rid="R57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919441"&gt;</code></p><p><code>6432</code><code>Begg et al., 2005&lt;/a&gt;</code></p><p><code>6433</code><code>; &lt;a href="#R958" rid="R958" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918769"&gt;</code></p><p><code>6434</code><code>Pertwee, 2005b&lt;/a&gt;</code></p><p><code>6435</code><code>,&lt;a href="#R959" rid="R959" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_539174731"&gt;</code></p><p><code>6436</code><code>c&lt;/a&gt;</code></p><p><code>6437</code><code>).&lt;/p&gt;</code></p><p><code>6438</code><code>&lt;p id="P167" class="p p-last"&gt;</code></p><p><code>6439</code><code>Collectively, it appears that both cannabinoids and antagonists of cannabinoid receptors may exert some beneficial effects in various rodent shock models. Further studies should establish the specificity of these effects and the relevance to various forms of circulatory shock in humans.&lt;/p&gt;</code></p><p><code>6440</code><code>&lt;/div&gt;</code></p><p><code>6441</code><code>&lt;div id="S38" class="sec"&gt;</code></p><p><code>6442</code><code>&lt;p&gt;</code></p><p><code>6443</code><code>&lt;/p&gt;</code></p><p><code>6444</code><code>&lt;h4 id="S38title" class="inline"&gt;</code></p><p><code>6445</code><code>3. Myocardial Reperfusion Injury &lt;/h4&gt;</code></p><p><code>6446</code><code>&lt;p id="P168" class="p p-first"&gt;</code></p><p><code>6447</code><code>The endocannabinoid system has been implicated in endotoxin-induced preconditioning against myocardial I/R injury (&lt;a href="#R641" rid="R641" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919238"&gt;</code></p><p><code>6448</code><code>Lagneux and Lamontagne, 2001&lt;/a&gt;</code></p><p><code>6449</code><code>). In this study, the effects of 90 min of low-flow ischemia followed by 60 min of reperfusion at normal flow were compared in isolated hearts from rats pretreated with LPS or saline. Endotoxin pretreatment enhanced functional recovery on reperfusion and reduced infarct size compared with controls, and pretreatment with the CB&lt;sub&gt;</code></p><p><code>6450</code><code>2&lt;/sub&gt;</code></p><p><code>6451</code><code> antagonist SR144528 but not the CB&lt;sub&gt;</code></p><p><code>6452</code><code>1&lt;/sub&gt;</code></p><p><code>6453</code><code> antagonist SR141716 abolished the beneficial effects of preconditioning (&lt;a href="#R641" rid="R641" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918820"&gt;</code></p><p><code>6454</code><code>Lagneux and Lamontagne, 2001&lt;/a&gt;</code></p><p><code>6455</code><code>). In a follow-up study, SR144528 but not SR141716 also abolished the infarct size-reducing effect of preconditioning induced by heat stress (&lt;a href="#R575" rid="R575" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919640"&gt;</code></p><p><code>6456</code><code>Joyeux et al., 2002&lt;/a&gt;</code></p><p><code>6457</code><code>). These initial studies have suggested that the protection was mediated by endocannabinoids acting on CB&lt;sub&gt;</code></p><p><code>6458</code><code>2&lt;/sub&gt;</code></p><p><code>6459</code><code> receptors. In preconditioning induced by a brief period of ischemia (5 min), either CB&lt;sub&gt;</code></p><p><code>6460</code><code>2&lt;/sub&gt;</code></p><p><code>6461</code><code> or CB&lt;sub&gt;</code></p><p><code>6462</code><code>1&lt;/sub&gt;</code></p><p><code>6463</code><code> receptor blockade abolished the protection, and both CB&lt;sub&gt;</code></p><p><code>6464</code><code>1&lt;/sub&gt;</code></p><p><code>6465</code><code> and CB&lt;sub&gt;</code></p><p><code>6466</code><code>2&lt;/sub&gt;</code></p><p><code>6467</code><code> receptors were implicated in the preservation of endothelium-dependent, 5-HT-induced vasodilation by ischemic preconditioning (&lt;a href="#R111" rid="R111" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919626"&gt;</code></p><p><code>6468</code><code>Bouchard et al., 2003&lt;/a&gt;</code></p><p><code>6469</code><code>). Perfusion of isolated rat hearts with PEA or 2-AG but not anandamide afforded protection against ischemia by improving myocardial recovery and decreasing myocardial damage and infarct size (&lt;a href="#R674" rid="R674" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919039"&gt;</code></p><p><code>6470</code><code>Lepicier et al., 2003&lt;/a&gt;</code></p><p><code>6471</code><code>). The cardioprotective effect of both PEA and 2-AG were completely blocked by SR144528, whereas SR141716 partially inhibited the effect of 2-AG only (&lt;a href="#R674" rid="R674" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918849"&gt;</code></p><p><code>6472</code><code>Lepicier et al., 2003&lt;/a&gt;</code></p><p><code>6473</code><code>). Likewise, the selective CB&lt;sub&gt;</code></p><p><code>6474</code><code>1&lt;/sub&gt;</code></p><p><code>6475</code><code> agonist ACEA and the selective CB&lt;sub&gt;</code></p><p><code>6476</code><code>2&lt;/sub&gt;</code></p><p><code>6477</code><code> agonist JWH-015 both reduced infarct size in this model, and the CB&lt;sub&gt;</code></p><p><code>6478</code><code>2&lt;/sub&gt;</code></p><p><code>6479</code><code> receptor-mediated cardioprotection by PEA involved activation of p38/extracellular signal-regulated kinases 1 and 2 and protein kinase C (&lt;a href="#R674" rid="R674" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919946"&gt;</code></p><p><code>6480</code><code>Lepicier et al., 2003&lt;/a&gt;</code></p><p><code>6481</code><code>). In another study using isolated perfused rat hearts subjected to ischemia and reperfusion, reduction of the infarct size by anandamide could be equally well antagonized by CB&lt;sub&gt;</code></p><p><code>6482</code><code>1&lt;/sub&gt;</code></p><p><code>6483</code><code> or CB&lt;sub&gt;</code></p><p><code>6484</code><code>2&lt;/sub&gt;</code></p><p><code>6485</code><code> antagonists but could not be mimicked by selective CB&lt;sub&gt;</code></p><p><code>6486</code><code>1&lt;/sub&gt;</code></p><p><code>6487</code><code> or CB&lt;sub&gt;</code></p><p><code>6488</code><code>2&lt;/sub&gt;</code></p><p><code>6489</code><code> agonists, suggesting the involvement of a site distinct from CB&lt;sub&gt;</code></p><p><code>6490</code><code>1&lt;/sub&gt;</code></p><p><code>6491</code><code> or CB&lt;sub&gt;</code></p><p><code>6492</code><code>2&lt;/sub&gt;</code></p><p><code>6493</code><code> receptors (&lt;a href="#R1203" rid="R1203" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919083"&gt;</code></p><p><code>6494</code><code>Underdown et al., 2005&lt;/a&gt;</code></p><p><code>6495</code><code>).&lt;/p&gt;</code></p><p><code>6496</code><code>&lt;p id="P169" class="p p-last"&gt;</code></p><p><code>6497</code><code>Others have used whole animal models of I/R injury induced by coronary occlusion/reocclusion in anesthetized rats. In this model, anandamide and HU-210 both decreased the incidence of ventricular arrhythmias and reduced infarct size through activation of CB&lt;sub&gt;</code></p><p><code>6498</code><code>2&lt;/sub&gt;</code></p><p><code>6499</code><code> but not CB&lt;sub&gt;</code></p><p><code>6500</code><code>1&lt;/sub&gt;</code></p><p><code>6501</code><code> receptors (&lt;a href="#R631" rid="R631" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919437"&gt;</code></p><p><code>6502</code><code>Krylatov et al., 2001&lt;/a&gt;</code></p><p><code>6503</code><code>, &lt;a href="#R629" rid="R629" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919133"&gt;</code></p><p><code>6504</code><code>2002a&lt;/a&gt;</code></p><p><code>6505</code><code>,&lt;a href="#R632" rid="R632" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919768"&gt;</code></p><p><code>6506</code><code>b&lt;/a&gt;</code></p><p><code>6507</code><code>,&lt;a href="#R633" rid="R633" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919757"&gt;</code></p><p><code>6508</code><code>c&lt;/a&gt;</code></p><p><code>6509</code><code>; &lt;a href="#R1199" rid="R1199" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919472"&gt;</code></p><p><code>6510</code><code>Ugdyzhekova et al., 2001&lt;/a&gt;</code></p><p><code>6511</code><code>, &lt;a href="#R1198" rid="R1198" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919581"&gt;</code></p><p><code>6512</code><code>2002&lt;/a&gt;</code></p><p><code>6513</code><code>). The moderately CB&lt;sub&gt;</code></p><p><code>6514</code><code>2&lt;/sub&gt;</code></p><p><code>6515</code><code>-selective agonist WIN 55,212-2 also reduced the extent of leukocyte-dependent myocardial damage in a more recent mouse study of myocardial I/R in vivo. This effect was abolished by the selective CB&lt;sub&gt;</code></p><p><code>6516</code><code>2&lt;/sub&gt;</code></p><p><code>6517</code><code> receptor antagonist AM630 but was unaffected by AM251 (&lt;a href="#R270" rid="R270" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919393"&gt;</code></p><p><code>6518</code><code>Di Filippo et al., 2004&lt;/a&gt;</code></p><p><code>6519</code><code>). In summary, evidence to date indicates that endocannabinoids protect against myocardial ischemic injury models predominantly via CB&lt;sub&gt;</code></p><p><code>6520</code><code>2&lt;/sub&gt;</code></p><p><code>6521</code><code> receptors.&lt;/p&gt;</code></p><p><code>6522</code><code>&lt;/div&gt;</code></p><p><code>6523</code><code>&lt;div id="S39" class="sec"&gt;</code></p><p><code>6524</code><code>&lt;p&gt;</code></p><p><code>6525</code><code>&lt;/p&gt;</code></p><p><code>6526</code><code>&lt;h4 id="S39title" class="inline"&gt;</code></p><p><code>6527</code><code>4. Atherosclerosis &lt;/h4&gt;</code></p><p><code>6528</code><code>&lt;p id="P170" class="p p-first-last"&gt;</code></p><p><code>6529</code><code>Chronic inflammation and the associated oxidative-nitrosative stress are key players in atherosclerosis and cardiovascular aging, and pharmacological modulation of these processes could be of therapeutic benefit (reviewed in &lt;a href="#R233" rid="R233" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919568"&gt;</code></p><p><code>6530</code><code>Csiszar et al., 2005&lt;/a&gt;</code></p><p><code>6531</code><code>; &lt;a href="#R684" rid="R684" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919469"&gt;</code></p><p><code>6532</code><code>Libby and Theroux, 2005&lt;/a&gt;</code></p><p><code>6533</code><code>). Using the apolipoprotein E knockout mouse model of atherosclerosis, &lt;a href="#R1136" rid="R1136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919558"&gt;</code></p><p><code>6534</code><code>Steffens et al. (2005)&lt;/a&gt;</code></p><p><code>6535</code><code> reported that orally administered THC significantly inhibited disease progression. Furthermore, CB&lt;sub&gt;</code></p><p><code>6536</code><code>2&lt;/sub&gt;</code></p><p><code>6537</code><code> receptor expressing immune cells were present both in human and mouse atherosclerotic plaques, lymphoid cells isolated from THC-treated mice had diminished proliferation capacity and decreased interferon-&lt;em&gt;</code></p><p><code>6538</code><code>&amp;#x003b3;&lt;/em&gt;</code></p><p><code>6539</code><code> production, and THC inhibited macrophage chemotaxis in vitro. Most importantly, all of these effects were completely blocked by a selective CB&lt;sub&gt;</code></p><p><code>6540</code><code>2&lt;/sub&gt;</code></p><p><code>6541</code><code> receptor antagonist, suggesting that targeting CB&lt;sub&gt;</code></p><p><code>6542</code><code>2&lt;/sub&gt;</code></p><p><code>6543</code><code> receptors may offer a new approach in the treatment of atherosclerosis (&lt;a href="#R1042" rid="R1042" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920243"&gt;</code></p><p><code>6544</code><code>Roth, 2005&lt;/a&gt;</code></p><p><code>6545</code><code>; &lt;a href="#R1136" rid="R1136" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919674"&gt;</code></p><p><code>6546</code><code>Steffens et al., 2005&lt;/a&gt;</code></p><p><code>6547</code><code>).&lt;/p&gt;</code></p><p><code>6548</code><code>&lt;/div&gt;</code></p><p><code>6549</code><code>&lt;div id="S40" class="sec sec-last"&gt;</code></p><p><code>6550</code><code>&lt;p&gt;</code></p><p><code>6551</code><code>&lt;/p&gt;</code></p><p><code>6552</code><code>&lt;h4 id="S40title" class="inline"&gt;</code></p><p><code>6553</code><code>5. Asthma &lt;/h4&gt;</code></p><p><code>6554</code><code>&lt;p id="P171" class="p p-first"&gt;</code></p><p><code>6555</code><code>The effect of marijuana on airway functions was among the first to be explored for potential therapeutic benefit (reviewed in &lt;a href="#R673" rid="R673" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919115"&gt;</code></p><p><code>6556</code><code>Lemberger, 1980&lt;/a&gt;</code></p><p><code>6557</code><code>; &lt;a href="#R1164" rid="R1164" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919590"&gt;</code></p><p><code>6558</code><code>Tashkin et al., 2002&lt;/a&gt;</code></p><p><code>6559</code><code>). Smoking marijuana and ingesting THC were both found to increase airway conductance in normal, healthy subjects (&lt;a href="#R1166" rid="R1166" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919376"&gt;</code></p><p><code>6560</code><code>Tashkin et al., 1973&lt;/a&gt;</code></p><p><code>6561</code><code>; &lt;a href="#R1207" rid="R1207" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919755"&gt;</code></p><p><code>6562</code><code>Vachon et al., 1973&lt;/a&gt;</code></p><p><code>6563</code><code>), and these effects lasted longer than the bronchodilator effect of the &lt;em&gt;</code></p><p><code>6564</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>6565</code><code>-adrenergic agonist isoproterenol. Bronchodilation induced by smoked marijuana and oral THC was also documented in subjects with mild to moderate asthma and in asthmatic patients with methacholine- or exercise-induced bronchoconstriction (&lt;a href="#R1167" rid="R1167" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919462"&gt;</code></p><p><code>6566</code><code>Tashkin et al., 1974&lt;/a&gt;</code></p><p><code>6567</code><code>, &lt;a href="#R1168" rid="R1168" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920052"&gt;</code></p><p><code>6568</code><code>1975&lt;/a&gt;</code></p><p><code>6569</code><code>). Bronchodilation without side effects was observed in asthmatic patients after a low dose (0.2 mg) of nebulized THC (&lt;a href="#R1291" rid="R1291" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919068"&gt;</code></p><p><code>6570</code><code>Williams et al., 1976&lt;/a&gt;</code></p><p><code>6571</code><code>; &lt;a href="#R473" rid="R473" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920351"&gt;</code></p><p><code>6572</code><code>Hartley et al., 1978&lt;/a&gt;</code></p><p><code>6573</code><code>). In contrast, aerosols containing larger doses of THC (5&amp;#x02013;20 mg) caused paradoxical bronchoconstriction attributed to local irritation (&lt;a href="#R1165" rid="R1165" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919533"&gt;</code></p><p><code>6574</code><code>Tashkin et al., 1977&lt;/a&gt;</code></p><p><code>6575</code><code>). In another study of normal and asthmatic subjects, orally administered THC elicited only minimal and inconsistent bronchodilation associated with significant CNS side effects (&lt;a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919378"&gt;</code></p><p><code>6576</code><code>Abboud and Sanders, 1976&lt;/a&gt;</code></p><p><code>6577</code><code>). Nevertheless, most of these initial observations had suggested some therapeutic benefit of using cannabinoids in asthma.&lt;/p&gt;</code></p><p><code>6578</code><code>&lt;p id="P172"&gt;</code></p><p><code>6579</code><code>As for the mechanisms underlying THC-induced bronchodilation, the potential involvement of &lt;em&gt;</code></p><p><code>6580</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>6581</code><code>-adrenergic and muscarinic receptors on airway smooth muscle could be excluded (&lt;a href="#R595" rid="R595" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919064"&gt;</code></p><p><code>6582</code><code>Kelly and Butcher, 1973&lt;/a&gt;</code></p><p><code>6583</code><code>; &lt;a href="#R1088" rid="R1088" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920144"&gt;</code></p><p><code>6584</code><code>Shapiro et al., 1977&lt;/a&gt;</code></p><p><code>6585</code><code>; &lt;a href="#R673" rid="R673" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919766"&gt;</code></p><p><code>6586</code><code>Lemberger, 1980&lt;/a&gt;</code></p><p><code>6587</code><code>). This conclusion was supported by the inability of THC to relax isolated rings of resting or precontracted human bronchioles (&lt;a href="#R912" rid="R912" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653496"&gt;</code></p><p><code>6588</code><code>Orzelek-O&amp;#x02019;Neil et al., 1980a&lt;/a&gt;</code></p><p><code>6589</code><code>,&lt;a href="#R913" rid="R913" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653366"&gt;</code></p><p><code>6590</code><code>b&lt;/a&gt;</code></p><p><code>6591</code><code>), suggesting a more proximal site of action in the lung (&lt;a href="#R164" rid="R164" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920215"&gt;</code></p><p><code>6592</code><code>Cavero et al., 1972&lt;/a&gt;</code></p><p><code>6593</code><code>) or a central mechanism.&lt;/p&gt;</code></p><p><code>6594</code><code>&lt;p id="P173"&gt;</code></p><p><code>6595</code><code>More recently, &lt;a href="#R146" rid="R146" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919827"&gt;</code></p><p><code>6596</code><code>Calignano et al. (2000)&lt;/a&gt;</code></p><p><code>6597</code><code> reported that CB&lt;sub&gt;</code></p><p><code>6598</code><code>1&lt;/sub&gt;</code></p><p><code>6599</code><code> receptors are present on axon terminals innervating airway smooth muscle, and anandamide inhibited capsaicin-induced bronchospasm and cough in guinea pigs in an SR141716-sensitive manner. They also documented calcium-induced biosynthesis of anandamide in lung tissue, suggesting that locally generated anandamide participates in the intrinsic control of airway responsiveness by inhibiting prejunctional acetylcholine release. Indeed, SR141716 treatment was found to enhance capsaicin-evoked bronchospasm and cough. Interestingly, when airway smooth muscle was completely relaxed by vagotomy and atropine treatment, anandamide caused dose-dependent bronchoconstriction, which could be also prevented by CB&lt;sub&gt;</code></p><p><code>6600</code><code>1&lt;/sub&gt;</code></p><p><code>6601</code><code> blockade. This effect was tentatively attributed to direct stimulation of putative cannabinoid receptors on the airway smooth muscle or a CB&lt;sub&gt;</code></p><p><code>6602</code><code>1&lt;/sub&gt;</code></p><p><code>6603</code><code>-mediated corelease of bronchoconstrictor neurotransmitters from nerve endings in the lung. In a follow-up study, presynaptic CB&lt;sub&gt;</code></p><p><code>6604</code><code>1&lt;/sub&gt;</code></p><p><code>6605</code><code> receptors in the guinea pig lung were only found on noradrenergic terminals where their stimulation by WIN 55,212-2 inhibited norepinephrine release (&lt;a href="#R1236" rid="R1236" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920261"&gt;</code></p><p><code>6606</code><code>Vizi et al., 2001&lt;/a&gt;</code></p><p><code>6607</code><code>), consistent with the lack of a mediated CB&lt;sub&gt;</code></p><p><code>6608</code><code>1&lt;/sub&gt;</code></p><p><code>6609</code><code>-mediated effect on acetylcholine release in guinea pig trachea (&lt;a href="#R1131" rid="R1131" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919280"&gt;</code></p><p><code>6610</code><code>Spicuzza et al., 2000&lt;/a&gt;</code></p><p><code>6611</code><code>). In contrast to the findings of &lt;a href="#R146" rid="R146" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919689"&gt;</code></p><p><code>6612</code><code>Calignano et al. (2000)&lt;/a&gt;</code></p><p><code>6613</code><code>, &lt;a href="#R1140" rid="R1140" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919135"&gt;</code></p><p><code>6614</code><code>Stengel et al. (1998)&lt;/a&gt;</code></p><p><code>6615</code><code> reported that anandamide given either intravenously or in aerosol did not affect airway resistance in guinea pigs, but possessed modest anti-inflammatory properties. It should be noted, however, that in this study bronchoconstriction was induced by a calcium ionophore rather than capsaicin. In an in vitro study of guinea pig airway smooth muscle (&lt;a href="#R1310" rid="R1310" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920310"&gt;</code></p><p><code>6616</code><code>Yoshihara et al., 2005&lt;/a&gt;</code></p><p><code>6617</code><code>), anandamide and palmitoylethanolamide inhibited contractions elicited by electrical field stimulation but not by neurokinin A, and also blocked capsaicin-capsaicin-induced release of substance P-like immunoreactivity. These effects were selectively inhibited by a CB&lt;sub&gt;</code></p><p><code>6618</code><code>2&lt;/sub&gt;</code></p><p><code>6619</code><code> but not a CB&lt;sub&gt;</code></p><p><code>6620</code><code>1&lt;/sub&gt;</code></p><p><code>6621</code><code> antagonist, or by maxi-K&lt;sup&gt;</code></p><p><code>6622</code><code>+&lt;/sup&gt;</code></p><p><code>6623</code><code> channel blockers, suggesting that CB&lt;sub&gt;</code></p><p><code>6624</code><code>2&lt;/sub&gt;</code></p><p><code>6625</code><code> agonists may have therapeutic value in asthma (&lt;a href="#R1310" rid="R1310" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920121"&gt;</code></p><p><code>6626</code><code>Yoshihara et al., 2005&lt;/a&gt;</code></p><p><code>6627</code><code>). In a recent study, inhibition of anandamide transport potently suppressed capsaicin-induced cough in mice, suggesting that the anandamide transporter may be a target for peripherally acting antitussive medications (&lt;a href="#R580" rid="R580" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919005"&gt;</code></p><p><code>6628</code><code>Kamei et al., 2006&lt;/a&gt;</code></p><p><code>6629</code><code>). Diverse effects of endocannabinoids and synthetic agonist have also been reported on respiratory function and pulmonary circulation both in vivo and in vitro (&lt;a href="#R1074" rid="R1074" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653509"&gt;</code></p><p><code>6630</code><code>Schmid et al., 2003&lt;/a&gt;</code></p><p><code>6631</code><code>; &lt;a href="#R1252" rid="R1252" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653485"&gt;</code></p><p><code>6632</code><code>Wahn et al., 2005&lt;/a&gt;</code></p><p><code>6633</code><code>).&lt;/p&gt;</code></p><p><code>6634</code><code>&lt;p id="P174"&gt;</code></p><p><code>6635</code><code>Allergic asthma is currently viewed as a complex inflammatory disorder characterized by recruitment of eosinophils into the lung, mucus hypersecretion by goblet cells, elevated serum IgE, and airway hyperresponsiveness (reviewed in &lt;a href="#R1292" rid="R1292" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919610"&gt;</code></p><p><code>6636</code><code>Wills-Karp, 1999&lt;/a&gt;</code></p><p><code>6637</code><code>). Given the well known anti-inflammatory effects of cannabinoids, these effects could also be of therapeutic value. Indeed, in a murine model of allergic airway disease induced by ovalbumin sensitization, pretreatment with cannabinol or THC blunted the increase in IL-2, IL-4, IL-5, and IL-13 mRNA expression and decreased mucus overproduction and serum IgE levels (&lt;a href="#R555" rid="R555" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920068"&gt;</code></p><p><code>6638</code><code>Jan et al., 2003&lt;/a&gt;</code></p><p><code>6639</code><code>). Anti-inflammatory effects of WIN 55,212-2, THC, anandamide, and palmitoylethanolamide were also reported in a mouse model of LPS-induced pulmonary inflammation (&lt;a href="#R68" rid="R68" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919868"&gt;</code></p><p><code>6640</code><code>Berdyshev et al., 1998&lt;/a&gt;</code></p><p><code>6641</code><code>).&lt;/p&gt;</code></p><p><code>6642</code><code>&lt;p id="P175" class="p p-last"&gt;</code></p><p><code>6643</code><code>In conclusion, the effects of cannabinoids on respiratory function are rather complex, and evidence for their therapeutic potential in asthma is equivocal. The possibility remains that novel, nonpsychoactive cannabinoid analogs with long-lasting anti-inflammatory activity turn out to be useful adjuncts in the treatment of allergic asthma.&lt;/p&gt;</code></p><p><code>6644</code><code>&lt;/div&gt;</code></p><p><code>6645</code><code>&lt;/div&gt;</code></p><p><code>6646</code><code>&lt;div id="S41" class="sec"&gt;</code></p><p><code>6647</code><code>&lt;h3 id="S41title"&gt;</code></p><p><code>6648</code><code>E. Eye Disorders (Glaucoma and Retinopathy)&lt;/h3&gt;</code></p><p><code>6649</code><code>&lt;p id="P176" class="p p-first"&gt;</code></p><p><code>6650</code><code>Glaucoma, the leading cause of irreversible blindness in the United States, is characterized by an increase in intraocular pressure and consequent damage to the optic nerve. Despite the multitude of effective medications that can be used to decrease ocular hypertension (e.g., cholinergic agonists, &lt;em&gt;</code></p><p><code>6651</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>6652</code><code>- and &lt;em&gt;</code></p><p><code>6653</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>6654</code><code>&lt;sub&gt;</code></p><p><code>6655</code><code>2&lt;/sub&gt;</code></p><p><code>6656</code><code>-adrenoceptor agonists, dopaminergic agonists, prostaglandins, and carbonic anhydrase inhibitors), some patients remain refractory to these drugs and may eventually become blind (reviewed in &lt;a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920084"&gt;</code></p><p><code>6657</code><code>Alward, 1998&lt;/a&gt;</code></p><p><code>6658</code><code>; &lt;a href="#R229" rid="R229" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919935"&gt;</code></p><p><code>6659</code><code>Crowston and Weinreb, 2005&lt;/a&gt;</code></p><p><code>6660</code><code>).&lt;/p&gt;</code></p><p><code>6661</code><code>&lt;p id="P177"&gt;</code></p><p><code>6662</code><code>A decrease in intraocular pressure in a small number of healthy marijuana smokers was a serendipitous finding (&lt;a href="#R482" rid="R482" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653453"&gt;</code></p><p><code>6663</code><code>Hepler and Frank, 1971&lt;/a&gt;</code></p><p><code>6664</code><code>), subsequently confirmed in a placebo-controlled, double-blind study of healthy volunteers who smoked either natural marijuana of known THC content or ingested synthetic THC (&lt;a href="#R483" rid="R483" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919831"&gt;</code></p><p><code>6665</code><code>Hepler et al., 1972&lt;/a&gt;</code></p><p><code>6666</code><code>). THC or marijuana decreased intraocular pressure whether administered orally, topically, or intravenously, with no major tolerance to their effect reported (&lt;a href="#R1089" rid="R1089" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919287"&gt;</code></p><p><code>6667</code><code>Shapiro, 1974&lt;/a&gt;</code></p><p><code>6668</code><code>; &lt;a href="#R989" rid="R989" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919398"&gt;</code></p><p><code>6669</code><code>Purnell and Gregg, 1975&lt;/a&gt;</code></p><p><code>6670</code><code>; &lt;a href="#R234" rid="R234" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919190"&gt;</code></p><p><code>6671</code><code>Cuendet et al., 1976&lt;/a&gt;</code></p><p><code>6672</code><code>; &lt;a href="#R481" rid="R481" class=" bibr popnode"&gt;</code></p><p><code>6673</code><code>Hepler et al., 1976&lt;/a&gt;</code></p><p><code>6674</code><code>; &lt;a href="#R125" rid="R125" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920128"&gt;</code></p><p><code>6675</code><code>Brown et al., 1977&lt;/a&gt;</code></p><p><code>6676</code><code>; &lt;a href="#R824" rid="R824" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919163"&gt;</code></p><p><code>6677</code><code>Merritt et al., 1980&lt;/a&gt;</code></p><p><code>6678</code><code>, &lt;a href="#R825" rid="R825" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918753"&gt;</code></p><p><code>6679</code><code>1981a&lt;/a&gt;</code></p><p><code>6680</code><code>,&lt;a href="#R826" rid="R826" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920168"&gt;</code></p><p><code>6681</code><code>b&lt;/a&gt;</code></p><p><code>6682</code><code>). Most of these studies also reported various systemic side effects, such as hypotension, tachycardia, euphoria, and dysphoria, as well as other ocular effects, such as changes in pupil size, decreased tear production, and conjunctival hyperemia. Endocannabinoids and synthetic cannabinoid ligands have also been reported to reduce intraocular pressure when given topically or systemically, both in animals and humans (&lt;a href="#R1089" rid="R1089" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918953"&gt;</code></p><p><code>6683</code><code>Shapiro, 1974&lt;/a&gt;</code></p><p><code>6684</code><code>; &lt;a href="#R299" rid="R299" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918995"&gt;</code></p><p><code>6685</code><code>ElSohly et al., 1981&lt;/a&gt;</code></p><p><code>6686</code><code>, &lt;a href="#R200" rid="R200" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919600"&gt;</code></p><p><code>6687</code><code>1984&lt;/a&gt;</code></p><p><code>6688</code><code>; &lt;a href="#R191" rid="R191" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919473"&gt;</code></p><p><code>6689</code><code>Colasanti et al., 1984a&lt;/a&gt;</code></p><p><code>6690</code><code>,b,c; &lt;a href="#R944" rid="R944" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920099"&gt;</code></p><p><code>6691</code><code>Pate et al., 1995&lt;/a&gt;</code></p><p><code>6692</code><code>; &lt;a href="#R978" rid="R978" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919049"&gt;</code></p><p><code>6693</code><code>Porcella et al., 1998&lt;/a&gt;</code></p><p><code>6694</code><code>; &lt;a href="#R127" rid="R127" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919070"&gt;</code></p><p><code>6695</code><code>Buchwald et al., 2002&lt;/a&gt;</code></p><p><code>6696</code><code>; &lt;a href="#R643" rid="R643" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919867"&gt;</code></p><p><code>6697</code><code>Laine et al., 2002a&lt;/a&gt;</code></p><p><code>6698</code><code>,&lt;a href="#R644" rid="R644" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919230"&gt;</code></p><p><code>6699</code><code>b&lt;/a&gt;</code></p><p><code>6700</code><code>; reviewed in &lt;a href="#R558" rid="R558" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919609"&gt;</code></p><p><code>6701</code><code>Jarvinen et al., 2002&lt;/a&gt;</code></p><p><code>6702</code><code>; &lt;a href="#R180" rid="R180" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918972"&gt;</code></p><p><code>6703</code><code>Chien et al., 2003&lt;/a&gt;</code></p><p><code>6704</code><code>; &lt;a href="#R1184" rid="R1184" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920255"&gt;</code></p><p><code>6705</code><code>Tomida et al., 2004&lt;/a&gt;</code></p><p><code>6706</code><code>).&lt;/p&gt;</code></p><p><code>6707</code><code>&lt;p id="P178"&gt;</code></p><p><code>6708</code><code>Early investigations into the mechanisms of the intraocular pressure-lowering effect of marijuana and THC implicated the sympathetic and central nervous systems in this effect (&lt;a href="#R425" rid="R425" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918853"&gt;</code></p><p><code>6709</code><code>Green and Pederson, 1973&lt;/a&gt;</code></p><p><code>6710</code><code>; &lt;a href="#R426" rid="R426" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919202"&gt;</code></p><p><code>6711</code><code>Green and Podos, 1974&lt;/a&gt;</code></p><p><code>6712</code><code>; &lt;a href="#R422" rid="R422" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919193"&gt;</code></p><p><code>6713</code><code>Green et al., 1977a&lt;/a&gt;</code></p><p><code>6714</code><code>,&lt;a href="#R423" rid="R423" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918821"&gt;</code></p><p><code>6715</code><code>b&lt;/a&gt;</code></p><p><code>6716</code><code>). However, in subsequent studies, the effect of a unilateral topical application of cannabinoids was limited to the treated eye, pointing toward a local site of action (&lt;a href="#R191" rid="R191" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919382"&gt;</code></p><p><code>6717</code><code>Colasanti et al., 1984a&lt;/a&gt;</code></p><p><code>6718</code><code>,&lt;a href="#R192" rid="R192" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919629"&gt;</code></p><p><code>6719</code><code>b&lt;/a&gt;</code></p><p><code>6720</code><code>,&lt;a href="#R193" rid="R193" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919324"&gt;</code></p><p><code>6721</code><code>c&lt;/a&gt;</code></p><p><code>6722</code><code>). Indeed, a CNS site of action could be ruled out by the lack of change in intraocular pressure upon intracerebroventricular or ventriculocisternal application of THC in rabbits (&lt;a href="#R697" rid="R697" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919335"&gt;</code></p><p><code>6723</code><code>Liu and Dacus, 1987&lt;/a&gt;</code></p><p><code>6724</code><code>).&lt;/p&gt;</code></p><p><code>6725</code><code>&lt;p id="P179"&gt;</code></p><p><code>6726</code><code>Multiple lines of evidence suggest that endocannabinoids and cannabinoid receptors, in particular CB&lt;sub&gt;</code></p><p><code>6727</code><code>1&lt;/sub&gt;</code></p><p><code>6728</code><code>, play an important role in the regulation of intraocular pressure, and topically applied cannabinoids and cannabinoid ligands may be of significant benefit in the treatment of glaucoma (reviewed in &lt;a href="#R558" rid="R558" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919879"&gt;</code></p><p><code>6729</code><code>Jarvinen et al., 2002&lt;/a&gt;</code></p><p><code>6730</code><code>; &lt;a href="#R1184" rid="R1184" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919579"&gt;</code></p><p><code>6731</code><code>Tomida et al., 2004&lt;/a&gt;</code></p><p><code>6732</code><code>). First, CB&lt;sub&gt;</code></p><p><code>6733</code><code>1&lt;/sub&gt;</code></p><p><code>6734</code><code> receptors are expressed in the rat ciliary body (&lt;a href="#R978" rid="R978" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919329"&gt;</code></p><p><code>6735</code><code>Porcella et al., 1998&lt;/a&gt;</code></p><p><code>6736</code><code>), in human ciliary epithelium, ciliary muscle, ciliary body vessels, trabecular meshwork, Schlemm&amp;#x02019;s canal, and retina (&lt;a href="#R1144" rid="R1144" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919530"&gt;</code></p><p><code>6737</code><code>Straiker et al., 1999a&lt;/a&gt;</code></p><p><code>6738</code><code>; &lt;a href="#R980" rid="R980" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919809"&gt;</code></p><p><code>6739</code><code>Porcella et al., 2000&lt;/a&gt;</code></p><p><code>6740</code><code>; &lt;a href="#R1133" rid="R1133" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919825"&gt;</code></p><p><code>6741</code><code>Stamer et al., 2001&lt;/a&gt;</code></p><p><code>6742</code><code>), and the retina of a variety of species (&lt;a href="#R1145" rid="R1145" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919775"&gt;</code></p><p><code>6743</code><code>Straiker et al., 1999b&lt;/a&gt;</code></p><p><code>6744</code><code>; &lt;a href="#R1306" rid="R1306" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920327"&gt;</code></p><p><code>6745</code><code>Yazulla et al., 1999&lt;/a&gt;</code></p><p><code>6746</code><code>, &lt;a href="#R1307" rid="R1307" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919510"&gt;</code></p><p><code>6747</code><code>2000&lt;/a&gt;</code></p><p><code>6748</code><code>). Second, ocular CB&lt;sub&gt;</code></p><p><code>6749</code><code>1&lt;/sub&gt;</code></p><p><code>6750</code><code> receptors are functionally active, as CB&lt;sub&gt;</code></p><p><code>6751</code><code>1&lt;/sub&gt;</code></p><p><code>6752</code><code> receptor agonists (CP55,940 and WIN 55,212-2) applied topically lower intraocular pressure both in animals and humans, and their effect can be antagonized by SR141716 (&lt;a href="#R945" rid="R945" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918689"&gt;</code></p><p><code>6753</code><code>Pate et al., 1998&lt;/a&gt;</code></p><p><code>6754</code><code>; &lt;a href="#R1126" rid="R1126" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919997"&gt;</code></p><p><code>6755</code><code>Song and Slowey, 2000&lt;/a&gt;</code></p><p><code>6756</code><code>; &lt;a href="#R981" rid="R981" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920017"&gt;</code></p><p><code>6757</code><code>Porcella et al., 2001&lt;/a&gt;</code></p><p><code>6758</code><code>; &lt;a href="#R180" rid="R180" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920111"&gt;</code></p><p><code>6759</code><code>Chien et al., 2003&lt;/a&gt;</code></p><p><code>6760</code><code>; &lt;a href="#R1147" rid="R1147" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918722"&gt;</code></p><p><code>6761</code><code>Stumpff et al., 2005&lt;/a&gt;</code></p><p><code>6762</code><code>; reviewed in &lt;a href="#R558" rid="R558" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918741"&gt;</code></p><p><code>6763</code><code>Jarvinen et al., 2002&lt;/a&gt;</code></p><p><code>6764</code><code>). The CB&lt;sub&gt;</code></p><p><code>6765</code><code>2&lt;/sub&gt;</code></p><p><code>6766</code><code> receptor agonist JWH-133 did not modify the intraocular pressure, suggesting that CB&lt;sub&gt;</code></p><p><code>6767</code><code>2&lt;/sub&gt;</code></p><p><code>6768</code><code> receptors may play only a minor, if any, role (&lt;a href="#R642" rid="R642" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919902"&gt;</code></p><p><code>6769</code><code>Laine et al., 2003&lt;/a&gt;</code></p><p><code>6770</code><code>). CB&lt;sub&gt;</code></p><p><code>6771</code><code>1&lt;/sub&gt;</code></p><p><code>6772</code><code> receptor signaling is also operational in the ocular trabecular meshwork (&lt;a href="#R1147" rid="R1147" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919506"&gt;</code></p><p><code>6773</code><code>Stumpff et al., 2005&lt;/a&gt;</code></p><p><code>6774</code><code>), and ciliary muscle (&lt;a href="#R701" rid="R701" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920230"&gt;</code></p><p><code>6775</code><code>Lograno and Romano, 2004&lt;/a&gt;</code></p><p><code>6776</code><code>). Third, endocannabinoids are detectable in ocular tissues including the retina, ciliary body, and choroids plexus (&lt;a href="#R90" rid="R90" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919756"&gt;</code></p><p><code>6777</code><code>Bisogno et al., 1999b&lt;/a&gt;</code></p><p><code>6778</code><code>; &lt;a href="#R1144" rid="R1144" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920332"&gt;</code></p><p><code>6779</code><code>Straiker et al., 1999a&lt;/a&gt;</code></p><p><code>6780</code><code>,&lt;a href="#R1145" rid="R1145" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919911"&gt;</code></p><p><code>6781</code><code>b&lt;/a&gt;</code></p><p><code>6782</code><code>; &lt;a href="#R1133" rid="R1133" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919273"&gt;</code></p><p><code>6783</code><code>Stamer et al., 2001&lt;/a&gt;</code></p><p><code>6784</code><code>; &lt;a href="#R173" rid="R173" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919086"&gt;</code></p><p><code>6785</code><code>Chen et al., 2005&lt;/a&gt;</code></p><p><code>6786</code><code>), and the levels of anandamide and especially 2-AG are significantly decreased in patients with glaucoma (&lt;a href="#R173" rid="R173" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919957"&gt;</code></p><p><code>6787</code><code>Chen et al., 2005&lt;/a&gt;</code></p><p><code>6788</code><code>).&lt;/p&gt;</code></p><p><code>6789</code><code>&lt;p id="P180"&gt;</code></p><p><code>6790</code><code>The cellular/molecular mechanisms responsible for the intraocular pressure-reducing effect of cannabinoids are not completely understood but may involve direct effects on ciliary processes such as vasodilation and reduction of capillary pressure and secretion and do not seem to be related to systemic reduction of arterial blood pressure (&lt;a href="#R425" rid="R425" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920314"&gt;</code></p><p><code>6791</code><code>Green and Pederson, 1973&lt;/a&gt;</code></p><p><code>6792</code><code>; &lt;a href="#R624" rid="R624" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919383"&gt;</code></p><p><code>6793</code><code>Korczyn, 1980&lt;/a&gt;</code></p><p><code>6794</code><code>). Cannabinoids may also inhibit calcium influx through presynaptic ion channels, thereby reducing norepinephrine release in the ciliary body, resulting in decreased aqueous humor production (&lt;a href="#R1151" rid="R1151" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918964"&gt;</code></p><p><code>6795</code><code>Sugrue, 1997&lt;/a&gt;</code></p><p><code>6796</code><code>). In addition, cannabinoids may improve the uveoscleral outflow by dilating blood vessels of the anterior uvea (&lt;a href="#R978" rid="R978" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919699"&gt;</code></p><p><code>6797</code><code>Porcella et al., 1998&lt;/a&gt;</code></p><p><code>6798</code><code>), most likely by induction of several outflow-facilitating mediators (&lt;a href="#R1037" rid="R1037" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918945"&gt;</code></p><p><code>6799</code><code>Rosch et al., 2006&lt;/a&gt;</code></p><p><code>6800</code><code>). Some evidence implicates prostanoids in the intraocular pressure-reducing effect of certain cannabinoids and anandamide (&lt;a href="#R943" rid="R943" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919299"&gt;</code></p><p><code>6801</code><code>Pate et al., 1996&lt;/a&gt;</code></p><p><code>6802</code><code>; &lt;a href="#R424" rid="R424" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919060"&gt;</code></p><p><code>6803</code><code>Green et al., 2001&lt;/a&gt;</code></p><p><code>6804</code><code>; &lt;a href="#R1037" rid="R1037" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919883"&gt;</code></p><p><code>6805</code><code>Rosch et al., 2006&lt;/a&gt;</code></p><p><code>6806</code><code>).&lt;/p&gt;</code></p><p><code>6807</code><code>&lt;p id="P181"&gt;</code></p><p><code>6808</code><code>Endocannabinoids as well as functional CB&lt;sub&gt;</code></p><p><code>6809</code><code>1&lt;/sub&gt;</code></p><p><code>6810</code><code> receptors are present in the retina (&lt;a href="#R90" rid="R90" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919914"&gt;</code></p><p><code>6811</code><code>Bisogno et al., 1999b&lt;/a&gt;</code></p><p><code>6812</code><code>; &lt;a href="#R1144" rid="R1144" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919007"&gt;</code></p><p><code>6813</code><code>Straiker et al., 1999a&lt;/a&gt;</code></p><p><code>6814</code><code>,&lt;a href="#R1145" rid="R1145" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919436"&gt;</code></p><p><code>6815</code><code>b&lt;/a&gt;</code></p><p><code>6816</code><code>; &lt;a href="#R311" rid="R311" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919586"&gt;</code></p><p><code>6817</code><code>Fan and Yazulla, 2003&lt;/a&gt;</code></p><p><code>6818</code><code>; &lt;a href="#R1069" rid="R1069" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919112"&gt;</code></p><p><code>6819</code><code>Savinainen and Laitinen, 2004&lt;/a&gt;</code></p><p><code>6820</code><code>). Cannabinoids exert neuroprotective effects against retinal neurotoxicity (&lt;a href="#R298" rid="R298" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919304"&gt;</code></p><p><code>6821</code><code>El-Remessy et al., 2003&lt;/a&gt;</code></p><p><code>6822</code><code>), and cannabidiol helps to preserve the blood-retinal barrier in experimental diabetes (&lt;a href="#R297" rid="R297" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919310"&gt;</code></p><p><code>6823</code><code>El-Remessy et al., 2006&lt;/a&gt;</code></p><p><code>6824</code><code>). These effects could suggest their usefulness in various retinopathies. Unlike CB&lt;sub&gt;</code></p><p><code>6825</code><code>1&lt;/sub&gt;</code></p><p><code>6826</code><code> receptors, CB&lt;sub&gt;</code></p><p><code>6827</code><code>2&lt;/sub&gt;</code></p><p><code>6828</code><code> receptors were undetectable in human retina, although they were found in the rat retina (&lt;a href="#R708" rid="R708" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920110"&gt;</code></p><p><code>6829</code><code>Lu et al., 2000&lt;/a&gt;</code></p><p><code>6830</code><code>; &lt;a href="#R980" rid="R980" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919264"&gt;</code></p><p><code>6831</code><code>Porcella et al., 2000&lt;/a&gt;</code></p><p><code>6832</code><code>).&lt;/p&gt;</code></p><p><code>6833</code><code>&lt;p id="P182" class="p p-last"&gt;</code></p><p><code>6834</code><code>Taken together, these findings indicate that cannabinoids may have great potential in the treatment of glaucoma, if the difficulty in formulating a stable and effective topical preparation and the problem of systemic side effects are conquered. Because of their well known neuroprotective, anti-inflammatory, and antiangiogenic effects, cannabinoid analogs may also be considered for the treatment of inflammatory and degenerative eye disorders and diabetic retinopathy.&lt;/p&gt;</code></p><p><code>6835</code><code>&lt;/div&gt;</code></p><p><code>6836</code><code>&lt;div id="S42" class="sec"&gt;</code></p><p><code>6837</code><code>&lt;h3 id="S42title"&gt;</code></p><p><code>6838</code><code>F. Cancer&lt;/h3&gt;</code></p><p><code>6839</code><code>&lt;p id="P183" class="p p-first"&gt;</code></p><p><code>6840</code><code>The palliative effects of cannabinoids in cancer patients are well known and may include appetite stimulation, inhibition of nausea and emesis associated with chemo- or radiotherapy, pain relief, mood elevation, and relief from insomnia (reviewed in &lt;a href="#R1260" rid="R1260" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919619"&gt;</code></p><p><code>6841</code><code>Walsh et al., 2003&lt;/a&gt;</code></p><p><code>6842</code><code>; &lt;a href="#R454" rid="R454" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920387"&gt;</code></p><p><code>6843</code><code>Hall et al., 2005&lt;/a&gt;</code></p><p><code>6844</code><code>) (&lt;a href="/pmc/articles/PMC2241751/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""&gt;</code></p><p><code>6845</code><code>&lt;span&gt;</code></p><p><code>6846</code><code>Table 1&lt;/span&gt;</code></p><p><code>6847</code><code>&lt;/a&gt;</code></p><p><code>6848</code><code>). &amp;#x00394;&lt;sup&gt;</code></p><p><code>6849</code><code>9&lt;/sup&gt;</code></p><p><code>6850</code><code>-THC (dronabinol, Marinol) and its synthetic derivative nabilone have been approved by the U.S. Food and Drug Administration to control nausea in cancer patients undergoing chemotherapy and to stimulate appetite in patients with AIDS (&lt;a href="#R1260" rid="R1260" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918761"&gt;</code></p><p><code>6851</code><code>Walsh et al., 2003&lt;/a&gt;</code></p><p><code>6852</code><code>; &lt;a href="#R454" rid="R454" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920294"&gt;</code></p><p><code>6853</code><code>Hall et al., 2005&lt;/a&gt;</code></p><p><code>6854</code><code>).&lt;/p&gt;</code></p><p><code>6855</code><code>&lt;p id="P184"&gt;</code></p><p><code>6856</code><code>Numerous recent studies have suggested that cannabinoids might directly inhibit cancer growth (reviewed in &lt;a href="#R942" rid="R942" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653393"&gt;</code></p><p><code>6857</code><code>Parolaro et al., 2002&lt;/a&gt;</code></p><p><code>6858</code><code>; &lt;a href="#R449" rid="R449" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919281"&gt;</code></p><p><code>6859</code><code>Guzm&amp;#x000e1;n et al., 2002&lt;/a&gt;</code></p><p><code>6860</code><code>; &lt;a href="#R448" rid="R448" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920019"&gt;</code></p><p><code>6861</code><code>Guzm&amp;#x000e1;n, 2003&lt;/a&gt;</code></p><p><code>6862</code><code>; &lt;a href="#R571" rid="R571" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919907"&gt;</code></p><p><code>6863</code><code>Jones and Howl, 2003&lt;/a&gt;</code></p><p><code>6864</code><code>; &lt;a href="#R1224" rid="R1224" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919384"&gt;</code></p><p><code>6865</code><code>Velasco et al., 2004&lt;/a&gt;</code></p><p><code>6866</code><code>; &lt;a href="#R951" rid="R951" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918967"&gt;</code></p><p><code>6867</code><code>Patsos et al., 2005&lt;/a&gt;</code></p><p><code>6868</code><code>). The proposed mechanisms are complex and may involve induction of apoptosis in tumor cells, antiproliferative action, and an antimetastatic effect through inhibition of angiogenesis and tumor cell migration (reviewed in &lt;a href="#R83" rid="R83" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918680"&gt;</code></p><p><code>6869</code><code>Bifulco and Di Marzo, 2002&lt;/a&gt;</code></p><p><code>6870</code><code>; &lt;a href="#R942" rid="R942" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653457"&gt;</code></p><p><code>6871</code><code>Parolaro et al., 2002&lt;/a&gt;</code></p><p><code>6872</code><code>; &lt;a href="#R449" rid="R449" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920386"&gt;</code></p><p><code>6873</code><code>Guzm&amp;#x000e1;n et al., 2002&lt;/a&gt;</code></p><p><code>6874</code><code>; &lt;a href="#R448" rid="R448" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919121"&gt;</code></p><p><code>6875</code><code>Guzm&amp;#x000e1;n, 2003&lt;/a&gt;</code></p><p><code>6876</code><code>; &lt;a href="#R571" rid="R571" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919994"&gt;</code></p><p><code>6877</code><code>Jones and Howl, 2003&lt;/a&gt;</code></p><p><code>6878</code><code>; &lt;a href="#R1224" rid="R1224" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918737"&gt;</code></p><p><code>6879</code><code>Velasco et al., 2004&lt;/a&gt;</code></p><p><code>6880</code><code>; &lt;a href="#R951" rid="R951" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919981"&gt;</code></p><p><code>6881</code><code>Patsos et al., 2005&lt;/a&gt;</code></p><p><code>6882</code><code>).&lt;/p&gt;</code></p><p><code>6883</code><code>&lt;p id="P185"&gt;</code></p><p><code>6884</code><code>Various cannabinoids, including cannabidiol, anandamide, and 2-AG, and endocannabinoid transport inhibitors have been shown to induce apoptotic cell death and to inhibit proliferation and migration in numerous murine and human tumor cell lines including glioma (C6, U87, U373, and H4), oligodendroglioma (Gos3), glioblastoma multiforme, astrocytoma (U373-MG, U87MG, and human grade IV astrocytoma), neuroblastoma (N18 TG2 and CHP100), pheochromocytoma (PC12), breast cancer (MCF-7, EFM-19, T47D, TSA-E1, and MDA-MB-231), prostate cancer (LNCaP, DU145, and PC3), colon carcinoma (SW 480), uterine cervix carcinoma (CxCa), thyroid cancer (KiMol), leukemia (CEM, HEL-92, HL60, and Jurkat cell lines), and lymphoid tumors (EL-4 and P815) tumor cells via CB&lt;sub&gt;</code></p><p><code>6885</code><code>1&lt;/sub&gt;</code></p><p><code>6886</code><code>/CB&lt;sub&gt;</code></p><p><code>6887</code><code>2&lt;/sub&gt;</code></p><p><code>6888</code><code>- and VR&lt;sub&gt;</code></p><p><code>6889</code><code>1&lt;/sub&gt;</code></p><p><code>6890</code><code> receptor-dependent or independent (e.g., cyclooxygenase) mechanisms (&lt;a href="#R253" rid="R253" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919356"&gt;</code></p><p><code>6891</code><code>De Petrocellis et al., 1998&lt;/a&gt;</code></p><p><code>6892</code><code>; &lt;a href="#R1058" rid="R1058" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919429"&gt;</code></p><p><code>6893</code><code>S&amp;#x000e1;nchez et al., 1998&lt;/a&gt;</code></p><p><code>6894</code><code>, &lt;a href="#R1060" rid="R1060" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919580"&gt;</code></p><p><code>6895</code><code>2003&lt;/a&gt;</code></p><p><code>6896</code><code>; &lt;a href="#R552" rid="R552" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918691"&gt;</code></p><p><code>6897</code><code>Jacobsson et al., 2000&lt;/a&gt;</code></p><p><code>6898</code><code>; &lt;a href="#R722" rid="R722" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919924"&gt;</code></p><p><code>6899</code><code>Maccarrone et al., 2000b&lt;/a&gt;</code></p><p><code>6900</code><code>; &lt;a href="#R1068" rid="R1068" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653372"&gt;</code></p><p><code>6901</code><code>Sarker et al., 2000&lt;/a&gt;</code></p><p><code>6902</code><code>; &lt;a href="#R797" rid="R797" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920185"&gt;</code></p><p><code>6903</code><code>McKallip et al., 2002a&lt;/a&gt;</code></p><p><code>6904</code><code>,&lt;a href="#R798" rid="R798" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919092"&gt;</code></p><p><code>6905</code><code>b&lt;/a&gt;</code></p><p><code>6906</code><code>; &lt;a href="#R332" rid="R332" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919480"&gt;</code></p><p><code>6907</code><code>Fowler et al., 2003&lt;/a&gt;</code></p><p><code>6908</code><code>; &lt;a href="#R572" rid="R572" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920066"&gt;</code></p><p><code>6909</code><code>Jonsson et al., 2003&lt;/a&gt;</code></p><p><code>6910</code><code>; &lt;a href="#R836" rid="R836" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920131"&gt;</code></p><p><code>6911</code><code>Mimeault et al., 2003&lt;/a&gt;</code></p><p><code>6912</code><code>; &lt;a href="#R85" rid="R85" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920071"&gt;</code></p><p><code>6913</code><code>Bifulco et al., 2004&lt;/a&gt;</code></p><p><code>6914</code><code>; &lt;a href="#R207" rid="R207" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919066"&gt;</code></p><p><code>6915</code><code>Contassot et al., 2004a&lt;/a&gt;</code></p><p><code>6916</code><code>,&lt;a href="#R208" rid="R208" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919311"&gt;</code></p><p><code>6917</code><code>b&lt;/a&gt;</code></p><p><code>6918</code><code>; &lt;a href="#R504" rid="R504" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918841"&gt;</code></p><p><code>6919</code><code>Hinz et al., 2004&lt;/a&gt;</code></p><p><code>6920</code><code>; &lt;a href="#R574" rid="R574" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918977"&gt;</code></p><p><code>6921</code><code>Joseph et al., 2004&lt;/a&gt;</code></p><p><code>6922</code><code>; &lt;a href="#R619" rid="R619" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919442"&gt;</code></p><p><code>6923</code><code>Kogan et al., 2004&lt;/a&gt;</code></p><p><code>6924</code><code>; &lt;a href="#R777" rid="R777" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920030"&gt;</code></p><p><code>6925</code><code>Massi et al., 2004&lt;/a&gt;</code></p><p><code>6926</code><code>; &lt;a href="#R894" rid="R894" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920219"&gt;</code></p><p><code>6927</code><code>Nithipatikom et al., 2004&lt;/a&gt;</code></p><p><code>6928</code><code>; &lt;a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919023"&gt;</code></p><p><code>6929</code><code>Allister et al., 2005&lt;/a&gt;</code></p><p><code>6930</code><code>; &lt;a href="#R294" rid="R294" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920188"&gt;</code></p><p><code>6931</code><code>Ellert-Miklaszewska et al., 2005&lt;/a&gt;</code></p><p><code>6932</code><code>; &lt;a href="#R489" rid="R489" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920064"&gt;</code></p><p><code>6933</code><code>Herrera et al., 2005&lt;/a&gt;</code></p><p><code>6934</code><code>, &lt;a href="#R488" rid="R488" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918788"&gt;</code></p><p><code>6935</code><code>2006&lt;/a&gt;</code></p><p><code>6936</code><code>; &lt;a href="#R702" rid="R702" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919300"&gt;</code></p><p><code>6937</code><code>Lombard et al., 2005&lt;/a&gt;</code></p><p><code>6938</code><code>; &lt;a href="#R984" rid="R984" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919298"&gt;</code></p><p><code>6939</code><code>Powles et al., 2005&lt;/a&gt;</code></p><p><code>6940</code><code>; &lt;a href="#R1066" rid="R1066" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918732"&gt;</code></p><p><code>6941</code><code>Sarfaraz et al., 2005&lt;/a&gt;</code></p><p><code>6942</code><code>; &lt;a href="#R1206" rid="R1206" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920226"&gt;</code></p><p><code>6943</code><code>Vaccani et al., 2005&lt;/a&gt;</code></p><p><code>6944</code><code>; &lt;a href="#R157" rid="R157" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919993"&gt;</code></p><p><code>6945</code><code>Carracedo et al., 2006&lt;/a&gt;</code></p><p><code>6946</code><code>; &lt;a href="#R432" rid="R432" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918877"&gt;</code></p><p><code>6947</code><code>Grimaldi et al., 2006&lt;/a&gt;</code></p><p><code>6948</code><code>; &lt;a href="#R690" rid="R690" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_393488948"&gt;</code></p><p><code>6949</code><code>Ligresti et al., 2006b&lt;/a&gt;</code></p><p><code>6950</code><code>). More importantly, systemic or local treatment with cannabinoids inhibited the growth of various types of tumor or tumor cell xenografts in vivo, including lung carcinoma (&lt;a href="#R864" rid="R864" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919556"&gt;</code></p><p><code>6951</code><code>Munson et al., 1975&lt;/a&gt;</code></p><p><code>6952</code><code>), glioma (&lt;a href="#R357" rid="R357" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919835"&gt;</code></p><p><code>6953</code><code>Galve-Roperh et al., 2000&lt;/a&gt;</code></p><p><code>6954</code><code>; &lt;a href="#R1057" rid="R1057" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653388"&gt;</code></p><p><code>6955</code><code>S&amp;#x000e1;nchez et al., 2001a&lt;/a&gt;</code></p><p><code>6956</code><code>; &lt;a href="#R777" rid="R777" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919522"&gt;</code></p><p><code>6957</code><code>Massi et al., 2004&lt;/a&gt;</code></p><p><code>6958</code><code>), thyroid epithelioma (&lt;a href="#R84" rid="R84" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919513"&gt;</code></p><p><code>6959</code><code>Bifulco et al., 2001&lt;/a&gt;</code></p><p><code>6960</code><code>), lymphoma (&lt;a href="#R797" rid="R797" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919229"&gt;</code></p><p><code>6961</code><code>McKallip et al., 2002a&lt;/a&gt;</code></p><p><code>6962</code><code>), and skin carcinoma (&lt;a href="#R160" rid="R160" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919450"&gt;</code></p><p><code>6963</code><code>Casanova et al., 2003&lt;/a&gt;</code></p><p><code>6964</code><code>) in mice.&lt;/p&gt;</code></p><p><code>6965</code><code>&lt;p id="P186"&gt;</code></p><p><code>6966</code><code>The proapoptotic effect of cannabinoids in tumor cells is complex and may involve increased synthesis of the proapoptotic sphingolipid ceramide (&lt;a href="#R357" rid="R357" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919541"&gt;</code></p><p><code>6967</code><code>Galve-Roperh et al., 2000&lt;/a&gt;</code></p><p><code>6968</code><code>; &lt;a href="#R407" rid="R407" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653350"&gt;</code></p><p><code>6969</code><code>G&amp;#x000f3;mez del Pulgar et al., 2002a&lt;/a&gt;</code></p><p><code>6970</code><code>,&lt;a href="#R409" rid="R409" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653445"&gt;</code></p><p><code>6971</code><code>b&lt;/a&gt;</code></p><p><code>6972</code><code>), ceramide-dependent up-regulation of the stress protein p8 and several downstream stress-related genes expressed in the endoplasmic reticulum (ATF-4, CHOP, and TRB3; &lt;a href="#R157" rid="R157" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919595"&gt;</code></p><p><code>6973</code><code>Carracedo et al., 2006&lt;/a&gt;</code></p><p><code>6974</code><code>), prolonged activation of the Raf-1/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling cascade (&lt;a href="#R357" rid="R357" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920046"&gt;</code></p><p><code>6975</code><code>Galve-Roperh et al., 2000&lt;/a&gt;</code></p><p><code>6976</code><code>), and inhibition of Akt (&lt;a href="#R408" rid="R408" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919540"&gt;</code></p><p><code>6977</code><code>G&amp;#x000f3;mez del Pulgar et al., 2000&lt;/a&gt;</code></p><p><code>6978</code><code>; &lt;a href="#R294" rid="R294" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919861"&gt;</code></p><p><code>6979</code><code>Ellert-Miklaszewska et al., 2005&lt;/a&gt;</code></p><p><code>6980</code><code>), c-Jun NH&lt;sub&gt;</code></p><p><code>6981</code><code>2&lt;/sub&gt;</code></p><p><code>6982</code><code>-terminal kinase and p38 mitogen-activated protein kinase (&lt;a href="#R357" rid="R357" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919525"&gt;</code></p><p><code>6983</code><code>Galve-Roperh et al., 2000&lt;/a&gt;</code></p><p><code>6984</code><code>; &lt;a href="#R1067" rid="R1067" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920333"&gt;</code></p><p><code>6985</code><code>Sarker et al., 2003&lt;/a&gt;</code></p><p><code>6986</code><code>; &lt;a href="#R504" rid="R504" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918802"&gt;</code></p><p><code>6987</code><code>Hinz et al., 2004&lt;/a&gt;</code></p><p><code>6988</code><code>; &lt;a href="#R984" rid="R984" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918772"&gt;</code></p><p><code>6989</code><code>Powles et al., 2005&lt;/a&gt;</code></p><p><code>6990</code><code>). As mentioned above, cannabinoids also inhibit the proliferation of various tumor cells, possibly through inhibition of adenylyl cyclase and the cAMP/protein kinase A pathway (&lt;a href="#R816" rid="R816" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919240"&gt;</code></p><p><code>6991</code><code>Melck et al., 1999&lt;/a&gt;</code></p><p><code>6992</code><code>), induction of the cyclin-dependent kinase inhibitor p27&lt;sup&gt;</code></p><p><code>6993</code><code>kip1&lt;/sup&gt;</code></p><p><code>6994</code><code> (&lt;a href="#R982" rid="R982" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918974"&gt;</code></p><p><code>6995</code><code>Portella et al., 2003&lt;/a&gt;</code></p><p><code>6996</code><code>), a decrease in epidermal growth factor receptor expression and/or the attenuation of epidermal growth factor receptor tyrosine kinase activity (&lt;a href="#R160" rid="R160" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919999"&gt;</code></p><p><code>6997</code><code>Casanova et al., 2003&lt;/a&gt;</code></p><p><code>6998</code><code>; &lt;a href="#R836" rid="R836" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919085"&gt;</code></p><p><code>6999</code><code>Mimeault et al., 2003&lt;/a&gt;</code></p><p><code>7000</code><code>), and a decrease in the activity and/or expression of nerve growth factor or vascular endothelial growth factor tyrosine kinase receptors and prolactin (&lt;a href="#R253" rid="R253" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919639"&gt;</code></p><p><code>7001</code><code>De Petrocellis et al., 1998&lt;/a&gt;</code></p><p><code>7002</code><code>; &lt;a href="#R815" rid="R815" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920162"&gt;</code></p><p><code>7003</code><code>Melck et al., 2000&lt;/a&gt;</code></p><p><code>7004</code><code>; &lt;a href="#R982" rid="R982" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919285"&gt;</code></p><p><code>7005</code><code>Portella et al., 2003&lt;/a&gt;</code></p><p><code>7006</code><code>). In addition to their proapoptotic and antiproliferative effects in tumor cells, cannabinoids also inhibit the expression of proangiogenic mediators or their receptors (e.g., vascular endothelial growth factor) and reduce vascular hyperplasia and cell migration, which play crucial roles in tumor growth and metastasis formation (&lt;a href="#R98" rid="R98" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918751"&gt;</code></p><p><code>7007</code><code>Bl&amp;#x000e1;zquez 2004&lt;/a&gt;</code></p><p><code>7008</code><code>;&lt;a href="#R97" rid="R97" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918816"&gt;</code></p><p><code>7009</code><code>et al., 2003&lt;/a&gt;</code></p><p><code>7010</code><code>, &lt;a href="#R98" rid="R98" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919804"&gt;</code></p><p><code>7011</code><code>2004&lt;/a&gt;</code></p><p><code>7012</code><code>; &lt;a href="#R160" rid="R160" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919998"&gt;</code></p><p><code>7013</code><code>Casanova et al., 2003&lt;/a&gt;</code></p><p><code>7014</code><code>; &lt;a href="#R982" rid="R982" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918940"&gt;</code></p><p><code>7015</code><code>Portella et al., 2003&lt;/a&gt;</code></p><p><code>7016</code><code>).&lt;/p&gt;</code></p><p><code>7017</code><code>&lt;p id="P187"&gt;</code></p><p><code>7018</code><code>In sharp contrast to the above, &lt;a href="#R472" rid="R472" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920094"&gt;</code></p><p><code>7019</code><code>Hart et al. (2004)&lt;/a&gt;</code></p><p><code>7020</code><code> have demonstrated that treatment of lung cancer (NCI-H292), squamous cell carcinoma (SCC-9), bladder carcinoma (5637), glioblastoma (U373-MG), astrocytoma (1321N1), and kidney cancer (A498) cells with nanomolar concentrations of cannabinoids such as THC, anandamide, HU-210, and WIN 55,212-2 leads to rapid epidermal growth factor receptor- and metalloprotease-dependent cancer cell proliferation. However, the same study also documented that at micromolar concentrations cannabinoids induced cancer cell apoptosis, in agreement with previous reports (&lt;a href="#R472" rid="R472" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919177"&gt;</code></p><p><code>7021</code><code>Hart et al., 2004&lt;/a&gt;</code></p><p><code>7022</code><code>). These results highlight the bimodal action of cannabinoids on cancer cell growth, with low concentrations being proproliferative and high concentrations having antiproliferative effects.&lt;/p&gt;</code></p><p><code>7023</code><code>&lt;p id="P188"&gt;</code></p><p><code>7024</code><code>The key role of the immune system in controlling the development of cancers is supported by findings that immunosuppressed individuals are at increased risk for developing cancer. For example, there is increased incidence of non-Hodgkin&amp;#x02019;s lymphoma, Burkitt&amp;#x02019;s lymphoma, Kaposi&amp;#x02019;s sarcoma, and cervical cancer in AIDS patients and increased susceptibility to various lymphomas and solid tumors after organ transplantation (&lt;a href="#R77" rid="R77" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919207"&gt;</code></p><p><code>7025</code><code>Bhatia et al., 2001&lt;/a&gt;</code></p><p><code>7026</code><code>; &lt;a href="#R1071" rid="R1071" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919973"&gt;</code></p><p><code>7027</code><code>Scadden, 2003&lt;/a&gt;</code></p><p><code>7028</code><code>; &lt;a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919047"&gt;</code></p><p><code>7029</code><code>Abu-Elmagd et al., 2004&lt;/a&gt;</code></p><p><code>7030</code><code>; &lt;a href="#R911" rid="R911" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653448"&gt;</code></p><p><code>7031</code><code>Oruc et al., 2004&lt;/a&gt;</code></p><p><code>7032</code><code>). This concept is particularly important, because cannabinoids have well-known immunosuppressant effects (reviewed in &lt;a href="#R612" rid="R612" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919733"&gt;</code></p><p><code>7033</code><code>Klein, 2005&lt;/a&gt;</code></p><p><code>7034</code><code>), which may compromise antitumor immune responses. Indeed, THC enhances breast and lung cancer growth and metastasis by suppressing CB&lt;sub&gt;</code></p><p><code>7035</code><code>2&lt;/sub&gt;</code></p><p><code>7036</code><code> receptor-mediated antitumor immune responses (&lt;a href="#R1322" rid="R1322" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919160"&gt;</code></p><p><code>7037</code><code>Zhu et al., 2000&lt;/a&gt;</code></p><p><code>7038</code><code>; &lt;a href="#R799" rid="R799" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919944"&gt;</code></p><p><code>7039</code><code>McKallip et al., 2005&lt;/a&gt;</code></p><p><code>7040</code><code>) and can also lead to increased susceptibility to infections with various pathogens such as herpes simplex virus, &lt;em&gt;</code></p><p><code>7041</code><code>Legionella pneumophila,&lt;/em&gt;</code></p><p><code>7042</code><code> and Fried leukemia virus (&lt;a href="#R849" rid="R849" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919416"&gt;</code></p><p><code>7043</code><code>Morahan et al., 1979&lt;/a&gt;</code></p><p><code>7044</code><code>; &lt;a href="#R141" rid="R141" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919727"&gt;</code></p><p><code>7045</code><code>Cabral et al., 1986&lt;/a&gt;</code></p><p><code>7046</code><code>; &lt;a href="#R1129" rid="R1129" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919216"&gt;</code></p><p><code>7047</code><code>Specter et al., 1991&lt;/a&gt;</code></p><p><code>7048</code><code>; &lt;a href="#R616" rid="R616" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918824"&gt;</code></p><p><code>7049</code><code>Klein et al., 2000b&lt;/a&gt;</code></p><p><code>7050</code><code>).&lt;/p&gt;</code></p><p><code>7051</code><code>&lt;p id="P189" class="p p-last"&gt;</code></p><p><code>7052</code><code>Epidemiological studies investigating the relationship of cannabis smoking and various forms of cancer have yielded inconsistent results, thus failing to resolve the conflicting findings in animal models of cancer or in cancer cell lines (&lt;a href="#R1169" rid="R1169" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919729"&gt;</code></p><p><code>7053</code><code>Taylor, 1988&lt;/a&gt;</code></p><p><code>7054</code><code>; &lt;a href="#R154" rid="R154" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920325"&gt;</code></p><p><code>7055</code><code>Caplan and Brigham, 1990&lt;/a&gt;</code></p><p><code>7056</code><code>; &lt;a href="#R634" rid="R634" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919438"&gt;</code></p><p><code>7057</code><code>Kuijten et al., 1992&lt;/a&gt;</code></p><p><code>7058</code><code>; &lt;a href="#R437" rid="R437" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920404"&gt;</code></p><p><code>7059</code><code>Grufferman et al., 1993&lt;/a&gt;</code></p><p><code>7060</code><code>; &lt;a href="#R1101" rid="R1101" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919539"&gt;</code></p><p><code>7061</code><code>Sidney et al., 1997&lt;/a&gt;</code></p><p><code>7062</code><code>; &lt;a href="#R45" rid="R45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920127"&gt;</code></p><p><code>7063</code><code>Barsky et al., 1998&lt;/a&gt;</code></p><p><code>7064</code><code>; &lt;a href="#R1319" rid="R1319" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919908"&gt;</code></p><p><code>7065</code><code>Zhang et al., 1999&lt;/a&gt;</code></p><p><code>7066</code><code>; &lt;a href="#R292" rid="R292" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919144"&gt;</code></p><p><code>7067</code><code>Efird et al., 2004&lt;/a&gt;</code></p><p><code>7068</code><code>; &lt;a href="#R699" rid="R699" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918721"&gt;</code></p><p><code>7069</code><code>Llewellyn et al., 2004&lt;/a&gt;</code></p><p><code>7070</code><code>; &lt;a href="#R1038" rid="R1038" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918851"&gt;</code></p><p><code>7071</code><code>Rosenblatt et al., 2004&lt;/a&gt;</code></p><p><code>7072</code><code>; reviewed in &lt;a href="#R454" rid="R454" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919723"&gt;</code></p><p><code>7073</code><code>Hall et al., 2005&lt;/a&gt;</code></p><p><code>7074</code><code>). The variability of the effects of cannabinoids in different tumor models may be related to the differential expression of CB&lt;sub&gt;</code></p><p><code>7075</code><code>1&lt;/sub&gt;</code></p><p><code>7076</code><code> and CB&lt;sub&gt;</code></p><p><code>7077</code><code>2&lt;/sub&gt;</code></p><p><code>7078</code><code> receptors. Thus, cannabinoids may be effective in killing tumors that abundantly express cannabinoid receptors, such as gliomas, but may increase the growth and metastasis of other types of tumors, such as breast cancer, with no or low expression of cannabinoid receptors, due to the suppression of the antitumor immune response (&lt;a href="#R799" rid="R799" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919345"&gt;</code></p><p><code>7079</code><code>McKallip et al., 2005&lt;/a&gt;</code></p><p><code>7080</code><code>). Nevertheless, the majority of the findings to date are encouraging and suggest that cannabinoids may be useful not only as palliative therapy but also because of their ability to inhibit tumor growth and metastasis.&lt;/p&gt;</code></p><p><code>7081</code><code>&lt;/div&gt;</code></p><p><code>7082</code><code>&lt;div id="S43" class="sec"&gt;</code></p><p><code>7083</code><code>&lt;h3 id="S43title"&gt;</code></p><p><code>7084</code><code>G. Gastrointestinal and Liver Disorders&lt;/h3&gt;</code></p><p><code>7085</code><code>&lt;p id="P190" class="p p-first"&gt;</code></p><p><code>7086</code><code>Cannabis has been used empirically for centuries to stimulate appetite and decrease emesis and diarrhea. Recent evidence indicates that the endocannabinoid system plays an important role in the control of gastrointestinal motility and secretion both under physiological conditions and in various gastrointestinal disorders (reviewed in &lt;a href="#R955" rid="R955" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918949"&gt;</code></p><p><code>7087</code><code>Pertwee, 2001&lt;/a&gt;</code></p><p><code>7088</code><code>; &lt;a href="#R970" rid="R970" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653500"&gt;</code></p><p><code>7089</code><code>Pinto et al., 2002a&lt;/a&gt;</code></p><p><code>7090</code><code>,&lt;a href="#R971" rid="R971" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920137"&gt;</code></p><p><code>7091</code><code>b&lt;/a&gt;</code></p><p><code>7092</code><code>; &lt;a href="#R269" rid="R269" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653504"&gt;</code></p><p><code>7093</code><code>Di Carlo and Izzo, 2003&lt;/a&gt;</code></p><p><code>7094</code><code>; &lt;a href="#R217" rid="R217" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919948"&gt;</code></p><p><code>7095</code><code>Coutts and Izzo, 2004&lt;/a&gt;</code></p><p><code>7096</code><code>; &lt;a href="#R288" rid="R288" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918728"&gt;</code></p><p><code>7097</code><code>Duncan et al., 2005&lt;/a&gt;</code></p><p><code>7098</code><code>; &lt;a href="#R776" rid="R776" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919900"&gt;</code></p><p><code>7099</code><code>Massa et al., 2005&lt;/a&gt;</code></p><p><code>7100</code><code>). Unexpectedly, recent data also implicate endocannabinoids and their receptors in several aspects of acute and chronic liver disease, including hemodynamic changes, modulation of inflammatory processes, fibrosis, and altered brain function (reviewed in &lt;a href="#R353" rid="R353" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920307"&gt;</code></p><p><code>7101</code><code>Gabbay et al., 2005&lt;/a&gt;</code></p><p><code>7102</code><code>; &lt;a href="#R561" rid="R561" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919129"&gt;</code></p><p><code>7103</code><code>Jimenez, 2005&lt;/a&gt;</code></p><p><code>7104</code><code>).&lt;/p&gt;</code></p><p><code>7105</code><code>&lt;p id="P191"&gt;</code></p><p><code>7106</code><code>Numerous studies using autoradiography, immunohistochemistry, and/or reverse transcription-polymerase chain reaction demonstrated colocalization of CB&lt;sub&gt;</code></p><p><code>7107</code><code>1&lt;/sub&gt;</code></p><p><code>7108</code><code> receptors with cholinergic neurons across the enteric nervous system, including sensory and interneuronal as well as motoneural cell bodies of the myenteric plexus, in mice (&lt;a href="#R772" rid="R772" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919657"&gt;</code></p><p><code>7109</code><code>Mascolo et al., 2002&lt;/a&gt;</code></p><p><code>7110</code><code>; &lt;a href="#R970" rid="R970" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653450"&gt;</code></p><p><code>7111</code><code>Pinto et al., 2002a&lt;/a&gt;</code></p><p><code>7112</code><code>,&lt;a href="#R971" rid="R971" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920231"&gt;</code></p><p><code>7113</code><code>b&lt;/a&gt;</code></p><p><code>7114</code><code>; &lt;a href="#R162" rid="R162" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919397"&gt;</code></p><p><code>7115</code><code>Casu et al., 2003&lt;/a&gt;</code></p><p><code>7116</code><code>; &lt;a href="#R546" rid="R546" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920258"&gt;</code></p><p><code>7117</code><code>Izzo et al., 2003&lt;/a&gt;</code></p><p><code>7118</code><code>; &lt;a href="#R1143" rid="R1143" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653447"&gt;</code></p><p><code>7119</code><code>Storr et al., 2004&lt;/a&gt;</code></p><p><code>7120</code><code>), rats (&lt;a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920161"&gt;</code></p><p><code>7121</code><code>Adami et al., 2002&lt;/a&gt;</code></p><p><code>7122</code><code>; &lt;a href="#R216" rid="R216" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920178"&gt;</code></p><p><code>7123</code><code>Coutts et al., 2002&lt;/a&gt;</code></p><p><code>7124</code><code>; &lt;a href="#R1142" rid="R1142" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919666"&gt;</code></p><p><code>7125</code><code>Storr et al., 2002&lt;/a&gt;</code></p><p><code>7126</code><code>; &lt;a href="#R131" rid="R131" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637245"&gt;</code></p><p><code>7127</code><code>Burdyga et al., 2004&lt;/a&gt;</code></p><p><code>7128</code><code>), guinea-pigs (&lt;a href="#R216" rid="R216" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920098"&gt;</code></p><p><code>7129</code><code>Coutts et al., 2002&lt;/a&gt;</code></p><p><code>7130</code><code>; &lt;a href="#R729" rid="R729" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653514"&gt;</code></p><p><code>7131</code><code>MacNaughton et al., 2004&lt;/a&gt;</code></p><p><code>7132</code><code>), and pigs (&lt;a href="#R635" rid="R635" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918882"&gt;</code></p><p><code>7133</code><code>Kulkarni-Narla and Brown, 2000&lt;/a&gt;</code></p><p><code>7134</code><code>). CB&lt;sub&gt;</code></p><p><code>7135</code><code>1&lt;/sub&gt;</code></p><p><code>7136</code><code> receptors are also colocalized with neuropeptide Y and vasoactive intestinal peptide in a small population of submucous plexus neurons (&lt;a href="#R635" rid="R635" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920288"&gt;</code></p><p><code>7137</code><code>Kulkarni-Narla and Brown, 2000&lt;/a&gt;</code></p><p><code>7138</code><code>; &lt;a href="#R216" rid="R216" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918887"&gt;</code></p><p><code>7139</code><code>Coutts et al., 2002&lt;/a&gt;</code></p><p><code>7140</code><code>). CB&lt;sub&gt;</code></p><p><code>7141</code><code>1&lt;/sub&gt;</code></p><p><code>7142</code><code> receptor immunoreactivity was evident in normal human colonic epithelium, smooth muscle, and the sub-mucosal myenteric plexus (&lt;a href="#R1302" rid="R1302" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920087"&gt;</code></p><p><code>7143</code><code>Wright et al., 2005&lt;/a&gt;</code></p><p><code>7144</code><code>). Both CB&lt;sub&gt;</code></p><p><code>7145</code><code>1&lt;/sub&gt;</code></p><p><code>7146</code><code> and CB&lt;sub&gt;</code></p><p><code>7147</code><code>2&lt;/sub&gt;</code></p><p><code>7148</code><code> receptors were found on plasma cells in the lamina propria, whereas only CB&lt;sub&gt;</code></p><p><code>7149</code><code>2&lt;/sub&gt;</code></p><p><code>7150</code><code> were detectable on macrophages (&lt;a href="#R1302" rid="R1302" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920337"&gt;</code></p><p><code>7151</code><code>Wright et al., 2005&lt;/a&gt;</code></p><p><code>7152</code><code>). Endocannabinoids are also present in the gastrointestinal tact. Indeed, 2-AG was originally isolated from gut tissue (&lt;a href="#R805" rid="R805" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920093"&gt;</code></p><p><code>7153</code><code>Mechoulam et al., 1995&lt;/a&gt;</code></p><p><code>7154</code><code>), and the intestinal content of anandamide was found to be regulated by feeding status (&lt;a href="#R410" rid="R410" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_814637247"&gt;</code></p><p><code>7155</code><code>Gomez et al., 2002&lt;/a&gt;</code></p><p><code>7156</code><code>).&lt;/p&gt;</code></p><p><code>7157</code><code>&lt;p id="P192"&gt;</code></p><p><code>7158</code><code>Although in earlier studies CB&lt;sub&gt;</code></p><p><code>7159</code><code>1&lt;/sub&gt;</code></p><p><code>7160</code><code> receptor expression was undetectable in the liver relative to the brain (&lt;a href="#R979" rid="R979" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919992"&gt;</code></p><p><code>7161</code><code>Porcella et al., 2002&lt;/a&gt;</code></p><p><code>7162</code><code>), several recent studies revealed the presence of low levels of both CB&lt;sub&gt;</code></p><p><code>7163</code><code>1&lt;/sub&gt;</code></p><p><code>7164</code><code> mRNA (&lt;a href="#R50" rid="R50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920385"&gt;</code></p><p><code>7165</code><code>B&amp;#x000e1;tkai et al., 2001&lt;/a&gt;</code></p><p><code>7166</code><code>; &lt;a href="#R830" rid="R830" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919837"&gt;</code></p><p><code>7167</code><code>Michalopoulos et al., 2003&lt;/a&gt;</code></p><p><code>7168</code><code>; &lt;a href="#R81" rid="R81" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918907"&gt;</code></p><p><code>7169</code><code>Biecker et al., 2004&lt;/a&gt;</code></p><p><code>7170</code><code>; &lt;a href="#R302" rid="R302" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919407"&gt;</code></p><p><code>7171</code><code>Engeli et al., 2005&lt;/a&gt;</code></p><p><code>7172</code><code>; &lt;a href="#R915" rid="R915" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918804"&gt;</code></p><p><code>7173</code><code>Osei-Hyiaman et al., 2005b&lt;/a&gt;</code></p><p><code>7174</code><code>; &lt;a href="#R1171" rid="R1171" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919053"&gt;</code></p><p><code>7175</code><code>Teixeira-Clerc et al., 2006&lt;/a&gt;</code></p><p><code>7176</code><code>) and CB&lt;sub&gt;</code></p><p><code>7177</code><code>1&lt;/sub&gt;</code></p><p><code>7178</code><code> immunoreactivity (&lt;a href="#R915" rid="R915" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918892"&gt;</code></p><p><code>7179</code><code>Osei-Hyiaman et al., 2005b&lt;/a&gt;</code></p><p><code>7180</code><code>) in whole liver or in various types of cells present in the liver, including hepatocytes (&lt;a href="#R830" rid="R830" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919502"&gt;</code></p><p><code>7181</code><code>Michalopoulos et al., 2003&lt;/a&gt;</code></p><p><code>7182</code><code>; &lt;a href="#R915" rid="R915" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919269"&gt;</code></p><p><code>7183</code><code>Osei-Hyiaman et al., 2005b&lt;/a&gt;</code></p><p><code>7184</code><code>), stellate cells (&lt;a href="#R1103" rid="R1103" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919623"&gt;</code></p><p><code>7185</code><code>Siegmund et al., 2005&lt;/a&gt;</code></p><p><code>7186</code><code>; &lt;a href="#R1171" rid="R1171" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920104"&gt;</code></p><p><code>7187</code><code>Teixeira-Clerc et al., 2006&lt;/a&gt;</code></p><p><code>7188</code><code>), and vascular endothelial cells (&lt;a href="#R50" rid="R50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918871"&gt;</code></p><p><code>7189</code><code>B&amp;#x000e1;tkai et al., 2001&lt;/a&gt;</code></p><p><code>7190</code><code>). CB&lt;sub&gt;</code></p><p><code>7191</code><code>2&lt;/sub&gt;</code></p><p><code>7192</code><code> receptor mRNA was also detected in cirrhotic but not in normal liver tissue (&lt;a href="#R577" rid="R577" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919062"&gt;</code></p><p><code>7193</code><code>Julien et al., 2005&lt;/a&gt;</code></p><p><code>7194</code><code>). Endocannabinoids are detectable in the liver or liver cells both in animals and humans at levels similar to those in the brain and play an important role under various physiological and pathophysiological conditions (&lt;a href="#R225" rid="R225" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919482"&gt;</code></p><p><code>7195</code><code>Cravatt et al., 2004&lt;/a&gt;</code></p><p><code>7196</code><code>; &lt;a href="#R639" rid="R639" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919722"&gt;</code></p><p><code>7197</code><code>Kurabayashi et al., 2005&lt;/a&gt;</code></p><p><code>7198</code><code>; &lt;a href="#R915" rid="R915" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920253"&gt;</code></p><p><code>7199</code><code>Osei-Hyiaman et al., 2005b&lt;/a&gt;</code></p><p><code>7200</code><code>) (see also section III.A.3.).&lt;/p&gt;</code></p><p><code>7201</code><code>&lt;p id="P193"&gt;</code></p><p><code>7202</code><code>A functional role for endocannabinoids and CB&lt;sub&gt;</code></p><p><code>7203</code><code>1&lt;/sub&gt;</code></p><p><code>7204</code><code> receptors in the gastrointestinal tract is supported by pharmacological studies demonstrating that anandamide and various CB&lt;sub&gt;</code></p><p><code>7205</code><code>1&lt;/sub&gt;</code></p><p><code>7206</code><code> agonists (WIN 55,212-2, CP55,940, and ACEA) but not the CB&lt;sub&gt;</code></p><p><code>7207</code><code>2&lt;/sub&gt;</code></p><p><code>7208</code><code>-selective agonists JWH-133 inhibit gastrointestinal motility in rodents in vivo and in isolated ileum and colon from both experimental animals and humans (&lt;a href="#R1098" rid="R1098" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919272"&gt;</code></p><p><code>7209</code><code>Shook and Burks, 1989&lt;/a&gt;</code></p><p><code>7210</code><code>; &lt;a href="#R961" rid="R961" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919303"&gt;</code></p><p><code>7211</code><code>Pertwee et al., 1995&lt;/a&gt;</code></p><p><code>7212</code><code>, &lt;a href="#R962" rid="R962" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919607"&gt;</code></p><p><code>7213</code><code>1996&lt;/a&gt;</code></p><p><code>7214</code><code>; &lt;a href="#R218" rid="R218" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918833"&gt;</code></p><p><code>7215</code><code>Coutts and Pertwee, 1997&lt;/a&gt;</code></p><p><code>7216</code><code>; &lt;a href="#R789" rid="R789" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920223"&gt;</code></p><p><code>7217</code><code>McCallum et al., 1999&lt;/a&gt;</code></p><p><code>7218</code><code>; &lt;a href="#R743" rid="R743" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920237"&gt;</code></p><p><code>7219</code><code>Mancinelli et al., 2001&lt;/a&gt;</code></p><p><code>7220</code><code>; &lt;a href="#R745" rid="R745" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919423"&gt;</code></p><p><code>7221</code><code>Mang et al., 2001&lt;/a&gt;</code></p><p><code>7222</code><code>; &lt;a href="#R650" rid="R650" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919749"&gt;</code></p><p><code>7223</code><code>Landi et al., 2002&lt;/a&gt;</code></p><p><code>7224</code><code>; &lt;a href="#R742" rid="R742" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919589"&gt;</code></p><p><code>7225</code><code>Manara et al., 2002&lt;/a&gt;</code></p><p><code>7226</code><code>; &lt;a href="#R503" rid="R503" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919011"&gt;</code></p><p><code>7227</code><code>Hinds et al., 2006&lt;/a&gt;</code></p><p><code>7228</code><code>). A similar role for endogenous substrates of FAAH is suggested by recent in vivo findings in mice, documenting inhibition of intestinal motility by the FAAH inhibitors &lt;em&gt;</code></p><p><code>7229</code><code>N&lt;/em&gt;</code></p><p><code>7230</code><code>-arachidonoylserotonin and palmitoyliso-propylamide and by the FAAH substrates palmitoylethanolamide, oleamide, and oleoylethanolamide in wild-type but not in FAAH knockout mice (&lt;a href="#R153" rid="R153" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919006"&gt;</code></p><p><code>7231</code><code>Capasso et al., 2005&lt;/a&gt;</code></p><p><code>7232</code><code>). Furthermore, the effect of &lt;em&gt;</code></p><p><code>7233</code><code>N&lt;/em&gt;</code></p><p><code>7234</code><code>-arachidonoylserotonin was reduced either by the CB&lt;sub&gt;</code></p><p><code>7235</code><code>1&lt;/sub&gt;</code></p><p><code>7236</code><code> receptor antagonist SR141716 or by CB&lt;sub&gt;</code></p><p><code>7237</code><code>1&lt;/sub&gt;</code></p><p><code>7238</code><code> deficiency, but not by the TRPV&lt;sub&gt;</code></p><p><code>7239</code><code>1&lt;/sub&gt;</code></p><p><code>7240</code><code> receptor antagonist 5&amp;#x02032;-iodoresiniferatoxin (&lt;a href="#R153" rid="R153" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918830"&gt;</code></p><p><code>7241</code><code>Capasso et al., 2005&lt;/a&gt;</code></p><p><code>7242</code><code>). Interestingly, in clinical trials using rimonabant for nicotine cessation or for the treatment of obesity, diarrhea was 2 to 2.4 times more frequent among subjects treated with the drug than with placebo, suggesting accelerated transit and/or enhanced secretion caused by CB&lt;sub&gt;</code></p><p><code>7243</code><code>1&lt;/sub&gt;</code></p><p><code>7244</code><code> blockade (&lt;a href="#R319" rid="R319" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653473"&gt;</code></p><p><code>7245</code><code>Fernandez and Allison, 2004&lt;/a&gt;</code></p><p><code>7246</code><code>; &lt;a href="#R1216" rid="R1216" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920209"&gt;</code></p><p><code>7247</code><code>Van Gaal et al., 2005&lt;/a&gt;</code></p><p><code>7248</code><code>). This and some of the above experimental reports suggest the existence of an inhibitory endocannabinoid tone in the gastrointestinal tract. Multiple mechanisms, including reduction of acetylcholine release from enteric nerves, inhibition of nonadrenergic/noncholinergic excitatory transmission, activation of apamin-sensitive K&lt;sup&gt;</code></p><p><code>7249</code><code>+&lt;/sup&gt;</code></p><p><code>7250</code><code> channels, and modulation of adenosine release have been proposed to explain the CB&lt;sub&gt;</code></p><p><code>7251</code><code>1&lt;/sub&gt;</code></p><p><code>7252</code><code>-mediated reduction in enteric contractility and peristalsis (reviewed in &lt;a href="#R217" rid="R217" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919668"&gt;</code></p><p><code>7253</code><code>Coutts and Izzo, 2004&lt;/a&gt;</code></p><p><code>7254</code><code>).&lt;/p&gt;</code></p><p><code>7255</code><code>&lt;p id="P194"&gt;</code></p><p><code>7256</code><code>Activation of both CB&lt;sub&gt;</code></p><p><code>7257</code><code>1&lt;/sub&gt;</code></p><p><code>7258</code><code> and CB&lt;sub&gt;</code></p><p><code>7259</code><code>2&lt;/sub&gt;</code></p><p><code>7260</code><code> receptors may decrease the pathologically increased intestinal motility elicited by an inflammatory stimulus. In a mouse model of croton oil-induced intestinal inflammation, the increased efficacy of cannabinoids in inhibiting intestinal motility was attributed to up-regulation of intestinal CB&lt;sub&gt;</code></p><p><code>7261</code><code>1&lt;/sub&gt;</code></p><p><code>7262</code><code> receptors (&lt;a href="#R547" rid="R547" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918780"&gt;</code></p><p><code>7263</code><code>Izzo et al., 2001a&lt;/a&gt;</code></p><p><code>7264</code><code>,&lt;a href="#R548" rid="R548" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919878"&gt;</code></p><p><code>7265</code><code>b&lt;/a&gt;</code></p><p><code>7266</code><code>). Conversely, the accelerated gastrointestinal transit induced by bacterial endotoxin in rats could be inhibited by CB&lt;sub&gt;</code></p><p><code>7267</code><code>2&lt;/sub&gt;</code></p><p><code>7268</code><code> but not CB&lt;sub&gt;</code></p><p><code>7269</code><code>1&lt;/sub&gt;</code></p><p><code>7270</code><code> receptor agonists (&lt;a href="#R778" rid="R778" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920149"&gt;</code></p><p><code>7271</code><code>Mathison et al., 2004&lt;/a&gt;</code></p><p><code>7272</code><code>). Interestingly, intestinal hypomotility in a mouse model of paralytic ileus has been linked, at least in part, to the enhancement of anandamide levels and CB&lt;sub&gt;</code></p><p><code>7273</code><code>1&lt;/sub&gt;</code></p><p><code>7274</code><code> expression in the gut, and it could be attenuated by CB&lt;sub&gt;</code></p><p><code>7275</code><code>1&lt;/sub&gt;</code></p><p><code>7276</code><code> receptor antagonists (&lt;a href="#R772" rid="R772" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919531"&gt;</code></p><p><code>7277</code><code>Mascolo et al., 2002&lt;/a&gt;</code></p><p><code>7278</code><code>). Additionally, there is evidence that CB&lt;sub&gt;</code></p><p><code>7279</code><code>1&lt;/sub&gt;</code></p><p><code>7280</code><code> receptors are involved in the regulation of the lower esophageal sphincter, and CB&lt;sub&gt;</code></p><p><code>7281</code><code>1&lt;/sub&gt;</code></p><p><code>7282</code><code> activation might be beneficial in gastroesophageal reflux disease (reviewed in &lt;a href="#R217" rid="R217" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920018"&gt;</code></p><p><code>7283</code><code>Coutts and Izzo, 2004&lt;/a&gt;</code></p><p><code>7284</code><code>; &lt;a href="#R776" rid="R776" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920081"&gt;</code></p><p><code>7285</code><code>Massa et al., 2005&lt;/a&gt;</code></p><p><code>7286</code><code>).&lt;/p&gt;</code></p><p><code>7287</code><code>&lt;p id="P195" class="p"&gt;</code></p><p><code>7288</code><code>The endocannabinoid system has also been implicated in the regulation of gastric acid and intestinal secretions. At high doses, THC decreased histamine-induced gastric acid secretion in isolated stomach preparations (&lt;a href="#R1022" rid="R1022" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919860"&gt;</code></p><p><code>7289</code><code>Rivas-V and Garcia, 1980&lt;/a&gt;</code></p><p><code>7290</code><code>) and in pylorus-ligated rats (&lt;a href="#R1122" rid="R1122" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919050"&gt;</code></p><p><code>7291</code><code>Sofia et al., 1978&lt;/a&gt;</code></p><p><code>7292</code><code>). Pentagastrin-induced gastric acid secretion was also inhibited by HU-210 and WIN 55,212-2, an effect that could be prevented by CB&lt;sub&gt;</code></p><p><code>7293</code><code>1&lt;/sub&gt;</code></p><p><code>7294</code><code> blockade (&lt;a href="#R211" rid="R211" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653367"&gt;</code></p><p><code>7295</code><code>Coruzzi et al., 1999&lt;/a&gt;</code></p><p><code>7296</code><code>; &lt;a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919814"&gt;</code></p><p><code>7297</code><code>Adami et al., 2002&lt;/a&gt;</code></p><p><code>7298</code><code>). These studies suggest a role for CB&lt;sub&gt;</code></p><p><code>7299</code><code>1&lt;/sub&gt;</code></p><p><code>7300</code><code> receptors located on preganglionic and postganglionic cholinergic pathways in the regulation of gastric acid secretion. The therapeutic relevance of this regulatory mechanism was highlighted by the CB&lt;sub&gt;</code></p><p><code>7301</code><code>1&lt;/sub&gt;</code></p><p><code>7302</code><code> receptor-mediated antiulcer activity of ACEA or WIN 55,212-2 treatment in a rat model of aspirin- and cold/restraint stress-induced gastric ulcers (&lt;a href="#R383" rid="R383" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653507"&gt;</code></p><p><code>7303</code><code>Germano et al., 2001&lt;/a&gt;</code></p><p><code>7304</code><code>; &lt;a href="#R1052" rid="R1052" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653479"&gt;</code></p><p><code>7305</code><code>Rutkowska and Fereniec-Goltbiewska, 2006&lt;/a&gt;</code></p><p><code>7306</code><code>). WIN 55,212-2 also reduced intestinal secretions evoked by electrical field stimulation or capsaicin (&lt;a href="#R729" rid="R729" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653373"&gt;</code></p><p><code>7307</code><code>MacNaughton et al., 2004&lt;/a&gt;</code></p><p><code>7308</code><code>). Anandamide, the anandamide transport inhibitor VDM11, and the CB&lt;sub&gt;</code></p><p><code>7309</code><code>1&lt;/sub&gt;</code></p><p><code>7310</code><code> agonist ACEA all inhibited intestinal secretion and fluid accumulation in mice treated with cholera toxin, whereas SR141716 exerted opposite effects (&lt;a href="#R546" rid="R546" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919947"&gt;</code></p><p><code>7311</code><code>Izzo et al., 2003&lt;/a&gt;</code></p><p><code>7312</code><code>). The ability of cannabinoids to inhibit gastrointestinal motility and secretion coupled with their anti-inflammatory properties strongly suggests that the modulation of this system could offer significant benefits in the treatment of various gastrointestinal pathological conditions, including inflammatory bowel disease (see below).&lt;/p&gt;</code></p><p><code>7313</code><code>&lt;div id="S44" class="sec"&gt;</code></p><p><code>7314</code><code>&lt;p&gt;</code></p><p><code>7315</code><code>&lt;/p&gt;</code></p><p><code>7316</code><code>&lt;h4 id="S44title" class="inline"&gt;</code></p><p><code>7317</code><code>1. Inflammatory Bowel Disease &lt;/h4&gt;</code></p><p><code>7318</code><code>&lt;p id="P196" class="p p-first"&gt;</code></p><p><code>7319</code><code>Idiopathic inflammatory bowel disease (IBD) includes ulcerative colitis and Crohn&amp;#x02019;s disease, and is characterized by intestinal inflammation presumably of autoimmune origin and a chronic relapsing course associated with local and systemic complications and affects &amp;#x0003e;1 million people in the United States (&lt;a href="#R700" rid="R700" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919598"&gt;</code></p><p><code>7320</code><code>Loftus, 2004&lt;/a&gt;</code></p><p><code>7321</code><code>). Although the etiology of IBD remains unclear, it may involve complex genetic, environmental, and immunological interactions. The most common symptoms of IBD are abdominal pain and diarrhea, which eventually lead to malabsorption and malnutrition, and in approximately half of patients surgery is eventually required to remove the affected bowel segment. Despite recent therapeutic advances, patients with IBD are often unresponsive to available treatment options.&lt;/p&gt;</code></p><p><code>7322</code><code>&lt;p id="P197"&gt;</code></p><p><code>7323</code><code>As discussed above, the endocannabinoid system plays an important role in the control of gastrointestinal motility and secretion. Studies using animal models of IBD have suggested that targeting the endocannabinoid system may offer significant benefits in the treatment of IBD. Several studies have indicated that chemically induced intestinal inflammation is associated with the up-regulation of intestinal CB&lt;sub&gt;</code></p><p><code>7324</code><code>1&lt;/sub&gt;</code></p><p><code>7325</code><code> receptors, which may represent a compensatory, protective mechanism. For example, in croton oil-treated mice, the ability of CB&lt;sub&gt;</code></p><p><code>7326</code><code>1&lt;/sub&gt;</code></p><p><code>7327</code><code> agonists to inhibit intestinal motility is increased compared with that in control animals (&lt;a href="#R547" rid="R547" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920054"&gt;</code></p><p><code>7328</code><code>Izzo et al., 2001a&lt;/a&gt;</code></p><p><code>7329</code><code>). More importantly, the anandamide transport inhibitor VDM11 was also shown to inhibit gastrointestinal motility and secretions in cholera toxin-treated mice, which implicates endocannabinoids in this action and holds out the promise of a nonpsychoactive form of treatment (&lt;a href="#R546" rid="R546" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918971"&gt;</code></p><p><code>7330</code><code>Izzo et al., 2003&lt;/a&gt;</code></p><p><code>7331</code><code>). In a mouse model of colitis induced by 2,4-dinitrobenzene sulfonic acid and dextrane sulfate, &lt;a href="#R775" rid="R775" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919649"&gt;</code></p><p><code>7332</code><code>Massa et al. (2004)&lt;/a&gt;</code></p><p><code>7333</code><code> have confirmed the up-regulation of CB&lt;sub&gt;</code></p><p><code>7334</code><code>1&lt;/sub&gt;</code></p><p><code>7335</code><code> receptors in experimental colitis. Furthermore, they demonstrated that the inflammation was more severe in mice deficient in CB&lt;sub&gt;</code></p><p><code>7336</code><code>1&lt;/sub&gt;</code></p><p><code>7337</code><code> receptors than in wild-type mice, whereas genetic ablation of FAAH resulted in protection against this chemically induced colitis (&lt;a href="#R775" rid="R775" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918729"&gt;</code></p><p><code>7338</code><code>Massa et al., 2004&lt;/a&gt;</code></p><p><code>7339</code><code>). In a recent study, the anandamide reuptake inhibitor VDM11 afforded protection against colitis in mice, and elevated anandamide levels have been measured in biopsy material from patients with ulcerative colitis (&lt;a href="#R240" rid="R240" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919800"&gt;</code></p><p><code>7340</code><code>D&amp;#x02019;Argenio et al., 2006&lt;/a&gt;</code></p><p><code>7341</code><code>). These findings strongly support the natural protective role of the endocannabinoid system in this form of experimental IBD. In contrast, &lt;a href="#R228" rid="R228" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919067"&gt;</code></p><p><code>7342</code><code>Croci et al. (2003)&lt;/a&gt;</code></p><p><code>7343</code><code> have reported a CB&lt;sub&gt;</code></p><p><code>7344</code><code>1&lt;/sub&gt;</code></p><p><code>7345</code><code> receptor-independent protective effect of SR141716 against indomethacin-induced inflammation and ulcer formation in the small intestine of rats. Elevated levels of anandamide and desensitization of the presynaptic neural CB&lt;sub&gt;</code></p><p><code>7346</code><code>1&lt;/sub&gt;</code></p><p><code>7347</code><code> receptor found in colonic longitudinal muscle strips from patients undergoing surgery for complicated diverticulitis suggest that the endocannabinoid system may be also involved in the pathophysiology of this frequent complication of colitis and/or colon cancer (&lt;a href="#R440" rid="R440" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920034"&gt;</code></p><p><code>7348</code><code>Guagnini et al., 2006&lt;/a&gt;</code></p><p><code>7349</code><code>).&lt;/p&gt;</code></p><p><code>7350</code><code>&lt;p id="P198" class="p p-last"&gt;</code></p><p><code>7351</code><code>Taken together, most of the above studies suggest that the endocannabinoid system in the gut is activated during inflammation, and endogenous anandamide may counteract inflammation (&lt;a href="#R638" rid="R638" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919178"&gt;</code></p><p><code>7352</code><code>Kunos and Pacher, 2004&lt;/a&gt;</code></p><p><code>7353</code><code>) (&lt;a href="/pmc/articles/PMC2241751/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"&gt;</code></p><p><code>7354</code><code>&lt;span&gt;</code></p><p><code>7355</code><code>Fig. 6&lt;/span&gt;</code></p><p><code>7356</code><code>&lt;/a&gt;</code></p><p><code>7357</code><code>). The findings of &lt;a href="#R775" rid="R775" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920101"&gt;</code></p><p><code>7358</code><code>Massa et al. (2004)&lt;/a&gt;</code></p><p><code>7359</code><code> and &lt;a href="#R240" rid="R240" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919769"&gt;</code></p><p><code>7360</code><code>D&amp;#x02019;Argenio et al. (2006)&lt;/a&gt;</code></p><p><code>7361</code><code> also suggest that inhibitors of FAAH or anandamide reuptake may amplify the natural protective action of endogenous anandamide, which warrants further studies to test such inhibitors in the treatment of experimental and, ultimately, human IBD (&lt;a href="#R638" rid="R638" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920059"&gt;</code></p><p><code>7362</code><code>Kunos and Pacher, 2004&lt;/a&gt;</code></p><p><code>7363</code><code>). Future studies should further explore the mechanisms of the anti-inflammatory effects of cannabinoids and the potential role of CB&lt;sub&gt;</code></p><p><code>7364</code><code>2&lt;/sub&gt;</code></p><p><code>7365</code><code> receptors as therapeutic targets (&lt;a href="#R778" rid="R778" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918814"&gt;</code></p><p><code>7366</code><code>Mathison et al., 2004&lt;/a&gt;</code></p><p><code>7367</code><code>; &lt;a href="#R1302" rid="R1302" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919465"&gt;</code></p><p><code>7368</code><code>Wright et al., 2005&lt;/a&gt;</code></p><p><code>7369</code><code>).&lt;/p&gt;</code></p><p><code>7370</code><code>&lt;!--fig ft0--&gt;</code></p><p><code>7371</code><code>&lt;!--fig mode=article f1--&gt;</code></p><p><code>7372</code><code>&lt;div class="fig iconblock whole_rhythm" id="F6" co-legend-rid="lgnd_F6"&gt;</code></p><p><code>7373</code><code>&lt;a href="/pmc/articles/PMC2241751/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6"&gt;</code></p><p><code>7374</code><code>&lt;!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--&gt;</code></p><p><code>7375</code><code>&lt;div data-largeobj="" data-largeobj-link-rid="largeobj_idm139779462199168" class="figure"&gt;</code></p><p><code>7376</code><code>&lt;img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms38123f6.jpg" title="An external file that holds a picture, illustration, etc.&amp;#10;Object name is nihms38123f6.jpg" src="/pmc/articles/PMC2241751/bin/nihms38123f6.jpg" /&gt;</code></p><p><code>7377</code><code>&lt;/div&gt;</code></p><p><code>7378</code><code>&lt;div id="largeobj_idm139779462199168" class="largeobj-link align_right" style="display: none"&gt;</code></p><p><code>7379</code><code>&lt;a target="object" rel="noopener" href="/pmc/articles/PMC2241751/figure/F6/?report=objectonly"&gt;</code></p><p><code>7380</code><code>Open in a separate window&lt;/a&gt;</code></p><p><code>7381</code><code>&lt;/div&gt;</code></p><p><code>7382</code><code>&lt;/a&gt;</code></p><p><code>7383</code><code>&lt;div class="icnblk_cntnt" id="lgnd_F6"&gt;</code></p><p><code>7384</code><code>&lt;div&gt;</code></p><p><code>7385</code><code>&lt;a class="figpopup" href="/pmc/articles/PMC2241751/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6"&gt;</code></p><p><code>7386</code><code>Fig. 6&lt;/a&gt;</code></p><p><code>7387</code><code>&lt;/div&gt;</code></p><p><code>7388</code><code>&lt;!--caption a7--&gt;</code></p><p><code>7389</code><code>&lt;div class="caption"&gt;</code></p><p><code>7390</code><code>&lt;p id="__p7"&gt;</code></p><p><code>7391</code><code>Cellular source and proposed targets of anti-inflammatory endocannabinoids in inflammatory bowel disease. a, cross-section of inflamed bowel with leukocyte infiltration [polymorphonuclear leukocytes (PNM), lymphocytes (Ly), macrophages, and mast cells]. b, in macrophages, LPS induces the production of TNF-&lt;em&gt;</code></p><p><code>7392</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>7393</code><code> and chemokines (such as MIP-2macrophage inflammatory protein-2 and CXCL-8) as well as anandamide. Anandamide is released to act as an autocrine mediator to inhibit TNF-&lt;em&gt;</code></p><p><code>7394</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>7395</code><code> and chemokine production via CB&lt;sub&gt;</code></p><p><code>7396</code><code>1&lt;/sub&gt;</code></p><p><code>7397</code><code> or CB&lt;sub&gt;</code></p><p><code>7398</code><code>2&lt;/sub&gt;</code></p><p><code>7399</code><code> receptors or both. Activation of CB&lt;sub&gt;</code></p><p><code>7400</code><code>1&lt;/sub&gt;</code></p><p><code>7401</code><code> and CB&lt;sub&gt;</code></p><p><code>7402</code><code>2&lt;/sub&gt;</code></p><p><code>7403</code><code> receptors may similarly inhibit TNF-&lt;em&gt;</code></p><p><code>7404</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>7405</code><code> production in mast cells, with these effects resulting in decreased leukocyte infiltration and inflammation. Paracrine activation of CB&lt;sub&gt;</code></p><p><code>7406</code><code>1&lt;/sub&gt;</code></p><p><code>7407</code><code> receptors on extrinsic and intrinsic enteric neurons inhibits acetylcholine (ACh) and tachykinin release, respectively, resulting in inhibition of gut motility. These effects are amplified by treatment with a FAAH inhibitor, which prevents the breakdown of anandamide. Reproduced with permission from &lt;a href="#R638" rid="R638" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919080"&gt;</code></p><p><code>7408</code><code>Kunos and Pacher (2004)&lt;/a&gt;</code></p><p><code>7409</code><code> &lt;em&gt;</code></p><p><code>7410</code><code>Nat Med&lt;/em&gt;</code></p><p><code>7411</code><code> &lt;strong&gt;</code></p><p><code>7412</code><code>10:&lt;/strong&gt;</code></p><p><code>7413</code><code>678&amp;#x02013;679. &amp;#x000a9; Nature Publishing Group.&lt;/p&gt;</code></p><p><code>7414</code><code>&lt;/div&gt;</code></p><p><code>7415</code><code>&lt;/div&gt;</code></p><p><code>7416</code><code>&lt;/div&gt;</code></p><p><code>7417</code><code>&lt;/div&gt;</code></p><p><code>7418</code><code>&lt;div id="S45" class="sec sec-last"&gt;</code></p><p><code>7419</code><code>&lt;p&gt;</code></p><p><code>7420</code><code>&lt;/p&gt;</code></p><p><code>7421</code><code>&lt;h4 id="S45title" class="inline"&gt;</code></p><p><code>7422</code><code>2. Acute and Chronic Liver Disease (Hepatitis and Liver Cirrhosis) &lt;/h4&gt;</code></p><p><code>7423</code><code>&lt;p id="P199" class="p p-first"&gt;</code></p><p><code>7424</code><code>Endocannabinoids and CB&lt;sub&gt;</code></p><p><code>7425</code><code>1&lt;/sub&gt;</code></p><p><code>7426</code><code> receptors have been implicated in the systemic and portal vasodilation and hypotension associated with chronic liver cirrhosis (&lt;a href="#R50" rid="R50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918759"&gt;</code></p><p><code>7427</code><code>B&amp;#x000e1;tkai et al., 2001&lt;/a&gt;</code></p><p><code>7428</code><code>; &lt;a href="#R362" rid="R362" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653483"&gt;</code></p><p><code>7429</code><code>Garcia et al., 2001&lt;/a&gt;</code></p><p><code>7430</code><code>; &lt;a href="#R1036" rid="R1036" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918867"&gt;</code></p><p><code>7431</code><code>Ros et al., 2002&lt;/a&gt;</code></p><p><code>7432</code><code>). These studies demonstrated that CB&lt;sub&gt;</code></p><p><code>7433</code><code>1&lt;/sub&gt;</code></p><p><code>7434</code><code> receptor blockade with SR141716 reversed the hypotension and low peripheral resistance and decreased the elevated mesenteric blood flow and portal pressure in rats with biliary and carbon tetrachloride-induced cirrhosis, whereas these hemodynamic parameters were unaffected by SR141716 in noncirrhotic control subjects (&lt;a href="#R50" rid="R50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919774"&gt;</code></p><p><code>7435</code><code>B&amp;#x000e1;tkai et al., 2001&lt;/a&gt;</code></p><p><code>7436</code><code>; &lt;a href="#R1036" rid="R1036" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919401"&gt;</code></p><p><code>7437</code><code>Ros et al., 2002&lt;/a&gt;</code></p><p><code>7438</code><code>). These findings suggested an increased endocannabinoid tone in cirrhosis, which could be attributed to both an up-regulation of CB&lt;sub&gt;</code></p><p><code>7439</code><code>1&lt;/sub&gt;</code></p><p><code>7440</code><code> receptors in hepatic vascular endothelial cells and an increased production of anandamide by circulating monocytes (&lt;a href="#R50" rid="R50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919737"&gt;</code></p><p><code>7441</code><code>B&amp;#x000e1;tkai et al., 2001&lt;/a&gt;</code></p><p><code>7442</code><code>). Increased expression of CB&lt;sub&gt;</code></p><p><code>7443</code><code>1&lt;/sub&gt;</code></p><p><code>7444</code><code> receptors was also reported in whole liver from bile duct-ligated mice (&lt;a href="#R81" rid="R81" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919226"&gt;</code></p><p><code>7445</code><code>Biecker et al., 2004&lt;/a&gt;</code></p><p><code>7446</code><code>). This increase was greater when bile duct ligation was performed in NO synthase-3 knockout compared with wild-type mice, which may account for the similar level of portal hypertension in the two strains despite the much higher systemic blood pressure in the knockout mice (&lt;a href="#R81" rid="R81" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919248"&gt;</code></p><p><code>7447</code><code>Biecker et al., 2004&lt;/a&gt;</code></p><p><code>7448</code><code>). Increased anandamide-induced vasorelaxation mediated by CB&lt;sub&gt;</code></p><p><code>7449</code><code>1&lt;/sub&gt;</code></p><p><code>7450</code><code> and TRPV&lt;sub&gt;</code></p><p><code>7451</code><code>1&lt;/sub&gt;</code></p><p><code>7452</code><code> receptors was also reported in mesenteric arteries isolated from cirrhotic compared with control rats (&lt;a href="#R280" rid="R280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918915"&gt;</code></p><p><code>7453</code><code>Domenicali et al., 2005&lt;/a&gt;</code></p><p><code>7454</code><code>). The increase in anandamide in monocytes from cirrhotic rats or humans is functionally important, as these cells elicit SR141716-sensitive hypotension when injected into normal recipient rats (&lt;a href="#R50" rid="R50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918758"&gt;</code></p><p><code>7455</code><code>B&amp;#x000e1;tkai et al., 2001&lt;/a&gt;</code></p><p><code>7456</code><code>; &lt;a href="#R1036" rid="R1036" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920141"&gt;</code></p><p><code>7457</code><code>Ros et al., 2002&lt;/a&gt;</code></p><p><code>7458</code><code>). Plasma endotoxin levels progressively increase as liver function deteriorates in cirrhosis (&lt;a href="#R710" rid="R710" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918843"&gt;</code></p><p><code>7459</code><code>Lumsden et al., 1988&lt;/a&gt;</code></p><p><code>7460</code><code>; &lt;a href="#R167" rid="R167" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918684"&gt;</code></p><p><code>7461</code><code>Chan et al., 1997&lt;/a&gt;</code></p><p><code>7462</code><code>), and this effect is probably responsible for the elevated endocannabinoid production in plasma monocytes and platelets of cirrhotic animals and patients (&lt;a href="#R50" rid="R50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920166"&gt;</code></p><p><code>7463</code><code>B&amp;#x000e1;tkai et al., 2001&lt;/a&gt;</code></p><p><code>7464</code><code>; &lt;a href="#R1036" rid="R1036" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919179"&gt;</code></p><p><code>7465</code><code>Ros et al., 2002&lt;/a&gt;</code></p><p><code>7466</code><code>; &lt;a href="#R693" rid="R693" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918697"&gt;</code></p><p><code>7467</code><code>Liu et al., 2003&lt;/a&gt;</code></p><p><code>7468</code><code>; &lt;a href="#R321" rid="R321" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919008"&gt;</code></p><p><code>7469</code><code>Fernandez-Rodriguez et al., 2004&lt;/a&gt;</code></p><p><code>7470</code><code>). There is also recent experimental evidence implicating increased signaling through myocardial CB&lt;sub&gt;</code></p><p><code>7471</code><code>1&lt;/sub&gt;</code></p><p><code>7472</code><code> receptors in the pathogenesis of cirrhotic cardiomyopathy (&lt;a href="#R370" rid="R370" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919567"&gt;</code></p><p><code>7473</code><code>Gaskari et al., 2005&lt;/a&gt;</code></p><p><code>7474</code><code>; &lt;a href="#R924" rid="R924" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920197"&gt;</code></p><p><code>7475</code><code>Pacher et al., 2005c&lt;/a&gt;</code></p><p><code>7476</code><code>).&lt;/p&gt;</code></p><p><code>7477</code><code>&lt;p id="P200"&gt;</code></p><p><code>7478</code><code>Beyond the vasculopathy of end-stage cirrhosis, the endocannabinoid system may also be involved in the pathogenesis of liver fibrosis. &lt;a href="#R1103" rid="R1103" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920406"&gt;</code></p><p><code>7479</code><code>Siegmund et al. (2005)&lt;/a&gt;</code></p><p><code>7480</code><code> have recently reported that anandamide exerts antifibrogenic effects in vitro by inhibiting activated hepatic stellate cells at low micromolar concentrations and by inducing their necrosis at higher concentrations, via CB&lt;sub&gt;</code></p><p><code>7481</code><code>1/2&lt;/sub&gt;</code></p><p><code>7482</code><code>- and TRPV&lt;sub&gt;</code></p><p><code>7483</code><code>1&lt;/sub&gt;</code></p><p><code>7484</code><code>-independent mechanism(s). In a study by &lt;a href="#R577" rid="R577" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919440"&gt;</code></p><p><code>7485</code><code>Julien et al. (2005)&lt;/a&gt;</code></p><p><code>7486</code><code>, the liver fibrosis induced by carbon tetrachloride was more severe in CB&lt;sub&gt;</code></p><p><code>7487</code><code>2&lt;/sub&gt;</code></p><p><code>7488</code><code> knockout mice compared with their wild-type littermates. Also, the expression of CB&lt;sub&gt;</code></p><p><code>7489</code><code>2&lt;/sub&gt;</code></p><p><code>7490</code><code> receptors was found to be strongly induced in liver biopsy specimens from patients with active cirrhosis of various etiologies, particularly in non-parenchymal cells located within and at the edge of fibrous septa (&lt;a href="#R577" rid="R577" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919550"&gt;</code></p><p><code>7491</code><code>Julien et al., 2005&lt;/a&gt;</code></p><p><code>7492</code><code>). Furthermore, CB&lt;sub&gt;</code></p><p><code>7493</code><code>2&lt;/sub&gt;</code></p><p><code>7494</code><code> receptor activation triggered growth inhibition and apoptosis in myofibroblasts and in activated hepatic stellate cells, highlighting the antifibrogenic role of CB&lt;sub&gt;</code></p><p><code>7495</code><code>2&lt;/sub&gt;</code></p><p><code>7496</code><code> receptors during chronic liver injury (&lt;a href="#R577" rid="R577" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919208"&gt;</code></p><p><code>7497</code><code>Julien et al., 2005&lt;/a&gt;</code></p><p><code>7498</code><code>). However, chronic marijuana use has been associated with hepatotoxicity rather than hepatoprotection as expected from the above results (&lt;a href="#R107" rid="R107" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919223"&gt;</code></p><p><code>7499</code><code>Borini et al., 2004&lt;/a&gt;</code></p><p><code>7500</code><code>), and results of a recent epidemiological study indicate that daily marijuana smoking is a risk factor for progression of fibrosis among people with chronic hepatitis C infection (&lt;a href="#R491" rid="R491" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919119"&gt;</code></p><p><code>7501</code><code>Hezode et al., 2005&lt;/a&gt;</code></p><p><code>7502</code><code>). This finding has triggered an investigation into the possible profibrogenic role of CB&lt;sub&gt;</code></p><p><code>7503</code><code>1&lt;/sub&gt;</code></p><p><code>7504</code><code> receptor activation, which is supported by the results of a preliminary study showing that the progression of experimental liver fibrosis induced by carbon tetrachloride is slower in mice with genetic ablation of CB&lt;sub&gt;</code></p><p><code>7505</code><code>1&lt;/sub&gt;</code></p><p><code>7506</code><code> receptors or treated with CB&lt;sub&gt;</code></p><p><code>7507</code><code>1&lt;/sub&gt;</code></p><p><code>7508</code><code> receptor antagonist SR141716 (&lt;a href="#R1171" rid="R1171" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918947"&gt;</code></p><p><code>7509</code><code>Teixeira-Clerc et al., 2006&lt;/a&gt;</code></p><p><code>7510</code><code>). These latter findings suggest a broader role of CB&lt;sub&gt;</code></p><p><code>7511</code><code>1&lt;/sub&gt;</code></p><p><code>7512</code><code> receptors in the pathogenesis of cirrhosis and forecast additional potential benefits from the therapeutic use of a CB&lt;sub&gt;</code></p><p><code>7513</code><code>1&lt;/sub&gt;</code></p><p><code>7514</code><code> antagonist in chronic liver disease.&lt;/p&gt;</code></p><p><code>7515</code><code>&lt;p id="P201"&gt;</code></p><p><code>7516</code><code>In contrast to the hepatotoxicity associated with chronic marijuana use, a synthetic, nonpsychotropic cannabinoid derivative (PRS-211,092) was reported to inhibit acute hepatitis induced by concanavalin A via negative cytokine regulation in mice (&lt;a href="#R664" rid="R664" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920138"&gt;</code></p><p><code>7517</code><code>Lavon et al., 2003&lt;/a&gt;</code></p><p><code>7518</code><code>). Interestingly, in animal models of acute hepatic failure-induced encephalopathy, both 2-AG and SR141716 have been reported to exert beneficial effects on neurological and cognitive function (&lt;a href="#R353" rid="R353" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919938"&gt;</code></p><p><code>7519</code><code>Gabbay et al., 2005&lt;/a&gt;</code></p><p><code>7520</code><code>; &lt;a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919761"&gt;</code></p><p><code>7521</code><code>Avraham et al., 2006&lt;/a&gt;</code></p><p><code>7522</code><code>). Cannabinoids may also be beneficial in intractable cholestatic pruritus (&lt;a href="#R882" rid="R882" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920167"&gt;</code></p><p><code>7523</code><code>Neff et al., 2002&lt;/a&gt;</code></p><p><code>7524</code><code>), which is associated with severe forms of liver disease, presumably by increasing the nociceptive threshold (&lt;a href="#R388" rid="R388" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919551"&gt;</code></p><p><code>7525</code><code>Gingold and Bergasa, 2003&lt;/a&gt;</code></p><p><code>7526</code><code>).&lt;/p&gt;</code></p><p><code>7527</code><code>&lt;p id="P202" class="p p-last"&gt;</code></p><p><code>7528</code><code>Collectively, the studies discussed in this section highlight the potential regulatory role of the endocannabinoid system in a variety of gastrointestinal and liver disorders, opening new avenues for their pharmacotherapy. It appears that CB&lt;sub&gt;</code></p><p><code>7529</code><code>1&lt;/sub&gt;</code></p><p><code>7530</code><code> agonists and perhaps FAAH antagonists might be beneficial in reducing increased gastrointestinal motility, bowel inflammation, and associated diarrhea, whereas CB&lt;sub&gt;</code></p><p><code>7531</code><code>1&lt;/sub&gt;</code></p><p><code>7532</code><code> antagonists could be used in the treatment of constipation. In chronic liver cirrhosis, CB&lt;sub&gt;</code></p><p><code>7533</code><code>1&lt;/sub&gt;</code></p><p><code>7534</code><code> antagonists may not only attenuate or reverse the adverse hemodynamic consequences of cirrhosis, thus extending life until a suitable liver becomes available for transplantation, but also could have additional benefits by slowing the progression of fibrosis and the neurological decline associated with hepatic encephalopathy. Selective CB&lt;sub&gt;</code></p><p><code>7535</code><code>2&lt;/sub&gt;</code></p><p><code>7536</code><code> receptor agonists might also be expected to protect against progression of liver fibrosis and perhaps against the chronic inflammation associated with IBD.&lt;/p&gt;</code></p><p><code>7537</code><code>&lt;/div&gt;</code></p><p><code>7538</code><code>&lt;/div&gt;</code></p><p><code>7539</code><code>&lt;div id="S46" class="sec"&gt;</code></p><p><code>7540</code><code>&lt;h3 id="S46title"&gt;</code></p><p><code>7541</code><code>H. Musculoskeletal Disorders&lt;/h3&gt;</code></p><p><code>7542</code><code>&lt;div id="S47" class="sec sec-first"&gt;</code></p><p><code>7543</code><code>&lt;p&gt;</code></p><p><code>7544</code><code>&lt;/p&gt;</code></p><p><code>7545</code><code>&lt;h4 id="S47title" class="inline"&gt;</code></p><p><code>7546</code><code>1. Arthritis &lt;/h4&gt;</code></p><p><code>7547</code><code>&lt;p id="P203" class="p p-first"&gt;</code></p><p><code>7548</code><code>Rheumatoid arthritis (RA) is a chronic, systemic, inflammatory autoimmune disease affecting ~0.8% of adults worldwide. RA is more common in women, and it leads to joint destruction, deformity, loss of function, chronic pain, and reduced quality of life. When unchecked, it leads to substantial disability and premature death (&lt;a href="#R902" rid="R902" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920028"&gt;</code></p><p><code>7549</code><code>O&amp;#x02019;Dell, 2004&lt;/a&gt;</code></p><p><code>7550</code><code>). Current medications used to treat rheumatoid arthritis are divided into three main classes: nonsteroidal anti-inflammatory drugs, corticosteroids, and disease-modifying antirheumatic drugs such as methotrexate (&lt;a href="#R902" rid="R902" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919535"&gt;</code></p><p><code>7551</code><code>O&amp;#x02019;Dell, 2004&lt;/a&gt;</code></p><p><code>7552</code><code>). A better understanding of the cytokine networks that are responsible for the ongoing inflammatory response in RA has led to the successful use of novel therapies that target TNF-&lt;em&gt;</code></p><p><code>7553</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>7554</code><code> and IL-1.&lt;/p&gt;</code></p><p><code>7555</code><code>&lt;p id="P204"&gt;</code></p><p><code>7556</code><code>The immunosuppressant and anti-inflammatory properties of cannabinoids are highly relevant for RA and other autoimmune disorders (e.g., systemic lupus erythematosus, autoimmune vasculitis, Sj&amp;#x000f6;gren&amp;#x02019;s syndrome, and ankylosing spondylitis). Indeed, ajulemic acid (THC-11-oic acid, CT-3, IP-751), a potent analog of the acid metabolites of THC (&lt;a href="#R135" rid="R135" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918985"&gt;</code></p><p><code>7557</code><code>Burstein, 2000&lt;/a&gt;</code></p><p><code>7558</code><code>, &lt;a href="#R134" rid="R134" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919875"&gt;</code></p><p><code>7559</code><code>2005&lt;/a&gt;</code></p><p><code>7560</code><code>) and cannabidiol have been shown to have analgesic, anti-inflammatory, and immunosuppressive effects in animal models of arthritis (&lt;a href="#R1330" rid="R1330" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919507"&gt;</code></p><p><code>7561</code><code>Zurier et al., 1998&lt;/a&gt;</code></p><p><code>7562</code><code>; &lt;a href="#R237" rid="R237" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918888"&gt;</code></p><p><code>7563</code><code>Dajani et al., 1999&lt;/a&gt;</code></p><p><code>7564</code><code>; &lt;a href="#R738" rid="R738" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918764"&gt;</code></p><p><code>7565</code><code>Malfait et al., 2000&lt;/a&gt;</code></p><p><code>7566</code><code>). Chronic administration of ajulemic acid attenuated joint inflammation in a murine model of adjuvant-induced arthritis and suppressed prostaglandin production in vitro to a greater extent than the potent nonsteroidal anti-inflammatory drug, indomethacin (&lt;a href="#R1330" rid="R1330" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919305"&gt;</code></p><p><code>7567</code><code>Zurier et al., 1998&lt;/a&gt;</code></p><p><code>7568</code><code>). In another study, ajulemic acid caused less gastrointestinal ulcerations and was more effective in reducing adjuvant-induced arthritis than common nonsteroidal anti-inflammatory agents (&lt;a href="#R237" rid="R237" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919278"&gt;</code></p><p><code>7569</code><code>Dajani et al., 1999&lt;/a&gt;</code></p><p><code>7570</code><code>). As discussed earlier in this review, ajulemic acid is a high-affinity agonist for human cannabinoid receptors and has CB&lt;sub&gt;</code></p><p><code>7571</code><code>1&lt;/sub&gt;</code></p><p><code>7572</code><code>-mediated, potent antihyperalgesic activity in models of chronic neuropathic and inflammatory pain in the rat (&lt;a href="#R290" rid="R290" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919200"&gt;</code></p><p><code>7573</code><code>Dyson et al., 2005&lt;/a&gt;</code></p><p><code>7574</code><code>). Ajulemic acid also induces apoptosis in human T lymphocytes (&lt;a href="#R80" rid="R80" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918976"&gt;</code></p><p><code>7575</code><code>Bidinger et al., 2003&lt;/a&gt;</code></p><p><code>7576</code><code>) and suppresses IL-1&lt;em&gt;</code></p><p><code>7577</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>7578</code><code> production in human monocytes (&lt;a href="#R1329" rid="R1329" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919543"&gt;</code></p><p><code>7579</code><code>Zurier et al., 2003&lt;/a&gt;</code></p><p><code>7580</code><code>), which could contribute to its therapeutic effects in RA and other inflammatory disorders. Treatment with cannabidiol or its more potent dimethylheptyl derivative (HU-320) reduced an LPS-induced increase in serum TNF-&lt;em&gt;</code></p><p><code>7581</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>7582</code><code> and immune function and effectively blocked the progression of collagen-induced arthritis in mice (&lt;a href="#R738" rid="R738" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918723"&gt;</code></p><p><code>7583</code><code>Malfait et al., 2000&lt;/a&gt;</code></p><p><code>7584</code><code>; &lt;a href="#R1152" rid="R1152" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918855"&gt;</code></p><p><code>7585</code><code>Sumariwalla et al., 2004&lt;/a&gt;</code></p><p><code>7586</code><code>). Other studies described the antinociceptive effects of anandamide and THC in rats with arthritis (&lt;a href="#R1123" rid="R1123" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919260"&gt;</code></p><p><code>7587</code><code>Sofia et al., 1973&lt;/a&gt;</code></p><p><code>7588</code><code>; &lt;a href="#R1116" rid="R1116" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919681"&gt;</code></p><p><code>7589</code><code>Smith et al., 1998&lt;/a&gt;</code></p><p><code>7590</code><code>; &lt;a href="#R219" rid="R219" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919789"&gt;</code></p><p><code>7591</code><code>Cox and Welch, 2004&lt;/a&gt;</code></p><p><code>7592</code><code>). &lt;a href="#R786" rid="R786" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920361"&gt;</code></p><p><code>7593</code><code>Mbvundula et al. (2005&lt;/a&gt;</code></p><p><code>7594</code><code>, &lt;a href="#R787" rid="R787" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919352"&gt;</code></p><p><code>7595</code><code>2006)&lt;/a&gt;</code></p><p><code>7596</code><code> have recently reported that WIN 55,212-2 and HU-210 inhibited IL-1-stimulated NO production in bovine articular chondrocytes, in contrast to AM281 and AM630, which elicited an opposite effect. Anandamide, WIN 55212-2, and HU-210 also inhibited the release of sulfated glycosaminoglycans in bovine cartilage explants and IL-1a stimulated proteoglycan and collagen degradation (&lt;a href="#R786" rid="R786" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919931"&gt;</code></p><p><code>7597</code><code>Mbvundula et al., 2005&lt;/a&gt;</code></p><p><code>7598</code><code>, &lt;a href="#R787" rid="R787" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919327"&gt;</code></p><p><code>7599</code><code>2006&lt;/a&gt;</code></p><p><code>7600</code><code>).&lt;/p&gt;</code></p><p><code>7601</code><code>&lt;p id="P205" class="p p-last"&gt;</code></p><p><code>7602</code><code>In a survey of 2969 people using cannabis for medicinal purposes, ~25% of subjects mentioned relief of arthritis symptoms as the main reason for cannabis smoking, which was surpassed only by chronic pain, MS, and depression (&lt;a href="#R1274" rid="R1274" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918837"&gt;</code></p><p><code>7603</code><code>Ware et al., 2003&lt;/a&gt;</code></p><p><code>7604</code><code>). Studies using cannabinoid-based extracts are also underway in patients with RA (&lt;a href="#R1050" rid="R1050" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919137"&gt;</code></p><p><code>7605</code><code>Russo, 2006&lt;/a&gt;</code></p><p><code>7606</code><code>). The potential benefit of cannabinoids in fibromyalgia, a syndrome of widespread musculoskeletal pain, nonrestorative sleep, disturbed mood, and fatigue of unknown etiology, has also been reviewed (&lt;a href="#R1051" rid="R1051" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918693"&gt;</code></p><p><code>7607</code><code>Russo, 2004&lt;/a&gt;</code></p><p><code>7608</code><code>).&lt;/p&gt;</code></p><p><code>7609</code><code>&lt;/div&gt;</code></p><p><code>7610</code><code>&lt;div id="S48" class="sec sec-last"&gt;</code></p><p><code>7611</code><code>&lt;p&gt;</code></p><p><code>7612</code><code>&lt;/p&gt;</code></p><p><code>7613</code><code>&lt;h4 id="S48title" class="inline"&gt;</code></p><p><code>7614</code><code>2. Osteoporosis &lt;/h4&gt;</code></p><p><code>7615</code><code>&lt;p id="P206" class="p p-first"&gt;</code></p><p><code>7616</code><code>Osteoporosis is a skeletal disorder characterized by low bone mass and microarchitectural deterioration of bone, leading to increased susceptibility to bone fractures. The associated fractures and the subsequent morbidity and mortality make osteoporosis an enormous public health concern. Osteoporosis is no longer considered an age-related disease, as it is increasingly recognized in children. Osteoporosis is thought to be a polygenic disorder, with vulnerability determined by multiple genes and environmental risk factors. It currently affects up to one in three women and 1 in 12 men worldwide (&lt;a href="#R594" rid="R594" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919743"&gt;</code></p><p><code>7617</code><code>Keen, 2003&lt;/a&gt;</code></p><p><code>7618</code><code>). Treatment options include general measures on lifestyle, calcium and vitamin D supplements, hormone therapy, raloxifene, and bisphosphonates.&lt;/p&gt;</code></p><p><code>7619</code><code>&lt;p id="P207"&gt;</code></p><p><code>7620</code><code>Cannabinoid receptors were first implicated in the regulation of bone mass by &lt;a href="#R587" rid="R587" class=" bibr popnode"&gt;</code></p><p><code>7621</code><code>Karsak et al. (2004)&lt;/a&gt;</code></p><p><code>7622</code><code>, who found that CB&lt;sub&gt;</code></p><p><code>7623</code><code>2&lt;/sub&gt;</code></p><p><code>7624</code><code> knockout mice had markedly accelerated age-related trabecular bone loss and cortical expansion accompanied by increased activity of trabecular osteoblasts, increased numbers of osteoclasts, and decreased numbers of diaphyseal osteoblast precursors (&lt;a href="#R903" rid="R903" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920058"&gt;</code></p><p><code>7625</code><code>Ofek et al., 2006&lt;/a&gt;</code></p><p><code>7626</code><code>). CB&lt;sub&gt;</code></p><p><code>7627</code><code>2&lt;/sub&gt;</code></p><p><code>7628</code><code> receptors were expressed in osteoblasts, osteocytes, and osteoclasts. The selective CB&lt;sub&gt;</code></p><p><code>7629</code><code>2&lt;/sub&gt;</code></p><p><code>7630</code><code> agonist HU-308, but not the CB&lt;sub&gt;</code></p><p><code>7631</code><code>1&lt;/sub&gt;</code></p><p><code>7632</code><code> agonist noladine ether, attenuated ovariectomy-induced bone loss and markedly stimulated cortical thickness through the suppression of osteoclast number and stimulation of endocortical bone formation (&lt;a href="#R903" rid="R903" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918929"&gt;</code></p><p><code>7633</code><code>Ofek et al., 2006&lt;/a&gt;</code></p><p><code>7634</code><code>). Furthermore, HU-308 dose dependently increased the number and activity of endocortical osteoblasts and restrained trabecular osteoclastogenesis by inhibiting proliferation of osteoclast precursors (&lt;a href="#R903" rid="R903" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919235"&gt;</code></p><p><code>7635</code><code>Ofek et al., 2006&lt;/a&gt;</code></p><p><code>7636</code><code>). These results, coupled with CB&lt;sub&gt;</code></p><p><code>7637</code><code>2&lt;/sub&gt;</code></p><p><code>7638</code><code> but not CB&lt;sub&gt;</code></p><p><code>7639</code><code>1&lt;/sub&gt;</code></p><p><code>7640</code><code> receptor mRNA expression during osteoblastic differentiation, suggested a role for CB&lt;sub&gt;</code></p><p><code>7641</code><code>2&lt;/sub&gt;</code></p><p><code>7642</code><code> receptors in bone remodeling. Such a role of CB&lt;sub&gt;</code></p><p><code>7643</code><code>2&lt;/sub&gt;</code></p><p><code>7644</code><code> but not CB&lt;sub&gt;</code></p><p><code>7645</code><code>1&lt;/sub&gt;</code></p><p><code>7646</code><code> receptors is also supported by a recent genetic association study in human samples of postmenopausal osteoporosis patients and matched female control subjects (&lt;a href="#R586" rid="R586" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919770"&gt;</code></p><p><code>7647</code><code>Karsak et al., 2005&lt;/a&gt;</code></p><p><code>7648</code><code>).&lt;/p&gt;</code></p><p><code>7649</code><code>&lt;p id="P208" class="p p-last"&gt;</code></p><p><code>7650</code><code>In contrast, &lt;a href="#R537" rid="R537" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918865"&gt;</code></p><p><code>7651</code><code>Idris et al. (2005)&lt;/a&gt;</code></p><p><code>7652</code><code> have recently reported that CB&lt;sub&gt;</code></p><p><code>7653</code><code>1&lt;/sub&gt;</code></p><p><code>7654</code><code> receptor knockout mice or mice treated with antagonists of either CB&lt;sub&gt;</code></p><p><code>7655</code><code>1&lt;/sub&gt;</code></p><p><code>7656</code><code> or CB&lt;sub&gt;</code></p><p><code>7657</code><code>2&lt;/sub&gt;</code></p><p><code>7658</code><code> receptors were protected from ovariectomy-induced bone loss. Furthermore, cannabinoid antagonists promoted osteoclast apoptosis, inhibited osteoclast activity, and decreased the production of several osteoclast survival factors in vitro, suggesting that cannabinoid antagonists may be beneficial in the treatment of osteoporosis. Although the reason for the discrepancy between the above studies is not clear; they suggest a role for the endocannabinoid system in the regulation of bone mass.&lt;/p&gt;</code></p><p><code>7659</code><code>&lt;/div&gt;</code></p><p><code>7660</code><code>&lt;/div&gt;</code></p><p><code>7661</code><code>&lt;div id="S49" class="sec sec-last"&gt;</code></p><p><code>7662</code><code>&lt;h3 id="S49title"&gt;</code></p><p><code>7663</code><code>I. Endocannabinoids and Reproductive Functions&lt;/h3&gt;</code></p><p><code>7664</code><code>&lt;p id="P209" class="p p-first"&gt;</code></p><p><code>7665</code><code>There is abundant evidence that the endocannabinoid system is involved in reproductive functions in both males and females and in both animals and humans, as discussed in more detail in recent reviews (&lt;a href="#R346" rid="R346" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920352"&gt;</code></p><p><code>7666</code><code>Fride, 2004&lt;/a&gt;</code></p><p><code>7667</code><code>; &lt;a href="#R939" rid="R939" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653428"&gt;</code></p><p><code>7668</code><code>Park et al., 2004&lt;/a&gt;</code></p><p><code>7669</code><code>; &lt;a href="#R1081" rid="R1081" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918963"&gt;</code></p><p><code>7670</code><code>Schuel and Burkman, 2005&lt;/a&gt;</code></p><p><code>7671</code><code>; &lt;a href="#R1187" rid="R1187" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918757"&gt;</code></p><p><code>7672</code><code>Tranguch et al., 2005&lt;/a&gt;</code></p><p><code>7673</code><code>; &lt;a href="#R1264" rid="R1264" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_393488952"&gt;</code></p><p><code>7674</code><code>Wang et al., 2006&lt;/a&gt;</code></p><p><code>7675</code><code>). In males, marijuana, synthetic cannabinoids, and anandamide adversely affect the fertilizing capacity of sperm, which express functional CB&lt;sub&gt;</code></p><p><code>7676</code><code>1&lt;/sub&gt;</code></p><p><code>7677</code><code> receptors (&lt;a href="#R1041" rid="R1041" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918726"&gt;</code></p><p><code>7678</code><code>Rossato et al., 2005&lt;/a&gt;</code></p><p><code>7679</code><code>; &lt;a href="#R1081" rid="R1081" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918823"&gt;</code></p><p><code>7680</code><code>Schuel and Burkman, 2005&lt;/a&gt;</code></p><p><code>7681</code><code>; &lt;a href="#R1283" rid="R1283" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919259"&gt;</code></p><p><code>7682</code><code>Whan et al., 2006&lt;/a&gt;</code></p><p><code>7683</code><code>). On the other hand, there is preclinical evidence to suggest that blockade of CB&lt;sub&gt;</code></p><p><code>7684</code><code>1&lt;/sub&gt;</code></p><p><code>7685</code><code> may be useful in the treatment of erectile dysfunction (&lt;a href="#R818" rid="R818" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919439"&gt;</code></p><p><code>7686</code><code>Melis et al., 2004b&lt;/a&gt;</code></p><p><code>7687</code><code>, &lt;a href="#R819" rid="R819" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918683"&gt;</code></p><p><code>7688</code><code>2006&lt;/a&gt;</code></p><p><code>7689</code><code>).&lt;/p&gt;</code></p><p><code>7690</code><code>&lt;p id="P210" class="p p-last"&gt;</code></p><p><code>7691</code><code>High levels of functional CB&lt;sub&gt;</code></p><p><code>7692</code><code>1&lt;/sub&gt;</code></p><p><code>7693</code><code> receptor, anandamide, and FAAH are present in the preimplantation embryo and/or in the uterus (&lt;a href="#R243" rid="R243" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918808"&gt;</code></p><p><code>7694</code><code>Das et al., 1995&lt;/a&gt;</code></p><p><code>7695</code><code>; &lt;a href="#R934" rid="R934" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919848"&gt;</code></p><p><code>7696</code><code>Paria et al., 1995&lt;/a&gt;</code></p><p><code>7697</code><code>, &lt;a href="#R935" rid="R935" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919132"&gt;</code></p><p><code>7698</code><code>2001&lt;/a&gt;</code></p><p><code>7699</code><code>; &lt;a href="#R1076" rid="R1076" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919713"&gt;</code></p><p><code>7700</code><code>Schmid et al., 1997&lt;/a&gt;</code></p><p><code>7701</code><code>; &lt;a href="#R938" rid="R938" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919929"&gt;</code></p><p><code>7702</code><code>Park et al., 2003&lt;/a&gt;</code></p><p><code>7703</code><code>; &lt;a href="#R447" rid="R447" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918885"&gt;</code></p><p><code>7704</code><code>Guo et al., 2005&lt;/a&gt;</code></p><p><code>7705</code><code>). Anandamide synthesized in the uterus exerts dose- and stage-specific effects on embryo development and implantation. A temporary reduction of anandamide levels is essential for embryo implantation, and higher anandamide levels are associated with uterine nonreceptivity and impairment of blastocyst formation, zona hatching, and trophoblast outgrowth via CB&lt;sub&gt;</code></p><p><code>7706</code><code>1&lt;/sub&gt;</code></p><p><code>7707</code><code> receptors (&lt;a href="#R243" rid="R243" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918959"&gt;</code></p><p><code>7708</code><code>Das et al., 1995&lt;/a&gt;</code></p><p><code>7709</code><code>; &lt;a href="#R934" rid="R934" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919840"&gt;</code></p><p><code>7710</code><code>Paria et al., 1995&lt;/a&gt;</code></p><p><code>7711</code><code>, &lt;a href="#R935" rid="R935" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919708"&gt;</code></p><p><code>7712</code><code>2001&lt;/a&gt;</code></p><p><code>7713</code><code>, &lt;a href="#R936" rid="R936" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919150"&gt;</code></p><p><code>7714</code><code>2002&lt;/a&gt;</code></p><p><code>7715</code><code>; &lt;a href="#R1076" rid="R1076" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919504"&gt;</code></p><p><code>7716</code><code>Schmid et al., 1997&lt;/a&gt;</code></p><p><code>7717</code><code>; &lt;a href="#R1266" rid="R1266" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919353"&gt;</code></p><p><code>7718</code><code>Wang et al., 1999&lt;/a&gt;</code></p><p><code>7719</code><code>; &lt;a href="#R447" rid="R447" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919015"&gt;</code></p><p><code>7720</code><code>Guo et al., 2005&lt;/a&gt;</code></p><p><code>7721</code><code>). Consequently, cannabinoids may retard the development of embryos, eventually leading to fetal loss and pregnancy failure (&lt;a href="#R99" rid="R99" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918771"&gt;</code></p><p><code>7722</code><code>Bloch et al., 1978&lt;/a&gt;</code></p><p><code>7723</code><code>; &lt;a href="#R1115" rid="R1115" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144920395"&gt;</code></p><p><code>7724</code><code>Smith and Asch, 1987&lt;/a&gt;</code></p><p><code>7725</code><code>; &lt;a href="#R939" rid="R939" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653370"&gt;</code></p><p><code>7726</code><code>Park et al., 2004&lt;/a&gt;</code></p><p><code>7727</code><code>). Anandamide levels in the uterus are regulated by FAAH activity (&lt;a href="#R934" rid="R934" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918768"&gt;</code></p><p><code>7728</code><code>Paria et al., 1995&lt;/a&gt;</code></p><p><code>7729</code><code>, &lt;a href="#R937" rid="R937" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918962"&gt;</code></p><p><code>7730</code><code>1999&lt;/a&gt;</code></p><p><code>7731</code><code>; &lt;a href="#R1076" rid="R1076" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919526"&gt;</code></p><p><code>7732</code><code>Schmid et al., 1997&lt;/a&gt;</code></p><p><code>7733</code><code>). Accordingly, pregnant women with low FAAH activity in lymphocytes were found to have an increased incidence of miscarriage (&lt;a href="#R723" rid="R723" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918889"&gt;</code></p><p><code>7734</code><code>Maccarrone et al., 2000c&lt;/a&gt;</code></p><p><code>7735</code><code>), and low FAAH activity also correlated with failure to maintain pregnancy after in vitro fertilization (&lt;a href="#R719" rid="R719" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919333"&gt;</code></p><p><code>7736</code><code>Maccarrone et al., 2002b&lt;/a&gt;</code></p><p><code>7737</code><code>). Finally, cannabinoids may also affect the levels of various hormones crucial for normal fertility and reproduction (&lt;a href="#R126" rid="R126" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919501"&gt;</code></p><p><code>7738</code><code>Brown and Dobs, 2002&lt;/a&gt;</code></p><p><code>7739</code><code>; &lt;a href="#R939" rid="R939" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_311653506"&gt;</code></p><p><code>7740</code><code>Park et al., 2004&lt;/a&gt;</code></p><p><code>7741</code><code>; &lt;a href="#R1082" rid="R1082" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919511"&gt;</code></p><p><code>7742</code><code>Scorticati et al., 2004&lt;/a&gt;</code></p><p><code>7743</code><code>; &lt;a href="#R360" rid="R360" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144918896"&gt;</code></p><p><code>7744</code><code>Gammon et al., 2005&lt;/a&gt;</code></p><p><code>7745</code><code>). Although such findings may suggest the potential usefulness of CB&lt;sub&gt;</code></p><p><code>7746</code><code>1&lt;/sub&gt;</code></p><p><code>7747</code><code> antagonists in the treatment of infertility problems, a note of caution is warranted because CB&lt;sub&gt;</code></p><p><code>7748</code><code>1&lt;/sub&gt;</code></p><p><code>7749</code><code> knockout mice were reported to have impaired oviductal transport of embryos, leading to embryo retention. This suggests that treatment with CB&lt;sub&gt;</code></p><p><code>7750</code><code>1&lt;/sub&gt;</code></p><p><code>7751</code><code> antagonists may facilitate ectopic pregnancy (&lt;a href="#R1265" rid="R1265" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919147"&gt;</code></p><p><code>7752</code><code>Wang et al., 2004&lt;/a&gt;</code></p><p><code>7753</code><code>).&lt;/p&gt;</code></p><p><code>7754</code><code>&lt;/div&gt;</code></p><p><code>7755</code><code>&lt;/div&gt;</code></p><p><code>7756</code><code>&lt;div id="S50" class="tsec sec"&gt;</code></p><p><code>7757</code><code>&lt;h2 class="head no_bottom_margin" id="S50title"&gt;</code></p><p><code>7758</code><code>IV. Future Directions&lt;/h2&gt;</code></p><p><code>7759</code><code>&lt;p id="P211" class="p p-first-last"&gt;</code></p><p><code>7760</code><code>The length of this review, necessitated by the steady growth in the number of indications for the potential therapeutic use of cannabinoid-related medications, is a clear sign of the emerging importance of this field. This is further underlined by the quantity of articles in the public database dealing with the biology of cannabinoids, which numbered ~200 to 300/year throughout the 1970s to reach an astonishing 5900 in 2004. The growing interest in the underlying science has been matched by a growth in the number of cannabinoid drugs in pharmaceutical development from two in 1995 to 27 in 2004, with the most actively pursued therapeutic targets being pain, obesity, and multiple sclerosis (&lt;a href="#R480" rid="R480" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_144919166"&gt;</code></p><p><code>7761</code><code>Hensen, 2005&lt;/a&gt;</code></p><p><code>7762</code><code>). As in any rapidly growing area of research, not all the leads will turn out to be useful or even valid. Nevertheless, it is safe to predict that new therapeutic agents that affect the activity of the endocannaboinoid system will emerge and become members of our therapeutic armamentarium. The plant-derived cannabinoid preparation Sativex has already gained regulatory approval in Canada for the treatment of spasticity and pain associated with multiple sclerosis, and the CB&lt;sub&gt;</code></p><p><code>7763</code><code>1&lt;/sub&gt;</code></p><p><code>7764</code><code> receptor antagonist rimonabant has been approved in Europe and is awaiting Food and Drug Administration approval in the United States for the treatment of the metabolic syndrome. Undoubtedly, these will be followed by new and improved compounds aimed at the same or additional targets in the endocannabinoid system. However, it may be only after the widespread therapeutic use of such compounds that some important side effects will emerge. Although this occurrence would be undesirable from a health care perspective, such side effects may shed further light on the biological functions of endocannabinoids in health and disease.&lt;/p&gt;</code></p><p><code>7765</code><code>&lt;/div&gt;</code></p><p><code>7766</code><code>&lt;div id="S52" class="tsec sec"&gt;</code></p><p><code>7767</code><code>&lt;h2 class="head no_bottom_margin" id="S52title"&gt;</code></p><p><code>7768</code><code>Acknowledgments&lt;/h2&gt;</code></p><p><code>7769</code><code>&lt;div class="sec"&gt;</code></p><p><code>7770</code><code>&lt;p id="__p10"&gt;</code></p><p><code>7771</code><code>We are indebted to Kimberly Bochniak for help with the list of references. P.P. dedicates this review to his beloved mother, Iren.&lt;/p&gt;</code></p><p><code>7772</code><code>&lt;p id="__p11"&gt;</code></p><p><code>7773</code><code>Work from the authors&amp;#x02019; laboratory was supported by the Intramural Research Program of the National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism.&lt;/p&gt;</code></p><p><code>7774</code><code>&lt;/div&gt;</code></p><p><code>7775</code><code>&lt;/div&gt;</code></p><p><code>7776</code><code>&lt;div id="idm139779461792832" class="tsec sec"&gt;</code></p><p><code>7777</code><code>&lt;h2 class="head no_bottom_margin" id="idm139779461792832title"&gt;</code></p><p><code>7778</code><code>Footnotes&lt;/h2&gt;</code></p><p><code>7779</code><code>&lt;!--back/fn-group--&gt;</code></p><p><code>7780</code><code>&lt;div class="fm-sec half_rhythm small"&gt;</code></p><p><code>7781</code><code>&lt;p class="fn sec" id="FN3"&gt;</code></p><p><code>7782</code><code>&lt;sup&gt;</code></p><p><code>7783</code><code>1&lt;/sup&gt;</code></p><p><code>7784</code><code>Abbreviations: THC or &amp;#x00394;&lt;sup&gt;</code></p><p><code>7785</code><code>9&lt;/sup&gt;</code></p><p><code>7786</code><code>-THC, &amp;#x00394;&lt;sup&gt;</code></p><p><code>7787</code><code>9&lt;/sup&gt;</code></p><p><code>7788</code><code>-tetrahydrocannabinol; CP-55,940, (1&lt;em&gt;</code></p><p><code>7789</code><code>R&lt;/em&gt;</code></p><p><code>7790</code><code>,3&lt;em&gt;</code></p><p><code>7791</code><code>R&lt;/em&gt;</code></p><p><code>7792</code><code>,4&lt;em&gt;</code></p><p><code>7793</code><code>R&lt;/em&gt;</code></p><p><code>7794</code><code>)-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-4-(3-hydroxypropyl)cyclohexan-1-ol; GPCR, G protein-coupled receptor; CB&lt;sub&gt;</code></p><p><code>7795</code><code>1&lt;/sub&gt;</code></p><p><code>7796</code><code> or CB&lt;sub&gt;</code></p><p><code>7797</code><code>2&lt;/sub&gt;</code></p><p><code>7798</code><code>, cannabinoid 1 or 2; CBD, cannabidiol; SR141716, &lt;em&gt;</code></p><p><code>7799</code><code>N&lt;/em&gt;</code></p><p><code>7800</code><code>-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1&lt;em&gt;</code></p><p><code>7801</code><code>H&lt;/em&gt;</code></p><p><code>7802</code><code>-pyrazole-3-carboximide hydrochloride (rimonabant); AM251, &lt;em&gt;</code></p><p><code>7803</code><code>N&lt;/em&gt;</code></p><p><code>7804</code><code>-(piperin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1&lt;em&gt;</code></p><p><code>7805</code><code>H&lt;/em&gt;</code></p><p><code>7806</code><code>-pyrazole-3-carboxamide; TRPV&lt;sub&gt;</code></p><p><code>7807</code><code>1&lt;/sub&gt;</code></p><p><code>7808</code><code> or VR&lt;sub&gt;</code></p><p><code>7809</code><code>1&lt;/sub&gt;</code></p><p><code>7810</code><code>, transient receptor potential vanilloid 1 or vanilloid 1; WIN 55,212-2, &lt;em&gt;</code></p><p><code>7811</code><code>R&lt;/em&gt;</code></p><p><code>7812</code><code>-(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo-[1,2,3-&lt;em&gt;</code></p><p><code>7813</code><code>de&lt;/em&gt;</code></p><p><code>7814</code><code>]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate; GTP&lt;em&gt;</code></p><p><code>7815</code><code>&amp;#x003b3;&lt;/em&gt;</code></p><p><code>7816</code><code>S, guanosine 5&amp;#x02032;-&lt;em&gt;</code></p><p><code>7817</code><code>O&lt;/em&gt;</code></p><p><code>7818</code><code>-(3-thio)triphosphate; HU-210, &amp;#x00394;&lt;sup&gt;</code></p><p><code>7819</code><code>8&lt;/sup&gt;</code></p><p><code>7820</code><code>-tetrahydrocannabinol dimethyl heptyl; DARPP-32, dopamine- and cAMP-regulated phosphoprotein of 32 kDa; 2-AG, 2-arachidonoylglycerol; NAPE; &lt;em&gt;</code></p><p><code>7821</code><code>N-&lt;/em&gt;</code></p><p><code>7822</code><code>arachidonoyl phosphatidylethanolamide; PE, phosphatidylethanolamine; PL, phospholipase; DAG, diacylglycerol; FAAH, fatty acid amide hydrolase; UCM707, &lt;em&gt;</code></p><p><code>7823</code><code>N-&lt;/em&gt;</code></p><p><code>7824</code><code>(3-furanylmethyl)-5&lt;em&gt;</code></p><p><code>7825</code><code>Z&lt;/em&gt;</code></p><p><code>7826</code><code>,8&lt;em&gt;</code></p><p><code>7827</code><code>Z&lt;/em&gt;</code></p><p><code>7828</code><code>,11&lt;em&gt;</code></p><p><code>7829</code><code>Z&lt;/em&gt;</code></p><p><code>7830</code><code>,14&lt;em&gt;</code></p><p><code>7831</code><code>Z&lt;/em&gt;</code></p><p><code>7832</code><code>-eicosatetraenamide; LY2318912, 5-(4-azido-3-iodo-benzoylaminomethyl]-tetrazole-1-carboxylic acid dimethylamide; MGL, monoacylglyceride lipase; DSI, depolarization-induced suppression of inhibition; SR144528, &lt;em&gt;</code></p><p><code>7833</code><code>N&lt;/em&gt;</code></p><p><code>7834</code><code>-((1&lt;em&gt;</code></p><p><code>7835</code><code>S&lt;/em&gt;</code></p><p><code>7836</code><code>)-endo-1,3,3-trimethyl bicyclo heptan-2-yl]-5-(4chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide); NPY, neuropeptide Y; MCH, melanin concentrating hormone; &lt;em&gt;</code></p><p><code>7837</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>7838</code><code>-MSH, &lt;em&gt;</code></p><p><code>7839</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>7840</code><code>-melanocyte-stimulating hormone; CRH, corticotropin-releasing hormone; CART, cocaine- and amphetamine-related transcript; AMPK, AMP-activated protein kinase; ACC1, acetyl CoA carboxylase-1; SREBP1c, sterol response element binding protein 1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; CNS, central nervous system; HIV, human immunodeficiency virus; LPS, lipopolysaccharide or endotoxin; TNF-&lt;em&gt;</code></p><p><code>7841</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>7842</code><code>, tumor necrosis factor-&lt;em&gt;</code></p><p><code>7843</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>7844</code><code>; IL, interleukin; CXCL, CXC chemokine ligand; NMDA receptor, &lt;em&gt;</code></p><p><code>7845</code><code>N-&lt;/em&gt;</code></p><p><code>7846</code><code>methyl-D-aspartate receptor; HU-211, dexanabinol; TBI, traumatic brain injury; BAY 38-7271, (&amp;#x02212;)-(&lt;em&gt;</code></p><p><code>7847</code><code>R&lt;/em&gt;</code></p><p><code>7848</code><code>)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate; MCAo, middle cerebral artery occlusion; GABA, gamma-aminobutyric acid; GPe or GPi, external or internal globus pallidus; HD, Huntington&amp;#x02019;s disease; HPA axis, hypothalamic-pituitary-adrenal axis; HU-211, dexanabinol; ICAM-1, intercellular adhesion molecule-1; IL, interleukin; I/R, ischemia reperfusion; KA, kainic acid; LID, levodopa-induced dyskinesia; methyl-D-aspartate receptor; NO, nitric oxide; PD, Parkinson&amp;#x02019;s disease; &lt;a id="__tag_814637252" class="tag_hotlink" href="/nuccore/LY320135" ref="/nuccore/LY320135"&gt;</code></p><p><code>7849</code><code>&lt;span class="tag-json" style="display:none"&gt;</code></p><p><code>7850</code><code>{"type":"entrez-nucleotide","attrs":{"text":"LY320135","term_id":"1257555575","term_text":"LY320135"}}&lt;/span&gt;</code></p><p><code>7851</code><code>LY320135&lt;/a&gt;</code></p><p><code>7852</code><code>, [6-methoxy-2-(4-methoxyphenyl)benzo[&lt;em&gt;</code></p><p><code>7853</code><code>b&lt;/em&gt;</code></p><p><code>7854</code><code>]-thien-3-yl][4-cyanophenyl] methanone; MS, multiple sclerosis; SCI, spinal cord injury; EAE, experimental autoimmune encephalomyelitis; JWH-133, 1,1-dimethylbutyl-1-deoxy-&amp;#x00394;&lt;sup&gt;</code></p><p><code>7855</code><code>9&lt;/sup&gt;</code></p><p><code>7856</code><code>-tetrahydrocannabinol; PEA, palmitoylethanolamide; ACEA, arachidonyl-2&amp;#x02032;-chloroethylamide/(all &lt;em&gt;</code></p><p><code>7857</code><code>Z&lt;/em&gt;</code></p><p><code>7858</code><code>)-&lt;em&gt;</code></p><p><code>7859</code><code>N&lt;/em&gt;</code></p><p><code>7860</code><code>-(2-cycloethyl)-5,8,11,14-eicosatetraenamide; JWH-015, (2-methyl-1-propyl-1&lt;em&gt;</code></p><p><code>7861</code><code>H&lt;/em&gt;</code></p><p><code>7862</code><code>-indol-3-yl)-1-naphthalenylmethanone; OM-DM1, (&lt;em&gt;</code></p><p><code>7863</code><code>R&lt;/em&gt;</code></p><p><code>7864</code><code>)-&lt;em&gt;</code></p><p><code>7865</code><code>N&lt;/em&gt;</code></p><p><code>7866</code><code>-oleoyl-(1&amp;#x02032;-hydroxybenzyl)-2&amp;#x02032;-ethanolamine; OMDM2, (&lt;em&gt;</code></p><p><code>7867</code><code>S&lt;/em&gt;</code></p><p><code>7868</code><code>)-&lt;em&gt;</code></p><p><code>7869</code><code>N&lt;/em&gt;</code></p><p><code>7870</code><code>-oleoyl-(1&amp;#x02032;-hydroxybenzyl)-2&amp;#x02032;-ethanolamine; SNr, substantia nigra pars reticulata; LID, levodopa-induced dyskinesia; GPe or GPi, external or internal globus pallidus; HD, Huntington&amp;#x02019;s disease; ALS, amyotrophic lateral sclerosis; AM404, &lt;em&gt;</code></p><p><code>7871</code><code>N&lt;/em&gt;</code></p><p><code>7872</code><code>-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide; VDM11, &lt;em&gt;</code></p><p><code>7873</code><code>N&lt;/em&gt;</code></p><p><code>7874</code><code>-(4-hydroxy-2-methylphenyl) arachidonoyl amide; AM374, palmitylsulfonyl fluoride; TS, Gilles de la Tourette&amp;#x02019;s syndrome; AD, Alzheimer&amp;#x02019;s disease; A&lt;em&gt;</code></p><p><code>7875</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>7876</code><code>, &lt;em&gt;</code></p><p><code>7877</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>7878</code><code>-amyloid; HPA, hypothalamic-pituitary-adrenal; URB597, cyclohexyl carbamic acid 3&amp;#x02032;-carbamoyl-biphenyl-3-yl ester; 5-HT, 5-hydroxytryptamine (serotonin); VTA, ventral tegmental area; nAc, nucleus accumbens; CPP, conditioned place preference; MDMA, 3,4-methylenedioxymethamphetamine (Ecstasy); SHR, spontaneously hypertensive rat(s); WKY, Wistar-Kyoto; AM281, &lt;em&gt;</code></p><p><code>7879</code><code>N&lt;/em&gt;</code></p><p><code>7880</code><code>-(morpholin-4-yl)-1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1&lt;em&gt;</code></p><p><code>7881</code><code>H&lt;/em&gt;</code></p><p><code>7882</code><code>-pyrazole-3-carboxamide; AM630, 6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1-&lt;em&gt;</code></p><p><code>7883</code><code>H&lt;/em&gt;</code></p><p><code>7884</code><code>-indol-3-yl(4-methoxyphenyl)-methanone; IBD, inflammatory bowel disease; PRS-211,092, [(+)-(6&lt;em&gt;</code></p><p><code>7885</code><code>aS&lt;/em&gt;</code></p><p><code>7886</code><code>,10&lt;em&gt;</code></p><p><code>7887</code><code>aS&lt;/em&gt;</code></p><p><code>7888</code><code>)-6,6-dimethyl-3-(1,1-dimethylheptyl)-1-hydroxy-9-(1&lt;em&gt;</code></p><p><code>7889</code><code>H&lt;/em&gt;</code></p><p><code>7890</code><code>-imidazol-2-ylsulfanylmethyl]-6&lt;em&gt;</code></p><p><code>7891</code><code>a-&lt;/em&gt;</code></p><p><code>7892</code><code>,7,10,10&lt;em&gt;</code></p><p><code>7893</code><code>a&lt;/em&gt;</code></p><p><code>7894</code><code>-tetrahydro-6&lt;em&gt;</code></p><p><code>7895</code><code>H&lt;/em&gt;</code></p><p><code>7896</code><code>-dibenzo[&lt;em&gt;</code></p><p><code>7897</code><code>b&lt;/em&gt;</code></p><p><code>7898</code><code>,&lt;em&gt;</code></p><p><code>7899</code><code>d&lt;/em&gt;</code></p><p><code>7900</code><code>]pyran; RA, rheumatoid arthritis; HU-320, cannabidiol-dimethylheptyl-7-oic acid; HU-308, (+)-(1-&lt;em&gt;</code></p><p><code>7901</code><code>aH&lt;/em&gt;</code></p><p><code>7902</code><code>,3&lt;em&gt;</code></p><p><code>7903</code><code>H&lt;/em&gt;</code></p><p><code>7904</code><code>,5&lt;em&gt;</code></p><p><code>7905</code><code>aH&lt;/em&gt;</code></p><p><code>7906</code><code>)-4-[2,6-dimethoxy-4-(1,1-dimethylheptyl)phenyl]-6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carbinol.&lt;/p&gt;</code></p><p><code>7907</code><code>&lt;/div&gt;</code></p><p><code>7908</code><code>&lt;/div&gt;</code></p><p><code>7909</code><code>&lt;div id="idm139779461762064" class="tsec sec"&gt;</code></p><p><code>7910</code><code>&lt;h2 class="head no_bottom_margin" id="idm139779461762064title"&gt;</code></p><p><code>7911</code><code>References&lt;/h2&gt;</code></p><p><code>7912</code><code>&lt;div class="ref-list-sec sec" id="reference-list"&gt;</code></p><p><code>7913</code><code>&lt;ul class="back-ref-list" style="list-style-type:decimal;"&gt;</code></p><p><code>7914</code><code>&lt;li id="R1"&gt;</code></p><p><code>7915</code><code>&lt;span class="citation"&gt;</code></p><p><code>7916</code><code>Aapro M. Optimising antiemetic therapy: what are the problems and how can they be overcome? &lt;span&gt;</code></p><p><code>7917</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>7918</code><code>Curr Med Res Opin. &lt;/span&gt;</code></p><p><code>7919</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>7920</code><code>21&lt;/span&gt;</code></p><p><code>7921</code><code>:885–897.&lt;/span&gt;</code></p><p><code>7922</code><code> [&lt;a href="/pubmed/15969889" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>7923</code><code>PubMed&lt;/a&gt;</code></p><p><code>7924</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>7925</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Med+Res+Opin&amp;amp;title=Optimising+antiemetic+therapy:+what+are+the+problems+and+how+can+they+be+overcome?&amp;amp;author=M+Aapro&amp;amp;volume=21&amp;amp;publication_year=2005&amp;amp;pages=885-897&amp;amp;pmid=15969889&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>7926</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>7927</code><code>]&lt;/span&gt;</code></p><p><code>7928</code><code>&lt;/span&gt;</code></p><p><code>7929</code><code>&lt;/li&gt;</code></p><p><code>7930</code><code>&lt;li id="R2"&gt;</code></p><p><code>7931</code><code>&lt;span class="citation"&gt;</code></p><p><code>7932</code><code>Abboud RT, Sanders HD. Effect of oral administration of &amp;#x00394;-tetrahydrocannabinol on airway mechanics in normal and asthmatic subjects. &lt;span&gt;</code></p><p><code>7933</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>7934</code><code>Chest. &lt;/span&gt;</code></p><p><code>7935</code><code>1976;&lt;span class="ref-vol"&gt;</code></p><p><code>7936</code><code>70&lt;/span&gt;</code></p><p><code>7937</code><code>:480–485.&lt;/span&gt;</code></p><p><code>7938</code><code> [&lt;a href="/pubmed/789025" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>7939</code><code>PubMed&lt;/a&gt;</code></p><p><code>7940</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>7941</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;amp;title=Effect+of+oral+administration+of+&amp;#x00394;-tetrahydrocannabinol+on+airway+mechanics+in+normal+and+asthmatic+subjects&amp;amp;author=RT+Abboud&amp;amp;author=HD+Sanders&amp;amp;volume=70&amp;amp;publication_year=1976&amp;amp;pages=480-485&amp;amp;pmid=789025&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>7942</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>7943</code><code>]&lt;/span&gt;</code></p><p><code>7944</code><code>&lt;/span&gt;</code></p><p><code>7945</code><code>&lt;/li&gt;</code></p><p><code>7946</code><code>&lt;li id="R3"&gt;</code></p><p><code>7947</code><code>&lt;span class="citation"&gt;</code></p><p><code>7948</code><code>Abel EL. Cannabis: effects on hunger and thirst. &lt;span&gt;</code></p><p><code>7949</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>7950</code><code>Behav Biol. &lt;/span&gt;</code></p><p><code>7951</code><code>1975;&lt;span class="ref-vol"&gt;</code></p><p><code>7952</code><code>15&lt;/span&gt;</code></p><p><code>7953</code><code>:255–281.&lt;/span&gt;</code></p><p><code>7954</code><code> [&lt;a href="/pubmed/1106391" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>7955</code><code>PubMed&lt;/a&gt;</code></p><p><code>7956</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>7957</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Behav+Biol&amp;amp;title=Cannabis:+effects+on+hunger+and+thirst&amp;amp;author=EL+Abel&amp;amp;volume=15&amp;amp;publication_year=1975&amp;amp;pages=255-281&amp;amp;pmid=1106391&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>7958</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>7959</code><code>]&lt;/span&gt;</code></p><p><code>7960</code><code>&lt;/span&gt;</code></p><p><code>7961</code><code>&lt;/li&gt;</code></p><p><code>7962</code><code>&lt;li id="R4"&gt;</code></p><p><code>7963</code><code>&lt;span class="citation"&gt;</code></p><p><code>7964</code><code>Abood ME, Rizvi G, Sallapudi N, McAllister SD. Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity. &lt;span&gt;</code></p><p><code>7965</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>7966</code><code>Neurosci Lett. &lt;/span&gt;</code></p><p><code>7967</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>7968</code><code>309&lt;/span&gt;</code></p><p><code>7969</code><code>:197–201.&lt;/span&gt;</code></p><p><code>7970</code><code> [&lt;a href="/pubmed/11514075" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>7971</code><code>PubMed&lt;/a&gt;</code></p><p><code>7972</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>7973</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Lett&amp;amp;title=Activation+of+the+CB1+cannabinoid+receptor+protects+cultured+mouse+spinal+neurons+against+excitotoxicity&amp;amp;author=ME+Abood&amp;amp;author=G+Rizvi&amp;amp;author=N+Sallapudi&amp;amp;author=SD+McAllister&amp;amp;volume=309&amp;amp;publication_year=2001&amp;amp;pages=197-201&amp;amp;pmid=11514075&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>7974</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>7975</code><code>]&lt;/span&gt;</code></p><p><code>7976</code><code>&lt;/span&gt;</code></p><p><code>7977</code><code>&lt;/li&gt;</code></p><p><code>7978</code><code>&lt;li id="R5"&gt;</code></p><p><code>7979</code><code>&lt;span class="citation"&gt;</code></p><p><code>7980</code><code>Abu-Elmagd KM, Zak M, Stamos JM, Bond GJ, Jain A, Youk AO, Ezzelarab M, Costa G, Wu T, Nalesnik MA, et al.  De novo malignancies after intestinal and multivisceral transplantation. &lt;span&gt;</code></p><p><code>7981</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>7982</code><code>Transplantation. &lt;/span&gt;</code></p><p><code>7983</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>7984</code><code>77&lt;/span&gt;</code></p><p><code>7985</code><code>:1719–1725.&lt;/span&gt;</code></p><p><code>7986</code><code> [&lt;a href="/pubmed/15201672" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>7987</code><code>PubMed&lt;/a&gt;</code></p><p><code>7988</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>7989</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Transplantation&amp;amp;title=De+novo+malignancies+after+intestinal+and+multivisceral+transplantation&amp;amp;author=KM+Abu-Elmagd&amp;amp;author=M+Zak&amp;amp;author=JM+Stamos&amp;amp;author=GJ+Bond&amp;amp;author=A+Jain&amp;amp;volume=77&amp;amp;publication_year=2004&amp;amp;pages=1719-1725&amp;amp;pmid=15201672&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>7990</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>7991</code><code>]&lt;/span&gt;</code></p><p><code>7992</code><code>&lt;/span&gt;</code></p><p><code>7993</code><code>&lt;/li&gt;</code></p><p><code>7994</code><code>&lt;li id="R6"&gt;</code></p><p><code>7995</code><code>&lt;span class="citation"&gt;</code></p><p><code>7996</code><code>Achiron A, Miron S, Lavie V, Margalit R, Biegon A. Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis. &lt;span&gt;</code></p><p><code>7997</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>7998</code><code>J Neuroimmunol. &lt;/span&gt;</code></p><p><code>7999</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>8000</code><code>102&lt;/span&gt;</code></p><p><code>8001</code><code>:26–31.&lt;/span&gt;</code></p><p><code>8002</code><code> [&lt;a href="/pubmed/10626663" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8003</code><code>PubMed&lt;/a&gt;</code></p><p><code>8004</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8005</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neuroimmunol&amp;amp;title=Dexanabinol+(HU-211)+effect+on+experimental+autoimmune+encephalomyelitis:+implications+for+the+treatment+of+acute+relapses+of+multiple+sclerosis&amp;amp;author=A+Achiron&amp;amp;author=S+Miron&amp;amp;author=V+Lavie&amp;amp;author=R+Margalit&amp;amp;author=A+Biegon&amp;amp;volume=102&amp;amp;publication_year=2000&amp;amp;pages=26-31&amp;amp;pmid=10626663&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8006</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8007</code><code>]&lt;/span&gt;</code></p><p><code>8008</code><code>&lt;/span&gt;</code></p><p><code>8009</code><code>&lt;/li&gt;</code></p><p><code>8010</code><code>&lt;li id="R7"&gt;</code></p><p><code>8011</code><code>&lt;span class="citation"&gt;</code></p><p><code>8012</code><code>Adami M, Frati P, Bertini S, Kulkarni-Narla A, Brown DR, de Caro G, Coruzzi G, Soldani G. Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach. &lt;span&gt;</code></p><p><code>8013</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8014</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>8015</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>8016</code><code>135&lt;/span&gt;</code></p><p><code>8017</code><code>:1598–1606.&lt;/span&gt;</code></p><p><code>8018</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>8019</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1573291/"&gt;</code></p><p><code>8020</code><code>PMC free article&lt;/a&gt;</code></p><p><code>8021</code><code>]&lt;/span&gt;</code></p><p><code>8022</code><code> [&lt;a href="/pubmed/11934799" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8023</code><code>PubMed&lt;/a&gt;</code></p><p><code>8024</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8025</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Gastric+antisecretory+role+and+immunohistochemical+localization+of+cannabinoid+receptors+in+the+rat+stomach&amp;amp;author=M+Adami&amp;amp;author=P+Frati&amp;amp;author=S+Bertini&amp;amp;author=A+Kulkarni-Narla&amp;amp;author=DR+Brown&amp;amp;volume=135&amp;amp;publication_year=2002&amp;amp;pages=1598-1606&amp;amp;pmid=11934799&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8026</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8027</code><code>]&lt;/span&gt;</code></p><p><code>8028</code><code>&lt;/span&gt;</code></p><p><code>8029</code><code>&lt;/li&gt;</code></p><p><code>8030</code><code>&lt;li id="R8"&gt;</code></p><p><code>8031</code><code>&lt;span class="citation"&gt;</code></p><p><code>8032</code><code>Adams MD, Chait LD, Earnhardt JT. Tolerance to the cardiovascular effects of &amp;#x00394;&lt;sup&gt;</code></p><p><code>8033</code><code>9&lt;/sup&gt;</code></p><p><code>8034</code><code>-tetrahydrocannabinol in the rat. &lt;span&gt;</code></p><p><code>8035</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8036</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>8037</code><code>1976;&lt;span class="ref-vol"&gt;</code></p><p><code>8038</code><code>56&lt;/span&gt;</code></p><p><code>8039</code><code>:43–48.&lt;/span&gt;</code></p><p><code>8040</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>8041</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1666746/"&gt;</code></p><p><code>8042</code><code>PMC free article&lt;/a&gt;</code></p><p><code>8043</code><code>]&lt;/span&gt;</code></p><p><code>8044</code><code> [&lt;a href="/pubmed/1252665" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8045</code><code>PubMed&lt;/a&gt;</code></p><p><code>8046</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8047</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Tolerance+to+the+cardiovascular+effects+of+&amp;#x00394;9-tetrahydrocannabinol+in+the+rat&amp;amp;author=MD+Adams&amp;amp;author=LD+Chait&amp;amp;author=JT+Earnhardt&amp;amp;volume=56&amp;amp;publication_year=1976&amp;amp;pages=43-48&amp;amp;pmid=1252665&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8048</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8049</code><code>]&lt;/span&gt;</code></p><p><code>8050</code><code>&lt;/span&gt;</code></p><p><code>8051</code><code>&lt;/li&gt;</code></p><p><code>8052</code><code>&lt;li id="R9"&gt;</code></p><p><code>8053</code><code>&lt;span class="citation"&gt;</code></p><p><code>8054</code><code>Adams MD, Earnhardt JT, Martin BR, Harris LS, Dewey WL, Razdan RK. A cannabinoid with cardiovascular activity but no overt behavioral effects. &lt;span&gt;</code></p><p><code>8055</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8056</code><code>Experientia (Basel) &lt;/span&gt;</code></p><p><code>8057</code><code>1977;&lt;span class="ref-vol"&gt;</code></p><p><code>8058</code><code>33&lt;/span&gt;</code></p><p><code>8059</code><code>:1204–1205.&lt;/span&gt;</code></p><p><code>8060</code><code> [&lt;a href="/pubmed/891878" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8061</code><code>PubMed&lt;/a&gt;</code></p><p><code>8062</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8063</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Experientia+(Basel)&amp;amp;title=A+cannabinoid+with+cardiovascular+activity+but+no+overt+behavioral+effects&amp;amp;author=MD+Adams&amp;amp;author=JT+Earnhardt&amp;amp;author=BR+Martin&amp;amp;author=LS+Harris&amp;amp;author=WL+Dewey&amp;amp;volume=33&amp;amp;publication_year=1977&amp;amp;pages=1204-1205&amp;amp;pmid=891878&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8064</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8065</code><code>]&lt;/span&gt;</code></p><p><code>8066</code><code>&lt;/span&gt;</code></p><p><code>8067</code><code>&lt;/li&gt;</code></p><p><code>8068</code><code>&lt;li id="R10"&gt;</code></p><p><code>8069</code><code>&lt;span class="citation"&gt;</code></p><p><code>8070</code><code>Aguado T, Monory K, Palazuelos J, Stella N, Cravatt B, Lutz B, Marsicano G, Kokaia Z, Guzm&amp;#x000e1;n M, Galve-Roperh I. The endocannabinoid system drives neural progenitor proliferation. &lt;span&gt;</code></p><p><code>8071</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8072</code><code>FASEB J. &lt;/span&gt;</code></p><p><code>8073</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>8074</code><code>19&lt;/span&gt;</code></p><p><code>8075</code><code>:1704–1706.&lt;/span&gt;</code></p><p><code>8076</code><code> [&lt;a href="/pubmed/16037095" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8077</code><code>PubMed&lt;/a&gt;</code></p><p><code>8078</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8079</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;amp;title=The+endocannabinoid+system+drives+neural+progenitor+proliferation&amp;amp;author=T+Aguado&amp;amp;author=K+Monory&amp;amp;author=J+Palazuelos&amp;amp;author=N+Stella&amp;amp;author=B+Cravatt&amp;amp;volume=19&amp;amp;publication_year=2005&amp;amp;pages=1704-1706&amp;amp;pmid=16037095&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8080</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8081</code><code>]&lt;/span&gt;</code></p><p><code>8082</code><code>&lt;/span&gt;</code></p><p><code>8083</code><code>&lt;/li&gt;</code></p><p><code>8084</code><code>&lt;li id="R11"&gt;</code></p><p><code>8085</code><code>&lt;span class="citation"&gt;</code></p><p><code>8086</code><code>Aguado T, Palazuelos J, Monory K, Stella N, Cravatt B, Lutz B, Marsicano G, Kokaia Z, Guzman M, Galve-Roperh I. The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. &lt;span&gt;</code></p><p><code>8087</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8088</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>8089</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>8090</code><code>26&lt;/span&gt;</code></p><p><code>8091</code><code>:1551–1561.&lt;/span&gt;</code></p><p><code>8092</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>8093</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6675499/"&gt;</code></p><p><code>8094</code><code>PMC free article&lt;/a&gt;</code></p><p><code>8095</code><code>]&lt;/span&gt;</code></p><p><code>8096</code><code> [&lt;a href="/pubmed/16452678" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8097</code><code>PubMed&lt;/a&gt;</code></p><p><code>8098</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8099</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=The+endocannabinoid+system+promotes+astroglial+differentiation+by+acting+on+neural+progenitor+cells&amp;amp;author=T+Aguado&amp;amp;author=J+Palazuelos&amp;amp;author=K+Monory&amp;amp;author=N+Stella&amp;amp;author=B+Cravatt&amp;amp;volume=26&amp;amp;publication_year=2006&amp;amp;pages=1551-1561&amp;amp;pmid=16452678&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8100</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8101</code><code>]&lt;/span&gt;</code></p><p><code>8102</code><code>&lt;/span&gt;</code></p><p><code>8103</code><code>&lt;/li&gt;</code></p><p><code>8104</code><code>&lt;li id="R12"&gt;</code></p><p><code>8105</code><code>&lt;span class="citation"&gt;</code></p><p><code>8106</code><code>Alger BE. Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. &lt;span&gt;</code></p><p><code>8107</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8108</code><code>Prog Neurobiol. &lt;/span&gt;</code></p><p><code>8109</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>8110</code><code>68&lt;/span&gt;</code></p><p><code>8111</code><code>:247–286.&lt;/span&gt;</code></p><p><code>8112</code><code> [&lt;a href="/pubmed/12498988" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8113</code><code>PubMed&lt;/a&gt;</code></p><p><code>8114</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8115</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Prog+Neurobiol&amp;amp;title=Retrograde+signaling+in+the+regulation+of+synaptic+transmission:+focus+on+endocannabinoids&amp;amp;author=BE+Alger&amp;amp;volume=68&amp;amp;publication_year=2002&amp;amp;pages=247-286&amp;amp;pmid=12498988&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8116</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8117</code><code>]&lt;/span&gt;</code></p><p><code>8118</code><code>&lt;/span&gt;</code></p><p><code>8119</code><code>&lt;/li&gt;</code></p><p><code>8120</code><code>&lt;li id="R13"&gt;</code></p><p><code>8121</code><code>&lt;span class="citation"&gt;</code></p><p><code>8122</code><code>Alger BE. Endocannabinoids and their implications for epilepsy. &lt;span&gt;</code></p><p><code>8123</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8124</code><code>Epilepsy Curr. &lt;/span&gt;</code></p><p><code>8125</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>8126</code><code>4&lt;/span&gt;</code></p><p><code>8127</code><code>:169–173.&lt;/span&gt;</code></p><p><code>8128</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>8129</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1176361/"&gt;</code></p><p><code>8130</code><code>PMC free article&lt;/a&gt;</code></p><p><code>8131</code><code>]&lt;/span&gt;</code></p><p><code>8132</code><code> [&lt;a href="/pubmed/16059489" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8133</code><code>PubMed&lt;/a&gt;</code></p><p><code>8134</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8135</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Epilepsy+Curr&amp;amp;title=Endocannabinoids+and+their+implications+for+epilepsy&amp;amp;author=BE+Alger&amp;amp;volume=4&amp;amp;publication_year=2004&amp;amp;pages=169-173&amp;amp;pmid=16059489&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8136</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8137</code><code>]&lt;/span&gt;</code></p><p><code>8138</code><code>&lt;/span&gt;</code></p><p><code>8139</code><code>&lt;/li&gt;</code></p><p><code>8140</code><code>&lt;li id="R14"&gt;</code></p><p><code>8141</code><code>&lt;span class="citation"&gt;</code></p><p><code>8142</code><code>Allen JH, de Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. &lt;span&gt;</code></p><p><code>8143</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8144</code><code>Gut. &lt;/span&gt;</code></p><p><code>8145</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>8146</code><code>53&lt;/span&gt;</code></p><p><code>8147</code><code>:1566–1570.&lt;/span&gt;</code></p><p><code>8148</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>8149</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1774264/"&gt;</code></p><p><code>8150</code><code>PMC free article&lt;/a&gt;</code></p><p><code>8151</code><code>]&lt;/span&gt;</code></p><p><code>8152</code><code> [&lt;a href="/pubmed/15479672" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8153</code><code>PubMed&lt;/a&gt;</code></p><p><code>8154</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8155</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;amp;title=Cannabinoid+hyperemesis:+cyclical+hyperemesis+in+association+with+chronic+cannabis+abuse&amp;amp;author=JH+Allen&amp;amp;author=GM+de+Moore&amp;amp;author=R+Heddle&amp;amp;author=JC+Twartz&amp;amp;volume=53&amp;amp;publication_year=2005&amp;amp;pages=1566-1570&amp;amp;pmid=15479672&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8156</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8157</code><code>]&lt;/span&gt;</code></p><p><code>8158</code><code>&lt;/span&gt;</code></p><p><code>8159</code><code>&lt;/li&gt;</code></p><p><code>8160</code><code>&lt;li id="R15"&gt;</code></p><p><code>8161</code><code>&lt;span class="citation"&gt;</code></p><p><code>8162</code><code>Allister SD, Chan C, Taft RJ, Luu T, Abood ME, Moore DH, Aldape K, Yount G. Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells. &lt;span&gt;</code></p><p><code>8163</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8164</code><code>J Neurooncol. &lt;/span&gt;</code></p><p><code>8165</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>8166</code><code>74&lt;/span&gt;</code></p><p><code>8167</code><code>:31–40.&lt;/span&gt;</code></p><p><code>8168</code><code> [&lt;a href="/pubmed/16078104" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8169</code><code>PubMed&lt;/a&gt;</code></p><p><code>8170</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8171</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurooncol&amp;amp;title=Cannabinoids+selectively+inhibit+proliferation+and+induce+death+of+cultured+human+glioblastoma+multiforme+cells&amp;amp;author=SD+Allister&amp;amp;author=C+Chan&amp;amp;author=RJ+Taft&amp;amp;author=T+Luu&amp;amp;author=ME+Abood&amp;amp;volume=74&amp;amp;publication_year=2005&amp;amp;pages=31-40&amp;amp;pmid=16078104&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8172</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8173</code><code>]&lt;/span&gt;</code></p><p><code>8174</code><code>&lt;/span&gt;</code></p><p><code>8175</code><code>&lt;/li&gt;</code></p><p><code>8176</code><code>&lt;li id="R16"&gt;</code></p><p><code>8177</code><code>&lt;span class="citation"&gt;</code></p><p><code>8178</code><code>Alward WL. Medical management of glaucoma. &lt;span&gt;</code></p><p><code>8179</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8180</code><code>N Engl J Med. &lt;/span&gt;</code></p><p><code>8181</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>8182</code><code>339&lt;/span&gt;</code></p><p><code>8183</code><code>:1298–1307.&lt;/span&gt;</code></p><p><code>8184</code><code> [&lt;a href="/pubmed/9791148" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8185</code><code>PubMed&lt;/a&gt;</code></p><p><code>8186</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8187</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;amp;title=Medical+management+of+glaucoma&amp;amp;author=WL+Alward&amp;amp;volume=339&amp;amp;publication_year=1998&amp;amp;pages=1298-1307&amp;amp;pmid=9791148&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8188</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8189</code><code>]&lt;/span&gt;</code></p><p><code>8190</code><code>&lt;/span&gt;</code></p><p><code>8191</code><code>&lt;/li&gt;</code></p><p><code>8192</code><code>&lt;li id="R17"&gt;</code></p><p><code>8193</code><code>&lt;span class="citation"&gt;</code></p><p><code>8194</code><code>Amaya F, Shimosato G, Kawasaki Y, Hashimoto S, Tanaka Y, Ji RR. Induction of CB(1) cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB(1) agonist. &lt;span&gt;</code></p><p><code>8195</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8196</code><code>Pain. &lt;/span&gt;</code></p><p><code>8197</code><code>2006&lt;/span&gt;</code></p><p><code>8198</code><code> in press. [&lt;a href="/pubmed/16709443" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8199</code><code>PubMed&lt;/a&gt;</code></p><p><code>8200</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8201</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;amp;title=Induction+of+CB(1)+cannabinoid+receptor+by+inflammation+in+primary+afferent+neurons+facilitates+antihyperalgesic+effect+of+peripheral+CB(1)+agonist&amp;amp;author=F+Amaya&amp;amp;author=G+Shimosato&amp;amp;author=Y+Kawasaki&amp;amp;author=S+Hashimoto&amp;amp;author=Y+Tanaka&amp;amp;publication_year=2006&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8202</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8203</code><code>]&lt;/span&gt;</code></p><p><code>8204</code><code>&lt;/span&gt;</code></p><p><code>8205</code><code>&lt;/li&gt;</code></p><p><code>8206</code><code>&lt;li id="R18"&gt;</code></p><p><code>8207</code><code>&lt;span class="citation"&gt;</code></p><p><code>8208</code><code>Ames FR, Cridland S. Anticonvulsant effect of cannabidiol. &lt;span&gt;</code></p><p><code>8209</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8210</code><code>S Afr Med J. &lt;/span&gt;</code></p><p><code>8211</code><code>1986;&lt;span class="ref-vol"&gt;</code></p><p><code>8212</code><code>69&lt;/span&gt;</code></p><p><code>8213</code><code>:14.&lt;/span&gt;</code></p><p><code>8214</code><code> [&lt;a href="/pubmed/3941934" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8215</code><code>PubMed&lt;/a&gt;</code></p><p><code>8216</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8217</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=S+Afr+Med+J&amp;amp;title=Anticonvulsant+effect+of+cannabidiol&amp;amp;author=FR+Ames&amp;amp;author=S+Cridland&amp;amp;volume=69&amp;amp;publication_year=1986&amp;amp;pages=14&amp;amp;pmid=3941934&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8218</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8219</code><code>]&lt;/span&gt;</code></p><p><code>8220</code><code>&lt;/span&gt;</code></p><p><code>8221</code><code>&lt;/li&gt;</code></p><p><code>8222</code><code>&lt;li id="R19"&gt;</code></p><p><code>8223</code><code>&lt;span class="citation"&gt;</code></p><p><code>8224</code><code>Anderson LA, Anderson JJ, Chase TN, Walters JR. The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D&lt;sub&gt;</code></p><p><code>8225</code><code>1&lt;/sub&gt;</code></p><p><code>8226</code><code> but not a D&lt;sub&gt;</code></p><p><code>8227</code><code>2&lt;/sub&gt;</code></p><p><code>8228</code><code> agonist in rats with unilateral lesions of the nigrostriatal pathway. &lt;span&gt;</code></p><p><code>8229</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8230</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>8231</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>8232</code><code>691&lt;/span&gt;</code></p><p><code>8233</code><code>:106–114.&lt;/span&gt;</code></p><p><code>8234</code><code> [&lt;a href="/pubmed/8590042" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8235</code><code>PubMed&lt;/a&gt;</code></p><p><code>8236</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8237</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=The+cannabinoid+agonists+WIN+55,212-2+and+CP+55,940+attenuate+rotational+behavior+induced+by+a+dopamine+D1+but+not+a+D2+agonist+in+rats+with+unilateral+lesions+of+the+nigrostriatal+pathway&amp;amp;author=LA+Anderson&amp;amp;author=JJ+Anderson&amp;amp;author=TN+Chase&amp;amp;author=JR+Walters&amp;amp;volume=691&amp;amp;publication_year=1995&amp;amp;pages=106-114&amp;amp;pmid=8590042&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8238</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8239</code><code>]&lt;/span&gt;</code></p><p><code>8240</code><code>&lt;/span&gt;</code></p><p><code>8241</code><code>&lt;/li&gt;</code></p><p><code>8242</code><code>&lt;li id="R20"&gt;</code></p><p><code>8243</code><code>&lt;span class="citation"&gt;</code></p><p><code>8244</code><code>Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. &lt;span&gt;</code></p><p><code>8245</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8246</code><code>Lancet. &lt;/span&gt;</code></p><p><code>8247</code><code>1987;&lt;span class="ref-vol"&gt;</code></p><p><code>8248</code><code>2&lt;/span&gt;</code></p><p><code>8249</code><code>:1483–1486.&lt;/span&gt;</code></p><p><code>8250</code><code> [&lt;a href="/pubmed/2892048" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8251</code><code>PubMed&lt;/a&gt;</code></p><p><code>8252</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8253</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;amp;title=Cannabis+and+schizophrenia:+a+longitudinal+study+of+Swedish+conscripts&amp;amp;author=S+Andreasson&amp;amp;author=P+Allebeck&amp;amp;author=A+Engstrom&amp;amp;author=U+Rydberg&amp;amp;volume=2&amp;amp;publication_year=1987&amp;amp;pages=1483-1486&amp;amp;pmid=2892048&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8254</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8255</code><code>]&lt;/span&gt;</code></p><p><code>8256</code><code>&lt;/span&gt;</code></p><p><code>8257</code><code>&lt;/li&gt;</code></p><p><code>8258</code><code>&lt;li id="R21"&gt;</code></p><p><code>8259</code><code>&lt;span class="citation"&gt;</code></p><p><code>8260</code><code>Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, Stevens VJ, Vollmer WM, Lin PH, Svetkey LP, et al.  Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. &lt;span&gt;</code></p><p><code>8261</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8262</code><code>J Am Med Assoc. &lt;/span&gt;</code></p><p><code>8263</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>8264</code><code>289&lt;/span&gt;</code></p><p><code>8265</code><code>:2083–2093.&lt;/span&gt;</code></p><p><code>8266</code><code> [&lt;a href="/pubmed/12709466" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8267</code><code>PubMed&lt;/a&gt;</code></p><p><code>8268</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8269</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Med+Assoc&amp;amp;title=Effects+of+comprehensive+lifestyle+modification+on+blood+pressure+control:+main+results+of+the+PREMIER+clinical+trial&amp;amp;author=LJ+Appel&amp;amp;author=CM+Champagne&amp;amp;author=DW+Harsha&amp;amp;author=LS+Cooper&amp;amp;author=E+Obarzanek&amp;amp;volume=289&amp;amp;publication_year=2003&amp;amp;pages=2083-2093&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8270</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8271</code><code>]&lt;/span&gt;</code></p><p><code>8272</code><code>&lt;/span&gt;</code></p><p><code>8273</code><code>&lt;/li&gt;</code></p><p><code>8274</code><code>&lt;li id="R22"&gt;</code></p><p><code>8275</code><code>&lt;span class="citation"&gt;</code></p><p><code>8276</code><code>Archer RA. The cannabinoids: therapeutic potentials. &lt;span&gt;</code></p><p><code>8277</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8278</code><code>Annu Rev Med Chem. &lt;/span&gt;</code></p><p><code>8279</code><code>1974;&lt;span class="ref-vol"&gt;</code></p><p><code>8280</code><code>9&lt;/span&gt;</code></p><p><code>8281</code><code>:253–259.&lt;/span&gt;</code></p><p><code>8282</code><code> [&lt;a href="/pubmed/12307093" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8283</code><code>PubMed&lt;/a&gt;</code></p><p><code>8284</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8285</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Med+Chem&amp;amp;title=The+cannabinoids:+therapeutic+potentials&amp;amp;author=RA+Archer&amp;amp;volume=9&amp;amp;publication_year=1974&amp;amp;pages=253-259&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8286</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8287</code><code>]&lt;/span&gt;</code></p><p><code>8288</code><code>&lt;/span&gt;</code></p><p><code>8289</code><code>&lt;/li&gt;</code></p><p><code>8290</code><code>&lt;li id="R23"&gt;</code></p><p><code>8291</code><code>&lt;span class="citation"&gt;</code></p><p><code>8292</code><code>Arevalo C, de Miguel R, Hernandez-Tristan R. Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters. &lt;span&gt;</code></p><p><code>8293</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8294</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>8295</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>8296</code><code>70&lt;/span&gt;</code></p><p><code>8297</code><code>:123–131.&lt;/span&gt;</code></p><p><code>8298</code><code> [&lt;a href="/pubmed/11566149" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8299</code><code>PubMed&lt;/a&gt;</code></p><p><code>8300</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8301</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Cannabinoid+effects+on+anxiety-related+behaviours+and+hypothalamic+neurotransmitters&amp;amp;author=C+Arevalo&amp;amp;author=R+de+Miguel&amp;amp;author=R+Hernandez-Tristan&amp;amp;volume=70&amp;amp;publication_year=2001&amp;amp;pages=123-131&amp;amp;pmid=11566149&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8302</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8303</code><code>]&lt;/span&gt;</code></p><p><code>8304</code><code>&lt;/span&gt;</code></p><p><code>8305</code><code>&lt;/li&gt;</code></p><p><code>8306</code><code>&lt;li id="R24"&gt;</code></p><p><code>8307</code><code>&lt;span class="citation"&gt;</code></p><p><code>8308</code><code>Arevalo-Martin A, Vela JM, Molina-Holgado E, Borrell J, Guaza C. Therapeutic action of cannabinoids in a murine model of multiple sclerosis. &lt;span&gt;</code></p><p><code>8309</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8310</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>8311</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>8312</code><code>23&lt;/span&gt;</code></p><p><code>8313</code><code>:2511–2516.&lt;/span&gt;</code></p><p><code>8314</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>8315</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6742100/"&gt;</code></p><p><code>8316</code><code>PMC free article&lt;/a&gt;</code></p><p><code>8317</code><code>]&lt;/span&gt;</code></p><p><code>8318</code><code> [&lt;a href="/pubmed/12684434" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8319</code><code>PubMed&lt;/a&gt;</code></p><p><code>8320</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8321</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Therapeutic+action+of+cannabinoids+in+a+murine+model+of+multiple+sclerosis&amp;amp;author=A+Arevalo-Martin&amp;amp;author=JM+Vela&amp;amp;author=E+Molina-Holgado&amp;amp;author=J+Borrell&amp;amp;author=C+Guaza&amp;amp;volume=23&amp;amp;publication_year=2003&amp;amp;pages=2511-2516&amp;amp;pmid=12684434&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8322</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8323</code><code>]&lt;/span&gt;</code></p><p><code>8324</code><code>&lt;/span&gt;</code></p><p><code>8325</code><code>&lt;/li&gt;</code></p><p><code>8326</code><code>&lt;li id="R25"&gt;</code></p><p><code>8327</code><code>&lt;span class="citation"&gt;</code></p><p><code>8328</code><code>Arnone M, Maruani J, Chaperon F, Thiebot MH, Poncelet M, Soubrie P, Le Fur G. Selective inhibition of sucrose and ethanol intake by SR141716, an antagonist of central cannabinoid (CB&lt;sub&gt;</code></p><p><code>8329</code><code>1&lt;/sub&gt;</code></p><p><code>8330</code><code>) receptors. &lt;span&gt;</code></p><p><code>8331</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8332</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>8333</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>8334</code><code>132&lt;/span&gt;</code></p><p><code>8335</code><code>:104–106.&lt;/span&gt;</code></p><p><code>8336</code><code> [&lt;a href="/pubmed/9272766" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8337</code><code>PubMed&lt;/a&gt;</code></p><p><code>8338</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8339</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Selective+inhibition+of+sucrose+and+ethanol+intake+by+SR141716,+an+antagonist+of+central+cannabinoid+(CB1)+receptors&amp;amp;author=M+Arnone&amp;amp;author=J+Maruani&amp;amp;author=F+Chaperon&amp;amp;author=MH+Thiebot&amp;amp;author=M+Poncelet&amp;amp;volume=132&amp;amp;publication_year=1997&amp;amp;pages=104-106&amp;amp;pmid=9272766&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8340</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8341</code><code>]&lt;/span&gt;</code></p><p><code>8342</code><code>&lt;/span&gt;</code></p><p><code>8343</code><code>&lt;/li&gt;</code></p><p><code>8344</code><code>&lt;li id="R26"&gt;</code></p><p><code>8345</code><code>&lt;span class="citation"&gt;</code></p><p><code>8346</code><code>Andersson M, Usiello A, Borgkvist A, Pozzi L, Dominguez C, Fienberg AA, Svenningsson P, Fredholm BB, Borrelli E, Greengard P, et al.  Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phospho-protein of 32 kDa at the protein kinase A site in striatal projection neurons. &lt;span&gt;</code></p><p><code>8347</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8348</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>8349</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>8350</code><code>25&lt;/span&gt;</code></p><p><code>8351</code><code>:8432–8438.&lt;/span&gt;</code></p><p><code>8352</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>8353</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6725667/"&gt;</code></p><p><code>8354</code><code>PMC free article&lt;/a&gt;</code></p><p><code>8355</code><code>]&lt;/span&gt;</code></p><p><code>8356</code><code> [&lt;a href="/pubmed/16162925" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8357</code><code>PubMed&lt;/a&gt;</code></p><p><code>8358</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8359</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Cannabinoid+action+depends+on+phosphorylation+of+dopamine-+and+cAMP-regulated+phospho-protein+of+32+kDa+at+the+protein+kinase+A+site+in+striatal+projection+neurons&amp;amp;author=M+Andersson&amp;amp;author=A+Usiello&amp;amp;author=A+Borgkvist&amp;amp;author=L+Pozzi&amp;amp;author=C+Dominguez&amp;amp;volume=25&amp;amp;publication_year=2005&amp;amp;pages=8432-8438&amp;amp;pmid=16162925&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8360</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8361</code><code>]&lt;/span&gt;</code></p><p><code>8362</code><code>&lt;/span&gt;</code></p><p><code>8363</code><code>&lt;/li&gt;</code></p><p><code>8364</code><code>&lt;li id="R27"&gt;</code></p><p><code>8365</code><code>&lt;span class="citation"&gt;</code></p><p><code>8366</code><code>Ashton CH. Adverse effects of cannabis and cannabinoids. &lt;span&gt;</code></p><p><code>8367</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8368</code><code>Br J Anaesth. &lt;/span&gt;</code></p><p><code>8369</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>8370</code><code>83&lt;/span&gt;</code></p><p><code>8371</code><code>:637–649.&lt;/span&gt;</code></p><p><code>8372</code><code> [&lt;a href="/pubmed/10673884" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8373</code><code>PubMed&lt;/a&gt;</code></p><p><code>8374</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8375</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Anaesth&amp;amp;title=Adverse+effects+of+cannabis+and+cannabinoids&amp;amp;author=CH+Ashton&amp;amp;volume=83&amp;amp;publication_year=1999&amp;amp;pages=637-649&amp;amp;pmid=10673884&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8376</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8377</code><code>]&lt;/span&gt;</code></p><p><code>8378</code><code>&lt;/span&gt;</code></p><p><code>8379</code><code>&lt;/li&gt;</code></p><p><code>8380</code><code>&lt;li id="R28"&gt;</code></p><p><code>8381</code><code>&lt;span class="citation"&gt;</code></p><p><code>8382</code><code>Ashton CH, Moore PB, Gallagher P, Young AH. Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. &lt;span&gt;</code></p><p><code>8383</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8384</code><code>J Psychopharmacol. &lt;/span&gt;</code></p><p><code>8385</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>8386</code><code>19&lt;/span&gt;</code></p><p><code>8387</code><code>:293–300.&lt;/span&gt;</code></p><p><code>8388</code><code> [&lt;a href="/pubmed/15888515" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8389</code><code>PubMed&lt;/a&gt;</code></p><p><code>8390</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8391</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Psychopharmacol&amp;amp;title=Cannabinoids+in+bipolar+affective+disorder:+a+review+and+discussion+of+their+therapeutic+potential&amp;amp;author=CH+Ashton&amp;amp;author=PB+Moore&amp;amp;author=P+Gallagher&amp;amp;author=AH+Young&amp;amp;volume=19&amp;amp;publication_year=2005&amp;amp;pages=293-300&amp;amp;pmid=15888515&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8392</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8393</code><code>]&lt;/span&gt;</code></p><p><code>8394</code><code>&lt;/span&gt;</code></p><p><code>8395</code><code>&lt;/li&gt;</code></p><p><code>8396</code><code>&lt;li id="R29"&gt;</code></p><p><code>8397</code><code>&lt;span class="citation"&gt;</code></p><p><code>8398</code><code>Ashton H, Golding J, Marsh VR, Millman JE, Thompson JW. The seed and the soil: effect of dosage, personality and starting state on the response to &amp;#x00394;&lt;sub&gt;</code></p><p><code>8399</code><code>9&lt;/sub&gt;</code></p><p><code>8400</code><code> tetrahydrocannabinol in man. &lt;span&gt;</code></p><p><code>8401</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8402</code><code>Br J Clin Pharmacol. &lt;/span&gt;</code></p><p><code>8403</code><code>1981;&lt;span class="ref-vol"&gt;</code></p><p><code>8404</code><code>12&lt;/span&gt;</code></p><p><code>8405</code><code>:705–720.&lt;/span&gt;</code></p><p><code>8406</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>8407</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1401962/"&gt;</code></p><p><code>8408</code><code>PMC free article&lt;/a&gt;</code></p><p><code>8409</code><code>]&lt;/span&gt;</code></p><p><code>8410</code><code> [&lt;a href="/pubmed/6277355" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8411</code><code>PubMed&lt;/a&gt;</code></p><p><code>8412</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8413</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Clin+Pharmacol&amp;amp;title=The+seed+and+the+soil:+effect+of+dosage,+personality+and+starting+state+on+the+response+to+&amp;#x00394;9+tetrahydrocannabinol+in+man&amp;amp;author=H+Ashton&amp;amp;author=J+Golding&amp;amp;author=VR+Marsh&amp;amp;author=JE+Millman&amp;amp;author=JW+Thompson&amp;amp;volume=12&amp;amp;publication_year=1981&amp;amp;pages=705-720&amp;amp;pmid=6277355&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8414</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8415</code><code>]&lt;/span&gt;</code></p><p><code>8416</code><code>&lt;/span&gt;</code></p><p><code>8417</code><code>&lt;/li&gt;</code></p><p><code>8418</code><code>&lt;li id="R30"&gt;</code></p><p><code>8419</code><code>&lt;span class="citation"&gt;</code></p><p><code>8420</code><code>Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. &lt;span&gt;</code></p><p><code>8421</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8422</code><code>Practitioner. &lt;/span&gt;</code></p><p><code>8423</code><code>1964;&lt;span class="ref-vol"&gt;</code></p><p><code>8424</code><code>192&lt;/span&gt;</code></p><p><code>8425</code><code>:540–542.&lt;/span&gt;</code></p><p><code>8426</code><code> [&lt;a href="/pubmed/14143329" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8427</code><code>PubMed&lt;/a&gt;</code></p><p><code>8428</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8429</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Practitioner&amp;amp;title=Preliminary+trial+of+carisoprodol+in+multiple+sclerosis&amp;amp;author=B+Ashworth&amp;amp;volume=192&amp;amp;publication_year=1964&amp;amp;pages=540-542&amp;amp;pmid=14143329&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8430</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8431</code><code>]&lt;/span&gt;</code></p><p><code>8432</code><code>&lt;/span&gt;</code></p><p><code>8433</code><code>&lt;/li&gt;</code></p><p><code>8434</code><code>&lt;li id="R31"&gt;</code></p><p><code>8435</code><code>&lt;span class="citation"&gt;</code></p><p><code>8436</code><code>Attal N, Brasseur L, Guirimand D, Clermond-Gnamien S, Atlami S, Bouhassira D. Are oral cannabinoids safe and effective in refractory neuropathic pain? &lt;span&gt;</code></p><p><code>8437</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8438</code><code>Eur J Pain. &lt;/span&gt;</code></p><p><code>8439</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>8440</code><code>8&lt;/span&gt;</code></p><p><code>8441</code><code>:173–177.&lt;/span&gt;</code></p><p><code>8442</code><code> [&lt;a href="/pubmed/14987627" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8443</code><code>PubMed&lt;/a&gt;</code></p><p><code>8444</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8445</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pain&amp;amp;title=Are+oral+cannabinoids+safe+and+effective+in+refractory+neuropathic+pain?&amp;amp;author=N+Attal&amp;amp;author=L+Brasseur&amp;amp;author=D+Guirimand&amp;amp;author=S+Clermond-Gnamien&amp;amp;author=S+Atlami&amp;amp;volume=8&amp;amp;publication_year=2004&amp;amp;pages=173-177&amp;amp;pmid=14987627&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8446</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8447</code><code>]&lt;/span&gt;</code></p><p><code>8448</code><code>&lt;/span&gt;</code></p><p><code>8449</code><code>&lt;/li&gt;</code></p><p><code>8450</code><code>&lt;li id="R32"&gt;</code></p><p><code>8451</code><code>&lt;span class="citation"&gt;</code></p><p><code>8452</code><code>Avraham Y, Israeli E, Gabbay E, Okun A, Zolotarev O, Silberman I, Ganzburg V, Dagon Y, Magen I, Vorobia L, et al.  Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. &lt;span&gt;</code></p><p><code>8453</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8454</code><code>Neurobiol Dis. &lt;/span&gt;</code></p><p><code>8455</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>8456</code><code>1&lt;/span&gt;</code></p><p><code>8457</code><code>:237–245.&lt;/span&gt;</code></p><p><code>8458</code><code> [&lt;a href="/pubmed/16102970" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8459</code><code>PubMed&lt;/a&gt;</code></p><p><code>8460</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8461</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurobiol+Dis&amp;amp;title=Endocannabinoids+affect+neurological+and+cognitive+function+in+thioacetamide-induced+hepatic+encephalopathy+in+mice&amp;amp;author=Y+Avraham&amp;amp;author=E+Israeli&amp;amp;author=E+Gabbay&amp;amp;author=A+Okun&amp;amp;author=O+Zolotarev&amp;amp;volume=1&amp;amp;publication_year=2006&amp;amp;pages=237-245&amp;amp;pmid=16102970&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8462</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8463</code><code>]&lt;/span&gt;</code></p><p><code>8464</code><code>&lt;/span&gt;</code></p><p><code>8465</code><code>&lt;/li&gt;</code></p><p><code>8466</code><code>&lt;li id="R33"&gt;</code></p><p><code>8467</code><code>&lt;span class="citation"&gt;</code></p><p><code>8468</code><code>Awumey EM, Howlett AC, Diz DI. Is there a role for anandamide in cardiovascular regulation? Insights from studies of endocannabinoid metabolism. &lt;span&gt;</code></p><p><code>8469</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8470</code><code>Am J Physiol. &lt;/span&gt;</code></p><p><code>8471</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>8472</code><code>289&lt;/span&gt;</code></p><p><code>8473</code><code>:H520–H521.&lt;/span&gt;</code></p><p><code>8474</code><code> [&lt;a href="/pubmed/16014613" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8475</code><code>PubMed&lt;/a&gt;</code></p><p><code>8476</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8477</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol&amp;amp;title=Is+there+a+role+for+anandamide+in+cardiovascular+regulation?+Insights+from+studies+of+endocannabinoid+metabolism&amp;amp;author=EM+Awumey&amp;amp;author=AC+Howlett&amp;amp;author=DI+Diz&amp;amp;volume=289&amp;amp;publication_year=2005&amp;amp;pages=H520-H521&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8478</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8479</code><code>]&lt;/span&gt;</code></p><p><code>8480</code><code>&lt;/span&gt;</code></p><p><code>8481</code><code>&lt;/li&gt;</code></p><p><code>8482</code><code>&lt;li id="R34"&gt;</code></p><p><code>8483</code><code>&lt;span class="citation"&gt;</code></p><p><code>8484</code><code>Azad SC, Eder M, Marsicano G, Lutz B, Zieglg&amp;#x000e4;nsberger W, Rammes G. Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse. &lt;span&gt;</code></p><p><code>8485</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8486</code><code>Learn Mem. &lt;/span&gt;</code></p><p><code>8487</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>8488</code><code>10&lt;/span&gt;</code></p><p><code>8489</code><code>:116–128.&lt;/span&gt;</code></p><p><code>8490</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>8491</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC196665/"&gt;</code></p><p><code>8492</code><code>PMC free article&lt;/a&gt;</code></p><p><code>8493</code><code>]&lt;/span&gt;</code></p><p><code>8494</code><code> [&lt;a href="/pubmed/12663750" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8495</code><code>PubMed&lt;/a&gt;</code></p><p><code>8496</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8497</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Learn+Mem&amp;amp;title=Activation+of+the+cannabinoid+receptor+type+1+decreases+glutamatergic+and+GABAergic+synaptic+transmission+in+the+lateral+amygdala+of+the+mouse&amp;amp;author=SC+Azad&amp;amp;author=M+Eder&amp;amp;author=G+Marsicano&amp;amp;author=B+Lutz&amp;amp;author=W+Zieglg&amp;#x000e4;nsberger&amp;amp;volume=10&amp;amp;publication_year=2003&amp;amp;pages=116-128&amp;amp;pmid=12663750&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8498</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8499</code><code>]&lt;/span&gt;</code></p><p><code>8500</code><code>&lt;/span&gt;</code></p><p><code>8501</code><code>&lt;/li&gt;</code></p><p><code>8502</code><code>&lt;li id="R35"&gt;</code></p><p><code>8503</code><code>&lt;span class="citation"&gt;</code></p><p><code>8504</code><code>Baker D, Pryce G. The therapeutic potential of cannabis in multiple sclerosis. &lt;span&gt;</code></p><p><code>8505</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8506</code><code>Expert Opin Invest Drugs. &lt;/span&gt;</code></p><p><code>8507</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>8508</code><code>12&lt;/span&gt;</code></p><p><code>8509</code><code>:561–567.&lt;/span&gt;</code></p><p><code>8510</code><code> [&lt;a href="/pubmed/12665412" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8511</code><code>PubMed&lt;/a&gt;</code></p><p><code>8512</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8513</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Expert+Opin+Invest+Drugs&amp;amp;title=The+therapeutic+potential+of+cannabis+in+multiple+sclerosis&amp;amp;author=D+Baker&amp;amp;author=G+Pryce&amp;amp;volume=12&amp;amp;publication_year=2003&amp;amp;pages=561-567&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8514</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8515</code><code>]&lt;/span&gt;</code></p><p><code>8516</code><code>&lt;/span&gt;</code></p><p><code>8517</code><code>&lt;/li&gt;</code></p><p><code>8518</code><code>&lt;li id="R36"&gt;</code></p><p><code>8519</code><code>&lt;span class="citation"&gt;</code></p><p><code>8520</code><code>Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Huffman JW, Layward L. Cannabinoids control spasticity and tremor in a multiple sclerosis model. &lt;span&gt;</code></p><p><code>8521</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8522</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>8523</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>8524</code><code>404&lt;/span&gt;</code></p><p><code>8525</code><code>:84–87.&lt;/span&gt;</code></p><p><code>8526</code><code> [&lt;a href="/pubmed/10716447" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8527</code><code>PubMed&lt;/a&gt;</code></p><p><code>8528</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8529</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Cannabinoids+control+spasticity+and+tremor+in+a+multiple+sclerosis+model&amp;amp;author=D+Baker&amp;amp;author=G+Pryce&amp;amp;author=JL+Croxford&amp;amp;author=P+Brown&amp;amp;author=RG+Pertwee&amp;amp;volume=404&amp;amp;publication_year=2000&amp;amp;pages=84-87&amp;amp;pmid=10716447&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8530</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8531</code><code>]&lt;/span&gt;</code></p><p><code>8532</code><code>&lt;/span&gt;</code></p><p><code>8533</code><code>&lt;/li&gt;</code></p><p><code>8534</code><code>&lt;li id="R37"&gt;</code></p><p><code>8535</code><code>&lt;span class="citation"&gt;</code></p><p><code>8536</code><code>Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Makriyannis A, Khanolkar A, Layward L, Fezza F, Bisogno T, et al.  Endocannabinoids control spasticity in a multiple sclerosis model. &lt;span&gt;</code></p><p><code>8537</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8538</code><code>FASEB J. &lt;/span&gt;</code></p><p><code>8539</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>8540</code><code>15&lt;/span&gt;</code></p><p><code>8541</code><code>:300–302.&lt;/span&gt;</code></p><p><code>8542</code><code> [&lt;a href="/pubmed/11156943" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8543</code><code>PubMed&lt;/a&gt;</code></p><p><code>8544</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8545</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;amp;title=Endocannabinoids+control+spasticity+in+a+multiple+sclerosis+model&amp;amp;author=D+Baker&amp;amp;author=G+Pryce&amp;amp;author=JL+Croxford&amp;amp;author=P+Brown&amp;amp;author=RG+Pertwee&amp;amp;volume=15&amp;amp;publication_year=2001&amp;amp;pages=300-302&amp;amp;pmid=11156943&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8546</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8547</code><code>]&lt;/span&gt;</code></p><p><code>8548</code><code>&lt;/span&gt;</code></p><p><code>8549</code><code>&lt;/li&gt;</code></p><p><code>8550</code><code>&lt;li id="R38"&gt;</code></p><p><code>8551</code><code>&lt;span class="citation"&gt;</code></p><p><code>8552</code><code>Balerio GN, Aso E, Maldonado R. Role of the cannabinoid system in the effects induced by nicotine an anxiety-like behaviour in mice. &lt;span&gt;</code></p><p><code>8553</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8554</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>8555</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>8556</code><code>184&lt;/span&gt;</code></p><p><code>8557</code><code>:504–513.&lt;/span&gt;</code></p><p><code>8558</code><code> [&lt;a href="/pubmed/16416159" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8559</code><code>PubMed&lt;/a&gt;</code></p><p><code>8560</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8561</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Role+of+the+cannabinoid+system+in+the+effects+induced+by+nicotine+an+anxiety-like+behaviour+in+mice&amp;amp;author=GN+Balerio&amp;amp;author=E+Aso&amp;amp;author=R+Maldonado&amp;amp;volume=184&amp;amp;publication_year=2006&amp;amp;pages=504-513&amp;amp;pmid=16416159&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8562</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8563</code><code>]&lt;/span&gt;</code></p><p><code>8564</code><code>&lt;/span&gt;</code></p><p><code>8565</code><code>&lt;/li&gt;</code></p><p><code>8566</code><code>&lt;li id="R39"&gt;</code></p><p><code>8567</code><code>&lt;span class="citation"&gt;</code></p><p><code>8568</code><code>Ballon N, Leroy S, Roy C, Bourdel MC, Charles-Nicolas A, Krebs MO, Poirier MF. (AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population. &lt;span&gt;</code></p><p><code>8569</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8570</code><code>Pharmacogenonics J. &lt;/span&gt;</code></p><p><code>8571</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>8572</code><code>6&lt;/span&gt;</code></p><p><code>8573</code><code>:126–130.&lt;/span&gt;</code></p><p><code>8574</code><code> [&lt;a href="/pubmed/16314880" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8575</code><code>PubMed&lt;/a&gt;</code></p><p><code>8576</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8577</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenonics+J&amp;amp;title=(AAT)n+repeat+in+the+cannabinoid+receptor+gene+(CNR1):+association+with+cocaine+addiction+in+an+African-Caribbean+population&amp;amp;author=N+Ballon&amp;amp;author=S+Leroy&amp;amp;author=C+Roy&amp;amp;author=MC+Bourdel&amp;amp;author=A+Charles-Nicolas&amp;amp;volume=6&amp;amp;publication_year=2006&amp;amp;pages=126-130&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8578</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8579</code><code>]&lt;/span&gt;</code></p><p><code>8580</code><code>&lt;/span&gt;</code></p><p><code>8581</code><code>&lt;/li&gt;</code></p><p><code>8582</code><code>&lt;li id="R40"&gt;</code></p><p><code>8583</code><code>&lt;span class="citation"&gt;</code></p><p><code>8584</code><code>Ban TA. Neuropsychopharmacology and the genetics of schizophrenia: a history of the diagnosis of schizophrenia. &lt;span&gt;</code></p><p><code>8585</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8586</code><code>Prog Neuropsychopharmacol Biol Psychiatry. &lt;/span&gt;</code></p><p><code>8587</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>8588</code><code>28&lt;/span&gt;</code></p><p><code>8589</code><code>:753–762.&lt;/span&gt;</code></p><p><code>8590</code><code> [&lt;a href="/pubmed/15363601" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8591</code><code>PubMed&lt;/a&gt;</code></p><p><code>8592</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8593</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Prog+Neuropsychopharmacol+Biol+Psychiatry&amp;amp;title=Neuropsychopharmacology+and+the+genetics+of+schizophrenia:+a+history+of+the+diagnosis+of+schizophrenia&amp;amp;author=TA+Ban&amp;amp;volume=28&amp;amp;publication_year=2004&amp;amp;pages=753-762&amp;amp;pmid=15363601&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8594</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8595</code><code>]&lt;/span&gt;</code></p><p><code>8596</code><code>&lt;/span&gt;</code></p><p><code>8597</code><code>&lt;/li&gt;</code></p><p><code>8598</code><code>&lt;li id="R41"&gt;</code></p><p><code>8599</code><code>&lt;span class="citation"&gt;</code></p><p><code>8600</code><code>Barann M, Molderings G, Br&amp;#x000fc;ss M, B&amp;#x000f6;nisch H, Urban BW, G&amp;#x000f6;thert M. Direct inhibition by cannabinoids of human 5-HT&lt;sub&gt;</code></p><p><code>8601</code><code>3A&lt;/sub&gt;</code></p><p><code>8602</code><code> receptors: probable involvement of an allosteric modulatory site. &lt;span&gt;</code></p><p><code>8603</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8604</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>8605</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>8606</code><code>137&lt;/span&gt;</code></p><p><code>8607</code><code>:589–596.&lt;/span&gt;</code></p><p><code>8608</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>8609</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1573528/"&gt;</code></p><p><code>8610</code><code>PMC free article&lt;/a&gt;</code></p><p><code>8611</code><code>]&lt;/span&gt;</code></p><p><code>8612</code><code> [&lt;a href="/pubmed/12381672" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8613</code><code>PubMed&lt;/a&gt;</code></p><p><code>8614</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8615</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Direct+inhibition+by+cannabinoids+of+human+5-HT3A+receptors:+probable+involvement+of+an+allosteric+modulatory+site&amp;amp;author=M+Barann&amp;amp;author=G+Molderings&amp;amp;author=M+Br&amp;#x000fc;ss&amp;amp;author=H+B&amp;#x000f6;nisch&amp;amp;author=BW+Urban&amp;amp;volume=137&amp;amp;publication_year=2002&amp;amp;pages=589-596&amp;amp;pmid=12381672&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8616</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8617</code><code>]&lt;/span&gt;</code></p><p><code>8618</code><code>&lt;/span&gt;</code></p><p><code>8619</code><code>&lt;/li&gt;</code></p><p><code>8620</code><code>&lt;li id="R42"&gt;</code></p><p><code>8621</code><code>&lt;span class="citation"&gt;</code></p><p><code>8622</code><code>Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. &lt;span&gt;</code></p><p><code>8623</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8624</code><code>Nat Rev Drug Discov. &lt;/span&gt;</code></p><p><code>8625</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>8626</code><code>3&lt;/span&gt;</code></p><p><code>8627</code><code>:205–214.&lt;/span&gt;</code></p><p><code>8628</code><code> [&lt;a href="/pubmed/15031734" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8629</code><code>PubMed&lt;/a&gt;</code></p><p><code>8630</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8631</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Drug+Discov&amp;amp;title=Neurodegenerative+diseases+and+oxidative+stress&amp;amp;author=KJ+Barnham&amp;amp;author=CL+Masters&amp;amp;author=AI+Bush&amp;amp;volume=3&amp;amp;publication_year=2004&amp;amp;pages=205-214&amp;amp;pmid=15031734&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8632</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8633</code><code>]&lt;/span&gt;</code></p><p><code>8634</code><code>&lt;/span&gt;</code></p><p><code>8635</code><code>&lt;/li&gt;</code></p><p><code>8636</code><code>&lt;li id="R43"&gt;</code></p><p><code>8637</code><code>&lt;span class="citation"&gt;</code></p><p><code>8638</code><code>Bar-Joseph A, Berkovitch Y, Adamchik J, Biegon A. Neuroprotective activity of HU-211, a novel NMDA antagonist, in global ischemia in gerbils. &lt;span&gt;</code></p><p><code>8639</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8640</code><code>Mol Chem Neuropathol. &lt;/span&gt;</code></p><p><code>8641</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>8642</code><code>23&lt;/span&gt;</code></p><p><code>8643</code><code>:125–135.&lt;/span&gt;</code></p><p><code>8644</code><code> [&lt;a href="/pubmed/7702703" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8645</code><code>PubMed&lt;/a&gt;</code></p><p><code>8646</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8647</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Chem+Neuropathol&amp;amp;title=Neuroprotective+activity+of+HU-211,+a+novel+NMDA+antagonist,+in+global+ischemia+in+gerbils&amp;amp;author=A+Bar-Joseph&amp;amp;author=Y+Berkovitch&amp;amp;author=J+Adamchik&amp;amp;author=A+Biegon&amp;amp;volume=23&amp;amp;publication_year=1994&amp;amp;pages=125-135&amp;amp;pmid=7702703&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8648</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8649</code><code>]&lt;/span&gt;</code></p><p><code>8650</code><code>&lt;/span&gt;</code></p><p><code>8651</code><code>&lt;/li&gt;</code></p><p><code>8652</code><code>&lt;li id="R44"&gt;</code></p><p><code>8653</code><code>&lt;span class="citation"&gt;</code></p><p><code>8654</code><code>Barratt ES, Beaver W, White R. The effects of marijuana on human sleep patterns. &lt;span&gt;</code></p><p><code>8655</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8656</code><code>Biol Psychiatry. &lt;/span&gt;</code></p><p><code>8657</code><code>1974;&lt;span class="ref-vol"&gt;</code></p><p><code>8658</code><code>8&lt;/span&gt;</code></p><p><code>8659</code><code>:47–54.&lt;/span&gt;</code></p><p><code>8660</code><code> [&lt;a href="/pubmed/4361028" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8661</code><code>PubMed&lt;/a&gt;</code></p><p><code>8662</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8663</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biol+Psychiatry&amp;amp;title=The+effects+of+marijuana+on+human+sleep+patterns&amp;amp;author=ES+Barratt&amp;amp;author=W+Beaver&amp;amp;author=R+White&amp;amp;volume=8&amp;amp;publication_year=1974&amp;amp;pages=47-54&amp;amp;pmid=4361028&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8664</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8665</code><code>]&lt;/span&gt;</code></p><p><code>8666</code><code>&lt;/span&gt;</code></p><p><code>8667</code><code>&lt;/li&gt;</code></p><p><code>8668</code><code>&lt;li id="R45"&gt;</code></p><p><code>8669</code><code>&lt;span class="citation"&gt;</code></p><p><code>8670</code><code>Barsky SH, Roth MD, Kleerup EC, Simmons M, Tashkin DP. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. &lt;span&gt;</code></p><p><code>8671</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8672</code><code>J Natl Cancer Inst. &lt;/span&gt;</code></p><p><code>8673</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>8674</code><code>90&lt;/span&gt;</code></p><p><code>8675</code><code>:1198–1205.&lt;/span&gt;</code></p><p><code>8676</code><code> [&lt;a href="/pubmed/9719080" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8677</code><code>PubMed&lt;/a&gt;</code></p><p><code>8678</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8679</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;amp;title=Histopathologic+and+molecular+alterations+in+bronchial+epithelium+in+habitual+smokers+of+marijuana,+cocaine,+and/or+tobacco&amp;amp;author=SH+Barsky&amp;amp;author=MD+Roth&amp;amp;author=EC+Kleerup&amp;amp;author=M+Simmons&amp;amp;author=DP+Tashkin&amp;amp;volume=90&amp;amp;publication_year=1998&amp;amp;pages=1198-1205&amp;amp;pmid=9719080&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8680</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8681</code><code>]&lt;/span&gt;</code></p><p><code>8682</code><code>&lt;/span&gt;</code></p><p><code>8683</code><code>&lt;/li&gt;</code></p><p><code>8684</code><code>&lt;li id="R46"&gt;</code></p><p><code>8685</code><code>&lt;span class="citation"&gt;</code></p><p><code>8686</code><code>Basavarajappa BS, Hungund BL. Down-regulation of cannabinoid receptor agonist-stimulated [&lt;sup&gt;</code></p><p><code>8687</code><code>35&lt;/sup&gt;</code></p><p><code>8688</code><code>S]GTP&lt;em&gt;</code></p><p><code>8689</code><code>&amp;#x003b3;&lt;/em&gt;</code></p><p><code>8690</code><code>S binding in synaptic plasma membrane from chronic ethanol exposed mice. &lt;span&gt;</code></p><p><code>8691</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8692</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>8693</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>8694</code><code>815&lt;/span&gt;</code></p><p><code>8695</code><code>:89–97.&lt;/span&gt;</code></p><p><code>8696</code><code> [&lt;a href="/pubmed/9974126" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8697</code><code>PubMed&lt;/a&gt;</code></p><p><code>8698</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8699</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Down-regulation+of+cannabinoid+receptor+agonist-stimulated+[35S]GTP&amp;#x003b3;S+binding+in+synaptic+plasma+membrane+from+chronic+ethanol+exposed+mice&amp;amp;author=BS+Basavarajappa&amp;amp;author=BL+Hungund&amp;amp;volume=815&amp;amp;publication_year=1999&amp;amp;pages=89-97&amp;amp;pmid=9974126&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8700</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8701</code><code>]&lt;/span&gt;</code></p><p><code>8702</code><code>&lt;/span&gt;</code></p><p><code>8703</code><code>&lt;/li&gt;</code></p><p><code>8704</code><code>&lt;li id="R47"&gt;</code></p><p><code>8705</code><code>&lt;span class="citation"&gt;</code></p><p><code>8706</code><code>Basavarajappa BS, Hungund BL. Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview. &lt;span&gt;</code></p><p><code>8707</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8708</code><code>Prostaglandins Leukotrienes Essent Fatty Acids. &lt;/span&gt;</code></p><p><code>8709</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>8710</code><code>66&lt;/span&gt;</code></p><p><code>8711</code><code>:287–299.&lt;/span&gt;</code></p><p><code>8712</code><code> [&lt;a href="/pubmed/12052043" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8713</code><code>PubMed&lt;/a&gt;</code></p><p><code>8714</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8715</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Prostaglandins+Leukotrienes+Essent+Fatty+Acids&amp;amp;title=Neuromodulatory+role+of+the+endocannabinoid+signaling+system+in+alcoholism:+an+overview&amp;amp;author=BS+Basavarajappa&amp;amp;author=BL+Hungund&amp;amp;volume=66&amp;amp;publication_year=2002&amp;amp;pages=287-299&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8716</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8717</code><code>]&lt;/span&gt;</code></p><p><code>8718</code><code>&lt;/span&gt;</code></p><p><code>8719</code><code>&lt;/li&gt;</code></p><p><code>8720</code><code>&lt;li id="R48"&gt;</code></p><p><code>8721</code><code>&lt;span class="citation"&gt;</code></p><p><code>8722</code><code>Basavarajappa BS, Yalamanchili R, Cravatt BF, Cooper TB, Hungund BL. Increased ethanol consumption and preference and decreased sensitivity in female FAAH knockout mice. &lt;span&gt;</code></p><p><code>8723</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8724</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>8725</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>8726</code><code>50&lt;/span&gt;</code></p><p><code>8727</code><code>:834–844.&lt;/span&gt;</code></p><p><code>8728</code><code> [&lt;a href="/pubmed/16448676" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8729</code><code>PubMed&lt;/a&gt;</code></p><p><code>8730</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8731</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=Increased+ethanol+consumption+and+preference+and+decreased+sensitivity+in+female+FAAH+knockout+mice&amp;amp;author=BS+Basavarajappa&amp;amp;author=R+Yalamanchili&amp;amp;author=BF+Cravatt&amp;amp;author=TB+Cooper&amp;amp;author=BL+Hungund&amp;amp;volume=50&amp;amp;publication_year=2006&amp;amp;pages=834-844&amp;amp;pmid=16448676&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8732</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8733</code><code>]&lt;/span&gt;</code></p><p><code>8734</code><code>&lt;/span&gt;</code></p><p><code>8735</code><code>&lt;/li&gt;</code></p><p><code>8736</code><code>&lt;li id="R49"&gt;</code></p><p><code>8737</code><code>&lt;span class="citation"&gt;</code></p><p><code>8738</code><code>Basile AS, Hanus L, Mendelson WB. Characterization of the hypnotic properties of oleamide. &lt;span&gt;</code></p><p><code>8739</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8740</code><code>Neuroreport. &lt;/span&gt;</code></p><p><code>8741</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>8742</code><code>10&lt;/span&gt;</code></p><p><code>8743</code><code>:947–951.&lt;/span&gt;</code></p><p><code>8744</code><code> [&lt;a href="/pubmed/10321465" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8745</code><code>PubMed&lt;/a&gt;</code></p><p><code>8746</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8747</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroreport&amp;amp;title=Characterization+of+the+hypnotic+properties+of+oleamide&amp;amp;author=AS+Basile&amp;amp;author=L+Hanus&amp;amp;author=WB+Mendelson&amp;amp;volume=10&amp;amp;publication_year=1999&amp;amp;pages=947-951&amp;amp;pmid=10321465&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8748</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8749</code><code>]&lt;/span&gt;</code></p><p><code>8750</code><code>&lt;/span&gt;</code></p><p><code>8751</code><code>&lt;/li&gt;</code></p><p><code>8752</code><code>&lt;li id="R50"&gt;</code></p><p><code>8753</code><code>&lt;span class="citation"&gt;</code></p><p><code>8754</code><code>B&amp;#x000e1;tkai S, J&amp;#x000e1;rai Z, Wagner JA, Goparaju SK, Varga K, Liu J, Wang L, Mirshahi F, Khanolkar AD, Makriyannis A, et al.  Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. &lt;span&gt;</code></p><p><code>8755</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8756</code><code>Nat Med. &lt;/span&gt;</code></p><p><code>8757</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>8758</code><code>7&lt;/span&gt;</code></p><p><code>8759</code><code>:827–832.&lt;/span&gt;</code></p><p><code>8760</code><code> [&lt;a href="/pubmed/11433348" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8761</code><code>PubMed&lt;/a&gt;</code></p><p><code>8762</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8763</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;amp;title=Endocannabinoids+acting+at+vascular+CB1+receptors+mediate+the+vasodilated+state+in+advanced+liver+cirrhosis&amp;amp;author=S+B&amp;#x000e1;tkai&amp;amp;author=Z+J&amp;#x000e1;rai&amp;amp;author=JA+Wagner&amp;amp;author=SK+Goparaju&amp;amp;author=K+Varga&amp;amp;volume=7&amp;amp;publication_year=2001&amp;amp;pages=827-832&amp;amp;pmid=11433348&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8764</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8765</code><code>]&lt;/span&gt;</code></p><p><code>8766</code><code>&lt;/span&gt;</code></p><p><code>8767</code><code>&lt;/li&gt;</code></p><p><code>8768</code><code>&lt;li id="R51"&gt;</code></p><p><code>8769</code><code>&lt;span class="citation"&gt;</code></p><p><code>8770</code><code>B&amp;#x000e1;tkai S, Pacher P, J&amp;#x000e1;rai Z, Wagner JA, Kunos G. Cannabinoid antagonist SR141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB&lt;sub&gt;</code></p><p><code>8771</code><code>1&lt;/sub&gt;</code></p><p><code>8772</code><code> or CB&lt;sub&gt;</code></p><p><code>8773</code><code>2&lt;/sub&gt;</code></p><p><code>8774</code><code> receptors. &lt;span&gt;</code></p><p><code>8775</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8776</code><code>Am J Physiol. &lt;/span&gt;</code></p><p><code>8777</code><code>2004a;&lt;span class="ref-vol"&gt;</code></p><p><code>8778</code><code>287&lt;/span&gt;</code></p><p><code>8779</code><code>:H595–H600.&lt;/span&gt;</code></p><p><code>8780</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>8781</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2543126/"&gt;</code></p><p><code>8782</code><code>PMC free article&lt;/a&gt;</code></p><p><code>8783</code><code>]&lt;/span&gt;</code></p><p><code>8784</code><code> [&lt;a href="/pubmed/15059774" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8785</code><code>PubMed&lt;/a&gt;</code></p><p><code>8786</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8787</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol&amp;amp;title=Cannabinoid+antagonist+SR141716+inhibits+endotoxic+hypotension+by+a+cardiac+mechanism+not+involving+CB1+or+CB2+receptors&amp;amp;author=S+B&amp;#x000e1;tkai&amp;amp;author=P+Pacher&amp;amp;author=Z+J&amp;#x000e1;rai&amp;amp;author=JA+Wagner&amp;amp;author=G+Kunos&amp;amp;volume=287&amp;amp;publication_year=2004a&amp;amp;pages=H595-H600&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8788</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8789</code><code>]&lt;/span&gt;</code></p><p><code>8790</code><code>&lt;/span&gt;</code></p><p><code>8791</code><code>&lt;/li&gt;</code></p><p><code>8792</code><code>&lt;li id="R52"&gt;</code></p><p><code>8793</code><code>&lt;span class="citation"&gt;</code></p><p><code>8794</code><code>B&amp;#x000e1;tkai S, Pacher P, Osei-Hyiaman D, Radaeva S, Liu J, Harvey-White J, Offert&amp;#x000e1;ler L, Mackie K, Rudd A, Bukoski RD, et al.  Endocannabinoids acting at CB&lt;sub&gt;</code></p><p><code>8795</code><code>1&lt;/sub&gt;</code></p><p><code>8796</code><code> receptors regulate cardiovascular function in hypertension. &lt;span&gt;</code></p><p><code>8797</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8798</code><code>Circulation. &lt;/span&gt;</code></p><p><code>8799</code><code>2004b;&lt;span class="ref-vol"&gt;</code></p><p><code>8800</code><code>110&lt;/span&gt;</code></p><p><code>8801</code><code>:1996–2002.&lt;/span&gt;</code></p><p><code>8802</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>8803</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2756479/"&gt;</code></p><p><code>8804</code><code>PMC free article&lt;/a&gt;</code></p><p><code>8805</code><code>]&lt;/span&gt;</code></p><p><code>8806</code><code> [&lt;a href="/pubmed/15451779" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8807</code><code>PubMed&lt;/a&gt;</code></p><p><code>8808</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8809</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;amp;title=Endocannabinoids+acting+at+CB1+receptors+regulate+cardiovascular+function+in+hypertension&amp;amp;author=S+B&amp;#x000e1;tkai&amp;amp;author=P+Pacher&amp;amp;author=D+Osei-Hyiaman&amp;amp;author=S+Radaeva&amp;amp;author=J+Liu&amp;amp;volume=110&amp;amp;publication_year=2004b&amp;amp;pages=1996-2002&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8810</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8811</code><code>]&lt;/span&gt;</code></p><p><code>8812</code><code>&lt;/span&gt;</code></p><p><code>8813</code><code>&lt;/li&gt;</code></p><p><code>8814</code><code>&lt;li id="R53"&gt;</code></p><p><code>8815</code><code>&lt;span class="citation"&gt;</code></p><p><code>8816</code><code>Bayir H, Kochanek PM, Clark RS. Traumatic brain injury in infants and children: mechanisms of secondary damage and treatment in the intensive care unit. &lt;span&gt;</code></p><p><code>8817</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8818</code><code>Crit Care Clin. &lt;/span&gt;</code></p><p><code>8819</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>8820</code><code>19&lt;/span&gt;</code></p><p><code>8821</code><code>:529–549.&lt;/span&gt;</code></p><p><code>8822</code><code> [&lt;a href="/pubmed/12848319" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8823</code><code>PubMed&lt;/a&gt;</code></p><p><code>8824</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8825</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Crit+Care+Clin&amp;amp;title=Traumatic+brain+injury+in+infants+and+children:+mechanisms+of+secondary+damage+and+treatment+in+the+intensive+care+unit&amp;amp;author=H+Bayir&amp;amp;author=PM+Kochanek&amp;amp;author=RS+Clark&amp;amp;volume=19&amp;amp;publication_year=2003&amp;amp;pages=529-549&amp;amp;pmid=12848319&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8826</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8827</code><code>]&lt;/span&gt;</code></p><p><code>8828</code><code>&lt;/span&gt;</code></p><p><code>8829</code><code>&lt;/li&gt;</code></p><p><code>8830</code><code>&lt;li id="R54"&gt;</code></p><p><code>8831</code><code>&lt;span class="citation"&gt;</code></p><p><code>8832</code><code>Beal JE, Olson R, Laubenstein L, Morales JO, Bellman P, Yangco B, Lefkowitz L, Plasse TF, Shepard KV. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. &lt;span&gt;</code></p><p><code>8833</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8834</code><code>J Pain Symptom Manage. &lt;/span&gt;</code></p><p><code>8835</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>8836</code><code>10&lt;/span&gt;</code></p><p><code>8837</code><code>:89–97.&lt;/span&gt;</code></p><p><code>8838</code><code> [&lt;a href="/pubmed/7730690" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8839</code><code>PubMed&lt;/a&gt;</code></p><p><code>8840</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8841</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pain+Symptom+Manage&amp;amp;title=Dronabinol+as+a+treatment+for+anorexia+associated+with+weight+loss+in+patients+with+AIDS&amp;amp;author=JE+Beal&amp;amp;author=R+Olson&amp;amp;author=L+Laubenstein&amp;amp;author=JO+Morales&amp;amp;author=P+Bellman&amp;amp;volume=10&amp;amp;publication_year=1995&amp;amp;pages=89-97&amp;amp;pmid=7730690&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8842</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8843</code><code>]&lt;/span&gt;</code></p><p><code>8844</code><code>&lt;/span&gt;</code></p><p><code>8845</code><code>&lt;/li&gt;</code></p><p><code>8846</code><code>&lt;li id="R55"&gt;</code></p><p><code>8847</code><code>&lt;span class="citation"&gt;</code></p><p><code>8848</code><code>Beal JE, Olson R, Lefkowitz L, Laubenstein L, Bellman P, Yangco B, Morales JO, Murphy R, Powderly W, Plasse TF, et al.  Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. &lt;span&gt;</code></p><p><code>8849</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8850</code><code>J Pain Symptom Manage. &lt;/span&gt;</code></p><p><code>8851</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>8852</code><code>14&lt;/span&gt;</code></p><p><code>8853</code><code>:7–14.&lt;/span&gt;</code></p><p><code>8854</code><code> [&lt;a href="/pubmed/9223837" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8855</code><code>PubMed&lt;/a&gt;</code></p><p><code>8856</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8857</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pain+Symptom+Manage&amp;amp;title=Long-term+efficacy+and+safety+of+dronabinol+for+acquired+immunodeficiency+syndrome-associated+anorexia&amp;amp;author=JE+Beal&amp;amp;author=R+Olson&amp;amp;author=L+Lefkowitz&amp;amp;author=L+Laubenstein&amp;amp;author=P+Bellman&amp;amp;volume=14&amp;amp;publication_year=1997&amp;amp;pages=7-14&amp;amp;pmid=9223837&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8858</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8859</code><code>]&lt;/span&gt;</code></p><p><code>8860</code><code>&lt;/span&gt;</code></p><p><code>8861</code><code>&lt;/li&gt;</code></p><p><code>8862</code><code>&lt;li id="R56"&gt;</code></p><p><code>8863</code><code>&lt;span class="citation"&gt;</code></p><p><code>8864</code><code>Begg M, Mo FM, Offertaler L, B&amp;#x000e1;tkai S, Pacher P, Razdan RK, Lovinger DM, Kunos G. G protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca&lt;sup&gt;</code></p><p><code>8865</code><code>2+&lt;/sup&gt;</code></p><p><code>8866</code><code>-dependent K&lt;sup&gt;</code></p><p><code>8867</code><code>+&lt;/sup&gt;</code></p><p><code>8868</code><code> current. &lt;span&gt;</code></p><p><code>8869</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8870</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>8871</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>8872</code><code>278&lt;/span&gt;</code></p><p><code>8873</code><code>:46188–46194.&lt;/span&gt;</code></p><p><code>8874</code><code> [&lt;a href="/pubmed/12952947" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8875</code><code>PubMed&lt;/a&gt;</code></p><p><code>8876</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8877</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=G+protein-coupled+endothelial+receptor+for+atypical+cannabinoid+ligands+modulates+a+Ca2+-dependent+K++current&amp;amp;author=M+Begg&amp;amp;author=FM+Mo&amp;amp;author=L+Offertaler&amp;amp;author=S+B&amp;#x000e1;tkai&amp;amp;author=P+Pacher&amp;amp;volume=278&amp;amp;publication_year=2003&amp;amp;pages=46188-46194&amp;amp;pmid=12952947&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8878</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8879</code><code>]&lt;/span&gt;</code></p><p><code>8880</code><code>&lt;/span&gt;</code></p><p><code>8881</code><code>&lt;/li&gt;</code></p><p><code>8882</code><code>&lt;li id="R57"&gt;</code></p><p><code>8883</code><code>&lt;span class="citation"&gt;</code></p><p><code>8884</code><code>Begg M, Pacher P, B&amp;#x000e1;tkai S, Osei-Hyiaman D, Offert&amp;#x000e1;ler L, Mo F-M, Liu J, Kunos G. Evidence for novel cannabinoid receptors. &lt;span&gt;</code></p><p><code>8885</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8886</code><code>Pharmacol Ther. &lt;/span&gt;</code></p><p><code>8887</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>8888</code><code>106&lt;/span&gt;</code></p><p><code>8889</code><code>:133–145.&lt;/span&gt;</code></p><p><code>8890</code><code> [&lt;a href="/pubmed/15866316" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8891</code><code>PubMed&lt;/a&gt;</code></p><p><code>8892</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8893</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Ther&amp;amp;title=Evidence+for+novel+cannabinoid+receptors&amp;amp;author=M+Begg&amp;amp;author=P+Pacher&amp;amp;author=S+B&amp;#x000e1;tkai&amp;amp;author=D+Osei-Hyiaman&amp;amp;author=L+Offert&amp;#x000e1;ler&amp;amp;volume=106&amp;amp;publication_year=2005&amp;amp;pages=133-145&amp;amp;pmid=15866316&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8894</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8895</code><code>]&lt;/span&gt;</code></p><p><code>8896</code><code>&lt;/span&gt;</code></p><p><code>8897</code><code>&lt;/li&gt;</code></p><p><code>8898</code><code>&lt;li id="R58"&gt;</code></p><p><code>8899</code><code>&lt;span class="citation"&gt;</code></p><p><code>8900</code><code>Behrens PF, Franz P, Woodman B, Lindenberg KS, Landwehrmeyer GB. Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. &lt;span&gt;</code></p><p><code>8901</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8902</code><code>Brain. &lt;/span&gt;</code></p><p><code>8903</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>8904</code><code>125&lt;/span&gt;</code></p><p><code>8905</code><code>:1908–1922.&lt;/span&gt;</code></p><p><code>8906</code><code> [&lt;a href="/pubmed/12135980" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8907</code><code>PubMed&lt;/a&gt;</code></p><p><code>8908</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8909</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;amp;title=Impaired+glutamate+transport+and+glutamate-glutamine+cycling:+downstream+effects+of+the+Huntington+mutation&amp;amp;author=PF+Behrens&amp;amp;author=P+Franz&amp;amp;author=B+Woodman&amp;amp;author=KS+Lindenberg&amp;amp;author=GB+Landwehrmeyer&amp;amp;volume=125&amp;amp;publication_year=2002&amp;amp;pages=1908-1922&amp;amp;pmid=12135980&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8910</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8911</code><code>]&lt;/span&gt;</code></p><p><code>8912</code><code>&lt;/span&gt;</code></p><p><code>8913</code><code>&lt;/li&gt;</code></p><p><code>8914</code><code>&lt;li id="R59"&gt;</code></p><p><code>8915</code><code>&lt;span class="citation"&gt;</code></p><p><code>8916</code><code>Beinfeld MC, Connolly K. Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids. &lt;span&gt;</code></p><p><code>8917</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8918</code><code>Neurosci Lett. &lt;/span&gt;</code></p><p><code>8919</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>8920</code><code>301&lt;/span&gt;</code></p><p><code>8921</code><code>:69–71.&lt;/span&gt;</code></p><p><code>8922</code><code> [&lt;a href="/pubmed/11239718" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8923</code><code>PubMed&lt;/a&gt;</code></p><p><code>8924</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8925</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Lett&amp;amp;title=Activation+of+CB1+cannabinoid+receptors+in+rat+hippocampal+slices+inhibits+potassium-evoked+cholecystokinin+release,+a+possible+mechanism+contributing+to+the+spatial+memory+defects+produced+by+cannabinoids&amp;amp;author=MC+Beinfeld&amp;amp;author=K+Connolly&amp;amp;volume=301&amp;amp;publication_year=2001&amp;amp;pages=69-71&amp;amp;pmid=11239718&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8926</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8927</code><code>]&lt;/span&gt;</code></p><p><code>8928</code><code>&lt;/span&gt;</code></p><p><code>8929</code><code>&lt;/li&gt;</code></p><p><code>8930</code><code>&lt;li id="R60"&gt;</code></p><p><code>8931</code><code>&lt;span class="citation"&gt;</code></p><p><code>8932</code><code>Belayev L, Bar-Joseph A, Adamchik J, Biegon A. HU-211, a nonpsychotropic cannabinoid, improves neurological signs and reduces brain damage after severe forebrain ischemia in rats. &lt;span&gt;</code></p><p><code>8933</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8934</code><code>Mol Chem Neuropathol. &lt;/span&gt;</code></p><p><code>8935</code><code>1995a;&lt;span class="ref-vol"&gt;</code></p><p><code>8936</code><code>25&lt;/span&gt;</code></p><p><code>8937</code><code>:19–33.&lt;/span&gt;</code></p><p><code>8938</code><code> [&lt;a href="/pubmed/7546016" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8939</code><code>PubMed&lt;/a&gt;</code></p><p><code>8940</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8941</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Chem+Neuropathol&amp;amp;title=HU-211,+a+nonpsychotropic+cannabinoid,+improves+neurological+signs+and+reduces+brain+damage+after+severe+forebrain+ischemia+in+rats&amp;amp;author=L+Belayev&amp;amp;author=A+Bar-Joseph&amp;amp;author=J+Adamchik&amp;amp;author=A+Biegon&amp;amp;volume=25&amp;amp;publication_year=1995a&amp;amp;pages=19-33&amp;amp;pmid=7546016&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8942</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8943</code><code>]&lt;/span&gt;</code></p><p><code>8944</code><code>&lt;/span&gt;</code></p><p><code>8945</code><code>&lt;/li&gt;</code></p><p><code>8946</code><code>&lt;li id="R61"&gt;</code></p><p><code>8947</code><code>&lt;span class="citation"&gt;</code></p><p><code>8948</code><code>Belayev L, Busto R, Watson BD, Ginsberg MD. Post-ischemic administration of HU-211, a novel non-competitive NMDA antagonist, protects against blood-brain barrier disruption in photochemical cortical infarction in rats: a quantitative study. &lt;span&gt;</code></p><p><code>8949</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8950</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>8951</code><code>1995b;&lt;span class="ref-vol"&gt;</code></p><p><code>8952</code><code>702&lt;/span&gt;</code></p><p><code>8953</code><code>:266–270.&lt;/span&gt;</code></p><p><code>8954</code><code> [&lt;a href="/pubmed/8846087" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8955</code><code>PubMed&lt;/a&gt;</code></p><p><code>8956</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8957</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Post-ischemic+administration+of+HU-211,+a+novel+non-competitive+NMDA+antagonist,+protects+against+blood-brain+barrier+disruption+in+photochemical+cortical+infarction+in+rats:+a+quantitative+study&amp;amp;author=L+Belayev&amp;amp;author=R+Busto&amp;amp;author=BD+Watson&amp;amp;author=MD+Ginsberg&amp;amp;volume=702&amp;amp;publication_year=1995b&amp;amp;pages=266-270&amp;amp;pmid=8846087&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8958</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8959</code><code>]&lt;/span&gt;</code></p><p><code>8960</code><code>&lt;/span&gt;</code></p><p><code>8961</code><code>&lt;/li&gt;</code></p><p><code>8962</code><code>&lt;li id="R62"&gt;</code></p><p><code>8963</code><code>&lt;span class="citation"&gt;</code></p><p><code>8964</code><code>Belayev L, Busto R, Zhao W, Ginsberg MD. HU-211, a novel noncompetitive &lt;em&gt;</code></p><p><code>8965</code><code>N-&lt;/em&gt;</code></p><p><code>8966</code><code>methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat. &lt;span&gt;</code></p><p><code>8967</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8968</code><code>Stroke. &lt;/span&gt;</code></p><p><code>8969</code><code>1995c;&lt;span class="ref-vol"&gt;</code></p><p><code>8970</code><code>26&lt;/span&gt;</code></p><p><code>8971</code><code>:2313–2320.&lt;/span&gt;</code></p><p><code>8972</code><code> [&lt;a href="/pubmed/7491657" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8973</code><code>PubMed&lt;/a&gt;</code></p><p><code>8974</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8975</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Stroke&amp;amp;title=HU-211,+a+novel+noncompetitive+N-methyl-D-aspartate+antagonist,+improves+neurological+deficit+and+reduces+infarct+volume+after+reversible+focal+cerebral+ischemia+in+the+rat&amp;amp;author=L+Belayev&amp;amp;author=R+Busto&amp;amp;author=W+Zhao&amp;amp;author=MD+Ginsberg&amp;amp;volume=26&amp;amp;publication_year=1995c&amp;amp;pages=2313-2320&amp;amp;pmid=7491657&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8976</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8977</code><code>]&lt;/span&gt;</code></p><p><code>8978</code><code>&lt;/span&gt;</code></p><p><code>8979</code><code>&lt;/li&gt;</code></p><p><code>8980</code><code>&lt;li id="R63"&gt;</code></p><p><code>8981</code><code>&lt;span class="citation"&gt;</code></p><p><code>8982</code><code>Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. &lt;span&gt;</code></p><p><code>8983</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>8984</code><code>Science (Wash DC) &lt;/span&gt;</code></p><p><code>8985</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>8986</code><code>277&lt;/span&gt;</code></p><p><code>8987</code><code>:1094–1097.&lt;/span&gt;</code></p><p><code>8988</code><code> [&lt;a href="/pubmed/9262477" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>8989</code><code>PubMed&lt;/a&gt;</code></p><p><code>8990</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>8991</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Science+(Wash+DC)&amp;amp;title=Functional+role+of+high-affinity+anandamide+transport,+as+revealed+by+selective+inhibition&amp;amp;author=M+Beltramo&amp;amp;author=N+Stella&amp;amp;author=A+Calignano&amp;amp;author=SY+Lin&amp;amp;author=A+Makriyannis&amp;amp;volume=277&amp;amp;publication_year=1997&amp;amp;pages=1094-1097&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>8992</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>8993</code><code>]&lt;/span&gt;</code></p><p><code>8994</code><code>&lt;/span&gt;</code></p><p><code>8995</code><code>&lt;/li&gt;</code></p><p><code>8996</code><code>&lt;li id="R64"&gt;</code></p><p><code>8997</code><code>&lt;span class="citation"&gt;</code></p><p><code>8998</code><code>Benito C, Nunez E, Tolon RM, Carrier EJ, Rabano A, Hillard CJ, Romero J. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer&amp;#x02019;s disease brains. &lt;span&gt;</code></p><p><code>8999</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9000</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>9001</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>9002</code><code>23&lt;/span&gt;</code></p><p><code>9003</code><code>:11136–11141.&lt;/span&gt;</code></p><p><code>9004</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>9005</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6741043/"&gt;</code></p><p><code>9006</code><code>PMC free article&lt;/a&gt;</code></p><p><code>9007</code><code>]&lt;/span&gt;</code></p><p><code>9008</code><code> [&lt;a href="/pubmed/14657172" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9009</code><code>PubMed&lt;/a&gt;</code></p><p><code>9010</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9011</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Cannabinoid+CB2+receptors+and+fatty+acid+amide+hydrolase+are+selectively+overexpressed+in+neuritic+plaque-associated+glia+in+Alzheimer&amp;#x02019;s+disease+brains&amp;amp;author=C+Benito&amp;amp;author=E+Nunez&amp;amp;author=RM+Tolon&amp;amp;author=EJ+Carrier&amp;amp;author=A+Rabano&amp;amp;volume=23&amp;amp;publication_year=2003&amp;amp;pages=11136-11141&amp;amp;pmid=14657172&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9012</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9013</code><code>]&lt;/span&gt;</code></p><p><code>9014</code><code>&lt;/span&gt;</code></p><p><code>9015</code><code>&lt;/li&gt;</code></p><p><code>9016</code><code>&lt;li id="R65"&gt;</code></p><p><code>9017</code><code>&lt;span class="citation"&gt;</code></p><p><code>9018</code><code>Benowitz NL, Jones RT. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. &lt;span&gt;</code></p><p><code>9019</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9020</code><code>Clin Pharmacol Ther. &lt;/span&gt;</code></p><p><code>9021</code><code>1975;&lt;span class="ref-vol"&gt;</code></p><p><code>9022</code><code>18&lt;/span&gt;</code></p><p><code>9023</code><code>:287–297.&lt;/span&gt;</code></p><p><code>9024</code><code> [&lt;a href="/pubmed/1164818" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9025</code><code>PubMed&lt;/a&gt;</code></p><p><code>9026</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9027</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;amp;title=Cardiovascular+effects+of+prolonged+delta-9-tetrahydrocannabinol+ingestion&amp;amp;author=NL+Benowitz&amp;amp;author=RT+Jones&amp;amp;volume=18&amp;amp;publication_year=1975&amp;amp;pages=287-297&amp;amp;pmid=1164818&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9028</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9029</code><code>]&lt;/span&gt;</code></p><p><code>9030</code><code>&lt;/span&gt;</code></p><p><code>9031</code><code>&lt;/li&gt;</code></p><p><code>9032</code><code>&lt;li id="R66"&gt;</code></p><p><code>9033</code><code>&lt;span class="citation"&gt;</code></p><p><code>9034</code><code>Ben-Shabat S, Fride E, Sheskin T, Tamiri T, Rhee MH, Vogel Z, Bisogno T, De Petrocellis L, Di Marzo V, Mechoulam R. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. &lt;span&gt;</code></p><p><code>9035</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9036</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>9037</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>9038</code><code>353&lt;/span&gt;</code></p><p><code>9039</code><code>:23–31.&lt;/span&gt;</code></p><p><code>9040</code><code> [&lt;a href="/pubmed/9721036" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9041</code><code>PubMed&lt;/a&gt;</code></p><p><code>9042</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9043</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=An+entourage+effect:+inactive+endogenous+fatty+acid+glycerol+esters+enhance+2-arachidonoyl-glycerol+cannabinoid+activity&amp;amp;author=S+Ben-Shabat&amp;amp;author=E+Fride&amp;amp;author=T+Sheskin&amp;amp;author=T+Tamiri&amp;amp;author=MH+Rhee&amp;amp;volume=353&amp;amp;publication_year=1998&amp;amp;pages=23-31&amp;amp;pmid=9721036&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9044</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9045</code><code>]&lt;/span&gt;</code></p><p><code>9046</code><code>&lt;/span&gt;</code></p><p><code>9047</code><code>&lt;/li&gt;</code></p><p><code>9048</code><code>&lt;li id="R67"&gt;</code></p><p><code>9049</code><code>&lt;span class="citation"&gt;</code></p><p><code>9050</code><code>Bensaid M, Gary-Bobo M, Esclangon A, Maffrand JP, Le Fur G, Oury-Donat F, Soubrie P. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese &lt;em&gt;</code></p><p><code>9051</code><code>fa/fa&lt;/em&gt;</code></p><p><code>9052</code><code> rats and in cultured adipocyte cells. &lt;span&gt;</code></p><p><code>9053</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9054</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>9055</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>9056</code><code>63&lt;/span&gt;</code></p><p><code>9057</code><code>:908–914.&lt;/span&gt;</code></p><p><code>9058</code><code> [&lt;a href="/pubmed/12644592" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9059</code><code>PubMed&lt;/a&gt;</code></p><p><code>9060</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9061</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=The+cannabinoid+CB1+receptor+antagonist+SR141716+increases+Acrp30+mRNA+expression+in+adipose+tissue+of+obese+fa/fa+rats+and+in+cultured+adipocyte+cells&amp;amp;author=M+Bensaid&amp;amp;author=M+Gary-Bobo&amp;amp;author=A+Esclangon&amp;amp;author=JP+Maffrand&amp;amp;author=G+Le+Fur&amp;amp;volume=63&amp;amp;publication_year=2003&amp;amp;pages=908-914&amp;amp;pmid=12644592&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9062</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9063</code><code>]&lt;/span&gt;</code></p><p><code>9064</code><code>&lt;/span&gt;</code></p><p><code>9065</code><code>&lt;/li&gt;</code></p><p><code>9066</code><code>&lt;li id="R68"&gt;</code></p><p><code>9067</code><code>&lt;span class="citation"&gt;</code></p><p><code>9068</code><code>Berdyshev E, Boichot E, Corbel M, Germain N, Lagente V. Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice. &lt;span&gt;</code></p><p><code>9069</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9070</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>9071</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>9072</code><code>63&lt;/span&gt;</code></p><p><code>9073</code><code>:PL125–PL129.&lt;/span&gt;</code></p><p><code>9074</code><code> [&lt;a href="/pubmed/9718090" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9075</code><code>PubMed&lt;/a&gt;</code></p><p><code>9076</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9077</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Effects+of+cannabinoid+receptor+ligands+on+LPS-induced+pulmonary+inflammation+in+mice&amp;amp;author=E+Berdyshev&amp;amp;author=E+Boichot&amp;amp;author=M+Corbel&amp;amp;author=N+Germain&amp;amp;author=V+Lagente&amp;amp;volume=63&amp;amp;publication_year=1998&amp;amp;pages=PL125-PL129&amp;amp;pmid=9718090&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9078</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9079</code><code>]&lt;/span&gt;</code></p><p><code>9080</code><code>&lt;/span&gt;</code></p><p><code>9081</code><code>&lt;/li&gt;</code></p><p><code>9082</code><code>&lt;li id="R69"&gt;</code></p><p><code>9083</code><code>&lt;span class="citation"&gt;</code></p><p><code>9084</code><code>Berger C, Schmid PC, Schabitz WR, Wolf M, Schwab S, Schmid HH. Massive accumulation of &lt;em&gt;</code></p><p><code>9085</code><code>N-&lt;/em&gt;</code></p><p><code>9086</code><code>acylethanolamines after stroke: cell signalling in acute cerebral ischemia? &lt;span&gt;</code></p><p><code>9087</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9088</code><code>J Neurochem. &lt;/span&gt;</code></p><p><code>9089</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>9090</code><code>88&lt;/span&gt;</code></p><p><code>9091</code><code>:1159–1167.&lt;/span&gt;</code></p><p><code>9092</code><code> [&lt;a href="/pubmed/15009671" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9093</code><code>PubMed&lt;/a&gt;</code></p><p><code>9094</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9095</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;amp;title=Massive+accumulation+of+N-acylethanolamines+after+stroke:+cell+signalling+in+acute+cerebral+ischemia?&amp;amp;author=C+Berger&amp;amp;author=PC+Schmid&amp;amp;author=WR+Schabitz&amp;amp;author=M+Wolf&amp;amp;author=S+Schwab&amp;amp;volume=88&amp;amp;publication_year=2004&amp;amp;pages=1159-1167&amp;amp;pmid=15009671&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9096</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9097</code><code>]&lt;/span&gt;</code></p><p><code>9098</code><code>&lt;/span&gt;</code></p><p><code>9099</code><code>&lt;/li&gt;</code></p><p><code>9100</code><code>&lt;li id="R70"&gt;</code></p><p><code>9101</code><code>&lt;span class="citation"&gt;</code></p><p><code>9102</code><code>Berghuis P, Dobszay MB, Wang X, Spano S, Ledda F, Sousa KM, Schulte G, Ernfors P, Mackie K, Paratcha G, et al.  Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. &lt;span&gt;</code></p><p><code>9103</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9104</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>9105</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>9106</code><code>102&lt;/span&gt;</code></p><p><code>9107</code><code>:19115–19120.&lt;/span&gt;</code></p><p><code>9108</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>9109</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1323195/"&gt;</code></p><p><code>9110</code><code>PMC free article&lt;/a&gt;</code></p><p><code>9111</code><code>]&lt;/span&gt;</code></p><p><code>9112</code><code> [&lt;a href="/pubmed/16357196" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9113</code><code>PubMed&lt;/a&gt;</code></p><p><code>9114</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9115</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Endocannabinoids+regulate+interneuron+migration+and+morphogenesis+by+transactivating+the+TrkB+receptor&amp;amp;author=P+Berghuis&amp;amp;author=MB+Dobszay&amp;amp;author=X+Wang&amp;amp;author=S+Spano&amp;amp;author=F+Ledda&amp;amp;volume=102&amp;amp;publication_year=2005&amp;amp;pages=19115-19120&amp;amp;pmid=16357196&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9116</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9117</code><code>]&lt;/span&gt;</code></p><p><code>9118</code><code>&lt;/span&gt;</code></p><p><code>9119</code><code>&lt;/li&gt;</code></p><p><code>9120</code><code>&lt;li id="R71"&gt;</code></p><p><code>9121</code><code>&lt;span class="citation"&gt;</code></p><p><code>9122</code><code>Berlach DM, Shir Y, Ware MA. Experience with the synthetic cannabinoid nabilone in chronic noncancer pain. &lt;span&gt;</code></p><p><code>9123</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9124</code><code>Pain Med. &lt;/span&gt;</code></p><p><code>9125</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>9126</code><code>7&lt;/span&gt;</code></p><p><code>9127</code><code>:25–29.&lt;/span&gt;</code></p><p><code>9128</code><code> [&lt;a href="/pubmed/16533193" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9129</code><code>PubMed&lt;/a&gt;</code></p><p><code>9130</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9131</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pain+Med&amp;amp;title=Experience+with+the+synthetic+cannabinoid+nabilone+in+chronic+noncancer+pain&amp;amp;author=DM+Berlach&amp;amp;author=Y+Shir&amp;amp;author=MA+Ware&amp;amp;volume=7&amp;amp;publication_year=2006&amp;amp;pages=25-29&amp;amp;pmid=16533193&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9132</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9133</code><code>]&lt;/span&gt;</code></p><p><code>9134</code><code>&lt;/span&gt;</code></p><p><code>9135</code><code>&lt;/li&gt;</code></p><p><code>9136</code><code>&lt;li id="R72"&gt;</code></p><p><code>9137</code><code>&lt;span class="citation"&gt;</code></p><p><code>9138</code><code>Berman JS, Symonds C, Birch R. Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial. &lt;span&gt;</code></p><p><code>9139</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9140</code><code>Pain. &lt;/span&gt;</code></p><p><code>9141</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>9142</code><code>112&lt;/span&gt;</code></p><p><code>9143</code><code>:299–306.&lt;/span&gt;</code></p><p><code>9144</code><code> [&lt;a href="/pubmed/15561385" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9145</code><code>PubMed&lt;/a&gt;</code></p><p><code>9146</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9147</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;amp;title=Efficacy+of+two+cannabis+based+medicinal+extracts+for+relief+of+central+neuropathic+pain+from+brachial+plexus+avulsion:+results+of+a+randomised+controlled+trial&amp;amp;author=JS+Berman&amp;amp;author=C+Symonds&amp;amp;author=R+Birch&amp;amp;volume=112&amp;amp;publication_year=2004&amp;amp;pages=299-306&amp;amp;pmid=15561385&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9148</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9149</code><code>]&lt;/span&gt;</code></p><p><code>9150</code><code>&lt;/span&gt;</code></p><p><code>9151</code><code>&lt;/li&gt;</code></p><p><code>9152</code><code>&lt;li id="R73"&gt;</code></p><p><code>9153</code><code>&lt;span class="citation"&gt;</code></p><p><code>9154</code><code>Berrendero F, Maldonado R. Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol.&amp;#x00394;&lt;sup&gt;</code></p><p><code>9155</code><code>9&lt;/sup&gt;</code></p><p><code>9156</code><code>-tetrahydrocannabinol. &lt;span&gt;</code></p><p><code>9157</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9158</code><code>Psychopharmacology (Berl) &lt;/span&gt;</code></p><p><code>9159</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>9160</code><code>163&lt;/span&gt;</code></p><p><code>9161</code><code>:111–117.&lt;/span&gt;</code></p><p><code>9162</code><code> [&lt;a href="/pubmed/12185408" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9163</code><code>PubMed&lt;/a&gt;</code></p><p><code>9164</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9165</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology+(Berl)&amp;amp;title=Involvement+of+the+opioid+system+in+the+anxiolytic-like+effects+induced+by+Delta(9)-tetrahydrocannabinol.&amp;#x00394;9-tetrahydrocannabinol&amp;amp;author=F+Berrendero&amp;amp;author=R+Maldonado&amp;amp;volume=163&amp;amp;publication_year=2002&amp;amp;pages=111-117&amp;amp;pmid=12185408&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9166</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9167</code><code>]&lt;/span&gt;</code></p><p><code>9168</code><code>&lt;/span&gt;</code></p><p><code>9169</code><code>&lt;/li&gt;</code></p><p><code>9170</code><code>&lt;li id="R74"&gt;</code></p><p><code>9171</code><code>&lt;span class="citation"&gt;</code></p><p><code>9172</code><code>Berrendero F, Sanchez A, Cabranes A, Puerta C, Ramos JA, Garcia-Merino A, Fernandez-Ruiz J. Changes in cannabinoid CB&lt;sub&gt;</code></p><p><code>9173</code><code>1&lt;/sub&gt;</code></p><p><code>9174</code><code> receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis. &lt;span&gt;</code></p><p><code>9175</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9176</code><code>Synapse. &lt;/span&gt;</code></p><p><code>9177</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>9178</code><code>41&lt;/span&gt;</code></p><p><code>9179</code><code>:195–202.&lt;/span&gt;</code></p><p><code>9180</code><code> [&lt;a href="/pubmed/11391780" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9181</code><code>PubMed&lt;/a&gt;</code></p><p><code>9182</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9183</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Synapse&amp;amp;title=Changes+in+cannabinoid+CB1+receptors+in+striatal+and+cortical+regions+of+rats+with+experimental+allergic+encephalomyelitis,+an+animal+model+of+multiple+sclerosis&amp;amp;author=F+Berrendero&amp;amp;author=A+Sanchez&amp;amp;author=A+Cabranes&amp;amp;author=C+Puerta&amp;amp;author=JA+Ramos&amp;amp;volume=41&amp;amp;publication_year=2001&amp;amp;pages=195-202&amp;amp;pmid=11391780&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9184</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9185</code><code>]&lt;/span&gt;</code></p><p><code>9186</code><code>&lt;/span&gt;</code></p><p><code>9187</code><code>&lt;/li&gt;</code></p><p><code>9188</code><code>&lt;li id="R75"&gt;</code></p><p><code>9189</code><code>&lt;span class="citation"&gt;</code></p><p><code>9190</code><code>Berry EM, Mechoulam R. Tetrahydrocannabinol and endocannabinoids in feeding and appetite. &lt;span&gt;</code></p><p><code>9191</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9192</code><code>Pharmacol Ther. &lt;/span&gt;</code></p><p><code>9193</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>9194</code><code>95&lt;/span&gt;</code></p><p><code>9195</code><code>:185–190.&lt;/span&gt;</code></p><p><code>9196</code><code> [&lt;a href="/pubmed/12182965" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9197</code><code>PubMed&lt;/a&gt;</code></p><p><code>9198</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9199</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Ther&amp;amp;title=Tetrahydrocannabinol+and+endocannabinoids+in+feeding+and+appetite&amp;amp;author=EM+Berry&amp;amp;author=R+Mechoulam&amp;amp;volume=95&amp;amp;publication_year=2002&amp;amp;pages=185-190&amp;amp;pmid=12182965&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9200</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9201</code><code>]&lt;/span&gt;</code></p><p><code>9202</code><code>&lt;/span&gt;</code></p><p><code>9203</code><code>&lt;/li&gt;</code></p><p><code>9204</code><code>&lt;li id="R76"&gt;</code></p><p><code>9205</code><code>&lt;span class="citation"&gt;</code></p><p><code>9206</code><code>Bezard E, Brotchie JM, Gross CE. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. &lt;span&gt;</code></p><p><code>9207</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9208</code><code>Nat Rev Neurosci. &lt;/span&gt;</code></p><p><code>9209</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>9210</code><code>2&lt;/span&gt;</code></p><p><code>9211</code><code>:577–588.&lt;/span&gt;</code></p><p><code>9212</code><code> [&lt;a href="/pubmed/11484001" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9213</code><code>PubMed&lt;/a&gt;</code></p><p><code>9214</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9215</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Neurosci&amp;amp;title=Pathophysiology+of+levodopa-induced+dyskinesia:+potential+for+new+therapies&amp;amp;author=E+Bezard&amp;amp;author=JM+Brotchie&amp;amp;author=CE+Gross&amp;amp;volume=2&amp;amp;publication_year=2001&amp;amp;pages=577-588&amp;amp;pmid=11484001&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9216</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9217</code><code>]&lt;/span&gt;</code></p><p><code>9218</code><code>&lt;/span&gt;</code></p><p><code>9219</code><code>&lt;/li&gt;</code></p><p><code>9220</code><code>&lt;li id="R77"&gt;</code></p><p><code>9221</code><code>&lt;span class="citation"&gt;</code></p><p><code>9222</code><code>Bhatia S, Louie AD, Bhatia R, O&amp;#x02019;Donnell MR, Fung H, Kashyap A, Krishnan A, Molina A, Nademanee A, Niland JC, et al.  Solid cancers after bone marrow transplantation. &lt;span&gt;</code></p><p><code>9223</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9224</code><code>J Clin Oncol. &lt;/span&gt;</code></p><p><code>9225</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>9226</code><code>19&lt;/span&gt;</code></p><p><code>9227</code><code>:464–471.&lt;/span&gt;</code></p><p><code>9228</code><code> [&lt;a href="/pubmed/11208840" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9229</code><code>PubMed&lt;/a&gt;</code></p><p><code>9230</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9231</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;amp;title=Solid+cancers+after+bone+marrow+transplantation&amp;amp;author=S+Bhatia&amp;amp;author=AD+Louie&amp;amp;author=R+Bhatia&amp;amp;author=MR+O&amp;#x02019;Donnell&amp;amp;author=H+Fung&amp;amp;volume=19&amp;amp;publication_year=2001&amp;amp;pages=464-471&amp;amp;pmid=11208840&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9232</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9233</code><code>]&lt;/span&gt;</code></p><p><code>9234</code><code>&lt;/span&gt;</code></p><p><code>9235</code><code>&lt;/li&gt;</code></p><p><code>9236</code><code>&lt;li id="R78"&gt;</code></p><p><code>9237</code><code>&lt;span class="citation"&gt;</code></p><p><code>9238</code><code>Biber B, Schaefer CF, Smolik MJ, Lerner MR, Brackett DJ, Wilson MF, Fagraeus L. Improved techniques for cardiovascular monitoring in rats as applied during endotoxemia. &lt;span&gt;</code></p><p><code>9239</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9240</code><code>Am J Physiol. &lt;/span&gt;</code></p><p><code>9241</code><code>1988;&lt;span class="ref-vol"&gt;</code></p><p><code>9242</code><code>254&lt;/span&gt;</code></p><p><code>9243</code><code>:H181–H186.&lt;/span&gt;</code></p><p><code>9244</code><code> [&lt;a href="/pubmed/3337254" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9245</code><code>PubMed&lt;/a&gt;</code></p><p><code>9246</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9247</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol&amp;amp;title=Improved+techniques+for+cardiovascular+monitoring+in+rats+as+applied+during+endotoxemia&amp;amp;author=B+Biber&amp;amp;author=CF+Schaefer&amp;amp;author=MJ+Smolik&amp;amp;author=MR+Lerner&amp;amp;author=DJ+Brackett&amp;amp;volume=254&amp;amp;publication_year=1988&amp;amp;pages=H181-H186&amp;amp;pmid=3337254&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9248</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9249</code><code>]&lt;/span&gt;</code></p><p><code>9250</code><code>&lt;/span&gt;</code></p><p><code>9251</code><code>&lt;/li&gt;</code></p><p><code>9252</code><code>&lt;li id="R79"&gt;</code></p><p><code>9253</code><code>&lt;span class="citation"&gt;</code></p><p><code>9254</code><code>Biddinger SB, Almind K, Miyazaki M, Kokkotou E, Ntambi JM, Kahn CR. Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome. &lt;span&gt;</code></p><p><code>9255</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9256</code><code>Diabetes. &lt;/span&gt;</code></p><p><code>9257</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>9258</code><code>54&lt;/span&gt;</code></p><p><code>9259</code><code>:1314–1323.&lt;/span&gt;</code></p><p><code>9260</code><code> [&lt;a href="/pubmed/15855315" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9261</code><code>PubMed&lt;/a&gt;</code></p><p><code>9262</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9263</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;amp;title=Effects+of+diet+and+genetic+background+on+sterol+regulatory+element-binding+protein-1c,+stearoyl-CoA+desaturase+1,+and+the+development+of+the+metabolic+syndrome&amp;amp;author=SB+Biddinger&amp;amp;author=K+Almind&amp;amp;author=M+Miyazaki&amp;amp;author=E+Kokkotou&amp;amp;author=JM+Ntambi&amp;amp;volume=54&amp;amp;publication_year=2005&amp;amp;pages=1314-1323&amp;amp;pmid=15855315&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9264</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9265</code><code>]&lt;/span&gt;</code></p><p><code>9266</code><code>&lt;/span&gt;</code></p><p><code>9267</code><code>&lt;/li&gt;</code></p><p><code>9268</code><code>&lt;li id="R80"&gt;</code></p><p><code>9269</code><code>&lt;span class="citation"&gt;</code></p><p><code>9270</code><code>Bidinger B, Torres R, Rossetti RG, Brown L, Beltre R, Burstein S, Lian JB, Stein GS, Zurier RB. Ajulemic acid, a nonpsychoactive cannabinoid acid, induces apoptosis in human T lymphocytes. &lt;span&gt;</code></p><p><code>9271</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9272</code><code>Clin Immunol. &lt;/span&gt;</code></p><p><code>9273</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>9274</code><code>108&lt;/span&gt;</code></p><p><code>9275</code><code>:95–102.&lt;/span&gt;</code></p><p><code>9276</code><code> [&lt;a href="/pubmed/12921755" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9277</code><code>PubMed&lt;/a&gt;</code></p><p><code>9278</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9279</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Clin+Immunol&amp;amp;title=Ajulemic+acid,+a+nonpsychoactive+cannabinoid+acid,+induces+apoptosis+in+human+T+lymphocytes&amp;amp;author=B+Bidinger&amp;amp;author=R+Torres&amp;amp;author=RG+Rossetti&amp;amp;author=L+Brown&amp;amp;author=R+Beltre&amp;amp;volume=108&amp;amp;publication_year=2003&amp;amp;pages=95-102&amp;amp;pmid=12921755&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9280</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9281</code><code>]&lt;/span&gt;</code></p><p><code>9282</code><code>&lt;/span&gt;</code></p><p><code>9283</code><code>&lt;/li&gt;</code></p><p><code>9284</code><code>&lt;li id="R81"&gt;</code></p><p><code>9285</code><code>&lt;span class="citation"&gt;</code></p><p><code>9286</code><code>Biecker E, Sagesser H, Reichen J. Vasodilator mRNA levels are increased in the livers of portal hypertensive NO-synthase 3-deficient mice. &lt;span&gt;</code></p><p><code>9287</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9288</code><code>Eur J Clin Investig. &lt;/span&gt;</code></p><p><code>9289</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>9290</code><code>34&lt;/span&gt;</code></p><p><code>9291</code><code>:283–289.&lt;/span&gt;</code></p><p><code>9292</code><code> [&lt;a href="/pubmed/15086360" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9293</code><code>PubMed&lt;/a&gt;</code></p><p><code>9294</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9295</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Clin+Investig&amp;amp;title=Vasodilator+mRNA+levels+are+increased+in+the+livers+of+portal+hypertensive+NO-synthase+3-deficient+mice&amp;amp;author=E+Biecker&amp;amp;author=H+Sagesser&amp;amp;author=J+Reichen&amp;amp;volume=34&amp;amp;publication_year=2004&amp;amp;pages=283-289&amp;amp;pmid=15086360&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9296</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9297</code><code>]&lt;/span&gt;</code></p><p><code>9298</code><code>&lt;/span&gt;</code></p><p><code>9299</code><code>&lt;/li&gt;</code></p><p><code>9300</code><code>&lt;li id="R82"&gt;</code></p><p><code>9301</code><code>&lt;span class="citation"&gt;</code></p><p><code>9302</code><code>Biegon A. Cannabinoids as neuroprotective agents in traumatic brain injury. &lt;span&gt;</code></p><p><code>9303</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9304</code><code>Curr Pharm Des. &lt;/span&gt;</code></p><p><code>9305</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>9306</code><code>10&lt;/span&gt;</code></p><p><code>9307</code><code>:2177–2183.&lt;/span&gt;</code></p><p><code>9308</code><code> [&lt;a href="/pubmed/15281893" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9309</code><code>PubMed&lt;/a&gt;</code></p><p><code>9310</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9311</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Pharm+Des&amp;amp;title=Cannabinoids+as+neuroprotective+agents+in+traumatic+brain+injury&amp;amp;author=A+Biegon&amp;amp;volume=10&amp;amp;publication_year=2004&amp;amp;pages=2177-2183&amp;amp;pmid=15281893&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9312</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9313</code><code>]&lt;/span&gt;</code></p><p><code>9314</code><code>&lt;/span&gt;</code></p><p><code>9315</code><code>&lt;/li&gt;</code></p><p><code>9316</code><code>&lt;li id="R83"&gt;</code></p><p><code>9317</code><code>&lt;span class="citation"&gt;</code></p><p><code>9318</code><code>Bifulco M, Di Marzo V. Targeting the endocannabinoid system in cancer therapy: a call for further research. &lt;span&gt;</code></p><p><code>9319</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9320</code><code>Nat Med. &lt;/span&gt;</code></p><p><code>9321</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>9322</code><code>8&lt;/span&gt;</code></p><p><code>9323</code><code>:547–550.&lt;/span&gt;</code></p><p><code>9324</code><code> [&lt;a href="/pubmed/12042794" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9325</code><code>PubMed&lt;/a&gt;</code></p><p><code>9326</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9327</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;amp;title=Targeting+the+endocannabinoid+system+in+cancer+therapy:+a+call+for+further+research&amp;amp;author=M+Bifulco&amp;amp;author=V+Di+Marzo&amp;amp;volume=8&amp;amp;publication_year=2002&amp;amp;pages=547-550&amp;amp;pmid=12042794&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9328</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9329</code><code>]&lt;/span&gt;</code></p><p><code>9330</code><code>&lt;/span&gt;</code></p><p><code>9331</code><code>&lt;/li&gt;</code></p><p><code>9332</code><code>&lt;li id="R84"&gt;</code></p><p><code>9333</code><code>&lt;span class="citation"&gt;</code></p><p><code>9334</code><code>Bifulco M, Laezza C, Portella G, Vitale M, Orlando P, De Petrocellis L, Di Marzo V. Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth. &lt;span&gt;</code></p><p><code>9335</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9336</code><code>FASEB J. &lt;/span&gt;</code></p><p><code>9337</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>9338</code><code>15&lt;/span&gt;</code></p><p><code>9339</code><code>:2745–2747.&lt;/span&gt;</code></p><p><code>9340</code><code> [&lt;a href="/pubmed/11687506" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9341</code><code>PubMed&lt;/a&gt;</code></p><p><code>9342</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9343</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;amp;title=Control+by+the+endogenous+cannabinoid+system+of+ras+oncogene-dependent+tumor+growth&amp;amp;author=M+Bifulco&amp;amp;author=C+Laezza&amp;amp;author=G+Portella&amp;amp;author=M+Vitale&amp;amp;author=P+Orlando&amp;amp;volume=15&amp;amp;publication_year=2001&amp;amp;pages=2745-2747&amp;amp;pmid=11687506&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9344</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9345</code><code>]&lt;/span&gt;</code></p><p><code>9346</code><code>&lt;/span&gt;</code></p><p><code>9347</code><code>&lt;/li&gt;</code></p><p><code>9348</code><code>&lt;li id="R85"&gt;</code></p><p><code>9349</code><code>&lt;span class="citation"&gt;</code></p><p><code>9350</code><code>Bifulco M, Laezza C, Valenti M, Ligresti A, Portella G, Di Marzo V. A new strategy to block tumor growth by inhibiting endocannabinoid inactivation. &lt;span&gt;</code></p><p><code>9351</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9352</code><code>FASEB J. &lt;/span&gt;</code></p><p><code>9353</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>9354</code><code>18&lt;/span&gt;</code></p><p><code>9355</code><code>:1606–1608.&lt;/span&gt;</code></p><p><code>9356</code><code> [&lt;a href="/pubmed/15289448" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9357</code><code>PubMed&lt;/a&gt;</code></p><p><code>9358</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9359</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;amp;title=A+new+strategy+to+block+tumor+growth+by+inhibiting+endocannabinoid+inactivation&amp;amp;author=M+Bifulco&amp;amp;author=C+Laezza&amp;amp;author=M+Valenti&amp;amp;author=A+Ligresti&amp;amp;author=G+Portella&amp;amp;volume=18&amp;amp;publication_year=2004&amp;amp;pages=1606-1608&amp;amp;pmid=15289448&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9360</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9361</code><code>]&lt;/span&gt;</code></p><p><code>9362</code><code>&lt;/span&gt;</code></p><p><code>9363</code><code>&lt;/li&gt;</code></p><p><code>9364</code><code>&lt;li id="R86"&gt;</code></p><p><code>9365</code><code>&lt;span class="citation"&gt;</code></p><p><code>9366</code><code>Bilkei-Gorzo A, Racz I, Valverde O, Otto M, Michel K, Sastre M, Zimmer A. Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors. &lt;span&gt;</code></p><p><code>9367</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9368</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>9369</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>9370</code><code>102&lt;/span&gt;</code></p><p><code>9371</code><code>:15670–15675.&lt;/span&gt;</code></p><p><code>9372</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>9373</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1266095/"&gt;</code></p><p><code>9374</code><code>PMC free article&lt;/a&gt;</code></p><p><code>9375</code><code>]&lt;/span&gt;</code></p><p><code>9376</code><code> [&lt;a href="/pubmed/16221768" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9377</code><code>PubMed&lt;/a&gt;</code></p><p><code>9378</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9379</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Early+age-related+cognitive+impairment+in+mice+lacking+cannabinoid+CB1+receptors&amp;amp;author=A+Bilkei-Gorzo&amp;amp;author=I+Racz&amp;amp;author=O+Valverde&amp;amp;author=M+Otto&amp;amp;author=K+Michel&amp;amp;volume=102&amp;amp;publication_year=2005&amp;amp;pages=15670-15675&amp;amp;pmid=16221768&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9380</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9381</code><code>]&lt;/span&gt;</code></p><p><code>9382</code><code>&lt;/span&gt;</code></p><p><code>9383</code><code>&lt;/li&gt;</code></p><p><code>9384</code><code>&lt;li id="R87"&gt;</code></p><p><code>9385</code><code>&lt;span class="citation"&gt;</code></p><p><code>9386</code><code>Bilsland LG, Dick JR, Pryce G, Petrosino S, Di Marzo V, Baker D, Greensmith L. Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice. &lt;span&gt;</code></p><p><code>9387</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9388</code><code>FASEB J. &lt;/span&gt;</code></p><p><code>9389</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>9390</code><code>20&lt;/span&gt;</code></p><p><code>9391</code><code>:1003–1005.&lt;/span&gt;</code></p><p><code>9392</code><code> [&lt;a href="/pubmed/16571781" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9393</code><code>PubMed&lt;/a&gt;</code></p><p><code>9394</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9395</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;amp;title=Increasing+cannabinoid+levels+by+pharmacological+and+genetic+manipulation+delay+disease+progression+in+SOD1+mice&amp;amp;author=LG+Bilsland&amp;amp;author=JR+Dick&amp;amp;author=G+Pryce&amp;amp;author=S+Petrosino&amp;amp;author=V+Di+Marzo&amp;amp;volume=20&amp;amp;publication_year=2006&amp;amp;pages=1003-1005&amp;amp;pmid=16571781&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9396</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9397</code><code>]&lt;/span&gt;</code></p><p><code>9398</code><code>&lt;/span&gt;</code></p><p><code>9399</code><code>&lt;/li&gt;</code></p><p><code>9400</code><code>&lt;li id="R88"&gt;</code></p><p><code>9401</code><code>&lt;span class="citation"&gt;</code></p><p><code>9402</code><code>Birmingham MK. Reduction by 9-tetrahydrocannabinol in the blood pressure of hypertensive rats bearing regenerated adrenal glands. &lt;span&gt;</code></p><p><code>9403</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9404</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>9405</code><code>1973;&lt;span class="ref-vol"&gt;</code></p><p><code>9406</code><code>48&lt;/span&gt;</code></p><p><code>9407</code><code>:169–171.&lt;/span&gt;</code></p><p><code>9408</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>9409</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1776093/"&gt;</code></p><p><code>9410</code><code>PMC free article&lt;/a&gt;</code></p><p><code>9411</code><code>]&lt;/span&gt;</code></p><p><code>9412</code><code> [&lt;a href="/pubmed/4724188" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9413</code><code>PubMed&lt;/a&gt;</code></p><p><code>9414</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9415</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Reduction+by+9-tetrahydrocannabinol+in+the+blood+pressure+of+hypertensive+rats+bearing+regenerated+adrenal+glands&amp;amp;author=MK+Birmingham&amp;amp;volume=48&amp;amp;publication_year=1973&amp;amp;pages=169-171&amp;amp;pmid=4724188&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9416</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9417</code><code>]&lt;/span&gt;</code></p><p><code>9418</code><code>&lt;/span&gt;</code></p><p><code>9419</code><code>&lt;/li&gt;</code></p><p><code>9420</code><code>&lt;li id="R89"&gt;</code></p><p><code>9421</code><code>&lt;span class="citation"&gt;</code></p><p><code>9422</code><code>Bisogno T, Berrendero F, Ambrosino G, Cebeira M, Ramos JA, Fernandez-Ruiz JJ, Di Marzo V. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. &lt;span&gt;</code></p><p><code>9423</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9424</code><code>Biochem Biophys Res Commun. &lt;/span&gt;</code></p><p><code>9425</code><code>1999a;&lt;span class="ref-vol"&gt;</code></p><p><code>9426</code><code>256&lt;/span&gt;</code></p><p><code>9427</code><code>:377–380.&lt;/span&gt;</code></p><p><code>9428</code><code> [&lt;a href="/pubmed/10079192" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9429</code><code>PubMed&lt;/a&gt;</code></p><p><code>9430</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9431</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;amp;title=Brain+regional+distribution+of+endocannabinoids:+implications+for+their+biosynthesis+and+biological+function&amp;amp;author=T+Bisogno&amp;amp;author=F+Berrendero&amp;amp;author=G+Ambrosino&amp;amp;author=M+Cebeira&amp;amp;author=JA+Ramos&amp;amp;volume=256&amp;amp;publication_year=1999a&amp;amp;pages=377-380&amp;amp;pmid=10079192&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9432</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9433</code><code>]&lt;/span&gt;</code></p><p><code>9434</code><code>&lt;/span&gt;</code></p><p><code>9435</code><code>&lt;/li&gt;</code></p><p><code>9436</code><code>&lt;li id="R90"&gt;</code></p><p><code>9437</code><code>&lt;span class="citation"&gt;</code></p><p><code>9438</code><code>Bisogno T, Delton-Vandenbroucke I, Milone A, Lagarde M, Di Marzo V. Biosynthesis and inactivation of &lt;em&gt;</code></p><p><code>9439</code><code>N-&lt;/em&gt;</code></p><p><code>9440</code><code>arachidonoylethanolamine (anandamide) and &lt;em&gt;</code></p><p><code>9441</code><code>N-&lt;/em&gt;</code></p><p><code>9442</code><code>docosahexaenoylethanolamine in bovine retina. &lt;span&gt;</code></p><p><code>9443</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9444</code><code>Arch Biochem Biophys. &lt;/span&gt;</code></p><p><code>9445</code><code>1999b;&lt;span class="ref-vol"&gt;</code></p><p><code>9446</code><code>370&lt;/span&gt;</code></p><p><code>9447</code><code>:300–307.&lt;/span&gt;</code></p><p><code>9448</code><code> [&lt;a href="/pubmed/10577359" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9449</code><code>PubMed&lt;/a&gt;</code></p><p><code>9450</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9451</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Arch+Biochem+Biophys&amp;amp;title=Biosynthesis+and+inactivation+of+N-arachidonoylethanolamine+(anandamide)+and+N-docosahexaenoylethanolamine+in+bovine+retina&amp;amp;author=T+Bisogno&amp;amp;author=I+Delton-Vandenbroucke&amp;amp;author=A+Milone&amp;amp;author=M+Lagarde&amp;amp;author=V+Di+Marzo&amp;amp;volume=370&amp;amp;publication_year=1999b&amp;amp;pages=300-307&amp;amp;pmid=10577359&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9452</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9453</code><code>]&lt;/span&gt;</code></p><p><code>9454</code><code>&lt;/span&gt;</code></p><p><code>9455</code><code>&lt;/li&gt;</code></p><p><code>9456</code><code>&lt;li id="R91"&gt;</code></p><p><code>9457</code><code>&lt;span class="citation"&gt;</code></p><p><code>9458</code><code>Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, Moriello AS, Davis JB, Mechoulam R, Di Marzo V. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. &lt;span&gt;</code></p><p><code>9459</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9460</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>9461</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>9462</code><code>134&lt;/span&gt;</code></p><p><code>9463</code><code>:845–852.&lt;/span&gt;</code></p><p><code>9464</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>9465</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1573017/"&gt;</code></p><p><code>9466</code><code>PMC free article&lt;/a&gt;</code></p><p><code>9467</code><code>]&lt;/span&gt;</code></p><p><code>9468</code><code> [&lt;a href="/pubmed/11606325" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9469</code><code>PubMed&lt;/a&gt;</code></p><p><code>9470</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9471</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Molecular+targets+for+cannabidiol+and+its+synthetic+analogues:+effect+on+vanilloid+VR1+receptors+and+on+the+cellular+uptake+and+enzymatic+hydrolysis+of+anandamide&amp;amp;author=T+Bisogno&amp;amp;author=L+Hanus&amp;amp;author=L+De+Petrocellis&amp;amp;author=S+Tchilibon&amp;amp;author=DE+Ponde&amp;amp;volume=134&amp;amp;publication_year=2001&amp;amp;pages=845-852&amp;amp;pmid=11606325&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9472</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9473</code><code>]&lt;/span&gt;</code></p><p><code>9474</code><code>&lt;/span&gt;</code></p><p><code>9475</code><code>&lt;/li&gt;</code></p><p><code>9476</code><code>&lt;li id="R92"&gt;</code></p><p><code>9477</code><code>&lt;span class="citation"&gt;</code></p><p><code>9478</code><code>Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello A, Paul P, Williams EJ, et al.  Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. &lt;span&gt;</code></p><p><code>9479</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9480</code><code>J Cell Biol. &lt;/span&gt;</code></p><p><code>9481</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>9482</code><code>163&lt;/span&gt;</code></p><p><code>9483</code><code>:463–468.&lt;/span&gt;</code></p><p><code>9484</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>9485</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2173631/"&gt;</code></p><p><code>9486</code><code>PMC free article&lt;/a&gt;</code></p><p><code>9487</code><code>]&lt;/span&gt;</code></p><p><code>9488</code><code> [&lt;a href="/pubmed/14610053" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9489</code><code>PubMed&lt;/a&gt;</code></p><p><code>9490</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9491</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Biol&amp;amp;title=Cloning+of+the+first+sn1-DAG+lipases+points+to+the+spatial+and+temporal+regulation+of+endocannabinoid+signaling+in+the+brain&amp;amp;author=T+Bisogno&amp;amp;author=F+Howell&amp;amp;author=G+Williams&amp;amp;author=A+Minassi&amp;amp;author=MG+Cascio&amp;amp;volume=163&amp;amp;publication_year=2003&amp;amp;pages=463-468&amp;amp;pmid=14610053&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9492</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9493</code><code>]&lt;/span&gt;</code></p><p><code>9494</code><code>&lt;/span&gt;</code></p><p><code>9495</code><code>&lt;/li&gt;</code></p><p><code>9496</code><code>&lt;li id="R93"&gt;</code></p><p><code>9497</code><code>&lt;span class="citation"&gt;</code></p><p><code>9498</code><code>Bisogno T, Ligresti A, Di Marzo V. The endocannabinoid signaling system: biochemical aspects. &lt;span&gt;</code></p><p><code>9499</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9500</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>9501</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>9502</code><code>81&lt;/span&gt;</code></p><p><code>9503</code><code>:224–238.&lt;/span&gt;</code></p><p><code>9504</code><code> [&lt;a href="/pubmed/15935454" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9505</code><code>PubMed&lt;/a&gt;</code></p><p><code>9506</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9507</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=The+endocannabinoid+signaling+system:+biochemical+aspects&amp;amp;author=T+Bisogno&amp;amp;author=A+Ligresti&amp;amp;author=V+Di+Marzo&amp;amp;volume=81&amp;amp;publication_year=2005&amp;amp;pages=224-238&amp;amp;pmid=15935454&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9508</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9509</code><code>]&lt;/span&gt;</code></p><p><code>9510</code><code>&lt;/span&gt;</code></p><p><code>9511</code><code>&lt;/li&gt;</code></p><p><code>9512</code><code>&lt;li id="R94"&gt;</code></p><p><code>9513</code><code>&lt;span class="citation"&gt;</code></p><p><code>9514</code><code>Bisogno T, Maurelli S, Melck D, De Petrocellis L, Di Marzo V. Biosynthesis, uptake and degradation of anandamide and palmitoylethanolamide in leukocytes. &lt;span&gt;</code></p><p><code>9515</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9516</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>9517</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>9518</code><code>272&lt;/span&gt;</code></p><p><code>9519</code><code>:3315–3323.&lt;/span&gt;</code></p><p><code>9520</code><code> [&lt;a href="/pubmed/9013571" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9521</code><code>PubMed&lt;/a&gt;</code></p><p><code>9522</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9523</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=Biosynthesis,+uptake+and+degradation+of+anandamide+and+palmitoylethanolamide+in+leukocytes&amp;amp;author=T+Bisogno&amp;amp;author=S+Maurelli&amp;amp;author=D+Melck&amp;amp;author=L+De+Petrocellis&amp;amp;author=V+Di+Marzo&amp;amp;volume=272&amp;amp;publication_year=1997&amp;amp;pages=3315-3323&amp;amp;pmid=9013571&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9524</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9525</code><code>]&lt;/span&gt;</code></p><p><code>9526</code><code>&lt;/span&gt;</code></p><p><code>9527</code><code>&lt;/li&gt;</code></p><p><code>9528</code><code>&lt;li id="R95"&gt;</code></p><p><code>9529</code><code>&lt;span class="citation"&gt;</code></p><p><code>9530</code><code>Bisogno T, Melck D, Bobrov MYu, Gretskaya NM, Bezuglov VV, De Petrocellis L, Di Marzo V. &lt;em&gt;</code></p><p><code>9531</code><code>N-&lt;/em&gt;</code></p><p><code>9532</code><code>Acyl-dopamines: novel synthetic CB&lt;sub&gt;</code></p><p><code>9533</code><code>1&lt;/sub&gt;</code></p><p><code>9534</code><code> cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. &lt;span&gt;</code></p><p><code>9535</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9536</code><code>Biochem J. &lt;/span&gt;</code></p><p><code>9537</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>9538</code><code>351&lt;/span&gt;</code></p><p><code>9539</code><code>:817–824.&lt;/span&gt;</code></p><p><code>9540</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>9541</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1221424/"&gt;</code></p><p><code>9542</code><code>PMC free article&lt;/a&gt;</code></p><p><code>9543</code><code>]&lt;/span&gt;</code></p><p><code>9544</code><code> [&lt;a href="/pubmed/11042139" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9545</code><code>PubMed&lt;/a&gt;</code></p><p><code>9546</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9547</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+J&amp;amp;title=N-Acyl-dopamines:+novel+synthetic+CB1+cannabinoid-receptor+ligands+and+inhibitors+of+anandamide+inactivation+with+cannabimimetic+activity+in+vitro+and+in+vivo&amp;amp;author=T+Bisogno&amp;amp;author=D+Melck&amp;amp;author=MYu+Bobrov&amp;amp;author=NM+Gretskaya&amp;amp;author=VV+Bezuglov&amp;amp;volume=351&amp;amp;publication_year=2000&amp;amp;pages=817-824&amp;amp;pmid=11042139&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9548</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9549</code><code>]&lt;/span&gt;</code></p><p><code>9550</code><code>&lt;/span&gt;</code></p><p><code>9551</code><code>&lt;/li&gt;</code></p><p><code>9552</code><code>&lt;li id="R96"&gt;</code></p><p><code>9553</code><code>&lt;span class="citation"&gt;</code></p><p><code>9554</code><code>Bisogno T, Melck D, De Petrocellis L, Bobrov MYu, Gretskaya NM, Bezuglov VV, Sitachitta N, Gerwick WH, Di Marzo V. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. &lt;span&gt;</code></p><p><code>9555</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9556</code><code>Biochem Biophys Res Commun. &lt;/span&gt;</code></p><p><code>9557</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>9558</code><code>248&lt;/span&gt;</code></p><p><code>9559</code><code>:515–522.&lt;/span&gt;</code></p><p><code>9560</code><code> [&lt;a href="/pubmed/9703957" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9561</code><code>PubMed&lt;/a&gt;</code></p><p><code>9562</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9563</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;amp;title=Arachidonoylserotonin+and+other+novel+inhibitors+of+fatty+acid+amide+hydrolase&amp;amp;author=T+Bisogno&amp;amp;author=D+Melck&amp;amp;author=L+De+Petrocellis&amp;amp;author=MYu+Bobrov&amp;amp;author=NM+Gretskaya&amp;amp;volume=248&amp;amp;publication_year=1998&amp;amp;pages=515-522&amp;amp;pmid=9703957&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9564</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9565</code><code>]&lt;/span&gt;</code></p><p><code>9566</code><code>&lt;/span&gt;</code></p><p><code>9567</code><code>&lt;/li&gt;</code></p><p><code>9568</code><code>&lt;li id="R97"&gt;</code></p><p><code>9569</code><code>&lt;span class="citation"&gt;</code></p><p><code>9570</code><code>Bl&amp;#x000e1;zquez C, Casanova ML, Planas A, Del Pulgar TG, Villanueva C, Fernandez-Acenero MJ, Aragones J, Huffman JW, Jorcano JL, Guzman M. Inhibition of tumor angiogenesis by cannabinoids. &lt;span&gt;</code></p><p><code>9571</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9572</code><code>FASEB J. &lt;/span&gt;</code></p><p><code>9573</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>9574</code><code>17&lt;/span&gt;</code></p><p><code>9575</code><code>:529–531.&lt;/span&gt;</code></p><p><code>9576</code><code> [&lt;a href="/pubmed/12514108" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9577</code><code>PubMed&lt;/a&gt;</code></p><p><code>9578</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9579</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;amp;title=Inhibition+of+tumor+angiogenesis+by+cannabinoids&amp;amp;author=C+Bl&amp;#x000e1;zquez&amp;amp;author=ML+Casanova&amp;amp;author=A+Planas&amp;amp;author=TG+Del+Pulgar&amp;amp;author=C+Villanueva&amp;amp;volume=17&amp;amp;publication_year=2003&amp;amp;pages=529-531&amp;amp;pmid=12514108&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9580</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9581</code><code>]&lt;/span&gt;</code></p><p><code>9582</code><code>&lt;/span&gt;</code></p><p><code>9583</code><code>&lt;/li&gt;</code></p><p><code>9584</code><code>&lt;li id="R98"&gt;</code></p><p><code>9585</code><code>&lt;span class="citation"&gt;</code></p><p><code>9586</code><code>Bl&amp;#x000e1;zquez C, Gonzalez-Feria L, Alvarez L, Haro A, Casanova ML, Guzman M. Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. &lt;span&gt;</code></p><p><code>9587</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9588</code><code>Cancer Res. &lt;/span&gt;</code></p><p><code>9589</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>9590</code><code>64&lt;/span&gt;</code></p><p><code>9591</code><code>:5617–5623.&lt;/span&gt;</code></p><p><code>9592</code><code> [&lt;a href="/pubmed/15313899" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9593</code><code>PubMed&lt;/a&gt;</code></p><p><code>9594</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9595</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=Cannabinoids+inhibit+the+vascular+endothelial+growth+factor+pathway+in+gliomas&amp;amp;author=C+Bl&amp;#x000e1;zquez&amp;amp;author=L+Gonzalez-Feria&amp;amp;author=L+Alvarez&amp;amp;author=A+Haro&amp;amp;author=ML+Casanova&amp;amp;volume=64&amp;amp;publication_year=2004&amp;amp;pages=5617-5623&amp;amp;pmid=15313899&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9596</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9597</code><code>]&lt;/span&gt;</code></p><p><code>9598</code><code>&lt;/span&gt;</code></p><p><code>9599</code><code>&lt;/li&gt;</code></p><p><code>9600</code><code>&lt;li id="R99"&gt;</code></p><p><code>9601</code><code>&lt;span class="citation"&gt;</code></p><p><code>9602</code><code>Bloch E, Thysen B, Morrill GA, Gardner E, Fujimoto G. Effects of cannabinoids on reproduction and development. &lt;span&gt;</code></p><p><code>9603</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9604</code><code>Vitam Horm. &lt;/span&gt;</code></p><p><code>9605</code><code>1978;&lt;span class="ref-vol"&gt;</code></p><p><code>9606</code><code>36&lt;/span&gt;</code></p><p><code>9607</code><code>:203–258.&lt;/span&gt;</code></p><p><code>9608</code><code> [&lt;a href="/pubmed/369121" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9609</code><code>PubMed&lt;/a&gt;</code></p><p><code>9610</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9611</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Vitam+Horm&amp;amp;title=Effects+of+cannabinoids+on+reproduction+and+development&amp;amp;author=E+Bloch&amp;amp;author=B+Thysen&amp;amp;author=GA+Morrill&amp;amp;author=E+Gardner&amp;amp;author=G+Fujimoto&amp;amp;volume=36&amp;amp;publication_year=1978&amp;amp;pages=203-258&amp;amp;pmid=369121&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9612</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9613</code><code>]&lt;/span&gt;</code></p><p><code>9614</code><code>&lt;/span&gt;</code></p><p><code>9615</code><code>&lt;/li&gt;</code></p><p><code>9616</code><code>&lt;li id="R100"&gt;</code></p><p><code>9617</code><code>&lt;span class="citation"&gt;</code></p><p><code>9618</code><code>Bloom AS, Dewey WL, Harris LS, Brosius KK. 9-Nor-9&lt;em&gt;</code></p><p><code>9619</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>9620</code><code>-hydroxyhexahy-drocannabinol a cannabinoid with potent antinociceptive activity: comparisons with morphine. &lt;span&gt;</code></p><p><code>9621</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9622</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>9623</code><code>1977;&lt;span class="ref-vol"&gt;</code></p><p><code>9624</code><code>200&lt;/span&gt;</code></p><p><code>9625</code><code>:263–270.&lt;/span&gt;</code></p><p><code>9626</code><code> [&lt;a href="/pubmed/839438" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9627</code><code>PubMed&lt;/a&gt;</code></p><p><code>9628</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9629</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=9-Nor-9&amp;#x003b2;-hydroxyhexahy-drocannabinol+a+cannabinoid+with+potent+antinociceptive+activity:+comparisons+with+morphine&amp;amp;author=AS+Bloom&amp;amp;author=WL+Dewey&amp;amp;author=LS+Harris&amp;amp;author=KK+Brosius&amp;amp;volume=200&amp;amp;publication_year=1977&amp;amp;pages=263-270&amp;amp;pmid=839438&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9630</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9631</code><code>]&lt;/span&gt;</code></p><p><code>9632</code><code>&lt;/span&gt;</code></p><p><code>9633</code><code>&lt;/li&gt;</code></p><p><code>9634</code><code>&lt;li id="R101"&gt;</code></p><p><code>9635</code><code>&lt;span class="citation"&gt;</code></p><p><code>9636</code><code>Boger DL, Henriksen SJ, Cravatt BF. Oleamide: an endogenous sleep-inducing lipid and prototypical member of a new class of biological signaling molecules. &lt;span&gt;</code></p><p><code>9637</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9638</code><code>Curr Pharm Des. &lt;/span&gt;</code></p><p><code>9639</code><code>1998a;&lt;span class="ref-vol"&gt;</code></p><p><code>9640</code><code>4&lt;/span&gt;</code></p><p><code>9641</code><code>:303–314.&lt;/span&gt;</code></p><p><code>9642</code><code> [&lt;a href="/pubmed/10197045" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9643</code><code>PubMed&lt;/a&gt;</code></p><p><code>9644</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9645</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Pharm+Des&amp;amp;title=Oleamide:+an+endogenous+sleep-inducing+lipid+and+prototypical+member+of+a+new+class+of+biological+signaling+molecules&amp;amp;author=DL+Boger&amp;amp;author=SJ+Henriksen&amp;amp;author=BF+Cravatt&amp;amp;volume=4&amp;amp;publication_year=1998a&amp;amp;pages=303-314&amp;amp;pmid=10197045&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9646</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9647</code><code>]&lt;/span&gt;</code></p><p><code>9648</code><code>&lt;/span&gt;</code></p><p><code>9649</code><code>&lt;/li&gt;</code></p><p><code>9650</code><code>&lt;li id="R102"&gt;</code></p><p><code>9651</code><code>&lt;span class="citation"&gt;</code></p><p><code>9652</code><code>Boger DL, Miyauchi H, Du W, Hardouin C, Fecik RA, Cheng H, Hwang I, Hedrick MP, Leung D, Acevedo O, et al.  Discovery of a potent, selective, and efficacious class of reversible &lt;em&gt;</code></p><p><code>9653</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>9654</code><code>-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics. &lt;span&gt;</code></p><p><code>9655</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9656</code><code>J Med Chem. &lt;/span&gt;</code></p><p><code>9657</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>9658</code><code>48&lt;/span&gt;</code></p><p><code>9659</code><code>:1849–1856.&lt;/span&gt;</code></p><p><code>9660</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>9661</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2492884/"&gt;</code></p><p><code>9662</code><code>PMC free article&lt;/a&gt;</code></p><p><code>9663</code><code>]&lt;/span&gt;</code></p><p><code>9664</code><code> [&lt;a href="/pubmed/15771430" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9665</code><code>PubMed&lt;/a&gt;</code></p><p><code>9666</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9667</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;amp;title=Discovery+of+a+potent,+selective,+and+efficacious+class+of+reversible+&amp;#x003b1;-ketoheterocycle+inhibitors+of+fatty+acid+amide+hydrolase+effective+as+analgesics&amp;amp;author=DL+Boger&amp;amp;author=H+Miyauchi&amp;amp;author=W+Du&amp;amp;author=C+Hardouin&amp;amp;author=RA+Fecik&amp;amp;volume=48&amp;amp;publication_year=2005&amp;amp;pages=1849-1856&amp;amp;pmid=15771430&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9668</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9669</code><code>]&lt;/span&gt;</code></p><p><code>9670</code><code>&lt;/span&gt;</code></p><p><code>9671</code><code>&lt;/li&gt;</code></p><p><code>9672</code><code>&lt;li id="R103"&gt;</code></p><p><code>9673</code><code>&lt;span class="citation"&gt;</code></p><p><code>9674</code><code>Boger DL, Patterson JE, Guan X, Cravatt BF, Lerner RA, Gilula NB. &lt;em&gt;</code></p><p><code>9675</code><code>)&lt;/em&gt;</code></p><p><code>9676</code><code> Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide. &lt;span&gt;</code></p><p><code>9677</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9678</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>9679</code><code>1998b;&lt;span class="ref-vol"&gt;</code></p><p><code>9680</code><code>95&lt;/span&gt;</code></p><p><code>9681</code><code>:4810–4815.&lt;/span&gt;</code></p><p><code>9682</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>9683</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC20169/"&gt;</code></p><p><code>9684</code><code>PMC free article&lt;/a&gt;</code></p><p><code>9685</code><code>]&lt;/span&gt;</code></p><p><code>9686</code><code> [&lt;a href="/pubmed/9560184" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9687</code><code>PubMed&lt;/a&gt;</code></p><p><code>9688</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9689</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=)+Chemical+requirements+for+inhibition+of+gap+junction+communication+by+the+biologically+active+lipid+oleamide&amp;amp;author=DL+Boger&amp;amp;author=JE+Patterson&amp;amp;author=X+Guan&amp;amp;author=BF+Cravatt&amp;amp;author=RA+Lerner&amp;amp;volume=95&amp;amp;publication_year=1998b&amp;amp;pages=4810-4815&amp;amp;pmid=9560184&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9690</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9691</code><code>]&lt;/span&gt;</code></p><p><code>9692</code><code>&lt;/span&gt;</code></p><p><code>9693</code><code>&lt;/li&gt;</code></p><p><code>9694</code><code>&lt;li id="R104"&gt;</code></p><p><code>9695</code><code>&lt;span class="citation"&gt;</code></p><p><code>9696</code><code>Bonz A, Laser M, Kullmer S, Kniesch S, Babin-Ebell J, Popp V, Ertl G, Wagner JA. Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle. &lt;span&gt;</code></p><p><code>9697</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9698</code><code>J Cardiovasc Pharmacol. &lt;/span&gt;</code></p><p><code>9699</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>9700</code><code>41&lt;/span&gt;</code></p><p><code>9701</code><code>:657–664.&lt;/span&gt;</code></p><p><code>9702</code><code> [&lt;a href="/pubmed/12658069" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9703</code><code>PubMed&lt;/a&gt;</code></p><p><code>9704</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9705</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Cardiovasc+Pharmacol&amp;amp;title=Cannabinoids+acting+on+CB1+receptors+decrease+contractile+performance+in+human+atrial+muscle&amp;amp;author=A+Bonz&amp;amp;author=M+Laser&amp;amp;author=S+Kullmer&amp;amp;author=S+Kniesch&amp;amp;author=J+Babin-Ebell&amp;amp;volume=41&amp;amp;publication_year=2003&amp;amp;pages=657-664&amp;amp;pmid=12658069&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9706</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9707</code><code>]&lt;/span&gt;</code></p><p><code>9708</code><code>&lt;/span&gt;</code></p><p><code>9709</code><code>&lt;/li&gt;</code></p><p><code>9710</code><code>&lt;li id="R105"&gt;</code></p><p><code>9711</code><code>&lt;span class="citation"&gt;</code></p><p><code>9712</code><code>Borcel E, Perez-Alvarez L, de Ceballos ML, Ramirez BG, Marco EM, Fernandez B, Rubio M, Guaza C, Viveros MP. Functional responses to the cannabinoid agonist WIN 55,212-2 in neonatal rats of both genders: influence of weaning. &lt;span&gt;</code></p><p><code>9713</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9714</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>9715</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>9716</code><code>78&lt;/span&gt;</code></p><p><code>9717</code><code>:593–602.&lt;/span&gt;</code></p><p><code>9718</code><code> [&lt;a href="/pubmed/15251268" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9719</code><code>PubMed&lt;/a&gt;</code></p><p><code>9720</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9721</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Functional+responses+to+the+cannabinoid+agonist+WIN+55,212-2+in+neonatal+rats+of+both+genders:+influence+of+weaning&amp;amp;author=E+Borcel&amp;amp;author=L+Perez-Alvarez&amp;amp;author=ML+de+Ceballos&amp;amp;author=BG+Ramirez&amp;amp;author=EM+Marco&amp;amp;volume=78&amp;amp;publication_year=2004&amp;amp;pages=593-602&amp;amp;pmid=15251268&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9722</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9723</code><code>]&lt;/span&gt;</code></p><p><code>9724</code><code>&lt;/span&gt;</code></p><p><code>9725</code><code>&lt;/li&gt;</code></p><p><code>9726</code><code>&lt;li id="R106"&gt;</code></p><p><code>9727</code><code>&lt;span class="citation"&gt;</code></p><p><code>9728</code><code>Boring DL, Berglund BA, Howlett AC. Cerebrodiene, arachidonylethanolamide, and hybrid structures: potential for interaction with brain cannabinoid receptors. &lt;span&gt;</code></p><p><code>9729</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9730</code><code>Prostaglandins Leukotrienes Essent Fatty Acids. &lt;/span&gt;</code></p><p><code>9731</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>9732</code><code>55&lt;/span&gt;</code></p><p><code>9733</code><code>:207–210.&lt;/span&gt;</code></p><p><code>9734</code><code> [&lt;a href="/pubmed/8931121" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9735</code><code>PubMed&lt;/a&gt;</code></p><p><code>9736</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9737</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Prostaglandins+Leukotrienes+Essent+Fatty+Acids&amp;amp;title=Cerebrodiene,+arachidonylethanolamide,+and+hybrid+structures:+potential+for+interaction+with+brain+cannabinoid+receptors&amp;amp;author=DL+Boring&amp;amp;author=BA+Berglund&amp;amp;author=AC+Howlett&amp;amp;volume=55&amp;amp;publication_year=1996&amp;amp;pages=207-210&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9738</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9739</code><code>]&lt;/span&gt;</code></p><p><code>9740</code><code>&lt;/span&gt;</code></p><p><code>9741</code><code>&lt;/li&gt;</code></p><p><code>9742</code><code>&lt;li id="R107"&gt;</code></p><p><code>9743</code><code>&lt;span class="citation"&gt;</code></p><p><code>9744</code><code>Borini P, Guimaraes RC, Borini SB. Possible hepatotoxicity of chronic marijuana usage. &lt;span&gt;</code></p><p><code>9745</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9746</code><code>Sao Paulo Med J. &lt;/span&gt;</code></p><p><code>9747</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>9748</code><code>122&lt;/span&gt;</code></p><p><code>9749</code><code>:110–116.&lt;/span&gt;</code></p><p><code>9750</code><code> [&lt;a href="/pubmed/15448809" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9751</code><code>PubMed&lt;/a&gt;</code></p><p><code>9752</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9753</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Sao+Paulo+Med+J&amp;amp;title=Possible+hepatotoxicity+of+chronic+marijuana+usage&amp;amp;author=P+Borini&amp;amp;author=RC+Guimaraes&amp;amp;author=SB+Borini&amp;amp;volume=122&amp;amp;publication_year=2004&amp;amp;pages=110-116&amp;amp;pmid=15448809&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9754</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9755</code><code>]&lt;/span&gt;</code></p><p><code>9756</code><code>&lt;/span&gt;</code></p><p><code>9757</code><code>&lt;/li&gt;</code></p><p><code>9758</code><code>&lt;li id="R108"&gt;</code></p><p><code>9759</code><code>&lt;span class="citation"&gt;</code></p><p><code>9760</code><code>Bortolato M, Campolongo P, Mangieri RA, Scattoni ML, Frau R, Trezza V, La Rana G, Russo R, Calignano A, Gessa GL, et al.  Anxiolytic-like properties of the anandamide transport inhibitor AM404. &lt;span&gt;</code></p><p><code>9761</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9762</code><code>Neuropsychopharmacology. &lt;/span&gt;</code></p><p><code>9763</code><code>2006&lt;/span&gt;</code></p><p><code>9764</code><code> in press. [&lt;a href="/pubmed/16541083" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9765</code><code>PubMed&lt;/a&gt;</code></p><p><code>9766</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9767</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;amp;title=Anxiolytic-like+properties+of+the+anandamide+transport+inhibitor+AM404&amp;amp;author=M+Bortolato&amp;amp;author=P+Campolongo&amp;amp;author=RA+Mangieri&amp;amp;author=ML+Scattoni&amp;amp;author=R+Frau&amp;amp;publication_year=2006&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9768</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9769</code><code>]&lt;/span&gt;</code></p><p><code>9770</code><code>&lt;/span&gt;</code></p><p><code>9771</code><code>&lt;/li&gt;</code></p><p><code>9772</code><code>&lt;li id="R109"&gt;</code></p><p><code>9773</code><code>&lt;span class="citation"&gt;</code></p><p><code>9774</code><code>Bouaboula M, Dussossoy D, Casellas P. Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528: implications for receptor biological responses. &lt;span&gt;</code></p><p><code>9775</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9776</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>9777</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>9778</code><code>274&lt;/span&gt;</code></p><p><code>9779</code><code>:20397–20405.&lt;/span&gt;</code></p><p><code>9780</code><code> [&lt;a href="/pubmed/10400664" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9781</code><code>PubMed&lt;/a&gt;</code></p><p><code>9782</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9783</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=Regulation+of+peripheral+cannabinoid+receptor+CB2+phosphorylation+by+the+inverse+agonist+SR+144528:+implications+for+receptor+biological+responses&amp;amp;author=M+Bouaboula&amp;amp;author=D+Dussossoy&amp;amp;author=P+Casellas&amp;amp;volume=274&amp;amp;publication_year=1999&amp;amp;pages=20397-20405&amp;amp;pmid=10400664&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9784</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9785</code><code>]&lt;/span&gt;</code></p><p><code>9786</code><code>&lt;/span&gt;</code></p><p><code>9787</code><code>&lt;/li&gt;</code></p><p><code>9788</code><code>&lt;li id="R110"&gt;</code></p><p><code>9789</code><code>&lt;span class="citation"&gt;</code></p><p><code>9790</code><code>Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F, Calandra B, Pecceu F, Lupker J, et al.  A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1: evidence for a new model of receptor/ligand interactions. &lt;span&gt;</code></p><p><code>9791</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9792</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>9793</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>9794</code><code>272&lt;/span&gt;</code></p><p><code>9795</code><code>:22330–22339.&lt;/span&gt;</code></p><p><code>9796</code><code> [&lt;a href="/pubmed/9268384" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9797</code><code>PubMed&lt;/a&gt;</code></p><p><code>9798</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9799</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=A+selective+inverse+agonist+for+central+cannabinoid+receptor+inhibits+mitogen-activated+protein+kinase+activation+stimulated+by+insulin+or+insulin-like+growth+factor+1:+evidence+for+a+new+model+of+receptor/ligand+interactions&amp;amp;author=M+Bouaboula&amp;amp;author=S+Perrachon&amp;amp;author=L+Milligan&amp;amp;author=X+Canat&amp;amp;author=M+Rinaldi-Carmona&amp;amp;volume=272&amp;amp;publication_year=1997&amp;amp;pages=22330-22339&amp;amp;pmid=9268384&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9800</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9801</code><code>]&lt;/span&gt;</code></p><p><code>9802</code><code>&lt;/span&gt;</code></p><p><code>9803</code><code>&lt;/li&gt;</code></p><p><code>9804</code><code>&lt;li id="R111"&gt;</code></p><p><code>9805</code><code>&lt;span class="citation"&gt;</code></p><p><code>9806</code><code>Bouchard JF, Lepicier P, Lamontagne D. Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart. &lt;span&gt;</code></p><p><code>9807</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9808</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>9809</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>9810</code><code>72&lt;/span&gt;</code></p><p><code>9811</code><code>:1859–1870.&lt;/span&gt;</code></p><p><code>9812</code><code> [&lt;a href="/pubmed/12586223" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9813</code><code>PubMed&lt;/a&gt;</code></p><p><code>9814</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9815</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Contribution+of+endocannabinoids+in+the+endothelial+protection+afforded+by+ischemic+preconditioning+in+the+isolated+rat+heart&amp;amp;author=JF+Bouchard&amp;amp;author=P+Lepicier&amp;amp;author=D+Lamontagne&amp;amp;volume=72&amp;amp;publication_year=2003&amp;amp;pages=1859-1870&amp;amp;pmid=12586223&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9816</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9817</code><code>]&lt;/span&gt;</code></p><p><code>9818</code><code>&lt;/span&gt;</code></p><p><code>9819</code><code>&lt;/li&gt;</code></p><p><code>9820</code><code>&lt;li id="R112"&gt;</code></p><p><code>9821</code><code>&lt;span class="citation"&gt;</code></p><p><code>9822</code><code>Bracey MH, Hanson MA, Masuda KR, Stevens RC, Cravatt BF. Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. &lt;span&gt;</code></p><p><code>9823</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9824</code><code>Science (Wash DC) &lt;/span&gt;</code></p><p><code>9825</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>9826</code><code>298&lt;/span&gt;</code></p><p><code>9827</code><code>:1793–1796.&lt;/span&gt;</code></p><p><code>9828</code><code> [&lt;a href="/pubmed/12459591" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9829</code><code>PubMed&lt;/a&gt;</code></p><p><code>9830</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9831</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Science+(Wash+DC)&amp;amp;title=Structural+adaptations+in+a+membrane+enzyme+that+terminates+endocannabinoid+signaling&amp;amp;author=MH+Bracey&amp;amp;author=MA+Hanson&amp;amp;author=KR+Masuda&amp;amp;author=RC+Stevens&amp;amp;author=BF+Cravatt&amp;amp;volume=298&amp;amp;publication_year=2002&amp;amp;pages=1793-1796&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9832</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9833</code><code>]&lt;/span&gt;</code></p><p><code>9834</code><code>&lt;/span&gt;</code></p><p><code>9835</code><code>&lt;/li&gt;</code></p><p><code>9836</code><code>&lt;li id="R113"&gt;</code></p><p><code>9837</code><code>&lt;span class="citation"&gt;</code></p><p><code>9838</code><code>Braida D, Iosue S, Pegorini S, Sala M. 3,4-Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system. &lt;span&gt;</code></p><p><code>9839</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9840</code><code>Pharmacol Res. &lt;/span&gt;</code></p><p><code>9841</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>9842</code><code>51&lt;/span&gt;</code></p><p><code>9843</code><code>:177–182.&lt;/span&gt;</code></p><p><code>9844</code><code> [&lt;a href="/pubmed/15629265" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9845</code><code>PubMed&lt;/a&gt;</code></p><p><code>9846</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9847</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Res&amp;amp;title=3,4-Methylenedioxymethamphetamine-induced+conditioned+place+preference+(CPP)+is+mediated+by+endocannabinoid+system&amp;amp;author=D+Braida&amp;amp;author=S+Iosue&amp;amp;author=S+Pegorini&amp;amp;author=M+Sala&amp;amp;volume=51&amp;amp;publication_year=2005&amp;amp;pages=177-182&amp;amp;pmid=15629265&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9848</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9849</code><code>]&lt;/span&gt;</code></p><p><code>9850</code><code>&lt;/span&gt;</code></p><p><code>9851</code><code>&lt;/li&gt;</code></p><p><code>9852</code><code>&lt;li id="R114"&gt;</code></p><p><code>9853</code><code>&lt;span class="citation"&gt;</code></p><p><code>9854</code><code>Braida D, Pozzi M, Parolaro D, Sala M. Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system. &lt;span&gt;</code></p><p><code>9855</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9856</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>9857</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>9858</code><code>413&lt;/span&gt;</code></p><p><code>9859</code><code>:227–234.&lt;/span&gt;</code></p><p><code>9860</code><code> [&lt;a href="/pubmed/11226397" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9861</code><code>PubMed&lt;/a&gt;</code></p><p><code>9862</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9863</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Intracerebral+self-administration+of+the+cannabinoid+receptor+agonist+CP+55,940+in+the+rat:+interaction+with+the+opioid+system&amp;amp;author=D+Braida&amp;amp;author=M+Pozzi&amp;amp;author=D+Parolaro&amp;amp;author=M+Sala&amp;amp;volume=413&amp;amp;publication_year=2001&amp;amp;pages=227-234&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9864</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9865</code><code>]&lt;/span&gt;</code></p><p><code>9866</code><code>&lt;/span&gt;</code></p><p><code>9867</code><code>&lt;/li&gt;</code></p><p><code>9868</code><code>&lt;li id="R115"&gt;</code></p><p><code>9869</code><code>&lt;span class="citation"&gt;</code></p><p><code>9870</code><code>Braida D, Sala M. Role of the endocannabinoid system in MDMA intra-cerebral self-administration in rats. &lt;span&gt;</code></p><p><code>9871</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9872</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>9873</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>9874</code><code>136&lt;/span&gt;</code></p><p><code>9875</code><code>:1089–1092.&lt;/span&gt;</code></p><p><code>9876</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>9877</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1573452/"&gt;</code></p><p><code>9878</code><code>PMC free article&lt;/a&gt;</code></p><p><code>9879</code><code>]&lt;/span&gt;</code></p><p><code>9880</code><code> [&lt;a href="/pubmed/12163340" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9881</code><code>PubMed&lt;/a&gt;</code></p><p><code>9882</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9883</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Role+of+the+endocannabinoid+system+in+MDMA+intra-cerebral+self-administration+in+rats&amp;amp;author=D+Braida&amp;amp;author=M+Sala&amp;amp;volume=136&amp;amp;publication_year=2002&amp;amp;pages=1089-1092&amp;amp;pmid=12163340&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9884</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9885</code><code>]&lt;/span&gt;</code></p><p><code>9886</code><code>&lt;/span&gt;</code></p><p><code>9887</code><code>&lt;/li&gt;</code></p><p><code>9888</code><code>&lt;li id="R116"&gt;</code></p><p><code>9889</code><code>&lt;span class="citation"&gt;</code></p><p><code>9890</code><code>Breakey WR, Goodell H, Lorenz PC, McHugh PR. Hallucinogenic drugs as precipitants of schizophrenia. &lt;span&gt;</code></p><p><code>9891</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9892</code><code>Psychol Med. &lt;/span&gt;</code></p><p><code>9893</code><code>1974;&lt;span class="ref-vol"&gt;</code></p><p><code>9894</code><code>4&lt;/span&gt;</code></p><p><code>9895</code><code>:255–261.&lt;/span&gt;</code></p><p><code>9896</code><code> [&lt;a href="/pubmed/4427973" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9897</code><code>PubMed&lt;/a&gt;</code></p><p><code>9898</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9899</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychol+Med&amp;amp;title=Hallucinogenic+drugs+as+precipitants+of+schizophrenia&amp;amp;author=WR+Breakey&amp;amp;author=H+Goodell&amp;amp;author=PC+Lorenz&amp;amp;author=PR+McHugh&amp;amp;volume=4&amp;amp;publication_year=1974&amp;amp;pages=255-261&amp;amp;pmid=4427973&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9900</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9901</code><code>]&lt;/span&gt;</code></p><p><code>9902</code><code>&lt;/span&gt;</code></p><p><code>9903</code><code>&lt;/li&gt;</code></p><p><code>9904</code><code>&lt;li id="R117"&gt;</code></p><p><code>9905</code><code>&lt;span class="citation"&gt;</code></p><p><code>9906</code><code>Bredt BM, Higuera-Alhino D, Shade SB, Hebert SJ, McCune JM, Abrams DI. Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients. &lt;span&gt;</code></p><p><code>9907</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9908</code><code>J Clin Pharmacol. &lt;/span&gt;</code></p><p><code>9909</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>9910</code><code>42&lt;/span&gt;</code></p><p><code>9911</code><code>:82s–89s.&lt;/span&gt;</code></p><p><code>9912</code><code> [&lt;a href="/pubmed/12412840" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9913</code><code>PubMed&lt;/a&gt;</code></p><p><code>9914</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9915</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pharmacol&amp;amp;title=Short-term+effects+of+cannabinoids+on+immune+phenotype+and+function+in+HIV-1-infected+patients&amp;amp;author=BM+Bredt&amp;amp;author=D+Higuera-Alhino&amp;amp;author=SB+Shade&amp;amp;author=SJ+Hebert&amp;amp;author=JM+McCune&amp;amp;volume=42&amp;amp;publication_year=2002&amp;amp;pages=82s-89s&amp;amp;pmid=12412840&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9916</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9917</code><code>]&lt;/span&gt;</code></p><p><code>9918</code><code>&lt;/span&gt;</code></p><p><code>9919</code><code>&lt;/li&gt;</code></p><p><code>9920</code><code>&lt;li id="R118"&gt;</code></p><p><code>9921</code><code>&lt;span class="citation"&gt;</code></p><p><code>9922</code><code>Breivogel CS, Griffin G, Di Marzo V, Martin BR. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. &lt;span&gt;</code></p><p><code>9923</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9924</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>9925</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>9926</code><code>60&lt;/span&gt;</code></p><p><code>9927</code><code>:155–163.&lt;/span&gt;</code></p><p><code>9928</code><code> [&lt;a href="/pubmed/11408610" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9929</code><code>PubMed&lt;/a&gt;</code></p><p><code>9930</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9931</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=Evidence+for+a+new+G+protein-coupled+cannabinoid+receptor+in+mouse+brain&amp;amp;author=CS+Breivogel&amp;amp;author=G+Griffin&amp;amp;author=V+Di+Marzo&amp;amp;author=BR+Martin&amp;amp;volume=60&amp;amp;publication_year=2001&amp;amp;pages=155-163&amp;amp;pmid=11408610&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9932</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9933</code><code>]&lt;/span&gt;</code></p><p><code>9934</code><code>&lt;/span&gt;</code></p><p><code>9935</code><code>&lt;/li&gt;</code></p><p><code>9936</code><code>&lt;li id="R119"&gt;</code></p><p><code>9937</code><code>&lt;span class="citation"&gt;</code></p><p><code>9938</code><code>Breivogel CS, Sim LJ, Childers SR. Regional differences in cannabinoid receptor/G-protein coupling in rat brain. &lt;span&gt;</code></p><p><code>9939</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9940</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>9941</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>9942</code><code>282&lt;/span&gt;</code></p><p><code>9943</code><code>:1632–1642.&lt;/span&gt;</code></p><p><code>9944</code><code> [&lt;a href="/pubmed/9316881" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9945</code><code>PubMed&lt;/a&gt;</code></p><p><code>9946</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9947</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Regional+differences+in+cannabinoid+receptor/G-protein+coupling+in+rat+brain&amp;amp;author=CS+Breivogel&amp;amp;author=LJ+Sim&amp;amp;author=SR+Childers&amp;amp;volume=282&amp;amp;publication_year=1997&amp;amp;pages=1632-1642&amp;amp;pmid=9316881&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9948</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9949</code><code>]&lt;/span&gt;</code></p><p><code>9950</code><code>&lt;/span&gt;</code></p><p><code>9951</code><code>&lt;/li&gt;</code></p><p><code>9952</code><code>&lt;li id="R120"&gt;</code></p><p><code>9953</code><code>&lt;span class="citation"&gt;</code></p><p><code>9954</code><code>Brenneisen R, Egli A, Elsohly MA, Henn V, Spiess Y. The effect of orally and rectally administered &amp;#x00394;&lt;sup&gt;</code></p><p><code>9955</code><code>9&lt;/sup&gt;</code></p><p><code>9956</code><code>-tetrahydrocannabinol on spasticity: a pilot study with 2 patients. &lt;span&gt;</code></p><p><code>9957</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9958</code><code>Int J Clin Pharmacol Ther. &lt;/span&gt;</code></p><p><code>9959</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>9960</code><code>34&lt;/span&gt;</code></p><p><code>9961</code><code>:446–452.&lt;/span&gt;</code></p><p><code>9962</code><code> [&lt;a href="/pubmed/8897084" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9963</code><code>PubMed&lt;/a&gt;</code></p><p><code>9964</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9965</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Clin+Pharmacol+Ther&amp;amp;title=The+effect+of+orally+and+rectally+administered+&amp;#x00394;9-tetrahydrocannabinol+on+spasticity:+a+pilot+study+with+2+patients&amp;amp;author=R+Brenneisen&amp;amp;author=A+Egli&amp;amp;author=MA+Elsohly&amp;amp;author=V+Henn&amp;amp;author=Y+Spiess&amp;amp;volume=34&amp;amp;publication_year=1996&amp;amp;pages=446-452&amp;amp;pmid=8897084&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9966</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9967</code><code>]&lt;/span&gt;</code></p><p><code>9968</code><code>&lt;/span&gt;</code></p><p><code>9969</code><code>&lt;/li&gt;</code></p><p><code>9970</code><code>&lt;li id="R121"&gt;</code></p><p><code>9971</code><code>&lt;span class="citation"&gt;</code></p><p><code>9972</code><code>Bridges D, Ahmad K, Rice AS. The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. &lt;span&gt;</code></p><p><code>9973</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9974</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>9975</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>9976</code><code>133&lt;/span&gt;</code></p><p><code>9977</code><code>:586–594.&lt;/span&gt;</code></p><p><code>9978</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>9979</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1572814/"&gt;</code></p><p><code>9980</code><code>PMC free article&lt;/a&gt;</code></p><p><code>9981</code><code>]&lt;/span&gt;</code></p><p><code>9982</code><code> [&lt;a href="/pubmed/11399676" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9983</code><code>PubMed&lt;/a&gt;</code></p><p><code>9984</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>9985</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=The+synthetic+cannabinoid+WIN55,212-2+attenuates+hyperalgesia+and+allodynia+in+a+rat+model+of+neuropathic+pain&amp;amp;author=D+Bridges&amp;amp;author=K+Ahmad&amp;amp;author=AS+Rice&amp;amp;volume=133&amp;amp;publication_year=2001&amp;amp;pages=586-594&amp;amp;pmid=11399676&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>9986</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>9987</code><code>]&lt;/span&gt;</code></p><p><code>9988</code><code>&lt;/span&gt;</code></p><p><code>9989</code><code>&lt;/li&gt;</code></p><p><code>9990</code><code>&lt;li id="R122"&gt;</code></p><p><code>9991</code><code>&lt;span class="citation"&gt;</code></p><p><code>9992</code><code>Britton DR, Koob GF, Rivier J, Vale W. Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. &lt;span&gt;</code></p><p><code>9993</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>9994</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>9995</code><code>1982;&lt;span class="ref-vol"&gt;</code></p><p><code>9996</code><code>31&lt;/span&gt;</code></p><p><code>9997</code><code>:363–367.&lt;/span&gt;</code></p><p><code>9998</code><code> [&lt;a href="/pubmed/6983018" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>9999</code><code>PubMed&lt;/a&gt;</code></p><p><code>10000</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10001</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Intraventricular+corticotropin-releasing+factor+enhances+behavioral+effects+of+novelty&amp;amp;author=DR+Britton&amp;amp;author=GF+Koob&amp;amp;author=J+Rivier&amp;amp;author=W+Vale&amp;amp;volume=31&amp;amp;publication_year=1982&amp;amp;pages=363-367&amp;amp;pmid=6983018&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10002</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10003</code><code>]&lt;/span&gt;</code></p><p><code>10004</code><code>&lt;/span&gt;</code></p><p><code>10005</code><code>&lt;/li&gt;</code></p><p><code>10006</code><code>&lt;li id="R123"&gt;</code></p><p><code>10007</code><code>&lt;span class="citation"&gt;</code></p><p><code>10008</code><code>Brotchie JM. CB&lt;sub&gt;</code></p><p><code>10009</code><code>1&lt;/sub&gt;</code></p><p><code>10010</code><code> cannabinoid receptor signalling in Parkinson&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>10011</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10012</code><code>Curr Opin Pharmacol. &lt;/span&gt;</code></p><p><code>10013</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>10014</code><code>3&lt;/span&gt;</code></p><p><code>10015</code><code>:54–61.&lt;/span&gt;</code></p><p><code>10016</code><code> [&lt;a href="/pubmed/12550742" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10017</code><code>PubMed&lt;/a&gt;</code></p><p><code>10018</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10019</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Pharmacol&amp;amp;title=CB1+cannabinoid+receptor+signalling+in+Parkinson&amp;#x02019;s+disease&amp;amp;author=JM+Brotchie&amp;amp;volume=3&amp;amp;publication_year=2003&amp;amp;pages=54-61&amp;amp;pmid=12550742&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10020</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10021</code><code>]&lt;/span&gt;</code></p><p><code>10022</code><code>&lt;/span&gt;</code></p><p><code>10023</code><code>&lt;/li&gt;</code></p><p><code>10024</code><code>&lt;li id="R124"&gt;</code></p><p><code>10025</code><code>&lt;span class="citation"&gt;</code></p><p><code>10026</code><code>Brown A, Wise A. GlaxoSmithKline, assignee. Identification of modulators of gpr55 activity. &lt;span&gt;</code></p><p><code>10027</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10028</code><code>US patent 20030113814. &lt;/span&gt;</code></p><p><code>10029</code><code>2003&lt;/span&gt;</code></p><p><code>10030</code><code> inventors. Jun 19, 2003. &lt;span class="nowrap"&gt;</code></p><p><code>10031</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=US+patent+20030113814&amp;amp;title=GlaxoSmithKline,+assignee.+Identification+of+modulators+of+gpr55+activity&amp;amp;author=A+Brown&amp;amp;author=A+Wise&amp;amp;publication_year=2003&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10032</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10033</code><code>]&lt;/span&gt;</code></p><p><code>10034</code><code>&lt;/span&gt;</code></p><p><code>10035</code><code>&lt;/li&gt;</code></p><p><code>10036</code><code>&lt;li id="R125"&gt;</code></p><p><code>10037</code><code>&lt;span class="citation"&gt;</code></p><p><code>10038</code><code>Brown B, Adams AJ, Haegerstrom-Portnoy G, Jones RT, Flom MC. Pupil size after use of marijuana and alcohol. &lt;span&gt;</code></p><p><code>10039</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10040</code><code>Am J Ophthalmol. &lt;/span&gt;</code></p><p><code>10041</code><code>1977;&lt;span class="ref-vol"&gt;</code></p><p><code>10042</code><code>83&lt;/span&gt;</code></p><p><code>10043</code><code>:350–354.&lt;/span&gt;</code></p><p><code>10044</code><code> [&lt;a href="/pubmed/322494" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10045</code><code>PubMed&lt;/a&gt;</code></p><p><code>10046</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10047</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Ophthalmol&amp;amp;title=Pupil+size+after+use+of+marijuana+and+alcohol&amp;amp;author=B+Brown&amp;amp;author=AJ+Adams&amp;amp;author=G+Haegerstrom-Portnoy&amp;amp;author=RT+Jones&amp;amp;author=MC+Flom&amp;amp;volume=83&amp;amp;publication_year=1977&amp;amp;pages=350-354&amp;amp;pmid=322494&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10048</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10049</code><code>]&lt;/span&gt;</code></p><p><code>10050</code><code>&lt;/span&gt;</code></p><p><code>10051</code><code>&lt;/li&gt;</code></p><p><code>10052</code><code>&lt;li id="R126"&gt;</code></p><p><code>10053</code><code>&lt;span class="citation"&gt;</code></p><p><code>10054</code><code>Brown TT, Dobs AS. Endocrine effects of marijuana. &lt;span&gt;</code></p><p><code>10055</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10056</code><code>J Clin Pharmacol. &lt;/span&gt;</code></p><p><code>10057</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>10058</code><code>42&lt;/span&gt;</code></p><p><code>10059</code><code>:90S–96S.&lt;/span&gt;</code></p><p><code>10060</code><code> [&lt;a href="/pubmed/12412841" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10061</code><code>PubMed&lt;/a&gt;</code></p><p><code>10062</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10063</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pharmacol&amp;amp;title=Endocrine+effects+of+marijuana&amp;amp;author=TT+Brown&amp;amp;author=AS+Dobs&amp;amp;volume=42&amp;amp;publication_year=2002&amp;amp;pages=90S-96S&amp;amp;pmid=12412841&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10064</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10065</code><code>]&lt;/span&gt;</code></p><p><code>10066</code><code>&lt;/span&gt;</code></p><p><code>10067</code><code>&lt;/li&gt;</code></p><p><code>10068</code><code>&lt;li id="R127"&gt;</code></p><p><code>10069</code><code>&lt;span class="citation"&gt;</code></p><p><code>10070</code><code>Buchwald A, Derendorf H, Ji F, Nagaraja NY, Wu WM, Bodor N. Soft cannabinoid analogues as potential anti-glaucoma agents. &lt;span&gt;</code></p><p><code>10071</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10072</code><code>Pharmazie. &lt;/span&gt;</code></p><p><code>10073</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>10074</code><code>57&lt;/span&gt;</code></p><p><code>10075</code><code>:108–114.&lt;/span&gt;</code></p><p><code>10076</code><code> [&lt;a href="/pubmed/11878185" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10077</code><code>PubMed&lt;/a&gt;</code></p><p><code>10078</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10079</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmazie&amp;amp;title=Soft+cannabinoid+analogues+as+potential+anti-glaucoma+agents&amp;amp;author=A+Buchwald&amp;amp;author=H+Derendorf&amp;amp;author=F+Ji&amp;amp;author=NY+Nagaraja&amp;amp;author=WM+Wu&amp;amp;volume=57&amp;amp;publication_year=2002&amp;amp;pages=108-114&amp;amp;pmid=11878185&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10080</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10081</code><code>]&lt;/span&gt;</code></p><p><code>10082</code><code>&lt;/span&gt;</code></p><p><code>10083</code><code>&lt;/li&gt;</code></p><p><code>10084</code><code>&lt;li id="R128"&gt;</code></p><p><code>10085</code><code>&lt;span class="citation"&gt;</code></p><p><code>10086</code><code>Buckley NE, McCoy KL, Mezey E, Bonner T, Zimmer A, Felder CC, Glass M, Zimmer A. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB&lt;sub&gt;</code></p><p><code>10087</code><code>2&lt;/sub&gt;</code></p><p><code>10088</code><code> receptor. &lt;span&gt;</code></p><p><code>10089</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10090</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>10091</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>10092</code><code>396&lt;/span&gt;</code></p><p><code>10093</code><code>:141–149.&lt;/span&gt;</code></p><p><code>10094</code><code> [&lt;a href="/pubmed/10822068" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10095</code><code>PubMed&lt;/a&gt;</code></p><p><code>10096</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10097</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Immunomodulation+by+cannabinoids+is+absent+in+mice+deficient+for+the+cannabinoid+CB2+receptor&amp;amp;author=NE+Buckley&amp;amp;author=KL+McCoy&amp;amp;author=E+Mezey&amp;amp;author=T+Bonner&amp;amp;author=A+Zimmer&amp;amp;volume=396&amp;amp;publication_year=2000&amp;amp;pages=141-149&amp;amp;pmid=10822068&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10098</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10099</code><code>]&lt;/span&gt;</code></p><p><code>10100</code><code>&lt;/span&gt;</code></p><p><code>10101</code><code>&lt;/li&gt;</code></p><p><code>10102</code><code>&lt;li id="R129"&gt;</code></p><p><code>10103</code><code>&lt;span class="citation"&gt;</code></p><p><code>10104</code><code>Buggy DJ, Toogood L, Maric S, Sharpe P, Lambert DG, Rowbotham DJ. Lack of analgesic efficacy of oral &amp;#x00394;-9-tetrahydrocannabinol in postoperative pain. &lt;span&gt;</code></p><p><code>10105</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10106</code><code>Pain. &lt;/span&gt;</code></p><p><code>10107</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>10108</code><code>106&lt;/span&gt;</code></p><p><code>10109</code><code>:169–172.&lt;/span&gt;</code></p><p><code>10110</code><code> [&lt;a href="/pubmed/14581124" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10111</code><code>PubMed&lt;/a&gt;</code></p><p><code>10112</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10113</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;amp;title=Lack+of+analgesic+efficacy+of+oral+&amp;#x00394;-9-tetrahydrocannabinol+in+postoperative+pain&amp;amp;author=DJ+Buggy&amp;amp;author=L+Toogood&amp;amp;author=S+Maric&amp;amp;author=P+Sharpe&amp;amp;author=DG+Lambert&amp;amp;volume=106&amp;amp;publication_year=2003&amp;amp;pages=169-172&amp;amp;pmid=14581124&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10114</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10115</code><code>]&lt;/span&gt;</code></p><p><code>10116</code><code>&lt;/span&gt;</code></p><p><code>10117</code><code>&lt;/li&gt;</code></p><p><code>10118</code><code>&lt;li id="R130"&gt;</code></p><p><code>10119</code><code>&lt;span class="citation"&gt;</code></p><p><code>10120</code><code>Buonamici M, Young GA, Khazan N. Effects of acute &amp;#x00394;&lt;sup&gt;</code></p><p><code>10121</code><code>9&lt;/sup&gt;</code></p><p><code>10122</code><code>-THC administration on EEG and EEG power spectra in the rat. &lt;span&gt;</code></p><p><code>10123</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10124</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>10125</code><code>1982;&lt;span class="ref-vol"&gt;</code></p><p><code>10126</code><code>21&lt;/span&gt;</code></p><p><code>10127</code><code>:825–829.&lt;/span&gt;</code></p><p><code>10128</code><code> [&lt;a href="/pubmed/6289162" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10129</code><code>PubMed&lt;/a&gt;</code></p><p><code>10130</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10131</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=Effects+of+acute+&amp;#x00394;9-THC+administration+on+EEG+and+EEG+power+spectra+in+the+rat&amp;amp;author=M+Buonamici&amp;amp;author=GA+Young&amp;amp;author=N+Khazan&amp;amp;volume=21&amp;amp;publication_year=1982&amp;amp;pages=825-829&amp;amp;pmid=6289162&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10132</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10133</code><code>]&lt;/span&gt;</code></p><p><code>10134</code><code>&lt;/span&gt;</code></p><p><code>10135</code><code>&lt;/li&gt;</code></p><p><code>10136</code><code>&lt;li id="R131"&gt;</code></p><p><code>10137</code><code>&lt;span class="citation"&gt;</code></p><p><code>10138</code><code>Burdyga G, Lal S, Varro A, Dimaline R, Thompson DG, Dockray DG. Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin. &lt;span&gt;</code></p><p><code>10139</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10140</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>10141</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>10142</code><code>24&lt;/span&gt;</code></p><p><code>10143</code><code>:2708–2715.&lt;/span&gt;</code></p><p><code>10144</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>10145</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6729520/"&gt;</code></p><p><code>10146</code><code>PMC free article&lt;/a&gt;</code></p><p><code>10147</code><code>]&lt;/span&gt;</code></p><p><code>10148</code><code> [&lt;a href="/pubmed/15028763" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10149</code><code>PubMed&lt;/a&gt;</code></p><p><code>10150</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10151</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Expression+of+cannabinoid+CB1+receptors+by+vagal+afferent+neurons+is+inhibited+by+cholecystokinin&amp;amp;author=G+Burdyga&amp;amp;author=S+Lal&amp;amp;author=A+Varro&amp;amp;author=R+Dimaline&amp;amp;author=DG+Thompson&amp;amp;volume=24&amp;amp;publication_year=2004&amp;amp;pages=2708-2715&amp;amp;pmid=15028763&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10152</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10153</code><code>]&lt;/span&gt;</code></p><p><code>10154</code><code>&lt;/span&gt;</code></p><p><code>10155</code><code>&lt;/li&gt;</code></p><p><code>10156</code><code>&lt;li id="R132"&gt;</code></p><p><code>10157</code><code>&lt;span class="citation"&gt;</code></p><p><code>10158</code><code>Burnette-Curley D, Cabral GA. Differential inhibition of RAW264.7 macrophage tumoricidal activity by &amp;#x00394;&lt;sup&gt;</code></p><p><code>10159</code><code>9&lt;/sup&gt;</code></p><p><code>10160</code><code>tetrahydrocannabinol: differential inhibition of RAW264.7 macrophage tumoricidal activity by &amp;#x00394;&lt;sup&gt;</code></p><p><code>10161</code><code>9&lt;/sup&gt;</code></p><p><code>10162</code><code>tetrahydrocannabinol. &lt;span&gt;</code></p><p><code>10163</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10164</code><code>Proc Soc Exp Biol Med. &lt;/span&gt;</code></p><p><code>10165</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>10166</code><code>210&lt;/span&gt;</code></p><p><code>10167</code><code>:64–76.&lt;/span&gt;</code></p><p><code>10168</code><code> [&lt;a href="/pubmed/7675800" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10169</code><code>PubMed&lt;/a&gt;</code></p><p><code>10170</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10171</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Soc+Exp+Biol+Med&amp;amp;title=Differential+inhibition+of+RAW264.7+macrophage+tumoricidal+activity+by+&amp;#x00394;9tetrahydrocannabinol:+differential+inhibition+of+RAW264.7+macrophage+tumoricidal+activity+by+&amp;#x00394;9tetrahydrocannabinol&amp;amp;author=D+Burnette-Curley&amp;amp;author=GA+Cabral&amp;amp;volume=210&amp;amp;publication_year=1995&amp;amp;pages=64-76&amp;amp;pmid=7675800&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10172</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10173</code><code>]&lt;/span&gt;</code></p><p><code>10174</code><code>&lt;/span&gt;</code></p><p><code>10175</code><code>&lt;/li&gt;</code></p><p><code>10176</code><code>&lt;li id="R133"&gt;</code></p><p><code>10177</code><code>&lt;span class="citation"&gt;</code></p><p><code>10178</code><code>Burns TL, Ineck JR. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain. &lt;span&gt;</code></p><p><code>10179</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10180</code><code>Ann Pharmacother. &lt;/span&gt;</code></p><p><code>10181</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>10182</code><code>40&lt;/span&gt;</code></p><p><code>10183</code><code>:251–260.&lt;/span&gt;</code></p><p><code>10184</code><code> [&lt;a href="/pubmed/16449552" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10185</code><code>PubMed&lt;/a&gt;</code></p><p><code>10186</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10187</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Ann+Pharmacother&amp;amp;title=Cannabinoid+analgesia+as+a+potential+new+therapeutic+option+in+the+treatment+of+chronic+pain&amp;amp;author=TL+Burns&amp;amp;author=JR+Ineck&amp;amp;volume=40&amp;amp;publication_year=2006&amp;amp;pages=251-260&amp;amp;pmid=16449552&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10188</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10189</code><code>]&lt;/span&gt;</code></p><p><code>10190</code><code>&lt;/span&gt;</code></p><p><code>10191</code><code>&lt;/li&gt;</code></p><p><code>10192</code><code>&lt;li id="R134"&gt;</code></p><p><code>10193</code><code>&lt;span class="citation"&gt;</code></p><p><code>10194</code><code>Burstein S. Ajulemic acid (IP-751): synthesis, proof of principle, toxicity studies, and clinical trials. &lt;span&gt;</code></p><p><code>10195</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10196</code><code>AAPS J. &lt;/span&gt;</code></p><p><code>10197</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>10198</code><code>7&lt;/span&gt;</code></p><p><code>10199</code><code>:E143–E148.&lt;/span&gt;</code></p><p><code>10200</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>10201</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2751505/"&gt;</code></p><p><code>10202</code><code>PMC free article&lt;/a&gt;</code></p><p><code>10203</code><code>]&lt;/span&gt;</code></p><p><code>10204</code><code> [&lt;a href="/pubmed/16146336" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10205</code><code>PubMed&lt;/a&gt;</code></p><p><code>10206</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10207</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=AAPS+J&amp;amp;title=Ajulemic+acid+(IP-751):+synthesis,+proof+of+principle,+toxicity+studies,+and+clinical+trials&amp;amp;author=S+Burstein&amp;amp;volume=7&amp;amp;publication_year=2005&amp;amp;pages=E143-E148&amp;amp;pmid=16146336&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10208</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10209</code><code>]&lt;/span&gt;</code></p><p><code>10210</code><code>&lt;/span&gt;</code></p><p><code>10211</code><code>&lt;/li&gt;</code></p><p><code>10212</code><code>&lt;li id="R135"&gt;</code></p><p><code>10213</code><code>&lt;span class="citation"&gt;</code></p><p><code>10214</code><code>Burstein SH. Ajulemic acid (CT3): a potent analog of the acid metabolites of THC. &lt;span&gt;</code></p><p><code>10215</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10216</code><code>Curr Pharm Des. &lt;/span&gt;</code></p><p><code>10217</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>10218</code><code>6&lt;/span&gt;</code></p><p><code>10219</code><code>:1339–1345.&lt;/span&gt;</code></p><p><code>10220</code><code> [&lt;a href="/pubmed/10903396" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10221</code><code>PubMed&lt;/a&gt;</code></p><p><code>10222</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10223</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Pharm+Des&amp;amp;title=Ajulemic+acid+(CT3):+a+potent+analog+of+the+acid+metabolites+of+THC&amp;amp;author=SH+Burstein&amp;amp;volume=6&amp;amp;publication_year=2000&amp;amp;pages=1339-1345&amp;amp;pmid=10903396&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10224</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10225</code><code>]&lt;/span&gt;</code></p><p><code>10226</code><code>&lt;/span&gt;</code></p><p><code>10227</code><code>&lt;/li&gt;</code></p><p><code>10228</code><code>&lt;li id="R136"&gt;</code></p><p><code>10229</code><code>&lt;span class="citation"&gt;</code></p><p><code>10230</code><code>Burstein SH, Audette CA, Breuer A, Devane WA, Colodner S, Doyle SA, Mechoulam R. Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities. &lt;span&gt;</code></p><p><code>10231</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10232</code><code>J Med Chem. &lt;/span&gt;</code></p><p><code>10233</code><code>1992;&lt;span class="ref-vol"&gt;</code></p><p><code>10234</code><code>35&lt;/span&gt;</code></p><p><code>10235</code><code>:3135–3141.&lt;/span&gt;</code></p><p><code>10236</code><code> [&lt;a href="/pubmed/1507202" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10237</code><code>PubMed&lt;/a&gt;</code></p><p><code>10238</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10239</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;amp;title=Synthetic+nonpsychotropic+cannabinoids+with+potent+antiinflammatory,+analgesic,+and+leukocyte+antiadhesion+activities&amp;amp;author=SH+Burstein&amp;amp;author=CA+Audette&amp;amp;author=A+Breuer&amp;amp;author=WA+Devane&amp;amp;author=S+Colodner&amp;amp;volume=35&amp;amp;publication_year=1992&amp;amp;pages=3135-3141&amp;amp;pmid=1507202&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10240</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10241</code><code>]&lt;/span&gt;</code></p><p><code>10242</code><code>&lt;/span&gt;</code></p><p><code>10243</code><code>&lt;/li&gt;</code></p><p><code>10244</code><code>&lt;li id="R137"&gt;</code></p><p><code>10245</code><code>&lt;span class="citation"&gt;</code></p><p><code>10246</code><code>Burstein SH, Friderichs E, Kogel B, Schneider J, Selve N. Analgesic effects of 1&amp;#x02032;,1&amp;#x02032; dimethylheptyl-&amp;#x00394;&lt;sup&gt;</code></p><p><code>10247</code><code>8&lt;/sup&gt;</code></p><p><code>10248</code><code>-THC-11-oic acid (CT3) in mice. &lt;span&gt;</code></p><p><code>10249</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10250</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>10251</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>10252</code><code>63&lt;/span&gt;</code></p><p><code>10253</code><code>:161–168.&lt;/span&gt;</code></p><p><code>10254</code><code> [&lt;a href="/pubmed/9698045" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10255</code><code>PubMed&lt;/a&gt;</code></p><p><code>10256</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10257</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Analgesic+effects+of+1&amp;#x02032;,1&amp;#x02032;+dimethylheptyl-&amp;#x00394;8-THC-11-oic+acid+(CT3)+in+mice&amp;amp;author=SH+Burstein&amp;amp;author=E+Friderichs&amp;amp;author=B+Kogel&amp;amp;author=J+Schneider&amp;amp;author=N+Selve&amp;amp;volume=63&amp;amp;publication_year=1998&amp;amp;pages=161-168&amp;amp;pmid=9698045&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10258</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10259</code><code>]&lt;/span&gt;</code></p><p><code>10260</code><code>&lt;/span&gt;</code></p><p><code>10261</code><code>&lt;/li&gt;</code></p><p><code>10262</code><code>&lt;li id="R138"&gt;</code></p><p><code>10263</code><code>&lt;span class="citation"&gt;</code></p><p><code>10264</code><code>Burstein SH, Karst M, Schneider U, Zurier RB. Ajulemic acid: a novel cannabinoid produces analgesia without a &amp;#x0201c;high. &lt;span&gt;</code></p><p><code>10265</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10266</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>10267</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>10268</code><code>75&lt;/span&gt;</code></p><p><code>10269</code><code>:1513–1522.&lt;/span&gt;</code></p><p><code>10270</code><code> [&lt;a href="/pubmed/15240185" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10271</code><code>PubMed&lt;/a&gt;</code></p><p><code>10272</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10273</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Ajulemic+acid:+a+novel+cannabinoid+produces+analgesia+without+a+&amp;#x0201c;high&amp;amp;author=SH+Burstein&amp;amp;author=M+Karst&amp;amp;author=U+Schneider&amp;amp;author=RB+Zurier&amp;amp;volume=75&amp;amp;publication_year=2004&amp;amp;pages=1513-1522&amp;amp;pmid=15240185&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10274</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10275</code><code>]&lt;/span&gt;</code></p><p><code>10276</code><code>&lt;/span&gt;</code></p><p><code>10277</code><code>&lt;/li&gt;</code></p><p><code>10278</code><code>&lt;li id="R139"&gt;</code></p><p><code>10279</code><code>&lt;span class="citation"&gt;</code></p><p><code>10280</code><code>Buxbaum DM. Analgesic activity of &amp;#x00394;&lt;sup&gt;</code></p><p><code>10281</code><code>9&lt;/sup&gt;</code></p><p><code>10282</code><code>-tetrahydrocannabinol in the rat and mouse. &lt;span&gt;</code></p><p><code>10283</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10284</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>10285</code><code>1972;&lt;span class="ref-vol"&gt;</code></p><p><code>10286</code><code>25&lt;/span&gt;</code></p><p><code>10287</code><code>:275–280.&lt;/span&gt;</code></p><p><code>10288</code><code> [&lt;a href="/pubmed/5044401" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10289</code><code>PubMed&lt;/a&gt;</code></p><p><code>10290</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10291</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Analgesic+activity+of+&amp;#x00394;9-tetrahydrocannabinol+in+the+rat+and+mouse&amp;amp;author=DM+Buxbaum&amp;amp;volume=25&amp;amp;publication_year=1972&amp;amp;pages=275-280&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10292</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10293</code><code>]&lt;/span&gt;</code></p><p><code>10294</code><code>&lt;/span&gt;</code></p><p><code>10295</code><code>&lt;/li&gt;</code></p><p><code>10296</code><code>&lt;li id="R140"&gt;</code></p><p><code>10297</code><code>&lt;span class="citation"&gt;</code></p><p><code>10298</code><code>Cabral GA, Fischer-Stenger K. Inhibition of macrophage inducible protein expression by &amp;#x00394;-9-tetrahydrocannabinol. &lt;span&gt;</code></p><p><code>10299</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10300</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>10301</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>10302</code><code>54&lt;/span&gt;</code></p><p><code>10303</code><code>:1831–1844.&lt;/span&gt;</code></p><p><code>10304</code><code> [&lt;a href="/pubmed/8196497" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10305</code><code>PubMed&lt;/a&gt;</code></p><p><code>10306</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10307</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Inhibition+of+macrophage+inducible+protein+expression+by+&amp;#x00394;-9-tetrahydrocannabinol&amp;amp;author=GA+Cabral&amp;amp;author=K+Fischer-Stenger&amp;amp;volume=54&amp;amp;publication_year=1994&amp;amp;pages=1831-1844&amp;amp;pmid=8196497&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10308</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10309</code><code>]&lt;/span&gt;</code></p><p><code>10310</code><code>&lt;/span&gt;</code></p><p><code>10311</code><code>&lt;/li&gt;</code></p><p><code>10312</code><code>&lt;li id="R141"&gt;</code></p><p><code>10313</code><code>&lt;span class="citation"&gt;</code></p><p><code>10314</code><code>Cabral GA, Mishkin EM, Marciano-Cabral F, Coleman P, Harris L, Munson AE. Effect of &amp;#x00394;&lt;sup&gt;</code></p><p><code>10315</code><code>9&lt;/sup&gt;</code></p><p><code>10316</code><code>-tetrahydrocannabinol on herpes simplex virus type 2 vaginal infection in the guinea pig. &lt;span&gt;</code></p><p><code>10317</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10318</code><code>Proc Soc Exp Biol Med. &lt;/span&gt;</code></p><p><code>10319</code><code>1986;&lt;span class="ref-vol"&gt;</code></p><p><code>10320</code><code>182&lt;/span&gt;</code></p><p><code>10321</code><code>:181–186.&lt;/span&gt;</code></p><p><code>10322</code><code> [&lt;a href="/pubmed/3010327" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10323</code><code>PubMed&lt;/a&gt;</code></p><p><code>10324</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10325</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Soc+Exp+Biol+Med&amp;amp;title=Effect+of+&amp;#x00394;9-tetrahydrocannabinol+on+herpes+simplex+virus+type+2+vaginal+infection+in+the+guinea+pig&amp;amp;author=GA+Cabral&amp;amp;author=EM+Mishkin&amp;amp;author=F+Marciano-Cabral&amp;amp;author=P+Coleman&amp;amp;author=L+Harris&amp;amp;volume=182&amp;amp;publication_year=1986&amp;amp;pages=181-186&amp;amp;pmid=3010327&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10326</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10327</code><code>]&lt;/span&gt;</code></p><p><code>10328</code><code>&lt;/span&gt;</code></p><p><code>10329</code><code>&lt;/li&gt;</code></p><p><code>10330</code><code>&lt;li id="R142"&gt;</code></p><p><code>10331</code><code>&lt;span class="citation"&gt;</code></p><p><code>10332</code><code>Cabral GA, Toney DM, Fischer-Stenger K, Harrison MP, Marciano-Cabral F. Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells. &lt;span&gt;</code></p><p><code>10333</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10334</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>10335</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>10336</code><code>56&lt;/span&gt;</code></p><p><code>10337</code><code>:2065–2072.&lt;/span&gt;</code></p><p><code>10338</code><code> [&lt;a href="/pubmed/7776833" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10339</code><code>PubMed&lt;/a&gt;</code></p><p><code>10340</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10341</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Anandamide+inhibits+macrophage-mediated+killing+of+tumor+necrosis+factor-sensitive+cells&amp;amp;author=GA+Cabral&amp;amp;author=DM+Toney&amp;amp;author=K+Fischer-Stenger&amp;amp;author=MP+Harrison&amp;amp;author=F+Marciano-Cabral&amp;amp;volume=56&amp;amp;publication_year=1995&amp;amp;pages=2065-2072&amp;amp;pmid=7776833&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10342</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10343</code><code>]&lt;/span&gt;</code></p><p><code>10344</code><code>&lt;/span&gt;</code></p><p><code>10345</code><code>&lt;/li&gt;</code></p><p><code>10346</code><code>&lt;li id="R143"&gt;</code></p><p><code>10347</code><code>&lt;span class="citation"&gt;</code></p><p><code>10348</code><code>Cadas H, di Tomaso E, Piomelli D. Occurrence and biosynthesis of endogenous cannabinoid precursor &lt;em&gt;</code></p><p><code>10349</code><code>N-&lt;/em&gt;</code></p><p><code>10350</code><code>arachidonoyl phosphatidylethanolamine in rat brain. &lt;span&gt;</code></p><p><code>10351</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10352</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>10353</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>10354</code><code>17&lt;/span&gt;</code></p><p><code>10355</code><code>:1226–1242.&lt;/span&gt;</code></p><p><code>10356</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>10357</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6793739/"&gt;</code></p><p><code>10358</code><code>PMC free article&lt;/a&gt;</code></p><p><code>10359</code><code>]&lt;/span&gt;</code></p><p><code>10360</code><code> [&lt;a href="/pubmed/9006968" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10361</code><code>PubMed&lt;/a&gt;</code></p><p><code>10362</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10363</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Occurrence+and+biosynthesis+of+endogenous+cannabinoid+precursor+N-arachidonoyl+phosphatidylethanolamine+in+rat+brain&amp;amp;author=H+Cadas&amp;amp;author=E+di+Tomaso&amp;amp;author=D+Piomelli&amp;amp;volume=17&amp;amp;publication_year=1997&amp;amp;pages=1226-1242&amp;amp;pmid=9006968&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10364</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10365</code><code>]&lt;/span&gt;</code></p><p><code>10366</code><code>&lt;/span&gt;</code></p><p><code>10367</code><code>&lt;/li&gt;</code></p><p><code>10368</code><code>&lt;li id="R144"&gt;</code></p><p><code>10369</code><code>&lt;span class="citation"&gt;</code></p><p><code>10370</code><code>Caill&amp;#x000e9; S, Parsons LH. Cannabinoid modulation of opiate reinforcement through the ventral striatopallidal pathway. &lt;span&gt;</code></p><p><code>10371</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10372</code><code>Neuropsychopharmacology. &lt;/span&gt;</code></p><p><code>10373</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>10374</code><code>31&lt;/span&gt;</code></p><p><code>10375</code><code>:804–813.&lt;/span&gt;</code></p><p><code>10376</code><code> [&lt;a href="/pubmed/16123766" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10377</code><code>PubMed&lt;/a&gt;</code></p><p><code>10378</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10379</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;amp;title=Cannabinoid+modulation+of+opiate+reinforcement+through+the+ventral+striatopallidal+pathway&amp;amp;author=S+Caill&amp;#x000e9;&amp;amp;author=LH+Parsons&amp;amp;volume=31&amp;amp;publication_year=2006&amp;amp;pages=804-813&amp;amp;pmid=16123766&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10380</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10381</code><code>]&lt;/span&gt;</code></p><p><code>10382</code><code>&lt;/span&gt;</code></p><p><code>10383</code><code>&lt;/li&gt;</code></p><p><code>10384</code><code>&lt;li id="R145"&gt;</code></p><p><code>10385</code><code>&lt;span class="citation"&gt;</code></p><p><code>10386</code><code>Cainazzo MM, Ferrazza G, Mioni C, Bazzani C, Bertolini A, Guarini S. Cannabinoid CB&lt;sub&gt;</code></p><p><code>10387</code><code>1&lt;/sub&gt;</code></p><p><code>10388</code><code> receptor blockade enhances the protective effect of melanocortins in hemorrhagic shock in the rat. &lt;span&gt;</code></p><p><code>10389</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10390</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>10391</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>10392</code><code>441&lt;/span&gt;</code></p><p><code>10393</code><code>:91–97.&lt;/span&gt;</code></p><p><code>10394</code><code> [&lt;a href="/pubmed/12007925" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10395</code><code>PubMed&lt;/a&gt;</code></p><p><code>10396</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10397</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Cannabinoid+CB1+receptor+blockade+enhances+the+protective+effect+of+melanocortins+in+hemorrhagic+shock+in+the+rat&amp;amp;author=MM+Cainazzo&amp;amp;author=G+Ferrazza&amp;amp;author=C+Mioni&amp;amp;author=C+Bazzani&amp;amp;author=A+Bertolini&amp;amp;volume=441&amp;amp;publication_year=2002&amp;amp;pages=91-97&amp;amp;pmid=12007925&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10398</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10399</code><code>]&lt;/span&gt;</code></p><p><code>10400</code><code>&lt;/span&gt;</code></p><p><code>10401</code><code>&lt;/li&gt;</code></p><p><code>10402</code><code>&lt;li id="R146"&gt;</code></p><p><code>10403</code><code>&lt;span class="citation"&gt;</code></p><p><code>10404</code><code>Calignano A, Katona I, Desarnaud F, Giuffrida A, La Rana G, Mackie K, Freund TF, Piomelli D. Bidirectional control of airway responsiveness by endogenous cannabinoids. &lt;span&gt;</code></p><p><code>10405</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10406</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>10407</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>10408</code><code>408&lt;/span&gt;</code></p><p><code>10409</code><code>:96–101.&lt;/span&gt;</code></p><p><code>10410</code><code> [&lt;a href="/pubmed/11081515" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10411</code><code>PubMed&lt;/a&gt;</code></p><p><code>10412</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10413</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Bidirectional+control+of+airway+responsiveness+by+endogenous+cannabinoids&amp;amp;author=A+Calignano&amp;amp;author=I+Katona&amp;amp;author=F+Desarnaud&amp;amp;author=A+Giuffrida&amp;amp;author=G+La+Rana&amp;amp;volume=408&amp;amp;publication_year=2000&amp;amp;pages=96-101&amp;amp;pmid=11081515&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10414</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10415</code><code>]&lt;/span&gt;</code></p><p><code>10416</code><code>&lt;/span&gt;</code></p><p><code>10417</code><code>&lt;/li&gt;</code></p><p><code>10418</code><code>&lt;li id="R147"&gt;</code></p><p><code>10419</code><code>&lt;span class="citation"&gt;</code></p><p><code>10420</code><code>Calignano A, La Rana G, Beltramo M, Makriyannis A, Piomelli D. Potentiation of anandamide hypotension by the transport inhibitor: AM404. &lt;span&gt;</code></p><p><code>10421</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10422</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>10423</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>10424</code><code>337&lt;/span&gt;</code></p><p><code>10425</code><code>:R1–R2.&lt;/span&gt;</code></p><p><code>10426</code><code> [&lt;a href="/pubmed/9389389" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10427</code><code>PubMed&lt;/a&gt;</code></p><p><code>10428</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10429</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Potentiation+of+anandamide+hypotension+by+the+transport+inhibitor:+AM404&amp;amp;author=A+Calignano&amp;amp;author=G+La+Rana&amp;amp;author=M+Beltramo&amp;amp;author=A+Makriyannis&amp;amp;author=D+Piomelli&amp;amp;volume=337&amp;amp;publication_year=1997&amp;amp;pages=R1-R2&amp;amp;pmid=9389389&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10430</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10431</code><code>]&lt;/span&gt;</code></p><p><code>10432</code><code>&lt;/span&gt;</code></p><p><code>10433</code><code>&lt;/li&gt;</code></p><p><code>10434</code><code>&lt;li id="R148"&gt;</code></p><p><code>10435</code><code>&lt;span class="citation"&gt;</code></p><p><code>10436</code><code>Calignano A, La Rana G, Giuffrida A, Piomelli D. Control of pain initiation by endogenous cannabinoids. &lt;span&gt;</code></p><p><code>10437</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10438</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>10439</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>10440</code><code>394&lt;/span&gt;</code></p><p><code>10441</code><code>:277–281.&lt;/span&gt;</code></p><p><code>10442</code><code> [&lt;a href="/pubmed/9685157" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10443</code><code>PubMed&lt;/a&gt;</code></p><p><code>10444</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10445</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Control+of+pain+initiation+by+endogenous+cannabinoids&amp;amp;author=A+Calignano&amp;amp;author=G+La+Rana&amp;amp;author=A+Giuffrida&amp;amp;author=D+Piomelli&amp;amp;volume=394&amp;amp;publication_year=1998&amp;amp;pages=277-281&amp;amp;pmid=9685157&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10446</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10447</code><code>]&lt;/span&gt;</code></p><p><code>10448</code><code>&lt;/span&gt;</code></p><p><code>10449</code><code>&lt;/li&gt;</code></p><p><code>10450</code><code>&lt;li id="R149"&gt;</code></p><p><code>10451</code><code>&lt;span class="citation"&gt;</code></p><p><code>10452</code><code>Campbell AD, McBride WJ. Serotonin-3 receptor and ethanol-stimulated dopamine release in the nucleus accumbens. &lt;span&gt;</code></p><p><code>10453</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10454</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>10455</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>10456</code><code>51&lt;/span&gt;</code></p><p><code>10457</code><code>:835–842.&lt;/span&gt;</code></p><p><code>10458</code><code> [&lt;a href="/pubmed/7675866" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10459</code><code>PubMed&lt;/a&gt;</code></p><p><code>10460</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10461</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Serotonin-3+receptor+and+ethanol-stimulated+dopamine+release+in+the+nucleus+accumbens&amp;amp;author=AD+Campbell&amp;amp;author=WJ+McBride&amp;amp;volume=51&amp;amp;publication_year=1995&amp;amp;pages=835-842&amp;amp;pmid=7675866&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10462</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10463</code><code>]&lt;/span&gt;</code></p><p><code>10464</code><code>&lt;/span&gt;</code></p><p><code>10465</code><code>&lt;/li&gt;</code></p><p><code>10466</code><code>&lt;li id="R150"&gt;</code></p><p><code>10467</code><code>&lt;span class="citation"&gt;</code></p><p><code>10468</code><code>Campbell FA, Tramer MR, Carroll D, Reynolds DJ, Moore RA, McQuay HJ. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. &lt;span&gt;</code></p><p><code>10469</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10470</code><code>BMJ. &lt;/span&gt;</code></p><p><code>10471</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>10472</code><code>323&lt;/span&gt;</code></p><p><code>10473</code><code>:13–16.&lt;/span&gt;</code></p><p><code>10474</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>10475</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC34324/"&gt;</code></p><p><code>10476</code><code>PMC free article&lt;/a&gt;</code></p><p><code>10477</code><code>]&lt;/span&gt;</code></p><p><code>10478</code><code> [&lt;a href="/pubmed/11440935" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10479</code><code>PubMed&lt;/a&gt;</code></p><p><code>10480</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10481</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;amp;title=Are+cannabinoids+an+effective+and+safe+treatment+option+in+the+management+of+pain?+A+qualitative+systematic+review&amp;amp;author=FA+Campbell&amp;amp;author=MR+Tramer&amp;amp;author=D+Carroll&amp;amp;author=DJ+Reynolds&amp;amp;author=RA+Moore&amp;amp;volume=323&amp;amp;publication_year=2001&amp;amp;pages=13-16&amp;amp;pmid=11440935&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10482</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10483</code><code>]&lt;/span&gt;</code></p><p><code>10484</code><code>&lt;/span&gt;</code></p><p><code>10485</code><code>&lt;/li&gt;</code></p><p><code>10486</code><code>&lt;li id="R151"&gt;</code></p><p><code>10487</code><code>&lt;span class="citation"&gt;</code></p><p><code>10488</code><code>Cani PD, Montoya ML, Neyrinck AM, Delzenne NM, Lambert DM. Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenoc cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide. &lt;span&gt;</code></p><p><code>10489</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10490</code><code>Br J Nutr. &lt;/span&gt;</code></p><p><code>10491</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>10492</code><code>92&lt;/span&gt;</code></p><p><code>10493</code><code>:757–761.&lt;/span&gt;</code></p><p><code>10494</code><code> [&lt;a href="/pubmed/15533263" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10495</code><code>PubMed&lt;/a&gt;</code></p><p><code>10496</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10497</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Nutr&amp;amp;title=Potential+modulation+of+plasma+ghrelin+and+glucagon-like+peptide-1+by+anorexigenoc+cannabinoid+compounds,+SR141716A+(rimonabant)+and+oleoylethanolamide&amp;amp;author=PD+Cani&amp;amp;author=ML+Montoya&amp;amp;author=AM+Neyrinck&amp;amp;author=NM+Delzenne&amp;amp;author=DM+Lambert&amp;amp;volume=92&amp;amp;publication_year=2004&amp;amp;pages=757-761&amp;amp;pmid=15533263&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10498</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10499</code><code>]&lt;/span&gt;</code></p><p><code>10500</code><code>&lt;/span&gt;</code></p><p><code>10501</code><code>&lt;/li&gt;</code></p><p><code>10502</code><code>&lt;li id="R152"&gt;</code></p><p><code>10503</code><code>&lt;span class="citation"&gt;</code></p><p><code>10504</code><code>Cannich A, Wotjak CT, Kamprath K, Hermann H, Lutz B, Marsicano G. CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice. &lt;span&gt;</code></p><p><code>10505</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10506</code><code>Learn Mem. &lt;/span&gt;</code></p><p><code>10507</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>10508</code><code>11&lt;/span&gt;</code></p><p><code>10509</code><code>:625–632.&lt;/span&gt;</code></p><p><code>10510</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>10511</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC523082/"&gt;</code></p><p><code>10512</code><code>PMC free article&lt;/a&gt;</code></p><p><code>10513</code><code>]&lt;/span&gt;</code></p><p><code>10514</code><code> [&lt;a href="/pubmed/15466318" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10515</code><code>PubMed&lt;/a&gt;</code></p><p><code>10516</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10517</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Learn+Mem&amp;amp;title=CB1+cannabinoid+receptors+modulate+kinase+and+phosphatase+activity+during+extinction+of+conditioned+fear+in+mice&amp;amp;author=A+Cannich&amp;amp;author=CT+Wotjak&amp;amp;author=K+Kamprath&amp;amp;author=H+Hermann&amp;amp;author=B+Lutz&amp;amp;volume=11&amp;amp;publication_year=2004&amp;amp;pages=625-632&amp;amp;pmid=15466318&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10518</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10519</code><code>]&lt;/span&gt;</code></p><p><code>10520</code><code>&lt;/span&gt;</code></p><p><code>10521</code><code>&lt;/li&gt;</code></p><p><code>10522</code><code>&lt;li id="R153"&gt;</code></p><p><code>10523</code><code>&lt;span class="citation"&gt;</code></p><p><code>10524</code><code>Capasso R, Matias I, Lutz B, Borrelli F, Capasso F, Marsicano G, Mascolo N, Petrosino S, Monory K, Valenti M, et al.  Fatty acid amide hydrolase controls mouse intestinal motility in vivo. &lt;span&gt;</code></p><p><code>10525</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10526</code><code>Gastroenterology. &lt;/span&gt;</code></p><p><code>10527</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>10528</code><code>129&lt;/span&gt;</code></p><p><code>10529</code><code>:941–951.&lt;/span&gt;</code></p><p><code>10530</code><code> [&lt;a href="/pubmed/16143133" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10531</code><code>PubMed&lt;/a&gt;</code></p><p><code>10532</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10533</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;amp;title=Fatty+acid+amide+hydrolase+controls+mouse+intestinal+motility+in+vivo&amp;amp;author=R+Capasso&amp;amp;author=I+Matias&amp;amp;author=B+Lutz&amp;amp;author=F+Borrelli&amp;amp;author=F+Capasso&amp;amp;volume=129&amp;amp;publication_year=2005&amp;amp;pages=941-951&amp;amp;pmid=16143133&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10534</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10535</code><code>]&lt;/span&gt;</code></p><p><code>10536</code><code>&lt;/span&gt;</code></p><p><code>10537</code><code>&lt;/li&gt;</code></p><p><code>10538</code><code>&lt;li id="R154"&gt;</code></p><p><code>10539</code><code>&lt;span class="citation"&gt;</code></p><p><code>10540</code><code>Caplan GA, Brigham BA. Marijuana smoking and carcinoma of the tongue: is there an association? &lt;span&gt;</code></p><p><code>10541</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10542</code><code>Cancer. &lt;/span&gt;</code></p><p><code>10543</code><code>1990;&lt;span class="ref-vol"&gt;</code></p><p><code>10544</code><code>66&lt;/span&gt;</code></p><p><code>10545</code><code>:1005–1006.&lt;/span&gt;</code></p><p><code>10546</code><code> [&lt;a href="/pubmed/2201429" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10547</code><code>PubMed&lt;/a&gt;</code></p><p><code>10548</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10549</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;amp;title=Marijuana+smoking+and+carcinoma+of+the+tongue:+is+there+an+association?&amp;amp;author=GA+Caplan&amp;amp;author=BA+Brigham&amp;amp;volume=66&amp;amp;publication_year=1990&amp;amp;pages=1005-1006&amp;amp;pmid=2201429&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10550</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10551</code><code>]&lt;/span&gt;</code></p><p><code>10552</code><code>&lt;/span&gt;</code></p><p><code>10553</code><code>&lt;/li&gt;</code></p><p><code>10554</code><code>&lt;li id="R155"&gt;</code></p><p><code>10555</code><code>&lt;span class="citation"&gt;</code></p><p><code>10556</code><code>Carlini EA, Mechoulam R, Lander N. Anticonvulsant activity of four oxygenated cannabidiol derivatives. &lt;span&gt;</code></p><p><code>10557</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10558</code><code>Res Commun Chem Pathol Pharmacol. &lt;/span&gt;</code></p><p><code>10559</code><code>1975;&lt;span class="ref-vol"&gt;</code></p><p><code>10560</code><code>12&lt;/span&gt;</code></p><p><code>10561</code><code>:1–15.&lt;/span&gt;</code></p><p><code>10562</code><code> [&lt;a href="/pubmed/1188178" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10563</code><code>PubMed&lt;/a&gt;</code></p><p><code>10564</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10565</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Res+Commun+Chem+Pathol+Pharmacol&amp;amp;title=Anticonvulsant+activity+of+four+oxygenated+cannabidiol+derivatives&amp;amp;author=EA+Carlini&amp;amp;author=R+Mechoulam&amp;amp;author=N+Lander&amp;amp;volume=12&amp;amp;publication_year=1975&amp;amp;pages=1-15&amp;amp;pmid=1188178&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10566</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10567</code><code>]&lt;/span&gt;</code></p><p><code>10568</code><code>&lt;/span&gt;</code></p><p><code>10569</code><code>&lt;/li&gt;</code></p><p><code>10570</code><code>&lt;li id="R156"&gt;</code></p><p><code>10571</code><code>&lt;span class="citation"&gt;</code></p><p><code>10572</code><code>Carlisle SJ, Marciano-Cabral F, Staab A, Ludwick C, Cabral GA. Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation. &lt;span&gt;</code></p><p><code>10573</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10574</code><code>Int Immunopharmacol. &lt;/span&gt;</code></p><p><code>10575</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>10576</code><code>2&lt;/span&gt;</code></p><p><code>10577</code><code>:69–82.&lt;/span&gt;</code></p><p><code>10578</code><code> [&lt;a href="/pubmed/11789671" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10579</code><code>PubMed&lt;/a&gt;</code></p><p><code>10580</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10581</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Int+Immunopharmacol&amp;amp;title=Differential+expression+of+the+CB2+cannabinoid+receptor+by+rodent+macrophages+and+macrophage-like+cells+in+relation+to+cell+activation&amp;amp;author=SJ+Carlisle&amp;amp;author=F+Marciano-Cabral&amp;amp;author=A+Staab&amp;amp;author=C+Ludwick&amp;amp;author=GA+Cabral&amp;amp;volume=2&amp;amp;publication_year=2002&amp;amp;pages=69-82&amp;amp;pmid=11789671&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10582</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10583</code><code>]&lt;/span&gt;</code></p><p><code>10584</code><code>&lt;/span&gt;</code></p><p><code>10585</code><code>&lt;/li&gt;</code></p><p><code>10586</code><code>&lt;li id="R157"&gt;</code></p><p><code>10587</code><code>&lt;span class="citation"&gt;</code></p><p><code>10588</code><code>Carracedo A, Lorente M, Egia A, Blazquez C, Garcia S, Giroux V, Malicet C, Villuendas R, Gironella M, Gonzalez-Feria L, et al.  The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells. &lt;span&gt;</code></p><p><code>10589</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10590</code><code>Cancer Cell. &lt;/span&gt;</code></p><p><code>10591</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>10592</code><code>9&lt;/span&gt;</code></p><p><code>10593</code><code>:301–312.&lt;/span&gt;</code></p><p><code>10594</code><code> [&lt;a href="/pubmed/16616335" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10595</code><code>PubMed&lt;/a&gt;</code></p><p><code>10596</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10597</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Cell&amp;amp;title=The+stress-regulated+protein+p8+mediates+cannabinoid-induced+apoptosis+of+tumor+cells&amp;amp;author=A+Carracedo&amp;amp;author=M+Lorente&amp;amp;author=A+Egia&amp;amp;author=C+Blazquez&amp;amp;author=S+Garcia&amp;amp;volume=9&amp;amp;publication_year=2006&amp;amp;pages=301-312&amp;amp;pmid=16616335&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10598</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10599</code><code>]&lt;/span&gt;</code></p><p><code>10600</code><code>&lt;/span&gt;</code></p><p><code>10601</code><code>&lt;/li&gt;</code></p><p><code>10602</code><code>&lt;li id="R158"&gt;</code></p><p><code>10603</code><code>&lt;span class="citation"&gt;</code></p><p><code>10604</code><code>Carrier EJ, Auchampach JA, Hillard CJ. Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. &lt;span&gt;</code></p><p><code>10605</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10606</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>10607</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>10608</code><code>103&lt;/span&gt;</code></p><p><code>10609</code><code>:7895–7900.&lt;/span&gt;</code></p><p><code>10610</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>10611</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1472541/"&gt;</code></p><p><code>10612</code><code>PMC free article&lt;/a&gt;</code></p><p><code>10613</code><code>]&lt;/span&gt;</code></p><p><code>10614</code><code> [&lt;a href="/pubmed/16672367" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10615</code><code>PubMed&lt;/a&gt;</code></p><p><code>10616</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10617</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Inhibition+of+an+equilibrative+nucleoside+transporter+by+cannabidiol:+a+mechanism+of+cannabinoid+immunosuppression&amp;amp;author=EJ+Carrier&amp;amp;author=JA+Auchampach&amp;amp;author=CJ+Hillard&amp;amp;volume=103&amp;amp;publication_year=2006&amp;amp;pages=7895-7900&amp;amp;pmid=16672367&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10618</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10619</code><code>]&lt;/span&gt;</code></p><p><code>10620</code><code>&lt;/span&gt;</code></p><p><code>10621</code><code>&lt;/li&gt;</code></p><p><code>10622</code><code>&lt;li id="R159"&gt;</code></p><p><code>10623</code><code>&lt;span class="citation"&gt;</code></p><p><code>10624</code><code>Carter GT, Rosen BS. Marijuana in the management of amyotrophic lateral sclerosis. &lt;span&gt;</code></p><p><code>10625</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10626</code><code>Am J Hosp Palliat Care. &lt;/span&gt;</code></p><p><code>10627</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>10628</code><code>18&lt;/span&gt;</code></p><p><code>10629</code><code>:264–270.&lt;/span&gt;</code></p><p><code>10630</code><code> [&lt;a href="/pubmed/11467101" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10631</code><code>PubMed&lt;/a&gt;</code></p><p><code>10632</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10633</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hosp+Palliat+Care&amp;amp;title=Marijuana+in+the+management+of+amyotrophic+lateral+sclerosis&amp;amp;author=GT+Carter&amp;amp;author=BS+Rosen&amp;amp;volume=18&amp;amp;publication_year=2001&amp;amp;pages=264-270&amp;amp;pmid=11467101&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10634</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10635</code><code>]&lt;/span&gt;</code></p><p><code>10636</code><code>&lt;/span&gt;</code></p><p><code>10637</code><code>&lt;/li&gt;</code></p><p><code>10638</code><code>&lt;li id="R160"&gt;</code></p><p><code>10639</code><code>&lt;span class="citation"&gt;</code></p><p><code>10640</code><code>Casanova ML, Blazquez C, Martinez-Palacio J, Villanueva C, Fernandez-Acenero MJ, Huffman JW, Jorcano JL, Guzman M. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. &lt;span&gt;</code></p><p><code>10641</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10642</code><code>J Clin Investig. &lt;/span&gt;</code></p><p><code>10643</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>10644</code><code>111&lt;/span&gt;</code></p><p><code>10645</code><code>:43–50.&lt;/span&gt;</code></p><p><code>10646</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>10647</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC151833/"&gt;</code></p><p><code>10648</code><code>PMC free article&lt;/a&gt;</code></p><p><code>10649</code><code>]&lt;/span&gt;</code></p><p><code>10650</code><code> [&lt;a href="/pubmed/12511587" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10651</code><code>PubMed&lt;/a&gt;</code></p><p><code>10652</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10653</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Investig&amp;amp;title=Inhibition+of+skin+tumor+growth+and+angiogenesis+in+vivo+by+activation+of+cannabinoid+receptors&amp;amp;author=ML+Casanova&amp;amp;author=C+Blazquez&amp;amp;author=J+Martinez-Palacio&amp;amp;author=C+Villanueva&amp;amp;author=MJ+Fernandez-Acenero&amp;amp;volume=111&amp;amp;publication_year=2003&amp;amp;pages=43-50&amp;amp;pmid=12511587&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10654</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10655</code><code>]&lt;/span&gt;</code></p><p><code>10656</code><code>&lt;/span&gt;</code></p><p><code>10657</code><code>&lt;/li&gt;</code></p><p><code>10658</code><code>&lt;li id="R161"&gt;</code></p><p><code>10659</code><code>&lt;span class="citation"&gt;</code></p><p><code>10660</code><code>Castane A, Valjent E, Ledent C, Parmentier M, Maldonado R, Valverde O. Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. &lt;span&gt;</code></p><p><code>10661</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10662</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>10663</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>10664</code><code>43&lt;/span&gt;</code></p><p><code>10665</code><code>:857–867.&lt;/span&gt;</code></p><p><code>10666</code><code> [&lt;a href="/pubmed/12384171" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10667</code><code>PubMed&lt;/a&gt;</code></p><p><code>10668</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10669</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=Lack+of+CB1+cannabinoid+receptors+modifies+nicotine+behavioural+responses,+but+not+nicotine+abstinence&amp;amp;author=A+Castane&amp;amp;author=E+Valjent&amp;amp;author=C+Ledent&amp;amp;author=M+Parmentier&amp;amp;author=R+Maldonado&amp;amp;volume=43&amp;amp;publication_year=2002&amp;amp;pages=857-867&amp;amp;pmid=12384171&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10670</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10671</code><code>]&lt;/span&gt;</code></p><p><code>10672</code><code>&lt;/span&gt;</code></p><p><code>10673</code><code>&lt;/li&gt;</code></p><p><code>10674</code><code>&lt;li id="R162"&gt;</code></p><p><code>10675</code><code>&lt;span class="citation"&gt;</code></p><p><code>10676</code><code>Casu MA, Porcella A, Ruiu S, Saba P, Marchese G, Carai MA, Reali R, Gessa GL, Pani L. Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract. &lt;span&gt;</code></p><p><code>10677</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10678</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>10679</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>10680</code><code>459&lt;/span&gt;</code></p><p><code>10681</code><code>:97–105.&lt;/span&gt;</code></p><p><code>10682</code><code> [&lt;a href="/pubmed/12505538" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10683</code><code>PubMed&lt;/a&gt;</code></p><p><code>10684</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10685</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Differential+distribution+of+functional+cannabinoid+CB1+receptors+in+the+mouse+gastroenteric+tract&amp;amp;author=MA+Casu&amp;amp;author=A+Porcella&amp;amp;author=S+Ruiu&amp;amp;author=P+Saba&amp;amp;author=G+Marchese&amp;amp;volume=459&amp;amp;publication_year=2003&amp;amp;pages=97-105&amp;amp;pmid=12505538&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10686</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10687</code><code>]&lt;/span&gt;</code></p><p><code>10688</code><code>&lt;/span&gt;</code></p><p><code>10689</code><code>&lt;/li&gt;</code></p><p><code>10690</code><code>&lt;li id="R163"&gt;</code></p><p><code>10691</code><code>&lt;span class="citation"&gt;</code></p><p><code>10692</code><code>Caulfield MP, Brown DA. Cannabinoid receptor agonists inhibit Ca current in NG108&amp;#x02013;15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. &lt;span&gt;</code></p><p><code>10693</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10694</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>10695</code><code>1992;&lt;span class="ref-vol"&gt;</code></p><p><code>10696</code><code>106&lt;/span&gt;</code></p><p><code>10697</code><code>:231–232.&lt;/span&gt;</code></p><p><code>10698</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>10699</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1907498/"&gt;</code></p><p><code>10700</code><code>PMC free article&lt;/a&gt;</code></p><p><code>10701</code><code>]&lt;/span&gt;</code></p><p><code>10702</code><code> [&lt;a href="/pubmed/1327374" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10703</code><code>PubMed&lt;/a&gt;</code></p><p><code>10704</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10705</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Cannabinoid+receptor+agonists+inhibit+Ca+current+in+NG108&amp;#x02013;15+neuroblastoma+cells+via+a+pertussis+toxin-sensitive+mechanism&amp;amp;author=MP+Caulfield&amp;amp;author=DA+Brown&amp;amp;volume=106&amp;amp;publication_year=1992&amp;amp;pages=231-232&amp;amp;pmid=1327374&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10706</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10707</code><code>]&lt;/span&gt;</code></p><p><code>10708</code><code>&lt;/span&gt;</code></p><p><code>10709</code><code>&lt;/li&gt;</code></p><p><code>10710</code><code>&lt;li id="R164"&gt;</code></p><p><code>10711</code><code>&lt;span class="citation"&gt;</code></p><p><code>10712</code><code>Cavero I, Buckley JP, Jandhyala BS. Parasympatholytic activity of (&amp;#x02212;)-9-&lt;em&gt;</code></p><p><code>10713</code><code>trans&lt;/em&gt;</code></p><p><code>10714</code><code>-tetrahydrocannabinol in mongrel dogs. &lt;span&gt;</code></p><p><code>10715</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10716</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>10717</code><code>1972;&lt;span class="ref-vol"&gt;</code></p><p><code>10718</code><code>19&lt;/span&gt;</code></p><p><code>10719</code><code>:301–304.&lt;/span&gt;</code></p><p><code>10720</code><code> [&lt;a href="/pubmed/5071803" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10721</code><code>PubMed&lt;/a&gt;</code></p><p><code>10722</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10723</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Parasympatholytic+activity+of+(&amp;#x02212;)-9-trans-tetrahydrocannabinol+in+mongrel+dogs&amp;amp;author=I+Cavero&amp;amp;author=JP+Buckley&amp;amp;author=BS+Jandhyala&amp;amp;volume=19&amp;amp;publication_year=1972&amp;amp;pages=301-304&amp;amp;pmid=5071803&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10724</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10725</code><code>]&lt;/span&gt;</code></p><p><code>10726</code><code>&lt;/span&gt;</code></p><p><code>10727</code><code>&lt;/li&gt;</code></p><p><code>10728</code><code>&lt;li id="R165"&gt;</code></p><p><code>10729</code><code>&lt;span class="citation"&gt;</code></p><p><code>10730</code><code>Centonze D, Gubellini P, Rossi S, Picconi B, Pisani A, Bernardi G, Calabresi P, Baunez C. Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism. &lt;span&gt;</code></p><p><code>10731</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10732</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>10733</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>10734</code><code>133&lt;/span&gt;</code></p><p><code>10735</code><code>:831–840.&lt;/span&gt;</code></p><p><code>10736</code><code> [&lt;a href="/pubmed/15893432" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10737</code><code>PubMed&lt;/a&gt;</code></p><p><code>10738</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10739</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Subthalamic+nucleus+lesion+reverses+motor+abnormalities+and+striatal+glutamatergic+overactivity+in+experimental+parkinsonism&amp;amp;author=D+Centonze&amp;amp;author=P+Gubellini&amp;amp;author=S+Rossi&amp;amp;author=B+Picconi&amp;amp;author=A+Pisani&amp;amp;volume=133&amp;amp;publication_year=2005&amp;amp;pages=831-840&amp;amp;pmid=15893432&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10740</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10741</code><code>]&lt;/span&gt;</code></p><p><code>10742</code><code>&lt;/span&gt;</code></p><p><code>10743</code><code>&lt;/li&gt;</code></p><p><code>10744</code><code>&lt;li id="R166"&gt;</code></p><p><code>10745</code><code>&lt;span class="citation"&gt;</code></p><p><code>10746</code><code>Chambers AP, Sharkey KA, Koopmans HS. Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the rat. &lt;span&gt;</code></p><p><code>10747</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10748</code><code>Physiol Behav. &lt;/span&gt;</code></p><p><code>10749</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>10750</code><code>82&lt;/span&gt;</code></p><p><code>10751</code><code>:863–869.&lt;/span&gt;</code></p><p><code>10752</code><code> [&lt;a href="/pubmed/15451651" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10753</code><code>PubMed&lt;/a&gt;</code></p><p><code>10754</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10755</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Physiol+Behav&amp;amp;title=Cannabinoid+(CB)1+receptor+antagonist,+AM+251,+causes+a+sustained+reduction+of+daily+food+intake+in+the+rat&amp;amp;author=AP+Chambers&amp;amp;author=KA+Sharkey&amp;amp;author=HS+Koopmans&amp;amp;volume=82&amp;amp;publication_year=2003&amp;amp;pages=863-869&amp;amp;pmid=15451651&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10756</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10757</code><code>]&lt;/span&gt;</code></p><p><code>10758</code><code>&lt;/span&gt;</code></p><p><code>10759</code><code>&lt;/li&gt;</code></p><p><code>10760</code><code>&lt;li id="R167"&gt;</code></p><p><code>10761</code><code>&lt;span class="citation"&gt;</code></p><p><code>10762</code><code>Chan CC, Hwang SJ, Lee FY, Wang SS, Chang FY, Li CP, Chu CJ, Lu RH, Lee SD. Prognostic value of plasma endotoxin levels in patients with cirrhosis. &lt;span&gt;</code></p><p><code>10763</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10764</code><code>Scand J Gastroenterol. &lt;/span&gt;</code></p><p><code>10765</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>10766</code><code>32&lt;/span&gt;</code></p><p><code>10767</code><code>:942–946.&lt;/span&gt;</code></p><p><code>10768</code><code> [&lt;a href="/pubmed/9299675" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10769</code><code>PubMed&lt;/a&gt;</code></p><p><code>10770</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10771</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Scand+J+Gastroenterol&amp;amp;title=Prognostic+value+of+plasma+endotoxin+levels+in+patients+with+cirrhosis&amp;amp;author=CC+Chan&amp;amp;author=SJ+Hwang&amp;amp;author=FY+Lee&amp;amp;author=SS+Wang&amp;amp;author=FY+Chang&amp;amp;volume=32&amp;amp;publication_year=1997&amp;amp;pages=942-946&amp;amp;pmid=9299675&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10772</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10773</code><code>]&lt;/span&gt;</code></p><p><code>10774</code><code>&lt;/span&gt;</code></p><p><code>10775</code><code>&lt;/li&gt;</code></p><p><code>10776</code><code>&lt;li id="R168"&gt;</code></p><p><code>10777</code><code>&lt;span class="citation"&gt;</code></p><p><code>10778</code><code>Chang L, Luo L, Palmer JA, Sutton S, Wilson SJ, Barbier AJ, Breitenbucher JG, Chaplan SR, Webb M. Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms. &lt;span&gt;</code></p><p><code>10779</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10780</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>10781</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>10782</code><code>148&lt;/span&gt;</code></p><p><code>10783</code><code>:102–113.&lt;/span&gt;</code></p><p><code>10784</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>10785</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1617043/"&gt;</code></p><p><code>10786</code><code>PMC free article&lt;/a&gt;</code></p><p><code>10787</code><code>]&lt;/span&gt;</code></p><p><code>10788</code><code> [&lt;a href="/pubmed/16501580" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10789</code><code>PubMed&lt;/a&gt;</code></p><p><code>10790</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10791</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Inhibition+of+fatty+acid+amide+hydrolase+produces+analgesia+by+multiple+mechanisms&amp;amp;author=L+Chang&amp;amp;author=L+Luo&amp;amp;author=JA+Palmer&amp;amp;author=S+Sutton&amp;amp;author=SJ+Wilson&amp;amp;volume=148&amp;amp;publication_year=2006&amp;amp;pages=102-113&amp;amp;pmid=16501580&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10792</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10793</code><code>]&lt;/span&gt;</code></p><p><code>10794</code><code>&lt;/span&gt;</code></p><p><code>10795</code><code>&lt;/li&gt;</code></p><p><code>10796</code><code>&lt;li id="R169"&gt;</code></p><p><code>10797</code><code>&lt;span class="citation"&gt;</code></p><p><code>10798</code><code>Chaperon F, Soubrie P, Puech AJ, Theibot MH. Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats. &lt;span&gt;</code></p><p><code>10799</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10800</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>10801</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>10802</code><code>135&lt;/span&gt;</code></p><p><code>10803</code><code>:324–332.&lt;/span&gt;</code></p><p><code>10804</code><code> [&lt;a href="/pubmed/9539255" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10805</code><code>PubMed&lt;/a&gt;</code></p><p><code>10806</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10807</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Involvement+of+central+cannabinoid+(CB1)+receptors+in+the+establishment+of+place+conditioning+in+rats&amp;amp;author=F+Chaperon&amp;amp;author=P+Soubrie&amp;amp;author=AJ+Puech&amp;amp;author=MH+Theibot&amp;amp;volume=135&amp;amp;publication_year=1998&amp;amp;pages=324-332&amp;amp;pmid=9539255&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10808</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10809</code><code>]&lt;/span&gt;</code></p><p><code>10810</code><code>&lt;/span&gt;</code></p><p><code>10811</code><code>&lt;/li&gt;</code></p><p><code>10812</code><code>&lt;li id="R170"&gt;</code></p><p><code>10813</code><code>&lt;span class="citation"&gt;</code></p><p><code>10814</code><code>Chapman V. The cannabinoid CB&lt;sub&gt;</code></p><p><code>10815</code><code>1&lt;/sub&gt;</code></p><p><code>10816</code><code> receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat. &lt;span&gt;</code></p><p><code>10817</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10818</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>10819</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>10820</code><code>127&lt;/span&gt;</code></p><p><code>10821</code><code>:1765–1767.&lt;/span&gt;</code></p><p><code>10822</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>10823</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1566187/"&gt;</code></p><p><code>10824</code><code>PMC free article&lt;/a&gt;</code></p><p><code>10825</code><code>]&lt;/span&gt;</code></p><p><code>10826</code><code> [&lt;a href="/pubmed/10482905" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10827</code><code>PubMed&lt;/a&gt;</code></p><p><code>10828</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10829</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=The+cannabinoid+CB1+receptor+antagonist,+SR141716A,+selectively+facilitates+nociceptive+responses+of+dorsal+horn+neurones+in+the+rat&amp;amp;author=V+Chapman&amp;amp;volume=127&amp;amp;publication_year=1999&amp;amp;pages=1765-1767&amp;amp;pmid=10482905&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10830</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10831</code><code>]&lt;/span&gt;</code></p><p><code>10832</code><code>&lt;/span&gt;</code></p><p><code>10833</code><code>&lt;/li&gt;</code></p><p><code>10834</code><code>&lt;li id="R171"&gt;</code></p><p><code>10835</code><code>&lt;span class="citation"&gt;</code></p><p><code>10836</code><code>Cheer JF, Marsden CA, Kendall DA, Mason R. Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study. &lt;span&gt;</code></p><p><code>10837</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10838</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>10839</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>10840</code><code>99&lt;/span&gt;</code></p><p><code>10841</code><code>:661–667.&lt;/span&gt;</code></p><p><code>10842</code><code> [&lt;a href="/pubmed/10974429" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10843</code><code>PubMed&lt;/a&gt;</code></p><p><code>10844</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10845</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Lack+of+response+suppression+follows+repeated+ventral+tegmental+cannabinoid+administration:+an+in+vitro+electrophysiological+study&amp;amp;author=JF+Cheer&amp;amp;author=CA+Marsden&amp;amp;author=DA+Kendall&amp;amp;author=R+Mason&amp;amp;volume=99&amp;amp;publication_year=2000&amp;amp;pages=661-667&amp;amp;pmid=10974429&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10846</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10847</code><code>]&lt;/span&gt;</code></p><p><code>10848</code><code>&lt;/span&gt;</code></p><p><code>10849</code><code>&lt;/li&gt;</code></p><p><code>10850</code><code>&lt;li id="R172"&gt;</code></p><p><code>10851</code><code>&lt;span class="citation"&gt;</code></p><p><code>10852</code><code>Chemin J, Monteil A, Perez-Reyes E, Nargeot J, Lory P. Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. &lt;span&gt;</code></p><p><code>10853</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10854</code><code>EMBO (Eur Mol Biol Organ) J. &lt;/span&gt;</code></p><p><code>10855</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>10856</code><code>20&lt;/span&gt;</code></p><p><code>10857</code><code>:7033–7040.&lt;/span&gt;</code></p><p><code>10858</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>10859</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC125779/"&gt;</code></p><p><code>10860</code><code>PMC free article&lt;/a&gt;</code></p><p><code>10861</code><code>]&lt;/span&gt;</code></p><p><code>10862</code><code> [&lt;a href="/pubmed/11742980" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10863</code><code>PubMed&lt;/a&gt;</code></p><p><code>10864</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10865</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=EMBO+(Eur+Mol+Biol+Organ)+J&amp;amp;title=Direct+inhibition+of+T-type+calcium+channels+by+the+endogenous+cannabinoid+anandamide&amp;amp;author=J+Chemin&amp;amp;author=A+Monteil&amp;amp;author=E+Perez-Reyes&amp;amp;author=J+Nargeot&amp;amp;author=P+Lory&amp;amp;volume=20&amp;amp;publication_year=2001&amp;amp;pages=7033-7040&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10866</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10867</code><code>]&lt;/span&gt;</code></p><p><code>10868</code><code>&lt;/span&gt;</code></p><p><code>10869</code><code>&lt;/li&gt;</code></p><p><code>10870</code><code>&lt;li id="R173"&gt;</code></p><p><code>10871</code><code>&lt;span class="citation"&gt;</code></p><p><code>10872</code><code>Chen J, Matias I, Dinh T, Lu T, Venezia S, Nieves A, Woodward DF, Di Marzo V. Finding of endocannabinoids in human eye tissues: implications for glaucoma. &lt;span&gt;</code></p><p><code>10873</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10874</code><code>Biochem Biophys Res Commun. &lt;/span&gt;</code></p><p><code>10875</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>10876</code><code>330&lt;/span&gt;</code></p><p><code>10877</code><code>:1062–1067.&lt;/span&gt;</code></p><p><code>10878</code><code> [&lt;a href="/pubmed/15823551" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10879</code><code>PubMed&lt;/a&gt;</code></p><p><code>10880</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10881</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;amp;title=Finding+of+endocannabinoids+in+human+eye+tissues:+implications+for+glaucoma&amp;amp;author=J+Chen&amp;amp;author=I+Matias&amp;amp;author=T+Dinh&amp;amp;author=T+Lu&amp;amp;author=S+Venezia&amp;amp;volume=330&amp;amp;publication_year=2005&amp;amp;pages=1062-1067&amp;amp;pmid=15823551&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10882</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10883</code><code>]&lt;/span&gt;</code></p><p><code>10884</code><code>&lt;/span&gt;</code></p><p><code>10885</code><code>&lt;/li&gt;</code></p><p><code>10886</code><code>&lt;li id="R174"&gt;</code></p><p><code>10887</code><code>&lt;span class="citation"&gt;</code></p><p><code>10888</code><code>Chen JP, Paredes W, Li J, Smith D, Lowinson J, Gardner EL. &amp;#x00394;&lt;sup&gt;</code></p><p><code>10889</code><code>9&lt;/sup&gt;</code></p><p><code>10890</code><code>-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely moving rats, as measured by intracerebral microdialysis. &lt;span&gt;</code></p><p><code>10891</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10892</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>10893</code><code>1990;&lt;span class="ref-vol"&gt;</code></p><p><code>10894</code><code>102&lt;/span&gt;</code></p><p><code>10895</code><code>:156–162.&lt;/span&gt;</code></p><p><code>10896</code><code> [&lt;a href="/pubmed/2177204" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10897</code><code>PubMed&lt;/a&gt;</code></p><p><code>10898</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10899</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=&amp;#x00394;9-Tetrahydrocannabinol+produces+naloxone-blockable+enhancement+of+presynaptic+basal+dopamine+efflux+in+nucleus+accumbens+of+conscious,+freely+moving+rats,+as+measured+by+intracerebral+microdialysis&amp;amp;author=JP+Chen&amp;amp;author=W+Paredes&amp;amp;author=J+Li&amp;amp;author=D+Smith&amp;amp;author=J+Lowinson&amp;amp;volume=102&amp;amp;publication_year=1990&amp;amp;pages=156-162&amp;amp;pmid=2177204&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10900</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10901</code><code>]&lt;/span&gt;</code></p><p><code>10902</code><code>&lt;/span&gt;</code></p><p><code>10903</code><code>&lt;/li&gt;</code></p><p><code>10904</code><code>&lt;li id="R175"&gt;</code></p><p><code>10905</code><code>&lt;span class="citation"&gt;</code></p><p><code>10906</code><code>Chen K, Ratzliff A, Hilgenberg L, Gulyas A, Freund TF, Smith M, Dinh TP, Piomelli D, Mackie K, Soltesz I. Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures. &lt;span&gt;</code></p><p><code>10907</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10908</code><code>Neuron. &lt;/span&gt;</code></p><p><code>10909</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>10910</code><code>39&lt;/span&gt;</code></p><p><code>10911</code><code>:599–611.&lt;/span&gt;</code></p><p><code>10912</code><code> [&lt;a href="/pubmed/12925275" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10913</code><code>PubMed&lt;/a&gt;</code></p><p><code>10914</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10915</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;amp;title=Long-term+plasticity+of+endocannabinoid+signaling+induced+by+developmental+febrile+seizures&amp;amp;author=K+Chen&amp;amp;author=A+Ratzliff&amp;amp;author=L+Hilgenberg&amp;amp;author=A+Gulyas&amp;amp;author=TF+Freund&amp;amp;volume=39&amp;amp;publication_year=2003&amp;amp;pages=599-611&amp;amp;pmid=12925275&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10916</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10917</code><code>]&lt;/span&gt;</code></p><p><code>10918</code><code>&lt;/span&gt;</code></p><p><code>10919</code><code>&lt;/li&gt;</code></p><p><code>10920</code><code>&lt;li id="R176"&gt;</code></p><p><code>10921</code><code>&lt;span class="citation"&gt;</code></p><p><code>10922</code><code>Chen RZ, Huang RR, Shen CP, MacNeil DJ, Fong TM. Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice. &lt;span&gt;</code></p><p><code>10923</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10924</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>10925</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>10926</code><code>999&lt;/span&gt;</code></p><p><code>10927</code><code>:227–230.&lt;/span&gt;</code></p><p><code>10928</code><code> [&lt;a href="/pubmed/14759503" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10929</code><code>PubMed&lt;/a&gt;</code></p><p><code>10930</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10931</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Synergistic+effects+of+cannabinoid+inverse+agonist+AM251+and+opioid+antagonist+nalmefene+on+food+intake+in+mice&amp;amp;author=RZ+Chen&amp;amp;author=RR+Huang&amp;amp;author=CP+Shen&amp;amp;author=DJ+MacNeil&amp;amp;author=TM+Fong&amp;amp;volume=999&amp;amp;publication_year=2004&amp;amp;pages=227-230&amp;amp;pmid=14759503&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10932</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10933</code><code>]&lt;/span&gt;</code></p><p><code>10934</code><code>&lt;/span&gt;</code></p><p><code>10935</code><code>&lt;/li&gt;</code></p><p><code>10936</code><code>&lt;li id="R177"&gt;</code></p><p><code>10937</code><code>&lt;span class="citation"&gt;</code></p><p><code>10938</code><code>Chen Y, Buck J. Cannabinoids protect cells from oxidative cell death: a receptor-independent mechanism. &lt;span&gt;</code></p><p><code>10939</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10940</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>10941</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>10942</code><code>293&lt;/span&gt;</code></p><p><code>10943</code><code>:807–812.&lt;/span&gt;</code></p><p><code>10944</code><code> [&lt;a href="/pubmed/10869379" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10945</code><code>PubMed&lt;/a&gt;</code></p><p><code>10946</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10947</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Cannabinoids+protect+cells+from+oxidative+cell+death:+a+receptor-independent+mechanism&amp;amp;author=Y+Chen&amp;amp;author=J+Buck&amp;amp;volume=293&amp;amp;publication_year=2000&amp;amp;pages=807-812&amp;amp;pmid=10869379&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10948</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10949</code><code>]&lt;/span&gt;</code></p><p><code>10950</code><code>&lt;/span&gt;</code></p><p><code>10951</code><code>&lt;/li&gt;</code></p><p><code>10952</code><code>&lt;li id="R178"&gt;</code></p><p><code>10953</code><code>&lt;span class="citation"&gt;</code></p><p><code>10954</code><code>Cheng X, Leung SW, Lo LS, Pang CC. Selective versus non-selective suppression of nitric oxide synthase on regional hemodynamics in rats with or without LPS-induced endotoxemia. &lt;span&gt;</code></p><p><code>10955</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10956</code><code>Naunyn-Schmiedeberg&amp;#x02019;s Arch Pharmacol. &lt;/span&gt;</code></p><p><code>10957</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>10958</code><code>367&lt;/span&gt;</code></p><p><code>10959</code><code>:372–379.&lt;/span&gt;</code></p><p><code>10960</code><code> [&lt;a href="/pubmed/12690429" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10961</code><code>PubMed&lt;/a&gt;</code></p><p><code>10962</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10963</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Naunyn-Schmiedeberg&amp;#x02019;s+Arch+Pharmacol&amp;amp;title=Selective+versus+non-selective+suppression+of+nitric+oxide+synthase+on+regional+hemodynamics+in+rats+with+or+without+LPS-induced+endotoxemia&amp;amp;author=X+Cheng&amp;amp;author=SW+Leung&amp;amp;author=LS+Lo&amp;amp;author=CC+Pang&amp;amp;volume=367&amp;amp;publication_year=2003&amp;amp;pages=372-379&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10964</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10965</code><code>]&lt;/span&gt;</code></p><p><code>10966</code><code>&lt;/span&gt;</code></p><p><code>10967</code><code>&lt;/li&gt;</code></p><p><code>10968</code><code>&lt;li id="R179"&gt;</code></p><p><code>10969</code><code>&lt;span class="citation"&gt;</code></p><p><code>10970</code><code>Chiang K, Gerber AL, Sipe JC, Cravatt BF. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. &lt;span&gt;</code></p><p><code>10971</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10972</code><code>Hum Mol Genet. &lt;/span&gt;</code></p><p><code>10973</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>10974</code><code>13&lt;/span&gt;</code></p><p><code>10975</code><code>:1–7.&lt;/span&gt;</code></p><p><code>10976</code><code> [&lt;a href="/pubmed/15254019" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10977</code><code>PubMed&lt;/a&gt;</code></p><p><code>10978</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10979</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Hum+Mol+Genet&amp;amp;title=Reduced+cellular+expression+and+activity+of+the+P129T+mutant+of+human+fatty+acid+amide+hydrolase:+evidence+for+a+link+between+defects+in+the+endocannabinoid+system+and+problem+drug+use&amp;amp;author=K+Chiang&amp;amp;author=AL+Gerber&amp;amp;author=JC+Sipe&amp;amp;author=BF+Cravatt&amp;amp;volume=13&amp;amp;publication_year=2004&amp;amp;pages=1-7&amp;amp;pmid=14613965&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10980</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10981</code><code>]&lt;/span&gt;</code></p><p><code>10982</code><code>&lt;/span&gt;</code></p><p><code>10983</code><code>&lt;/li&gt;</code></p><p><code>10984</code><code>&lt;li id="R180"&gt;</code></p><p><code>10985</code><code>&lt;span class="citation"&gt;</code></p><p><code>10986</code><code>Chien FY, Wang RF, Mittag TW, Podos SM. Effect of WIN 55212-2, a cannabinoid receptor agonist, on aqueous humor dynamics in monkeys. &lt;span&gt;</code></p><p><code>10987</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>10988</code><code>Arch Ophthalmol. &lt;/span&gt;</code></p><p><code>10989</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>10990</code><code>121&lt;/span&gt;</code></p><p><code>10991</code><code>:87–90.&lt;/span&gt;</code></p><p><code>10992</code><code> [&lt;a href="/pubmed/12523891" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>10993</code><code>PubMed&lt;/a&gt;</code></p><p><code>10994</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>10995</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Arch+Ophthalmol&amp;amp;title=Effect+of+WIN+55212-2,+a+cannabinoid+receptor+agonist,+on+aqueous+humor+dynamics+in+monkeys&amp;amp;author=FY+Chien&amp;amp;author=RF+Wang&amp;amp;author=TW+Mittag&amp;amp;author=SM+Podos&amp;amp;volume=121&amp;amp;publication_year=2003&amp;amp;pages=87-90&amp;amp;pmid=12523891&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>10996</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>10997</code><code>]&lt;/span&gt;</code></p><p><code>10998</code><code>&lt;/span&gt;</code></p><p><code>10999</code><code>&lt;/li&gt;</code></p><p><code>11000</code><code>&lt;li id="R181"&gt;</code></p><p><code>11001</code><code>&lt;span class="citation"&gt;</code></p><p><code>11002</code><code>Chiu P, Olsen DM, Borys HK, Karler R, Turkanis SA. The influence of cannabidiol and &amp;#x00394;&lt;sup&gt;</code></p><p><code>11003</code><code>9&lt;/sup&gt;</code></p><p><code>11004</code><code>-tetrahydrocannabinol on cobalt epilepsy in rats. &lt;span&gt;</code></p><p><code>11005</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11006</code><code>Epilepsia. &lt;/span&gt;</code></p><p><code>11007</code><code>1979;&lt;span class="ref-vol"&gt;</code></p><p><code>11008</code><code>20&lt;/span&gt;</code></p><p><code>11009</code><code>:365–375.&lt;/span&gt;</code></p><p><code>11010</code><code> [&lt;a href="/pubmed/113206" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11011</code><code>PubMed&lt;/a&gt;</code></p><p><code>11012</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11013</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Epilepsia&amp;amp;title=The+influence+of+cannabidiol+and+&amp;#x00394;9-tetrahydrocannabinol+on+cobalt+epilepsy+in+rats&amp;amp;author=P+Chiu&amp;amp;author=DM+Olsen&amp;amp;author=HK+Borys&amp;amp;author=R+Karler&amp;amp;author=SA+Turkanis&amp;amp;volume=20&amp;amp;publication_year=1979&amp;amp;pages=365-375&amp;amp;pmid=113206&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11014</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11015</code><code>]&lt;/span&gt;</code></p><p><code>11016</code><code>&lt;/span&gt;</code></p><p><code>11017</code><code>&lt;/li&gt;</code></p><p><code>11018</code><code>&lt;li id="R182"&gt;</code></p><p><code>11019</code><code>&lt;span class="citation"&gt;</code></p><p><code>11020</code><code>Chopra GS, Smith JW. Psychotic reactions following cannabis use in East Indians. &lt;span&gt;</code></p><p><code>11021</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11022</code><code>Arch Gen Psychiatry. &lt;/span&gt;</code></p><p><code>11023</code><code>1974;&lt;span class="ref-vol"&gt;</code></p><p><code>11024</code><code>30&lt;/span&gt;</code></p><p><code>11025</code><code>:24–27.&lt;/span&gt;</code></p><p><code>11026</code><code> [&lt;a href="/pubmed/4808733" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11027</code><code>PubMed&lt;/a&gt;</code></p><p><code>11028</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11029</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Arch+Gen+Psychiatry&amp;amp;title=Psychotic+reactions+following+cannabis+use+in+East+Indians&amp;amp;author=GS+Chopra&amp;amp;author=JW+Smith&amp;amp;volume=30&amp;amp;publication_year=1974&amp;amp;pages=24-27&amp;amp;pmid=4808733&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11030</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11031</code><code>]&lt;/span&gt;</code></p><p><code>11032</code><code>&lt;/span&gt;</code></p><p><code>11033</code><code>&lt;/li&gt;</code></p><p><code>11034</code><code>&lt;li id="R183"&gt;</code></p><p><code>11035</code><code>&lt;span class="citation"&gt;</code></p><p><code>11036</code><code>Cippitelli A, Bilbao A, Hansson AC, del Arco I, Sommer W, Heilig M, Massi M, Bermudez-Silva FJ, Navarro M, Ciccocioppo R, et al.  The Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats. &lt;span&gt;</code></p><p><code>11037</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11038</code><code>Eur J Neurosci. &lt;/span&gt;</code></p><p><code>11039</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>11040</code><code>21&lt;/span&gt;</code></p><p><code>11041</code><code>:2243–2251.&lt;/span&gt;</code></p><p><code>11042</code><code> [&lt;a href="/pubmed/15869521" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11043</code><code>PubMed&lt;/a&gt;</code></p><p><code>11044</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11045</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurosci&amp;amp;title=The+Cannabinoid+CB1+receptor+antagonism+reduces+conditioned+reinstatement+of+ethanol-seeking+behavior+in+rats&amp;amp;author=A+Cippitelli&amp;amp;author=A+Bilbao&amp;amp;author=AC+Hansson&amp;amp;author=I+del+Arco&amp;amp;author=W+Sommer&amp;amp;volume=21&amp;amp;publication_year=2005&amp;amp;pages=2243-2251&amp;amp;pmid=15869521&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11046</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11047</code><code>]&lt;/span&gt;</code></p><p><code>11048</code><code>&lt;/span&gt;</code></p><p><code>11049</code><code>&lt;/li&gt;</code></p><p><code>11050</code><code>&lt;li id="R184"&gt;</code></p><p><code>11051</code><code>&lt;span class="citation"&gt;</code></p><p><code>11052</code><code>Clark JT, Kalra PS, Crowley WR, Kalra SP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. &lt;span&gt;</code></p><p><code>11053</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11054</code><code>Endocrinology. &lt;/span&gt;</code></p><p><code>11055</code><code>1984;&lt;span class="ref-vol"&gt;</code></p><p><code>11056</code><code>115&lt;/span&gt;</code></p><p><code>11057</code><code>:427–429.&lt;/span&gt;</code></p><p><code>11058</code><code> [&lt;a href="/pubmed/6547387" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11059</code><code>PubMed&lt;/a&gt;</code></p><p><code>11060</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11061</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;amp;title=Neuropeptide+Y+and+human+pancreatic+polypeptide+stimulate+feeding+behavior+in+rats&amp;amp;author=JT+Clark&amp;amp;author=PS+Kalra&amp;amp;author=WR+Crowley&amp;amp;author=SP+Kalra&amp;amp;volume=115&amp;amp;publication_year=1984&amp;amp;pages=427-429&amp;amp;pmid=6547387&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11062</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11063</code><code>]&lt;/span&gt;</code></p><p><code>11064</code><code>&lt;/span&gt;</code></p><p><code>11065</code><code>&lt;/li&gt;</code></p><p><code>11066</code><code>&lt;li id="R185"&gt;</code></p><p><code>11067</code><code>&lt;span class="citation"&gt;</code></p><p><code>11068</code><code>Clayton N, Marshall FH, Bountra C, O&amp;#x02019;Shaughnessy CT. CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. &lt;span&gt;</code></p><p><code>11069</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11070</code><code>Pain. &lt;/span&gt;</code></p><p><code>11071</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>11072</code><code>96&lt;/span&gt;</code></p><p><code>11073</code><code>:253–260.&lt;/span&gt;</code></p><p><code>11074</code><code> [&lt;a href="/pubmed/11972997" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11075</code><code>PubMed&lt;/a&gt;</code></p><p><code>11076</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11077</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;amp;title=CB1+and+CB2+cannabinoid+receptors+are+implicated+in+inflammatory+pain&amp;amp;author=N+Clayton&amp;amp;author=FH+Marshall&amp;amp;author=C+Bountra&amp;amp;author=CT+O&amp;#x02019;Shaughnessy&amp;amp;volume=96&amp;amp;publication_year=2002&amp;amp;pages=253-260&amp;amp;pmid=11972997&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11078</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11079</code><code>]&lt;/span&gt;</code></p><p><code>11080</code><code>&lt;/span&gt;</code></p><p><code>11081</code><code>&lt;/li&gt;</code></p><p><code>11082</code><code>&lt;li id="R186"&gt;</code></p><p><code>11083</code><code>&lt;span class="citation"&gt;</code></p><p><code>11084</code><code>Clement AB, Hawkins EG, Lichtman AH, Cravatt BF. Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase. &lt;span&gt;</code></p><p><code>11085</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11086</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>11087</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>11088</code><code>23&lt;/span&gt;</code></p><p><code>11089</code><code>:3916–3923.&lt;/span&gt;</code></p><p><code>11090</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>11091</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6742184/"&gt;</code></p><p><code>11092</code><code>PMC free article&lt;/a&gt;</code></p><p><code>11093</code><code>]&lt;/span&gt;</code></p><p><code>11094</code><code> [&lt;a href="/pubmed/12736361" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11095</code><code>PubMed&lt;/a&gt;</code></p><p><code>11096</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11097</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Increased+seizure+susceptibility+and+proconvulsant+activity+of+anandamide+in+mice+lacking+fatty+acid+amide+hydrolase&amp;amp;author=AB+Clement&amp;amp;author=EG+Hawkins&amp;amp;author=AH+Lichtman&amp;amp;author=BF+Cravatt&amp;amp;volume=23&amp;amp;publication_year=2003&amp;amp;pages=3916-3923&amp;amp;pmid=12736361&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11098</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11099</code><code>]&lt;/span&gt;</code></p><p><code>11100</code><code>&lt;/span&gt;</code></p><p><code>11101</code><code>&lt;/li&gt;</code></p><p><code>11102</code><code>&lt;li id="R187"&gt;</code></p><p><code>11103</code><code>&lt;span class="citation"&gt;</code></p><p><code>11104</code><code>Clifford DB. Tetrahydrocannabinol for tremor in multiple sclerosis. &lt;span&gt;</code></p><p><code>11105</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11106</code><code>Ann Neurol. &lt;/span&gt;</code></p><p><code>11107</code><code>1983;&lt;span class="ref-vol"&gt;</code></p><p><code>11108</code><code>13&lt;/span&gt;</code></p><p><code>11109</code><code>:669–671.&lt;/span&gt;</code></p><p><code>11110</code><code> [&lt;a href="/pubmed/6309074" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11111</code><code>PubMed&lt;/a&gt;</code></p><p><code>11112</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11113</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Ann+Neurol&amp;amp;title=Tetrahydrocannabinol+for+tremor+in+multiple+sclerosis&amp;amp;author=DB+Clifford&amp;amp;volume=13&amp;amp;publication_year=1983&amp;amp;pages=669-671&amp;amp;pmid=6309074&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11114</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11115</code><code>]&lt;/span&gt;</code></p><p><code>11116</code><code>&lt;/span&gt;</code></p><p><code>11117</code><code>&lt;/li&gt;</code></p><p><code>11118</code><code>&lt;li id="R188"&gt;</code></p><p><code>11119</code><code>&lt;span class="citation"&gt;</code></p><p><code>11120</code><code>Cohen A, Perrault G, Griebel G, Soubrie P. Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB&lt;sub&gt;</code></p><p><code>11121</code><code>1&lt;/sub&gt;</code></p><p><code>11122</code><code>) receptor antagonist rimonabant (SR141716) &lt;span&gt;</code></p><p><code>11123</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11124</code><code>Neuropsychopharmacology. &lt;/span&gt;</code></p><p><code>11125</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>11126</code><code>30&lt;/span&gt;</code></p><p><code>11127</code><code>:145–155.&lt;/span&gt;</code></p><p><code>11128</code><code> [&lt;a href="/pubmed/15292905" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11129</code><code>PubMed&lt;/a&gt;</code></p><p><code>11130</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11131</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;amp;title=Nicotine-associated+cues+maintain+nicotine-seeking+behavior+in+rats+several+weeks+after+nicotine+withdrawal:+reversal+by+the+cannabinoid+(CB1)+receptor+antagonist+rimonabant+(SR141716)&amp;amp;author=A+Cohen&amp;amp;author=G+Perrault&amp;amp;author=G+Griebel&amp;amp;author=P+Soubrie&amp;amp;volume=30&amp;amp;publication_year=2005&amp;amp;pages=145-155&amp;amp;pmid=15292905&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11132</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11133</code><code>]&lt;/span&gt;</code></p><p><code>11134</code><code>&lt;/span&gt;</code></p><p><code>11135</code><code>&lt;/li&gt;</code></p><p><code>11136</code><code>&lt;li id="R189"&gt;</code></p><p><code>11137</code><code>&lt;span class="citation"&gt;</code></p><p><code>11138</code><code>Cohen C, Perrault G, Voltz C, Steinberg R, Soubrie P. SR141716, a central cannabinoid (CB&lt;sub&gt;</code></p><p><code>11139</code><code>1&lt;/sub&gt;</code></p><p><code>11140</code><code>) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. &lt;span&gt;</code></p><p><code>11141</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11142</code><code>Behav Pharmacol. &lt;/span&gt;</code></p><p><code>11143</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>11144</code><code>13&lt;/span&gt;</code></p><p><code>11145</code><code>:451–463.&lt;/span&gt;</code></p><p><code>11146</code><code> [&lt;a href="/pubmed/12394421" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11147</code><code>PubMed&lt;/a&gt;</code></p><p><code>11148</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11149</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Behav+Pharmacol&amp;amp;title=SR141716,+a+central+cannabinoid+(CB1)+receptor+antagonist,+blocks+the+motivational+and+dopamine-releasing+effects+of+nicotine+in+rats&amp;amp;author=C+Cohen&amp;amp;author=G+Perrault&amp;amp;author=C+Voltz&amp;amp;author=R+Steinberg&amp;amp;author=P+Soubrie&amp;amp;volume=13&amp;amp;publication_year=2002&amp;amp;pages=451-463&amp;amp;pmid=12394421&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11150</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11151</code><code>]&lt;/span&gt;</code></p><p><code>11152</code><code>&lt;/span&gt;</code></p><p><code>11153</code><code>&lt;/li&gt;</code></p><p><code>11154</code><code>&lt;li id="R190"&gt;</code></p><p><code>11155</code><code>&lt;span class="citation"&gt;</code></p><p><code>11156</code><code>Colasanti BK, Lindamood C, 3rd, Craig CR. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats. &lt;span&gt;</code></p><p><code>11157</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11158</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>11159</code><code>1982;&lt;span class="ref-vol"&gt;</code></p><p><code>11160</code><code>16&lt;/span&gt;</code></p><p><code>11161</code><code>:573–578.&lt;/span&gt;</code></p><p><code>11162</code><code> [&lt;a href="/pubmed/6280204" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11163</code><code>PubMed&lt;/a&gt;</code></p><p><code>11164</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11165</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Effects+of+marihuana+cannabinoids+on+seizure+activity+in+cobalt-epileptic+rats&amp;amp;author=BK+Colasanti&amp;amp;author=C+Lindamood&amp;amp;author=CR+Craig&amp;amp;volume=16&amp;amp;publication_year=1982&amp;amp;pages=573-578&amp;amp;pmid=6280204&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11166</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11167</code><code>]&lt;/span&gt;</code></p><p><code>11168</code><code>&lt;/span&gt;</code></p><p><code>11169</code><code>&lt;/li&gt;</code></p><p><code>11170</code><code>&lt;li id="R191"&gt;</code></p><p><code>11171</code><code>&lt;span class="citation"&gt;</code></p><p><code>11172</code><code>Colasanti BK, Brown RE, Craig CR. Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol. &lt;span&gt;</code></p><p><code>11173</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11174</code><code>Gen Pharmacol. &lt;/span&gt;</code></p><p><code>11175</code><code>1984a;&lt;span class="ref-vol"&gt;</code></p><p><code>11176</code><code>15&lt;/span&gt;</code></p><p><code>11177</code><code>:479–484.&lt;/span&gt;</code></p><p><code>11178</code><code> [&lt;a href="/pubmed/6098513" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11179</code><code>PubMed&lt;/a&gt;</code></p><p><code>11180</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11181</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gen+Pharmacol&amp;amp;title=Ocular+hypotension,+ocular+toxicity,+and+neurotoxicity+in+response+to+marihuana+extract+and+cannabidiol&amp;amp;author=BK+Colasanti&amp;amp;author=RE+Brown&amp;amp;author=CR+Craig&amp;amp;volume=15&amp;amp;publication_year=1984a&amp;amp;pages=479-484&amp;amp;pmid=6098513&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11182</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11183</code><code>]&lt;/span&gt;</code></p><p><code>11184</code><code>&lt;/span&gt;</code></p><p><code>11185</code><code>&lt;/li&gt;</code></p><p><code>11186</code><code>&lt;li id="R192"&gt;</code></p><p><code>11187</code><code>&lt;span class="citation"&gt;</code></p><p><code>11188</code><code>Colasanti BK, Craig CR, Allara RD. Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol. &lt;span&gt;</code></p><p><code>11189</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11190</code><code>Exp Eye Res. &lt;/span&gt;</code></p><p><code>11191</code><code>1984b;&lt;span class="ref-vol"&gt;</code></p><p><code>11192</code><code>39&lt;/span&gt;</code></p><p><code>11193</code><code>:251–259.&lt;/span&gt;</code></p><p><code>11194</code><code> [&lt;a href="/pubmed/6499952" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11195</code><code>PubMed&lt;/a&gt;</code></p><p><code>11196</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11197</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Exp+Eye+Res&amp;amp;title=Intraocular+pressure,+ocular+toxicity+and+neurotoxicity+after+administration+of+cannabinol+or+cannabigerol&amp;amp;author=BK+Colasanti&amp;amp;author=CR+Craig&amp;amp;author=RD+Allara&amp;amp;volume=39&amp;amp;publication_year=1984b&amp;amp;pages=251-259&amp;amp;pmid=6499952&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11198</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11199</code><code>]&lt;/span&gt;</code></p><p><code>11200</code><code>&lt;/span&gt;</code></p><p><code>11201</code><code>&lt;/li&gt;</code></p><p><code>11202</code><code>&lt;li id="R193"&gt;</code></p><p><code>11203</code><code>&lt;span class="citation"&gt;</code></p><p><code>11204</code><code>Colasanti BK, Powell SR, Craig CR. Intraocular pressure, ocular toxicity and neurotoxicity after administration of &amp;#x00394;&lt;sup&gt;</code></p><p><code>11205</code><code>9&lt;/sup&gt;</code></p><p><code>11206</code><code>-tetrahydrocannabinol or cannabichromene. &lt;span&gt;</code></p><p><code>11207</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11208</code><code>Exp Eye Res. &lt;/span&gt;</code></p><p><code>11209</code><code>1984c;&lt;span class="ref-vol"&gt;</code></p><p><code>11210</code><code>38&lt;/span&gt;</code></p><p><code>11211</code><code>:63–71.&lt;/span&gt;</code></p><p><code>11212</code><code> [&lt;a href="/pubmed/6323206" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11213</code><code>PubMed&lt;/a&gt;</code></p><p><code>11214</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11215</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Exp+Eye+Res&amp;amp;title=Intraocular+pressure,+ocular+toxicity+and+neurotoxicity+after+administration+of+&amp;#x00394;9-tetrahydrocannabinol+or+cannabichromene&amp;amp;author=BK+Colasanti&amp;amp;author=SR+Powell&amp;amp;author=CR+Craig&amp;amp;volume=38&amp;amp;publication_year=1984c&amp;amp;pages=63-71&amp;amp;pmid=6323206&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11216</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11217</code><code>]&lt;/span&gt;</code></p><p><code>11218</code><code>&lt;/span&gt;</code></p><p><code>11219</code><code>&lt;/li&gt;</code></p><p><code>11220</code><code>&lt;li id="R194"&gt;</code></p><p><code>11221</code><code>&lt;span class="citation"&gt;</code></p><p><code>11222</code><code>Colombo G, Agabio R, Diaz G, Lobina C, Reali R, Gessa GL. Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. &lt;span&gt;</code></p><p><code>11223</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11224</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>11225</code><code>1998a;&lt;span class="ref-vol"&gt;</code></p><p><code>11226</code><code>63&lt;/span&gt;</code></p><p><code>11227</code><code>:PL113–PL117.&lt;/span&gt;</code></p><p><code>11228</code><code> [&lt;a href="/pubmed/9718088" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11229</code><code>PubMed&lt;/a&gt;</code></p><p><code>11230</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11231</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Appetite+suppression+and+weight+loss+after+the+cannabinoid+antagonist+SR+141716&amp;amp;author=G+Colombo&amp;amp;author=R+Agabio&amp;amp;author=G+Diaz&amp;amp;author=C+Lobina&amp;amp;author=R+Reali&amp;amp;volume=63&amp;amp;publication_year=1998a&amp;amp;pages=PL113-PL117&amp;amp;pmid=9718088&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11232</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11233</code><code>]&lt;/span&gt;</code></p><p><code>11234</code><code>&lt;/span&gt;</code></p><p><code>11235</code><code>&lt;/li&gt;</code></p><p><code>11236</code><code>&lt;li id="R195"&gt;</code></p><p><code>11237</code><code>&lt;span class="citation"&gt;</code></p><p><code>11238</code><code>Colombo G, Agabio R, Fa M, Guano L, Lobina C, Loche A, Reali R, Gessa GL. Reduction of voluntary ethanol intake in ethanol preferring sP rats by the cannabinoid antagonist SR141716A. &lt;span&gt;</code></p><p><code>11239</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11240</code><code>Alcohol Alcohol. &lt;/span&gt;</code></p><p><code>11241</code><code>1998b;&lt;span class="ref-vol"&gt;</code></p><p><code>11242</code><code>33&lt;/span&gt;</code></p><p><code>11243</code><code>:126–130.&lt;/span&gt;</code></p><p><code>11244</code><code> [&lt;a href="/pubmed/9566474" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11245</code><code>PubMed&lt;/a&gt;</code></p><p><code>11246</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11247</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Alcohol+Alcohol&amp;amp;title=Reduction+of+voluntary+ethanol+intake+in+ethanol+preferring+sP+rats+by+the+cannabinoid+antagonist+SR141716A&amp;amp;author=G+Colombo&amp;amp;author=R+Agabio&amp;amp;author=M+Fa&amp;amp;author=L+Guano&amp;amp;author=C+Lobina&amp;amp;volume=33&amp;amp;publication_year=1998b&amp;amp;pages=126-130&amp;amp;pmid=9566474&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11248</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11249</code><code>]&lt;/span&gt;</code></p><p><code>11250</code><code>&lt;/span&gt;</code></p><p><code>11251</code><code>&lt;/li&gt;</code></p><p><code>11252</code><code>&lt;li id="R196"&gt;</code></p><p><code>11253</code><code>&lt;span class="citation"&gt;</code></p><p><code>11254</code><code>Colombo G, Serra S, Brunetti G, Gomez R, Melis S, Vacca G, Carai MM, Gessa L. Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. &lt;span&gt;</code></p><p><code>11255</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11256</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>11257</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>11258</code><code>159&lt;/span&gt;</code></p><p><code>11259</code><code>:181–187.&lt;/span&gt;</code></p><p><code>11260</code><code> [&lt;a href="/pubmed/11862347" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11261</code><code>PubMed&lt;/a&gt;</code></p><p><code>11262</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11263</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Stimulation+of+voluntary+ethanol+intake+by+cannabinoid+receptor+agonists+in+ethanol-preferring+sP+rats&amp;amp;author=G+Colombo&amp;amp;author=S+Serra&amp;amp;author=G+Brunetti&amp;amp;author=R+Gomez&amp;amp;author=S+Melis&amp;amp;volume=159&amp;amp;publication_year=2002&amp;amp;pages=181-187&amp;amp;pmid=11862347&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11264</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11265</code><code>]&lt;/span&gt;</code></p><p><code>11266</code><code>&lt;/span&gt;</code></p><p><code>11267</code><code>&lt;/li&gt;</code></p><p><code>11268</code><code>&lt;li id="R197"&gt;</code></p><p><code>11269</code><code>&lt;span class="citation"&gt;</code></p><p><code>11270</code><code>Colombo G, Serra S, Vacca G, Carai MAM, Gessa L. Endocannabinoid system and alcohol addiction: pharmacological studies. &lt;span&gt;</code></p><p><code>11271</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11272</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>11273</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>11274</code><code>81&lt;/span&gt;</code></p><p><code>11275</code><code>:369–380.&lt;/span&gt;</code></p><p><code>11276</code><code> [&lt;a href="/pubmed/15939463" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11277</code><code>PubMed&lt;/a&gt;</code></p><p><code>11278</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11279</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Endocannabinoid+system+and+alcohol+addiction:+pharmacological+studies&amp;amp;author=G+Colombo&amp;amp;author=S+Serra&amp;amp;author=G+Vacca&amp;amp;author=MAM+Carai&amp;amp;author=L+Gessa&amp;amp;volume=81&amp;amp;publication_year=2005&amp;amp;pages=369-380&amp;amp;pmid=15939463&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11280</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11281</code><code>]&lt;/span&gt;</code></p><p><code>11282</code><code>&lt;/span&gt;</code></p><p><code>11283</code><code>&lt;/li&gt;</code></p><p><code>11284</code><code>&lt;li id="R198"&gt;</code></p><p><code>11285</code><code>&lt;span class="citation"&gt;</code></p><p><code>11286</code><code>Colombo G, Serra S, Vacca G, Gessa L, Carai MAM. Suppression by baclofen of the stimulation of alcohol intake induced by morphine and WIN 55,212-2 in alcohol-preferring rats. &lt;span&gt;</code></p><p><code>11287</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11288</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>11289</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>11290</code><code>492&lt;/span&gt;</code></p><p><code>11291</code><code>:189–193.&lt;/span&gt;</code></p><p><code>11292</code><code> [&lt;a href="/pubmed/15178364" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11293</code><code>PubMed&lt;/a&gt;</code></p><p><code>11294</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11295</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Suppression+by+baclofen+of+the+stimulation+of+alcohol+intake+induced+by+morphine+and+WIN+55,212-2+in+alcohol-preferring+rats&amp;amp;author=G+Colombo&amp;amp;author=S+Serra&amp;amp;author=G+Vacca&amp;amp;author=L+Gessa&amp;amp;author=MAM+Carai&amp;amp;volume=492&amp;amp;publication_year=2004&amp;amp;pages=189-193&amp;amp;pmid=15178364&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11296</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11297</code><code>]&lt;/span&gt;</code></p><p><code>11298</code><code>&lt;/span&gt;</code></p><p><code>11299</code><code>&lt;/li&gt;</code></p><p><code>11300</code><code>&lt;li id="R199"&gt;</code></p><p><code>11301</code><code>&lt;span class="citation"&gt;</code></p><p><code>11302</code><code>Compston A, Coles A. Multiple sclerosis. &lt;span&gt;</code></p><p><code>11303</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11304</code><code>Lancet. &lt;/span&gt;</code></p><p><code>11305</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>11306</code><code>359&lt;/span&gt;</code></p><p><code>11307</code><code>:1221–1231.&lt;/span&gt;</code></p><p><code>11308</code><code> [&lt;a href="/pubmed/11955556" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11309</code><code>PubMed&lt;/a&gt;</code></p><p><code>11310</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11311</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;amp;title=Multiple+sclerosis&amp;amp;author=A+Compston&amp;amp;author=A+Coles&amp;amp;volume=359&amp;amp;publication_year=2002&amp;amp;pages=1221-1231&amp;amp;pmid=11955556&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11312</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11313</code><code>]&lt;/span&gt;</code></p><p><code>11314</code><code>&lt;/span&gt;</code></p><p><code>11315</code><code>&lt;/li&gt;</code></p><p><code>11316</code><code>&lt;li id="R200"&gt;</code></p><p><code>11317</code><code>&lt;span class="citation"&gt;</code></p><p><code>11318</code><code>Consroe P. Brain cannabinoid systems as targets for the therapy of neurological disorders. &lt;span&gt;</code></p><p><code>11319</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11320</code><code>Neurobiol Dis. &lt;/span&gt;</code></p><p><code>11321</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>11322</code><code>5&lt;/span&gt;</code></p><p><code>11323</code><code>:534–551.&lt;/span&gt;</code></p><p><code>11324</code><code> [&lt;a href="/pubmed/9974182" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11325</code><code>PubMed&lt;/a&gt;</code></p><p><code>11326</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11327</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurobiol+Dis&amp;amp;title=Brain+cannabinoid+systems+as+targets+for+the+therapy+of+neurological+disorders&amp;amp;author=P+Consroe&amp;amp;volume=5&amp;amp;publication_year=1998&amp;amp;pages=534-551&amp;amp;pmid=9974182&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11328</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11329</code><code>]&lt;/span&gt;</code></p><p><code>11330</code><code>&lt;/span&gt;</code></p><p><code>11331</code><code>&lt;/li&gt;</code></p><p><code>11332</code><code>&lt;li id="R201"&gt;</code></p><p><code>11333</code><code>&lt;span class="citation"&gt;</code></p><p><code>11334</code><code>Consroe P, Laguna J, Allender J, Snider S, Stern L, Sandyk R, Kennedy K, Schram K. Controlled clinical trial of cannabidiol in Huntington&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>11335</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11336</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>11337</code><code>1991;&lt;span class="ref-vol"&gt;</code></p><p><code>11338</code><code>40&lt;/span&gt;</code></p><p><code>11339</code><code>:701–708.&lt;/span&gt;</code></p><p><code>11340</code><code> [&lt;a href="/pubmed/1839644" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11341</code><code>PubMed&lt;/a&gt;</code></p><p><code>11342</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11343</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Controlled+clinical+trial+of+cannabidiol+in+Huntington&amp;#x02019;s+disease&amp;amp;author=P+Consroe&amp;amp;author=J+Laguna&amp;amp;author=J+Allender&amp;amp;author=S+Snider&amp;amp;author=L+Stern&amp;amp;volume=40&amp;amp;publication_year=1991&amp;amp;pages=701-708&amp;amp;pmid=1839644&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11344</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11345</code><code>]&lt;/span&gt;</code></p><p><code>11346</code><code>&lt;/span&gt;</code></p><p><code>11347</code><code>&lt;/li&gt;</code></p><p><code>11348</code><code>&lt;li id="R202"&gt;</code></p><p><code>11349</code><code>&lt;span class="citation"&gt;</code></p><p><code>11350</code><code>Consroe P, Martin A, Singh V. Antiepileptic potential of cannabidiol analogs. &lt;span&gt;</code></p><p><code>11351</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11352</code><code>J Clin Pharmacol. &lt;/span&gt;</code></p><p><code>11353</code><code>1981;&lt;span class="ref-vol"&gt;</code></p><p><code>11354</code><code>21&lt;/span&gt;</code></p><p><code>11355</code><code>:428S–436S.&lt;/span&gt;</code></p><p><code>11356</code><code> [&lt;a href="/pubmed/7298873" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11357</code><code>PubMed&lt;/a&gt;</code></p><p><code>11358</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11359</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pharmacol&amp;amp;title=Antiepileptic+potential+of+cannabidiol+analogs&amp;amp;author=P+Consroe&amp;amp;author=A+Martin&amp;amp;author=V+Singh&amp;amp;volume=21&amp;amp;publication_year=1981&amp;amp;pages=428S-436S&amp;amp;pmid=7298873&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11360</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11361</code><code>]&lt;/span&gt;</code></p><p><code>11362</code><code>&lt;/span&gt;</code></p><p><code>11363</code><code>&lt;/li&gt;</code></p><p><code>11364</code><code>&lt;li id="R203"&gt;</code></p><p><code>11365</code><code>&lt;span class="citation"&gt;</code></p><p><code>11366</code><code>Consroe P, Mechoulam R. Anticonvulsant and neurotoxic effects of tetrahydrocannabinol stereoisomers. &lt;span&gt;</code></p><p><code>11367</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11368</code><code>NIDA Res Monogr. &lt;/span&gt;</code></p><p><code>11369</code><code>1987;&lt;span class="ref-vol"&gt;</code></p><p><code>11370</code><code>79&lt;/span&gt;</code></p><p><code>11371</code><code>:59–66.&lt;/span&gt;</code></p><p><code>11372</code><code> [&lt;a href="/pubmed/2830538" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11373</code><code>PubMed&lt;/a&gt;</code></p><p><code>11374</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11375</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=NIDA+Res+Monogr&amp;amp;title=Anticonvulsant+and+neurotoxic+effects+of+tetrahydrocannabinol+stereoisomers&amp;amp;author=P+Consroe&amp;amp;author=R+Mechoulam&amp;amp;volume=79&amp;amp;publication_year=1987&amp;amp;pages=59-66&amp;amp;pmid=2830538&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11376</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11377</code><code>]&lt;/span&gt;</code></p><p><code>11378</code><code>&lt;/span&gt;</code></p><p><code>11379</code><code>&lt;/li&gt;</code></p><p><code>11380</code><code>&lt;li id="R204"&gt;</code></p><p><code>11381</code><code>&lt;span class="citation"&gt;</code></p><p><code>11382</code><code>Consroe P, Musty R, Rein J, Tillery W, Pertwee R. The perceived effects of smoked cannabis on patients with multiple sclerosis. &lt;span&gt;</code></p><p><code>11383</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11384</code><code>Eur Neurol. &lt;/span&gt;</code></p><p><code>11385</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>11386</code><code>38&lt;/span&gt;</code></p><p><code>11387</code><code>:44–48.&lt;/span&gt;</code></p><p><code>11388</code><code> [&lt;a href="/pubmed/9252798" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11389</code><code>PubMed&lt;/a&gt;</code></p><p><code>11390</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11391</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+Neurol&amp;amp;title=The+perceived+effects+of+smoked+cannabis+on+patients+with+multiple+sclerosis&amp;amp;author=P+Consroe&amp;amp;author=R+Musty&amp;amp;author=J+Rein&amp;amp;author=W+Tillery&amp;amp;author=R+Pertwee&amp;amp;volume=38&amp;amp;publication_year=1997&amp;amp;pages=44-48&amp;amp;pmid=9252798&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11392</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11393</code><code>]&lt;/span&gt;</code></p><p><code>11394</code><code>&lt;/span&gt;</code></p><p><code>11395</code><code>&lt;/li&gt;</code></p><p><code>11396</code><code>&lt;li id="R205"&gt;</code></p><p><code>11397</code><code>&lt;span class="citation"&gt;</code></p><p><code>11398</code><code>Consroe P, Wolkin A. Cannabidiol-antiepileptic drug comparisons and interactions in experimentally induced seizures in rats. &lt;span&gt;</code></p><p><code>11399</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11400</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>11401</code><code>1977;&lt;span class="ref-vol"&gt;</code></p><p><code>11402</code><code>201&lt;/span&gt;</code></p><p><code>11403</code><code>:26–32.&lt;/span&gt;</code></p><p><code>11404</code><code> [&lt;a href="/pubmed/850145" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11405</code><code>PubMed&lt;/a&gt;</code></p><p><code>11406</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11407</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Cannabidiol-antiepileptic+drug+comparisons+and+interactions+in+experimentally+induced+seizures+in+rats&amp;amp;author=P+Consroe&amp;amp;author=A+Wolkin&amp;amp;volume=201&amp;amp;publication_year=1977&amp;amp;pages=26-32&amp;amp;pmid=850145&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11408</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11409</code><code>]&lt;/span&gt;</code></p><p><code>11410</code><code>&lt;/span&gt;</code></p><p><code>11411</code><code>&lt;/li&gt;</code></p><p><code>11412</code><code>&lt;li id="R206"&gt;</code></p><p><code>11413</code><code>&lt;span class="citation"&gt;</code></p><p><code>11414</code><code>Consroe PF, Wood GC, Buchsbaum H. Anticonvulsant nature of marihuana smoking. &lt;span&gt;</code></p><p><code>11415</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11416</code><code>J Am Med Assoc. &lt;/span&gt;</code></p><p><code>11417</code><code>1975;&lt;span class="ref-vol"&gt;</code></p><p><code>11418</code><code>234&lt;/span&gt;</code></p><p><code>11419</code><code>:306–307.&lt;/span&gt;</code></p><p><code>11420</code><code> [&lt;a href="/pubmed/808653" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11421</code><code>PubMed&lt;/a&gt;</code></p><p><code>11422</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11423</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Med+Assoc&amp;amp;title=Anticonvulsant+nature+of+marihuana+smoking&amp;amp;author=PF+Consroe&amp;amp;author=GC+Wood&amp;amp;author=H+Buchsbaum&amp;amp;volume=234&amp;amp;publication_year=1975&amp;amp;pages=306-307&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11424</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11425</code><code>]&lt;/span&gt;</code></p><p><code>11426</code><code>&lt;/span&gt;</code></p><p><code>11427</code><code>&lt;/li&gt;</code></p><p><code>11428</code><code>&lt;li id="R207"&gt;</code></p><p><code>11429</code><code>&lt;span class="citation"&gt;</code></p><p><code>11430</code><code>Contassot E, Tenan M, Schnuriger V, Pelte MF, Dietrich PY. Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1. &lt;span&gt;</code></p><p><code>11431</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11432</code><code>Gynecol Oncol. &lt;/span&gt;</code></p><p><code>11433</code><code>2004a;&lt;span class="ref-vol"&gt;</code></p><p><code>11434</code><code>93&lt;/span&gt;</code></p><p><code>11435</code><code>:182–188.&lt;/span&gt;</code></p><p><code>11436</code><code> [&lt;a href="/pubmed/15047233" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11437</code><code>PubMed&lt;/a&gt;</code></p><p><code>11438</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11439</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gynecol+Oncol&amp;amp;title=Arachidonyl+ethanolamide+induces+apoptosis+of+uterine+cervix+cancer+cells+via+aberrantly+expressed+vanilloid+receptor-1&amp;amp;author=E+Contassot&amp;amp;author=M+Tenan&amp;amp;author=V+Schnuriger&amp;amp;author=MF+Pelte&amp;amp;author=PY+Dietrich&amp;amp;volume=93&amp;amp;publication_year=2004a&amp;amp;pages=182-188&amp;amp;pmid=15047233&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11440</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11441</code><code>]&lt;/span&gt;</code></p><p><code>11442</code><code>&lt;/span&gt;</code></p><p><code>11443</code><code>&lt;/li&gt;</code></p><p><code>11444</code><code>&lt;li id="R208"&gt;</code></p><p><code>11445</code><code>&lt;span class="citation"&gt;</code></p><p><code>11446</code><code>Contassot E, Wilmotte R, Tenan M, Belkouch MC, Schnuriger V, de Tribolet N, Burkhardt K, Dietrich PY. Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1. &lt;span&gt;</code></p><p><code>11447</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11448</code><code>J Neuropathol Exp Neurol. &lt;/span&gt;</code></p><p><code>11449</code><code>2004b;&lt;span class="ref-vol"&gt;</code></p><p><code>11450</code><code>63&lt;/span&gt;</code></p><p><code>11451</code><code>:956–963.&lt;/span&gt;</code></p><p><code>11452</code><code> [&lt;a href="/pubmed/15453094" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11453</code><code>PubMed&lt;/a&gt;</code></p><p><code>11454</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11455</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neuropathol+Exp+Neurol&amp;amp;title=Arachidonylethanolamide+induces+apoptosis+of+human+glioma+cells+through+vanilloid+receptor-1&amp;amp;author=E+Contassot&amp;amp;author=R+Wilmotte&amp;amp;author=M+Tenan&amp;amp;author=MC+Belkouch&amp;amp;author=V+Schnuriger&amp;amp;volume=63&amp;amp;publication_year=2004b&amp;amp;pages=956-963&amp;amp;pmid=15453094&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11456</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11457</code><code>]&lt;/span&gt;</code></p><p><code>11458</code><code>&lt;/span&gt;</code></p><p><code>11459</code><code>&lt;/li&gt;</code></p><p><code>11460</code><code>&lt;li id="R209"&gt;</code></p><p><code>11461</code><code>&lt;span class="citation"&gt;</code></p><p><code>11462</code><code>Corcoran ME, McCaughran JA, Jr, Wada JA. Antiepileptic and prophylactic effects of tetrahydrocannabinols in amygdaloid kindled rats. &lt;span&gt;</code></p><p><code>11463</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11464</code><code>Epilepsia. &lt;/span&gt;</code></p><p><code>11465</code><code>1978;&lt;span class="ref-vol"&gt;</code></p><p><code>11466</code><code>19&lt;/span&gt;</code></p><p><code>11467</code><code>:47–55.&lt;/span&gt;</code></p><p><code>11468</code><code> [&lt;a href="/pubmed/624268" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11469</code><code>PubMed&lt;/a&gt;</code></p><p><code>11470</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11471</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Epilepsia&amp;amp;title=Antiepileptic+and+prophylactic+effects+of+tetrahydrocannabinols+in+amygdaloid+kindled+rats&amp;amp;author=ME+Corcoran&amp;amp;author=JA+McCaughran&amp;amp;author=JA+Wada&amp;amp;volume=19&amp;amp;publication_year=1978&amp;amp;pages=47-55&amp;amp;pmid=624268&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11472</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11473</code><code>]&lt;/span&gt;</code></p><p><code>11474</code><code>&lt;/span&gt;</code></p><p><code>11475</code><code>&lt;/li&gt;</code></p><p><code>11476</code><code>&lt;li id="R210"&gt;</code></p><p><code>11477</code><code>&lt;span class="citation"&gt;</code></p><p><code>11478</code><code>Correa F, Mestre L, Molina-Holgado E, Arevalo-Martin A, Docagne F, Romero E, Molina-Holgado F, Borrell J, Guaza C. The role of cannabinoid system on immune modulation: therapeutic implications on CNS inflammation. &lt;span&gt;</code></p><p><code>11479</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11480</code><code>Mini Rev Med Chem. &lt;/span&gt;</code></p><p><code>11481</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>11482</code><code>5&lt;/span&gt;</code></p><p><code>11483</code><code>:671–675.&lt;/span&gt;</code></p><p><code>11484</code><code> [&lt;a href="/pubmed/16026313" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11485</code><code>PubMed&lt;/a&gt;</code></p><p><code>11486</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11487</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mini+Rev+Med+Chem&amp;amp;title=The+role+of+cannabinoid+system+on+immune+modulation:+therapeutic+implications+on+CNS+inflammation&amp;amp;author=F+Correa&amp;amp;author=L+Mestre&amp;amp;author=E+Molina-Holgado&amp;amp;author=A+Arevalo-Martin&amp;amp;author=F+Docagne&amp;amp;volume=5&amp;amp;publication_year=2005&amp;amp;pages=671-675&amp;amp;pmid=16026313&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11488</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11489</code><code>]&lt;/span&gt;</code></p><p><code>11490</code><code>&lt;/span&gt;</code></p><p><code>11491</code><code>&lt;/li&gt;</code></p><p><code>11492</code><code>&lt;li id="R211"&gt;</code></p><p><code>11493</code><code>&lt;span class="citation"&gt;</code></p><p><code>11494</code><code>Coruzzi G, Adami M, Coppelli G, Frati P, Soldani G. Inhibitory effect of the cannabinoid receptor agonist WIN 55,212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat. &lt;span&gt;</code></p><p><code>11495</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11496</code><code>Naunyn-Schmiedeberg&amp;#x02019;s Arch Pharmacol. &lt;/span&gt;</code></p><p><code>11497</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>11498</code><code>360&lt;/span&gt;</code></p><p><code>11499</code><code>:715–718.&lt;/span&gt;</code></p><p><code>11500</code><code> [&lt;a href="/pubmed/10619190" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11501</code><code>PubMed&lt;/a&gt;</code></p><p><code>11502</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11503</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Naunyn-Schmiedeberg&amp;#x02019;s+Arch+Pharmacol&amp;amp;title=Inhibitory+effect+of+the+cannabinoid+receptor+agonist+WIN+55,212-2+on+pentagastrin-induced+gastric+acid+secretion+in+the+anaesthetized+rat&amp;amp;author=G+Coruzzi&amp;amp;author=M+Adami&amp;amp;author=G+Coppelli&amp;amp;author=P+Frati&amp;amp;author=G+Soldani&amp;amp;volume=360&amp;amp;publication_year=1999&amp;amp;pages=715-718&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11504</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11505</code><code>]&lt;/span&gt;</code></p><p><code>11506</code><code>&lt;/span&gt;</code></p><p><code>11507</code><code>&lt;/li&gt;</code></p><p><code>11508</code><code>&lt;li id="R212"&gt;</code></p><p><code>11509</code><code>&lt;span class="citation"&gt;</code></p><p><code>11510</code><code>Cossu G, Ledent C, Fattore L, Imperato A, Bohme GA, Parmentier M, Fratta W. Cannabinoid CB&lt;sub&gt;</code></p><p><code>11511</code><code>1&lt;/sub&gt;</code></p><p><code>11512</code><code> receptor knockout mice fail to self-administer morphine but not other drugs of abuse. &lt;span&gt;</code></p><p><code>11513</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11514</code><code>Behav Brain Res. &lt;/span&gt;</code></p><p><code>11515</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>11516</code><code>118&lt;/span&gt;</code></p><p><code>11517</code><code>:61–65.&lt;/span&gt;</code></p><p><code>11518</code><code> [&lt;a href="/pubmed/11163634" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11519</code><code>PubMed&lt;/a&gt;</code></p><p><code>11520</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11521</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Behav+Brain+Res&amp;amp;title=Cannabinoid+CB1+receptor+knockout+mice+fail+to+self-administer+morphine+but+not+other+drugs+of+abuse&amp;amp;author=G+Cossu&amp;amp;author=C+Ledent&amp;amp;author=L+Fattore&amp;amp;author=A+Imperato&amp;amp;author=GA+Bohme&amp;amp;volume=118&amp;amp;publication_year=2001&amp;amp;pages=61-65&amp;amp;pmid=11163634&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11522</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11523</code><code>]&lt;/span&gt;</code></p><p><code>11524</code><code>&lt;/span&gt;</code></p><p><code>11525</code><code>&lt;/li&gt;</code></p><p><code>11526</code><code>&lt;li id="R213"&gt;</code></p><p><code>11527</code><code>&lt;span class="citation"&gt;</code></p><p><code>11528</code><code>Costa B, Colleoni M, Conti S, Parolaro D, Franke C, Trovato AE, Giagnoni G. Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw. &lt;span&gt;</code></p><p><code>11529</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11530</code><code>Naunyn-Schmiedeberg&amp;#x02019;s Arch Pharmacol. &lt;/span&gt;</code></p><p><code>11531</code><code>2004a;&lt;span class="ref-vol"&gt;</code></p><p><code>11532</code><code>369&lt;/span&gt;</code></p><p><code>11533</code><code>:294–299.&lt;/span&gt;</code></p><p><code>11534</code><code> [&lt;a href="/pubmed/14963641" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11535</code><code>PubMed&lt;/a&gt;</code></p><p><code>11536</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11537</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Naunyn-Schmiedeberg&amp;#x02019;s+Arch+Pharmacol&amp;amp;title=Oral+anti-inflammatory+activity+of+cannabidiol,+a+non-psychoactive+constituent+of+cannabis,+in+acute+carrageenan-induced+inflammation+in+the+rat+paw&amp;amp;author=B+Costa&amp;amp;author=M+Colleoni&amp;amp;author=S+Conti&amp;amp;author=D+Parolaro&amp;amp;author=C+Franke&amp;amp;volume=369&amp;amp;publication_year=2004a&amp;amp;pages=294-299&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11538</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11539</code><code>]&lt;/span&gt;</code></p><p><code>11540</code><code>&lt;/span&gt;</code></p><p><code>11541</code><code>&lt;/li&gt;</code></p><p><code>11542</code><code>&lt;li id="R214"&gt;</code></p><p><code>11543</code><code>&lt;span class="citation"&gt;</code></p><p><code>11544</code><code>Costa B, Colleoni M, Conti S, Trovato AE, Bianchi M, Sotgiu ML, Giagnoni G. Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain. &lt;span&gt;</code></p><p><code>11545</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11546</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>11547</code><code>2004b;&lt;span class="ref-vol"&gt;</code></p><p><code>11548</code><code>141&lt;/span&gt;</code></p><p><code>11549</code><code>:4–8.&lt;/span&gt;</code></p><p><code>11550</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>11551</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1574173/"&gt;</code></p><p><code>11552</code><code>PMC free article&lt;/a&gt;</code></p><p><code>11553</code><code>]&lt;/span&gt;</code></p><p><code>11554</code><code> [&lt;a href="/pubmed/14662732" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11555</code><code>PubMed&lt;/a&gt;</code></p><p><code>11556</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11557</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Repeated+treatment+with+the+synthetic+cannabinoid+WIN+55,212-2+reduces+both+hyperalgesia+and+production+of+pronociceptive+mediators+in+a+rat+model+of+neuropathic+pain&amp;amp;author=B+Costa&amp;amp;author=M+Colleoni&amp;amp;author=S+Conti&amp;amp;author=AE+Trovato&amp;amp;author=M+Bianchi&amp;amp;volume=141&amp;amp;publication_year=2004b&amp;amp;pages=4-8&amp;amp;pmid=14662732&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11558</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11559</code><code>]&lt;/span&gt;</code></p><p><code>11560</code><code>&lt;/span&gt;</code></p><p><code>11561</code><code>&lt;/li&gt;</code></p><p><code>11562</code><code>&lt;li id="R215"&gt;</code></p><p><code>11563</code><code>&lt;span class="citation"&gt;</code></p><p><code>11564</code><code>Cota D, Marsicano G, Tschop M, Grubler Y, Flachskamm C, Schubert M, Auer D, Yassouridis A, Thone-Reineke C, Ortmann S, et al.  The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. &lt;span&gt;</code></p><p><code>11565</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11566</code><code>J Clin Investig. &lt;/span&gt;</code></p><p><code>11567</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>11568</code><code>112&lt;/span&gt;</code></p><p><code>11569</code><code>:423–431.&lt;/span&gt;</code></p><p><code>11570</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>11571</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC166293/"&gt;</code></p><p><code>11572</code><code>PMC free article&lt;/a&gt;</code></p><p><code>11573</code><code>]&lt;/span&gt;</code></p><p><code>11574</code><code> [&lt;a href="/pubmed/12897210" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11575</code><code>PubMed&lt;/a&gt;</code></p><p><code>11576</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11577</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Investig&amp;amp;title=The+endogenous+cannabinoid+system+affects+energy+balance+via+central+orexigenic+drive+and+peripheral+lipogenesis&amp;amp;author=D+Cota&amp;amp;author=G+Marsicano&amp;amp;author=M+Tschop&amp;amp;author=Y+Grubler&amp;amp;author=C+Flachskamm&amp;amp;volume=112&amp;amp;publication_year=2003&amp;amp;pages=423-431&amp;amp;pmid=12897210&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11578</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11579</code><code>]&lt;/span&gt;</code></p><p><code>11580</code><code>&lt;/span&gt;</code></p><p><code>11581</code><code>&lt;/li&gt;</code></p><p><code>11582</code><code>&lt;li id="R216"&gt;</code></p><p><code>11583</code><code>&lt;span class="citation"&gt;</code></p><p><code>11584</code><code>Coutts AA, Irving AJ, Mackie K, Pertwee RG, Anavi-Goffer S. Localisation of cannabinoid CB&lt;sub&gt;</code></p><p><code>11585</code><code>1&lt;/sub&gt;</code></p><p><code>11586</code><code> receptor immunoreactivity in the guinea pig and rat myenteric plexus. &lt;span&gt;</code></p><p><code>11587</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11588</code><code>J Comp Neurol. &lt;/span&gt;</code></p><p><code>11589</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>11590</code><code>448&lt;/span&gt;</code></p><p><code>11591</code><code>:410–422.&lt;/span&gt;</code></p><p><code>11592</code><code> [&lt;a href="/pubmed/12115703" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11593</code><code>PubMed&lt;/a&gt;</code></p><p><code>11594</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11595</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Comp+Neurol&amp;amp;title=Localisation+of+cannabinoid+CB1+receptor+immunoreactivity+in+the+guinea+pig+and+rat+myenteric+plexus&amp;amp;author=AA+Coutts&amp;amp;author=AJ+Irving&amp;amp;author=K+Mackie&amp;amp;author=RG+Pertwee&amp;amp;author=S+Anavi-Goffer&amp;amp;volume=448&amp;amp;publication_year=2002&amp;amp;pages=410-422&amp;amp;pmid=12115703&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11596</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11597</code><code>]&lt;/span&gt;</code></p><p><code>11598</code><code>&lt;/span&gt;</code></p><p><code>11599</code><code>&lt;/li&gt;</code></p><p><code>11600</code><code>&lt;li id="R217"&gt;</code></p><p><code>11601</code><code>&lt;span class="citation"&gt;</code></p><p><code>11602</code><code>Coutts AA, Izzo AA. The gastrointestinal pharmacology of cannabinoids: an update. &lt;span&gt;</code></p><p><code>11603</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11604</code><code>Curr Opin Pharmacol. &lt;/span&gt;</code></p><p><code>11605</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>11606</code><code>4&lt;/span&gt;</code></p><p><code>11607</code><code>:572–579.&lt;/span&gt;</code></p><p><code>11608</code><code> [&lt;a href="/pubmed/15525546" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11609</code><code>PubMed&lt;/a&gt;</code></p><p><code>11610</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11611</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Pharmacol&amp;amp;title=The+gastrointestinal+pharmacology+of+cannabinoids:+an+update&amp;amp;author=AA+Coutts&amp;amp;author=AA+Izzo&amp;amp;volume=4&amp;amp;publication_year=2004&amp;amp;pages=572-579&amp;amp;pmid=15525546&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11612</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11613</code><code>]&lt;/span&gt;</code></p><p><code>11614</code><code>&lt;/span&gt;</code></p><p><code>11615</code><code>&lt;/li&gt;</code></p><p><code>11616</code><code>&lt;li id="R218"&gt;</code></p><p><code>11617</code><code>&lt;span class="citation"&gt;</code></p><p><code>11618</code><code>Coutts AA, Pertwee RG. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus. &lt;span&gt;</code></p><p><code>11619</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11620</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>11621</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>11622</code><code>121&lt;/span&gt;</code></p><p><code>11623</code><code>:1557–1566.&lt;/span&gt;</code></p><p><code>11624</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>11625</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1564859/"&gt;</code></p><p><code>11626</code><code>PMC free article&lt;/a&gt;</code></p><p><code>11627</code><code>]&lt;/span&gt;</code></p><p><code>11628</code><code> [&lt;a href="/pubmed/9283688" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11629</code><code>PubMed&lt;/a&gt;</code></p><p><code>11630</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11631</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Inhibition+by+cannabinoid+receptor+agonists+of+acetylcholine+release+from+the+guinea-pig+myenteric+plexus&amp;amp;author=AA+Coutts&amp;amp;author=RG+Pertwee&amp;amp;volume=121&amp;amp;publication_year=1997&amp;amp;pages=1557-1566&amp;amp;pmid=9283688&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11632</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11633</code><code>]&lt;/span&gt;</code></p><p><code>11634</code><code>&lt;/span&gt;</code></p><p><code>11635</code><code>&lt;/li&gt;</code></p><p><code>11636</code><code>&lt;li id="R219"&gt;</code></p><p><code>11637</code><code>&lt;span class="citation"&gt;</code></p><p><code>11638</code><code>Cox ML, Welch SP. The antinociceptive effect of &amp;#x00394;&lt;sup&gt;</code></p><p><code>11639</code><code>9&lt;/sup&gt;</code></p><p><code>11640</code><code>-tetrahydrocannabinol in the arthritic rat. &lt;span&gt;</code></p><p><code>11641</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11642</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>11643</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>11644</code><code>493&lt;/span&gt;</code></p><p><code>11645</code><code>:65–74.&lt;/span&gt;</code></p><p><code>11646</code><code> [&lt;a href="/pubmed/15189765" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11647</code><code>PubMed&lt;/a&gt;</code></p><p><code>11648</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11649</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=The+antinociceptive+effect+of+&amp;#x00394;9-tetrahydrocannabinol+in+the+arthritic+rat&amp;amp;author=ML+Cox&amp;amp;author=SP+Welch&amp;amp;volume=493&amp;amp;publication_year=2004&amp;amp;pages=65-74&amp;amp;pmid=15189765&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11650</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11651</code><code>]&lt;/span&gt;</code></p><p><code>11652</code><code>&lt;/span&gt;</code></p><p><code>11653</code><code>&lt;/li&gt;</code></p><p><code>11654</code><code>&lt;li id="R220"&gt;</code></p><p><code>11655</code><code>&lt;span class="citation"&gt;</code></p><p><code>11656</code><code>Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. &lt;span&gt;</code></p><p><code>11657</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11658</code><code>Science (Wash DC) &lt;/span&gt;</code></p><p><code>11659</code><code>1993;&lt;span class="ref-vol"&gt;</code></p><p><code>11660</code><code>262&lt;/span&gt;</code></p><p><code>11661</code><code>:689–695.&lt;/span&gt;</code></p><p><code>11662</code><code> [&lt;a href="/pubmed/7901908" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11663</code><code>PubMed&lt;/a&gt;</code></p><p><code>11664</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11665</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Science+(Wash+DC)&amp;amp;title=Oxidative+stress,+glutamate,+and+neurodegenerative+disorders&amp;amp;author=JT+Coyle&amp;amp;author=P+Puttfarcken&amp;amp;volume=262&amp;amp;publication_year=1993&amp;amp;pages=689-695&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11666</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11667</code><code>]&lt;/span&gt;</code></p><p><code>11668</code><code>&lt;/span&gt;</code></p><p><code>11669</code><code>&lt;/li&gt;</code></p><p><code>11670</code><code>&lt;li id="R221"&gt;</code></p><p><code>11671</code><code>&lt;span class="citation"&gt;</code></p><p><code>11672</code><code>Coyne L, Lees G, Nicholson RA, Zheng J, Neufield KD. The sleep hormone oleamide modulates inhibitory ionotropic receptors in mammalian CNS in vitro. &lt;span&gt;</code></p><p><code>11673</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11674</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>11675</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>11676</code><code>135&lt;/span&gt;</code></p><p><code>11677</code><code>:1977–1987.&lt;/span&gt;</code></p><p><code>11678</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>11679</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1573315/"&gt;</code></p><p><code>11680</code><code>PMC free article&lt;/a&gt;</code></p><p><code>11681</code><code>]&lt;/span&gt;</code></p><p><code>11682</code><code> [&lt;a href="/pubmed/11959801" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11683</code><code>PubMed&lt;/a&gt;</code></p><p><code>11684</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11685</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=The+sleep+hormone+oleamide+modulates+inhibitory+ionotropic+receptors+in+mammalian+CNS+in+vitro&amp;amp;author=L+Coyne&amp;amp;author=G+Lees&amp;amp;author=RA+Nicholson&amp;amp;author=J+Zheng&amp;amp;author=KD+Neufield&amp;amp;volume=135&amp;amp;publication_year=2002&amp;amp;pages=1977-1987&amp;amp;pmid=11959801&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11686</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11687</code><code>]&lt;/span&gt;</code></p><p><code>11688</code><code>&lt;/span&gt;</code></p><p><code>11689</code><code>&lt;/li&gt;</code></p><p><code>11690</code><code>&lt;li id="R222"&gt;</code></p><p><code>11691</code><code>&lt;span class="citation"&gt;</code></p><p><code>11692</code><code>Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, Lichtman AH. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. &lt;span&gt;</code></p><p><code>11693</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11694</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>11695</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>11696</code><code>98&lt;/span&gt;</code></p><p><code>11697</code><code>:9371–9376.&lt;/span&gt;</code></p><p><code>11698</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>11699</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC55427/"&gt;</code></p><p><code>11700</code><code>PMC free article&lt;/a&gt;</code></p><p><code>11701</code><code>]&lt;/span&gt;</code></p><p><code>11702</code><code> [&lt;a href="/pubmed/11470906" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11703</code><code>PubMed&lt;/a&gt;</code></p><p><code>11704</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11705</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Supersensitivity+to+anandamide+and+enhanced+endogenous+cannabinoid+signaling+in+mice+lacking+fatty+acid+amide+hydrolase&amp;amp;author=BF+Cravatt&amp;amp;author=K+Demarest&amp;amp;author=MP+Patricelli&amp;amp;author=MH+Bracey&amp;amp;author=DK+Giang&amp;amp;volume=98&amp;amp;publication_year=2001&amp;amp;pages=9371-9376&amp;amp;pmid=11470906&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11706</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11707</code><code>]&lt;/span&gt;</code></p><p><code>11708</code><code>&lt;/span&gt;</code></p><p><code>11709</code><code>&lt;/li&gt;</code></p><p><code>11710</code><code>&lt;li id="R223"&gt;</code></p><p><code>11711</code><code>&lt;span class="citation"&gt;</code></p><p><code>11712</code><code>Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. &lt;span&gt;</code></p><p><code>11713</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11714</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>11715</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>11716</code><code>384&lt;/span&gt;</code></p><p><code>11717</code><code>:83–87.&lt;/span&gt;</code></p><p><code>11718</code><code> [&lt;a href="/pubmed/8900284" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11719</code><code>PubMed&lt;/a&gt;</code></p><p><code>11720</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11721</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Molecular+characterization+of+an+enzyme+that+degrades+neuromodulatory+fatty-acid+amides&amp;amp;author=BF+Cravatt&amp;amp;author=DK+Giang&amp;amp;author=SP+Mayfield&amp;amp;author=DL+Boger&amp;amp;author=RA+Lerner&amp;amp;volume=384&amp;amp;publication_year=1996&amp;amp;pages=83-87&amp;amp;pmid=8900284&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11722</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11723</code><code>]&lt;/span&gt;</code></p><p><code>11724</code><code>&lt;/span&gt;</code></p><p><code>11725</code><code>&lt;/li&gt;</code></p><p><code>11726</code><code>&lt;li id="R224"&gt;</code></p><p><code>11727</code><code>&lt;span class="citation"&gt;</code></p><p><code>11728</code><code>Cravatt BF, Prospero-Garcia O, Siuzdak G, Gilula NB, Henriksen SJ, Boger DL, Lerner RA. Chemical characterization of a family of brain lipids that induce sleep. &lt;span&gt;</code></p><p><code>11729</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11730</code><code>Science (Wash DC) &lt;/span&gt;</code></p><p><code>11731</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>11732</code><code>268&lt;/span&gt;</code></p><p><code>11733</code><code>:1506–1509.&lt;/span&gt;</code></p><p><code>11734</code><code> [&lt;a href="/pubmed/7770779" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11735</code><code>PubMed&lt;/a&gt;</code></p><p><code>11736</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11737</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Science+(Wash+DC)&amp;amp;title=Chemical+characterization+of+a+family+of+brain+lipids+that+induce+sleep&amp;amp;author=BF+Cravatt&amp;amp;author=O+Prospero-Garcia&amp;amp;author=G+Siuzdak&amp;amp;author=NB+Gilula&amp;amp;author=SJ+Henriksen&amp;amp;volume=268&amp;amp;publication_year=1995&amp;amp;pages=1506-1509&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11738</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11739</code><code>]&lt;/span&gt;</code></p><p><code>11740</code><code>&lt;/span&gt;</code></p><p><code>11741</code><code>&lt;/li&gt;</code></p><p><code>11742</code><code>&lt;li id="R225"&gt;</code></p><p><code>11743</code><code>&lt;span class="citation"&gt;</code></p><p><code>11744</code><code>Cravatt BF, Saghatelian A, Hawkins EG, Clement AB, Bracey MH, Lichtman AH. Functional disassociation of the central and peripheral fatty acid amide signaling systems. &lt;span&gt;</code></p><p><code>11745</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11746</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>11747</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>11748</code><code>101&lt;/span&gt;</code></p><p><code>11749</code><code>:10821–10826.&lt;/span&gt;</code></p><p><code>11750</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>11751</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC490018/"&gt;</code></p><p><code>11752</code><code>PMC free article&lt;/a&gt;</code></p><p><code>11753</code><code>]&lt;/span&gt;</code></p><p><code>11754</code><code> [&lt;a href="/pubmed/15247426" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11755</code><code>PubMed&lt;/a&gt;</code></p><p><code>11756</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11757</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Functional+disassociation+of+the+central+and+peripheral+fatty+acid+amide+signaling+systems&amp;amp;author=BF+Cravatt&amp;amp;author=A+Saghatelian&amp;amp;author=EG+Hawkins&amp;amp;author=AB+Clement&amp;amp;author=MH+Bracey&amp;amp;volume=101&amp;amp;publication_year=2004&amp;amp;pages=10821-10826&amp;amp;pmid=15247426&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11758</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11759</code><code>]&lt;/span&gt;</code></p><p><code>11760</code><code>&lt;/span&gt;</code></p><p><code>11761</code><code>&lt;/li&gt;</code></p><p><code>11762</code><code>&lt;li id="R226"&gt;</code></p><p><code>11763</code><code>&lt;span class="citation"&gt;</code></p><p><code>11764</code><code>Crawford WJ, Merritt JC. Effects of tetrahydrocannabinol on arterial and intraocular hypertension. &lt;span&gt;</code></p><p><code>11765</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11766</code><code>Int J Clin Pharmacol Biopharm. &lt;/span&gt;</code></p><p><code>11767</code><code>1979;&lt;span class="ref-vol"&gt;</code></p><p><code>11768</code><code>17&lt;/span&gt;</code></p><p><code>11769</code><code>:191–196.&lt;/span&gt;</code></p><p><code>11770</code><code> [&lt;a href="/pubmed/468444" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11771</code><code>PubMed&lt;/a&gt;</code></p><p><code>11772</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11773</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Clin+Pharmacol+Biopharm&amp;amp;title=Effects+of+tetrahydrocannabinol+on+arterial+and+intraocular+hypertension&amp;amp;author=WJ+Crawford&amp;amp;author=JC+Merritt&amp;amp;volume=17&amp;amp;publication_year=1979&amp;amp;pages=191-196&amp;amp;pmid=468444&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11774</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11775</code><code>]&lt;/span&gt;</code></p><p><code>11776</code><code>&lt;/span&gt;</code></p><p><code>11777</code><code>&lt;/li&gt;</code></p><p><code>11778</code><code>&lt;li id="R227"&gt;</code></p><p><code>11779</code><code>&lt;span class="citation"&gt;</code></p><p><code>11780</code><code>Crawley JN, Corwin RL, Robinson JK, Felder CC, Devane WA, Axelrod J. Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. &lt;span&gt;</code></p><p><code>11781</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11782</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>11783</code><code>1993;&lt;span class="ref-vol"&gt;</code></p><p><code>11784</code><code>46&lt;/span&gt;</code></p><p><code>11785</code><code>:967–972.&lt;/span&gt;</code></p><p><code>11786</code><code> [&lt;a href="/pubmed/7906042" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11787</code><code>PubMed&lt;/a&gt;</code></p><p><code>11788</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11789</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Anandamide,+an+endogenous+ligand+of+the+cannabinoid+receptor,+induces+hypomotility+and+hypothermia+in+vivo+in+rodents&amp;amp;author=JN+Crawley&amp;amp;author=RL+Corwin&amp;amp;author=JK+Robinson&amp;amp;author=CC+Felder&amp;amp;author=WA+Devane&amp;amp;volume=46&amp;amp;publication_year=1993&amp;amp;pages=967-972&amp;amp;pmid=7906042&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11790</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11791</code><code>]&lt;/span&gt;</code></p><p><code>11792</code><code>&lt;/span&gt;</code></p><p><code>11793</code><code>&lt;/li&gt;</code></p><p><code>11794</code><code>&lt;li id="R228"&gt;</code></p><p><code>11795</code><code>&lt;span class="citation"&gt;</code></p><p><code>11796</code><code>Croci T, Landi M, Galzin AM, Marini P. Role of cannabinoid CB&lt;sub&gt;</code></p><p><code>11797</code><code>1&lt;/sub&gt;</code></p><p><code>11798</code><code> receptors and tumor necrosis factor-&lt;em&gt;</code></p><p><code>11799</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>11800</code><code> in the gut and systemic anti-inflammatory activity of SR 141716 (rimonabant) in rodents. &lt;span&gt;</code></p><p><code>11801</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11802</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>11803</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>11804</code><code>140&lt;/span&gt;</code></p><p><code>11805</code><code>:115–122.&lt;/span&gt;</code></p><p><code>11806</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>11807</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1574010/"&gt;</code></p><p><code>11808</code><code>PMC free article&lt;/a&gt;</code></p><p><code>11809</code><code>]&lt;/span&gt;</code></p><p><code>11810</code><code> [&lt;a href="/pubmed/12967941" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11811</code><code>PubMed&lt;/a&gt;</code></p><p><code>11812</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11813</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Role+of+cannabinoid+CB1+receptors+and+tumor+necrosis+factor-&amp;#x003b1;+in+the+gut+and+systemic+anti-inflammatory+activity+of+SR+141716+(rimonabant)+in+rodents&amp;amp;author=T+Croci&amp;amp;author=M+Landi&amp;amp;author=AM+Galzin&amp;amp;author=P+Marini&amp;amp;volume=140&amp;amp;publication_year=2003&amp;amp;pages=115-122&amp;amp;pmid=12967941&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11814</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11815</code><code>]&lt;/span&gt;</code></p><p><code>11816</code><code>&lt;/span&gt;</code></p><p><code>11817</code><code>&lt;/li&gt;</code></p><p><code>11818</code><code>&lt;li id="R229"&gt;</code></p><p><code>11819</code><code>&lt;span class="citation"&gt;</code></p><p><code>11820</code><code>Crowston JG, Weinreb RN. Glaucoma medication and aqueous humor dynamics. &lt;span&gt;</code></p><p><code>11821</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11822</code><code>Curr Opin Ophthalmol. &lt;/span&gt;</code></p><p><code>11823</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>11824</code><code>16&lt;/span&gt;</code></p><p><code>11825</code><code>:94–100.&lt;/span&gt;</code></p><p><code>11826</code><code> [&lt;a href="/pubmed/15744139" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11827</code><code>PubMed&lt;/a&gt;</code></p><p><code>11828</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11829</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Ophthalmol&amp;amp;title=Glaucoma+medication+and+aqueous+humor+dynamics&amp;amp;author=JG+Crowston&amp;amp;author=RN+Weinreb&amp;amp;volume=16&amp;amp;publication_year=2005&amp;amp;pages=94-100&amp;amp;pmid=15744139&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11830</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11831</code><code>]&lt;/span&gt;</code></p><p><code>11832</code><code>&lt;/span&gt;</code></p><p><code>11833</code><code>&lt;/li&gt;</code></p><p><code>11834</code><code>&lt;li id="R230"&gt;</code></p><p><code>11835</code><code>&lt;span class="citation"&gt;</code></p><p><code>11836</code><code>Croxford JL. Therapeutic potential of cannabinoids in CNS disease. &lt;span&gt;</code></p><p><code>11837</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11838</code><code>CNS Drugs. &lt;/span&gt;</code></p><p><code>11839</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>11840</code><code>17&lt;/span&gt;</code></p><p><code>11841</code><code>:179–202.&lt;/span&gt;</code></p><p><code>11842</code><code> [&lt;a href="/pubmed/12617697" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11843</code><code>PubMed&lt;/a&gt;</code></p><p><code>11844</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11845</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=CNS+Drugs&amp;amp;title=Therapeutic+potential+of+cannabinoids+in+CNS+disease&amp;amp;author=JL+Croxford&amp;amp;volume=17&amp;amp;publication_year=2003&amp;amp;pages=179-202&amp;amp;pmid=12617697&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11846</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11847</code><code>]&lt;/span&gt;</code></p><p><code>11848</code><code>&lt;/span&gt;</code></p><p><code>11849</code><code>&lt;/li&gt;</code></p><p><code>11850</code><code>&lt;li id="R231"&gt;</code></p><p><code>11851</code><code>&lt;span class="citation"&gt;</code></p><p><code>11852</code><code>Croxford JL, Miller SD. Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212. &lt;span&gt;</code></p><p><code>11853</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11854</code><code>J Clin Investig. &lt;/span&gt;</code></p><p><code>11855</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>11856</code><code>111&lt;/span&gt;</code></p><p><code>11857</code><code>:1231–1240.&lt;/span&gt;</code></p><p><code>11858</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>11859</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC152941/"&gt;</code></p><p><code>11860</code><code>PMC free article&lt;/a&gt;</code></p><p><code>11861</code><code>]&lt;/span&gt;</code></p><p><code>11862</code><code> [&lt;a href="/pubmed/12697742" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11863</code><code>PubMed&lt;/a&gt;</code></p><p><code>11864</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11865</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Investig&amp;amp;title=Immunoregulation+of+a+viral+model+of+multiple+sclerosis+using+the+synthetic+cannabinoid+R+WIN55,212&amp;amp;author=JL+Croxford&amp;amp;author=SD+Miller&amp;amp;volume=111&amp;amp;publication_year=2003&amp;amp;pages=1231-1240&amp;amp;pmid=12697742&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11866</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11867</code><code>]&lt;/span&gt;</code></p><p><code>11868</code><code>&lt;/span&gt;</code></p><p><code>11869</code><code>&lt;/li&gt;</code></p><p><code>11870</code><code>&lt;li id="R232"&gt;</code></p><p><code>11871</code><code>&lt;span class="citation"&gt;</code></p><p><code>11872</code><code>Croxford JL, Yamamura T. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases? &lt;span&gt;</code></p><p><code>11873</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11874</code><code>J Neuroimmunol. &lt;/span&gt;</code></p><p><code>11875</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>11876</code><code>166&lt;/span&gt;</code></p><p><code>11877</code><code>:3–18.&lt;/span&gt;</code></p><p><code>11878</code><code> [&lt;a href="/pubmed/16023222" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11879</code><code>PubMed&lt;/a&gt;</code></p><p><code>11880</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11881</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neuroimmunol&amp;amp;title=Cannabinoids+and+the+immune+system:+potential+for+the+treatment+of+inflammatory+diseases?&amp;amp;author=JL+Croxford&amp;amp;author=T+Yamamura&amp;amp;volume=166&amp;amp;publication_year=2005&amp;amp;pages=3-18&amp;amp;pmid=16023222&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11882</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11883</code><code>]&lt;/span&gt;</code></p><p><code>11884</code><code>&lt;/span&gt;</code></p><p><code>11885</code><code>&lt;/li&gt;</code></p><p><code>11886</code><code>&lt;li id="R233"&gt;</code></p><p><code>11887</code><code>&lt;span class="citation"&gt;</code></p><p><code>11888</code><code>Csiszar A, Pacher P, Kaley G, Ungvari Z. Role of oxidative and nitrosative stress, longevity genes and poly(ADP-ribose) polymerase in cardiovascular dysfunction associated with aging. &lt;span&gt;</code></p><p><code>11889</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11890</code><code>Curr Vasc Pharmacol. &lt;/span&gt;</code></p><p><code>11891</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>11892</code><code>3&lt;/span&gt;</code></p><p><code>11893</code><code>:285–291.&lt;/span&gt;</code></p><p><code>11894</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>11895</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2228271/"&gt;</code></p><p><code>11896</code><code>PMC free article&lt;/a&gt;</code></p><p><code>11897</code><code>]&lt;/span&gt;</code></p><p><code>11898</code><code> [&lt;a href="/pubmed/16026324" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11899</code><code>PubMed&lt;/a&gt;</code></p><p><code>11900</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11901</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Vasc+Pharmacol&amp;amp;title=Role+of+oxidative+and+nitrosative+stress,+longevity+genes+and+poly(ADP-ribose)+polymerase+in+cardiovascular+dysfunction+associated+with+aging&amp;amp;author=A+Csiszar&amp;amp;author=P+Pacher&amp;amp;author=G+Kaley&amp;amp;author=Z+Ungvari&amp;amp;volume=3&amp;amp;publication_year=2005&amp;amp;pages=285-291&amp;amp;pmid=16026324&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11902</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11903</code><code>]&lt;/span&gt;</code></p><p><code>11904</code><code>&lt;/span&gt;</code></p><p><code>11905</code><code>&lt;/li&gt;</code></p><p><code>11906</code><code>&lt;li id="R234"&gt;</code></p><p><code>11907</code><code>&lt;span class="citation"&gt;</code></p><p><code>11908</code><code>Cuendet JF, Shapiro D, Calanca A, Faggioni R, Ducrey N. Action of &amp;#x00394;-9-tetrahydrocannabinol on ophthalmotonus. &lt;span&gt;</code></p><p><code>11909</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11910</code><code>Ophthalmologica. &lt;/span&gt;</code></p><p><code>11911</code><code>1976;&lt;span class="ref-vol"&gt;</code></p><p><code>11912</code><code>172&lt;/span&gt;</code></p><p><code>11913</code><code>:122–127.&lt;/span&gt;</code></p><p><code>11914</code><code> [&lt;a href="/pubmed/1256748" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11915</code><code>PubMed&lt;/a&gt;</code></p><p><code>11916</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11917</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Ophthalmologica&amp;amp;title=Action+of+&amp;#x00394;-9-tetrahydrocannabinol+on+ophthalmotonus&amp;amp;author=JF+Cuendet&amp;amp;author=D+Shapiro&amp;amp;author=A+Calanca&amp;amp;author=R+Faggioni&amp;amp;author=N+Ducrey&amp;amp;volume=172&amp;amp;publication_year=1976&amp;amp;pages=122-127&amp;amp;pmid=1256748&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11918</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11919</code><code>]&lt;/span&gt;</code></p><p><code>11920</code><code>&lt;/span&gt;</code></p><p><code>11921</code><code>&lt;/li&gt;</code></p><p><code>11922</code><code>&lt;li id="R235"&gt;</code></p><p><code>11923</code><code>&lt;span class="citation"&gt;</code></p><p><code>11924</code><code>Cunha JM, Carlini EA, Pereira AE, Ramos OL, Pimentel C, Gagliardi R, Sanvito WL, Lander N, Mechoulam R. Chronic administration of cannabidiol to healthy volunteers and epileptic patients. &lt;span&gt;</code></p><p><code>11925</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11926</code><code>Pharmacology. &lt;/span&gt;</code></p><p><code>11927</code><code>1980;&lt;span class="ref-vol"&gt;</code></p><p><code>11928</code><code>21&lt;/span&gt;</code></p><p><code>11929</code><code>:175–185.&lt;/span&gt;</code></p><p><code>11930</code><code> [&lt;a href="/pubmed/7413719" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11931</code><code>PubMed&lt;/a&gt;</code></p><p><code>11932</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11933</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology&amp;amp;title=Chronic+administration+of+cannabidiol+to+healthy+volunteers+and+epileptic+patients&amp;amp;author=JM+Cunha&amp;amp;author=EA+Carlini&amp;amp;author=AE+Pereira&amp;amp;author=OL+Ramos&amp;amp;author=C+Pimentel&amp;amp;volume=21&amp;amp;publication_year=1980&amp;amp;pages=175-185&amp;amp;pmid=7413719&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11934</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11935</code><code>]&lt;/span&gt;</code></p><p><code>11936</code><code>&lt;/span&gt;</code></p><p><code>11937</code><code>&lt;/li&gt;</code></p><p><code>11938</code><code>&lt;li id="R236"&gt;</code></p><p><code>11939</code><code>&lt;span class="citation"&gt;</code></p><p><code>11940</code><code>Curtis MA, Faull RL, Glass M. A novel population of progenitor cells expressing cannabinoid receptors in the subependymal layer of the adult normal and Huntington&amp;#x02019;s disease human brain. &lt;span&gt;</code></p><p><code>11941</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11942</code><code>J Chem Neuroanat. &lt;/span&gt;</code></p><p><code>11943</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>11944</code><code>31&lt;/span&gt;</code></p><p><code>11945</code><code>:210–215.&lt;/span&gt;</code></p><p><code>11946</code><code> [&lt;a href="/pubmed/16533591" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11947</code><code>PubMed&lt;/a&gt;</code></p><p><code>11948</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11949</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Chem+Neuroanat&amp;amp;title=A+novel+population+of+progenitor+cells+expressing+cannabinoid+receptors+in+the+subependymal+layer+of+the+adult+normal+and+Huntington&amp;#x02019;s+disease+human+brain&amp;amp;author=MA+Curtis&amp;amp;author=RL+Faull&amp;amp;author=M+Glass&amp;amp;volume=31&amp;amp;publication_year=2006&amp;amp;pages=210-215&amp;amp;pmid=16533591&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11950</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11951</code><code>]&lt;/span&gt;</code></p><p><code>11952</code><code>&lt;/span&gt;</code></p><p><code>11953</code><code>&lt;/li&gt;</code></p><p><code>11954</code><code>&lt;li id="R237"&gt;</code></p><p><code>11955</code><code>&lt;span class="citation"&gt;</code></p><p><code>11956</code><code>Dajani EZ, Larsen KR, Taylor J, Dajani NE, Shahwan TG, Neeleman SD, Taylor MS, Dayton MT, Mir GN. 1&amp;#x02032;,1&amp;#x02032;-Dimethylheptyl-&amp;#x00394;-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties. &lt;span&gt;</code></p><p><code>11957</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11958</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>11959</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>11960</code><code>291&lt;/span&gt;</code></p><p><code>11961</code><code>:31–38.&lt;/span&gt;</code></p><p><code>11962</code><code> [&lt;a href="/pubmed/10490883" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11963</code><code>PubMed&lt;/a&gt;</code></p><p><code>11964</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11965</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=1&amp;#x02032;,1&amp;#x02032;-Dimethylheptyl-&amp;#x00394;-8-tetrahydrocannabinol-11-oic+acid:+a+novel,+orally+effective+cannabinoid+with+analgesic+and+anti-inflammatory+properties&amp;amp;author=EZ+Dajani&amp;amp;author=KR+Larsen&amp;amp;author=J+Taylor&amp;amp;author=NE+Dajani&amp;amp;author=TG+Shahwan&amp;amp;volume=291&amp;amp;publication_year=1999&amp;amp;pages=31-38&amp;amp;pmid=10490883&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11966</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11967</code><code>]&lt;/span&gt;</code></p><p><code>11968</code><code>&lt;/span&gt;</code></p><p><code>11969</code><code>&lt;/li&gt;</code></p><p><code>11970</code><code>&lt;li id="R238"&gt;</code></p><p><code>11971</code><code>&lt;span class="citation"&gt;</code></p><p><code>11972</code><code>Dale LC, Anthenelli RM. Rimonabant as an aid to smoking cessation in smokers motivated to quit: results from a U.S. Multicenter Study&amp;#x02014;STRATUS U.S. Trial. Proceedings of the Annual Scientific Session of the American College of Cardiology; 2004 March 7&amp;#x02013;10; New Orleans, LA. 2004.  &lt;span class="nowrap"&gt;</code></p><p><code>11973</code><code>[&lt;a href="https://scholar.google.com/scholar?q=Dale+LC+Anthenelli+RM+2004+Rimonabant+as+an+aid+to+smoking+cessation+in+smokers+motivated+to+quit:+results+from+a+U.S.+Multicenter+Study&amp;#x02014;STRATUS+U.S.+Trial+Proceedings+of+the+Annual+Scientific+Session+of+the+American+College+of+Cardiology+2004+March+7&amp;#x02013;10+New+Orleans,+LA+" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11974</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11975</code><code>]&lt;/span&gt;</code></p><p><code>11976</code><code>&lt;/span&gt;</code></p><p><code>11977</code><code>&lt;/li&gt;</code></p><p><code>11978</code><code>&lt;li id="R239"&gt;</code></p><p><code>11979</code><code>&lt;span class="citation"&gt;</code></p><p><code>11980</code><code>Dannon PN, Lowengrub K, Amiaz R, Grunhaus L, Kotler M. Comorbid cannabis use and panic disorder: short term and long term follow-up study. &lt;span&gt;</code></p><p><code>11981</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11982</code><code>Hum Psychopharmacol. &lt;/span&gt;</code></p><p><code>11983</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>11984</code><code>19&lt;/span&gt;</code></p><p><code>11985</code><code>:97–101.&lt;/span&gt;</code></p><p><code>11986</code><code> [&lt;a href="/pubmed/14994319" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>11987</code><code>PubMed&lt;/a&gt;</code></p><p><code>11988</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>11989</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Hum+Psychopharmacol&amp;amp;title=Comorbid+cannabis+use+and+panic+disorder:+short+term+and+long+term+follow-up+study&amp;amp;author=PN+Dannon&amp;amp;author=K+Lowengrub&amp;amp;author=R+Amiaz&amp;amp;author=L+Grunhaus&amp;amp;author=M+Kotler&amp;amp;volume=19&amp;amp;publication_year=2004&amp;amp;pages=97-101&amp;amp;pmid=14994319&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>11990</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>11991</code><code>]&lt;/span&gt;</code></p><p><code>11992</code><code>&lt;/span&gt;</code></p><p><code>11993</code><code>&lt;/li&gt;</code></p><p><code>11994</code><code>&lt;li id="R240"&gt;</code></p><p><code>11995</code><code>&lt;span class="citation"&gt;</code></p><p><code>11996</code><code>D&amp;#x02019;Argenio G, Valenti M, Scaglione G, Cosenza V, Sorrentini I, Di Marzo V. Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. &lt;span&gt;</code></p><p><code>11997</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>11998</code><code>FASEB J. &lt;/span&gt;</code></p><p><code>11999</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>12000</code><code>20&lt;/span&gt;</code></p><p><code>12001</code><code>:568–570.&lt;/span&gt;</code></p><p><code>12002</code><code> [&lt;a href="/pubmed/16403786" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12003</code><code>PubMed&lt;/a&gt;</code></p><p><code>12004</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12005</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;amp;title=Up-regulation+of+anandamide+levels+as+an+endogenous+mechanism+and+a+pharmacological+strategy+to+limit+colon+inflammation&amp;amp;author=G+D&amp;#x02019;Argenio&amp;amp;author=M+Valenti&amp;amp;author=G+Scaglione&amp;amp;author=V+Cosenza&amp;amp;author=I+Sorrentini&amp;amp;volume=20&amp;amp;publication_year=2006&amp;amp;pages=568-570&amp;amp;pmid=16403786&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12006</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12007</code><code>]&lt;/span&gt;</code></p><p><code>12008</code><code>&lt;/span&gt;</code></p><p><code>12009</code><code>&lt;/li&gt;</code></p><p><code>12010</code><code>&lt;li id="R241"&gt;</code></p><p><code>12011</code><code>&lt;span class="citation"&gt;</code></p><p><code>12012</code><code>Darmani NA. &amp;#x00394;&lt;sup&gt;</code></p><p><code>12013</code><code>9&lt;/sup&gt;</code></p><p><code>12014</code><code>-Tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB&lt;sub&gt;</code></p><p><code>12015</code><code>1&lt;/sub&gt;</code></p><p><code>12016</code><code> receptor antagonist/inverse agonist SR 141716A. &lt;span&gt;</code></p><p><code>12017</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12018</code><code>Neuropsychopharmacology. &lt;/span&gt;</code></p><p><code>12019</code><code>2001a;&lt;span class="ref-vol"&gt;</code></p><p><code>12020</code><code>24&lt;/span&gt;</code></p><p><code>12021</code><code>:198–203.&lt;/span&gt;</code></p><p><code>12022</code><code> [&lt;a href="/pubmed/11120402" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12023</code><code>PubMed&lt;/a&gt;</code></p><p><code>12024</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12025</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;amp;title=&amp;#x00394;9-Tetrahydrocannabinol+and+synthetic+cannabinoids+prevent+emesis+produced+by+the+cannabinoid+CB1+receptor+antagonist/inverse+agonist+SR+141716A&amp;amp;author=NA+Darmani&amp;amp;volume=24&amp;amp;publication_year=2001a&amp;amp;pages=198-203&amp;amp;pmid=11120402&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12026</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12027</code><code>]&lt;/span&gt;</code></p><p><code>12028</code><code>&lt;/span&gt;</code></p><p><code>12029</code><code>&lt;/li&gt;</code></p><p><code>12030</code><code>&lt;li id="R242"&gt;</code></p><p><code>12031</code><code>&lt;span class="citation"&gt;</code></p><p><code>12032</code><code>Darmani NA. &amp;#x00394;-9-Tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB&lt;sub&gt;</code></p><p><code>12033</code><code>1&lt;/sub&gt;</code></p><p><code>12034</code><code> receptors in the least shrew. &lt;span&gt;</code></p><p><code>12035</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12036</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>12037</code><code>2001b;&lt;span class="ref-vol"&gt;</code></p><p><code>12038</code><code>69&lt;/span&gt;</code></p><p><code>12039</code><code>:239–249.&lt;/span&gt;</code></p><p><code>12040</code><code> [&lt;a href="/pubmed/11420092" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12041</code><code>PubMed&lt;/a&gt;</code></p><p><code>12042</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12043</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=&amp;#x00394;-9-Tetrahydrocannabinol+differentially+suppresses+cisplatin-induced+emesis+and+indices+of+motor+function+via+cannabinoid+CB1+receptors+in+the+least+shrew&amp;amp;author=NA+Darmani&amp;amp;volume=69&amp;amp;publication_year=2001b&amp;amp;pages=239-249&amp;amp;pmid=11420092&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12044</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12045</code><code>]&lt;/span&gt;</code></p><p><code>12046</code><code>&lt;/span&gt;</code></p><p><code>12047</code><code>&lt;/li&gt;</code></p><p><code>12048</code><code>&lt;li id="R243"&gt;</code></p><p><code>12049</code><code>&lt;span class="citation"&gt;</code></p><p><code>12050</code><code>Das SK, Paria BC, Chakraborty I, Dey SK. Cannabinoid ligand-receptor signaling in the mouse uterus. &lt;span&gt;</code></p><p><code>12051</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12052</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>12053</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>12054</code><code>92&lt;/span&gt;</code></p><p><code>12055</code><code>:4332–4336.&lt;/span&gt;</code></p><p><code>12056</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>12057</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC41938/"&gt;</code></p><p><code>12058</code><code>PMC free article&lt;/a&gt;</code></p><p><code>12059</code><code>]&lt;/span&gt;</code></p><p><code>12060</code><code> [&lt;a href="/pubmed/7753807" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12061</code><code>PubMed&lt;/a&gt;</code></p><p><code>12062</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12063</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Cannabinoid+ligand-receptor+signaling+in+the+mouse+uterus&amp;amp;author=SK+Das&amp;amp;author=BC+Paria&amp;amp;author=I+Chakraborty&amp;amp;author=SK+Dey&amp;amp;volume=92&amp;amp;publication_year=1995&amp;amp;pages=4332-4336&amp;amp;pmid=7753807&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12064</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12065</code><code>]&lt;/span&gt;</code></p><p><code>12066</code><code>&lt;/span&gt;</code></p><p><code>12067</code><code>&lt;/li&gt;</code></p><p><code>12068</code><code>&lt;li id="R244"&gt;</code></p><p><code>12069</code><code>&lt;span class="citation"&gt;</code></p><p><code>12070</code><code>Davis MI, Ronesi J, Lovinger DM. A predominant role for inhibition of the adenylate cyclase/protein kinase A pathway in ERK activation by cannabinoid receptor 1 in N1E-115 neuroblastoma cells. &lt;span&gt;</code></p><p><code>12071</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12072</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>12073</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>12074</code><code>278&lt;/span&gt;</code></p><p><code>12075</code><code>:48973–48980.&lt;/span&gt;</code></p><p><code>12076</code><code> [&lt;a href="/pubmed/14517212" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12077</code><code>PubMed&lt;/a&gt;</code></p><p><code>12078</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12079</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=A+predominant+role+for+inhibition+of+the+adenylate+cyclase/protein+kinase+A+pathway+in+ERK+activation+by+cannabinoid+receptor+1+in+N1E-115+neuroblastoma+cells&amp;amp;author=MI+Davis&amp;amp;author=J+Ronesi&amp;amp;author=DM+Lovinger&amp;amp;volume=278&amp;amp;publication_year=2003&amp;amp;pages=48973-48980&amp;amp;pmid=14517212&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12080</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12081</code><code>]&lt;/span&gt;</code></p><p><code>12082</code><code>&lt;/span&gt;</code></p><p><code>12083</code><code>&lt;/li&gt;</code></p><p><code>12084</code><code>&lt;li id="R245"&gt;</code></p><p><code>12085</code><code>&lt;span class="citation"&gt;</code></p><p><code>12086</code><code>Dean B, Sundram S, Bradbury R, Scarr E, Copolov D. Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. &lt;span&gt;</code></p><p><code>12087</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12088</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>12089</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>12090</code><code>103&lt;/span&gt;</code></p><p><code>12091</code><code>:9–15.&lt;/span&gt;</code></p><p><code>12092</code><code> [&lt;a href="/pubmed/11311783" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12093</code><code>PubMed&lt;/a&gt;</code></p><p><code>12094</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12095</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Studies+on+[3H]CP-55940+binding+in+the+human+central+nervous+system:+regional+specific+changes+in+density+of+cannabinoid-1+receptors+associated+with+schizophrenia+and+cannabis+use&amp;amp;author=B+Dean&amp;amp;author=S+Sundram&amp;amp;author=R+Bradbury&amp;amp;author=E+Scarr&amp;amp;author=D+Copolov&amp;amp;volume=103&amp;amp;publication_year=2001&amp;amp;pages=9-15&amp;amp;pmid=11311783&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12096</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12097</code><code>]&lt;/span&gt;</code></p><p><code>12098</code><code>&lt;/span&gt;</code></p><p><code>12099</code><code>&lt;/li&gt;</code></p><p><code>12100</code><code>&lt;li id="R246"&gt;</code></p><p><code>12101</code><code>&lt;span class="citation"&gt;</code></p><p><code>12102</code><code>de Lago E, de Miguel R, Lastres-Becker I, Ramos JA, Fernandez-Ruiz J. Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence. &lt;span&gt;</code></p><p><code>12103</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12104</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>12105</code><code>2004a;&lt;span class="ref-vol"&gt;</code></p><p><code>12106</code><code>1007&lt;/span&gt;</code></p><p><code>12107</code><code>:152–159.&lt;/span&gt;</code></p><p><code>12108</code><code> [&lt;a href="/pubmed/15064146" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12109</code><code>PubMed&lt;/a&gt;</code></p><p><code>12110</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12111</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Involvement+of+vanilloid-like+receptors+in+the+effects+of+anandamide+on+motor+behavior+and+nigrostriatal+dopaminergic+activity:+in+vivo+and+in+vitro+evidence&amp;amp;author=E+de+Lago&amp;amp;author=R+de+Miguel&amp;amp;author=I+Lastres-Becker&amp;amp;author=JA+Ramos&amp;amp;author=J+Fernandez-Ruiz&amp;amp;volume=1007&amp;amp;publication_year=2004a&amp;amp;pages=152-159&amp;amp;pmid=15064146&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12112</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12113</code><code>]&lt;/span&gt;</code></p><p><code>12114</code><code>&lt;/span&gt;</code></p><p><code>12115</code><code>&lt;/li&gt;</code></p><p><code>12116</code><code>&lt;li id="R247"&gt;</code></p><p><code>12117</code><code>&lt;span class="citation"&gt;</code></p><p><code>12118</code><code>de Lago E, Fernandez-Ruiz J, Ortega-Gutierrez S, Cabranes A, Pryce G, Baker D, Lopez-Rodriguez M, Ramos JA. UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington&amp;#x02019;s disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders. &lt;span&gt;</code></p><p><code>12119</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12120</code><code>Eur Neuropsychopharmacol. &lt;/span&gt;</code></p><p><code>12121</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>12122</code><code>16&lt;/span&gt;</code></p><p><code>12123</code><code>:7–18.&lt;/span&gt;</code></p><p><code>12124</code><code> [&lt;a href="/pubmed/16006105" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12125</code><code>PubMed&lt;/a&gt;</code></p><p><code>12126</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12127</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+Neuropsychopharmacol&amp;amp;title=UCM707,+an+inhibitor+of+the+anandamide+uptake,+behaves+as+a+symptom+control+agent+in+models+of+Huntington&amp;#x02019;s+disease+and+multiple+sclerosis,+but+fails+to+delay/arrest+the+progression+of+different+motor-related+disorders&amp;amp;author=E+de+Lago&amp;amp;author=J+Fernandez-Ruiz&amp;amp;author=S+Ortega-Gutierrez&amp;amp;author=A+Cabranes&amp;amp;author=G+Pryce&amp;amp;volume=16&amp;amp;publication_year=2006&amp;amp;pages=7-18&amp;amp;pmid=16006105&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12128</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12129</code><code>]&lt;/span&gt;</code></p><p><code>12130</code><code>&lt;/span&gt;</code></p><p><code>12131</code><code>&lt;/li&gt;</code></p><p><code>12132</code><code>&lt;li id="R248"&gt;</code></p><p><code>12133</code><code>&lt;span class="citation"&gt;</code></p><p><code>12134</code><code>de Lago E, Fernandez-Ruiz J, Ortega-Gutierrez S, Viso A, Lopez-Rodriguez ML, Ramos JA. UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide. &lt;span&gt;</code></p><p><code>12135</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12136</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>12137</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>12138</code><code>449&lt;/span&gt;</code></p><p><code>12139</code><code>:99–103.&lt;/span&gt;</code></p><p><code>12140</code><code> [&lt;a href="/pubmed/12163112" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12141</code><code>PubMed&lt;/a&gt;</code></p><p><code>12142</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12143</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=UCM707,+a+potent+and+selective+inhibitor+of+endocannabinoid+uptake,+potentiates+hypokinetic+and+antinociceptive+effects+of+anandamide&amp;amp;author=E+de+Lago&amp;amp;author=J+Fernandez-Ruiz&amp;amp;author=S+Ortega-Gutierrez&amp;amp;author=A+Viso&amp;amp;author=ML+Lopez-Rodriguez&amp;amp;volume=449&amp;amp;publication_year=2002&amp;amp;pages=99-103&amp;amp;pmid=12163112&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12144</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12145</code><code>]&lt;/span&gt;</code></p><p><code>12146</code><code>&lt;/span&gt;</code></p><p><code>12147</code><code>&lt;/li&gt;</code></p><p><code>12148</code><code>&lt;li id="R249"&gt;</code></p><p><code>12149</code><code>&lt;span class="citation"&gt;</code></p><p><code>12150</code><code>de Lago E, Ligresti A, Ortar G, Morera E, Cabranes A, Pryce G, Bifulco M, Baker D, Fernandez-Ruiz J, Di Marzo V. In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake. &lt;span&gt;</code></p><p><code>12151</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12152</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>12153</code><code>2004b;&lt;span class="ref-vol"&gt;</code></p><p><code>12154</code><code>484&lt;/span&gt;</code></p><p><code>12155</code><code>:249–257.&lt;/span&gt;</code></p><p><code>12156</code><code> [&lt;a href="/pubmed/14744610" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12157</code><code>PubMed&lt;/a&gt;</code></p><p><code>12158</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12159</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=In+vivo+pharmacological+actions+of+two+novel+inhibitors+of+anandamide+cellular+uptake&amp;amp;author=E+de+Lago&amp;amp;author=A+Ligresti&amp;amp;author=G+Ortar&amp;amp;author=E+Morera&amp;amp;author=A+Cabranes&amp;amp;volume=484&amp;amp;publication_year=2004b&amp;amp;pages=249-257&amp;amp;pmid=14744610&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12160</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12161</code><code>]&lt;/span&gt;</code></p><p><code>12162</code><code>&lt;/span&gt;</code></p><p><code>12163</code><code>&lt;/li&gt;</code></p><p><code>12164</code><code>&lt;li id="R250"&gt;</code></p><p><code>12165</code><code>&lt;span class="citation"&gt;</code></p><p><code>12166</code><code>de Lago E, Urbani P, Ramos JA, Di Marzo V, Fernandez-Ruiz J. Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>12167</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12168</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>12169</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>12170</code><code>1050&lt;/span&gt;</code></p><p><code>12171</code><code>:210–216.&lt;/span&gt;</code></p><p><code>12172</code><code> [&lt;a href="/pubmed/15975564" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12173</code><code>PubMed&lt;/a&gt;</code></p><p><code>12174</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12175</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Arvanil,+a+hybrid+endocannabinoid+and+vanilloid+compound,+behaves+as+an+antihyperkinetic+agent+in+a+rat+model+of+Huntington&amp;#x02019;s+disease&amp;amp;author=E+de+Lago&amp;amp;author=P+Urbani&amp;amp;author=JA+Ramos&amp;amp;author=V+Di+Marzo&amp;amp;author=J+Fernandez-Ruiz&amp;amp;volume=1050&amp;amp;publication_year=2005&amp;amp;pages=210-216&amp;amp;pmid=15975564&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12176</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12177</code><code>]&lt;/span&gt;</code></p><p><code>12178</code><code>&lt;/span&gt;</code></p><p><code>12179</code><code>&lt;/li&gt;</code></p><p><code>12180</code><code>&lt;li id="R251"&gt;</code></p><p><code>12181</code><code>&lt;span class="citation"&gt;</code></p><p><code>12182</code><code>De Marchi N, De Petrocellis L, Orlando P, Daniele F, Fezza F, Di Marzo V. Endocannabinoid signalling in the blood of patients with schizophrenia. &lt;span&gt;</code></p><p><code>12183</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12184</code><code>Lipids Health Dis. &lt;/span&gt;</code></p><p><code>12185</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>12186</code><code>2&lt;/span&gt;</code></p><p><code>12187</code><code>:5.&lt;/span&gt;</code></p><p><code>12188</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>12189</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC194767/"&gt;</code></p><p><code>12190</code><code>PMC free article&lt;/a&gt;</code></p><p><code>12191</code><code>]&lt;/span&gt;</code></p><p><code>12192</code><code> [&lt;a href="/pubmed/12969514" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12193</code><code>PubMed&lt;/a&gt;</code></p><p><code>12194</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12195</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Lipids+Health+Dis&amp;amp;title=Endocannabinoid+signalling+in+the+blood+of+patients+with+schizophrenia&amp;amp;author=N+De+Marchi&amp;amp;author=L+De+Petrocellis&amp;amp;author=P+Orlando&amp;amp;author=F+Daniele&amp;amp;author=F+Fezza&amp;amp;volume=2&amp;amp;publication_year=2003&amp;amp;pages=5&amp;amp;pmid=12969514&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12196</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12197</code><code>]&lt;/span&gt;</code></p><p><code>12198</code><code>&lt;/span&gt;</code></p><p><code>12199</code><code>&lt;/li&gt;</code></p><p><code>12200</code><code>&lt;li id="R252"&gt;</code></p><p><code>12201</code><code>&lt;span class="citation"&gt;</code></p><p><code>12202</code><code>De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, Di Marzo V. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. &lt;span&gt;</code></p><p><code>12203</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12204</code><code>FEBS Lett. &lt;/span&gt;</code></p><p><code>12205</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>12206</code><code>483&lt;/span&gt;</code></p><p><code>12207</code><code>:52–56.&lt;/span&gt;</code></p><p><code>12208</code><code> [&lt;a href="/pubmed/11033355" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12209</code><code>PubMed&lt;/a&gt;</code></p><p><code>12210</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12211</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;amp;title=Overlap+between+the+ligand+recognition+properties+of+the+anandamide+transporter+and+the+VR1+vanilloid+receptor:+inhibitors+of+anandamide+uptake+with+negligible+capsaicin-like+activity&amp;amp;author=L+De+Petrocellis&amp;amp;author=T+Bisogno&amp;amp;author=JB+Davis&amp;amp;author=RG+Pertwee&amp;amp;author=V+Di+Marzo&amp;amp;volume=483&amp;amp;publication_year=2000&amp;amp;pages=52-56&amp;amp;pmid=11033355&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12212</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12213</code><code>]&lt;/span&gt;</code></p><p><code>12214</code><code>&lt;/span&gt;</code></p><p><code>12215</code><code>&lt;/li&gt;</code></p><p><code>12216</code><code>&lt;li id="R253"&gt;</code></p><p><code>12217</code><code>&lt;span class="citation"&gt;</code></p><p><code>12218</code><code>De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, Di Marzo V. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. &lt;span&gt;</code></p><p><code>12219</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12220</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>12221</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>12222</code><code>95&lt;/span&gt;</code></p><p><code>12223</code><code>:8375–8380.&lt;/span&gt;</code></p><p><code>12224</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>12225</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC20983/"&gt;</code></p><p><code>12226</code><code>PMC free article&lt;/a&gt;</code></p><p><code>12227</code><code>]&lt;/span&gt;</code></p><p><code>12228</code><code> [&lt;a href="/pubmed/9653194" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12229</code><code>PubMed&lt;/a&gt;</code></p><p><code>12230</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12231</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=The+endogenous+cannabinoid+anandamide+inhibits+human+breast+cancer+cell+proliferation&amp;amp;author=L+De+Petrocellis&amp;amp;author=D+Melck&amp;amp;author=A+Palmisano&amp;amp;author=T+Bisogno&amp;amp;author=C+Laezza&amp;amp;volume=95&amp;amp;publication_year=1998&amp;amp;pages=8375-8380&amp;amp;pmid=9653194&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12232</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12233</code><code>]&lt;/span&gt;</code></p><p><code>12234</code><code>&lt;/span&gt;</code></p><p><code>12235</code><code>&lt;/li&gt;</code></p><p><code>12236</code><code>&lt;li id="R254"&gt;</code></p><p><code>12237</code><code>&lt;span class="citation"&gt;</code></p><p><code>12238</code><code>De Vries TJ, Schoffelmeer AN. Cannabinoid CB&lt;sub&gt;</code></p><p><code>12239</code><code>1&lt;/sub&gt;</code></p><p><code>12240</code><code> receptors control conditioned drug seeking. &lt;span&gt;</code></p><p><code>12241</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12242</code><code>Trends Pharmacol Sci. &lt;/span&gt;</code></p><p><code>12243</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>12244</code><code>26&lt;/span&gt;</code></p><p><code>12245</code><code>:420–426.&lt;/span&gt;</code></p><p><code>12246</code><code> [&lt;a href="/pubmed/15992935" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12247</code><code>PubMed&lt;/a&gt;</code></p><p><code>12248</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12249</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Trends+Pharmacol+Sci&amp;amp;title=Cannabinoid+CB1+receptors+control+conditioned+drug+seeking&amp;amp;author=TJ+De+Vries&amp;amp;author=AN+Schoffelmeer&amp;amp;volume=26&amp;amp;publication_year=2005&amp;amp;pages=420-426&amp;amp;pmid=15992935&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12250</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12251</code><code>]&lt;/span&gt;</code></p><p><code>12252</code><code>&lt;/span&gt;</code></p><p><code>12253</code><code>&lt;/li&gt;</code></p><p><code>12254</code><code>&lt;li id="R255"&gt;</code></p><p><code>12255</code><code>&lt;span class="citation"&gt;</code></p><p><code>12256</code><code>De Vries TJ, Shaham Y, Homberg JR, Crombag H, Schuurman K, Dieben J, Vander-schuren LJ, Schoffelmeer AN. A cannabinoid mechanism of relapse to cocaine seeking. &lt;span&gt;</code></p><p><code>12257</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12258</code><code>Nat Med. &lt;/span&gt;</code></p><p><code>12259</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>12260</code><code>7&lt;/span&gt;</code></p><p><code>12261</code><code>:1151–1154.&lt;/span&gt;</code></p><p><code>12262</code><code> [&lt;a href="/pubmed/11590440" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12263</code><code>PubMed&lt;/a&gt;</code></p><p><code>12264</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12265</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;amp;title=A+cannabinoid+mechanism+of+relapse+to+cocaine+seeking&amp;amp;author=TJ+De+Vries&amp;amp;author=Y+Shaham&amp;amp;author=JR+Homberg&amp;amp;author=H+Crombag&amp;amp;author=K+Schuurman&amp;amp;volume=7&amp;amp;publication_year=2001&amp;amp;pages=1151-1154&amp;amp;pmid=11590440&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12266</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12267</code><code>]&lt;/span&gt;</code></p><p><code>12268</code><code>&lt;/span&gt;</code></p><p><code>12269</code><code>&lt;/li&gt;</code></p><p><code>12270</code><code>&lt;li id="R256"&gt;</code></p><p><code>12271</code><code>&lt;span class="citation"&gt;</code></p><p><code>12272</code><code>del Carmen Godino M, Torres M, Sanchez-Prieto J. The modulation of Ca&lt;sup&gt;</code></p><p><code>12273</code><code>2+&lt;/sup&gt;</code></p><p><code>12274</code><code> and K&lt;sup&gt;</code></p><p><code>12275</code><code>+&lt;/sup&gt;</code></p><p><code>12276</code><code> channels but not changes in cAMP signaling contribute to the inhibition of glutamate release by cannabinoid receptors in cerebrocortical nerve terminals. &lt;span&gt;</code></p><p><code>12277</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12278</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>12279</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>12280</code><code>48&lt;/span&gt;</code></p><p><code>12281</code><code>:547–557.&lt;/span&gt;</code></p><p><code>12282</code><code> [&lt;a href="/pubmed/15755482" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12283</code><code>PubMed&lt;/a&gt;</code></p><p><code>12284</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12285</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=The+modulation+of+Ca2++and+K++channels+but+not+changes+in+cAMP+signaling+contribute+to+the+inhibition+of+glutamate+release+by+cannabinoid+receptors+in+cerebrocortical+nerve+terminals&amp;amp;author=M+del+Carmen+Godino&amp;amp;author=M+Torres&amp;amp;author=J+Sanchez-Prieto&amp;amp;volume=48&amp;amp;publication_year=2005&amp;amp;pages=547-557&amp;amp;pmid=15755482&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12286</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12287</code><code>]&lt;/span&gt;</code></p><p><code>12288</code><code>&lt;/span&gt;</code></p><p><code>12289</code><code>&lt;/li&gt;</code></p><p><code>12290</code><code>&lt;li id="R257"&gt;</code></p><p><code>12291</code><code>&lt;span class="citation"&gt;</code></p><p><code>12292</code><code>Denovan-Wright EM, Robertson HA. Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington&amp;#x02019;s disease mice. &lt;span&gt;</code></p><p><code>12293</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12294</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>12295</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>12296</code><code>98&lt;/span&gt;</code></p><p><code>12297</code><code>:705–713.&lt;/span&gt;</code></p><p><code>12298</code><code> [&lt;a href="/pubmed/10891614" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12299</code><code>PubMed&lt;/a&gt;</code></p><p><code>12300</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12301</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Cannabinoid+receptor+messenger+RNA+levels+decrease+in+a+subset+of+neurons+of+the+lateral+striatum,+cortex+and+hippocampus+of+transgenic+Huntington&amp;#x02019;s+disease+mice&amp;amp;author=EM+Denovan-Wright&amp;amp;author=HA+Robertson&amp;amp;volume=98&amp;amp;publication_year=2000&amp;amp;pages=705-713&amp;amp;pmid=10891614&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12302</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12303</code><code>]&lt;/span&gt;</code></p><p><code>12304</code><code>&lt;/span&gt;</code></p><p><code>12305</code><code>&lt;/li&gt;</code></p><p><code>12306</code><code>&lt;li id="R258"&gt;</code></p><p><code>12307</code><code>&lt;span class="citation"&gt;</code></p><p><code>12308</code><code>Derkinderen P, Ledent C, Parmentier M, Girault JA. Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus. &lt;span&gt;</code></p><p><code>12309</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12310</code><code>J Neurochem. &lt;/span&gt;</code></p><p><code>12311</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>12312</code><code>77&lt;/span&gt;</code></p><p><code>12313</code><code>:957–960.&lt;/span&gt;</code></p><p><code>12314</code><code> [&lt;a href="/pubmed/11331425" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12315</code><code>PubMed&lt;/a&gt;</code></p><p><code>12316</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12317</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;amp;title=Cannabinoids+activate+p38+mitogen-activated+protein+kinases+through+CB1+receptors+in+hippocampus&amp;amp;author=P+Derkinderen&amp;amp;author=C+Ledent&amp;amp;author=M+Parmentier&amp;amp;author=JA+Girault&amp;amp;volume=77&amp;amp;publication_year=2001&amp;amp;pages=957-960&amp;amp;pmid=11331425&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12318</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12319</code><code>]&lt;/span&gt;</code></p><p><code>12320</code><code>&lt;/span&gt;</code></p><p><code>12321</code><code>&lt;/li&gt;</code></p><p><code>12322</code><code>&lt;li id="R259"&gt;</code></p><p><code>12323</code><code>&lt;span class="citation"&gt;</code></p><p><code>12324</code><code>Deroche-Gamonet V, Le Moal M, Piazza PV, Soubrie P. SR141716, a CB&lt;sub&gt;</code></p><p><code>12325</code><code>1&lt;/sub&gt;</code></p><p><code>12326</code><code> receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats. &lt;span&gt;</code></p><p><code>12327</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12328</code><code>Psychoharmacology. &lt;/span&gt;</code></p><p><code>12329</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>12330</code><code>157&lt;/span&gt;</code></p><p><code>12331</code><code>:254–259.&lt;/span&gt;</code></p><p><code>12332</code><code> [&lt;a href="/pubmed/11605080" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12333</code><code>PubMed&lt;/a&gt;</code></p><p><code>12334</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12335</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychoharmacology&amp;amp;title=SR141716,+a+CB1+receptor+antagonist,+decreases+the+sensitivity+to+the+reinforcing+effects+of+electrical+brain+stimulation+in+rats&amp;amp;author=V+Deroche-Gamonet&amp;amp;author=M+Le+Moal&amp;amp;author=PV+Piazza&amp;amp;author=P+Soubrie&amp;amp;volume=157&amp;amp;publication_year=2001&amp;amp;pages=254-259&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12336</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12337</code><code>]&lt;/span&gt;</code></p><p><code>12338</code><code>&lt;/span&gt;</code></p><p><code>12339</code><code>&lt;/li&gt;</code></p><p><code>12340</code><code>&lt;li id="R260"&gt;</code></p><p><code>12341</code><code>&lt;span class="citation"&gt;</code></p><p><code>12342</code><code>Despr&amp;#x000e9;s J-P, Golay A, Sj&amp;#x000f6;str&amp;#x000f6;m L for the Rimonabant in Obesity-Lipids Study Group. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. &lt;span&gt;</code></p><p><code>12343</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12344</code><code>N Engl J Med. &lt;/span&gt;</code></p><p><code>12345</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>12346</code><code>353&lt;/span&gt;</code></p><p><code>12347</code><code>:2121–2134.&lt;/span&gt;</code></p><p><code>12348</code><code> [&lt;a href="/pubmed/16291982" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12349</code><code>PubMed&lt;/a&gt;</code></p><p><code>12350</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12351</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;amp;title=Effects+of+rimonabant+on+metabolic+risk+factors+in+overweight+patients+with+dyslipidemia&amp;amp;author=J-P+Despr&amp;#x000e9;s&amp;amp;author=A+Golay&amp;amp;author=L+Sj&amp;#x000f6;str&amp;#x000f6;m&amp;amp;volume=353&amp;amp;publication_year=2005&amp;amp;pages=2121-2134&amp;amp;pmid=16291982&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12352</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12353</code><code>]&lt;/span&gt;</code></p><p><code>12354</code><code>&lt;/span&gt;</code></p><p><code>12355</code><code>&lt;/li&gt;</code></p><p><code>12356</code><code>&lt;li id="R261"&gt;</code></p><p><code>12357</code><code>&lt;span class="citation"&gt;</code></p><p><code>12358</code><code>Deutsch DG, Lin S, Hill WA, Morse KL, Salehani D, Arreaza G, Omeir RL, Makriyannis A. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor. &lt;span&gt;</code></p><p><code>12359</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12360</code><code>Biochem Biophys Res Commun. &lt;/span&gt;</code></p><p><code>12361</code><code>1997a;&lt;span class="ref-vol"&gt;</code></p><p><code>12362</code><code>231&lt;/span&gt;</code></p><p><code>12363</code><code>:217–221.&lt;/span&gt;</code></p><p><code>12364</code><code> [&lt;a href="/pubmed/9070252" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12365</code><code>PubMed&lt;/a&gt;</code></p><p><code>12366</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12367</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;amp;title=Fatty+acid+sulfonyl+fluorides+inhibit+anandamide+metabolism+and+bind+to+the+cannabinoid+receptor&amp;amp;author=DG+Deutsch&amp;amp;author=S+Lin&amp;amp;author=WA+Hill&amp;amp;author=KL+Morse&amp;amp;author=D+Salehani&amp;amp;volume=231&amp;amp;publication_year=1997a&amp;amp;pages=217-221&amp;amp;pmid=9070252&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12368</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12369</code><code>]&lt;/span&gt;</code></p><p><code>12370</code><code>&lt;/span&gt;</code></p><p><code>12371</code><code>&lt;/li&gt;</code></p><p><code>12372</code><code>&lt;li id="R262"&gt;</code></p><p><code>12373</code><code>&lt;span class="citation"&gt;</code></p><p><code>12374</code><code>Deutsch DG, Omeir R, Arreaza G, Salehani D, Prestwich GD, Huang Z, Howlett A. Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase. &lt;span&gt;</code></p><p><code>12375</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12376</code><code>Biochem Pharmacol. &lt;/span&gt;</code></p><p><code>12377</code><code>1997b;&lt;span class="ref-vol"&gt;</code></p><p><code>12378</code><code>53&lt;/span&gt;</code></p><p><code>12379</code><code>:255–260.&lt;/span&gt;</code></p><p><code>12380</code><code> [&lt;a href="/pubmed/9065728" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12381</code><code>PubMed&lt;/a&gt;</code></p><p><code>12382</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12383</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;amp;title=Methyl+arachidonyl+fluorophosphonate:+a+potent+irreversible+inhibitor+of+anandamide+amidase&amp;amp;author=DG+Deutsch&amp;amp;author=R+Omeir&amp;amp;author=G+Arreaza&amp;amp;author=D+Salehani&amp;amp;author=GD+Prestwich&amp;amp;volume=53&amp;amp;publication_year=1997b&amp;amp;pages=255-260&amp;amp;pmid=9065728&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12384</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12385</code><code>]&lt;/span&gt;</code></p><p><code>12386</code><code>&lt;/span&gt;</code></p><p><code>12387</code><code>&lt;/li&gt;</code></p><p><code>12388</code><code>&lt;li id="R263"&gt;</code></p><p><code>12389</code><code>&lt;span class="citation"&gt;</code></p><p><code>12390</code><code>Devane WA, Dysarz FA, III, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of a cannabinoid receptor in rat brain. &lt;span&gt;</code></p><p><code>12391</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12392</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>12393</code><code>1988;&lt;span class="ref-vol"&gt;</code></p><p><code>12394</code><code>34&lt;/span&gt;</code></p><p><code>12395</code><code>:605–613.&lt;/span&gt;</code></p><p><code>12396</code><code> [&lt;a href="/pubmed/2848184" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12397</code><code>PubMed&lt;/a&gt;</code></p><p><code>12398</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12399</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=Determination+and+characterization+of+a+cannabinoid+receptor+in+rat+brain&amp;amp;author=WA+Devane&amp;amp;author=FA+Dysarz&amp;amp;author=MR+Johnson&amp;amp;author=LS+Melvin&amp;amp;author=AC+Howlett&amp;amp;volume=34&amp;amp;publication_year=1988&amp;amp;pages=605-613&amp;amp;pmid=2848184&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12400</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12401</code><code>]&lt;/span&gt;</code></p><p><code>12402</code><code>&lt;/span&gt;</code></p><p><code>12403</code><code>&lt;/li&gt;</code></p><p><code>12404</code><code>&lt;li id="R264"&gt;</code></p><p><code>12405</code><code>&lt;span class="citation"&gt;</code></p><p><code>12406</code><code>Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulame R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. &lt;span&gt;</code></p><p><code>12407</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12408</code><code>Science (Wash DC) &lt;/span&gt;</code></p><p><code>12409</code><code>1992;&lt;span class="ref-vol"&gt;</code></p><p><code>12410</code><code>258&lt;/span&gt;</code></p><p><code>12411</code><code>:1946–1949.&lt;/span&gt;</code></p><p><code>12412</code><code> [&lt;a href="/pubmed/1470919" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12413</code><code>PubMed&lt;/a&gt;</code></p><p><code>12414</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12415</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Science+(Wash+DC)&amp;amp;title=Isolation+and+structure+of+a+brain+constituent+that+binds+to+the+cannabinoid+receptor&amp;amp;author=WA+Devane&amp;amp;author=L+Hanus&amp;amp;author=A+Breuer&amp;amp;author=RG+Pertwee&amp;amp;author=LA+Stevenson&amp;amp;volume=258&amp;amp;publication_year=1992&amp;amp;pages=1946-1949&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12416</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12417</code><code>]&lt;/span&gt;</code></p><p><code>12418</code><code>&lt;/span&gt;</code></p><p><code>12419</code><code>&lt;/li&gt;</code></p><p><code>12420</code><code>&lt;li id="R265"&gt;</code></p><p><code>12421</code><code>&lt;span class="citation"&gt;</code></p><p><code>12422</code><code>Dewey WL. Cannabinoid pharmacology. &lt;span&gt;</code></p><p><code>12423</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12424</code><code>Pharmacol Rev. &lt;/span&gt;</code></p><p><code>12425</code><code>1986;&lt;span class="ref-vol"&gt;</code></p><p><code>12426</code><code>38&lt;/span&gt;</code></p><p><code>12427</code><code>:151–178.&lt;/span&gt;</code></p><p><code>12428</code><code> [&lt;a href="/pubmed/3529128" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12429</code><code>PubMed&lt;/a&gt;</code></p><p><code>12430</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12431</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Rev&amp;amp;title=Cannabinoid+pharmacology&amp;amp;author=WL+Dewey&amp;amp;volume=38&amp;amp;publication_year=1986&amp;amp;pages=151-178&amp;amp;pmid=3529128&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12432</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12433</code><code>]&lt;/span&gt;</code></p><p><code>12434</code><code>&lt;/span&gt;</code></p><p><code>12435</code><code>&lt;/li&gt;</code></p><p><code>12436</code><code>&lt;li id="R266"&gt;</code></p><p><code>12437</code><code>&lt;span class="citation"&gt;</code></p><p><code>12438</code><code>Di S, Boudaba C, Popescu R, Weng FJ, Harris C, Marcheselli VL, Bazan NG, Tasker JG. Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. &lt;span&gt;</code></p><p><code>12439</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12440</code><code>J Physiol (Lond) &lt;/span&gt;</code></p><p><code>12441</code><code>2005a;&lt;span class="ref-vol"&gt;</code></p><p><code>12442</code><code>569&lt;/span&gt;</code></p><p><code>12443</code><code>:751–760.&lt;/span&gt;</code></p><p><code>12444</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>12445</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1464259/"&gt;</code></p><p><code>12446</code><code>PMC free article&lt;/a&gt;</code></p><p><code>12447</code><code>]&lt;/span&gt;</code></p><p><code>12448</code><code> [&lt;a href="/pubmed/16239276" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12449</code><code>PubMed&lt;/a&gt;</code></p><p><code>12450</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12451</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Physiol+(Lond)&amp;amp;title=Activity-dependent+release+and+actions+of+endocannabinoids+in+the+rat+hypothalamic+supraoptic+nucleus&amp;amp;author=S+Di&amp;amp;author=C+Boudaba&amp;amp;author=R+Popescu&amp;amp;author=FJ+Weng&amp;amp;author=C+Harris&amp;amp;volume=569&amp;amp;publication_year=2005a&amp;amp;pages=751-760&amp;amp;pmid=16239276&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12452</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12453</code><code>]&lt;/span&gt;</code></p><p><code>12454</code><code>&lt;/span&gt;</code></p><p><code>12455</code><code>&lt;/li&gt;</code></p><p><code>12456</code><code>&lt;li id="R267"&gt;</code></p><p><code>12457</code><code>&lt;span class="citation"&gt;</code></p><p><code>12458</code><code>Di S, Malcher-Lopes R, Halmos KC, Tasker JG. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. &lt;span&gt;</code></p><p><code>12459</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12460</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>12461</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>12462</code><code>23&lt;/span&gt;</code></p><p><code>12463</code><code>:4850–4857.&lt;/span&gt;</code></p><p><code>12464</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>12465</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6741208/"&gt;</code></p><p><code>12466</code><code>PMC free article&lt;/a&gt;</code></p><p><code>12467</code><code>]&lt;/span&gt;</code></p><p><code>12468</code><code> [&lt;a href="/pubmed/12832507" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12469</code><code>PubMed&lt;/a&gt;</code></p><p><code>12470</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12471</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Nongenomic+glucocorticoid+inhibition+via+endocannabinoid+release+in+the+hypothalamus:+a+fast+feedback+mechanism&amp;amp;author=S+Di&amp;amp;author=R+Malcher-Lopes&amp;amp;author=KC+Halmos&amp;amp;author=JG+Tasker&amp;amp;volume=23&amp;amp;publication_year=2003&amp;amp;pages=4850-4857&amp;amp;pmid=12832507&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12472</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12473</code><code>]&lt;/span&gt;</code></p><p><code>12474</code><code>&lt;/span&gt;</code></p><p><code>12475</code><code>&lt;/li&gt;</code></p><p><code>12476</code><code>&lt;li id="R268"&gt;</code></p><p><code>12477</code><code>&lt;span class="citation"&gt;</code></p><p><code>12478</code><code>Di S, Malcher-Lopes R, Marcheselli VL, Bazan NG, Tasker JG. Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and &lt;em&gt;</code></p><p><code>12479</code><code>&amp;#x003b3;&lt;/em&gt;</code></p><p><code>12480</code><code>-aminobutyric acid inputs to hypothalamic magnocellular neurons. &lt;span&gt;</code></p><p><code>12481</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12482</code><code>Endocrinology. &lt;/span&gt;</code></p><p><code>12483</code><code>2005b;&lt;span class="ref-vol"&gt;</code></p><p><code>12484</code><code>146&lt;/span&gt;</code></p><p><code>12485</code><code>:4292–4301.&lt;/span&gt;</code></p><p><code>12486</code><code> [&lt;a href="/pubmed/15994343" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12487</code><code>PubMed&lt;/a&gt;</code></p><p><code>12488</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12489</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;amp;title=Rapid+glucocorticoid-mediated+endocannabinoid+release+and+opposing+regulation+of+glutamate+and+&amp;#x003b3;-aminobutyric+acid+inputs+to+hypothalamic+magnocellular+neurons&amp;amp;author=S+Di&amp;amp;author=R+Malcher-Lopes&amp;amp;author=VL+Marcheselli&amp;amp;author=NG+Bazan&amp;amp;author=JG+Tasker&amp;amp;volume=146&amp;amp;publication_year=2005b&amp;amp;pages=4292-4301&amp;amp;pmid=15994343&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12490</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12491</code><code>]&lt;/span&gt;</code></p><p><code>12492</code><code>&lt;/span&gt;</code></p><p><code>12493</code><code>&lt;/li&gt;</code></p><p><code>12494</code><code>&lt;li id="R269"&gt;</code></p><p><code>12495</code><code>&lt;span class="citation"&gt;</code></p><p><code>12496</code><code>Di Carlo G, Izzo AA. Cannabinoids for gastrointestinal diseases: potential therapeutic applications. &lt;span&gt;</code></p><p><code>12497</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12498</code><code>Expert Opin Investig Drugs. &lt;/span&gt;</code></p><p><code>12499</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>12500</code><code>12&lt;/span&gt;</code></p><p><code>12501</code><code>:39–49.&lt;/span&gt;</code></p><p><code>12502</code><code> [&lt;a href="/pubmed/12517253" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12503</code><code>PubMed&lt;/a&gt;</code></p><p><code>12504</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12505</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Expert+Opin+Investig+Drugs&amp;amp;title=Cannabinoids+for+gastrointestinal+diseases:+potential+therapeutic+applications&amp;amp;author=G+Di+Carlo&amp;amp;author=AA+Izzo&amp;amp;volume=12&amp;amp;publication_year=2003&amp;amp;pages=39-49&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12506</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12507</code><code>]&lt;/span&gt;</code></p><p><code>12508</code><code>&lt;/span&gt;</code></p><p><code>12509</code><code>&lt;/li&gt;</code></p><p><code>12510</code><code>&lt;li id="R270"&gt;</code></p><p><code>12511</code><code>&lt;span class="citation"&gt;</code></p><p><code>12512</code><code>Di Filippo C, Rossi F, Rossi S, D&amp;#x02019;Amico M. Cannabinoid CB&lt;sub&gt;</code></p><p><code>12513</code><code>2&lt;/sub&gt;</code></p><p><code>12514</code><code> receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN. &lt;span&gt;</code></p><p><code>12515</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12516</code><code>J Leukoc Biol. &lt;/span&gt;</code></p><p><code>12517</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>12518</code><code>75&lt;/span&gt;</code></p><p><code>12519</code><code>:453–459.&lt;/span&gt;</code></p><p><code>12520</code><code> [&lt;a href="/pubmed/14657208" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12521</code><code>PubMed&lt;/a&gt;</code></p><p><code>12522</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12523</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Leukoc+Biol&amp;amp;title=Cannabinoid+CB2+receptor+activation+reduces+mouse+myocardial+ischemia-reperfusion+injury:+involvement+of+cytokine/chemokines+and+PMN&amp;amp;author=C+Di+Filippo&amp;amp;author=F+Rossi&amp;amp;author=S+Rossi&amp;amp;author=M+D&amp;#x02019;Amico&amp;amp;volume=75&amp;amp;publication_year=2004&amp;amp;pages=453-459&amp;amp;pmid=14657208&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12524</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12525</code><code>]&lt;/span&gt;</code></p><p><code>12526</code><code>&lt;/span&gt;</code></p><p><code>12527</code><code>&lt;/li&gt;</code></p><p><code>12528</code><code>&lt;li id="R271"&gt;</code></p><p><code>12529</code><code>&lt;span class="citation"&gt;</code></p><p><code>12530</code><code>Di Marzo V, Bifulco M, De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. &lt;span&gt;</code></p><p><code>12531</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12532</code><code>Nat Rev Drug Discov. &lt;/span&gt;</code></p><p><code>12533</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>12534</code><code>3&lt;/span&gt;</code></p><p><code>12535</code><code>:771–784.&lt;/span&gt;</code></p><p><code>12536</code><code> [&lt;a href="/pubmed/15340387" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12537</code><code>PubMed&lt;/a&gt;</code></p><p><code>12538</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12539</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Drug+Discov&amp;amp;title=The+endocannabinoid+system+and+its+therapeutic+exploitation&amp;amp;author=V+Di+Marzo&amp;amp;author=M+Bifulco&amp;amp;author=L+De+Petrocellis&amp;amp;volume=3&amp;amp;publication_year=2004&amp;amp;pages=771-784&amp;amp;pmid=15340387&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12540</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12541</code><code>]&lt;/span&gt;</code></p><p><code>12542</code><code>&lt;/span&gt;</code></p><p><code>12543</code><code>&lt;/li&gt;</code></p><p><code>12544</code><code>&lt;li id="R272"&gt;</code></p><p><code>12545</code><code>&lt;span class="citation"&gt;</code></p><p><code>12546</code><code>Di Marzo V, Bisogno T, De Petrocellis L, Brandi I, Jefferson RG, Winckler RL, Davis JB, Dasse O, Mahadevan A, Razdan RK, et al.  Highly selective CB&lt;sub&gt;</code></p><p><code>12547</code><code>1&lt;/sub&gt;</code></p><p><code>12548</code><code> cannabinoid receptor ligands and novel CB&lt;sub&gt;</code></p><p><code>12549</code><code>1&lt;/sub&gt;</code></p><p><code>12550</code><code>/VR&lt;sub&gt;</code></p><p><code>12551</code><code>1&lt;/sub&gt;</code></p><p><code>12552</code><code> vanilloid receptor &amp;#x0201c;hybrid&amp;#x0201d; ligands. &lt;span&gt;</code></p><p><code>12553</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12554</code><code>Biochem Biophys Res Commun. &lt;/span&gt;</code></p><p><code>12555</code><code>2001a;&lt;span class="ref-vol"&gt;</code></p><p><code>12556</code><code>281&lt;/span&gt;</code></p><p><code>12557</code><code>:444–451.&lt;/span&gt;</code></p><p><code>12558</code><code> [&lt;a href="/pubmed/11181068" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12559</code><code>PubMed&lt;/a&gt;</code></p><p><code>12560</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12561</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;amp;title=Highly+selective+CB1+cannabinoid+receptor+ligands+and+novel+CB1/VR1+vanilloid+receptor+&amp;#x0201c;hybrid&amp;#x0201d;+ligands&amp;amp;author=V+Di+Marzo&amp;amp;author=T+Bisogno&amp;amp;author=L+De+Petrocellis&amp;amp;author=I+Brandi&amp;amp;author=RG+Jefferson&amp;amp;volume=281&amp;amp;publication_year=2001a&amp;amp;pages=444-451&amp;amp;pmid=11181068&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12562</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12563</code><code>]&lt;/span&gt;</code></p><p><code>12564</code><code>&lt;/span&gt;</code></p><p><code>12565</code><code>&lt;/li&gt;</code></p><p><code>12566</code><code>&lt;li id="R273"&gt;</code></p><p><code>12567</code><code>&lt;span class="citation"&gt;</code></p><p><code>12568</code><code>Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. &lt;span&gt;</code></p><p><code>12569</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12570</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>12571</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>12572</code><code>372&lt;/span&gt;</code></p><p><code>12573</code><code>:686–691.&lt;/span&gt;</code></p><p><code>12574</code><code> [&lt;a href="/pubmed/7990962" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12575</code><code>PubMed&lt;/a&gt;</code></p><p><code>12576</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12577</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Formation+and+inactivation+of+endogenous+cannabinoid+anandamide+in+central+neurons&amp;amp;author=V+Di+Marzo&amp;amp;author=A+Fontana&amp;amp;author=H+Cadas&amp;amp;author=S+Schinelli&amp;amp;author=G+Cimino&amp;amp;volume=372&amp;amp;publication_year=1994&amp;amp;pages=686-691&amp;amp;pmid=7990962&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12578</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12579</code><code>]&lt;/span&gt;</code></p><p><code>12580</code><code>&lt;/span&gt;</code></p><p><code>12581</code><code>&lt;/li&gt;</code></p><p><code>12582</code><code>&lt;li id="R274"&gt;</code></p><p><code>12583</code><code>&lt;span class="citation"&gt;</code></p><p><code>12584</code><code>Di Marzo V, Goparaju SK, Wang L, Liu J, B&amp;#x000e1;tkai S, J&amp;#x000e1;rai Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, et al.  Leptin-regulated endocannabinoids are involved in maintaining food intake. &lt;span&gt;</code></p><p><code>12585</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12586</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>12587</code><code>2001b;&lt;span class="ref-vol"&gt;</code></p><p><code>12588</code><code>410&lt;/span&gt;</code></p><p><code>12589</code><code>:822–825.&lt;/span&gt;</code></p><p><code>12590</code><code> [&lt;a href="/pubmed/11298451" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12591</code><code>PubMed&lt;/a&gt;</code></p><p><code>12592</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12593</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Leptin-regulated+endocannabinoids+are+involved+in+maintaining+food+intake&amp;amp;author=V+Di+Marzo&amp;amp;author=SK+Goparaju&amp;amp;author=L+Wang&amp;amp;author=J+Liu&amp;amp;author=S+B&amp;#x000e1;tkai&amp;amp;volume=410&amp;amp;publication_year=2001b&amp;amp;pages=822-825&amp;amp;pmid=11298451&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12594</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12595</code><code>]&lt;/span&gt;</code></p><p><code>12596</code><code>&lt;/span&gt;</code></p><p><code>12597</code><code>&lt;/li&gt;</code></p><p><code>12598</code><code>&lt;li id="R275"&gt;</code></p><p><code>12599</code><code>&lt;span class="citation"&gt;</code></p><p><code>12600</code><code>Di Marzo V, Hill MP, Bisogno T, Crossman AR, Brotchie JM. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>12601</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12602</code><code>FASEB J. &lt;/span&gt;</code></p><p><code>12603</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>12604</code><code>14&lt;/span&gt;</code></p><p><code>12605</code><code>:1432–1438.&lt;/span&gt;</code></p><p><code>12606</code><code> [&lt;a href="/pubmed/10877836" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12607</code><code>PubMed&lt;/a&gt;</code></p><p><code>12608</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12609</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;amp;title=Enhanced+levels+of+endogenous+cannabinoids+in+the+globus+pallidus+are+associated+with+a+reduction+in+movement+in+an+animal+model+of+Parkinson&amp;#x02019;s+disease&amp;amp;author=V+Di+Marzo&amp;amp;author=MP+Hill&amp;amp;author=T+Bisogno&amp;amp;author=AR+Crossman&amp;amp;author=JM+Brotchie&amp;amp;volume=14&amp;amp;publication_year=2000&amp;amp;pages=1432-1438&amp;amp;pmid=10877836&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12610</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12611</code><code>]&lt;/span&gt;</code></p><p><code>12612</code><code>&lt;/span&gt;</code></p><p><code>12613</code><code>&lt;/li&gt;</code></p><p><code>12614</code><code>&lt;li id="R276"&gt;</code></p><p><code>12615</code><code>&lt;span class="citation"&gt;</code></p><p><code>12616</code><code>Di Marzo V, Matias I. Endocannabinoid control of food intake and energy balance. &lt;span&gt;</code></p><p><code>12617</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12618</code><code>Nat Neurosci. &lt;/span&gt;</code></p><p><code>12619</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>12620</code><code>8&lt;/span&gt;</code></p><p><code>12621</code><code>:585–589.&lt;/span&gt;</code></p><p><code>12622</code><code> [&lt;a href="/pubmed/15856067" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12623</code><code>PubMed&lt;/a&gt;</code></p><p><code>12624</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12625</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Neurosci&amp;amp;title=Endocannabinoid+control+of+food+intake+and+energy+balance&amp;amp;author=V+Di+Marzo&amp;amp;author=I+Matias&amp;amp;volume=8&amp;amp;publication_year=2005&amp;amp;pages=585-589&amp;amp;pmid=15856067&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12626</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12627</code><code>]&lt;/span&gt;</code></p><p><code>12628</code><code>&lt;/span&gt;</code></p><p><code>12629</code><code>&lt;/li&gt;</code></p><p><code>12630</code><code>&lt;li id="R277"&gt;</code></p><p><code>12631</code><code>&lt;span class="citation"&gt;</code></p><p><code>12632</code><code>Di Marzo V, Petrocellis LD. Plant, synthetic, and endogenous cannabinoids in medicine. &lt;span&gt;</code></p><p><code>12633</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12634</code><code>Annu Rev Med. &lt;/span&gt;</code></p><p><code>12635</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>12636</code><code>57&lt;/span&gt;</code></p><p><code>12637</code><code>:553–574.&lt;/span&gt;</code></p><p><code>12638</code><code> [&lt;a href="/pubmed/16409166" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12639</code><code>PubMed&lt;/a&gt;</code></p><p><code>12640</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12641</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Med&amp;amp;title=Plant,+synthetic,+and+endogenous+cannabinoids+in+medicine&amp;amp;author=V+Di+Marzo&amp;amp;author=LD+Petrocellis&amp;amp;volume=57&amp;amp;publication_year=2006&amp;amp;pages=553-574&amp;amp;pmid=16409166&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12642</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12643</code><code>]&lt;/span&gt;</code></p><p><code>12644</code><code>&lt;/span&gt;</code></p><p><code>12645</code><code>&lt;/li&gt;</code></p><p><code>12646</code><code>&lt;li id="R278"&gt;</code></p><p><code>12647</code><code>&lt;span class="citation"&gt;</code></p><p><code>12648</code><code>Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S, Piomelli D. Brain monoglyceride lipase participating in endocannabinoid inactivation. &lt;span&gt;</code></p><p><code>12649</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12650</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>12651</code><code>2002a;&lt;span class="ref-vol"&gt;</code></p><p><code>12652</code><code>99&lt;/span&gt;</code></p><p><code>12653</code><code>:10819–10824.&lt;/span&gt;</code></p><p><code>12654</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>12655</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC125056/"&gt;</code></p><p><code>12656</code><code>PMC free article&lt;/a&gt;</code></p><p><code>12657</code><code>]&lt;/span&gt;</code></p><p><code>12658</code><code> [&lt;a href="/pubmed/12136125" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12659</code><code>PubMed&lt;/a&gt;</code></p><p><code>12660</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12661</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Brain+monoglyceride+lipase+participating+in+endocannabinoid+inactivation&amp;amp;author=TP+Dinh&amp;amp;author=D+Carpenter&amp;amp;author=FM+Leslie&amp;amp;author=TF+Freund&amp;amp;author=I+Katona&amp;amp;volume=99&amp;amp;publication_year=2002a&amp;amp;pages=10819-10824&amp;amp;pmid=12136125&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12662</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12663</code><code>]&lt;/span&gt;</code></p><p><code>12664</code><code>&lt;/span&gt;</code></p><p><code>12665</code><code>&lt;/li&gt;</code></p><p><code>12666</code><code>&lt;li id="R279"&gt;</code></p><p><code>12667</code><code>&lt;span class="citation"&gt;</code></p><p><code>12668</code><code>Dinh TP, Freund TF, Piomelli D. A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. &lt;span&gt;</code></p><p><code>12669</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12670</code><code>Chem Phys Lipids. &lt;/span&gt;</code></p><p><code>12671</code><code>2002b;&lt;span class="ref-vol"&gt;</code></p><p><code>12672</code><code>121&lt;/span&gt;</code></p><p><code>12673</code><code>:149–158.&lt;/span&gt;</code></p><p><code>12674</code><code> [&lt;a href="/pubmed/12505697" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12675</code><code>PubMed&lt;/a&gt;</code></p><p><code>12676</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12677</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Chem+Phys+Lipids&amp;amp;title=A+role+for+monoglyceride+lipase+in+2-arachidonoylglycerol+inactivation&amp;amp;author=TP+Dinh&amp;amp;author=TF+Freund&amp;amp;author=D+Piomelli&amp;amp;volume=121&amp;amp;publication_year=2002b&amp;amp;pages=149-158&amp;amp;pmid=12505697&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12678</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12679</code><code>]&lt;/span&gt;</code></p><p><code>12680</code><code>&lt;/span&gt;</code></p><p><code>12681</code><code>&lt;/li&gt;</code></p><p><code>12682</code><code>&lt;li id="R280"&gt;</code></p><p><code>12683</code><code>&lt;span class="citation"&gt;</code></p><p><code>12684</code><code>Domenicali M, Ros J, Fernandez-Varo G, Cejudo-Martin P, Crespo M, Morales-Ruiz M, Briones AM, Campistol JM, Arroyo V, Vila E, et al.  Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors. &lt;span&gt;</code></p><p><code>12685</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12686</code><code>Gut. &lt;/span&gt;</code></p><p><code>12687</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>12688</code><code>54&lt;/span&gt;</code></p><p><code>12689</code><code>:522–527.&lt;/span&gt;</code></p><p><code>12690</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>12691</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1774428/"&gt;</code></p><p><code>12692</code><code>PMC free article&lt;/a&gt;</code></p><p><code>12693</code><code>]&lt;/span&gt;</code></p><p><code>12694</code><code> [&lt;a href="/pubmed/15753538" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12695</code><code>PubMed&lt;/a&gt;</code></p><p><code>12696</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12697</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;amp;title=Increased+anandamide+induced+relaxation+in+mesenteric+arteries+of+cirrhotic+rats:+role+of+cannabinoid+and+vanilloid+receptors&amp;amp;author=M+Domenicali&amp;amp;author=J+Ros&amp;amp;author=G+Fernandez-Varo&amp;amp;author=P+Cejudo-Martin&amp;amp;author=M+Crespo&amp;amp;volume=54&amp;amp;publication_year=2005&amp;amp;pages=522-527&amp;amp;pmid=15753538&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12698</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12699</code><code>]&lt;/span&gt;</code></p><p><code>12700</code><code>&lt;/span&gt;</code></p><p><code>12701</code><code>&lt;/li&gt;</code></p><p><code>12702</code><code>&lt;li id="R281"&gt;</code></p><p><code>12703</code><code>&lt;span class="citation"&gt;</code></p><p><code>12704</code><code>Donovan M. On the physical and medicinal qualities of Indian hemp (Cannabis indica) &lt;span&gt;</code></p><p><code>12705</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12706</code><code>Dublin J Med Sci. &lt;/span&gt;</code></p><p><code>12707</code><code>1845;&lt;span class="ref-vol"&gt;</code></p><p><code>12708</code><code>26&lt;/span&gt;</code></p><p><code>12709</code><code>:368–402.&lt;/span&gt;</code></p><p><code>12710</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>12711</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Dublin+J+Med+Sci&amp;amp;title=On+the+physical+and+medicinal+qualities+of+Indian+hemp+(Cannabis+indica)&amp;amp;author=M+Donovan&amp;amp;volume=26&amp;amp;publication_year=1845&amp;amp;pages=368-402&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12712</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12713</code><code>]&lt;/span&gt;</code></p><p><code>12714</code><code>&lt;/span&gt;</code></p><p><code>12715</code><code>&lt;/li&gt;</code></p><p><code>12716</code><code>&lt;li id="R282"&gt;</code></p><p><code>12717</code><code>&lt;span class="citation"&gt;</code></p><p><code>12718</code><code>Drew LJ, Harris J, Millns PJ, Kendall DA, Chapman V. Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [&lt;sup&gt;</code></p><p><code>12719</code><code>35&lt;/sup&gt;</code></p><p><code>12720</code><code>S]GTP&lt;em&gt;</code></p><p><code>12721</code><code>&amp;#x003b3;&lt;/em&gt;</code></p><p><code>12722</code><code>S binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats. &lt;span&gt;</code></p><p><code>12723</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12724</code><code>Eur J Neurosci. &lt;/span&gt;</code></p><p><code>12725</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>12726</code><code>12&lt;/span&gt;</code></p><p><code>12727</code><code>:2079–2086.&lt;/span&gt;</code></p><p><code>12728</code><code> [&lt;a href="/pubmed/10886347" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12729</code><code>PubMed&lt;/a&gt;</code></p><p><code>12730</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12731</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurosci&amp;amp;title=Activation+of+spinal+cannabinoid+1+receptors+inhibits+C-fibre+driven+hyperexcitable+neuronal+responses+and+increases+[35S]GTP&amp;#x003b3;S+binding+in+the+dorsal+horn+of+the+spinal+cord+of+noninflamed+and+inflamed+rats&amp;amp;author=LJ+Drew&amp;amp;author=J+Harris&amp;amp;author=PJ+Millns&amp;amp;author=DA+Kendall&amp;amp;author=V+Chapman&amp;amp;volume=12&amp;amp;publication_year=2000&amp;amp;pages=2079-2086&amp;amp;pmid=10886347&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12732</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12733</code><code>]&lt;/span&gt;</code></p><p><code>12734</code><code>&lt;/span&gt;</code></p><p><code>12735</code><code>&lt;/li&gt;</code></p><p><code>12736</code><code>&lt;li id="R283"&gt;</code></p><p><code>12737</code><code>&lt;span class="citation"&gt;</code></p><p><code>12738</code><code>Drmota T, Greasley P, Groblewski T. inventors, AstraZeneca, assignee. Screening assays for cannabinoid-ligand-type modulators of GPR55; World Intellectual Property Organization patent application PCT/GB2004/000571; 2004.  2004 Sept 2. &lt;span class="nowrap"&gt;</code></p><p><code>12739</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=World+Intellectual+Property+Organization+patent+application+PCT/GB2004/000571&amp;amp;title=inventors,+AstraZeneca,+assignee.+Screening+assays+for+cannabinoid-ligand-type+modulators+of+GPR55&amp;amp;author=T+Drmota&amp;amp;author=P+Greasley&amp;amp;author=T+Groblewski&amp;amp;publication_year=2004&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12740</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12741</code><code>]&lt;/span&gt;</code></p><p><code>12742</code><code>&lt;/span&gt;</code></p><p><code>12743</code><code>&lt;/li&gt;</code></p><p><code>12744</code><code>&lt;li id="R284"&gt;</code></p><p><code>12745</code><code>&lt;span class="citation"&gt;</code></p><p><code>12746</code><code>Drysdale AJ, Platt B. Cannabinoids: mechanisms and therapeutic applications in the CNS. &lt;span&gt;</code></p><p><code>12747</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12748</code><code>Curr Med Chem. &lt;/span&gt;</code></p><p><code>12749</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>12750</code><code>10&lt;/span&gt;</code></p><p><code>12751</code><code>:2719–2732.&lt;/span&gt;</code></p><p><code>12752</code><code> [&lt;a href="/pubmed/14529462" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12753</code><code>PubMed&lt;/a&gt;</code></p><p><code>12754</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12755</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Med+Chem&amp;amp;title=Cannabinoids:+mechanisms+and+therapeutic+applications+in+the+CNS&amp;amp;author=AJ+Drysdale&amp;amp;author=B+Platt&amp;amp;volume=10&amp;amp;publication_year=2003&amp;amp;pages=2719-2732&amp;amp;pmid=14529462&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12756</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12757</code><code>]&lt;/span&gt;</code></p><p><code>12758</code><code>&lt;/span&gt;</code></p><p><code>12759</code><code>&lt;/li&gt;</code></p><p><code>12760</code><code>&lt;li id="R285"&gt;</code></p><p><code>12761</code><code>&lt;span class="citation"&gt;</code></p><p><code>12762</code><code>D&amp;#x02019;Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G, Gueorguieva R, Cooper TB, Krystal JH. &amp;#x00394;-9-Tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. &lt;span&gt;</code></p><p><code>12763</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12764</code><code>Biol Psychiatry. &lt;/span&gt;</code></p><p><code>12765</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>12766</code><code>57&lt;/span&gt;</code></p><p><code>12767</code><code>:594–608.&lt;/span&gt;</code></p><p><code>12768</code><code> [&lt;a href="/pubmed/15780846" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12769</code><code>PubMed&lt;/a&gt;</code></p><p><code>12770</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12771</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biol+Psychiatry&amp;amp;title=&amp;#x00394;-9-Tetrahydrocannabinol+effects+in+schizophrenia:+implications+for+cognition,+psychosis,+and+addiction&amp;amp;author=DC+D&amp;#x02019;Souza&amp;amp;author=WM+Abi-Saab&amp;amp;author=S+Madonick&amp;amp;author=K+Forselius-Bielen&amp;amp;author=A+Doersch&amp;amp;volume=57&amp;amp;publication_year=2005&amp;amp;pages=594-608&amp;amp;pmid=15780846&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12772</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12773</code><code>]&lt;/span&gt;</code></p><p><code>12774</code><code>&lt;/span&gt;</code></p><p><code>12775</code><code>&lt;/li&gt;</code></p><p><code>12776</code><code>&lt;li id="R286"&gt;</code></p><p><code>12777</code><code>&lt;span class="citation"&gt;</code></p><p><code>12778</code><code>D&amp;#x02019;Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH. The psychotomimetic effects of intravenous &amp;#x00394;-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. &lt;span&gt;</code></p><p><code>12779</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12780</code><code>Neuropsychopharmacology. &lt;/span&gt;</code></p><p><code>12781</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>12782</code><code>29&lt;/span&gt;</code></p><p><code>12783</code><code>:1558–1572.&lt;/span&gt;</code></p><p><code>12784</code><code> [&lt;a href="/pubmed/15173844" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12785</code><code>PubMed&lt;/a&gt;</code></p><p><code>12786</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12787</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;amp;title=The+psychotomimetic+effects+of+intravenous+&amp;#x00394;-9-tetrahydrocannabinol+in+healthy+individuals:+implications+for+psychosis&amp;amp;author=DC+D&amp;#x02019;Souza&amp;amp;author=E+Perry&amp;amp;author=L+MacDougall&amp;amp;author=Y+Ammerman&amp;amp;author=T+Cooper&amp;amp;volume=29&amp;amp;publication_year=2004&amp;amp;pages=1558-1572&amp;amp;pmid=15173844&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12788</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12789</code><code>]&lt;/span&gt;</code></p><p><code>12790</code><code>&lt;/span&gt;</code></p><p><code>12791</code><code>&lt;/li&gt;</code></p><p><code>12792</code><code>&lt;li id="R287"&gt;</code></p><p><code>12793</code><code>&lt;span class="citation"&gt;</code></p><p><code>12794</code><code>Duncan GE, Dagirmanjian R. &amp;#x00394;&lt;sup&gt;</code></p><p><code>12795</code><code>9&lt;/sup&gt;</code></p><p><code>12796</code><code>-Tetrahydrocannabinol sensitization of the rat brain to direct cholinergic stimulation. &lt;span&gt;</code></p><p><code>12797</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12798</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>12799</code><code>1979;&lt;span class="ref-vol"&gt;</code></p><p><code>12800</code><code>60&lt;/span&gt;</code></p><p><code>12801</code><code>:237–240.&lt;/span&gt;</code></p><p><code>12802</code><code> [&lt;a href="/pubmed/108700" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12803</code><code>PubMed&lt;/a&gt;</code></p><p><code>12804</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12805</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=&amp;#x00394;9-Tetrahydrocannabinol+sensitization+of+the+rat+brain+to+direct+cholinergic+stimulation&amp;amp;author=GE+Duncan&amp;amp;author=R+Dagirmanjian&amp;amp;volume=60&amp;amp;publication_year=1979&amp;amp;pages=237-240&amp;amp;pmid=108700&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12806</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12807</code><code>]&lt;/span&gt;</code></p><p><code>12808</code><code>&lt;/span&gt;</code></p><p><code>12809</code><code>&lt;/li&gt;</code></p><p><code>12810</code><code>&lt;li id="R288"&gt;</code></p><p><code>12811</code><code>&lt;span class="citation"&gt;</code></p><p><code>12812</code><code>Duncan M, Davison JS, Sharkey KA. Review article: endocannabinoids and their receptors in the enteric nervous system. &lt;span&gt;</code></p><p><code>12813</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12814</code><code>Aliment Pharmacol Ther. &lt;/span&gt;</code></p><p><code>12815</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>12816</code><code>22&lt;/span&gt;</code></p><p><code>12817</code><code>:667–683.&lt;/span&gt;</code></p><p><code>12818</code><code> [&lt;a href="/pubmed/16197488" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12819</code><code>PubMed&lt;/a&gt;</code></p><p><code>12820</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12821</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Aliment+Pharmacol+Ther&amp;amp;title=Review+article:+endocannabinoids+and+their+receptors+in+the+enteric+nervous+system&amp;amp;author=M+Duncan&amp;amp;author=JS+Davison&amp;amp;author=KA+Sharkey&amp;amp;volume=22&amp;amp;publication_year=2005&amp;amp;pages=667-683&amp;amp;pmid=16197488&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12822</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12823</code><code>]&lt;/span&gt;</code></p><p><code>12824</code><code>&lt;/span&gt;</code></p><p><code>12825</code><code>&lt;/li&gt;</code></p><p><code>12826</code><code>&lt;li id="R289"&gt;</code></p><p><code>12827</code><code>&lt;span class="citation"&gt;</code></p><p><code>12828</code><code>Dunn M, Davis R. The perceived effects of marijuana on spinal cord injured males. &lt;span&gt;</code></p><p><code>12829</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12830</code><code>Paraplegia. &lt;/span&gt;</code></p><p><code>12831</code><code>1974;&lt;span class="ref-vol"&gt;</code></p><p><code>12832</code><code>12&lt;/span&gt;</code></p><p><code>12833</code><code>:175.&lt;/span&gt;</code></p><p><code>12834</code><code> [&lt;a href="/pubmed/4453421" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12835</code><code>PubMed&lt;/a&gt;</code></p><p><code>12836</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12837</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Paraplegia&amp;amp;title=The+perceived+effects+of+marijuana+on+spinal+cord+injured+males&amp;amp;author=M+Dunn&amp;amp;author=R+Davis&amp;amp;volume=12&amp;amp;publication_year=1974&amp;amp;pages=175&amp;amp;pmid=4453421&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12838</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12839</code><code>]&lt;/span&gt;</code></p><p><code>12840</code><code>&lt;/span&gt;</code></p><p><code>12841</code><code>&lt;/li&gt;</code></p><p><code>12842</code><code>&lt;li id="R290"&gt;</code></p><p><code>12843</code><code>&lt;span class="citation"&gt;</code></p><p><code>12844</code><code>Dyson A, Peacock M, Chen A, Courade JP, Yaqoob M, Groarke A, Brain C, Loong Y, Fox A. Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat. &lt;span&gt;</code></p><p><code>12845</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12846</code><code>Pain. &lt;/span&gt;</code></p><p><code>12847</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>12848</code><code>116&lt;/span&gt;</code></p><p><code>12849</code><code>:129–137.&lt;/span&gt;</code></p><p><code>12850</code><code> [&lt;a href="/pubmed/15936883" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12851</code><code>PubMed&lt;/a&gt;</code></p><p><code>12852</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12853</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;amp;title=Antihyperalgesic+properties+of+the+cannabinoid+CT-3+in+chronic+neuropathic+and+inflammatory+pain+states+in+the+rat&amp;amp;author=A+Dyson&amp;amp;author=M+Peacock&amp;amp;author=A+Chen&amp;amp;author=JP+Courade&amp;amp;author=M+Yaqoob&amp;amp;volume=116&amp;amp;publication_year=2005&amp;amp;pages=129-137&amp;amp;pmid=15936883&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12854</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12855</code><code>]&lt;/span&gt;</code></p><p><code>12856</code><code>&lt;/span&gt;</code></p><p><code>12857</code><code>&lt;/li&gt;</code></p><p><code>12858</code><code>&lt;li id="R291"&gt;</code></p><p><code>12859</code><code>&lt;span class="citation"&gt;</code></p><p><code>12860</code><code>Economidou D, Mattioli L, Cifani C, Perfumi M, Massi M, Cuomo V, Trabace L, Ciccocioppo R. Effect of cannabinoid CB&lt;sub&gt;</code></p><p><code>12861</code><code>1&lt;/sub&gt;</code></p><p><code>12862</code><code> receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behavior in rats. &lt;span&gt;</code></p><p><code>12863</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12864</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>12865</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>12866</code><code>183&lt;/span&gt;</code></p><p><code>12867</code><code>:394–403.&lt;/span&gt;</code></p><p><code>12868</code><code> [&lt;a href="/pubmed/16261315" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12869</code><code>PubMed&lt;/a&gt;</code></p><p><code>12870</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12871</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Effect+of+cannabinoid+CB1+receptor+antagonist+SR-141716A+on+ethanol+self-administration+and+ethanol-seeking+behavior+in+rats&amp;amp;author=D+Economidou&amp;amp;author=L+Mattioli&amp;amp;author=C+Cifani&amp;amp;author=M+Perfumi&amp;amp;author=M+Massi&amp;amp;volume=183&amp;amp;publication_year=2006&amp;amp;pages=394-403&amp;amp;pmid=16261315&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12872</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12873</code><code>]&lt;/span&gt;</code></p><p><code>12874</code><code>&lt;/span&gt;</code></p><p><code>12875</code><code>&lt;/li&gt;</code></p><p><code>12876</code><code>&lt;li id="R292"&gt;</code></p><p><code>12877</code><code>&lt;span class="citation"&gt;</code></p><p><code>12878</code><code>Efird JT, Friedman GD, Sidney S, Klatsky A, Habel LA, Udaltsova NV, Van den Eeden S, Nelson LM. The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. &lt;span&gt;</code></p><p><code>12879</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12880</code><code>J Neurooncol. &lt;/span&gt;</code></p><p><code>12881</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>12882</code><code>68&lt;/span&gt;</code></p><p><code>12883</code><code>:57–69.&lt;/span&gt;</code></p><p><code>12884</code><code> [&lt;a href="/pubmed/15174522" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12885</code><code>PubMed&lt;/a&gt;</code></p><p><code>12886</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12887</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurooncol&amp;amp;title=The+risk+for+malignant+primary+adult-onset+glioma+in+a+large,+multiethnic,+managed-care+cohort:+cigarette+smoking+and+other+lifestyle+behaviors&amp;amp;author=JT+Efird&amp;amp;author=GD+Friedman&amp;amp;author=S+Sidney&amp;amp;author=A+Klatsky&amp;amp;author=LA+Habel&amp;amp;volume=68&amp;amp;publication_year=2004&amp;amp;pages=57-69&amp;amp;pmid=15174522&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12888</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12889</code><code>]&lt;/span&gt;</code></p><p><code>12890</code><code>&lt;/span&gt;</code></p><p><code>12891</code><code>&lt;/li&gt;</code></p><p><code>12892</code><code>&lt;li id="R293"&gt;</code></p><p><code>12893</code><code>&lt;span class="citation"&gt;</code></p><p><code>12894</code><code>Eljaschewitsch E, Witting A, Mawrin C, Lee T, Schmidt PM, Wolf S, Hoertnagl H, Raine CS, Schneider-Stock R, Nitsch R, et al.  The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. &lt;span&gt;</code></p><p><code>12895</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12896</code><code>Neuron. &lt;/span&gt;</code></p><p><code>12897</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>12898</code><code>49&lt;/span&gt;</code></p><p><code>12899</code><code>:67–79.&lt;/span&gt;</code></p><p><code>12900</code><code> [&lt;a href="/pubmed/16387640" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12901</code><code>PubMed&lt;/a&gt;</code></p><p><code>12902</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12903</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;amp;title=The+endocannabinoid+anandamide+protects+neurons+during+CNS+inflammation+by+induction+of+MKP-1+in+microglial+cells&amp;amp;author=E+Eljaschewitsch&amp;amp;author=A+Witting&amp;amp;author=C+Mawrin&amp;amp;author=T+Lee&amp;amp;author=PM+Schmidt&amp;amp;volume=49&amp;amp;publication_year=2006&amp;amp;pages=67-79&amp;amp;pmid=16387640&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12904</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12905</code><code>]&lt;/span&gt;</code></p><p><code>12906</code><code>&lt;/span&gt;</code></p><p><code>12907</code><code>&lt;/li&gt;</code></p><p><code>12908</code><code>&lt;li id="R294"&gt;</code></p><p><code>12909</code><code>&lt;span class="citation"&gt;</code></p><p><code>12910</code><code>Ellert-Miklaszewska A, Kaminska B, Konarska L. Cannabinoids down-regulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein. &lt;span&gt;</code></p><p><code>12911</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12912</code><code>Cell Signal. &lt;/span&gt;</code></p><p><code>12913</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>12914</code><code>17&lt;/span&gt;</code></p><p><code>12915</code><code>:25–37.&lt;/span&gt;</code></p><p><code>12916</code><code> [&lt;a href="/pubmed/15451022" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12917</code><code>PubMed&lt;/a&gt;</code></p><p><code>12918</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12919</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cell+Signal&amp;amp;title=Cannabinoids+down-regulate+PI3K/Akt+and+Erk+signalling+pathways+and+activate+proapoptotic+function+of+Bad+protein&amp;amp;author=A+Ellert-Miklaszewska&amp;amp;author=B+Kaminska&amp;amp;author=L+Konarska&amp;amp;volume=17&amp;amp;publication_year=2005&amp;amp;pages=25-37&amp;amp;pmid=15451022&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12920</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12921</code><code>]&lt;/span&gt;</code></p><p><code>12922</code><code>&lt;/span&gt;</code></p><p><code>12923</code><code>&lt;/li&gt;</code></p><p><code>12924</code><code>&lt;li id="R295"&gt;</code></p><p><code>12925</code><code>&lt;span class="citation"&gt;</code></p><p><code>12926</code><code>Ellison JM, Gelwan E, Ogletree J. Complex partial seizure symptoms affected by marijuana abuse. &lt;span&gt;</code></p><p><code>12927</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12928</code><code>J Clin Psychiatry. &lt;/span&gt;</code></p><p><code>12929</code><code>1990;&lt;span class="ref-vol"&gt;</code></p><p><code>12930</code><code>51&lt;/span&gt;</code></p><p><code>12931</code><code>:439–440.&lt;/span&gt;</code></p><p><code>12932</code><code> [&lt;a href="/pubmed/2211545" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12933</code><code>PubMed&lt;/a&gt;</code></p><p><code>12934</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12935</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Psychiatry&amp;amp;title=Complex+partial+seizure+symptoms+affected+by+marijuana+abuse&amp;amp;author=JM+Ellison&amp;amp;author=E+Gelwan&amp;amp;author=J+Ogletree&amp;amp;volume=51&amp;amp;publication_year=1990&amp;amp;pages=439-440&amp;amp;pmid=2211545&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12936</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12937</code><code>]&lt;/span&gt;</code></p><p><code>12938</code><code>&lt;/span&gt;</code></p><p><code>12939</code><code>&lt;/li&gt;</code></p><p><code>12940</code><code>&lt;li id="R296"&gt;</code></p><p><code>12941</code><code>&lt;span class="citation"&gt;</code></p><p><code>12942</code><code>Elmes SJ, Jhaveri MD, Smart D, Kendall DA, Chapman V. Cannabinoid CB&lt;sub&gt;</code></p><p><code>12943</code><code>2&lt;/sub&gt;</code></p><p><code>12944</code><code> receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naive rats and in rat models of inflammatory and neuropathic pain. &lt;span&gt;</code></p><p><code>12945</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12946</code><code>Eur J Neurosci. &lt;/span&gt;</code></p><p><code>12947</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>12948</code><code>20&lt;/span&gt;</code></p><p><code>12949</code><code>:2311–2320.&lt;/span&gt;</code></p><p><code>12950</code><code> [&lt;a href="/pubmed/15525273" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12951</code><code>PubMed&lt;/a&gt;</code></p><p><code>12952</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12953</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurosci&amp;amp;title=Cannabinoid+CB2+receptor+activation+inhibits+mechanically+evoked+responses+of+wide+dynamic+range+dorsal+horn+neurons+in+naive+rats+and+in+rat+models+of+inflammatory+and+neuropathic+pain&amp;amp;author=SJ+Elmes&amp;amp;author=MD+Jhaveri&amp;amp;author=D+Smart&amp;amp;author=DA+Kendall&amp;amp;author=V+Chapman&amp;amp;volume=20&amp;amp;publication_year=2004&amp;amp;pages=2311-2320&amp;amp;pmid=15525273&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12954</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12955</code><code>]&lt;/span&gt;</code></p><p><code>12956</code><code>&lt;/span&gt;</code></p><p><code>12957</code><code>&lt;/li&gt;</code></p><p><code>12958</code><code>&lt;li id="R297"&gt;</code></p><p><code>12959</code><code>&lt;span class="citation"&gt;</code></p><p><code>12960</code><code>El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai NT, Caldwell RB, Liou GI. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. &lt;span&gt;</code></p><p><code>12961</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12962</code><code>Am J Pathol. &lt;/span&gt;</code></p><p><code>12963</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>12964</code><code>168&lt;/span&gt;</code></p><p><code>12965</code><code>:235–244.&lt;/span&gt;</code></p><p><code>12966</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>12967</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1592672/"&gt;</code></p><p><code>12968</code><code>PMC free article&lt;/a&gt;</code></p><p><code>12969</code><code>]&lt;/span&gt;</code></p><p><code>12970</code><code> [&lt;a href="/pubmed/16400026" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12971</code><code>PubMed&lt;/a&gt;</code></p><p><code>12972</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12973</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Pathol&amp;amp;title=Neuroprotective+and+blood-retinal+barrier-preserving+effects+of+cannabidiol+in+experimental+diabetes&amp;amp;author=AB+El-Remessy&amp;amp;author=M+Al-Shabrawey&amp;amp;author=Y+Khalifa&amp;amp;author=NT+Tsai&amp;amp;author=RB+Caldwell&amp;amp;volume=168&amp;amp;publication_year=2006&amp;amp;pages=235-244&amp;amp;pmid=16400026&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12974</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12975</code><code>]&lt;/span&gt;</code></p><p><code>12976</code><code>&lt;/span&gt;</code></p><p><code>12977</code><code>&lt;/li&gt;</code></p><p><code>12978</code><code>&lt;li id="R298"&gt;</code></p><p><code>12979</code><code>&lt;span class="citation"&gt;</code></p><p><code>12980</code><code>El-Remessy AB, Khalil IE, Matragoon S, Abou-Mohamed G, Tsai NJ, Roon P, Caldwell RB, Caldwell RW, Green K, Liou GI. Neuroprotective effect of (&amp;#x02212;) &amp;#x00394;&lt;sup&gt;</code></p><p><code>12981</code><code>9&lt;/sup&gt;</code></p><p><code>12982</code><code>-tetrahydrocannabinol and cannabidiol in &lt;em&gt;</code></p><p><code>12983</code><code>N-&lt;/em&gt;</code></p><p><code>12984</code><code>methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite. &lt;span&gt;</code></p><p><code>12985</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>12986</code><code>Am J Pathol. &lt;/span&gt;</code></p><p><code>12987</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>12988</code><code>163&lt;/span&gt;</code></p><p><code>12989</code><code>:1997–2008.&lt;/span&gt;</code></p><p><code>12990</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>12991</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1892413/"&gt;</code></p><p><code>12992</code><code>PMC free article&lt;/a&gt;</code></p><p><code>12993</code><code>]&lt;/span&gt;</code></p><p><code>12994</code><code> [&lt;a href="/pubmed/14578199" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>12995</code><code>PubMed&lt;/a&gt;</code></p><p><code>12996</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>12997</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Pathol&amp;amp;title=Neuroprotective+effect+of+(&amp;#x02212;)+&amp;#x00394;9-tetrahydrocannabinol+and+cannabidiol+in+N-methyl-D-aspartate-induced+retinal+neurotoxicity:+involvement+of+peroxynitrite&amp;amp;author=AB+El-Remessy&amp;amp;author=IE+Khalil&amp;amp;author=S+Matragoon&amp;amp;author=G+Abou-Mohamed&amp;amp;author=NJ+Tsai&amp;amp;volume=163&amp;amp;publication_year=2003&amp;amp;pages=1997-2008&amp;amp;pmid=14578199&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>12998</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>12999</code><code>]&lt;/span&gt;</code></p><p><code>13000</code><code>&lt;/span&gt;</code></p><p><code>13001</code><code>&lt;/li&gt;</code></p><p><code>13002</code><code>&lt;li id="R299"&gt;</code></p><p><code>13003</code><code>&lt;span class="citation"&gt;</code></p><p><code>13004</code><code>ElSohly MA, Harland E, Murphy JC, Wirth P, Waller CW. Cannabinoids in glaucoma: a primary screening procedure. &lt;span&gt;</code></p><p><code>13005</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13006</code><code>J Clin Pharmacol. &lt;/span&gt;</code></p><p><code>13007</code><code>1981;&lt;span class="ref-vol"&gt;</code></p><p><code>13008</code><code>21&lt;/span&gt;</code></p><p><code>13009</code><code>:472S–478S.&lt;/span&gt;</code></p><p><code>13010</code><code> [&lt;a href="/pubmed/6271842" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13011</code><code>PubMed&lt;/a&gt;</code></p><p><code>13012</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13013</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pharmacol&amp;amp;title=Cannabinoids+in+glaucoma:+a+primary+screening+procedure&amp;amp;author=MA+ElSohly&amp;amp;author=E+Harland&amp;amp;author=JC+Murphy&amp;amp;author=P+Wirth&amp;amp;author=CW+Waller&amp;amp;volume=21&amp;amp;publication_year=1981&amp;amp;pages=472S-478S&amp;amp;pmid=6271842&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13014</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13015</code><code>]&lt;/span&gt;</code></p><p><code>13016</code><code>&lt;/span&gt;</code></p><p><code>13017</code><code>&lt;/li&gt;</code></p><p><code>13018</code><code>&lt;li id="R300"&gt;</code></p><p><code>13019</code><code>&lt;span class="citation"&gt;</code></p><p><code>13020</code><code>ElSohly MA, Harland EC, Benigni DA, Waller CW. Cannabinoids in glaucoma. II: the effect of different cannabinoids on intraocular pressure of the rabbit. &lt;span&gt;</code></p><p><code>13021</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13022</code><code>Curr Eye Res. &lt;/span&gt;</code></p><p><code>13023</code><code>1984;&lt;span class="ref-vol"&gt;</code></p><p><code>13024</code><code>3&lt;/span&gt;</code></p><p><code>13025</code><code>:841–850.&lt;/span&gt;</code></p><p><code>13026</code><code> [&lt;a href="/pubmed/6329602" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13027</code><code>PubMed&lt;/a&gt;</code></p><p><code>13028</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13029</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Eye+Res&amp;amp;title=Cannabinoids+in+glaucoma.+II:+the+effect+of+different+cannabinoids+on+intraocular+pressure+of+the+rabbit&amp;amp;author=MA+ElSohly&amp;amp;author=EC+Harland&amp;amp;author=DA+Benigni&amp;amp;author=CW+Waller&amp;amp;volume=3&amp;amp;publication_year=1984&amp;amp;pages=841-850&amp;amp;pmid=6329602&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13030</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13031</code><code>]&lt;/span&gt;</code></p><p><code>13032</code><code>&lt;/span&gt;</code></p><p><code>13033</code><code>&lt;/li&gt;</code></p><p><code>13034</code><code>&lt;li id="R301"&gt;</code></p><p><code>13035</code><code>&lt;span class="citation"&gt;</code></p><p><code>13036</code><code>Emrich HM, Leweke FM, Schneider U. Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. &lt;span&gt;</code></p><p><code>13037</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13038</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>13039</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>13040</code><code>56&lt;/span&gt;</code></p><p><code>13041</code><code>:803–807.&lt;/span&gt;</code></p><p><code>13042</code><code> [&lt;a href="/pubmed/9130308" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13043</code><code>PubMed&lt;/a&gt;</code></p><p><code>13044</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13045</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Towards+a+cannabinoid+hypothesis+of+schizophrenia:+cognitive+impairments+due+to+dysregulation+of+the+endogenous+cannabinoid+system&amp;amp;author=HM+Emrich&amp;amp;author=FM+Leweke&amp;amp;author=U+Schneider&amp;amp;volume=56&amp;amp;publication_year=1997&amp;amp;pages=803-807&amp;amp;pmid=9130308&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13046</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13047</code><code>]&lt;/span&gt;</code></p><p><code>13048</code><code>&lt;/span&gt;</code></p><p><code>13049</code><code>&lt;/li&gt;</code></p><p><code>13050</code><code>&lt;li id="R302"&gt;</code></p><p><code>13051</code><code>&lt;span class="citation"&gt;</code></p><p><code>13052</code><code>Engeli S, Bohnke J, Feldpausch M, Gorzelniak K, Janke J, B&amp;#x000e1;tkai S, Pacher P, Harvey-White J, Luft FC, Sharma AM, et al.  Activation of the peripheral endocannabinoid system in human obesity. &lt;span&gt;</code></p><p><code>13053</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13054</code><code>Diabetes. &lt;/span&gt;</code></p><p><code>13055</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>13056</code><code>54&lt;/span&gt;</code></p><p><code>13057</code><code>:2838–2843.&lt;/span&gt;</code></p><p><code>13058</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>13059</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2228268/"&gt;</code></p><p><code>13060</code><code>PMC free article&lt;/a&gt;</code></p><p><code>13061</code><code>]&lt;/span&gt;</code></p><p><code>13062</code><code> [&lt;a href="/pubmed/16186383" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13063</code><code>PubMed&lt;/a&gt;</code></p><p><code>13064</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13065</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;amp;title=Activation+of+the+peripheral+endocannabinoid+system+in+human+obesity&amp;amp;author=S+Engeli&amp;amp;author=J+Bohnke&amp;amp;author=M+Feldpausch&amp;amp;author=K+Gorzelniak&amp;amp;author=J+Janke&amp;amp;volume=54&amp;amp;publication_year=2005&amp;amp;pages=2838-2843&amp;amp;pmid=16186383&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13066</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13067</code><code>]&lt;/span&gt;</code></p><p><code>13068</code><code>&lt;/span&gt;</code></p><p><code>13069</code><code>&lt;/li&gt;</code></p><p><code>13070</code><code>&lt;li id="R303"&gt;</code></p><p><code>13071</code><code>&lt;span class="citation"&gt;</code></p><p><code>13072</code><code>Eriksen JL, Wszolek Z, Petrucelli L. Molecular pathogenesis of Parkinson disease. &lt;span&gt;</code></p><p><code>13073</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13074</code><code>Arch Neurol. &lt;/span&gt;</code></p><p><code>13075</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>13076</code><code>62&lt;/span&gt;</code></p><p><code>13077</code><code>:353–357.&lt;/span&gt;</code></p><p><code>13078</code><code> [&lt;a href="/pubmed/15767499" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13079</code><code>PubMed&lt;/a&gt;</code></p><p><code>13080</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13081</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Arch+Neurol&amp;amp;title=Molecular+pathogenesis+of+Parkinson+disease&amp;amp;author=JL+Eriksen&amp;amp;author=Z+Wszolek&amp;amp;author=L+Petrucelli&amp;amp;volume=62&amp;amp;publication_year=2005&amp;amp;pages=353-357&amp;amp;pmid=15767499&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13082</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13083</code><code>]&lt;/span&gt;</code></p><p><code>13084</code><code>&lt;/span&gt;</code></p><p><code>13085</code><code>&lt;/li&gt;</code></p><p><code>13086</code><code>&lt;li id="R304"&gt;</code></p><p><code>13087</code><code>&lt;span class="citation"&gt;</code></p><p><code>13088</code><code>Eshhar N, Striem S, Biegon A. HU-211, a non-psychotropic cannabinoid, rescues cortical neurones from excitatory amino acid toxicity in culture. &lt;span&gt;</code></p><p><code>13089</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13090</code><code>Neuroreport. &lt;/span&gt;</code></p><p><code>13091</code><code>1993;&lt;span class="ref-vol"&gt;</code></p><p><code>13092</code><code>5&lt;/span&gt;</code></p><p><code>13093</code><code>:237–240.&lt;/span&gt;</code></p><p><code>13094</code><code> [&lt;a href="/pubmed/8298080" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13095</code><code>PubMed&lt;/a&gt;</code></p><p><code>13096</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13097</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroreport&amp;amp;title=HU-211,+a+non-psychotropic+cannabinoid,+rescues+cortical+neurones+from+excitatory+amino+acid+toxicity+in+culture&amp;amp;author=N+Eshhar&amp;amp;author=S+Striem&amp;amp;author=A+Biegon&amp;amp;volume=5&amp;amp;publication_year=1993&amp;amp;pages=237-240&amp;amp;pmid=8298080&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13098</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13099</code><code>]&lt;/span&gt;</code></p><p><code>13100</code><code>&lt;/span&gt;</code></p><p><code>13101</code><code>&lt;/li&gt;</code></p><p><code>13102</code><code>&lt;li id="R305"&gt;</code></p><p><code>13103</code><code>&lt;span class="citation"&gt;</code></p><p><code>13104</code><code>Eshhar N, Striem S, Kohen R, Tirosh O, Biegon A. Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist. &lt;span&gt;</code></p><p><code>13105</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13106</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>13107</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>13108</code><code>283&lt;/span&gt;</code></p><p><code>13109</code><code>:19–29.&lt;/span&gt;</code></p><p><code>13110</code><code> [&lt;a href="/pubmed/7498309" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13111</code><code>PubMed&lt;/a&gt;</code></p><p><code>13112</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13113</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Neuroprotective+and+antioxidant+activities+of+HU-211,+a+novel+NMDA+receptor+antagonist&amp;amp;author=N+Eshhar&amp;amp;author=S+Striem&amp;amp;author=R+Kohen&amp;amp;author=O+Tirosh&amp;amp;author=A+Biegon&amp;amp;volume=283&amp;amp;publication_year=1995&amp;amp;pages=19-29&amp;amp;pmid=7498309&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13114</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13115</code><code>]&lt;/span&gt;</code></p><p><code>13116</code><code>&lt;/span&gt;</code></p><p><code>13117</code><code>&lt;/li&gt;</code></p><p><code>13118</code><code>&lt;li id="R306"&gt;</code></p><p><code>13119</code><code>&lt;span class="citation"&gt;</code></p><p><code>13120</code><code>Evgenov OV, Liaudet L. Role of nitrosative stress and activation of poly(ADP-ribose) polymerase-1 in cardiovascular failure associated with septic and hemorrhagic shock. &lt;span&gt;</code></p><p><code>13121</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13122</code><code>Curr Vasc Pharmacol. &lt;/span&gt;</code></p><p><code>13123</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>13124</code><code>3&lt;/span&gt;</code></p><p><code>13125</code><code>:293–299.&lt;/span&gt;</code></p><p><code>13126</code><code> [&lt;a href="/pubmed/16026325" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13127</code><code>PubMed&lt;/a&gt;</code></p><p><code>13128</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13129</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Vasc+Pharmacol&amp;amp;title=Role+of+nitrosative+stress+and+activation+of+poly(ADP-ribose)+polymerase-1+in+cardiovascular+failure+associated+with+septic+and+hemorrhagic+shock&amp;amp;author=OV+Evgenov&amp;amp;author=L+Liaudet&amp;amp;volume=3&amp;amp;publication_year=2005&amp;amp;pages=293-299&amp;amp;pmid=16026325&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13130</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13131</code><code>]&lt;/span&gt;</code></p><p><code>13132</code><code>&lt;/span&gt;</code></p><p><code>13133</code><code>&lt;/li&gt;</code></p><p><code>13134</code><code>&lt;li id="R307"&gt;</code></p><p><code>13135</code><code>&lt;span class="citation"&gt;</code></p><p><code>13136</code><code>Fabre LF, McLendon D. The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety. &lt;span&gt;</code></p><p><code>13137</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13138</code><code>J Clin Pharmacol. &lt;/span&gt;</code></p><p><code>13139</code><code>1981;&lt;span class="ref-vol"&gt;</code></p><p><code>13140</code><code>21&lt;/span&gt;</code></p><p><code>13141</code><code>:377S–382S.&lt;/span&gt;</code></p><p><code>13142</code><code> [&lt;a href="/pubmed/6117575" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13143</code><code>PubMed&lt;/a&gt;</code></p><p><code>13144</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13145</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pharmacol&amp;amp;title=The+efficacy+and+safety+of+nabilone+(a+synthetic+cannabinoid)+in+the+treatment+of+anxiety&amp;amp;author=LF+Fabre&amp;amp;author=D+McLendon&amp;amp;volume=21&amp;amp;publication_year=1981&amp;amp;pages=377S-382S&amp;amp;pmid=6117575&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13146</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13147</code><code>]&lt;/span&gt;</code></p><p><code>13148</code><code>&lt;/span&gt;</code></p><p><code>13149</code><code>&lt;/li&gt;</code></p><p><code>13150</code><code>&lt;li id="R308"&gt;</code></p><p><code>13151</code><code>&lt;span class="citation"&gt;</code></p><p><code>13152</code><code>Fadel J, Deutch AY. Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. &lt;span&gt;</code></p><p><code>13153</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13154</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>13155</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>13156</code><code>111&lt;/span&gt;</code></p><p><code>13157</code><code>:379–387.&lt;/span&gt;</code></p><p><code>13158</code><code> [&lt;a href="/pubmed/11983323" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13159</code><code>PubMed&lt;/a&gt;</code></p><p><code>13160</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13161</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Anatomical+substrates+of+orexin-dopamine+interactions:+lateral+hypothalamic+projections+to+the+ventral+tegmental+area&amp;amp;author=J+Fadel&amp;amp;author=AY+Deutch&amp;amp;volume=111&amp;amp;publication_year=2002&amp;amp;pages=379-387&amp;amp;pmid=11983323&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13162</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13163</code><code>]&lt;/span&gt;</code></p><p><code>13164</code><code>&lt;/span&gt;</code></p><p><code>13165</code><code>&lt;/li&gt;</code></p><p><code>13166</code><code>&lt;li id="R309"&gt;</code></p><p><code>13167</code><code>&lt;span class="citation"&gt;</code></p><p><code>13168</code><code>Faden AI. Neuroprotection and traumatic brain injury: theoretical option or realistic proposition. &lt;span&gt;</code></p><p><code>13169</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13170</code><code>Curr Opin Neurol. &lt;/span&gt;</code></p><p><code>13171</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>13172</code><code>15&lt;/span&gt;</code></p><p><code>13173</code><code>:707–712.&lt;/span&gt;</code></p><p><code>13174</code><code> [&lt;a href="/pubmed/12447109" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13175</code><code>PubMed&lt;/a&gt;</code></p><p><code>13176</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13177</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Neurol&amp;amp;title=Neuroprotection+and+traumatic+brain+injury:+theoretical+option+or+realistic+proposition&amp;amp;author=AI+Faden&amp;amp;volume=15&amp;amp;publication_year=2002&amp;amp;pages=707-712&amp;amp;pmid=12447109&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13178</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13179</code><code>]&lt;/span&gt;</code></p><p><code>13180</code><code>&lt;/span&gt;</code></p><p><code>13181</code><code>&lt;/li&gt;</code></p><p><code>13182</code><code>&lt;li id="R310"&gt;</code></p><p><code>13183</code><code>&lt;span class="citation"&gt;</code></p><p><code>13184</code><code>Fan P. Cannabinoid agonists inhibit the activation of 5-HT&lt;sub&gt;</code></p><p><code>13185</code><code>3&lt;/sub&gt;</code></p><p><code>13186</code><code> receptors in rat nodose ganglion neurons. &lt;span&gt;</code></p><p><code>13187</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13188</code><code>J Neurophysiol. &lt;/span&gt;</code></p><p><code>13189</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>13190</code><code>73&lt;/span&gt;</code></p><p><code>13191</code><code>:907–910.&lt;/span&gt;</code></p><p><code>13192</code><code> [&lt;a href="/pubmed/7760148" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13193</code><code>PubMed&lt;/a&gt;</code></p><p><code>13194</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13195</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurophysiol&amp;amp;title=Cannabinoid+agonists+inhibit+the+activation+of+5-HT3+receptors+in+rat+nodose+ganglion+neurons&amp;amp;author=P+Fan&amp;amp;volume=73&amp;amp;publication_year=1995&amp;amp;pages=907-910&amp;amp;pmid=7760148&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13196</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13197</code><code>]&lt;/span&gt;</code></p><p><code>13198</code><code>&lt;/span&gt;</code></p><p><code>13199</code><code>&lt;/li&gt;</code></p><p><code>13200</code><code>&lt;li id="R311"&gt;</code></p><p><code>13201</code><code>&lt;span class="citation"&gt;</code></p><p><code>13202</code><code>Fan SF, Yazulla S. Biphasic modulation of voltage-dependent currents of retinal cones by cannabinoid CB&lt;sub&gt;</code></p><p><code>13203</code><code>1&lt;/sub&gt;</code></p><p><code>13204</code><code> receptor agonist WIN 55212-2. &lt;span&gt;</code></p><p><code>13205</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13206</code><code>Vis Neurosci. &lt;/span&gt;</code></p><p><code>13207</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>13208</code><code>20&lt;/span&gt;</code></p><p><code>13209</code><code>:177–188.&lt;/span&gt;</code></p><p><code>13210</code><code> [&lt;a href="/pubmed/12916739" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13211</code><code>PubMed&lt;/a&gt;</code></p><p><code>13212</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13213</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Vis+Neurosci&amp;amp;title=Biphasic+modulation+of+voltage-dependent+currents+of+retinal+cones+by+cannabinoid+CB1+receptor+agonist+WIN+55212-2&amp;amp;author=SF+Fan&amp;amp;author=S+Yazulla&amp;amp;volume=20&amp;amp;publication_year=2003&amp;amp;pages=177-188&amp;amp;pmid=12916739&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13214</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13215</code><code>]&lt;/span&gt;</code></p><p><code>13216</code><code>&lt;/span&gt;</code></p><p><code>13217</code><code>&lt;/li&gt;</code></p><p><code>13218</code><code>&lt;li id="R312"&gt;</code></p><p><code>13219</code><code>&lt;span class="citation"&gt;</code></p><p><code>13220</code><code>Fattore L, Deiana S, Spano SM, Cossu G, Fadda P, Scherma M, Fratta W. Endocannabinoid system and opioid addiction: behavioural aspects. &lt;span&gt;</code></p><p><code>13221</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13222</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>13223</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>13224</code><code>81&lt;/span&gt;</code></p><p><code>13225</code><code>:343–359.&lt;/span&gt;</code></p><p><code>13226</code><code> [&lt;a href="/pubmed/15935459" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13227</code><code>PubMed&lt;/a&gt;</code></p><p><code>13228</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13229</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Endocannabinoid+system+and+opioid+addiction:+behavioural+aspects&amp;amp;author=L+Fattore&amp;amp;author=S+Deiana&amp;amp;author=SM+Spano&amp;amp;author=G+Cossu&amp;amp;author=P+Fadda&amp;amp;volume=81&amp;amp;publication_year=2005&amp;amp;pages=343-359&amp;amp;pmid=15935459&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13230</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13231</code><code>]&lt;/span&gt;</code></p><p><code>13232</code><code>&lt;/span&gt;</code></p><p><code>13233</code><code>&lt;/li&gt;</code></p><p><code>13234</code><code>&lt;li id="R313"&gt;</code></p><p><code>13235</code><code>&lt;span class="citation"&gt;</code></p><p><code>13236</code><code>Fattore L, Martellotta MC, Cossu G, Mascia MS, Fratta W. CB&lt;sub&gt;</code></p><p><code>13237</code><code>1&lt;/sub&gt;</code></p><p><code>13238</code><code> cannabinoid receptor agonist WIN 55,212-2 decreases cocaine self-administration in rats. &lt;span&gt;</code></p><p><code>13239</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13240</code><code>Behav Brain Res. &lt;/span&gt;</code></p><p><code>13241</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>13242</code><code>104&lt;/span&gt;</code></p><p><code>13243</code><code>:141–146.&lt;/span&gt;</code></p><p><code>13244</code><code> [&lt;a href="/pubmed/11125733" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13245</code><code>PubMed&lt;/a&gt;</code></p><p><code>13246</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13247</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Behav+Brain+Res&amp;amp;title=CB1+cannabinoid+receptor+agonist+WIN+55,212-2+decreases+cocaine+self-administration+in+rats&amp;amp;author=L+Fattore&amp;amp;author=MC+Martellotta&amp;amp;author=G+Cossu&amp;amp;author=MS+Mascia&amp;amp;author=W+Fratta&amp;amp;volume=104&amp;amp;publication_year=1999&amp;amp;pages=141-146&amp;amp;pmid=11125733&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13248</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13249</code><code>]&lt;/span&gt;</code></p><p><code>13250</code><code>&lt;/span&gt;</code></p><p><code>13251</code><code>&lt;/li&gt;</code></p><p><code>13252</code><code>&lt;li id="R314"&gt;</code></p><p><code>13253</code><code>&lt;span class="citation"&gt;</code></p><p><code>13254</code><code>Fegley D, Kathuria S, Mercier R, Li C, Goutopoulos A, Makriyannis A, Piomelli D. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. &lt;span&gt;</code></p><p><code>13255</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13256</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>13257</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>13258</code><code>101&lt;/span&gt;</code></p><p><code>13259</code><code>:8756–8761.&lt;/span&gt;</code></p><p><code>13260</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>13261</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC423268/"&gt;</code></p><p><code>13262</code><code>PMC free article&lt;/a&gt;</code></p><p><code>13263</code><code>]&lt;/span&gt;</code></p><p><code>13264</code><code> [&lt;a href="/pubmed/15138300" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13265</code><code>PubMed&lt;/a&gt;</code></p><p><code>13266</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13267</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Anandamide+transport+is+independent+of+fatty-acid+amide+hydrolase+activity+and+is+blocked+by+the+hydrolysis-resistant+inhibitor+AM1172&amp;amp;author=D+Fegley&amp;amp;author=S+Kathuria&amp;amp;author=R+Mercier&amp;amp;author=C+Li&amp;amp;author=A+Goutopoulos&amp;amp;volume=101&amp;amp;publication_year=2004&amp;amp;pages=8756-8761&amp;amp;pmid=15138300&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13268</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13269</code><code>]&lt;/span&gt;</code></p><p><code>13270</code><code>&lt;/span&gt;</code></p><p><code>13271</code><code>&lt;/li&gt;</code></p><p><code>13272</code><code>&lt;li id="R315"&gt;</code></p><p><code>13273</code><code>&lt;span class="citation"&gt;</code></p><p><code>13274</code><code>Felder CC, Joyce KE, Briley EM, Glass M, Mackie KP, Fahey KJ, Cullinan GJ, Hunden DC, Johnson DW, Chaney MO, et al.  LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. &lt;span&gt;</code></p><p><code>13275</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13276</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>13277</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>13278</code><code>284&lt;/span&gt;</code></p><p><code>13279</code><code>:291–297.&lt;/span&gt;</code></p><p><code>13280</code><code> [&lt;a href="/pubmed/9435190" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13281</code><code>PubMed&lt;/a&gt;</code></p><p><code>13282</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13283</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=LY320135,+a+novel+cannabinoid+CB1+receptor+antagonist,+unmasks+coupling+of+the+CB1+receptor+to+stimulation+of+cAMP+accumulation&amp;amp;author=CC+Felder&amp;amp;author=KE+Joyce&amp;amp;author=EM+Briley&amp;amp;author=M+Glass&amp;amp;author=KP+Mackie&amp;amp;volume=284&amp;amp;publication_year=1998&amp;amp;pages=291-297&amp;amp;pmid=9435190&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13284</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13285</code><code>]&lt;/span&gt;</code></p><p><code>13286</code><code>&lt;/span&gt;</code></p><p><code>13287</code><code>&lt;/li&gt;</code></p><p><code>13288</code><code>&lt;li id="R316"&gt;</code></p><p><code>13289</code><code>&lt;span class="citation"&gt;</code></p><p><code>13290</code><code>Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma AL, Mitchell RL. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. &lt;span&gt;</code></p><p><code>13291</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13292</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>13293</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>13294</code><code>48&lt;/span&gt;</code></p><p><code>13295</code><code>:443–450.&lt;/span&gt;</code></p><p><code>13296</code><code> [&lt;a href="/pubmed/7565624" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13297</code><code>PubMed&lt;/a&gt;</code></p><p><code>13298</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13299</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=Comparison+of+the+pharmacology+and+signal+transduction+of+the+human+cannabinoid+CB1+and+CB2+receptors&amp;amp;author=CC+Felder&amp;amp;author=KE+Joyce&amp;amp;author=EM+Briley&amp;amp;author=J+Mansouri&amp;amp;author=K+Mackie&amp;amp;volume=48&amp;amp;publication_year=1995&amp;amp;pages=443-450&amp;amp;pmid=7565624&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13300</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13301</code><code>]&lt;/span&gt;</code></p><p><code>13302</code><code>&lt;/span&gt;</code></p><p><code>13303</code><code>&lt;/li&gt;</code></p><p><code>13304</code><code>&lt;li id="R317"&gt;</code></p><p><code>13305</code><code>&lt;span class="citation"&gt;</code></p><p><code>13306</code><code>Feinberg I, Jones R, Walker J, Cavness C, Floyd T. Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns. &lt;span&gt;</code></p><p><code>13307</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13308</code><code>Clin Pharmacol Ther. &lt;/span&gt;</code></p><p><code>13309</code><code>1976;&lt;span class="ref-vol"&gt;</code></p><p><code>13310</code><code>19&lt;/span&gt;</code></p><p><code>13311</code><code>:782–794.&lt;/span&gt;</code></p><p><code>13312</code><code> [&lt;a href="/pubmed/178475" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13313</code><code>PubMed&lt;/a&gt;</code></p><p><code>13314</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13315</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;amp;title=Effects+of+marijuana+extract+and+tetrahydrocannabinol+on+electroencephalographic+sleep+patterns&amp;amp;author=I+Feinberg&amp;amp;author=R+Jones&amp;amp;author=J+Walker&amp;amp;author=C+Cavness&amp;amp;author=T+Floyd&amp;amp;volume=19&amp;amp;publication_year=1976&amp;amp;pages=782-794&amp;amp;pmid=178475&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13316</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13317</code><code>]&lt;/span&gt;</code></p><p><code>13318</code><code>&lt;/span&gt;</code></p><p><code>13319</code><code>&lt;/li&gt;</code></p><p><code>13320</code><code>&lt;li id="R318"&gt;</code></p><p><code>13321</code><code>&lt;span class="citation"&gt;</code></p><p><code>13322</code><code>Feinberg I, Jones R, Walker JM, Cavness C, March J. Effects of high dosage &amp;#x00394;-9-tetrahydrocannabinol on sleep patterns in man. &lt;span&gt;</code></p><p><code>13323</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13324</code><code>Clin Pharmacol Ther. &lt;/span&gt;</code></p><p><code>13325</code><code>1975;&lt;span class="ref-vol"&gt;</code></p><p><code>13326</code><code>17&lt;/span&gt;</code></p><p><code>13327</code><code>:458–466.&lt;/span&gt;</code></p><p><code>13328</code><code> [&lt;a href="/pubmed/164314" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13329</code><code>PubMed&lt;/a&gt;</code></p><p><code>13330</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13331</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;amp;title=Effects+of+high+dosage+&amp;#x00394;-9-tetrahydrocannabinol+on+sleep+patterns+in+man&amp;amp;author=I+Feinberg&amp;amp;author=R+Jones&amp;amp;author=JM+Walker&amp;amp;author=C+Cavness&amp;amp;author=J+March&amp;amp;volume=17&amp;amp;publication_year=1975&amp;amp;pages=458-466&amp;amp;pmid=164314&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13332</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13333</code><code>]&lt;/span&gt;</code></p><p><code>13334</code><code>&lt;/span&gt;</code></p><p><code>13335</code><code>&lt;/li&gt;</code></p><p><code>13336</code><code>&lt;li id="R319"&gt;</code></p><p><code>13337</code><code>&lt;span class="citation"&gt;</code></p><p><code>13338</code><code>Fernandez JR, Allison DB. Rimonabant Sanofi-Synthelabo. &lt;span&gt;</code></p><p><code>13339</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13340</code><code>Curr Opin Investig Drugs. &lt;/span&gt;</code></p><p><code>13341</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>13342</code><code>5&lt;/span&gt;</code></p><p><code>13343</code><code>:430–435.&lt;/span&gt;</code></p><p><code>13344</code><code> [&lt;a href="/pubmed/15134285" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13345</code><code>PubMed&lt;/a&gt;</code></p><p><code>13346</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13347</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Investig+Drugs&amp;amp;title=Rimonabant+Sanofi-Synthelabo&amp;amp;author=JR+Fernandez&amp;amp;author=DB+Allison&amp;amp;volume=5&amp;amp;publication_year=2004&amp;amp;pages=430-435&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13348</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13349</code><code>]&lt;/span&gt;</code></p><p><code>13350</code><code>&lt;/span&gt;</code></p><p><code>13351</code><code>&lt;/li&gt;</code></p><p><code>13352</code><code>&lt;li id="R320"&gt;</code></p><p><code>13353</code><code>&lt;span class="citation"&gt;</code></p><p><code>13354</code><code>Fernandez-Espejo E, Caraballo I, de Fonseca FR, El Banoua F, Ferrer B, Flores JA, Galan-Rodriguez B. Cannabinoid CB&lt;sub&gt;</code></p><p><code>13355</code><code>1&lt;/sub&gt;</code></p><p><code>13356</code><code> antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism. &lt;span&gt;</code></p><p><code>13357</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13358</code><code>Neurobiol Dis. &lt;/span&gt;</code></p><p><code>13359</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>13360</code><code>18&lt;/span&gt;</code></p><p><code>13361</code><code>:591–601.&lt;/span&gt;</code></p><p><code>13362</code><code> [&lt;a href="/pubmed/15755685" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13363</code><code>PubMed&lt;/a&gt;</code></p><p><code>13364</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13365</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurobiol+Dis&amp;amp;title=Cannabinoid+CB1+antagonists+possess+antiparkinsonian+efficacy+only+in+rats+with+very+severe+nigral+lesion+in+experimental+parkinsonism&amp;amp;author=E+Fernandez-Espejo&amp;amp;author=I+Caraballo&amp;amp;author=FR+de+Fonseca&amp;amp;author=F+El+Banoua&amp;amp;author=B+Ferrer&amp;amp;volume=18&amp;amp;publication_year=2005&amp;amp;pages=591-601&amp;amp;pmid=15755685&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13366</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13367</code><code>]&lt;/span&gt;</code></p><p><code>13368</code><code>&lt;/span&gt;</code></p><p><code>13369</code><code>&lt;/li&gt;</code></p><p><code>13370</code><code>&lt;li id="R321"&gt;</code></p><p><code>13371</code><code>&lt;span class="citation"&gt;</code></p><p><code>13372</code><code>Fernandez-Rodriguez CM, Romero J, Petros TJ, Bradshaw H, Gasalla JM, Gutierrez ML, Lledo JL, Santander C, Fernandez TP, Tomas E, et al.  Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis. &lt;span&gt;</code></p><p><code>13373</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13374</code><code>Liver Int. &lt;/span&gt;</code></p><p><code>13375</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>13376</code><code>24&lt;/span&gt;</code></p><p><code>13377</code><code>:477–483.&lt;/span&gt;</code></p><p><code>13378</code><code> [&lt;a href="/pubmed/15482346" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13379</code><code>PubMed&lt;/a&gt;</code></p><p><code>13380</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13381</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Liver+Int&amp;amp;title=Circulating+endogenous+cannabinoid+anandamide+and+portal,+systemic+and+renal+hemodynamics+in+cirrhosis&amp;amp;author=CM+Fernandez-Rodriguez&amp;amp;author=J+Romero&amp;amp;author=TJ+Petros&amp;amp;author=H+Bradshaw&amp;amp;author=JM+Gasalla&amp;amp;volume=24&amp;amp;publication_year=2004&amp;amp;pages=477-483&amp;amp;pmid=15482346&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13382</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13383</code><code>]&lt;/span&gt;</code></p><p><code>13384</code><code>&lt;/span&gt;</code></p><p><code>13385</code><code>&lt;/li&gt;</code></p><p><code>13386</code><code>&lt;li id="R322"&gt;</code></p><p><code>13387</code><code>&lt;span class="citation"&gt;</code></p><p><code>13388</code><code>Fernandez-Ruiz J, Gonzalez S.  Cannabinoid control of motor function at the basal ganglia. In: Pertwee R, editor. &lt;span class="ref-journal"&gt;</code></p><p><code>13389</code><code>Cannabinoids.&lt;/span&gt;</code></p><p><code>13390</code><code> Springer; New York: 2005. pp. 479–509. &lt;span class="nowrap"&gt;</code></p><p><code>13391</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?title=Cannabinoids&amp;amp;author=J+Fernandez-Ruiz&amp;amp;author=S+Gonzalez&amp;amp;publication_year=2005&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13392</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13393</code><code>]&lt;/span&gt;</code></p><p><code>13394</code><code>&lt;/span&gt;</code></p><p><code>13395</code><code>&lt;/li&gt;</code></p><p><code>13396</code><code>&lt;li id="R323"&gt;</code></p><p><code>13397</code><code>&lt;span class="citation"&gt;</code></p><p><code>13398</code><code>Ferrer B, Asbrock N, Kathuria S, Piomelli D, Giuffrida A. Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias. &lt;span&gt;</code></p><p><code>13399</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13400</code><code>Eur J Neurosci. &lt;/span&gt;</code></p><p><code>13401</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>13402</code><code>18&lt;/span&gt;</code></p><p><code>13403</code><code>:1607–1614.&lt;/span&gt;</code></p><p><code>13404</code><code> [&lt;a href="/pubmed/14511339" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13405</code><code>PubMed&lt;/a&gt;</code></p><p><code>13406</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13407</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurosci&amp;amp;title=Effects+of+levodopa+on+endocannabinoid+levels+in+rat+basal+ganglia:+implications+for+the+treatment+of+levodopa-induced+dyskinesias&amp;amp;author=B+Ferrer&amp;amp;author=N+Asbrock&amp;amp;author=S+Kathuria&amp;amp;author=D+Piomelli&amp;amp;author=A+Giuffrida&amp;amp;volume=18&amp;amp;publication_year=2003&amp;amp;pages=1607-1614&amp;amp;pmid=14511339&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13408</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13409</code><code>]&lt;/span&gt;</code></p><p><code>13410</code><code>&lt;/span&gt;</code></p><p><code>13411</code><code>&lt;/li&gt;</code></p><p><code>13412</code><code>&lt;li id="R324"&gt;</code></p><p><code>13413</code><code>&lt;span class="citation"&gt;</code></p><p><code>13414</code><code>Fischer-Stenger K, Dove Pettit DA, Cabral GA, Fischer-Stenger K, Dove Pettit DA, Cabral GA. &amp;#x00394;9-Tetrahydrocannabinol inhibition of tumor necrosis factor-&lt;em&gt;</code></p><p><code>13415</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>13416</code><code>: suppression of post-translational events. &lt;span&gt;</code></p><p><code>13417</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13418</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>13419</code><code>1993;&lt;span class="ref-vol"&gt;</code></p><p><code>13420</code><code>267&lt;/span&gt;</code></p><p><code>13421</code><code>:1558–1565.&lt;/span&gt;</code></p><p><code>13422</code><code> [&lt;a href="/pubmed/8263818" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13423</code><code>PubMed&lt;/a&gt;</code></p><p><code>13424</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13425</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=&amp;#x00394;9-Tetrahydrocannabinol+inhibition+of+tumor+necrosis+factor-&amp;#x003b1;:+suppression+of+post-translational+events&amp;amp;author=K+Fischer-Stenger&amp;amp;author=DA+Dove+Pettit&amp;amp;author=GA+Cabral&amp;amp;author=K+Fischer-Stenger&amp;amp;author=DA+Dove+Pettit&amp;amp;volume=267&amp;amp;publication_year=1993&amp;amp;pages=1558-1565&amp;amp;pmid=8263818&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13426</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13427</code><code>]&lt;/span&gt;</code></p><p><code>13428</code><code>&lt;/span&gt;</code></p><p><code>13429</code><code>&lt;/li&gt;</code></p><p><code>13430</code><code>&lt;li id="R325"&gt;</code></p><p><code>13431</code><code>&lt;span class="citation"&gt;</code></p><p><code>13432</code><code>Fish BS, Consroe P. The ontogeny of &amp;#x00394;-9-tetrahydrocannabinol responsiveness in the rabbit. &lt;span&gt;</code></p><p><code>13433</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13434</code><code>Dev Psychobiol. &lt;/span&gt;</code></p><p><code>13435</code><code>1983;&lt;span class="ref-vol"&gt;</code></p><p><code>13436</code><code>16&lt;/span&gt;</code></p><p><code>13437</code><code>:147–158.&lt;/span&gt;</code></p><p><code>13438</code><code> [&lt;a href="/pubmed/6299864" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13439</code><code>PubMed&lt;/a&gt;</code></p><p><code>13440</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13441</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Dev+Psychobiol&amp;amp;title=The+ontogeny+of+&amp;#x00394;-9-tetrahydrocannabinol+responsiveness+in+the+rabbit&amp;amp;author=BS+Fish&amp;amp;author=P+Consroe&amp;amp;volume=16&amp;amp;publication_year=1983&amp;amp;pages=147-158&amp;amp;pmid=6299864&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13442</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13443</code><code>]&lt;/span&gt;</code></p><p><code>13444</code><code>&lt;/span&gt;</code></p><p><code>13445</code><code>&lt;/li&gt;</code></p><p><code>13446</code><code>&lt;li id="R326"&gt;</code></p><p><code>13447</code><code>&lt;span class="citation"&gt;</code></p><p><code>13448</code><code>Fish BS, Consroe P, Fox RR. Inheritance of &amp;#x00394;&lt;sup&gt;</code></p><p><code>13449</code><code>9&lt;/sup&gt;</code></p><p><code>13450</code><code>-tetrahydrocannabinol seizure susceptibility in rabbits. &lt;span&gt;</code></p><p><code>13451</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13452</code><code>J Hered. &lt;/span&gt;</code></p><p><code>13453</code><code>1981;&lt;span class="ref-vol"&gt;</code></p><p><code>13454</code><code>72&lt;/span&gt;</code></p><p><code>13455</code><code>:215–216.&lt;/span&gt;</code></p><p><code>13456</code><code> [&lt;a href="/pubmed/6268703" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13457</code><code>PubMed&lt;/a&gt;</code></p><p><code>13458</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13459</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Hered&amp;amp;title=Inheritance+of+&amp;#x00394;9-tetrahydrocannabinol+seizure+susceptibility+in+rabbits&amp;amp;author=BS+Fish&amp;amp;author=P+Consroe&amp;amp;author=RR+Fox&amp;amp;volume=72&amp;amp;publication_year=1981&amp;amp;pages=215-216&amp;amp;pmid=6268703&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13460</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13461</code><code>]&lt;/span&gt;</code></p><p><code>13462</code><code>&lt;/span&gt;</code></p><p><code>13463</code><code>&lt;/li&gt;</code></p><p><code>13464</code><code>&lt;li id="R327"&gt;</code></p><p><code>13465</code><code>&lt;span class="citation"&gt;</code></p><p><code>13466</code><code>Foltin RW, Fishman MW, Pippen PA, Kelly TH. Behavioral effects of cocaine alone and in combination of ethanol and marijuana in humans. &lt;span&gt;</code></p><p><code>13467</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13468</code><code>Drug Alcohol Depend. &lt;/span&gt;</code></p><p><code>13469</code><code>1993;&lt;span class="ref-vol"&gt;</code></p><p><code>13470</code><code>32&lt;/span&gt;</code></p><p><code>13471</code><code>:93–106.&lt;/span&gt;</code></p><p><code>13472</code><code> [&lt;a href="/pubmed/8508730" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13473</code><code>PubMed&lt;/a&gt;</code></p><p><code>13474</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13475</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Drug+Alcohol+Depend&amp;amp;title=Behavioral+effects+of+cocaine+alone+and+in+combination+of+ethanol+and+marijuana+in+humans&amp;amp;author=RW+Foltin&amp;amp;author=MW+Fishman&amp;amp;author=PA+Pippen&amp;amp;author=TH+Kelly&amp;amp;volume=32&amp;amp;publication_year=1993&amp;amp;pages=93-106&amp;amp;pmid=8508730&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13476</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13477</code><code>]&lt;/span&gt;</code></p><p><code>13478</code><code>&lt;/span&gt;</code></p><p><code>13479</code><code>&lt;/li&gt;</code></p><p><code>13480</code><code>&lt;li id="R328"&gt;</code></p><p><code>13481</code><code>&lt;span class="citation"&gt;</code></p><p><code>13482</code><code>Ford WR, Honan SA, White R, Hiley CR. Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilator responses in rat isolated hearts. &lt;span&gt;</code></p><p><code>13483</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13484</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>13485</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>13486</code><code>135&lt;/span&gt;</code></p><p><code>13487</code><code>:1191–1198.&lt;/span&gt;</code></p><p><code>13488</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>13489</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1573229/"&gt;</code></p><p><code>13490</code><code>PMC free article&lt;/a&gt;</code></p><p><code>13491</code><code>]&lt;/span&gt;</code></p><p><code>13492</code><code> [&lt;a href="/pubmed/11877326" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13493</code><code>PubMed&lt;/a&gt;</code></p><p><code>13494</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13495</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Evidence+of+a+novel+site+mediating+anandamide-induced+negative+inotropic+and+coronary+vasodilator+responses+in+rat+isolated+hearts&amp;amp;author=WR+Ford&amp;amp;author=SA+Honan&amp;amp;author=R+White&amp;amp;author=CR+Hiley&amp;amp;volume=135&amp;amp;publication_year=2002&amp;amp;pages=1191-1198&amp;amp;pmid=11877326&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13496</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13497</code><code>]&lt;/span&gt;</code></p><p><code>13498</code><code>&lt;/span&gt;</code></p><p><code>13499</code><code>&lt;/li&gt;</code></p><p><code>13500</code><code>&lt;li id="R329"&gt;</code></p><p><code>13501</code><code>&lt;span class="citation"&gt;</code></p><p><code>13502</code><code>Forget B, Hamon M, Thiebot MH. Cannabinoid CB&lt;sub&gt;</code></p><p><code>13503</code><code>1&lt;/sub&gt;</code></p><p><code>13504</code><code> receptors are involved in motivational effects of nicotine in rats. &lt;span&gt;</code></p><p><code>13505</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13506</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>13507</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>13508</code><code>181&lt;/span&gt;</code></p><p><code>13509</code><code>:722–734.&lt;/span&gt;</code></p><p><code>13510</code><code> [&lt;a href="/pubmed/15986197" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13511</code><code>PubMed&lt;/a&gt;</code></p><p><code>13512</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13513</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Cannabinoid+CB1+receptors+are+involved+in+motivational+effects+of+nicotine+in+rats&amp;amp;author=B+Forget&amp;amp;author=M+Hamon&amp;amp;author=MH+Thiebot&amp;amp;volume=181&amp;amp;publication_year=2005&amp;amp;pages=722-734&amp;amp;pmid=15986197&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13514</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13515</code><code>]&lt;/span&gt;</code></p><p><code>13516</code><code>&lt;/span&gt;</code></p><p><code>13517</code><code>&lt;/li&gt;</code></p><p><code>13518</code><code>&lt;li id="R330"&gt;</code></p><p><code>13519</code><code>&lt;span class="citation"&gt;</code></p><p><code>13520</code><code>Formukong EA, Evans AT, Evans FJ. Analgesic and antiinflammatory activity of constituents of &lt;em&gt;</code></p><p><code>13521</code><code>Cannabis sativa&lt;/em&gt;</code></p><p><code>13522</code><code> L. &lt;span&gt;</code></p><p><code>13523</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13524</code><code>Inflammation. &lt;/span&gt;</code></p><p><code>13525</code><code>1988;&lt;span class="ref-vol"&gt;</code></p><p><code>13526</code><code>12&lt;/span&gt;</code></p><p><code>13527</code><code>:361–371.&lt;/span&gt;</code></p><p><code>13528</code><code> [&lt;a href="/pubmed/3169967" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13529</code><code>PubMed&lt;/a&gt;</code></p><p><code>13530</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13531</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Inflammation&amp;amp;title=Analgesic+and+antiinflammatory+activity+of+constituents+of+Cannabis+sativa+L&amp;amp;author=EA+Formukong&amp;amp;author=AT+Evans&amp;amp;author=FJ+Evans&amp;amp;volume=12&amp;amp;publication_year=1988&amp;amp;pages=361-371&amp;amp;pmid=3169967&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13532</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13533</code><code>]&lt;/span&gt;</code></p><p><code>13534</code><code>&lt;/span&gt;</code></p><p><code>13535</code><code>&lt;/li&gt;</code></p><p><code>13536</code><code>&lt;li id="R331"&gt;</code></p><p><code>13537</code><code>&lt;span class="citation"&gt;</code></p><p><code>13538</code><code>Fowler CJ. Oleamide: a member of the endocannabinoid family? &lt;span&gt;</code></p><p><code>13539</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13540</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>13541</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>13542</code><code>141&lt;/span&gt;</code></p><p><code>13543</code><code>:195–196.&lt;/span&gt;</code></p><p><code>13544</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>13545</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1574195/"&gt;</code></p><p><code>13546</code><code>PMC free article&lt;/a&gt;</code></p><p><code>13547</code><code>]&lt;/span&gt;</code></p><p><code>13548</code><code> [&lt;a href="/pubmed/14691053" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13549</code><code>PubMed&lt;/a&gt;</code></p><p><code>13550</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13551</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Oleamide:+a+member+of+the+endocannabinoid+family?&amp;amp;author=CJ+Fowler&amp;amp;volume=141&amp;amp;publication_year=2004&amp;amp;pages=195-196&amp;amp;pmid=14691053&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13552</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13553</code><code>]&lt;/span&gt;</code></p><p><code>13554</code><code>&lt;/span&gt;</code></p><p><code>13555</code><code>&lt;/li&gt;</code></p><p><code>13556</code><code>&lt;li id="R332"&gt;</code></p><p><code>13557</code><code>&lt;span class="citation"&gt;</code></p><p><code>13558</code><code>Fowler CJ, Jonsson KO, Andersson A, Juntunen J, Jarvinen T, Vandevoorde S, Lambert DM, Jerman JC, Smart D. Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid. &lt;span&gt;</code></p><p><code>13559</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13560</code><code>Biochem Pharmacol. &lt;/span&gt;</code></p><p><code>13561</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>13562</code><code>66&lt;/span&gt;</code></p><p><code>13563</code><code>:757–767.&lt;/span&gt;</code></p><p><code>13564</code><code> [&lt;a href="/pubmed/12948856" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13565</code><code>PubMed&lt;/a&gt;</code></p><p><code>13566</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13567</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;amp;title=Inhibition+of+C6+glioma+cell+proliferation+by+anandamide,+1-arachidonoylglycerol,+and+by+a+water+soluble+phosphate+ester+of+anandamide:+variability+in+response+and+involvement+of+arachidonic+acid&amp;amp;author=CJ+Fowler&amp;amp;author=KO+Jonsson&amp;amp;author=A+Andersson&amp;amp;author=J+Juntunen&amp;amp;author=T+Jarvinen&amp;amp;volume=66&amp;amp;publication_year=2003&amp;amp;pages=757-767&amp;amp;pmid=12948856&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13568</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13569</code><code>]&lt;/span&gt;</code></p><p><code>13570</code><code>&lt;/span&gt;</code></p><p><code>13571</code><code>&lt;/li&gt;</code></p><p><code>13572</code><code>&lt;li id="R333"&gt;</code></p><p><code>13573</code><code>&lt;span class="citation"&gt;</code></p><p><code>13574</code><code>Fowler CJ, Tiger G, Ligresti A, Lopez-Rodriguez ML, Di Marzo V. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis&amp;#x02014;a difficult issue to handle. &lt;span&gt;</code></p><p><code>13575</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13576</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>13577</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>13578</code><code>492&lt;/span&gt;</code></p><p><code>13579</code><code>:1–11.&lt;/span&gt;</code></p><p><code>13580</code><code> [&lt;a href="/pubmed/15145699" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13581</code><code>PubMed&lt;/a&gt;</code></p><p><code>13582</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13583</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Selective+inhibition+of+anandamide+cellular+uptake+versus+enzymatic+hydrolysis&amp;#x02014;a+difficult+issue+to+handle&amp;amp;author=CJ+Fowler&amp;amp;author=G+Tiger&amp;amp;author=A+Ligresti&amp;amp;author=ML+Lopez-Rodriguez&amp;amp;author=V+Di+Marzo&amp;amp;volume=492&amp;amp;publication_year=2004&amp;amp;pages=1-11&amp;amp;pmid=15145699&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13584</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13585</code><code>]&lt;/span&gt;</code></p><p><code>13586</code><code>&lt;/span&gt;</code></p><p><code>13587</code><code>&lt;/li&gt;</code></p><p><code>13588</code><code>&lt;li id="R334"&gt;</code></p><p><code>13589</code><code>&lt;span class="citation"&gt;</code></p><p><code>13590</code><code>Fox A, Bevan S. Therapeutic potential of cannabinoid receptor agonists as analgesic agents. &lt;span&gt;</code></p><p><code>13591</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13592</code><code>Expert Opin Investig Drugs. &lt;/span&gt;</code></p><p><code>13593</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>13594</code><code>14&lt;/span&gt;</code></p><p><code>13595</code><code>:695–703.&lt;/span&gt;</code></p><p><code>13596</code><code> [&lt;a href="/pubmed/16004597" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13597</code><code>PubMed&lt;/a&gt;</code></p><p><code>13598</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13599</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Expert+Opin+Investig+Drugs&amp;amp;title=Therapeutic+potential+of+cannabinoid+receptor+agonists+as+analgesic+agents&amp;amp;author=A+Fox&amp;amp;author=S+Bevan&amp;amp;volume=14&amp;amp;publication_year=2005&amp;amp;pages=695-703&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13600</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13601</code><code>]&lt;/span&gt;</code></p><p><code>13602</code><code>&lt;/span&gt;</code></p><p><code>13603</code><code>&lt;/li&gt;</code></p><p><code>13604</code><code>&lt;li id="R335"&gt;</code></p><p><code>13605</code><code>&lt;span class="citation"&gt;</code></p><p><code>13606</code><code>Fox A, Kesingland A, Gentry C, McNair K, Patel S, Urban L, James I. The role of central and peripheral cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. &lt;span&gt;</code></p><p><code>13607</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13608</code><code>Pain. &lt;/span&gt;</code></p><p><code>13609</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>13610</code><code>92&lt;/span&gt;</code></p><p><code>13611</code><code>:91–100.&lt;/span&gt;</code></p><p><code>13612</code><code> [&lt;a href="/pubmed/11323130" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13613</code><code>PubMed&lt;/a&gt;</code></p><p><code>13614</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13615</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;amp;title=The+role+of+central+and+peripheral+cannabinoid1+receptors+in+the+antihyperalgesic+activity+of+cannabinoids+in+a+model+of+neuropathic+pain&amp;amp;author=A+Fox&amp;amp;author=A+Kesingland&amp;amp;author=C+Gentry&amp;amp;author=K+McNair&amp;amp;author=S+Patel&amp;amp;volume=92&amp;amp;publication_year=2001&amp;amp;pages=91-100&amp;amp;pmid=11323130&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13616</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13617</code><code>]&lt;/span&gt;</code></p><p><code>13618</code><code>&lt;/span&gt;</code></p><p><code>13619</code><code>&lt;/li&gt;</code></p><p><code>13620</code><code>&lt;li id="R336"&gt;</code></p><p><code>13621</code><code>&lt;span class="citation"&gt;</code></p><p><code>13622</code><code>Fox P, Bain PG, Glickman S, Carroll C, Zajicek J. The effect of cannabis on tremor in patients with multiple sclerosis. &lt;span&gt;</code></p><p><code>13623</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13624</code><code>Neurology. &lt;/span&gt;</code></p><p><code>13625</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>13626</code><code>62&lt;/span&gt;</code></p><p><code>13627</code><code>:1105–1109.&lt;/span&gt;</code></p><p><code>13628</code><code> [&lt;a href="/pubmed/15079008" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13629</code><code>PubMed&lt;/a&gt;</code></p><p><code>13630</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13631</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;amp;title=The+effect+of+cannabis+on+tremor+in+patients+with+multiple+sclerosis&amp;amp;author=P+Fox&amp;amp;author=PG+Bain&amp;amp;author=S+Glickman&amp;amp;author=C+Carroll&amp;amp;author=J+Zajicek&amp;amp;volume=62&amp;amp;publication_year=2004&amp;amp;pages=1105-1109&amp;amp;pmid=15079008&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13632</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13633</code><code>]&lt;/span&gt;</code></p><p><code>13634</code><code>&lt;/span&gt;</code></p><p><code>13635</code><code>&lt;/li&gt;</code></p><p><code>13636</code><code>&lt;li id="R337"&gt;</code></p><p><code>13637</code><code>&lt;span class="citation"&gt;</code></p><p><code>13638</code><code>Fox SH, Henry B, Hill M, Crossman A, Brotchie J. Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>13639</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13640</code><code>Mov Disord. &lt;/span&gt;</code></p><p><code>13641</code><code>2002a;&lt;span class="ref-vol"&gt;</code></p><p><code>13642</code><code>17&lt;/span&gt;</code></p><p><code>13643</code><code>:1180–1187.&lt;/span&gt;</code></p><p><code>13644</code><code> [&lt;a href="/pubmed/12465055" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13645</code><code>PubMed&lt;/a&gt;</code></p><p><code>13646</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13647</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mov+Disord&amp;amp;title=Stimulation+of+cannabinoid+receptors+reduces+levodopa-induced+dyskinesia+in+the+MPTP-lesioned+nonhuman+primate+model+of+Parkinson&amp;#x02019;s+disease&amp;amp;author=SH+Fox&amp;amp;author=B+Henry&amp;amp;author=M+Hill&amp;amp;author=A+Crossman&amp;amp;author=J+Brotchie&amp;amp;volume=17&amp;amp;publication_year=2002a&amp;amp;pages=1180-1187&amp;amp;pmid=12465055&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13648</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13649</code><code>]&lt;/span&gt;</code></p><p><code>13650</code><code>&lt;/span&gt;</code></p><p><code>13651</code><code>&lt;/li&gt;</code></p><p><code>13652</code><code>&lt;li id="R338"&gt;</code></p><p><code>13653</code><code>&lt;span class="citation"&gt;</code></p><p><code>13654</code><code>Fox SH, Kellett M, Moore AP, Crossman AR, Brotchie JM. Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia. &lt;span&gt;</code></p><p><code>13655</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13656</code><code>Mov Disord. &lt;/span&gt;</code></p><p><code>13657</code><code>2002b;&lt;span class="ref-vol"&gt;</code></p><p><code>13658</code><code>17&lt;/span&gt;</code></p><p><code>13659</code><code>:145–149.&lt;/span&gt;</code></p><p><code>13660</code><code> [&lt;a href="/pubmed/11835452" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13661</code><code>PubMed&lt;/a&gt;</code></p><p><code>13662</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13663</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mov+Disord&amp;amp;title=Randomised,+double-blind,+placebo-controlled+trial+to+assess+the+potential+of+cannabinoid+receptor+stimulation+in+the+treatment+of+dystonia&amp;amp;author=SH+Fox&amp;amp;author=M+Kellett&amp;amp;author=AP+Moore&amp;amp;author=AR+Crossman&amp;amp;author=JM+Brotchie&amp;amp;volume=17&amp;amp;publication_year=2002b&amp;amp;pages=145-149&amp;amp;pmid=11835452&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13664</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13665</code><code>]&lt;/span&gt;</code></p><p><code>13666</code><code>&lt;/span&gt;</code></p><p><code>13667</code><code>&lt;/li&gt;</code></p><p><code>13668</code><code>&lt;li id="R339"&gt;</code></p><p><code>13669</code><code>&lt;span class="citation"&gt;</code></p><p><code>13670</code><code>Freedland CS, Poston JS, Porrino LJ. Effects of Sr141716A, a central cannabinoid receptor antagonist, on food-maintained responding. &lt;span&gt;</code></p><p><code>13671</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13672</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>13673</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>13674</code><code>67&lt;/span&gt;</code></p><p><code>13675</code><code>:265–270.&lt;/span&gt;</code></p><p><code>13676</code><code> [&lt;a href="/pubmed/11124390" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13677</code><code>PubMed&lt;/a&gt;</code></p><p><code>13678</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13679</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Effects+of+Sr141716A,+a+central+cannabinoid+receptor+antagonist,+on+food-maintained+responding&amp;amp;author=CS+Freedland&amp;amp;author=JS+Poston&amp;amp;author=LJ+Porrino&amp;amp;volume=67&amp;amp;publication_year=2000&amp;amp;pages=265-270&amp;amp;pmid=11124390&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13680</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13681</code><code>]&lt;/span&gt;</code></p><p><code>13682</code><code>&lt;/span&gt;</code></p><p><code>13683</code><code>&lt;/li&gt;</code></p><p><code>13684</code><code>&lt;li id="R340"&gt;</code></p><p><code>13685</code><code>&lt;span class="citation"&gt;</code></p><p><code>13686</code><code>Freedland CS, Sharpe AL, Samson HH, Porrino LJ. Effects of SR141716A on ethanol and sucrose self-administration. &lt;span&gt;</code></p><p><code>13687</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13688</code><code>Alcohol Clin Exp Res. &lt;/span&gt;</code></p><p><code>13689</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>13690</code><code>25&lt;/span&gt;</code></p><p><code>13691</code><code>:277–282.&lt;/span&gt;</code></p><p><code>13692</code><code> [&lt;a href="/pubmed/11236843" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13693</code><code>PubMed&lt;/a&gt;</code></p><p><code>13694</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13695</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Alcohol+Clin+Exp+Res&amp;amp;title=Effects+of+SR141716A+on+ethanol+and+sucrose+self-administration&amp;amp;author=CS+Freedland&amp;amp;author=AL+Sharpe&amp;amp;author=HH+Samson&amp;amp;author=LJ+Porrino&amp;amp;volume=25&amp;amp;publication_year=2001&amp;amp;pages=277-282&amp;amp;pmid=11236843&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13696</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13697</code><code>]&lt;/span&gt;</code></p><p><code>13698</code><code>&lt;/span&gt;</code></p><p><code>13699</code><code>&lt;/li&gt;</code></p><p><code>13700</code><code>&lt;li id="R341"&gt;</code></p><p><code>13701</code><code>&lt;span class="citation"&gt;</code></p><p><code>13702</code><code>Freedland CS, Whitlow CT, Smith HR, Porrino LJ. Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[&lt;sup&gt;</code></p><p><code>13703</code><code>14&lt;/sup&gt;</code></p><p><code>13704</code><code>C]deoxyglucose study. &lt;span&gt;</code></p><p><code>13705</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13706</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>13707</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>13708</code><code>962&lt;/span&gt;</code></p><p><code>13709</code><code>:169–179.&lt;/span&gt;</code></p><p><code>13710</code><code> [&lt;a href="/pubmed/12543468" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13711</code><code>PubMed&lt;/a&gt;</code></p><p><code>13712</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13713</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Functional+consequences+of+the+acute+administration+of+the+cannabinoid+receptor+antagonist,+SR141716A,+in+cannabinoid-naive+and+-tolerant+animals:+a+quantitative+2-[14C]deoxyglucose+study&amp;amp;author=CS+Freedland&amp;amp;author=CT+Whitlow&amp;amp;author=HR+Smith&amp;amp;author=LJ+Porrino&amp;amp;volume=962&amp;amp;publication_year=2003&amp;amp;pages=169-179&amp;amp;pmid=12543468&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13714</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13715</code><code>]&lt;/span&gt;</code></p><p><code>13716</code><code>&lt;/span&gt;</code></p><p><code>13717</code><code>&lt;/li&gt;</code></p><p><code>13718</code><code>&lt;li id="R342"&gt;</code></p><p><code>13719</code><code>&lt;span class="citation"&gt;</code></p><p><code>13720</code><code>Freemon FR. Effects of marihuana on sleeping states. &lt;span&gt;</code></p><p><code>13721</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13722</code><code>J Am Med Assoc. &lt;/span&gt;</code></p><p><code>13723</code><code>1972;&lt;span class="ref-vol"&gt;</code></p><p><code>13724</code><code>220&lt;/span&gt;</code></p><p><code>13725</code><code>:1364–1365.&lt;/span&gt;</code></p><p><code>13726</code><code> [&lt;a href="/pubmed/4336774" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13727</code><code>PubMed&lt;/a&gt;</code></p><p><code>13728</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13729</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Med+Assoc&amp;amp;title=Effects+of+marihuana+on+sleeping+states&amp;amp;author=FR+Freemon&amp;amp;volume=220&amp;amp;publication_year=1972&amp;amp;pages=1364-1365&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13730</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13731</code><code>]&lt;/span&gt;</code></p><p><code>13732</code><code>&lt;/span&gt;</code></p><p><code>13733</code><code>&lt;/li&gt;</code></p><p><code>13734</code><code>&lt;li id="R343"&gt;</code></p><p><code>13735</code><code>&lt;span class="citation"&gt;</code></p><p><code>13736</code><code>Freemon FR. The effect of chronically administered &amp;#x00394;-9-tetrahydrocannabinol upon the polygraphically monitored sleep of normal volunteers. &lt;span&gt;</code></p><p><code>13737</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13738</code><code>Drug Alcohol Depend. &lt;/span&gt;</code></p><p><code>13739</code><code>1982;&lt;span class="ref-vol"&gt;</code></p><p><code>13740</code><code>10&lt;/span&gt;</code></p><p><code>13741</code><code>:345–353.&lt;/span&gt;</code></p><p><code>13742</code><code> [&lt;a href="/pubmed/6299682" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13743</code><code>PubMed&lt;/a&gt;</code></p><p><code>13744</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13745</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Drug+Alcohol+Depend&amp;amp;title=The+effect+of+chronically+administered+&amp;#x00394;-9-tetrahydrocannabinol+upon+the+polygraphically+monitored+sleep+of+normal+volunteers&amp;amp;author=FR+Freemon&amp;amp;volume=10&amp;amp;publication_year=1982&amp;amp;pages=345-353&amp;amp;pmid=6299682&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13746</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13747</code><code>]&lt;/span&gt;</code></p><p><code>13748</code><code>&lt;/span&gt;</code></p><p><code>13749</code><code>&lt;/li&gt;</code></p><p><code>13750</code><code>&lt;li id="R344"&gt;</code></p><p><code>13751</code><code>&lt;span class="citation"&gt;</code></p><p><code>13752</code><code>French ED. &amp;#x00394;&lt;sup&gt;</code></p><p><code>13753</code><code>9&lt;/sup&gt;</code></p><p><code>13754</code><code>-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. &lt;span&gt;</code></p><p><code>13755</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13756</code><code>Neurosci Lett. &lt;/span&gt;</code></p><p><code>13757</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>13758</code><code>226&lt;/span&gt;</code></p><p><code>13759</code><code>:159–162.&lt;/span&gt;</code></p><p><code>13760</code><code> [&lt;a href="/pubmed/9175591" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13761</code><code>PubMed&lt;/a&gt;</code></p><p><code>13762</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13763</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Lett&amp;amp;title=&amp;#x00394;9-Tetrahydrocannabinol+excites+rat+VTA+dopamine+neurons+through+activation+of+cannabinoid+CB1+but+not+opioid+receptors&amp;amp;author=ED+French&amp;amp;volume=226&amp;amp;publication_year=1997&amp;amp;pages=159-162&amp;amp;pmid=9175591&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13764</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13765</code><code>]&lt;/span&gt;</code></p><p><code>13766</code><code>&lt;/span&gt;</code></p><p><code>13767</code><code>&lt;/li&gt;</code></p><p><code>13768</code><code>&lt;li id="R345"&gt;</code></p><p><code>13769</code><code>&lt;span class="citation"&gt;</code></p><p><code>13770</code><code>Freund TF, Katona I, Piomelli D. Role of endogenous cannabinoids in synaptic signaling. &lt;span&gt;</code></p><p><code>13771</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13772</code><code>Physiol Rev. &lt;/span&gt;</code></p><p><code>13773</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>13774</code><code>83&lt;/span&gt;</code></p><p><code>13775</code><code>:1017–1066.&lt;/span&gt;</code></p><p><code>13776</code><code> [&lt;a href="/pubmed/12843414" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13777</code><code>PubMed&lt;/a&gt;</code></p><p><code>13778</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13779</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Physiol+Rev&amp;amp;title=Role+of+endogenous+cannabinoids+in+synaptic+signaling&amp;amp;author=TF+Freund&amp;amp;author=I+Katona&amp;amp;author=D+Piomelli&amp;amp;volume=83&amp;amp;publication_year=2003&amp;amp;pages=1017-1066&amp;amp;pmid=12843414&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13780</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13781</code><code>]&lt;/span&gt;</code></p><p><code>13782</code><code>&lt;/span&gt;</code></p><p><code>13783</code><code>&lt;/li&gt;</code></p><p><code>13784</code><code>&lt;li id="R346"&gt;</code></p><p><code>13785</code><code>&lt;span class="citation"&gt;</code></p><p><code>13786</code><code>Fride E. The endocannabinoid-CB&lt;sub&gt;</code></p><p><code>13787</code><code>1&lt;/sub&gt;</code></p><p><code>13788</code><code> receptor system during gestation and postnatal development. &lt;span&gt;</code></p><p><code>13789</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13790</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>13791</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>13792</code><code>500&lt;/span&gt;</code></p><p><code>13793</code><code>:289–297.&lt;/span&gt;</code></p><p><code>13794</code><code> [&lt;a href="/pubmed/15464041" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13795</code><code>PubMed&lt;/a&gt;</code></p><p><code>13796</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13797</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=The+endocannabinoid-CB1+receptor+system+during+gestation+and+postnatal+development&amp;amp;author=E+Fride&amp;amp;volume=500&amp;amp;publication_year=2004&amp;amp;pages=289-297&amp;amp;pmid=15464041&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13798</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13799</code><code>]&lt;/span&gt;</code></p><p><code>13800</code><code>&lt;/span&gt;</code></p><p><code>13801</code><code>&lt;/li&gt;</code></p><p><code>13802</code><code>&lt;li id="R347"&gt;</code></p><p><code>13803</code><code>&lt;span class="citation"&gt;</code></p><p><code>13804</code><code>Fride E, Bregman T, Kirkham TC. Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood. &lt;span&gt;</code></p><p><code>13805</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13806</code><code>Exp Biol Med. &lt;/span&gt;</code></p><p><code>13807</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>13808</code><code>230&lt;/span&gt;</code></p><p><code>13809</code><code>:225–234.&lt;/span&gt;</code></p><p><code>13810</code><code> [&lt;a href="/pubmed/15792943" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13811</code><code>PubMed&lt;/a&gt;</code></p><p><code>13812</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13813</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Exp+Biol+Med&amp;amp;title=Endocannabinoids+and+food+intake:+newborn+suckling+and+appetite+regulation+in+adulthood&amp;amp;author=E+Fride&amp;amp;author=T+Bregman&amp;amp;author=TC+Kirkham&amp;amp;volume=230&amp;amp;publication_year=2005&amp;amp;pages=225-234&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13814</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13815</code><code>]&lt;/span&gt;</code></p><p><code>13816</code><code>&lt;/span&gt;</code></p><p><code>13817</code><code>&lt;/li&gt;</code></p><p><code>13818</code><code>&lt;li id="R348"&gt;</code></p><p><code>13819</code><code>&lt;span class="citation"&gt;</code></p><p><code>13820</code><code>Fride E, Foox A, Rosenberg E, Faigenboim M, Cohen V, Barda L, Blau H, Mechoulam R. Milk intake and survival in newborn cannabinoid CB&lt;sub&gt;</code></p><p><code>13821</code><code>1&lt;/sub&gt;</code></p><p><code>13822</code><code> receptor knockout mice: evidence for a &amp;#x0201c;CB3&amp;#x0201d; receptor. &lt;span&gt;</code></p><p><code>13823</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13824</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>13825</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>13826</code><code>461&lt;/span&gt;</code></p><p><code>13827</code><code>:27–34.&lt;/span&gt;</code></p><p><code>13828</code><code> [&lt;a href="/pubmed/12568912" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13829</code><code>PubMed&lt;/a&gt;</code></p><p><code>13830</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13831</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Milk+intake+and+survival+in+newborn+cannabinoid+CB1+receptor+knockout+mice:+evidence+for+a+&amp;#x0201c;CB3&amp;#x0201d;+receptor&amp;amp;author=E+Fride&amp;amp;author=A+Foox&amp;amp;author=E+Rosenberg&amp;amp;author=M+Faigenboim&amp;amp;author=V+Cohen&amp;amp;volume=461&amp;amp;publication_year=2003&amp;amp;pages=27-34&amp;amp;pmid=12568912&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13832</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13833</code><code>]&lt;/span&gt;</code></p><p><code>13834</code><code>&lt;/span&gt;</code></p><p><code>13835</code><code>&lt;/li&gt;</code></p><p><code>13836</code><code>&lt;li id="R349"&gt;</code></p><p><code>13837</code><code>&lt;span class="citation"&gt;</code></p><p><code>13838</code><code>Fride E, Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. &lt;span&gt;</code></p><p><code>13839</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13840</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>13841</code><code>1993;&lt;span class="ref-vol"&gt;</code></p><p><code>13842</code><code>231&lt;/span&gt;</code></p><p><code>13843</code><code>:313–314.&lt;/span&gt;</code></p><p><code>13844</code><code> [&lt;a href="/pubmed/8384116" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13845</code><code>PubMed&lt;/a&gt;</code></p><p><code>13846</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13847</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Pharmacological+activity+of+the+cannabinoid+receptor+agonist,+anandamide,+a+brain+constituent&amp;amp;author=E+Fride&amp;amp;author=R+Mechoulam&amp;amp;volume=231&amp;amp;publication_year=1993&amp;amp;pages=313-314&amp;amp;pmid=8384116&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13848</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13849</code><code>]&lt;/span&gt;</code></p><p><code>13850</code><code>&lt;/span&gt;</code></p><p><code>13851</code><code>&lt;/li&gt;</code></p><p><code>13852</code><code>&lt;li id="R350"&gt;</code></p><p><code>13853</code><code>&lt;span class="citation"&gt;</code></p><p><code>13854</code><code>Fride E, Shohami E. The endocannabinoid system: function in survival of the embryo, the newborn and the neuron. &lt;span&gt;</code></p><p><code>13855</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13856</code><code>Neuroreport. &lt;/span&gt;</code></p><p><code>13857</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>13858</code><code>13&lt;/span&gt;</code></p><p><code>13859</code><code>:1833–1841.&lt;/span&gt;</code></p><p><code>13860</code><code> [&lt;a href="/pubmed/12395075" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13861</code><code>PubMed&lt;/a&gt;</code></p><p><code>13862</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13863</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroreport&amp;amp;title=The+endocannabinoid+system:+function+in+survival+of+the+embryo,+the+newborn+and+the+neuron&amp;amp;author=E+Fride&amp;amp;author=E+Shohami&amp;amp;volume=13&amp;amp;publication_year=2002&amp;amp;pages=1833-1841&amp;amp;pmid=12395075&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13864</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13865</code><code>]&lt;/span&gt;</code></p><p><code>13866</code><code>&lt;/span&gt;</code></p><p><code>13867</code><code>&lt;/li&gt;</code></p><p><code>13868</code><code>&lt;li id="R351"&gt;</code></p><p><code>13869</code><code>&lt;span class="citation"&gt;</code></p><p><code>13870</code><code>Friedman H, Klein TW, Newton C, Daaka Y. Marijuana, receptors and immunomodulation. &lt;span&gt;</code></p><p><code>13871</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13872</code><code>Adv Exp Med Biol. &lt;/span&gt;</code></p><p><code>13873</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>13874</code><code>373&lt;/span&gt;</code></p><p><code>13875</code><code>:103–113.&lt;/span&gt;</code></p><p><code>13876</code><code> [&lt;a href="/pubmed/7668140" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13877</code><code>PubMed&lt;/a&gt;</code></p><p><code>13878</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13879</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Adv+Exp+Med+Biol&amp;amp;title=Marijuana,+receptors+and+immunomodulation&amp;amp;author=H+Friedman&amp;amp;author=TW+Klein&amp;amp;author=C+Newton&amp;amp;author=Y+Daaka&amp;amp;volume=373&amp;amp;publication_year=1995&amp;amp;pages=103-113&amp;amp;pmid=7668140&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13880</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13881</code><code>]&lt;/span&gt;</code></p><p><code>13882</code><code>&lt;/span&gt;</code></p><p><code>13883</code><code>&lt;/li&gt;</code></p><p><code>13884</code><code>&lt;li id="R352"&gt;</code></p><p><code>13885</code><code>&lt;span class="citation"&gt;</code></p><p><code>13886</code><code>Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodriguez de Fonseca F, Rosengarth A, Luecke H, Di Giacomo B, Tarzia G, et al.  Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-&lt;em&gt;</code></p><p><code>13887</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>13888</code><code> &lt;span&gt;</code></p><p><code>13889</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13890</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>13891</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>13892</code><code>425&lt;/span&gt;</code></p><p><code>13893</code><code>:90–93.&lt;/span&gt;</code></p><p><code>13894</code><code> [&lt;a href="/pubmed/12955147" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13895</code><code>PubMed&lt;/a&gt;</code></p><p><code>13896</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13897</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Oleylethanolamide+regulates+feeding+and+body+weight+through+activation+of+the+nuclear+receptor+PPAR-&amp;#x003b1;&amp;amp;author=J+Fu&amp;amp;author=S+Gaetani&amp;amp;author=F+Oveisi&amp;amp;author=J+Lo+Verme&amp;amp;author=A+Serrano&amp;amp;volume=425&amp;amp;publication_year=2003&amp;amp;pages=90-93&amp;amp;pmid=12955147&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13898</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13899</code><code>]&lt;/span&gt;</code></p><p><code>13900</code><code>&lt;/span&gt;</code></p><p><code>13901</code><code>&lt;/li&gt;</code></p><p><code>13902</code><code>&lt;li id="R353"&gt;</code></p><p><code>13903</code><code>&lt;span class="citation"&gt;</code></p><p><code>13904</code><code>Gabbay E, Avraham Y, Ilan Y, Israeli E, Berry EM. Endocannabinoids and liver disease&amp;#x02014;review. &lt;span&gt;</code></p><p><code>13905</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13906</code><code>Liver Int. &lt;/span&gt;</code></p><p><code>13907</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>13908</code><code>25&lt;/span&gt;</code></p><p><code>13909</code><code>:921–926.&lt;/span&gt;</code></p><p><code>13910</code><code> [&lt;a href="/pubmed/16162147" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13911</code><code>PubMed&lt;/a&gt;</code></p><p><code>13912</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13913</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Liver+Int&amp;amp;title=Endocannabinoids+and+liver+disease&amp;#x02014;review&amp;amp;author=E+Gabbay&amp;amp;author=Y+Avraham&amp;amp;author=Y+Ilan&amp;amp;author=E+Israeli&amp;amp;author=EM+Berry&amp;amp;volume=25&amp;amp;publication_year=2005&amp;amp;pages=921-926&amp;amp;pmid=16162147&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13914</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13915</code><code>]&lt;/span&gt;</code></p><p><code>13916</code><code>&lt;/span&gt;</code></p><p><code>13917</code><code>&lt;/li&gt;</code></p><p><code>13918</code><code>&lt;li id="R354"&gt;</code></p><p><code>13919</code><code>&lt;span class="citation"&gt;</code></p><p><code>13920</code><code>Gallate JE, Saharov T, Mallet PE, McGregor IS. Increased motivation for beer in rats following administration of a cannabinoid CB&lt;sub&gt;</code></p><p><code>13921</code><code>1&lt;/sub&gt;</code></p><p><code>13922</code><code> receptor agonist. &lt;span&gt;</code></p><p><code>13923</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13924</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>13925</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>13926</code><code>370&lt;/span&gt;</code></p><p><code>13927</code><code>:233–240.&lt;/span&gt;</code></p><p><code>13928</code><code> [&lt;a href="/pubmed/10334497" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13929</code><code>PubMed&lt;/a&gt;</code></p><p><code>13930</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13931</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Increased+motivation+for+beer+in+rats+following+administration+of+a+cannabinoid+CB1+receptor+agonist&amp;amp;author=JE+Gallate&amp;amp;author=T+Saharov&amp;amp;author=PE+Mallet&amp;amp;author=IS+McGregor&amp;amp;volume=370&amp;amp;publication_year=1999&amp;amp;pages=233-240&amp;amp;pmid=10334497&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13932</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13933</code><code>]&lt;/span&gt;</code></p><p><code>13934</code><code>&lt;/span&gt;</code></p><p><code>13935</code><code>&lt;/li&gt;</code></p><p><code>13936</code><code>&lt;li id="R355"&gt;</code></p><p><code>13937</code><code>&lt;span class="citation"&gt;</code></p><p><code>13938</code><code>Gallily R, Breuer A, Mechoulam R. 2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-&lt;em&gt;</code></p><p><code>13939</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>13940</code><code> production in murine macrophages, and in mice. &lt;span&gt;</code></p><p><code>13941</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13942</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>13943</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>13944</code><code>406&lt;/span&gt;</code></p><p><code>13945</code><code>:R5–R7.&lt;/span&gt;</code></p><p><code>13946</code><code> [&lt;a href="/pubmed/11011050" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13947</code><code>PubMed&lt;/a&gt;</code></p><p><code>13948</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13949</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=2-Arachidonylglycerol,+an+endogenous+cannabinoid,+inhibits+tumor+necrosis+factor-&amp;#x003b1;+production+in+murine+macrophages,+and+in+mice&amp;amp;author=R+Gallily&amp;amp;author=A+Breuer&amp;amp;author=R+Mechoulam&amp;amp;volume=406&amp;amp;publication_year=2000&amp;amp;pages=R5-R7&amp;amp;pmid=11011050&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13950</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13951</code><code>]&lt;/span&gt;</code></p><p><code>13952</code><code>&lt;/span&gt;</code></p><p><code>13953</code><code>&lt;/li&gt;</code></p><p><code>13954</code><code>&lt;li id="R356"&gt;</code></p><p><code>13955</code><code>&lt;span class="citation"&gt;</code></p><p><code>13956</code><code>Galve-Roperh I, Rueda D, G&amp;#x000f3;mez Del Pulgar T, Velasco G, Guzman M. Mechanism of extracellular signal-regulated kinase activation by the CB&lt;sub&gt;</code></p><p><code>13957</code><code>1&lt;/sub&gt;</code></p><p><code>13958</code><code> cannabinoid receptor. &lt;span&gt;</code></p><p><code>13959</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13960</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>13961</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>13962</code><code>62&lt;/span&gt;</code></p><p><code>13963</code><code>:1385–1392.&lt;/span&gt;</code></p><p><code>13964</code><code> [&lt;a href="/pubmed/12435806" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13965</code><code>PubMed&lt;/a&gt;</code></p><p><code>13966</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13967</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=Mechanism+of+extracellular+signal-regulated+kinase+activation+by+the+CB1+cannabinoid+receptor&amp;amp;author=I+Galve-Roperh&amp;amp;author=D+Rueda&amp;amp;author=T+G&amp;#x000f3;mez+Del+Pulgar&amp;amp;author=G+Velasco&amp;amp;author=M+Guzman&amp;amp;volume=62&amp;amp;publication_year=2002&amp;amp;pages=1385-1392&amp;amp;pmid=12435806&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13968</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13969</code><code>]&lt;/span&gt;</code></p><p><code>13970</code><code>&lt;/span&gt;</code></p><p><code>13971</code><code>&lt;/li&gt;</code></p><p><code>13972</code><code>&lt;li id="R357"&gt;</code></p><p><code>13973</code><code>&lt;span class="citation"&gt;</code></p><p><code>13974</code><code>Galve-Roperh I, Sanchez C, Cortes ML, del Pulgar TG, Izquierdo M, Guzman M. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. &lt;span&gt;</code></p><p><code>13975</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13976</code><code>Nat Med. &lt;/span&gt;</code></p><p><code>13977</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>13978</code><code>6&lt;/span&gt;</code></p><p><code>13979</code><code>:313–319.&lt;/span&gt;</code></p><p><code>13980</code><code> [&lt;a href="/pubmed/10700234" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13981</code><code>PubMed&lt;/a&gt;</code></p><p><code>13982</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13983</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;amp;title=Anti-tumoral+action+of+cannabinoids:+involvement+of+sustained+ceramide+accumulation+and+extracellular+signal-regulated+kinase+activation&amp;amp;author=I+Galve-Roperh&amp;amp;author=C+Sanchez&amp;amp;author=ML+Cortes&amp;amp;author=TG+del+Pulgar&amp;amp;author=M+Izquierdo&amp;amp;volume=6&amp;amp;publication_year=2000&amp;amp;pages=313-319&amp;amp;pmid=10700234&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>13984</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>13985</code><code>]&lt;/span&gt;</code></p><p><code>13986</code><code>&lt;/span&gt;</code></p><p><code>13987</code><code>&lt;/li&gt;</code></p><p><code>13988</code><code>&lt;li id="R358"&gt;</code></p><p><code>13989</code><code>&lt;span class="citation"&gt;</code></p><p><code>13990</code><code>Gamber KM, Macarthur H, Westfall TC. Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus. &lt;span&gt;</code></p><p><code>13991</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>13992</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>13993</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>13994</code><code>49&lt;/span&gt;</code></p><p><code>13995</code><code>:646–652.&lt;/span&gt;</code></p><p><code>13996</code><code> [&lt;a href="/pubmed/15949823" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>13997</code><code>PubMed&lt;/a&gt;</code></p><p><code>13998</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>13999</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=Cannabinoids+augment+the+release+of+neuropeptide+Y+in+the+rat+hypothalamus&amp;amp;author=KM+Gamber&amp;amp;author=H+Macarthur&amp;amp;author=TC+Westfall&amp;amp;volume=49&amp;amp;publication_year=2005&amp;amp;pages=646-652&amp;amp;pmid=15949823&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14000</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14001</code><code>]&lt;/span&gt;</code></p><p><code>14002</code><code>&lt;/span&gt;</code></p><p><code>14003</code><code>&lt;/li&gt;</code></p><p><code>14004</code><code>&lt;li id="R359"&gt;</code></p><p><code>14005</code><code>&lt;span class="citation"&gt;</code></p><p><code>14006</code><code>Gambi F, De Berardis D, Sepede G, Quartesan R, Calcagni E, Salerno RM, Conti CM, Ferro FM. Cannabinoid receptors and their relationships with neuropsychiatric disorders. &lt;span&gt;</code></p><p><code>14007</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14008</code><code>Int J Immunopathol Pharmacol. &lt;/span&gt;</code></p><p><code>14009</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>14010</code><code>18&lt;/span&gt;</code></p><p><code>14011</code><code>:15–19.&lt;/span&gt;</code></p><p><code>14012</code><code> [&lt;a href="/pubmed/15698507" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14013</code><code>PubMed&lt;/a&gt;</code></p><p><code>14014</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14015</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Immunopathol+Pharmacol&amp;amp;title=Cannabinoid+receptors+and+their+relationships+with+neuropsychiatric+disorders&amp;amp;author=F+Gambi&amp;amp;author=D+De+Berardis&amp;amp;author=G+Sepede&amp;amp;author=R+Quartesan&amp;amp;author=E+Calcagni&amp;amp;volume=18&amp;amp;publication_year=2005&amp;amp;pages=15-19&amp;amp;pmid=15698507&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14016</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14017</code><code>]&lt;/span&gt;</code></p><p><code>14018</code><code>&lt;/span&gt;</code></p><p><code>14019</code><code>&lt;/li&gt;</code></p><p><code>14020</code><code>&lt;li id="R360"&gt;</code></p><p><code>14021</code><code>&lt;span class="citation"&gt;</code></p><p><code>14022</code><code>Gammon CM, Freeman GM, Jr, Xie W, Petersen SL, Wetsel WC. Regulation of gonadotropin-releasing hormone secretion by cannabinoids. &lt;span&gt;</code></p><p><code>14023</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14024</code><code>Endocrinology. &lt;/span&gt;</code></p><p><code>14025</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>14026</code><code>146&lt;/span&gt;</code></p><p><code>14027</code><code>:4491–4499.&lt;/span&gt;</code></p><p><code>14028</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>14029</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1237039/"&gt;</code></p><p><code>14030</code><code>PMC free article&lt;/a&gt;</code></p><p><code>14031</code><code>]&lt;/span&gt;</code></p><p><code>14032</code><code> [&lt;a href="/pubmed/16020480" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14033</code><code>PubMed&lt;/a&gt;</code></p><p><code>14034</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14035</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;amp;title=Regulation+of+gonadotropin-releasing+hormone+secretion+by+cannabinoids&amp;amp;author=CM+Gammon&amp;amp;author=GM+Freeman&amp;amp;author=W+Xie&amp;amp;author=SL+Petersen&amp;amp;author=WC+Wetsel&amp;amp;volume=146&amp;amp;publication_year=2005&amp;amp;pages=4491-4499&amp;amp;pmid=16020480&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14036</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14037</code><code>]&lt;/span&gt;</code></p><p><code>14038</code><code>&lt;/span&gt;</code></p><p><code>14039</code><code>&lt;/li&gt;</code></p><p><code>14040</code><code>&lt;li id="R361"&gt;</code></p><p><code>14041</code><code>&lt;span class="citation"&gt;</code></p><p><code>14042</code><code>Gaoni Y, Mechoulam R. Isolation, structure and partial synthesis of an active constituent of hashish. &lt;span&gt;</code></p><p><code>14043</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14044</code><code>J Am Chem Soc. &lt;/span&gt;</code></p><p><code>14045</code><code>1964;&lt;span class="ref-vol"&gt;</code></p><p><code>14046</code><code>86&lt;/span&gt;</code></p><p><code>14047</code><code>:1646–1647.&lt;/span&gt;</code></p><p><code>14048</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>14049</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Chem+Soc&amp;amp;title=Isolation,+structure+and+partial+synthesis+of+an+active+constituent+of+hashish&amp;amp;author=Y+Gaoni&amp;amp;author=R+Mechoulam&amp;amp;volume=86&amp;amp;publication_year=1964&amp;amp;pages=1646-1647&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14050</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14051</code><code>]&lt;/span&gt;</code></p><p><code>14052</code><code>&lt;/span&gt;</code></p><p><code>14053</code><code>&lt;/li&gt;</code></p><p><code>14054</code><code>&lt;li id="R362"&gt;</code></p><p><code>14055</code><code>&lt;span class="citation"&gt;</code></p><p><code>14056</code><code>Garcia N, Jr, Jarai Z, Mirshahi F, Kunos G, Sanyal AJ. Systemic and portal hemodynamic effects of anandamide. &lt;span&gt;</code></p><p><code>14057</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14058</code><code>Am J Physiol. &lt;/span&gt;</code></p><p><code>14059</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>14060</code><code>280&lt;/span&gt;</code></p><p><code>14061</code><code>:G14–G20.&lt;/span&gt;</code></p><p><code>14062</code><code> [&lt;a href="/pubmed/11123193" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14063</code><code>PubMed&lt;/a&gt;</code></p><p><code>14064</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14065</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol&amp;amp;title=Systemic+and+portal+hemodynamic+effects+of+anandamide&amp;amp;author=N+Garcia&amp;amp;author=Z+Jarai&amp;amp;author=F+Mirshahi&amp;amp;author=G+Kunos&amp;amp;author=AJ+Sanyal&amp;amp;volume=280&amp;amp;publication_year=2001&amp;amp;pages=G14-G20&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14066</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14067</code><code>]&lt;/span&gt;</code></p><p><code>14068</code><code>&lt;/span&gt;</code></p><p><code>14069</code><code>&lt;/li&gt;</code></p><p><code>14070</code><code>&lt;li id="R363"&gt;</code></p><p><code>14071</code><code>&lt;span class="citation"&gt;</code></p><p><code>14072</code><code>Gardiner SM, March JE, Kemp PA, Bennett T. Regional haemodynamic responses to the cannabinoid agonist, WIN 55212-2, in conscious, normotensive rats, and in hypertensive, transgenic rats. &lt;span&gt;</code></p><p><code>14073</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14074</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>14075</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>14076</code><code>133&lt;/span&gt;</code></p><p><code>14077</code><code>:445–453.&lt;/span&gt;</code></p><p><code>14078</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>14079</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1572802/"&gt;</code></p><p><code>14080</code><code>PMC free article&lt;/a&gt;</code></p><p><code>14081</code><code>]&lt;/span&gt;</code></p><p><code>14082</code><code> [&lt;a href="/pubmed/11375262" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14083</code><code>PubMed&lt;/a&gt;</code></p><p><code>14084</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14085</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Regional+haemodynamic+responses+to+the+cannabinoid+agonist,+WIN+55212-2,+in+conscious,+normotensive+rats,+and+in+hypertensive,+transgenic+rats&amp;amp;author=SM+Gardiner&amp;amp;author=JE+March&amp;amp;author=PA+Kemp&amp;amp;author=T+Bennett&amp;amp;volume=133&amp;amp;publication_year=2001&amp;amp;pages=445-453&amp;amp;pmid=11375262&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14086</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14087</code><code>]&lt;/span&gt;</code></p><p><code>14088</code><code>&lt;/span&gt;</code></p><p><code>14089</code><code>&lt;/li&gt;</code></p><p><code>14090</code><code>&lt;li id="R364"&gt;</code></p><p><code>14091</code><code>&lt;span class="citation"&gt;</code></p><p><code>14092</code><code>Gardiner SM, March JE, Kemp PA, Bennett T. Complex regional haemodynamic effects of anandamide in conscious rats. &lt;span&gt;</code></p><p><code>14093</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14094</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>14095</code><code>2002a;&lt;span class="ref-vol"&gt;</code></p><p><code>14096</code><code>135&lt;/span&gt;</code></p><p><code>14097</code><code>:1889–1896.&lt;/span&gt;</code></p><p><code>14098</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>14099</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1573314/"&gt;</code></p><p><code>14100</code><code>PMC free article&lt;/a&gt;</code></p><p><code>14101</code><code>]&lt;/span&gt;</code></p><p><code>14102</code><code> [&lt;a href="/pubmed/11959791" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14103</code><code>PubMed&lt;/a&gt;</code></p><p><code>14104</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14105</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Complex+regional+haemodynamic+effects+of+anandamide+in+conscious+rats&amp;amp;author=SM+Gardiner&amp;amp;author=JE+March&amp;amp;author=PA+Kemp&amp;amp;author=T+Bennett&amp;amp;volume=135&amp;amp;publication_year=2002a&amp;amp;pages=1889-1896&amp;amp;pmid=11959791&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14106</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14107</code><code>]&lt;/span&gt;</code></p><p><code>14108</code><code>&lt;/span&gt;</code></p><p><code>14109</code><code>&lt;/li&gt;</code></p><p><code>14110</code><code>&lt;li id="R365"&gt;</code></p><p><code>14111</code><code>&lt;span class="citation"&gt;</code></p><p><code>14112</code><code>Gardiner SM, March JE, Kemp PA, Bennett T. Influence of the CB&lt;sub&gt;</code></p><p><code>14113</code><code>1&lt;/sub&gt;</code></p><p><code>14114</code><code> receptor antagonist, AM 251, on the regional haemodynamic effects of WIN-55212-2 or HU 210 in conscious rats. &lt;span&gt;</code></p><p><code>14115</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14116</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>14117</code><code>2002b;&lt;span class="ref-vol"&gt;</code></p><p><code>14118</code><code>136&lt;/span&gt;</code></p><p><code>14119</code><code>:581–587.&lt;/span&gt;</code></p><p><code>14120</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>14121</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1573379/"&gt;</code></p><p><code>14122</code><code>PMC free article&lt;/a&gt;</code></p><p><code>14123</code><code>]&lt;/span&gt;</code></p><p><code>14124</code><code> [&lt;a href="/pubmed/12055136" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14125</code><code>PubMed&lt;/a&gt;</code></p><p><code>14126</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14127</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Influence+of+the+CB1+receptor+antagonist,+AM+251,+on+the+regional+haemodynamic+effects+of+WIN-55212-2+or+HU+210+in+conscious+rats&amp;amp;author=SM+Gardiner&amp;amp;author=JE+March&amp;amp;author=PA+Kemp&amp;amp;author=T+Bennett&amp;amp;volume=136&amp;amp;publication_year=2002b&amp;amp;pages=581-587&amp;amp;pmid=12055136&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14128</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14129</code><code>]&lt;/span&gt;</code></p><p><code>14130</code><code>&lt;/span&gt;</code></p><p><code>14131</code><code>&lt;/li&gt;</code></p><p><code>14132</code><code>&lt;li id="R366"&gt;</code></p><p><code>14133</code><code>&lt;span class="citation"&gt;</code></p><p><code>14134</code><code>Gardiner SM, March JE, Kemp PA, Bennett T. Involvement of CB1-receptors and &lt;em&gt;</code></p><p><code>14135</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>14136</code><code>-adrenoceptors in the regional hemodynamic responses to lipopoly-saccharide infusion in conscious rats. &lt;span&gt;</code></p><p><code>14137</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14138</code><code>Am J Physiol. &lt;/span&gt;</code></p><p><code>14139</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>14140</code><code>288&lt;/span&gt;</code></p><p><code>14141</code><code>:H2280–H2288.&lt;/span&gt;</code></p><p><code>14142</code><code> [&lt;a href="/pubmed/15604130" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14143</code><code>PubMed&lt;/a&gt;</code></p><p><code>14144</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14145</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol&amp;amp;title=Involvement+of+CB1-receptors+and+&amp;#x003b2;-adrenoceptors+in+the+regional+hemodynamic+responses+to+lipopoly-saccharide+infusion+in+conscious+rats&amp;amp;author=SM+Gardiner&amp;amp;author=JE+March&amp;amp;author=PA+Kemp&amp;amp;author=T+Bennett&amp;amp;volume=288&amp;amp;publication_year=2005&amp;amp;pages=H2280-H2288&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14146</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14147</code><code>]&lt;/span&gt;</code></p><p><code>14148</code><code>&lt;/span&gt;</code></p><p><code>14149</code><code>&lt;/li&gt;</code></p><p><code>14150</code><code>&lt;li id="R367"&gt;</code></p><p><code>14151</code><code>&lt;span class="citation"&gt;</code></p><p><code>14152</code><code>Gardner EL. Endocannabinoid signaling system and brain reward: emphasis on dopamine. &lt;span&gt;</code></p><p><code>14153</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14154</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>14155</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>14156</code><code>81&lt;/span&gt;</code></p><p><code>14157</code><code>:263–284.&lt;/span&gt;</code></p><p><code>14158</code><code> [&lt;a href="/pubmed/15936806" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14159</code><code>PubMed&lt;/a&gt;</code></p><p><code>14160</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14161</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Endocannabinoid+signaling+system+and+brain+reward:+emphasis+on+dopamine&amp;amp;author=EL+Gardner&amp;amp;volume=81&amp;amp;publication_year=2005&amp;amp;pages=263-284&amp;amp;pmid=15936806&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14162</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14163</code><code>]&lt;/span&gt;</code></p><p><code>14164</code><code>&lt;/span&gt;</code></p><p><code>14165</code><code>&lt;/li&gt;</code></p><p><code>14166</code><code>&lt;li id="R368"&gt;</code></p><p><code>14167</code><code>&lt;span class="citation"&gt;</code></p><p><code>14168</code><code>Gardner EL, Paredes W, Smith D, Donner A, Milling C, Cohen D, Morrison D. Facilitation of brain stimulation reward by 9-tetrahydrocannabinol.&amp;#x00394;&lt;sup&gt;</code></p><p><code>14169</code><code>9&lt;/sup&gt;</code></p><p><code>14170</code><code>-tetrahydrocannabinol. &lt;span&gt;</code></p><p><code>14171</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14172</code><code>Psychopharmacology (Berl) &lt;/span&gt;</code></p><p><code>14173</code><code>1988;&lt;span class="ref-vol"&gt;</code></p><p><code>14174</code><code>96&lt;/span&gt;</code></p><p><code>14175</code><code>:142–144.&lt;/span&gt;</code></p><p><code>14176</code><code> [&lt;a href="/pubmed/2852376" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14177</code><code>PubMed&lt;/a&gt;</code></p><p><code>14178</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14179</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology+(Berl)&amp;amp;title=Facilitation+of+brain+stimulation+reward+by+9-tetrahydrocannabinol.&amp;#x00394;9-tetrahydrocannabinol&amp;amp;author=EL+Gardner&amp;amp;author=W+Paredes&amp;amp;author=D+Smith&amp;amp;author=A+Donner&amp;amp;author=C+Milling&amp;amp;volume=96&amp;amp;publication_year=1988&amp;amp;pages=142-144&amp;amp;pmid=2852376&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14180</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14181</code><code>]&lt;/span&gt;</code></p><p><code>14182</code><code>&lt;/span&gt;</code></p><p><code>14183</code><code>&lt;/li&gt;</code></p><p><code>14184</code><code>&lt;li id="R369"&gt;</code></p><p><code>14185</code><code>&lt;span class="citation"&gt;</code></p><p><code>14186</code><code>Gareau Y, Dufresne C, Gallant M, Rochette C, Sawyer N, Slipetz DM, Tremblay N, Weech PK, Metters KM, Labelle M. Structure activity relationships of tetrahydrocannabinol analogues on human cannabinoid receptors. &lt;span&gt;</code></p><p><code>14187</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14188</code><code>Bioorg Med Chem Lett. &lt;/span&gt;</code></p><p><code>14189</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>14190</code><code>6&lt;/span&gt;</code></p><p><code>14191</code><code>:189–194.&lt;/span&gt;</code></p><p><code>14192</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>14193</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Bioorg+Med+Chem+Lett&amp;amp;title=Structure+activity+relationships+of+tetrahydrocannabinol+analogues+on+human+cannabinoid+receptors&amp;amp;author=Y+Gareau&amp;amp;author=C+Dufresne&amp;amp;author=M+Gallant&amp;amp;author=C+Rochette&amp;amp;author=N+Sawyer&amp;amp;volume=6&amp;amp;publication_year=1996&amp;amp;pages=189-194&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14194</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14195</code><code>]&lt;/span&gt;</code></p><p><code>14196</code><code>&lt;/span&gt;</code></p><p><code>14197</code><code>&lt;/li&gt;</code></p><p><code>14198</code><code>&lt;li id="R370"&gt;</code></p><p><code>14199</code><code>&lt;span class="citation"&gt;</code></p><p><code>14200</code><code>Gaskari SA, Liu H, Moezi L, Li Y, Baik SK, Lee SS. Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. &lt;span&gt;</code></p><p><code>14201</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14202</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>14203</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>14204</code><code>146&lt;/span&gt;</code></p><p><code>14205</code><code>:315–323.&lt;/span&gt;</code></p><p><code>14206</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>14207</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1576281/"&gt;</code></p><p><code>14208</code><code>PMC free article&lt;/a&gt;</code></p><p><code>14209</code><code>]&lt;/span&gt;</code></p><p><code>14210</code><code> [&lt;a href="/pubmed/16025138" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14211</code><code>PubMed&lt;/a&gt;</code></p><p><code>14212</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14213</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Role+of+endocannabinoids+in+the+pathogenesis+of+cirrhotic+cardiomyopathy+in+bile+duct-ligated+rats&amp;amp;author=SA+Gaskari&amp;amp;author=H+Liu&amp;amp;author=L+Moezi&amp;amp;author=Y+Li&amp;amp;author=SK+Baik&amp;amp;volume=146&amp;amp;publication_year=2005&amp;amp;pages=315-323&amp;amp;pmid=16025138&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14214</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14215</code><code>]&lt;/span&gt;</code></p><p><code>14216</code><code>&lt;/span&gt;</code></p><p><code>14217</code><code>&lt;/li&gt;</code></p><p><code>14218</code><code>&lt;li id="R371"&gt;</code></p><p><code>14219</code><code>&lt;span class="citation"&gt;</code></p><p><code>14220</code><code>Gatley SJ, Lan R, Pyatt B, Gifford AN, Volkow ND, Makriyannis A. Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors. &lt;span&gt;</code></p><p><code>14221</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14222</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>14223</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>14224</code><code>61&lt;/span&gt;</code></p><p><code>14225</code><code>:191–197.&lt;/span&gt;</code></p><p><code>14226</code><code> [&lt;a href="/pubmed/9335234" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14227</code><code>PubMed&lt;/a&gt;</code></p><p><code>14228</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14229</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Binding+of+the+non-classical+cannabinoid+CP+55,940,+and+the+diarylpyrazole+AM251+to+rodent+brain+cannabinoid+receptors&amp;amp;author=SJ+Gatley&amp;amp;author=R+Lan&amp;amp;author=B+Pyatt&amp;amp;author=AN+Gifford&amp;amp;author=ND+Volkow&amp;amp;volume=61&amp;amp;publication_year=1997&amp;amp;pages=191-197&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14230</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14231</code><code>]&lt;/span&gt;</code></p><p><code>14232</code><code>&lt;/span&gt;</code></p><p><code>14233</code><code>&lt;/li&gt;</code></p><p><code>14234</code><code>&lt;li id="R372"&gt;</code></p><p><code>14235</code><code>&lt;span class="citation"&gt;</code></p><p><code>14236</code><code>Gebremedhin D, Lange AR, Campbell WB, Hillard CJ, Harder DR. Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca&lt;sup&gt;</code></p><p><code>14237</code><code>2+&lt;/sup&gt;</code></p><p><code>14238</code><code> channel current. &lt;span&gt;</code></p><p><code>14239</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14240</code><code>Am J Physiol. &lt;/span&gt;</code></p><p><code>14241</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>14242</code><code>266&lt;/span&gt;</code></p><p><code>14243</code><code>:H2085–H2093.&lt;/span&gt;</code></p><p><code>14244</code><code> [&lt;a href="/pubmed/10362691" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14245</code><code>PubMed&lt;/a&gt;</code></p><p><code>14246</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14247</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol&amp;amp;title=Cannabinoid+CB1+receptor+of+cat+cerebral+arterial+muscle+functions+to+inhibit+L-type+Ca2++channel+current&amp;amp;author=D+Gebremedhin&amp;amp;author=AR+Lange&amp;amp;author=WB+Campbell&amp;amp;author=CJ+Hillard&amp;amp;author=DR+Harder&amp;amp;volume=266&amp;amp;publication_year=1999&amp;amp;pages=H2085-H2093&amp;amp;pmid=10362691&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14248</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14249</code><code>]&lt;/span&gt;</code></p><p><code>14250</code><code>&lt;/span&gt;</code></p><p><code>14251</code><code>&lt;/li&gt;</code></p><p><code>14252</code><code>&lt;li id="R373"&gt;</code></p><p><code>14253</code><code>&lt;span class="citation"&gt;</code></p><p><code>14254</code><code>Gelinas D, Miller R, Abood M. A pilot study of safety and tolerability of &amp;#x00394;9-THC (Marinol) treatment for ALS. &lt;span&gt;</code></p><p><code>14255</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14256</code><code>Amyotroph Lateral Scler Other Motor Neuron Disord. &lt;/span&gt;</code></p><p><code>14257</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>14258</code><code>3&lt;/span&gt;</code></p><p><code>14259</code><code>:23.&lt;/span&gt;</code></p><p><code>14260</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>14261</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Amyotroph+Lateral+Scler+Other+Motor+Neuron+Disord&amp;amp;title=A+pilot+study+of+safety+and+tolerability+of+&amp;#x00394;9-THC+(Marinol)+treatment+for+ALS&amp;amp;author=D+Gelinas&amp;amp;author=R+Miller&amp;amp;author=M+Abood&amp;amp;volume=3&amp;amp;publication_year=2002&amp;amp;pages=23&amp;amp;pmid=12061945&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14262</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14263</code><code>]&lt;/span&gt;</code></p><p><code>14264</code><code>&lt;/span&gt;</code></p><p><code>14265</code><code>&lt;/li&gt;</code></p><p><code>14266</code><code>&lt;li id="R374"&gt;</code></p><p><code>14267</code><code>&lt;span class="citation"&gt;</code></p><p><code>14268</code><code>Genn RF, Tucci S, Marco E, Viveros MP, File SE. Anxiolytic and anxiogenic effects of the cannabinoid agonist CP 55,940 in animal tests of anxiety. &lt;span&gt;</code></p><p><code>14269</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14270</code><code>J Psychopharmacology. &lt;/span&gt;</code></p><p><code>14271</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>14272</code><code>17&lt;/span&gt;</code></p><p><code>14273</code><code>:A27.&lt;/span&gt;</code></p><p><code>14274</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>14275</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Psychopharmacology&amp;amp;title=Anxiolytic+and+anxiogenic+effects+of+the+cannabinoid+agonist+CP+55,940+in+animal+tests+of+anxiety&amp;amp;author=RF+Genn&amp;amp;author=S+Tucci&amp;amp;author=E+Marco&amp;amp;author=MP+Viveros&amp;amp;author=SE+File&amp;amp;volume=17&amp;amp;publication_year=2003&amp;amp;pages=A27&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14276</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14277</code><code>]&lt;/span&gt;</code></p><p><code>14278</code><code>&lt;/span&gt;</code></p><p><code>14279</code><code>&lt;/li&gt;</code></p><p><code>14280</code><code>&lt;li id="R375"&gt;</code></p><p><code>14281</code><code>&lt;span class="citation"&gt;</code></p><p><code>14282</code><code>Genn RF, Tucci S, Marco EM, Viveros MP, File SE. Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test. &lt;span&gt;</code></p><p><code>14283</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14284</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>14285</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>14286</code><code>77&lt;/span&gt;</code></p><p><code>14287</code><code>:567–573.&lt;/span&gt;</code></p><p><code>14288</code><code> [&lt;a href="/pubmed/15006468" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14289</code><code>PubMed&lt;/a&gt;</code></p><p><code>14290</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14291</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Unconditioned+and+conditioned+anxiogenic+effects+of+the+cannabinoid+receptor+agonist+CP+55,940+in+the+social+interaction+test&amp;amp;author=RF+Genn&amp;amp;author=S+Tucci&amp;amp;author=EM+Marco&amp;amp;author=MP+Viveros&amp;amp;author=SE+File&amp;amp;volume=77&amp;amp;publication_year=2004&amp;amp;pages=567-573&amp;amp;pmid=15006468&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14292</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14293</code><code>]&lt;/span&gt;</code></p><p><code>14294</code><code>&lt;/span&gt;</code></p><p><code>14295</code><code>&lt;/li&gt;</code></p><p><code>14296</code><code>&lt;li id="R376"&gt;</code></p><p><code>14297</code><code>&lt;span class="citation"&gt;</code></p><p><code>14298</code><code>Gentleman SM, Leclercq PD, Moyes L, Graham DI, Smith C, Griffin WS, Nicoll JA. Long-term intracerebral inflammatory response after traumatic brain injury. &lt;span&gt;</code></p><p><code>14299</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14300</code><code>Forensic Sci Int. &lt;/span&gt;</code></p><p><code>14301</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>14302</code><code>146&lt;/span&gt;</code></p><p><code>14303</code><code>:97–104.&lt;/span&gt;</code></p><p><code>14304</code><code> [&lt;a href="/pubmed/15542269" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14305</code><code>PubMed&lt;/a&gt;</code></p><p><code>14306</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14307</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Forensic+Sci+Int&amp;amp;title=Long-term+intracerebral+inflammatory+response+after+traumatic+brain+injury&amp;amp;author=SM+Gentleman&amp;amp;author=PD+Leclercq&amp;amp;author=L+Moyes&amp;amp;author=DI+Graham&amp;amp;author=C+Smith&amp;amp;volume=146&amp;amp;publication_year=2004&amp;amp;pages=97-104&amp;amp;pmid=15542269&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14308</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14309</code><code>]&lt;/span&gt;</code></p><p><code>14310</code><code>&lt;/span&gt;</code></p><p><code>14311</code><code>&lt;/li&gt;</code></p><p><code>14312</code><code>&lt;li id="R377"&gt;</code></p><p><code>14313</code><code>&lt;span class="citation"&gt;</code></p><p><code>14314</code><code>George SR, Fan T, Roldan L, Naranjo CA. Corticotropin-releasing factor is altered in brains of animals with high preference for ethanol. &lt;span&gt;</code></p><p><code>14315</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14316</code><code>Alcohol Clin Exp Res. &lt;/span&gt;</code></p><p><code>14317</code><code>1990;&lt;span class="ref-vol"&gt;</code></p><p><code>14318</code><code>14&lt;/span&gt;</code></p><p><code>14319</code><code>:425–429.&lt;/span&gt;</code></p><p><code>14320</code><code> [&lt;a href="/pubmed/2378427" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14321</code><code>PubMed&lt;/a&gt;</code></p><p><code>14322</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14323</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Alcohol+Clin+Exp+Res&amp;amp;title=Corticotropin-releasing+factor+is+altered+in+brains+of+animals+with+high+preference+for+ethanol&amp;amp;author=SR+George&amp;amp;author=T+Fan&amp;amp;author=L+Roldan&amp;amp;author=CA+Naranjo&amp;amp;volume=14&amp;amp;publication_year=1990&amp;amp;pages=425-429&amp;amp;pmid=2378427&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14324</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14325</code><code>]&lt;/span&gt;</code></p><p><code>14326</code><code>&lt;/span&gt;</code></p><p><code>14327</code><code>&lt;/li&gt;</code></p><p><code>14328</code><code>&lt;li id="R378"&gt;</code></p><p><code>14329</code><code>&lt;span class="citation"&gt;</code></p><p><code>14330</code><code>Gerdeman G, Lovinger DM. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. &lt;span&gt;</code></p><p><code>14331</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14332</code><code>J Neurophysiol. &lt;/span&gt;</code></p><p><code>14333</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>14334</code><code>85&lt;/span&gt;</code></p><p><code>14335</code><code>:468–471.&lt;/span&gt;</code></p><p><code>14336</code><code> [&lt;a href="/pubmed/11152748" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14337</code><code>PubMed&lt;/a&gt;</code></p><p><code>14338</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14339</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurophysiol&amp;amp;title=CB1+cannabinoid+receptor+inhibits+synaptic+release+of+glutamate+in+rat+dorsolateral+striatum&amp;amp;author=G+Gerdeman&amp;amp;author=DM+Lovinger&amp;amp;volume=85&amp;amp;publication_year=2001&amp;amp;pages=468-471&amp;amp;pmid=11152748&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14340</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14341</code><code>]&lt;/span&gt;</code></p><p><code>14342</code><code>&lt;/span&gt;</code></p><p><code>14343</code><code>&lt;/li&gt;</code></p><p><code>14344</code><code>&lt;li id="R379"&gt;</code></p><p><code>14345</code><code>&lt;span class="citation"&gt;</code></p><p><code>14346</code><code>Gerdeman GL, Lovinger DM. Emerging roles for endocannabinoids in long-term synaptic plasticity. &lt;span&gt;</code></p><p><code>14347</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14348</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>14349</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>14350</code><code>140&lt;/span&gt;</code></p><p><code>14351</code><code>:781–789.&lt;/span&gt;</code></p><p><code>14352</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>14353</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1574086/"&gt;</code></p><p><code>14354</code><code>PMC free article&lt;/a&gt;</code></p><p><code>14355</code><code>]&lt;/span&gt;</code></p><p><code>14356</code><code> [&lt;a href="/pubmed/14504143" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14357</code><code>PubMed&lt;/a&gt;</code></p><p><code>14358</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14359</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Emerging+roles+for+endocannabinoids+in+long-term+synaptic+plasticity&amp;amp;author=GL+Gerdeman&amp;amp;author=DM+Lovinger&amp;amp;volume=140&amp;amp;publication_year=2003&amp;amp;pages=781-789&amp;amp;pmid=14504143&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14360</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14361</code><code>]&lt;/span&gt;</code></p><p><code>14362</code><code>&lt;/span&gt;</code></p><p><code>14363</code><code>&lt;/li&gt;</code></p><p><code>14364</code><code>&lt;li id="R380"&gt;</code></p><p><code>14365</code><code>&lt;span class="citation"&gt;</code></p><p><code>14366</code><code>Gerdeman GL, Partridge JG, Lupica CR, Lovinger DM. It could be habit forming: drugs of abuse and striatal synaptic plasticity. &lt;span&gt;</code></p><p><code>14367</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14368</code><code>Trends Neurosci. &lt;/span&gt;</code></p><p><code>14369</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>14370</code><code>26&lt;/span&gt;</code></p><p><code>14371</code><code>:184–192.&lt;/span&gt;</code></p><p><code>14372</code><code> [&lt;a href="/pubmed/12689769" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14373</code><code>PubMed&lt;/a&gt;</code></p><p><code>14374</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14375</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Trends+Neurosci&amp;amp;title=It+could+be+habit+forming:+drugs+of+abuse+and+striatal+synaptic+plasticity&amp;amp;author=GL+Gerdeman&amp;amp;author=JG+Partridge&amp;amp;author=CR+Lupica&amp;amp;author=DM+Lovinger&amp;amp;volume=26&amp;amp;publication_year=2003&amp;amp;pages=184-192&amp;amp;pmid=12689769&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14376</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14377</code><code>]&lt;/span&gt;</code></p><p><code>14378</code><code>&lt;/span&gt;</code></p><p><code>14379</code><code>&lt;/li&gt;</code></p><p><code>14380</code><code>&lt;li id="R381"&gt;</code></p><p><code>14381</code><code>&lt;span class="citation"&gt;</code></p><p><code>14382</code><code>Gerdeman GL, Ronesi J, Lovinger DM. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. &lt;span&gt;</code></p><p><code>14383</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14384</code><code>Nat Neurosci. &lt;/span&gt;</code></p><p><code>14385</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>14386</code><code>5&lt;/span&gt;</code></p><p><code>14387</code><code>:446–451.&lt;/span&gt;</code></p><p><code>14388</code><code> [&lt;a href="/pubmed/11976704" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14389</code><code>PubMed&lt;/a&gt;</code></p><p><code>14390</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14391</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Neurosci&amp;amp;title=Postsynaptic+endocannabinoid+release+is+critical+to+long-term+depression+in+the+striatum&amp;amp;author=GL+Gerdeman&amp;amp;author=J+Ronesi&amp;amp;author=DM+Lovinger&amp;amp;volume=5&amp;amp;publication_year=2002&amp;amp;pages=446-451&amp;amp;pmid=11976704&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14392</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14393</code><code>]&lt;/span&gt;</code></p><p><code>14394</code><code>&lt;/span&gt;</code></p><p><code>14395</code><code>&lt;/li&gt;</code></p><p><code>14396</code><code>&lt;li id="R382"&gt;</code></p><p><code>14397</code><code>&lt;span class="citation"&gt;</code></p><p><code>14398</code><code>Germain N, Boichot E, Advenier C, Berdyshev EV, Lagente V. Effect of the cannabinoid receptor ligand, WIN 55,212-2, on superoxide anion and TNF-&lt;em&gt;</code></p><p><code>14399</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>14400</code><code> production by human mononuclear cells. &lt;span&gt;</code></p><p><code>14401</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14402</code><code>Int Immunopharmacol. &lt;/span&gt;</code></p><p><code>14403</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>14404</code><code>2&lt;/span&gt;</code></p><p><code>14405</code><code>:537–543.&lt;/span&gt;</code></p><p><code>14406</code><code> [&lt;a href="/pubmed/11962732" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14407</code><code>PubMed&lt;/a&gt;</code></p><p><code>14408</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14409</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Int+Immunopharmacol&amp;amp;title=Effect+of+the+cannabinoid+receptor+ligand,+WIN+55,212-2,+on+superoxide+anion+and+TNF-&amp;#x003b1;+production+by+human+mononuclear+cells&amp;amp;author=N+Germain&amp;amp;author=E+Boichot&amp;amp;author=C+Advenier&amp;amp;author=EV+Berdyshev&amp;amp;author=V+Lagente&amp;amp;volume=2&amp;amp;publication_year=2002&amp;amp;pages=537-543&amp;amp;pmid=11962732&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14410</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14411</code><code>]&lt;/span&gt;</code></p><p><code>14412</code><code>&lt;/span&gt;</code></p><p><code>14413</code><code>&lt;/li&gt;</code></p><p><code>14414</code><code>&lt;li id="R383"&gt;</code></p><p><code>14415</code><code>&lt;span class="citation"&gt;</code></p><p><code>14416</code><code>Germano MP, D&amp;#x02019;Angelo V, Mondello MR, Pergolizzi S, Capasso F, Capasso R, Izzo AA, Mascolo N, De Pasquale R. Cannabinoid CB&lt;sub&gt;</code></p><p><code>14417</code><code>1&lt;/sub&gt;</code></p><p><code>14418</code><code>-mediated inhibition of stress-induced gastric ulcers in rats. &lt;span&gt;</code></p><p><code>14419</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14420</code><code>Naunyn-Schmiedeberg&amp;#x02019;s Arch Pharmacol. &lt;/span&gt;</code></p><p><code>14421</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>14422</code><code>363&lt;/span&gt;</code></p><p><code>14423</code><code>:241–244.&lt;/span&gt;</code></p><p><code>14424</code><code> [&lt;a href="/pubmed/11218077" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14425</code><code>PubMed&lt;/a&gt;</code></p><p><code>14426</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14427</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Naunyn-Schmiedeberg&amp;#x02019;s+Arch+Pharmacol&amp;amp;title=Cannabinoid+CB1-mediated+inhibition+of+stress-induced+gastric+ulcers+in+rats&amp;amp;author=MP+Germano&amp;amp;author=V+D&amp;#x02019;Angelo&amp;amp;author=MR+Mondello&amp;amp;author=S+Pergolizzi&amp;amp;author=F+Capasso&amp;amp;volume=363&amp;amp;publication_year=2001&amp;amp;pages=241-244&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14428</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14429</code><code>]&lt;/span&gt;</code></p><p><code>14430</code><code>&lt;/span&gt;</code></p><p><code>14431</code><code>&lt;/li&gt;</code></p><p><code>14432</code><code>&lt;li id="R384"&gt;</code></p><p><code>14433</code><code>&lt;span class="citation"&gt;</code></p><p><code>14434</code><code>Gessa GL, Orru A, Lai P, Maccioni P, Lecca R, Lobina C, Carai MA, Colombo G. Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats. &lt;span&gt;</code></p><p><code>14435</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14436</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>14437</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>14438</code><code>185&lt;/span&gt;</code></p><p><code>14439</code><code>:248–254.&lt;/span&gt;</code></p><p><code>14440</code><code> [&lt;a href="/pubmed/16491428" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14441</code><code>PubMed&lt;/a&gt;</code></p><p><code>14442</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14443</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Lack+of+tolerance+to+the+suppressing+effect+of+rimonabant+on+chocolate+intake+in+rats&amp;amp;author=GL+Gessa&amp;amp;author=A+Orru&amp;amp;author=P+Lai&amp;amp;author=P+Maccioni&amp;amp;author=R+Lecca&amp;amp;volume=185&amp;amp;publication_year=2006&amp;amp;pages=248-254&amp;amp;pmid=16491428&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14444</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14445</code><code>]&lt;/span&gt;</code></p><p><code>14446</code><code>&lt;/span&gt;</code></p><p><code>14447</code><code>&lt;/li&gt;</code></p><p><code>14448</code><code>&lt;li id="R385"&gt;</code></p><p><code>14449</code><code>&lt;span class="citation"&gt;</code></p><p><code>14450</code><code>Ghozland S, Matthes HW, Simonin F, Filliol D, Kieffer BL, Maldonado R. Motivational effects of cannabinoids are mediated by &lt;em&gt;</code></p><p><code>14451</code><code>&amp;#x003bc;&lt;/em&gt;</code></p><p><code>14452</code><code>-opioid and &lt;em&gt;</code></p><p><code>14453</code><code>&amp;#x003ba;&lt;/em&gt;</code></p><p><code>14454</code><code>-opioid receptors. &lt;span&gt;</code></p><p><code>14455</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14456</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>14457</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>14458</code><code>22&lt;/span&gt;</code></p><p><code>14459</code><code>:1146–1154.&lt;/span&gt;</code></p><p><code>14460</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>14461</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6758535/"&gt;</code></p><p><code>14462</code><code>PMC free article&lt;/a&gt;</code></p><p><code>14463</code><code>]&lt;/span&gt;</code></p><p><code>14464</code><code> [&lt;a href="/pubmed/11826143" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14465</code><code>PubMed&lt;/a&gt;</code></p><p><code>14466</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14467</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Motivational+effects+of+cannabinoids+are+mediated+by+&amp;#x003bc;-opioid+and+&amp;#x003ba;-opioid+receptors&amp;amp;author=S+Ghozland&amp;amp;author=HW+Matthes&amp;amp;author=F+Simonin&amp;amp;author=D+Filliol&amp;amp;author=BL+Kieffer&amp;amp;volume=22&amp;amp;publication_year=2002&amp;amp;pages=1146-1154&amp;amp;pmid=11826143&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14468</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14469</code><code>]&lt;/span&gt;</code></p><p><code>14470</code><code>&lt;/span&gt;</code></p><p><code>14471</code><code>&lt;/li&gt;</code></p><p><code>14472</code><code>&lt;li id="R386"&gt;</code></p><p><code>14473</code><code>&lt;span class="citation"&gt;</code></p><p><code>14474</code><code>Gifford AN, Ashby CR., Jr Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. &lt;span&gt;</code></p><p><code>14475</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14476</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>14477</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>14478</code><code>277&lt;/span&gt;</code></p><p><code>14479</code><code>:1431–1436.&lt;/span&gt;</code></p><p><code>14480</code><code> [&lt;a href="/pubmed/8667207" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14481</code><code>PubMed&lt;/a&gt;</code></p><p><code>14482</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14483</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Electrically+evoked+acetylcholine+release+from+hippocampal+slices+is+inhibited+by+the+cannabinoid+receptor+agonist,+WIN+55212-2,+and+is+potentiated+by+the+cannabinoid+antagonist,+SR+141716A&amp;amp;author=AN+Gifford&amp;amp;author=CR+Ashby&amp;amp;volume=277&amp;amp;publication_year=1996&amp;amp;pages=1431-1436&amp;amp;pmid=8667207&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14484</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14485</code><code>]&lt;/span&gt;</code></p><p><code>14486</code><code>&lt;/span&gt;</code></p><p><code>14487</code><code>&lt;/li&gt;</code></p><p><code>14488</code><code>&lt;li id="R387"&gt;</code></p><p><code>14489</code><code>&lt;span class="citation"&gt;</code></p><p><code>14490</code><code>Gilgun-Sherki Y, Melamed E, Mechoulam R, Offen D. The CB&lt;sub&gt;</code></p><p><code>14491</code><code>1&lt;/sub&gt;</code></p><p><code>14492</code><code> cannabinoid receptor agonist, HU-210, reduces levodopa-induced rotations in 6-hydroxy-dopamine-lesioned rats. &lt;span&gt;</code></p><p><code>14493</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14494</code><code>Pharmacol Toxicol. &lt;/span&gt;</code></p><p><code>14495</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>14496</code><code>93&lt;/span&gt;</code></p><p><code>14497</code><code>:66–70.&lt;/span&gt;</code></p><p><code>14498</code><code> [&lt;a href="/pubmed/12899667" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14499</code><code>PubMed&lt;/a&gt;</code></p><p><code>14500</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14501</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Toxicol&amp;amp;title=The+CB1+cannabinoid+receptor+agonist,+HU-210,+reduces+levodopa-induced+rotations+in+6-hydroxy-dopamine-lesioned+rats&amp;amp;author=Y+Gilgun-Sherki&amp;amp;author=E+Melamed&amp;amp;author=R+Mechoulam&amp;amp;author=D+Offen&amp;amp;volume=93&amp;amp;publication_year=2003&amp;amp;pages=66-70&amp;amp;pmid=12899667&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14502</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14503</code><code>]&lt;/span&gt;</code></p><p><code>14504</code><code>&lt;/span&gt;</code></p><p><code>14505</code><code>&lt;/li&gt;</code></p><p><code>14506</code><code>&lt;li id="R388"&gt;</code></p><p><code>14507</code><code>&lt;span class="citation"&gt;</code></p><p><code>14508</code><code>Gingold AR, Bergasa NV. The cannabinoid agonist WIN 55,212-2 increases nociception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis. &lt;span&gt;</code></p><p><code>14509</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14510</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>14511</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>14512</code><code>73&lt;/span&gt;</code></p><p><code>14513</code><code>:2741–2747.&lt;/span&gt;</code></p><p><code>14514</code><code> [&lt;a href="/pubmed/13679241" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14515</code><code>PubMed&lt;/a&gt;</code></p><p><code>14516</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14517</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=The+cannabinoid+agonist+WIN+55,212-2+increases+nociception+threshold+in+cholestatic+rats:+implications+for+the+treatment+of+the+pruritus+of+cholestasis&amp;amp;author=AR+Gingold&amp;amp;author=NV+Bergasa&amp;amp;volume=73&amp;amp;publication_year=2003&amp;amp;pages=2741-2747&amp;amp;pmid=13679241&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14518</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14519</code><code>]&lt;/span&gt;</code></p><p><code>14520</code><code>&lt;/span&gt;</code></p><p><code>14521</code><code>&lt;/li&gt;</code></p><p><code>14522</code><code>&lt;li id="R389"&gt;</code></p><p><code>14523</code><code>&lt;span class="citation"&gt;</code></p><p><code>14524</code><code>Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. &lt;span&gt;</code></p><p><code>14525</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14526</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>14527</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>14528</code><code>379&lt;/span&gt;</code></p><p><code>14529</code><code>:606–612.&lt;/span&gt;</code></p><p><code>14530</code><code> [&lt;a href="/pubmed/8628395" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14531</code><code>PubMed&lt;/a&gt;</code></p><p><code>14532</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14533</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Hyperlocomotion+and+indifference+to+cocaine+and+amphetamine+in+mice+lacking+the+dopamine+transporter&amp;amp;author=B+Giros&amp;amp;author=M+Jaber&amp;amp;author=SR+Jones&amp;amp;author=RM+Wightman&amp;amp;author=MG+Caron&amp;amp;volume=379&amp;amp;publication_year=1996&amp;amp;pages=606-612&amp;amp;pmid=8628395&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14534</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14535</code><code>]&lt;/span&gt;</code></p><p><code>14536</code><code>&lt;/span&gt;</code></p><p><code>14537</code><code>&lt;/li&gt;</code></p><p><code>14538</code><code>&lt;li id="R390"&gt;</code></p><p><code>14539</code><code>&lt;span class="citation"&gt;</code></p><p><code>14540</code><code>Giuffrida A, Leweke FM, Gerth CW, Schreiber D, Koethe D, Faulhaber J, Klosterkotter J, Piomelli D. Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. &lt;span&gt;</code></p><p><code>14541</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14542</code><code>Neuropsychopharmacology. &lt;/span&gt;</code></p><p><code>14543</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>14544</code><code>29&lt;/span&gt;</code></p><p><code>14545</code><code>:2108–2114.&lt;/span&gt;</code></p><p><code>14546</code><code> [&lt;a href="/pubmed/15354183" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14547</code><code>PubMed&lt;/a&gt;</code></p><p><code>14548</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14549</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;amp;title=Cerebrospinal+anandamide+levels+are+elevated+in+acute+schizophrenia+and+are+inversely+correlated+with+psychotic+symptoms&amp;amp;author=A+Giuffrida&amp;amp;author=FM+Leweke&amp;amp;author=CW+Gerth&amp;amp;author=D+Schreiber&amp;amp;author=D+Koethe&amp;amp;volume=29&amp;amp;publication_year=2004&amp;amp;pages=2108-2114&amp;amp;pmid=15354183&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14550</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14551</code><code>]&lt;/span&gt;</code></p><p><code>14552</code><code>&lt;/span&gt;</code></p><p><code>14553</code><code>&lt;/li&gt;</code></p><p><code>14554</code><code>&lt;li id="R391"&gt;</code></p><p><code>14555</code><code>&lt;span class="citation"&gt;</code></p><p><code>14556</code><code>Giuffrida A, Parsons LH, Kerr TM, Rodriguez de Fonseca F, Navarro M, Piomelli D. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. &lt;span&gt;</code></p><p><code>14557</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14558</code><code>Nat Neurosci. &lt;/span&gt;</code></p><p><code>14559</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>14560</code><code>2&lt;/span&gt;</code></p><p><code>14561</code><code>:358–363.&lt;/span&gt;</code></p><p><code>14562</code><code> [&lt;a href="/pubmed/10204543" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14563</code><code>PubMed&lt;/a&gt;</code></p><p><code>14564</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14565</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Neurosci&amp;amp;title=Dopamine+activation+of+endogenous+cannabinoid+signaling+in+dorsal+striatum&amp;amp;author=A+Giuffrida&amp;amp;author=LH+Parsons&amp;amp;author=TM+Kerr&amp;amp;author=F+Rodriguez+de+Fonseca&amp;amp;author=M+Navarro&amp;amp;volume=2&amp;amp;publication_year=1999&amp;amp;pages=358-363&amp;amp;pmid=10204543&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14566</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14567</code><code>]&lt;/span&gt;</code></p><p><code>14568</code><code>&lt;/span&gt;</code></p><p><code>14569</code><code>&lt;/li&gt;</code></p><p><code>14570</code><code>&lt;li id="R392"&gt;</code></p><p><code>14571</code><code>&lt;span class="citation"&gt;</code></p><p><code>14572</code><code>Giuliani D, Ferrari F, Ottani A. The cannabinoid agonist HU210 modifies behavioural responses to novelty and stress. &lt;span&gt;</code></p><p><code>14573</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14574</code><code>Pharmacol Res. &lt;/span&gt;</code></p><p><code>14575</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>14576</code><code>41&lt;/span&gt;</code></p><p><code>14577</code><code>:45–51.&lt;/span&gt;</code></p><p><code>14578</code><code> [&lt;a href="/pubmed/10712826" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14579</code><code>PubMed&lt;/a&gt;</code></p><p><code>14580</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14581</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Res&amp;amp;title=The+cannabinoid+agonist+HU210+modifies+behavioural+responses+to+novelty+and+stress&amp;amp;author=D+Giuliani&amp;amp;author=F+Ferrari&amp;amp;author=A+Ottani&amp;amp;volume=41&amp;amp;publication_year=2000&amp;amp;pages=45-51&amp;amp;pmid=10712826&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14582</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14583</code><code>]&lt;/span&gt;</code></p><p><code>14584</code><code>&lt;/span&gt;</code></p><p><code>14585</code><code>&lt;/li&gt;</code></p><p><code>14586</code><code>&lt;li id="R393"&gt;</code></p><p><code>14587</code><code>&lt;span class="citation"&gt;</code></p><p><code>14588</code><code>Glaser ST, Abumrad NA, Fatade F, Kaczocha M, Studholme KM, Deutsch DG. Evidence against the presence of an anandamide transporter. &lt;span&gt;</code></p><p><code>14589</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14590</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>14591</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>14592</code><code>100&lt;/span&gt;</code></p><p><code>14593</code><code>:4269–4274.&lt;/span&gt;</code></p><p><code>14594</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>14595</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC153082/"&gt;</code></p><p><code>14596</code><code>PMC free article&lt;/a&gt;</code></p><p><code>14597</code><code>]&lt;/span&gt;</code></p><p><code>14598</code><code> [&lt;a href="/pubmed/12655057" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14599</code><code>PubMed&lt;/a&gt;</code></p><p><code>14600</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14601</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Evidence+against+the+presence+of+an+anandamide+transporter&amp;amp;author=ST+Glaser&amp;amp;author=NA+Abumrad&amp;amp;author=F+Fatade&amp;amp;author=M+Kaczocha&amp;amp;author=KM+Studholme&amp;amp;volume=100&amp;amp;publication_year=2003&amp;amp;pages=4269-4274&amp;amp;pmid=12655057&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14602</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14603</code><code>]&lt;/span&gt;</code></p><p><code>14604</code><code>&lt;/span&gt;</code></p><p><code>14605</code><code>&lt;/li&gt;</code></p><p><code>14606</code><code>&lt;li id="R394"&gt;</code></p><p><code>14607</code><code>&lt;span class="citation"&gt;</code></p><p><code>14608</code><code>Glaser ST, Kaczocha M, Deutsch DG. Anandamide transport: a critical review. &lt;span&gt;</code></p><p><code>14609</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14610</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>14611</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>14612</code><code>77&lt;/span&gt;</code></p><p><code>14613</code><code>:1584–1604.&lt;/span&gt;</code></p><p><code>14614</code><code> [&lt;a href="/pubmed/15979096" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14615</code><code>PubMed&lt;/a&gt;</code></p><p><code>14616</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14617</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Anandamide+transport:+a+critical+review&amp;amp;author=ST+Glaser&amp;amp;author=M+Kaczocha&amp;amp;author=DG+Deutsch&amp;amp;volume=77&amp;amp;publication_year=2005&amp;amp;pages=1584-1604&amp;amp;pmid=15979096&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14618</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14619</code><code>]&lt;/span&gt;</code></p><p><code>14620</code><code>&lt;/span&gt;</code></p><p><code>14621</code><code>&lt;/li&gt;</code></p><p><code>14622</code><code>&lt;li id="R395"&gt;</code></p><p><code>14623</code><code>&lt;span class="citation"&gt;</code></p><p><code>14624</code><code>Glass M. The role of cannabinoids in neurodegenerative diseases. &lt;span&gt;</code></p><p><code>14625</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14626</code><code>Prog Neuropsychopharmacol Biol Psychiatry. &lt;/span&gt;</code></p><p><code>14627</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>14628</code><code>25&lt;/span&gt;</code></p><p><code>14629</code><code>:743–765.&lt;/span&gt;</code></p><p><code>14630</code><code> [&lt;a href="/pubmed/11383976" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14631</code><code>PubMed&lt;/a&gt;</code></p><p><code>14632</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14633</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Prog+Neuropsychopharmacol+Biol+Psychiatry&amp;amp;title=The+role+of+cannabinoids+in+neurodegenerative+diseases&amp;amp;author=M+Glass&amp;amp;volume=25&amp;amp;publication_year=2001&amp;amp;pages=743-765&amp;amp;pmid=11383976&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14634</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14635</code><code>]&lt;/span&gt;</code></p><p><code>14636</code><code>&lt;/span&gt;</code></p><p><code>14637</code><code>&lt;/li&gt;</code></p><p><code>14638</code><code>&lt;li id="R396"&gt;</code></p><p><code>14639</code><code>&lt;span class="citation"&gt;</code></p><p><code>14640</code><code>Glass M, Brotchie JM, Maneuf YP. Modulation of neurotransmission by cannabinoids in the basal ganglia. &lt;span&gt;</code></p><p><code>14641</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14642</code><code>Eur J Neurosci. &lt;/span&gt;</code></p><p><code>14643</code><code>1997a;&lt;span class="ref-vol"&gt;</code></p><p><code>14644</code><code>9&lt;/span&gt;</code></p><p><code>14645</code><code>:199–203.&lt;/span&gt;</code></p><p><code>14646</code><code> [&lt;a href="/pubmed/9058040" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14647</code><code>PubMed&lt;/a&gt;</code></p><p><code>14648</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14649</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurosci&amp;amp;title=Modulation+of+neurotransmission+by+cannabinoids+in+the+basal+ganglia&amp;amp;author=M+Glass&amp;amp;author=JM+Brotchie&amp;amp;author=YP+Maneuf&amp;amp;volume=9&amp;amp;publication_year=1997a&amp;amp;pages=199-203&amp;amp;pmid=9058040&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14650</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14651</code><code>]&lt;/span&gt;</code></p><p><code>14652</code><code>&lt;/span&gt;</code></p><p><code>14653</code><code>&lt;/li&gt;</code></p><p><code>14654</code><code>&lt;li id="R397"&gt;</code></p><p><code>14655</code><code>&lt;span class="citation"&gt;</code></p><p><code>14656</code><code>Glass M, Dragunow M, Faull RL. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. &lt;span&gt;</code></p><p><code>14657</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14658</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>14659</code><code>1997b;&lt;span class="ref-vol"&gt;</code></p><p><code>14660</code><code>77&lt;/span&gt;</code></p><p><code>14661</code><code>:299–318.&lt;/span&gt;</code></p><p><code>14662</code><code> [&lt;a href="/pubmed/9472392" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14663</code><code>PubMed&lt;/a&gt;</code></p><p><code>14664</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14665</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Cannabinoid+receptors+in+the+human+brain:+a+detailed+anatomical+and+quantitative+autoradiographic+study+in+the+fetal,+neonatal+and+adult+human+brain&amp;amp;author=M+Glass&amp;amp;author=M+Dragunow&amp;amp;author=RL+Faull&amp;amp;volume=77&amp;amp;publication_year=1997b&amp;amp;pages=299-318&amp;amp;pmid=9472392&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14666</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14667</code><code>]&lt;/span&gt;</code></p><p><code>14668</code><code>&lt;/span&gt;</code></p><p><code>14669</code><code>&lt;/li&gt;</code></p><p><code>14670</code><code>&lt;li id="R398"&gt;</code></p><p><code>14671</code><code>&lt;span class="citation"&gt;</code></p><p><code>14672</code><code>Glass M, Dragunow M, Faull RL. The pattern of neurodegeneration in Huntington&amp;#x02019;s disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>14673</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14674</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>14675</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>14676</code><code>97&lt;/span&gt;</code></p><p><code>14677</code><code>:505–519.&lt;/span&gt;</code></p><p><code>14678</code><code> [&lt;a href="/pubmed/10828533" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14679</code><code>PubMed&lt;/a&gt;</code></p><p><code>14680</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14681</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=The+pattern+of+neurodegeneration+in+Huntington&amp;#x02019;s+disease:+a+comparative+study+of+cannabinoid,+dopamine,+adenosine+and+GABA(A)+receptor+alterations+in+the+human+basal+ganglia+in+Huntington&amp;#x02019;s+disease&amp;amp;author=M+Glass&amp;amp;author=M+Dragunow&amp;amp;author=RL+Faull&amp;amp;volume=97&amp;amp;publication_year=2000&amp;amp;pages=505-519&amp;amp;pmid=10828533&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14682</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14683</code><code>]&lt;/span&gt;</code></p><p><code>14684</code><code>&lt;/span&gt;</code></p><p><code>14685</code><code>&lt;/li&gt;</code></p><p><code>14686</code><code>&lt;li id="R399"&gt;</code></p><p><code>14687</code><code>&lt;span class="citation"&gt;</code></p><p><code>14688</code><code>Glass M, Faull RL, Dragunow M. Loss of cannabinoid receptors in the substantia nigra in Huntington&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>14689</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14690</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>14691</code><code>1993;&lt;span class="ref-vol"&gt;</code></p><p><code>14692</code><code>56&lt;/span&gt;</code></p><p><code>14693</code><code>:523–527.&lt;/span&gt;</code></p><p><code>14694</code><code> [&lt;a href="/pubmed/8255419" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14695</code><code>PubMed&lt;/a&gt;</code></p><p><code>14696</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14697</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Loss+of+cannabinoid+receptors+in+the+substantia+nigra+in+Huntington&amp;#x02019;s+disease&amp;amp;author=M+Glass&amp;amp;author=RL+Faull&amp;amp;author=M+Dragunow&amp;amp;volume=56&amp;amp;publication_year=1993&amp;amp;pages=523-527&amp;amp;pmid=8255419&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14698</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14699</code><code>]&lt;/span&gt;</code></p><p><code>14700</code><code>&lt;/span&gt;</code></p><p><code>14701</code><code>&lt;/li&gt;</code></p><p><code>14702</code><code>&lt;li id="R400"&gt;</code></p><p><code>14703</code><code>&lt;span class="citation"&gt;</code></p><p><code>14704</code><code>Glass M, Felder CC. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a G&lt;sub&gt;</code></p><p><code>14705</code><code>s&lt;/sub&gt;</code></p><p><code>14706</code><code> linkage to the CB1 receptor. &lt;span&gt;</code></p><p><code>14707</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14708</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>14709</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>14710</code><code>17&lt;/span&gt;</code></p><p><code>14711</code><code>:5327–5333.&lt;/span&gt;</code></p><p><code>14712</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>14713</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6793808/"&gt;</code></p><p><code>14714</code><code>PMC free article&lt;/a&gt;</code></p><p><code>14715</code><code>]&lt;/span&gt;</code></p><p><code>14716</code><code> [&lt;a href="/pubmed/9204917" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14717</code><code>PubMed&lt;/a&gt;</code></p><p><code>14718</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14719</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Concurrent+stimulation+of+cannabinoid+CB1+and+dopamine+D2+receptors+augments+cAMP+accumulation+in+striatal+neurons:+evidence+for+a+Gs+linkage+to+the+CB1+receptor&amp;amp;author=M+Glass&amp;amp;author=CC+Felder&amp;amp;volume=17&amp;amp;publication_year=1997&amp;amp;pages=5327-5333&amp;amp;pmid=9204917&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14720</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14721</code><code>]&lt;/span&gt;</code></p><p><code>14722</code><code>&lt;/span&gt;</code></p><p><code>14723</code><code>&lt;/li&gt;</code></p><p><code>14724</code><code>&lt;li id="R401"&gt;</code></p><p><code>14725</code><code>&lt;span class="citation"&gt;</code></p><p><code>14726</code><code>Glass M, Northup JK. Agonist selective regulation of G proteins by cannabinoid CB&lt;sub&gt;</code></p><p><code>14727</code><code>1&lt;/sub&gt;</code></p><p><code>14728</code><code> and CB&lt;sub&gt;</code></p><p><code>14729</code><code>2&lt;/sub&gt;</code></p><p><code>14730</code><code> receptors. &lt;span&gt;</code></p><p><code>14731</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14732</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>14733</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>14734</code><code>56&lt;/span&gt;</code></p><p><code>14735</code><code>:1362–1369.&lt;/span&gt;</code></p><p><code>14736</code><code> [&lt;a href="/pubmed/10570066" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14737</code><code>PubMed&lt;/a&gt;</code></p><p><code>14738</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14739</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=Agonist+selective+regulation+of+G+proteins+by+cannabinoid+CB1+and+CB2+receptors&amp;amp;author=M+Glass&amp;amp;author=JK+Northup&amp;amp;volume=56&amp;amp;publication_year=1999&amp;amp;pages=1362-1369&amp;amp;pmid=10570066&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14740</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14741</code><code>]&lt;/span&gt;</code></p><p><code>14742</code><code>&lt;/span&gt;</code></p><p><code>14743</code><code>&lt;/li&gt;</code></p><p><code>14744</code><code>&lt;li id="R402"&gt;</code></p><p><code>14745</code><code>&lt;span class="citation"&gt;</code></p><p><code>14746</code><code>Glass M, van Dellen A, Blakemore C, Hannan AJ, Faull RL. Delayed onset of Huntington&amp;#x02019;s disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors. &lt;span&gt;</code></p><p><code>14747</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14748</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>14749</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>14750</code><code>123&lt;/span&gt;</code></p><p><code>14751</code><code>:207–212.&lt;/span&gt;</code></p><p><code>14752</code><code> [&lt;a href="/pubmed/14667455" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14753</code><code>PubMed&lt;/a&gt;</code></p><p><code>14754</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14755</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Delayed+onset+of+Huntington&amp;#x02019;s+disease+in+mice+in+an+enriched+environment+correlates+with+delayed+loss+of+cannabinoid+CB1+receptors&amp;amp;author=M+Glass&amp;amp;author=A+van+Dellen&amp;amp;author=C+Blakemore&amp;amp;author=AJ+Hannan&amp;amp;author=RL+Faull&amp;amp;volume=123&amp;amp;publication_year=2004&amp;amp;pages=207-212&amp;amp;pmid=14667455&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14756</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14757</code><code>]&lt;/span&gt;</code></p><p><code>14758</code><code>&lt;/span&gt;</code></p><p><code>14759</code><code>&lt;/li&gt;</code></p><p><code>14760</code><code>&lt;li id="R403"&gt;</code></p><p><code>14761</code><code>&lt;span class="citation"&gt;</code></p><p><code>14762</code><code>Glass RM, Uhlenhuth EH, Hartel FW, Schuster CR, Fischman MW. A single dose study of nabilone, a synthetic cannabinoid. &lt;span&gt;</code></p><p><code>14763</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14764</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>14765</code><code>1980;&lt;span class="ref-vol"&gt;</code></p><p><code>14766</code><code>71&lt;/span&gt;</code></p><p><code>14767</code><code>:137–142.&lt;/span&gt;</code></p><p><code>14768</code><code> [&lt;a href="/pubmed/6108592" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14769</code><code>PubMed&lt;/a&gt;</code></p><p><code>14770</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14771</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=A+single+dose+study+of+nabilone,+a+synthetic+cannabinoid&amp;amp;author=RM+Glass&amp;amp;author=EH+Uhlenhuth&amp;amp;author=FW+Hartel&amp;amp;author=CR+Schuster&amp;amp;author=MW+Fischman&amp;amp;volume=71&amp;amp;publication_year=1980&amp;amp;pages=137-142&amp;amp;pmid=6108592&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14772</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14773</code><code>]&lt;/span&gt;</code></p><p><code>14774</code><code>&lt;/span&gt;</code></p><p><code>14775</code><code>&lt;/li&gt;</code></p><p><code>14776</code><code>&lt;li id="R404"&gt;</code></p><p><code>14777</code><code>&lt;span class="citation"&gt;</code></p><p><code>14778</code><code>Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG, Debonnel G, Duranti A, et al.  Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. &lt;span&gt;</code></p><p><code>14779</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14780</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>14781</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>14782</code><code>102&lt;/span&gt;</code></p><p><code>14783</code><code>:18620–18625.&lt;/span&gt;</code></p><p><code>14784</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>14785</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1317988/"&gt;</code></p><p><code>14786</code><code>PMC free article&lt;/a&gt;</code></p><p><code>14787</code><code>]&lt;/span&gt;</code></p><p><code>14788</code><code> [&lt;a href="/pubmed/16352709" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14789</code><code>PubMed&lt;/a&gt;</code></p><p><code>14790</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14791</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Antidepressant-like+activity+and+modulation+of+brain+monoaminergic+transmission+by+blockade+of+anandamide+hydrolysis&amp;amp;author=G+Gobbi&amp;amp;author=FR+Bambico&amp;amp;author=R+Mangieri&amp;amp;author=M+Bortolato&amp;amp;author=P+Campolongo&amp;amp;volume=102&amp;amp;publication_year=2005&amp;amp;pages=18620-18625&amp;amp;pmid=16352709&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14792</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14793</code><code>]&lt;/span&gt;</code></p><p><code>14794</code><code>&lt;/span&gt;</code></p><p><code>14795</code><code>&lt;/li&gt;</code></p><p><code>14796</code><code>&lt;li id="R405"&gt;</code></p><p><code>14797</code><code>&lt;span class="citation"&gt;</code></p><p><code>14798</code><code>Godino MC, Torres M, Sanchez-Prieto J. Inhibition of N- and P/Q-type Ca&lt;sup&gt;</code></p><p><code>14799</code><code>2+&lt;/sup&gt;</code></p><p><code>14800</code><code> channels by cannabinoid receptors in single cerebrocortical nerve terminals. &lt;span&gt;</code></p><p><code>14801</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14802</code><code>FEBS Lett. &lt;/span&gt;</code></p><p><code>14803</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>14804</code><code>579&lt;/span&gt;</code></p><p><code>14805</code><code>:768–772.&lt;/span&gt;</code></p><p><code>14806</code><code> [&lt;a href="/pubmed/15670844" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14807</code><code>PubMed&lt;/a&gt;</code></p><p><code>14808</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14809</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;amp;title=Inhibition+of+N-+and+P/Q-type+Ca2++channels+by+cannabinoid+receptors+in+single+cerebrocortical+nerve+terminals&amp;amp;author=MC+Godino&amp;amp;author=M+Torres&amp;amp;author=J+Sanchez-Prieto&amp;amp;volume=579&amp;amp;publication_year=2005&amp;amp;pages=768-772&amp;amp;pmid=15670844&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14810</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14811</code><code>]&lt;/span&gt;</code></p><p><code>14812</code><code>&lt;/span&gt;</code></p><p><code>14813</code><code>&lt;/li&gt;</code></p><p><code>14814</code><code>&lt;li id="R406"&gt;</code></p><p><code>14815</code><code>&lt;span class="citation"&gt;</code></p><p><code>14816</code><code>Godlewski G, Malinowska B, Schlicker E. Presynaptic cannabinoid CB&lt;sub&gt;</code></p><p><code>14817</code><code>1&lt;/sub&gt;</code></p><p><code>14818</code><code> receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed rats. &lt;span&gt;</code></p><p><code>14819</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14820</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>14821</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>14822</code><code>142&lt;/span&gt;</code></p><p><code>14823</code><code>:701–708.&lt;/span&gt;</code></p><p><code>14824</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>14825</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1575049/"&gt;</code></p><p><code>14826</code><code>PMC free article&lt;/a&gt;</code></p><p><code>14827</code><code>]&lt;/span&gt;</code></p><p><code>14828</code><code> [&lt;a href="/pubmed/15159284" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14829</code><code>PubMed&lt;/a&gt;</code></p><p><code>14830</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14831</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Presynaptic+cannabinoid+CB1+receptors+are+involved+in+the+inhibition+of+the+neurogenic+vasopressor+response+during+septic+shock+in+pithed+rats&amp;amp;author=G+Godlewski&amp;amp;author=B+Malinowska&amp;amp;author=E+Schlicker&amp;amp;volume=142&amp;amp;publication_year=2004&amp;amp;pages=701-708&amp;amp;pmid=15159284&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14832</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14833</code><code>]&lt;/span&gt;</code></p><p><code>14834</code><code>&lt;/span&gt;</code></p><p><code>14835</code><code>&lt;/li&gt;</code></p><p><code>14836</code><code>&lt;li id="R407"&gt;</code></p><p><code>14837</code><code>&lt;span class="citation"&gt;</code></p><p><code>14838</code><code>G&amp;#x000f3;mez Del Pulgar T, De Ceballos ML, Guzman M, Velasco G. Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway. &lt;span&gt;</code></p><p><code>14839</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14840</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>14841</code><code>2002a;&lt;span class="ref-vol"&gt;</code></p><p><code>14842</code><code>277&lt;/span&gt;</code></p><p><code>14843</code><code>:36527–36533.&lt;/span&gt;</code></p><p><code>14844</code><code> [&lt;a href="/pubmed/12133838" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14845</code><code>PubMed&lt;/a&gt;</code></p><p><code>14846</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14847</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=Cannabinoids+protect+astrocytes+from+ceramide-induced+apoptosis+through+the+phosphatidylinositol+3-kinase/protein+kinase+B+pathway&amp;amp;author=T+G&amp;#x000f3;mez+Del+Pulgar&amp;amp;author=ML+De+Ceballos&amp;amp;author=M+Guzman&amp;amp;author=G+Velasco&amp;amp;volume=277&amp;amp;publication_year=2002a&amp;amp;pages=36527-36533&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14848</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14849</code><code>]&lt;/span&gt;</code></p><p><code>14850</code><code>&lt;/span&gt;</code></p><p><code>14851</code><code>&lt;/li&gt;</code></p><p><code>14852</code><code>&lt;li id="R408"&gt;</code></p><p><code>14853</code><code>&lt;span class="citation"&gt;</code></p><p><code>14854</code><code>G&amp;#x000f3;mez Del Pulgar T, Velasco G, Guzman M. The CB&lt;sub&gt;</code></p><p><code>14855</code><code>1&lt;/sub&gt;</code></p><p><code>14856</code><code> cannabinoid receptor is coupled to the activation of protein kinase B/Akt. &lt;span&gt;</code></p><p><code>14857</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14858</code><code>Biochem J. &lt;/span&gt;</code></p><p><code>14859</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>14860</code><code>347&lt;/span&gt;</code></p><p><code>14861</code><code>:369–373.&lt;/span&gt;</code></p><p><code>14862</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>14863</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1220968/"&gt;</code></p><p><code>14864</code><code>PMC free article&lt;/a&gt;</code></p><p><code>14865</code><code>]&lt;/span&gt;</code></p><p><code>14866</code><code> [&lt;a href="/pubmed/10749665" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14867</code><code>PubMed&lt;/a&gt;</code></p><p><code>14868</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14869</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+J&amp;amp;title=The+CB1+cannabinoid+receptor+is+coupled+to+the+activation+of+protein+kinase+B/Akt&amp;amp;author=T+G&amp;#x000f3;mez+Del+Pulgar&amp;amp;author=G+Velasco&amp;amp;author=M+Guzman&amp;amp;volume=347&amp;amp;publication_year=2000&amp;amp;pages=369-373&amp;amp;pmid=10749665&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14870</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14871</code><code>]&lt;/span&gt;</code></p><p><code>14872</code><code>&lt;/span&gt;</code></p><p><code>14873</code><code>&lt;/li&gt;</code></p><p><code>14874</code><code>&lt;li id="R409"&gt;</code></p><p><code>14875</code><code>&lt;span class="citation"&gt;</code></p><p><code>14876</code><code>G&amp;#x000f3;mez Del Pulgar T, Velasco G, Sanchez C, Haro A, Guzman M. De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis. &lt;span&gt;</code></p><p><code>14877</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14878</code><code>Biochem J. &lt;/span&gt;</code></p><p><code>14879</code><code>2002b;&lt;span class="ref-vol"&gt;</code></p><p><code>14880</code><code>363&lt;/span&gt;</code></p><p><code>14881</code><code>:183–188.&lt;/span&gt;</code></p><p><code>14882</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>14883</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1222465/"&gt;</code></p><p><code>14884</code><code>PMC free article&lt;/a&gt;</code></p><p><code>14885</code><code>]&lt;/span&gt;</code></p><p><code>14886</code><code> [&lt;a href="/pubmed/11903061" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14887</code><code>PubMed&lt;/a&gt;</code></p><p><code>14888</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14889</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+J&amp;amp;title=De+novo-synthesized+ceramide+is+involved+in+cannabinoid-induced+apoptosis&amp;amp;author=T+G&amp;#x000f3;mez+Del+Pulgar&amp;amp;author=G+Velasco&amp;amp;author=C+Sanchez&amp;amp;author=A+Haro&amp;amp;author=M+Guzman&amp;amp;volume=363&amp;amp;publication_year=2002b&amp;amp;pages=183-188&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14890</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14891</code><code>]&lt;/span&gt;</code></p><p><code>14892</code><code>&lt;/span&gt;</code></p><p><code>14893</code><code>&lt;/li&gt;</code></p><p><code>14894</code><code>&lt;li id="R410"&gt;</code></p><p><code>14895</code><code>&lt;span class="citation"&gt;</code></p><p><code>14896</code><code>Gomez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, Del Arco I, Cippitelli A, Nava F, Piomelli D, Rodriguez de Fonseca F. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. &lt;span&gt;</code></p><p><code>14897</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14898</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>14899</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>14900</code><code>22&lt;/span&gt;</code></p><p><code>14901</code><code>:9612–9617.&lt;/span&gt;</code></p><p><code>14902</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>14903</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6758016/"&gt;</code></p><p><code>14904</code><code>PMC free article&lt;/a&gt;</code></p><p><code>14905</code><code>]&lt;/span&gt;</code></p><p><code>14906</code><code> [&lt;a href="/pubmed/12417686" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14907</code><code>PubMed&lt;/a&gt;</code></p><p><code>14908</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14909</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=A+peripheral+mechanism+for+CB1+cannabinoid+receptor-dependent+modulation+of+feeding&amp;amp;author=R+Gomez&amp;amp;author=M+Navarro&amp;amp;author=B+Ferrer&amp;amp;author=JM+Trigo&amp;amp;author=A+Bilbao&amp;amp;volume=22&amp;amp;publication_year=2002&amp;amp;pages=9612-9617&amp;amp;pmid=12417686&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14910</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14911</code><code>]&lt;/span&gt;</code></p><p><code>14912</code><code>&lt;/span&gt;</code></p><p><code>14913</code><code>&lt;/li&gt;</code></p><p><code>14914</code><code>&lt;li id="R411"&gt;</code></p><p><code>14915</code><code>&lt;span class="citation"&gt;</code></p><p><code>14916</code><code>Gong J-P, Onaivi ES, Ishiguro H, Liu Q-R, Tagliaferro PA, Brusco A, Uhl GR. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. &lt;span&gt;</code></p><p><code>14917</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14918</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>14919</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>14920</code><code>1071&lt;/span&gt;</code></p><p><code>14921</code><code>:10–23.&lt;/span&gt;</code></p><p><code>14922</code><code> [&lt;a href="/pubmed/16472786" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14923</code><code>PubMed&lt;/a&gt;</code></p><p><code>14924</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14925</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Cannabinoid+CB2+receptors:+immunohistochemical+localization+in+rat+brain&amp;amp;author=J-P+Gong&amp;amp;author=ES+Onaivi&amp;amp;author=H+Ishiguro&amp;amp;author=Q-R+Liu&amp;amp;author=PA+Tagliaferro&amp;amp;volume=1071&amp;amp;publication_year=2006&amp;amp;pages=10-23&amp;amp;pmid=16472786&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14926</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14927</code><code>]&lt;/span&gt;</code></p><p><code>14928</code><code>&lt;/span&gt;</code></p><p><code>14929</code><code>&lt;/li&gt;</code></p><p><code>14930</code><code>&lt;li id="R412"&gt;</code></p><p><code>14931</code><code>&lt;span class="citation"&gt;</code></p><p><code>14932</code><code>Gonsiorek W, Lunn C, Fan X, Narula S, Lundell D, Hipkin RW. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. &lt;span&gt;</code></p><p><code>14933</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14934</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>14935</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>14936</code><code>57&lt;/span&gt;</code></p><p><code>14937</code><code>:1045–1050.&lt;/span&gt;</code></p><p><code>14938</code><code> [&lt;a href="/pubmed/10779390" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14939</code><code>PubMed&lt;/a&gt;</code></p><p><code>14940</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14941</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=Endocannabinoid+2-arachidonyl+glycerol+is+a+full+agonist+through+human+type+2+cannabinoid+receptor:+antagonism+by+anandamide&amp;amp;author=W+Gonsiorek&amp;amp;author=C+Lunn&amp;amp;author=X+Fan&amp;amp;author=S+Narula&amp;amp;author=D+Lundell&amp;amp;volume=57&amp;amp;publication_year=2000&amp;amp;pages=1045-1050&amp;amp;pmid=10779390&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14942</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14943</code><code>]&lt;/span&gt;</code></p><p><code>14944</code><code>&lt;/span&gt;</code></p><p><code>14945</code><code>&lt;/li&gt;</code></p><p><code>14946</code><code>&lt;li id="R413"&gt;</code></p><p><code>14947</code><code>&lt;span class="citation"&gt;</code></p><p><code>14948</code><code>Gonzalez S, Cascio MG, Fernandez-Ruiz J, Sparpaglione V, Parolaro D, Ramos JA. Changes in endocannabinoid content in the brain of rats chronically exposed to nicotine, ethanol or cocaine. &lt;span&gt;</code></p><p><code>14949</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14950</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>14951</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>14952</code><code>954&lt;/span&gt;</code></p><p><code>14953</code><code>:73–81.&lt;/span&gt;</code></p><p><code>14954</code><code> [&lt;a href="/pubmed/12393235" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14955</code><code>PubMed&lt;/a&gt;</code></p><p><code>14956</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14957</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Changes+in+endocannabinoid+content+in+the+brain+of+rats+chronically+exposed+to+nicotine,+ethanol+or+cocaine&amp;amp;author=S+Gonzalez&amp;amp;author=MG+Cascio&amp;amp;author=J+Fernandez-Ruiz&amp;amp;author=V+Sparpaglione&amp;amp;author=D+Parolaro&amp;amp;volume=954&amp;amp;publication_year=2002&amp;amp;pages=73-81&amp;amp;pmid=12393235&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14958</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14959</code><code>]&lt;/span&gt;</code></p><p><code>14960</code><code>&lt;/span&gt;</code></p><p><code>14961</code><code>&lt;/li&gt;</code></p><p><code>14962</code><code>&lt;li id="R414"&gt;</code></p><p><code>14963</code><code>&lt;span class="citation"&gt;</code></p><p><code>14964</code><code>Gonzalez S, Mena MA, Lastres-Becker I, Serrano A, de Yebenes JG, Ramos JA, Fernandez-Ruiz J. Cannabinoid CB&lt;sub&gt;</code></p><p><code>14965</code><code>1&lt;/sub&gt;</code></p><p><code>14966</code><code> receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice. &lt;span&gt;</code></p><p><code>14967</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14968</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>14969</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>14970</code><code>1046&lt;/span&gt;</code></p><p><code>14971</code><code>:195–206.&lt;/span&gt;</code></p><p><code>14972</code><code> [&lt;a href="/pubmed/15882845" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14973</code><code>PubMed&lt;/a&gt;</code></p><p><code>14974</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14975</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Cannabinoid+CB1+receptors+in+the+basal+ganglia+and+motor+response+to+activation+or+blockade+of+these+receptors+in+parkin-null+mice&amp;amp;author=S+Gonzalez&amp;amp;author=MA+Mena&amp;amp;author=I+Lastres-Becker&amp;amp;author=A+Serrano&amp;amp;author=JG+de+Yebenes&amp;amp;volume=1046&amp;amp;publication_year=2005&amp;amp;pages=195-206&amp;amp;pmid=15882845&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14976</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14977</code><code>]&lt;/span&gt;</code></p><p><code>14978</code><code>&lt;/span&gt;</code></p><p><code>14979</code><code>&lt;/li&gt;</code></p><p><code>14980</code><code>&lt;li id="R415"&gt;</code></p><p><code>14981</code><code>&lt;span class="citation"&gt;</code></p><p><code>14982</code><code>Gonzalez S, Scorticati C, Garcia-Arencibia M, de Miguel R, Ramos JA, Fernandez-Ruiz J. Effects of rimonabant, a selective cannabinoid CB&lt;sub&gt;</code></p><p><code>14983</code><code>1&lt;/sub&gt;</code></p><p><code>14984</code><code> receptor antagonist, in a rat model of Parkinson&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>14985</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>14986</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>14987</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>14988</code><code>1073&amp;#x02013;1074&lt;/span&gt;</code></p><p><code>14989</code><code>:209–219.&lt;/span&gt;</code></p><p><code>14990</code><code> [&lt;a href="/pubmed/16412990" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>14991</code><code>PubMed&lt;/a&gt;</code></p><p><code>14992</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>14993</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Effects+of+rimonabant,+a+selective+cannabinoid+CB1+receptor+antagonist,+in+a+rat+model+of+Parkinson&amp;#x02019;s+disease&amp;amp;author=S+Gonzalez&amp;amp;author=C+Scorticati&amp;amp;author=M+Garcia-Arencibia&amp;amp;author=R+de+Miguel&amp;amp;author=JA+Ramos&amp;amp;volume=1073&amp;#x02013;1074&amp;amp;publication_year=2006&amp;amp;pages=209-219&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>14994</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>14995</code><code>]&lt;/span&gt;</code></p><p><code>14996</code><code>&lt;/span&gt;</code></p><p><code>14997</code><code>&lt;/li&gt;</code></p><p><code>14998</code><code>&lt;li id="R416"&gt;</code></p><p><code>14999</code><code>&lt;span class="citation"&gt;</code></p><p><code>15000</code><code>Goparaju SK, Ueda N, Taniguchi K, Yamamoto S. Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. &lt;span&gt;</code></p><p><code>15001</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15002</code><code>Biochem Pharmacol. &lt;/span&gt;</code></p><p><code>15003</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>15004</code><code>57&lt;/span&gt;</code></p><p><code>15005</code><code>:417–423.&lt;/span&gt;</code></p><p><code>15006</code><code> [&lt;a href="/pubmed/9933030" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15007</code><code>PubMed&lt;/a&gt;</code></p><p><code>15008</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15009</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;amp;title=Enzymes+of+porcine+brain+hydrolyzing+2-arachidonoylglycerol,+an+endogenous+ligand+of+cannabinoid+receptors&amp;amp;author=SK+Goparaju&amp;amp;author=N+Ueda&amp;amp;author=K+Taniguchi&amp;amp;author=S+Yamamoto&amp;amp;volume=57&amp;amp;publication_year=1999&amp;amp;pages=417-423&amp;amp;pmid=9933030&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15010</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15011</code><code>]&lt;/span&gt;</code></p><p><code>15012</code><code>&lt;/span&gt;</code></p><p><code>15013</code><code>&lt;/li&gt;</code></p><p><code>15014</code><code>&lt;li id="R417"&gt;</code></p><p><code>15015</code><code>&lt;span class="citation"&gt;</code></p><p><code>15016</code><code>Goparaju SK, Ueda N, Yamaguchi H, Yamamoto S. Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. &lt;span&gt;</code></p><p><code>15017</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15018</code><code>FEBS Lett. &lt;/span&gt;</code></p><p><code>15019</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>15020</code><code>422&lt;/span&gt;</code></p><p><code>15021</code><code>:69–73.&lt;/span&gt;</code></p><p><code>15022</code><code> [&lt;a href="/pubmed/9475172" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15023</code><code>PubMed&lt;/a&gt;</code></p><p><code>15024</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15025</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;amp;title=Anandamide+amidohydrolase+reacting+with+2-arachidonoylglycerol,+another+cannabinoid+receptor+ligand&amp;amp;author=SK+Goparaju&amp;amp;author=N+Ueda&amp;amp;author=H+Yamaguchi&amp;amp;author=S+Yamamoto&amp;amp;volume=422&amp;amp;publication_year=1998&amp;amp;pages=69-73&amp;amp;pmid=9475172&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15026</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15027</code><code>]&lt;/span&gt;</code></p><p><code>15028</code><code>&lt;/span&gt;</code></p><p><code>15029</code><code>&lt;/li&gt;</code></p><p><code>15030</code><code>&lt;li id="R418"&gt;</code></p><p><code>15031</code><code>&lt;span class="citation"&gt;</code></p><p><code>15032</code><code>Gordon E, Devinsky O. Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy. &lt;span&gt;</code></p><p><code>15033</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15034</code><code>Epilepsia. &lt;/span&gt;</code></p><p><code>15035</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>15036</code><code>42&lt;/span&gt;</code></p><p><code>15037</code><code>:1266–1272.&lt;/span&gt;</code></p><p><code>15038</code><code> [&lt;a href="/pubmed/11737161" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15039</code><code>PubMed&lt;/a&gt;</code></p><p><code>15040</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15041</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Epilepsia&amp;amp;title=Alcohol+and+marijuana:+effects+on+epilepsy+and+use+by+patients+with+epilepsy&amp;amp;author=E+Gordon&amp;amp;author=O+Devinsky&amp;amp;volume=42&amp;amp;publication_year=2001&amp;amp;pages=1266-1272&amp;amp;pmid=11737161&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15042</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15043</code><code>]&lt;/span&gt;</code></p><p><code>15044</code><code>&lt;/span&gt;</code></p><p><code>15045</code><code>&lt;/li&gt;</code></p><p><code>15046</code><code>&lt;li id="R419"&gt;</code></p><p><code>15047</code><code>&lt;span class="citation"&gt;</code></p><p><code>15048</code><code>Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Huestis MA. The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers. &lt;span&gt;</code></p><p><code>15049</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15050</code><code>Am Heart J. &lt;/span&gt;</code></p><p><code>15051</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>15052</code><code>151&lt;/span&gt;</code></p><p><code>15053</code><code>:754.e1–754.e5.&lt;/span&gt;</code></p><p><code>15054</code><code> [&lt;a href="/pubmed/16504646" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15055</code><code>PubMed&lt;/a&gt;</code></p><p><code>15056</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15057</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+Heart+J&amp;amp;title=The+cannabinoid+CB1+receptor+antagonist+rimonabant+attenuates+the+hypotensive+effect+of+smoked+marijuana+in+male+smokers&amp;amp;author=DA+Gorelick&amp;amp;author=SJ+Heishman&amp;amp;author=KL+Preston&amp;amp;author=RA+Nelson&amp;amp;author=ET+Moolchan&amp;amp;volume=151&amp;amp;publication_year=2006&amp;amp;pages=754.e1-754.e5&amp;amp;pmid=16504646&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15058</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15059</code><code>]&lt;/span&gt;</code></p><p><code>15060</code><code>&lt;/span&gt;</code></p><p><code>15061</code><code>&lt;/li&gt;</code></p><p><code>15062</code><code>&lt;li id="R420"&gt;</code></p><p><code>15063</code><code>&lt;span class="citation"&gt;</code></p><p><code>15064</code><code>Gorter R, Seefried M, Volberding P. Dronabinol effects on weight in patients with HIV infection. &lt;span&gt;</code></p><p><code>15065</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15066</code><code>AIDS. &lt;/span&gt;</code></p><p><code>15067</code><code>1992;&lt;span class="ref-vol"&gt;</code></p><p><code>15068</code><code>6&lt;/span&gt;</code></p><p><code>15069</code><code>:127.&lt;/span&gt;</code></p><p><code>15070</code><code> [&lt;a href="/pubmed/1311935" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15071</code><code>PubMed&lt;/a&gt;</code></p><p><code>15072</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15073</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=AIDS&amp;amp;title=Dronabinol+effects+on+weight+in+patients+with+HIV+infection&amp;amp;author=R+Gorter&amp;amp;author=M+Seefried&amp;amp;author=P+Volberding&amp;amp;volume=6&amp;amp;publication_year=1992&amp;amp;pages=127&amp;amp;pmid=1311935&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15074</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15075</code><code>]&lt;/span&gt;</code></p><p><code>15076</code><code>&lt;/span&gt;</code></p><p><code>15077</code><code>&lt;/li&gt;</code></p><p><code>15078</code><code>&lt;li id="R421"&gt;</code></p><p><code>15079</code><code>&lt;span class="citation"&gt;</code></p><p><code>15080</code><code>Goutopoulos A, Fan P, Khanolkar AD, Xie XQ, Lin S, Makriyannis A. Stereochemical selectivity of methanandamides for the CB1 and CB2 cannabinoid receptors and their metabolic stability. &lt;span&gt;</code></p><p><code>15081</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15082</code><code>Bioorg Med Chem. &lt;/span&gt;</code></p><p><code>15083</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>15084</code><code>9&lt;/span&gt;</code></p><p><code>15085</code><code>:1673–1684.&lt;/span&gt;</code></p><p><code>15086</code><code> [&lt;a href="/pubmed/11425567" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15087</code><code>PubMed&lt;/a&gt;</code></p><p><code>15088</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15089</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Bioorg+Med+Chem&amp;amp;title=Stereochemical+selectivity+of+methanandamides+for+the+CB1+and+CB2+cannabinoid+receptors+and+their+metabolic+stability&amp;amp;author=A+Goutopoulos&amp;amp;author=P+Fan&amp;amp;author=AD+Khanolkar&amp;amp;author=XQ+Xie&amp;amp;author=S+Lin&amp;amp;volume=9&amp;amp;publication_year=2001&amp;amp;pages=1673-1684&amp;amp;pmid=11425567&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15090</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15091</code><code>]&lt;/span&gt;</code></p><p><code>15092</code><code>&lt;/span&gt;</code></p><p><code>15093</code><code>&lt;/li&gt;</code></p><p><code>15094</code><code>&lt;li id="R422"&gt;</code></p><p><code>15095</code><code>&lt;span class="citation"&gt;</code></p><p><code>15096</code><code>Green K, Bigger JF, Kim K, Bowman K. Cannabinoid action on the eye as mediated through the central nervous system and local adrenergic activity. &lt;span&gt;</code></p><p><code>15097</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15098</code><code>Exp Eye Res. &lt;/span&gt;</code></p><p><code>15099</code><code>1977a;&lt;span class="ref-vol"&gt;</code></p><p><code>15100</code><code>24&lt;/span&gt;</code></p><p><code>15101</code><code>:189–196.&lt;/span&gt;</code></p><p><code>15102</code><code> [&lt;a href="/pubmed/844512" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15103</code><code>PubMed&lt;/a&gt;</code></p><p><code>15104</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15105</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Exp+Eye+Res&amp;amp;title=Cannabinoid+action+on+the+eye+as+mediated+through+the+central+nervous+system+and+local+adrenergic+activity&amp;amp;author=K+Green&amp;amp;author=JF+Bigger&amp;amp;author=K+Kim&amp;amp;author=K+Bowman&amp;amp;volume=24&amp;amp;publication_year=1977a&amp;amp;pages=189-196&amp;amp;pmid=844512&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15106</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15107</code><code>]&lt;/span&gt;</code></p><p><code>15108</code><code>&lt;/span&gt;</code></p><p><code>15109</code><code>&lt;/li&gt;</code></p><p><code>15110</code><code>&lt;li id="R423"&gt;</code></p><p><code>15111</code><code>&lt;span class="citation"&gt;</code></p><p><code>15112</code><code>Green K, Bigger JF, Kim K, Bowman K. Cannabinoid penetration and chronic effects in the eye. &lt;span&gt;</code></p><p><code>15113</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15114</code><code>Exp Eye Res. &lt;/span&gt;</code></p><p><code>15115</code><code>1977b;&lt;span class="ref-vol"&gt;</code></p><p><code>15116</code><code>24&lt;/span&gt;</code></p><p><code>15117</code><code>:197–205.&lt;/span&gt;</code></p><p><code>15118</code><code> [&lt;a href="/pubmed/844513" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15119</code><code>PubMed&lt;/a&gt;</code></p><p><code>15120</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15121</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Exp+Eye+Res&amp;amp;title=Cannabinoid+penetration+and+chronic+effects+in+the+eye&amp;amp;author=K+Green&amp;amp;author=JF+Bigger&amp;amp;author=K+Kim&amp;amp;author=K+Bowman&amp;amp;volume=24&amp;amp;publication_year=1977b&amp;amp;pages=197-205&amp;amp;pmid=844513&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15122</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15123</code><code>]&lt;/span&gt;</code></p><p><code>15124</code><code>&lt;/span&gt;</code></p><p><code>15125</code><code>&lt;/li&gt;</code></p><p><code>15126</code><code>&lt;li id="R424"&gt;</code></p><p><code>15127</code><code>&lt;span class="citation"&gt;</code></p><p><code>15128</code><code>Green K, Kearse EC, McIntyre OL. Interaction between &amp;#x00394;-9-tetrahydrocannabinol and indomethacin. &lt;span&gt;</code></p><p><code>15129</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15130</code><code>Ophthalmic Res. &lt;/span&gt;</code></p><p><code>15131</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>15132</code><code>33&lt;/span&gt;</code></p><p><code>15133</code><code>:217–220.&lt;/span&gt;</code></p><p><code>15134</code><code> [&lt;a href="/pubmed/11464074" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15135</code><code>PubMed&lt;/a&gt;</code></p><p><code>15136</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15137</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Ophthalmic+Res&amp;amp;title=Interaction+between+&amp;#x00394;-9-tetrahydrocannabinol+and+indomethacin&amp;amp;author=K+Green&amp;amp;author=EC+Kearse&amp;amp;author=OL+McIntyre&amp;amp;volume=33&amp;amp;publication_year=2001&amp;amp;pages=217-220&amp;amp;pmid=11464074&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15138</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15139</code><code>]&lt;/span&gt;</code></p><p><code>15140</code><code>&lt;/span&gt;</code></p><p><code>15141</code><code>&lt;/li&gt;</code></p><p><code>15142</code><code>&lt;li id="R425"&gt;</code></p><p><code>15143</code><code>&lt;span class="citation"&gt;</code></p><p><code>15144</code><code>Green K, Pederson JE. Effect of 1-tetrahydrocannabinol on aqueous dynamics and ciliary body permeability in the rabbit. &lt;span&gt;</code></p><p><code>15145</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15146</code><code>Exp Eye Res. &lt;/span&gt;</code></p><p><code>15147</code><code>1973;&lt;span class="ref-vol"&gt;</code></p><p><code>15148</code><code>15&lt;/span&gt;</code></p><p><code>15149</code><code>:499–507.&lt;/span&gt;</code></p><p><code>15150</code><code> [&lt;a href="/pubmed/4702382" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15151</code><code>PubMed&lt;/a&gt;</code></p><p><code>15152</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15153</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Exp+Eye+Res&amp;amp;title=Effect+of+1-tetrahydrocannabinol+on+aqueous+dynamics+and+ciliary+body+permeability+in+the+rabbit&amp;amp;author=K+Green&amp;amp;author=JE+Pederson&amp;amp;volume=15&amp;amp;publication_year=1973&amp;amp;pages=499-507&amp;amp;pmid=4702382&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15154</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15155</code><code>]&lt;/span&gt;</code></p><p><code>15156</code><code>&lt;/span&gt;</code></p><p><code>15157</code><code>&lt;/li&gt;</code></p><p><code>15158</code><code>&lt;li id="R426"&gt;</code></p><p><code>15159</code><code>&lt;span class="citation"&gt;</code></p><p><code>15160</code><code>Green K, Podos SM. Antagonism of arachidonic acid-induced ocular effects by &amp;#x00394;&lt;sup&gt;</code></p><p><code>15161</code><code>1&lt;/sup&gt;</code></p><p><code>15162</code><code>-tetrahydrocannabinol. &lt;span&gt;</code></p><p><code>15163</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15164</code><code>Investig Ophthalmol. &lt;/span&gt;</code></p><p><code>15165</code><code>1974;&lt;span class="ref-vol"&gt;</code></p><p><code>15166</code><code>13&lt;/span&gt;</code></p><p><code>15167</code><code>:422–429.&lt;/span&gt;</code></p><p><code>15168</code><code> [&lt;a href="/pubmed/4831696" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15169</code><code>PubMed&lt;/a&gt;</code></p><p><code>15170</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15171</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Investig+Ophthalmol&amp;amp;title=Antagonism+of+arachidonic+acid-induced+ocular+effects+by+&amp;#x00394;1-tetrahydrocannabinol&amp;amp;author=K+Green&amp;amp;author=SM+Podos&amp;amp;volume=13&amp;amp;publication_year=1974&amp;amp;pages=422-429&amp;amp;pmid=4831696&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15172</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15173</code><code>]&lt;/span&gt;</code></p><p><code>15174</code><code>&lt;/span&gt;</code></p><p><code>15175</code><code>&lt;/li&gt;</code></p><p><code>15176</code><code>&lt;li id="R427"&gt;</code></p><p><code>15177</code><code>&lt;span class="citation"&gt;</code></p><p><code>15178</code><code>Greenberg HS, Werness SA, Pugh JE, Andrus RO, Anderson DJ, Domino EF. Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers. &lt;span&gt;</code></p><p><code>15179</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15180</code><code>Clin Pharmacol Ther. &lt;/span&gt;</code></p><p><code>15181</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>15182</code><code>55&lt;/span&gt;</code></p><p><code>15183</code><code>:324–328.&lt;/span&gt;</code></p><p><code>15184</code><code> [&lt;a href="/pubmed/8143398" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15185</code><code>PubMed&lt;/a&gt;</code></p><p><code>15186</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15187</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;amp;title=Short-term+effects+of+smoking+marijuana+on+balance+in+patients+with+multiple+sclerosis+and+normal+volunteers&amp;amp;author=HS+Greenberg&amp;amp;author=SA+Werness&amp;amp;author=JE+Pugh&amp;amp;author=RO+Andrus&amp;amp;author=DJ+Anderson&amp;amp;volume=55&amp;amp;publication_year=1994&amp;amp;pages=324-328&amp;amp;pmid=8143398&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15188</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15189</code><code>]&lt;/span&gt;</code></p><p><code>15190</code><code>&lt;/span&gt;</code></p><p><code>15191</code><code>&lt;/li&gt;</code></p><p><code>15192</code><code>&lt;li id="R428"&gt;</code></p><p><code>15193</code><code>&lt;span class="citation"&gt;</code></p><p><code>15194</code><code>Greenberg I, Kuehnle J, Mendelson JH, Bernstein JG. Effects of marijuana use on body weight and energy intake in humans. &lt;span&gt;</code></p><p><code>15195</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15196</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>15197</code><code>1976;&lt;span class="ref-vol"&gt;</code></p><p><code>15198</code><code>49&lt;/span&gt;</code></p><p><code>15199</code><code>:79–84.&lt;/span&gt;</code></p><p><code>15200</code><code> [&lt;a href="/pubmed/822452" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15201</code><code>PubMed&lt;/a&gt;</code></p><p><code>15202</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15203</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Effects+of+marijuana+use+on+body+weight+and+energy+intake+in+humans&amp;amp;author=I+Greenberg&amp;amp;author=J+Kuehnle&amp;amp;author=JH+Mendelson&amp;amp;author=JG+Bernstein&amp;amp;volume=49&amp;amp;publication_year=1976&amp;amp;pages=79-84&amp;amp;pmid=822452&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15204</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15205</code><code>]&lt;/span&gt;</code></p><p><code>15206</code><code>&lt;/span&gt;</code></p><p><code>15207</code><code>&lt;/li&gt;</code></p><p><code>15208</code><code>&lt;li id="R429"&gt;</code></p><p><code>15209</code><code>&lt;span class="citation"&gt;</code></p><p><code>15210</code><code>Greengard P. The neurobiology of slow synaptic transmission. &lt;span&gt;</code></p><p><code>15211</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15212</code><code>Science (Wash DC) &lt;/span&gt;</code></p><p><code>15213</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>15214</code><code>294&lt;/span&gt;</code></p><p><code>15215</code><code>:1024–1030.&lt;/span&gt;</code></p><p><code>15216</code><code> [&lt;a href="/pubmed/11691979" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15217</code><code>PubMed&lt;/a&gt;</code></p><p><code>15218</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15219</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Science+(Wash+DC)&amp;amp;title=The+neurobiology+of+slow+synaptic+transmission&amp;amp;author=P+Greengard&amp;amp;volume=294&amp;amp;publication_year=2001&amp;amp;pages=1024-1030&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15220</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15221</code><code>]&lt;/span&gt;</code></p><p><code>15222</code><code>&lt;/span&gt;</code></p><p><code>15223</code><code>&lt;/li&gt;</code></p><p><code>15224</code><code>&lt;li id="R430"&gt;</code></p><p><code>15225</code><code>&lt;span class="citation"&gt;</code></p><p><code>15226</code><code>Grenard P, Julien B, Tran Van Nhieu J, Li L, Ledent C, Mallat A, Lotersztajn S. Reduced fibrosis in mice invalidated for CB&lt;sub&gt;</code></p><p><code>15227</code><code>1&lt;/sub&gt;</code></p><p><code>15228</code><code> receptor. Proceedings of the 2004 Symposium on the Cannabinoids; 2004 June 22&amp;#x02013;27; Peastum, Italy. Burlington, VT: International Cannabinoid Research Society; 2004. p. 60. &lt;span class="nowrap"&gt;</code></p><p><code>15229</code><code>[&lt;a href="https://scholar.google.com/scholar?q=Grenard+P+Julien+B+Tran+Van+Nhieu+J+Li+L+Ledent+C+Mallat+A+Lotersztajn+S+2004+Reduced+fibrosis+in+mice+invalidated+for+CB+1++receptor+Proceedings+of+the+2004+Symposium+on+the+Cannabinoids+2004+June+22&amp;#x02013;27+Peastum,+Italy+60+International+Cannabinoid+Research+Society+Burlington,+VT+" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15230</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15231</code><code>]&lt;/span&gt;</code></p><p><code>15232</code><code>&lt;/span&gt;</code></p><p><code>15233</code><code>&lt;/li&gt;</code></p><p><code>15234</code><code>&lt;li id="R431"&gt;</code></p><p><code>15235</code><code>&lt;span class="citation"&gt;</code></p><p><code>15236</code><code>Grigorenko E, Kittler J, Clayton C, Wallace D, Zhuang S, Bridges D, Bundey S, Boon A, Pagget C, Hayashizaki S, et al.  Assessment of cannabinoid induced gene changes: tolerance and neuroprotection. &lt;span&gt;</code></p><p><code>15237</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15238</code><code>Chem Phys Lipids. &lt;/span&gt;</code></p><p><code>15239</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>15240</code><code>121&lt;/span&gt;</code></p><p><code>15241</code><code>:257–266.&lt;/span&gt;</code></p><p><code>15242</code><code> [&lt;a href="/pubmed/12505705" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15243</code><code>PubMed&lt;/a&gt;</code></p><p><code>15244</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15245</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Chem+Phys+Lipids&amp;amp;title=Assessment+of+cannabinoid+induced+gene+changes:+tolerance+and+neuroprotection&amp;amp;author=E+Grigorenko&amp;amp;author=J+Kittler&amp;amp;author=C+Clayton&amp;amp;author=D+Wallace&amp;amp;author=S+Zhuang&amp;amp;volume=121&amp;amp;publication_year=2002&amp;amp;pages=257-266&amp;amp;pmid=12505705&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15246</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15247</code><code>]&lt;/span&gt;</code></p><p><code>15248</code><code>&lt;/span&gt;</code></p><p><code>15249</code><code>&lt;/li&gt;</code></p><p><code>15250</code><code>&lt;li id="R432"&gt;</code></p><p><code>15251</code><code>&lt;span class="citation"&gt;</code></p><p><code>15252</code><code>Grimaldi C, Pisanti S, Laezza C, Malfitano AM, Santoro A, Vitale M, Caruso MG, Notarnicola M, Iacuzzo I, Portella G, et al.  Anandamide inhibits adhesion and migration of breast cancer cells. &lt;span&gt;</code></p><p><code>15253</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15254</code><code>Exp Cell Res. &lt;/span&gt;</code></p><p><code>15255</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>15256</code><code>312&lt;/span&gt;</code></p><p><code>15257</code><code>:363–373.&lt;/span&gt;</code></p><p><code>15258</code><code> [&lt;a href="/pubmed/16343481" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15259</code><code>PubMed&lt;/a&gt;</code></p><p><code>15260</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15261</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Exp+Cell+Res&amp;amp;title=Anandamide+inhibits+adhesion+and+migration+of+breast+cancer+cells&amp;amp;author=C+Grimaldi&amp;amp;author=S+Pisanti&amp;amp;author=C+Laezza&amp;amp;author=AM+Malfitano&amp;amp;author=A+Santoro&amp;amp;volume=312&amp;amp;publication_year=2006&amp;amp;pages=363-373&amp;amp;pmid=16343481&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15262</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15263</code><code>]&lt;/span&gt;</code></p><p><code>15264</code><code>&lt;/span&gt;</code></p><p><code>15265</code><code>&lt;/li&gt;</code></p><p><code>15266</code><code>&lt;li id="R433"&gt;</code></p><p><code>15267</code><code>&lt;span class="citation"&gt;</code></p><p><code>15268</code><code>Grinspoon L, Bakalar JB.  &lt;span class="ref-journal"&gt;</code></p><p><code>15269</code><code>Marihuana: The Forbidden Medicine.&lt;/span&gt;</code></p><p><code>15270</code><code> Yale University Press; New Haven, CT: 1993. The history of cannabis; pp. 1–23. &lt;span class="nowrap"&gt;</code></p><p><code>15271</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?title=Marihuana:+The+Forbidden+Medicine&amp;amp;author=L+Grinspoon&amp;amp;author=JB+Bakalar&amp;amp;publication_year=1993&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15272</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15273</code><code>]&lt;/span&gt;</code></p><p><code>15274</code><code>&lt;/span&gt;</code></p><p><code>15275</code><code>&lt;/li&gt;</code></p><p><code>15276</code><code>&lt;li id="R434"&gt;</code></p><p><code>15277</code><code>&lt;span class="citation"&gt;</code></p><p><code>15278</code><code>Grinspoon L, Bakalar JB. The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research. &lt;span&gt;</code></p><p><code>15279</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15280</code><code>J Psychoact Drugs. &lt;/span&gt;</code></p><p><code>15281</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>15282</code><code>30&lt;/span&gt;</code></p><p><code>15283</code><code>:171–177.&lt;/span&gt;</code></p><p><code>15284</code><code> [&lt;a href="/pubmed/9692379" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15285</code><code>PubMed&lt;/a&gt;</code></p><p><code>15286</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15287</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Psychoact+Drugs&amp;amp;title=The+use+of+cannabis+as+a+mood+stabilizer+in+bipolar+disorder:+anecdotal+evidence+and+the+need+for+clinical+research&amp;amp;author=L+Grinspoon&amp;amp;author=JB+Bakalar&amp;amp;volume=30&amp;amp;publication_year=1998&amp;amp;pages=171-177&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15288</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15289</code><code>]&lt;/span&gt;</code></p><p><code>15290</code><code>&lt;/span&gt;</code></p><p><code>15291</code><code>&lt;/li&gt;</code></p><p><code>15292</code><code>&lt;li id="R435"&gt;</code></p><p><code>15293</code><code>&lt;span class="citation"&gt;</code></p><p><code>15294</code><code>Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. &lt;span&gt;</code></p><p><code>15295</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15296</code><code>Clin Pharmacokinet. &lt;/span&gt;</code></p><p><code>15297</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>15298</code><code>42&lt;/span&gt;</code></p><p><code>15299</code><code>:327–360.&lt;/span&gt;</code></p><p><code>15300</code><code> [&lt;a href="/pubmed/12648025" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15301</code><code>PubMed&lt;/a&gt;</code></p><p><code>15302</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15303</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacokinet&amp;amp;title=Pharmacokinetics+and+pharmacodynamics+of+cannabinoids&amp;amp;author=F+Grotenhermen&amp;amp;volume=42&amp;amp;publication_year=2003&amp;amp;pages=327-360&amp;amp;pmid=12648025&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15304</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15305</code><code>]&lt;/span&gt;</code></p><p><code>15306</code><code>&lt;/span&gt;</code></p><p><code>15307</code><code>&lt;/li&gt;</code></p><p><code>15308</code><code>&lt;li id="R436"&gt;</code></p><p><code>15309</code><code>&lt;span class="citation"&gt;</code></p><p><code>15310</code><code>Grotenhermen F. Pharmacology of cannabinoids. &lt;span&gt;</code></p><p><code>15311</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15312</code><code>Neuro Endocrinol Lett. &lt;/span&gt;</code></p><p><code>15313</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>15314</code><code>25&lt;/span&gt;</code></p><p><code>15315</code><code>:14–23.&lt;/span&gt;</code></p><p><code>15316</code><code> [&lt;a href="/pubmed/15159677" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15317</code><code>PubMed&lt;/a&gt;</code></p><p><code>15318</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15319</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuro+Endocrinol+Lett&amp;amp;title=Pharmacology+of+cannabinoids&amp;amp;author=F+Grotenhermen&amp;amp;volume=25&amp;amp;publication_year=2004&amp;amp;pages=14-23&amp;amp;pmid=15159677&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15320</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15321</code><code>]&lt;/span&gt;</code></p><p><code>15322</code><code>&lt;/span&gt;</code></p><p><code>15323</code><code>&lt;/li&gt;</code></p><p><code>15324</code><code>&lt;li id="R437"&gt;</code></p><p><code>15325</code><code>&lt;span class="citation"&gt;</code></p><p><code>15326</code><code>Grufferman S, Schwartz AG, Ruymann FB, Maurer HM. Parents&amp;#x02019; use of cocaine and marijuana and increased risk of rhabdomyosarcoma in their children. &lt;span&gt;</code></p><p><code>15327</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15328</code><code>Cancer Causes Control. &lt;/span&gt;</code></p><p><code>15329</code><code>1993;&lt;span class="ref-vol"&gt;</code></p><p><code>15330</code><code>4&lt;/span&gt;</code></p><p><code>15331</code><code>:217–224.&lt;/span&gt;</code></p><p><code>15332</code><code> [&lt;a href="/pubmed/8318638" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15333</code><code>PubMed&lt;/a&gt;</code></p><p><code>15334</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15335</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Causes+Control&amp;amp;title=Parents&amp;#x02019;+use+of+cocaine+and+marijuana+and+increased+risk+of+rhabdomyosarcoma+in+their+children&amp;amp;author=S+Grufferman&amp;amp;author=AG+Schwartz&amp;amp;author=FB+Ruymann&amp;amp;author=HM+Maurer&amp;amp;volume=4&amp;amp;publication_year=1993&amp;amp;pages=217-224&amp;amp;pmid=8318638&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15336</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15337</code><code>]&lt;/span&gt;</code></p><p><code>15338</code><code>&lt;/span&gt;</code></p><p><code>15339</code><code>&lt;/li&gt;</code></p><p><code>15340</code><code>&lt;li id="R438"&gt;</code></p><p><code>15341</code><code>&lt;span class="citation"&gt;</code></p><p><code>15342</code><code>Grundy RI. The therapeutic potential of the cannabinoids in neuroprotection. &lt;span&gt;</code></p><p><code>15343</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15344</code><code>Expert Opin Investig Drugs. &lt;/span&gt;</code></p><p><code>15345</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>15346</code><code>11&lt;/span&gt;</code></p><p><code>15347</code><code>:1365–1374.&lt;/span&gt;</code></p><p><code>15348</code><code> [&lt;a href="/pubmed/12387700" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15349</code><code>PubMed&lt;/a&gt;</code></p><p><code>15350</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15351</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Expert+Opin+Investig+Drugs&amp;amp;title=The+therapeutic+potential+of+the+cannabinoids+in+neuroprotection&amp;amp;author=RI+Grundy&amp;amp;volume=11&amp;amp;publication_year=2002&amp;amp;pages=1365-1374&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15352</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15353</code><code>]&lt;/span&gt;</code></p><p><code>15354</code><code>&lt;/span&gt;</code></p><p><code>15355</code><code>&lt;/li&gt;</code></p><p><code>15356</code><code>&lt;li id="R439"&gt;</code></p><p><code>15357</code><code>&lt;span class="citation"&gt;</code></p><p><code>15358</code><code>Gubellini P, Picconi B, Bari M, Battista N, Calabresi P, Centonze D, Bernardi G, Finazzi-Agro A, Maccarrone M. Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. &lt;span&gt;</code></p><p><code>15359</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15360</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>15361</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>15362</code><code>22&lt;/span&gt;</code></p><p><code>15363</code><code>:6900–6907.&lt;/span&gt;</code></p><p><code>15364</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>15365</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6757864/"&gt;</code></p><p><code>15366</code><code>PMC free article&lt;/a&gt;</code></p><p><code>15367</code><code>]&lt;/span&gt;</code></p><p><code>15368</code><code> [&lt;a href="/pubmed/12177188" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15369</code><code>PubMed&lt;/a&gt;</code></p><p><code>15370</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15371</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Experimental+parkinsonism+alters+endocannabinoid+degradation:+implications+for+striatal+glutamatergic+transmission&amp;amp;author=P+Gubellini&amp;amp;author=B+Picconi&amp;amp;author=M+Bari&amp;amp;author=N+Battista&amp;amp;author=P+Calabresi&amp;amp;volume=22&amp;amp;publication_year=2002&amp;amp;pages=6900-6907&amp;amp;pmid=12177188&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15372</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15373</code><code>]&lt;/span&gt;</code></p><p><code>15374</code><code>&lt;/span&gt;</code></p><p><code>15375</code><code>&lt;/li&gt;</code></p><p><code>15376</code><code>&lt;li id="R440"&gt;</code></p><p><code>15377</code><code>&lt;span class="citation"&gt;</code></p><p><code>15378</code><code>Guagnini F, Valenti M, Mukenge S, Matias I, Bianchetti A, Di Palo S, Ferla G, Di Marzo V, Croci T. Neural contractions in colonic strips from patients with diverticulosis: role of endocannabinoids and substance P. &lt;span&gt;</code></p><p><code>15379</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15380</code><code>Gut. &lt;/span&gt;</code></p><p><code>15381</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>15382</code><code>55&lt;/span&gt;</code></p><p><code>15383</code><code>:946–953.&lt;/span&gt;</code></p><p><code>15384</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>15385</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1856307/"&gt;</code></p><p><code>15386</code><code>PMC free article&lt;/a&gt;</code></p><p><code>15387</code><code>]&lt;/span&gt;</code></p><p><code>15388</code><code> [&lt;a href="/pubmed/16423891" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15389</code><code>PubMed&lt;/a&gt;</code></p><p><code>15390</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15391</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;amp;title=Neural+contractions+in+colonic+strips+from+patients+with+diverticulosis:+role+of+endocannabinoids+and+substance+P&amp;amp;author=F+Guagnini&amp;amp;author=M+Valenti&amp;amp;author=S+Mukenge&amp;amp;author=I+Matias&amp;amp;author=A+Bianchetti&amp;amp;volume=55&amp;amp;publication_year=2006&amp;amp;pages=946-953&amp;amp;pmid=16423891&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15392</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15393</code><code>]&lt;/span&gt;</code></p><p><code>15394</code><code>&lt;/span&gt;</code></p><p><code>15395</code><code>&lt;/li&gt;</code></p><p><code>15396</code><code>&lt;li id="R441"&gt;</code></p><p><code>15397</code><code>&lt;span class="citation"&gt;</code></p><p><code>15398</code><code>Guimaraes FS, Chiaretti TM, Graeff FG, Zuardi AW. Antianxiety effect of cannabidiol in the elevated plus-maze. &lt;span&gt;</code></p><p><code>15399</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15400</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>15401</code><code>1990;&lt;span class="ref-vol"&gt;</code></p><p><code>15402</code><code>100&lt;/span&gt;</code></p><p><code>15403</code><code>:558–559.&lt;/span&gt;</code></p><p><code>15404</code><code> [&lt;a href="/pubmed/1969666" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15405</code><code>PubMed&lt;/a&gt;</code></p><p><code>15406</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15407</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Antianxiety+effect+of+cannabidiol+in+the+elevated+plus-maze&amp;amp;author=FS+Guimaraes&amp;amp;author=TM+Chiaretti&amp;amp;author=FG+Graeff&amp;amp;author=AW+Zuardi&amp;amp;volume=100&amp;amp;publication_year=1990&amp;amp;pages=558-559&amp;amp;pmid=1969666&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15408</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15409</code><code>]&lt;/span&gt;</code></p><p><code>15410</code><code>&lt;/span&gt;</code></p><p><code>15411</code><code>&lt;/li&gt;</code></p><p><code>15412</code><code>&lt;li id="R442"&gt;</code></p><p><code>15413</code><code>&lt;span class="citation"&gt;</code></p><p><code>15414</code><code>Guimaraes FS, de Aguiar JC, Mechoulam R, Breuer A. Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze. &lt;span&gt;</code></p><p><code>15415</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15416</code><code>Gen Pharmacol. &lt;/span&gt;</code></p><p><code>15417</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>15418</code><code>25&lt;/span&gt;</code></p><p><code>15419</code><code>:161–164.&lt;/span&gt;</code></p><p><code>15420</code><code> [&lt;a href="/pubmed/7913072" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15421</code><code>PubMed&lt;/a&gt;</code></p><p><code>15422</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15423</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gen+Pharmacol&amp;amp;title=Anxiolytic+effect+of+cannabidiol+derivatives+in+the+elevated+plus-maze&amp;amp;author=FS+Guimaraes&amp;amp;author=JC+de+Aguiar&amp;amp;author=R+Mechoulam&amp;amp;author=A+Breuer&amp;amp;volume=25&amp;amp;publication_year=1994&amp;amp;pages=161-164&amp;amp;pmid=7913072&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15424</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15425</code><code>]&lt;/span&gt;</code></p><p><code>15426</code><code>&lt;/span&gt;</code></p><p><code>15427</code><code>&lt;/li&gt;</code></p><p><code>15428</code><code>&lt;li id="R443"&gt;</code></p><p><code>15429</code><code>&lt;span class="citation"&gt;</code></p><p><code>15430</code><code>Guindon J, Beaulieu P. Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain. &lt;span&gt;</code></p><p><code>15431</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15432</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>15433</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>15434</code><code>50&lt;/span&gt;</code></p><p><code>15435</code><code>:814–823.&lt;/span&gt;</code></p><p><code>15436</code><code> [&lt;a href="/pubmed/16442133" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15437</code><code>PubMed&lt;/a&gt;</code></p><p><code>15438</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15439</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=Antihyperalgesic+effects+of+local+injections+of+anandamide,+ibuprofen,+rofecoxib+and+their+combinations+in+a+model+of+neuropathic+pain&amp;amp;author=J+Guindon&amp;amp;author=P+Beaulieu&amp;amp;volume=50&amp;amp;publication_year=2006&amp;amp;pages=814-823&amp;amp;pmid=16442133&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15440</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15441</code><code>]&lt;/span&gt;</code></p><p><code>15442</code><code>&lt;/span&gt;</code></p><p><code>15443</code><code>&lt;/li&gt;</code></p><p><code>15444</code><code>&lt;li id="R444"&gt;</code></p><p><code>15445</code><code>&lt;span class="citation"&gt;</code></p><p><code>15446</code><code>Guindon J, De Lean A, Beaulieu P. Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain. &lt;span&gt;</code></p><p><code>15447</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15448</code><code>Pain. &lt;/span&gt;</code></p><p><code>15449</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>15450</code><code>121&lt;/span&gt;</code></p><p><code>15451</code><code>:85–93.&lt;/span&gt;</code></p><p><code>15452</code><code> [&lt;a href="/pubmed/16480822" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15453</code><code>PubMed&lt;/a&gt;</code></p><p><code>15454</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15455</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;amp;title=Local+interactions+between+anandamide,+an+endocannabinoid,+and+ibuprofen,+a+nonsteroidal+anti-inflammatory+drug,+in+acute+and+inflammatory+pain&amp;amp;author=J+Guindon&amp;amp;author=A+De+Lean&amp;amp;author=P+Beaulieu&amp;amp;volume=121&amp;amp;publication_year=2006&amp;amp;pages=85-93&amp;amp;pmid=16480822&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15456</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15457</code><code>]&lt;/span&gt;</code></p><p><code>15458</code><code>&lt;/span&gt;</code></p><p><code>15459</code><code>&lt;/li&gt;</code></p><p><code>15460</code><code>&lt;li id="R445"&gt;</code></p><p><code>15461</code><code>&lt;span class="citation"&gt;</code></p><p><code>15462</code><code>Gulyas AI, Cravatt BF, Bracey MH, Dinh TP, Piomelli D, Boscia F, Freund TF. Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. &lt;span&gt;</code></p><p><code>15463</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15464</code><code>Eur J Neurosci. &lt;/span&gt;</code></p><p><code>15465</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>15466</code><code>20&lt;/span&gt;</code></p><p><code>15467</code><code>:441–458.&lt;/span&gt;</code></p><p><code>15468</code><code> [&lt;a href="/pubmed/15233753" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15469</code><code>PubMed&lt;/a&gt;</code></p><p><code>15470</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15471</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurosci&amp;amp;title=Segregation+of+two+endocannabinoid-hydrolyzing+enzymes+into+pre-+and+postsynaptic+compartments+in+the+rat+hippocampus,+cerebellum+and+amygdala&amp;amp;author=AI+Gulyas&amp;amp;author=BF+Cravatt&amp;amp;author=MH+Bracey&amp;amp;author=TP+Dinh&amp;amp;author=D+Piomelli&amp;amp;volume=20&amp;amp;publication_year=2004&amp;amp;pages=441-458&amp;amp;pmid=15233753&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15472</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15473</code><code>]&lt;/span&gt;</code></p><p><code>15474</code><code>&lt;/span&gt;</code></p><p><code>15475</code><code>&lt;/li&gt;</code></p><p><code>15476</code><code>&lt;li id="R446"&gt;</code></p><p><code>15477</code><code>&lt;span class="citation"&gt;</code></p><p><code>15478</code><code>Guo J, Ikeda SR. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. &lt;span&gt;</code></p><p><code>15479</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15480</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>15481</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>15482</code><code>65&lt;/span&gt;</code></p><p><code>15483</code><code>:665–674.&lt;/span&gt;</code></p><p><code>15484</code><code> [&lt;a href="/pubmed/14978245" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15485</code><code>PubMed&lt;/a&gt;</code></p><p><code>15486</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15487</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=Endocannabinoids+modulate+N-type+calcium+channels+and+G-protein-coupled+inwardly+rectifying+potassium+channels+via+CB1+cannabinoid+receptors+heterologously+expressed+in+mammalian+neurons&amp;amp;author=J+Guo&amp;amp;author=SR+Ikeda&amp;amp;volume=65&amp;amp;publication_year=2004&amp;amp;pages=665-674&amp;amp;pmid=14978245&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15488</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15489</code><code>]&lt;/span&gt;</code></p><p><code>15490</code><code>&lt;/span&gt;</code></p><p><code>15491</code><code>&lt;/li&gt;</code></p><p><code>15492</code><code>&lt;li id="R447"&gt;</code></p><p><code>15493</code><code>&lt;span class="citation"&gt;</code></p><p><code>15494</code><code>Guo Y, Wang H, Okamoto Y, Ueda N, Kingsley PJ, Marnett LJ, Schmid HH, Das SK, Dey SK. &lt;em&gt;</code></p><p><code>15495</code><code>N-&lt;/em&gt;</code></p><p><code>15496</code><code>Acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. &lt;span&gt;</code></p><p><code>15497</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15498</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>15499</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>15500</code><code>280&lt;/span&gt;</code></p><p><code>15501</code><code>:23429–23432.&lt;/span&gt;</code></p><p><code>15502</code><code> [&lt;a href="/pubmed/15890658" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15503</code><code>PubMed&lt;/a&gt;</code></p><p><code>15504</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15505</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=N-Acylphosphatidylethanolamine-hydrolyzing+phospholipase+D+is+an+important+determinant+of+uterine+anandamide+levels+during+implantation&amp;amp;author=Y+Guo&amp;amp;author=H+Wang&amp;amp;author=Y+Okamoto&amp;amp;author=N+Ueda&amp;amp;author=PJ+Kingsley&amp;amp;volume=280&amp;amp;publication_year=2005&amp;amp;pages=23429-23432&amp;amp;pmid=15890658&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15506</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15507</code><code>]&lt;/span&gt;</code></p><p><code>15508</code><code>&lt;/span&gt;</code></p><p><code>15509</code><code>&lt;/li&gt;</code></p><p><code>15510</code><code>&lt;li id="R448"&gt;</code></p><p><code>15511</code><code>&lt;span class="citation"&gt;</code></p><p><code>15512</code><code>Guzm&amp;#x000e1;n M. Cannabinoids: potential anticancer agents. &lt;span&gt;</code></p><p><code>15513</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15514</code><code>Nat Rev Cancer. &lt;/span&gt;</code></p><p><code>15515</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>15516</code><code>3&lt;/span&gt;</code></p><p><code>15517</code><code>:745–755.&lt;/span&gt;</code></p><p><code>15518</code><code> [&lt;a href="/pubmed/14570037" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15519</code><code>PubMed&lt;/a&gt;</code></p><p><code>15520</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15521</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cancer&amp;amp;title=Cannabinoids:+potential+anticancer+agents&amp;amp;author=M+Guzm&amp;#x000e1;n&amp;amp;volume=3&amp;amp;publication_year=2003&amp;amp;pages=745-755&amp;amp;pmid=14570037&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15522</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15523</code><code>]&lt;/span&gt;</code></p><p><code>15524</code><code>&lt;/span&gt;</code></p><p><code>15525</code><code>&lt;/li&gt;</code></p><p><code>15526</code><code>&lt;li id="R449"&gt;</code></p><p><code>15527</code><code>&lt;span class="citation"&gt;</code></p><p><code>15528</code><code>Guzm&amp;#x000e1;n M, Sanchez C, Galve-Roperh I. Cannabinoids and cell fate. &lt;span&gt;</code></p><p><code>15529</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15530</code><code>Pharmacol Ther. &lt;/span&gt;</code></p><p><code>15531</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>15532</code><code>95&lt;/span&gt;</code></p><p><code>15533</code><code>:175–184.&lt;/span&gt;</code></p><p><code>15534</code><code> [&lt;a href="/pubmed/12182964" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15535</code><code>PubMed&lt;/a&gt;</code></p><p><code>15536</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15537</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Ther&amp;amp;title=Cannabinoids+and+cell+fate&amp;amp;author=M+Guzm&amp;#x000e1;n&amp;amp;author=C+Sanchez&amp;amp;author=I+Galve-Roperh&amp;amp;volume=95&amp;amp;publication_year=2002&amp;amp;pages=175-184&amp;amp;pmid=12182964&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15538</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15539</code><code>]&lt;/span&gt;</code></p><p><code>15540</code><code>&lt;/span&gt;</code></p><p><code>15541</code><code>&lt;/li&gt;</code></p><p><code>15542</code><code>&lt;li id="R450"&gt;</code></p><p><code>15543</code><code>&lt;span class="citation"&gt;</code></p><p><code>15544</code><code>H&amp;#x000e1;jos N, Freund TF. Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. &lt;span&gt;</code></p><p><code>15545</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15546</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>15547</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>15548</code><code>43&lt;/span&gt;</code></p><p><code>15549</code><code>:503–510.&lt;/span&gt;</code></p><p><code>15550</code><code> [&lt;a href="/pubmed/12367597" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15551</code><code>PubMed&lt;/a&gt;</code></p><p><code>15552</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15553</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=Pharmacological+separation+of+cannabinoid+sensitive+receptors+on+hippocampal+excitatory+and+inhibitory+fibers&amp;amp;author=N+H&amp;#x000e1;jos&amp;amp;author=TF+Freund&amp;amp;volume=43&amp;amp;publication_year=2002&amp;amp;pages=503-510&amp;amp;pmid=12367597&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15554</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15555</code><code>]&lt;/span&gt;</code></p><p><code>15556</code><code>&lt;/span&gt;</code></p><p><code>15557</code><code>&lt;/li&gt;</code></p><p><code>15558</code><code>&lt;li id="R451"&gt;</code></p><p><code>15559</code><code>&lt;span class="citation"&gt;</code></p><p><code>15560</code><code>H&amp;#x000e1;jos N, Ledent C, Freund TF. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. &lt;span&gt;</code></p><p><code>15561</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15562</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>15563</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>15564</code><code>106&lt;/span&gt;</code></p><p><code>15565</code><code>:1–4.&lt;/span&gt;</code></p><p><code>15566</code><code> [&lt;a href="/pubmed/11564411" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15567</code><code>PubMed&lt;/a&gt;</code></p><p><code>15568</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15569</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Novel+cannabinoid-sensitive+receptor+mediates+inhibition+of+glutamatergic+synaptic+transmission+in+the+hippocampus&amp;amp;author=N+H&amp;#x000e1;jos&amp;amp;author=C+Ledent&amp;amp;author=TF+Freund&amp;amp;volume=106&amp;amp;publication_year=2001&amp;amp;pages=1-4&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15570</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15571</code><code>]&lt;/span&gt;</code></p><p><code>15572</code><code>&lt;/span&gt;</code></p><p><code>15573</code><code>&lt;/li&gt;</code></p><p><code>15574</code><code>&lt;li id="R452"&gt;</code></p><p><code>15575</code><code>&lt;span class="citation"&gt;</code></p><p><code>15576</code><code>Halikas JA, Goodwin DW, Guze SB. Marihuana use and psychiatric illness. &lt;span&gt;</code></p><p><code>15577</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15578</code><code>Arch Gen Psychiatry. &lt;/span&gt;</code></p><p><code>15579</code><code>1972;&lt;span class="ref-vol"&gt;</code></p><p><code>15580</code><code>27&lt;/span&gt;</code></p><p><code>15581</code><code>:162–165.&lt;/span&gt;</code></p><p><code>15582</code><code> [&lt;a href="/pubmed/5042824" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15583</code><code>PubMed&lt;/a&gt;</code></p><p><code>15584</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15585</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Arch+Gen+Psychiatry&amp;amp;title=Marihuana+use+and+psychiatric+illness&amp;amp;author=JA+Halikas&amp;amp;author=DW+Goodwin&amp;amp;author=SB+Guze&amp;amp;volume=27&amp;amp;publication_year=1972&amp;amp;pages=162-165&amp;amp;pmid=5042824&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15586</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15587</code><code>]&lt;/span&gt;</code></p><p><code>15588</code><code>&lt;/span&gt;</code></p><p><code>15589</code><code>&lt;/li&gt;</code></p><p><code>15590</code><code>&lt;li id="R453"&gt;</code></p><p><code>15591</code><code>&lt;span class="citation"&gt;</code></p><p><code>15592</code><code>Hall W, Solowij N. Adverse effects of cannabis. &lt;span&gt;</code></p><p><code>15593</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15594</code><code>Lancet. &lt;/span&gt;</code></p><p><code>15595</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>15596</code><code>352&lt;/span&gt;</code></p><p><code>15597</code><code>:1611–1616.&lt;/span&gt;</code></p><p><code>15598</code><code> [&lt;a href="/pubmed/9843121" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15599</code><code>PubMed&lt;/a&gt;</code></p><p><code>15600</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15601</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;amp;title=Adverse+effects+of+cannabis&amp;amp;author=W+Hall&amp;amp;author=N+Solowij&amp;amp;volume=352&amp;amp;publication_year=1998&amp;amp;pages=1611-1616&amp;amp;pmid=9843121&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15602</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15603</code><code>]&lt;/span&gt;</code></p><p><code>15604</code><code>&lt;/span&gt;</code></p><p><code>15605</code><code>&lt;/li&gt;</code></p><p><code>15606</code><code>&lt;li id="R454"&gt;</code></p><p><code>15607</code><code>&lt;span class="citation"&gt;</code></p><p><code>15608</code><code>Hall W, Christie M, Currow D. Cannabinoids and cancer: causation, remediation, and palliation. &lt;span&gt;</code></p><p><code>15609</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15610</code><code>Lancet Oncol. &lt;/span&gt;</code></p><p><code>15611</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>15612</code><code>6&lt;/span&gt;</code></p><p><code>15613</code><code>:35–42.&lt;/span&gt;</code></p><p><code>15614</code><code> [&lt;a href="/pubmed/15629274" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15615</code><code>PubMed&lt;/a&gt;</code></p><p><code>15616</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15617</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Oncol&amp;amp;title=Cannabinoids+and+cancer:+causation,+remediation,+and+palliation&amp;amp;author=W+Hall&amp;amp;author=M+Christie&amp;amp;author=D+Currow&amp;amp;volume=6&amp;amp;publication_year=2005&amp;amp;pages=35-42&amp;amp;pmid=15629274&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15618</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15619</code><code>]&lt;/span&gt;</code></p><p><code>15620</code><code>&lt;/span&gt;</code></p><p><code>15621</code><code>&lt;/li&gt;</code></p><p><code>15622</code><code>&lt;li id="R455"&gt;</code></p><p><code>15623</code><code>&lt;span class="citation"&gt;</code></p><p><code>15624</code><code>Hall W, Degenhardt L, Teesson M. Cannabis use and psychotic disorders: an update. &lt;span&gt;</code></p><p><code>15625</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15626</code><code>Drug Alcohol Rev. &lt;/span&gt;</code></p><p><code>15627</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>15628</code><code>23&lt;/span&gt;</code></p><p><code>15629</code><code>:433–443.&lt;/span&gt;</code></p><p><code>15630</code><code> [&lt;a href="/pubmed/15763748" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15631</code><code>PubMed&lt;/a&gt;</code></p><p><code>15632</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15633</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Drug+Alcohol+Rev&amp;amp;title=Cannabis+use+and+psychotic+disorders:+an+update&amp;amp;author=W+Hall&amp;amp;author=L+Degenhardt&amp;amp;author=M+Teesson&amp;amp;volume=23&amp;amp;publication_year=2004&amp;amp;pages=433-443&amp;amp;pmid=15763748&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15634</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15635</code><code>]&lt;/span&gt;</code></p><p><code>15636</code><code>&lt;/span&gt;</code></p><p><code>15637</code><code>&lt;/li&gt;</code></p><p><code>15638</code><code>&lt;li id="R456"&gt;</code></p><p><code>15639</code><code>&lt;span class="citation"&gt;</code></p><p><code>15640</code><code>Haller J, Bakos N, Szirmay M, Ledent C, Freund TF. The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. &lt;span&gt;</code></p><p><code>15641</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15642</code><code>Eur J Neurosci. &lt;/span&gt;</code></p><p><code>15643</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>15644</code><code>16&lt;/span&gt;</code></p><p><code>15645</code><code>:1395–1398.&lt;/span&gt;</code></p><p><code>15646</code><code> [&lt;a href="/pubmed/12405999" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15647</code><code>PubMed&lt;/a&gt;</code></p><p><code>15648</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15649</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurosci&amp;amp;title=The+effects+of+genetic+and+pharmacological+blockade+of+the+CB1+cannabinoid+receptor+on+anxiety&amp;amp;author=J+Haller&amp;amp;author=N+Bakos&amp;amp;author=M+Szirmay&amp;amp;author=C+Ledent&amp;amp;author=TF+Freund&amp;amp;volume=16&amp;amp;publication_year=2002&amp;amp;pages=1395-1398&amp;amp;pmid=12405999&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15650</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15651</code><code>]&lt;/span&gt;</code></p><p><code>15652</code><code>&lt;/span&gt;</code></p><p><code>15653</code><code>&lt;/li&gt;</code></p><p><code>15654</code><code>&lt;li id="R457"&gt;</code></p><p><code>15655</code><code>&lt;span class="citation"&gt;</code></p><p><code>15656</code><code>Haller J, Varga B, Ledent C, Barna I, Freund TF. Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. &lt;span&gt;</code></p><p><code>15657</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15658</code><code>Eur J Neurosci. &lt;/span&gt;</code></p><p><code>15659</code><code>2004a;&lt;span class="ref-vol"&gt;</code></p><p><code>15660</code><code>19&lt;/span&gt;</code></p><p><code>15661</code><code>:1906–1912.&lt;/span&gt;</code></p><p><code>15662</code><code> [&lt;a href="/pubmed/15078564" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15663</code><code>PubMed&lt;/a&gt;</code></p><p><code>15664</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15665</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurosci&amp;amp;title=Context-dependent+effects+of+CB1+cannabinoid+gene+disruption+on+anxiety-like+and+social+behaviour+in+mice&amp;amp;author=J+Haller&amp;amp;author=B+Varga&amp;amp;author=C+Ledent&amp;amp;author=I+Barna&amp;amp;author=TF+Freund&amp;amp;volume=19&amp;amp;publication_year=2004a&amp;amp;pages=1906-1912&amp;amp;pmid=15078564&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15666</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15667</code><code>]&lt;/span&gt;</code></p><p><code>15668</code><code>&lt;/span&gt;</code></p><p><code>15669</code><code>&lt;/li&gt;</code></p><p><code>15670</code><code>&lt;li id="R458"&gt;</code></p><p><code>15671</code><code>&lt;span class="citation"&gt;</code></p><p><code>15672</code><code>Haller J, Varga B, Ledent C, Freund TF. CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents. &lt;span&gt;</code></p><p><code>15673</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15674</code><code>Behav Pharmacol. &lt;/span&gt;</code></p><p><code>15675</code><code>2004b;&lt;span class="ref-vol"&gt;</code></p><p><code>15676</code><code>15&lt;/span&gt;</code></p><p><code>15677</code><code>:299–304.&lt;/span&gt;</code></p><p><code>15678</code><code> [&lt;a href="/pubmed/15252281" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15679</code><code>PubMed&lt;/a&gt;</code></p><p><code>15680</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15681</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Behav+Pharmacol&amp;amp;title=CB1+cannabinoid+receptors+mediate+anxiolytic+effects:+convergent+genetic+and+pharmacological+evidence+with+CB1-specific+agents&amp;amp;author=J+Haller&amp;amp;author=B+Varga&amp;amp;author=C+Ledent&amp;amp;author=TF+Freund&amp;amp;volume=15&amp;amp;publication_year=2004b&amp;amp;pages=299-304&amp;amp;pmid=15252281&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15682</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15683</code><code>]&lt;/span&gt;</code></p><p><code>15684</code><code>&lt;/span&gt;</code></p><p><code>15685</code><code>&lt;/li&gt;</code></p><p><code>15686</code><code>&lt;li id="R459"&gt;</code></p><p><code>15687</code><code>&lt;span class="citation"&gt;</code></p><p><code>15688</code><code>Hamann W, di Vadi PP. Analgesic effect of the cannabinoid analogue nabilone is not mediated by opioid receptors. &lt;span&gt;</code></p><p><code>15689</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15690</code><code>Lancet. &lt;/span&gt;</code></p><p><code>15691</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>15692</code><code>353&lt;/span&gt;</code></p><p><code>15693</code><code>:560.&lt;/span&gt;</code></p><p><code>15694</code><code> [&lt;a href="/pubmed/10028992" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15695</code><code>PubMed&lt;/a&gt;</code></p><p><code>15696</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15697</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;amp;title=Analgesic+effect+of+the+cannabinoid+analogue+nabilone+is+not+mediated+by+opioid+receptors&amp;amp;author=W+Hamann&amp;amp;author=PP+di+Vadi&amp;amp;volume=353&amp;amp;publication_year=1999&amp;amp;pages=560&amp;amp;pmid=10028992&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15698</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15699</code><code>]&lt;/span&gt;</code></p><p><code>15700</code><code>&lt;/span&gt;</code></p><p><code>15701</code><code>&lt;/li&gt;</code></p><p><code>15702</code><code>&lt;li id="R460"&gt;</code></p><p><code>15703</code><code>&lt;span class="citation"&gt;</code></p><p><code>15704</code><code>Hampson AJ, Grimaldi M, Axelrod J, Wink D. Cannabidiol and (&amp;#x02212;) &amp;#x00394;&lt;sup&gt;</code></p><p><code>15705</code><code>9&lt;/sup&gt;</code></p><p><code>15706</code><code>-tetrahydrocannabinol are neuroprotective antioxidants. &lt;span&gt;</code></p><p><code>15707</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15708</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>15709</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>15710</code><code>95&lt;/span&gt;</code></p><p><code>15711</code><code>:8268–8273.&lt;/span&gt;</code></p><p><code>15712</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>15713</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC20965/"&gt;</code></p><p><code>15714</code><code>PMC free article&lt;/a&gt;</code></p><p><code>15715</code><code>]&lt;/span&gt;</code></p><p><code>15716</code><code> [&lt;a href="/pubmed/9653176" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15717</code><code>PubMed&lt;/a&gt;</code></p><p><code>15718</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15719</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Cannabidiol+and+(&amp;#x02212;)+&amp;#x00394;9-tetrahydrocannabinol+are+neuroprotective+antioxidants&amp;amp;author=AJ+Hampson&amp;amp;author=M+Grimaldi&amp;amp;author=J+Axelrod&amp;amp;author=D+Wink&amp;amp;volume=95&amp;amp;publication_year=1998&amp;amp;pages=8268-8273&amp;amp;pmid=9653176&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15720</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15721</code><code>]&lt;/span&gt;</code></p><p><code>15722</code><code>&lt;/span&gt;</code></p><p><code>15723</code><code>&lt;/li&gt;</code></p><p><code>15724</code><code>&lt;li id="R461"&gt;</code></p><p><code>15725</code><code>&lt;span class="citation"&gt;</code></p><p><code>15726</code><code>Hampson AJ, Grimaldi M, Lolic M, Wink D, Rosenthal R, Axelrod J. Neuroprotective antioxidants from marijuana. &lt;span&gt;</code></p><p><code>15727</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15728</code><code>Ann NY Acad Sci. &lt;/span&gt;</code></p><p><code>15729</code><code>2000a;&lt;span class="ref-vol"&gt;</code></p><p><code>15730</code><code>899&lt;/span&gt;</code></p><p><code>15731</code><code>:274–282.&lt;/span&gt;</code></p><p><code>15732</code><code> [&lt;a href="/pubmed/10863546" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15733</code><code>PubMed&lt;/a&gt;</code></p><p><code>15734</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15735</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Ann+NY+Acad+Sci&amp;amp;title=Neuroprotective+antioxidants+from+marijuana&amp;amp;author=AJ+Hampson&amp;amp;author=M+Grimaldi&amp;amp;author=M+Lolic&amp;amp;author=D+Wink&amp;amp;author=R+Rosenthal&amp;amp;volume=899&amp;amp;publication_year=2000a&amp;amp;pages=274-282&amp;amp;pmid=10863546&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15736</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15737</code><code>]&lt;/span&gt;</code></p><p><code>15738</code><code>&lt;/span&gt;</code></p><p><code>15739</code><code>&lt;/li&gt;</code></p><p><code>15740</code><code>&lt;li id="R462"&gt;</code></p><p><code>15741</code><code>&lt;span class="citation"&gt;</code></p><p><code>15742</code><code>Hampson RE, Mu J, Deadwyler SA. Cannabinoid and &lt;em&gt;</code></p><p><code>15743</code><code>&amp;#x003ba;&lt;/em&gt;</code></p><p><code>15744</code><code> opioid receptors reduce potassium K current via activation of G&lt;sub&gt;</code></p><p><code>15745</code><code>s&lt;/sub&gt;</code></p><p><code>15746</code><code> proteins in cultured hippocampal neurons. &lt;span&gt;</code></p><p><code>15747</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15748</code><code>J Neurophysiol. &lt;/span&gt;</code></p><p><code>15749</code><code>2000b;&lt;span class="ref-vol"&gt;</code></p><p><code>15750</code><code>84&lt;/span&gt;</code></p><p><code>15751</code><code>:2356–2364.&lt;/span&gt;</code></p><p><code>15752</code><code> [&lt;a href="/pubmed/11067978" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15753</code><code>PubMed&lt;/a&gt;</code></p><p><code>15754</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15755</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurophysiol&amp;amp;title=Cannabinoid+and+&amp;#x003ba;+opioid+receptors+reduce+potassium+K+current+via+activation+of+Gs+proteins+in+cultured+hippocampal+neurons&amp;amp;author=RE+Hampson&amp;amp;author=J+Mu&amp;amp;author=SA+Deadwyler&amp;amp;volume=84&amp;amp;publication_year=2000b&amp;amp;pages=2356-2364&amp;amp;pmid=11067978&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15756</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15757</code><code>]&lt;/span&gt;</code></p><p><code>15758</code><code>&lt;/span&gt;</code></p><p><code>15759</code><code>&lt;/li&gt;</code></p><p><code>15760</code><code>&lt;li id="R463"&gt;</code></p><p><code>15761</code><code>&lt;span class="citation"&gt;</code></p><p><code>15762</code><code>Hansen HH, Ikonomidou C, Bittigau P, Hansen SH, Hansen HS. Accumulation of the anandamide precursor and other &lt;em&gt;</code></p><p><code>15763</code><code>N-&lt;/em&gt;</code></p><p><code>15764</code><code>acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death. &lt;span&gt;</code></p><p><code>15765</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15766</code><code>J Neurochem. &lt;/span&gt;</code></p><p><code>15767</code><code>2001a;&lt;span class="ref-vol"&gt;</code></p><p><code>15768</code><code>76&lt;/span&gt;</code></p><p><code>15769</code><code>:39–46.&lt;/span&gt;</code></p><p><code>15770</code><code> [&lt;a href="/pubmed/11145976" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15771</code><code>PubMed&lt;/a&gt;</code></p><p><code>15772</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15773</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;amp;title=Accumulation+of+the+anandamide+precursor+and+other+N-acylethanolamine+phospholipids+in+infant+rat+models+of+in+vivo+necrotic+and+apoptotic+neuronal+death&amp;amp;author=HH+Hansen&amp;amp;author=C+Ikonomidou&amp;amp;author=P+Bittigau&amp;amp;author=SH+Hansen&amp;amp;author=HS+Hansen&amp;amp;volume=76&amp;amp;publication_year=2001a&amp;amp;pages=39-46&amp;amp;pmid=11145976&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15774</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15775</code><code>]&lt;/span&gt;</code></p><p><code>15776</code><code>&lt;/span&gt;</code></p><p><code>15777</code><code>&lt;/li&gt;</code></p><p><code>15778</code><code>&lt;li id="R464"&gt;</code></p><p><code>15779</code><code>&lt;span class="citation"&gt;</code></p><p><code>15780</code><code>Hansen HH, Schmid PC, Bittigau P, Lastres-Becker I, Berrendero F, Manzanares J, Ikonomidou C, Schmid HH, Fernandez-Ruiz JJ, Hansen HS. Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. &lt;span&gt;</code></p><p><code>15781</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15782</code><code>J Neurochem. &lt;/span&gt;</code></p><p><code>15783</code><code>2001b;&lt;span class="ref-vol"&gt;</code></p><p><code>15784</code><code>78&lt;/span&gt;</code></p><p><code>15785</code><code>:1415–1427.&lt;/span&gt;</code></p><p><code>15786</code><code> [&lt;a href="/pubmed/11579150" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15787</code><code>PubMed&lt;/a&gt;</code></p><p><code>15788</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15789</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;amp;title=Anandamide,+but+not+2-arachidonoylglycerol,+accumulates+during+in+vivo+neurodegeneration&amp;amp;author=HH+Hansen&amp;amp;author=PC+Schmid&amp;amp;author=P+Bittigau&amp;amp;author=I+Lastres-Becker&amp;amp;author=F+Berrendero&amp;amp;volume=78&amp;amp;publication_year=2001b&amp;amp;pages=1415-1427&amp;amp;pmid=11579150&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15790</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15791</code><code>]&lt;/span&gt;</code></p><p><code>15792</code><code>&lt;/span&gt;</code></p><p><code>15793</code><code>&lt;/li&gt;</code></p><p><code>15794</code><code>&lt;li id="R465"&gt;</code></p><p><code>15795</code><code>&lt;span class="citation"&gt;</code></p><p><code>15796</code><code>Hansson AC, Bermudez-Silva FJ, Malinen H, Hyytia P, Sanchez-Vera I, Rimondini R, Rodriguez de Fonseca F, Kunos G, Sommer WH, Heilig M. Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. &lt;span&gt;</code></p><p><code>15797</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15798</code><code>Neuropsychopharmacology. &lt;/span&gt;</code></p><p><code>15799</code><code>2006&lt;/span&gt;</code></p><p><code>15800</code><code> in press. [&lt;a href="/pubmed/16482090" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15801</code><code>PubMed&lt;/a&gt;</code></p><p><code>15802</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15803</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;amp;title=Genetic+impairment+of+frontocortical+endocannabinoid+degradation+and+high+alcohol+preference&amp;amp;author=AC+Hansson&amp;amp;author=FJ+Bermudez-Silva&amp;amp;author=H+Malinen&amp;amp;author=P+Hyytia&amp;amp;author=I+Sanchez-Vera&amp;amp;publication_year=2006&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15804</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15805</code><code>]&lt;/span&gt;</code></p><p><code>15806</code><code>&lt;/span&gt;</code></p><p><code>15807</code><code>&lt;/li&gt;</code></p><p><code>15808</code><code>&lt;li id="R466"&gt;</code></p><p><code>15809</code><code>&lt;span class="citation"&gt;</code></p><p><code>15810</code><code>Hanus L, Abu-Lafi S, Fride E, Breuer A, Vogel Z, Shalev DE, Kustanovich I, Mechoulam R. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. &lt;span&gt;</code></p><p><code>15811</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15812</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>15813</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>15814</code><code>98&lt;/span&gt;</code></p><p><code>15815</code><code>:3662–3665.&lt;/span&gt;</code></p><p><code>15816</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>15817</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC31108/"&gt;</code></p><p><code>15818</code><code>PMC free article&lt;/a&gt;</code></p><p><code>15819</code><code>]&lt;/span&gt;</code></p><p><code>15820</code><code> [&lt;a href="/pubmed/11259648" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15821</code><code>PubMed&lt;/a&gt;</code></p><p><code>15822</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15823</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=2-Arachidonyl+glyceryl+ether,+an+endogenous+agonist+of+the+cannabinoid+CB1+receptor&amp;amp;author=L+Hanus&amp;amp;author=S+Abu-Lafi&amp;amp;author=E+Fride&amp;amp;author=A+Breuer&amp;amp;author=Z+Vogel&amp;amp;volume=98&amp;amp;publication_year=2001&amp;amp;pages=3662-3665&amp;amp;pmid=11259648&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15824</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15825</code><code>]&lt;/span&gt;</code></p><p><code>15826</code><code>&lt;/span&gt;</code></p><p><code>15827</code><code>&lt;/li&gt;</code></p><p><code>15828</code><code>&lt;li id="R467"&gt;</code></p><p><code>15829</code><code>&lt;span class="citation"&gt;</code></p><p><code>15830</code><code>Hanus L, Breuer A, Tchilibon S, Shiloah S, Goldenberg D, Horowitz M, Pertwee RG, Ross RA, Mechovlam R, Fride E. HU-308: a specific agonist for CB&lt;sub&gt;</code></p><p><code>15831</code><code>2&lt;/sub&gt;</code></p><p><code>15832</code><code>, a peripheral cannabinoid receptor. &lt;span&gt;</code></p><p><code>15833</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15834</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>15835</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>15836</code><code>96&lt;/span&gt;</code></p><p><code>15837</code><code>:14228–14233.&lt;/span&gt;</code></p><p><code>15838</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>15839</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC24419/"&gt;</code></p><p><code>15840</code><code>PMC free article&lt;/a&gt;</code></p><p><code>15841</code><code>]&lt;/span&gt;</code></p><p><code>15842</code><code> [&lt;a href="/pubmed/10588688" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15843</code><code>PubMed&lt;/a&gt;</code></p><p><code>15844</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15845</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=HU-308:+a+specific+agonist+for+CB2,+a+peripheral+cannabinoid+receptor&amp;amp;author=L+Hanus&amp;amp;author=A+Breuer&amp;amp;author=S+Tchilibon&amp;amp;author=S+Shiloah&amp;amp;author=D+Goldenberg&amp;amp;volume=96&amp;amp;publication_year=1999&amp;amp;pages=14228-14233&amp;amp;pmid=10588688&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15846</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15847</code><code>]&lt;/span&gt;</code></p><p><code>15848</code><code>&lt;/span&gt;</code></p><p><code>15849</code><code>&lt;/li&gt;</code></p><p><code>15850</code><code>&lt;li id="R468"&gt;</code></p><p><code>15851</code><code>&lt;span class="citation"&gt;</code></p><p><code>15852</code><code>Hao S, Avraham Y, Mechoulam R, Berry EM. Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. &lt;span&gt;</code></p><p><code>15853</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15854</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>15855</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>15856</code><code>392&lt;/span&gt;</code></p><p><code>15857</code><code>:147–156.&lt;/span&gt;</code></p><p><code>15858</code><code> [&lt;a href="/pubmed/10762668" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15859</code><code>PubMed&lt;/a&gt;</code></p><p><code>15860</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15861</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Low+dose+anandamide+affects+food+intake,+cognitive+function,+neurotransmitter+and+corticosterone+levels+in+diet-restricted+mice&amp;amp;author=S+Hao&amp;amp;author=Y+Avraham&amp;amp;author=R+Mechoulam&amp;amp;author=EM+Berry&amp;amp;volume=392&amp;amp;publication_year=2000&amp;amp;pages=147-156&amp;amp;pmid=10762668&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15862</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15863</code><code>]&lt;/span&gt;</code></p><p><code>15864</code><code>&lt;/span&gt;</code></p><p><code>15865</code><code>&lt;/li&gt;</code></p><p><code>15866</code><code>&lt;li id="R469"&gt;</code></p><p><code>15867</code><code>&lt;span class="citation"&gt;</code></p><p><code>15868</code><code>Harris GC, Wimmer M, Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. &lt;span&gt;</code></p><p><code>15869</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15870</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>15871</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>15872</code><code>437&lt;/span&gt;</code></p><p><code>15873</code><code>:556–559.&lt;/span&gt;</code></p><p><code>15874</code><code> [&lt;a href="/pubmed/16100511" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15875</code><code>PubMed&lt;/a&gt;</code></p><p><code>15876</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15877</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=A+role+for+lateral+hypothalamic+orexin+neurons+in+reward+seeking&amp;amp;author=GC+Harris&amp;amp;author=M+Wimmer&amp;amp;author=G+Aston-Jones&amp;amp;volume=437&amp;amp;publication_year=2005&amp;amp;pages=556-559&amp;amp;pmid=16100511&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15878</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15879</code><code>]&lt;/span&gt;</code></p><p><code>15880</code><code>&lt;/span&gt;</code></p><p><code>15881</code><code>&lt;/li&gt;</code></p><p><code>15882</code><code>&lt;li id="R470"&gt;</code></p><p><code>15883</code><code>&lt;span class="citation"&gt;</code></p><p><code>15884</code><code>Harrold JA, Elliott JC, King PJ, Widdowson PS, Williams G. Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food? &lt;span&gt;</code></p><p><code>15885</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15886</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>15887</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>15888</code><code>952&lt;/span&gt;</code></p><p><code>15889</code><code>:232–238.&lt;/span&gt;</code></p><p><code>15890</code><code> [&lt;a href="/pubmed/12376184" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15891</code><code>PubMed&lt;/a&gt;</code></p><p><code>15892</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15893</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Down-regulation+of+cannabinoid-1+(CB-1)+receptors+in+specific+extrahypothalamic+regions+of+rats+with+dietary+obesity:+a+role+for+endogenous+cannabinoids+in+driving+appetite+for+palatable+food?&amp;amp;author=JA+Harrold&amp;amp;author=JC+Elliott&amp;amp;author=PJ+King&amp;amp;author=PS+Widdowson&amp;amp;author=G+Williams&amp;amp;volume=952&amp;amp;publication_year=2002&amp;amp;pages=232-238&amp;amp;pmid=12376184&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15894</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15895</code><code>]&lt;/span&gt;</code></p><p><code>15896</code><code>&lt;/span&gt;</code></p><p><code>15897</code><code>&lt;/li&gt;</code></p><p><code>15898</code><code>&lt;li id="R471"&gt;</code></p><p><code>15899</code><code>&lt;span class="citation"&gt;</code></p><p><code>15900</code><code>Harrold JA, Williams G. The cannabinoid system: a role in both the homeostatic and hedonic control of eating? &lt;span&gt;</code></p><p><code>15901</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15902</code><code>Br J Nutr. &lt;/span&gt;</code></p><p><code>15903</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>15904</code><code>90&lt;/span&gt;</code></p><p><code>15905</code><code>:729–734.&lt;/span&gt;</code></p><p><code>15906</code><code> [&lt;a href="/pubmed/13129440" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15907</code><code>PubMed&lt;/a&gt;</code></p><p><code>15908</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15909</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Nutr&amp;amp;title=The+cannabinoid+system:+a+role+in+both+the+homeostatic+and+hedonic+control+of+eating?&amp;amp;author=JA+Harrold&amp;amp;author=G+Williams&amp;amp;volume=90&amp;amp;publication_year=2003&amp;amp;pages=729-734&amp;amp;pmid=13129440&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15910</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15911</code><code>]&lt;/span&gt;</code></p><p><code>15912</code><code>&lt;/span&gt;</code></p><p><code>15913</code><code>&lt;/li&gt;</code></p><p><code>15914</code><code>&lt;li id="R472"&gt;</code></p><p><code>15915</code><code>&lt;span class="citation"&gt;</code></p><p><code>15916</code><code>Hart S, Fischer OM, Ullrich A. Cannabinoids induce cancer cell proliferation via tumor necrosis factor &lt;em&gt;</code></p><p><code>15917</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>15918</code><code>-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. &lt;span&gt;</code></p><p><code>15919</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15920</code><code>Cancer Res. &lt;/span&gt;</code></p><p><code>15921</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>15922</code><code>64&lt;/span&gt;</code></p><p><code>15923</code><code>:1943–1950.&lt;/span&gt;</code></p><p><code>15924</code><code> [&lt;a href="/pubmed/15026328" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15925</code><code>PubMed&lt;/a&gt;</code></p><p><code>15926</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15927</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=Cannabinoids+induce+cancer+cell+proliferation+via+tumor+necrosis+factor+&amp;#x003b1;-converting+enzyme+(TACE/ADAM17)-mediated+transactivation+of+the+epidermal+growth+factor+receptor&amp;amp;author=S+Hart&amp;amp;author=OM+Fischer&amp;amp;author=A+Ullrich&amp;amp;volume=64&amp;amp;publication_year=2004&amp;amp;pages=1943-1950&amp;amp;pmid=15026328&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15928</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15929</code><code>]&lt;/span&gt;</code></p><p><code>15930</code><code>&lt;/span&gt;</code></p><p><code>15931</code><code>&lt;/li&gt;</code></p><p><code>15932</code><code>&lt;li id="R473"&gt;</code></p><p><code>15933</code><code>&lt;span class="citation"&gt;</code></p><p><code>15934</code><code>Hartley JP, Nogrady SG, Seaton A. Bronchodilator effect of &amp;#x00394;&lt;sup&gt;</code></p><p><code>15935</code><code>1&lt;/sup&gt;</code></p><p><code>15936</code><code>-tetrahydrocannabinol. &lt;span&gt;</code></p><p><code>15937</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15938</code><code>Br J Clin Pharmacol. &lt;/span&gt;</code></p><p><code>15939</code><code>1978;&lt;span class="ref-vol"&gt;</code></p><p><code>15940</code><code>5&lt;/span&gt;</code></p><p><code>15941</code><code>:523–525.&lt;/span&gt;</code></p><p><code>15942</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>15943</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1429361/"&gt;</code></p><p><code>15944</code><code>PMC free article&lt;/a&gt;</code></p><p><code>15945</code><code>]&lt;/span&gt;</code></p><p><code>15946</code><code> [&lt;a href="/pubmed/656294" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15947</code><code>PubMed&lt;/a&gt;</code></p><p><code>15948</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15949</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Clin+Pharmacol&amp;amp;title=Bronchodilator+effect+of+&amp;#x00394;1-tetrahydrocannabinol&amp;amp;author=JP+Hartley&amp;amp;author=SG+Nogrady&amp;amp;author=A+Seaton&amp;amp;volume=5&amp;amp;publication_year=1978&amp;amp;pages=523-525&amp;amp;pmid=656294&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15950</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15951</code><code>]&lt;/span&gt;</code></p><p><code>15952</code><code>&lt;/span&gt;</code></p><p><code>15953</code><code>&lt;/li&gt;</code></p><p><code>15954</code><code>&lt;li id="R474"&gt;</code></p><p><code>15955</code><code>&lt;span class="citation"&gt;</code></p><p><code>15956</code><code>Hattori N, Mizuno Y. Pathogenetic mechanisms of parkin in Parkinson&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>15957</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15958</code><code>Lancet. &lt;/span&gt;</code></p><p><code>15959</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>15960</code><code>364&lt;/span&gt;</code></p><p><code>15961</code><code>:722–724.&lt;/span&gt;</code></p><p><code>15962</code><code> [&lt;a href="/pubmed/15325839" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15963</code><code>PubMed&lt;/a&gt;</code></p><p><code>15964</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15965</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;amp;title=Pathogenetic+mechanisms+of+parkin+in+Parkinson&amp;#x02019;s+disease&amp;amp;author=N+Hattori&amp;amp;author=Y+Mizuno&amp;amp;volume=364&amp;amp;publication_year=2004&amp;amp;pages=722-724&amp;amp;pmid=15325839&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15966</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15967</code><code>]&lt;/span&gt;</code></p><p><code>15968</code><code>&lt;/span&gt;</code></p><p><code>15969</code><code>&lt;/li&gt;</code></p><p><code>15970</code><code>&lt;li id="R475"&gt;</code></p><p><code>15971</code><code>&lt;span class="citation"&gt;</code></p><p><code>15972</code><code>Hayakawa K, Mishima K, Abe K, Hasebe N, Takamatsu F, Yasuda H, Ikeda T, Inui K, Egashira N, Iwasaki K, et al.  Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism. &lt;span&gt;</code></p><p><code>15973</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15974</code><code>Neuroreport. &lt;/span&gt;</code></p><p><code>15975</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>15976</code><code>15&lt;/span&gt;</code></p><p><code>15977</code><code>:2381–2385.&lt;/span&gt;</code></p><p><code>15978</code><code> [&lt;a href="/pubmed/15640760" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15979</code><code>PubMed&lt;/a&gt;</code></p><p><code>15980</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15981</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroreport&amp;amp;title=Cannabidiol+prevents+infarction+via+the+non-CB1+cannabinoid+receptor+mechanism&amp;amp;author=K+Hayakawa&amp;amp;author=K+Mishima&amp;amp;author=K+Abe&amp;amp;author=N+Hasebe&amp;amp;author=F+Takamatsu&amp;amp;volume=15&amp;amp;publication_year=2004&amp;amp;pages=2381-2385&amp;amp;pmid=15640760&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15982</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15983</code><code>]&lt;/span&gt;</code></p><p><code>15984</code><code>&lt;/span&gt;</code></p><p><code>15985</code><code>&lt;/li&gt;</code></p><p><code>15986</code><code>&lt;li id="R476"&gt;</code></p><p><code>15987</code><code>&lt;span class="citation"&gt;</code></p><p><code>15988</code><code>Hayase T, Yamamoto Y, Yamamoto K. Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms. &lt;span&gt;</code></p><p><code>15989</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>15990</code><code>J Pharm Pharmacol. &lt;/span&gt;</code></p><p><code>15991</code><code>2001a;&lt;span class="ref-vol"&gt;</code></p><p><code>15992</code><code>53&lt;/span&gt;</code></p><p><code>15993</code><code>:1525–1532.&lt;/span&gt;</code></p><p><code>15994</code><code> [&lt;a href="/pubmed/11732755" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>15995</code><code>PubMed&lt;/a&gt;</code></p><p><code>15996</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>15997</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Pharmacol&amp;amp;title=Protective+effects+of+cannabinoid+receptor+agonists+against+cocaine+and+other+convulsant-induced+toxic+behavioural+symptoms&amp;amp;author=T+Hayase&amp;amp;author=Y+Yamamoto&amp;amp;author=K+Yamamoto&amp;amp;volume=53&amp;amp;publication_year=2001a&amp;amp;pages=1525-1532&amp;amp;pmid=11732755&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>15998</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>15999</code><code>]&lt;/span&gt;</code></p><p><code>16000</code><code>&lt;/span&gt;</code></p><p><code>16001</code><code>&lt;/li&gt;</code></p><p><code>16002</code><code>&lt;li id="R477"&gt;</code></p><p><code>16003</code><code>&lt;span class="citation"&gt;</code></p><p><code>16004</code><code>Hayase T, Yamamoto Y, Yamamoto K. Protective effects of cannabinoid receptor ligands analogous to anandamide against cocaine toxicity. &lt;span&gt;</code></p><p><code>16005</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16006</code><code>Nihon Arukoru Yakubutsu Igakkai Zasshi. &lt;/span&gt;</code></p><p><code>16007</code><code>2001b;&lt;span class="ref-vol"&gt;</code></p><p><code>16008</code><code>36&lt;/span&gt;</code></p><p><code>16009</code><code>:596–608.&lt;/span&gt;</code></p><p><code>16010</code><code> [&lt;a href="/pubmed/11828716" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16011</code><code>PubMed&lt;/a&gt;</code></p><p><code>16012</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16013</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nihon+Arukoru+Yakubutsu+Igakkai+Zasshi&amp;amp;title=Protective+effects+of+cannabinoid+receptor+ligands+analogous+to+anandamide+against+cocaine+toxicity&amp;amp;author=T+Hayase&amp;amp;author=Y+Yamamoto&amp;amp;author=K+Yamamoto&amp;amp;volume=36&amp;amp;publication_year=2001b&amp;amp;pages=596-608&amp;amp;pmid=11828716&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16014</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16015</code><code>]&lt;/span&gt;</code></p><p><code>16016</code><code>&lt;/span&gt;</code></p><p><code>16017</code><code>&lt;/li&gt;</code></p><p><code>16018</code><code>&lt;li id="R478"&gt;</code></p><p><code>16019</code><code>&lt;span class="citation"&gt;</code></p><p><code>16020</code><code>Hedlund PB, Carson MJ, Sutcliffe JG, Thomas EA. Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine&lt;sub&gt;</code></p><p><code>16021</code><code>7&lt;/sub&gt;</code></p><p><code>16022</code><code> receptors. &lt;span&gt;</code></p><p><code>16023</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16024</code><code>Biochem Pharmacol. &lt;/span&gt;</code></p><p><code>16025</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>16026</code><code>58&lt;/span&gt;</code></p><p><code>16027</code><code>:1807–1813.&lt;/span&gt;</code></p><p><code>16028</code><code> [&lt;a href="/pubmed/10571256" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16029</code><code>PubMed&lt;/a&gt;</code></p><p><code>16030</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16031</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;amp;title=Allosteric+regulation+by+oleamide+of+the+binding+properties+of+5-hydroxytryptamine7+receptors&amp;amp;author=PB+Hedlund&amp;amp;author=MJ+Carson&amp;amp;author=JG+Sutcliffe&amp;amp;author=EA+Thomas&amp;amp;volume=58&amp;amp;publication_year=1999&amp;amp;pages=1807-1813&amp;amp;pmid=10571256&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16032</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16033</code><code>]&lt;/span&gt;</code></p><p><code>16034</code><code>&lt;/span&gt;</code></p><p><code>16035</code><code>&lt;/li&gt;</code></p><p><code>16036</code><code>&lt;li id="R479"&gt;</code></p><p><code>16037</code><code>&lt;span class="citation"&gt;</code></p><p><code>16038</code><code>Heilig M, Soderpalm B, Engel JA, Viderlow E. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. &lt;span&gt;</code></p><p><code>16039</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16040</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>16041</code><code>1989;&lt;span class="ref-vol"&gt;</code></p><p><code>16042</code><code>98&lt;/span&gt;</code></p><p><code>16043</code><code>:524–529.&lt;/span&gt;</code></p><p><code>16044</code><code> [&lt;a href="/pubmed/2570434" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16045</code><code>PubMed&lt;/a&gt;</code></p><p><code>16046</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16047</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Centrally+administered+neuropeptide+Y+(NPY)+produces+anxiolytic-like+effects+in+animal+anxiety+models&amp;amp;author=M+Heilig&amp;amp;author=B+Soderpalm&amp;amp;author=JA+Engel&amp;amp;author=E+Viderlow&amp;amp;volume=98&amp;amp;publication_year=1989&amp;amp;pages=524-529&amp;amp;pmid=2570434&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16048</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16049</code><code>]&lt;/span&gt;</code></p><p><code>16050</code><code>&lt;/span&gt;</code></p><p><code>16051</code><code>&lt;/li&gt;</code></p><p><code>16052</code><code>&lt;li id="R480"&gt;</code></p><p><code>16053</code><code>&lt;span class="citation"&gt;</code></p><p><code>16054</code><code>Hensen B. Cannabinoid therapeutics: high hopes for the future. &lt;span&gt;</code></p><p><code>16055</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16056</code><code>Drug Discov Today. &lt;/span&gt;</code></p><p><code>16057</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>16058</code><code>10&lt;/span&gt;</code></p><p><code>16059</code><code>:459–462.&lt;/span&gt;</code></p><p><code>16060</code><code> [&lt;a href="/pubmed/15809190" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16061</code><code>PubMed&lt;/a&gt;</code></p><p><code>16062</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16063</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Drug+Discov+Today&amp;amp;title=Cannabinoid+therapeutics:+high+hopes+for+the+future&amp;amp;author=B+Hensen&amp;amp;volume=10&amp;amp;publication_year=2005&amp;amp;pages=459-462&amp;amp;pmid=15809190&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16064</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16065</code><code>]&lt;/span&gt;</code></p><p><code>16066</code><code>&lt;/span&gt;</code></p><p><code>16067</code><code>&lt;/li&gt;</code></p><p><code>16068</code><code>&lt;li id="R481"&gt;</code></p><p><code>16069</code><code>&lt;span class="citation"&gt;</code></p><p><code>16070</code><code>Hepler RS, Frank IM, Petrus R.  Ocular effects of marijuana. In: Braude M, Szara S, editors. &lt;span class="ref-journal"&gt;</code></p><p><code>16071</code><code>Pharmacology of Cannabis.&lt;/span&gt;</code></p><p><code>16072</code><code> Raven; New York: 1976.  &lt;span class="nowrap"&gt;</code></p><p><code>16073</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?title=Pharmacology+of+Cannabis&amp;amp;author=RS+Hepler&amp;amp;author=IM+Frank&amp;amp;author=R+Petrus&amp;amp;publication_year=1976&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16074</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16075</code><code>]&lt;/span&gt;</code></p><p><code>16076</code><code>&lt;/span&gt;</code></p><p><code>16077</code><code>&lt;/li&gt;</code></p><p><code>16078</code><code>&lt;li id="R482"&gt;</code></p><p><code>16079</code><code>&lt;span class="citation"&gt;</code></p><p><code>16080</code><code>Hepler RS, Frank IR. Marihuana smoking and intraocular pressure. &lt;span&gt;</code></p><p><code>16081</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16082</code><code>J Am Med Assoc. &lt;/span&gt;</code></p><p><code>16083</code><code>1971;&lt;span class="ref-vol"&gt;</code></p><p><code>16084</code><code>217&lt;/span&gt;</code></p><p><code>16085</code><code>:1392.&lt;/span&gt;</code></p><p><code>16086</code><code> [&lt;a href="/pubmed/5109652" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16087</code><code>PubMed&lt;/a&gt;</code></p><p><code>16088</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16089</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Med+Assoc&amp;amp;title=Marihuana+smoking+and+intraocular+pressure&amp;amp;author=RS+Hepler&amp;amp;author=IR+Frank&amp;amp;volume=217&amp;amp;publication_year=1971&amp;amp;pages=1392&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16090</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16091</code><code>]&lt;/span&gt;</code></p><p><code>16092</code><code>&lt;/span&gt;</code></p><p><code>16093</code><code>&lt;/li&gt;</code></p><p><code>16094</code><code>&lt;li id="R483"&gt;</code></p><p><code>16095</code><code>&lt;span class="citation"&gt;</code></p><p><code>16096</code><code>Hepler RS, Frank IM, Ungerleider JT. Pupillary constriction after marijuana smoking. &lt;span&gt;</code></p><p><code>16097</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16098</code><code>Am J Ophthalmol. &lt;/span&gt;</code></p><p><code>16099</code><code>1972;&lt;span class="ref-vol"&gt;</code></p><p><code>16100</code><code>74&lt;/span&gt;</code></p><p><code>16101</code><code>:1185–1190.&lt;/span&gt;</code></p><p><code>16102</code><code> [&lt;a href="/pubmed/4646726" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16103</code><code>PubMed&lt;/a&gt;</code></p><p><code>16104</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16105</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Ophthalmol&amp;amp;title=Pupillary+constriction+after+marijuana+smoking&amp;amp;author=RS+Hepler&amp;amp;author=IM+Frank&amp;amp;author=JT+Ungerleider&amp;amp;volume=74&amp;amp;publication_year=1972&amp;amp;pages=1185-1190&amp;amp;pmid=4646726&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16106</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16107</code><code>]&lt;/span&gt;</code></p><p><code>16108</code><code>&lt;/span&gt;</code></p><p><code>16109</code><code>&lt;/li&gt;</code></p><p><code>16110</code><code>&lt;li id="R484"&gt;</code></p><p><code>16111</code><code>&lt;span class="citation"&gt;</code></p><p><code>16112</code><code>Herkenham M, Groen BG, Lynn AB, De Costa BR, Richfield EK. Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum. &lt;span&gt;</code></p><p><code>16113</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16114</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>16115</code><code>1991a;&lt;span class="ref-vol"&gt;</code></p><p><code>16116</code><code>552&lt;/span&gt;</code></p><p><code>16117</code><code>:301–310.&lt;/span&gt;</code></p><p><code>16118</code><code> [&lt;a href="/pubmed/1913192" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16119</code><code>PubMed&lt;/a&gt;</code></p><p><code>16120</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16121</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Neuronal+localization+of+cannabinoid+receptors+and+second+messengers+in+mutant+mouse+cerebellum&amp;amp;author=M+Herkenham&amp;amp;author=BG+Groen&amp;amp;author=AB+Lynn&amp;amp;author=BR+De+Costa&amp;amp;author=EK+Richfield&amp;amp;volume=552&amp;amp;publication_year=1991a&amp;amp;pages=301-310&amp;amp;pmid=1913192&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16122</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16123</code><code>]&lt;/span&gt;</code></p><p><code>16124</code><code>&lt;/span&gt;</code></p><p><code>16125</code><code>&lt;/li&gt;</code></p><p><code>16126</code><code>&lt;li id="R485"&gt;</code></p><p><code>16127</code><code>&lt;span class="citation"&gt;</code></p><p><code>16128</code><code>Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. &lt;span&gt;</code></p><p><code>16129</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16130</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>16131</code><code>1991b;&lt;span class="ref-vol"&gt;</code></p><p><code>16132</code><code>11&lt;/span&gt;</code></p><p><code>16133</code><code>:563–583.&lt;/span&gt;</code></p><p><code>16134</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>16135</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6575215/"&gt;</code></p><p><code>16136</code><code>PMC free article&lt;/a&gt;</code></p><p><code>16137</code><code>]&lt;/span&gt;</code></p><p><code>16138</code><code> [&lt;a href="/pubmed/1992016" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16139</code><code>PubMed&lt;/a&gt;</code></p><p><code>16140</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16141</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Characterization+and+localization+of+cannabinoid+receptors+in+rat+brain:+a+quantitative+in+vitro+autoradiographic+study&amp;amp;author=M+Herkenham&amp;amp;author=AB+Lynn&amp;amp;author=MR+Johnson&amp;amp;author=LS+Melvin&amp;amp;author=BR+de+Costa&amp;amp;volume=11&amp;amp;publication_year=1991b&amp;amp;pages=563-583&amp;amp;pmid=1992016&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16142</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16143</code><code>]&lt;/span&gt;</code></p><p><code>16144</code><code>&lt;/span&gt;</code></p><p><code>16145</code><code>&lt;/li&gt;</code></p><p><code>16146</code><code>&lt;li id="R486"&gt;</code></p><p><code>16147</code><code>&lt;span class="citation"&gt;</code></p><p><code>16148</code><code>Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC. Cannabinoid receptor localization in brain. &lt;span&gt;</code></p><p><code>16149</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16150</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>16151</code><code>1990;&lt;span class="ref-vol"&gt;</code></p><p><code>16152</code><code>87&lt;/span&gt;</code></p><p><code>16153</code><code>:1932–1936.&lt;/span&gt;</code></p><p><code>16154</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>16155</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC53598/"&gt;</code></p><p><code>16156</code><code>PMC free article&lt;/a&gt;</code></p><p><code>16157</code><code>]&lt;/span&gt;</code></p><p><code>16158</code><code> [&lt;a href="/pubmed/2308954" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16159</code><code>PubMed&lt;/a&gt;</code></p><p><code>16160</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16161</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Cannabinoid+receptor+localization+in+brain&amp;amp;author=M+Herkenham&amp;amp;author=AB+Lynn&amp;amp;author=MD+Little&amp;amp;author=MR+Johnson&amp;amp;author=LS+Melvin&amp;amp;volume=87&amp;amp;publication_year=1990&amp;amp;pages=1932-1936&amp;amp;pmid=2308954&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16162</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16163</code><code>]&lt;/span&gt;</code></p><p><code>16164</code><code>&lt;/span&gt;</code></p><p><code>16165</code><code>&lt;/li&gt;</code></p><p><code>16166</code><code>&lt;li id="R487"&gt;</code></p><p><code>16167</code><code>&lt;span class="citation"&gt;</code></p><p><code>16168</code><code>Hermann H, Lutz B. Coexpression of the cannabinoid receptor type 1 with the corticotrophin-releasing hormone receptor type 1 in distinct regions of the adult mouse forebrain. &lt;span&gt;</code></p><p><code>16169</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16170</code><code>Neurosci Lett. &lt;/span&gt;</code></p><p><code>16171</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>16172</code><code>375&lt;/span&gt;</code></p><p><code>16173</code><code>:13–18.&lt;/span&gt;</code></p><p><code>16174</code><code> [&lt;a href="/pubmed/15664114" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16175</code><code>PubMed&lt;/a&gt;</code></p><p><code>16176</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16177</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Lett&amp;amp;title=Coexpression+of+the+cannabinoid+receptor+type+1+with+the+corticotrophin-releasing+hormone+receptor+type+1+in+distinct+regions+of+the+adult+mouse+forebrain&amp;amp;author=H+Hermann&amp;amp;author=B+Lutz&amp;amp;volume=375&amp;amp;publication_year=2005&amp;amp;pages=13-18&amp;amp;pmid=15664114&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16178</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16179</code><code>]&lt;/span&gt;</code></p><p><code>16180</code><code>&lt;/span&gt;</code></p><p><code>16181</code><code>&lt;/li&gt;</code></p><p><code>16182</code><code>&lt;li id="R488"&gt;</code></p><p><code>16183</code><code>&lt;span class="citation"&gt;</code></p><p><code>16184</code><code>Herrera B, Carracedo A, Diez-Zaera M, Gomez Del Pulgar T, Guzman M, Velasco G. The CB(2) cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway. &lt;span&gt;</code></p><p><code>16185</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16186</code><code>Exp Cell Res. &lt;/span&gt;</code></p><p><code>16187</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>16188</code><code>312&lt;/span&gt;</code></p><p><code>16189</code><code>:2121–2131.&lt;/span&gt;</code></p><p><code>16190</code><code> [&lt;a href="/pubmed/16624285" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16191</code><code>PubMed&lt;/a&gt;</code></p><p><code>16192</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16193</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Exp+Cell+Res&amp;amp;title=The+CB(2)+cannabinoid+receptor+signals+apoptosis+via+ceramide-dependent+activation+of+the+mitochondrial+intrinsic+pathway&amp;amp;author=B+Herrera&amp;amp;author=A+Carracedo&amp;amp;author=M+Diez-Zaera&amp;amp;author=T+Gomez+Del+Pulgar&amp;amp;author=M+Guzman&amp;amp;volume=312&amp;amp;publication_year=2006&amp;amp;pages=2121-2131&amp;amp;pmid=16624285&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16194</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16195</code><code>]&lt;/span&gt;</code></p><p><code>16196</code><code>&lt;/span&gt;</code></p><p><code>16197</code><code>&lt;/li&gt;</code></p><p><code>16198</code><code>&lt;li id="R489"&gt;</code></p><p><code>16199</code><code>&lt;span class="citation"&gt;</code></p><p><code>16200</code><code>Herrera B, Carracedo A, Diez-Zaera M, Guzman M, Velasco G. p38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells. &lt;span&gt;</code></p><p><code>16201</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16202</code><code>FEBS Lett. &lt;/span&gt;</code></p><p><code>16203</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>16204</code><code>579&lt;/span&gt;</code></p><p><code>16205</code><code>:5084–5088.&lt;/span&gt;</code></p><p><code>16206</code><code> [&lt;a href="/pubmed/16139274" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16207</code><code>PubMed&lt;/a&gt;</code></p><p><code>16208</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16209</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;amp;title=p38+MAPK+is+involved+in+CB2+receptor-induced+apoptosis+of+human+leukaemia+cells&amp;amp;author=B+Herrera&amp;amp;author=A+Carracedo&amp;amp;author=M+Diez-Zaera&amp;amp;author=M+Guzman&amp;amp;author=G+Velasco&amp;amp;volume=579&amp;amp;publication_year=2005&amp;amp;pages=5084-5088&amp;amp;pmid=16139274&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16210</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16211</code><code>]&lt;/span&gt;</code></p><p><code>16212</code><code>&lt;/span&gt;</code></p><p><code>16213</code><code>&lt;/li&gt;</code></p><p><code>16214</code><code>&lt;li id="R490"&gt;</code></p><p><code>16215</code><code>&lt;span class="citation"&gt;</code></p><p><code>16216</code><code>Herzberg U, Eliav E, Bennett GJ, Kopin IJ. The analgesic effects of &lt;em&gt;</code></p><p><code>16217</code><code>R&lt;/em&gt;</code></p><p><code>16218</code><code>(+)-WIN 55,212-2 mesylate a high affinity cannabinoid agonist, in a rat model of neuropathic pain. &lt;span&gt;</code></p><p><code>16219</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16220</code><code>Neurosci Lett. &lt;/span&gt;</code></p><p><code>16221</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>16222</code><code>221&lt;/span&gt;</code></p><p><code>16223</code><code>:157–160.&lt;/span&gt;</code></p><p><code>16224</code><code> [&lt;a href="/pubmed/9121688" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16225</code><code>PubMed&lt;/a&gt;</code></p><p><code>16226</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16227</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Lett&amp;amp;title=The+analgesic+effects+of+R(+)-WIN+55,212-2+mesylate+a+high+affinity+cannabinoid+agonist,+in+a+rat+model+of+neuropathic+pain&amp;amp;author=U+Herzberg&amp;amp;author=E+Eliav&amp;amp;author=GJ+Bennett&amp;amp;author=IJ+Kopin&amp;amp;volume=221&amp;amp;publication_year=1997&amp;amp;pages=157-160&amp;amp;pmid=9121688&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16228</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16229</code><code>]&lt;/span&gt;</code></p><p><code>16230</code><code>&lt;/span&gt;</code></p><p><code>16231</code><code>&lt;/li&gt;</code></p><p><code>16232</code><code>&lt;li id="R491"&gt;</code></p><p><code>16233</code><code>&lt;span class="citation"&gt;</code></p><p><code>16234</code><code>Hezode C, Roudot-Thoraval F, Nguyen S, Grenard P, Julien B, Zafrani ES, Pawlostky JM, Dhumeaux D, Lotersztajn S, Mallat A. Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. &lt;span&gt;</code></p><p><code>16235</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16236</code><code>Hepatology. &lt;/span&gt;</code></p><p><code>16237</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>16238</code><code>42&lt;/span&gt;</code></p><p><code>16239</code><code>:63–71.&lt;/span&gt;</code></p><p><code>16240</code><code> [&lt;a href="/pubmed/15892090" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16241</code><code>PubMed&lt;/a&gt;</code></p><p><code>16242</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16243</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;amp;title=Daily+cannabis+smoking+as+a+risk+factor+for+progression+of+fibrosis+in+chronic+hepatitis+C&amp;amp;author=C+Hezode&amp;amp;author=F+Roudot-Thoraval&amp;amp;author=S+Nguyen&amp;amp;author=P+Grenard&amp;amp;author=B+Julien&amp;amp;volume=42&amp;amp;publication_year=2005&amp;amp;pages=63-71&amp;amp;pmid=15892090&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16244</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16245</code><code>]&lt;/span&gt;</code></p><p><code>16246</code><code>&lt;/span&gt;</code></p><p><code>16247</code><code>&lt;/li&gt;</code></p><p><code>16248</code><code>&lt;li id="R492"&gt;</code></p><p><code>16249</code><code>&lt;span class="citation"&gt;</code></p><p><code>16250</code><code>Hilairet S, Bouaboula M, Carriere D, Le Fur G, Casellas P. Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716. &lt;span&gt;</code></p><p><code>16251</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16252</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>16253</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>16254</code><code>278&lt;/span&gt;</code></p><p><code>16255</code><code>:23731–23737.&lt;/span&gt;</code></p><p><code>16256</code><code> [&lt;a href="/pubmed/12690115" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16257</code><code>PubMed&lt;/a&gt;</code></p><p><code>16258</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16259</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=Hypersensitization+of+the+Orexin+1+receptor+by+the+CB1+receptor:+evidence+for+cross-talk+blocked+by+the+specific+CB1+antagonist,+SR141716&amp;amp;author=S+Hilairet&amp;amp;author=M+Bouaboula&amp;amp;author=D+Carriere&amp;amp;author=G+Le+Fur&amp;amp;author=P+Casellas&amp;amp;volume=278&amp;amp;publication_year=2003&amp;amp;pages=23731-23737&amp;amp;pmid=12690115&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16260</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16261</code><code>]&lt;/span&gt;</code></p><p><code>16262</code><code>&lt;/span&gt;</code></p><p><code>16263</code><code>&lt;/li&gt;</code></p><p><code>16264</code><code>&lt;li id="R493"&gt;</code></p><p><code>16265</code><code>&lt;span class="citation"&gt;</code></p><p><code>16266</code><code>Hildebrandt AL, Kelly-Sullivan DM, Black SC. Antiobesity effects of chronic cannabinoid CB&lt;sub&gt;</code></p><p><code>16267</code><code>1&lt;/sub&gt;</code></p><p><code>16268</code><code> receptor antagonist treatment in diet-induced obese mice. &lt;span&gt;</code></p><p><code>16269</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16270</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>16271</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>16272</code><code>462&lt;/span&gt;</code></p><p><code>16273</code><code>:125–132.&lt;/span&gt;</code></p><p><code>16274</code><code> [&lt;a href="/pubmed/12591104" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16275</code><code>PubMed&lt;/a&gt;</code></p><p><code>16276</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16277</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Antiobesity+effects+of+chronic+cannabinoid+CB1+receptor+antagonist+treatment+in+diet-induced+obese+mice&amp;amp;author=AL+Hildebrandt&amp;amp;author=DM+Kelly-Sullivan&amp;amp;author=SC+Black&amp;amp;volume=462&amp;amp;publication_year=2003&amp;amp;pages=125-132&amp;amp;pmid=12591104&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16278</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16279</code><code>]&lt;/span&gt;</code></p><p><code>16280</code><code>&lt;/span&gt;</code></p><p><code>16281</code><code>&lt;/li&gt;</code></p><p><code>16282</code><code>&lt;li id="R494"&gt;</code></p><p><code>16283</code><code>&lt;span class="citation"&gt;</code></p><p><code>16284</code><code>Hiley CR, Ford WR. Endocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction? &lt;span&gt;</code></p><p><code>16285</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16286</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>16287</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>16288</code><code>138&lt;/span&gt;</code></p><p><code>16289</code><code>:1183–1184.&lt;/span&gt;</code></p><p><code>16290</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>16291</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1573769/"&gt;</code></p><p><code>16292</code><code>PMC free article&lt;/a&gt;</code></p><p><code>16293</code><code>]&lt;/span&gt;</code></p><p><code>16294</code><code> [&lt;a href="/pubmed/12711614" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16295</code><code>PubMed&lt;/a&gt;</code></p><p><code>16296</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16297</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Endocannabinoids+as+mediators+in+the+heart:+a+potential+target+for+therapy+of+remodelling+after+myocardial+infarction?&amp;amp;author=CR+Hiley&amp;amp;author=WR+Ford&amp;amp;volume=138&amp;amp;publication_year=2003&amp;amp;pages=1183-1184&amp;amp;pmid=12711614&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16298</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16299</code><code>]&lt;/span&gt;</code></p><p><code>16300</code><code>&lt;/span&gt;</code></p><p><code>16301</code><code>&lt;/li&gt;</code></p><p><code>16302</code><code>&lt;li id="R495"&gt;</code></p><p><code>16303</code><code>&lt;span class="citation"&gt;</code></p><p><code>16304</code><code>Hiley CR, Ford WR. Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signaling. &lt;span&gt;</code></p><p><code>16305</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16306</code><code>Biol Rev Camb Philos Soc. &lt;/span&gt;</code></p><p><code>16307</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>16308</code><code>79&lt;/span&gt;</code></p><p><code>16309</code><code>:187–205.&lt;/span&gt;</code></p><p><code>16310</code><code> [&lt;a href="/pubmed/15005177" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16311</code><code>PubMed&lt;/a&gt;</code></p><p><code>16312</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16313</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biol+Rev+Camb+Philos+Soc&amp;amp;title=Cannabinoid+pharmacology+in+the+cardiovascular+system:+potential+protective+mechanisms+through+lipid+signaling&amp;amp;author=CR+Hiley&amp;amp;author=WR+Ford&amp;amp;volume=79&amp;amp;publication_year=2004&amp;amp;pages=187-205&amp;amp;pmid=15005177&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16314</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16315</code><code>]&lt;/span&gt;</code></p><p><code>16316</code><code>&lt;/span&gt;</code></p><p><code>16317</code><code>&lt;/li&gt;</code></p><p><code>16318</code><code>&lt;li id="R496"&gt;</code></p><p><code>16319</code><code>&lt;span class="citation"&gt;</code></p><p><code>16320</code><code>Hill MN, Ho WS, Sinopoli KJ, Viau V, Hillard CJ, Gorzalka BB. Involvement of the endocannabinoid system in the ability of long-term tricyclic antide-pressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis. &lt;span&gt;</code></p><p><code>16321</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16322</code><code>Neuropsychopharmacology. &lt;/span&gt;</code></p><p><code>16323</code><code>2006&lt;/span&gt;</code></p><p><code>16324</code><code> in press. [&lt;a href="/pubmed/16710317" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16325</code><code>PubMed&lt;/a&gt;</code></p><p><code>16326</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16327</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;amp;title=Involvement+of+the+endocannabinoid+system+in+the+ability+of+long-term+tricyclic+antide-pressant+treatment+to+suppress+stress-induced+activation+of+the+hypothalamic-pituitary-adrenal+axis&amp;amp;author=MN+Hill&amp;amp;author=WS+Ho&amp;amp;author=KJ+Sinopoli&amp;amp;author=V+Viau&amp;amp;author=CJ+Hillard&amp;amp;publication_year=2006&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16328</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16329</code><code>]&lt;/span&gt;</code></p><p><code>16330</code><code>&lt;/span&gt;</code></p><p><code>16331</code><code>&lt;/li&gt;</code></p><p><code>16332</code><code>&lt;li id="R497"&gt;</code></p><p><code>16333</code><code>&lt;span class="citation"&gt;</code></p><p><code>16334</code><code>Hill MN, Patel S, Carrier EJ, Rademacher DJ, Ormerod BK, Hillard CJ, Gorzalka BB. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. &lt;span&gt;</code></p><p><code>16335</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16336</code><code>Neuropsychopharmacology. &lt;/span&gt;</code></p><p><code>16337</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>16338</code><code>30&lt;/span&gt;</code></p><p><code>16339</code><code>:508–515.&lt;/span&gt;</code></p><p><code>16340</code><code> [&lt;a href="/pubmed/15525997" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16341</code><code>PubMed&lt;/a&gt;</code></p><p><code>16342</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16343</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;amp;title=Downregulation+of+endocannabinoid+signaling+in+the+hippocampus+following+chronic+unpredictable+stress&amp;amp;author=MN+Hill&amp;amp;author=S+Patel&amp;amp;author=EJ+Carrier&amp;amp;author=DJ+Rademacher&amp;amp;author=BK+Ormerod&amp;amp;volume=30&amp;amp;publication_year=2005&amp;amp;pages=508-515&amp;amp;pmid=15525997&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16344</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16345</code><code>]&lt;/span&gt;</code></p><p><code>16346</code><code>&lt;/span&gt;</code></p><p><code>16347</code><code>&lt;/li&gt;</code></p><p><code>16348</code><code>&lt;li id="R498"&gt;</code></p><p><code>16349</code><code>&lt;span class="citation"&gt;</code></p><p><code>16350</code><code>Hillard CJ. Endocannabinoids and vascular function. &lt;span&gt;</code></p><p><code>16351</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16352</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>16353</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>16354</code><code>294&lt;/span&gt;</code></p><p><code>16355</code><code>:27–32.&lt;/span&gt;</code></p><p><code>16356</code><code> [&lt;a href="/pubmed/10871291" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16357</code><code>PubMed&lt;/a&gt;</code></p><p><code>16358</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16359</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Endocannabinoids+and+vascular+function&amp;amp;author=CJ+Hillard&amp;amp;volume=294&amp;amp;publication_year=2000&amp;amp;pages=27-32&amp;amp;pmid=10871291&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16360</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16361</code><code>]&lt;/span&gt;</code></p><p><code>16362</code><code>&lt;/span&gt;</code></p><p><code>16363</code><code>&lt;/li&gt;</code></p><p><code>16364</code><code>&lt;li id="R499"&gt;</code></p><p><code>16365</code><code>&lt;span class="citation"&gt;</code></p><p><code>16366</code><code>Hillard CJ, Jarrahian A. The movement of &lt;em&gt;</code></p><p><code>16367</code><code>N-&lt;/em&gt;</code></p><p><code>16368</code><code>arachidonolethanolamide (anandamide) across cellular membranes. &lt;span&gt;</code></p><p><code>16369</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16370</code><code>Chem Phys Lipids. &lt;/span&gt;</code></p><p><code>16371</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>16372</code><code>108&lt;/span&gt;</code></p><p><code>16373</code><code>:123–134.&lt;/span&gt;</code></p><p><code>16374</code><code> [&lt;a href="/pubmed/11106786" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16375</code><code>PubMed&lt;/a&gt;</code></p><p><code>16376</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16377</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Chem+Phys+Lipids&amp;amp;title=The+movement+of+N-arachidonolethanolamide+(anandamide)+across+cellular+membranes&amp;amp;author=CJ+Hillard&amp;amp;author=A+Jarrahian&amp;amp;volume=108&amp;amp;publication_year=2000&amp;amp;pages=123-134&amp;amp;pmid=11106786&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16378</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16379</code><code>]&lt;/span&gt;</code></p><p><code>16380</code><code>&lt;/span&gt;</code></p><p><code>16381</code><code>&lt;/li&gt;</code></p><p><code>16382</code><code>&lt;li id="R500"&gt;</code></p><p><code>16383</code><code>&lt;span class="citation"&gt;</code></p><p><code>16384</code><code>Hillard CJ, Jarrahian A. Cellular accumulation of anandamide: consensus and controversy. &lt;span&gt;</code></p><p><code>16385</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16386</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>16387</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>16388</code><code>140&lt;/span&gt;</code></p><p><code>16389</code><code>:802–808.&lt;/span&gt;</code></p><p><code>16390</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>16391</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1574088/"&gt;</code></p><p><code>16392</code><code>PMC free article&lt;/a&gt;</code></p><p><code>16393</code><code>]&lt;/span&gt;</code></p><p><code>16394</code><code> [&lt;a href="/pubmed/12970089" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16395</code><code>PubMed&lt;/a&gt;</code></p><p><code>16396</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16397</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Cellular+accumulation+of+anandamide:+consensus+and+controversy&amp;amp;author=CJ+Hillard&amp;amp;author=A+Jarrahian&amp;amp;volume=140&amp;amp;publication_year=2003&amp;amp;pages=802-808&amp;amp;pmid=12970089&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16398</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16399</code><code>]&lt;/span&gt;</code></p><p><code>16400</code><code>&lt;/span&gt;</code></p><p><code>16401</code><code>&lt;/li&gt;</code></p><p><code>16402</code><code>&lt;li id="R501"&gt;</code></p><p><code>16403</code><code>&lt;span class="citation"&gt;</code></p><p><code>16404</code><code>Hillard CJ, Manna S, Greenberg MJ, DiCamelli R, Ross RA, Stevenson LA, Murphy V, Pertwee RG, Campbell WB. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1) &lt;span&gt;</code></p><p><code>16405</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16406</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>16407</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>16408</code><code>289&lt;/span&gt;</code></p><p><code>16409</code><code>:1427–1433.&lt;/span&gt;</code></p><p><code>16410</code><code> [&lt;a href="/pubmed/10336536" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16411</code><code>PubMed&lt;/a&gt;</code></p><p><code>16412</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16413</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Synthesis+and+characterization+of+potent+and+selective+agonists+of+the+neuronal+cannabinoid+receptor+(CB1)&amp;amp;author=CJ+Hillard&amp;amp;author=S+Manna&amp;amp;author=MJ+Greenberg&amp;amp;author=R+DiCamelli&amp;amp;author=RA+Ross&amp;amp;volume=289&amp;amp;publication_year=1999&amp;amp;pages=1427-1433&amp;amp;pmid=10336536&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16414</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16415</code><code>]&lt;/span&gt;</code></p><p><code>16416</code><code>&lt;/span&gt;</code></p><p><code>16417</code><code>&lt;/li&gt;</code></p><p><code>16418</code><code>&lt;li id="R502"&gt;</code></p><p><code>16419</code><code>&lt;span class="citation"&gt;</code></p><p><code>16420</code><code>Hinderer SR, Gupta S. Functional outcome measures to assess interventions for spasticity. &lt;span&gt;</code></p><p><code>16421</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16422</code><code>Arch Phys Med Rehabil. &lt;/span&gt;</code></p><p><code>16423</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>16424</code><code>77&lt;/span&gt;</code></p><p><code>16425</code><code>:1083–1089.&lt;/span&gt;</code></p><p><code>16426</code><code> [&lt;a href="/pubmed/8857891" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16427</code><code>PubMed&lt;/a&gt;</code></p><p><code>16428</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16429</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Arch+Phys+Med+Rehabil&amp;amp;title=Functional+outcome+measures+to+assess+interventions+for+spasticity&amp;amp;author=SR+Hinderer&amp;amp;author=S+Gupta&amp;amp;volume=77&amp;amp;publication_year=1996&amp;amp;pages=1083-1089&amp;amp;pmid=8857891&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16430</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16431</code><code>]&lt;/span&gt;</code></p><p><code>16432</code><code>&lt;/span&gt;</code></p><p><code>16433</code><code>&lt;/li&gt;</code></p><p><code>16434</code><code>&lt;li id="R503"&gt;</code></p><p><code>16435</code><code>&lt;span class="citation"&gt;</code></p><p><code>16436</code><code>Hinds NM, Ullrich K, Smid SD. Cannabinoid 1 (CB&lt;sub&gt;</code></p><p><code>16437</code><code>1&lt;/sub&gt;</code></p><p><code>16438</code><code> receptors coupled to cholinergic motorneurones inhibit neurogenic circular muscle contractility in the human colon. &lt;span&gt;</code></p><p><code>16439</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16440</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>16441</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>16442</code><code>148&lt;/span&gt;</code></p><p><code>16443</code><code>:191–200.&lt;/span&gt;</code></p><p><code>16444</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>16445</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1617060/"&gt;</code></p><p><code>16446</code><code>PMC free article&lt;/a&gt;</code></p><p><code>16447</code><code>]&lt;/span&gt;</code></p><p><code>16448</code><code> [&lt;a href="/pubmed/16520743" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16449</code><code>PubMed&lt;/a&gt;</code></p><p><code>16450</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16451</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Cannabinoid+1+(CB1+receptors+coupled+to+cholinergic+motorneurones+inhibit+neurogenic+circular+muscle+contractility+in+the+human+colon&amp;amp;author=NM+Hinds&amp;amp;author=K+Ullrich&amp;amp;author=SD+Smid&amp;amp;volume=148&amp;amp;publication_year=2006&amp;amp;pages=191-200&amp;amp;pmid=16520743&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16452</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16453</code><code>]&lt;/span&gt;</code></p><p><code>16454</code><code>&lt;/span&gt;</code></p><p><code>16455</code><code>&lt;/li&gt;</code></p><p><code>16456</code><code>&lt;li id="R504"&gt;</code></p><p><code>16457</code><code>&lt;span class="citation"&gt;</code></p><p><code>16458</code><code>Hinz B, Ramer R, Eichele K, Weinzierl U, Brune K. Up-regulation of cyclooxygenase-2 expression is involved in &lt;em&gt;</code></p><p><code>16459</code><code>R&lt;/em&gt;</code></p><p><code>16460</code><code>(+)-methanandamide-induced apoptotic death of human neuroglioma cells. &lt;span&gt;</code></p><p><code>16461</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16462</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>16463</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>16464</code><code>66&lt;/span&gt;</code></p><p><code>16465</code><code>:1643–1651.&lt;/span&gt;</code></p><p><code>16466</code><code> [&lt;a href="/pubmed/15361550" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16467</code><code>PubMed&lt;/a&gt;</code></p><p><code>16468</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16469</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=Up-regulation+of+cyclooxygenase-2+expression+is+involved+in+R(+)-methanandamide-induced+apoptotic+death+of+human+neuroglioma+cells&amp;amp;author=B+Hinz&amp;amp;author=R+Ramer&amp;amp;author=K+Eichele&amp;amp;author=U+Weinzierl&amp;amp;author=K+Brune&amp;amp;volume=66&amp;amp;publication_year=2004&amp;amp;pages=1643-1651&amp;amp;pmid=15361550&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16470</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16471</code><code>]&lt;/span&gt;</code></p><p><code>16472</code><code>&lt;/span&gt;</code></p><p><code>16473</code><code>&lt;/li&gt;</code></p><p><code>16474</code><code>&lt;li id="R505"&gt;</code></p><p><code>16475</code><code>&lt;span class="citation"&gt;</code></p><p><code>16476</code><code>Ho WS, Hiley CR. Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery. &lt;span&gt;</code></p><p><code>16477</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16478</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>16479</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>16480</code><code>138&lt;/span&gt;</code></p><p><code>16481</code><code>:1320–1332.&lt;/span&gt;</code></p><p><code>16482</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>16483</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1573773/"&gt;</code></p><p><code>16484</code><code>PMC free article&lt;/a&gt;</code></p><p><code>16485</code><code>]&lt;/span&gt;</code></p><p><code>16486</code><code> [&lt;a href="/pubmed/12711633" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16487</code><code>PubMed&lt;/a&gt;</code></p><p><code>16488</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16489</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Vasodilator+actions+of+abnormal-cannabidiol+in+rat+isolated+small+mesenteric+artery&amp;amp;author=WS+Ho&amp;amp;author=CR+Hiley&amp;amp;volume=138&amp;amp;publication_year=2003&amp;amp;pages=1320-1332&amp;amp;pmid=12711633&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16490</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16491</code><code>]&lt;/span&gt;</code></p><p><code>16492</code><code>&lt;/span&gt;</code></p><p><code>16493</code><code>&lt;/li&gt;</code></p><p><code>16494</code><code>&lt;li id="R506"&gt;</code></p><p><code>16495</code><code>&lt;span class="citation"&gt;</code></p><p><code>16496</code><code>Hohmann AG, Briley EM, Herkenham M. Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord. &lt;span&gt;</code></p><p><code>16497</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16498</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>16499</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>16500</code><code>822&lt;/span&gt;</code></p><p><code>16501</code><code>:17–25.&lt;/span&gt;</code></p><p><code>16502</code><code> [&lt;a href="/pubmed/10082879" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16503</code><code>PubMed&lt;/a&gt;</code></p><p><code>16504</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16505</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Pre-+and+postsynaptic+distribution+of+cannabinoid+and+mu+opioid+receptors+in+rat+spinal+cord&amp;amp;author=AG+Hohmann&amp;amp;author=EM+Briley&amp;amp;author=M+Herkenham&amp;amp;volume=822&amp;amp;publication_year=1999&amp;amp;pages=17-25&amp;amp;pmid=10082879&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16506</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16507</code><code>]&lt;/span&gt;</code></p><p><code>16508</code><code>&lt;/span&gt;</code></p><p><code>16509</code><code>&lt;/li&gt;</code></p><p><code>16510</code><code>&lt;li id="R507"&gt;</code></p><p><code>16511</code><code>&lt;span class="citation"&gt;</code></p><p><code>16512</code><code>Hohmann AG, Farthing JN, Zvonok AM, Makriyannis A. Selective activation of cannabinoid CB2 receptors suppresses hyperalgesia evoked by intradermal capsaicin. &lt;span&gt;</code></p><p><code>16513</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16514</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>16515</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>16516</code><code>308&lt;/span&gt;</code></p><p><code>16517</code><code>:446–453.&lt;/span&gt;</code></p><p><code>16518</code><code> [&lt;a href="/pubmed/14610224" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16519</code><code>PubMed&lt;/a&gt;</code></p><p><code>16520</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16521</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Selective+activation+of+cannabinoid+CB2+receptors+suppresses+hyperalgesia+evoked+by+intradermal+capsaicin&amp;amp;author=AG+Hohmann&amp;amp;author=JN+Farthing&amp;amp;author=AM+Zvonok&amp;amp;author=A+Makriyannis&amp;amp;volume=308&amp;amp;publication_year=2004&amp;amp;pages=446-453&amp;amp;pmid=14610224&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16522</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16523</code><code>]&lt;/span&gt;</code></p><p><code>16524</code><code>&lt;/span&gt;</code></p><p><code>16525</code><code>&lt;/li&gt;</code></p><p><code>16526</code><code>&lt;li id="R508"&gt;</code></p><p><code>16527</code><code>&lt;span class="citation"&gt;</code></p><p><code>16528</code><code>Hohmann AG, Herkenham M. Regulation of cannabinoid and mu opioid receptors in rat lumbar spinal cord following neonatal capsaicin treatment. &lt;span&gt;</code></p><p><code>16529</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16530</code><code>Neurosci Lett. &lt;/span&gt;</code></p><p><code>16531</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>16532</code><code>252&lt;/span&gt;</code></p><p><code>16533</code><code>:13–16.&lt;/span&gt;</code></p><p><code>16534</code><code> [&lt;a href="/pubmed/9756347" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16535</code><code>PubMed&lt;/a&gt;</code></p><p><code>16536</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16537</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Lett&amp;amp;title=Regulation+of+cannabinoid+and+mu+opioid+receptors+in+rat+lumbar+spinal+cord+following+neonatal+capsaicin+treatment&amp;amp;author=AG+Hohmann&amp;amp;author=M+Herkenham&amp;amp;volume=252&amp;amp;publication_year=1998&amp;amp;pages=13-16&amp;amp;pmid=9756347&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16538</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16539</code><code>]&lt;/span&gt;</code></p><p><code>16540</code><code>&lt;/span&gt;</code></p><p><code>16541</code><code>&lt;/li&gt;</code></p><p><code>16542</code><code>&lt;li id="R509"&gt;</code></p><p><code>16543</code><code>&lt;span class="citation"&gt;</code></p><p><code>16544</code><code>Hohmann AG, Herkenham M. Cannabinoid receptors undergo axonal flow in sensory nerves. &lt;span&gt;</code></p><p><code>16545</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16546</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>16547</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>16548</code><code>92&lt;/span&gt;</code></p><p><code>16549</code><code>:1171–1175.&lt;/span&gt;</code></p><p><code>16550</code><code> [&lt;a href="/pubmed/10426476" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16551</code><code>PubMed&lt;/a&gt;</code></p><p><code>16552</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16553</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Cannabinoid+receptors+undergo+axonal+flow+in+sensory+nerves&amp;amp;author=AG+Hohmann&amp;amp;author=M+Herkenham&amp;amp;volume=92&amp;amp;publication_year=1999&amp;amp;pages=1171-1175&amp;amp;pmid=10426476&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16554</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16555</code><code>]&lt;/span&gt;</code></p><p><code>16556</code><code>&lt;/span&gt;</code></p><p><code>16557</code><code>&lt;/li&gt;</code></p><p><code>16558</code><code>&lt;li id="R510"&gt;</code></p><p><code>16559</code><code>&lt;span class="citation"&gt;</code></p><p><code>16560</code><code>Hohmann AG, Herkenham M. Localization of cannabinoid CB&lt;sub&gt;</code></p><p><code>16561</code><code>1&lt;/sub&gt;</code></p><p><code>16562</code><code> receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. &lt;span&gt;</code></p><p><code>16563</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16564</code><code>Synapse. &lt;/span&gt;</code></p><p><code>16565</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>16566</code><code>37&lt;/span&gt;</code></p><p><code>16567</code><code>:71–80.&lt;/span&gt;</code></p><p><code>16568</code><code> [&lt;a href="/pubmed/10842353" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16569</code><code>PubMed&lt;/a&gt;</code></p><p><code>16570</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16571</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Synapse&amp;amp;title=Localization+of+cannabinoid+CB1+receptor+mRNA+in+neuronal+subpopulations+of+rat+striatum:+a+double-label+in+situ+hybridization+study&amp;amp;author=AG+Hohmann&amp;amp;author=M+Herkenham&amp;amp;volume=37&amp;amp;publication_year=2000&amp;amp;pages=71-80&amp;amp;pmid=10842353&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16572</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16573</code><code>]&lt;/span&gt;</code></p><p><code>16574</code><code>&lt;/span&gt;</code></p><p><code>16575</code><code>&lt;/li&gt;</code></p><p><code>16576</code><code>&lt;li id="R511"&gt;</code></p><p><code>16577</code><code>&lt;span class="citation"&gt;</code></p><p><code>16578</code><code>Hohmann AG, Martin WJ, Tsou K, Walker JM. Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2. &lt;span&gt;</code></p><p><code>16579</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16580</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>16581</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>16582</code><code>56&lt;/span&gt;</code></p><p><code>16583</code><code>:2111–2119.&lt;/span&gt;</code></p><p><code>16584</code><code> [&lt;a href="/pubmed/7776839" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16585</code><code>PubMed&lt;/a&gt;</code></p><p><code>16586</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16587</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Inhibition+of+noxious+stimulus-evoked+activity+of+spinal+cord+dorsal+horn+neurons+by+the+cannabinoid+WIN+55,212-2&amp;amp;author=AG+Hohmann&amp;amp;author=WJ+Martin&amp;amp;author=K+Tsou&amp;amp;author=JM+Walker&amp;amp;volume=56&amp;amp;publication_year=1995&amp;amp;pages=2111-2119&amp;amp;pmid=7776839&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16588</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16589</code><code>]&lt;/span&gt;</code></p><p><code>16590</code><code>&lt;/span&gt;</code></p><p><code>16591</code><code>&lt;/li&gt;</code></p><p><code>16592</code><code>&lt;li id="R512"&gt;</code></p><p><code>16593</code><code>&lt;span class="citation"&gt;</code></p><p><code>16594</code><code>Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R, Krey JF, Walker JM, Holmes PV, Crystal JD, et al.  An endocannabinoid mechanism for stress-induced analgesia. &lt;span&gt;</code></p><p><code>16595</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16596</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>16597</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>16598</code><code>435&lt;/span&gt;</code></p><p><code>16599</code><code>:1108–1112.&lt;/span&gt;</code></p><p><code>16600</code><code> [&lt;a href="/pubmed/15973410" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16601</code><code>PubMed&lt;/a&gt;</code></p><p><code>16602</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16603</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=An+endocannabinoid+mechanism+for+stress-induced+analgesia&amp;amp;author=AG+Hohmann&amp;amp;author=RL+Suplita&amp;amp;author=NM+Bolton&amp;amp;author=MH+Neely&amp;amp;author=D+Fegley&amp;amp;volume=435&amp;amp;publication_year=2005&amp;amp;pages=1108-1112&amp;amp;pmid=15973410&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16604</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16605</code><code>]&lt;/span&gt;</code></p><p><code>16606</code><code>&lt;/span&gt;</code></p><p><code>16607</code><code>&lt;/li&gt;</code></p><p><code>16608</code><code>&lt;li id="R513"&gt;</code></p><p><code>16609</code><code>&lt;span class="citation"&gt;</code></p><p><code>16610</code><code>Hohmann AG, Tsou K, Walker JM. Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2. &lt;span&gt;</code></p><p><code>16611</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16612</code><code>Neurosci Let. &lt;/span&gt;</code></p><p><code>16613</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>16614</code><code>257&lt;/span&gt;</code></p><p><code>16615</code><code>:1–4.&lt;/span&gt;</code></p><p><code>16616</code><code> [&lt;a href="/pubmed/9870334" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16617</code><code>PubMed&lt;/a&gt;</code></p><p><code>16618</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16619</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Let&amp;amp;title=Cannabinoid+modulation+of+wide+dynamic+range+neurons+in+the+lumbar+dorsal+horn+of+the+rat+by+spinally+administered+WIN55,212-2&amp;amp;author=AG+Hohmann&amp;amp;author=K+Tsou&amp;amp;author=JM+Walker&amp;amp;volume=257&amp;amp;publication_year=1998&amp;amp;pages=1-4&amp;amp;pmid=9857951&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16620</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16621</code><code>]&lt;/span&gt;</code></p><p><code>16622</code><code>&lt;/span&gt;</code></p><p><code>16623</code><code>&lt;/li&gt;</code></p><p><code>16624</code><code>&lt;li id="R514"&gt;</code></p><p><code>16625</code><code>&lt;span class="citation"&gt;</code></p><p><code>16626</code><code>Hohmann AG, Walker JM. Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat. &lt;span&gt;</code></p><p><code>16627</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16628</code><code>J Neurophysiol. &lt;/span&gt;</code></p><p><code>16629</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>16630</code><code>81&lt;/span&gt;</code></p><p><code>16631</code><code>:575–583.&lt;/span&gt;</code></p><p><code>16632</code><code> [&lt;a href="/pubmed/10036261" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16633</code><code>PubMed&lt;/a&gt;</code></p><p><code>16634</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16635</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurophysiol&amp;amp;title=Cannabinoid+suppression+of+noxious+heat-evoked+activity+in+wide+dynamic+range+neurons+in+the+lumbar+dorsal+horn+of+the+rat&amp;amp;author=AG+Hohmann&amp;amp;author=JM+Walker&amp;amp;volume=81&amp;amp;publication_year=1999&amp;amp;pages=575-583&amp;amp;pmid=10036261&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16636</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16637</code><code>]&lt;/span&gt;</code></p><p><code>16638</code><code>&lt;/span&gt;</code></p><p><code>16639</code><code>&lt;/li&gt;</code></p><p><code>16640</code><code>&lt;li id="R515"&gt;</code></p><p><code>16641</code><code>&lt;span class="citation"&gt;</code></p><p><code>16642</code><code>Holdcroft A, Smith M, Jacklin A, Hodgson H, Smith B, Newton M, Evans F. Pain relief with oral cannabinoids in familial Mediterranean fever. &lt;span&gt;</code></p><p><code>16643</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16644</code><code>Anaesthesia. &lt;/span&gt;</code></p><p><code>16645</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>16646</code><code>52&lt;/span&gt;</code></p><p><code>16647</code><code>:483–486.&lt;/span&gt;</code></p><p><code>16648</code><code> [&lt;a href="/pubmed/9165969" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16649</code><code>PubMed&lt;/a&gt;</code></p><p><code>16650</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16651</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Anaesthesia&amp;amp;title=Pain+relief+with+oral+cannabinoids+in+familial+Mediterranean+fever&amp;amp;author=A+Holdcroft&amp;amp;author=M+Smith&amp;amp;author=A+Jacklin&amp;amp;author=H+Hodgson&amp;amp;author=B+Smith&amp;amp;volume=52&amp;amp;publication_year=1997&amp;amp;pages=483-486&amp;amp;pmid=9165969&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16652</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16653</code><code>]&lt;/span&gt;</code></p><p><code>16654</code><code>&lt;/span&gt;</code></p><p><code>16655</code><code>&lt;/li&gt;</code></p><p><code>16656</code><code>&lt;li id="R516"&gt;</code></p><p><code>16657</code><code>&lt;span class="citation"&gt;</code></p><p><code>16658</code><code>Hollister LE. Hunger and appetite after single doses of marijuana, alcohol and dextroamphetamine. &lt;span&gt;</code></p><p><code>16659</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16660</code><code>Clin Pharmacol Ther. &lt;/span&gt;</code></p><p><code>16661</code><code>1971;&lt;span class="ref-vol"&gt;</code></p><p><code>16662</code><code>12&lt;/span&gt;</code></p><p><code>16663</code><code>:45–49.&lt;/span&gt;</code></p><p><code>16664</code><code> [&lt;a href="/pubmed/5541134" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16665</code><code>PubMed&lt;/a&gt;</code></p><p><code>16666</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16667</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;amp;title=Hunger+and+appetite+after+single+doses+of+marijuana,+alcohol+and+dextroamphetamine&amp;amp;author=LE+Hollister&amp;amp;volume=12&amp;amp;publication_year=1971&amp;amp;pages=45-49&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16668</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16669</code><code>]&lt;/span&gt;</code></p><p><code>16670</code><code>&lt;/span&gt;</code></p><p><code>16671</code><code>&lt;/li&gt;</code></p><p><code>16672</code><code>&lt;li id="R517"&gt;</code></p><p><code>16673</code><code>&lt;span class="citation"&gt;</code></p><p><code>16674</code><code>Hollister LE. Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of &amp;#x00394;&lt;sup&gt;</code></p><p><code>16675</code><code>9&lt;/sup&gt;</code></p><p><code>16676</code><code>-tetrahydrocannabinol. &lt;span&gt;</code></p><p><code>16677</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16678</code><code>Pharmacology. &lt;/span&gt;</code></p><p><code>16679</code><code>1974;&lt;span class="ref-vol"&gt;</code></p><p><code>16680</code><code>11&lt;/span&gt;</code></p><p><code>16681</code><code>:3–11.&lt;/span&gt;</code></p><p><code>16682</code><code> [&lt;a href="/pubmed/4610598" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16683</code><code>PubMed&lt;/a&gt;</code></p><p><code>16684</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16685</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology&amp;amp;title=Structure-activity+relationships+in+man+of+cannabis+constituents,+and+homologs+and+metabolites+of+&amp;#x00394;9-tetrahydrocannabinol&amp;amp;author=LE+Hollister&amp;amp;volume=11&amp;amp;publication_year=1974&amp;amp;pages=3-11&amp;amp;pmid=4610598&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16686</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16687</code><code>]&lt;/span&gt;</code></p><p><code>16688</code><code>&lt;/span&gt;</code></p><p><code>16689</code><code>&lt;/li&gt;</code></p><p><code>16690</code><code>&lt;li id="R518"&gt;</code></p><p><code>16691</code><code>&lt;span class="citation"&gt;</code></p><p><code>16692</code><code>Hollister LE. Health aspects of cannabis. &lt;span&gt;</code></p><p><code>16693</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16694</code><code>Pharmacol Rev. &lt;/span&gt;</code></p><p><code>16695</code><code>1986;&lt;span class="ref-vol"&gt;</code></p><p><code>16696</code><code>38&lt;/span&gt;</code></p><p><code>16697</code><code>:1–20.&lt;/span&gt;</code></p><p><code>16698</code><code> [&lt;a href="/pubmed/3520605" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16699</code><code>PubMed&lt;/a&gt;</code></p><p><code>16700</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16701</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Rev&amp;amp;title=Health+aspects+of+cannabis&amp;amp;author=LE+Hollister&amp;amp;volume=38&amp;amp;publication_year=1986&amp;amp;pages=1-20&amp;amp;pmid=3520605&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16702</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16703</code><code>]&lt;/span&gt;</code></p><p><code>16704</code><code>&lt;/span&gt;</code></p><p><code>16705</code><code>&lt;/li&gt;</code></p><p><code>16706</code><code>&lt;li id="R519"&gt;</code></p><p><code>16707</code><code>&lt;span class="citation"&gt;</code></p><p><code>16708</code><code>Holdcroft A, Maze M, Dore C, Tebbs S, Thompson S. A multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis extract (Cannador) for postoperative pain management. &lt;span&gt;</code></p><p><code>16709</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16710</code><code>Anesthesiology. &lt;/span&gt;</code></p><p><code>16711</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>16712</code><code>104&lt;/span&gt;</code></p><p><code>16713</code><code>:1040–1046.&lt;/span&gt;</code></p><p><code>16714</code><code> [&lt;a href="/pubmed/16645457" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16715</code><code>PubMed&lt;/a&gt;</code></p><p><code>16716</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16717</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Anesthesiology&amp;amp;title=A+multicenter+dose-escalation+study+of+the+analgesic+and+adverse+effects+of+an+oral+cannabis+extract+(Cannador)+for+postoperative+pain+management&amp;amp;author=A+Holdcroft&amp;amp;author=M+Maze&amp;amp;author=C+Dore&amp;amp;author=S+Tebbs&amp;amp;author=S+Thompson&amp;amp;volume=104&amp;amp;publication_year=2006&amp;amp;pages=1040-1046&amp;amp;pmid=16645457&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16718</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16719</code><code>]&lt;/span&gt;</code></p><p><code>16720</code><code>&lt;/span&gt;</code></p><p><code>16721</code><code>&lt;/li&gt;</code></p><p><code>16722</code><code>&lt;li id="R520"&gt;</code></p><p><code>16723</code><code>&lt;span class="citation"&gt;</code></p><p><code>16724</code><code>Holm L, Cassidy JD, Carroll LJ, Borg J. Neurotrauma Task Force on Mild Traumatic Brain Injury of the WHO Collaborating Centre: summary of the WHO Collaborating Centre for Neurotrauma Task Force on mild traumatic brain injury. &lt;span&gt;</code></p><p><code>16725</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16726</code><code>J Rehabil Med. &lt;/span&gt;</code></p><p><code>16727</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>16728</code><code>37&lt;/span&gt;</code></p><p><code>16729</code><code>:137–141.&lt;/span&gt;</code></p><p><code>16730</code><code> [&lt;a href="/pubmed/16040469" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16731</code><code>PubMed&lt;/a&gt;</code></p><p><code>16732</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16733</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Rehabil+Med&amp;amp;title=Neurotrauma+Task+Force+on+Mild+Traumatic+Brain+Injury+of+the+WHO+Collaborating+Centre:+summary+of+the+WHO+Collaborating+Centre+for+Neurotrauma+Task+Force+on+mild+traumatic+brain+injury&amp;amp;author=L+Holm&amp;amp;author=JD+Cassidy&amp;amp;author=LJ+Carroll&amp;amp;author=J+Borg&amp;amp;volume=37&amp;amp;publication_year=2005&amp;amp;pages=137-141&amp;amp;pmid=16040469&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16734</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16735</code><code>]&lt;/span&gt;</code></p><p><code>16736</code><code>&lt;/span&gt;</code></p><p><code>16737</code><code>&lt;/li&gt;</code></p><p><code>16738</code><code>&lt;li id="R521"&gt;</code></p><p><code>16739</code><code>&lt;span class="citation"&gt;</code></p><p><code>16740</code><code>Holmes GL, Ben-Ari Y. Seizures in the developing brain: perhaps not so benign after all. &lt;span&gt;</code></p><p><code>16741</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16742</code><code>Neuron. &lt;/span&gt;</code></p><p><code>16743</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>16744</code><code>21&lt;/span&gt;</code></p><p><code>16745</code><code>:1231–1234.&lt;/span&gt;</code></p><p><code>16746</code><code> [&lt;a href="/pubmed/9883716" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16747</code><code>PubMed&lt;/a&gt;</code></p><p><code>16748</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16749</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;amp;title=Seizures+in+the+developing+brain:+perhaps+not+so+benign+after+all&amp;amp;author=GL+Holmes&amp;amp;author=Y+Ben-Ari&amp;amp;volume=21&amp;amp;publication_year=1998&amp;amp;pages=1231-1234&amp;amp;pmid=9883716&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16750</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16751</code><code>]&lt;/span&gt;</code></p><p><code>16752</code><code>&lt;/span&gt;</code></p><p><code>16753</code><code>&lt;/li&gt;</code></p><p><code>16754</code><code>&lt;li id="R522"&gt;</code></p><p><code>16755</code><code>&lt;span class="citation"&gt;</code></p><p><code>16756</code><code>Horn S, Stern MB. The comparative effects of medical therapies for Parkinson&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>16757</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16758</code><code>Neurology. &lt;/span&gt;</code></p><p><code>16759</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>16760</code><code>63&lt;/span&gt;</code></p><p><code>16761</code><code>:S7–S12.&lt;/span&gt;</code></p><p><code>16762</code><code> [&lt;a href="/pubmed/15477585" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16763</code><code>PubMed&lt;/a&gt;</code></p><p><code>16764</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16765</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;amp;title=The+comparative+effects+of+medical+therapies+for+Parkinson&amp;#x02019;s+disease&amp;amp;author=S+Horn&amp;amp;author=MB+Stern&amp;amp;volume=63&amp;amp;publication_year=2004&amp;amp;pages=S7-S12&amp;amp;pmid=15477585&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16766</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16767</code><code>]&lt;/span&gt;</code></p><p><code>16768</code><code>&lt;/span&gt;</code></p><p><code>16769</code><code>&lt;/li&gt;</code></p><p><code>16770</code><code>&lt;li id="R523"&gt;</code></p><p><code>16771</code><code>&lt;span class="citation"&gt;</code></p><p><code>16772</code><code>Houchi H, Babovic D, Pierrefiche O, Ledent C, Daoust M, Naassila M. CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors. &lt;span&gt;</code></p><p><code>16773</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16774</code><code>Neuropsychopharmacology. &lt;/span&gt;</code></p><p><code>16775</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>16776</code><code>30&lt;/span&gt;</code></p><p><code>16777</code><code>:339–349.&lt;/span&gt;</code></p><p><code>16778</code><code> [&lt;a href="/pubmed/15383833" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16779</code><code>PubMed&lt;/a&gt;</code></p><p><code>16780</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16781</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;amp;title=CB1+receptor+knockout+mice+display+reduced+ethanol-induced+conditioned+place+preference+and+increased+striatal+dopamine+D2+receptors&amp;amp;author=H+Houchi&amp;amp;author=D+Babovic&amp;amp;author=O+Pierrefiche&amp;amp;author=C+Ledent&amp;amp;author=M+Daoust&amp;amp;volume=30&amp;amp;publication_year=2004&amp;amp;pages=339-349&amp;amp;pmid=15383833&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16782</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16783</code><code>]&lt;/span&gt;</code></p><p><code>16784</code><code>&lt;/span&gt;</code></p><p><code>16785</code><code>&lt;/li&gt;</code></p><p><code>16786</code><code>&lt;li id="R524"&gt;</code></p><p><code>16787</code><code>&lt;span class="citation"&gt;</code></p><p><code>16788</code><code>Houser SJ, Eads M, Embrey JP, Welch SP. Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, &amp;#x00394;&lt;sup&gt;</code></p><p><code>16789</code><code>9&lt;/sup&gt;</code></p><p><code>16790</code><code>-THC and anandamide. &lt;span&gt;</code></p><p><code>16791</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16792</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>16793</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>16794</code><code>857&lt;/span&gt;</code></p><p><code>16795</code><code>:337–342.&lt;/span&gt;</code></p><p><code>16796</code><code> [&lt;a href="/pubmed/10700588" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16797</code><code>PubMed&lt;/a&gt;</code></p><p><code>16798</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16799</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Dynorphin+B+and+spinal+analgesia:+induction+of+antinociception+by+the+cannabinoids+CP55,940,+&amp;#x00394;9-THC+and+anandamide&amp;amp;author=SJ+Houser&amp;amp;author=M+Eads&amp;amp;author=JP+Embrey&amp;amp;author=SP+Welch&amp;amp;volume=857&amp;amp;publication_year=2000&amp;amp;pages=337-342&amp;amp;pmid=10700588&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16800</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16801</code><code>]&lt;/span&gt;</code></p><p><code>16802</code><code>&lt;/span&gt;</code></p><p><code>16803</code><code>&lt;/li&gt;</code></p><p><code>16804</code><code>&lt;li id="R525"&gt;</code></p><p><code>16805</code><code>&lt;span class="citation"&gt;</code></p><p><code>16806</code><code>Howlett AC. Efficacy in CB1 receptor-mediated signal transduction. &lt;span&gt;</code></p><p><code>16807</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16808</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>16809</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>16810</code><code>142&lt;/span&gt;</code></p><p><code>16811</code><code>:1209–1218.&lt;/span&gt;</code></p><p><code>16812</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>16813</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1575189/"&gt;</code></p><p><code>16814</code><code>PMC free article&lt;/a&gt;</code></p><p><code>16815</code><code>]&lt;/span&gt;</code></p><p><code>16816</code><code> [&lt;a href="/pubmed/15308578" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16817</code><code>PubMed&lt;/a&gt;</code></p><p><code>16818</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16819</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Efficacy+in+CB1+receptor-mediated+signal+transduction&amp;amp;author=AC+Howlett&amp;amp;volume=142&amp;amp;publication_year=2004&amp;amp;pages=1209-1218&amp;amp;pmid=15308578&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16820</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16821</code><code>]&lt;/span&gt;</code></p><p><code>16822</code><code>&lt;/span&gt;</code></p><p><code>16823</code><code>&lt;/li&gt;</code></p><p><code>16824</code><code>&lt;li id="R526"&gt;</code></p><p><code>16825</code><code>&lt;span class="citation"&gt;</code></p><p><code>16826</code><code>Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, et al.  International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. &lt;span&gt;</code></p><p><code>16827</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16828</code><code>Pharmacol Rev. &lt;/span&gt;</code></p><p><code>16829</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>16830</code><code>54&lt;/span&gt;</code></p><p><code>16831</code><code>:161–202.&lt;/span&gt;</code></p><p><code>16832</code><code> [&lt;a href="/pubmed/12037135" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16833</code><code>PubMed&lt;/a&gt;</code></p><p><code>16834</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16835</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Rev&amp;amp;title=International+Union+of+Pharmacology.+XXVII.+Classification+of+cannabinoid+receptors&amp;amp;author=AC+Howlett&amp;amp;author=F+Barth&amp;amp;author=TI+Bonner&amp;amp;author=G+Cabral&amp;amp;author=P+Casellas&amp;amp;volume=54&amp;amp;publication_year=2002&amp;amp;pages=161-202&amp;amp;pmid=12037135&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16836</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16837</code><code>]&lt;/span&gt;</code></p><p><code>16838</code><code>&lt;/span&gt;</code></p><p><code>16839</code><code>&lt;/li&gt;</code></p><p><code>16840</code><code>&lt;li id="R527"&gt;</code></p><p><code>16841</code><code>&lt;span class="citation"&gt;</code></p><p><code>16842</code><code>Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ. Cannabinoid physiology and pharmacology: 30 years of progress. &lt;span&gt;</code></p><p><code>16843</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16844</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>16845</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>16846</code><code>47 &lt;/span&gt;</code></p><p><code>16847</code><code>(Suppl 1):345–358.&lt;/span&gt;</code></p><p><code>16848</code><code> [&lt;a href="/pubmed/15464149" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16849</code><code>PubMed&lt;/a&gt;</code></p><p><code>16850</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16851</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=Cannabinoid+physiology+and+pharmacology:+30+years+of+progress&amp;amp;author=AC+Howlett&amp;amp;author=CS+Breivogel&amp;amp;author=SR+Childers&amp;amp;author=SA+Deadwyler&amp;amp;author=RE+Hampson&amp;amp;volume=47+&amp;amp;issue=Suppl+1&amp;amp;publication_year=2004&amp;amp;pages=345-358&amp;amp;pmid=15464149&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16852</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16853</code><code>]&lt;/span&gt;</code></p><p><code>16854</code><code>&lt;/span&gt;</code></p><p><code>16855</code><code>&lt;/li&gt;</code></p><p><code>16856</code><code>&lt;li id="R528"&gt;</code></p><p><code>16857</code><code>&lt;span class="citation"&gt;</code></p><p><code>16858</code><code>Hu CC, Qing K, Chen Y. Diet-induced changes in stearoyl-CoA desaturase 1 expression in obesity-prone and -resistant mice. &lt;span&gt;</code></p><p><code>16859</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16860</code><code>Obes Res. &lt;/span&gt;</code></p><p><code>16861</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>16862</code><code>12&lt;/span&gt;</code></p><p><code>16863</code><code>:1264–1270.&lt;/span&gt;</code></p><p><code>16864</code><code> [&lt;a href="/pubmed/15340109" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16865</code><code>PubMed&lt;/a&gt;</code></p><p><code>16866</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16867</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Obes+Res&amp;amp;title=Diet-induced+changes+in+stearoyl-CoA+desaturase+1+expression+in+obesity-prone+and+-resistant+mice&amp;amp;author=CC+Hu&amp;amp;author=K+Qing&amp;amp;author=Y+Chen&amp;amp;volume=12&amp;amp;publication_year=2004&amp;amp;pages=1264-1270&amp;amp;pmid=15340109&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16868</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16869</code><code>]&lt;/span&gt;</code></p><p><code>16870</code><code>&lt;/span&gt;</code></p><p><code>16871</code><code>&lt;/li&gt;</code></p><p><code>16872</code><code>&lt;li id="R529"&gt;</code></p><p><code>16873</code><code>&lt;span class="citation"&gt;</code></p><p><code>16874</code><code>Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, Tognetto M, Petros TJ, Krey JF, Chu CJ, et al.  An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. &lt;span&gt;</code></p><p><code>16875</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16876</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>16877</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>16878</code><code>99&lt;/span&gt;</code></p><p><code>16879</code><code>:8400–8405.&lt;/span&gt;</code></p><p><code>16880</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>16881</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC123079/"&gt;</code></p><p><code>16882</code><code>PMC free article&lt;/a&gt;</code></p><p><code>16883</code><code>]&lt;/span&gt;</code></p><p><code>16884</code><code> [&lt;a href="/pubmed/12060783" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16885</code><code>PubMed&lt;/a&gt;</code></p><p><code>16886</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16887</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=An+endogenous+capsaicin-like+substance+with+high+potency+at+recombinant+and+native+vanilloid+VR1+receptors&amp;amp;author=SM+Huang&amp;amp;author=T+Bisogno&amp;amp;author=M+Trevisani&amp;amp;author=A+Al-Hayani&amp;amp;author=L+De+Petrocellis&amp;amp;volume=99&amp;amp;publication_year=2002&amp;amp;pages=8400-8405&amp;amp;pmid=12060783&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16888</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16889</code><code>]&lt;/span&gt;</code></p><p><code>16890</code><code>&lt;/span&gt;</code></p><p><code>16891</code><code>&lt;/li&gt;</code></p><p><code>16892</code><code>&lt;li id="R530"&gt;</code></p><p><code>16893</code><code>&lt;span class="citation"&gt;</code></p><p><code>16894</code><code>Huang YC, Wang SJ, Chiou LC, Gean PW. Mediation of amphetamine-induced long-term depression of synaptic transmission by CB1 cannabinoid receptors in the rat amygdala. &lt;span&gt;</code></p><p><code>16895</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16896</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>16897</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>16898</code><code>23&lt;/span&gt;</code></p><p><code>16899</code><code>:10311–10320.&lt;/span&gt;</code></p><p><code>16900</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>16901</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6741012/"&gt;</code></p><p><code>16902</code><code>PMC free article&lt;/a&gt;</code></p><p><code>16903</code><code>]&lt;/span&gt;</code></p><p><code>16904</code><code> [&lt;a href="/pubmed/14614090" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16905</code><code>PubMed&lt;/a&gt;</code></p><p><code>16906</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16907</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Mediation+of+amphetamine-induced+long-term+depression+of+synaptic+transmission+by+CB1+cannabinoid+receptors+in+the+rat+amygdala&amp;amp;author=YC+Huang&amp;amp;author=SJ+Wang&amp;amp;author=LC+Chiou&amp;amp;author=PW+Gean&amp;amp;volume=23&amp;amp;publication_year=2003&amp;amp;pages=10311-10320&amp;amp;pmid=14614090&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16908</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16909</code><code>]&lt;/span&gt;</code></p><p><code>16910</code><code>&lt;/span&gt;</code></p><p><code>16911</code><code>&lt;/li&gt;</code></p><p><code>16912</code><code>&lt;li id="R531"&gt;</code></p><p><code>16913</code><code>&lt;span class="citation"&gt;</code></p><p><code>16914</code><code>H&amp;#x000fc;bschle T, Thom E, Watson A, Roth J, Klaus S, Meyerhof W. Leptin-induced nuclear translocation of STAT3 immunoreactivity in hypothalamic nuclei involved in body weight regulation. &lt;span&gt;</code></p><p><code>16915</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16916</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>16917</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>16918</code><code>21&lt;/span&gt;</code></p><p><code>16919</code><code>:2413–2424.&lt;/span&gt;</code></p><p><code>16920</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>16921</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6762388/"&gt;</code></p><p><code>16922</code><code>PMC free article&lt;/a&gt;</code></p><p><code>16923</code><code>]&lt;/span&gt;</code></p><p><code>16924</code><code> [&lt;a href="/pubmed/11264315" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16925</code><code>PubMed&lt;/a&gt;</code></p><p><code>16926</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16927</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Leptin-induced+nuclear+translocation+of+STAT3+immunoreactivity+in+hypothalamic+nuclei+involved+in+body+weight+regulation&amp;amp;author=T+H&amp;#x000fc;bschle&amp;amp;author=E+Thom&amp;amp;author=A+Watson&amp;amp;author=J+Roth&amp;amp;author=S+Klaus&amp;amp;volume=21&amp;amp;publication_year=2001&amp;amp;pages=2413-2424&amp;amp;pmid=11264315&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16928</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16929</code><code>]&lt;/span&gt;</code></p><p><code>16930</code><code>&lt;/span&gt;</code></p><p><code>16931</code><code>&lt;/li&gt;</code></p><p><code>16932</code><code>&lt;li id="R532"&gt;</code></p><p><code>16933</code><code>&lt;span class="citation"&gt;</code></p><p><code>16934</code><code>Huffman JW, Liddle J, Yu S, Aung MM, Abood ME, Wiley JL, Martin BR. 3-(1&amp;#x02032;,1&amp;#x02032;-Dimethylbutyl)-1-deoxy-&amp;#x00394;&lt;sup&gt;</code></p><p><code>16935</code><code>8&lt;/sup&gt;</code></p><p><code>16936</code><code>-THC and related compounds: synthesis of selective ligands for the CB2 receptor. &lt;span&gt;</code></p><p><code>16937</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16938</code><code>Bioorg Med Chem. &lt;/span&gt;</code></p><p><code>16939</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>16940</code><code>7&lt;/span&gt;</code></p><p><code>16941</code><code>:2905–2914.&lt;/span&gt;</code></p><p><code>16942</code><code> [&lt;a href="/pubmed/10658595" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16943</code><code>PubMed&lt;/a&gt;</code></p><p><code>16944</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16945</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Bioorg+Med+Chem&amp;amp;title=3-(1&amp;#x02032;,1&amp;#x02032;-Dimethylbutyl)-1-deoxy-&amp;#x00394;8-THC+and+related+compounds:+synthesis+of+selective+ligands+for+the+CB2+receptor&amp;amp;author=JW+Huffman&amp;amp;author=J+Liddle&amp;amp;author=S+Yu&amp;amp;author=MM+Aung&amp;amp;author=ME+Abood&amp;amp;volume=7&amp;amp;publication_year=1999&amp;amp;pages=2905-2914&amp;amp;pmid=10658595&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16946</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16947</code><code>]&lt;/span&gt;</code></p><p><code>16948</code><code>&lt;/span&gt;</code></p><p><code>16949</code><code>&lt;/li&gt;</code></p><p><code>16950</code><code>&lt;li id="R533"&gt;</code></p><p><code>16951</code><code>&lt;span class="citation"&gt;</code></p><p><code>16952</code><code>Hungund BL, Szakall I, Adam A, Basavarajappa BS, Vadasz C. Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. &lt;span&gt;</code></p><p><code>16953</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16954</code><code>J Neurochem. &lt;/span&gt;</code></p><p><code>16955</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>16956</code><code>84&lt;/span&gt;</code></p><p><code>16957</code><code>:698–704.&lt;/span&gt;</code></p><p><code>16958</code><code> [&lt;a href="/pubmed/12562514" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16959</code><code>PubMed&lt;/a&gt;</code></p><p><code>16960</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16961</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;amp;title=Cannabinoid+CB1+receptor+knockout+mice+exhibit+markedly+reduced+voluntary+alcohol+consumption+and+lack+alcohol-induced+dopamine+release+in+the+nucleus+accumbens&amp;amp;author=BL+Hungund&amp;amp;author=I+Szakall&amp;amp;author=A+Adam&amp;amp;author=BS+Basavarajappa&amp;amp;author=C+Vadasz&amp;amp;volume=84&amp;amp;publication_year=2003&amp;amp;pages=698-704&amp;amp;pmid=12562514&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16962</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16963</code><code>]&lt;/span&gt;</code></p><p><code>16964</code><code>&lt;/span&gt;</code></p><p><code>16965</code><code>&lt;/li&gt;</code></p><p><code>16966</code><code>&lt;li id="R534"&gt;</code></p><p><code>16967</code><code>&lt;span class="citation"&gt;</code></p><p><code>16968</code><code>Ibrahim MM, Deng H, Zvonok A, Cockayne DA, Kwan J, Mata HP, Vanderah TW, Lai J, Porreca F, Makriyannis A, et al.  Activation of CB&lt;sub&gt;</code></p><p><code>16969</code><code>2&lt;/sub&gt;</code></p><p><code>16970</code><code> cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. &lt;span&gt;</code></p><p><code>16971</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16972</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>16973</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>16974</code><code>100&lt;/span&gt;</code></p><p><code>16975</code><code>:10529–10533.&lt;/span&gt;</code></p><p><code>16976</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>16977</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC193595/"&gt;</code></p><p><code>16978</code><code>PMC free article&lt;/a&gt;</code></p><p><code>16979</code><code>]&lt;/span&gt;</code></p><p><code>16980</code><code> [&lt;a href="/pubmed/12917492" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>16981</code><code>PubMed&lt;/a&gt;</code></p><p><code>16982</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>16983</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Activation+of+CB2+cannabinoid+receptors+by+AM1241+inhibits+experimental+neuropathic+pain:+pain+inhibition+by+receptors+not+present+in+the+CNS&amp;amp;author=MM+Ibrahim&amp;amp;author=H+Deng&amp;amp;author=A+Zvonok&amp;amp;author=DA+Cockayne&amp;amp;author=J+Kwan&amp;amp;volume=100&amp;amp;publication_year=2003&amp;amp;pages=10529-10533&amp;amp;pmid=12917492&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>16984</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>16985</code><code>]&lt;/span&gt;</code></p><p><code>16986</code><code>&lt;/span&gt;</code></p><p><code>16987</code><code>&lt;/li&gt;</code></p><p><code>16988</code><code>&lt;li id="R535"&gt;</code></p><p><code>16989</code><code>&lt;span class="citation"&gt;</code></p><p><code>16990</code><code>Ibrahim MM, Porreca F, Lai J, Albrecht PJ, Rice FL, Khodorova A, Davar G, Makriyannis A, Vanderah TW, Mata HP, et al.  CB&lt;sub&gt;</code></p><p><code>16991</code><code>2&lt;/sub&gt;</code></p><p><code>16992</code><code> cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. &lt;span&gt;</code></p><p><code>16993</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>16994</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>16995</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>16996</code><code>102&lt;/span&gt;</code></p><p><code>16997</code><code>:3093–3098.&lt;/span&gt;</code></p><p><code>16998</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>16999</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC549497/"&gt;</code></p><p><code>17000</code><code>PMC free article&lt;/a&gt;</code></p><p><code>17001</code><code>]&lt;/span&gt;</code></p><p><code>17002</code><code> [&lt;a href="/pubmed/15705714" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17003</code><code>PubMed&lt;/a&gt;</code></p><p><code>17004</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17005</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=CB2+cannabinoid+receptor+activation+produces+antinociception+by+stimulating+peripheral+release+of+endogenous+opioids&amp;amp;author=MM+Ibrahim&amp;amp;author=F+Porreca&amp;amp;author=J+Lai&amp;amp;author=PJ+Albrecht&amp;amp;author=FL+Rice&amp;amp;volume=102&amp;amp;publication_year=2005&amp;amp;pages=3093-3098&amp;amp;pmid=15705714&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17006</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17007</code><code>]&lt;/span&gt;</code></p><p><code>17008</code><code>&lt;/span&gt;</code></p><p><code>17009</code><code>&lt;/li&gt;</code></p><p><code>17010</code><code>&lt;li id="R536"&gt;</code></p><p><code>17011</code><code>&lt;span class="citation"&gt;</code></p><p><code>17012</code><code>Ibrahim MM, Rude ML, Stagg NJ, Mata HP, Lai J, Vanderah TW, Porreca F, Buckley NE, Makriyannis A, Malan TP., Jr CB2 cannabinoid receptor mediation of antinociception. &lt;span&gt;</code></p><p><code>17013</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17014</code><code>Pain. &lt;/span&gt;</code></p><p><code>17015</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>17016</code><code>122&lt;/span&gt;</code></p><p><code>17017</code><code>:36–42.&lt;/span&gt;</code></p><p><code>17018</code><code> [&lt;a href="/pubmed/16563625" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17019</code><code>PubMed&lt;/a&gt;</code></p><p><code>17020</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17021</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;amp;title=CB2+cannabinoid+receptor+mediation+of+antinociception&amp;amp;author=MM+Ibrahim&amp;amp;author=ML+Rude&amp;amp;author=NJ+Stagg&amp;amp;author=HP+Mata&amp;amp;author=J+Lai&amp;amp;volume=122&amp;amp;publication_year=2006&amp;amp;pages=36-42&amp;amp;pmid=16563625&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17022</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17023</code><code>]&lt;/span&gt;</code></p><p><code>17024</code><code>&lt;/span&gt;</code></p><p><code>17025</code><code>&lt;/li&gt;</code></p><p><code>17026</code><code>&lt;li id="R537"&gt;</code></p><p><code>17027</code><code>&lt;span class="citation"&gt;</code></p><p><code>17028</code><code>Idris AI, van&amp;#x02019;t Hof RJ, Greig IR, Ridge SA, Baker D, Ross RA, Ralston SH. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. &lt;span&gt;</code></p><p><code>17029</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17030</code><code>Nat Med. &lt;/span&gt;</code></p><p><code>17031</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>17032</code><code>11&lt;/span&gt;</code></p><p><code>17033</code><code>:774–779.&lt;/span&gt;</code></p><p><code>17034</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>17035</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1430341/"&gt;</code></p><p><code>17036</code><code>PMC free article&lt;/a&gt;</code></p><p><code>17037</code><code>]&lt;/span&gt;</code></p><p><code>17038</code><code> [&lt;a href="/pubmed/15908955" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17039</code><code>PubMed&lt;/a&gt;</code></p><p><code>17040</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17041</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;amp;title=Regulation+of+bone+mass,+bone+loss+and+osteoclast+activity+by+cannabinoid+receptors&amp;amp;author=AI+Idris&amp;amp;author=RJ+van&amp;#x02019;t+Hof&amp;amp;author=IR+Greig&amp;amp;author=SA+Ridge&amp;amp;author=D+Baker&amp;amp;volume=11&amp;amp;publication_year=2005&amp;amp;pages=774-779&amp;amp;pmid=15908955&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17042</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17043</code><code>]&lt;/span&gt;</code></p><p><code>17044</code><code>&lt;/span&gt;</code></p><p><code>17045</code><code>&lt;/li&gt;</code></p><p><code>17046</code><code>&lt;li id="R538"&gt;</code></p><p><code>17047</code><code>&lt;span class="citation"&gt;</code></p><p><code>17048</code><code>Ikeda SR. Voltage-dependent modulation of N-type calcium channels by G-protein &lt;em&gt;</code></p><p><code>17049</code><code>&amp;#x003b2;&amp;#x003b3;&lt;/em&gt;</code></p><p><code>17050</code><code>subunits. &lt;span&gt;</code></p><p><code>17051</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17052</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>17053</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>17054</code><code>380&lt;/span&gt;</code></p><p><code>17055</code><code>:255–258.&lt;/span&gt;</code></p><p><code>17056</code><code> [&lt;a href="/pubmed/8637575" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17057</code><code>PubMed&lt;/a&gt;</code></p><p><code>17058</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17059</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Voltage-dependent+modulation+of+N-type+calcium+channels+by+G-protein+&amp;#x003b2;&amp;#x003b3;subunits&amp;amp;author=SR+Ikeda&amp;amp;volume=380&amp;amp;publication_year=1996&amp;amp;pages=255-258&amp;amp;pmid=8637575&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17060</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17061</code><code>]&lt;/span&gt;</code></p><p><code>17062</code><code>&lt;/span&gt;</code></p><p><code>17063</code><code>&lt;/li&gt;</code></p><p><code>17064</code><code>&lt;li id="R539"&gt;</code></p><p><code>17065</code><code>&lt;span class="citation"&gt;</code></p><p><code>17066</code><code>Ilaria RL, Thornby JI, Fann WE. Nabilone, a cannabinol derivative, in the treatment of anxiety neurosis. &lt;span&gt;</code></p><p><code>17067</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17068</code><code>Curr Ther Res. &lt;/span&gt;</code></p><p><code>17069</code><code>1981;&lt;span class="ref-vol"&gt;</code></p><p><code>17070</code><code>29&lt;/span&gt;</code></p><p><code>17071</code><code>:943–949.&lt;/span&gt;</code></p><p><code>17072</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>17073</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Ther+Res&amp;amp;title=Nabilone,+a+cannabinol+derivative,+in+the+treatment+of+anxiety+neurosis&amp;amp;author=RL+Ilaria&amp;amp;author=JI+Thornby&amp;amp;author=WE+Fann&amp;amp;volume=29&amp;amp;publication_year=1981&amp;amp;pages=943-949&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17074</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17075</code><code>]&lt;/span&gt;</code></p><p><code>17076</code><code>&lt;/span&gt;</code></p><p><code>17077</code><code>&lt;/li&gt;</code></p><p><code>17078</code><code>&lt;li id="R540"&gt;</code></p><p><code>17079</code><code>&lt;span class="citation"&gt;</code></p><p><code>17080</code><code>Iqbal J, Pompolo S, Murakami T, Grouzmann E, Sakurai T, Meister B, Clarke IJ. Immunohistochemical characterization of localization of long-form leptin receptor (OB-Rb) in neurochemically defined cells in the ovine hypothalamus. &lt;span&gt;</code></p><p><code>17081</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17082</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>17083</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>17084</code><code>920&lt;/span&gt;</code></p><p><code>17085</code><code>:55–64.&lt;/span&gt;</code></p><p><code>17086</code><code> [&lt;a href="/pubmed/11716811" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17087</code><code>PubMed&lt;/a&gt;</code></p><p><code>17088</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17089</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Immunohistochemical+characterization+of+localization+of+long-form+leptin+receptor+(OB-Rb)+in+neurochemically+defined+cells+in+the+ovine+hypothalamus&amp;amp;author=J+Iqbal&amp;amp;author=S+Pompolo&amp;amp;author=T+Murakami&amp;amp;author=E+Grouzmann&amp;amp;author=T+Sakurai&amp;amp;volume=920&amp;amp;publication_year=2001&amp;amp;pages=55-64&amp;amp;pmid=11716811&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17090</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17091</code><code>]&lt;/span&gt;</code></p><p><code>17092</code><code>&lt;/span&gt;</code></p><p><code>17093</code><code>&lt;/li&gt;</code></p><p><code>17094</code><code>&lt;li id="R541"&gt;</code></p><p><code>17095</code><code>&lt;span class="citation"&gt;</code></p><p><code>17096</code><code>Ishac EJ, Jiang L, Lake KD, Varga K, Abood ME, Kunos G. Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. &lt;span&gt;</code></p><p><code>17097</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17098</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>17099</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>17100</code><code>118&lt;/span&gt;</code></p><p><code>17101</code><code>:2023–2028.&lt;/span&gt;</code></p><p><code>17102</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>17103</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1909901/"&gt;</code></p><p><code>17104</code><code>PMC free article&lt;/a&gt;</code></p><p><code>17105</code><code>]&lt;/span&gt;</code></p><p><code>17106</code><code> [&lt;a href="/pubmed/8864538" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17107</code><code>PubMed&lt;/a&gt;</code></p><p><code>17108</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17109</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Inhibition+of+exocytotic+noradrenaline+release+by+presynaptic+cannabinoid+CB1+receptors+on+peripheral+sympathetic+nerves&amp;amp;author=EJ+Ishac&amp;amp;author=L+Jiang&amp;amp;author=KD+Lake&amp;amp;author=K+Varga&amp;amp;author=ME+Abood&amp;amp;volume=118&amp;amp;publication_year=1996&amp;amp;pages=2023-2028&amp;amp;pmid=8864538&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17110</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17111</code><code>]&lt;/span&gt;</code></p><p><code>17112</code><code>&lt;/span&gt;</code></p><p><code>17113</code><code>&lt;/li&gt;</code></p><p><code>17114</code><code>&lt;li id="R542"&gt;</code></p><p><code>17115</code><code>&lt;span class="citation"&gt;</code></p><p><code>17116</code><code>Isokawa M, Alger BE. Retrograde endocannabinoid regulation of GABAergic inhibition in the rat dentate gyrus granule cell. &lt;span&gt;</code></p><p><code>17117</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17118</code><code>J Physiol (Lond) &lt;/span&gt;</code></p><p><code>17119</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>17120</code><code>567 &lt;/span&gt;</code></p><p><code>17121</code><code>(Pt 3):1001–1010.&lt;/span&gt;</code></p><p><code>17122</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>17123</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1474217/"&gt;</code></p><p><code>17124</code><code>PMC free article&lt;/a&gt;</code></p><p><code>17125</code><code>]&lt;/span&gt;</code></p><p><code>17126</code><code> [&lt;a href="/pubmed/16037085" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17127</code><code>PubMed&lt;/a&gt;</code></p><p><code>17128</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17129</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Physiol+(Lond)&amp;amp;title=Retrograde+endocannabinoid+regulation+of+GABAergic+inhibition+in+the+rat+dentate+gyrus+granule+cell&amp;amp;author=M+Isokawa&amp;amp;author=BE+Alger&amp;amp;volume=567+&amp;amp;issue=Pt+3&amp;amp;publication_year=2005&amp;amp;pages=1001-1010&amp;amp;pmid=16037085&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17130</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17131</code><code>]&lt;/span&gt;</code></p><p><code>17132</code><code>&lt;/span&gt;</code></p><p><code>17133</code><code>&lt;/li&gt;</code></p><p><code>17134</code><code>&lt;li id="R543"&gt;</code></p><p><code>17135</code><code>&lt;span class="citation"&gt;</code></p><p><code>17136</code><code>Iuvone T, Esposito G, Esposito R, Santamaria R, Di Rosa M, Izzo AA. Neuroprotective effect of cannabidiol, a non-psychoactive component from &lt;em&gt;</code></p><p><code>17137</code><code>Cannabis sativa&lt;/em&gt;</code></p><p><code>17138</code><code>, on &lt;em&gt;</code></p><p><code>17139</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>17140</code><code>-amyloid-induced toxicity in PC12 cells. &lt;span&gt;</code></p><p><code>17141</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17142</code><code>J Neurochem. &lt;/span&gt;</code></p><p><code>17143</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>17144</code><code>89&lt;/span&gt;</code></p><p><code>17145</code><code>:134–141.&lt;/span&gt;</code></p><p><code>17146</code><code> [&lt;a href="/pubmed/15030397" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17147</code><code>PubMed&lt;/a&gt;</code></p><p><code>17148</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17149</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;amp;title=Neuroprotective+effect+of+cannabidiol,+a+non-psychoactive+component+from+Cannabis+sativa,+on+&amp;#x003b2;-amyloid-induced+toxicity+in+PC12+cells&amp;amp;author=T+Iuvone&amp;amp;author=G+Esposito&amp;amp;author=R+Esposito&amp;amp;author=R+Santamaria&amp;amp;author=M+Di+Rosa&amp;amp;volume=89&amp;amp;publication_year=2004&amp;amp;pages=134-141&amp;amp;pmid=15030397&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17150</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17151</code><code>]&lt;/span&gt;</code></p><p><code>17152</code><code>&lt;/span&gt;</code></p><p><code>17153</code><code>&lt;/li&gt;</code></p><p><code>17154</code><code>&lt;li id="R544"&gt;</code></p><p><code>17155</code><code>&lt;span class="citation"&gt;</code></p><p><code>17156</code><code>Iversen LL.  &lt;span class="ref-journal"&gt;</code></p><p><code>17157</code><code>The Science of Marijuana.&lt;/span&gt;</code></p><p><code>17158</code><code> Oxford University Press; Oxford, UK: 2000.  &lt;span class="nowrap"&gt;</code></p><p><code>17159</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?title=The+Science+of+Marijuana&amp;amp;author=LL+Iversen&amp;amp;publication_year=2000&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17160</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17161</code><code>]&lt;/span&gt;</code></p><p><code>17162</code><code>&lt;/span&gt;</code></p><p><code>17163</code><code>&lt;/li&gt;</code></p><p><code>17164</code><code>&lt;li id="R545"&gt;</code></p><p><code>17165</code><code>&lt;span class="citation"&gt;</code></p><p><code>17166</code><code>Iwamura H, Suzuki H, Ueda Y, Kaya T, Inaba T. In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor. &lt;span&gt;</code></p><p><code>17167</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17168</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>17169</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>17170</code><code>296&lt;/span&gt;</code></p><p><code>17171</code><code>:420–425.&lt;/span&gt;</code></p><p><code>17172</code><code> [&lt;a href="/pubmed/11160626" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17173</code><code>PubMed&lt;/a&gt;</code></p><p><code>17174</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17175</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=In+vitro+and+in+vivo+pharmacological+characterization+of+JTE-907,+a+novel+selective+ligand+for+cannabinoid+CB2+receptor&amp;amp;author=H+Iwamura&amp;amp;author=H+Suzuki&amp;amp;author=Y+Ueda&amp;amp;author=T+Kaya&amp;amp;author=T+Inaba&amp;amp;volume=296&amp;amp;publication_year=2001&amp;amp;pages=420-425&amp;amp;pmid=11160626&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17176</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17177</code><code>]&lt;/span&gt;</code></p><p><code>17178</code><code>&lt;/span&gt;</code></p><p><code>17179</code><code>&lt;/li&gt;</code></p><p><code>17180</code><code>&lt;li id="R546"&gt;</code></p><p><code>17181</code><code>&lt;span class="citation"&gt;</code></p><p><code>17182</code><code>Izzo AA, Capasso F, Costagliola A, Bisogno T, Marsicano G, Ligresti A, Matias I, Capasso R, Pinto L, Borrelli F, et al.  An endogenous cannabinoid tone attenuates cholera toxin-induced fluidaccumulation in mice. &lt;span&gt;</code></p><p><code>17183</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17184</code><code>Gastroenterology. &lt;/span&gt;</code></p><p><code>17185</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>17186</code><code>125&lt;/span&gt;</code></p><p><code>17187</code><code>:765–774.&lt;/span&gt;</code></p><p><code>17188</code><code> [&lt;a href="/pubmed/12949722" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17189</code><code>PubMed&lt;/a&gt;</code></p><p><code>17190</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17191</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;amp;title=An+endogenous+cannabinoid+tone+attenuates+cholera+toxin-induced+fluidaccumulation+in+mice&amp;amp;author=AA+Izzo&amp;amp;author=F+Capasso&amp;amp;author=A+Costagliola&amp;amp;author=T+Bisogno&amp;amp;author=G+Marsicano&amp;amp;volume=125&amp;amp;publication_year=2003&amp;amp;pages=765-774&amp;amp;pmid=12949722&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17192</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17193</code><code>]&lt;/span&gt;</code></p><p><code>17194</code><code>&lt;/span&gt;</code></p><p><code>17195</code><code>&lt;/li&gt;</code></p><p><code>17196</code><code>&lt;li id="R547"&gt;</code></p><p><code>17197</code><code>&lt;span class="citation"&gt;</code></p><p><code>17198</code><code>Izzo AA, Fezza F, Capasso R, Bisogno T, Pinto L, Iuvone T, Esposito G, Mascolo N, Di Marzo V, Capasso F. Cannabinoid CB&lt;sub&gt;</code></p><p><code>17199</code><code>1&lt;/sub&gt;</code></p><p><code>17200</code><code>-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. &lt;span&gt;</code></p><p><code>17201</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17202</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>17203</code><code>2001a;&lt;span class="ref-vol"&gt;</code></p><p><code>17204</code><code>134&lt;/span&gt;</code></p><p><code>17205</code><code>:563–570.&lt;/span&gt;</code></p><p><code>17206</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>17207</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1572987/"&gt;</code></p><p><code>17208</code><code>PMC free article&lt;/a&gt;</code></p><p><code>17209</code><code>]&lt;/span&gt;</code></p><p><code>17210</code><code> [&lt;a href="/pubmed/11588110" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17211</code><code>PubMed&lt;/a&gt;</code></p><p><code>17212</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17213</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Cannabinoid+CB1-receptor+mediated+regulation+of+gastrointestinal+motility+in+mice+in+a+model+of+intestinal+inflammation&amp;amp;author=AA+Izzo&amp;amp;author=F+Fezza&amp;amp;author=R+Capasso&amp;amp;author=T+Bisogno&amp;amp;author=L+Pinto&amp;amp;volume=134&amp;amp;publication_year=2001a&amp;amp;pages=563-570&amp;amp;pmid=11588110&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17214</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17215</code><code>]&lt;/span&gt;</code></p><p><code>17216</code><code>&lt;/span&gt;</code></p><p><code>17217</code><code>&lt;/li&gt;</code></p><p><code>17218</code><code>&lt;li id="R548"&gt;</code></p><p><code>17219</code><code>&lt;span class="citation"&gt;</code></p><p><code>17220</code><code>Izzo AA, Mascolo N, Capasso F. The gastrointestinal pharmacology of cannabinoids. &lt;span&gt;</code></p><p><code>17221</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17222</code><code>Curr Opin Pharmacol. &lt;/span&gt;</code></p><p><code>17223</code><code>2001b;&lt;span class="ref-vol"&gt;</code></p><p><code>17224</code><code>1&lt;/span&gt;</code></p><p><code>17225</code><code>:597–603.&lt;/span&gt;</code></p><p><code>17226</code><code> [&lt;a href="/pubmed/11757815" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17227</code><code>PubMed&lt;/a&gt;</code></p><p><code>17228</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17229</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Pharmacol&amp;amp;title=The+gastrointestinal+pharmacology+of+cannabinoids&amp;amp;author=AA+Izzo&amp;amp;author=N+Mascolo&amp;amp;author=F+Capasso&amp;amp;volume=1&amp;amp;publication_year=2001b&amp;amp;pages=597-603&amp;amp;pmid=11757815&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17230</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17231</code><code>]&lt;/span&gt;</code></p><p><code>17232</code><code>&lt;/span&gt;</code></p><p><code>17233</code><code>&lt;/li&gt;</code></p><p><code>17234</code><code>&lt;li id="R549"&gt;</code></p><p><code>17235</code><code>&lt;span class="citation"&gt;</code></p><p><code>17236</code><code>Jabusch HC, Schneider U, Altenmuller E. &amp;#x00394;&lt;sup&gt;</code></p><p><code>17237</code><code>9&lt;/sup&gt;</code></p><p><code>17238</code><code>-Tetrahydrocannabinol improves motor control in a patient with musician&amp;#x02019;s dystonia. &lt;span&gt;</code></p><p><code>17239</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17240</code><code>Mov Disord. &lt;/span&gt;</code></p><p><code>17241</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>17242</code><code>19&lt;/span&gt;</code></p><p><code>17243</code><code>:990–991.&lt;/span&gt;</code></p><p><code>17244</code><code> [&lt;a href="/pubmed/15300675" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17245</code><code>PubMed&lt;/a&gt;</code></p><p><code>17246</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17247</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mov+Disord&amp;amp;title=&amp;#x00394;9-Tetrahydrocannabinol+improves+motor+control+in+a+patient+with+musician&amp;#x02019;s+dystonia&amp;amp;author=HC+Jabusch&amp;amp;author=U+Schneider&amp;amp;author=E+Altenmuller&amp;amp;volume=19&amp;amp;publication_year=2004&amp;amp;pages=990-991&amp;amp;pmid=15300675&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17248</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17249</code><code>]&lt;/span&gt;</code></p><p><code>17250</code><code>&lt;/span&gt;</code></p><p><code>17251</code><code>&lt;/li&gt;</code></p><p><code>17252</code><code>&lt;li id="R550"&gt;</code></p><p><code>17253</code><code>&lt;span class="citation"&gt;</code></p><p><code>17254</code><code>Jackson SJ, Diemel LT, Pryce G, Baker D. Cannabinoids and neuroprotection in CNS inflammatory disease. &lt;span&gt;</code></p><p><code>17255</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17256</code><code>J Neurol Sci. &lt;/span&gt;</code></p><p><code>17257</code><code>2005a;&lt;span class="ref-vol"&gt;</code></p><p><code>17258</code><code>233&lt;/span&gt;</code></p><p><code>17259</code><code>:21–25.&lt;/span&gt;</code></p><p><code>17260</code><code> [&lt;a href="/pubmed/15894331" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17261</code><code>PubMed&lt;/a&gt;</code></p><p><code>17262</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17263</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurol+Sci&amp;amp;title=Cannabinoids+and+neuroprotection+in+CNS+inflammatory+disease&amp;amp;author=SJ+Jackson&amp;amp;author=LT+Diemel&amp;amp;author=G+Pryce&amp;amp;author=D+Baker&amp;amp;volume=233&amp;amp;publication_year=2005a&amp;amp;pages=21-25&amp;amp;pmid=15894331&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17264</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17265</code><code>]&lt;/span&gt;</code></p><p><code>17266</code><code>&lt;/span&gt;</code></p><p><code>17267</code><code>&lt;/li&gt;</code></p><p><code>17268</code><code>&lt;li id="R551"&gt;</code></p><p><code>17269</code><code>&lt;span class="citation"&gt;</code></p><p><code>17270</code><code>Jackson SJ, Pryce G, Diemel LT, Cuzner ML, Baker D. Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation. &lt;span&gt;</code></p><p><code>17271</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17272</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>17273</code><code>2005b;&lt;span class="ref-vol"&gt;</code></p><p><code>17274</code><code>134&lt;/span&gt;</code></p><p><code>17275</code><code>:261–266.&lt;/span&gt;</code></p><p><code>17276</code><code> [&lt;a href="/pubmed/15953683" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17277</code><code>PubMed&lt;/a&gt;</code></p><p><code>17278</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17279</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Cannabinoid-receptor+1+null+mice+are+susceptible+to+neurofilament+damage+and+caspase+3+activation&amp;amp;author=SJ+Jackson&amp;amp;author=G+Pryce&amp;amp;author=LT+Diemel&amp;amp;author=ML+Cuzner&amp;amp;author=D+Baker&amp;amp;volume=134&amp;amp;publication_year=2005b&amp;amp;pages=261-266&amp;amp;pmid=15953683&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17280</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17281</code><code>]&lt;/span&gt;</code></p><p><code>17282</code><code>&lt;/span&gt;</code></p><p><code>17283</code><code>&lt;/li&gt;</code></p><p><code>17284</code><code>&lt;li id="R552"&gt;</code></p><p><code>17285</code><code>&lt;span class="citation"&gt;</code></p><p><code>17286</code><code>Jacobsson SO, Rongard E, Stridh M, Tiger G, Fowler CJ. Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability. &lt;span&gt;</code></p><p><code>17287</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17288</code><code>Biochem Pharmacol. &lt;/span&gt;</code></p><p><code>17289</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>17290</code><code>60&lt;/span&gt;</code></p><p><code>17291</code><code>:1807–1813.&lt;/span&gt;</code></p><p><code>17292</code><code> [&lt;a href="/pubmed/11108795" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17293</code><code>PubMed&lt;/a&gt;</code></p><p><code>17294</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17295</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;amp;title=Serum-dependent+effects+of+tamoxifen+and+cannabinoids+upon+C6+glioma+cell+viability&amp;amp;author=SO+Jacobsson&amp;amp;author=E+Rongard&amp;amp;author=M+Stridh&amp;amp;author=G+Tiger&amp;amp;author=CJ+Fowler&amp;amp;volume=60&amp;amp;publication_year=2000&amp;amp;pages=1807-1813&amp;amp;pmid=11108795&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17296</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17297</code><code>]&lt;/span&gt;</code></p><p><code>17298</code><code>&lt;/span&gt;</code></p><p><code>17299</code><code>&lt;/li&gt;</code></p><p><code>17300</code><code>&lt;li id="R553"&gt;</code></p><p><code>17301</code><code>&lt;span class="citation"&gt;</code></p><p><code>17302</code><code>Jayamanne A, Greenwood R, Mitchell VA, Aslan S, Piomelli D, Vaughan CW. Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models. &lt;span&gt;</code></p><p><code>17303</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17304</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>17305</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>17306</code><code>147&lt;/span&gt;</code></p><p><code>17307</code><code>:281–288.&lt;/span&gt;</code></p><p><code>17308</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>17309</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1751298/"&gt;</code></p><p><code>17310</code><code>PMC free article&lt;/a&gt;</code></p><p><code>17311</code><code>]&lt;/span&gt;</code></p><p><code>17312</code><code> [&lt;a href="/pubmed/16331291" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17313</code><code>PubMed&lt;/a&gt;</code></p><p><code>17314</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17315</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Actions+of+the+FAAH+inhibitor+URB597+in+neuropathic+and+inflammatory+chronic+pain+models&amp;amp;author=A+Jayamanne&amp;amp;author=R+Greenwood&amp;amp;author=VA+Mitchell&amp;amp;author=S+Aslan&amp;amp;author=D+Piomelli&amp;amp;volume=147&amp;amp;publication_year=2006&amp;amp;pages=281-288&amp;amp;pmid=16331291&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17316</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17317</code><code>]&lt;/span&gt;</code></p><p><code>17318</code><code>&lt;/span&gt;</code></p><p><code>17319</code><code>&lt;/li&gt;</code></p><p><code>17320</code><code>&lt;li id="R554"&gt;</code></p><p><code>17321</code><code>&lt;span class="citation"&gt;</code></p><p><code>17322</code><code>Jamshidi N, Taylor DA. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. &lt;span&gt;</code></p><p><code>17323</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17324</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>17325</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>17326</code><code>134&lt;/span&gt;</code></p><p><code>17327</code><code>:1151–1154.&lt;/span&gt;</code></p><p><code>17328</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>17329</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1573067/"&gt;</code></p><p><code>17330</code><code>PMC free article&lt;/a&gt;</code></p><p><code>17331</code><code>]&lt;/span&gt;</code></p><p><code>17332</code><code> [&lt;a href="/pubmed/11704633" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17333</code><code>PubMed&lt;/a&gt;</code></p><p><code>17334</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17335</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Anandamide+administration+into+the+ventromedial+hypothalamus+stimulates+appetite+in+rats&amp;amp;author=N+Jamshidi&amp;amp;author=DA+Taylor&amp;amp;volume=134&amp;amp;publication_year=2001&amp;amp;pages=1151-1154&amp;amp;pmid=11704633&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17336</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17337</code><code>]&lt;/span&gt;</code></p><p><code>17338</code><code>&lt;/span&gt;</code></p><p><code>17339</code><code>&lt;/li&gt;</code></p><p><code>17340</code><code>&lt;li id="R555"&gt;</code></p><p><code>17341</code><code>&lt;span class="citation"&gt;</code></p><p><code>17342</code><code>Jan TR, Farraj AK, Harkema JR, Kaminski NE. Attenuation of the ovalbumin-induced allergic airway response by cannabinoid treatment in A/J mice. &lt;span&gt;</code></p><p><code>17343</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17344</code><code>Toxicol Appl Pharmacol. &lt;/span&gt;</code></p><p><code>17345</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>17346</code><code>188&lt;/span&gt;</code></p><p><code>17347</code><code>:24–35.&lt;/span&gt;</code></p><p><code>17348</code><code> [&lt;a href="/pubmed/12668119" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17349</code><code>PubMed&lt;/a&gt;</code></p><p><code>17350</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17351</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Toxicol+Appl+Pharmacol&amp;amp;title=Attenuation+of+the+ovalbumin-induced+allergic+airway+response+by+cannabinoid+treatment+in+A/J+mice&amp;amp;author=TR+Jan&amp;amp;author=AK+Farraj&amp;amp;author=JR+Harkema&amp;amp;author=NE+Kaminski&amp;amp;volume=188&amp;amp;publication_year=2003&amp;amp;pages=24-35&amp;amp;pmid=12668119&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17352</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17353</code><code>]&lt;/span&gt;</code></p><p><code>17354</code><code>&lt;/span&gt;</code></p><p><code>17355</code><code>&lt;/li&gt;</code></p><p><code>17356</code><code>&lt;li id="R556"&gt;</code></p><p><code>17357</code><code>&lt;span class="citation"&gt;</code></p><p><code>17358</code><code>J&amp;#x000e1;rai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, et al.  Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. &lt;span&gt;</code></p><p><code>17359</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17360</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>17361</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>17362</code><code>96&lt;/span&gt;</code></p><p><code>17363</code><code>:14136–14141.&lt;/span&gt;</code></p><p><code>17364</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>17365</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC24203/"&gt;</code></p><p><code>17366</code><code>PMC free article&lt;/a&gt;</code></p><p><code>17367</code><code>]&lt;/span&gt;</code></p><p><code>17368</code><code> [&lt;a href="/pubmed/10570211" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17369</code><code>PubMed&lt;/a&gt;</code></p><p><code>17370</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17371</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Cannabinoid-induced+mesenteric+vasodilation+through+an+endothelial+site+distinct+from+CB1+or+CB2+receptors&amp;amp;author=Z+J&amp;#x000e1;rai&amp;amp;author=JA+Wagner&amp;amp;author=K+Varga&amp;amp;author=KD+Lake&amp;amp;author=DR+Compton&amp;amp;volume=96&amp;amp;publication_year=1999&amp;amp;pages=14136-14141&amp;amp;pmid=10570211&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17372</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17373</code><code>]&lt;/span&gt;</code></p><p><code>17374</code><code>&lt;/span&gt;</code></p><p><code>17375</code><code>&lt;/li&gt;</code></p><p><code>17376</code><code>&lt;li id="R557"&gt;</code></p><p><code>17377</code><code>&lt;span class="citation"&gt;</code></p><p><code>17378</code><code>Jarrahian A, Manna S, Edgemond WS, Campbell WB, Hillard CJ. Structure-activity relationships among &lt;em&gt;</code></p><p><code>17379</code><code>N-&lt;/em&gt;</code></p><p><code>17380</code><code>arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. &lt;span&gt;</code></p><p><code>17381</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17382</code><code>J Neurochem. &lt;/span&gt;</code></p><p><code>17383</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>17384</code><code>74&lt;/span&gt;</code></p><p><code>17385</code><code>:2597–2606.&lt;/span&gt;</code></p><p><code>17386</code><code> [&lt;a href="/pubmed/10820223" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17387</code><code>PubMed&lt;/a&gt;</code></p><p><code>17388</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17389</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;amp;title=Structure-activity+relationships+among+N-arachidonylethanolamine+(Anandamide)+head+group+analogues+for+the+anandamide+transporter&amp;amp;author=A+Jarrahian&amp;amp;author=S+Manna&amp;amp;author=WS+Edgemond&amp;amp;author=WB+Campbell&amp;amp;author=CJ+Hillard&amp;amp;volume=74&amp;amp;publication_year=2000&amp;amp;pages=2597-2606&amp;amp;pmid=10820223&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17390</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17391</code><code>]&lt;/span&gt;</code></p><p><code>17392</code><code>&lt;/span&gt;</code></p><p><code>17393</code><code>&lt;/li&gt;</code></p><p><code>17394</code><code>&lt;li id="R558"&gt;</code></p><p><code>17395</code><code>&lt;span class="citation"&gt;</code></p><p><code>17396</code><code>Jarvinen T, Pate DW, Laine K. Cannabinoids in the treatment of glaucoma. &lt;span&gt;</code></p><p><code>17397</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17398</code><code>Pharmacol Ther. &lt;/span&gt;</code></p><p><code>17399</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>17400</code><code>95&lt;/span&gt;</code></p><p><code>17401</code><code>:203–220.&lt;/span&gt;</code></p><p><code>17402</code><code> [&lt;a href="/pubmed/12182967" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17403</code><code>PubMed&lt;/a&gt;</code></p><p><code>17404</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17405</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Ther&amp;amp;title=Cannabinoids+in+the+treatment+of+glaucoma&amp;amp;author=T+Jarvinen&amp;amp;author=DW+Pate&amp;amp;author=K+Laine&amp;amp;volume=95&amp;amp;publication_year=2002&amp;amp;pages=203-220&amp;amp;pmid=12182967&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17406</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17407</code><code>]&lt;/span&gt;</code></p><p><code>17408</code><code>&lt;/span&gt;</code></p><p><code>17409</code><code>&lt;/li&gt;</code></p><p><code>17410</code><code>&lt;li id="R559"&gt;</code></p><p><code>17411</code><code>&lt;span class="citation"&gt;</code></p><p><code>17412</code><code>Jbilo O, Ravinet Trillou C, Arnone M, Buisson I, Bribes E, P&amp;#x000e9;leraux A, P&amp;#x000e9;narier G, Soubri&amp;#x000e9; P, Le Fur G, Gali&amp;#x000e8;ge S, et al.  The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. &lt;span&gt;</code></p><p><code>17413</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17414</code><code>FASEB J. &lt;/span&gt;</code></p><p><code>17415</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>17416</code><code>19&lt;/span&gt;</code></p><p><code>17417</code><code>:1567–1569.&lt;/span&gt;</code></p><p><code>17418</code><code> [&lt;a href="/pubmed/16009704" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17419</code><code>PubMed&lt;/a&gt;</code></p><p><code>17420</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17421</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;amp;title=The+CB1+receptor+antagonist+rimonabant+reverses+the+diet-induced+obesity+phenotype+through+the+regulation+of+lipolysis+and+energy+balance&amp;amp;author=O+Jbilo&amp;amp;author=C+Ravinet+Trillou&amp;amp;author=M+Arnone&amp;amp;author=I+Buisson&amp;amp;author=E+Bribes&amp;amp;volume=19&amp;amp;publication_year=2005&amp;amp;pages=1567-1569&amp;amp;pmid=16009704&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17422</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17423</code><code>]&lt;/span&gt;</code></p><p><code>17424</code><code>&lt;/span&gt;</code></p><p><code>17425</code><code>&lt;/li&gt;</code></p><p><code>17426</code><code>&lt;li id="R560"&gt;</code></p><p><code>17427</code><code>&lt;span class="citation"&gt;</code></p><p><code>17428</code><code>Jiang W, Zhang Y, Xiao L, Van Cleemput J, Ji SP, Bai G, Zhang X. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. &lt;span&gt;</code></p><p><code>17429</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17430</code><code>J Clin Investig. &lt;/span&gt;</code></p><p><code>17431</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>17432</code><code>115&lt;/span&gt;</code></p><p><code>17433</code><code>:3104–3116.&lt;/span&gt;</code></p><p><code>17434</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>17435</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1253627/"&gt;</code></p><p><code>17436</code><code>PMC free article&lt;/a&gt;</code></p><p><code>17437</code><code>]&lt;/span&gt;</code></p><p><code>17438</code><code> [&lt;a href="/pubmed/16224541" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17439</code><code>PubMed&lt;/a&gt;</code></p><p><code>17440</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17441</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Investig&amp;amp;title=Cannabinoids+promote+embryonic+and+adult+hippocampus+neurogenesis+and+produce+anxiolytic-+and+antidepressant-like+effects&amp;amp;author=W+Jiang&amp;amp;author=Y+Zhang&amp;amp;author=L+Xiao&amp;amp;author=J+Van+Cleemput&amp;amp;author=SP+Ji&amp;amp;volume=115&amp;amp;publication_year=2005&amp;amp;pages=3104-3116&amp;amp;pmid=16224541&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17442</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17443</code><code>]&lt;/span&gt;</code></p><p><code>17444</code><code>&lt;/span&gt;</code></p><p><code>17445</code><code>&lt;/li&gt;</code></p><p><code>17446</code><code>&lt;li id="R561"&gt;</code></p><p><code>17447</code><code>&lt;span class="citation"&gt;</code></p><p><code>17448</code><code>Jimenez W. Endocannabinoids and liver disease. &lt;span&gt;</code></p><p><code>17449</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17450</code><code>Hepatology. &lt;/span&gt;</code></p><p><code>17451</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>17452</code><code>41&lt;/span&gt;</code></p><p><code>17453</code><code>:983–985.&lt;/span&gt;</code></p><p><code>17454</code><code> [&lt;a href="/pubmed/15841444" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17455</code><code>PubMed&lt;/a&gt;</code></p><p><code>17456</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17457</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;amp;title=Endocannabinoids+and+liver+disease&amp;amp;author=W+Jimenez&amp;amp;volume=41&amp;amp;publication_year=2005&amp;amp;pages=983-985&amp;amp;pmid=15841444&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17458</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17459</code><code>]&lt;/span&gt;</code></p><p><code>17460</code><code>&lt;/span&gt;</code></p><p><code>17461</code><code>&lt;/li&gt;</code></p><p><code>17462</code><code>&lt;li id="R562"&gt;</code></p><p><code>17463</code><code>&lt;span class="citation"&gt;</code></p><p><code>17464</code><code>Jin KL, Mao XO, Goldsmith PC, Greenberg DA. CB1 cannabinoid receptor induction in experimental stroke. &lt;span&gt;</code></p><p><code>17465</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17466</code><code>Ann Neurol. &lt;/span&gt;</code></p><p><code>17467</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>17468</code><code>48&lt;/span&gt;</code></p><p><code>17469</code><code>:257–261.&lt;/span&gt;</code></p><p><code>17470</code><code> [&lt;a href="/pubmed/10939579" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17471</code><code>PubMed&lt;/a&gt;</code></p><p><code>17472</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17473</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Ann+Neurol&amp;amp;title=CB1+cannabinoid+receptor+induction+in+experimental+stroke&amp;amp;author=KL+Jin&amp;amp;author=XO+Mao&amp;amp;author=PC+Goldsmith&amp;amp;author=DA+Greenberg&amp;amp;volume=48&amp;amp;publication_year=2000&amp;amp;pages=257-261&amp;amp;pmid=10939579&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17474</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17475</code><code>]&lt;/span&gt;</code></p><p><code>17476</code><code>&lt;/span&gt;</code></p><p><code>17477</code><code>&lt;/li&gt;</code></p><p><code>17478</code><code>&lt;li id="R563"&gt;</code></p><p><code>17479</code><code>&lt;span class="citation"&gt;</code></p><p><code>17480</code><code>Jin W, Brown S, Roche JP, Hsieh C, Celver JP, Kovoor A, Chavkin C, Mackie K. Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. &lt;span&gt;</code></p><p><code>17481</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17482</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>17483</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>17484</code><code>19&lt;/span&gt;</code></p><p><code>17485</code><code>:3773–3780.&lt;/span&gt;</code></p><p><code>17486</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>17487</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6782730/"&gt;</code></p><p><code>17488</code><code>PMC free article&lt;/a&gt;</code></p><p><code>17489</code><code>]&lt;/span&gt;</code></p><p><code>17490</code><code> [&lt;a href="/pubmed/10234009" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17491</code><code>PubMed&lt;/a&gt;</code></p><p><code>17492</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17493</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Distinct+domains+of+the+CB1+cannabinoid+receptor+mediate+desensitization+and+internalization&amp;amp;author=W+Jin&amp;amp;author=S+Brown&amp;amp;author=JP+Roche&amp;amp;author=C+Hsieh&amp;amp;author=JP+Celver&amp;amp;volume=19&amp;amp;publication_year=1999&amp;amp;pages=3773-3780&amp;amp;pmid=10234009&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17494</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17495</code><code>]&lt;/span&gt;</code></p><p><code>17496</code><code>&lt;/span&gt;</code></p><p><code>17497</code><code>&lt;/li&gt;</code></p><p><code>17498</code><code>&lt;li id="R564"&gt;</code></p><p><code>17499</code><code>&lt;span class="citation"&gt;</code></p><p><code>17500</code><code>Jo Y-H, Chen Y-JJ, Chua SC, Jr, Talmage DA, Role LW. Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. &lt;span&gt;</code></p><p><code>17501</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17502</code><code>Neuron. &lt;/span&gt;</code></p><p><code>17503</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>17504</code><code>48&lt;/span&gt;</code></p><p><code>17505</code><code>:1055–1066.&lt;/span&gt;</code></p><p><code>17506</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>17507</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2280039/"&gt;</code></p><p><code>17508</code><code>PMC free article&lt;/a&gt;</code></p><p><code>17509</code><code>]&lt;/span&gt;</code></p><p><code>17510</code><code> [&lt;a href="/pubmed/16364907" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17511</code><code>PubMed&lt;/a&gt;</code></p><p><code>17512</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17513</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;amp;title=Integration+of+endocannabinoid+and+leptin+signaling+in+an+appetite-related+neural+circuit&amp;amp;author=Y-H+Jo&amp;amp;author=Y-JJ+Chen&amp;amp;author=SC+Chua&amp;amp;author=DA+Talmage&amp;amp;author=LW+Role&amp;amp;volume=48&amp;amp;publication_year=2005&amp;amp;pages=1055-1066&amp;amp;pmid=16364907&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17514</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17515</code><code>]&lt;/span&gt;</code></p><p><code>17516</code><code>&lt;/span&gt;</code></p><p><code>17517</code><code>&lt;/li&gt;</code></p><p><code>17518</code><code>&lt;li id="R565"&gt;</code></p><p><code>17519</code><code>&lt;span class="citation"&gt;</code></p><p><code>17520</code><code>Johanek LM, Heitmiller DR, Turner M, Nader N, Hodges J, Simone DA. Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms. &lt;span&gt;</code></p><p><code>17521</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17522</code><code>Pain. &lt;/span&gt;</code></p><p><code>17523</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>17524</code><code>93&lt;/span&gt;</code></p><p><code>17525</code><code>:303–315.&lt;/span&gt;</code></p><p><code>17526</code><code> [&lt;a href="/pubmed/11514089" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17527</code><code>PubMed&lt;/a&gt;</code></p><p><code>17528</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17529</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;amp;title=Cannabinoids+attenuate+capsaicin-evoked+hyperalgesia+through+spinal+and+peripheral+mechanisms&amp;amp;author=LM+Johanek&amp;amp;author=DR+Heitmiller&amp;amp;author=M+Turner&amp;amp;author=N+Nader&amp;amp;author=J+Hodges&amp;amp;volume=93&amp;amp;publication_year=2001&amp;amp;pages=303-315&amp;amp;pmid=11514089&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17530</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17531</code><code>]&lt;/span&gt;</code></p><p><code>17532</code><code>&lt;/span&gt;</code></p><p><code>17533</code><code>&lt;/li&gt;</code></p><p><code>17534</code><code>&lt;li id="R566"&gt;</code></p><p><code>17535</code><code>&lt;span class="citation"&gt;</code></p><p><code>17536</code><code>Johanek LM, Simone DA. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury. &lt;span&gt;</code></p><p><code>17537</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17538</code><code>Pain. &lt;/span&gt;</code></p><p><code>17539</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>17540</code><code>109&lt;/span&gt;</code></p><p><code>17541</code><code>:432–442.&lt;/span&gt;</code></p><p><code>17542</code><code> [&lt;a href="/pubmed/15157704" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17543</code><code>PubMed&lt;/a&gt;</code></p><p><code>17544</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17545</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;amp;title=Activation+of+peripheral+cannabinoid+receptors+attenuates+cutaneous+hyperalgesia+produced+by+a+heat+injury&amp;amp;author=LM+Johanek&amp;amp;author=DA+Simone&amp;amp;volume=109&amp;amp;publication_year=2004&amp;amp;pages=432-442&amp;amp;pmid=15157704&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17546</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17547</code><code>]&lt;/span&gt;</code></p><p><code>17548</code><code>&lt;/span&gt;</code></p><p><code>17549</code><code>&lt;/li&gt;</code></p><p><code>17550</code><code>&lt;li id="R567"&gt;</code></p><p><code>17551</code><code>&lt;span class="citation"&gt;</code></p><p><code>17552</code><code>Johns A. Psychiatric effects of cannabis. &lt;span&gt;</code></p><p><code>17553</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17554</code><code>Br J Psychiatry. &lt;/span&gt;</code></p><p><code>17555</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>17556</code><code>178&lt;/span&gt;</code></p><p><code>17557</code><code>:116–122.&lt;/span&gt;</code></p><p><code>17558</code><code> [&lt;a href="/pubmed/11157424" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17559</code><code>PubMed&lt;/a&gt;</code></p><p><code>17560</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17561</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Psychiatry&amp;amp;title=Psychiatric+effects+of+cannabis&amp;amp;author=A+Johns&amp;amp;volume=178&amp;amp;publication_year=2001&amp;amp;pages=116-122&amp;amp;pmid=11157424&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17562</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17563</code><code>]&lt;/span&gt;</code></p><p><code>17564</code><code>&lt;/span&gt;</code></p><p><code>17565</code><code>&lt;/li&gt;</code></p><p><code>17566</code><code>&lt;li id="R568"&gt;</code></p><p><code>17567</code><code>&lt;span class="citation"&gt;</code></p><p><code>17568</code><code>Johnson SW, North RA. Opioids excite dopamine neurons by hyperpolarization of local interneurons. &lt;span&gt;</code></p><p><code>17569</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17570</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>17571</code><code>1992;&lt;span class="ref-vol"&gt;</code></p><p><code>17572</code><code>12&lt;/span&gt;</code></p><p><code>17573</code><code>:483–488.&lt;/span&gt;</code></p><p><code>17574</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>17575</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6575608/"&gt;</code></p><p><code>17576</code><code>PMC free article&lt;/a&gt;</code></p><p><code>17577</code><code>]&lt;/span&gt;</code></p><p><code>17578</code><code> [&lt;a href="/pubmed/1346804" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17579</code><code>PubMed&lt;/a&gt;</code></p><p><code>17580</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17581</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Opioids+excite+dopamine+neurons+by+hyperpolarization+of+local+interneurons&amp;amp;author=SW+Johnson&amp;amp;author=RA+North&amp;amp;volume=12&amp;amp;publication_year=1992&amp;amp;pages=483-488&amp;amp;pmid=1346804&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17582</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17583</code><code>]&lt;/span&gt;</code></p><p><code>17584</code><code>&lt;/span&gt;</code></p><p><code>17585</code><code>&lt;/li&gt;</code></p><p><code>17586</code><code>&lt;li id="R569"&gt;</code></p><p><code>17587</code><code>&lt;span class="citation"&gt;</code></p><p><code>17588</code><code>Johnson DD, McNeill JR, Crawford RD, Wilcox WC. Epileptiform seizures in domestic fowl. V. The anticonvulsant activity of &amp;#x00394;&lt;sup&gt;</code></p><p><code>17589</code><code>9&lt;/sup&gt;</code></p><p><code>17590</code><code>-tetrahydrocannabinol. &lt;span&gt;</code></p><p><code>17591</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17592</code><code>Can J Physiol Pharmacol. &lt;/span&gt;</code></p><p><code>17593</code><code>1975;&lt;span class="ref-vol"&gt;</code></p><p><code>17594</code><code>53&lt;/span&gt;</code></p><p><code>17595</code><code>:1007–1013.&lt;/span&gt;</code></p><p><code>17596</code><code> [&lt;a href="/pubmed/1222370" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17597</code><code>PubMed&lt;/a&gt;</code></p><p><code>17598</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17599</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Can+J+Physiol+Pharmacol&amp;amp;title=Epileptiform+seizures+in+domestic+fowl.+V.+The+anticonvulsant+activity+of+&amp;#x00394;9-tetrahydrocannabinol&amp;amp;author=DD+Johnson&amp;amp;author=JR+McNeill&amp;amp;author=RD+Crawford&amp;amp;author=WC+Wilcox&amp;amp;volume=53&amp;amp;publication_year=1975&amp;amp;pages=1007-1013&amp;amp;pmid=1222370&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17600</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17601</code><code>]&lt;/span&gt;</code></p><p><code>17602</code><code>&lt;/span&gt;</code></p><p><code>17603</code><code>&lt;/li&gt;</code></p><p><code>17604</code><code>&lt;li id="R570"&gt;</code></p><p><code>17605</code><code>&lt;span class="citation"&gt;</code></p><p><code>17606</code><code>Jones G, Pertwee RG, Gill EW, Paton WD, Nilsson IM, Widman M, Agurell S. Relative pharmacological potency in mice of optical isomers of &amp;#x00394;&lt;sup&gt;</code></p><p><code>17607</code><code>1&lt;/sup&gt;</code></p><p><code>17608</code><code>-tetrahydrocannabinol. &lt;span&gt;</code></p><p><code>17609</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17610</code><code>Biochem Pharmacol. &lt;/span&gt;</code></p><p><code>17611</code><code>1974;&lt;span class="ref-vol"&gt;</code></p><p><code>17612</code><code>23&lt;/span&gt;</code></p><p><code>17613</code><code>:439–446.&lt;/span&gt;</code></p><p><code>17614</code><code> [&lt;a href="/pubmed/4813356" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17615</code><code>PubMed&lt;/a&gt;</code></p><p><code>17616</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17617</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;amp;title=Relative+pharmacological+potency+in+mice+of+optical+isomers+of+&amp;#x00394;1-tetrahydrocannabinol&amp;amp;author=G+Jones&amp;amp;author=RG+Pertwee&amp;amp;author=EW+Gill&amp;amp;author=WD+Paton&amp;amp;author=IM+Nilsson&amp;amp;volume=23&amp;amp;publication_year=1974&amp;amp;pages=439-446&amp;amp;pmid=4813356&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17618</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17619</code><code>]&lt;/span&gt;</code></p><p><code>17620</code><code>&lt;/span&gt;</code></p><p><code>17621</code><code>&lt;/li&gt;</code></p><p><code>17622</code><code>&lt;li id="R571"&gt;</code></p><p><code>17623</code><code>&lt;span class="citation"&gt;</code></p><p><code>17624</code><code>Jones S, Howl J. Cannabinoid receptor systems: therapeutic targets for tumour intervention. &lt;span&gt;</code></p><p><code>17625</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17626</code><code>Expert Opin Ther Targets. &lt;/span&gt;</code></p><p><code>17627</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>17628</code><code>7&lt;/span&gt;</code></p><p><code>17629</code><code>:749–758.&lt;/span&gt;</code></p><p><code>17630</code><code> [&lt;a href="/pubmed/14640910" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17631</code><code>PubMed&lt;/a&gt;</code></p><p><code>17632</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17633</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Expert+Opin+Ther+Targets&amp;amp;title=Cannabinoid+receptor+systems:+therapeutic+targets+for+tumour+intervention&amp;amp;author=S+Jones&amp;amp;author=J+Howl&amp;amp;volume=7&amp;amp;publication_year=2003&amp;amp;pages=749-758&amp;amp;pmid=14640910&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17634</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17635</code><code>]&lt;/span&gt;</code></p><p><code>17636</code><code>&lt;/span&gt;</code></p><p><code>17637</code><code>&lt;/li&gt;</code></p><p><code>17638</code><code>&lt;li id="R572"&gt;</code></p><p><code>17639</code><code>&lt;span class="citation"&gt;</code></p><p><code>17640</code><code>Jonsson KO, Andersson A, Jacobsson SO, Vandevoorde S, Lambert DM, Fowler CJ. AM404 and VDM 11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide. &lt;span&gt;</code></p><p><code>17641</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17642</code><code>Arch Toxicol. &lt;/span&gt;</code></p><p><code>17643</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>17644</code><code>77&lt;/span&gt;</code></p><p><code>17645</code><code>:201–207.&lt;/span&gt;</code></p><p><code>17646</code><code> [&lt;a href="/pubmed/12698235" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17647</code><code>PubMed&lt;/a&gt;</code></p><p><code>17648</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17649</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Arch+Toxicol&amp;amp;title=AM404+and+VDM+11+non-specifically+inhibit+C6+glioma+cell+proliferation+at+concentrations+used+to+block+the+cellular+accumulation+of+the+endocannabinoid+anandamide&amp;amp;author=KO+Jonsson&amp;amp;author=A+Andersson&amp;amp;author=SO+Jacobsson&amp;amp;author=S+Vandevoorde&amp;amp;author=DM+Lambert&amp;amp;volume=77&amp;amp;publication_year=2003&amp;amp;pages=201-207&amp;amp;pmid=12698235&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17650</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17651</code><code>]&lt;/span&gt;</code></p><p><code>17652</code><code>&lt;/span&gt;</code></p><p><code>17653</code><code>&lt;/li&gt;</code></p><p><code>17654</code><code>&lt;li id="R573"&gt;</code></p><p><code>17655</code><code>&lt;span class="citation"&gt;</code></p><p><code>17656</code><code>Jordt SE, Bautista DM, Chuang HH, McKemy DD, Zygmunt PM, Hogestatt ED, Meng ID, Julius D. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. &lt;span&gt;</code></p><p><code>17657</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17658</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>17659</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>17660</code><code>427&lt;/span&gt;</code></p><p><code>17661</code><code>:260–265.&lt;/span&gt;</code></p><p><code>17662</code><code> [&lt;a href="/pubmed/14712238" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17663</code><code>PubMed&lt;/a&gt;</code></p><p><code>17664</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17665</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Mustard+oils+and+cannabinoids+excite+sensory+nerve+fibres+through+the+TRP+channel+ANKTM1&amp;amp;author=SE+Jordt&amp;amp;author=DM+Bautista&amp;amp;author=HH+Chuang&amp;amp;author=DD+McKemy&amp;amp;author=PM+Zygmunt&amp;amp;volume=427&amp;amp;publication_year=2004&amp;amp;pages=260-265&amp;amp;pmid=14712238&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17666</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17667</code><code>]&lt;/span&gt;</code></p><p><code>17668</code><code>&lt;/span&gt;</code></p><p><code>17669</code><code>&lt;/li&gt;</code></p><p><code>17670</code><code>&lt;li id="R574"&gt;</code></p><p><code>17671</code><code>&lt;span class="citation"&gt;</code></p><p><code>17672</code><code>Joseph J, Niggemann B, Zaenker KS, Entschladen F. Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes. &lt;span&gt;</code></p><p><code>17673</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17674</code><code>Cancer Immunol Immunother. &lt;/span&gt;</code></p><p><code>17675</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>17676</code><code>53&lt;/span&gt;</code></p><p><code>17677</code><code>:723–728.&lt;/span&gt;</code></p><p><code>17678</code><code> [&lt;a href="/pubmed/15034673" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17679</code><code>PubMed&lt;/a&gt;</code></p><p><code>17680</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17681</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Immunol+Immunother&amp;amp;title=Anandamide+is+an+endogenous+inhibitor+for+the+migration+of+tumor+cells+and+T+lymphocytes&amp;amp;author=J+Joseph&amp;amp;author=B+Niggemann&amp;amp;author=KS+Zaenker&amp;amp;author=F+Entschladen&amp;amp;volume=53&amp;amp;publication_year=2004&amp;amp;pages=723-728&amp;amp;pmid=15034673&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17682</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17683</code><code>]&lt;/span&gt;</code></p><p><code>17684</code><code>&lt;/span&gt;</code></p><p><code>17685</code><code>&lt;/li&gt;</code></p><p><code>17686</code><code>&lt;li id="R575"&gt;</code></p><p><code>17687</code><code>&lt;span class="citation"&gt;</code></p><p><code>17688</code><code>Joyeux M, Arnaud C, Godin-Ribuot D, Demenge P, Lamontagne D, Ribuot C. Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts. &lt;span&gt;</code></p><p><code>17689</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17690</code><code>Cardiovasc Res. &lt;/span&gt;</code></p><p><code>17691</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>17692</code><code>55&lt;/span&gt;</code></p><p><code>17693</code><code>:619–625.&lt;/span&gt;</code></p><p><code>17694</code><code> [&lt;a href="/pubmed/12160959" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17695</code><code>PubMed&lt;/a&gt;</code></p><p><code>17696</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17697</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cardiovasc+Res&amp;amp;title=Endocannabinoids+are+implicated+in+the+infarct+size-reducing+effect+conferred+by+heat+stress+preconditioning+in+isolated+rat+hearts&amp;amp;author=M+Joyeux&amp;amp;author=C+Arnaud&amp;amp;author=D+Godin-Ribuot&amp;amp;author=P+Demenge&amp;amp;author=D+Lamontagne&amp;amp;volume=55&amp;amp;publication_year=2002&amp;amp;pages=619-625&amp;amp;pmid=12160959&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17698</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17699</code><code>]&lt;/span&gt;</code></p><p><code>17700</code><code>&lt;/span&gt;</code></p><p><code>17701</code><code>&lt;/li&gt;</code></p><p><code>17702</code><code>&lt;li id="R576"&gt;</code></p><p><code>17703</code><code>&lt;span class="citation"&gt;</code></p><p><code>17704</code><code>Juan-Pico P, Fuentes E, Javier Bermudez-Silva F, Javier Diaz-Molina F, Ripoll C, Rodriguez de Fonseca F, Nadal A. Cannabinoid receptors regulate Ca&lt;sup&gt;</code></p><p><code>17705</code><code>2+&lt;/sup&gt;</code></p><p><code>17706</code><code> signals and insulin secretion in pancreatic &lt;em&gt;</code></p><p><code>17707</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>17708</code><code>-cell. &lt;span&gt;</code></p><p><code>17709</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17710</code><code>Cell Calcium. &lt;/span&gt;</code></p><p><code>17711</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>17712</code><code>39&lt;/span&gt;</code></p><p><code>17713</code><code>:155–162.&lt;/span&gt;</code></p><p><code>17714</code><code> [&lt;a href="/pubmed/16321437" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17715</code><code>PubMed&lt;/a&gt;</code></p><p><code>17716</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17717</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cell+Calcium&amp;amp;title=Cannabinoid+receptors+regulate+Ca2++signals+and+insulin+secretion+in+pancreatic+&amp;#x003b2;-cell&amp;amp;author=P+Juan-Pico&amp;amp;author=E+Fuentes&amp;amp;author=F+Javier+Bermudez-Silva&amp;amp;author=F+Javier+Diaz-Molina&amp;amp;author=C+Ripoll&amp;amp;volume=39&amp;amp;publication_year=2005&amp;amp;pages=155-162&amp;amp;pmid=16321437&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17718</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17719</code><code>]&lt;/span&gt;</code></p><p><code>17720</code><code>&lt;/span&gt;</code></p><p><code>17721</code><code>&lt;/li&gt;</code></p><p><code>17722</code><code>&lt;li id="R577"&gt;</code></p><p><code>17723</code><code>&lt;span class="citation"&gt;</code></p><p><code>17724</code><code>Julien B, Grenard P, Teixeira-Clerc F, Van Nhieu JT, Li L, Karsak M, Zimmer A, Mallat A, Lotersztajn S. Antifibrogenic role of the cannabinoid receptor CB2 in the liver. &lt;span&gt;</code></p><p><code>17725</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17726</code><code>Gastroenterology. &lt;/span&gt;</code></p><p><code>17727</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>17728</code><code>128&lt;/span&gt;</code></p><p><code>17729</code><code>:742–755.&lt;/span&gt;</code></p><p><code>17730</code><code> [&lt;a href="/pubmed/15765409" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17731</code><code>PubMed&lt;/a&gt;</code></p><p><code>17732</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17733</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;amp;title=Antifibrogenic+role+of+the+cannabinoid+receptor+CB2+in+the+liver&amp;amp;author=B+Julien&amp;amp;author=P+Grenard&amp;amp;author=F+Teixeira-Clerc&amp;amp;author=JT+Van+Nhieu&amp;amp;author=L+Li&amp;amp;volume=128&amp;amp;publication_year=2005&amp;amp;pages=742-755&amp;amp;pmid=15765409&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17734</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17735</code><code>]&lt;/span&gt;</code></p><p><code>17736</code><code>&lt;/span&gt;</code></p><p><code>17737</code><code>&lt;/li&gt;</code></p><p><code>17738</code><code>&lt;li id="R578"&gt;</code></p><p><code>17739</code><code>&lt;span class="citation"&gt;</code></p><p><code>17740</code><code>Kadoi Y, Hinohara H, Kunimoto F, Kuwano H, Saito S, Goto F. Effects of AM281, a cannabinoid antagonist, on systemic haemodynamics, internal carotid artery blood flow and mortality in septic shock in rats. &lt;span&gt;</code></p><p><code>17741</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17742</code><code>Br J Anaesth. &lt;/span&gt;</code></p><p><code>17743</code><code>2005a;&lt;span class="ref-vol"&gt;</code></p><p><code>17744</code><code>94&lt;/span&gt;</code></p><p><code>17745</code><code>:563–568.&lt;/span&gt;</code></p><p><code>17746</code><code> [&lt;a href="/pubmed/15734782" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17747</code><code>PubMed&lt;/a&gt;</code></p><p><code>17748</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17749</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Anaesth&amp;amp;title=Effects+of+AM281,+a+cannabinoid+antagonist,+on+systemic+haemodynamics,+internal+carotid+artery+blood+flow+and+mortality+in+septic+shock+in+rats&amp;amp;author=Y+Kadoi&amp;amp;author=H+Hinohara&amp;amp;author=F+Kunimoto&amp;amp;author=H+Kuwano&amp;amp;author=S+Saito&amp;amp;volume=94&amp;amp;publication_year=2005a&amp;amp;pages=563-568&amp;amp;pmid=15734782&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17750</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17751</code><code>]&lt;/span&gt;</code></p><p><code>17752</code><code>&lt;/span&gt;</code></p><p><code>17753</code><code>&lt;/li&gt;</code></p><p><code>17754</code><code>&lt;li id="R579"&gt;</code></p><p><code>17755</code><code>&lt;span class="citation"&gt;</code></p><p><code>17756</code><code>Kadoi Y, Hinohara H, Kunimoto F, Saito S, Goto F. Cannabinoid antagonist AM 281 reduces mortality rate and neurologic dysfunction after cecal ligation and puncture in rats. &lt;span&gt;</code></p><p><code>17757</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17758</code><code>Crit Care Med. &lt;/span&gt;</code></p><p><code>17759</code><code>2005b;&lt;span class="ref-vol"&gt;</code></p><p><code>17760</code><code>33&lt;/span&gt;</code></p><p><code>17761</code><code>:2629–2636.&lt;/span&gt;</code></p><p><code>17762</code><code> [&lt;a href="/pubmed/16276190" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17763</code><code>PubMed&lt;/a&gt;</code></p><p><code>17764</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17765</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Crit+Care+Med&amp;amp;title=Cannabinoid+antagonist+AM+281+reduces+mortality+rate+and+neurologic+dysfunction+after+cecal+ligation+and+puncture+in+rats&amp;amp;author=Y+Kadoi&amp;amp;author=H+Hinohara&amp;amp;author=F+Kunimoto&amp;amp;author=S+Saito&amp;amp;author=F+Goto&amp;amp;volume=33&amp;amp;publication_year=2005b&amp;amp;pages=2629-2636&amp;amp;pmid=16276190&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17766</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17767</code><code>]&lt;/span&gt;</code></p><p><code>17768</code><code>&lt;/span&gt;</code></p><p><code>17769</code><code>&lt;/li&gt;</code></p><p><code>17770</code><code>&lt;li id="R580"&gt;</code></p><p><code>17771</code><code>&lt;span class="citation"&gt;</code></p><p><code>17772</code><code>Kamei J, Yoshikawa Y, Saitoh A. Effect of &lt;em&gt;</code></p><p><code>17773</code><code>N&lt;/em&gt;</code></p><p><code>17774</code><code>-arachidonoyl-(2-methyl-4-hydroxyphenyl) amine (VDM11), an anandamide transporter inhibitor, on capsaicin-induced cough in mice. &lt;span&gt;</code></p><p><code>17775</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17776</code><code>Cough. &lt;/span&gt;</code></p><p><code>17777</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>17778</code><code>2&lt;/span&gt;</code></p><p><code>17779</code><code>:2.&lt;/span&gt;</code></p><p><code>17780</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>17781</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1448189/"&gt;</code></p><p><code>17782</code><code>PMC free article&lt;/a&gt;</code></p><p><code>17783</code><code>]&lt;/span&gt;</code></p><p><code>17784</code><code> [&lt;a href="/pubmed/16623933" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17785</code><code>PubMed&lt;/a&gt;</code></p><p><code>17786</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17787</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cough&amp;amp;title=Effect+of+N-arachidonoyl-(2-methyl-4-hydroxyphenyl)+amine+(VDM11),+an+anandamide+transporter+inhibitor,+on+capsaicin-induced+cough+in+mice&amp;amp;author=J+Kamei&amp;amp;author=Y+Yoshikawa&amp;amp;author=A+Saitoh&amp;amp;volume=2&amp;amp;publication_year=2006&amp;amp;pages=2&amp;amp;pmid=16623933&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17788</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17789</code><code>]&lt;/span&gt;</code></p><p><code>17790</code><code>&lt;/span&gt;</code></p><p><code>17791</code><code>&lt;/li&gt;</code></p><p><code>17792</code><code>&lt;li id="R581"&gt;</code></p><p><code>17793</code><code>&lt;span class="citation"&gt;</code></p><p><code>17794</code><code>Kanakis C, Jr, Pouget JM, Rosen KM. The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade. &lt;span&gt;</code></p><p><code>17795</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17796</code><code>Circulation. &lt;/span&gt;</code></p><p><code>17797</code><code>1976;&lt;span class="ref-vol"&gt;</code></p><p><code>17798</code><code>53&lt;/span&gt;</code></p><p><code>17799</code><code>:703–707.&lt;/span&gt;</code></p><p><code>17800</code><code> [&lt;a href="/pubmed/1253395" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17801</code><code>PubMed&lt;/a&gt;</code></p><p><code>17802</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17803</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;amp;title=The+effects+of+delta-9-tetrahydrocannabinol+(cannabis)+on+cardiac+performance+with+and+without+beta+blockade&amp;amp;author=C+Kanakis&amp;amp;author=JM+Pouget&amp;amp;author=KM+Rosen&amp;amp;volume=53&amp;amp;publication_year=1976&amp;amp;pages=703-707&amp;amp;pmid=1253395&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17804</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17805</code><code>]&lt;/span&gt;</code></p><p><code>17806</code><code>&lt;/span&gt;</code></p><p><code>17807</code><code>&lt;/li&gt;</code></p><p><code>17808</code><code>&lt;li id="R582"&gt;</code></p><p><code>17809</code><code>&lt;span class="citation"&gt;</code></p><p><code>17810</code><code>Kaplan BL, Ouyang Y, Herring A, Yea SS, Razdan R, Kaminski NE. Inhibition of leukocyte function and interleukin-2 gene expression by 2-methyl-arachidonyl-(2&amp;#x02032;-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide. &lt;span&gt;</code></p><p><code>17811</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17812</code><code>Toxicol Appl Pharmacol. &lt;/span&gt;</code></p><p><code>17813</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>17814</code><code>205&lt;/span&gt;</code></p><p><code>17815</code><code>:107–115.&lt;/span&gt;</code></p><p><code>17816</code><code> [&lt;a href="/pubmed/15893538" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17817</code><code>PubMed&lt;/a&gt;</code></p><p><code>17818</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17819</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Toxicol+Appl+Pharmacol&amp;amp;title=Inhibition+of+leukocyte+function+and+interleukin-2+gene+expression+by+2-methyl-arachidonyl-(2&amp;#x02032;-fluoroethyl)amide,+a+stable+congener+of+the+endogenous+cannabinoid+receptor+ligand+anandamide&amp;amp;author=BL+Kaplan&amp;amp;author=Y+Ouyang&amp;amp;author=A+Herring&amp;amp;author=SS+Yea&amp;amp;author=R+Razdan&amp;amp;volume=205&amp;amp;publication_year=2005&amp;amp;pages=107-115&amp;amp;pmid=15893538&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17820</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17821</code><code>]&lt;/span&gt;</code></p><p><code>17822</code><code>&lt;/span&gt;</code></p><p><code>17823</code><code>&lt;/li&gt;</code></p><p><code>17824</code><code>&lt;li id="R583"&gt;</code></p><p><code>17825</code><code>&lt;span class="citation"&gt;</code></p><p><code>17826</code><code>Karler R, Calder LD, Sangdee P, Turkanis SA. Interaction between &amp;#x00394;-9-tetrahydrocannabinol and kindling by electrical and chemical stimuli in mice. &lt;span&gt;</code></p><p><code>17827</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17828</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>17829</code><code>1984;&lt;span class="ref-vol"&gt;</code></p><p><code>17830</code><code>23&lt;/span&gt;</code></p><p><code>17831</code><code>:1315–1320.&lt;/span&gt;</code></p><p><code>17832</code><code> [&lt;a href="/pubmed/6098847" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17833</code><code>PubMed&lt;/a&gt;</code></p><p><code>17834</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17835</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=Interaction+between+&amp;#x00394;-9-tetrahydrocannabinol+and+kindling+by+electrical+and+chemical+stimuli+in+mice&amp;amp;author=R+Karler&amp;amp;author=LD+Calder&amp;amp;author=P+Sangdee&amp;amp;author=SA+Turkanis&amp;amp;volume=23&amp;amp;publication_year=1984&amp;amp;pages=1315-1320&amp;amp;pmid=6098847&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17836</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17837</code><code>]&lt;/span&gt;</code></p><p><code>17838</code><code>&lt;/span&gt;</code></p><p><code>17839</code><code>&lt;/li&gt;</code></p><p><code>17840</code><code>&lt;li id="R584"&gt;</code></p><p><code>17841</code><code>&lt;span class="citation"&gt;</code></p><p><code>17842</code><code>Karler R, Calder LD, Turkanis SA. Prolonged CNS hyperexcitability in mice after a single exposure to &amp;#x00394;-9-tetrahydrocannabinol. &lt;span&gt;</code></p><p><code>17843</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17844</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>17845</code><code>1986;&lt;span class="ref-vol"&gt;</code></p><p><code>17846</code><code>25&lt;/span&gt;</code></p><p><code>17847</code><code>:441–446.&lt;/span&gt;</code></p><p><code>17848</code><code> [&lt;a href="/pubmed/3012403" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17849</code><code>PubMed&lt;/a&gt;</code></p><p><code>17850</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17851</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=Prolonged+CNS+hyperexcitability+in+mice+after+a+single+exposure+to+&amp;#x00394;-9-tetrahydrocannabinol&amp;amp;author=R+Karler&amp;amp;author=LD+Calder&amp;amp;author=SA+Turkanis&amp;amp;volume=25&amp;amp;publication_year=1986&amp;amp;pages=441-446&amp;amp;pmid=3012403&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17852</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17853</code><code>]&lt;/span&gt;</code></p><p><code>17854</code><code>&lt;/span&gt;</code></p><p><code>17855</code><code>&lt;/li&gt;</code></p><p><code>17856</code><code>&lt;li id="R585"&gt;</code></p><p><code>17857</code><code>&lt;span class="citation"&gt;</code></p><p><code>17858</code><code>Karler R, Turkanis SA. The cannabinoids as potential antiepileptics. &lt;span&gt;</code></p><p><code>17859</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17860</code><code>J Clin Pharmacol. &lt;/span&gt;</code></p><p><code>17861</code><code>1981;&lt;span class="ref-vol"&gt;</code></p><p><code>17862</code><code>21&lt;/span&gt;</code></p><p><code>17863</code><code>:437S–448S.&lt;/span&gt;</code></p><p><code>17864</code><code> [&lt;a href="/pubmed/6975285" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17865</code><code>PubMed&lt;/a&gt;</code></p><p><code>17866</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17867</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pharmacol&amp;amp;title=The+cannabinoids+as+potential+antiepileptics&amp;amp;author=R+Karler&amp;amp;author=SA+Turkanis&amp;amp;volume=21&amp;amp;publication_year=1981&amp;amp;pages=437S-448S&amp;amp;pmid=6975285&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17868</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17869</code><code>]&lt;/span&gt;</code></p><p><code>17870</code><code>&lt;/span&gt;</code></p><p><code>17871</code><code>&lt;/li&gt;</code></p><p><code>17872</code><code>&lt;li id="R586"&gt;</code></p><p><code>17873</code><code>&lt;span class="citation"&gt;</code></p><p><code>17874</code><code>Karsak M, Cohen-Solal M, Freudenberg J, Ostertag A, Morieux C, Kornak U, Essig J, Erxlebe E, Bab I, Kubisch C, et al.  The cannabinoid receptor type 2 (CNR2) gene is associated with human osteoporosis. &lt;span&gt;</code></p><p><code>17875</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17876</code><code>Hum Mol Genet. &lt;/span&gt;</code></p><p><code>17877</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>17878</code><code>14&lt;/span&gt;</code></p><p><code>17879</code><code>:3389–3396.&lt;/span&gt;</code></p><p><code>17880</code><code> [&lt;a href="/pubmed/16204352" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17881</code><code>PubMed&lt;/a&gt;</code></p><p><code>17882</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17883</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Hum+Mol+Genet&amp;amp;title=The+cannabinoid+receptor+type+2+(CNR2)+gene+is+associated+with+human+osteoporosis&amp;amp;author=M+Karsak&amp;amp;author=M+Cohen-Solal&amp;amp;author=J+Freudenberg&amp;amp;author=A+Ostertag&amp;amp;author=C+Morieux&amp;amp;volume=14&amp;amp;publication_year=2005&amp;amp;pages=3389-3396&amp;amp;pmid=16204352&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17884</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17885</code><code>]&lt;/span&gt;</code></p><p><code>17886</code><code>&lt;/span&gt;</code></p><p><code>17887</code><code>&lt;/li&gt;</code></p><p><code>17888</code><code>&lt;li id="R587"&gt;</code></p><p><code>17889</code><code>&lt;span class="citation"&gt;</code></p><p><code>17890</code><code>Karsak M, Ofek O, Fogel M, Wright K, Tam J, Gabet Y, Birenboim R, Attar-Namdar M, M&amp;#x000fc;ller R, Cohen-Solal M. The cannabinoid CB2 receptor: a potential target for the treatment of osteoporosis. &lt;span&gt;</code></p><p><code>17891</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17892</code><code>J Bone Miner Res. &lt;/span&gt;</code></p><p><code>17893</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>17894</code><code>19&lt;/span&gt;</code></p><p><code>17895</code><code>:S383.&lt;/span&gt;</code></p><p><code>17896</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>17897</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Bone+Miner+Res&amp;amp;title=The+cannabinoid+CB2+receptor:+a+potential+target+for+the+treatment+of+osteoporosis&amp;amp;author=M+Karsak&amp;amp;author=O+Ofek&amp;amp;author=M+Fogel&amp;amp;author=K+Wright&amp;amp;author=J+Tam&amp;amp;volume=19&amp;amp;publication_year=2004&amp;amp;pages=S383&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17898</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17899</code><code>]&lt;/span&gt;</code></p><p><code>17900</code><code>&lt;/span&gt;</code></p><p><code>17901</code><code>&lt;/li&gt;</code></p><p><code>17902</code><code>&lt;li id="R588"&gt;</code></p><p><code>17903</code><code>&lt;span class="citation"&gt;</code></p><p><code>17904</code><code>Karst M, Salim K, Burstein S, Conrad I, Hoy L, Schneider U. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. &lt;span&gt;</code></p><p><code>17905</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17906</code><code>J Am Med Assoc. &lt;/span&gt;</code></p><p><code>17907</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>17908</code><code>290&lt;/span&gt;</code></p><p><code>17909</code><code>:1757–1762.&lt;/span&gt;</code></p><p><code>17910</code><code> [&lt;a href="/pubmed/14519710" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17911</code><code>PubMed&lt;/a&gt;</code></p><p><code>17912</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17913</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Med+Assoc&amp;amp;title=Analgesic+effect+of+the+synthetic+cannabinoid+CT-3+on+chronic+neuropathic+pain:+a+randomized+controlled+trial&amp;amp;author=M+Karst&amp;amp;author=K+Salim&amp;amp;author=S+Burstein&amp;amp;author=I+Conrad&amp;amp;author=L+Hoy&amp;amp;volume=290&amp;amp;publication_year=2003&amp;amp;pages=1757-1762&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17914</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17915</code><code>]&lt;/span&gt;</code></p><p><code>17916</code><code>&lt;/span&gt;</code></p><p><code>17917</code><code>&lt;/li&gt;</code></p><p><code>17918</code><code>&lt;li id="R589"&gt;</code></p><p><code>17919</code><code>&lt;span class="citation"&gt;</code></p><p><code>17920</code><code>Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, et al.  Modulation of anxiety through blockade of anandamide hydrolysis. &lt;span&gt;</code></p><p><code>17921</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17922</code><code>Nat Med. &lt;/span&gt;</code></p><p><code>17923</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>17924</code><code>9&lt;/span&gt;</code></p><p><code>17925</code><code>:76–81.&lt;/span&gt;</code></p><p><code>17926</code><code> [&lt;a href="/pubmed/12461523" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17927</code><code>PubMed&lt;/a&gt;</code></p><p><code>17928</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17929</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;amp;title=Modulation+of+anxiety+through+blockade+of+anandamide+hydrolysis&amp;amp;author=S+Kathuria&amp;amp;author=S+Gaetani&amp;amp;author=D+Fegley&amp;amp;author=F+Valino&amp;amp;author=A+Duranti&amp;amp;volume=9&amp;amp;publication_year=2003&amp;amp;pages=76-81&amp;amp;pmid=12461523&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17930</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17931</code><code>]&lt;/span&gt;</code></p><p><code>17932</code><code>&lt;/span&gt;</code></p><p><code>17933</code><code>&lt;/li&gt;</code></p><p><code>17934</code><code>&lt;li id="R590"&gt;</code></p><p><code>17935</code><code>&lt;span class="citation"&gt;</code></p><p><code>17936</code><code>Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, Freund TF. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. &lt;span&gt;</code></p><p><code>17937</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17938</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>17939</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>17940</code><code>21&lt;/span&gt;</code></p><p><code>17941</code><code>:9506–9518.&lt;/span&gt;</code></p><p><code>17942</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>17943</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6763903/"&gt;</code></p><p><code>17944</code><code>PMC free article&lt;/a&gt;</code></p><p><code>17945</code><code>]&lt;/span&gt;</code></p><p><code>17946</code><code> [&lt;a href="/pubmed/11717385" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17947</code><code>PubMed&lt;/a&gt;</code></p><p><code>17948</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17949</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Distribution+of+CB1+cannabinoid+receptors+in+the+amygdala+and+their+role+in+the+control+of+GABAergic+transmission&amp;amp;author=I+Katona&amp;amp;author=EA+Rancz&amp;amp;author=L+Acsady&amp;amp;author=C+Ledent&amp;amp;author=K+Mackie&amp;amp;volume=21&amp;amp;publication_year=2001&amp;amp;pages=9506-9518&amp;amp;pmid=11717385&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17950</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17951</code><code>]&lt;/span&gt;</code></p><p><code>17952</code><code>&lt;/span&gt;</code></p><p><code>17953</code><code>&lt;/li&gt;</code></p><p><code>17954</code><code>&lt;li id="R591"&gt;</code></p><p><code>17955</code><code>&lt;span class="citation"&gt;</code></p><p><code>17956</code><code>Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K, Freund TF. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. &lt;span&gt;</code></p><p><code>17957</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17958</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>17959</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>17960</code><code>19&lt;/span&gt;</code></p><p><code>17961</code><code>:4544–4558.&lt;/span&gt;</code></p><p><code>17962</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>17963</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6782612/"&gt;</code></p><p><code>17964</code><code>PMC free article&lt;/a&gt;</code></p><p><code>17965</code><code>]&lt;/span&gt;</code></p><p><code>17966</code><code> [&lt;a href="/pubmed/10341254" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17967</code><code>PubMed&lt;/a&gt;</code></p><p><code>17968</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17969</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Presynaptically+located+CB1+cannabinoid+receptors+regulate+GABA+release+from+axon+terminals+of+specific+hippocampal+interneurons&amp;amp;author=I+Katona&amp;amp;author=B+Sperlagh&amp;amp;author=A+Sik&amp;amp;author=A+Kafalvi&amp;amp;author=ES+Vizi&amp;amp;volume=19&amp;amp;publication_year=1999&amp;amp;pages=4544-4558&amp;amp;pmid=10341254&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17970</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17971</code><code>]&lt;/span&gt;</code></p><p><code>17972</code><code>&lt;/span&gt;</code></p><p><code>17973</code><code>&lt;/li&gt;</code></p><p><code>17974</code><code>&lt;li id="R592"&gt;</code></p><p><code>17975</code><code>&lt;span class="citation"&gt;</code></p><p><code>17976</code><code>Kearn CS, Blake-Palmer K, Daniel E, Mackie K, Glass M. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? &lt;span&gt;</code></p><p><code>17977</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17978</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>17979</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>17980</code><code>67&lt;/span&gt;</code></p><p><code>17981</code><code>:1697–1704.&lt;/span&gt;</code></p><p><code>17982</code><code> [&lt;a href="/pubmed/15710746" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17983</code><code>PubMed&lt;/a&gt;</code></p><p><code>17984</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>17985</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=Concurrent+stimulation+of+cannabinoid+CB1+and+dopamine+D2+receptors+enhances+heterodimer+formation:+a+mechanism+for+receptor+cross-talk?&amp;amp;author=CS+Kearn&amp;amp;author=K+Blake-Palmer&amp;amp;author=E+Daniel&amp;amp;author=K+Mackie&amp;amp;author=M+Glass&amp;amp;volume=67&amp;amp;publication_year=2005&amp;amp;pages=1697-1704&amp;amp;pmid=15710746&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>17986</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>17987</code><code>]&lt;/span&gt;</code></p><p><code>17988</code><code>&lt;/span&gt;</code></p><p><code>17989</code><code>&lt;/li&gt;</code></p><p><code>17990</code><code>&lt;li id="R593"&gt;</code></p><p><code>17991</code><code>&lt;span class="citation"&gt;</code></p><p><code>17992</code><code>Keeler MH, Reifler CB. Grand mal convulsions subsequent to marijuana use: case report. &lt;span&gt;</code></p><p><code>17993</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>17994</code><code>Dis Nerv Syst. &lt;/span&gt;</code></p><p><code>17995</code><code>1967;&lt;span class="ref-vol"&gt;</code></p><p><code>17996</code><code>28&lt;/span&gt;</code></p><p><code>17997</code><code>:474–475.&lt;/span&gt;</code></p><p><code>17998</code><code> [&lt;a href="/pubmed/5006458" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>17999</code><code>PubMed&lt;/a&gt;</code></p><p><code>18000</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18001</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Dis+Nerv+Syst&amp;amp;title=Grand+mal+convulsions+subsequent+to+marijuana+use:+case+report&amp;amp;author=MH+Keeler&amp;amp;author=CB+Reifler&amp;amp;volume=28&amp;amp;publication_year=1967&amp;amp;pages=474-475&amp;amp;pmid=5006458&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18002</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18003</code><code>]&lt;/span&gt;</code></p><p><code>18004</code><code>&lt;/span&gt;</code></p><p><code>18005</code><code>&lt;/li&gt;</code></p><p><code>18006</code><code>&lt;li id="R594"&gt;</code></p><p><code>18007</code><code>&lt;span class="citation"&gt;</code></p><p><code>18008</code><code>Keen RW. Burden of osteoporosis and fractures. &lt;span&gt;</code></p><p><code>18009</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18010</code><code>Curr Osteoporos Rep. &lt;/span&gt;</code></p><p><code>18011</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>18012</code><code>1&lt;/span&gt;</code></p><p><code>18013</code><code>:66–70.&lt;/span&gt;</code></p><p><code>18014</code><code> [&lt;a href="/pubmed/16036067" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18015</code><code>PubMed&lt;/a&gt;</code></p><p><code>18016</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18017</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Osteoporos+Rep&amp;amp;title=Burden+of+osteoporosis+and+fractures&amp;amp;author=RW+Keen&amp;amp;volume=1&amp;amp;publication_year=2003&amp;amp;pages=66-70&amp;amp;pmid=16036067&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18018</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18019</code><code>]&lt;/span&gt;</code></p><p><code>18020</code><code>&lt;/span&gt;</code></p><p><code>18021</code><code>&lt;/li&gt;</code></p><p><code>18022</code><code>&lt;li id="R595"&gt;</code></p><p><code>18023</code><code>&lt;span class="citation"&gt;</code></p><p><code>18024</code><code>Kelly LA, Butcher RW. The effects of &amp;#x00394;&lt;sup&gt;</code></p><p><code>18025</code><code>1&lt;/sup&gt;</code></p><p><code>18026</code><code>-tetrahydrocannabinol on cyclic AMP levels in WI-38 fibroblasts. &lt;span&gt;</code></p><p><code>18027</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18028</code><code>Biochim Biophys Acta. &lt;/span&gt;</code></p><p><code>18029</code><code>1973;&lt;span class="ref-vol"&gt;</code></p><p><code>18030</code><code>320&lt;/span&gt;</code></p><p><code>18031</code><code>:540–544.&lt;/span&gt;</code></p><p><code>18032</code><code> [&lt;a href="/pubmed/4356301" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18033</code><code>PubMed&lt;/a&gt;</code></p><p><code>18034</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18035</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochim+Biophys+Acta&amp;amp;title=The+effects+of+&amp;#x00394;1-tetrahydrocannabinol+on+cyclic+AMP+levels+in+WI-38+fibroblasts&amp;amp;author=LA+Kelly&amp;amp;author=RW+Butcher&amp;amp;volume=320&amp;amp;publication_year=1973&amp;amp;pages=540-544&amp;amp;pmid=4356301&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18036</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18037</code><code>]&lt;/span&gt;</code></p><p><code>18038</code><code>&lt;/span&gt;</code></p><p><code>18039</code><code>&lt;/li&gt;</code></p><p><code>18040</code><code>&lt;li id="R596"&gt;</code></p><p><code>18041</code><code>&lt;span class="citation"&gt;</code></p><p><code>18042</code><code>Kelly S, Jhaveri MD, Sagar DR, Kendall DA, Chapman V. Activation of peripheral cannabinoid CB1 receptors inhibits mechanically evoked responses of spinal neurons in noninflamed rats and rats with hindpaw inflammation. &lt;span&gt;</code></p><p><code>18043</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18044</code><code>Eur J Neurosci. &lt;/span&gt;</code></p><p><code>18045</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>18046</code><code>18&lt;/span&gt;</code></p><p><code>18047</code><code>:2239–2243.&lt;/span&gt;</code></p><p><code>18048</code><code> [&lt;a href="/pubmed/14622184" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18049</code><code>PubMed&lt;/a&gt;</code></p><p><code>18050</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18051</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurosci&amp;amp;title=Activation+of+peripheral+cannabinoid+CB1+receptors+inhibits+mechanically+evoked+responses+of+spinal+neurons+in+noninflamed+rats+and+rats+with+hindpaw+inflammation&amp;amp;author=S+Kelly&amp;amp;author=MD+Jhaveri&amp;amp;author=DR+Sagar&amp;amp;author=DA+Kendall&amp;amp;author=V+Chapman&amp;amp;volume=18&amp;amp;publication_year=2003&amp;amp;pages=2239-2243&amp;amp;pmid=14622184&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18052</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18053</code><code>]&lt;/span&gt;</code></p><p><code>18054</code><code>&lt;/span&gt;</code></p><p><code>18055</code><code>&lt;/li&gt;</code></p><p><code>18056</code><code>&lt;li id="R597"&gt;</code></p><p><code>18057</code><code>&lt;span class="citation"&gt;</code></p><p><code>18058</code><code>Khanolkar AD, Abadji V, Lin S, Hill WA, Taha G, Abouzid K, Meng Z, Fan P, Makriyannis A. Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand. &lt;span&gt;</code></p><p><code>18059</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18060</code><code>J Med Chem. &lt;/span&gt;</code></p><p><code>18061</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>18062</code><code>39&lt;/span&gt;</code></p><p><code>18063</code><code>:4515–4519.&lt;/span&gt;</code></p><p><code>18064</code><code> [&lt;a href="/pubmed/8893848" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18065</code><code>PubMed&lt;/a&gt;</code></p><p><code>18066</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18067</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;amp;title=Head+group+analogs+of+arachidonylethanolamide,+the+endogenous+cannabinoid+ligand&amp;amp;author=AD+Khanolkar&amp;amp;author=V+Abadji&amp;amp;author=S+Lin&amp;amp;author=WA+Hill&amp;amp;author=G+Taha&amp;amp;volume=39&amp;amp;publication_year=1996&amp;amp;pages=4515-4519&amp;amp;pmid=8893848&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18068</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18069</code><code>]&lt;/span&gt;</code></p><p><code>18070</code><code>&lt;/span&gt;</code></p><p><code>18071</code><code>&lt;/li&gt;</code></p><p><code>18072</code><code>&lt;li id="R598"&gt;</code></p><p><code>18073</code><code>&lt;span class="citation"&gt;</code></p><p><code>18074</code><code>Khaspekov LG, Brenz Verca MS, Frumkina LE, Hermann H, Marsicano G, Lutz B. Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity. &lt;span&gt;</code></p><p><code>18075</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18076</code><code>Eur J Neurosci. &lt;/span&gt;</code></p><p><code>18077</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>18078</code><code>19&lt;/span&gt;</code></p><p><code>18079</code><code>:1691–1698.&lt;/span&gt;</code></p><p><code>18080</code><code> [&lt;a href="/pubmed/15078543" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18081</code><code>PubMed&lt;/a&gt;</code></p><p><code>18082</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18083</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurosci&amp;amp;title=Involvement+of+brain-derived+neurotrophic+factor+in+cannabinoid+receptor-dependent+protection+against+excitotoxicity&amp;amp;author=LG+Khaspekov&amp;amp;author=MS+Brenz+Verca&amp;amp;author=LE+Frumkina&amp;amp;author=H+Hermann&amp;amp;author=G+Marsicano&amp;amp;volume=19&amp;amp;publication_year=2004&amp;amp;pages=1691-1698&amp;amp;pmid=15078543&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18084</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18085</code><code>]&lt;/span&gt;</code></p><p><code>18086</code><code>&lt;/span&gt;</code></p><p><code>18087</code><code>&lt;/li&gt;</code></p><p><code>18088</code><code>&lt;li id="R599"&gt;</code></p><p><code>18089</code><code>&lt;span class="citation"&gt;</code></p><p><code>18090</code><code>Killestein J, Hoogervorst EL, Reif M, Blauw B, Smits M, Uitdehaag BM, Nagelkerken L, Polman CH. Immunomodulatory effects of orally administered cannabinoids in multiple sclerosis. &lt;span&gt;</code></p><p><code>18091</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18092</code><code>J Neuroimmunol. &lt;/span&gt;</code></p><p><code>18093</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>18094</code><code>137&lt;/span&gt;</code></p><p><code>18095</code><code>:140–143.&lt;/span&gt;</code></p><p><code>18096</code><code> [&lt;a href="/pubmed/12667658" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18097</code><code>PubMed&lt;/a&gt;</code></p><p><code>18098</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18099</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neuroimmunol&amp;amp;title=Immunomodulatory+effects+of+orally+administered+cannabinoids+in+multiple+sclerosis&amp;amp;author=J+Killestein&amp;amp;author=EL+Hoogervorst&amp;amp;author=M+Reif&amp;amp;author=B+Blauw&amp;amp;author=M+Smits&amp;amp;volume=137&amp;amp;publication_year=2003&amp;amp;pages=140-143&amp;amp;pmid=12667658&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18100</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18101</code><code>]&lt;/span&gt;</code></p><p><code>18102</code><code>&lt;/span&gt;</code></p><p><code>18103</code><code>&lt;/li&gt;</code></p><p><code>18104</code><code>&lt;li id="R600"&gt;</code></p><p><code>18105</code><code>&lt;span class="citation"&gt;</code></p><p><code>18106</code><code>Killestein J, Hoogervorst EL, Reif M, Kalkers NF, Van Loenen AC, Staats PG, Gorter RW, Uitdehaag BM, Polman CH. Safety, tolerability, and efficacy of orally administered cannabinoids in MS. &lt;span&gt;</code></p><p><code>18107</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18108</code><code>Neurology. &lt;/span&gt;</code></p><p><code>18109</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>18110</code><code>58&lt;/span&gt;</code></p><p><code>18111</code><code>:1404–1407.&lt;/span&gt;</code></p><p><code>18112</code><code> [&lt;a href="/pubmed/12011290" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18113</code><code>PubMed&lt;/a&gt;</code></p><p><code>18114</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18115</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;amp;title=Safety,+tolerability,+and+efficacy+of+orally+administered+cannabinoids+in+MS&amp;amp;author=J+Killestein&amp;amp;author=EL+Hoogervorst&amp;amp;author=M+Reif&amp;amp;author=NF+Kalkers&amp;amp;author=AC+Van+Loenen&amp;amp;volume=58&amp;amp;publication_year=2002&amp;amp;pages=1404-1407&amp;amp;pmid=12011290&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18116</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18117</code><code>]&lt;/span&gt;</code></p><p><code>18118</code><code>&lt;/span&gt;</code></p><p><code>18119</code><code>&lt;/li&gt;</code></p><p><code>18120</code><code>&lt;li id="R601"&gt;</code></p><p><code>18121</code><code>&lt;span class="citation"&gt;</code></p><p><code>18122</code><code>Killestein J, Polman CH. Current trials in multiple sclerosis: established evidence and future hopes. &lt;span&gt;</code></p><p><code>18123</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18124</code><code>Curr Opin Neurol. &lt;/span&gt;</code></p><p><code>18125</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>18126</code><code>18&lt;/span&gt;</code></p><p><code>18127</code><code>:253–260.&lt;/span&gt;</code></p><p><code>18128</code><code> [&lt;a href="/pubmed/15891408" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18129</code><code>PubMed&lt;/a&gt;</code></p><p><code>18130</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18131</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Neurol&amp;amp;title=Current+trials+in+multiple+sclerosis:+established+evidence+and+future+hopes&amp;amp;author=J+Killestein&amp;amp;author=CH+Polman&amp;amp;volume=18&amp;amp;publication_year=2005&amp;amp;pages=253-260&amp;amp;pmid=15891408&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18132</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18133</code><code>]&lt;/span&gt;</code></p><p><code>18134</code><code>&lt;/span&gt;</code></p><p><code>18135</code><code>&lt;/li&gt;</code></p><p><code>18136</code><code>&lt;li id="R602"&gt;</code></p><p><code>18137</code><code>&lt;span class="citation"&gt;</code></p><p><code>18138</code><code>Killestein J, Uitdehaag BM, Polman CH. Cannabinoids in multiple sclerosis: do they have a therapeutic role? &lt;span&gt;</code></p><p><code>18139</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18140</code><code>Drugs. &lt;/span&gt;</code></p><p><code>18141</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>18142</code><code>64&lt;/span&gt;</code></p><p><code>18143</code><code>:1–11.&lt;/span&gt;</code></p><p><code>18144</code><code> [&lt;a href="/pubmed/14723555" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18145</code><code>PubMed&lt;/a&gt;</code></p><p><code>18146</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18147</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Drugs&amp;amp;title=Cannabinoids+in+multiple+sclerosis:+do+they+have+a+therapeutic+role?&amp;amp;author=J+Killestein&amp;amp;author=BM+Uitdehaag&amp;amp;author=CH+Polman&amp;amp;volume=64&amp;amp;publication_year=2004&amp;amp;pages=1-11&amp;amp;pmid=14723555&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18148</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18149</code><code>]&lt;/span&gt;</code></p><p><code>18150</code><code>&lt;/span&gt;</code></p><p><code>18151</code><code>&lt;/li&gt;</code></p><p><code>18152</code><code>&lt;li id="R603"&gt;</code></p><p><code>18153</code><code>&lt;span class="citation"&gt;</code></p><p><code>18154</code><code>Kim EK, Miller I, Aja S, Landree LE, Pinn M, McFadden J, Kuhajda FP, Moran TH, Ronnett GV. C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase. &lt;span&gt;</code></p><p><code>18155</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18156</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>18157</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>18158</code><code>279&lt;/span&gt;</code></p><p><code>18159</code><code>:19970–19976.&lt;/span&gt;</code></p><p><code>18160</code><code> [&lt;a href="/pubmed/15028725" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18161</code><code>PubMed&lt;/a&gt;</code></p><p><code>18162</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18163</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=C75,+a+fatty+acid+synthase+inhibitor,+reduces+food+intake+via+hypothalamic+AMP-activated+protein+kinase&amp;amp;author=EK+Kim&amp;amp;author=I+Miller&amp;amp;author=S+Aja&amp;amp;author=LE+Landree&amp;amp;author=M+Pinn&amp;amp;volume=279&amp;amp;publication_year=2004&amp;amp;pages=19970-19976&amp;amp;pmid=15028725&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18164</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18165</code><code>]&lt;/span&gt;</code></p><p><code>18166</code><code>&lt;/span&gt;</code></p><p><code>18167</code><code>&lt;/li&gt;</code></p><p><code>18168</code><code>&lt;li id="R604"&gt;</code></p><p><code>18169</code><code>&lt;span class="citation"&gt;</code></p><p><code>18170</code><code>Kim J, Alger BE. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. &lt;span&gt;</code></p><p><code>18171</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18172</code><code>Nat Neurosci. &lt;/span&gt;</code></p><p><code>18173</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>18174</code><code>7&lt;/span&gt;</code></p><p><code>18175</code><code>:697–698.&lt;/span&gt;</code></p><p><code>18176</code><code> [&lt;a href="/pubmed/15184902" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18177</code><code>PubMed&lt;/a&gt;</code></p><p><code>18178</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18179</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Neurosci&amp;amp;title=Inhibition+of+cyclooxygenase-2+potentiates+retrograde+endocannabinoid+effects+in+hippocampus&amp;amp;author=J+Kim&amp;amp;author=BE+Alger&amp;amp;volume=7&amp;amp;publication_year=2004&amp;amp;pages=697-698&amp;amp;pmid=15184902&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18180</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18181</code><code>]&lt;/span&gt;</code></p><p><code>18182</code><code>&lt;/span&gt;</code></p><p><code>18183</code><code>&lt;/li&gt;</code></p><p><code>18184</code><code>&lt;li id="R605"&gt;</code></p><p><code>18185</code><code>&lt;span class="citation"&gt;</code></p><p><code>18186</code><code>Kim J, Isokawa M, Ledent C, Alger BE. Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. &lt;span&gt;</code></p><p><code>18187</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18188</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>18189</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>18190</code><code>22&lt;/span&gt;</code></p><p><code>18191</code><code>:10182–10191.&lt;/span&gt;</code></p><p><code>18192</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>18193</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6758770/"&gt;</code></p><p><code>18194</code><code>PMC free article&lt;/a&gt;</code></p><p><code>18195</code><code>]&lt;/span&gt;</code></p><p><code>18196</code><code> [&lt;a href="/pubmed/12451119" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18197</code><code>PubMed&lt;/a&gt;</code></p><p><code>18198</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18199</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Activation+of+muscarinic+acetylcholine+receptors+enhances+the+release+of+endogenous+cannabinoids+in+the+hippocampus&amp;amp;author=J+Kim&amp;amp;author=M+Isokawa&amp;amp;author=C+Ledent&amp;amp;author=BE+Alger&amp;amp;volume=22&amp;amp;publication_year=2002&amp;amp;pages=10182-10191&amp;amp;pmid=12451119&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18200</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18201</code><code>]&lt;/span&gt;</code></p><p><code>18202</code><code>&lt;/span&gt;</code></p><p><code>18203</code><code>&lt;/li&gt;</code></p><p><code>18204</code><code>&lt;li id="R606"&gt;</code></p><p><code>18205</code><code>&lt;span class="citation"&gt;</code></p><p><code>18206</code><code>Kim SH, Won SJ, Mao XO, Jin K, Greenberg DA. Involvement of protein kinase A in cannabinoid receptor-mediated protection from oxidative neuronal injury. &lt;span&gt;</code></p><p><code>18207</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18208</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>18209</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>18210</code><code>313&lt;/span&gt;</code></p><p><code>18211</code><code>:88–94.&lt;/span&gt;</code></p><p><code>18212</code><code> [&lt;a href="/pubmed/15626718" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18213</code><code>PubMed&lt;/a&gt;</code></p><p><code>18214</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18215</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Involvement+of+protein+kinase+A+in+cannabinoid+receptor-mediated+protection+from+oxidative+neuronal+injury&amp;amp;author=SH+Kim&amp;amp;author=SJ+Won&amp;amp;author=XO+Mao&amp;amp;author=K+Jin&amp;amp;author=DA+Greenberg&amp;amp;volume=313&amp;amp;publication_year=2005&amp;amp;pages=88-94&amp;amp;pmid=15626718&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18216</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18217</code><code>]&lt;/span&gt;</code></p><p><code>18218</code><code>&lt;/span&gt;</code></p><p><code>18219</code><code>&lt;/li&gt;</code></p><p><code>18220</code><code>&lt;li id="R607"&gt;</code></p><p><code>18221</code><code>&lt;span class="citation"&gt;</code></p><p><code>18222</code><code>Kirkham TC.  Cannabinoids and medicine: eating disorders, nausea and emesis. In: Di Marzo V, editor. &lt;span class="ref-journal"&gt;</code></p><p><code>18223</code><code>Cannabinoids.&lt;/span&gt;</code></p><p><code>18224</code><code> Landes Bioscience; Georgetown, TX: 2004. pp. 147–160. &lt;span class="nowrap"&gt;</code></p><p><code>18225</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?title=Cannabinoids&amp;amp;author=TC+Kirkham&amp;amp;publication_year=2004&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18226</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18227</code><code>]&lt;/span&gt;</code></p><p><code>18228</code><code>&lt;/span&gt;</code></p><p><code>18229</code><code>&lt;/li&gt;</code></p><p><code>18230</code><code>&lt;li id="R608"&gt;</code></p><p><code>18231</code><code>&lt;span class="citation"&gt;</code></p><p><code>18232</code><code>Kirkham TC. Endocannabinoids in the regulation of appetite and body weight. &lt;span&gt;</code></p><p><code>18233</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18234</code><code>Behav Pharmacol. &lt;/span&gt;</code></p><p><code>18235</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>18236</code><code>16&lt;/span&gt;</code></p><p><code>18237</code><code>:297–313.&lt;/span&gt;</code></p><p><code>18238</code><code> [&lt;a href="/pubmed/16148436" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18239</code><code>PubMed&lt;/a&gt;</code></p><p><code>18240</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18241</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Behav+Pharmacol&amp;amp;title=Endocannabinoids+in+the+regulation+of+appetite+and+body+weight&amp;amp;author=TC+Kirkham&amp;amp;volume=16&amp;amp;publication_year=2005&amp;amp;pages=297-313&amp;amp;pmid=16148436&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18242</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18243</code><code>]&lt;/span&gt;</code></p><p><code>18244</code><code>&lt;/span&gt;</code></p><p><code>18245</code><code>&lt;/li&gt;</code></p><p><code>18246</code><code>&lt;li id="R609"&gt;</code></p><p><code>18247</code><code>&lt;span class="citation"&gt;</code></p><p><code>18248</code><code>Kirkham TC, Williams CM. Endogenous cannabinoids and appetite. &lt;span&gt;</code></p><p><code>18249</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18250</code><code>Nutr Res Rev. &lt;/span&gt;</code></p><p><code>18251</code><code>2001a;&lt;span class="ref-vol"&gt;</code></p><p><code>18252</code><code>14&lt;/span&gt;</code></p><p><code>18253</code><code>:65–86.&lt;/span&gt;</code></p><p><code>18254</code><code> [&lt;a href="/pubmed/19087417" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18255</code><code>PubMed&lt;/a&gt;</code></p><p><code>18256</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18257</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nutr+Res+Rev&amp;amp;title=Endogenous+cannabinoids+and+appetite&amp;amp;author=TC+Kirkham&amp;amp;author=CM+Williams&amp;amp;volume=14&amp;amp;publication_year=2001a&amp;amp;pages=65-86&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18258</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18259</code><code>]&lt;/span&gt;</code></p><p><code>18260</code><code>&lt;/span&gt;</code></p><p><code>18261</code><code>&lt;/li&gt;</code></p><p><code>18262</code><code>&lt;li id="R610"&gt;</code></p><p><code>18263</code><code>&lt;span class="citation"&gt;</code></p><p><code>18264</code><code>Kirkham TC, Williams CM. Synergistic effects of opioid and cannabinoid antagonists on food intake. &lt;span&gt;</code></p><p><code>18265</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18266</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>18267</code><code>2001b;&lt;span class="ref-vol"&gt;</code></p><p><code>18268</code><code>159&lt;/span&gt;</code></p><p><code>18269</code><code>:267–270.&lt;/span&gt;</code></p><p><code>18270</code><code> [&lt;a href="/pubmed/11205430" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18271</code><code>PubMed&lt;/a&gt;</code></p><p><code>18272</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18273</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Synergistic+effects+of+opioid+and+cannabinoid+antagonists+on+food+intake&amp;amp;author=TC+Kirkham&amp;amp;author=CM+Williams&amp;amp;volume=159&amp;amp;publication_year=2001b&amp;amp;pages=267-270&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18274</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18275</code><code>]&lt;/span&gt;</code></p><p><code>18276</code><code>&lt;/span&gt;</code></p><p><code>18277</code><code>&lt;/li&gt;</code></p><p><code>18278</code><code>&lt;li id="R611"&gt;</code></p><p><code>18279</code><code>&lt;span class="citation"&gt;</code></p><p><code>18280</code><code>Kirkham TC, Williams CM, Fezza M, Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. &lt;span&gt;</code></p><p><code>18281</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18282</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>18283</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>18284</code><code>136&lt;/span&gt;</code></p><p><code>18285</code><code>:550–557.&lt;/span&gt;</code></p><p><code>18286</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>18287</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1573386/"&gt;</code></p><p><code>18288</code><code>PMC free article&lt;/a&gt;</code></p><p><code>18289</code><code>]&lt;/span&gt;</code></p><p><code>18290</code><code> [&lt;a href="/pubmed/12055133" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18291</code><code>PubMed&lt;/a&gt;</code></p><p><code>18292</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18293</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Endocannabinoid+levels+in+rat+limbic+forebrain+and+hypothalamus+in+relation+to+fasting,+feeding+and+satiation:+stimulation+of+eating+by+2-arachidonoyl+glycerol&amp;amp;author=TC+Kirkham&amp;amp;author=CM+Williams&amp;amp;author=M+Fezza&amp;amp;author=V+Di+Marzo&amp;amp;volume=136&amp;amp;publication_year=2002&amp;amp;pages=550-557&amp;amp;pmid=12055133&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18294</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18295</code><code>]&lt;/span&gt;</code></p><p><code>18296</code><code>&lt;/span&gt;</code></p><p><code>18297</code><code>&lt;/li&gt;</code></p><p><code>18298</code><code>&lt;li id="R612"&gt;</code></p><p><code>18299</code><code>&lt;span class="citation"&gt;</code></p><p><code>18300</code><code>Klein TW. Cannabinoid-based drugs as anti-inflammatory therapeutics. &lt;span&gt;</code></p><p><code>18301</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18302</code><code>Nat Rev Immunol. &lt;/span&gt;</code></p><p><code>18303</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>18304</code><code>5&lt;/span&gt;</code></p><p><code>18305</code><code>:400–411.&lt;/span&gt;</code></p><p><code>18306</code><code> [&lt;a href="/pubmed/15864274" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18307</code><code>PubMed&lt;/a&gt;</code></p><p><code>18308</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18309</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Immunol&amp;amp;title=Cannabinoid-based+drugs+as+anti-inflammatory+therapeutics&amp;amp;author=TW+Klein&amp;amp;volume=5&amp;amp;publication_year=2005&amp;amp;pages=400-411&amp;amp;pmid=15864274&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18310</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18311</code><code>]&lt;/span&gt;</code></p><p><code>18312</code><code>&lt;/span&gt;</code></p><p><code>18313</code><code>&lt;/li&gt;</code></p><p><code>18314</code><code>&lt;li id="R613"&gt;</code></p><p><code>18315</code><code>&lt;span class="citation"&gt;</code></p><p><code>18316</code><code>Klein TW, Friedman H, Specter SC. Marijuana, immunity and infection. &lt;span&gt;</code></p><p><code>18317</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18318</code><code>J Neuroimmunol. &lt;/span&gt;</code></p><p><code>18319</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>18320</code><code>83&lt;/span&gt;</code></p><p><code>18321</code><code>:102–115.&lt;/span&gt;</code></p><p><code>18322</code><code> [&lt;a href="/pubmed/9610678" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18323</code><code>PubMed&lt;/a&gt;</code></p><p><code>18324</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18325</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neuroimmunol&amp;amp;title=Marijuana,+immunity+and+infection&amp;amp;author=TW+Klein&amp;amp;author=H+Friedman&amp;amp;author=SC+Specter&amp;amp;volume=83&amp;amp;publication_year=1998&amp;amp;pages=102-115&amp;amp;pmid=9610678&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18326</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18327</code><code>]&lt;/span&gt;</code></p><p><code>18328</code><code>&lt;/span&gt;</code></p><p><code>18329</code><code>&lt;/li&gt;</code></p><p><code>18330</code><code>&lt;li id="R614"&gt;</code></p><p><code>18331</code><code>&lt;span class="citation"&gt;</code></p><p><code>18332</code><code>Klein TW, Lane B, Newton CA, Friedman H. The cannabinoid system and cytokine network. &lt;span&gt;</code></p><p><code>18333</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18334</code><code>Proc Soc Exp Biol Med. &lt;/span&gt;</code></p><p><code>18335</code><code>2000a;&lt;span class="ref-vol"&gt;</code></p><p><code>18336</code><code>225&lt;/span&gt;</code></p><p><code>18337</code><code>:1–8.&lt;/span&gt;</code></p><p><code>18338</code><code> [&lt;a href="/pubmed/10998193" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18339</code><code>PubMed&lt;/a&gt;</code></p><p><code>18340</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18341</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Soc+Exp+Biol+Med&amp;amp;title=The+cannabinoid+system+and+cytokine+network&amp;amp;author=TW+Klein&amp;amp;author=B+Lane&amp;amp;author=CA+Newton&amp;amp;author=H+Friedman&amp;amp;volume=225&amp;amp;publication_year=2000a&amp;amp;pages=1-8&amp;amp;pmid=10998193&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18342</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18343</code><code>]&lt;/span&gt;</code></p><p><code>18344</code><code>&lt;/span&gt;</code></p><p><code>18345</code><code>&lt;/li&gt;</code></p><p><code>18346</code><code>&lt;li id="R615"&gt;</code></p><p><code>18347</code><code>&lt;span class="citation"&gt;</code></p><p><code>18348</code><code>Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, Friedman H. The cannabinoid system and immune modulation. &lt;span&gt;</code></p><p><code>18349</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18350</code><code>J Leukoc Biol. &lt;/span&gt;</code></p><p><code>18351</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>18352</code><code>74&lt;/span&gt;</code></p><p><code>18353</code><code>:486–496.&lt;/span&gt;</code></p><p><code>18354</code><code> [&lt;a href="/pubmed/12960289" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18355</code><code>PubMed&lt;/a&gt;</code></p><p><code>18356</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18357</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Leukoc+Biol&amp;amp;title=The+cannabinoid+system+and+immune+modulation&amp;amp;author=TW+Klein&amp;amp;author=C+Newton&amp;amp;author=K+Larsen&amp;amp;author=L+Lu&amp;amp;author=I+Perkins&amp;amp;volume=74&amp;amp;publication_year=2003&amp;amp;pages=486-496&amp;amp;pmid=12960289&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18358</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18359</code><code>]&lt;/span&gt;</code></p><p><code>18360</code><code>&lt;/span&gt;</code></p><p><code>18361</code><code>&lt;/li&gt;</code></p><p><code>18362</code><code>&lt;li id="R616"&gt;</code></p><p><code>18363</code><code>&lt;span class="citation"&gt;</code></p><p><code>18364</code><code>Klein TW, Newton CA, Nakachi N, Friedman H. &amp;#x00394;&lt;sup&gt;</code></p><p><code>18365</code><code>9&lt;/sup&gt;</code></p><p><code>18366</code><code>-Tetrahydrocannab-inol treatment suppresses immunity and early IFN-&lt;em&gt;</code></p><p><code>18367</code><code>&amp;#x003b3;&lt;/em&gt;</code></p><p><code>18368</code><code>, IL-12, and IL-12 receptor &lt;em&gt;</code></p><p><code>18369</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>18370</code><code> 2 responses to Legionella pneumophila infection. &lt;span&gt;</code></p><p><code>18371</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18372</code><code>J Immunol. &lt;/span&gt;</code></p><p><code>18373</code><code>2000b;&lt;span class="ref-vol"&gt;</code></p><p><code>18374</code><code>164&lt;/span&gt;</code></p><p><code>18375</code><code>:6461–6466.&lt;/span&gt;</code></p><p><code>18376</code><code> [&lt;a href="/pubmed/10843702" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18377</code><code>PubMed&lt;/a&gt;</code></p><p><code>18378</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18379</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;amp;title=&amp;#x00394;9-Tetrahydrocannab-inol+treatment+suppresses+immunity+and+early+IFN-&amp;#x003b3;,+IL-12,+and+IL-12+receptor+&amp;#x003b2;+2+responses+to+Legionella+pneumophila+infection&amp;amp;author=TW+Klein&amp;amp;author=CA+Newton&amp;amp;author=N+Nakachi&amp;amp;author=H+Friedman&amp;amp;volume=164&amp;amp;publication_year=2000b&amp;amp;pages=6461-6466&amp;amp;pmid=10843702&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18380</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18381</code><code>]&lt;/span&gt;</code></p><p><code>18382</code><code>&lt;/span&gt;</code></p><p><code>18383</code><code>&lt;/li&gt;</code></p><p><code>18384</code><code>&lt;li id="R617"&gt;</code></p><p><code>18385</code><code>&lt;span class="citation"&gt;</code></p><p><code>18386</code><code>Klijn CJ, Hankey GJ. American Stroke Association and European Stroke Initiative: management of acute ischaemic stroke: new guidelines from the American Stroke Association and European Stroke Initiative. &lt;span&gt;</code></p><p><code>18387</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18388</code><code>Lancet Neurol. &lt;/span&gt;</code></p><p><code>18389</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>18390</code><code>2&lt;/span&gt;</code></p><p><code>18391</code><code>:698–701.&lt;/span&gt;</code></p><p><code>18392</code><code> [&lt;a href="/pubmed/14572738" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18393</code><code>PubMed&lt;/a&gt;</code></p><p><code>18394</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18395</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Neurol&amp;amp;title=American+Stroke+Association+and+European+Stroke+Initiative:+management+of+acute+ischaemic+stroke:+new+guidelines+from+the+American+Stroke+Association+and+European+Stroke+Initiative&amp;amp;author=CJ+Klijn&amp;amp;author=GJ+Hankey&amp;amp;volume=2&amp;amp;publication_year=2003&amp;amp;pages=698-701&amp;amp;pmid=14572738&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18396</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18397</code><code>]&lt;/span&gt;</code></p><p><code>18398</code><code>&lt;/span&gt;</code></p><p><code>18399</code><code>&lt;/li&gt;</code></p><p><code>18400</code><code>&lt;li id="R618"&gt;</code></p><p><code>18401</code><code>&lt;span class="citation"&gt;</code></p><p><code>18402</code><code>Knoller N, Levi L, Shoshan I, Reichenthal E, Razon N, Rappaport ZH, Biegon A. Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial. &lt;span&gt;</code></p><p><code>18403</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18404</code><code>Crit Care Med. &lt;/span&gt;</code></p><p><code>18405</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>18406</code><code>30&lt;/span&gt;</code></p><p><code>18407</code><code>:548–554.&lt;/span&gt;</code></p><p><code>18408</code><code> [&lt;a href="/pubmed/11990913" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18409</code><code>PubMed&lt;/a&gt;</code></p><p><code>18410</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18411</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Crit+Care+Med&amp;amp;title=Dexanabinol+(HU-211)+in+the+treatment+of+severe+closed+head+injury:+a+randomized,+placebo-controlled,+phase+II+clinical+trial&amp;amp;author=N+Knoller&amp;amp;author=L+Levi&amp;amp;author=I+Shoshan&amp;amp;author=E+Reichenthal&amp;amp;author=N+Razon&amp;amp;volume=30&amp;amp;publication_year=2002&amp;amp;pages=548-554&amp;amp;pmid=11990913&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18412</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18413</code><code>]&lt;/span&gt;</code></p><p><code>18414</code><code>&lt;/span&gt;</code></p><p><code>18415</code><code>&lt;/li&gt;</code></p><p><code>18416</code><code>&lt;li id="R619"&gt;</code></p><p><code>18417</code><code>&lt;span class="citation"&gt;</code></p><p><code>18418</code><code>Kogan NM, Rabinowitz R, Levi P, Gibson D, Sandor P, Schlesinger M, Mechoulam R. Synthesis and antitumor activity of quinonoid derivatives of cannabinoids. &lt;span&gt;</code></p><p><code>18419</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18420</code><code>J Med Chem. &lt;/span&gt;</code></p><p><code>18421</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>18422</code><code>47&lt;/span&gt;</code></p><p><code>18423</code><code>:3800–3806.&lt;/span&gt;</code></p><p><code>18424</code><code> [&lt;a href="/pubmed/15239658" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18425</code><code>PubMed&lt;/a&gt;</code></p><p><code>18426</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18427</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;amp;title=Synthesis+and+antitumor+activity+of+quinonoid+derivatives+of+cannabinoids&amp;amp;author=NM+Kogan&amp;amp;author=R+Rabinowitz&amp;amp;author=P+Levi&amp;amp;author=D+Gibson&amp;amp;author=P+Sandor&amp;amp;volume=47&amp;amp;publication_year=2004&amp;amp;pages=3800-3806&amp;amp;pmid=15239658&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18428</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18429</code><code>]&lt;/span&gt;</code></p><p><code>18430</code><code>&lt;/span&gt;</code></p><p><code>18431</code><code>&lt;/li&gt;</code></p><p><code>18432</code><code>&lt;li id="R620"&gt;</code></p><p><code>18433</code><code>&lt;span class="citation"&gt;</code></p><p><code>18434</code><code>Kola B, Hubina E, Tucci SA, Kirkham TC, Garcia EA, Mitchell SE, Williams LM, Hawley SA, Hardie DG, Grossman AB, et al.  Cannabinoids and ghrelin have both central and peripheral metabolic effects via AMP-activated protein kinase. &lt;span&gt;</code></p><p><code>18435</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18436</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>18437</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>18438</code><code>280&lt;/span&gt;</code></p><p><code>18439</code><code>:25196–25201.&lt;/span&gt;</code></p><p><code>18440</code><code> [&lt;a href="/pubmed/15899896" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18441</code><code>PubMed&lt;/a&gt;</code></p><p><code>18442</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18443</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=Cannabinoids+and+ghrelin+have+both+central+and+peripheral+metabolic+effects+via+AMP-activated+protein+kinase&amp;amp;author=B+Kola&amp;amp;author=E+Hubina&amp;amp;author=SA+Tucci&amp;amp;author=TC+Kirkham&amp;amp;author=EA+Garcia&amp;amp;volume=280&amp;amp;publication_year=2005&amp;amp;pages=25196-25201&amp;amp;pmid=15899896&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18444</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18445</code><code>]&lt;/span&gt;</code></p><p><code>18446</code><code>&lt;/span&gt;</code></p><p><code>18447</code><code>&lt;/li&gt;</code></p><p><code>18448</code><code>&lt;li id="R621"&gt;</code></p><p><code>18449</code><code>&lt;span class="citation"&gt;</code></p><p><code>18450</code><code>Koob GF. Drugs of abuse: anatomy, pharmacology and function of reward pathways. &lt;span&gt;</code></p><p><code>18451</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18452</code><code>Trends Pharmacol Sci. &lt;/span&gt;</code></p><p><code>18453</code><code>1992;&lt;span class="ref-vol"&gt;</code></p><p><code>18454</code><code>13&lt;/span&gt;</code></p><p><code>18455</code><code>:177–184.&lt;/span&gt;</code></p><p><code>18456</code><code> [&lt;a href="/pubmed/1604710" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18457</code><code>PubMed&lt;/a&gt;</code></p><p><code>18458</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18459</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Trends+Pharmacol+Sci&amp;amp;title=Drugs+of+abuse:+anatomy,+pharmacology+and+function+of+reward+pathways&amp;amp;author=GF+Koob&amp;amp;volume=13&amp;amp;publication_year=1992&amp;amp;pages=177-184&amp;amp;pmid=1604710&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18460</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18461</code><code>]&lt;/span&gt;</code></p><p><code>18462</code><code>&lt;/span&gt;</code></p><p><code>18463</code><code>&lt;/li&gt;</code></p><p><code>18464</code><code>&lt;li id="R622"&gt;</code></p><p><code>18465</code><code>&lt;span class="citation"&gt;</code></p><p><code>18466</code><code>Koob GF. Drug addiction: the yin and yang of hedonic homeostasis. &lt;span&gt;</code></p><p><code>18467</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18468</code><code>Neuron. &lt;/span&gt;</code></p><p><code>18469</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>18470</code><code>16&lt;/span&gt;</code></p><p><code>18471</code><code>:893–896.&lt;/span&gt;</code></p><p><code>18472</code><code> [&lt;a href="/pubmed/8630244" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18473</code><code>PubMed&lt;/a&gt;</code></p><p><code>18474</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18475</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;amp;title=Drug+addiction:+the+yin+and+yang+of+hedonic+homeostasis&amp;amp;author=GF+Koob&amp;amp;volume=16&amp;amp;publication_year=1996&amp;amp;pages=893-896&amp;amp;pmid=8630244&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18476</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18477</code><code>]&lt;/span&gt;</code></p><p><code>18478</code><code>&lt;/span&gt;</code></p><p><code>18479</code><code>&lt;/li&gt;</code></p><p><code>18480</code><code>&lt;li id="R623"&gt;</code></p><p><code>18481</code><code>&lt;span class="citation"&gt;</code></p><p><code>18482</code><code>Koob GF, Thatcher-Britton K. Stimulant and anxiogenic effects of corticotropin releasing factor. &lt;span&gt;</code></p><p><code>18483</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18484</code><code>Prog Clin Biol Res. &lt;/span&gt;</code></p><p><code>18485</code><code>1985;&lt;span class="ref-vol"&gt;</code></p><p><code>18486</code><code>192&lt;/span&gt;</code></p><p><code>18487</code><code>:499–506.&lt;/span&gt;</code></p><p><code>18488</code><code> [&lt;a href="/pubmed/3878524" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18489</code><code>PubMed&lt;/a&gt;</code></p><p><code>18490</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18491</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Prog+Clin+Biol+Res&amp;amp;title=Stimulant+and+anxiogenic+effects+of+corticotropin+releasing+factor&amp;amp;author=GF+Koob&amp;amp;author=K+Thatcher-Britton&amp;amp;volume=192&amp;amp;publication_year=1985&amp;amp;pages=499-506&amp;amp;pmid=3878524&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18492</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18493</code><code>]&lt;/span&gt;</code></p><p><code>18494</code><code>&lt;/span&gt;</code></p><p><code>18495</code><code>&lt;/li&gt;</code></p><p><code>18496</code><code>&lt;li id="R624"&gt;</code></p><p><code>18497</code><code>&lt;span class="citation"&gt;</code></p><p><code>18498</code><code>Korczyn AD. The ocular effects of cannabinoids. &lt;span&gt;</code></p><p><code>18499</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18500</code><code>Gen Pharmacol. &lt;/span&gt;</code></p><p><code>18501</code><code>1980;&lt;span class="ref-vol"&gt;</code></p><p><code>18502</code><code>11&lt;/span&gt;</code></p><p><code>18503</code><code>:419–423.&lt;/span&gt;</code></p><p><code>18504</code><code> [&lt;a href="/pubmed/6998830" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18505</code><code>PubMed&lt;/a&gt;</code></p><p><code>18506</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18507</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gen+Pharmacol&amp;amp;title=The+ocular+effects+of+cannabinoids&amp;amp;author=AD+Korczyn&amp;amp;volume=11&amp;amp;publication_year=1980&amp;amp;pages=419-423&amp;amp;pmid=6998830&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18508</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18509</code><code>]&lt;/span&gt;</code></p><p><code>18510</code><code>&lt;/span&gt;</code></p><p><code>18511</code><code>&lt;/li&gt;</code></p><p><code>18512</code><code>&lt;li id="R625"&gt;</code></p><p><code>18513</code><code>&lt;span class="citation"&gt;</code></p><p><code>18514</code><code>Kosersky DS. Antihypertensive effects of &amp;#x00394;&lt;sup&gt;</code></p><p><code>18515</code><code>9&lt;/sup&gt;</code></p><p><code>18516</code><code>-tetrahydrocannabinol. &lt;span&gt;</code></p><p><code>18517</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18518</code><code>Arch Int Pharmacodyn Ther. &lt;/span&gt;</code></p><p><code>18519</code><code>1978;&lt;span class="ref-vol"&gt;</code></p><p><code>18520</code><code>233&lt;/span&gt;</code></p><p><code>18521</code><code>:76–81.&lt;/span&gt;</code></p><p><code>18522</code><code> [&lt;a href="/pubmed/686909" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18523</code><code>PubMed&lt;/a&gt;</code></p><p><code>18524</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18525</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Arch+Int+Pharmacodyn+Ther&amp;amp;title=Antihypertensive+effects+of+&amp;#x00394;9-tetrahydrocannabinol&amp;amp;author=DS+Kosersky&amp;amp;volume=233&amp;amp;publication_year=1978&amp;amp;pages=76-81&amp;amp;pmid=686909&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18526</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18527</code><code>]&lt;/span&gt;</code></p><p><code>18528</code><code>&lt;/span&gt;</code></p><p><code>18529</code><code>&lt;/li&gt;</code></p><p><code>18530</code><code>&lt;li id="R626"&gt;</code></p><p><code>18531</code><code>&lt;span class="citation"&gt;</code></p><p><code>18532</code><code>Koutek B, Prestwich GD, Howlett AC, Chin SA, Salehani D, Akhavan N, Deutsch DG. Inhibitors of arachidonoyl ethanolamide hydrolysis. &lt;span&gt;</code></p><p><code>18533</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18534</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>18535</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>18536</code><code>269&lt;/span&gt;</code></p><p><code>18537</code><code>:22937–22940.&lt;/span&gt;</code></p><p><code>18538</code><code> [&lt;a href="/pubmed/8083191" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18539</code><code>PubMed&lt;/a&gt;</code></p><p><code>18540</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18541</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=Inhibitors+of+arachidonoyl+ethanolamide+hydrolysis&amp;amp;author=B+Koutek&amp;amp;author=GD+Prestwich&amp;amp;author=AC+Howlett&amp;amp;author=SA+Chin&amp;amp;author=D+Salehani&amp;amp;volume=269&amp;amp;publication_year=1994&amp;amp;pages=22937-22940&amp;amp;pmid=8083191&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18542</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18543</code><code>]&lt;/span&gt;</code></p><p><code>18544</code><code>&lt;/span&gt;</code></p><p><code>18545</code><code>&lt;/li&gt;</code></p><p><code>18546</code><code>&lt;li id="R627"&gt;</code></p><p><code>18547</code><code>&lt;span class="citation"&gt;</code></p><p><code>18548</code><code>Kreutzer AC, Regehr WG. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. &lt;span&gt;</code></p><p><code>18549</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18550</code><code>Neuron. &lt;/span&gt;</code></p><p><code>18551</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>18552</code><code>29&lt;/span&gt;</code></p><p><code>18553</code><code>:717–727.&lt;/span&gt;</code></p><p><code>18554</code><code> [&lt;a href="/pubmed/11301030" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18555</code><code>PubMed&lt;/a&gt;</code></p><p><code>18556</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18557</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;amp;title=Retrograde+inhibition+of+presynaptic+calcium+influx+by+endogenous+cannabinoids+at+excitatory+synapses+onto+Purkinje+cells&amp;amp;author=AC+Kreutzer&amp;amp;author=WG+Regehr&amp;amp;volume=29&amp;amp;publication_year=2001&amp;amp;pages=717-727&amp;amp;pmid=11301030&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18558</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18559</code><code>]&lt;/span&gt;</code></p><p><code>18560</code><code>&lt;/span&gt;</code></p><p><code>18561</code><code>&lt;/li&gt;</code></p><p><code>18562</code><code>&lt;li id="R628"&gt;</code></p><p><code>18563</code><code>&lt;span class="citation"&gt;</code></p><p><code>18564</code><code>Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, et al.  Hypothalamic CART is a new anorectic peptide regulated by leptin. &lt;span&gt;</code></p><p><code>18565</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18566</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>18567</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>18568</code><code>393&lt;/span&gt;</code></p><p><code>18569</code><code>:72–76.&lt;/span&gt;</code></p><p><code>18570</code><code> [&lt;a href="/pubmed/9590691" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18571</code><code>PubMed&lt;/a&gt;</code></p><p><code>18572</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18573</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Hypothalamic+CART+is+a+new+anorectic+peptide+regulated+by+leptin&amp;amp;author=P+Kristensen&amp;amp;author=ME+Judge&amp;amp;author=L+Thim&amp;amp;author=U+Ribel&amp;amp;author=KN+Christjansen&amp;amp;volume=393&amp;amp;publication_year=1998&amp;amp;pages=72-76&amp;amp;pmid=9590691&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18574</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18575</code><code>]&lt;/span&gt;</code></p><p><code>18576</code><code>&lt;/span&gt;</code></p><p><code>18577</code><code>&lt;/li&gt;</code></p><p><code>18578</code><code>&lt;li id="R629"&gt;</code></p><p><code>18579</code><code>&lt;span class="citation"&gt;</code></p><p><code>18580</code><code>Krylatov AV, Bernatskaia NA, Maslov LN, Pertwee RG, Mechoulam R, Stefano GB, Sharaevskii MA, Sal&amp;#x02019;nikova OM. Increase of the heart arrhythmogenic resistance and decrease of the myocardialnecrosis zone during activation of cannabinoid receptors. &lt;span&gt;</code></p><p><code>18581</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18582</code><code>Ross Fiziol Zh Im I M Sechenova. &lt;/span&gt;</code></p><p><code>18583</code><code>2002a;&lt;span class="ref-vol"&gt;</code></p><p><code>18584</code><code>88&lt;/span&gt;</code></p><p><code>18585</code><code>:560–567.&lt;/span&gt;</code></p><p><code>18586</code><code> [&lt;a href="/pubmed/12136723" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18587</code><code>PubMed&lt;/a&gt;</code></p><p><code>18588</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18589</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Ross+Fiziol+Zh+Im+I+M+Sechenova&amp;amp;title=Increase+of+the+heart+arrhythmogenic+resistance+and+decrease+of+the+myocardialnecrosis+zone+during+activation+of+cannabinoid+receptors&amp;amp;author=AV+Krylatov&amp;amp;author=NA+Bernatskaia&amp;amp;author=LN+Maslov&amp;amp;author=RG+Pertwee&amp;amp;author=R+Mechoulam&amp;amp;volume=88&amp;amp;publication_year=2002a&amp;amp;pages=560-567&amp;amp;pmid=12136723&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18590</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18591</code><code>]&lt;/span&gt;</code></p><p><code>18592</code><code>&lt;/span&gt;</code></p><p><code>18593</code><code>&lt;/li&gt;</code></p><p><code>18594</code><code>&lt;li id="R630"&gt;</code></p><p><code>18595</code><code>&lt;span class="citation"&gt;</code></p><p><code>18596</code><code>Krylatov AV, Maslov LN, Lasukova OV, Pertwee RG. Cannabinoid receptor antagonists SR141716 and SR144528 exhibit properties of partial agonists in experiments on isolated perfused rat heart. &lt;span&gt;</code></p><p><code>18597</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18598</code><code>Bull Exp Biol Med. &lt;/span&gt;</code></p><p><code>18599</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>18600</code><code>139&lt;/span&gt;</code></p><p><code>18601</code><code>:558–561.&lt;/span&gt;</code></p><p><code>18602</code><code> [&lt;a href="/pubmed/16224548" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18603</code><code>PubMed&lt;/a&gt;</code></p><p><code>18604</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18605</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Bull+Exp+Biol+Med&amp;amp;title=Cannabinoid+receptor+antagonists+SR141716+and+SR144528+exhibit+properties+of+partial+agonists+in+experiments+on+isolated+perfused+rat+heart&amp;amp;author=AV+Krylatov&amp;amp;author=LN+Maslov&amp;amp;author=OV+Lasukova&amp;amp;author=RG+Pertwee&amp;amp;volume=139&amp;amp;publication_year=2005&amp;amp;pages=558-561&amp;amp;pmid=16224548&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18606</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18607</code><code>]&lt;/span&gt;</code></p><p><code>18608</code><code>&lt;/span&gt;</code></p><p><code>18609</code><code>&lt;/li&gt;</code></p><p><code>18610</code><code>&lt;li id="R631"&gt;</code></p><p><code>18611</code><code>&lt;span class="citation"&gt;</code></p><p><code>18612</code><code>Krylatov AV, Ugdyzhekova DS, Bernatskaya NA, Maslov LN, Mekhoulam R, Pertwee RG, Stephano GB. Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion. &lt;span&gt;</code></p><p><code>18613</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18614</code><code>Bull Exp Biol Med. &lt;/span&gt;</code></p><p><code>18615</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>18616</code><code>131&lt;/span&gt;</code></p><p><code>18617</code><code>:523–525.&lt;/span&gt;</code></p><p><code>18618</code><code> [&lt;a href="/pubmed/11586395" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18619</code><code>PubMed&lt;/a&gt;</code></p><p><code>18620</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18621</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Bull+Exp+Biol+Med&amp;amp;title=Activation+of+type+II+cannabinoid+receptors+improves+myocardial+tolerance+to+arrhythmogenic+effects+of+coronary+occlusion+and+reperfusion&amp;amp;author=AV+Krylatov&amp;amp;author=DS+Ugdyzhekova&amp;amp;author=NA+Bernatskaya&amp;amp;author=LN+Maslov&amp;amp;author=R+Mekhoulam&amp;amp;volume=131&amp;amp;publication_year=2001&amp;amp;pages=523-525&amp;amp;pmid=11586395&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18622</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18623</code><code>]&lt;/span&gt;</code></p><p><code>18624</code><code>&lt;/span&gt;</code></p><p><code>18625</code><code>&lt;/li&gt;</code></p><p><code>18626</code><code>&lt;li id="R632"&gt;</code></p><p><code>18627</code><code>&lt;span class="citation"&gt;</code></p><p><code>18628</code><code>Krylatov AV, Uzhachenko RV, Maslov LN, Bernatskaya NA, Makriyannis A, Mechoulam R, Pertwee RG, Sal&amp;#x02019;nikova OM, Stefano JB, Lishmanov Y. Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism. &lt;span&gt;</code></p><p><code>18629</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18630</code><code>Bull Exp Biol Med. &lt;/span&gt;</code></p><p><code>18631</code><code>2002b;&lt;span class="ref-vol"&gt;</code></p><p><code>18632</code><code>133&lt;/span&gt;</code></p><p><code>18633</code><code>:122–124.&lt;/span&gt;</code></p><p><code>18634</code><code> [&lt;a href="/pubmed/12428277" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18635</code><code>PubMed&lt;/a&gt;</code></p><p><code>18636</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18637</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Bull+Exp+Biol+Med&amp;amp;title=Endogenous+cannabinoids+improve+myocardial+resistance+to+arrhythmogenic+effects+of+coronary+occlusion+and+reperfusion:+a+possible+mechanism&amp;amp;author=AV+Krylatov&amp;amp;author=RV+Uzhachenko&amp;amp;author=LN+Maslov&amp;amp;author=NA+Bernatskaya&amp;amp;author=A+Makriyannis&amp;amp;volume=133&amp;amp;publication_year=2002b&amp;amp;pages=122-124&amp;amp;pmid=12428277&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18638</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18639</code><code>]&lt;/span&gt;</code></p><p><code>18640</code><code>&lt;/span&gt;</code></p><p><code>18641</code><code>&lt;/li&gt;</code></p><p><code>18642</code><code>&lt;li id="R633"&gt;</code></p><p><code>18643</code><code>&lt;span class="citation"&gt;</code></p><p><code>18644</code><code>Krylatov AV, Uzhachenko RV, Maslov LN, Ugdyzhekova DS, Bernatskaia NA, Pertwee R, Stefano GB, Makriyannis A. Anandamide and &lt;em&gt;</code></p><p><code>18645</code><code>R&lt;/em&gt;</code></p><p><code>18646</code><code>-(+)-methanandamide prevent development of ischemic and reperfusion arrhythmia in rats by stimulation of CB2-receptors. &lt;span&gt;</code></p><p><code>18647</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18648</code><code>Eksp Klin Farmakol. &lt;/span&gt;</code></p><p><code>18649</code><code>2002c;&lt;span class="ref-vol"&gt;</code></p><p><code>18650</code><code>65&lt;/span&gt;</code></p><p><code>18651</code><code>:6–9.&lt;/span&gt;</code></p><p><code>18652</code><code> [&lt;a href="/pubmed/12227101" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18653</code><code>PubMed&lt;/a&gt;</code></p><p><code>18654</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18655</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eksp+Klin+Farmakol&amp;amp;title=Anandamide+and+R-(+)-methanandamide+prevent+development+of+ischemic+and+reperfusion+arrhythmia+in+rats+by+stimulation+of+CB2-receptors&amp;amp;author=AV+Krylatov&amp;amp;author=RV+Uzhachenko&amp;amp;author=LN+Maslov&amp;amp;author=DS+Ugdyzhekova&amp;amp;author=NA+Bernatskaia&amp;amp;volume=65&amp;amp;publication_year=2002c&amp;amp;pages=6-9&amp;amp;pmid=12227101&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18656</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18657</code><code>]&lt;/span&gt;</code></p><p><code>18658</code><code>&lt;/span&gt;</code></p><p><code>18659</code><code>&lt;/li&gt;</code></p><p><code>18660</code><code>&lt;li id="R634"&gt;</code></p><p><code>18661</code><code>&lt;span class="citation"&gt;</code></p><p><code>18662</code><code>Kuijten RR, Bunin GR, Nass CC, Meadows AT. Parental occupation and childhood astrocytoma: results of a case-control study. &lt;span&gt;</code></p><p><code>18663</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18664</code><code>Cancer Res. &lt;/span&gt;</code></p><p><code>18665</code><code>1992;&lt;span class="ref-vol"&gt;</code></p><p><code>18666</code><code>52&lt;/span&gt;</code></p><p><code>18667</code><code>:782–786.&lt;/span&gt;</code></p><p><code>18668</code><code> [&lt;a href="/pubmed/1737337" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18669</code><code>PubMed&lt;/a&gt;</code></p><p><code>18670</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18671</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=Parental+occupation+and+childhood+astrocytoma:+results+of+a+case-control+study&amp;amp;author=RR+Kuijten&amp;amp;author=GR+Bunin&amp;amp;author=CC+Nass&amp;amp;author=AT+Meadows&amp;amp;volume=52&amp;amp;publication_year=1992&amp;amp;pages=782-786&amp;amp;pmid=1737337&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18672</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18673</code><code>]&lt;/span&gt;</code></p><p><code>18674</code><code>&lt;/span&gt;</code></p><p><code>18675</code><code>&lt;/li&gt;</code></p><p><code>18676</code><code>&lt;li id="R635"&gt;</code></p><p><code>18677</code><code>&lt;span class="citation"&gt;</code></p><p><code>18678</code><code>Kulkarni-Narla A, Brown DR. Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system. &lt;span&gt;</code></p><p><code>18679</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18680</code><code>Cell Tissue Res. &lt;/span&gt;</code></p><p><code>18681</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>18682</code><code>302&lt;/span&gt;</code></p><p><code>18683</code><code>:73–80.&lt;/span&gt;</code></p><p><code>18684</code><code> [&lt;a href="/pubmed/11079717" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18685</code><code>PubMed&lt;/a&gt;</code></p><p><code>18686</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18687</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cell+Tissue+Res&amp;amp;title=Localization+of+CB1-cannabinoid+receptor+immunoreactivity+in+the+porcine+enteric+nervous+system&amp;amp;author=A+Kulkarni-Narla&amp;amp;author=DR+Brown&amp;amp;volume=302&amp;amp;publication_year=2000&amp;amp;pages=73-80&amp;amp;pmid=11079717&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18688</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18689</code><code>]&lt;/span&gt;</code></p><p><code>18690</code><code>&lt;/span&gt;</code></p><p><code>18691</code><code>&lt;/li&gt;</code></p><p><code>18692</code><code>&lt;li id="R636"&gt;</code></p><p><code>18693</code><code>&lt;span class="citation"&gt;</code></p><p><code>18694</code><code>Kunos G, B&amp;#x000e1;tkai S, Offert&amp;#x000e1;ler L, Mo F, Liu J, Karcher J, Harvey-White J. The quest for a vascular endothelial cannabinoids receptor. &lt;span&gt;</code></p><p><code>18695</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18696</code><code>Chem Phys Lipids. &lt;/span&gt;</code></p><p><code>18697</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>18698</code><code>121&lt;/span&gt;</code></p><p><code>18699</code><code>:45–56.&lt;/span&gt;</code></p><p><code>18700</code><code> [&lt;a href="/pubmed/12505689" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18701</code><code>PubMed&lt;/a&gt;</code></p><p><code>18702</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18703</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Chem+Phys+Lipids&amp;amp;title=The+quest+for+a+vascular+endothelial+cannabinoids+receptor&amp;amp;author=G+Kunos&amp;amp;author=S+B&amp;#x000e1;tkai&amp;amp;author=L+Offert&amp;#x000e1;ler&amp;amp;author=F+Mo&amp;amp;author=J+Liu&amp;amp;volume=121&amp;amp;publication_year=2002&amp;amp;pages=45-56&amp;amp;pmid=12505689&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18704</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18705</code><code>]&lt;/span&gt;</code></p><p><code>18706</code><code>&lt;/span&gt;</code></p><p><code>18707</code><code>&lt;/li&gt;</code></p><p><code>18708</code><code>&lt;li id="R637"&gt;</code></p><p><code>18709</code><code>&lt;span class="citation"&gt;</code></p><p><code>18710</code><code>Kunos G, J&amp;#x000e1;rai Z, B&amp;#x000e1;tkai S, Goparaju SK, Ishac EJ, Liu J, Wang L, Wagner JA. Endocannabinoids as cardiovascular modulators. &lt;span&gt;</code></p><p><code>18711</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18712</code><code>Chem Phys Lipids. &lt;/span&gt;</code></p><p><code>18713</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>18714</code><code>108&lt;/span&gt;</code></p><p><code>18715</code><code>:159–168.&lt;/span&gt;</code></p><p><code>18716</code><code> [&lt;a href="/pubmed/11106789" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18717</code><code>PubMed&lt;/a&gt;</code></p><p><code>18718</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18719</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Chem+Phys+Lipids&amp;amp;title=Endocannabinoids+as+cardiovascular+modulators&amp;amp;author=G+Kunos&amp;amp;author=Z+J&amp;#x000e1;rai&amp;amp;author=S+B&amp;#x000e1;tkai&amp;amp;author=SK+Goparaju&amp;amp;author=EJ+Ishac&amp;amp;volume=108&amp;amp;publication_year=2000&amp;amp;pages=159-168&amp;amp;pmid=11106789&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18720</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18721</code><code>]&lt;/span&gt;</code></p><p><code>18722</code><code>&lt;/span&gt;</code></p><p><code>18723</code><code>&lt;/li&gt;</code></p><p><code>18724</code><code>&lt;li id="R638"&gt;</code></p><p><code>18725</code><code>&lt;span class="citation"&gt;</code></p><p><code>18726</code><code>Kunos G, Pacher P. Cannabinoids cool the intestine. &lt;span&gt;</code></p><p><code>18727</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18728</code><code>Nat Med. &lt;/span&gt;</code></p><p><code>18729</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>18730</code><code>10&lt;/span&gt;</code></p><p><code>18731</code><code>:678–679.&lt;/span&gt;</code></p><p><code>18732</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>18733</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2516444/"&gt;</code></p><p><code>18734</code><code>PMC free article&lt;/a&gt;</code></p><p><code>18735</code><code>]&lt;/span&gt;</code></p><p><code>18736</code><code> [&lt;a href="/pubmed/15229512" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18737</code><code>PubMed&lt;/a&gt;</code></p><p><code>18738</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18739</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;amp;title=Cannabinoids+cool+the+intestine&amp;amp;author=G+Kunos&amp;amp;author=P+Pacher&amp;amp;volume=10&amp;amp;publication_year=2004&amp;amp;pages=678-679&amp;amp;pmid=15229512&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18740</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18741</code><code>]&lt;/span&gt;</code></p><p><code>18742</code><code>&lt;/span&gt;</code></p><p><code>18743</code><code>&lt;/li&gt;</code></p><p><code>18744</code><code>&lt;li id="R639"&gt;</code></p><p><code>18745</code><code>&lt;span class="citation"&gt;</code></p><p><code>18746</code><code>Kurabayashi M, Takeyoshi I, Yoshinari D, Matsumoto K, Maruyama I, Morishita Y. 2-Arachidonoylglycerol increases in ischemia-reperfusion injury of the rat liver. &lt;span&gt;</code></p><p><code>18747</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18748</code><code>J Investig Surg. &lt;/span&gt;</code></p><p><code>18749</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>18750</code><code>18&lt;/span&gt;</code></p><p><code>18751</code><code>:25–31.&lt;/span&gt;</code></p><p><code>18752</code><code> [&lt;a href="/pubmed/15804949" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18753</code><code>PubMed&lt;/a&gt;</code></p><p><code>18754</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18755</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Investig+Surg&amp;amp;title=2-Arachidonoylglycerol+increases+in+ischemia-reperfusion+injury+of+the+rat+liver&amp;amp;author=M+Kurabayashi&amp;amp;author=I+Takeyoshi&amp;amp;author=D+Yoshinari&amp;amp;author=K+Matsumoto&amp;amp;author=I+Maruyama&amp;amp;volume=18&amp;amp;publication_year=2005&amp;amp;pages=25-31&amp;amp;pmid=15804949&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18756</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18757</code><code>]&lt;/span&gt;</code></p><p><code>18758</code><code>&lt;/span&gt;</code></p><p><code>18759</code><code>&lt;/li&gt;</code></p><p><code>18760</code><code>&lt;li id="R640"&gt;</code></p><p><code>18761</code><code>&lt;span class="citation"&gt;</code></p><p><code>18762</code><code>Kwolek G, Zakrzeska A, Schlicker E, Gothert M, Godlewski G, Malinowska B. Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats. &lt;span&gt;</code></p><p><code>18763</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18764</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>18765</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>18766</code><code>145&lt;/span&gt;</code></p><p><code>18767</code><code>:567–575.&lt;/span&gt;</code></p><p><code>18768</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>18769</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1576172/"&gt;</code></p><p><code>18770</code><code>PMC free article&lt;/a&gt;</code></p><p><code>18771</code><code>]&lt;/span&gt;</code></p><p><code>18772</code><code> [&lt;a href="/pubmed/15834445" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18773</code><code>PubMed&lt;/a&gt;</code></p><p><code>18774</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18775</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Central+and+peripheral+components+of+the+pressor+effect+of+anandamide+in+urethane-anaesthetized+rats&amp;amp;author=G+Kwolek&amp;amp;author=A+Zakrzeska&amp;amp;author=E+Schlicker&amp;amp;author=M+Gothert&amp;amp;author=G+Godlewski&amp;amp;volume=145&amp;amp;publication_year=2005&amp;amp;pages=567-575&amp;amp;pmid=15834445&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18776</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18777</code><code>]&lt;/span&gt;</code></p><p><code>18778</code><code>&lt;/span&gt;</code></p><p><code>18779</code><code>&lt;/li&gt;</code></p><p><code>18780</code><code>&lt;li id="R641"&gt;</code></p><p><code>18781</code><code>&lt;span class="citation"&gt;</code></p><p><code>18782</code><code>Lagneux C, Lamontagne D. Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide. &lt;span&gt;</code></p><p><code>18783</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18784</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>18785</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>18786</code><code>132&lt;/span&gt;</code></p><p><code>18787</code><code>:793–796.&lt;/span&gt;</code></p><p><code>18788</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>18789</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1572634/"&gt;</code></p><p><code>18790</code><code>PMC free article&lt;/a&gt;</code></p><p><code>18791</code><code>]&lt;/span&gt;</code></p><p><code>18792</code><code> [&lt;a href="/pubmed/11181418" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18793</code><code>PubMed&lt;/a&gt;</code></p><p><code>18794</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18795</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Involvement+of+cannabinoids+in+the+cardioprotection+induced+by+lipopolysaccharide&amp;amp;author=C+Lagneux&amp;amp;author=D+Lamontagne&amp;amp;volume=132&amp;amp;publication_year=2001&amp;amp;pages=793-796&amp;amp;pmid=11181418&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18796</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18797</code><code>]&lt;/span&gt;</code></p><p><code>18798</code><code>&lt;/span&gt;</code></p><p><code>18799</code><code>&lt;/li&gt;</code></p><p><code>18800</code><code>&lt;li id="R642"&gt;</code></p><p><code>18801</code><code>&lt;span class="citation"&gt;</code></p><p><code>18802</code><code>Laine K, Jarvinen K, Jarvinen T. Topically administered CB&lt;sub&gt;</code></p><p><code>18803</code><code>2&lt;/sub&gt;</code></p><p><code>18804</code><code>-receptor agonist, JWH-133, does not decrease intraocular pressure (IOP) in normotensive rabbits. &lt;span&gt;</code></p><p><code>18805</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18806</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>18807</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>18808</code><code>72&lt;/span&gt;</code></p><p><code>18809</code><code>:837–842.&lt;/span&gt;</code></p><p><code>18810</code><code> [&lt;a href="/pubmed/12479982" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18811</code><code>PubMed&lt;/a&gt;</code></p><p><code>18812</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18813</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Topically+administered+CB2-receptor+agonist,+JWH-133,+does+not+decrease+intraocular+pressure+(IOP)+in+normotensive+rabbits&amp;amp;author=K+Laine&amp;amp;author=K+Jarvinen&amp;amp;author=T+Jarvinen&amp;amp;volume=72&amp;amp;publication_year=2003&amp;amp;pages=837-842&amp;amp;pmid=12479982&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18814</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18815</code><code>]&lt;/span&gt;</code></p><p><code>18816</code><code>&lt;/span&gt;</code></p><p><code>18817</code><code>&lt;/li&gt;</code></p><p><code>18818</code><code>&lt;li id="R643"&gt;</code></p><p><code>18819</code><code>&lt;span class="citation"&gt;</code></p><p><code>18820</code><code>Laine K, Jarvinen K, Mechoulam R, Breuer A, Jarvinen T. Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid. &lt;span&gt;</code></p><p><code>18821</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18822</code><code>Investig Ophthalmol Vis Sci. &lt;/span&gt;</code></p><p><code>18823</code><code>2002a;&lt;span class="ref-vol"&gt;</code></p><p><code>18824</code><code>43&lt;/span&gt;</code></p><p><code>18825</code><code>:3216–3222.&lt;/span&gt;</code></p><p><code>18826</code><code> [&lt;a href="/pubmed/12356827" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18827</code><code>PubMed&lt;/a&gt;</code></p><p><code>18828</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18829</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Investig+Ophthalmol+Vis+Sci&amp;amp;title=Comparison+of+the+enzymatic+stability+and+intraocular+pressure+effects+of+2-arachidonylglycerol+and+noladin+ether,+a+novel+putative+endocannabinoid&amp;amp;author=K+Laine&amp;amp;author=K+Jarvinen&amp;amp;author=R+Mechoulam&amp;amp;author=A+Breuer&amp;amp;author=T+Jarvinen&amp;amp;volume=43&amp;amp;publication_year=2002a&amp;amp;pages=3216-3222&amp;amp;pmid=12356827&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18830</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18831</code><code>]&lt;/span&gt;</code></p><p><code>18832</code><code>&lt;/span&gt;</code></p><p><code>18833</code><code>&lt;/li&gt;</code></p><p><code>18834</code><code>&lt;li id="R644"&gt;</code></p><p><code>18835</code><code>&lt;span class="citation"&gt;</code></p><p><code>18836</code><code>Laine K, Jarvinen K, Pate DW, Urtti A, Jarvinen T. Effect of the enzyme inhibitor, phenylmethylsulfonyl fluoride, on the IOP profiles of topical anandamides. &lt;span&gt;</code></p><p><code>18837</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18838</code><code>Investig Ophthalmol Vis Sci. &lt;/span&gt;</code></p><p><code>18839</code><code>2002b;&lt;span class="ref-vol"&gt;</code></p><p><code>18840</code><code>43&lt;/span&gt;</code></p><p><code>18841</code><code>:393–397.&lt;/span&gt;</code></p><p><code>18842</code><code> [&lt;a href="/pubmed/11818382" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18843</code><code>PubMed&lt;/a&gt;</code></p><p><code>18844</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18845</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Investig+Ophthalmol+Vis+Sci&amp;amp;title=Effect+of+the+enzyme+inhibitor,+phenylmethylsulfonyl+fluoride,+on+the+IOP+profiles+of+topical+anandamides&amp;amp;author=K+Laine&amp;amp;author=K+Jarvinen&amp;amp;author=DW+Pate&amp;amp;author=A+Urtti&amp;amp;author=T+Jarvinen&amp;amp;volume=43&amp;amp;publication_year=2002b&amp;amp;pages=393-397&amp;amp;pmid=11818382&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18846</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18847</code><code>]&lt;/span&gt;</code></p><p><code>18848</code><code>&lt;/span&gt;</code></p><p><code>18849</code><code>&lt;/li&gt;</code></p><p><code>18850</code><code>&lt;li id="R645"&gt;</code></p><p><code>18851</code><code>&lt;span class="citation"&gt;</code></p><p><code>18852</code><code>Lake KD, Compton DR, Varga K, Martin BR, Kunos G. Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors. &lt;span&gt;</code></p><p><code>18853</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18854</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>18855</code><code>1997a;&lt;span class="ref-vol"&gt;</code></p><p><code>18856</code><code>281&lt;/span&gt;</code></p><p><code>18857</code><code>:30–1037.&lt;/span&gt;</code></p><p><code>18858</code><code> [&lt;a href="/pubmed/9190833" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18859</code><code>PubMed&lt;/a&gt;</code></p><p><code>18860</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18861</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Cannabinoid-induced+hypotension+and+bradycardia+in+rats+mediated+by+CB1-like+cannabinoid+receptors&amp;amp;author=KD+Lake&amp;amp;author=DR+Compton&amp;amp;author=K+Varga&amp;amp;author=BR+Martin&amp;amp;author=G+Kunos&amp;amp;volume=281&amp;amp;publication_year=1997a&amp;amp;pages=30-1037&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18862</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18863</code><code>]&lt;/span&gt;</code></p><p><code>18864</code><code>&lt;/span&gt;</code></p><p><code>18865</code><code>&lt;/li&gt;</code></p><p><code>18866</code><code>&lt;li id="R646"&gt;</code></p><p><code>18867</code><code>&lt;span class="citation"&gt;</code></p><p><code>18868</code><code>Lake KD, Martin BR, Kunos G, Varga K. Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. &lt;span&gt;</code></p><p><code>18869</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18870</code><code>Hypertension. &lt;/span&gt;</code></p><p><code>18871</code><code>1997b;&lt;span class="ref-vol"&gt;</code></p><p><code>18872</code><code>29&lt;/span&gt;</code></p><p><code>18873</code><code>:1204–1210.&lt;/span&gt;</code></p><p><code>18874</code><code> [&lt;a href="/pubmed/9149688" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18875</code><code>PubMed&lt;/a&gt;</code></p><p><code>18876</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18877</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;amp;title=Cardiovascular+effects+of+anandamide+in+anesthetized+and+conscious+normotensive+and+hypertensive+rats&amp;amp;author=KD+Lake&amp;amp;author=BR+Martin&amp;amp;author=G+Kunos&amp;amp;author=K+Varga&amp;amp;volume=29&amp;amp;publication_year=1997b&amp;amp;pages=1204-1210&amp;amp;pmid=9149688&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18878</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18879</code><code>]&lt;/span&gt;</code></p><p><code>18880</code><code>&lt;/span&gt;</code></p><p><code>18881</code><code>&lt;/li&gt;</code></p><p><code>18882</code><code>&lt;li id="R647"&gt;</code></p><p><code>18883</code><code>&lt;span class="citation"&gt;</code></p><p><code>18884</code><code>Lallemand F, de Witte P. Ethanol induces higher BEC in CB&lt;sub&gt;</code></p><p><code>18885</code><code>1&lt;/sub&gt;</code></p><p><code>18886</code><code> cannabinoid receptor knockout mice while decreasing ethanol preference. &lt;span&gt;</code></p><p><code>18887</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18888</code><code>Alcohol Alcohol. &lt;/span&gt;</code></p><p><code>18889</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>18890</code><code>40&lt;/span&gt;</code></p><p><code>18891</code><code>:54–62.&lt;/span&gt;</code></p><p><code>18892</code><code> [&lt;a href="/pubmed/15550449" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18893</code><code>PubMed&lt;/a&gt;</code></p><p><code>18894</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18895</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Alcohol+Alcohol&amp;amp;title=Ethanol+induces+higher+BEC+in+CB1+cannabinoid+receptor+knockout+mice+while+decreasing+ethanol+preference&amp;amp;author=F+Lallemand&amp;amp;author=P+de+Witte&amp;amp;volume=40&amp;amp;publication_year=2004&amp;amp;pages=54-62&amp;amp;pmid=15550449&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18896</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18897</code><code>]&lt;/span&gt;</code></p><p><code>18898</code><code>&lt;/span&gt;</code></p><p><code>18899</code><code>&lt;/li&gt;</code></p><p><code>18900</code><code>&lt;li id="R648"&gt;</code></p><p><code>18901</code><code>&lt;span class="citation"&gt;</code></p><p><code>18902</code><code>Lan R, Gatley J, Lu Q, Fan P, Fernando SR, Volkow ND, Pertwee R, Makriyannis A design and synthesis of the CB1 selective cannabinoid antagonist AM281: a potential human SPECT ligand. &lt;span&gt;</code></p><p><code>18903</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18904</code><code>AAPS PharmSci. &lt;/span&gt;</code></p><p><code>18905</code><code>1999a;&lt;span class="ref-vol"&gt;</code></p><p><code>18906</code><code>1&lt;/span&gt;</code></p><p><code>18907</code><code>:E4.&lt;/span&gt;</code></p><p><code>18908</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>18909</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2761119/"&gt;</code></p><p><code>18910</code><code>PMC free article&lt;/a&gt;</code></p><p><code>18911</code><code>]&lt;/span&gt;</code></p><p><code>18912</code><code> [&lt;a href="/pubmed/11741201" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18913</code><code>PubMed&lt;/a&gt;</code></p><p><code>18914</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18915</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=AAPS+PharmSci&amp;amp;title=A+design+and+synthesis+of+the+CB1+selective+cannabinoid+antagonist+AM281:+a+potential+human+SPECT+ligand&amp;amp;author=R+Lan&amp;amp;author=J+Gatley&amp;amp;author=Q+Lu&amp;amp;author=P+Fan&amp;amp;author=SR+Fernando&amp;amp;volume=1&amp;amp;publication_year=1999a&amp;amp;pages=E4&amp;amp;pmid=11741201&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18916</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18917</code><code>]&lt;/span&gt;</code></p><p><code>18918</code><code>&lt;/span&gt;</code></p><p><code>18919</code><code>&lt;/li&gt;</code></p><p><code>18920</code><code>&lt;li id="R649"&gt;</code></p><p><code>18921</code><code>&lt;span class="citation"&gt;</code></p><p><code>18922</code><code>Lan R, Liu Q, Fan P, Lin S, Fernando SR, McCallion D, Pertwee R, Makriyannis A. Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. &lt;span&gt;</code></p><p><code>18923</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18924</code><code>J Med Chem. &lt;/span&gt;</code></p><p><code>18925</code><code>1999b;&lt;span class="ref-vol"&gt;</code></p><p><code>18926</code><code>42&lt;/span&gt;</code></p><p><code>18927</code><code>:769–776.&lt;/span&gt;</code></p><p><code>18928</code><code> [&lt;a href="/pubmed/10052983" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18929</code><code>PubMed&lt;/a&gt;</code></p><p><code>18930</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18931</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;amp;title=Structure-activity+relationships+of+pyrazole+derivatives+as+cannabinoid+receptor+antagonists&amp;amp;author=R+Lan&amp;amp;author=Q+Liu&amp;amp;author=P+Fan&amp;amp;author=S+Lin&amp;amp;author=SR+Fernando&amp;amp;volume=42&amp;amp;publication_year=1999b&amp;amp;pages=769-776&amp;amp;pmid=10052983&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18932</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18933</code><code>]&lt;/span&gt;</code></p><p><code>18934</code><code>&lt;/span&gt;</code></p><p><code>18935</code><code>&lt;/li&gt;</code></p><p><code>18936</code><code>&lt;li id="R650"&gt;</code></p><p><code>18937</code><code>&lt;span class="citation"&gt;</code></p><p><code>18938</code><code>Landi M, Croci T, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Manara L. Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB&lt;sub&gt;</code></p><p><code>18939</code><code>1&lt;/sub&gt;</code></p><p><code>18940</code><code> receptors. &lt;span&gt;</code></p><p><code>18941</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18942</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>18943</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>18944</code><code>450&lt;/span&gt;</code></p><p><code>18945</code><code>:77–83.&lt;/span&gt;</code></p><p><code>18946</code><code> [&lt;a href="/pubmed/12176112" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18947</code><code>PubMed&lt;/a&gt;</code></p><p><code>18948</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18949</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Modulation+of+gastric+emptying+and+gastrointestinal+transit+in+rats+through+intestinal+cannabinoid+CB1+receptors&amp;amp;author=M+Landi&amp;amp;author=T+Croci&amp;amp;author=M+Rinaldi-Carmona&amp;amp;author=JP+Maffrand&amp;amp;author=G+Le+Fur&amp;amp;volume=450&amp;amp;publication_year=2002&amp;amp;pages=77-83&amp;amp;pmid=12176112&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18950</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18951</code><code>]&lt;/span&gt;</code></p><p><code>18952</code><code>&lt;/span&gt;</code></p><p><code>18953</code><code>&lt;/li&gt;</code></p><p><code>18954</code><code>&lt;li id="R651"&gt;</code></p><p><code>18955</code><code>&lt;span class="citation"&gt;</code></p><p><code>18956</code><code>Lang W, Qin C, Lin S, Khanolkar AD, Goutopoulos A, Fan P, Abouzid K, Meng Z, Biegel D, Makriyannis A. Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase. &lt;span&gt;</code></p><p><code>18957</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18958</code><code>J Med Chem. &lt;/span&gt;</code></p><p><code>18959</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>18960</code><code>42&lt;/span&gt;</code></p><p><code>18961</code><code>:896–902.&lt;/span&gt;</code></p><p><code>18962</code><code> [&lt;a href="/pubmed/10072686" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18963</code><code>PubMed&lt;/a&gt;</code></p><p><code>18964</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18965</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;amp;title=Substrate+specificity+and+stereoselectivity+of+rat+brain+microsomal+anandamide+amidohydrolase&amp;amp;author=W+Lang&amp;amp;author=C+Qin&amp;amp;author=S+Lin&amp;amp;author=AD+Khanolkar&amp;amp;author=A+Goutopoulos&amp;amp;volume=42&amp;amp;publication_year=1999&amp;amp;pages=896-902&amp;amp;pmid=10072686&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18966</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18967</code><code>]&lt;/span&gt;</code></p><p><code>18968</code><code>&lt;/span&gt;</code></p><p><code>18969</code><code>&lt;/li&gt;</code></p><p><code>18970</code><code>&lt;li id="R652"&gt;</code></p><p><code>18971</code><code>&lt;span class="citation"&gt;</code></p><p><code>18972</code><code>La Rana G, Russo R, Campolongo P, Bortolato M, Mangieri RA, Cuomo V, Iacono A, Mattace Raso G, Meli R, Piomelli D, et al.  Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404. &lt;span&gt;</code></p><p><code>18973</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18974</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>18975</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>18976</code><code>317&lt;/span&gt;</code></p><p><code>18977</code><code>:1365–1371.&lt;/span&gt;</code></p><p><code>18978</code><code> [&lt;a href="/pubmed/16510698" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18979</code><code>PubMed&lt;/a&gt;</code></p><p><code>18980</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18981</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Modulation+of+neuropathic+and+inflammatory+pain+by+the+endocannabinoid+transport+inhibitor+AM404&amp;amp;author=G+La+Rana&amp;amp;author=R+Russo&amp;amp;author=P+Campolongo&amp;amp;author=M+Bortolato&amp;amp;author=RA+Mangieri&amp;amp;volume=317&amp;amp;publication_year=2006&amp;amp;pages=1365-1371&amp;amp;pmid=16510698&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18982</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18983</code><code>]&lt;/span&gt;</code></p><p><code>18984</code><code>&lt;/span&gt;</code></p><p><code>18985</code><code>&lt;/li&gt;</code></p><p><code>18986</code><code>&lt;li id="R653"&gt;</code></p><p><code>18987</code><code>&lt;span class="citation"&gt;</code></p><p><code>18988</code><code>LaRoche SM, Helmers SL. The new antiepileptic drugs: scientific review. &lt;span&gt;</code></p><p><code>18989</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>18990</code><code>J Am Med Assoc. &lt;/span&gt;</code></p><p><code>18991</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>18992</code><code>291&lt;/span&gt;</code></p><p><code>18993</code><code>:605–614.&lt;/span&gt;</code></p><p><code>18994</code><code> [&lt;a href="/pubmed/14762040" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>18995</code><code>PubMed&lt;/a&gt;</code></p><p><code>18996</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>18997</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Med+Assoc&amp;amp;title=The+new+antiepileptic+drugs:+scientific+review&amp;amp;author=SM+LaRoche&amp;amp;author=SL+Helmers&amp;amp;volume=291&amp;amp;publication_year=2004&amp;amp;pages=605-614&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>18998</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>18999</code><code>]&lt;/span&gt;</code></p><p><code>19000</code><code>&lt;/span&gt;</code></p><p><code>19001</code><code>&lt;/li&gt;</code></p><p><code>19002</code><code>&lt;li id="R654"&gt;</code></p><p><code>19003</code><code>&lt;span class="citation"&gt;</code></p><p><code>19004</code><code>Lastres-Becker I, Berrendero F, Lucas JJ, Martin-Aparicio E, Yamamoto A, Ramos JA, Fernandez-Ruiz JJ. Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB&lt;sub&gt;</code></p><p><code>19005</code><code>1&lt;/sub&gt;</code></p><p><code>19006</code><code> receptors in the basal ganglia of a transgenic model of Huntington&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>19007</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19008</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>19009</code><code>2002a;&lt;span class="ref-vol"&gt;</code></p><p><code>19010</code><code>929&lt;/span&gt;</code></p><p><code>19011</code><code>:236–242.&lt;/span&gt;</code></p><p><code>19012</code><code> [&lt;a href="/pubmed/11864629" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19013</code><code>PubMed&lt;/a&gt;</code></p><p><code>19014</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19015</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Loss+of+mRNA+levels,+binding+and+activation+of+GTP-binding+proteins+for+cannabinoid+CB1+receptors+in+the+basal+ganglia+of+a+transgenic+model+of+Huntington&amp;#x02019;s+disease&amp;amp;author=I+Lastres-Becker&amp;amp;author=F+Berrendero&amp;amp;author=JJ+Lucas&amp;amp;author=E+Martin-Aparicio&amp;amp;author=A+Yamamoto&amp;amp;volume=929&amp;amp;publication_year=2002a&amp;amp;pages=236-242&amp;amp;pmid=11864629&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19016</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19017</code><code>]&lt;/span&gt;</code></p><p><code>19018</code><code>&lt;/span&gt;</code></p><p><code>19019</code><code>&lt;/li&gt;</code></p><p><code>19020</code><code>&lt;li id="R655"&gt;</code></p><p><code>19021</code><code>&lt;span class="citation"&gt;</code></p><p><code>19022</code><code>Lastres-Becker I, Cebeira M, de Ceballos ML, Zeng BY, Jenner P, Ramos JA, Fernandez-Ruiz JJ. Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson&amp;#x02019;s syndrome and of MPTP-treated marmosets. &lt;span&gt;</code></p><p><code>19023</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19024</code><code>Eur J Neurosci. &lt;/span&gt;</code></p><p><code>19025</code><code>2001a;&lt;span class="ref-vol"&gt;</code></p><p><code>19026</code><code>14&lt;/span&gt;</code></p><p><code>19027</code><code>:1827–1832.&lt;/span&gt;</code></p><p><code>19028</code><code> [&lt;a href="/pubmed/11860478" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19029</code><code>PubMed&lt;/a&gt;</code></p><p><code>19030</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19031</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurosci&amp;amp;title=Increased+cannabinoid+CB1+receptor+binding+and+activation+of+GTP-binding+proteins+in+the+basal+ganglia+of+patients+with+Parkinson&amp;#x02019;s+syndrome+and+of+MPTP-treated+marmosets&amp;amp;author=I+Lastres-Becker&amp;amp;author=M+Cebeira&amp;amp;author=ML+de+Ceballos&amp;amp;author=BY+Zeng&amp;amp;author=P+Jenner&amp;amp;volume=14&amp;amp;publication_year=2001a&amp;amp;pages=1827-1832&amp;amp;pmid=11860478&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19032</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19033</code><code>]&lt;/span&gt;</code></p><p><code>19034</code><code>&lt;/span&gt;</code></p><p><code>19035</code><code>&lt;/li&gt;</code></p><p><code>19036</code><code>&lt;li id="R656"&gt;</code></p><p><code>19037</code><code>&lt;span class="citation"&gt;</code></p><p><code>19038</code><code>Lastres-Becker I, de Miguel R, De Petrocellis L, Makriyannis A, Di Marzo V, Fernandez-Ruiz J. Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>19039</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19040</code><code>J Neurochem. &lt;/span&gt;</code></p><p><code>19041</code><code>2003a;&lt;span class="ref-vol"&gt;</code></p><p><code>19042</code><code>84&lt;/span&gt;</code></p><p><code>19043</code><code>:1097–1109.&lt;/span&gt;</code></p><p><code>19044</code><code> [&lt;a href="/pubmed/12603833" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19045</code><code>PubMed&lt;/a&gt;</code></p><p><code>19046</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19047</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;amp;title=Compounds+acting+at+the+endocannabinoid+and/or+endovanilloid+systems+reduce+hyperkinesia+in+a+rat+model+of+Huntington&amp;#x02019;s+disease&amp;amp;author=I+Lastres-Becker&amp;amp;author=R+de+Miguel&amp;amp;author=L+De+Petrocellis&amp;amp;author=A+Makriyannis&amp;amp;author=V+Di+Marzo&amp;amp;volume=84&amp;amp;publication_year=2003a&amp;amp;pages=1097-1109&amp;amp;pmid=12603833&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19048</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19049</code><code>]&lt;/span&gt;</code></p><p><code>19050</code><code>&lt;/span&gt;</code></p><p><code>19051</code><code>&lt;/li&gt;</code></p><p><code>19052</code><code>&lt;li id="R657"&gt;</code></p><p><code>19053</code><code>&lt;span class="citation"&gt;</code></p><p><code>19054</code><code>Lastres-Becker I, De Miguel R, Fernandez-Ruiz JJ. The endocannabinoid system and Huntington&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>19055</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19056</code><code>Curr Drug Targets CNS Neurol Disord. &lt;/span&gt;</code></p><p><code>19057</code><code>2003b;&lt;span class="ref-vol"&gt;</code></p><p><code>19058</code><code>2&lt;/span&gt;</code></p><p><code>19059</code><code>:335–347.&lt;/span&gt;</code></p><p><code>19060</code><code> [&lt;a href="/pubmed/14529364" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19061</code><code>PubMed&lt;/a&gt;</code></p><p><code>19062</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19063</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Drug+Targets+CNS+Neurol+Disord&amp;amp;title=The+endocannabinoid+system+and+Huntington&amp;#x02019;s+disease&amp;amp;author=I+Lastres-Becker&amp;amp;author=R+De+Miguel&amp;amp;author=JJ+Fernandez-Ruiz&amp;amp;volume=2&amp;amp;publication_year=2003b&amp;amp;pages=335-347&amp;amp;pmid=14529364&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19064</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19065</code><code>]&lt;/span&gt;</code></p><p><code>19066</code><code>&lt;/span&gt;</code></p><p><code>19067</code><code>&lt;/li&gt;</code></p><p><code>19068</code><code>&lt;li id="R658"&gt;</code></p><p><code>19069</code><code>&lt;span class="citation"&gt;</code></p><p><code>19070</code><code>Lastres-Becker I, Fezza F, Cebeira M, Bisogno T, Ramos JA, Milone A, Fernandez-Ruiz J, Di Marzo V. Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>19071</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19072</code><code>Neuroreport. &lt;/span&gt;</code></p><p><code>19073</code><code>2001b;&lt;span class="ref-vol"&gt;</code></p><p><code>19074</code><code>12&lt;/span&gt;</code></p><p><code>19075</code><code>:2125–2129.&lt;/span&gt;</code></p><p><code>19076</code><code> [&lt;a href="/pubmed/11447320" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19077</code><code>PubMed&lt;/a&gt;</code></p><p><code>19078</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19079</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroreport&amp;amp;title=Changes+in+endocannabinoid+transmission+in+the+basal+ganglia+in+a+rat+model+of+Huntington&amp;#x02019;s+disease&amp;amp;author=I+Lastres-Becker&amp;amp;author=F+Fezza&amp;amp;author=M+Cebeira&amp;amp;author=T+Bisogno&amp;amp;author=JA+Ramos&amp;amp;volume=12&amp;amp;publication_year=2001b&amp;amp;pages=2125-2129&amp;amp;pmid=11447320&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19080</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19081</code><code>]&lt;/span&gt;</code></p><p><code>19082</code><code>&lt;/span&gt;</code></p><p><code>19083</code><code>&lt;/li&gt;</code></p><p><code>19084</code><code>&lt;li id="R659"&gt;</code></p><p><code>19085</code><code>&lt;span class="citation"&gt;</code></p><p><code>19086</code><code>Lastres-Becker I, Gomez M, De Miguel R, Ramos JA, Fernandez-Ruiz J. Loss of cannabinoid CB&lt;sub&gt;</code></p><p><code>19087</code><code>1&lt;/sub&gt;</code></p><p><code>19088</code><code> receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>19089</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19090</code><code>Neurotox Res. &lt;/span&gt;</code></p><p><code>19091</code><code>2002b;&lt;span class="ref-vol"&gt;</code></p><p><code>19092</code><code>4&lt;/span&gt;</code></p><p><code>19093</code><code>:601–608.&lt;/span&gt;</code></p><p><code>19094</code><code> [&lt;a href="/pubmed/12709298" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19095</code><code>PubMed&lt;/a&gt;</code></p><p><code>19096</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19097</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurotox+Res&amp;amp;title=Loss+of+cannabinoid+CB1+receptors+in+the+basal+ganglia+in+the+late+akinetic+phase+of+rats+with+experimental+Huntington&amp;#x02019;s+disease&amp;amp;author=I+Lastres-Becker&amp;amp;author=M+Gomez&amp;amp;author=R+De+Miguel&amp;amp;author=JA+Ramos&amp;amp;author=J+Fernandez-Ruiz&amp;amp;volume=4&amp;amp;publication_year=2002b&amp;amp;pages=601-608&amp;amp;pmid=12709298&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19098</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19099</code><code>]&lt;/span&gt;</code></p><p><code>19100</code><code>&lt;/span&gt;</code></p><p><code>19101</code><code>&lt;/li&gt;</code></p><p><code>19102</code><code>&lt;li id="R660"&gt;</code></p><p><code>19103</code><code>&lt;span class="citation"&gt;</code></p><p><code>19104</code><code>Lastres-Becker I, Molina-Holgado F, Ramos JA, Mechoulam R, Fernandez-Ruiz J. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>19105</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19106</code><code>Neurobiol Dis. &lt;/span&gt;</code></p><p><code>19107</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>19108</code><code>19&lt;/span&gt;</code></p><p><code>19109</code><code>:96–107.&lt;/span&gt;</code></p><p><code>19110</code><code> [&lt;a href="/pubmed/15837565" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19111</code><code>PubMed&lt;/a&gt;</code></p><p><code>19112</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19113</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurobiol+Dis&amp;amp;title=Cannabinoids+provide+neuroprotection+against+6-hydroxydopamine+toxicity+in+vivo+and+in+vitro:+relevance+to+Parkinson&amp;#x02019;s+disease&amp;amp;author=I+Lastres-Becker&amp;amp;author=F+Molina-Holgado&amp;amp;author=JA+Ramos&amp;amp;author=R+Mechoulam&amp;amp;author=J+Fernandez-Ruiz&amp;amp;volume=19&amp;amp;publication_year=2005&amp;amp;pages=96-107&amp;amp;pmid=15837565&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19114</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19115</code><code>]&lt;/span&gt;</code></p><p><code>19116</code><code>&lt;/span&gt;</code></p><p><code>19117</code><code>&lt;/li&gt;</code></p><p><code>19118</code><code>&lt;li id="R661"&gt;</code></p><p><code>19119</code><code>&lt;span class="citation"&gt;</code></p><p><code>19120</code><code>Lauckner JE, Hille B, Mackie K. The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. &lt;span&gt;</code></p><p><code>19121</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19122</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>19123</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>19124</code><code>102&lt;/span&gt;</code></p><p><code>19125</code><code>:19144–19149.&lt;/span&gt;</code></p><p><code>19126</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>19127</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1323208/"&gt;</code></p><p><code>19128</code><code>PMC free article&lt;/a&gt;</code></p><p><code>19129</code><code>]&lt;/span&gt;</code></p><p><code>19130</code><code> [&lt;a href="/pubmed/16365309" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19131</code><code>PubMed&lt;/a&gt;</code></p><p><code>19132</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19133</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=The+cannabinoid+agonist+WIN55,212-2+increases+intracellular+calcium+via+CB1+receptor+coupling+to+Gq/11+G+proteins&amp;amp;author=JE+Lauckner&amp;amp;author=B+Hille&amp;amp;author=K+Mackie&amp;amp;volume=102&amp;amp;publication_year=2005&amp;amp;pages=19144-19149&amp;amp;pmid=16365309&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19134</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19135</code><code>]&lt;/span&gt;</code></p><p><code>19136</code><code>&lt;/span&gt;</code></p><p><code>19137</code><code>&lt;/li&gt;</code></p><p><code>19138</code><code>&lt;li id="R662"&gt;</code></p><p><code>19139</code><code>&lt;span class="citation"&gt;</code></p><p><code>19140</code><code>Lavie G, Teichner A, Shohami E, Ovadia H, Leker RR. Long term cerebroprotective effects of dexanabinol in a model of focal cerebral ischemia. &lt;span&gt;</code></p><p><code>19141</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19142</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>19143</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>19144</code><code>901&lt;/span&gt;</code></p><p><code>19145</code><code>:195–201.&lt;/span&gt;</code></p><p><code>19146</code><code> [&lt;a href="/pubmed/11368967" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19147</code><code>PubMed&lt;/a&gt;</code></p><p><code>19148</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19149</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Long+term+cerebroprotective+effects+of+dexanabinol+in+a+model+of+focal+cerebral+ischemia&amp;amp;author=G+Lavie&amp;amp;author=A+Teichner&amp;amp;author=E+Shohami&amp;amp;author=H+Ovadia&amp;amp;author=RR+Leker&amp;amp;volume=901&amp;amp;publication_year=2001&amp;amp;pages=195-201&amp;amp;pmid=11368967&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19150</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19151</code><code>]&lt;/span&gt;</code></p><p><code>19152</code><code>&lt;/span&gt;</code></p><p><code>19153</code><code>&lt;/li&gt;</code></p><p><code>19154</code><code>&lt;li id="R663"&gt;</code></p><p><code>19155</code><code>&lt;span class="citation"&gt;</code></p><p><code>19156</code><code>Laviolette SR, Grace AA. The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction. &lt;span&gt;</code></p><p><code>19157</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19158</code><code>Cell Mol Life Sci. &lt;/span&gt;</code></p><p><code>19159</code><code>2006&lt;/span&gt;</code></p><p><code>19160</code><code> in press. [&lt;a href="/pubmed/16699809" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19161</code><code>PubMed&lt;/a&gt;</code></p><p><code>19162</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19163</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cell+Mol+Life+Sci&amp;amp;title=The+roles+of+cannabinoid+and+dopamine+receptor+systems+in+neural+emotional+learning+circuits:+implications+for+schizophrenia+and+addiction&amp;amp;author=SR+Laviolette&amp;amp;author=AA+Grace&amp;amp;publication_year=2006&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19164</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19165</code><code>]&lt;/span&gt;</code></p><p><code>19166</code><code>&lt;/span&gt;</code></p><p><code>19167</code><code>&lt;/li&gt;</code></p><p><code>19168</code><code>&lt;li id="R664"&gt;</code></p><p><code>19169</code><code>&lt;span class="citation"&gt;</code></p><p><code>19170</code><code>Lavon I, Sheinin T, Meilin S, Biton E, Weksler A, Efroni G, Bar-Joseph A, Fink G, Avraham A. A novel synthetic cannabinoid derivative inhibits inflammatory liver damage via negative cytokine regulation. &lt;span&gt;</code></p><p><code>19171</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19172</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>19173</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>19174</code><code>64&lt;/span&gt;</code></p><p><code>19175</code><code>:1334–1341.&lt;/span&gt;</code></p><p><code>19176</code><code> [&lt;a href="/pubmed/14645663" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19177</code><code>PubMed&lt;/a&gt;</code></p><p><code>19178</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19179</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=A+novel+synthetic+cannabinoid+derivative+inhibits+inflammatory+liver+damage+via+negative+cytokine+regulation&amp;amp;author=I+Lavon&amp;amp;author=T+Sheinin&amp;amp;author=S+Meilin&amp;amp;author=E+Biton&amp;amp;author=A+Weksler&amp;amp;volume=64&amp;amp;publication_year=2003&amp;amp;pages=1334-1341&amp;amp;pmid=14645663&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19180</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19181</code><code>]&lt;/span&gt;</code></p><p><code>19182</code><code>&lt;/span&gt;</code></p><p><code>19183</code><code>&lt;/li&gt;</code></p><p><code>19184</code><code>&lt;li id="R665"&gt;</code></p><p><code>19185</code><code>&lt;span class="citation"&gt;</code></p><p><code>19186</code><code>Lawrence DK, Gill EW. The effects of &amp;#x00394;&lt;sup&gt;</code></p><p><code>19187</code><code>1&lt;/sup&gt;</code></p><p><code>19188</code><code>-tetrahydrocannabinol and other cannabinoids on spin-labeled liposomes and their relationship to mechanisms of general anesthesia. &lt;span&gt;</code></p><p><code>19189</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19190</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>19191</code><code>1975;&lt;span class="ref-vol"&gt;</code></p><p><code>19192</code><code>11&lt;/span&gt;</code></p><p><code>19193</code><code>:595–602.&lt;/span&gt;</code></p><p><code>19194</code><code> [&lt;a href="/pubmed/170503" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19195</code><code>PubMed&lt;/a&gt;</code></p><p><code>19196</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19197</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=The+effects+of+&amp;#x00394;1-tetrahydrocannabinol+and+other+cannabinoids+on+spin-labeled+liposomes+and+their+relationship+to+mechanisms+of+general+anesthesia&amp;amp;author=DK+Lawrence&amp;amp;author=EW+Gill&amp;amp;volume=11&amp;amp;publication_year=1975&amp;amp;pages=595-602&amp;amp;pmid=170503&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19198</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19199</code><code>]&lt;/span&gt;</code></p><p><code>19200</code><code>&lt;/span&gt;</code></p><p><code>19201</code><code>&lt;/li&gt;</code></p><p><code>19202</code><code>&lt;li id="R666"&gt;</code></p><p><code>19203</code><code>&lt;span class="citation"&gt;</code></p><p><code>19204</code><code>Le Foll B, Goldberg SR. Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences. &lt;span&gt;</code></p><p><code>19205</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19206</code><code>Neuroreport. &lt;/span&gt;</code></p><p><code>19207</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>19208</code><code>15&lt;/span&gt;</code></p><p><code>19209</code><code>:2139–2143.&lt;/span&gt;</code></p><p><code>19210</code><code> [&lt;a href="/pubmed/15486497" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19211</code><code>PubMed&lt;/a&gt;</code></p><p><code>19212</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19213</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroreport&amp;amp;title=Rimonabant,+a+CB1+antagonist,+blocks+nicotine-conditioned+place+preferences&amp;amp;author=B+Le+Foll&amp;amp;author=SR+Goldberg&amp;amp;volume=15&amp;amp;publication_year=2004&amp;amp;pages=2139-2143&amp;amp;pmid=15486497&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19214</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19215</code><code>]&lt;/span&gt;</code></p><p><code>19216</code><code>&lt;/span&gt;</code></p><p><code>19217</code><code>&lt;/li&gt;</code></p><p><code>19218</code><code>&lt;li id="R667"&gt;</code></p><p><code>19219</code><code>&lt;span class="citation"&gt;</code></p><p><code>19220</code><code>Le Foll B, Goldberg DR. Cannabinoid CB&lt;sub&gt;</code></p><p><code>19221</code><code>1&lt;/sub&gt;</code></p><p><code>19222</code><code> receptor antagonists as promising new medications for drug dependence. &lt;span&gt;</code></p><p><code>19223</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19224</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>19225</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>19226</code><code>312&lt;/span&gt;</code></p><p><code>19227</code><code>:875–883.&lt;/span&gt;</code></p><p><code>19228</code><code> [&lt;a href="/pubmed/15525797" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19229</code><code>PubMed&lt;/a&gt;</code></p><p><code>19230</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19231</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Cannabinoid+CB1+receptor+antagonists+as+promising+new+medications+for+drug+dependence&amp;amp;author=B+Le+Foll&amp;amp;author=DR+Goldberg&amp;amp;volume=312&amp;amp;publication_year=2005&amp;amp;pages=875-883&amp;amp;pmid=15525797&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19232</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19233</code><code>]&lt;/span&gt;</code></p><p><code>19234</code><code>&lt;/span&gt;</code></p><p><code>19235</code><code>&lt;/li&gt;</code></p><p><code>19236</code><code>&lt;li id="R668"&gt;</code></p><p><code>19237</code><code>&lt;span class="citation"&gt;</code></p><p><code>19238</code><code>Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Bohme GA, Imperato A, Pedrazzini T, Roques BP, et al.  Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. &lt;span&gt;</code></p><p><code>19239</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19240</code><code>Science (Wash DC) &lt;/span&gt;</code></p><p><code>19241</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>19242</code><code>283&lt;/span&gt;</code></p><p><code>19243</code><code>:401–404.&lt;/span&gt;</code></p><p><code>19244</code><code> [&lt;a href="/pubmed/9888857" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19245</code><code>PubMed&lt;/a&gt;</code></p><p><code>19246</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19247</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Science+(Wash+DC)&amp;amp;title=Unresponsiveness+to+cannabinoids+and+reduced+addictive+effects+of+opiates+in+CB1+receptor+knockout+mice&amp;amp;author=C+Ledent&amp;amp;author=O+Valverde&amp;amp;author=G+Cossu&amp;amp;author=F+Petitet&amp;amp;author=JF+Aubert&amp;amp;volume=283&amp;amp;publication_year=1999&amp;amp;pages=401-404&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19248</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19249</code><code>]&lt;/span&gt;</code></p><p><code>19250</code><code>&lt;/span&gt;</code></p><p><code>19251</code><code>&lt;/li&gt;</code></p><p><code>19252</code><code>&lt;li id="R669"&gt;</code></p><p><code>19253</code><code>&lt;span class="citation"&gt;</code></p><p><code>19254</code><code>Lees G, Dougalis A. Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro. &lt;span&gt;</code></p><p><code>19255</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19256</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>19257</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>19258</code><code>997&lt;/span&gt;</code></p><p><code>19259</code><code>:1–14.&lt;/span&gt;</code></p><p><code>19260</code><code> [&lt;a href="/pubmed/14715144" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19261</code><code>PubMed&lt;/a&gt;</code></p><p><code>19262</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19263</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Differential+effects+of+the+sleep-inducing+lipid+oleamide+and+cannabinoids+on+the+induction+of+long-term+potentiation+in+the+CA1+neurons+of+the+rat+hippocampus+in+vitro&amp;amp;author=G+Lees&amp;amp;author=A+Dougalis&amp;amp;volume=997&amp;amp;publication_year=2004&amp;amp;pages=1-14&amp;amp;pmid=14715144&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19264</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19265</code><code>]&lt;/span&gt;</code></p><p><code>19266</code><code>&lt;/span&gt;</code></p><p><code>19267</code><code>&lt;/li&gt;</code></p><p><code>19268</code><code>&lt;li id="R670"&gt;</code></p><p><code>19269</code><code>&lt;span class="citation"&gt;</code></p><p><code>19270</code><code>Leggett JD, Aspley S, Beckett SR, D&amp;#x02019;Antona AM, Kendall DA, Kendall DA. Oleamide is a selective endogenous agonist of rat and human CB&lt;sub&gt;</code></p><p><code>19271</code><code>1&lt;/sub&gt;</code></p><p><code>19272</code><code> cannabinoid receptors. &lt;span&gt;</code></p><p><code>19273</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19274</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>19275</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>19276</code><code>141&lt;/span&gt;</code></p><p><code>19277</code><code>:253–262.&lt;/span&gt;</code></p><p><code>19278</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>19279</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1574194/"&gt;</code></p><p><code>19280</code><code>PMC free article&lt;/a&gt;</code></p><p><code>19281</code><code>]&lt;/span&gt;</code></p><p><code>19282</code><code> [&lt;a href="/pubmed/14707029" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19283</code><code>PubMed&lt;/a&gt;</code></p><p><code>19284</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19285</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Oleamide+is+a+selective+endogenous+agonist+of+rat+and+human+CB1+cannabinoid+receptors&amp;amp;author=JD+Leggett&amp;amp;author=S+Aspley&amp;amp;author=SR+Beckett&amp;amp;author=AM+D&amp;#x02019;Antona&amp;amp;author=DA+Kendall&amp;amp;volume=141&amp;amp;publication_year=2004&amp;amp;pages=253-262&amp;amp;pmid=14707029&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19286</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19287</code><code>]&lt;/span&gt;</code></p><p><code>19288</code><code>&lt;/span&gt;</code></p><p><code>19289</code><code>&lt;/li&gt;</code></p><p><code>19290</code><code>&lt;li id="R671"&gt;</code></p><p><code>19291</code><code>&lt;span class="citation"&gt;</code></p><p><code>19292</code><code>Leker RR, Gai N, Mechoulam R, Ovadia H. Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210. &lt;span&gt;</code></p><p><code>19293</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19294</code><code>Stroke. &lt;/span&gt;</code></p><p><code>19295</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>19296</code><code>34&lt;/span&gt;</code></p><p><code>19297</code><code>:2000–2006.&lt;/span&gt;</code></p><p><code>19298</code><code> [&lt;a href="/pubmed/12829867" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19299</code><code>PubMed&lt;/a&gt;</code></p><p><code>19300</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19301</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Stroke&amp;amp;title=Drug-induced+hypothermia+reduces+ischemic+damage:+effects+of+the+cannabinoid+HU-210&amp;amp;author=RR+Leker&amp;amp;author=N+Gai&amp;amp;author=R+Mechoulam&amp;amp;author=H+Ovadia&amp;amp;volume=34&amp;amp;publication_year=2003&amp;amp;pages=2000-2006&amp;amp;pmid=12829867&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19302</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19303</code><code>]&lt;/span&gt;</code></p><p><code>19304</code><code>&lt;/span&gt;</code></p><p><code>19305</code><code>&lt;/li&gt;</code></p><p><code>19306</code><code>&lt;li id="R672"&gt;</code></p><p><code>19307</code><code>&lt;span class="citation"&gt;</code></p><p><code>19308</code><code>Leker RR, Shohami E, Abramsky O, Ovadia H. Dexanabinol; a novel neuroprotective drug in experimental focal cerebral ischemia. &lt;span&gt;</code></p><p><code>19309</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19310</code><code>J Neurol Sci. &lt;/span&gt;</code></p><p><code>19311</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>19312</code><code>162&lt;/span&gt;</code></p><p><code>19313</code><code>:114–119.&lt;/span&gt;</code></p><p><code>19314</code><code> [&lt;a href="/pubmed/10202976" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19315</code><code>PubMed&lt;/a&gt;</code></p><p><code>19316</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19317</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurol+Sci&amp;amp;title=Dexanabinol;+a+novel+neuroprotective+drug+in+experimental+focal+cerebral+ischemia&amp;amp;author=RR+Leker&amp;amp;author=E+Shohami&amp;amp;author=O+Abramsky&amp;amp;author=H+Ovadia&amp;amp;volume=162&amp;amp;publication_year=1999&amp;amp;pages=114-119&amp;amp;pmid=10202976&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19318</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19319</code><code>]&lt;/span&gt;</code></p><p><code>19320</code><code>&lt;/span&gt;</code></p><p><code>19321</code><code>&lt;/li&gt;</code></p><p><code>19322</code><code>&lt;li id="R673"&gt;</code></p><p><code>19323</code><code>&lt;span class="citation"&gt;</code></p><p><code>19324</code><code>Lemberger L. Potential therapeutic usefulness of marijuana. &lt;span&gt;</code></p><p><code>19325</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19326</code><code>Annu Rev Pharmacol Toxicol. &lt;/span&gt;</code></p><p><code>19327</code><code>1980;&lt;span class="ref-vol"&gt;</code></p><p><code>19328</code><code>20&lt;/span&gt;</code></p><p><code>19329</code><code>:151–172.&lt;/span&gt;</code></p><p><code>19330</code><code> [&lt;a href="/pubmed/6104468" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19331</code><code>PubMed&lt;/a&gt;</code></p><p><code>19332</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19333</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Pharmacol+Toxicol&amp;amp;title=Potential+therapeutic+usefulness+of+marijuana&amp;amp;author=L+Lemberger&amp;amp;volume=20&amp;amp;publication_year=1980&amp;amp;pages=151-172&amp;amp;pmid=6104468&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19334</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19335</code><code>]&lt;/span&gt;</code></p><p><code>19336</code><code>&lt;/span&gt;</code></p><p><code>19337</code><code>&lt;/li&gt;</code></p><p><code>19338</code><code>&lt;li id="R674"&gt;</code></p><p><code>19339</code><code>&lt;span class="citation"&gt;</code></p><p><code>19340</code><code>Lepicier P, Bouchard JF, Lagneux C, Lamontagne D. Endocannabinoids protect the rat isolated heart against ischaemia. &lt;span&gt;</code></p><p><code>19341</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19342</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>19343</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>19344</code><code>139&lt;/span&gt;</code></p><p><code>19345</code><code>:805–815.&lt;/span&gt;</code></p><p><code>19346</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>19347</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1573907/"&gt;</code></p><p><code>19348</code><code>PMC free article&lt;/a&gt;</code></p><p><code>19349</code><code>]&lt;/span&gt;</code></p><p><code>19350</code><code> [&lt;a href="/pubmed/12813004" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19351</code><code>PubMed&lt;/a&gt;</code></p><p><code>19352</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19353</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Endocannabinoids+protect+the+rat+isolated+heart+against+ischaemia&amp;amp;author=P+Lepicier&amp;amp;author=JF+Bouchard&amp;amp;author=C+Lagneux&amp;amp;author=D+Lamontagne&amp;amp;volume=139&amp;amp;publication_year=2003&amp;amp;pages=805-815&amp;amp;pmid=12813004&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19354</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19355</code><code>]&lt;/span&gt;</code></p><p><code>19356</code><code>&lt;/span&gt;</code></p><p><code>19357</code><code>&lt;/li&gt;</code></p><p><code>19358</code><code>&lt;li id="R675"&gt;</code></p><p><code>19359</code><code>&lt;span class="citation"&gt;</code></p><p><code>19360</code><code>Lepore M, Vorel SR, Lowinson J, Gardner EL. Conditioned place preference induced by &amp;#x00394;&lt;sup&gt;</code></p><p><code>19361</code><code>9&lt;/sup&gt;</code></p><p><code>19362</code><code>-tetrahydrocannabinol: comparison with cocaine, morphine and food reward. &lt;span&gt;</code></p><p><code>19363</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19364</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>19365</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>19366</code><code>56&lt;/span&gt;</code></p><p><code>19367</code><code>:2073–2080.&lt;/span&gt;</code></p><p><code>19368</code><code> [&lt;a href="/pubmed/7776834" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19369</code><code>PubMed&lt;/a&gt;</code></p><p><code>19370</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19371</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Conditioned+place+preference+induced+by+&amp;#x00394;9-tetrahydrocannabinol:+comparison+with+cocaine,+morphine+and+food+reward&amp;amp;author=M+Lepore&amp;amp;author=SR+Vorel&amp;amp;author=J+Lowinson&amp;amp;author=EL+Gardner&amp;amp;volume=56&amp;amp;publication_year=1995&amp;amp;pages=2073-2080&amp;amp;pmid=7776834&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19372</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19373</code><code>]&lt;/span&gt;</code></p><p><code>19374</code><code>&lt;/span&gt;</code></p><p><code>19375</code><code>&lt;/li&gt;</code></p><p><code>19376</code><code>&lt;li id="R676"&gt;</code></p><p><code>19377</code><code>&lt;span class="citation"&gt;</code></p><p><code>19378</code><code>Leroy S, Griffon N, Bourdel MC, Olie JP, Poirier MF, Krebs MO. Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1. &lt;span&gt;</code></p><p><code>19379</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19380</code><code>Am J Med Genet. &lt;/span&gt;</code></p><p><code>19381</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>19382</code><code>105&lt;/span&gt;</code></p><p><code>19383</code><code>:749–752.&lt;/span&gt;</code></p><p><code>19384</code><code> [&lt;a href="/pubmed/11803524" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19385</code><code>PubMed&lt;/a&gt;</code></p><p><code>19386</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19387</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Med+Genet&amp;amp;title=Schizophrenia+and+the+cannabinoid+receptor+type+1+(CB1):+association+study+using+a+single-base+polymorphism+in+coding+exon+1&amp;amp;author=S+Leroy&amp;amp;author=N+Griffon&amp;amp;author=MC+Bourdel&amp;amp;author=JP+Olie&amp;amp;author=MF+Poirier&amp;amp;volume=105&amp;amp;publication_year=2001&amp;amp;pages=749-752&amp;amp;pmid=11803524&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19388</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19389</code><code>]&lt;/span&gt;</code></p><p><code>19390</code><code>&lt;/span&gt;</code></p><p><code>19391</code><code>&lt;/li&gt;</code></p><p><code>19392</code><code>&lt;li id="R677"&gt;</code></p><p><code>19393</code><code>&lt;span class="citation"&gt;</code></p><p><code>19394</code><code>Lesscher HMB, Hoogveld E, Burbach PH, van Ree JM, Gerrits MAFM. Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioral sensitization. &lt;span&gt;</code></p><p><code>19395</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19396</code><code>Eur Neuropsychopharmacol. &lt;/span&gt;</code></p><p><code>19397</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>19398</code><code>15&lt;/span&gt;</code></p><p><code>19399</code><code>:31–37.&lt;/span&gt;</code></p><p><code>19400</code><code> [&lt;a href="/pubmed/15572271" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19401</code><code>PubMed&lt;/a&gt;</code></p><p><code>19402</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19403</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+Neuropsychopharmacol&amp;amp;title=Endogenous+cannabinoids+are+not+involved+in+cocaine+reinforcement+and+development+of+cocaine-induced+behavioral+sensitization&amp;amp;author=HMB+Lesscher&amp;amp;author=E+Hoogveld&amp;amp;author=PH+Burbach&amp;amp;author=JM+van+Ree&amp;amp;author=MAFM+Gerrits&amp;amp;volume=15&amp;amp;publication_year=2005&amp;amp;pages=31-37&amp;amp;pmid=15572271&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19404</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19405</code><code>]&lt;/span&gt;</code></p><p><code>19406</code><code>&lt;/span&gt;</code></p><p><code>19407</code><code>&lt;/li&gt;</code></p><p><code>19408</code><code>&lt;li id="R678"&gt;</code></p><p><code>19409</code><code>&lt;span class="citation"&gt;</code></p><p><code>19410</code><code>Leung D, Saghatelian A, Simon GM, Cravatt BF. Inactivation of &lt;em&gt;</code></p><p><code>19411</code><code>N-&lt;/em&gt;</code></p><p><code>19412</code><code>acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. &lt;span&gt;</code></p><p><code>19413</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19414</code><code>Biochemistry. &lt;/span&gt;</code></p><p><code>19415</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>19416</code><code>45&lt;/span&gt;</code></p><p><code>19417</code><code>:4720–4725.&lt;/span&gt;</code></p><p><code>19418</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>19419</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1538545/"&gt;</code></p><p><code>19420</code><code>PMC free article&lt;/a&gt;</code></p><p><code>19421</code><code>]&lt;/span&gt;</code></p><p><code>19422</code><code> [&lt;a href="/pubmed/16605240" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19423</code><code>PubMed&lt;/a&gt;</code></p><p><code>19424</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19425</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;amp;title=Inactivation+of+N-acyl+phosphatidylethanolamine+phospholipase+D+reveals+multiple+mechanisms+for+the+biosynthesis+of+endocannabinoids&amp;amp;author=D+Leung&amp;amp;author=A+Saghatelian&amp;amp;author=GM+Simon&amp;amp;author=BF+Cravatt&amp;amp;volume=45&amp;amp;publication_year=2006&amp;amp;pages=4720-4725&amp;amp;pmid=16605240&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19426</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19427</code><code>]&lt;/span&gt;</code></p><p><code>19428</code><code>&lt;/span&gt;</code></p><p><code>19429</code><code>&lt;/li&gt;</code></p><p><code>19430</code><code>&lt;li id="R679"&gt;</code></p><p><code>19431</code><code>&lt;span class="citation"&gt;</code></p><p><code>19432</code><code>Leweke FM, Gerth CW, Klosterkotter J. Cannabis-associated psychosis: current status of research. &lt;span&gt;</code></p><p><code>19433</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19434</code><code>CNS Drugs. &lt;/span&gt;</code></p><p><code>19435</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>19436</code><code>18&lt;/span&gt;</code></p><p><code>19437</code><code>:895–910.&lt;/span&gt;</code></p><p><code>19438</code><code> [&lt;a href="/pubmed/15521792" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19439</code><code>PubMed&lt;/a&gt;</code></p><p><code>19440</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19441</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=CNS+Drugs&amp;amp;title=Cannabis-associated+psychosis:+current+status+of+research&amp;amp;author=FM+Leweke&amp;amp;author=CW+Gerth&amp;amp;author=J+Klosterkotter&amp;amp;volume=18&amp;amp;publication_year=2004&amp;amp;pages=895-910&amp;amp;pmid=15521792&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19442</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19443</code><code>]&lt;/span&gt;</code></p><p><code>19444</code><code>&lt;/span&gt;</code></p><p><code>19445</code><code>&lt;/li&gt;</code></p><p><code>19446</code><code>&lt;li id="R680"&gt;</code></p><p><code>19447</code><code>&lt;span class="citation"&gt;</code></p><p><code>19448</code><code>Leweke FM, Giuffrida A, Wurster U, Emrich HM, Piomelli D. Elevated endogenous cannabinoids in schizophrenia. &lt;span&gt;</code></p><p><code>19449</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19450</code><code>Neuroreport. &lt;/span&gt;</code></p><p><code>19451</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>19452</code><code>10&lt;/span&gt;</code></p><p><code>19453</code><code>:1665–1669.&lt;/span&gt;</code></p><p><code>19454</code><code> [&lt;a href="/pubmed/10501554" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19455</code><code>PubMed&lt;/a&gt;</code></p><p><code>19456</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19457</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroreport&amp;amp;title=Elevated+endogenous+cannabinoids+in+schizophrenia&amp;amp;author=FM+Leweke&amp;amp;author=A+Giuffrida&amp;amp;author=U+Wurster&amp;amp;author=HM+Emrich&amp;amp;author=D+Piomelli&amp;amp;volume=10&amp;amp;publication_year=1999&amp;amp;pages=1665-1669&amp;amp;pmid=10501554&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19458</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19459</code><code>]&lt;/span&gt;</code></p><p><code>19460</code><code>&lt;/span&gt;</code></p><p><code>19461</code><code>&lt;/li&gt;</code></p><p><code>19462</code><code>&lt;li id="R681"&gt;</code></p><p><code>19463</code><code>&lt;span class="citation"&gt;</code></p><p><code>19464</code><code>Lewis DA, Hashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia. &lt;span&gt;</code></p><p><code>19465</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19466</code><code>Nat Rev Neurosci. &lt;/span&gt;</code></p><p><code>19467</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>19468</code><code>6&lt;/span&gt;</code></p><p><code>19469</code><code>:312–324.&lt;/span&gt;</code></p><p><code>19470</code><code> [&lt;a href="/pubmed/15803162" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19471</code><code>PubMed&lt;/a&gt;</code></p><p><code>19472</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19473</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Neurosci&amp;amp;title=Cortical+inhibitory+neurons+and+schizophrenia&amp;amp;author=DA+Lewis&amp;amp;author=T+Hashimoto&amp;amp;author=DW+Volk&amp;amp;volume=6&amp;amp;publication_year=2005&amp;amp;pages=312-324&amp;amp;pmid=15803162&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19474</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19475</code><code>]&lt;/span&gt;</code></p><p><code>19476</code><code>&lt;/span&gt;</code></p><p><code>19477</code><code>&lt;/li&gt;</code></p><p><code>19478</code><code>&lt;li id="R682"&gt;</code></p><p><code>19479</code><code>&lt;span class="citation"&gt;</code></p><p><code>19480</code><code>Li J, Kaminski NE, Wang DH. Anandamide-induced depressor effect in spontaneously hypertensive rats: role of the vanilloid receptor. &lt;span&gt;</code></p><p><code>19481</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19482</code><code>Hypertension. &lt;/span&gt;</code></p><p><code>19483</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>19484</code><code>41&lt;/span&gt;</code></p><p><code>19485</code><code>:757–762.&lt;/span&gt;</code></p><p><code>19486</code><code> [&lt;a href="/pubmed/12623992" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19487</code><code>PubMed&lt;/a&gt;</code></p><p><code>19488</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19489</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;amp;title=Anandamide-induced+depressor+effect+in+spontaneously+hypertensive+rats:+role+of+the+vanilloid+receptor&amp;amp;author=J+Li&amp;amp;author=NE+Kaminski&amp;amp;author=DH+Wang&amp;amp;volume=41&amp;amp;publication_year=2003&amp;amp;pages=757-762&amp;amp;pmid=12623992&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19490</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19491</code><code>]&lt;/span&gt;</code></p><p><code>19492</code><code>&lt;/span&gt;</code></p><p><code>19493</code><code>&lt;/li&gt;</code></p><p><code>19494</code><code>&lt;li id="R683"&gt;</code></p><p><code>19495</code><code>&lt;span class="citation"&gt;</code></p><p><code>19496</code><code>Liang YC, Huang CC, Hsu KS. Therapeutic potential of cannabinoids in trigeminal neuralgia. &lt;span&gt;</code></p><p><code>19497</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19498</code><code>Curr Drug Targets CNS Neurol Disord. &lt;/span&gt;</code></p><p><code>19499</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>19500</code><code>3&lt;/span&gt;</code></p><p><code>19501</code><code>:507–514.&lt;/span&gt;</code></p><p><code>19502</code><code> [&lt;a href="/pubmed/15578967" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19503</code><code>PubMed&lt;/a&gt;</code></p><p><code>19504</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19505</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Drug+Targets+CNS+Neurol+Disord&amp;amp;title=Therapeutic+potential+of+cannabinoids+in+trigeminal+neuralgia&amp;amp;author=YC+Liang&amp;amp;author=CC+Huang&amp;amp;author=KS+Hsu&amp;amp;volume=3&amp;amp;publication_year=2004&amp;amp;pages=507-514&amp;amp;pmid=15578967&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19506</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19507</code><code>]&lt;/span&gt;</code></p><p><code>19508</code><code>&lt;/span&gt;</code></p><p><code>19509</code><code>&lt;/li&gt;</code></p><p><code>19510</code><code>&lt;li id="R684"&gt;</code></p><p><code>19511</code><code>&lt;span class="citation"&gt;</code></p><p><code>19512</code><code>Libby P, Theroux P. Pathophysiology of coronary artery disease. &lt;span&gt;</code></p><p><code>19513</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19514</code><code>Circulation. &lt;/span&gt;</code></p><p><code>19515</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>19516</code><code>111&lt;/span&gt;</code></p><p><code>19517</code><code>:3481–3488.&lt;/span&gt;</code></p><p><code>19518</code><code> [&lt;a href="/pubmed/15983262" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19519</code><code>PubMed&lt;/a&gt;</code></p><p><code>19520</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19521</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;amp;title=Pathophysiology+of+coronary+artery+disease&amp;amp;author=P+Libby&amp;amp;author=P+Theroux&amp;amp;volume=111&amp;amp;publication_year=2005&amp;amp;pages=3481-3488&amp;amp;pmid=15983262&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19522</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19523</code><code>]&lt;/span&gt;</code></p><p><code>19524</code><code>&lt;/span&gt;</code></p><p><code>19525</code><code>&lt;/li&gt;</code></p><p><code>19526</code><code>&lt;li id="R685"&gt;</code></p><p><code>19527</code><code>&lt;span class="citation"&gt;</code></p><p><code>19528</code><code>Lichtman AH, Leung D, Shelton CC, Saghatelian A, Hardouin C, Boger DL, Cravatt BF. Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity. &lt;span&gt;</code></p><p><code>19529</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19530</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>19531</code><code>2004a;&lt;span class="ref-vol"&gt;</code></p><p><code>19532</code><code>311&lt;/span&gt;</code></p><p><code>19533</code><code>:441–448.&lt;/span&gt;</code></p><p><code>19534</code><code> [&lt;a href="/pubmed/15229230" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19535</code><code>PubMed&lt;/a&gt;</code></p><p><code>19536</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19537</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Reversible+inhibitors+of+fatty+acid+amide+hydrolase+that+promote+analgesia:+evidence+for+an+unprecedented+combination+of+potency+and+selectivity&amp;amp;author=AH+Lichtman&amp;amp;author=D+Leung&amp;amp;author=CC+Shelton&amp;amp;author=A+Saghatelian&amp;amp;author=C+Hardouin&amp;amp;volume=311&amp;amp;publication_year=2004a&amp;amp;pages=441-448&amp;amp;pmid=15229230&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19538</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19539</code><code>]&lt;/span&gt;</code></p><p><code>19540</code><code>&lt;/span&gt;</code></p><p><code>19541</code><code>&lt;/li&gt;</code></p><p><code>19542</code><code>&lt;li id="R686"&gt;</code></p><p><code>19543</code><code>&lt;span class="citation"&gt;</code></p><p><code>19544</code><code>Lichtman AH, Martin BR. Cannabinoid-induced antinociception is mediated by a spinal &lt;em&gt;</code></p><p><code>19545</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>19546</code><code>&lt;sub&gt;</code></p><p><code>19547</code><code>2&lt;/sub&gt;</code></p><p><code>19548</code><code>-noradrenergic mechanism. &lt;span&gt;</code></p><p><code>19549</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19550</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>19551</code><code>1991a;&lt;span class="ref-vol"&gt;</code></p><p><code>19552</code><code>559&lt;/span&gt;</code></p><p><code>19553</code><code>:309–314.&lt;/span&gt;</code></p><p><code>19554</code><code> [&lt;a href="/pubmed/1665384" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19555</code><code>PubMed&lt;/a&gt;</code></p><p><code>19556</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19557</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Cannabinoid-induced+antinociception+is+mediated+by+a+spinal+&amp;#x003b1;2-noradrenergic+mechanism&amp;amp;author=AH+Lichtman&amp;amp;author=BR+Martin&amp;amp;volume=559&amp;amp;publication_year=1991a&amp;amp;pages=309-314&amp;amp;pmid=1665384&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19558</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19559</code><code>]&lt;/span&gt;</code></p><p><code>19560</code><code>&lt;/span&gt;</code></p><p><code>19561</code><code>&lt;/li&gt;</code></p><p><code>19562</code><code>&lt;li id="R687"&gt;</code></p><p><code>19563</code><code>&lt;span class="citation"&gt;</code></p><p><code>19564</code><code>Lichtman AH, Martin BR. Spinal and supraspinal components of cannabinoid-induced antinociception. &lt;span&gt;</code></p><p><code>19565</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19566</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>19567</code><code>1991b;&lt;span class="ref-vol"&gt;</code></p><p><code>19568</code><code>258&lt;/span&gt;</code></p><p><code>19569</code><code>:517–523.&lt;/span&gt;</code></p><p><code>19570</code><code> [&lt;a href="/pubmed/1650831" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19571</code><code>PubMed&lt;/a&gt;</code></p><p><code>19572</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19573</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Spinal+and+supraspinal+components+of+cannabinoid-induced+antinociception&amp;amp;author=AH+Lichtman&amp;amp;author=BR+Martin&amp;amp;volume=258&amp;amp;publication_year=1991b&amp;amp;pages=517-523&amp;amp;pmid=1650831&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19574</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19575</code><code>]&lt;/span&gt;</code></p><p><code>19576</code><code>&lt;/span&gt;</code></p><p><code>19577</code><code>&lt;/li&gt;</code></p><p><code>19578</code><code>&lt;li id="R688"&gt;</code></p><p><code>19579</code><code>&lt;span class="citation"&gt;</code></p><p><code>19580</code><code>Lichtman AH, Shelton CC, Advani T, Cravatt BF. Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. &lt;span&gt;</code></p><p><code>19581</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19582</code><code>Pain. &lt;/span&gt;</code></p><p><code>19583</code><code>2004b;&lt;span class="ref-vol"&gt;</code></p><p><code>19584</code><code>109&lt;/span&gt;</code></p><p><code>19585</code><code>:319–327.&lt;/span&gt;</code></p><p><code>19586</code><code> [&lt;a href="/pubmed/15157693" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19587</code><code>PubMed&lt;/a&gt;</code></p><p><code>19588</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19589</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;amp;title=Mice+lacking+fatty+acid+amide+hydrolase+exhibit+a+cannabinoid+receptor-mediated+phenotypic+hypoalgesia&amp;amp;author=AH+Lichtman&amp;amp;author=CC+Shelton&amp;amp;author=T+Advani&amp;amp;author=BF+Cravatt&amp;amp;volume=109&amp;amp;publication_year=2004b&amp;amp;pages=319-327&amp;amp;pmid=15157693&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19590</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19591</code><code>]&lt;/span&gt;</code></p><p><code>19592</code><code>&lt;/span&gt;</code></p><p><code>19593</code><code>&lt;/li&gt;</code></p><p><code>19594</code><code>&lt;li id="R689"&gt;</code></p><p><code>19595</code><code>&lt;span class="citation"&gt;</code></p><p><code>19596</code><code>Ligresti A, Cascio MG, Pryce G, Kulasegram S, Beletskaya I, De Petrocellis L, Saha B, Mahadevan A, Visintin C, Wiley JL, et al.  New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis. &lt;span&gt;</code></p><p><code>19597</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19598</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>19599</code><code>2006a;&lt;span class="ref-vol"&gt;</code></p><p><code>19600</code><code>147&lt;/span&gt;</code></p><p><code>19601</code><code>:83–91.&lt;/span&gt;</code></p><p><code>19602</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>19603</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1615845/"&gt;</code></p><p><code>19604</code><code>PMC free article&lt;/a&gt;</code></p><p><code>19605</code><code>]&lt;/span&gt;</code></p><p><code>19606</code><code> [&lt;a href="/pubmed/16284631" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19607</code><code>PubMed&lt;/a&gt;</code></p><p><code>19608</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19609</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=New+potent+and+selective+inhibitors+of+anandamide+reuptake+with+antispastic+activity+in+a+mouse+model+of+multiple+sclerosis&amp;amp;author=A+Ligresti&amp;amp;author=MG+Cascio&amp;amp;author=G+Pryce&amp;amp;author=S+Kulasegram&amp;amp;author=I+Beletskaya&amp;amp;volume=147&amp;amp;publication_year=2006a&amp;amp;pages=83-91&amp;amp;pmid=16284631&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19610</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19611</code><code>]&lt;/span&gt;</code></p><p><code>19612</code><code>&lt;/span&gt;</code></p><p><code>19613</code><code>&lt;/li&gt;</code></p><p><code>19614</code><code>&lt;li id="R690"&gt;</code></p><p><code>19615</code><code>&lt;span class="citation"&gt;</code></p><p><code>19616</code><code>Ligresti A, Schiano Moriello A, Starowicz K, Matias I, Pisanti S, De Petrocellis L, Laezza C, Portella G, Bifulco M, Di Marzo V. Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. &lt;span&gt;</code></p><p><code>19617</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19618</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>19619</code><code>2006b&lt;/span&gt;</code></p><p><code>19620</code><code> in press. [&lt;a href="/pubmed/16728591" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19621</code><code>PubMed&lt;/a&gt;</code></p><p><code>19622</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19623</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Anti-tumor+activity+of+plant+cannabinoids+with+emphasis+on+the+effect+of+cannabidiol+on+human+breast+carcinoma&amp;amp;author=A+Ligresti&amp;amp;author=A+Schiano+Moriello&amp;amp;author=K+Starowicz&amp;amp;author=I+Matias&amp;amp;author=S+Pisanti&amp;amp;publication_year=2006b&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19624</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19625</code><code>]&lt;/span&gt;</code></p><p><code>19626</code><code>&lt;/span&gt;</code></p><p><code>19627</code><code>&lt;/li&gt;</code></p><p><code>19628</code><code>&lt;li id="R691"&gt;</code></p><p><code>19629</code><code>&lt;span class="citation"&gt;</code></p><p><code>19630</code><code>Lin S, Khanolkar AD, Fan P, Goutopoulos A, Qin C, Papahadjis D, Makriyannis A. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability. &lt;span&gt;</code></p><p><code>19631</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19632</code><code>J Med Chem. &lt;/span&gt;</code></p><p><code>19633</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>19634</code><code>41&lt;/span&gt;</code></p><p><code>19635</code><code>:5353–5361.&lt;/span&gt;</code></p><p><code>19636</code><code> [&lt;a href="/pubmed/9876105" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19637</code><code>PubMed&lt;/a&gt;</code></p><p><code>19638</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19639</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;amp;title=Novel+analogues+of+arachidonylethanolamide+(anandamide):+affinities+for+the+CB1+and+CB2+cannabinoid+receptors+and+metabolic+stability&amp;amp;author=S+Lin&amp;amp;author=AD+Khanolkar&amp;amp;author=P+Fan&amp;amp;author=A+Goutopoulos&amp;amp;author=C+Qin&amp;amp;volume=41&amp;amp;publication_year=1998&amp;amp;pages=5353-5361&amp;amp;pmid=9876105&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19640</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19641</code><code>]&lt;/span&gt;</code></p><p><code>19642</code><code>&lt;/span&gt;</code></p><p><code>19643</code><code>&lt;/li&gt;</code></p><p><code>19644</code><code>&lt;li id="R692"&gt;</code></p><p><code>19645</code><code>&lt;span class="citation"&gt;</code></p><p><code>19646</code><code>Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. &lt;span&gt;</code></p><p><code>19647</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19648</code><code>Arch Gen Psychiatry. &lt;/span&gt;</code></p><p><code>19649</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>19650</code><code>51&lt;/span&gt;</code></p><p><code>19651</code><code>:273–279.&lt;/span&gt;</code></p><p><code>19652</code><code> [&lt;a href="/pubmed/8161287" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19653</code><code>PubMed&lt;/a&gt;</code></p><p><code>19654</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19655</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Arch+Gen+Psychiatry&amp;amp;title=Cannabis+abuse+and+the+course+of+recent-onset+schizophrenic+disorders&amp;amp;author=DH+Linszen&amp;amp;author=PM+Dingemans&amp;amp;author=ME+Lenior&amp;amp;volume=51&amp;amp;publication_year=1994&amp;amp;pages=273-279&amp;amp;pmid=8161287&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19656</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19657</code><code>]&lt;/span&gt;</code></p><p><code>19658</code><code>&lt;/span&gt;</code></p><p><code>19659</code><code>&lt;/li&gt;</code></p><p><code>19660</code><code>&lt;li id="R693"&gt;</code></p><p><code>19661</code><code>&lt;span class="citation"&gt;</code></p><p><code>19662</code><code>Liu J, B&amp;#x000e1;tkai S, Pacher P, Harvey-White J, Wagner JA, Cravatt BF, Gao B, Kunos G. LPS induces anandamide synthesis in macrophages via CD14/MAPK/PI3K/NF-&lt;em&gt;</code></p><p><code>19663</code><code>&amp;#x003ba;&lt;/em&gt;</code></p><p><code>19664</code><code>B independently of platelet activating factor. &lt;span&gt;</code></p><p><code>19665</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19666</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>19667</code><code>2003a;&lt;span class="ref-vol"&gt;</code></p><p><code>19668</code><code>278&lt;/span&gt;</code></p><p><code>19669</code><code>:45034–45039.&lt;/span&gt;</code></p><p><code>19670</code><code> [&lt;a href="/pubmed/12949078" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19671</code><code>PubMed&lt;/a&gt;</code></p><p><code>19672</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19673</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=LPS+induces+anandamide+synthesis+in+macrophages+via+CD14/MAPK/PI3K/NF-&amp;#x003ba;B+independently+of+platelet+activating+factor&amp;amp;author=J+Liu&amp;amp;author=S+B&amp;#x000e1;tkai&amp;amp;author=P+Pacher&amp;amp;author=J+Harvey-White&amp;amp;author=JA+Wagner&amp;amp;volume=278&amp;amp;publication_year=2003a&amp;amp;pages=45034-45039&amp;amp;pmid=12949078&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19674</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19675</code><code>]&lt;/span&gt;</code></p><p><code>19676</code><code>&lt;/span&gt;</code></p><p><code>19677</code><code>&lt;/li&gt;</code></p><p><code>19678</code><code>&lt;li id="R694"&gt;</code></p><p><code>19679</code><code>&lt;span class="citation"&gt;</code></p><p><code>19680</code><code>Liu J, Gao B, Mirshahi F, Sanyal AJ, Khanolkar AD, Makriyannis A, Kunos G. Functional CB1 cannabinoid receptors in human vascular endothelial cells. &lt;span&gt;</code></p><p><code>19681</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19682</code><code>Biochem J. &lt;/span&gt;</code></p><p><code>19683</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>19684</code><code>346&lt;/span&gt;</code></p><p><code>19685</code><code>:835–840.&lt;/span&gt;</code></p><p><code>19686</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>19687</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1220920/"&gt;</code></p><p><code>19688</code><code>PMC free article&lt;/a&gt;</code></p><p><code>19689</code><code>]&lt;/span&gt;</code></p><p><code>19690</code><code> [&lt;a href="/pubmed/10698714" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19691</code><code>PubMed&lt;/a&gt;</code></p><p><code>19692</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19693</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+J&amp;amp;title=Functional+CB1+cannabinoid+receptors+in+human+vascular+endothelial+cells&amp;amp;author=J+Liu&amp;amp;author=B+Gao&amp;amp;author=F+Mirshahi&amp;amp;author=AJ+Sanyal&amp;amp;author=AD+Khanolkar&amp;amp;volume=346&amp;amp;publication_year=2000&amp;amp;pages=835-840&amp;amp;pmid=10698714&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19694</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19695</code><code>]&lt;/span&gt;</code></p><p><code>19696</code><code>&lt;/span&gt;</code></p><p><code>19697</code><code>&lt;/li&gt;</code></p><p><code>19698</code><code>&lt;li id="R695"&gt;</code></p><p><code>19699</code><code>&lt;span class="citation"&gt;</code></p><p><code>19700</code><code>Liu J, Li H, Burstein SH, Zurier RB, Chen JD. Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid. &lt;span&gt;</code></p><p><code>19701</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19702</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>19703</code><code>2003b;&lt;span class="ref-vol"&gt;</code></p><p><code>19704</code><code>63&lt;/span&gt;</code></p><p><code>19705</code><code>:983–992.&lt;/span&gt;</code></p><p><code>19706</code><code> [&lt;a href="/pubmed/12695526" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19707</code><code>PubMed&lt;/a&gt;</code></p><p><code>19708</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19709</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=Activation+and+binding+of+peroxisome+proliferator-activated+receptor+gamma+by+synthetic+cannabinoid+ajulemic+acid&amp;amp;author=J+Liu&amp;amp;author=H+Li&amp;amp;author=SH+Burstein&amp;amp;author=RB+Zurier&amp;amp;author=JD+Chen&amp;amp;volume=63&amp;amp;publication_year=2003b&amp;amp;pages=983-992&amp;amp;pmid=12695526&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19710</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19711</code><code>]&lt;/span&gt;</code></p><p><code>19712</code><code>&lt;/span&gt;</code></p><p><code>19713</code><code>&lt;/li&gt;</code></p><p><code>19714</code><code>&lt;li id="R696"&gt;</code></p><p><code>19715</code><code>&lt;span class="citation"&gt;</code></p><p><code>19716</code><code>Liu J, Wang L, Harvey-White J, Osei-Hyiaman D, Razdan RK, Zhou Z, Chen A, Huang B, Kim HY, Kunos G. Novel biosynthetic pathway for anandamide. &lt;span&gt;</code></p><p><code>19717</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19718</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>19719</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>19720</code><code>103&lt;/span&gt;</code></p><p><code>19721</code><code>:13345–13350.&lt;/span&gt;</code></p><p><code>19722</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>19723</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1557387/"&gt;</code></p><p><code>19724</code><code>PMC free article&lt;/a&gt;</code></p><p><code>19725</code><code>]&lt;/span&gt;</code></p><p><code>19726</code><code> [&lt;a href="/pubmed/16938887" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19727</code><code>PubMed&lt;/a&gt;</code></p><p><code>19728</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19729</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Novel+biosynthetic+pathway+for+anandamide&amp;amp;author=J+Liu&amp;amp;author=L+Wang&amp;amp;author=J+Harvey-White&amp;amp;author=D+Osei-Hyiaman&amp;amp;author=RK+Razdan&amp;amp;volume=103&amp;amp;publication_year=2006&amp;amp;pages=13345-13350&amp;amp;pmid=16938887&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19730</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19731</code><code>]&lt;/span&gt;</code></p><p><code>19732</code><code>&lt;/span&gt;</code></p><p><code>19733</code><code>&lt;/li&gt;</code></p><p><code>19734</code><code>&lt;li id="R697"&gt;</code></p><p><code>19735</code><code>&lt;span class="citation"&gt;</code></p><p><code>19736</code><code>Liu JH, Dacus AC. Central nervous system and peripheral mechanisms in ocular hypotensive effect of cannabinoids. &lt;span&gt;</code></p><p><code>19737</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19738</code><code>Arch Ophthalmol. &lt;/span&gt;</code></p><p><code>19739</code><code>1987;&lt;span class="ref-vol"&gt;</code></p><p><code>19740</code><code>105&lt;/span&gt;</code></p><p><code>19741</code><code>:245–248.&lt;/span&gt;</code></p><p><code>19742</code><code> [&lt;a href="/pubmed/3813958" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19743</code><code>PubMed&lt;/a&gt;</code></p><p><code>19744</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19745</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Arch+Ophthalmol&amp;amp;title=Central+nervous+system+and+peripheral+mechanisms+in+ocular+hypotensive+effect+of+cannabinoids&amp;amp;author=JH+Liu&amp;amp;author=AC+Dacus&amp;amp;volume=105&amp;amp;publication_year=1987&amp;amp;pages=245-248&amp;amp;pmid=3813958&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19746</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19747</code><code>]&lt;/span&gt;</code></p><p><code>19748</code><code>&lt;/span&gt;</code></p><p><code>19749</code><code>&lt;/li&gt;</code></p><p><code>19750</code><code>&lt;li id="R698"&gt;</code></p><p><code>19751</code><code>&lt;span class="citation"&gt;</code></p><p><code>19752</code><code>Liu YL, Connoley IP, Wilson CA, Stock MJ. Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in &lt;em&gt;</code></p><p><code>19753</code><code>Lep&lt;/em&gt;</code></p><p><code>19754</code><code>&lt;sup&gt;</code></p><p><code>19755</code><code>ob&lt;/sup&gt;</code></p><p><code>19756</code><code>/&lt;em&gt;</code></p><p><code>19757</code><code>Lep&lt;/em&gt;</code></p><p><code>19758</code><code>&lt;sup&gt;</code></p><p><code>19759</code><code>ob&lt;/sup&gt;</code></p><p><code>19760</code><code> mice. &lt;span&gt;</code></p><p><code>19761</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19762</code><code>Int J Obes Relat Metab Disord. &lt;/span&gt;</code></p><p><code>19763</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>19764</code><code>29&lt;/span&gt;</code></p><p><code>19765</code><code>:183–187.&lt;/span&gt;</code></p><p><code>19766</code><code> [&lt;a href="/pubmed/15558076" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19767</code><code>PubMed&lt;/a&gt;</code></p><p><code>19768</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19769</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Obes+Relat+Metab+Disord&amp;amp;title=Effects+of+the+cannabinoid+CB1+receptor+antagonist+SR141716+on+oxygen+consumption+and+soleus+muscle+glucose+uptake+in+Lepob/Lepob+mice&amp;amp;author=YL+Liu&amp;amp;author=IP+Connoley&amp;amp;author=CA+Wilson&amp;amp;author=MJ+Stock&amp;amp;volume=29&amp;amp;publication_year=2005&amp;amp;pages=183-187&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19770</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19771</code><code>]&lt;/span&gt;</code></p><p><code>19772</code><code>&lt;/span&gt;</code></p><p><code>19773</code><code>&lt;/li&gt;</code></p><p><code>19774</code><code>&lt;li id="R699"&gt;</code></p><p><code>19775</code><code>&lt;span class="citation"&gt;</code></p><p><code>19776</code><code>Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya S. An analysis of risk factors for oral cancer in young people: a case-control study. &lt;span&gt;</code></p><p><code>19777</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19778</code><code>Oral Oncol. &lt;/span&gt;</code></p><p><code>19779</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>19780</code><code>40&lt;/span&gt;</code></p><p><code>19781</code><code>:304–313.&lt;/span&gt;</code></p><p><code>19782</code><code> [&lt;a href="/pubmed/14747062" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19783</code><code>PubMed&lt;/a&gt;</code></p><p><code>19784</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19785</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Oral+Oncol&amp;amp;title=An+analysis+of+risk+factors+for+oral+cancer+in+young+people:+a+case-control+study&amp;amp;author=CD+Llewellyn&amp;amp;author=K+Linklater&amp;amp;author=J+Bell&amp;amp;author=NW+Johnson&amp;amp;author=S+Warnakulasuriya&amp;amp;volume=40&amp;amp;publication_year=2004&amp;amp;pages=304-313&amp;amp;pmid=14747062&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19786</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19787</code><code>]&lt;/span&gt;</code></p><p><code>19788</code><code>&lt;/span&gt;</code></p><p><code>19789</code><code>&lt;/li&gt;</code></p><p><code>19790</code><code>&lt;li id="R700"&gt;</code></p><p><code>19791</code><code>&lt;span class="citation"&gt;</code></p><p><code>19792</code><code>Loftus EV., Jr Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. &lt;span&gt;</code></p><p><code>19793</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19794</code><code>Gastroenterology. &lt;/span&gt;</code></p><p><code>19795</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>19796</code><code>126&lt;/span&gt;</code></p><p><code>19797</code><code>:1504–1517.&lt;/span&gt;</code></p><p><code>19798</code><code> [&lt;a href="/pubmed/15168363" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19799</code><code>PubMed&lt;/a&gt;</code></p><p><code>19800</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19801</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;amp;title=Clinical+epidemiology+of+inflammatory+bowel+disease:+incidence,+prevalence,+and+environmental+influences&amp;amp;author=EV+Loftus&amp;amp;volume=126&amp;amp;publication_year=2004&amp;amp;pages=1504-1517&amp;amp;pmid=15168363&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19802</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19803</code><code>]&lt;/span&gt;</code></p><p><code>19804</code><code>&lt;/span&gt;</code></p><p><code>19805</code><code>&lt;/li&gt;</code></p><p><code>19806</code><code>&lt;li id="R701"&gt;</code></p><p><code>19807</code><code>&lt;span class="citation"&gt;</code></p><p><code>19808</code><code>Lograno MD, Romano MR. Cannabinoid agonists induce contractile responses through G&lt;sub&gt;</code></p><p><code>19809</code><code>i/o&lt;/sub&gt;</code></p><p><code>19810</code><code>-dependent activation of phospholipase C in the bovine ciliary muscle. &lt;span&gt;</code></p><p><code>19811</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19812</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>19813</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>19814</code><code>494&lt;/span&gt;</code></p><p><code>19815</code><code>:55–62.&lt;/span&gt;</code></p><p><code>19816</code><code> [&lt;a href="/pubmed/15194451" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19817</code><code>PubMed&lt;/a&gt;</code></p><p><code>19818</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19819</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Cannabinoid+agonists+induce+contractile+responses+through+Gi/o-dependent+activation+of+phospholipase+C+in+the+bovine+ciliary+muscle&amp;amp;author=MD+Lograno&amp;amp;author=MR+Romano&amp;amp;volume=494&amp;amp;publication_year=2004&amp;amp;pages=55-62&amp;amp;pmid=15194451&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19820</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19821</code><code>]&lt;/span&gt;</code></p><p><code>19822</code><code>&lt;/span&gt;</code></p><p><code>19823</code><code>&lt;/li&gt;</code></p><p><code>19824</code><code>&lt;li id="R702"&gt;</code></p><p><code>19825</code><code>&lt;span class="citation"&gt;</code></p><p><code>19826</code><code>Lombard C, Nagarkatti M, Nagarkatti PS. Targeting cannabinoid receptors to treat leukemia: role of cross-talk between extrinsic and intrinsic pathways in &amp;#x00394;&lt;sup&gt;</code></p><p><code>19827</code><code>9&lt;/sup&gt;</code></p><p><code>19828</code><code>-tetrahydrocannabinol (THC)-induced apoptosis of Jurkat cells. &lt;span&gt;</code></p><p><code>19829</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19830</code><code>Leuk Res. &lt;/span&gt;</code></p><p><code>19831</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>19832</code><code>29&lt;/span&gt;</code></p><p><code>19833</code><code>:915–922.&lt;/span&gt;</code></p><p><code>19834</code><code> [&lt;a href="/pubmed/15978942" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19835</code><code>PubMed&lt;/a&gt;</code></p><p><code>19836</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19837</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Leuk+Res&amp;amp;title=Targeting+cannabinoid+receptors+to+treat+leukemia:+role+of+cross-talk+between+extrinsic+and+intrinsic+pathways+in+&amp;#x00394;9-tetrahydrocannabinol+(THC)-induced+apoptosis+of+Jurkat+cells&amp;amp;author=C+Lombard&amp;amp;author=M+Nagarkatti&amp;amp;author=PS+Nagarkatti&amp;amp;volume=29&amp;amp;publication_year=2005&amp;amp;pages=915-922&amp;amp;pmid=15978942&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19838</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19839</code><code>]&lt;/span&gt;</code></p><p><code>19840</code><code>&lt;/span&gt;</code></p><p><code>19841</code><code>&lt;/li&gt;</code></p><p><code>19842</code><code>&lt;li id="R703"&gt;</code></p><p><code>19843</code><code>&lt;span class="citation"&gt;</code></p><p><code>19844</code><code>Long LE, Malone DT, Taylor DA. Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice. &lt;span&gt;</code></p><p><code>19845</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19846</code><code>Neuropsychopharmacology. &lt;/span&gt;</code></p><p><code>19847</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>19848</code><code>31&lt;/span&gt;</code></p><p><code>19849</code><code>:795–803.&lt;/span&gt;</code></p><p><code>19850</code><code> [&lt;a href="/pubmed/16052245" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19851</code><code>PubMed&lt;/a&gt;</code></p><p><code>19852</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19853</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;amp;title=Cannabidiol+reverses+MK-801-induced+disruption+of+prepulse+inhibition+in+mice&amp;amp;author=LE+Long&amp;amp;author=DT+Malone&amp;amp;author=DA+Taylor&amp;amp;volume=31&amp;amp;publication_year=2006&amp;amp;pages=795-803&amp;amp;pmid=16052245&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19854</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19855</code><code>]&lt;/span&gt;</code></p><p><code>19856</code><code>&lt;/span&gt;</code></p><p><code>19857</code><code>&lt;/li&gt;</code></p><p><code>19858</code><code>&lt;li id="R704"&gt;</code></p><p><code>19859</code><code>&lt;span class="citation"&gt;</code></p><p><code>19860</code><code>Lopez-Moreno JA, Gonzalez-Cuevas G, Rodriguez de Fonseca F, Navarro M. Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation. &lt;span&gt;</code></p><p><code>19861</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19862</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>19863</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>19864</code><code>24&lt;/span&gt;</code></p><p><code>19865</code><code>:8245–8252.&lt;/span&gt;</code></p><p><code>19866</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>19867</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6729684/"&gt;</code></p><p><code>19868</code><code>PMC free article&lt;/a&gt;</code></p><p><code>19869</code><code>]&lt;/span&gt;</code></p><p><code>19870</code><code> [&lt;a href="/pubmed/15385608" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19871</code><code>PubMed&lt;/a&gt;</code></p><p><code>19872</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19873</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Long-lasting+increase+of+alcohol+relapse+by+the+cannabinoid+receptor+agonist+WIN+55,212-2+during+alcohol+deprivation&amp;amp;author=JA+Lopez-Moreno&amp;amp;author=G+Gonzalez-Cuevas&amp;amp;author=F+Rodriguez+de+Fonseca&amp;amp;author=M+Navarro&amp;amp;volume=24&amp;amp;publication_year=2005&amp;amp;pages=8245-8252&amp;amp;pmid=15385608&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19874</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19875</code><code>]&lt;/span&gt;</code></p><p><code>19876</code><code>&lt;/span&gt;</code></p><p><code>19877</code><code>&lt;/li&gt;</code></p><p><code>19878</code><code>&lt;li id="R705"&gt;</code></p><p><code>19879</code><code>&lt;span class="citation"&gt;</code></p><p><code>19880</code><code>Lopez-Rodriguez ML, Viso A, Ortega-Gutierrez S, Fowler CJ, Tiger G, de Lago E, Fernandez-Ruiz J, Ramos JA. Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors. &lt;span&gt;</code></p><p><code>19881</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19882</code><code>Eur J Med Chem. &lt;/span&gt;</code></p><p><code>19883</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>19884</code><code>38&lt;/span&gt;</code></p><p><code>19885</code><code>:403–412.&lt;/span&gt;</code></p><p><code>19886</code><code> [&lt;a href="/pubmed/12750028" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19887</code><code>PubMed&lt;/a&gt;</code></p><p><code>19888</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19889</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Med+Chem&amp;amp;title=Design,+synthesis+and+biological+evaluation+of+new+endocannabinoid+transporter+inhibitors&amp;amp;author=ML+Lopez-Rodriguez&amp;amp;author=A+Viso&amp;amp;author=S+Ortega-Gutierrez&amp;amp;author=CJ+Fowler&amp;amp;author=G+Tiger&amp;amp;volume=38&amp;amp;publication_year=2003&amp;amp;pages=403-412&amp;amp;pmid=12750028&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19890</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19891</code><code>]&lt;/span&gt;</code></p><p><code>19892</code><code>&lt;/span&gt;</code></p><p><code>19893</code><code>&lt;/li&gt;</code></p><p><code>19894</code><code>&lt;li id="R706"&gt;</code></p><p><code>19895</code><code>&lt;span class="citation"&gt;</code></p><p><code>19896</code><code>Lopez-Rodriguez ML, Viso A, Ortega-Gutierrez S, Lastres-Becker I, Gonzalez S, Fernandez-Ruiz J, Ramos JA. Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors. &lt;span&gt;</code></p><p><code>19897</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19898</code><code>J Med Chem. &lt;/span&gt;</code></p><p><code>19899</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>19900</code><code>44&lt;/span&gt;</code></p><p><code>19901</code><code>:4505–4508.&lt;/span&gt;</code></p><p><code>19902</code><code> [&lt;a href="/pubmed/11741470" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19903</code><code>PubMed&lt;/a&gt;</code></p><p><code>19904</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19905</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;amp;title=Design,+synthesis+and+biological+evaluation+of+novel+arachidonic+acid+derivatives+as+highly+potent+and+selective+endocannabinoid+transporter+inhibitors&amp;amp;author=ML+Lopez-Rodriguez&amp;amp;author=A+Viso&amp;amp;author=S+Ortega-Gutierrez&amp;amp;author=I+Lastres-Becker&amp;amp;author=S+Gonzalez&amp;amp;volume=44&amp;amp;publication_year=2001&amp;amp;pages=4505-4508&amp;amp;pmid=11741470&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19906</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19907</code><code>]&lt;/span&gt;</code></p><p><code>19908</code><code>&lt;/span&gt;</code></p><p><code>19909</code><code>&lt;/li&gt;</code></p><p><code>19910</code><code>&lt;li id="R707"&gt;</code></p><p><code>19911</code><code>&lt;span class="citation"&gt;</code></p><p><code>19912</code><code>Louw DF, Yang FW, Sutherland GR. The effect of &amp;#x00394;-9-tetrahydrocannab-inol on forebrain ischemia in rat. &lt;span&gt;</code></p><p><code>19913</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19914</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>19915</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>19916</code><code>857&lt;/span&gt;</code></p><p><code>19917</code><code>:183–187.&lt;/span&gt;</code></p><p><code>19918</code><code> [&lt;a href="/pubmed/10700566" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19919</code><code>PubMed&lt;/a&gt;</code></p><p><code>19920</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19921</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=The+effect+of+&amp;#x00394;-9-tetrahydrocannab-inol+on+forebrain+ischemia+in+rat&amp;amp;author=DF+Louw&amp;amp;author=FW+Yang&amp;amp;author=GR+Sutherland&amp;amp;volume=857&amp;amp;publication_year=2000&amp;amp;pages=183-187&amp;amp;pmid=10700566&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19922</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19923</code><code>]&lt;/span&gt;</code></p><p><code>19924</code><code>&lt;/span&gt;</code></p><p><code>19925</code><code>&lt;/li&gt;</code></p><p><code>19926</code><code>&lt;li id="R708"&gt;</code></p><p><code>19927</code><code>&lt;span class="citation"&gt;</code></p><p><code>19928</code><code>Lu Q, Straiker A, Lu Q, Maguire G. Expression of CB2 cannabinoid receptor mRNA in adult rat retina. &lt;span&gt;</code></p><p><code>19929</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19930</code><code>Vis Neurosci. &lt;/span&gt;</code></p><p><code>19931</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>19932</code><code>17&lt;/span&gt;</code></p><p><code>19933</code><code>:91–95.&lt;/span&gt;</code></p><p><code>19934</code><code> [&lt;a href="/pubmed/10750830" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19935</code><code>PubMed&lt;/a&gt;</code></p><p><code>19936</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19937</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Vis+Neurosci&amp;amp;title=Expression+of+CB2+cannabinoid+receptor+mRNA+in+adult+rat+retina&amp;amp;author=Q+Lu&amp;amp;author=A+Straiker&amp;amp;author=Q+Lu&amp;amp;author=G+Maguire&amp;amp;volume=17&amp;amp;publication_year=2000&amp;amp;pages=91-95&amp;amp;pmid=10750830&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19938</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19939</code><code>]&lt;/span&gt;</code></p><p><code>19940</code><code>&lt;/span&gt;</code></p><p><code>19941</code><code>&lt;/li&gt;</code></p><p><code>19942</code><code>&lt;li id="R709"&gt;</code></p><p><code>19943</code><code>&lt;span class="citation"&gt;</code></p><p><code>19944</code><code>Lukas SE, Sholar M, Kouri E, Fukuzako H, Mendelson JH. Marihuana smoking increases plasma cocaine levels and subjective reports of euphoria in male volunteers. &lt;span&gt;</code></p><p><code>19945</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19946</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>19947</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>19948</code><code>48&lt;/span&gt;</code></p><p><code>19949</code><code>:715–721.&lt;/span&gt;</code></p><p><code>19950</code><code> [&lt;a href="/pubmed/7938127" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19951</code><code>PubMed&lt;/a&gt;</code></p><p><code>19952</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19953</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Marihuana+smoking+increases+plasma+cocaine+levels+and+subjective+reports+of+euphoria+in+male+volunteers&amp;amp;author=SE+Lukas&amp;amp;author=M+Sholar&amp;amp;author=E+Kouri&amp;amp;author=H+Fukuzako&amp;amp;author=JH+Mendelson&amp;amp;volume=48&amp;amp;publication_year=1994&amp;amp;pages=715-721&amp;amp;pmid=7938127&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19954</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19955</code><code>]&lt;/span&gt;</code></p><p><code>19956</code><code>&lt;/span&gt;</code></p><p><code>19957</code><code>&lt;/li&gt;</code></p><p><code>19958</code><code>&lt;li id="R710"&gt;</code></p><p><code>19959</code><code>&lt;span class="citation"&gt;</code></p><p><code>19960</code><code>Lumsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromatographic assay in portal, hepatic and peripheral blood in patients with cirrhosis. &lt;span&gt;</code></p><p><code>19961</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19962</code><code>Hepatology. &lt;/span&gt;</code></p><p><code>19963</code><code>1988;&lt;span class="ref-vol"&gt;</code></p><p><code>19964</code><code>8&lt;/span&gt;</code></p><p><code>19965</code><code>:232–236.&lt;/span&gt;</code></p><p><code>19966</code><code> [&lt;a href="/pubmed/3281884" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19967</code><code>PubMed&lt;/a&gt;</code></p><p><code>19968</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19969</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;amp;title=Endotoxin+levels+measured+by+a+chromatographic+assay+in+portal,+hepatic+and+peripheral+blood+in+patients+with+cirrhosis&amp;amp;author=AB+Lumsden&amp;amp;author=JM+Henderson&amp;amp;author=MH+Kutner&amp;amp;volume=8&amp;amp;publication_year=1988&amp;amp;pages=232-236&amp;amp;pmid=3281884&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19970</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19971</code><code>]&lt;/span&gt;</code></p><p><code>19972</code><code>&lt;/span&gt;</code></p><p><code>19973</code><code>&lt;/li&gt;</code></p><p><code>19974</code><code>&lt;li id="R711"&gt;</code></p><p><code>19975</code><code>&lt;span class="citation"&gt;</code></p><p><code>19976</code><code>Lupica CR, Riegel AC, Hoffman AF. Marijuana and cannabinoid regulation of brain reward circuits. &lt;span&gt;</code></p><p><code>19977</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19978</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>19979</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>19980</code><code>143&lt;/span&gt;</code></p><p><code>19981</code><code>:227–234.&lt;/span&gt;</code></p><p><code>19982</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>19983</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1575338/"&gt;</code></p><p><code>19984</code><code>PMC free article&lt;/a&gt;</code></p><p><code>19985</code><code>]&lt;/span&gt;</code></p><p><code>19986</code><code> [&lt;a href="/pubmed/15313883" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>19987</code><code>PubMed&lt;/a&gt;</code></p><p><code>19988</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>19989</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Marijuana+and+cannabinoid+regulation+of+brain+reward+circuits&amp;amp;author=CR+Lupica&amp;amp;author=AC+Riegel&amp;amp;author=AF+Hoffman&amp;amp;volume=143&amp;amp;publication_year=2004&amp;amp;pages=227-234&amp;amp;pmid=15313883&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>19990</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>19991</code><code>]&lt;/span&gt;</code></p><p><code>19992</code><code>&lt;/span&gt;</code></p><p><code>19993</code><code>&lt;/li&gt;</code></p><p><code>19994</code><code>&lt;li id="R712"&gt;</code></p><p><code>19995</code><code>&lt;span class="citation"&gt;</code></p><p><code>19996</code><code>Lutz B. Molecular biology of cannabinoid receptors. &lt;span&gt;</code></p><p><code>19997</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>19998</code><code>Prostaglandins Leukotrienes Essent Fatty Acids. &lt;/span&gt;</code></p><p><code>19999</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>20000</code><code>66&lt;/span&gt;</code></p><p><code>20001</code><code>:123–142.&lt;/span&gt;</code></p><p><code>20002</code><code> [&lt;a href="/pubmed/12052031" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20003</code><code>PubMed&lt;/a&gt;</code></p><p><code>20004</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20005</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Prostaglandins+Leukotrienes+Essent+Fatty+Acids&amp;amp;title=Molecular+biology+of+cannabinoid+receptors&amp;amp;author=B+Lutz&amp;amp;volume=66&amp;amp;publication_year=2002&amp;amp;pages=123-142&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20006</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20007</code><code>]&lt;/span&gt;</code></p><p><code>20008</code><code>&lt;/span&gt;</code></p><p><code>20009</code><code>&lt;/li&gt;</code></p><p><code>20010</code><code>&lt;li id="R713"&gt;</code></p><p><code>20011</code><code>&lt;span class="citation"&gt;</code></p><p><code>20012</code><code>Lutz B. On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. &lt;span&gt;</code></p><p><code>20013</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20014</code><code>Biochem Pharmacol. &lt;/span&gt;</code></p><p><code>20015</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>20016</code><code>68&lt;/span&gt;</code></p><p><code>20017</code><code>:1691–1698.&lt;/span&gt;</code></p><p><code>20018</code><code> [&lt;a href="/pubmed/15450934" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20019</code><code>PubMed&lt;/a&gt;</code></p><p><code>20020</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20021</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;amp;title=On-demand+activation+of+the+endocannabinoid+system+in+the+control+of+neuronal+excitability+and+epileptiform+seizures&amp;amp;author=B+Lutz&amp;amp;volume=68&amp;amp;publication_year=2004&amp;amp;pages=1691-1698&amp;amp;pmid=15450934&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20022</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20023</code><code>]&lt;/span&gt;</code></p><p><code>20024</code><code>&lt;/span&gt;</code></p><p><code>20025</code><code>&lt;/li&gt;</code></p><p><code>20026</code><code>&lt;li id="R714"&gt;</code></p><p><code>20027</code><code>&lt;span class="citation"&gt;</code></p><p><code>20028</code><code>Lyman WD, Sonett JR, Brosnan CF, Elkin R, Bornstein MB. &amp;#x00394;-9-Tetrahydrocannabinol: a novel treatment for experimental autoimmune encepha-lomyelitis. &lt;span&gt;</code></p><p><code>20029</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20030</code><code>J Neuroimmunol. &lt;/span&gt;</code></p><p><code>20031</code><code>1989;&lt;span class="ref-vol"&gt;</code></p><p><code>20032</code><code>23&lt;/span&gt;</code></p><p><code>20033</code><code>:73–81.&lt;/span&gt;</code></p><p><code>20034</code><code> [&lt;a href="/pubmed/2542370" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20035</code><code>PubMed&lt;/a&gt;</code></p><p><code>20036</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20037</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neuroimmunol&amp;amp;title=&amp;#x00394;-9-Tetrahydrocannabinol:+a+novel+treatment+for+experimental+autoimmune+encepha-lomyelitis&amp;amp;author=WD+Lyman&amp;amp;author=JR+Sonett&amp;amp;author=CF+Brosnan&amp;amp;author=R+Elkin&amp;amp;author=MB+Bornstein&amp;amp;volume=23&amp;amp;publication_year=1989&amp;amp;pages=73-81&amp;amp;pmid=2542370&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20038</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20039</code><code>]&lt;/span&gt;</code></p><p><code>20040</code><code>&lt;/span&gt;</code></p><p><code>20041</code><code>&lt;/li&gt;</code></p><p><code>20042</code><code>&lt;li id="R715"&gt;</code></p><p><code>20043</code><code>&lt;span class="citation"&gt;</code></p><p><code>20044</code><code>Maas AI, Marmarou A, Murray GD, Steyerberg EW. Clinical trials in traumatic brain injury: current problems and future solutions. &lt;span&gt;</code></p><p><code>20045</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20046</code><code>Acta Neurochir Suppl. &lt;/span&gt;</code></p><p><code>20047</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>20048</code><code>89&lt;/span&gt;</code></p><p><code>20049</code><code>:113–118.&lt;/span&gt;</code></p><p><code>20050</code><code> [&lt;a href="/pubmed/15335110" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20051</code><code>PubMed&lt;/a&gt;</code></p><p><code>20052</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20053</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Acta+Neurochir+Suppl&amp;amp;title=Clinical+trials+in+traumatic+brain+injury:+current+problems+and+future+solutions&amp;amp;author=AI+Maas&amp;amp;author=A+Marmarou&amp;amp;author=GD+Murray&amp;amp;author=EW+Steyerberg&amp;amp;volume=89&amp;amp;publication_year=2004&amp;amp;pages=113-118&amp;amp;pmid=15335110&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20054</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20055</code><code>]&lt;/span&gt;</code></p><p><code>20056</code><code>&lt;/span&gt;</code></p><p><code>20057</code><code>&lt;/li&gt;</code></p><p><code>20058</code><code>&lt;li id="R716"&gt;</code></p><p><code>20059</code><code>&lt;span class="citation"&gt;</code></p><p><code>20060</code><code>Maas AI, Murray G, Henney H, 3rd, Kassem N, Legrand V, Mangelus M, Muizelaar JP, Stocchetti N, Knoller N Pharmos TBI Investigators. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. &lt;span&gt;</code></p><p><code>20061</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20062</code><code>Lancet Neurol. &lt;/span&gt;</code></p><p><code>20063</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>20064</code><code>5&lt;/span&gt;</code></p><p><code>20065</code><code>:38–45.&lt;/span&gt;</code></p><p><code>20066</code><code> [&lt;a href="/pubmed/16361021" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20067</code><code>PubMed&lt;/a&gt;</code></p><p><code>20068</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20069</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Neurol&amp;amp;title=Efficacy+and+safety+of+dexanabinol+in+severe+traumatic+brain+injury:+results+of+a+phase+III+randomised,+placebo-controlled,+clinical+trial&amp;amp;author=AI+Maas&amp;amp;author=G+Murray&amp;amp;author=H+Henney&amp;amp;author=N+Kassem&amp;amp;author=V+Legrand&amp;amp;volume=5&amp;amp;publication_year=2006&amp;amp;pages=38-45&amp;amp;pmid=16361021&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20070</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20071</code><code>]&lt;/span&gt;</code></p><p><code>20072</code><code>&lt;/span&gt;</code></p><p><code>20073</code><code>&lt;/li&gt;</code></p><p><code>20074</code><code>&lt;li id="R717"&gt;</code></p><p><code>20075</code><code>&lt;span class="citation"&gt;</code></p><p><code>20076</code><code>Maccarrone M, Bari M, Battista N, Finazzi-Agro A. Endocannabinoid degradation, endotoxic shock and inflammation. &lt;span&gt;</code></p><p><code>20077</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20078</code><code>Curr Drug Targets Inflamm Allergy. &lt;/span&gt;</code></p><p><code>20079</code><code>2002a;&lt;span class="ref-vol"&gt;</code></p><p><code>20080</code><code>1&lt;/span&gt;</code></p><p><code>20081</code><code>:53–63.&lt;/span&gt;</code></p><p><code>20082</code><code> [&lt;a href="/pubmed/14561206" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20083</code><code>PubMed&lt;/a&gt;</code></p><p><code>20084</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20085</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Drug+Targets+Inflamm+Allergy&amp;amp;title=Endocannabinoid+degradation,+endotoxic+shock+and+inflammation&amp;amp;author=M+Maccarrone&amp;amp;author=M+Bari&amp;amp;author=N+Battista&amp;amp;author=A+Finazzi-Agro&amp;amp;volume=1&amp;amp;publication_year=2002a&amp;amp;pages=53-63&amp;amp;pmid=14561206&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20086</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20087</code><code>]&lt;/span&gt;</code></p><p><code>20088</code><code>&lt;/span&gt;</code></p><p><code>20089</code><code>&lt;/li&gt;</code></p><p><code>20090</code><code>&lt;li id="R718"&gt;</code></p><p><code>20091</code><code>&lt;span class="citation"&gt;</code></p><p><code>20092</code><code>Maccarrone M, Bari M, Lorenzon T, Bisogno T, Di Marzo V, Finazzi-Agro A. Anandamide uptake by human endothelial cells and is regulation by nitric oxide. &lt;span&gt;</code></p><p><code>20093</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20094</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>20095</code><code>2000a;&lt;span class="ref-vol"&gt;</code></p><p><code>20096</code><code>275&lt;/span&gt;</code></p><p><code>20097</code><code>:13484–13492.&lt;/span&gt;</code></p><p><code>20098</code><code> [&lt;a href="/pubmed/10788462" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20099</code><code>PubMed&lt;/a&gt;</code></p><p><code>20100</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20101</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=Anandamide+uptake+by+human+endothelial+cells+and+is+regulation+by+nitric+oxide&amp;amp;author=M+Maccarrone&amp;amp;author=M+Bari&amp;amp;author=T+Lorenzon&amp;amp;author=T+Bisogno&amp;amp;author=V+Di+Marzo&amp;amp;volume=275&amp;amp;publication_year=2000a&amp;amp;pages=13484-13492&amp;amp;pmid=10788462&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20102</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20103</code><code>]&lt;/span&gt;</code></p><p><code>20104</code><code>&lt;/span&gt;</code></p><p><code>20105</code><code>&lt;/li&gt;</code></p><p><code>20106</code><code>&lt;li id="R719"&gt;</code></p><p><code>20107</code><code>&lt;span class="citation"&gt;</code></p><p><code>20108</code><code>Maccarrone M, Bisogno T, Valensise H, Lazzarin N, Fezza F, Manna C, Di Marzo V, Finazzi-Agro A. Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. &lt;span&gt;</code></p><p><code>20109</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20110</code><code>Mol Hum Reprod. &lt;/span&gt;</code></p><p><code>20111</code><code>2002b;&lt;span class="ref-vol"&gt;</code></p><p><code>20112</code><code>8&lt;/span&gt;</code></p><p><code>20113</code><code>:188–195.&lt;/span&gt;</code></p><p><code>20114</code><code> [&lt;a href="/pubmed/11818522" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20115</code><code>PubMed&lt;/a&gt;</code></p><p><code>20116</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20117</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Hum+Reprod&amp;amp;title=Low+fatty+acid+amide+hydrolase+and+high+anandamide+levels+are+associated+with+failure+to+achieve+an+ongoing+pregnancy+after+IVF+and+embryo+transfer&amp;amp;author=M+Maccarrone&amp;amp;author=T+Bisogno&amp;amp;author=H+Valensise&amp;amp;author=N+Lazzarin&amp;amp;author=F+Fezza&amp;amp;volume=8&amp;amp;publication_year=2002b&amp;amp;pages=188-195&amp;amp;pmid=11818522&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20118</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20119</code><code>]&lt;/span&gt;</code></p><p><code>20120</code><code>&lt;/span&gt;</code></p><p><code>20121</code><code>&lt;/li&gt;</code></p><p><code>20122</code><code>&lt;li id="R720"&gt;</code></p><p><code>20123</code><code>&lt;span class="citation"&gt;</code></p><p><code>20124</code><code>Maccarrone M, De Petrocellis L, Bari M, Fezza F, Salvati S, Di Marzo V, Finazzi-Agro A. Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes. &lt;span&gt;</code></p><p><code>20125</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20126</code><code>Arch Biochem Biophys. &lt;/span&gt;</code></p><p><code>20127</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>20128</code><code>393&lt;/span&gt;</code></p><p><code>20129</code><code>:321–328.&lt;/span&gt;</code></p><p><code>20130</code><code> [&lt;a href="/pubmed/11556820" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20131</code><code>PubMed&lt;/a&gt;</code></p><p><code>20132</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20133</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Arch+Biochem+Biophys&amp;amp;title=Lipopolysaccharide+downregulates+fatty+acid+amide+hydrolase+expression+and+increases+anandamide+levels+in+human+peripheral+lymphocytes&amp;amp;author=M+Maccarrone&amp;amp;author=L+De+Petrocellis&amp;amp;author=M+Bari&amp;amp;author=F+Fezza&amp;amp;author=S+Salvati&amp;amp;volume=393&amp;amp;publication_year=2001&amp;amp;pages=321-328&amp;amp;pmid=11556820&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20134</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20135</code><code>]&lt;/span&gt;</code></p><p><code>20136</code><code>&lt;/span&gt;</code></p><p><code>20137</code><code>&lt;/li&gt;</code></p><p><code>20138</code><code>&lt;li id="R721"&gt;</code></p><p><code>20139</code><code>&lt;span class="citation"&gt;</code></p><p><code>20140</code><code>Maccarrone M, Gubellini P, Bari M, Picconi B, Battista N, Centonze D, Bernardi G, Finazzi-Agro A, Calabresi P. Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism. &lt;span&gt;</code></p><p><code>20141</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20142</code><code>J Neurochem. &lt;/span&gt;</code></p><p><code>20143</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>20144</code><code>85&lt;/span&gt;</code></p><p><code>20145</code><code>:1018–1025.&lt;/span&gt;</code></p><p><code>20146</code><code> [&lt;a href="/pubmed/12716433" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20147</code><code>PubMed&lt;/a&gt;</code></p><p><code>20148</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20149</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;amp;title=Levodopa+treatment+reverses+endocannabinoid+system+abnormalities+in+experimental+parkinsonism&amp;amp;author=M+Maccarrone&amp;amp;author=P+Gubellini&amp;amp;author=M+Bari&amp;amp;author=B+Picconi&amp;amp;author=N+Battista&amp;amp;volume=85&amp;amp;publication_year=2003&amp;amp;pages=1018-1025&amp;amp;pmid=12716433&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20150</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20151</code><code>]&lt;/span&gt;</code></p><p><code>20152</code><code>&lt;/span&gt;</code></p><p><code>20153</code><code>&lt;/li&gt;</code></p><p><code>20154</code><code>&lt;li id="R722"&gt;</code></p><p><code>20155</code><code>&lt;span class="citation"&gt;</code></p><p><code>20156</code><code>Maccarrone M, Lorenzon T, Bari M, Melino G, Finazzi-Agro A. Anandamide induces apoptosis in human cells via vanilloid receptors: evidence for a protective role of cannabinoid receptors. &lt;span&gt;</code></p><p><code>20157</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20158</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>20159</code><code>2000b;&lt;span class="ref-vol"&gt;</code></p><p><code>20160</code><code>275&lt;/span&gt;</code></p><p><code>20161</code><code>:31938–31945.&lt;/span&gt;</code></p><p><code>20162</code><code> [&lt;a href="/pubmed/10913156" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20163</code><code>PubMed&lt;/a&gt;</code></p><p><code>20164</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20165</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=Anandamide+induces+apoptosis+in+human+cells+via+vanilloid+receptors:+evidence+for+a+protective+role+of+cannabinoid+receptors&amp;amp;author=M+Maccarrone&amp;amp;author=T+Lorenzon&amp;amp;author=M+Bari&amp;amp;author=G+Melino&amp;amp;author=A+Finazzi-Agro&amp;amp;volume=275&amp;amp;publication_year=2000b&amp;amp;pages=31938-31945&amp;amp;pmid=10913156&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20166</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20167</code><code>]&lt;/span&gt;</code></p><p><code>20168</code><code>&lt;/span&gt;</code></p><p><code>20169</code><code>&lt;/li&gt;</code></p><p><code>20170</code><code>&lt;li id="R723"&gt;</code></p><p><code>20171</code><code>&lt;span class="citation"&gt;</code></p><p><code>20172</code><code>Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Agro A. Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. &lt;span&gt;</code></p><p><code>20173</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20174</code><code>Lancet. &lt;/span&gt;</code></p><p><code>20175</code><code>2000c;&lt;span class="ref-vol"&gt;</code></p><p><code>20176</code><code>355&lt;/span&gt;</code></p><p><code>20177</code><code>:1326–1329.&lt;/span&gt;</code></p><p><code>20178</code><code> [&lt;a href="/pubmed/10776746" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20179</code><code>PubMed&lt;/a&gt;</code></p><p><code>20180</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20181</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;amp;title=Relation+between+decreased+anandamide+hydrolase+concentrations+in+human+lymphocytes+and+miscarriage&amp;amp;author=M+Maccarrone&amp;amp;author=H+Valensise&amp;amp;author=M+Bari&amp;amp;author=N+Lazzarin&amp;amp;author=C+Romanini&amp;amp;volume=355&amp;amp;publication_year=2000c&amp;amp;pages=1326-1329&amp;amp;pmid=10776746&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20182</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20183</code><code>]&lt;/span&gt;</code></p><p><code>20184</code><code>&lt;/span&gt;</code></p><p><code>20185</code><code>&lt;/li&gt;</code></p><p><code>20186</code><code>&lt;li id="R724"&gt;</code></p><p><code>20187</code><code>&lt;span class="citation"&gt;</code></p><p><code>20188</code><code>Mackie K. Cannabinoid receptor homo- and heterodimerization. &lt;span&gt;</code></p><p><code>20189</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20190</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>20191</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>20192</code><code>77&lt;/span&gt;</code></p><p><code>20193</code><code>:1667–1673.&lt;/span&gt;</code></p><p><code>20194</code><code> [&lt;a href="/pubmed/15978631" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20195</code><code>PubMed&lt;/a&gt;</code></p><p><code>20196</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20197</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Cannabinoid+receptor+homo-+and+heterodimerization&amp;amp;author=K+Mackie&amp;amp;volume=77&amp;amp;publication_year=2005&amp;amp;pages=1667-1673&amp;amp;pmid=15978631&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20198</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20199</code><code>]&lt;/span&gt;</code></p><p><code>20200</code><code>&lt;/span&gt;</code></p><p><code>20201</code><code>&lt;/li&gt;</code></p><p><code>20202</code><code>&lt;li id="R725"&gt;</code></p><p><code>20203</code><code>&lt;span class="citation"&gt;</code></p><p><code>20204</code><code>Mackie K. Cannabinoid receptors as therapeutic targets. &lt;span&gt;</code></p><p><code>20205</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20206</code><code>Annu Rev Pharmacol Toxicol. &lt;/span&gt;</code></p><p><code>20207</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>20208</code><code>46&lt;/span&gt;</code></p><p><code>20209</code><code>:101–122.&lt;/span&gt;</code></p><p><code>20210</code><code> [&lt;a href="/pubmed/16402900" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20211</code><code>PubMed&lt;/a&gt;</code></p><p><code>20212</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20213</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Pharmacol+Toxicol&amp;amp;title=Cannabinoid+receptors+as+therapeutic+targets&amp;amp;author=K+Mackie&amp;amp;volume=46&amp;amp;publication_year=2006&amp;amp;pages=101-122&amp;amp;pmid=16402900&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20214</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20215</code><code>]&lt;/span&gt;</code></p><p><code>20216</code><code>&lt;/span&gt;</code></p><p><code>20217</code><code>&lt;/li&gt;</code></p><p><code>20218</code><code>&lt;li id="R726"&gt;</code></p><p><code>20219</code><code>&lt;span class="citation"&gt;</code></p><p><code>20220</code><code>Mackie K, Devane WA, Hille B. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. &lt;span&gt;</code></p><p><code>20221</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20222</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>20223</code><code>1993;&lt;span class="ref-vol"&gt;</code></p><p><code>20224</code><code>44&lt;/span&gt;</code></p><p><code>20225</code><code>:498–503.&lt;/span&gt;</code></p><p><code>20226</code><code> [&lt;a href="/pubmed/8371711" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20227</code><code>PubMed&lt;/a&gt;</code></p><p><code>20228</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20229</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=Anandamide,+an+endogenous+cannabinoid,+inhibits+calcium+currents+as+a+partial+agonist+in+N18+neuroblastoma+cells&amp;amp;author=K+Mackie&amp;amp;author=WA+Devane&amp;amp;author=B+Hille&amp;amp;volume=44&amp;amp;publication_year=1993&amp;amp;pages=498-503&amp;amp;pmid=8371711&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20230</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20231</code><code>]&lt;/span&gt;</code></p><p><code>20232</code><code>&lt;/span&gt;</code></p><p><code>20233</code><code>&lt;/li&gt;</code></p><p><code>20234</code><code>&lt;li id="R727"&gt;</code></p><p><code>20235</code><code>&lt;span class="citation"&gt;</code></p><p><code>20236</code><code>Mackie K, Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastomaglioma cells. &lt;span&gt;</code></p><p><code>20237</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20238</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>20239</code><code>1992;&lt;span class="ref-vol"&gt;</code></p><p><code>20240</code><code>89&lt;/span&gt;</code></p><p><code>20241</code><code>:3825–3829.&lt;/span&gt;</code></p><p><code>20242</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>20243</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC525583/"&gt;</code></p><p><code>20244</code><code>PMC free article&lt;/a&gt;</code></p><p><code>20245</code><code>]&lt;/span&gt;</code></p><p><code>20246</code><code> [&lt;a href="/pubmed/1315042" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20247</code><code>PubMed&lt;/a&gt;</code></p><p><code>20248</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20249</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Cannabinoids+inhibit+N-type+calcium+channels+in+neuroblastomaglioma+cells&amp;amp;author=K+Mackie&amp;amp;author=B+Hille&amp;amp;volume=89&amp;amp;publication_year=1992&amp;amp;pages=3825-3829&amp;amp;pmid=1315042&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20250</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20251</code><code>]&lt;/span&gt;</code></p><p><code>20252</code><code>&lt;/span&gt;</code></p><p><code>20253</code><code>&lt;/li&gt;</code></p><p><code>20254</code><code>&lt;li id="R728"&gt;</code></p><p><code>20255</code><code>&lt;span class="citation"&gt;</code></p><p><code>20256</code><code>Mackie K, Lai Y, Westenbroek R, Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. &lt;span&gt;</code></p><p><code>20257</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20258</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>20259</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>20260</code><code>15&lt;/span&gt;</code></p><p><code>20261</code><code>:6552–6561.&lt;/span&gt;</code></p><p><code>20262</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>20263</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6578016/"&gt;</code></p><p><code>20264</code><code>PMC free article&lt;/a&gt;</code></p><p><code>20265</code><code>]&lt;/span&gt;</code></p><p><code>20266</code><code> [&lt;a href="/pubmed/7472417" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20267</code><code>PubMed&lt;/a&gt;</code></p><p><code>20268</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20269</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Cannabinoids+activate+an+inwardly+rectifying+potassium+conductance+and+inhibit+Q-type+calcium+currents+in+AtT20+cells+transfected+with+rat+brain+cannabinoid+receptor&amp;amp;author=K+Mackie&amp;amp;author=Y+Lai&amp;amp;author=R+Westenbroek&amp;amp;author=R+Mitchell&amp;amp;volume=15&amp;amp;publication_year=1995&amp;amp;pages=6552-6561&amp;amp;pmid=7472417&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20270</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20271</code><code>]&lt;/span&gt;</code></p><p><code>20272</code><code>&lt;/span&gt;</code></p><p><code>20273</code><code>&lt;/li&gt;</code></p><p><code>20274</code><code>&lt;li id="R729"&gt;</code></p><p><code>20275</code><code>&lt;span class="citation"&gt;</code></p><p><code>20276</code><code>MacNaughton WK, Van Sickle MD, Keenan CM, Cushing K, Mackie K, Sharkey KA. Distribution and function of the cannabinoid-1 receptor in the modulation of ion transport in the guinea pig ileum: relationship to capsaicin-sensitive nerves. &lt;span&gt;</code></p><p><code>20277</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20278</code><code>Am J Physiol. &lt;/span&gt;</code></p><p><code>20279</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>20280</code><code>286&lt;/span&gt;</code></p><p><code>20281</code><code>:G863–G871.&lt;/span&gt;</code></p><p><code>20282</code><code> [&lt;a href="/pubmed/14701723" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20283</code><code>PubMed&lt;/a&gt;</code></p><p><code>20284</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20285</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol&amp;amp;title=Distribution+and+function+of+the+cannabinoid-1+receptor+in+the+modulation+of+ion+transport+in+the+guinea+pig+ileum:+relationship+to+capsaicin-sensitive+nerves&amp;amp;author=WK+MacNaughton&amp;amp;author=MD+Van+Sickle&amp;amp;author=CM+Keenan&amp;amp;author=K+Cushing&amp;amp;author=K+Mackie&amp;amp;volume=286&amp;amp;publication_year=2004&amp;amp;pages=G863-G871&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20286</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20287</code><code>]&lt;/span&gt;</code></p><p><code>20288</code><code>&lt;/span&gt;</code></p><p><code>20289</code><code>&lt;/li&gt;</code></p><p><code>20290</code><code>&lt;li id="R730"&gt;</code></p><p><code>20291</code><code>&lt;span class="citation"&gt;</code></p><p><code>20292</code><code>Mailleux P, Vanderhaeghen JJ. Localization of cannabinoid receptor in the human developing and adult basal ganglia: higher levels in the striatonigral neurons. &lt;span&gt;</code></p><p><code>20293</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20294</code><code>Neurosci Lett. &lt;/span&gt;</code></p><p><code>20295</code><code>1992;&lt;span class="ref-vol"&gt;</code></p><p><code>20296</code><code>148&lt;/span&gt;</code></p><p><code>20297</code><code>:173–176.&lt;/span&gt;</code></p><p><code>20298</code><code> [&lt;a href="/pubmed/1300492" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20299</code><code>PubMed&lt;/a&gt;</code></p><p><code>20300</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20301</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Lett&amp;amp;title=Localization+of+cannabinoid+receptor+in+the+human+developing+and+adult+basal+ganglia:+higher+levels+in+the+striatonigral+neurons&amp;amp;author=P+Mailleux&amp;amp;author=JJ+Vanderhaeghen&amp;amp;volume=148&amp;amp;publication_year=1992&amp;amp;pages=173-176&amp;amp;pmid=1300492&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20302</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20303</code><code>]&lt;/span&gt;</code></p><p><code>20304</code><code>&lt;/span&gt;</code></p><p><code>20305</code><code>&lt;/li&gt;</code></p><p><code>20306</code><code>&lt;li id="R731"&gt;</code></p><p><code>20307</code><code>&lt;span class="citation"&gt;</code></p><p><code>20308</code><code>Mailleux P, Vanderhaeghen JJ. Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study. &lt;span&gt;</code></p><p><code>20309</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20310</code><code>J Neurochem. &lt;/span&gt;</code></p><p><code>20311</code><code>1993;&lt;span class="ref-vol"&gt;</code></p><p><code>20312</code><code>61&lt;/span&gt;</code></p><p><code>20313</code><code>:1705–1712.&lt;/span&gt;</code></p><p><code>20314</code><code> [&lt;a href="/pubmed/7901331" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20315</code><code>PubMed&lt;/a&gt;</code></p><p><code>20316</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20317</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;amp;title=Dopaminergic+regulation+of+cannabinoid+receptor+mRNA+levels+in+the+rat+caudate-putamen:+an+in+situ+hybridization+study&amp;amp;author=P+Mailleux&amp;amp;author=JJ+Vanderhaeghen&amp;amp;volume=61&amp;amp;publication_year=1993&amp;amp;pages=1705-1712&amp;amp;pmid=7901331&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20318</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20319</code><code>]&lt;/span&gt;</code></p><p><code>20320</code><code>&lt;/span&gt;</code></p><p><code>20321</code><code>&lt;/li&gt;</code></p><p><code>20322</code><code>&lt;li id="R732"&gt;</code></p><p><code>20323</code><code>&lt;span class="citation"&gt;</code></p><p><code>20324</code><code>Maingret F, Patel AJ, Lazdunski M, Honore E. The endocannabinoid anandamide is a direct and selective blocker of the background K&lt;sup&gt;</code></p><p><code>20325</code><code>+&lt;/sup&gt;</code></p><p><code>20326</code><code> channel TASK-1. &lt;span&gt;</code></p><p><code>20327</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20328</code><code>EMBO (Eur Mol Biol Organ) J. &lt;/span&gt;</code></p><p><code>20329</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>20330</code><code>20&lt;/span&gt;</code></p><p><code>20331</code><code>:47–54.&lt;/span&gt;</code></p><p><code>20332</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>20333</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC140203/"&gt;</code></p><p><code>20334</code><code>PMC free article&lt;/a&gt;</code></p><p><code>20335</code><code>]&lt;/span&gt;</code></p><p><code>20336</code><code> [&lt;a href="/pubmed/11226154" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20337</code><code>PubMed&lt;/a&gt;</code></p><p><code>20338</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20339</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=EMBO+(Eur+Mol+Biol+Organ)+J&amp;amp;title=The+endocannabinoid+anandamide+is+a+direct+and+selective+blocker+of+the+background+K++channel+TASK-1&amp;amp;author=F+Maingret&amp;amp;author=AJ+Patel&amp;amp;author=M+Lazdunski&amp;amp;author=E+Honore&amp;amp;volume=20&amp;amp;publication_year=2001&amp;amp;pages=47-54&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20340</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20341</code><code>]&lt;/span&gt;</code></p><p><code>20342</code><code>&lt;/span&gt;</code></p><p><code>20343</code><code>&lt;/li&gt;</code></p><p><code>20344</code><code>&lt;li id="R733"&gt;</code></p><p><code>20345</code><code>&lt;span class="citation"&gt;</code></p><p><code>20346</code><code>Maione S, Bisogno T, de Novellis V, Palazzo E, Christino L, Valenti M, Petrosino S, Guglielmotti V, Rossi F, Di Marzo V. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors. &lt;span&gt;</code></p><p><code>20347</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20348</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>20349</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>20350</code><code>316&lt;/span&gt;</code></p><p><code>20351</code><code>:969–982.&lt;/span&gt;</code></p><p><code>20352</code><code> [&lt;a href="/pubmed/16284279" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20353</code><code>PubMed&lt;/a&gt;</code></p><p><code>20354</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20355</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Elevation+of+endocannabinoid+levels+in+the+ventrolateral+periaqueductal+grey+through+inhibition+of+fatty+acid+amide+hydrolase+affects+descending+nociceptive+pathways+via+both+cannabinoid+receptor+type+1+and+transient+receptor+potential+vanilloid+type-1+receptors&amp;amp;author=S+Maione&amp;amp;author=T+Bisogno&amp;amp;author=V+de+Novellis&amp;amp;author=E+Palazzo&amp;amp;author=L+Christino&amp;amp;volume=316&amp;amp;publication_year=2006&amp;amp;pages=969-982&amp;amp;pmid=16284279&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20356</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20357</code><code>]&lt;/span&gt;</code></p><p><code>20358</code><code>&lt;/span&gt;</code></p><p><code>20359</code><code>&lt;/li&gt;</code></p><p><code>20360</code><code>&lt;li id="R734"&gt;</code></p><p><code>20361</code><code>&lt;span class="citation"&gt;</code></p><p><code>20362</code><code>Makara JK, Mor M, Fegley D, Szabo SI, Kathuria S, Astarita G, Duranti A, Tontini A, Tarzia G, Rivara S, Freund TF, Piomelli D. Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus. &lt;span&gt;</code></p><p><code>20363</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20364</code><code>Nat Neurosci. &lt;/span&gt;</code></p><p><code>20365</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>20366</code><code>8&lt;/span&gt;</code></p><p><code>20367</code><code>:1139–1141.&lt;/span&gt;</code></p><p><code>20368</code><code> [&lt;a href="/pubmed/16116451" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20369</code><code>PubMed&lt;/a&gt;</code></p><p><code>20370</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20371</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Neurosci&amp;amp;title=Selective+inhibition+of+2-AG+hydrolysis+enhances+endocannabinoid+signaling+in+hippocampus&amp;amp;author=JK+Makara&amp;amp;author=M+Mor&amp;amp;author=D+Fegley&amp;amp;author=SI+Szabo&amp;amp;author=S+Kathuria&amp;amp;volume=8&amp;amp;publication_year=2005&amp;amp;pages=1139-1141&amp;amp;pmid=16116451&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20372</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20373</code><code>]&lt;/span&gt;</code></p><p><code>20374</code><code>&lt;/span&gt;</code></p><p><code>20375</code><code>&lt;/li&gt;</code></p><p><code>20376</code><code>&lt;li id="R735"&gt;</code></p><p><code>20377</code><code>&lt;span class="citation"&gt;</code></p><p><code>20378</code><code>Malan TP, Jr, Ibrahim MM, Deng H, Liu Q, Mata HP, Vanderah T, Porreca F, Makriyannis A. CB2 cannabinoid receptor-mediated peripheral antinociception. &lt;span&gt;</code></p><p><code>20379</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20380</code><code>Pain. &lt;/span&gt;</code></p><p><code>20381</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>20382</code><code>93&lt;/span&gt;</code></p><p><code>20383</code><code>:239–245.&lt;/span&gt;</code></p><p><code>20384</code><code> [&lt;a href="/pubmed/11514083" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20385</code><code>PubMed&lt;/a&gt;</code></p><p><code>20386</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20387</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;amp;title=CB2+cannabinoid+receptor-mediated+peripheral+antinociception&amp;amp;author=TP+Malan&amp;amp;author=MM+Ibrahim&amp;amp;author=H+Deng&amp;amp;author=Q+Liu&amp;amp;author=HP+Mata&amp;amp;volume=93&amp;amp;publication_year=2001&amp;amp;pages=239-245&amp;amp;pmid=11514083&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20388</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20389</code><code>]&lt;/span&gt;</code></p><p><code>20390</code><code>&lt;/span&gt;</code></p><p><code>20391</code><code>&lt;/li&gt;</code></p><p><code>20392</code><code>&lt;li id="R736"&gt;</code></p><p><code>20393</code><code>&lt;span class="citation"&gt;</code></p><p><code>20394</code><code>Malcher-Lopes R, Di S, Marcheselli VS, Weng F-J, Stuart CT, Bazan NG, Tasker JG. Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. &lt;span&gt;</code></p><p><code>20395</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20396</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>20397</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>20398</code><code>26&lt;/span&gt;</code></p><p><code>20399</code><code>:6643–6650.&lt;/span&gt;</code></p><p><code>20400</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>20401</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6674033/"&gt;</code></p><p><code>20402</code><code>PMC free article&lt;/a&gt;</code></p><p><code>20403</code><code>]&lt;/span&gt;</code></p><p><code>20404</code><code> [&lt;a href="/pubmed/16775153" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20405</code><code>PubMed&lt;/a&gt;</code></p><p><code>20406</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20407</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Opposing+crosstalk+between+leptin+and+glucocorticoids+rapidly+modulates+synaptic+excitation+via+endocannabinoid+release&amp;amp;author=R+Malcher-Lopes&amp;amp;author=S+Di&amp;amp;author=VS+Marcheselli&amp;amp;author=F-J+Weng&amp;amp;author=CT+Stuart&amp;amp;volume=26&amp;amp;publication_year=2006&amp;amp;pages=6643-6650&amp;amp;pmid=16775153&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20408</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20409</code><code>]&lt;/span&gt;</code></p><p><code>20410</code><code>&lt;/span&gt;</code></p><p><code>20411</code><code>&lt;/li&gt;</code></p><p><code>20412</code><code>&lt;li id="R737"&gt;</code></p><p><code>20413</code><code>&lt;span class="citation"&gt;</code></p><p><code>20414</code><code>Maldonado R, Valverde O, Berrendero F. Involvement of the endocannabinoid system in drug addiction. &lt;span&gt;</code></p><p><code>20415</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20416</code><code>Trends Pharmacol Sci. &lt;/span&gt;</code></p><p><code>20417</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>20418</code><code>29&lt;/span&gt;</code></p><p><code>20419</code><code>:225–232.&lt;/span&gt;</code></p><p><code>20420</code><code> [&lt;a href="/pubmed/16483675" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20421</code><code>PubMed&lt;/a&gt;</code></p><p><code>20422</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20423</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Trends+Pharmacol+Sci&amp;amp;title=Involvement+of+the+endocannabinoid+system+in+drug+addiction&amp;amp;author=R+Maldonado&amp;amp;author=O+Valverde&amp;amp;author=F+Berrendero&amp;amp;volume=29&amp;amp;publication_year=2006&amp;amp;pages=225-232&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20424</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20425</code><code>]&lt;/span&gt;</code></p><p><code>20426</code><code>&lt;/span&gt;</code></p><p><code>20427</code><code>&lt;/li&gt;</code></p><p><code>20428</code><code>&lt;li id="R738"&gt;</code></p><p><code>20429</code><code>&lt;span class="citation"&gt;</code></p><p><code>20430</code><code>Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. &lt;span&gt;</code></p><p><code>20431</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20432</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>20433</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>20434</code><code>97&lt;/span&gt;</code></p><p><code>20435</code><code>:9561–9566.&lt;/span&gt;</code></p><p><code>20436</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>20437</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC16904/"&gt;</code></p><p><code>20438</code><code>PMC free article&lt;/a&gt;</code></p><p><code>20439</code><code>]&lt;/span&gt;</code></p><p><code>20440</code><code> [&lt;a href="/pubmed/10920191" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20441</code><code>PubMed&lt;/a&gt;</code></p><p><code>20442</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20443</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=The+nonpsychoactive+cannabis+constituent+cannabidiol+is+an+oral+anti-arthritic+therapeutic+in+murine+collagen-induced+arthritis&amp;amp;author=AM+Malfait&amp;amp;author=R+Gallily&amp;amp;author=PF+Sumariwalla&amp;amp;author=AS+Malik&amp;amp;author=E+Andreakos&amp;amp;volume=97&amp;amp;publication_year=2000&amp;amp;pages=9561-9566&amp;amp;pmid=10920191&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20444</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20445</code><code>]&lt;/span&gt;</code></p><p><code>20446</code><code>&lt;/span&gt;</code></p><p><code>20447</code><code>&lt;/li&gt;</code></p><p><code>20448</code><code>&lt;li id="R739"&gt;</code></p><p><code>20449</code><code>&lt;span class="citation"&gt;</code></p><p><code>20450</code><code>Malinowska B, Godlewski G, Boucher B, Schlicker E. Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat. &lt;span&gt;</code></p><p><code>20451</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20452</code><code>Naunyn-Schmiedeberg&amp;#x02019;s Arch Pharmacol. &lt;/span&gt;</code></p><p><code>20453</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>20454</code><code>356&lt;/span&gt;</code></p><p><code>20455</code><code>:197–202.&lt;/span&gt;</code></p><p><code>20456</code><code> [&lt;a href="/pubmed/9272725" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20457</code><code>PubMed&lt;/a&gt;</code></p><p><code>20458</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20459</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Naunyn-Schmiedeberg&amp;#x02019;s+Arch+Pharmacol&amp;amp;title=Cannabinoid+CB1+receptor-mediated+inhibition+of+the+neurogenic+vasopressor+response+in+the+pithed+rat&amp;amp;author=B+Malinowska&amp;amp;author=G+Godlewski&amp;amp;author=B+Boucher&amp;amp;author=E+Schlicker&amp;amp;volume=356&amp;amp;publication_year=1997&amp;amp;pages=197-202&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20460</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20461</code><code>]&lt;/span&gt;</code></p><p><code>20462</code><code>&lt;/span&gt;</code></p><p><code>20463</code><code>&lt;/li&gt;</code></p><p><code>20464</code><code>&lt;li id="R740"&gt;</code></p><p><code>20465</code><code>&lt;span class="citation"&gt;</code></p><p><code>20466</code><code>Malinowska B, Kwolek G, Gothert M. Anandamide and methanandamide induce both vanilloid VR1- and cannabinoids CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats. &lt;span&gt;</code></p><p><code>20467</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20468</code><code>Naunyn-Schmiedeberg&amp;#x02019;s Arch Pharmacol. &lt;/span&gt;</code></p><p><code>20469</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>20470</code><code>364&lt;/span&gt;</code></p><p><code>20471</code><code>:562–569.&lt;/span&gt;</code></p><p><code>20472</code><code> [&lt;a href="/pubmed/11770012" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20473</code><code>PubMed&lt;/a&gt;</code></p><p><code>20474</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20475</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Naunyn-Schmiedeberg&amp;#x02019;s+Arch+Pharmacol&amp;amp;title=Anandamide+and+methanandamide+induce+both+vanilloid+VR1-+and+cannabinoids+CB1+receptor-mediated+changes+in+heart+rate+and+blood+pressure+in+anaesthetized+rats&amp;amp;author=B+Malinowska&amp;amp;author=G+Kwolek&amp;amp;author=M+Gothert&amp;amp;volume=364&amp;amp;publication_year=2001&amp;amp;pages=562-569&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20476</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20477</code><code>]&lt;/span&gt;</code></p><p><code>20478</code><code>&lt;/span&gt;</code></p><p><code>20479</code><code>&lt;/li&gt;</code></p><p><code>20480</code><code>&lt;li id="R741"&gt;</code></p><p><code>20481</code><code>&lt;span class="citation"&gt;</code></p><p><code>20482</code><code>Malone DT, Taylor DA. Involvement of somatodendritic 5-HT&lt;sub&gt;</code></p><p><code>20483</code><code>1A&lt;/sub&gt;</code></p><p><code>20484</code><code> receptors in &amp;#x00394;&lt;sup&gt;</code></p><p><code>20485</code><code>9&lt;/sup&gt;</code></p><p><code>20486</code><code>-tetrahydrocannabinol-induced hypothermia in the rat. &lt;span&gt;</code></p><p><code>20487</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20488</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>20489</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>20490</code><code>69&lt;/span&gt;</code></p><p><code>20491</code><code>:595–601.&lt;/span&gt;</code></p><p><code>20492</code><code> [&lt;a href="/pubmed/11509221" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20493</code><code>PubMed&lt;/a&gt;</code></p><p><code>20494</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20495</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Involvement+of+somatodendritic+5-HT1A+receptors+in+&amp;#x00394;9-tetrahydrocannabinol-induced+hypothermia+in+the+rat&amp;amp;author=DT+Malone&amp;amp;author=DA+Taylor&amp;amp;volume=69&amp;amp;publication_year=2001&amp;amp;pages=595-601&amp;amp;pmid=11509221&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20496</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20497</code><code>]&lt;/span&gt;</code></p><p><code>20498</code><code>&lt;/span&gt;</code></p><p><code>20499</code><code>&lt;/li&gt;</code></p><p><code>20500</code><code>&lt;li id="R742"&gt;</code></p><p><code>20501</code><code>&lt;span class="citation"&gt;</code></p><p><code>20502</code><code>Manara L, Croci T, Guagnini F, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Mukenge S, Ferla G. Functional assessment of neuronal cannabinoid receptors in the muscular layers of human ileum and colon. &lt;span&gt;</code></p><p><code>20503</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20504</code><code>Dig Liver Dis. &lt;/span&gt;</code></p><p><code>20505</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>20506</code><code>34&lt;/span&gt;</code></p><p><code>20507</code><code>:262–269.&lt;/span&gt;</code></p><p><code>20508</code><code> [&lt;a href="/pubmed/12038810" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20509</code><code>PubMed&lt;/a&gt;</code></p><p><code>20510</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20511</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Dig+Liver+Dis&amp;amp;title=Functional+assessment+of+neuronal+cannabinoid+receptors+in+the+muscular+layers+of+human+ileum+and+colon&amp;amp;author=L+Manara&amp;amp;author=T+Croci&amp;amp;author=F+Guagnini&amp;amp;author=M+Rinaldi-Carmona&amp;amp;author=JP+Maffrand&amp;amp;volume=34&amp;amp;publication_year=2002&amp;amp;pages=262-269&amp;amp;pmid=12038810&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20512</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20513</code><code>]&lt;/span&gt;</code></p><p><code>20514</code><code>&lt;/span&gt;</code></p><p><code>20515</code><code>&lt;/li&gt;</code></p><p><code>20516</code><code>&lt;li id="R743"&gt;</code></p><p><code>20517</code><code>&lt;span class="citation"&gt;</code></p><p><code>20518</code><code>Mancinelli R, Fabrizi A, Del Monaco S, Azzena GB, Vargiu R, Colombo GC, Gessa GL. Inhibition of peristaltic activity by cannabinoids in the isolated distal colon of mouse. &lt;span&gt;</code></p><p><code>20519</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20520</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>20521</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>20522</code><code>69&lt;/span&gt;</code></p><p><code>20523</code><code>:101–111.&lt;/span&gt;</code></p><p><code>20524</code><code> [&lt;a href="/pubmed/11411800" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20525</code><code>PubMed&lt;/a&gt;</code></p><p><code>20526</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20527</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Inhibition+of+peristaltic+activity+by+cannabinoids+in+the+isolated+distal+colon+of+mouse&amp;amp;author=R+Mancinelli&amp;amp;author=A+Fabrizi&amp;amp;author=S+Del+Monaco&amp;amp;author=GB+Azzena&amp;amp;author=R+Vargiu&amp;amp;volume=69&amp;amp;publication_year=2001&amp;amp;pages=101-111&amp;amp;pmid=11411800&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20528</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20529</code><code>]&lt;/span&gt;</code></p><p><code>20530</code><code>&lt;/span&gt;</code></p><p><code>20531</code><code>&lt;/li&gt;</code></p><p><code>20532</code><code>&lt;li id="R744"&gt;</code></p><p><code>20533</code><code>&lt;span class="citation"&gt;</code></p><p><code>20534</code><code>Maneuf YP, Crossman AR, Brotchie JM. The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>20535</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20536</code><code>Exp Neurol. &lt;/span&gt;</code></p><p><code>20537</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>20538</code><code>148&lt;/span&gt;</code></p><p><code>20539</code><code>:265–270.&lt;/span&gt;</code></p><p><code>20540</code><code> [&lt;a href="/pubmed/9398468" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20541</code><code>PubMed&lt;/a&gt;</code></p><p><code>20542</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20543</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Exp+Neurol&amp;amp;title=The+cannabinoid+receptor+agonist+WIN+55,212-2+reduces+D2,+but+not+D1,+dopamine+receptor-mediated+alleviation+of+akinesia+in+the+reserpine-treated+rat+model+of+Parkinson&amp;#x02019;s+disease&amp;amp;author=YP+Maneuf&amp;amp;author=AR+Crossman&amp;amp;author=JM+Brotchie&amp;amp;volume=148&amp;amp;publication_year=1997&amp;amp;pages=265-270&amp;amp;pmid=9398468&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20544</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20545</code><code>]&lt;/span&gt;</code></p><p><code>20546</code><code>&lt;/span&gt;</code></p><p><code>20547</code><code>&lt;/li&gt;</code></p><p><code>20548</code><code>&lt;li id="R745"&gt;</code></p><p><code>20549</code><code>&lt;span class="citation"&gt;</code></p><p><code>20550</code><code>Mang CF, Erbelding D, Kilbinger H. Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors. &lt;span&gt;</code></p><p><code>20551</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20552</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>20553</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>20554</code><code>134&lt;/span&gt;</code></p><p><code>20555</code><code>:161–167.&lt;/span&gt;</code></p><p><code>20556</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>20557</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1572920/"&gt;</code></p><p><code>20558</code><code>PMC free article&lt;/a&gt;</code></p><p><code>20559</code><code>]&lt;/span&gt;</code></p><p><code>20560</code><code> [&lt;a href="/pubmed/11522608" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20561</code><code>PubMed&lt;/a&gt;</code></p><p><code>20562</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20563</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Differential+effects+of+anandamide+on+acetylcholine+release+in+the+guinea-pig+ileum+mediated+via+vanilloid+and+non-CB1+cannabinoid+receptors&amp;amp;author=CF+Mang&amp;amp;author=D+Erbelding&amp;amp;author=H+Kilbinger&amp;amp;volume=134&amp;amp;publication_year=2001&amp;amp;pages=161-167&amp;amp;pmid=11522608&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20564</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20565</code><code>]&lt;/span&gt;</code></p><p><code>20566</code><code>&lt;/span&gt;</code></p><p><code>20567</code><code>&lt;/li&gt;</code></p><p><code>20568</code><code>&lt;li id="R746"&gt;</code></p><p><code>20569</code><code>&lt;span class="citation"&gt;</code></p><p><code>20570</code><code>Manzanares J, Corchero J, Fuentes JA. Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of &amp;#x00394;&lt;sup&gt;</code></p><p><code>20571</code><code>9&lt;/sup&gt;</code></p><p><code>20572</code><code>-tetrahydrocannabinol in rats. &lt;span&gt;</code></p><p><code>20573</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20574</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>20575</code><code>1999a;&lt;span class="ref-vol"&gt;</code></p><p><code>20576</code><code>839&lt;/span&gt;</code></p><p><code>20577</code><code>:173–179.&lt;/span&gt;</code></p><p><code>20578</code><code> [&lt;a href="/pubmed/10482810" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20579</code><code>PubMed&lt;/a&gt;</code></p><p><code>20580</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20581</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Opioid+and+cannabinoid+receptor-mediated+regulation+of+the+increase+in+adrenocorticotropin+hormone+and+corticosterone+plasma+concentrations+induced+by+central+administration+of+&amp;#x00394;9-tetrahydrocannabinol+in+rats&amp;amp;author=J+Manzanares&amp;amp;author=J+Corchero&amp;amp;author=JA+Fuentes&amp;amp;volume=839&amp;amp;publication_year=1999a&amp;amp;pages=173-179&amp;amp;pmid=10482810&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20582</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20583</code><code>]&lt;/span&gt;</code></p><p><code>20584</code><code>&lt;/span&gt;</code></p><p><code>20585</code><code>&lt;/li&gt;</code></p><p><code>20586</code><code>&lt;li id="R747"&gt;</code></p><p><code>20587</code><code>&lt;span class="citation"&gt;</code></p><p><code>20588</code><code>Manzanares J, Corchero J, Romero J, Fernandez-Ruiz JJ, Ramos JA, Fuentes JA. Pharmacological and biochemical interactions between opioids and cannabinoids. &lt;span&gt;</code></p><p><code>20589</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20590</code><code>Trends Pharmacol Sci. &lt;/span&gt;</code></p><p><code>20591</code><code>1999b;&lt;span class="ref-vol"&gt;</code></p><p><code>20592</code><code>20&lt;/span&gt;</code></p><p><code>20593</code><code>:287–294.&lt;/span&gt;</code></p><p><code>20594</code><code> [&lt;a href="/pubmed/10390647" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20595</code><code>PubMed&lt;/a&gt;</code></p><p><code>20596</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20597</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Trends+Pharmacol+Sci&amp;amp;title=Pharmacological+and+biochemical+interactions+between+opioids+and+cannabinoids&amp;amp;author=J+Manzanares&amp;amp;author=J+Corchero&amp;amp;author=J+Romero&amp;amp;author=JJ+Fernandez-Ruiz&amp;amp;author=JA+Ramos&amp;amp;volume=20&amp;amp;publication_year=1999b&amp;amp;pages=287-294&amp;amp;pmid=10390647&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20598</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20599</code><code>]&lt;/span&gt;</code></p><p><code>20600</code><code>&lt;/span&gt;</code></p><p><code>20601</code><code>&lt;/li&gt;</code></p><p><code>20602</code><code>&lt;li id="R748"&gt;</code></p><p><code>20603</code><code>&lt;span class="citation"&gt;</code></p><p><code>20604</code><code>Manzanares J, Uriguen L, Rubio G, Palomo T. Role of endocannabinoid system in mental diseases. &lt;span&gt;</code></p><p><code>20605</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20606</code><code>Neurotox Res. &lt;/span&gt;</code></p><p><code>20607</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>20608</code><code>6&lt;/span&gt;</code></p><p><code>20609</code><code>:213–224.&lt;/span&gt;</code></p><p><code>20610</code><code> [&lt;a href="/pubmed/15325960" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20611</code><code>PubMed&lt;/a&gt;</code></p><p><code>20612</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20613</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurotox+Res&amp;amp;title=Role+of+endocannabinoid+system+in+mental+diseases&amp;amp;author=J+Manzanares&amp;amp;author=L+Uriguen&amp;amp;author=G+Rubio&amp;amp;author=T+Palomo&amp;amp;volume=6&amp;amp;publication_year=2004&amp;amp;pages=213-224&amp;amp;pmid=15325960&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20614</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20615</code><code>]&lt;/span&gt;</code></p><p><code>20616</code><code>&lt;/span&gt;</code></p><p><code>20617</code><code>&lt;/li&gt;</code></p><p><code>20618</code><code>&lt;li id="R749"&gt;</code></p><p><code>20619</code><code>&lt;span class="citation"&gt;</code></p><p><code>20620</code><code>Marco EM, Perez-Alvarez L, Borcel E, Rubio M, Guaza C, Ambrosio E, File SE, Viveros MP. Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats. &lt;span&gt;</code></p><p><code>20621</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20622</code><code>Behav Pharmacol. &lt;/span&gt;</code></p><p><code>20623</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>20624</code><code>15&lt;/span&gt;</code></p><p><code>20625</code><code>:21–27.&lt;/span&gt;</code></p><p><code>20626</code><code> [&lt;a href="/pubmed/15075623" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20627</code><code>PubMed&lt;/a&gt;</code></p><p><code>20628</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20629</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Behav+Pharmacol&amp;amp;title=Involvement+of+5-HT1A+receptors+in+behavioural+effects+of+the+cannabinoid+receptor+agonist+CP+55,940+in+male+rats&amp;amp;author=EM+Marco&amp;amp;author=L+Perez-Alvarez&amp;amp;author=E+Borcel&amp;amp;author=M+Rubio&amp;amp;author=C+Guaza&amp;amp;volume=15&amp;amp;publication_year=2004&amp;amp;pages=21-27&amp;amp;pmid=15075623&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20630</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20631</code><code>]&lt;/span&gt;</code></p><p><code>20632</code><code>&lt;/span&gt;</code></p><p><code>20633</code><code>&lt;/li&gt;</code></p><p><code>20634</code><code>&lt;li id="R750"&gt;</code></p><p><code>20635</code><code>&lt;span class="citation"&gt;</code></p><p><code>20636</code><code>Marin S, Marco E, Biscaia M, Fernandez B, Rubio M, Guaza C, Schmidhammer H, Viveros MP. Involvement of the &lt;em&gt;</code></p><p><code>20637</code><code>&amp;#x003ba;&lt;/em&gt;</code></p><p><code>20638</code><code>-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats. &lt;span&gt;</code></p><p><code>20639</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20640</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>20641</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>20642</code><code>74&lt;/span&gt;</code></p><p><code>20643</code><code>:649–656.&lt;/span&gt;</code></p><p><code>20644</code><code> [&lt;a href="/pubmed/12543231" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20645</code><code>PubMed&lt;/a&gt;</code></p><p><code>20646</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20647</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Involvement+of+the+&amp;#x003ba;-opioid+receptor+in+the+anxiogenic-like+effect+of+CP+55,940+in+male+rats&amp;amp;author=S+Marin&amp;amp;author=E+Marco&amp;amp;author=M+Biscaia&amp;amp;author=B+Fernandez&amp;amp;author=M+Rubio&amp;amp;volume=74&amp;amp;publication_year=2003&amp;amp;pages=649-656&amp;amp;pmid=12543231&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20648</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20649</code><code>]&lt;/span&gt;</code></p><p><code>20650</code><code>&lt;/span&gt;</code></p><p><code>20651</code><code>&lt;/li&gt;</code></p><p><code>20652</code><code>&lt;li id="R751"&gt;</code></p><p><code>20653</code><code>&lt;span class="citation"&gt;</code></p><p><code>20654</code><code>Markus FW. Cannabivarin and tetrahydrocannabivarin, two constituents of hashish. &lt;span&gt;</code></p><p><code>20655</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20656</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>20657</code><code>1971;&lt;span class="ref-vol"&gt;</code></p><p><code>20658</code><code>232&lt;/span&gt;</code></p><p><code>20659</code><code>:579–580.&lt;/span&gt;</code></p><p><code>20660</code><code> [&lt;a href="/pubmed/4937510" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20661</code><code>PubMed&lt;/a&gt;</code></p><p><code>20662</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20663</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Cannabivarin+and+tetrahydrocannabivarin,+two+constituents+of+hashish&amp;amp;author=FW+Markus&amp;amp;volume=232&amp;amp;publication_year=1971&amp;amp;pages=579-580&amp;amp;pmid=4937510&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20664</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20665</code><code>]&lt;/span&gt;</code></p><p><code>20666</code><code>&lt;/span&gt;</code></p><p><code>20667</code><code>&lt;/li&gt;</code></p><p><code>20668</code><code>&lt;li id="R752"&gt;</code></p><p><code>20669</code><code>&lt;span class="citation"&gt;</code></p><p><code>20670</code><code>Marsicano G, Lutz B. Expression of the cannabinoid receptor CB&lt;sub&gt;</code></p><p><code>20671</code><code>1&lt;/sub&gt;</code></p><p><code>20672</code><code> in distinct neuronal subpopulations in the adult mouse forebrain. &lt;span&gt;</code></p><p><code>20673</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20674</code><code>Eur J Neurosci. &lt;/span&gt;</code></p><p><code>20675</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>20676</code><code>11&lt;/span&gt;</code></p><p><code>20677</code><code>:4213–4225.&lt;/span&gt;</code></p><p><code>20678</code><code> [&lt;a href="/pubmed/10594647" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20679</code><code>PubMed&lt;/a&gt;</code></p><p><code>20680</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20681</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurosci&amp;amp;title=Expression+of+the+cannabinoid+receptor+CB1+in+distinct+neuronal+subpopulations+in+the+adult+mouse+forebrain&amp;amp;author=G+Marsicano&amp;amp;author=B+Lutz&amp;amp;volume=11&amp;amp;publication_year=1999&amp;amp;pages=4213-4225&amp;amp;pmid=10594647&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20682</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20683</code><code>]&lt;/span&gt;</code></p><p><code>20684</code><code>&lt;/span&gt;</code></p><p><code>20685</code><code>&lt;/li&gt;</code></p><p><code>20686</code><code>&lt;li id="R753"&gt;</code></p><p><code>20687</code><code>&lt;span class="citation"&gt;</code></p><p><code>20688</code><code>Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, Guti&amp;#x000e9;rrez SO, van der Stelt M, et al.  CB&lt;sub&gt;</code></p><p><code>20689</code><code>1&lt;/sub&gt;</code></p><p><code>20690</code><code> cannabinoid receptors and on-demand defense against excitotoxicity. &lt;span&gt;</code></p><p><code>20691</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20692</code><code>Science (Wash DC) &lt;/span&gt;</code></p><p><code>20693</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>20694</code><code>302&lt;/span&gt;</code></p><p><code>20695</code><code>:84–88.&lt;/span&gt;</code></p><p><code>20696</code><code> [&lt;a href="/pubmed/14526074" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20697</code><code>PubMed&lt;/a&gt;</code></p><p><code>20698</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20699</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Science+(Wash+DC)&amp;amp;title=CB1+cannabinoid+receptors+and+on-demand+defense+against+excitotoxicity&amp;amp;author=G+Marsicano&amp;amp;author=S+Goodenough&amp;amp;author=K+Monory&amp;amp;author=H+Hermann&amp;amp;author=M+Eder&amp;amp;volume=302&amp;amp;publication_year=2003&amp;amp;pages=84-88&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20700</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20701</code><code>]&lt;/span&gt;</code></p><p><code>20702</code><code>&lt;/span&gt;</code></p><p><code>20703</code><code>&lt;/li&gt;</code></p><p><code>20704</code><code>&lt;li id="R754"&gt;</code></p><p><code>20705</code><code>&lt;span class="citation"&gt;</code></p><p><code>20706</code><code>Marsicano G, Moosmann B, Hermann H, Lutz B, Behl C. Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. &lt;span&gt;</code></p><p><code>20707</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20708</code><code>J Neurochem. &lt;/span&gt;</code></p><p><code>20709</code><code>2002a;&lt;span class="ref-vol"&gt;</code></p><p><code>20710</code><code>80&lt;/span&gt;</code></p><p><code>20711</code><code>:448–456.&lt;/span&gt;</code></p><p><code>20712</code><code> [&lt;a href="/pubmed/11905991" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20713</code><code>PubMed&lt;/a&gt;</code></p><p><code>20714</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20715</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;amp;title=Neuroprotective+properties+of+cannabinoids+against+oxidative+stress:+role+of+the+cannabinoid+receptor+CB1&amp;amp;author=G+Marsicano&amp;amp;author=B+Moosmann&amp;amp;author=H+Hermann&amp;amp;author=B+Lutz&amp;amp;author=C+Behl&amp;amp;volume=80&amp;amp;publication_year=2002a&amp;amp;pages=448-456&amp;amp;pmid=11905991&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20716</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20717</code><code>]&lt;/span&gt;</code></p><p><code>20718</code><code>&lt;/span&gt;</code></p><p><code>20719</code><code>&lt;/li&gt;</code></p><p><code>20720</code><code>&lt;li id="R755"&gt;</code></p><p><code>20721</code><code>&lt;span class="citation"&gt;</code></p><p><code>20722</code><code>Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgansberger W, et al.  The endogenous cannabinoid system controls extinction of aversive memories. &lt;span&gt;</code></p><p><code>20723</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20724</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>20725</code><code>2002b;&lt;span class="ref-vol"&gt;</code></p><p><code>20726</code><code>418&lt;/span&gt;</code></p><p><code>20727</code><code>:530–534.&lt;/span&gt;</code></p><p><code>20728</code><code> [&lt;a href="/pubmed/12152079" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20729</code><code>PubMed&lt;/a&gt;</code></p><p><code>20730</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20731</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=The+endogenous+cannabinoid+system+controls+extinction+of+aversive+memories&amp;amp;author=G+Marsicano&amp;amp;author=CT+Wotjak&amp;amp;author=SC+Azad&amp;amp;author=T+Bisogno&amp;amp;author=G+Rammes&amp;amp;volume=418&amp;amp;publication_year=2002b&amp;amp;pages=530-534&amp;amp;pmid=12152079&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20732</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20733</code><code>]&lt;/span&gt;</code></p><p><code>20734</code><code>&lt;/span&gt;</code></p><p><code>20735</code><code>&lt;/li&gt;</code></p><p><code>20736</code><code>&lt;li id="R756"&gt;</code></p><p><code>20737</code><code>&lt;span class="citation"&gt;</code></p><p><code>20738</code><code>Martellotta MC, Cossu G, Fattore L, Gessa GL, Fratta G. Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-na&amp;#x000ef;ve rats. &lt;span&gt;</code></p><p><code>20739</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20740</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>20741</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>20742</code><code>85&lt;/span&gt;</code></p><p><code>20743</code><code>:327–330.&lt;/span&gt;</code></p><p><code>20744</code><code> [&lt;a href="/pubmed/9622233" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20745</code><code>PubMed&lt;/a&gt;</code></p><p><code>20746</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20747</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Self-administration+of+the+cannabinoid+receptor+agonist+WIN+55,212-2+in+drug-na&amp;#x000ef;ve+rats&amp;amp;author=MC+Martellotta&amp;amp;author=G+Cossu&amp;amp;author=L+Fattore&amp;amp;author=GL+Gessa&amp;amp;author=G+Fratta&amp;amp;volume=85&amp;amp;publication_year=1998&amp;amp;pages=327-330&amp;amp;pmid=9622233&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20748</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20749</code><code>]&lt;/span&gt;</code></p><p><code>20750</code><code>&lt;/span&gt;</code></p><p><code>20751</code><code>&lt;/li&gt;</code></p><p><code>20752</code><code>&lt;li id="R757"&gt;</code></p><p><code>20753</code><code>&lt;span class="citation"&gt;</code></p><p><code>20754</code><code>Martin AR, Consroe P, Kane VV, Shah V, Singh V, Lander N, Mechoulam R, Srebnik M. Structure-anticonvulsant activity relationships of cannabidiol analogs. &lt;span&gt;</code></p><p><code>20755</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20756</code><code>NIDA Res Monogr. &lt;/span&gt;</code></p><p><code>20757</code><code>1987;&lt;span class="ref-vol"&gt;</code></p><p><code>20758</code><code>79&lt;/span&gt;</code></p><p><code>20759</code><code>:48–58.&lt;/span&gt;</code></p><p><code>20760</code><code> [&lt;a href="/pubmed/3125480" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20761</code><code>PubMed&lt;/a&gt;</code></p><p><code>20762</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20763</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=NIDA+Res+Monogr&amp;amp;title=Structure-anticonvulsant+activity+relationships+of+cannabidiol+analogs&amp;amp;author=AR+Martin&amp;amp;author=P+Consroe&amp;amp;author=VV+Kane&amp;amp;author=V+Shah&amp;amp;author=V+Singh&amp;amp;volume=79&amp;amp;publication_year=1987&amp;amp;pages=48-58&amp;amp;pmid=3125480&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20764</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20765</code><code>]&lt;/span&gt;</code></p><p><code>20766</code><code>&lt;/span&gt;</code></p><p><code>20767</code><code>&lt;/li&gt;</code></p><p><code>20768</code><code>&lt;li id="R758"&gt;</code></p><p><code>20769</code><code>&lt;span class="citation"&gt;</code></p><p><code>20770</code><code>Martin BR, Wiley JL. Mechanism of action of cannabinoids: how it may lead to treatment of cachexia, emesis, and pain. &lt;span&gt;</code></p><p><code>20771</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20772</code><code>J Support Oncol. &lt;/span&gt;</code></p><p><code>20773</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>20774</code><code>2&lt;/span&gt;</code></p><p><code>20775</code><code>:305–334. 314–316.&lt;/span&gt;</code></p><p><code>20776</code><code> [&lt;a href="/pubmed/15357514" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20777</code><code>PubMed&lt;/a&gt;</code></p><p><code>20778</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20779</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Support+Oncol&amp;amp;title=Mechanism+of+action+of+cannabinoids:+how+it+may+lead+to+treatment+of+cachexia,+emesis,+and+pain&amp;amp;author=BR+Martin&amp;amp;author=JL+Wiley&amp;amp;volume=2&amp;amp;publication_year=2004&amp;amp;pages=305-334&amp;amp;pmid=15357514&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20780</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20781</code><code>]&lt;/span&gt;</code></p><p><code>20782</code><code>&lt;/span&gt;</code></p><p><code>20783</code><code>&lt;/li&gt;</code></p><p><code>20784</code><code>&lt;li id="R759"&gt;</code></p><p><code>20785</code><code>&lt;span class="citation"&gt;</code></p><p><code>20786</code><code>Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O. Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. &lt;span&gt;</code></p><p><code>20787</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20788</code><code>Eur J Neurosci. &lt;/span&gt;</code></p><p><code>20789</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>20790</code><code>12&lt;/span&gt;</code></p><p><code>20791</code><code>:4038–4046.&lt;/span&gt;</code></p><p><code>20792</code><code> [&lt;a href="/pubmed/11069600" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20793</code><code>PubMed&lt;/a&gt;</code></p><p><code>20794</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20795</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurosci&amp;amp;title=Cocaine,+but+not+morphine,+induces+conditioned+place+preference+and+sensitization+to+locomotor+responses+in+CB1+knockout+mice&amp;amp;author=M+Martin&amp;amp;author=C+Ledent&amp;amp;author=M+Parmentier&amp;amp;author=R+Maldonado&amp;amp;author=O+Valverde&amp;amp;volume=12&amp;amp;publication_year=2000&amp;amp;pages=4038-4046&amp;amp;pmid=11069600&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20796</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20797</code><code>]&lt;/span&gt;</code></p><p><code>20798</code><code>&lt;/span&gt;</code></p><p><code>20799</code><code>&lt;/li&gt;</code></p><p><code>20800</code><code>&lt;li id="R760"&gt;</code></p><p><code>20801</code><code>&lt;span class="citation"&gt;</code></p><p><code>20802</code><code>Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O. Involvement of CB1 cannabinoid receptors in emotional behaviour. &lt;span&gt;</code></p><p><code>20803</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20804</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>20805</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>20806</code><code>159&lt;/span&gt;</code></p><p><code>20807</code><code>:379–387.&lt;/span&gt;</code></p><p><code>20808</code><code> [&lt;a href="/pubmed/11823890" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20809</code><code>PubMed&lt;/a&gt;</code></p><p><code>20810</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20811</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Involvement+of+CB1+cannabinoid+receptors+in+emotional+behaviour&amp;amp;author=M+Martin&amp;amp;author=C+Ledent&amp;amp;author=M+Parmentier&amp;amp;author=R+Maldonado&amp;amp;author=O+Valverde&amp;amp;volume=159&amp;amp;publication_year=2002&amp;amp;pages=379-387&amp;amp;pmid=11823890&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20812</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20813</code><code>]&lt;/span&gt;</code></p><p><code>20814</code><code>&lt;/span&gt;</code></p><p><code>20815</code><code>&lt;/li&gt;</code></p><p><code>20816</code><code>&lt;li id="R761"&gt;</code></p><p><code>20817</code><code>&lt;span class="citation"&gt;</code></p><p><code>20818</code><code>Martin WJ, Coffin PO, Attias E, Balinsky M, Tsou K, Walker JM. Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections. &lt;span&gt;</code></p><p><code>20819</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20820</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>20821</code><code>1999a;&lt;span class="ref-vol"&gt;</code></p><p><code>20822</code><code>822&lt;/span&gt;</code></p><p><code>20823</code><code>:237–242.&lt;/span&gt;</code></p><p><code>20824</code><code> [&lt;a href="/pubmed/10082902" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20825</code><code>PubMed&lt;/a&gt;</code></p><p><code>20826</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20827</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Anatomical+basis+for+cannabinoid-induced+antinociception+as+revealed+by+intracerebral+microinjections&amp;amp;author=WJ+Martin&amp;amp;author=PO+Coffin&amp;amp;author=E+Attias&amp;amp;author=M+Balinsky&amp;amp;author=K+Tsou&amp;amp;volume=822&amp;amp;publication_year=1999a&amp;amp;pages=237-242&amp;amp;pmid=10082902&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20828</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20829</code><code>]&lt;/span&gt;</code></p><p><code>20830</code><code>&lt;/span&gt;</code></p><p><code>20831</code><code>&lt;/li&gt;</code></p><p><code>20832</code><code>&lt;li id="R762"&gt;</code></p><p><code>20833</code><code>&lt;span class="citation"&gt;</code></p><p><code>20834</code><code>Martin WJ, Hohmann AG, Walker JM. Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by the cannabinoid WIN 55,212-2:correlation between electrophysiological and antinociceptive effects. &lt;span&gt;</code></p><p><code>20835</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20836</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>20837</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>20838</code><code>16&lt;/span&gt;</code></p><p><code>20839</code><code>:6601–6611.&lt;/span&gt;</code></p><p><code>20840</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>20841</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6578910/"&gt;</code></p><p><code>20842</code><code>PMC free article&lt;/a&gt;</code></p><p><code>20843</code><code>]&lt;/span&gt;</code></p><p><code>20844</code><code> [&lt;a href="/pubmed/8815936" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20845</code><code>PubMed&lt;/a&gt;</code></p><p><code>20846</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20847</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Suppression+of+noxious+stimulus-evoked+activity+in+the+ventral+posterolateral+nucleus+of+the+thalamus+by+the+cannabinoid+WIN+55,212-2:correlation+between+electrophysiological+and+antinociceptive+effects&amp;amp;author=WJ+Martin&amp;amp;author=AG+Hohmann&amp;amp;author=JM+Walker&amp;amp;volume=16&amp;amp;publication_year=1996&amp;amp;pages=6601-6611&amp;amp;pmid=8815936&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20848</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20849</code><code>]&lt;/span&gt;</code></p><p><code>20850</code><code>&lt;/span&gt;</code></p><p><code>20851</code><code>&lt;/li&gt;</code></p><p><code>20852</code><code>&lt;li id="R763"&gt;</code></p><p><code>20853</code><code>&lt;span class="citation"&gt;</code></p><p><code>20854</code><code>Martin WJ, Lai NK, Patrick SL, Tsou K, Walker JM. Antinociceptive actions of WIN 55,212-2 following intraventricular administration in rats. &lt;span&gt;</code></p><p><code>20855</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20856</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>20857</code><code>1993;&lt;span class="ref-vol"&gt;</code></p><p><code>20858</code><code>629&lt;/span&gt;</code></p><p><code>20859</code><code>:300–304.&lt;/span&gt;</code></p><p><code>20860</code><code> [&lt;a href="/pubmed/8111633" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20861</code><code>PubMed&lt;/a&gt;</code></p><p><code>20862</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20863</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Antinociceptive+actions+of+WIN+55,212-2+following+intraventricular+administration+in+rats&amp;amp;author=WJ+Martin&amp;amp;author=NK+Lai&amp;amp;author=SL+Patrick&amp;amp;author=K+Tsou&amp;amp;author=JM+Walker&amp;amp;volume=629&amp;amp;publication_year=1993&amp;amp;pages=300-304&amp;amp;pmid=8111633&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20864</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20865</code><code>]&lt;/span&gt;</code></p><p><code>20866</code><code>&lt;/span&gt;</code></p><p><code>20867</code><code>&lt;/li&gt;</code></p><p><code>20868</code><code>&lt;li id="R764"&gt;</code></p><p><code>20869</code><code>&lt;span class="citation"&gt;</code></p><p><code>20870</code><code>Martin WJ, Loo CM, Basbaum AI. Spinal cannabinoids are anti-allodynic in rats with persistent inflammation. &lt;span&gt;</code></p><p><code>20871</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20872</code><code>Pain. &lt;/span&gt;</code></p><p><code>20873</code><code>1999b;&lt;span class="ref-vol"&gt;</code></p><p><code>20874</code><code>82&lt;/span&gt;</code></p><p><code>20875</code><code>:199–205.&lt;/span&gt;</code></p><p><code>20876</code><code> [&lt;a href="/pubmed/10467924" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20877</code><code>PubMed&lt;/a&gt;</code></p><p><code>20878</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20879</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;amp;title=Spinal+cannabinoids+are+anti-allodynic+in+rats+with+persistent+inflammation&amp;amp;author=WJ+Martin&amp;amp;author=CM+Loo&amp;amp;author=AI+Basbaum&amp;amp;volume=82&amp;amp;publication_year=1999b&amp;amp;pages=199-205&amp;amp;pmid=10467924&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20880</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20881</code><code>]&lt;/span&gt;</code></p><p><code>20882</code><code>&lt;/span&gt;</code></p><p><code>20883</code><code>&lt;/li&gt;</code></p><p><code>20884</code><code>&lt;li id="R765"&gt;</code></p><p><code>20885</code><code>&lt;span class="citation"&gt;</code></p><p><code>20886</code><code>Martin WJ, Patrick SL, Coffin PO, Tsou K, Walker JM. An examination of the central sites of action of cannabinoid-induced antinociception in the rat. &lt;span&gt;</code></p><p><code>20887</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20888</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>20889</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>20890</code><code>56&lt;/span&gt;</code></p><p><code>20891</code><code>:2103–2110.&lt;/span&gt;</code></p><p><code>20892</code><code> [&lt;a href="/pubmed/7776838" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20893</code><code>PubMed&lt;/a&gt;</code></p><p><code>20894</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20895</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=An+examination+of+the+central+sites+of+action+of+cannabinoid-induced+antinociception+in+the+rat&amp;amp;author=WJ+Martin&amp;amp;author=SL+Patrick&amp;amp;author=PO+Coffin&amp;amp;author=K+Tsou&amp;amp;author=JM+Walker&amp;amp;volume=56&amp;amp;publication_year=1995&amp;amp;pages=2103-2110&amp;amp;pmid=7776838&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20896</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20897</code><code>]&lt;/span&gt;</code></p><p><code>20898</code><code>&lt;/span&gt;</code></p><p><code>20899</code><code>&lt;/li&gt;</code></p><p><code>20900</code><code>&lt;li id="R766"&gt;</code></p><p><code>20901</code><code>&lt;span class="citation"&gt;</code></p><p><code>20902</code><code>Martin WJ, Tsou K, Walker JM. Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla. &lt;span&gt;</code></p><p><code>20903</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20904</code><code>Neurosci Let. &lt;/span&gt;</code></p><p><code>20905</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>20906</code><code>232&lt;/span&gt;</code></p><p><code>20907</code><code>:33–36.&lt;/span&gt;</code></p><p><code>20908</code><code> [&lt;a href="/pubmed/9509998" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20909</code><code>PubMed&lt;/a&gt;</code></p><p><code>20910</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20911</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Let&amp;amp;title=Cannabinoid+receptor-mediated+inhibition+of+the+rat+tail-flick+reflex+after+microinjection+into+the+rostral+ventromedial+medulla&amp;amp;author=WJ+Martin&amp;amp;author=K+Tsou&amp;amp;author=JM+Walker&amp;amp;volume=232&amp;amp;publication_year=1998&amp;amp;pages=33-36&amp;amp;pmid=9509998&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20912</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20913</code><code>]&lt;/span&gt;</code></p><p><code>20914</code><code>&lt;/span&gt;</code></p><p><code>20915</code><code>&lt;/li&gt;</code></p><p><code>20916</code><code>&lt;li id="R767"&gt;</code></p><p><code>20917</code><code>&lt;span class="citation"&gt;</code></p><p><code>20918</code><code>Martin-Calderon JL, Munoz RM, Villanua MA, del Arco I, Moreno JL, de Fonseca FR, Navarro M. Characterization of the acute endocrine actions of (&amp;#x02212;)-11-hydroxy-&amp;#x00394;8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats. &lt;span&gt;</code></p><p><code>20919</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20920</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>20921</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>20922</code><code>344&lt;/span&gt;</code></p><p><code>20923</code><code>:77–86.&lt;/span&gt;</code></p><p><code>20924</code><code> [&lt;a href="/pubmed/9580419" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20925</code><code>PubMed&lt;/a&gt;</code></p><p><code>20926</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20927</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Characterization+of+the+acute+endocrine+actions+of+(&amp;#x02212;)-11-hydroxy-&amp;#x00394;8-tetrahydrocannabinol-dimethylheptyl+(HU-210),+a+potent+synthetic+cannabinoid+in+rats&amp;amp;author=JL+Martin-Calderon&amp;amp;author=RM+Munoz&amp;amp;author=MA+Villanua&amp;amp;author=I+del+Arco&amp;amp;author=JL+Moreno&amp;amp;volume=344&amp;amp;publication_year=1998&amp;amp;pages=77-86&amp;amp;pmid=9580419&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20928</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20929</code><code>]&lt;/span&gt;</code></p><p><code>20930</code><code>&lt;/span&gt;</code></p><p><code>20931</code><code>&lt;/li&gt;</code></p><p><code>20932</code><code>&lt;li id="R768"&gt;</code></p><p><code>20933</code><code>&lt;span class="citation"&gt;</code></p><p><code>20934</code><code>Martinez-Arevalo MJ, Calcedo-Ordonez A, Varo-Prieto JR. Cannabis consumption as a prognostic factor in schizophrenia. &lt;span&gt;</code></p><p><code>20935</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20936</code><code>Br J Psychiatry. &lt;/span&gt;</code></p><p><code>20937</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>20938</code><code>164&lt;/span&gt;</code></p><p><code>20939</code><code>:679–681.&lt;/span&gt;</code></p><p><code>20940</code><code> [&lt;a href="/pubmed/7921721" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20941</code><code>PubMed&lt;/a&gt;</code></p><p><code>20942</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20943</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Psychiatry&amp;amp;title=Cannabis+consumption+as+a+prognostic+factor+in+schizophrenia&amp;amp;author=MJ+Martinez-Arevalo&amp;amp;author=A+Calcedo-Ordonez&amp;amp;author=JR+Varo-Prieto&amp;amp;volume=164&amp;amp;publication_year=1994&amp;amp;pages=679-681&amp;amp;pmid=7921721&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20944</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20945</code><code>]&lt;/span&gt;</code></p><p><code>20946</code><code>&lt;/span&gt;</code></p><p><code>20947</code><code>&lt;/li&gt;</code></p><p><code>20948</code><code>&lt;li id="R769"&gt;</code></p><p><code>20949</code><code>&lt;span class="citation"&gt;</code></p><p><code>20950</code><code>Martinez-Vargas M, Murillo-Rodriguez E, Gonzalez-Rivera R, Landa A, Mendez-Diaz M, Prospro-Garcia O, Navarro L. Sleep modulates cannabinoid receptor 1 expression in the pons of rats. &lt;span&gt;</code></p><p><code>20951</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20952</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>20953</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>20954</code><code>117&lt;/span&gt;</code></p><p><code>20955</code><code>:197–201.&lt;/span&gt;</code></p><p><code>20956</code><code> [&lt;a href="/pubmed/12605905" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20957</code><code>PubMed&lt;/a&gt;</code></p><p><code>20958</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20959</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Sleep+modulates+cannabinoid+receptor+1+expression+in+the+pons+of+rats&amp;amp;author=M+Martinez-Vargas&amp;amp;author=E+Murillo-Rodriguez&amp;amp;author=R+Gonzalez-Rivera&amp;amp;author=A+Landa&amp;amp;author=M+Mendez-Diaz&amp;amp;volume=117&amp;amp;publication_year=2003&amp;amp;pages=197-201&amp;amp;pmid=12605905&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20960</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20961</code><code>]&lt;/span&gt;</code></p><p><code>20962</code><code>&lt;/span&gt;</code></p><p><code>20963</code><code>&lt;/li&gt;</code></p><p><code>20964</code><code>&lt;li id="R770"&gt;</code></p><p><code>20965</code><code>&lt;span class="citation"&gt;</code></p><p><code>20966</code><code>Martyn CN, Illis LS, Thom J. Nabilone in the treatment of multiple sclerosis. &lt;span&gt;</code></p><p><code>20967</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20968</code><code>Lancet. &lt;/span&gt;</code></p><p><code>20969</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>20970</code><code>345&lt;/span&gt;</code></p><p><code>20971</code><code>:579.&lt;/span&gt;</code></p><p><code>20972</code><code> [&lt;a href="/pubmed/7776785" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20973</code><code>PubMed&lt;/a&gt;</code></p><p><code>20974</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20975</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;amp;title=Nabilone+in+the+treatment+of+multiple+sclerosis&amp;amp;author=CN+Martyn&amp;amp;author=LS+Illis&amp;amp;author=J+Thom&amp;amp;volume=345&amp;amp;publication_year=1995&amp;amp;pages=579&amp;amp;pmid=7776785&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20976</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20977</code><code>]&lt;/span&gt;</code></p><p><code>20978</code><code>&lt;/span&gt;</code></p><p><code>20979</code><code>&lt;/li&gt;</code></p><p><code>20980</code><code>&lt;li id="R771"&gt;</code></p><p><code>20981</code><code>&lt;span class="citation"&gt;</code></p><p><code>20982</code><code>Mascia MS, Obinu MC, Ledent C, Parmentier M, B&amp;#x000f6;hme GA, Imperato A, Fratta W. lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB&lt;sub&gt;</code></p><p><code>20983</code><code>1&lt;/sub&gt;</code></p><p><code>20984</code><code> receptor knockout mice. &lt;span&gt;</code></p><p><code>20985</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>20986</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>20987</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>20988</code><code>383&lt;/span&gt;</code></p><p><code>20989</code><code>:R1–R2.&lt;/span&gt;</code></p><p><code>20990</code><code> [&lt;a href="/pubmed/10594337" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>20991</code><code>PubMed&lt;/a&gt;</code></p><p><code>20992</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>20993</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=lack+of+morphine-induced+dopamine+release+in+the+nucleus+accumbens+of+cannabinoid+CB1+receptor+knockout+mice&amp;amp;author=MS+Mascia&amp;amp;author=MC+Obinu&amp;amp;author=C+Ledent&amp;amp;author=M+Parmentier&amp;amp;author=GA+B&amp;#x000f6;hme&amp;amp;volume=383&amp;amp;publication_year=1999&amp;amp;pages=R1-R2&amp;amp;pmid=10594337&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>20994</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>20995</code><code>]&lt;/span&gt;</code></p><p><code>20996</code><code>&lt;/span&gt;</code></p><p><code>20997</code><code>&lt;/li&gt;</code></p><p><code>20998</code><code>&lt;li id="R772"&gt;</code></p><p><code>20999</code><code>&lt;span class="citation"&gt;</code></p><p><code>21000</code><code>Mascolo N, Izzo AA, Ligresti A, Costagliola A, Pinto L, Cascio MG, Maffia P, Cecio A, Capasso F, Di Marzo V. The endocannabinoid system and the molecular basis of paralytic ileus in mice. &lt;span&gt;</code></p><p><code>21001</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21002</code><code>FASEB J. &lt;/span&gt;</code></p><p><code>21003</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>21004</code><code>16&lt;/span&gt;</code></p><p><code>21005</code><code>:1973–1975.&lt;/span&gt;</code></p><p><code>21006</code><code> [&lt;a href="/pubmed/12397089" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21007</code><code>PubMed&lt;/a&gt;</code></p><p><code>21008</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21009</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;amp;title=The+endocannabinoid+system+and+the+molecular+basis+of+paralytic+ileus+in+mice&amp;amp;author=N+Mascolo&amp;amp;author=AA+Izzo&amp;amp;author=A+Ligresti&amp;amp;author=A+Costagliola&amp;amp;author=L+Pinto&amp;amp;volume=16&amp;amp;publication_year=2002&amp;amp;pages=1973-1975&amp;amp;pmid=12397089&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21010</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21011</code><code>]&lt;/span&gt;</code></p><p><code>21012</code><code>&lt;/span&gt;</code></p><p><code>21013</code><code>&lt;/li&gt;</code></p><p><code>21014</code><code>&lt;li id="R773"&gt;</code></p><p><code>21015</code><code>&lt;span class="citation"&gt;</code></p><p><code>21016</code><code>Maslov LN, Lasukova OV, Krylatov AV, Uzhachenko RV, Pertwee R. Selective cannabinoid receptor agonist HU-210 decreases pump function of isolated perfused heart: role of cAMP and cGMP. &lt;span&gt;</code></p><p><code>21017</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21018</code><code>Bull Exp Biol Med. &lt;/span&gt;</code></p><p><code>21019</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>21020</code><code>138&lt;/span&gt;</code></p><p><code>21021</code><code>:550–553.&lt;/span&gt;</code></p><p><code>21022</code><code> [&lt;a href="/pubmed/16134810" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21023</code><code>PubMed&lt;/a&gt;</code></p><p><code>21024</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21025</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Bull+Exp+Biol+Med&amp;amp;title=Selective+cannabinoid+receptor+agonist+HU-210+decreases+pump+function+of+isolated+perfused+heart:+role+of+cAMP+and+cGMP&amp;amp;author=LN+Maslov&amp;amp;author=OV+Lasukova&amp;amp;author=AV+Krylatov&amp;amp;author=RV+Uzhachenko&amp;amp;author=R+Pertwee&amp;amp;volume=138&amp;amp;publication_year=2004&amp;amp;pages=550-553&amp;amp;pmid=16134810&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21026</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21027</code><code>]&lt;/span&gt;</code></p><p><code>21028</code><code>&lt;/span&gt;</code></p><p><code>21029</code><code>&lt;/li&gt;</code></p><p><code>21030</code><code>&lt;li id="R774"&gt;</code></p><p><code>21031</code><code>&lt;span class="citation"&gt;</code></p><p><code>21032</code><code>Mas-Nieto M, Pommier B, Tzavara ET, Caneparo A, Da Nascimento S, Le Fur G, Roques BP, Noble F. Reduction of opioid dependence by the CB&lt;sub&gt;</code></p><p><code>21033</code><code>1&lt;/sub&gt;</code></p><p><code>21034</code><code> antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction. &lt;span&gt;</code></p><p><code>21035</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21036</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>21037</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>21038</code><code>132&lt;/span&gt;</code></p><p><code>21039</code><code>:1809–1816.&lt;/span&gt;</code></p><p><code>21040</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>21041</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1572728/"&gt;</code></p><p><code>21042</code><code>PMC free article&lt;/a&gt;</code></p><p><code>21043</code><code>]&lt;/span&gt;</code></p><p><code>21044</code><code> [&lt;a href="/pubmed/11309253" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21045</code><code>PubMed&lt;/a&gt;</code></p><p><code>21046</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21047</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Reduction+of+opioid+dependence+by+the+CB1+antagonist+SR141716A+in+mice:+evaluation+of+the+interest+in+pharmacotherapy+of+opioid+addiction&amp;amp;author=M+Mas-Nieto&amp;amp;author=B+Pommier&amp;amp;author=ET+Tzavara&amp;amp;author=A+Caneparo&amp;amp;author=S+Da+Nascimento&amp;amp;volume=132&amp;amp;publication_year=2001&amp;amp;pages=1809-1816&amp;amp;pmid=11309253&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21048</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21049</code><code>]&lt;/span&gt;</code></p><p><code>21050</code><code>&lt;/span&gt;</code></p><p><code>21051</code><code>&lt;/li&gt;</code></p><p><code>21052</code><code>&lt;li id="R775"&gt;</code></p><p><code>21053</code><code>&lt;span class="citation"&gt;</code></p><p><code>21054</code><code>Massa F, Marsicano G, Hermann H, Cannich A, Monory K, Cravatt BF, Ferri GL, Sibaev A, Storr M, Lutz B. The endogenous cannabinoid system protects against colonic inflammation. &lt;span&gt;</code></p><p><code>21055</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21056</code><code>J Clin Investig. &lt;/span&gt;</code></p><p><code>21057</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>21058</code><code>113&lt;/span&gt;</code></p><p><code>21059</code><code>:1202–1209.&lt;/span&gt;</code></p><p><code>21060</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>21061</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC385396/"&gt;</code></p><p><code>21062</code><code>PMC free article&lt;/a&gt;</code></p><p><code>21063</code><code>]&lt;/span&gt;</code></p><p><code>21064</code><code> [&lt;a href="/pubmed/15085199" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21065</code><code>PubMed&lt;/a&gt;</code></p><p><code>21066</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21067</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Investig&amp;amp;title=The+endogenous+cannabinoid+system+protects+against+colonic+inflammation&amp;amp;author=F+Massa&amp;amp;author=G+Marsicano&amp;amp;author=H+Hermann&amp;amp;author=A+Cannich&amp;amp;author=K+Monory&amp;amp;volume=113&amp;amp;publication_year=2004&amp;amp;pages=1202-1209&amp;amp;pmid=15085199&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21068</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21069</code><code>]&lt;/span&gt;</code></p><p><code>21070</code><code>&lt;/span&gt;</code></p><p><code>21071</code><code>&lt;/li&gt;</code></p><p><code>21072</code><code>&lt;li id="R776"&gt;</code></p><p><code>21073</code><code>&lt;span class="citation"&gt;</code></p><p><code>21074</code><code>Massa F, Storr M, Lutz B. The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract. &lt;span&gt;</code></p><p><code>21075</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21076</code><code>J Mol Med. &lt;/span&gt;</code></p><p><code>21077</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>21078</code><code>83&lt;/span&gt;</code></p><p><code>21079</code><code>:944–954.&lt;/span&gt;</code></p><p><code>21080</code><code> [&lt;a href="/pubmed/16133420" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21081</code><code>PubMed&lt;/a&gt;</code></p><p><code>21082</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21083</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Mol+Med&amp;amp;title=The+endocannabinoid+system+in+the+physiology+and+pathophysiology+of+the+gastrointestinal+tract&amp;amp;author=F+Massa&amp;amp;author=M+Storr&amp;amp;author=B+Lutz&amp;amp;volume=83&amp;amp;publication_year=2005&amp;amp;pages=944-954&amp;amp;pmid=16133420&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21084</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21085</code><code>]&lt;/span&gt;</code></p><p><code>21086</code><code>&lt;/span&gt;</code></p><p><code>21087</code><code>&lt;/li&gt;</code></p><p><code>21088</code><code>&lt;li id="R777"&gt;</code></p><p><code>21089</code><code>&lt;span class="citation"&gt;</code></p><p><code>21090</code><code>Massi P, Vaccani A, Ceruti S, Colombo A, Abbracchio MP, Parolaro D. Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines. &lt;span&gt;</code></p><p><code>21091</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21092</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>21093</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>21094</code><code>308&lt;/span&gt;</code></p><p><code>21095</code><code>:838–845.&lt;/span&gt;</code></p><p><code>21096</code><code> [&lt;a href="/pubmed/14617682" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21097</code><code>PubMed&lt;/a&gt;</code></p><p><code>21098</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21099</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Antitumor+effects+of+cannabidiol,+a+nonpsychoactive+cannabinoid,+on+human+glioma+cell+lines&amp;amp;author=P+Massi&amp;amp;author=A+Vaccani&amp;amp;author=S+Ceruti&amp;amp;author=A+Colombo&amp;amp;author=MP+Abbracchio&amp;amp;volume=308&amp;amp;publication_year=2004&amp;amp;pages=838-845&amp;amp;pmid=14617682&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21100</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21101</code><code>]&lt;/span&gt;</code></p><p><code>21102</code><code>&lt;/span&gt;</code></p><p><code>21103</code><code>&lt;/li&gt;</code></p><p><code>21104</code><code>&lt;li id="R778"&gt;</code></p><p><code>21105</code><code>&lt;span class="citation"&gt;</code></p><p><code>21106</code><code>Mathison R, Ho W, Pittman QJ, Davison JS, Sharkey KA. Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats. &lt;span&gt;</code></p><p><code>21107</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21108</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>21109</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>21110</code><code>142&lt;/span&gt;</code></p><p><code>21111</code><code>:1247–1254.&lt;/span&gt;</code></p><p><code>21112</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>21113</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1575196/"&gt;</code></p><p><code>21114</code><code>PMC free article&lt;/a&gt;</code></p><p><code>21115</code><code>]&lt;/span&gt;</code></p><p><code>21116</code><code> [&lt;a href="/pubmed/15249429" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21117</code><code>PubMed&lt;/a&gt;</code></p><p><code>21118</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21119</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Effects+of+cannabinoid+receptor-2+activation+on+accelerated+gastrointestinal+transit+in+lipopolysaccharide-treated+rats&amp;amp;author=R+Mathison&amp;amp;author=W+Ho&amp;amp;author=QJ+Pittman&amp;amp;author=JS+Davison&amp;amp;author=KA+Sharkey&amp;amp;volume=142&amp;amp;publication_year=2004&amp;amp;pages=1247-1254&amp;amp;pmid=15249429&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21120</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21121</code><code>]&lt;/span&gt;</code></p><p><code>21122</code><code>&lt;/span&gt;</code></p><p><code>21123</code><code>&lt;/li&gt;</code></p><p><code>21124</code><code>&lt;li id="R779"&gt;</code></p><p><code>21125</code><code>&lt;span class="citation"&gt;</code></p><p><code>21126</code><code>Matias I, Gonthier M-P, Monteleone P, Di Marzo V. Peripheral upregulation of the endocannabionoid system in obesity. Proceedings of the 2005 Symposium on the Cannabinoids; Burlington, VT: International Cannabinoid Research Society; 2005. p. 58. &lt;span class="nowrap"&gt;</code></p><p><code>21127</code><code>[&lt;a href="https://scholar.google.com/scholar?q=Matias+I+Gonthier+M-P+Monteleone+P+Di+Marzo+V+2005+Peripheral+upregulation+of+the+endocannabionoid+system+in+obesity+Proceedings+of+the+2005+Symposium+on+the+Cannabinoids+58+International+Cannabinoid+Research+Society+Burlington,+VT+" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21128</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21129</code><code>]&lt;/span&gt;</code></p><p><code>21130</code><code>&lt;/span&gt;</code></p><p><code>21131</code><code>&lt;/li&gt;</code></p><p><code>21132</code><code>&lt;li id="R780"&gt;</code></p><p><code>21133</code><code>&lt;span class="citation"&gt;</code></p><p><code>21134</code><code>Matias I, Gonthier M-P, Orlando P, Martiadis V, De Petrocellis L, Cervino C, Petrosino S, Hoareau L, Festy F, Pasquali R, et al.  Regulation, function and dysregulation of endocannabionoids in obesity and hyperglycemis. &lt;span&gt;</code></p><p><code>21135</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21136</code><code>J Clin Endocr Metab. &lt;/span&gt;</code></p><p><code>21137</code><code>2006&lt;/span&gt;</code></p><p><code>21138</code><code> in press. [&lt;a href="/pubmed/16684820" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21139</code><code>PubMed&lt;/a&gt;</code></p><p><code>21140</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21141</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocr+Metab&amp;amp;title=Regulation,+function+and+dysregulation+of+endocannabionoids+in+obesity+and+hyperglycemis&amp;amp;author=I+Matias&amp;amp;author=M-P+Gonthier&amp;amp;author=P+Orlando&amp;amp;author=V+Martiadis&amp;amp;author=L+De+Petrocellis&amp;amp;publication_year=2006&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21142</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21143</code><code>]&lt;/span&gt;</code></p><p><code>21144</code><code>&lt;/span&gt;</code></p><p><code>21145</code><code>&lt;/li&gt;</code></p><p><code>21146</code><code>&lt;li id="R781"&gt;</code></p><p><code>21147</code><code>&lt;span class="citation"&gt;</code></p><p><code>21148</code><code>Mato S, Chevaleyre V, Robbe D, Pazos A, Castillo PE, Manzoni OJ. A single in-vivo exposure to &amp;#x00394;&lt;sup&gt;</code></p><p><code>21149</code><code>9&lt;/sup&gt;</code></p><p><code>21150</code><code>THC blocks endocannabinoid-mediated synaptic plasticity. &lt;span&gt;</code></p><p><code>21151</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21152</code><code>Nat Neurosci. &lt;/span&gt;</code></p><p><code>21153</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>21154</code><code>7&lt;/span&gt;</code></p><p><code>21155</code><code>:585–586.&lt;/span&gt;</code></p><p><code>21156</code><code> [&lt;a href="/pubmed/15146190" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21157</code><code>PubMed&lt;/a&gt;</code></p><p><code>21158</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21159</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Neurosci&amp;amp;title=A+single+in-vivo+exposure+to+&amp;#x00394;9THC+blocks+endocannabinoid-mediated+synaptic+plasticity&amp;amp;author=S+Mato&amp;amp;author=V+Chevaleyre&amp;amp;author=D+Robbe&amp;amp;author=A+Pazos&amp;amp;author=PE+Castillo&amp;amp;volume=7&amp;amp;publication_year=2004&amp;amp;pages=585-586&amp;amp;pmid=15146190&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21160</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21161</code><code>]&lt;/span&gt;</code></p><p><code>21162</code><code>&lt;/span&gt;</code></p><p><code>21163</code><code>&lt;/li&gt;</code></p><p><code>21164</code><code>&lt;li id="R782"&gt;</code></p><p><code>21165</code><code>&lt;span class="citation"&gt;</code></p><p><code>21166</code><code>Matsuda K, Mikami Y, Takeda K, Fukuyama S, Egawa S, Sunamura M, Maruyama I, Matsuno S. The cannabinoid 1 receptor antagonist, AM251, prolongs the survival of rats with severe acute pancreatitis. &lt;span&gt;</code></p><p><code>21167</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21168</code><code>Tohoku J Exp Med. &lt;/span&gt;</code></p><p><code>21169</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>21170</code><code>207&lt;/span&gt;</code></p><p><code>21171</code><code>:99–107.&lt;/span&gt;</code></p><p><code>21172</code><code> [&lt;a href="/pubmed/16141678" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21173</code><code>PubMed&lt;/a&gt;</code></p><p><code>21174</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21175</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Tohoku+J+Exp+Med&amp;amp;title=The+cannabinoid+1+receptor+antagonist,+AM251,+prolongs+the+survival+of+rats+with+severe+acute+pancreatitis&amp;amp;author=K+Matsuda&amp;amp;author=Y+Mikami&amp;amp;author=K+Takeda&amp;amp;author=S+Fukuyama&amp;amp;author=S+Egawa&amp;amp;volume=207&amp;amp;publication_year=2005&amp;amp;pages=99-107&amp;amp;pmid=16141678&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21176</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21177</code><code>]&lt;/span&gt;</code></p><p><code>21178</code><code>&lt;/span&gt;</code></p><p><code>21179</code><code>&lt;/li&gt;</code></p><p><code>21180</code><code>&lt;li id="R783"&gt;</code></p><p><code>21181</code><code>&lt;span class="citation"&gt;</code></p><p><code>21182</code><code>Matsuda LA, Lolait SJ, Brownstein MJ, Young CA, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. &lt;span&gt;</code></p><p><code>21183</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21184</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>21185</code><code>1990;&lt;span class="ref-vol"&gt;</code></p><p><code>21186</code><code>346&lt;/span&gt;</code></p><p><code>21187</code><code>:561–564.&lt;/span&gt;</code></p><p><code>21188</code><code> [&lt;a href="/pubmed/2165569" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21189</code><code>PubMed&lt;/a&gt;</code></p><p><code>21190</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21191</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Structure+of+a+cannabinoid+receptor+and+functional+expression+of+the+cloned+cDNA&amp;amp;author=LA+Matsuda&amp;amp;author=SJ+Lolait&amp;amp;author=MJ+Brownstein&amp;amp;author=CA+Young&amp;amp;author=TI+Bonner&amp;amp;volume=346&amp;amp;publication_year=1990&amp;amp;pages=561-564&amp;amp;pmid=2165569&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21192</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21193</code><code>]&lt;/span&gt;</code></p><p><code>21194</code><code>&lt;/span&gt;</code></p><p><code>21195</code><code>&lt;/li&gt;</code></p><p><code>21196</code><code>&lt;li id="R784"&gt;</code></p><p><code>21197</code><code>&lt;span class="citation"&gt;</code></p><p><code>21198</code><code>Mauler F, Mittendorf J, Horvath E, De Vry J. Characterization of the diarylether sulfonylester (&amp;#x02212;)-(&lt;em&gt;</code></p><p><code>21199</code><code>R&lt;/em&gt;</code></p><p><code>21200</code><code>)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties. &lt;span&gt;</code></p><p><code>21201</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21202</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>21203</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>21204</code><code>302&lt;/span&gt;</code></p><p><code>21205</code><code>:359–368.&lt;/span&gt;</code></p><p><code>21206</code><code> [&lt;a href="/pubmed/12065738" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21207</code><code>PubMed&lt;/a&gt;</code></p><p><code>21208</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21209</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Characterization+of+the+diarylether+sulfonylester+(&amp;#x02212;)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate+(BAY+38-7271)+as+a+potent+cannabinoid+receptor+agonist+with+neuroprotective+properties&amp;amp;author=F+Mauler&amp;amp;author=J+Mittendorf&amp;amp;author=E+Horvath&amp;amp;author=J+De+Vry&amp;amp;volume=302&amp;amp;publication_year=2002&amp;amp;pages=359-368&amp;amp;pmid=12065738&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21210</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21211</code><code>]&lt;/span&gt;</code></p><p><code>21212</code><code>&lt;/span&gt;</code></p><p><code>21213</code><code>&lt;/li&gt;</code></p><p><code>21214</code><code>&lt;li id="R785"&gt;</code></p><p><code>21215</code><code>&lt;span class="citation"&gt;</code></p><p><code>21216</code><code>Mazzola C, Micale V, Drago F. Amnesia induced by &lt;em&gt;</code></p><p><code>21217</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>21218</code><code>-amyloid fragments is counteracted by cannabinoid CB&lt;sub&gt;</code></p><p><code>21219</code><code>1&lt;/sub&gt;</code></p><p><code>21220</code><code> receptor blockade. &lt;span&gt;</code></p><p><code>21221</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21222</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>21223</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>21224</code><code>477&lt;/span&gt;</code></p><p><code>21225</code><code>:219–225.&lt;/span&gt;</code></p><p><code>21226</code><code> [&lt;a href="/pubmed/14522360" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21227</code><code>PubMed&lt;/a&gt;</code></p><p><code>21228</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21229</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Amnesia+induced+by+&amp;#x003b2;-amyloid+fragments+is+counteracted+by+cannabinoid+CB1+receptor+blockade&amp;amp;author=C+Mazzola&amp;amp;author=V+Micale&amp;amp;author=F+Drago&amp;amp;volume=477&amp;amp;publication_year=2003&amp;amp;pages=219-225&amp;amp;pmid=14522360&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21230</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21231</code><code>]&lt;/span&gt;</code></p><p><code>21232</code><code>&lt;/span&gt;</code></p><p><code>21233</code><code>&lt;/li&gt;</code></p><p><code>21234</code><code>&lt;li id="R786"&gt;</code></p><p><code>21235</code><code>&lt;span class="citation"&gt;</code></p><p><code>21236</code><code>Mbvundula EC, Bunning RA, Rainsford KD. Effects of cannabinoids on nitric oxide production by chondrocytes and proteoglycan degradation in cartilage. &lt;span&gt;</code></p><p><code>21237</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21238</code><code>Biochem Pharmacol. &lt;/span&gt;</code></p><p><code>21239</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>21240</code><code>69&lt;/span&gt;</code></p><p><code>21241</code><code>:635–640.&lt;/span&gt;</code></p><p><code>21242</code><code> [&lt;a href="/pubmed/15670582" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21243</code><code>PubMed&lt;/a&gt;</code></p><p><code>21244</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21245</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;amp;title=Effects+of+cannabinoids+on+nitric+oxide+production+by+chondrocytes+and+proteoglycan+degradation+in+cartilage&amp;amp;author=EC+Mbvundula&amp;amp;author=RA+Bunning&amp;amp;author=KD+Rainsford&amp;amp;volume=69&amp;amp;publication_year=2005&amp;amp;pages=635-640&amp;amp;pmid=15670582&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21246</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21247</code><code>]&lt;/span&gt;</code></p><p><code>21248</code><code>&lt;/span&gt;</code></p><p><code>21249</code><code>&lt;/li&gt;</code></p><p><code>21250</code><code>&lt;li id="R787"&gt;</code></p><p><code>21251</code><code>&lt;span class="citation"&gt;</code></p><p><code>21252</code><code>Mbvundula EC, Bunning RA, Rainsford KD. Arthritis and cannabinoids: HU-210 and Win-55,212-2 prevent IL-1&lt;em&gt;</code></p><p><code>21253</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>21254</code><code>-induced matrix degradation in bovine articular chondrocytes in-vitro. &lt;span&gt;</code></p><p><code>21255</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21256</code><code>J Pharm Pharmacol. &lt;/span&gt;</code></p><p><code>21257</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>21258</code><code>58&lt;/span&gt;</code></p><p><code>21259</code><code>:351–358.&lt;/span&gt;</code></p><p><code>21260</code><code> [&lt;a href="/pubmed/16536902" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21261</code><code>PubMed&lt;/a&gt;</code></p><p><code>21262</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21263</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Pharmacol&amp;amp;title=Arthritis+and+cannabinoids:+HU-210+and+Win-55,212-2+prevent+IL-1&amp;#x003b1;-induced+matrix+degradation+in+bovine+articular+chondrocytes+in-vitro&amp;amp;author=EC+Mbvundula&amp;amp;author=RA+Bunning&amp;amp;author=KD+Rainsford&amp;amp;volume=58&amp;amp;publication_year=2006&amp;amp;pages=351-358&amp;amp;pmid=16536902&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21264</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21265</code><code>]&lt;/span&gt;</code></p><p><code>21266</code><code>&lt;/span&gt;</code></p><p><code>21267</code><code>&lt;/li&gt;</code></p><p><code>21268</code><code>&lt;li id="R788"&gt;</code></p><p><code>21269</code><code>&lt;span class="citation"&gt;</code></p><p><code>21270</code><code>McAllister SD, Rizvi G, Anavi-Goffer S, Hurst DP, Barnett-Norris J, Lynch DL, Reggio PH, Abood ME. An aromatic microdomain at the cannabinoid CB&lt;sub&gt;</code></p><p><code>21271</code><code>1&lt;/sub&gt;</code></p><p><code>21272</code><code> receptor constitutes an agonist/inverse agonist binding region. &lt;span&gt;</code></p><p><code>21273</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21274</code><code>J Med Chem. &lt;/span&gt;</code></p><p><code>21275</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>21276</code><code>46&lt;/span&gt;</code></p><p><code>21277</code><code>:5139–5152.&lt;/span&gt;</code></p><p><code>21278</code><code> [&lt;a href="/pubmed/14613317" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21279</code><code>PubMed&lt;/a&gt;</code></p><p><code>21280</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21281</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;amp;title=An+aromatic+microdomain+at+the+cannabinoid+CB1+receptor+constitutes+an+agonist/inverse+agonist+binding+region&amp;amp;author=SD+McAllister&amp;amp;author=G+Rizvi&amp;amp;author=S+Anavi-Goffer&amp;amp;author=DP+Hurst&amp;amp;author=J+Barnett-Norris&amp;amp;volume=46&amp;amp;publication_year=2003&amp;amp;pages=5139-5152&amp;amp;pmid=14613317&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21282</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21283</code><code>]&lt;/span&gt;</code></p><p><code>21284</code><code>&lt;/span&gt;</code></p><p><code>21285</code><code>&lt;/li&gt;</code></p><p><code>21286</code><code>&lt;li id="R789"&gt;</code></p><p><code>21287</code><code>&lt;span class="citation"&gt;</code></p><p><code>21288</code><code>McCallum RW, Soykan I, Sridhar KR, Ricci DA, Lange RC, Plankey MW. &amp;#x00394;-9-Tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study. &lt;span&gt;</code></p><p><code>21289</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21290</code><code>Aliment Pharmacol Ther. &lt;/span&gt;</code></p><p><code>21291</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>21292</code><code>13&lt;/span&gt;</code></p><p><code>21293</code><code>:77–80.&lt;/span&gt;</code></p><p><code>21294</code><code> [&lt;a href="/pubmed/9892882" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21295</code><code>PubMed&lt;/a&gt;</code></p><p><code>21296</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21297</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Aliment+Pharmacol+Ther&amp;amp;title=&amp;#x00394;-9-Tetrahydrocannabinol+delays+the+gastric+emptying+of+solid+food+in+humans:+a+double-blind,+randomized+study&amp;amp;author=RW+McCallum&amp;amp;author=I+Soykan&amp;amp;author=KR+Sridhar&amp;amp;author=DA+Ricci&amp;amp;author=RC+Lange&amp;amp;volume=13&amp;amp;publication_year=1999&amp;amp;pages=77-80&amp;amp;pmid=9892882&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21298</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21299</code><code>]&lt;/span&gt;</code></p><p><code>21300</code><code>&lt;/span&gt;</code></p><p><code>21301</code><code>&lt;/li&gt;</code></p><p><code>21302</code><code>&lt;li id="R790"&gt;</code></p><p><code>21303</code><code>&lt;span class="citation"&gt;</code></p><p><code>21304</code><code>McCaw EA, Hu H, Gomez GT, Hebb AL, Kelly ME, Denovan-Wright EM. Structure, expression and regulation of the cannabinoid receptor gene (&lt;em&gt;</code></p><p><code>21305</code><code>CB1&lt;/em&gt;</code></p><p><code>21306</code><code>) in Huntington&amp;#x02019;s disease transgenic mice. &lt;span&gt;</code></p><p><code>21307</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21308</code><code>Eur J Biochem. &lt;/span&gt;</code></p><p><code>21309</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>21310</code><code>271&lt;/span&gt;</code></p><p><code>21311</code><code>:4909–4920.&lt;/span&gt;</code></p><p><code>21312</code><code> [&lt;a href="/pubmed/15606779" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21313</code><code>PubMed&lt;/a&gt;</code></p><p><code>21314</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21315</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Biochem&amp;amp;title=Structure,+expression+and+regulation+of+the+cannabinoid+receptor+gene+(CB1)+in+Huntington&amp;#x02019;s+disease+transgenic+mice&amp;amp;author=EA+McCaw&amp;amp;author=H+Hu&amp;amp;author=GT+Gomez&amp;amp;author=AL+Hebb&amp;amp;author=ME+Kelly&amp;amp;volume=271&amp;amp;publication_year=2004&amp;amp;pages=4909-4920&amp;amp;pmid=15606779&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21316</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21317</code><code>]&lt;/span&gt;</code></p><p><code>21318</code><code>&lt;/span&gt;</code></p><p><code>21319</code><code>&lt;/li&gt;</code></p><p><code>21320</code><code>&lt;li id="R791"&gt;</code></p><p><code>21321</code><code>&lt;span class="citation"&gt;</code></p><p><code>21322</code><code>McCormick DA, Contreras D. On the cellular and network bases of epileptic seizures. &lt;span&gt;</code></p><p><code>21323</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21324</code><code>Annu Rev Physiol. &lt;/span&gt;</code></p><p><code>21325</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>21326</code><code>63&lt;/span&gt;</code></p><p><code>21327</code><code>:815–846.&lt;/span&gt;</code></p><p><code>21328</code><code> [&lt;a href="/pubmed/11181977" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21329</code><code>PubMed&lt;/a&gt;</code></p><p><code>21330</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21331</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Physiol&amp;amp;title=On+the+cellular+and+network+bases+of+epileptic+seizures&amp;amp;author=DA+McCormick&amp;amp;author=D+Contreras&amp;amp;volume=63&amp;amp;publication_year=2001&amp;amp;pages=815-846&amp;amp;pmid=11181977&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21332</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21333</code><code>]&lt;/span&gt;</code></p><p><code>21334</code><code>&lt;/span&gt;</code></p><p><code>21335</code><code>&lt;/li&gt;</code></p><p><code>21336</code><code>&lt;li id="R792"&gt;</code></p><p><code>21337</code><code>&lt;span class="citation"&gt;</code></p><p><code>21338</code><code>McFarland MJ, Barker EL. Anandamide transport. &lt;span&gt;</code></p><p><code>21339</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21340</code><code>Pharmacol Ther. &lt;/span&gt;</code></p><p><code>21341</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>21342</code><code>104&lt;/span&gt;</code></p><p><code>21343</code><code>:117–135.&lt;/span&gt;</code></p><p><code>21344</code><code> [&lt;a href="/pubmed/15518883" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21345</code><code>PubMed&lt;/a&gt;</code></p><p><code>21346</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21347</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Ther&amp;amp;title=Anandamide+transport&amp;amp;author=MJ+McFarland&amp;amp;author=EL+Barker&amp;amp;volume=104&amp;amp;publication_year=2004&amp;amp;pages=117-135&amp;amp;pmid=15518883&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21348</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21349</code><code>]&lt;/span&gt;</code></p><p><code>21350</code><code>&lt;/span&gt;</code></p><p><code>21351</code><code>&lt;/li&gt;</code></p><p><code>21352</code><code>&lt;li id="R793"&gt;</code></p><p><code>21353</code><code>&lt;span class="citation"&gt;</code></p><p><code>21354</code><code>McGarry JD. What if Minkowski had been ageusic? An alternative angle on diabetes. &lt;span&gt;</code></p><p><code>21355</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21356</code><code>Science (Wash DC) &lt;/span&gt;</code></p><p><code>21357</code><code>1992;&lt;span class="ref-vol"&gt;</code></p><p><code>21358</code><code>258&lt;/span&gt;</code></p><p><code>21359</code><code>:766–770.&lt;/span&gt;</code></p><p><code>21360</code><code> [&lt;a href="/pubmed/1439783" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21361</code><code>PubMed&lt;/a&gt;</code></p><p><code>21362</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21363</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Science+(Wash+DC)&amp;amp;title=What+if+Minkowski+had+been+ageusic?+An+alternative+angle+on+diabetes&amp;amp;author=JD+McGarry&amp;amp;volume=258&amp;amp;publication_year=1992&amp;amp;pages=766-770&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21364</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21365</code><code>]&lt;/span&gt;</code></p><p><code>21366</code><code>&lt;/span&gt;</code></p><p><code>21367</code><code>&lt;/li&gt;</code></p><p><code>21368</code><code>&lt;li id="R794"&gt;</code></p><p><code>21369</code><code>&lt;span class="citation"&gt;</code></p><p><code>21370</code><code>McGregor IS, Dastur FN, McLellan RA, Brown RE. Cannabinoid modulation of rat pup ultrasonic vocalizations. &lt;span&gt;</code></p><p><code>21371</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21372</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>21373</code><code>1996a;&lt;span class="ref-vol"&gt;</code></p><p><code>21374</code><code>313&lt;/span&gt;</code></p><p><code>21375</code><code>:43–49.&lt;/span&gt;</code></p><p><code>21376</code><code> [&lt;a href="/pubmed/8905327" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21377</code><code>PubMed&lt;/a&gt;</code></p><p><code>21378</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21379</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Cannabinoid+modulation+of+rat+pup+ultrasonic+vocalizations&amp;amp;author=IS+McGregor&amp;amp;author=FN+Dastur&amp;amp;author=RA+McLellan&amp;amp;author=RE+Brown&amp;amp;volume=313&amp;amp;publication_year=1996a&amp;amp;pages=43-49&amp;amp;pmid=8905327&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21380</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21381</code><code>]&lt;/span&gt;</code></p><p><code>21382</code><code>&lt;/span&gt;</code></p><p><code>21383</code><code>&lt;/li&gt;</code></p><p><code>21384</code><code>&lt;li id="R795"&gt;</code></p><p><code>21385</code><code>&lt;span class="citation"&gt;</code></p><p><code>21386</code><code>McGregor IS, Issakidis CN, Prior G. Aversive effects of the synthetic cannabinoid CP 55,940 in rats. &lt;span&gt;</code></p><p><code>21387</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21388</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>21389</code><code>1996b;&lt;span class="ref-vol"&gt;</code></p><p><code>21390</code><code>53&lt;/span&gt;</code></p><p><code>21391</code><code>:657–664.&lt;/span&gt;</code></p><p><code>21392</code><code> [&lt;a href="/pubmed/8866969" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21393</code><code>PubMed&lt;/a&gt;</code></p><p><code>21394</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21395</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Aversive+effects+of+the+synthetic+cannabinoid+CP+55,940+in+rats&amp;amp;author=IS+McGregor&amp;amp;author=CN+Issakidis&amp;amp;author=G+Prior&amp;amp;volume=53&amp;amp;publication_year=1996b&amp;amp;pages=657-664&amp;amp;pmid=8866969&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21396</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21397</code><code>]&lt;/span&gt;</code></p><p><code>21398</code><code>&lt;/span&gt;</code></p><p><code>21399</code><code>&lt;/li&gt;</code></p><p><code>21400</code><code>&lt;li id="R796"&gt;</code></p><p><code>21401</code><code>&lt;span class="citation"&gt;</code></p><p><code>21402</code><code>McGuire PK, Jones P, Harvey I, Bebbington P, Toone B, Lewis S, Murray RM. Cannabis and acute psychosis. &lt;span&gt;</code></p><p><code>21403</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21404</code><code>Schizophr Res. &lt;/span&gt;</code></p><p><code>21405</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>21406</code><code>13&lt;/span&gt;</code></p><p><code>21407</code><code>:161–167.&lt;/span&gt;</code></p><p><code>21408</code><code> [&lt;a href="/pubmed/7986773" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21409</code><code>PubMed&lt;/a&gt;</code></p><p><code>21410</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21411</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Schizophr+Res&amp;amp;title=Cannabis+and+acute+psychosis&amp;amp;author=PK+McGuire&amp;amp;author=P+Jones&amp;amp;author=I+Harvey&amp;amp;author=P+Bebbington&amp;amp;author=B+Toone&amp;amp;volume=13&amp;amp;publication_year=1994&amp;amp;pages=161-167&amp;amp;pmid=7986773&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21412</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21413</code><code>]&lt;/span&gt;</code></p><p><code>21414</code><code>&lt;/span&gt;</code></p><p><code>21415</code><code>&lt;/li&gt;</code></p><p><code>21416</code><code>&lt;li id="R797"&gt;</code></p><p><code>21417</code><code>&lt;span class="citation"&gt;</code></p><p><code>21418</code><code>McKallip RJ, Lombard C, Fisher M, Martin BR, Ryu S, Grant S, Nagarkatti PS, Nagarkatti M. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. &lt;span&gt;</code></p><p><code>21419</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21420</code><code>Blood. &lt;/span&gt;</code></p><p><code>21421</code><code>2002a;&lt;span class="ref-vol"&gt;</code></p><p><code>21422</code><code>100&lt;/span&gt;</code></p><p><code>21423</code><code>:627–634.&lt;/span&gt;</code></p><p><code>21424</code><code> [&lt;a href="/pubmed/12091357" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21425</code><code>PubMed&lt;/a&gt;</code></p><p><code>21426</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21427</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;amp;title=Targeting+CB2+cannabinoid+receptors+as+a+novel+therapy+to+treat+malignant+lymphoblastic+disease&amp;amp;author=RJ+McKallip&amp;amp;author=C+Lombard&amp;amp;author=M+Fisher&amp;amp;author=BR+Martin&amp;amp;author=S+Ryu&amp;amp;volume=100&amp;amp;publication_year=2002a&amp;amp;pages=627-634&amp;amp;pmid=12091357&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21428</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21429</code><code>]&lt;/span&gt;</code></p><p><code>21430</code><code>&lt;/span&gt;</code></p><p><code>21431</code><code>&lt;/li&gt;</code></p><p><code>21432</code><code>&lt;li id="R798"&gt;</code></p><p><code>21433</code><code>&lt;span class="citation"&gt;</code></p><p><code>21434</code><code>McKallip RJ, Lombard C, Martin BR, Nagarkatti M, Nagarkatti PS. &amp;#x00394;&lt;sup&gt;</code></p><p><code>21435</code><code>9&lt;/sup&gt;</code></p><p><code>21436</code><code>-Tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo. &lt;span&gt;</code></p><p><code>21437</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21438</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>21439</code><code>2002b;&lt;span class="ref-vol"&gt;</code></p><p><code>21440</code><code>302&lt;/span&gt;</code></p><p><code>21441</code><code>:451–465.&lt;/span&gt;</code></p><p><code>21442</code><code> [&lt;a href="/pubmed/12130702" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21443</code><code>PubMed&lt;/a&gt;</code></p><p><code>21444</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21445</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=&amp;#x00394;9-Tetrahydrocannabinol-induced+apoptosis+in+the+thymus+and+spleen+as+a+mechanism+of+immunosuppression+in+vitro+and+in+vivo&amp;amp;author=RJ+McKallip&amp;amp;author=C+Lombard&amp;amp;author=BR+Martin&amp;amp;author=M+Nagarkatti&amp;amp;author=PS+Nagarkatti&amp;amp;volume=302&amp;amp;publication_year=2002b&amp;amp;pages=451-465&amp;amp;pmid=12130702&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21446</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21447</code><code>]&lt;/span&gt;</code></p><p><code>21448</code><code>&lt;/span&gt;</code></p><p><code>21449</code><code>&lt;/li&gt;</code></p><p><code>21450</code><code>&lt;li id="R799"&gt;</code></p><p><code>21451</code><code>&lt;span class="citation"&gt;</code></p><p><code>21452</code><code>McKallip RJ, Nagarkatti M, Nagarkatti PS. &amp;#x00394;-9-Tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. &lt;span&gt;</code></p><p><code>21453</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21454</code><code>J Immunol. &lt;/span&gt;</code></p><p><code>21455</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>21456</code><code>174&lt;/span&gt;</code></p><p><code>21457</code><code>:3281–3289.&lt;/span&gt;</code></p><p><code>21458</code><code> [&lt;a href="/pubmed/15749859" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21459</code><code>PubMed&lt;/a&gt;</code></p><p><code>21460</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21461</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;amp;title=&amp;#x00394;-9-Tetrahydrocannabinol+enhances+breast+cancer+growth+and+metastasis+by+suppression+of+the+antitumor+immune+response&amp;amp;author=RJ+McKallip&amp;amp;author=M+Nagarkatti&amp;amp;author=PS+Nagarkatti&amp;amp;volume=174&amp;amp;publication_year=2005&amp;amp;pages=3281-3289&amp;amp;pmid=15749859&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21462</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21463</code><code>]&lt;/span&gt;</code></p><p><code>21464</code><code>&lt;/span&gt;</code></p><p><code>21465</code><code>&lt;/li&gt;</code></p><p><code>21466</code><code>&lt;li id="R800"&gt;</code></p><p><code>21467</code><code>&lt;span class="citation"&gt;</code></p><p><code>21468</code><code>McKinney MK, Cravatt BF. Structure and function of fatty acid amide hydrolase. &lt;span&gt;</code></p><p><code>21469</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21470</code><code>Annu Rev Biochem. &lt;/span&gt;</code></p><p><code>21471</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>21472</code><code>74&lt;/span&gt;</code></p><p><code>21473</code><code>:411–434.&lt;/span&gt;</code></p><p><code>21474</code><code> [&lt;a href="/pubmed/15952893" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21475</code><code>PubMed&lt;/a&gt;</code></p><p><code>21476</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21477</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Biochem&amp;amp;title=Structure+and+function+of+fatty+acid+amide+hydrolase&amp;amp;author=MK+McKinney&amp;amp;author=BF+Cravatt&amp;amp;volume=74&amp;amp;publication_year=2005&amp;amp;pages=411-434&amp;amp;pmid=15952893&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21478</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21479</code><code>]&lt;/span&gt;</code></p><p><code>21480</code><code>&lt;/span&gt;</code></p><p><code>21481</code><code>&lt;/li&gt;</code></p><p><code>21482</code><code>&lt;li id="R801"&gt;</code></p><p><code>21483</code><code>&lt;span class="citation"&gt;</code></p><p><code>21484</code><code>McLaughlin PJ, Winston K, Swezey L, Wisniecki A, Aberman J, Tardif DJ, Betz AJ, Ishiwari K, Makriyannis A, Salamone JD. The cannabinoid CB1 antagonists SR141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats. &lt;span&gt;</code></p><p><code>21485</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21486</code><code>Behav Pharmacol. &lt;/span&gt;</code></p><p><code>21487</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>21488</code><code>14&lt;/span&gt;</code></p><p><code>21489</code><code>:583–588.&lt;/span&gt;</code></p><p><code>21490</code><code> [&lt;a href="/pubmed/14665975" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21491</code><code>PubMed&lt;/a&gt;</code></p><p><code>21492</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21493</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Behav+Pharmacol&amp;amp;title=The+cannabinoid+CB1+antagonists+SR141716A+and+AM+251+suppress+food+intake+and+food-reinforced+behavior+in+a+variety+of+tasks+in+rats&amp;amp;author=PJ+McLaughlin&amp;amp;author=K+Winston&amp;amp;author=L+Swezey&amp;amp;author=A+Wisniecki&amp;amp;author=J+Aberman&amp;amp;volume=14&amp;amp;publication_year=2003&amp;amp;pages=583-588&amp;amp;pmid=14665975&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21494</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21495</code><code>]&lt;/span&gt;</code></p><p><code>21496</code><code>&lt;/span&gt;</code></p><p><code>21497</code><code>&lt;/li&gt;</code></p><p><code>21498</code><code>&lt;li id="R802"&gt;</code></p><p><code>21499</code><code>&lt;span class="citation"&gt;</code></p><p><code>21500</code><code>McNamara JO. Emerging insights into the genesis of epilepsy. &lt;span&gt;</code></p><p><code>21501</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21502</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>21503</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>21504</code><code>399&lt;/span&gt;</code></p><p><code>21505</code><code>:A15–A22.&lt;/span&gt;</code></p><p><code>21506</code><code> [&lt;a href="/pubmed/10392576" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21507</code><code>PubMed&lt;/a&gt;</code></p><p><code>21508</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21509</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Emerging+insights+into+the+genesis+of+epilepsy&amp;amp;author=JO+McNamara&amp;amp;volume=399&amp;amp;publication_year=1999&amp;amp;pages=A15-A22&amp;amp;pmid=10392576&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21510</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21511</code><code>]&lt;/span&gt;</code></p><p><code>21512</code><code>&lt;/span&gt;</code></p><p><code>21513</code><code>&lt;/li&gt;</code></p><p><code>21514</code><code>&lt;li id="R803"&gt;</code></p><p><code>21515</code><code>&lt;span class="citation"&gt;</code></p><p><code>21516</code><code>McPartland JM, Russo EB. Cannabis and cannabis extracts: greater than the sum of their parts? &lt;span&gt;</code></p><p><code>21517</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21518</code><code>J Cannabis Ther. &lt;/span&gt;</code></p><p><code>21519</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>21520</code><code>1&lt;/span&gt;</code></p><p><code>21521</code><code>:103–132.&lt;/span&gt;</code></p><p><code>21522</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>21523</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Cannabis+Ther&amp;amp;title=Cannabis+and+cannabis+extracts:+greater+than+the+sum+of+their+parts?&amp;amp;author=JM+McPartland&amp;amp;author=EB+Russo&amp;amp;volume=1&amp;amp;publication_year=2001&amp;amp;pages=103-132&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21524</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21525</code><code>]&lt;/span&gt;</code></p><p><code>21526</code><code>&lt;/span&gt;</code></p><p><code>21527</code><code>&lt;/li&gt;</code></p><p><code>21528</code><code>&lt;li id="R804"&gt;</code></p><p><code>21529</code><code>&lt;span class="citation"&gt;</code></p><p><code>21530</code><code>Mechoulam R.  The pharmacohistory of cannabis sativa. In: Mechoulam R, editor. &lt;span class="ref-journal"&gt;</code></p><p><code>21531</code><code>Cannabis as Therapeutic Agent.&lt;/span&gt;</code></p><p><code>21532</code><code> CRC Press; Boca Raton, FL: 1986. pp. 1–19. &lt;span class="nowrap"&gt;</code></p><p><code>21533</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?title=Cannabis+as+Therapeutic+Agent&amp;amp;author=R+Mechoulam&amp;amp;publication_year=1986&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21534</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21535</code><code>]&lt;/span&gt;</code></p><p><code>21536</code><code>&lt;/span&gt;</code></p><p><code>21537</code><code>&lt;/li&gt;</code></p><p><code>21538</code><code>&lt;li id="R805"&gt;</code></p><p><code>21539</code><code>&lt;span class="citation"&gt;</code></p><p><code>21540</code><code>Mechoulam R, Benshabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Sholomo A, Martin BR, Compton DR, et al.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. &lt;span&gt;</code></p><p><code>21541</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21542</code><code>Biochem Pharmacol. &lt;/span&gt;</code></p><p><code>21543</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>21544</code><code>50&lt;/span&gt;</code></p><p><code>21545</code><code>:83–90.&lt;/span&gt;</code></p><p><code>21546</code><code> [&lt;a href="/pubmed/7605349" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21547</code><code>PubMed&lt;/a&gt;</code></p><p><code>21548</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21549</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;amp;title=Identification+of+an+endogenous+2-monoglyceride,+present+in+canine+gut,+that+binds+to+cannabinoid+receptors&amp;amp;author=R+Mechoulam&amp;amp;author=S+Benshabat&amp;amp;author=L+Hanus&amp;amp;author=M+Ligumsky&amp;amp;author=NE+Kaminski&amp;amp;volume=50&amp;amp;publication_year=1995&amp;amp;pages=83-90&amp;amp;pmid=7605349&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21550</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21551</code><code>]&lt;/span&gt;</code></p><p><code>21552</code><code>&lt;/span&gt;</code></p><p><code>21553</code><code>&lt;/li&gt;</code></p><p><code>21554</code><code>&lt;li id="R806"&gt;</code></p><p><code>21555</code><code>&lt;span class="citation"&gt;</code></p><p><code>21556</code><code>Mechoulam R, Fride E, Di Marzo V. Endocannabionoids. &lt;span&gt;</code></p><p><code>21557</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21558</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>21559</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>21560</code><code>359&lt;/span&gt;</code></p><p><code>21561</code><code>:1–18.&lt;/span&gt;</code></p><p><code>21562</code><code> [&lt;a href="/pubmed/9831287" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21563</code><code>PubMed&lt;/a&gt;</code></p><p><code>21564</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21565</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Endocannabionoids&amp;amp;author=R+Mechoulam&amp;amp;author=E+Fride&amp;amp;author=V+Di+Marzo&amp;amp;volume=359&amp;amp;publication_year=1998&amp;amp;pages=1-18&amp;amp;pmid=9831287&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21566</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21567</code><code>]&lt;/span&gt;</code></p><p><code>21568</code><code>&lt;/span&gt;</code></p><p><code>21569</code><code>&lt;/li&gt;</code></p><p><code>21570</code><code>&lt;li id="R807"&gt;</code></p><p><code>21571</code><code>&lt;span class="citation"&gt;</code></p><p><code>21572</code><code>Mechoulam R, Fride E, Hanus L, Sheskin T, Bisogno T, Di Marzo V, Bayewitch M, Vogel Z. Anandamide may mediate sleep induction. &lt;span&gt;</code></p><p><code>21573</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21574</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>21575</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>21576</code><code>389&lt;/span&gt;</code></p><p><code>21577</code><code>:25–26.&lt;/span&gt;</code></p><p><code>21578</code><code> [&lt;a href="/pubmed/9288961" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21579</code><code>PubMed&lt;/a&gt;</code></p><p><code>21580</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21581</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Anandamide+may+mediate+sleep+induction&amp;amp;author=R+Mechoulam&amp;amp;author=E+Fride&amp;amp;author=L+Hanus&amp;amp;author=T+Sheskin&amp;amp;author=T+Bisogno&amp;amp;volume=389&amp;amp;publication_year=1997&amp;amp;pages=25-26&amp;amp;pmid=9288961&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21582</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21583</code><code>]&lt;/span&gt;</code></p><p><code>21584</code><code>&lt;/span&gt;</code></p><p><code>21585</code><code>&lt;/li&gt;</code></p><p><code>21586</code><code>&lt;li id="R808"&gt;</code></p><p><code>21587</code><code>&lt;span class="citation"&gt;</code></p><p><code>21588</code><code>Mechoulam R, Gaoni Y. The absolute configuration of &amp;#x00394;-1-tetrahydrocannabinol, the major active constituent of hashish. &lt;span&gt;</code></p><p><code>21589</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21590</code><code>Tetrahedron Lett. &lt;/span&gt;</code></p><p><code>21591</code><code>1967;&lt;span class="ref-vol"&gt;</code></p><p><code>21592</code><code>12&lt;/span&gt;</code></p><p><code>21593</code><code>:1109–1111.&lt;/span&gt;</code></p><p><code>21594</code><code> [&lt;a href="/pubmed/6039537" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21595</code><code>PubMed&lt;/a&gt;</code></p><p><code>21596</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21597</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Tetrahedron+Lett&amp;amp;title=The+absolute+configuration+of+&amp;#x00394;-1-tetrahydrocannabinol,+the+major+active+constituent+of+hashish&amp;amp;author=R+Mechoulam&amp;amp;author=Y+Gaoni&amp;amp;volume=12&amp;amp;publication_year=1967&amp;amp;pages=1109-1111&amp;amp;pmid=6039537&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21598</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21599</code><code>]&lt;/span&gt;</code></p><p><code>21600</code><code>&lt;/span&gt;</code></p><p><code>21601</code><code>&lt;/li&gt;</code></p><p><code>21602</code><code>&lt;li id="R809"&gt;</code></p><p><code>21603</code><code>&lt;span class="citation"&gt;</code></p><p><code>21604</code><code>Mechoulam R, Hanus L. A historical overview of chemical research on cannabinoids. &lt;span&gt;</code></p><p><code>21605</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21606</code><code>Chem Phys Lipids. &lt;/span&gt;</code></p><p><code>21607</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>21608</code><code>108&lt;/span&gt;</code></p><p><code>21609</code><code>:1–13.&lt;/span&gt;</code></p><p><code>21610</code><code> [&lt;a href="/pubmed/11106779" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21611</code><code>PubMed&lt;/a&gt;</code></p><p><code>21612</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21613</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Chem+Phys+Lipids&amp;amp;title=A+historical+overview+of+chemical+research+on+cannabinoids&amp;amp;author=R+Mechoulam&amp;amp;author=L+Hanus&amp;amp;volume=108&amp;amp;publication_year=2000&amp;amp;pages=1-13&amp;amp;pmid=11106779&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21614</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21615</code><code>]&lt;/span&gt;</code></p><p><code>21616</code><code>&lt;/span&gt;</code></p><p><code>21617</code><code>&lt;/li&gt;</code></p><p><code>21618</code><code>&lt;li id="R810"&gt;</code></p><p><code>21619</code><code>&lt;span class="citation"&gt;</code></p><p><code>21620</code><code>Mechoulam R, Hanus L. Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects. &lt;span&gt;</code></p><p><code>21621</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21622</code><code>Chem Phys Lipids. &lt;/span&gt;</code></p><p><code>21623</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>21624</code><code>121&lt;/span&gt;</code></p><p><code>21625</code><code>:35–43.&lt;/span&gt;</code></p><p><code>21626</code><code> [&lt;a href="/pubmed/12505688" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21627</code><code>PubMed&lt;/a&gt;</code></p><p><code>21628</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21629</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Chem+Phys+Lipids&amp;amp;title=Cannabidiol:+an+overview+of+some+chemical+and+pharmacological+aspects.+Part+I:+chemical+aspects&amp;amp;author=R+Mechoulam&amp;amp;author=L+Hanus&amp;amp;volume=121&amp;amp;publication_year=2002&amp;amp;pages=35-43&amp;amp;pmid=12505688&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21630</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21631</code><code>]&lt;/span&gt;</code></p><p><code>21632</code><code>&lt;/span&gt;</code></p><p><code>21633</code><code>&lt;/li&gt;</code></p><p><code>21634</code><code>&lt;li id="R811"&gt;</code></p><p><code>21635</code><code>&lt;span class="citation"&gt;</code></p><p><code>21636</code><code>Mechoulam R, Spatz M, Shohami E. Endocannabinoids and neuroprotection. &lt;span&gt;</code></p><p><code>21637</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21638</code><code>Sci STKE. &lt;/span&gt;</code></p><p><code>21639</code><code>2002a;&lt;span class="ref-vol"&gt;</code></p><p><code>21640</code><code>2002&lt;/span&gt;</code></p><p><code>21641</code><code>:129–RE5.&lt;/span&gt;</code></p><p><code>21642</code><code> [&lt;a href="/pubmed/11972360" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21643</code><code>PubMed&lt;/a&gt;</code></p><p><code>21644</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21645</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Sci+STKE&amp;amp;title=Endocannabinoids+and+neuroprotection&amp;amp;author=R+Mechoulam&amp;amp;author=M+Spatz&amp;amp;author=E+Shohami&amp;amp;volume=2002&amp;amp;publication_year=2002a&amp;amp;pages=129-RE5&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21646</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21647</code><code>]&lt;/span&gt;</code></p><p><code>21648</code><code>&lt;/span&gt;</code></p><p><code>21649</code><code>&lt;/li&gt;</code></p><p><code>21650</code><code>&lt;li id="R812"&gt;</code></p><p><code>21651</code><code>&lt;span class="citation"&gt;</code></p><p><code>21652</code><code>Mechoulam R, Panikashvili D, Shohami E. Cannabinoids and brain injury: therapeutic implications. &lt;span&gt;</code></p><p><code>21653</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21654</code><code>Trends Mol Med. &lt;/span&gt;</code></p><p><code>21655</code><code>2002b;&lt;span class="ref-vol"&gt;</code></p><p><code>21656</code><code>8&lt;/span&gt;</code></p><p><code>21657</code><code>:58–61.&lt;/span&gt;</code></p><p><code>21658</code><code> [&lt;a href="/pubmed/11815270" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21659</code><code>PubMed&lt;/a&gt;</code></p><p><code>21660</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21661</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Trends+Mol+Med&amp;amp;title=Cannabinoids+and+brain+injury:+therapeutic+implications&amp;amp;author=R+Mechoulam&amp;amp;author=D+Panikashvili&amp;amp;author=E+Shohami&amp;amp;volume=8&amp;amp;publication_year=2002b&amp;amp;pages=58-61&amp;amp;pmid=11815270&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21662</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21663</code><code>]&lt;/span&gt;</code></p><p><code>21664</code><code>&lt;/span&gt;</code></p><p><code>21665</code><code>&lt;/li&gt;</code></p><p><code>21666</code><code>&lt;li id="R813"&gt;</code></p><p><code>21667</code><code>&lt;span class="citation"&gt;</code></p><p><code>21668</code><code>Mechoulam R, Parker LA, Gallily R. Cannabidiol: an overview of some pharmacological aspects. &lt;span&gt;</code></p><p><code>21669</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21670</code><code>J Clin Pharmacol. &lt;/span&gt;</code></p><p><code>21671</code><code>2002c;&lt;span class="ref-vol"&gt;</code></p><p><code>21672</code><code>42&lt;/span&gt;</code></p><p><code>21673</code><code>:11S–19S.&lt;/span&gt;</code></p><p><code>21674</code><code> [&lt;a href="/pubmed/12412831" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21675</code><code>PubMed&lt;/a&gt;</code></p><p><code>21676</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21677</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pharmacol&amp;amp;title=Cannabidiol:+an+overview+of+some+pharmacological+aspects&amp;amp;author=R+Mechoulam&amp;amp;author=LA+Parker&amp;amp;author=R+Gallily&amp;amp;volume=42&amp;amp;publication_year=2002c&amp;amp;pages=11S-19S&amp;amp;pmid=12412831&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21678</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21679</code><code>]&lt;/span&gt;</code></p><p><code>21680</code><code>&lt;/span&gt;</code></p><p><code>21681</code><code>&lt;/li&gt;</code></p><p><code>21682</code><code>&lt;li id="R814"&gt;</code></p><p><code>21683</code><code>&lt;span class="citation"&gt;</code></p><p><code>21684</code><code>Meinck HM, Schonle PW, Conrad B. Effect of cannabinoids on spasticity and ataxia in multiple sclerosis. &lt;span&gt;</code></p><p><code>21685</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21686</code><code>J Neurol. &lt;/span&gt;</code></p><p><code>21687</code><code>1989;&lt;span class="ref-vol"&gt;</code></p><p><code>21688</code><code>236&lt;/span&gt;</code></p><p><code>21689</code><code>:120–122.&lt;/span&gt;</code></p><p><code>21690</code><code> [&lt;a href="/pubmed/2709054" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21691</code><code>PubMed&lt;/a&gt;</code></p><p><code>21692</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21693</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurol&amp;amp;title=Effect+of+cannabinoids+on+spasticity+and+ataxia+in+multiple+sclerosis&amp;amp;author=HM+Meinck&amp;amp;author=PW+Schonle&amp;amp;author=B+Conrad&amp;amp;volume=236&amp;amp;publication_year=1989&amp;amp;pages=120-122&amp;amp;pmid=2709054&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21694</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21695</code><code>]&lt;/span&gt;</code></p><p><code>21696</code><code>&lt;/span&gt;</code></p><p><code>21697</code><code>&lt;/li&gt;</code></p><p><code>21698</code><code>&lt;li id="R815"&gt;</code></p><p><code>21699</code><code>&lt;span class="citation"&gt;</code></p><p><code>21700</code><code>Melck D, De Petrocellis L, Orlando P, Bisogno T, Laezza C, Bifulco M, Di Marzo V. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. &lt;span&gt;</code></p><p><code>21701</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21702</code><code>Endocrinology. &lt;/span&gt;</code></p><p><code>21703</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>21704</code><code>141&lt;/span&gt;</code></p><p><code>21705</code><code>:118–126.&lt;/span&gt;</code></p><p><code>21706</code><code> [&lt;a href="/pubmed/10614630" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21707</code><code>PubMed&lt;/a&gt;</code></p><p><code>21708</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21709</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;amp;title=Suppression+of+nerve+growth+factor+Trk+receptors+and+prolactin+receptors+by+endocannabinoids+leads+to+inhibition+of+human+breast+and+prostate+cancer+cell+proliferation&amp;amp;author=D+Melck&amp;amp;author=L+De+Petrocellis&amp;amp;author=P+Orlando&amp;amp;author=T+Bisogno&amp;amp;author=C+Laezza&amp;amp;volume=141&amp;amp;publication_year=2000&amp;amp;pages=118-126&amp;amp;pmid=10614630&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21710</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21711</code><code>]&lt;/span&gt;</code></p><p><code>21712</code><code>&lt;/span&gt;</code></p><p><code>21713</code><code>&lt;/li&gt;</code></p><p><code>21714</code><code>&lt;li id="R816"&gt;</code></p><p><code>21715</code><code>&lt;span class="citation"&gt;</code></p><p><code>21716</code><code>Melck D, Rueda D, Galve-Roperh I, De Petrocellis L, Guzman M, Di Marzo V. Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells. &lt;span&gt;</code></p><p><code>21717</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21718</code><code>FEBS Lett. &lt;/span&gt;</code></p><p><code>21719</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>21720</code><code>463&lt;/span&gt;</code></p><p><code>21721</code><code>:235–240.&lt;/span&gt;</code></p><p><code>21722</code><code> [&lt;a href="/pubmed/10606728" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21723</code><code>PubMed&lt;/a&gt;</code></p><p><code>21724</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21725</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;amp;title=Involvement+of+the+cAMP/protein+kinase+A+pathway+and+of+mitogen-activated+protein+kinase+in+the+anti-proliferative+effects+of+anandamide+in+human+breast+cancer+cells&amp;amp;author=D+Melck&amp;amp;author=D+Rueda&amp;amp;author=I+Galve-Roperh&amp;amp;author=L+De+Petrocellis&amp;amp;author=M+Guzman&amp;amp;volume=463&amp;amp;publication_year=1999&amp;amp;pages=235-240&amp;amp;pmid=10606728&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21726</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21727</code><code>]&lt;/span&gt;</code></p><p><code>21728</code><code>&lt;/span&gt;</code></p><p><code>21729</code><code>&lt;/li&gt;</code></p><p><code>21730</code><code>&lt;li id="R817"&gt;</code></p><p><code>21731</code><code>&lt;span class="citation"&gt;</code></p><p><code>21732</code><code>Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in ventral tegmental area dopamine neurons through activation of CB1 receptors. &lt;span&gt;</code></p><p><code>21733</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21734</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>21735</code><code>2004a;&lt;span class="ref-vol"&gt;</code></p><p><code>21736</code><code>24&lt;/span&gt;</code></p><p><code>21737</code><code>:53–62.&lt;/span&gt;</code></p><p><code>21738</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>21739</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6729571/"&gt;</code></p><p><code>21740</code><code>PMC free article&lt;/a&gt;</code></p><p><code>21741</code><code>]&lt;/span&gt;</code></p><p><code>21742</code><code> [&lt;a href="/pubmed/14715937" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21743</code><code>PubMed&lt;/a&gt;</code></p><p><code>21744</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21745</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Endocannabinoids+mediate+presynaptic+inhibition+of+glutamatergic+transmission+in+ventral+tegmental+area+dopamine+neurons+through+activation+of+CB1+receptors&amp;amp;author=M+Melis&amp;amp;author=M+Pistis&amp;amp;author=S+Perra&amp;amp;author=AL+Muntoni&amp;amp;author=G+Pillolla&amp;amp;volume=24&amp;amp;publication_year=2004a&amp;amp;pages=53-62&amp;amp;pmid=14715937&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21746</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21747</code><code>]&lt;/span&gt;</code></p><p><code>21748</code><code>&lt;/span&gt;</code></p><p><code>21749</code><code>&lt;/li&gt;</code></p><p><code>21750</code><code>&lt;li id="R818"&gt;</code></p><p><code>21751</code><code>&lt;span class="citation"&gt;</code></p><p><code>21752</code><code>Melis MR, Succu S, Mascia MS, Argiolas A. Antagonism of cannabinoid CB1 receptors in the paraventricular nucleus of male rats induces penile erection. &lt;span&gt;</code></p><p><code>21753</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21754</code><code>Neurosci Lett. &lt;/span&gt;</code></p><p><code>21755</code><code>2004b;&lt;span class="ref-vol"&gt;</code></p><p><code>21756</code><code>359&lt;/span&gt;</code></p><p><code>21757</code><code>:17–20.&lt;/span&gt;</code></p><p><code>21758</code><code> [&lt;a href="/pubmed/15050701" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21759</code><code>PubMed&lt;/a&gt;</code></p><p><code>21760</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21761</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Lett&amp;amp;title=Antagonism+of+cannabinoid+CB1+receptors+in+the+paraventricular+nucleus+of+male+rats+induces+penile+erection&amp;amp;author=MR+Melis&amp;amp;author=S+Succu&amp;amp;author=MS+Mascia&amp;amp;author=A+Argiolas&amp;amp;volume=359&amp;amp;publication_year=2004b&amp;amp;pages=17-20&amp;amp;pmid=15050701&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21762</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21763</code><code>]&lt;/span&gt;</code></p><p><code>21764</code><code>&lt;/span&gt;</code></p><p><code>21765</code><code>&lt;/li&gt;</code></p><p><code>21766</code><code>&lt;li id="R819"&gt;</code></p><p><code>21767</code><code>&lt;span class="citation"&gt;</code></p><p><code>21768</code><code>Melis MR, Succu S, Mascia MS, Sanna F, Melis T, Castelli MP, Argiolas A. The cannabinoid receptor antagonist SR-141716A induces penile erection in male rats: involvement of paraventricular glutamic acid and nitric oxide. &lt;span&gt;</code></p><p><code>21769</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21770</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>21771</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>21772</code><code>50&lt;/span&gt;</code></p><p><code>21773</code><code>:219–228.&lt;/span&gt;</code></p><p><code>21774</code><code> [&lt;a href="/pubmed/16288932" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21775</code><code>PubMed&lt;/a&gt;</code></p><p><code>21776</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21777</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=The+cannabinoid+receptor+antagonist+SR-141716A+induces+penile+erection+in+male+rats:+involvement+of+paraventricular+glutamic+acid+and+nitric+oxide&amp;amp;author=MR+Melis&amp;amp;author=S+Succu&amp;amp;author=MS+Mascia&amp;amp;author=F+Sanna&amp;amp;author=T+Melis&amp;amp;volume=50&amp;amp;publication_year=2006&amp;amp;pages=219-228&amp;amp;pmid=16288932&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21778</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21779</code><code>]&lt;/span&gt;</code></p><p><code>21780</code><code>&lt;/span&gt;</code></p><p><code>21781</code><code>&lt;/li&gt;</code></p><p><code>21782</code><code>&lt;li id="R820"&gt;</code></p><p><code>21783</code><code>&lt;span class="citation"&gt;</code></p><p><code>21784</code><code>Melone MA, Jori FP, Peluso G. Huntington&amp;#x02019;s disease: new frontiers for molecular and cell therapy. &lt;span&gt;</code></p><p><code>21785</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21786</code><code>Curr Drug Targets. &lt;/span&gt;</code></p><p><code>21787</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>21788</code><code>6&lt;/span&gt;</code></p><p><code>21789</code><code>:43–56.&lt;/span&gt;</code></p><p><code>21790</code><code> [&lt;a href="/pubmed/15720212" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21791</code><code>PubMed&lt;/a&gt;</code></p><p><code>21792</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21793</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Drug+Targets&amp;amp;title=Huntington&amp;#x02019;s+disease:+new+frontiers+for+molecular+and+cell+therapy&amp;amp;author=MA+Melone&amp;amp;author=FP+Jori&amp;amp;author=G+Peluso&amp;amp;volume=6&amp;amp;publication_year=2005&amp;amp;pages=43-56&amp;amp;pmid=15720212&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21794</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21795</code><code>]&lt;/span&gt;</code></p><p><code>21796</code><code>&lt;/span&gt;</code></p><p><code>21797</code><code>&lt;/li&gt;</code></p><p><code>21798</code><code>&lt;li id="R821"&gt;</code></p><p><code>21799</code><code>&lt;span class="citation"&gt;</code></p><p><code>21800</code><code>Meltzer HY, Arvanitis L, Bauer D, Rein W Meta-Trial Study Group. Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder. &lt;span&gt;</code></p><p><code>21801</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21802</code><code>Am J Psychiatry. &lt;/span&gt;</code></p><p><code>21803</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>21804</code><code>161&lt;/span&gt;</code></p><p><code>21805</code><code>:975–984.&lt;/span&gt;</code></p><p><code>21806</code><code> [&lt;a href="/pubmed/15169685" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21807</code><code>PubMed&lt;/a&gt;</code></p><p><code>21808</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21809</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Psychiatry&amp;amp;title=Placebo-controlled+evaluation+of+four+novel+compounds+for+the+treatment+of+schizophrenia+and+schizoaffective+disorder&amp;amp;author=HY+Meltzer&amp;amp;author=L+Arvanitis&amp;amp;author=D+Bauer&amp;amp;author=W+Rein&amp;amp;volume=161&amp;amp;publication_year=2004&amp;amp;pages=975-984&amp;amp;pmid=15169685&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21810</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21811</code><code>]&lt;/span&gt;</code></p><p><code>21812</code><code>&lt;/span&gt;</code></p><p><code>21813</code><code>&lt;/li&gt;</code></p><p><code>21814</code><code>&lt;li id="R822"&gt;</code></p><p><code>21815</code><code>&lt;span class="citation"&gt;</code></p><p><code>21816</code><code>Mendelson WB, Basile AS. The hypnotic actions of oleamide are blocked by a cannabinoid receptor antagonist. &lt;span&gt;</code></p><p><code>21817</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21818</code><code>Neuroreport. &lt;/span&gt;</code></p><p><code>21819</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>21820</code><code>10&lt;/span&gt;</code></p><p><code>21821</code><code>:3237–3239.&lt;/span&gt;</code></p><p><code>21822</code><code> [&lt;a href="/pubmed/10574567" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21823</code><code>PubMed&lt;/a&gt;</code></p><p><code>21824</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21825</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroreport&amp;amp;title=The+hypnotic+actions+of+oleamide+are+blocked+by+a+cannabinoid+receptor+antagonist&amp;amp;author=WB+Mendelson&amp;amp;author=AS+Basile&amp;amp;volume=10&amp;amp;publication_year=1999&amp;amp;pages=3237-3239&amp;amp;pmid=10574567&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21826</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21827</code><code>]&lt;/span&gt;</code></p><p><code>21828</code><code>&lt;/span&gt;</code></p><p><code>21829</code><code>&lt;/li&gt;</code></p><p><code>21830</code><code>&lt;li id="R823"&gt;</code></p><p><code>21831</code><code>&lt;span class="citation"&gt;</code></p><p><code>21832</code><code>Meng ID, Manning BH, Martin WJ, Fields HL. An analgesia circuit activated by cannabinoids. &lt;span&gt;</code></p><p><code>21833</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21834</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>21835</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>21836</code><code>395&lt;/span&gt;</code></p><p><code>21837</code><code>:381–383.&lt;/span&gt;</code></p><p><code>21838</code><code> [&lt;a href="/pubmed/9759727" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21839</code><code>PubMed&lt;/a&gt;</code></p><p><code>21840</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21841</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=An+analgesia+circuit+activated+by+cannabinoids&amp;amp;author=ID+Meng&amp;amp;author=BH+Manning&amp;amp;author=WJ+Martin&amp;amp;author=HL+Fields&amp;amp;volume=395&amp;amp;publication_year=1998&amp;amp;pages=381-383&amp;amp;pmid=9759727&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21842</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21843</code><code>]&lt;/span&gt;</code></p><p><code>21844</code><code>&lt;/span&gt;</code></p><p><code>21845</code><code>&lt;/li&gt;</code></p><p><code>21846</code><code>&lt;li id="R824"&gt;</code></p><p><code>21847</code><code>&lt;span class="citation"&gt;</code></p><p><code>21848</code><code>Merritt JC, Crawford WJ, Alexander PC, Anduze AL, Gelbart SS. Effect of marihuana on intraocular and blood pressure in glaucoma. &lt;span&gt;</code></p><p><code>21849</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21850</code><code>Ophthalmology. &lt;/span&gt;</code></p><p><code>21851</code><code>1980;&lt;span class="ref-vol"&gt;</code></p><p><code>21852</code><code>87&lt;/span&gt;</code></p><p><code>21853</code><code>:222–228.&lt;/span&gt;</code></p><p><code>21854</code><code> [&lt;a href="/pubmed/7053160" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21855</code><code>PubMed&lt;/a&gt;</code></p><p><code>21856</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21857</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Ophthalmology&amp;amp;title=Effect+of+marihuana+on+intraocular+and+blood+pressure+in+glaucoma&amp;amp;author=JC+Merritt&amp;amp;author=WJ+Crawford&amp;amp;author=PC+Alexander&amp;amp;author=AL+Anduze&amp;amp;author=SS+Gelbart&amp;amp;volume=87&amp;amp;publication_year=1980&amp;amp;pages=222-228&amp;amp;pmid=7053160&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21858</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21859</code><code>]&lt;/span&gt;</code></p><p><code>21860</code><code>&lt;/span&gt;</code></p><p><code>21861</code><code>&lt;/li&gt;</code></p><p><code>21862</code><code>&lt;li id="R825"&gt;</code></p><p><code>21863</code><code>&lt;span class="citation"&gt;</code></p><p><code>21864</code><code>Merritt JC, Olsen JL, Armstrong JR, McKinnon SM. Topical &amp;#x00394;&lt;sup&gt;</code></p><p><code>21865</code><code>9&lt;/sup&gt;</code></p><p><code>21866</code><code>-tetrahydrocannabinol in hypertensive glaucomas. &lt;span&gt;</code></p><p><code>21867</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21868</code><code>J Pharm Pharmacol. &lt;/span&gt;</code></p><p><code>21869</code><code>1981a;&lt;span class="ref-vol"&gt;</code></p><p><code>21870</code><code>33&lt;/span&gt;</code></p><p><code>21871</code><code>:40–41.&lt;/span&gt;</code></p><p><code>21872</code><code> [&lt;a href="/pubmed/6114151" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21873</code><code>PubMed&lt;/a&gt;</code></p><p><code>21874</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21875</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Pharmacol&amp;amp;title=Topical+&amp;#x00394;9-tetrahydrocannabinol+in+hypertensive+glaucomas&amp;amp;author=JC+Merritt&amp;amp;author=JL+Olsen&amp;amp;author=JR+Armstrong&amp;amp;author=SM+McKinnon&amp;amp;volume=33&amp;amp;publication_year=1981a&amp;amp;pages=40-41&amp;amp;pmid=6114151&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21876</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21877</code><code>]&lt;/span&gt;</code></p><p><code>21878</code><code>&lt;/span&gt;</code></p><p><code>21879</code><code>&lt;/li&gt;</code></p><p><code>21880</code><code>&lt;li id="R826"&gt;</code></p><p><code>21881</code><code>&lt;span class="citation"&gt;</code></p><p><code>21882</code><code>Merritt JC, Perry DD, Russell DN, Jones BF. Topical &amp;#x00394;&lt;sup&gt;</code></p><p><code>21883</code><code>9&lt;/sup&gt;</code></p><p><code>21884</code><code>-tetrahydrocannabinol and aqueous dynamics in glaucoma. &lt;span&gt;</code></p><p><code>21885</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21886</code><code>J Clin Pharmacol. &lt;/span&gt;</code></p><p><code>21887</code><code>1981b;&lt;span class="ref-vol"&gt;</code></p><p><code>21888</code><code>21&lt;/span&gt;</code></p><p><code>21889</code><code>:467S–471S.&lt;/span&gt;</code></p><p><code>21890</code><code> [&lt;a href="/pubmed/6271841" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21891</code><code>PubMed&lt;/a&gt;</code></p><p><code>21892</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21893</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pharmacol&amp;amp;title=Topical+&amp;#x00394;9-tetrahydrocannabinol+and+aqueous+dynamics+in+glaucoma&amp;amp;author=JC+Merritt&amp;amp;author=DD+Perry&amp;amp;author=DN+Russell&amp;amp;author=BF+Jones&amp;amp;volume=21&amp;amp;publication_year=1981b&amp;amp;pages=467S-471S&amp;amp;pmid=6271841&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21894</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21895</code><code>]&lt;/span&gt;</code></p><p><code>21896</code><code>&lt;/span&gt;</code></p><p><code>21897</code><code>&lt;/li&gt;</code></p><p><code>21898</code><code>&lt;li id="R827"&gt;</code></p><p><code>21899</code><code>&lt;span class="citation"&gt;</code></p><p><code>21900</code><code>Meschler JP, Howlett AC, Madras BK. Cannabinoid receptor agonist and antagonist effects on motor function in normal and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-treated non-human primates. &lt;span&gt;</code></p><p><code>21901</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21902</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>21903</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>21904</code><code>156&lt;/span&gt;</code></p><p><code>21905</code><code>:79–85.&lt;/span&gt;</code></p><p><code>21906</code><code> [&lt;a href="/pubmed/11465637" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21907</code><code>PubMed&lt;/a&gt;</code></p><p><code>21908</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21909</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Cannabinoid+receptor+agonist+and+antagonist+effects+on+motor+function+in+normal+and+1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine+(MPTP)-treated+non-human+primates&amp;amp;author=JP+Meschler&amp;amp;author=AC+Howlett&amp;amp;author=BK+Madras&amp;amp;volume=156&amp;amp;publication_year=2001&amp;amp;pages=79-85&amp;amp;pmid=11465637&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21910</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21911</code><code>]&lt;/span&gt;</code></p><p><code>21912</code><code>&lt;/span&gt;</code></p><p><code>21913</code><code>&lt;/li&gt;</code></p><p><code>21914</code><code>&lt;li id="R828"&gt;</code></p><p><code>21915</code><code>&lt;span class="citation"&gt;</code></p><p><code>21916</code><code>Mesnage V, Houeto JL, Bonnet AM, Clavier I, Arnulf I, Cattelin F, Le Fur G, Damier P, Welter ML, Agid Y. Neurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson disease. &lt;span&gt;</code></p><p><code>21917</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21918</code><code>Clin Neuropharmacol. &lt;/span&gt;</code></p><p><code>21919</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>21920</code><code>27&lt;/span&gt;</code></p><p><code>21921</code><code>:108–110.&lt;/span&gt;</code></p><p><code>21922</code><code> [&lt;a href="/pubmed/15190231" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21923</code><code>PubMed&lt;/a&gt;</code></p><p><code>21924</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21925</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Clin+Neuropharmacol&amp;amp;title=Neurokinin+B,+neurotensin,+and+cannabinoid+receptor+antagonists+and+Parkinson+disease&amp;amp;author=V+Mesnage&amp;amp;author=JL+Houeto&amp;amp;author=AM+Bonnet&amp;amp;author=I+Clavier&amp;amp;author=I+Arnulf&amp;amp;volume=27&amp;amp;publication_year=2004&amp;amp;pages=108-110&amp;amp;pmid=15190231&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21926</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21927</code><code>]&lt;/span&gt;</code></p><p><code>21928</code><code>&lt;/span&gt;</code></p><p><code>21929</code><code>&lt;/li&gt;</code></p><p><code>21930</code><code>&lt;li id="R829"&gt;</code></p><p><code>21931</code><code>&lt;span class="citation"&gt;</code></p><p><code>21932</code><code>Mestre L, Correa F, Arevalo-Martin A, Molina-Holgado E, Valenti M, Ortar G, Di Marzo V, Guaza C. Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis. &lt;span&gt;</code></p><p><code>21933</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21934</code><code>J Neurochem. &lt;/span&gt;</code></p><p><code>21935</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>21936</code><code>92&lt;/span&gt;</code></p><p><code>21937</code><code>:1327–1339.&lt;/span&gt;</code></p><p><code>21938</code><code> [&lt;a href="/pubmed/15748152" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21939</code><code>PubMed&lt;/a&gt;</code></p><p><code>21940</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21941</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;amp;title=Pharmacological+modulation+of+the+endocannabinoid+system+in+a+viral+model+of+multiple+sclerosis&amp;amp;author=L+Mestre&amp;amp;author=F+Correa&amp;amp;author=A+Arevalo-Martin&amp;amp;author=E+Molina-Holgado&amp;amp;author=M+Valenti&amp;amp;volume=92&amp;amp;publication_year=2005&amp;amp;pages=1327-1339&amp;amp;pmid=15748152&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21942</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21943</code><code>]&lt;/span&gt;</code></p><p><code>21944</code><code>&lt;/span&gt;</code></p><p><code>21945</code><code>&lt;/li&gt;</code></p><p><code>21946</code><code>&lt;li id="R830"&gt;</code></p><p><code>21947</code><code>&lt;span class="citation"&gt;</code></p><p><code>21948</code><code>Michalopoulos GK, Bowen WC, Kule K, Luo J. HGF-, EGF-, and dexa-methasone-induced gene expression patterns during formation of tissue in hepatic organoid cultures. &lt;span&gt;</code></p><p><code>21949</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21950</code><code>Gene Expr. &lt;/span&gt;</code></p><p><code>21951</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>21952</code><code>11&lt;/span&gt;</code></p><p><code>21953</code><code>:55–75.&lt;/span&gt;</code></p><p><code>21954</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>21955</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1913286/"&gt;</code></p><p><code>21956</code><code>PMC free article&lt;/a&gt;</code></p><p><code>21957</code><code>]&lt;/span&gt;</code></p><p><code>21958</code><code> [&lt;a href="/pubmed/12837037" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21959</code><code>PubMed&lt;/a&gt;</code></p><p><code>21960</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21961</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gene+Expr&amp;amp;title=HGF-,+EGF-,+and+dexa-methasone-induced+gene+expression+patterns+during+formation+of+tissue+in+hepatic+organoid+cultures&amp;amp;author=GK+Michalopoulos&amp;amp;author=WC+Bowen&amp;amp;author=K+Kule&amp;amp;author=J+Luo&amp;amp;volume=11&amp;amp;publication_year=2003&amp;amp;pages=55-75&amp;amp;pmid=12837037&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21962</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21963</code><code>]&lt;/span&gt;</code></p><p><code>21964</code><code>&lt;/span&gt;</code></p><p><code>21965</code><code>&lt;/li&gt;</code></p><p><code>21966</code><code>&lt;li id="R831"&gt;</code></p><p><code>21967</code><code>&lt;span class="citation"&gt;</code></p><p><code>21968</code><code>Miller AS, Sanudo-Pena MC, Walker JM. Ipsilateral turning behavior induced by unilateral microinjections of a cannabinoid into the rat subthalamic nucleus. &lt;span&gt;</code></p><p><code>21969</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21970</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>21971</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>21972</code><code>793&lt;/span&gt;</code></p><p><code>21973</code><code>:7–11.&lt;/span&gt;</code></p><p><code>21974</code><code> [&lt;a href="/pubmed/9630477" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21975</code><code>PubMed&lt;/a&gt;</code></p><p><code>21976</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21977</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Ipsilateral+turning+behavior+induced+by+unilateral+microinjections+of+a+cannabinoid+into+the+rat+subthalamic+nucleus&amp;amp;author=AS+Miller&amp;amp;author=MC+Sanudo-Pena&amp;amp;author=JM+Walker&amp;amp;volume=793&amp;amp;publication_year=1998&amp;amp;pages=7-11&amp;amp;pmid=9630477&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21978</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21979</code><code>]&lt;/span&gt;</code></p><p><code>21980</code><code>&lt;/span&gt;</code></p><p><code>21981</code><code>&lt;/li&gt;</code></p><p><code>21982</code><code>&lt;li id="R832"&gt;</code></p><p><code>21983</code><code>&lt;span class="citation"&gt;</code></p><p><code>21984</code><code>Miller CC, Murray TF, Freeman KG, Edwards GL. Cannabinoid agonist, CP 55,940, facilitates intake of palatable foods when injected into the hindbrain. &lt;span&gt;</code></p><p><code>21985</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>21986</code><code>Physiol Behav. &lt;/span&gt;</code></p><p><code>21987</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>21988</code><code>80&lt;/span&gt;</code></p><p><code>21989</code><code>:611–616.&lt;/span&gt;</code></p><p><code>21990</code><code> [&lt;a href="/pubmed/14984793" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>21991</code><code>PubMed&lt;/a&gt;</code></p><p><code>21992</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>21993</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Physiol+Behav&amp;amp;title=Cannabinoid+agonist,+CP+55,940,+facilitates+intake+of+palatable+foods+when+injected+into+the+hindbrain&amp;amp;author=CC+Miller&amp;amp;author=TF+Murray&amp;amp;author=KG+Freeman&amp;amp;author=GL+Edwards&amp;amp;volume=80&amp;amp;publication_year=2004&amp;amp;pages=611-616&amp;amp;pmid=14984793&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>21994</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>21995</code><code>]&lt;/span&gt;</code></p><p><code>21996</code><code>&lt;/span&gt;</code></p><p><code>21997</code><code>&lt;/li&gt;</code></p><p><code>21998</code><code>&lt;li id="R833"&gt;</code></p><p><code>21999</code><code>&lt;span class="citation"&gt;</code></p><p><code>22000</code><code>Miller P, Lawrie SM, Hodges A, Clafferty R, Cosway R, Johnstone EC. Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia. &lt;span&gt;</code></p><p><code>22001</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22002</code><code>Soc Psychiatry Psychiatr Epidemiol. &lt;/span&gt;</code></p><p><code>22003</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>22004</code><code>36&lt;/span&gt;</code></p><p><code>22005</code><code>:338–342.&lt;/span&gt;</code></p><p><code>22006</code><code> [&lt;a href="/pubmed/11606002" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22007</code><code>PubMed&lt;/a&gt;</code></p><p><code>22008</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22009</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Soc+Psychiatry+Psychiatr+Epidemiol&amp;amp;title=Genetic+liability,+illicit+drug+use,+life+stress+and+psychotic+symptoms:+preliminary+findings+from+the+Edinburgh+study+of+people+at+high+risk+for+schizophrenia&amp;amp;author=P+Miller&amp;amp;author=SM+Lawrie&amp;amp;author=A+Hodges&amp;amp;author=R+Clafferty&amp;amp;author=R+Cosway&amp;amp;volume=36&amp;amp;publication_year=2001&amp;amp;pages=338-342&amp;amp;pmid=11606002&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22010</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22011</code><code>]&lt;/span&gt;</code></p><p><code>22012</code><code>&lt;/span&gt;</code></p><p><code>22013</code><code>&lt;/li&gt;</code></p><p><code>22014</code><code>&lt;li id="R834"&gt;</code></p><p><code>22015</code><code>&lt;span class="citation"&gt;</code></p><p><code>22016</code><code>Milman G, Maor Y, Abu-Lafi S, Horowitz M, Gallily R, Batkai S, Mo FM, Offertaler L, Pacher P, Kunos G, et al.  N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties. &lt;span&gt;</code></p><p><code>22017</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22018</code><code>Proc Natl Sci USA. &lt;/span&gt;</code></p><p><code>22019</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>22020</code><code>103&lt;/span&gt;</code></p><p><code>22021</code><code>:2428–2433.&lt;/span&gt;</code></p><p><code>22022</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>22023</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1413724/"&gt;</code></p><p><code>22024</code><code>PMC free article&lt;/a&gt;</code></p><p><code>22025</code><code>]&lt;/span&gt;</code></p><p><code>22026</code><code> [&lt;a href="/pubmed/16467152" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22027</code><code>PubMed&lt;/a&gt;</code></p><p><code>22028</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22029</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Sci+USA&amp;amp;title=N-arachidonoyl+L-serine,+an+endocannabinoid-like+brain+constituent+with+vasodilatory+properties&amp;amp;author=G+Milman&amp;amp;author=Y+Maor&amp;amp;author=S+Abu-Lafi&amp;amp;author=M+Horowitz&amp;amp;author=R+Gallily&amp;amp;volume=103&amp;amp;publication_year=2006&amp;amp;pages=2428-2433&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22030</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22031</code><code>]&lt;/span&gt;</code></p><p><code>22032</code><code>&lt;/span&gt;</code></p><p><code>22033</code><code>&lt;/li&gt;</code></p><p><code>22034</code><code>&lt;li id="R835"&gt;</code></p><p><code>22035</code><code>&lt;span class="citation"&gt;</code></p><p><code>22036</code><code>Milton NG. Anandamide and noladin ether prevent neurotoxicity of the human amyloid-&lt;em&gt;</code></p><p><code>22037</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>22038</code><code> peptide. &lt;span&gt;</code></p><p><code>22039</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22040</code><code>Neurosci Lett. &lt;/span&gt;</code></p><p><code>22041</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>22042</code><code>332&lt;/span&gt;</code></p><p><code>22043</code><code>:127–130.&lt;/span&gt;</code></p><p><code>22044</code><code> [&lt;a href="/pubmed/12384227" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22045</code><code>PubMed&lt;/a&gt;</code></p><p><code>22046</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22047</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Lett&amp;amp;title=Anandamide+and+noladin+ether+prevent+neurotoxicity+of+the+human+amyloid-&amp;#x003b2;+peptide&amp;amp;author=NG+Milton&amp;amp;volume=332&amp;amp;publication_year=2002&amp;amp;pages=127-130&amp;amp;pmid=12384227&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22048</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22049</code><code>]&lt;/span&gt;</code></p><p><code>22050</code><code>&lt;/span&gt;</code></p><p><code>22051</code><code>&lt;/li&gt;</code></p><p><code>22052</code><code>&lt;li id="R836"&gt;</code></p><p><code>22053</code><code>&lt;span class="citation"&gt;</code></p><p><code>22054</code><code>Mimeault M, Pommery N, Wattez N, Bailly C, Henichart JP. Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production. &lt;span&gt;</code></p><p><code>22055</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22056</code><code>Prostate. &lt;/span&gt;</code></p><p><code>22057</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>22058</code><code>56&lt;/span&gt;</code></p><p><code>22059</code><code>:1–12.&lt;/span&gt;</code></p><p><code>22060</code><code> [&lt;a href="/pubmed/12746841" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22061</code><code>PubMed&lt;/a&gt;</code></p><p><code>22062</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22063</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Prostate&amp;amp;title=Anti-proliferative+and+apoptotic+effects+of+anandamide+in+human+prostatic+cancer+cell+lines:+implication+of+epidermal+growth+factor+receptor+down-regulation+and+ceramide+production&amp;amp;author=M+Mimeault&amp;amp;author=N+Pommery&amp;amp;author=N+Wattez&amp;amp;author=C+Bailly&amp;amp;author=JP+Henichart&amp;amp;volume=56&amp;amp;publication_year=2003&amp;amp;pages=1-12&amp;amp;pmid=12746841&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22064</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22065</code><code>]&lt;/span&gt;</code></p><p><code>22066</code><code>&lt;/span&gt;</code></p><p><code>22067</code><code>&lt;/li&gt;</code></p><p><code>22068</code><code>&lt;li id="R837"&gt;</code></p><p><code>22069</code><code>&lt;span class="citation"&gt;</code></p><p><code>22070</code><code>Minokoshi Y, Alquier T, Furakawa N, Kim YB, Lee A, Xue B, Mu J, Foufelle F, Ferre P, Birnbaum MJ, et al.  AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. &lt;span&gt;</code></p><p><code>22071</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22072</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>22073</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>22074</code><code>428&lt;/span&gt;</code></p><p><code>22075</code><code>:569–574.&lt;/span&gt;</code></p><p><code>22076</code><code> [&lt;a href="/pubmed/15058305" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22077</code><code>PubMed&lt;/a&gt;</code></p><p><code>22078</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22079</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=AMP-kinase+regulates+food+intake+by+responding+to+hormonal+and+nutrient+signals+in+the+hypothalamus&amp;amp;author=Y+Minokoshi&amp;amp;author=T+Alquier&amp;amp;author=N+Furakawa&amp;amp;author=YB+Kim&amp;amp;author=A+Lee&amp;amp;volume=428&amp;amp;publication_year=2004&amp;amp;pages=569-574&amp;amp;pmid=15058305&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22080</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22081</code><code>]&lt;/span&gt;</code></p><p><code>22082</code><code>&lt;/span&gt;</code></p><p><code>22083</code><code>&lt;/li&gt;</code></p><p><code>22084</code><code>&lt;li id="R838"&gt;</code></p><p><code>22085</code><code>&lt;span class="citation"&gt;</code></p><p><code>22086</code><code>Mitchell VA, Aslan S, Safaei R, Vaughan CW. Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain. &lt;span&gt;</code></p><p><code>22087</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22088</code><code>Neurosci Lett. &lt;/span&gt;</code></p><p><code>22089</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>22090</code><code>382&lt;/span&gt;</code></p><p><code>22091</code><code>:231–235.&lt;/span&gt;</code></p><p><code>22092</code><code> [&lt;a href="/pubmed/15925096" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22093</code><code>PubMed&lt;/a&gt;</code></p><p><code>22094</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22095</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Lett&amp;amp;title=Effect+of+the+cannabinoid+ajulemic+acid+on+rat+models+of+neuropathic+and+inflammatory+pain&amp;amp;author=VA+Mitchell&amp;amp;author=S+Aslan&amp;amp;author=R+Safaei&amp;amp;author=CW+Vaughan&amp;amp;volume=382&amp;amp;publication_year=2005&amp;amp;pages=231-235&amp;amp;pmid=15925096&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22096</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22097</code><code>]&lt;/span&gt;</code></p><p><code>22098</code><code>&lt;/span&gt;</code></p><p><code>22099</code><code>&lt;/li&gt;</code></p><p><code>22100</code><code>&lt;li id="R839"&gt;</code></p><p><code>22101</code><code>&lt;span class="citation"&gt;</code></p><p><code>22102</code><code>Mo FM, Offert&amp;#x000e1;ler L, Kunos G. Atypical cannabinoid stimulates endothelial cell migration via G&lt;sub&gt;</code></p><p><code>22103</code><code>i&lt;/sub&gt;</code></p><p><code>22104</code><code>/G&lt;sub&gt;</code></p><p><code>22105</code><code>o&lt;/sub&gt;</code></p><p><code>22106</code><code>-coupled receptor distinct from CB&lt;sub&gt;</code></p><p><code>22107</code><code>1&lt;/sub&gt;</code></p><p><code>22108</code><code>, CB&lt;sub&gt;</code></p><p><code>22109</code><code>2&lt;/sub&gt;</code></p><p><code>22110</code><code> or EDG-1. &lt;span&gt;</code></p><p><code>22111</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22112</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>22113</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>22114</code><code>489&lt;/span&gt;</code></p><p><code>22115</code><code>:21–27.&lt;/span&gt;</code></p><p><code>22116</code><code> [&lt;a href="/pubmed/15063151" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22117</code><code>PubMed&lt;/a&gt;</code></p><p><code>22118</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22119</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Atypical+cannabinoid+stimulates+endothelial+cell+migration+via+Gi/Go-coupled+receptor+distinct+from+CB1,+CB2+or+EDG-1&amp;amp;author=FM+Mo&amp;amp;author=L+Offert&amp;#x000e1;ler&amp;amp;author=G+Kunos&amp;amp;volume=489&amp;amp;publication_year=2004&amp;amp;pages=21-27&amp;amp;pmid=15063151&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22120</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22121</code><code>]&lt;/span&gt;</code></p><p><code>22122</code><code>&lt;/span&gt;</code></p><p><code>22123</code><code>&lt;/li&gt;</code></p><p><code>22124</code><code>&lt;li id="R840"&gt;</code></p><p><code>22125</code><code>&lt;span class="citation"&gt;</code></p><p><code>22126</code><code>Moldrich G, Wenger T. Localization of the CB1 cannabinoid receptor in the rat brain: an immunohistochemical study. &lt;span&gt;</code></p><p><code>22127</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22128</code><code>Peptides. &lt;/span&gt;</code></p><p><code>22129</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>22130</code><code>21&lt;/span&gt;</code></p><p><code>22131</code><code>:1735–1742.&lt;/span&gt;</code></p><p><code>22132</code><code> [&lt;a href="/pubmed/11090929" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22133</code><code>PubMed&lt;/a&gt;</code></p><p><code>22134</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22135</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Peptides&amp;amp;title=Localization+of+the+CB1+cannabinoid+receptor+in+the+rat+brain:+an+immunohistochemical+study&amp;amp;author=G+Moldrich&amp;amp;author=T+Wenger&amp;amp;volume=21&amp;amp;publication_year=2000&amp;amp;pages=1735-1742&amp;amp;pmid=11090929&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22136</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22137</code><code>]&lt;/span&gt;</code></p><p><code>22138</code><code>&lt;/span&gt;</code></p><p><code>22139</code><code>&lt;/li&gt;</code></p><p><code>22140</code><code>&lt;li id="R841"&gt;</code></p><p><code>22141</code><code>&lt;span class="citation"&gt;</code></p><p><code>22142</code><code>Molina-Holgado E, Vela JM, Arevalo-Martin A, Almazan G, Molina-Holgado F, Borrell J, Guaza C. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling. &lt;span&gt;</code></p><p><code>22143</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22144</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>22145</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>22146</code><code>22&lt;/span&gt;</code></p><p><code>22147</code><code>:9742–9753.&lt;/span&gt;</code></p><p><code>22148</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>22149</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6757831/"&gt;</code></p><p><code>22150</code><code>PMC free article&lt;/a&gt;</code></p><p><code>22151</code><code>]&lt;/span&gt;</code></p><p><code>22152</code><code> [&lt;a href="/pubmed/12427829" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22153</code><code>PubMed&lt;/a&gt;</code></p><p><code>22154</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22155</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Cannabinoids+promote+oligodendrocyte+progenitor+survival:+involvement+of+cannabinoid+receptors+and+phosphatidylinositol-3+kinase/Akt+signaling&amp;amp;author=E+Molina-Holgado&amp;amp;author=JM+Vela&amp;amp;author=A+Arevalo-Martin&amp;amp;author=G+Almazan&amp;amp;author=F+Molina-Holgado&amp;amp;volume=22&amp;amp;publication_year=2002&amp;amp;pages=9742-9753&amp;amp;pmid=12427829&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22156</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22157</code><code>]&lt;/span&gt;</code></p><p><code>22158</code><code>&lt;/span&gt;</code></p><p><code>22159</code><code>&lt;/li&gt;</code></p><p><code>22160</code><code>&lt;li id="R842"&gt;</code></p><p><code>22161</code><code>&lt;span class="citation"&gt;</code></p><p><code>22162</code><code>Molina-Holgado F, Lledo A, Guaza C. Anandamide suppresses nitric oxide and TNF-&lt;em&gt;</code></p><p><code>22163</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>22164</code><code> responses to Theiler&amp;#x02019;s virus or endotoxin in astrocytes. &lt;span&gt;</code></p><p><code>22165</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22166</code><code>Neuroreport. &lt;/span&gt;</code></p><p><code>22167</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>22168</code><code>8&lt;/span&gt;</code></p><p><code>22169</code><code>:1929–1933.&lt;/span&gt;</code></p><p><code>22170</code><code> [&lt;a href="/pubmed/9223079" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22171</code><code>PubMed&lt;/a&gt;</code></p><p><code>22172</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22173</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroreport&amp;amp;title=Anandamide+suppresses+nitric+oxide+and+TNF-&amp;#x003b1;+responses+to+Theiler&amp;#x02019;s+virus+or+endotoxin+in+astrocytes&amp;amp;author=F+Molina-Holgado&amp;amp;author=A+Lledo&amp;amp;author=C+Guaza&amp;amp;volume=8&amp;amp;publication_year=1997&amp;amp;pages=1929-1933&amp;amp;pmid=9223079&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22174</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22175</code><code>]&lt;/span&gt;</code></p><p><code>22176</code><code>&lt;/span&gt;</code></p><p><code>22177</code><code>&lt;/li&gt;</code></p><p><code>22178</code><code>&lt;li id="R843"&gt;</code></p><p><code>22179</code><code>&lt;span class="citation"&gt;</code></p><p><code>22180</code><code>Moller HJ. Antipsychotic agents: gradually improving treatment from the traditional oral neuroleptics to the first atypical depot. &lt;span&gt;</code></p><p><code>22181</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22182</code><code>Eur Psychiatry. &lt;/span&gt;</code></p><p><code>22183</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>22184</code><code>20&lt;/span&gt;</code></p><p><code>22185</code><code>:379–385.&lt;/span&gt;</code></p><p><code>22186</code><code> [&lt;a href="/pubmed/15994065" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22187</code><code>PubMed&lt;/a&gt;</code></p><p><code>22188</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22189</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+Psychiatry&amp;amp;title=Antipsychotic+agents:+gradually+improving+treatment+from+the+traditional+oral+neuroleptics+to+the+first+atypical+depot&amp;amp;author=HJ+Moller&amp;amp;volume=20&amp;amp;publication_year=2005&amp;amp;pages=379-385&amp;amp;pmid=15994065&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22190</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22191</code><code>]&lt;/span&gt;</code></p><p><code>22192</code><code>&lt;/span&gt;</code></p><p><code>22193</code><code>&lt;/li&gt;</code></p><p><code>22194</code><code>&lt;li id="R844"&gt;</code></p><p><code>22195</code><code>&lt;span class="citation"&gt;</code></p><p><code>22196</code><code>Monory K, Massa F, Blaudzub H, Marsicano G, Lutz B. The role of different neuronal populations in the pharmacological actions of &amp;#x00394;&lt;sup&gt;</code></p><p><code>22197</code><code>9&lt;/sup&gt;</code></p><p><code>22198</code><code>-tetrahydro-cannabinolin. Proceedings of the 2005 Symposium on the Cannabinoids; Burlington, VT: International Cannabinoid Research Society; 2005. p. 18. &lt;span class="nowrap"&gt;</code></p><p><code>22199</code><code>[&lt;a href="https://scholar.google.com/scholar?q=Monory+K+Massa+F+Blaudzub+H+Marsicano+G+Lutz+B+2005+The+role+of+different+neuronal+populations+in+the+pharmacological+actions+of+&amp;#x00394;+9+-tetrahydro-cannabinolin+Proceedings+of+the+2005+Symposium+on+the+Cannabinoids+18+International+Cannabinoid+Research+Society+Burlington,+VT+" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22200</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22201</code><code>]&lt;/span&gt;</code></p><p><code>22202</code><code>&lt;/span&gt;</code></p><p><code>22203</code><code>&lt;/li&gt;</code></p><p><code>22204</code><code>&lt;li id="R845"&gt;</code></p><p><code>22205</code><code>&lt;span class="citation"&gt;</code></p><p><code>22206</code><code>Monteleone P, Fabbrazzo M, Tortorella A, Fuschino A, Maj M. Opposite modifications in circulating leptin and soluble leptin receptor across the eating disorder spectrum. &lt;span&gt;</code></p><p><code>22207</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22208</code><code>Mol Psychiatry. &lt;/span&gt;</code></p><p><code>22209</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>22210</code><code>7&lt;/span&gt;</code></p><p><code>22211</code><code>:641–646.&lt;/span&gt;</code></p><p><code>22212</code><code> [&lt;a href="/pubmed/12140788" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22213</code><code>PubMed&lt;/a&gt;</code></p><p><code>22214</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22215</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Psychiatry&amp;amp;title=Opposite+modifications+in+circulating+leptin+and+soluble+leptin+receptor+across+the+eating+disorder+spectrum&amp;amp;author=P+Monteleone&amp;amp;author=M+Fabbrazzo&amp;amp;author=A+Tortorella&amp;amp;author=A+Fuschino&amp;amp;author=M+Maj&amp;amp;volume=7&amp;amp;publication_year=2002&amp;amp;pages=641-646&amp;amp;pmid=12140788&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22216</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22217</code><code>]&lt;/span&gt;</code></p><p><code>22218</code><code>&lt;/span&gt;</code></p><p><code>22219</code><code>&lt;/li&gt;</code></p><p><code>22220</code><code>&lt;li id="R846"&gt;</code></p><p><code>22221</code><code>&lt;span class="citation"&gt;</code></p><p><code>22222</code><code>Monteleone P, Matias I, Martiadis V, De Petrocellis L, Maj M, Di Marzo V. Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. &lt;span&gt;</code></p><p><code>22223</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22224</code><code>Neuropsychopharmacology. &lt;/span&gt;</code></p><p><code>22225</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>22226</code><code>30&lt;/span&gt;</code></p><p><code>22227</code><code>:1216–1221.&lt;/span&gt;</code></p><p><code>22228</code><code> [&lt;a href="/pubmed/15841111" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22229</code><code>PubMed&lt;/a&gt;</code></p><p><code>22230</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22231</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;amp;title=Blood+levels+of+the+endocannabinoid+anandamide+are+increased+in+anorexia+nervosa+and+in+binge-eating+disorder,+but+not+in+bulimia+nervosa&amp;amp;author=P+Monteleone&amp;amp;author=I+Matias&amp;amp;author=V+Martiadis&amp;amp;author=L+De+Petrocellis&amp;amp;author=M+Maj&amp;amp;volume=30&amp;amp;publication_year=2005&amp;amp;pages=1216-1221&amp;amp;pmid=15841111&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22232</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22233</code><code>]&lt;/span&gt;</code></p><p><code>22234</code><code>&lt;/span&gt;</code></p><p><code>22235</code><code>&lt;/li&gt;</code></p><p><code>22236</code><code>&lt;li id="R847"&gt;</code></p><p><code>22237</code><code>&lt;span class="citation"&gt;</code></p><p><code>22238</code><code>Monti JM. Hypnoticlike effects of cannabidiol in the rat. &lt;span&gt;</code></p><p><code>22239</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22240</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>22241</code><code>1977;&lt;span class="ref-vol"&gt;</code></p><p><code>22242</code><code>55&lt;/span&gt;</code></p><p><code>22243</code><code>:263–265.&lt;/span&gt;</code></p><p><code>22244</code><code> [&lt;a href="/pubmed/414288" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22245</code><code>PubMed&lt;/a&gt;</code></p><p><code>22246</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22247</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Hypnoticlike+effects+of+cannabidiol+in+the+rat&amp;amp;author=JM+Monti&amp;amp;volume=55&amp;amp;publication_year=1977&amp;amp;pages=263-265&amp;amp;pmid=414288&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22248</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22249</code><code>]&lt;/span&gt;</code></p><p><code>22250</code><code>&lt;/span&gt;</code></p><p><code>22251</code><code>&lt;/li&gt;</code></p><p><code>22252</code><code>&lt;li id="R848"&gt;</code></p><p><code>22253</code><code>&lt;span class="citation"&gt;</code></p><p><code>22254</code><code>Moore SA, Nomikos GG, Dickason-Chesterfield AK, Schober DA, Schaus JM, Ying B-P, Xu Y-C, Phebus L, Simmons RMA, Li D, et al.  Identification of a high-affinity binding site involved in the transport of endocannabinoids. &lt;span&gt;</code></p><p><code>22255</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22256</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>22257</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>22258</code><code>102&lt;/span&gt;</code></p><p><code>22259</code><code>:17852–17857.&lt;/span&gt;</code></p><p><code>22260</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>22261</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1295594/"&gt;</code></p><p><code>22262</code><code>PMC free article&lt;/a&gt;</code></p><p><code>22263</code><code>]&lt;/span&gt;</code></p><p><code>22264</code><code> [&lt;a href="/pubmed/16314570" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22265</code><code>PubMed&lt;/a&gt;</code></p><p><code>22266</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22267</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Identification+of+a+high-affinity+binding+site+involved+in+the+transport+of+endocannabinoids&amp;amp;author=SA+Moore&amp;amp;author=GG+Nomikos&amp;amp;author=AK+Dickason-Chesterfield&amp;amp;author=DA+Schober&amp;amp;author=JM+Schaus&amp;amp;volume=102&amp;amp;publication_year=2005&amp;amp;pages=17852-17857&amp;amp;pmid=16314570&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22268</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22269</code><code>]&lt;/span&gt;</code></p><p><code>22270</code><code>&lt;/span&gt;</code></p><p><code>22271</code><code>&lt;/li&gt;</code></p><p><code>22272</code><code>&lt;li id="R849"&gt;</code></p><p><code>22273</code><code>&lt;span class="citation"&gt;</code></p><p><code>22274</code><code>Morahan PS, Klykken PC, Smith SH, Harris LS, Munson AE. Effects of cannabinoids on host resistance to &lt;em&gt;</code></p><p><code>22275</code><code>Listeria monocytogenes&lt;/em&gt;</code></p><p><code>22276</code><code> and herpes simplex virus. &lt;span&gt;</code></p><p><code>22277</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22278</code><code>Infect Immun. &lt;/span&gt;</code></p><p><code>22279</code><code>1979;&lt;span class="ref-vol"&gt;</code></p><p><code>22280</code><code>23&lt;/span&gt;</code></p><p><code>22281</code><code>:670–674.&lt;/span&gt;</code></p><p><code>22282</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>22283</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC414217/"&gt;</code></p><p><code>22284</code><code>PMC free article&lt;/a&gt;</code></p><p><code>22285</code><code>]&lt;/span&gt;</code></p><p><code>22286</code><code> [&lt;a href="/pubmed/313368" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22287</code><code>PubMed&lt;/a&gt;</code></p><p><code>22288</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22289</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Infect+Immun&amp;amp;title=Effects+of+cannabinoids+on+host+resistance+to+Listeria+monocytogenes+and+herpes+simplex+virus&amp;amp;author=PS+Morahan&amp;amp;author=PC+Klykken&amp;amp;author=SH+Smith&amp;amp;author=LS+Harris&amp;amp;author=AE+Munson&amp;amp;volume=23&amp;amp;publication_year=1979&amp;amp;pages=670-674&amp;amp;pmid=313368&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22290</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22291</code><code>]&lt;/span&gt;</code></p><p><code>22292</code><code>&lt;/span&gt;</code></p><p><code>22293</code><code>&lt;/li&gt;</code></p><p><code>22294</code><code>&lt;li id="R850"&gt;</code></p><p><code>22295</code><code>&lt;span class="citation"&gt;</code></p><p><code>22296</code><code>Morales M, Wang S-D, Diaz-Ruiz O, Jho DH-J. Cannabinoid CB1 receptor and serotonin 3 receptor subunit A (5-HT&lt;sub&gt;</code></p><p><code>22297</code><code>3A&lt;/sub&gt;</code></p><p><code>22298</code><code>) are co-expressed in GABA neurons in the rat telencephalon. &lt;span&gt;</code></p><p><code>22299</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22300</code><code>J Comp Neurol. &lt;/span&gt;</code></p><p><code>22301</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>22302</code><code>468&lt;/span&gt;</code></p><p><code>22303</code><code>:205–216.&lt;/span&gt;</code></p><p><code>22304</code><code> [&lt;a href="/pubmed/14648680" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22305</code><code>PubMed&lt;/a&gt;</code></p><p><code>22306</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22307</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Comp+Neurol&amp;amp;title=Cannabinoid+CB1+receptor+and+serotonin+3+receptor+subunit+A+(5-HT3A)+are+co-expressed+in+GABA+neurons+in+the+rat+telencephalon&amp;amp;author=M+Morales&amp;amp;author=S-D+Wang&amp;amp;author=O+Diaz-Ruiz&amp;amp;author=DH-J+Jho&amp;amp;volume=468&amp;amp;publication_year=2004&amp;amp;pages=205-216&amp;amp;pmid=14648680&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22308</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22309</code><code>]&lt;/span&gt;</code></p><p><code>22310</code><code>&lt;/span&gt;</code></p><p><code>22311</code><code>&lt;/li&gt;</code></p><p><code>22312</code><code>&lt;li id="R851"&gt;</code></p><p><code>22313</code><code>&lt;span class="citation"&gt;</code></p><p><code>22314</code><code>Morley JE. Anorexia, sarcopenia, and aging. &lt;span&gt;</code></p><p><code>22315</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22316</code><code>Nutrition. &lt;/span&gt;</code></p><p><code>22317</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>22318</code><code>17&lt;/span&gt;</code></p><p><code>22319</code><code>:660–663.&lt;/span&gt;</code></p><p><code>22320</code><code> [&lt;a href="/pubmed/11448592" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22321</code><code>PubMed&lt;/a&gt;</code></p><p><code>22322</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22323</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nutrition&amp;amp;title=Anorexia,+sarcopenia,+and+aging&amp;amp;author=JE+Morley&amp;amp;volume=17&amp;amp;publication_year=2001&amp;amp;pages=660-663&amp;amp;pmid=11448592&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22324</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22325</code><code>]&lt;/span&gt;</code></p><p><code>22326</code><code>&lt;/span&gt;</code></p><p><code>22327</code><code>&lt;/li&gt;</code></p><p><code>22328</code><code>&lt;li id="R852"&gt;</code></p><p><code>22329</code><code>&lt;span class="citation"&gt;</code></p><p><code>22330</code><code>Mukhopadhyay S, Chapnick BM, Howlett AC. Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. &lt;span&gt;</code></p><p><code>22331</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22332</code><code>Am J Physiol. &lt;/span&gt;</code></p><p><code>22333</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>22334</code><code>282&lt;/span&gt;</code></p><p><code>22335</code><code>:H2046–H2054.&lt;/span&gt;</code></p><p><code>22336</code><code> [&lt;a href="/pubmed/12003810" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22337</code><code>PubMed&lt;/a&gt;</code></p><p><code>22338</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22339</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol&amp;amp;title=Anandamide-induced+vasorelaxation+in+rabbit+aortic+rings+has+two+components:+G+protein+dependent+and+independent&amp;amp;author=S+Mukhopadhyay&amp;amp;author=BM+Chapnick&amp;amp;author=AC+Howlett&amp;amp;volume=282&amp;amp;publication_year=2002&amp;amp;pages=H2046-H2054&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22340</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22341</code><code>]&lt;/span&gt;</code></p><p><code>22342</code><code>&lt;/span&gt;</code></p><p><code>22343</code><code>&lt;/li&gt;</code></p><p><code>22344</code><code>&lt;li id="R853"&gt;</code></p><p><code>22345</code><code>&lt;span class="citation"&gt;</code></p><p><code>22346</code><code>Mukhopadhyay S, Howlett AC. Chemically distinct ligands promote differential CB&lt;sub&gt;</code></p><p><code>22347</code><code>1&lt;/sub&gt;</code></p><p><code>22348</code><code> cannabinoid receptor-Gi protein interactions. &lt;span&gt;</code></p><p><code>22349</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22350</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>22351</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>22352</code><code>67&lt;/span&gt;</code></p><p><code>22353</code><code>:2016–2024.&lt;/span&gt;</code></p><p><code>22354</code><code> [&lt;a href="/pubmed/15749995" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22355</code><code>PubMed&lt;/a&gt;</code></p><p><code>22356</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22357</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=Chemically+distinct+ligands+promote+differential+CB1+cannabinoid+receptor-Gi+protein+interactions&amp;amp;author=S+Mukhopadhyay&amp;amp;author=AC+Howlett&amp;amp;volume=67&amp;amp;publication_year=2005&amp;amp;pages=2016-2024&amp;amp;pmid=15749995&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22358</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22359</code><code>]&lt;/span&gt;</code></p><p><code>22360</code><code>&lt;/span&gt;</code></p><p><code>22361</code><code>&lt;/li&gt;</code></p><p><code>22362</code><code>&lt;li id="R854"&gt;</code></p><p><code>22363</code><code>&lt;span class="citation"&gt;</code></p><p><code>22364</code><code>M&amp;#x000fc;ller-Vahl KR. Cannabinoids reduce symptoms of Tourette&amp;#x02019;s syndrome. &lt;span&gt;</code></p><p><code>22365</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22366</code><code>Expert Opin Pharmacother. &lt;/span&gt;</code></p><p><code>22367</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>22368</code><code>4&lt;/span&gt;</code></p><p><code>22369</code><code>:1717–1725.&lt;/span&gt;</code></p><p><code>22370</code><code> [&lt;a href="/pubmed/14521482" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22371</code><code>PubMed&lt;/a&gt;</code></p><p><code>22372</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22373</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Expert+Opin+Pharmacother&amp;amp;title=Cannabinoids+reduce+symptoms+of+Tourette&amp;#x02019;s+syndrome&amp;amp;author=KR+M&amp;#x000fc;ller-Vahl&amp;amp;volume=4&amp;amp;publication_year=2003&amp;amp;pages=1717-1725&amp;amp;pmid=14521482&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22374</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22375</code><code>]&lt;/span&gt;</code></p><p><code>22376</code><code>&lt;/span&gt;</code></p><p><code>22377</code><code>&lt;/li&gt;</code></p><p><code>22378</code><code>&lt;li id="R855"&gt;</code></p><p><code>22379</code><code>&lt;span class="citation"&gt;</code></p><p><code>22380</code><code>M&amp;#x000fc;ller-Vahl KR, Kolbe H, Dengler R. Gilles de la Tourette syndrome: effect of nicotine, alcohol and marihuana on clinical symptoms. &lt;span&gt;</code></p><p><code>22381</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22382</code><code>Nervenarzt. &lt;/span&gt;</code></p><p><code>22383</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>22384</code><code>68&lt;/span&gt;</code></p><p><code>22385</code><code>:985–989.&lt;/span&gt;</code></p><p><code>22386</code><code> [&lt;a href="/pubmed/9465342" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22387</code><code>PubMed&lt;/a&gt;</code></p><p><code>22388</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22389</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nervenarzt&amp;amp;title=Gilles+de+la+Tourette+syndrome:+effect+of+nicotine,+alcohol+and+marihuana+on+clinical+symptoms&amp;amp;author=KR+M&amp;#x000fc;ller-Vahl&amp;amp;author=H+Kolbe&amp;amp;author=R+Dengler&amp;amp;volume=68&amp;amp;publication_year=1997&amp;amp;pages=985-989&amp;amp;pmid=9465342&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22390</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22391</code><code>]&lt;/span&gt;</code></p><p><code>22392</code><code>&lt;/span&gt;</code></p><p><code>22393</code><code>&lt;/li&gt;</code></p><p><code>22394</code><code>&lt;li id="R856"&gt;</code></p><p><code>22395</code><code>&lt;span class="citation"&gt;</code></p><p><code>22396</code><code>M&amp;#x000fc;ller-Vahl KR, Kolbe H, Schneider U, Emrich HM. Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome. &lt;span&gt;</code></p><p><code>22397</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22398</code><code>Acta Psychiatr Scand. &lt;/span&gt;</code></p><p><code>22399</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>22400</code><code>98&lt;/span&gt;</code></p><p><code>22401</code><code>:502–506.&lt;/span&gt;</code></p><p><code>22402</code><code> [&lt;a href="/pubmed/9879795" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22403</code><code>PubMed&lt;/a&gt;</code></p><p><code>22404</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22405</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Acta+Psychiatr+Scand&amp;amp;title=Cannabinoids:+possible+role+in+patho-physiology+and+therapy+of+Gilles+de+la+Tourette+syndrome&amp;amp;author=KR+M&amp;#x000fc;ller-Vahl&amp;amp;author=H+Kolbe&amp;amp;author=U+Schneider&amp;amp;author=HM+Emrich&amp;amp;volume=98&amp;amp;publication_year=1998&amp;amp;pages=502-506&amp;amp;pmid=9879795&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22406</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22407</code><code>]&lt;/span&gt;</code></p><p><code>22408</code><code>&lt;/span&gt;</code></p><p><code>22409</code><code>&lt;/li&gt;</code></p><p><code>22410</code><code>&lt;li id="R857"&gt;</code></p><p><code>22411</code><code>&lt;span class="citation"&gt;</code></p><p><code>22412</code><code>M&amp;#x000fc;ller-Vahl KR, Kolbe H, Schneider U, Emrich HM. Cannabis in movement disorders. &lt;span&gt;</code></p><p><code>22413</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22414</code><code>Forsch Komplementarmed. &lt;/span&gt;</code></p><p><code>22415</code><code>1999a;&lt;span class="ref-vol"&gt;</code></p><p><code>22416</code><code>6&lt;/span&gt;</code></p><p><code>22417</code><code>:23–27.&lt;/span&gt;</code></p><p><code>22418</code><code> [&lt;a href="/pubmed/10627163" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22419</code><code>PubMed&lt;/a&gt;</code></p><p><code>22420</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22421</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Forsch+Komplementarmed&amp;amp;title=Cannabis+in+movement+disorders&amp;amp;author=KR+M&amp;#x000fc;ller-Vahl&amp;amp;author=H+Kolbe&amp;amp;author=U+Schneider&amp;amp;author=HM+Emrich&amp;amp;volume=6&amp;amp;publication_year=1999a&amp;amp;pages=23-27&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22422</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22423</code><code>]&lt;/span&gt;</code></p><p><code>22424</code><code>&lt;/span&gt;</code></p><p><code>22425</code><code>&lt;/li&gt;</code></p><p><code>22426</code><code>&lt;li id="R858"&gt;</code></p><p><code>22427</code><code>&lt;span class="citation"&gt;</code></p><p><code>22428</code><code>M&amp;#x000fc;ller-Vahl KR, Prevedel H, Theloe K, Kolbe H, Emrich HM, Schneider U. Treatment of Tourette syndrome with &amp;#x00394;-9-tetrahydrocannabinol (&amp;#x00394;&lt;sup&gt;</code></p><p><code>22429</code><code>9&lt;/sup&gt;</code></p><p><code>22430</code><code>-THC): no influence on neuropsychological performance. &lt;span&gt;</code></p><p><code>22431</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22432</code><code>Neuropsychopharmacology. &lt;/span&gt;</code></p><p><code>22433</code><code>2003a;&lt;span class="ref-vol"&gt;</code></p><p><code>22434</code><code>28&lt;/span&gt;</code></p><p><code>22435</code><code>:384–388.&lt;/span&gt;</code></p><p><code>22436</code><code> [&lt;a href="/pubmed/12589392" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22437</code><code>PubMed&lt;/a&gt;</code></p><p><code>22438</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22439</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;amp;title=Treatment+of+Tourette+syndrome+with+&amp;#x00394;-9-tetrahydrocannabinol+(&amp;#x00394;9-THC):+no+influence+on+neuropsychological+performance&amp;amp;author=KR+M&amp;#x000fc;ller-Vahl&amp;amp;author=H+Prevedel&amp;amp;author=K+Theloe&amp;amp;author=H+Kolbe&amp;amp;author=HM+Emrich&amp;amp;volume=28&amp;amp;publication_year=2003a&amp;amp;pages=384-388&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22440</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22441</code><code>]&lt;/span&gt;</code></p><p><code>22442</code><code>&lt;/span&gt;</code></p><p><code>22443</code><code>&lt;/li&gt;</code></p><p><code>22444</code><code>&lt;li id="R859"&gt;</code></p><p><code>22445</code><code>&lt;span class="citation"&gt;</code></p><p><code>22446</code><code>M&amp;#x000fc;ller-Vahl KR, Schneider U, Emrich HM. Nabilone increases choreatic movements in Huntington&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>22447</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22448</code><code>Mov Disord. &lt;/span&gt;</code></p><p><code>22449</code><code>1999b;&lt;span class="ref-vol"&gt;</code></p><p><code>22450</code><code>14&lt;/span&gt;</code></p><p><code>22451</code><code>:1038–1040.&lt;/span&gt;</code></p><p><code>22452</code><code> [&lt;a href="/pubmed/10584686" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22453</code><code>PubMed&lt;/a&gt;</code></p><p><code>22454</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22455</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mov+Disord&amp;amp;title=Nabilone+increases+choreatic+movements+in+Huntington&amp;#x02019;s+disease&amp;amp;author=KR+M&amp;#x000fc;ller-Vahl&amp;amp;author=U+Schneider&amp;amp;author=HM+Emrich&amp;amp;volume=14&amp;amp;publication_year=1999b&amp;amp;pages=1038-1040&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22456</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22457</code><code>]&lt;/span&gt;</code></p><p><code>22458</code><code>&lt;/span&gt;</code></p><p><code>22459</code><code>&lt;/li&gt;</code></p><p><code>22460</code><code>&lt;li id="R860"&gt;</code></p><p><code>22461</code><code>&lt;span class="citation"&gt;</code></p><p><code>22462</code><code>M&amp;#x000fc;ller-Vahl KR, Schneider U, Koblenz A, Jobges M, Kolbe H, Daldrup T, Emrich HM. Treatment of Tourette&amp;#x02019;s syndrome with &amp;#x00394;&lt;sup&gt;</code></p><p><code>22463</code><code>9&lt;/sup&gt;</code></p><p><code>22464</code><code>-tetrahydrocannabinol (THC): a randomized crossover trial. &lt;span&gt;</code></p><p><code>22465</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22466</code><code>Pharmacopsychiatry. &lt;/span&gt;</code></p><p><code>22467</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>22468</code><code>35&lt;/span&gt;</code></p><p><code>22469</code><code>:57–61.&lt;/span&gt;</code></p><p><code>22470</code><code> [&lt;a href="/pubmed/11951146" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22471</code><code>PubMed&lt;/a&gt;</code></p><p><code>22472</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22473</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacopsychiatry&amp;amp;title=Treatment+of+Tourette&amp;#x02019;s+syndrome+with+&amp;#x00394;9-tetrahydrocannabinol+(THC):+a+randomized+crossover+trial&amp;amp;author=KR+M&amp;#x000fc;ller-Vahl&amp;amp;author=U+Schneider&amp;amp;author=A+Koblenz&amp;amp;author=M+Jobges&amp;amp;author=H+Kolbe&amp;amp;volume=35&amp;amp;publication_year=2002&amp;amp;pages=57-61&amp;amp;pmid=11951146&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22474</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22475</code><code>]&lt;/span&gt;</code></p><p><code>22476</code><code>&lt;/span&gt;</code></p><p><code>22477</code><code>&lt;/li&gt;</code></p><p><code>22478</code><code>&lt;li id="R861"&gt;</code></p><p><code>22479</code><code>&lt;span class="citation"&gt;</code></p><p><code>22480</code><code>M&amp;#x000fc;ller-Vahl KR, Schneider U, Kolbe H, Emrich HM. Treatment of Tourette&amp;#x02019;s syndrome with &amp;#x00394;-9-tetrahydrocannabinol. &lt;span&gt;</code></p><p><code>22481</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22482</code><code>Am J Psychiatry. &lt;/span&gt;</code></p><p><code>22483</code><code>1999c;&lt;span class="ref-vol"&gt;</code></p><p><code>22484</code><code>156&lt;/span&gt;</code></p><p><code>22485</code><code>:495.&lt;/span&gt;</code></p><p><code>22486</code><code> [&lt;a href="/pubmed/10080574" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22487</code><code>PubMed&lt;/a&gt;</code></p><p><code>22488</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22489</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Psychiatry&amp;amp;title=Treatment+of+Tourette&amp;#x02019;s+syndrome+with+&amp;#x00394;-9-tetrahydrocannabinol&amp;amp;author=KR+M&amp;#x000fc;ller-Vahl&amp;amp;author=U+Schneider&amp;amp;author=H+Kolbe&amp;amp;author=HM+Emrich&amp;amp;volume=156&amp;amp;publication_year=1999c&amp;amp;pages=495&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22490</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22491</code><code>]&lt;/span&gt;</code></p><p><code>22492</code><code>&lt;/span&gt;</code></p><p><code>22493</code><code>&lt;/li&gt;</code></p><p><code>22494</code><code>&lt;li id="R862"&gt;</code></p><p><code>22495</code><code>&lt;span class="citation"&gt;</code></p><p><code>22496</code><code>M&amp;#x000fc;ller-Vahl KR, Schneider U, Prevedel H, Theloe K, Kolbe H, Daldrup T, Emrich HM. &amp;#x00394;&lt;sup&gt;</code></p><p><code>22497</code><code>9&lt;/sup&gt;</code></p><p><code>22498</code><code>-Tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. &lt;span&gt;</code></p><p><code>22499</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22500</code><code>J Clin Psychiatry. &lt;/span&gt;</code></p><p><code>22501</code><code>2003b;&lt;span class="ref-vol"&gt;</code></p><p><code>22502</code><code>64&lt;/span&gt;</code></p><p><code>22503</code><code>:459–465.&lt;/span&gt;</code></p><p><code>22504</code><code> [&lt;a href="/pubmed/12716250" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22505</code><code>PubMed&lt;/a&gt;</code></p><p><code>22506</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22507</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Psychiatry&amp;amp;title=&amp;#x00394;9-Tetrahydrocannabinol+(THC)+is+effective+in+the+treatment+of+tics+in+Tourette+syndrome:+a+6-week+randomized+trial&amp;amp;author=KR+M&amp;#x000fc;ller-Vahl&amp;amp;author=U+Schneider&amp;amp;author=H+Prevedel&amp;amp;author=K+Theloe&amp;amp;author=H+Kolbe&amp;amp;volume=64&amp;amp;publication_year=2003b&amp;amp;pages=459-465&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22508</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22509</code><code>]&lt;/span&gt;</code></p><p><code>22510</code><code>&lt;/span&gt;</code></p><p><code>22511</code><code>&lt;/li&gt;</code></p><p><code>22512</code><code>&lt;li id="R863"&gt;</code></p><p><code>22513</code><code>&lt;span class="citation"&gt;</code></p><p><code>22514</code><code>Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. &lt;span&gt;</code></p><p><code>22515</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22516</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>22517</code><code>1993;&lt;span class="ref-vol"&gt;</code></p><p><code>22518</code><code>365&lt;/span&gt;</code></p><p><code>22519</code><code>:61–65.&lt;/span&gt;</code></p><p><code>22520</code><code> [&lt;a href="/pubmed/7689702" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22521</code><code>PubMed&lt;/a&gt;</code></p><p><code>22522</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22523</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Molecular+characterization+of+a+peripheral+receptor+for+cannabinoids&amp;amp;author=S+Munro&amp;amp;author=KL+Thomas&amp;amp;author=M+Abu-Shaar&amp;amp;volume=365&amp;amp;publication_year=1993&amp;amp;pages=61-65&amp;amp;pmid=7689702&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22524</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22525</code><code>]&lt;/span&gt;</code></p><p><code>22526</code><code>&lt;/span&gt;</code></p><p><code>22527</code><code>&lt;/li&gt;</code></p><p><code>22528</code><code>&lt;li id="R864"&gt;</code></p><p><code>22529</code><code>&lt;span class="citation"&gt;</code></p><p><code>22530</code><code>Munson AE, Harris LS, Friedman MA, Dewey WL, Carchman RA. Anti-neoplastic activity of cannabinoids. &lt;span&gt;</code></p><p><code>22531</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22532</code><code>J Natl Cancer Inst. &lt;/span&gt;</code></p><p><code>22533</code><code>1975;&lt;span class="ref-vol"&gt;</code></p><p><code>22534</code><code>55&lt;/span&gt;</code></p><p><code>22535</code><code>:597–602.&lt;/span&gt;</code></p><p><code>22536</code><code> [&lt;a href="/pubmed/1159836" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22537</code><code>PubMed&lt;/a&gt;</code></p><p><code>22538</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22539</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;amp;title=Anti-neoplastic+activity+of+cannabinoids&amp;amp;author=AE+Munson&amp;amp;author=LS+Harris&amp;amp;author=MA+Friedman&amp;amp;author=WL+Dewey&amp;amp;author=RA+Carchman&amp;amp;volume=55&amp;amp;publication_year=1975&amp;amp;pages=597-602&amp;amp;pmid=1159836&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22540</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22541</code><code>]&lt;/span&gt;</code></p><p><code>22542</code><code>&lt;/span&gt;</code></p><p><code>22543</code><code>&lt;/li&gt;</code></p><p><code>22544</code><code>&lt;li id="R865"&gt;</code></p><p><code>22545</code><code>&lt;span class="citation"&gt;</code></p><p><code>22546</code><code>Murillo-Rodriguez E, Blanco-Centurion C, Sanchez C, Piomelli D, Shiromani PJ. Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study. &lt;span&gt;</code></p><p><code>22547</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22548</code><code>Sleep. &lt;/span&gt;</code></p><p><code>22549</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>22550</code><code>26&lt;/span&gt;</code></p><p><code>22551</code><code>:943–947.&lt;/span&gt;</code></p><p><code>22552</code><code> [&lt;a href="/pubmed/14746372" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22553</code><code>PubMed&lt;/a&gt;</code></p><p><code>22554</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22555</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Sleep&amp;amp;title=Anandamide+enhances+extracellular+levels+of+adenosine+and+induces+sleep:+an+in+vivo+microdialysis+study&amp;amp;author=E+Murillo-Rodriguez&amp;amp;author=C+Blanco-Centurion&amp;amp;author=C+Sanchez&amp;amp;author=D+Piomelli&amp;amp;author=PJ+Shiromani&amp;amp;volume=26&amp;amp;publication_year=2003&amp;amp;pages=943-947&amp;amp;pmid=14746372&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22556</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22557</code><code>]&lt;/span&gt;</code></p><p><code>22558</code><code>&lt;/span&gt;</code></p><p><code>22559</code><code>&lt;/li&gt;</code></p><p><code>22560</code><code>&lt;li id="R866"&gt;</code></p><p><code>22561</code><code>&lt;span class="citation"&gt;</code></p><p><code>22562</code><code>Murillo-Rodriguez E, Cabeza R, Mendez-Diaz M, Navarro L, Prospero-Garcia O. Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor. &lt;span&gt;</code></p><p><code>22563</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22564</code><code>Neuroreport. &lt;/span&gt;</code></p><p><code>22565</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>22566</code><code>12&lt;/span&gt;</code></p><p><code>22567</code><code>:2131–2136.&lt;/span&gt;</code></p><p><code>22568</code><code> [&lt;a href="/pubmed/11447321" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22569</code><code>PubMed&lt;/a&gt;</code></p><p><code>22570</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22571</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroreport&amp;amp;title=Anandamide-induced+sleep+is+blocked+by+SR141716A,+a+CB1+receptor+antagonist+and+by+U73122,+a+phospholipase+C+inhibitor&amp;amp;author=E+Murillo-Rodriguez&amp;amp;author=R+Cabeza&amp;amp;author=M+Mendez-Diaz&amp;amp;author=L+Navarro&amp;amp;author=O+Prospero-Garcia&amp;amp;volume=12&amp;amp;publication_year=2001&amp;amp;pages=2131-2136&amp;amp;pmid=11447321&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22572</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22573</code><code>]&lt;/span&gt;</code></p><p><code>22574</code><code>&lt;/span&gt;</code></p><p><code>22575</code><code>&lt;/li&gt;</code></p><p><code>22576</code><code>&lt;li id="R867"&gt;</code></p><p><code>22577</code><code>&lt;span class="citation"&gt;</code></p><p><code>22578</code><code>Murillo-Rodriguez E, Sanchez-Alavez M, Navarro L, Martinez-Gonzalez D, Drucker-Colin R, Prospero-Garcia O. Anandamide modulates sleep and memory in rats. &lt;span&gt;</code></p><p><code>22579</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22580</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>22581</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>22582</code><code>812&lt;/span&gt;</code></p><p><code>22583</code><code>:270–274.&lt;/span&gt;</code></p><p><code>22584</code><code> [&lt;a href="/pubmed/9813364" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22585</code><code>PubMed&lt;/a&gt;</code></p><p><code>22586</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22587</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Anandamide+modulates+sleep+and+memory+in+rats&amp;amp;author=E+Murillo-Rodriguez&amp;amp;author=M+Sanchez-Alavez&amp;amp;author=L+Navarro&amp;amp;author=D+Martinez-Gonzalez&amp;amp;author=R+Drucker-Colin&amp;amp;volume=812&amp;amp;publication_year=1998&amp;amp;pages=270-274&amp;amp;pmid=9813364&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22588</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22589</code><code>]&lt;/span&gt;</code></p><p><code>22590</code><code>&lt;/span&gt;</code></p><p><code>22591</code><code>&lt;/li&gt;</code></p><p><code>22592</code><code>&lt;li id="R868"&gt;</code></p><p><code>22593</code><code>&lt;span class="citation"&gt;</code></p><p><code>22594</code><code>Muthian S, Rademacher DJ, Roelke CT, Gross GJ, Hillard CJ. Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. &lt;span&gt;</code></p><p><code>22595</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22596</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>22597</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>22598</code><code>129&lt;/span&gt;</code></p><p><code>22599</code><code>:743–750.&lt;/span&gt;</code></p><p><code>22600</code><code> [&lt;a href="/pubmed/15541895" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22601</code><code>PubMed&lt;/a&gt;</code></p><p><code>22602</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22603</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Anandamide+content+is+increased+and+CB1+cannabinoid+receptor+blockade+is+protective+during+transient,+focal+cerebral+ischemia&amp;amp;author=S+Muthian&amp;amp;author=DJ+Rademacher&amp;amp;author=CT+Roelke&amp;amp;author=GJ+Gross&amp;amp;author=CJ+Hillard&amp;amp;volume=129&amp;amp;publication_year=2004&amp;amp;pages=743-750&amp;amp;pmid=15541895&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22604</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22605</code><code>]&lt;/span&gt;</code></p><p><code>22606</code><code>&lt;/span&gt;</code></p><p><code>22607</code><code>&lt;/li&gt;</code></p><p><code>22608</code><code>&lt;li id="R869"&gt;</code></p><p><code>22609</code><code>&lt;span class="citation"&gt;</code></p><p><code>22610</code><code>Naassila M, Pierrefiche O, Ledent C, Daoust M. Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice. &lt;span&gt;</code></p><p><code>22611</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22612</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>22613</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>22614</code><code>46&lt;/span&gt;</code></p><p><code>22615</code><code>:243–253.&lt;/span&gt;</code></p><p><code>22616</code><code> [&lt;a href="/pubmed/14680762" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22617</code><code>PubMed&lt;/a&gt;</code></p><p><code>22618</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22619</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=Decreased+alcohol+self-administration+and+increased+alcohol+sensitivity+and+withdrawal+in+CB1+receptor+knockout+mice&amp;amp;author=M+Naassila&amp;amp;author=O+Pierrefiche&amp;amp;author=C+Ledent&amp;amp;author=M+Daoust&amp;amp;volume=46&amp;amp;publication_year=2004&amp;amp;pages=243-253&amp;amp;pmid=14680762&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22620</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22621</code><code>]&lt;/span&gt;</code></p><p><code>22622</code><code>&lt;/span&gt;</code></p><p><code>22623</code><code>&lt;/li&gt;</code></p><p><code>22624</code><code>&lt;li id="R870"&gt;</code></p><p><code>22625</code><code>&lt;span class="citation"&gt;</code></p><p><code>22626</code><code>Nackley AG, Makriyannis A, Hohmann AG. Selective activation of cannabinoid CB&lt;sub&gt;</code></p><p><code>22627</code><code>2&lt;/sub&gt;</code></p><p><code>22628</code><code> receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. &lt;span&gt;</code></p><p><code>22629</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22630</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>22631</code><code>2003a;&lt;span class="ref-vol"&gt;</code></p><p><code>22632</code><code>119&lt;/span&gt;</code></p><p><code>22633</code><code>:747–757.&lt;/span&gt;</code></p><p><code>22634</code><code> [&lt;a href="/pubmed/12809695" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22635</code><code>PubMed&lt;/a&gt;</code></p><p><code>22636</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22637</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Selective+activation+of+cannabinoid+CB2+receptors+suppresses+spinal+fos+protein+expression+and+pain+behavior+in+a+rat+model+of+inflammation&amp;amp;author=AG+Nackley&amp;amp;author=A+Makriyannis&amp;amp;author=AG+Hohmann&amp;amp;volume=119&amp;amp;publication_year=2003a&amp;amp;pages=747-757&amp;amp;pmid=12809695&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22638</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22639</code><code>]&lt;/span&gt;</code></p><p><code>22640</code><code>&lt;/span&gt;</code></p><p><code>22641</code><code>&lt;/li&gt;</code></p><p><code>22642</code><code>&lt;li id="R871"&gt;</code></p><p><code>22643</code><code>&lt;span class="citation"&gt;</code></p><p><code>22644</code><code>Nackley AG, Suplita RL, 2nd, Hohmann AG. A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. &lt;span&gt;</code></p><p><code>22645</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22646</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>22647</code><code>2003b;&lt;span class="ref-vol"&gt;</code></p><p><code>22648</code><code>117&lt;/span&gt;</code></p><p><code>22649</code><code>:659–670.&lt;/span&gt;</code></p><p><code>22650</code><code> [&lt;a href="/pubmed/12617970" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22651</code><code>PubMed&lt;/a&gt;</code></p><p><code>22652</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22653</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=A+peripheral+cannabinoid+mechanism+suppresses+spinal+fos+protein+expression+and+pain+behavior+in+a+rat+model+of+inflammation&amp;amp;author=AG+Nackley&amp;amp;author=RL+Suplita&amp;amp;author=AG+Hohmann&amp;amp;volume=117&amp;amp;publication_year=2003b&amp;amp;pages=659-670&amp;amp;pmid=12617970&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22654</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22655</code><code>]&lt;/span&gt;</code></p><p><code>22656</code><code>&lt;/span&gt;</code></p><p><code>22657</code><code>&lt;/li&gt;</code></p><p><code>22658</code><code>&lt;li id="R872"&gt;</code></p><p><code>22659</code><code>&lt;span class="citation"&gt;</code></p><p><code>22660</code><code>Nackley AG, Zvonok AM, Makriyannis A, Hohmann AG. Activation of cannabinoid CB&lt;sub&gt;</code></p><p><code>22661</code><code>2&lt;/sub&gt;</code></p><p><code>22662</code><code> receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation. &lt;span&gt;</code></p><p><code>22663</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22664</code><code>J Neurophysiol. &lt;/span&gt;</code></p><p><code>22665</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>22666</code><code>92&lt;/span&gt;</code></p><p><code>22667</code><code>:3562–3574.&lt;/span&gt;</code></p><p><code>22668</code><code> [&lt;a href="/pubmed/15317842" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22669</code><code>PubMed&lt;/a&gt;</code></p><p><code>22670</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22671</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurophysiol&amp;amp;title=Activation+of+cannabinoid+CB2+receptors+suppresses+C-fiber+responses+and+windup+in+spinal+wide+dynamic+range+neurons+in+the+absence+and+presence+of+inflammation&amp;amp;author=AG+Nackley&amp;amp;author=AM+Zvonok&amp;amp;author=A+Makriyannis&amp;amp;author=AG+Hohmann&amp;amp;volume=92&amp;amp;publication_year=2004&amp;amp;pages=3562-3574&amp;amp;pmid=15317842&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22672</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22673</code><code>]&lt;/span&gt;</code></p><p><code>22674</code><code>&lt;/span&gt;</code></p><p><code>22675</code><code>&lt;/li&gt;</code></p><p><code>22676</code><code>&lt;li id="R873"&gt;</code></p><p><code>22677</code><code>&lt;span class="citation"&gt;</code></p><p><code>22678</code><code>Naderi N, Shafaghi B, Khodayar MJ, Zarindast MR. Interaction between &lt;em&gt;</code></p><p><code>22679</code><code>&amp;#x003b3;&lt;/em&gt;</code></p><p><code>22680</code><code>-aminobutyric acid GABAB and cannabinoid CB1 receptors in spinal pain pathways in rat. &lt;span&gt;</code></p><p><code>22681</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22682</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>22683</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>22684</code><code>514&lt;/span&gt;</code></p><p><code>22685</code><code>:159–164.&lt;/span&gt;</code></p><p><code>22686</code><code> [&lt;a href="/pubmed/15910802" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22687</code><code>PubMed&lt;/a&gt;</code></p><p><code>22688</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22689</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Interaction+between+&amp;#x003b3;-aminobutyric+acid+GABAB+and+cannabinoid+CB1+receptors+in+spinal+pain+pathways+in+rat&amp;amp;author=N+Naderi&amp;amp;author=B+Shafaghi&amp;amp;author=MJ+Khodayar&amp;amp;author=MR+Zarindast&amp;amp;volume=514&amp;amp;publication_year=2005&amp;amp;pages=159-164&amp;amp;pmid=15910802&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22690</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22691</code><code>]&lt;/span&gt;</code></p><p><code>22692</code><code>&lt;/span&gt;</code></p><p><code>22693</code><code>&lt;/li&gt;</code></p><p><code>22694</code><code>&lt;li id="R874"&gt;</code></p><p><code>22695</code><code>&lt;span class="citation"&gt;</code></p><p><code>22696</code><code>Nadler V, Biegon A, Beit-Yannai E, Adamchik J, Shohami E. &lt;sup&gt;</code></p><p><code>22697</code><code>45&lt;/sup&gt;</code></p><p><code>22698</code><code>Ca accumulation in rat brain after closed head injury; attenuation by the novel neuroprotective agent HU-211. &lt;span&gt;</code></p><p><code>22699</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22700</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>22701</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>22702</code><code>685&lt;/span&gt;</code></p><p><code>22703</code><code>:1–11.&lt;/span&gt;</code></p><p><code>22704</code><code> [&lt;a href="/pubmed/7583233" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22705</code><code>PubMed&lt;/a&gt;</code></p><p><code>22706</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22707</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=45Ca+accumulation+in+rat+brain+after+closed+head+injury;+attenuation+by+the+novel+neuroprotective+agent+HU-211&amp;amp;author=V+Nadler&amp;amp;author=A+Biegon&amp;amp;author=E+Beit-Yannai&amp;amp;author=J+Adamchik&amp;amp;author=E+Shohami&amp;amp;volume=685&amp;amp;publication_year=1995&amp;amp;pages=1-11&amp;amp;pmid=7583233&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22708</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22709</code><code>]&lt;/span&gt;</code></p><p><code>22710</code><code>&lt;/span&gt;</code></p><p><code>22711</code><code>&lt;/li&gt;</code></p><p><code>22712</code><code>&lt;li id="R875"&gt;</code></p><p><code>22713</code><code>&lt;span class="citation"&gt;</code></p><p><code>22714</code><code>Nadler V, Mechoulam R, Sokolovsky M. Blockade of &lt;sup&gt;</code></p><p><code>22715</code><code>45&lt;/sup&gt;</code></p><p><code>22716</code><code>Ca&lt;sup&gt;</code></p><p><code>22717</code><code>2+&lt;/sup&gt;</code></p><p><code>22718</code><code> influx through the &lt;em&gt;</code></p><p><code>22719</code><code>N-&lt;/em&gt;</code></p><p><code>22720</code><code>methyl-D-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211. &lt;span&gt;</code></p><p><code>22721</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22722</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>22723</code><code>1993a;&lt;span class="ref-vol"&gt;</code></p><p><code>22724</code><code>622&lt;/span&gt;</code></p><p><code>22725</code><code>:79–85.&lt;/span&gt;</code></p><p><code>22726</code><code> [&lt;a href="/pubmed/8242387" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22727</code><code>PubMed&lt;/a&gt;</code></p><p><code>22728</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22729</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Blockade+of+45Ca2++influx+through+the+N-methyl-D-aspartate+receptor+ion+channel+by+the+non-psychoactive+cannabinoid+HU-211&amp;amp;author=V+Nadler&amp;amp;author=R+Mechoulam&amp;amp;author=M+Sokolovsky&amp;amp;volume=622&amp;amp;publication_year=1993a&amp;amp;pages=79-85&amp;amp;pmid=8242387&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22730</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22731</code><code>]&lt;/span&gt;</code></p><p><code>22732</code><code>&lt;/span&gt;</code></p><p><code>22733</code><code>&lt;/li&gt;</code></p><p><code>22734</code><code>&lt;li id="R876"&gt;</code></p><p><code>22735</code><code>&lt;span class="citation"&gt;</code></p><p><code>22736</code><code>Nadler V, Mechoulam R, Sokolovsky M. The non-psychotropic cannabinoid (+)-(3&lt;em&gt;</code></p><p><code>22737</code><code>S&lt;/em&gt;</code></p><p><code>22738</code><code>,4&lt;em&gt;</code></p><p><code>22739</code><code>S&lt;/em&gt;</code></p><p><code>22740</code><code>)-7-hydroxy-&amp;#x00394;&lt;sup&gt;</code></p><p><code>22741</code><code>6&lt;/sup&gt;</code></p><p><code>22742</code><code>- tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates &lt;em&gt;</code></p><p><code>22743</code><code>N-&lt;/em&gt;</code></p><p><code>22744</code><code>methyl-D-aspartate receptor-mediated neurotoxicity in primary cultures of rat forebrain. &lt;span&gt;</code></p><p><code>22745</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22746</code><code>Neurosci Lett. &lt;/span&gt;</code></p><p><code>22747</code><code>1993b;&lt;span class="ref-vol"&gt;</code></p><p><code>22748</code><code>162&lt;/span&gt;</code></p><p><code>22749</code><code>:43–45.&lt;/span&gt;</code></p><p><code>22750</code><code> [&lt;a href="/pubmed/8121633" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22751</code><code>PubMed&lt;/a&gt;</code></p><p><code>22752</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22753</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Lett&amp;amp;title=The+non-psychotropic+cannabinoid+(+)-(3S,4S)-7-hydroxy-&amp;#x00394;6-+tetrahydrocannabinol+1,1-dimethylheptyl+(HU-211)+attenuates+N-methyl-D-aspartate+receptor-mediated+neurotoxicity+in+primary+cultures+of+rat+forebrain&amp;amp;author=V+Nadler&amp;amp;author=R+Mechoulam&amp;amp;author=M+Sokolovsky&amp;amp;volume=162&amp;amp;publication_year=1993b&amp;amp;pages=43-45&amp;amp;pmid=8121633&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22754</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22755</code><code>]&lt;/span&gt;</code></p><p><code>22756</code><code>&lt;/span&gt;</code></p><p><code>22757</code><code>&lt;/li&gt;</code></p><p><code>22758</code><code>&lt;li id="R877"&gt;</code></p><p><code>22759</code><code>&lt;span class="citation"&gt;</code></p><p><code>22760</code><code>Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, Greenberg DA. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. &lt;span&gt;</code></p><p><code>22761</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22762</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>22763</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>22764</code><code>19&lt;/span&gt;</code></p><p><code>22765</code><code>:2987–2995.&lt;/span&gt;</code></p><p><code>22766</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>22767</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6782289/"&gt;</code></p><p><code>22768</code><code>PMC free article&lt;/a&gt;</code></p><p><code>22769</code><code>]&lt;/span&gt;</code></p><p><code>22770</code><code> [&lt;a href="/pubmed/10191316" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22771</code><code>PubMed&lt;/a&gt;</code></p><p><code>22772</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22773</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Cannabinoids+and+neuroprotection+in+global+and+focal+cerebral+ischemia+and+in+neuronal+cultures&amp;amp;author=T+Nagayama&amp;amp;author=AD+Sinor&amp;amp;author=RP+Simon&amp;amp;author=J+Chen&amp;amp;author=SH+Graham&amp;amp;volume=19&amp;amp;publication_year=1999&amp;amp;pages=2987-2995&amp;amp;pmid=10191316&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22774</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22775</code><code>]&lt;/span&gt;</code></p><p><code>22776</code><code>&lt;/span&gt;</code></p><p><code>22777</code><code>&lt;/li&gt;</code></p><p><code>22778</code><code>&lt;li id="R878"&gt;</code></p><p><code>22779</code><code>&lt;span class="citation"&gt;</code></p><p><code>22780</code><code>Navarro L, Martinez-vargas M, Murillo-rodriguez E, Landa A, Mendez-diaz M, Prospero-garcia O. Potential role of the cannabinoid receptor CB1 in rapid eye movement sleep rebound. &lt;span&gt;</code></p><p><code>22781</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22782</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>22783</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>22784</code><code>120&lt;/span&gt;</code></p><p><code>22785</code><code>:855–859.&lt;/span&gt;</code></p><p><code>22786</code><code> [&lt;a href="/pubmed/12895525" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22787</code><code>PubMed&lt;/a&gt;</code></p><p><code>22788</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22789</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Potential+role+of+the+cannabinoid+receptor+CB1+in+rapid+eye+movement+sleep+rebound&amp;amp;author=L+Navarro&amp;amp;author=M+Martinez-vargas&amp;amp;author=E+Murillo-rodriguez&amp;amp;author=A+Landa&amp;amp;author=M+Mendez-diaz&amp;amp;volume=120&amp;amp;publication_year=2003&amp;amp;pages=855-859&amp;amp;pmid=12895525&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22790</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22791</code><code>]&lt;/span&gt;</code></p><p><code>22792</code><code>&lt;/span&gt;</code></p><p><code>22793</code><code>&lt;/li&gt;</code></p><p><code>22794</code><code>&lt;li id="R879"&gt;</code></p><p><code>22795</code><code>&lt;span class="citation"&gt;</code></p><p><code>22796</code><code>Navarro M, Carrera MR, Del Arco I, Trigo JM, Koob GF, Rodriguez de Fonseca F. Cannabinoid receptor antagonist reduces heroin self-administration only in dependent rats. &lt;span&gt;</code></p><p><code>22797</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22798</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>22799</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>22800</code><code>501&lt;/span&gt;</code></p><p><code>22801</code><code>:235–237.&lt;/span&gt;</code></p><p><code>22802</code><code> [&lt;a href="/pubmed/15464083" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22803</code><code>PubMed&lt;/a&gt;</code></p><p><code>22804</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22805</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Cannabinoid+receptor+antagonist+reduces+heroin+self-administration+only+in+dependent+rats&amp;amp;author=M+Navarro&amp;amp;author=MR+Carrera&amp;amp;author=I+Del+Arco&amp;amp;author=JM+Trigo&amp;amp;author=GF+Koob&amp;amp;volume=501&amp;amp;publication_year=2004&amp;amp;pages=235-237&amp;amp;pmid=15464083&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22806</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22807</code><code>]&lt;/span&gt;</code></p><p><code>22808</code><code>&lt;/span&gt;</code></p><p><code>22809</code><code>&lt;/li&gt;</code></p><p><code>22810</code><code>&lt;li id="R880"&gt;</code></p><p><code>22811</code><code>&lt;span class="citation"&gt;</code></p><p><code>22812</code><code>Navarro M, Carrera MR, Fratta W, Valverde O, Cossu G, Fattore L, Chowen JA, Gomez R, del Arco I, Villanua MA, et al.  Functional interaction between opioid and cannabinoid receptors in drug self-administration. &lt;span&gt;</code></p><p><code>22813</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22814</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>22815</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>22816</code><code>21&lt;/span&gt;</code></p><p><code>22817</code><code>:5344–5350.&lt;/span&gt;</code></p><p><code>22818</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>22819</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6762870/"&gt;</code></p><p><code>22820</code><code>PMC free article&lt;/a&gt;</code></p><p><code>22821</code><code>]&lt;/span&gt;</code></p><p><code>22822</code><code> [&lt;a href="/pubmed/11438610" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22823</code><code>PubMed&lt;/a&gt;</code></p><p><code>22824</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22825</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Functional+interaction+between+opioid+and+cannabinoid+receptors+in+drug+self-administration&amp;amp;author=M+Navarro&amp;amp;author=MR+Carrera&amp;amp;author=W+Fratta&amp;amp;author=O+Valverde&amp;amp;author=G+Cossu&amp;amp;volume=21&amp;amp;publication_year=2001&amp;amp;pages=5344-5350&amp;amp;pmid=11438610&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22826</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22827</code><code>]&lt;/span&gt;</code></p><p><code>22828</code><code>&lt;/span&gt;</code></p><p><code>22829</code><code>&lt;/li&gt;</code></p><p><code>22830</code><code>&lt;li id="R881"&gt;</code></p><p><code>22831</code><code>&lt;span class="citation"&gt;</code></p><p><code>22832</code><code>Navarro M, Hernandez E, Munoz RM, del Arco I, Villanua MA, Carrera MR, Rodriguez de Fonseca F. Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. &lt;span&gt;</code></p><p><code>22833</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22834</code><code>Neuroreport. &lt;/span&gt;</code></p><p><code>22835</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>22836</code><code>8&lt;/span&gt;</code></p><p><code>22837</code><code>:491–496.&lt;/span&gt;</code></p><p><code>22838</code><code> [&lt;a href="/pubmed/9080435" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22839</code><code>PubMed&lt;/a&gt;</code></p><p><code>22840</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22841</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroreport&amp;amp;title=Acute+administration+of+the+CB1+cannabinoid+receptor+antagonist+SR+141716A+induces+anxiety-like+responses+in+the+rat&amp;amp;author=M+Navarro&amp;amp;author=E+Hernandez&amp;amp;author=RM+Munoz&amp;amp;author=I+del+Arco&amp;amp;author=MA+Villanua&amp;amp;volume=8&amp;amp;publication_year=1997&amp;amp;pages=491-496&amp;amp;pmid=9080435&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22842</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22843</code><code>]&lt;/span&gt;</code></p><p><code>22844</code><code>&lt;/span&gt;</code></p><p><code>22845</code><code>&lt;/li&gt;</code></p><p><code>22846</code><code>&lt;li id="R882"&gt;</code></p><p><code>22847</code><code>&lt;span class="citation"&gt;</code></p><p><code>22848</code><code>Neff GW, O&amp;#x02019;Brien CB, Reddy KR, Bergasa NV, Regev A, Molina E, Amaro R, Rodriguez MJ, Chase V, Jeffers L, et al.  Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease. &lt;span&gt;</code></p><p><code>22849</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22850</code><code>Am J Gastroenterol. &lt;/span&gt;</code></p><p><code>22851</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>22852</code><code>97&lt;/span&gt;</code></p><p><code>22853</code><code>:2117–2119.&lt;/span&gt;</code></p><p><code>22854</code><code> [&lt;a href="/pubmed/12190187" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22855</code><code>PubMed&lt;/a&gt;</code></p><p><code>22856</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22857</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Gastroenterol&amp;amp;title=Preliminary+observation+with+dronabinol+in+patients+with+intractable+pruritus+secondary+to+cholestatic+liver+disease&amp;amp;author=GW+Neff&amp;amp;author=CB+O&amp;#x02019;Brien&amp;amp;author=KR+Reddy&amp;amp;author=NV+Bergasa&amp;amp;author=A+Regev&amp;amp;volume=97&amp;amp;publication_year=2002&amp;amp;pages=2117-2119&amp;amp;pmid=12190187&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22858</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22859</code><code>]&lt;/span&gt;</code></p><p><code>22860</code><code>&lt;/span&gt;</code></p><p><code>22861</code><code>&lt;/li&gt;</code></p><p><code>22862</code><code>&lt;li id="R883"&gt;</code></p><p><code>22863</code><code>&lt;span class="citation"&gt;</code></p><p><code>22864</code><code>Negrete JC. Cannabis and schizophrenia. &lt;span&gt;</code></p><p><code>22865</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22866</code><code>Br J Addict. &lt;/span&gt;</code></p><p><code>22867</code><code>1989;&lt;span class="ref-vol"&gt;</code></p><p><code>22868</code><code>84&lt;/span&gt;</code></p><p><code>22869</code><code>:349–351.&lt;/span&gt;</code></p><p><code>22870</code><code> [&lt;a href="/pubmed/2785829" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22871</code><code>PubMed&lt;/a&gt;</code></p><p><code>22872</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22873</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Addict&amp;amp;title=Cannabis+and+schizophrenia&amp;amp;author=JC+Negrete&amp;amp;volume=84&amp;amp;publication_year=1989&amp;amp;pages=349-351&amp;amp;pmid=2785829&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22874</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22875</code><code>]&lt;/span&gt;</code></p><p><code>22876</code><code>&lt;/span&gt;</code></p><p><code>22877</code><code>&lt;/li&gt;</code></p><p><code>22878</code><code>&lt;li id="R884"&gt;</code></p><p><code>22879</code><code>&lt;span class="citation"&gt;</code></p><p><code>22880</code><code>Nelson K, Walsh D, Deeter P, Sheehan F. A phase II study of &amp;#x00394;-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. &lt;span&gt;</code></p><p><code>22881</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22882</code><code>J Palliat Care. &lt;/span&gt;</code></p><p><code>22883</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>22884</code><code>10&lt;/span&gt;</code></p><p><code>22885</code><code>:14–18.&lt;/span&gt;</code></p><p><code>22886</code><code> [&lt;a href="/pubmed/8035251" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22887</code><code>PubMed&lt;/a&gt;</code></p><p><code>22888</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22889</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Palliat+Care&amp;amp;title=A+phase+II+study+of+&amp;#x00394;-9-tetrahydrocannabinol+for+appetite+stimulation+in+cancer-associated+anorexia&amp;amp;author=K+Nelson&amp;amp;author=D+Walsh&amp;amp;author=P+Deeter&amp;amp;author=F+Sheehan&amp;amp;volume=10&amp;amp;publication_year=1994&amp;amp;pages=14-18&amp;amp;pmid=8035251&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22890</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22891</code><code>]&lt;/span&gt;</code></p><p><code>22892</code><code>&lt;/span&gt;</code></p><p><code>22893</code><code>&lt;/li&gt;</code></p><p><code>22894</code><code>&lt;li id="R885"&gt;</code></p><p><code>22895</code><code>&lt;span class="citation"&gt;</code></p><p><code>22896</code><code>Nestler EJ. Molecular mechanism of drug addiction in the mesolimbic dopaminergic pathway. &lt;span&gt;</code></p><p><code>22897</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22898</code><code>Semin Neurosci. &lt;/span&gt;</code></p><p><code>22899</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>22900</code><code>5&lt;/span&gt;</code></p><p><code>22901</code><code>:369–376.&lt;/span&gt;</code></p><p><code>22902</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>22903</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Semin+Neurosci&amp;amp;title=Molecular+mechanism+of+drug+addiction+in+the+mesolimbic+dopaminergic+pathway&amp;amp;author=EJ+Nestler&amp;amp;volume=5&amp;amp;publication_year=2003&amp;amp;pages=369-376&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22904</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22905</code><code>]&lt;/span&gt;</code></p><p><code>22906</code><code>&lt;/span&gt;</code></p><p><code>22907</code><code>&lt;/li&gt;</code></p><p><code>22908</code><code>&lt;li id="R886"&gt;</code></p><p><code>22909</code><code>&lt;span class="citation"&gt;</code></p><p><code>22910</code><code>Newell KA, Deng C, Huang XF. Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia. &lt;span&gt;</code></p><p><code>22911</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22912</code><code>Exp Brain Res. &lt;/span&gt;</code></p><p><code>22913</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>22914</code><code>172&lt;/span&gt;</code></p><p><code>22915</code><code>:556–560.&lt;/span&gt;</code></p><p><code>22916</code><code> [&lt;a href="/pubmed/16710682" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22917</code><code>PubMed&lt;/a&gt;</code></p><p><code>22918</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22919</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Exp+Brain+Res&amp;amp;title=Increased+cannabinoid+receptor+density+in+the+posterior+cingulate+cortex+in+schizophrenia&amp;amp;author=KA+Newell&amp;amp;author=C+Deng&amp;amp;author=XF+Huang&amp;amp;volume=172&amp;amp;publication_year=2006&amp;amp;pages=556-560&amp;amp;pmid=16710682&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22920</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22921</code><code>]&lt;/span&gt;</code></p><p><code>22922</code><code>&lt;/span&gt;</code></p><p><code>22923</code><code>&lt;/li&gt;</code></p><p><code>22924</code><code>&lt;li id="R887"&gt;</code></p><p><code>22925</code><code>&lt;span class="citation"&gt;</code></p><p><code>22926</code><code>Newton C, Klein T, Friedman H. The role of macrophages in THC-induced alteration of the cytokine network. &lt;span&gt;</code></p><p><code>22927</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22928</code><code>Adv Exp Med Biol. &lt;/span&gt;</code></p><p><code>22929</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>22930</code><code>437&lt;/span&gt;</code></p><p><code>22931</code><code>:207–214.&lt;/span&gt;</code></p><p><code>22932</code><code> [&lt;a href="/pubmed/9666273" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22933</code><code>PubMed&lt;/a&gt;</code></p><p><code>22934</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22935</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Adv+Exp+Med+Biol&amp;amp;title=The+role+of+macrophages+in+THC-induced+alteration+of+the+cytokine+network&amp;amp;author=C+Newton&amp;amp;author=T+Klein&amp;amp;author=H+Friedman&amp;amp;volume=437&amp;amp;publication_year=1998&amp;amp;pages=207-214&amp;amp;pmid=9666273&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22936</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22937</code><code>]&lt;/span&gt;</code></p><p><code>22938</code><code>&lt;/span&gt;</code></p><p><code>22939</code><code>&lt;/li&gt;</code></p><p><code>22940</code><code>&lt;li id="R888"&gt;</code></p><p><code>22941</code><code>&lt;span class="citation"&gt;</code></p><p><code>22942</code><code>Ng SK, Brust JC, Hauser WA, Susser M. Illicit drug use and the risk of new-onset seizures. &lt;span&gt;</code></p><p><code>22943</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22944</code><code>Am J Epidemiol. &lt;/span&gt;</code></p><p><code>22945</code><code>1990;&lt;span class="ref-vol"&gt;</code></p><p><code>22946</code><code>132&lt;/span&gt;</code></p><p><code>22947</code><code>:47–57.&lt;/span&gt;</code></p><p><code>22948</code><code> [&lt;a href="/pubmed/2356813" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22949</code><code>PubMed&lt;/a&gt;</code></p><p><code>22950</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22951</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Epidemiol&amp;amp;title=Illicit+drug+use+and+the+risk+of+new-onset+seizures&amp;amp;author=SK+Ng&amp;amp;author=JC+Brust&amp;amp;author=WA+Hauser&amp;amp;author=M+Susser&amp;amp;volume=132&amp;amp;publication_year=1990&amp;amp;pages=47-57&amp;amp;pmid=2356813&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22952</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22953</code><code>]&lt;/span&gt;</code></p><p><code>22954</code><code>&lt;/span&gt;</code></p><p><code>22955</code><code>&lt;/li&gt;</code></p><p><code>22956</code><code>&lt;li id="R889"&gt;</code></p><p><code>22957</code><code>&lt;span class="citation"&gt;</code></p><p><code>22958</code><code>Ni X, Geller EB, Eppihimer MJ, Eisenstein TK, Adler MW, Tuma RF. Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model. &lt;span&gt;</code></p><p><code>22959</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22960</code><code>Mult Scler. &lt;/span&gt;</code></p><p><code>22961</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>22962</code><code>10&lt;/span&gt;</code></p><p><code>22963</code><code>:158–164.&lt;/span&gt;</code></p><p><code>22964</code><code> [&lt;a href="/pubmed/15124761" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22965</code><code>PubMed&lt;/a&gt;</code></p><p><code>22966</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22967</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mult+Scler&amp;amp;title=Win+55212-2,+a+cannabinoid+receptor+agonist,+attenuates+leukocyte/endothelial+interactions+in+an+experimental+autoimmune+encephalomyelitis+model&amp;amp;author=X+Ni&amp;amp;author=EB+Geller&amp;amp;author=MJ+Eppihimer&amp;amp;author=TK+Eisenstein&amp;amp;author=MW+Adler&amp;amp;volume=10&amp;amp;publication_year=2004&amp;amp;pages=158-164&amp;amp;pmid=15124761&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22968</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22969</code><code>]&lt;/span&gt;</code></p><p><code>22970</code><code>&lt;/span&gt;</code></p><p><code>22971</code><code>&lt;/li&gt;</code></p><p><code>22972</code><code>&lt;li id="R890"&gt;</code></p><p><code>22973</code><code>&lt;span class="citation"&gt;</code></p><p><code>22974</code><code>Nicholson AN, Turner C, Stone BM, Robson PJ. Effect of &amp;#x00394;-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. &lt;span&gt;</code></p><p><code>22975</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22976</code><code>J Clin Psychopharmacol. &lt;/span&gt;</code></p><p><code>22977</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>22978</code><code>24&lt;/span&gt;</code></p><p><code>22979</code><code>:305–313.&lt;/span&gt;</code></p><p><code>22980</code><code> [&lt;a href="/pubmed/15118485" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22981</code><code>PubMed&lt;/a&gt;</code></p><p><code>22982</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22983</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Psychopharmacol&amp;amp;title=Effect+of+&amp;#x00394;-9-tetrahydrocannabinol+and+cannabidiol+on+nocturnal+sleep+and+early-morning+behavior+in+young+adults&amp;amp;author=AN+Nicholson&amp;amp;author=C+Turner&amp;amp;author=BM+Stone&amp;amp;author=PJ+Robson&amp;amp;volume=24&amp;amp;publication_year=2004&amp;amp;pages=305-313&amp;amp;pmid=15118485&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>22984</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>22985</code><code>]&lt;/span&gt;</code></p><p><code>22986</code><code>&lt;/span&gt;</code></p><p><code>22987</code><code>&lt;/li&gt;</code></p><p><code>22988</code><code>&lt;li id="R891"&gt;</code></p><p><code>22989</code><code>&lt;span class="citation"&gt;</code></p><p><code>22990</code><code>Nicholson RA, Liao C, Zheng J, David LS, Coyne L, Errington AC, Singh G, Lees G. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain. &lt;span&gt;</code></p><p><code>22991</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>22992</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>22993</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>22994</code><code>978&lt;/span&gt;</code></p><p><code>22995</code><code>:194–204.&lt;/span&gt;</code></p><p><code>22996</code><code> [&lt;a href="/pubmed/12834914" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>22997</code><code>PubMed&lt;/a&gt;</code></p><p><code>22998</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>22999</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Sodium+channel+inhibition+by+anandamide+and+synthetic+cannabimimetics+in+brain&amp;amp;author=RA+Nicholson&amp;amp;author=C+Liao&amp;amp;author=J+Zheng&amp;amp;author=LS+David&amp;amp;author=L+Coyne&amp;amp;volume=978&amp;amp;publication_year=2003&amp;amp;pages=194-204&amp;amp;pmid=12834914&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23000</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23001</code><code>]&lt;/span&gt;</code></p><p><code>23002</code><code>&lt;/span&gt;</code></p><p><code>23003</code><code>&lt;/li&gt;</code></p><p><code>23004</code><code>&lt;li id="R892"&gt;</code></p><p><code>23005</code><code>&lt;span class="citation"&gt;</code></p><p><code>23006</code><code>Niederhoffer N, Schmid K, Szabo B. The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression. &lt;span&gt;</code></p><p><code>23007</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23008</code><code>Naunyn-Schmiedeberg&amp;#x02019;s Arch Pharmacol. &lt;/span&gt;</code></p><p><code>23009</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>23010</code><code>367&lt;/span&gt;</code></p><p><code>23011</code><code>:434–443.&lt;/span&gt;</code></p><p><code>23012</code><code> [&lt;a href="/pubmed/12709782" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23013</code><code>PubMed&lt;/a&gt;</code></p><p><code>23014</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23015</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Naunyn-Schmiedeberg&amp;#x02019;s+Arch+Pharmacol&amp;amp;title=The+peripheral+sympathetic+nervous+system+is+the+major+target+of+cannabinoids+in+eliciting+cardiovascular+depression&amp;amp;author=N+Niederhoffer&amp;amp;author=K+Schmid&amp;amp;author=B+Szabo&amp;amp;volume=367&amp;amp;publication_year=2003&amp;amp;pages=434-443&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23016</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23017</code><code>]&lt;/span&gt;</code></p><p><code>23018</code><code>&lt;/span&gt;</code></p><p><code>23019</code><code>&lt;/li&gt;</code></p><p><code>23020</code><code>&lt;li id="R893"&gt;</code></p><p><code>23021</code><code>&lt;span class="citation"&gt;</code></p><p><code>23022</code><code>Niederhoffer N, Szabo B. Cannabinoids cause central sympathoexcitation and bradycardia in rabbits. &lt;span&gt;</code></p><p><code>23023</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23024</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>23025</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>23026</code><code>294&lt;/span&gt;</code></p><p><code>23027</code><code>:707–713.&lt;/span&gt;</code></p><p><code>23028</code><code> [&lt;a href="/pubmed/10900251" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23029</code><code>PubMed&lt;/a&gt;</code></p><p><code>23030</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23031</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Cannabinoids+cause+central+sympathoexcitation+and+bradycardia+in+rabbits&amp;amp;author=N+Niederhoffer&amp;amp;author=B+Szabo&amp;amp;volume=294&amp;amp;publication_year=2000&amp;amp;pages=707-713&amp;amp;pmid=10900251&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23032</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23033</code><code>]&lt;/span&gt;</code></p><p><code>23034</code><code>&lt;/span&gt;</code></p><p><code>23035</code><code>&lt;/li&gt;</code></p><p><code>23036</code><code>&lt;li id="R894"&gt;</code></p><p><code>23037</code><code>&lt;span class="citation"&gt;</code></p><p><code>23038</code><code>Nithipatikom K, Endsley MP, Isbell MA, Falck JR, Iwamoto Y, Hillard CJ, Campbell WB. 2-Arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. &lt;span&gt;</code></p><p><code>23039</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23040</code><code>Cancer Res. &lt;/span&gt;</code></p><p><code>23041</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>23042</code><code>64&lt;/span&gt;</code></p><p><code>23043</code><code>:8826–8830.&lt;/span&gt;</code></p><p><code>23044</code><code> [&lt;a href="/pubmed/15604240" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23045</code><code>PubMed&lt;/a&gt;</code></p><p><code>23046</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23047</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=2-Arachidonoylglycerol:+a+novel+inhibitor+of+androgen-independent+prostate+cancer+cell+invasion&amp;amp;author=K+Nithipatikom&amp;amp;author=MP+Endsley&amp;amp;author=MA+Isbell&amp;amp;author=JR+Falck&amp;amp;author=Y+Iwamoto&amp;amp;volume=64&amp;amp;publication_year=2004&amp;amp;pages=8826-8830&amp;amp;pmid=15604240&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23048</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23049</code><code>]&lt;/span&gt;</code></p><p><code>23050</code><code>&lt;/span&gt;</code></p><p><code>23051</code><code>&lt;/li&gt;</code></p><p><code>23052</code><code>&lt;li id="R895"&gt;</code></p><p><code>23053</code><code>&lt;span class="citation"&gt;</code></p><p><code>23054</code><code>Nogueron MI, Porgilsson B, Schneider WE, Stucky CL, Hillard CJ. Cannabinoid receptor agonists inhibit depolarization-induced calcium influx in cerebellar granule neurons. &lt;span&gt;</code></p><p><code>23055</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23056</code><code>J Neurochem. &lt;/span&gt;</code></p><p><code>23057</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>23058</code><code>79&lt;/span&gt;</code></p><p><code>23059</code><code>:371–381.&lt;/span&gt;</code></p><p><code>23060</code><code> [&lt;a href="/pubmed/11677265" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23061</code><code>PubMed&lt;/a&gt;</code></p><p><code>23062</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23063</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;amp;title=Cannabinoid+receptor+agonists+inhibit+depolarization-induced+calcium+influx+in+cerebellar+granule+neurons&amp;amp;author=MI+Nogueron&amp;amp;author=B+Porgilsson&amp;amp;author=WE+Schneider&amp;amp;author=CL+Stucky&amp;amp;author=CJ+Hillard&amp;amp;volume=79&amp;amp;publication_year=2001&amp;amp;pages=371-381&amp;amp;pmid=11677265&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23064</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23065</code><code>]&lt;/span&gt;</code></p><p><code>23066</code><code>&lt;/span&gt;</code></p><p><code>23067</code><code>&lt;/li&gt;</code></p><p><code>23068</code><code>&lt;li id="R896"&gt;</code></p><p><code>23069</code><code>&lt;span class="citation"&gt;</code></p><p><code>23070</code><code>Nordmann AJ, Nordmann A, Briel M, Keller U, Yancy WS, Brehm BJ, Bucher HC. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. &lt;span&gt;</code></p><p><code>23071</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23072</code><code>Arch Intern Med. &lt;/span&gt;</code></p><p><code>23073</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>23074</code><code>166&lt;/span&gt;</code></p><p><code>23075</code><code>:285–293.&lt;/span&gt;</code></p><p><code>23076</code><code> [&lt;a href="/pubmed/16476868" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23077</code><code>PubMed&lt;/a&gt;</code></p><p><code>23078</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23079</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Arch+Intern+Med&amp;amp;title=Effects+of+low-carbohydrate+vs+low-fat+diets+on+weight+loss+and+cardiovascular+risk+factors:+a+meta-analysis+of+randomized+controlled+trials&amp;amp;author=AJ+Nordmann&amp;amp;author=A+Nordmann&amp;amp;author=M+Briel&amp;amp;author=U+Keller&amp;amp;author=WS+Yancy&amp;amp;volume=166&amp;amp;publication_year=2006&amp;amp;pages=285-293&amp;amp;pmid=16476868&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23080</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23081</code><code>]&lt;/span&gt;</code></p><p><code>23082</code><code>&lt;/span&gt;</code></p><p><code>23083</code><code>&lt;/li&gt;</code></p><p><code>23084</code><code>&lt;li id="R897"&gt;</code></p><p><code>23085</code><code>&lt;span class="citation"&gt;</code></p><p><code>23086</code><code>Notcutt W, Price M, Miller R, Newport S, Phillips C, Simmons S, Sansom C. Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 &amp;#x02018;N of 1&amp;#x02032; studies. &lt;span&gt;</code></p><p><code>23087</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23088</code><code>Anaesthesia. &lt;/span&gt;</code></p><p><code>23089</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>23090</code><code>59&lt;/span&gt;</code></p><p><code>23091</code><code>:440–452.&lt;/span&gt;</code></p><p><code>23092</code><code> [&lt;a href="/pubmed/15096238" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23093</code><code>PubMed&lt;/a&gt;</code></p><p><code>23094</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23095</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Anaesthesia&amp;amp;title=Initial+experiences+with+medicinal+extracts+of+cannabis+for+chronic+pain:+results+from+34+&amp;#x02018;N+of+1&amp;#x02032;+studies&amp;amp;author=W+Notcutt&amp;amp;author=M+Price&amp;amp;author=R+Miller&amp;amp;author=S+Newport&amp;amp;author=C+Phillips&amp;amp;volume=59&amp;amp;publication_year=2004&amp;amp;pages=440-452&amp;amp;pmid=15096238&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23096</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23097</code><code>]&lt;/span&gt;</code></p><p><code>23098</code><code>&lt;/span&gt;</code></p><p><code>23099</code><code>&lt;/li&gt;</code></p><p><code>23100</code><code>&lt;li id="R898"&gt;</code></p><p><code>23101</code><code>&lt;span class="citation"&gt;</code></p><p><code>23102</code><code>Noyes R, Jr, Brunk SF, Avery DH, Canter A. The analgesic properties of &amp;#x00394;-9-tetrahydrocannabinol and codeine. &lt;span&gt;</code></p><p><code>23103</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23104</code><code>Clin Pharmacol Ther. &lt;/span&gt;</code></p><p><code>23105</code><code>1975a;&lt;span class="ref-vol"&gt;</code></p><p><code>23106</code><code>18&lt;/span&gt;</code></p><p><code>23107</code><code>:84–89.&lt;/span&gt;</code></p><p><code>23108</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>23109</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC8332526/"&gt;</code></p><p><code>23110</code><code>PMC free article&lt;/a&gt;</code></p><p><code>23111</code><code>]&lt;/span&gt;</code></p><p><code>23112</code><code> [&lt;a href="/pubmed/50159" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23113</code><code>PubMed&lt;/a&gt;</code></p><p><code>23114</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23115</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;amp;title=The+analgesic+properties+of+&amp;#x00394;-9-tetrahydrocannabinol+and+codeine&amp;amp;author=R+Noyes&amp;amp;author=SF+Brunk&amp;amp;author=DH+Avery&amp;amp;author=A+Canter&amp;amp;volume=18&amp;amp;publication_year=1975a&amp;amp;pages=84-89&amp;amp;pmid=50159&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23116</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23117</code><code>]&lt;/span&gt;</code></p><p><code>23118</code><code>&lt;/span&gt;</code></p><p><code>23119</code><code>&lt;/li&gt;</code></p><p><code>23120</code><code>&lt;li id="R899"&gt;</code></p><p><code>23121</code><code>&lt;span class="citation"&gt;</code></p><p><code>23122</code><code>Noyes R, Jr, Brunk SF, Baram DA, Canter A. Analgesic effect of &amp;#x00394;-9-tetrahydrocannabinol. &lt;span&gt;</code></p><p><code>23123</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23124</code><code>J Clin Pharmacol. &lt;/span&gt;</code></p><p><code>23125</code><code>1975b;&lt;span class="ref-vol"&gt;</code></p><p><code>23126</code><code>1&lt;/span&gt;</code></p><p><code>23127</code><code>:139–143.&lt;/span&gt;</code></p><p><code>23128</code><code> [&lt;a href="/pubmed/1091664" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23129</code><code>PubMed&lt;/a&gt;</code></p><p><code>23130</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23131</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pharmacol&amp;amp;title=Analgesic+effect+of+&amp;#x00394;-9-tetrahydrocannabinol&amp;amp;author=R+Noyes&amp;amp;author=SF+Brunk&amp;amp;author=DA+Baram&amp;amp;author=A+Canter&amp;amp;volume=1&amp;amp;publication_year=1975b&amp;amp;pages=139-143&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23132</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23133</code><code>]&lt;/span&gt;</code></p><p><code>23134</code><code>&lt;/span&gt;</code></p><p><code>23135</code><code>&lt;/li&gt;</code></p><p><code>23136</code><code>&lt;li id="R900"&gt;</code></p><p><code>23137</code><code>&lt;span class="citation"&gt;</code></p><p><code>23138</code><code>Obeso JA, Rodriguez-Oroz MC, Rodriguez M, DeLong MR, Olanow CW. Pathophysiology of levodopa-induced dyskinesias in Parkinson&amp;#x02019;s disease: problems with the current model. &lt;span&gt;</code></p><p><code>23139</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23140</code><code>Ann Neurol. &lt;/span&gt;</code></p><p><code>23141</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>23142</code><code>47&lt;/span&gt;</code></p><p><code>23143</code><code>:S22–S34.&lt;/span&gt;</code></p><p><code>23144</code><code> [&lt;a href="/pubmed/10762129" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23145</code><code>PubMed&lt;/a&gt;</code></p><p><code>23146</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23147</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Ann+Neurol&amp;amp;title=Pathophysiology+of+levodopa-induced+dyskinesias+in+Parkinson&amp;#x02019;s+disease:+problems+with+the+current+model&amp;amp;author=JA+Obeso&amp;amp;author=MC+Rodriguez-Oroz&amp;amp;author=M+Rodriguez&amp;amp;author=MR+DeLong&amp;amp;author=CW+Olanow&amp;amp;volume=47&amp;amp;publication_year=2000&amp;amp;pages=S22-S34&amp;amp;pmid=10762129&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23148</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23149</code><code>]&lt;/span&gt;</code></p><p><code>23150</code><code>&lt;/span&gt;</code></p><p><code>23151</code><code>&lt;/li&gt;</code></p><p><code>23152</code><code>&lt;li id="R901"&gt;</code></p><p><code>23153</code><code>&lt;span class="citation"&gt;</code></p><p><code>23154</code><code>Obici S, Feng Z, Arduini A, Conti R, Rossetti R. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. &lt;span&gt;</code></p><p><code>23155</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23156</code><code>Nat Med. &lt;/span&gt;</code></p><p><code>23157</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>23158</code><code>9&lt;/span&gt;</code></p><p><code>23159</code><code>:756–761.&lt;/span&gt;</code></p><p><code>23160</code><code> [&lt;a href="/pubmed/12754501" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23161</code><code>PubMed&lt;/a&gt;</code></p><p><code>23162</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23163</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;amp;title=Inhibition+of+hypothalamic+carnitine+palmitoyltransferase-1+decreases+food+intake+and+glucose+production&amp;amp;author=S+Obici&amp;amp;author=Z+Feng&amp;amp;author=A+Arduini&amp;amp;author=R+Conti&amp;amp;author=R+Rossetti&amp;amp;volume=9&amp;amp;publication_year=2003&amp;amp;pages=756-761&amp;amp;pmid=12754501&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23164</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23165</code><code>]&lt;/span&gt;</code></p><p><code>23166</code><code>&lt;/span&gt;</code></p><p><code>23167</code><code>&lt;/li&gt;</code></p><p><code>23168</code><code>&lt;li id="R902"&gt;</code></p><p><code>23169</code><code>&lt;span class="citation"&gt;</code></p><p><code>23170</code><code>O&amp;#x02019;Dell JR. Therapeutic strategies for rheumatoid arthritis. &lt;span&gt;</code></p><p><code>23171</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23172</code><code>N Engl J Med. &lt;/span&gt;</code></p><p><code>23173</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>23174</code><code>350&lt;/span&gt;</code></p><p><code>23175</code><code>:2591–2602.&lt;/span&gt;</code></p><p><code>23176</code><code> [&lt;a href="/pubmed/15201416" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23177</code><code>PubMed&lt;/a&gt;</code></p><p><code>23178</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23179</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;amp;title=Therapeutic+strategies+for+rheumatoid+arthritis&amp;amp;author=JR+O&amp;#x02019;Dell&amp;amp;volume=350&amp;amp;publication_year=2004&amp;amp;pages=2591-2602&amp;amp;pmid=15201416&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23180</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23181</code><code>]&lt;/span&gt;</code></p><p><code>23182</code><code>&lt;/span&gt;</code></p><p><code>23183</code><code>&lt;/li&gt;</code></p><p><code>23184</code><code>&lt;li id="R903"&gt;</code></p><p><code>23185</code><code>&lt;span class="citation"&gt;</code></p><p><code>23186</code><code>Ofek O, Karsak M, Leclerc N, Fogel M, Frenkel B, Wright K, Tam J, Attar-Namdar M, Kram V, Shohami E, et al.  Peripheral cannabinoid receptor, CB2, regulates bone mass. &lt;span&gt;</code></p><p><code>23187</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23188</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>23189</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>23190</code><code>103&lt;/span&gt;</code></p><p><code>23191</code><code>:696–701.&lt;/span&gt;</code></p><p><code>23192</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>23193</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1334629/"&gt;</code></p><p><code>23194</code><code>PMC free article&lt;/a&gt;</code></p><p><code>23195</code><code>]&lt;/span&gt;</code></p><p><code>23196</code><code> [&lt;a href="/pubmed/16407142" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23197</code><code>PubMed&lt;/a&gt;</code></p><p><code>23198</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23199</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Peripheral+cannabinoid+receptor,+CB2,+regulates+bone+mass&amp;amp;author=O+Ofek&amp;amp;author=M+Karsak&amp;amp;author=N+Leclerc&amp;amp;author=M+Fogel&amp;amp;author=B+Frenkel&amp;amp;volume=103&amp;amp;publication_year=2006&amp;amp;pages=696-701&amp;amp;pmid=16407142&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23200</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23201</code><code>]&lt;/span&gt;</code></p><p><code>23202</code><code>&lt;/span&gt;</code></p><p><code>23203</code><code>&lt;/li&gt;</code></p><p><code>23204</code><code>&lt;li id="R904"&gt;</code></p><p><code>23205</code><code>&lt;span class="citation"&gt;</code></p><p><code>23206</code><code>Offert&amp;#x000e1;ler L, Mo FM, B&amp;#x000e1;tkai S, Liu J, Begg M, Razdan RK, Martin BR, Bukoski RD, Kunos G. Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. &lt;span&gt;</code></p><p><code>23207</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23208</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>23209</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>23210</code><code>63&lt;/span&gt;</code></p><p><code>23211</code><code>:699–705.&lt;/span&gt;</code></p><p><code>23212</code><code> [&lt;a href="/pubmed/12606780" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23213</code><code>PubMed&lt;/a&gt;</code></p><p><code>23214</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23215</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=Selective+ligands+and+cellular+effectors+of+a+G+protein-coupled+endothelial+cannabinoid+receptor&amp;amp;author=L+Offert&amp;#x000e1;ler&amp;amp;author=FM+Mo&amp;amp;author=S+B&amp;#x000e1;tkai&amp;amp;author=J+Liu&amp;amp;author=M+Begg&amp;amp;volume=63&amp;amp;publication_year=2003&amp;amp;pages=699-705&amp;amp;pmid=12606780&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23216</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23217</code><code>]&lt;/span&gt;</code></p><p><code>23218</code><code>&lt;/span&gt;</code></p><p><code>23219</code><code>&lt;/li&gt;</code></p><p><code>23220</code><code>&lt;li id="R905"&gt;</code></p><p><code>23221</code><code>&lt;span class="citation"&gt;</code></p><p><code>23222</code><code>Ohno-Shosaku T, Maejima T, Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. &lt;span&gt;</code></p><p><code>23223</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23224</code><code>Neuron. &lt;/span&gt;</code></p><p><code>23225</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>23226</code><code>29&lt;/span&gt;</code></p><p><code>23227</code><code>:729–738.&lt;/span&gt;</code></p><p><code>23228</code><code> [&lt;a href="/pubmed/11301031" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23229</code><code>PubMed&lt;/a&gt;</code></p><p><code>23230</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23231</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;amp;title=Endogenous+cannabinoids+mediate+retrograde+signals+from+depolarized+postsynaptic+neurons+to+presynaptic+terminals&amp;amp;author=T+Ohno-Shosaku&amp;amp;author=T+Maejima&amp;amp;author=M+Kano&amp;amp;volume=29&amp;amp;publication_year=2001&amp;amp;pages=729-738&amp;amp;pmid=11301031&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23232</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23233</code><code>]&lt;/span&gt;</code></p><p><code>23234</code><code>&lt;/span&gt;</code></p><p><code>23235</code><code>&lt;/li&gt;</code></p><p><code>23236</code><code>&lt;li id="R906"&gt;</code></p><p><code>23237</code><code>&lt;span class="citation"&gt;</code></p><p><code>23238</code><code>Okamoto Y, Morishita J, Tsuboi K, Tonai T, Ueda N. Molecular characterization of a phospholipase D generating anandamide and its congeners. &lt;span&gt;</code></p><p><code>23239</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23240</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>23241</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>23242</code><code>279&lt;/span&gt;</code></p><p><code>23243</code><code>:5298–5305.&lt;/span&gt;</code></p><p><code>23244</code><code> [&lt;a href="/pubmed/14634025" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23245</code><code>PubMed&lt;/a&gt;</code></p><p><code>23246</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23247</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=Molecular+characterization+of+a+phospholipase+D+generating+anandamide+and+its+congeners&amp;amp;author=Y+Okamoto&amp;amp;author=J+Morishita&amp;amp;author=K+Tsuboi&amp;amp;author=T+Tonai&amp;amp;author=N+Ueda&amp;amp;volume=279&amp;amp;publication_year=2004&amp;amp;pages=5298-5305&amp;amp;pmid=14634025&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23248</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23249</code><code>]&lt;/span&gt;</code></p><p><code>23250</code><code>&lt;/span&gt;</code></p><p><code>23251</code><code>&lt;/li&gt;</code></p><p><code>23252</code><code>&lt;li id="R907"&gt;</code></p><p><code>23253</code><code>&lt;span class="citation"&gt;</code></p><p><code>23254</code><code>Onaivi ES, Green MR, Martin BR. Pharmacological characterization of cannabinoids in the elevated plus maze. &lt;span&gt;</code></p><p><code>23255</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23256</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>23257</code><code>1990;&lt;span class="ref-vol"&gt;</code></p><p><code>23258</code><code>253&lt;/span&gt;</code></p><p><code>23259</code><code>:1002–1009.&lt;/span&gt;</code></p><p><code>23260</code><code> [&lt;a href="/pubmed/2162942" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23261</code><code>PubMed&lt;/a&gt;</code></p><p><code>23262</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23263</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Pharmacological+characterization+of+cannabinoids+in+the+elevated+plus+maze&amp;amp;author=ES+Onaivi&amp;amp;author=MR+Green&amp;amp;author=BR+Martin&amp;amp;volume=253&amp;amp;publication_year=1990&amp;amp;pages=1002-1009&amp;amp;pmid=2162942&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23264</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23265</code><code>]&lt;/span&gt;</code></p><p><code>23266</code><code>&lt;/span&gt;</code></p><p><code>23267</code><code>&lt;/li&gt;</code></p><p><code>23268</code><code>&lt;li id="R908"&gt;</code></p><p><code>23269</code><code>&lt;span class="citation"&gt;</code></p><p><code>23270</code><code>Ortar G, Ligresti A, De Petrocellis L, Morera E, Di Marzo V. Novel selective and metabolically stable inhibitors of anandamide cellular uptake. &lt;span&gt;</code></p><p><code>23271</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23272</code><code>Biochem Pharmacol. &lt;/span&gt;</code></p><p><code>23273</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>23274</code><code>65&lt;/span&gt;</code></p><p><code>23275</code><code>:1473–1481.&lt;/span&gt;</code></p><p><code>23276</code><code> [&lt;a href="/pubmed/12732359" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23277</code><code>PubMed&lt;/a&gt;</code></p><p><code>23278</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23279</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;amp;title=Novel+selective+and+metabolically+stable+inhibitors+of+anandamide+cellular+uptake&amp;amp;author=G+Ortar&amp;amp;author=A+Ligresti&amp;amp;author=L+De+Petrocellis&amp;amp;author=E+Morera&amp;amp;author=V+Di+Marzo&amp;amp;volume=65&amp;amp;publication_year=2003&amp;amp;pages=1473-1481&amp;amp;pmid=12732359&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23280</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23281</code><code>]&lt;/span&gt;</code></p><p><code>23282</code><code>&lt;/span&gt;</code></p><p><code>23283</code><code>&lt;/li&gt;</code></p><p><code>23284</code><code>&lt;li id="R909"&gt;</code></p><p><code>23285</code><code>&lt;span class="citation"&gt;</code></p><p><code>23286</code><code>Ortega-Gutierrez S, Hawkins EG, Viso A, Lopez-Rodriguez ML, Cravatt BF. Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake. &lt;span&gt;</code></p><p><code>23287</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23288</code><code>Biochemistry. &lt;/span&gt;</code></p><p><code>23289</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>23290</code><code>43&lt;/span&gt;</code></p><p><code>23291</code><code>:8184–8190.&lt;/span&gt;</code></p><p><code>23292</code><code> [&lt;a href="/pubmed/15209515" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23293</code><code>PubMed&lt;/a&gt;</code></p><p><code>23294</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23295</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;amp;title=Comparison+of+anandamide+transport+in+FAAH+wild-type+and+knockout+neurons:+evidence+for+contributions+by+both+FAAH+and+the+CB1+receptor+to+anandamide+uptake&amp;amp;author=S+Ortega-Gutierrez&amp;amp;author=EG+Hawkins&amp;amp;author=A+Viso&amp;amp;author=ML+Lopez-Rodriguez&amp;amp;author=BF+Cravatt&amp;amp;volume=43&amp;amp;publication_year=2004&amp;amp;pages=8184-8190&amp;amp;pmid=15209515&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23296</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23297</code><code>]&lt;/span&gt;</code></p><p><code>23298</code><code>&lt;/span&gt;</code></p><p><code>23299</code><code>&lt;/li&gt;</code></p><p><code>23300</code><code>&lt;li id="R910"&gt;</code></p><p><code>23301</code><code>&lt;span class="citation"&gt;</code></p><p><code>23302</code><code>Ortega-Gutierrez S, Molina-Holgado E, Arevalo-Martin A, Correa F, Viso A, Lopez-Rodriguez ML, Di Marzo V, Guaza C. Activation of the endocannabinoid system as a therapeutic approach in a murine model of multiple sclerosis. &lt;span&gt;</code></p><p><code>23303</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23304</code><code>FASEB J. &lt;/span&gt;</code></p><p><code>23305</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>23306</code><code>19&lt;/span&gt;</code></p><p><code>23307</code><code>:1338–1343.&lt;/span&gt;</code></p><p><code>23308</code><code> [&lt;a href="/pubmed/15941768" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23309</code><code>PubMed&lt;/a&gt;</code></p><p><code>23310</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23311</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;amp;title=Activation+of+the+endocannabinoid+system+as+a+therapeutic+approach+in+a+murine+model+of+multiple+sclerosis&amp;amp;author=S+Ortega-Gutierrez&amp;amp;author=E+Molina-Holgado&amp;amp;author=A+Arevalo-Martin&amp;amp;author=F+Correa&amp;amp;author=A+Viso&amp;amp;volume=19&amp;amp;publication_year=2005&amp;amp;pages=1338-1343&amp;amp;pmid=15941768&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23312</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23313</code><code>]&lt;/span&gt;</code></p><p><code>23314</code><code>&lt;/span&gt;</code></p><p><code>23315</code><code>&lt;/li&gt;</code></p><p><code>23316</code><code>&lt;li id="R911"&gt;</code></p><p><code>23317</code><code>&lt;span class="citation"&gt;</code></p><p><code>23318</code><code>Oruc MT, Soran A, Jain AK, Wilson JW, Fung J. De novo breast cancer in patients with liver transplantation: University of Pittsburgh&amp;#x02019;s experience and review of the literature. &lt;span&gt;</code></p><p><code>23319</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23320</code><code>Liver Transplant. &lt;/span&gt;</code></p><p><code>23321</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>23322</code><code>10&lt;/span&gt;</code></p><p><code>23323</code><code>:1–6.&lt;/span&gt;</code></p><p><code>23324</code><code> [&lt;a href="/pubmed/14755771" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23325</code><code>PubMed&lt;/a&gt;</code></p><p><code>23326</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23327</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Liver+Transplant&amp;amp;title=De+novo+breast+cancer+in+patients+with+liver+transplantation:+University+of+Pittsburgh&amp;#x02019;s+experience+and+review+of+the+literature&amp;amp;author=MT+Oruc&amp;amp;author=A+Soran&amp;amp;author=AK+Jain&amp;amp;author=JW+Wilson&amp;amp;author=J+Fung&amp;amp;volume=10&amp;amp;publication_year=2004&amp;amp;pages=1-6&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23328</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23329</code><code>]&lt;/span&gt;</code></p><p><code>23330</code><code>&lt;/span&gt;</code></p><p><code>23331</code><code>&lt;/li&gt;</code></p><p><code>23332</code><code>&lt;li id="R912"&gt;</code></p><p><code>23333</code><code>&lt;span class="citation"&gt;</code></p><p><code>23334</code><code>Orzelek-O&amp;#x02019;Neil RM, Goodman FR, Forney RB. &amp;#x00394;-9-Tetrahydrocannabinol on isolated human bronchioles. &lt;span&gt;</code></p><p><code>23335</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23336</code><code>Arch Int Pharmacodyn Ther. &lt;/span&gt;</code></p><p><code>23337</code><code>1980a;&lt;span class="ref-vol"&gt;</code></p><p><code>23338</code><code>246&lt;/span&gt;</code></p><p><code>23339</code><code>:71–83.&lt;/span&gt;</code></p><p><code>23340</code><code> [&lt;a href="/pubmed/6255881" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23341</code><code>PubMed&lt;/a&gt;</code></p><p><code>23342</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23343</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Arch+Int+Pharmacodyn+Ther&amp;amp;title=&amp;#x00394;-9-Tetrahydrocannabinol+on+isolated+human+bronchioles&amp;amp;author=RM+Orzelek-O&amp;#x02019;Neil&amp;amp;author=FR+Goodman&amp;amp;author=RB+Forney&amp;amp;volume=246&amp;amp;publication_year=1980a&amp;amp;pages=71-83&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23344</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23345</code><code>]&lt;/span&gt;</code></p><p><code>23346</code><code>&lt;/span&gt;</code></p><p><code>23347</code><code>&lt;/li&gt;</code></p><p><code>23348</code><code>&lt;li id="R913"&gt;</code></p><p><code>23349</code><code>&lt;span class="citation"&gt;</code></p><p><code>23350</code><code>Orzelek-O&amp;#x02019;Neil RM, Goodman FR, Forney RB. The effects of &amp;#x00394;9-tetrahydrocannabinol and nabilone on the isolated guinea pig bronchus. &lt;span&gt;</code></p><p><code>23351</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23352</code><code>Toxicol Appl Pharmacol. &lt;/span&gt;</code></p><p><code>23353</code><code>1980b;&lt;span class="ref-vol"&gt;</code></p><p><code>23354</code><code>54&lt;/span&gt;</code></p><p><code>23355</code><code>:493–500.&lt;/span&gt;</code></p><p><code>23356</code><code> [&lt;a href="/pubmed/6249002" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23357</code><code>PubMed&lt;/a&gt;</code></p><p><code>23358</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23359</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Toxicol+Appl+Pharmacol&amp;amp;title=The+effects+of+&amp;#x00394;9-tetrahydrocannabinol+and+nabilone+on+the+isolated+guinea+pig+bronchus&amp;amp;author=RM+Orzelek-O&amp;#x02019;Neil&amp;amp;author=FR+Goodman&amp;amp;author=RB+Forney&amp;amp;volume=54&amp;amp;publication_year=1980b&amp;amp;pages=493-500&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23360</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23361</code><code>]&lt;/span&gt;</code></p><p><code>23362</code><code>&lt;/span&gt;</code></p><p><code>23363</code><code>&lt;/li&gt;</code></p><p><code>23364</code><code>&lt;li id="R914"&gt;</code></p><p><code>23365</code><code>&lt;span class="citation"&gt;</code></p><p><code>23366</code><code>Osei-Hyiaman D, Depetrillo M, Harvey-White J, Bannon AW, Cravatt BF, Kuhar MJ, Mackie K, Palkovits M, Kunos G. Cocaine- and amphetamine-related transcript peptide is involved in the orexigenic effect of endogenous anandamide. &lt;span&gt;</code></p><p><code>23367</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23368</code><code>Neuroendocrinology. &lt;/span&gt;</code></p><p><code>23369</code><code>2005a;&lt;span class="ref-vol"&gt;</code></p><p><code>23370</code><code>81&lt;/span&gt;</code></p><p><code>23371</code><code>:273–282.&lt;/span&gt;</code></p><p><code>23372</code><code> [&lt;a href="/pubmed/16131814" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23373</code><code>PubMed&lt;/a&gt;</code></p><p><code>23374</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23375</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroendocrinology&amp;amp;title=Cocaine-+and+amphetamine-related+transcript+peptide+is+involved+in+the+orexigenic+effect+of+endogenous+anandamide&amp;amp;author=D+Osei-Hyiaman&amp;amp;author=M+Depetrillo&amp;amp;author=J+Harvey-White&amp;amp;author=AW+Bannon&amp;amp;author=BF+Cravatt&amp;amp;volume=81&amp;amp;publication_year=2005a&amp;amp;pages=273-282&amp;amp;pmid=16131814&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23376</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23377</code><code>]&lt;/span&gt;</code></p><p><code>23378</code><code>&lt;/span&gt;</code></p><p><code>23379</code><code>&lt;/li&gt;</code></p><p><code>23380</code><code>&lt;li id="R915"&gt;</code></p><p><code>23381</code><code>&lt;span class="citation"&gt;</code></p><p><code>23382</code><code>Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, Batkai S, Harvey-White J, Mackie K, Offertaler L, Wang L, et al.  Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. &lt;span&gt;</code></p><p><code>23383</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23384</code><code>J Clin Investig. &lt;/span&gt;</code></p><p><code>23385</code><code>2005b;&lt;span class="ref-vol"&gt;</code></p><p><code>23386</code><code>115&lt;/span&gt;</code></p><p><code>23387</code><code>:1298–1305.&lt;/span&gt;</code></p><p><code>23388</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>23389</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1087161/"&gt;</code></p><p><code>23390</code><code>PMC free article&lt;/a&gt;</code></p><p><code>23391</code><code>]&lt;/span&gt;</code></p><p><code>23392</code><code> [&lt;a href="/pubmed/15864349" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23393</code><code>PubMed&lt;/a&gt;</code></p><p><code>23394</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23395</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Investig&amp;amp;title=Endocannabinoid+activation+at+hepatic+CB1+receptors+stimulates+fatty+acid+synthesis+and+contributes+to+diet-induced+obesity&amp;amp;author=D+Osei-Hyiaman&amp;amp;author=M+DePetrillo&amp;amp;author=P+Pacher&amp;amp;author=J+Liu&amp;amp;author=S+Radaeva&amp;amp;volume=115&amp;amp;publication_year=2005b&amp;amp;pages=1298-1305&amp;amp;pmid=15864349&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23396</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23397</code><code>]&lt;/span&gt;</code></p><p><code>23398</code><code>&lt;/span&gt;</code></p><p><code>23399</code><code>&lt;/li&gt;</code></p><p><code>23400</code><code>&lt;li id="R916"&gt;</code></p><p><code>23401</code><code>&lt;span class="citation"&gt;</code></p><p><code>23402</code><code>O&amp;#x02019;Sullivan SE, Kendall DA, Randall MD. Characterisation of the vasorelaxant properties of the novel endocannabinoid &lt;em&gt;</code></p><p><code>23403</code><code>N-&lt;/em&gt;</code></p><p><code>23404</code><code>arachidonoyl-dopamine (NADA) &lt;span&gt;</code></p><p><code>23405</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23406</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>23407</code><code>2004a;&lt;span class="ref-vol"&gt;</code></p><p><code>23408</code><code>141&lt;/span&gt;</code></p><p><code>23409</code><code>:803–812.&lt;/span&gt;</code></p><p><code>23410</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>23411</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1574254/"&gt;</code></p><p><code>23412</code><code>PMC free article&lt;/a&gt;</code></p><p><code>23413</code><code>]&lt;/span&gt;</code></p><p><code>23414</code><code> [&lt;a href="/pubmed/14769783" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23415</code><code>PubMed&lt;/a&gt;</code></p><p><code>23416</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23417</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Characterisation+of+the+vasorelaxant+properties+of+the+novel+endocannabinoid+N-arachidonoyl-dopamine+(NADA)&amp;amp;author=SE+O&amp;#x02019;Sullivan&amp;amp;author=DA+Kendall&amp;amp;author=MD+Randall&amp;amp;volume=141&amp;amp;publication_year=2004a&amp;amp;pages=803-812&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23418</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23419</code><code>]&lt;/span&gt;</code></p><p><code>23420</code><code>&lt;/span&gt;</code></p><p><code>23421</code><code>&lt;/li&gt;</code></p><p><code>23422</code><code>&lt;li id="R917"&gt;</code></p><p><code>23423</code><code>&lt;span class="citation"&gt;</code></p><p><code>23424</code><code>O&amp;#x02019;Sullivan SE, Kendall DA, Randall MD. Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries. &lt;span&gt;</code></p><p><code>23425</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23426</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>23427</code><code>2004b;&lt;span class="ref-vol"&gt;</code></p><p><code>23428</code><code>142&lt;/span&gt;</code></p><p><code>23429</code><code>:435–442.&lt;/span&gt;</code></p><p><code>23430</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>23431</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1574972/"&gt;</code></p><p><code>23432</code><code>PMC free article&lt;/a&gt;</code></p><p><code>23433</code><code>]&lt;/span&gt;</code></p><p><code>23434</code><code> [&lt;a href="/pubmed/15148250" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23435</code><code>PubMed&lt;/a&gt;</code></p><p><code>23436</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23437</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Heterogeneity+in+the+mechanisms+of+vasorelaxation+to+anandamide+in+resistance+and+conduit+rat+mesenteric+arteries&amp;amp;author=SE+O&amp;#x02019;Sullivan&amp;amp;author=DA+Kendall&amp;amp;author=MD+Randall&amp;amp;volume=142&amp;amp;publication_year=2004b&amp;amp;pages=435-442&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23438</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23439</code><code>]&lt;/span&gt;</code></p><p><code>23440</code><code>&lt;/span&gt;</code></p><p><code>23441</code><code>&lt;/li&gt;</code></p><p><code>23442</code><code>&lt;li id="R918"&gt;</code></p><p><code>23443</code><code>&lt;span class="citation"&gt;</code></p><p><code>23444</code><code>Ottani A, Leone S, Sandrini M, Ferrari A, Bertolini A. The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors. &lt;span&gt;</code></p><p><code>23445</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23446</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>23447</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>23448</code><code>531&lt;/span&gt;</code></p><p><code>23449</code><code>:280–281.&lt;/span&gt;</code></p><p><code>23450</code><code> [&lt;a href="/pubmed/16438952" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23451</code><code>PubMed&lt;/a&gt;</code></p><p><code>23452</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23453</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=The+analgesic+activity+of+paracetamol+is+prevented+by+the+blockade+of+cannabinoid+CB1+receptors&amp;amp;author=A+Ottani&amp;amp;author=S+Leone&amp;amp;author=M+Sandrini&amp;amp;author=A+Ferrari&amp;amp;author=A+Bertolini&amp;amp;volume=531&amp;amp;publication_year=2006&amp;amp;pages=280-281&amp;amp;pmid=16438952&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23454</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23455</code><code>]&lt;/span&gt;</code></p><p><code>23456</code><code>&lt;/span&gt;</code></p><p><code>23457</code><code>&lt;/li&gt;</code></p><p><code>23458</code><code>&lt;li id="R919"&gt;</code></p><p><code>23459</code><code>&lt;span class="citation"&gt;</code></p><p><code>23460</code><code>Oz M, Tchugunova Y, Dinc M. Differential effects of endogenous and synthetic cannabinoids on voltage-dependent calcium fluxes in rabbit T-tubule membranes: comparison with fatty acids. &lt;span&gt;</code></p><p><code>23461</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23462</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>23463</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>23464</code><code>502&lt;/span&gt;</code></p><p><code>23465</code><code>:47–58.&lt;/span&gt;</code></p><p><code>23466</code><code> [&lt;a href="/pubmed/15464089" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23467</code><code>PubMed&lt;/a&gt;</code></p><p><code>23468</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23469</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Differential+effects+of+endogenous+and+synthetic+cannabinoids+on+voltage-dependent+calcium+fluxes+in+rabbit+T-tubule+membranes:+comparison+with+fatty+acids&amp;amp;author=M+Oz&amp;amp;author=Y+Tchugunova&amp;amp;author=M+Dinc&amp;amp;volume=502&amp;amp;publication_year=2004&amp;amp;pages=47-58&amp;amp;pmid=15464089&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23470</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23471</code><code>]&lt;/span&gt;</code></p><p><code>23472</code><code>&lt;/span&gt;</code></p><p><code>23473</code><code>&lt;/li&gt;</code></p><p><code>23474</code><code>&lt;li id="R920"&gt;</code></p><p><code>23475</code><code>&lt;span class="citation"&gt;</code></p><p><code>23476</code><code>Oz M, Tchugunova YB, Dunn SM. Endogenous cannabinoid anandamide directly inhibits voltage-dependent Ca&lt;sup&gt;</code></p><p><code>23477</code><code>2+&lt;/sup&gt;</code></p><p><code>23478</code><code> fluxes in rabbit T-tubule membranes. &lt;span&gt;</code></p><p><code>23479</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23480</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>23481</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>23482</code><code>404&lt;/span&gt;</code></p><p><code>23483</code><code>:13–20.&lt;/span&gt;</code></p><p><code>23484</code><code> [&lt;a href="/pubmed/10980258" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23485</code><code>PubMed&lt;/a&gt;</code></p><p><code>23486</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23487</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Endogenous+cannabinoid+anandamide+directly+inhibits+voltage-dependent+Ca2++fluxes+in+rabbit+T-tubule+membranes&amp;amp;author=M+Oz&amp;amp;author=YB+Tchugunova&amp;amp;author=SM+Dunn&amp;amp;volume=404&amp;amp;publication_year=2000&amp;amp;pages=13-20&amp;amp;pmid=10980258&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23488</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23489</code><code>]&lt;/span&gt;</code></p><p><code>23490</code><code>&lt;/span&gt;</code></p><p><code>23491</code><code>&lt;/li&gt;</code></p><p><code>23492</code><code>&lt;li id="R921"&gt;</code></p><p><code>23493</code><code>&lt;span class="citation"&gt;</code></p><p><code>23494</code><code>Pacher P, B&amp;#x000e1;tkai S, Kunos G. Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice. &lt;span&gt;</code></p><p><code>23495</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23496</code><code>J Physiol (Lond) &lt;/span&gt;</code></p><p><code>23497</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>23498</code><code>558&lt;/span&gt;</code></p><p><code>23499</code><code>:647–657.&lt;/span&gt;</code></p><p><code>23500</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>23501</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1664980/"&gt;</code></p><p><code>23502</code><code>PMC free article&lt;/a&gt;</code></p><p><code>23503</code><code>]&lt;/span&gt;</code></p><p><code>23504</code><code> [&lt;a href="/pubmed/15121805" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23505</code><code>PubMed&lt;/a&gt;</code></p><p><code>23506</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23507</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Physiol+(Lond)&amp;amp;title=Haemodynamic+profile+and+responsiveness+to+anandamide+of+TRPV1+receptor+knock-out+mice&amp;amp;author=P+Pacher&amp;amp;author=S+B&amp;#x000e1;tkai&amp;amp;author=G+Kunos&amp;amp;volume=558&amp;amp;publication_year=2004&amp;amp;pages=647-657&amp;amp;pmid=15121805&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23508</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23509</code><code>]&lt;/span&gt;</code></p><p><code>23510</code><code>&lt;/span&gt;</code></p><p><code>23511</code><code>&lt;/li&gt;</code></p><p><code>23512</code><code>&lt;li id="R922"&gt;</code></p><p><code>23513</code><code>&lt;span class="citation"&gt;</code></p><p><code>23514</code><code>Pacher P, B&amp;#x000e1;tkai S, Kunos G. Blood pressure regulation by endocannabinoids and their receptors. &lt;span&gt;</code></p><p><code>23515</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23516</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>23517</code><code>2005a;&lt;span class="ref-vol"&gt;</code></p><p><code>23518</code><code>48&lt;/span&gt;</code></p><p><code>23519</code><code>:1130–1138.&lt;/span&gt;</code></p><p><code>23520</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>23521</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2225528/"&gt;</code></p><p><code>23522</code><code>PMC free article&lt;/a&gt;</code></p><p><code>23523</code><code>]&lt;/span&gt;</code></p><p><code>23524</code><code> [&lt;a href="/pubmed/15910888" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23525</code><code>PubMed&lt;/a&gt;</code></p><p><code>23526</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23527</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=Blood+pressure+regulation+by+endocannabinoids+and+their+receptors&amp;amp;author=P+Pacher&amp;amp;author=S+B&amp;#x000e1;tkai&amp;amp;author=G+Kunos&amp;amp;volume=48&amp;amp;publication_year=2005a&amp;amp;pages=1130-1138&amp;amp;pmid=15910888&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23528</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23529</code><code>]&lt;/span&gt;</code></p><p><code>23530</code><code>&lt;/span&gt;</code></p><p><code>23531</code><code>&lt;/li&gt;</code></p><p><code>23532</code><code>&lt;li id="R923"&gt;</code></p><p><code>23533</code><code>&lt;span class="citation"&gt;</code></p><p><code>23534</code><code>Pacher P, B&amp;#x000e1;tkai S, Kunos G.  Cardiovascular pharmacology of cannabinoids. In: Pertwee R, editor. &lt;span class="ref-journal"&gt;</code></p><p><code>23535</code><code>Cannabinoids.&lt;/span&gt;</code></p><p><code>23536</code><code> Springer; New York: 2005b. pp. 599–627. &lt;span class="nowrap"&gt;</code></p><p><code>23537</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?title=Cannabinoids&amp;amp;author=P+Pacher&amp;amp;author=S+B&amp;#x000e1;tkai&amp;amp;author=G+Kunos&amp;amp;publication_year=2005b&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23538</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23539</code><code>]&lt;/span&gt;</code></p><p><code>23540</code><code>&lt;/span&gt;</code></p><p><code>23541</code><code>&lt;/li&gt;</code></p><p><code>23542</code><code>&lt;li id="R924"&gt;</code></p><p><code>23543</code><code>&lt;span class="citation"&gt;</code></p><p><code>23544</code><code>Pacher P, B&amp;#x000e1;tkai S, Kunos G. Cirrhotic cardiomyopathy: an endocannabinoid connection? &lt;span&gt;</code></p><p><code>23545</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23546</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>23547</code><code>2005c;&lt;span class="ref-vol"&gt;</code></p><p><code>23548</code><code>146&lt;/span&gt;</code></p><p><code>23549</code><code>:313–314.&lt;/span&gt;</code></p><p><code>23550</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>23551</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1576282/"&gt;</code></p><p><code>23552</code><code>PMC free article&lt;/a&gt;</code></p><p><code>23553</code><code>]&lt;/span&gt;</code></p><p><code>23554</code><code> [&lt;a href="/pubmed/16025137" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23555</code><code>PubMed&lt;/a&gt;</code></p><p><code>23556</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23557</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Cirrhotic+cardiomyopathy:+an+endocannabinoid+connection?&amp;amp;author=P+Pacher&amp;amp;author=S+B&amp;#x000e1;tkai&amp;amp;author=G+Kunos&amp;amp;volume=146&amp;amp;publication_year=2005c&amp;amp;pages=313-314&amp;amp;pmid=16025137&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23558</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23559</code><code>]&lt;/span&gt;</code></p><p><code>23560</code><code>&lt;/span&gt;</code></p><p><code>23561</code><code>&lt;/li&gt;</code></p><p><code>23562</code><code>&lt;li id="R925"&gt;</code></p><p><code>23563</code><code>&lt;span class="citation"&gt;</code></p><p><code>23564</code><code>Pacher P, B&amp;#x000e1;tkai S, Osei-Hyiaman D, Offertaler L, Liu J, Harvey-White J, Brassai A, Jarai Z, Cravatt BF, Kunos G. Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase. &lt;span&gt;</code></p><p><code>23565</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23566</code><code>Am J Physiol. &lt;/span&gt;</code></p><p><code>23567</code><code>2005d;&lt;span class="ref-vol"&gt;</code></p><p><code>23568</code><code>289&lt;/span&gt;</code></p><p><code>23569</code><code>:H533–H541.&lt;/span&gt;</code></p><p><code>23570</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>23571</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2225481/"&gt;</code></p><p><code>23572</code><code>PMC free article&lt;/a&gt;</code></p><p><code>23573</code><code>]&lt;/span&gt;</code></p><p><code>23574</code><code> [&lt;a href="/pubmed/15821037" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23575</code><code>PubMed&lt;/a&gt;</code></p><p><code>23576</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23577</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol&amp;amp;title=Hemodynamic+profile,+responsiveness+to+anandamide,+and+baroreflex+sensitivity+of+mice+lacking+fatty+acid+amide+hydrolase&amp;amp;author=P+Pacher&amp;amp;author=S+B&amp;#x000e1;tkai&amp;amp;author=D+Osei-Hyiaman&amp;amp;author=L+Offertaler&amp;amp;author=J+Liu&amp;amp;volume=289&amp;amp;publication_year=2005d&amp;amp;pages=H533-H541&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23578</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23579</code><code>]&lt;/span&gt;</code></p><p><code>23580</code><code>&lt;/span&gt;</code></p><p><code>23581</code><code>&lt;/li&gt;</code></p><p><code>23582</code><code>&lt;li id="R926"&gt;</code></p><p><code>23583</code><code>&lt;span class="citation"&gt;</code></p><p><code>23584</code><code>Pacher P, Kecskem&amp;#x000e9;ti V. Trends in the development of new antidepressants: is there a light at the end of the tunnel? &lt;span&gt;</code></p><p><code>23585</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23586</code><code>Curr Med Chem. &lt;/span&gt;</code></p><p><code>23587</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>23588</code><code>11&lt;/span&gt;</code></p><p><code>23589</code><code>:925–943.&lt;/span&gt;</code></p><p><code>23590</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>23591</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2495050/"&gt;</code></p><p><code>23592</code><code>PMC free article&lt;/a&gt;</code></p><p><code>23593</code><code>]&lt;/span&gt;</code></p><p><code>23594</code><code> [&lt;a href="/pubmed/15078174" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23595</code><code>PubMed&lt;/a&gt;</code></p><p><code>23596</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23597</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Med+Chem&amp;amp;title=Trends+in+the+development+of+new+antidepressants:+is+there+a+light+at+the+end+of+the+tunnel?&amp;amp;author=P+Pacher&amp;amp;author=V+Kecskem&amp;#x000e9;ti&amp;amp;volume=11&amp;amp;publication_year=2004&amp;amp;pages=925-943&amp;amp;pmid=15078174&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23598</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23599</code><code>]&lt;/span&gt;</code></p><p><code>23600</code><code>&lt;/span&gt;</code></p><p><code>23601</code><code>&lt;/li&gt;</code></p><p><code>23602</code><code>&lt;li id="R927"&gt;</code></p><p><code>23603</code><code>&lt;span class="citation"&gt;</code></p><p><code>23604</code><code>Pacher P, Nivorozhkin A, Szabo C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. &lt;span&gt;</code></p><p><code>23605</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23606</code><code>Pharmacol Rev. &lt;/span&gt;</code></p><p><code>23607</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>23608</code><code>58&lt;/span&gt;</code></p><p><code>23609</code><code>:87–114.&lt;/span&gt;</code></p><p><code>23610</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>23611</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2233605/"&gt;</code></p><p><code>23612</code><code>PMC free article&lt;/a&gt;</code></p><p><code>23613</code><code>]&lt;/span&gt;</code></p><p><code>23614</code><code> [&lt;a href="/pubmed/16507884" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23615</code><code>PubMed&lt;/a&gt;</code></p><p><code>23616</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23617</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Rev&amp;amp;title=Therapeutic+effects+of+xanthine+oxidase+inhibitors:+renaissance+half+a+century+after+the+discovery+of+allopurinol&amp;amp;author=P+Pacher&amp;amp;author=A+Nivorozhkin&amp;amp;author=C+Szabo&amp;amp;volume=58&amp;amp;publication_year=2006&amp;amp;pages=87-114&amp;amp;pmid=16507884&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23618</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23619</code><code>]&lt;/span&gt;</code></p><p><code>23620</code><code>&lt;/span&gt;</code></p><p><code>23621</code><code>&lt;/li&gt;</code></p><p><code>23622</code><code>&lt;li id="R928"&gt;</code></p><p><code>23623</code><code>&lt;span class="citation"&gt;</code></p><p><code>23624</code><code>Pacher P, Schulz R, Liaudet L, Szabo C. Nitrosative stress and pharmacological modulation of heart failure. &lt;span&gt;</code></p><p><code>23625</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23626</code><code>Trends Pharmacol Sci. &lt;/span&gt;</code></p><p><code>23627</code><code>2005e;&lt;span class="ref-vol"&gt;</code></p><p><code>23628</code><code>26&lt;/span&gt;</code></p><p><code>23629</code><code>:302–310.&lt;/span&gt;</code></p><p><code>23630</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>23631</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2228264/"&gt;</code></p><p><code>23632</code><code>PMC free article&lt;/a&gt;</code></p><p><code>23633</code><code>]&lt;/span&gt;</code></p><p><code>23634</code><code> [&lt;a href="/pubmed/15925705" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23635</code><code>PubMed&lt;/a&gt;</code></p><p><code>23636</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23637</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Trends+Pharmacol+Sci&amp;amp;title=Nitrosative+stress+and+pharmacological+modulation+of+heart+failure&amp;amp;author=P+Pacher&amp;amp;author=R+Schulz&amp;amp;author=L+Liaudet&amp;amp;author=C+Szabo&amp;amp;volume=26&amp;amp;publication_year=2005e&amp;amp;pages=302-310&amp;amp;pmid=15925705&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23638</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23639</code><code>]&lt;/span&gt;</code></p><p><code>23640</code><code>&lt;/span&gt;</code></p><p><code>23641</code><code>&lt;/li&gt;</code></p><p><code>23642</code><code>&lt;li id="R929"&gt;</code></p><p><code>23643</code><code>&lt;span class="citation"&gt;</code></p><p><code>23644</code><code>Page KJ, Besret L, Jain M, Monaghan EM, Dunnett SB, Everitt BJ. Effects of systemic 3-nitropropionic acid-induced lesions of the dorsal striatum on cannabinoid and &lt;em&gt;</code></p><p><code>23645</code><code>&amp;#x003bc;&lt;/em&gt;</code></p><p><code>23646</code><code>-opioid receptor binding in the basal ganglia. &lt;span&gt;</code></p><p><code>23647</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23648</code><code>Exp Brain Res. &lt;/span&gt;</code></p><p><code>23649</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>23650</code><code>130&lt;/span&gt;</code></p><p><code>23651</code><code>:142–150.&lt;/span&gt;</code></p><p><code>23652</code><code> [&lt;a href="/pubmed/10672467" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23653</code><code>PubMed&lt;/a&gt;</code></p><p><code>23654</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23655</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Exp+Brain+Res&amp;amp;title=Effects+of+systemic+3-nitropropionic+acid-induced+lesions+of+the+dorsal+striatum+on+cannabinoid+and+&amp;#x003bc;-opioid+receptor+binding+in+the+basal+ganglia&amp;amp;author=KJ+Page&amp;amp;author=L+Besret&amp;amp;author=M+Jain&amp;amp;author=EM+Monaghan&amp;amp;author=SB+Dunnett&amp;amp;volume=130&amp;amp;publication_year=2000&amp;amp;pages=142-150&amp;amp;pmid=10672467&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23656</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23657</code><code>]&lt;/span&gt;</code></p><p><code>23658</code><code>&lt;/span&gt;</code></p><p><code>23659</code><code>&lt;/li&gt;</code></p><p><code>23660</code><code>&lt;li id="R930"&gt;</code></p><p><code>23661</code><code>&lt;span class="citation"&gt;</code></p><p><code>23662</code><code>Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. &lt;span&gt;</code></p><p><code>23663</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23664</code><code>Endocr Rev. &lt;/span&gt;</code></p><p><code>23665</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>23666</code><code>27&lt;/span&gt;</code></p><p><code>23667</code><code>:73–100.&lt;/span&gt;</code></p><p><code>23668</code><code> [&lt;a href="/pubmed/16306385" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23669</code><code>PubMed&lt;/a&gt;</code></p><p><code>23670</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23671</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Endocr+Rev&amp;amp;title=The+emerging+role+of+the+endocannabinoid+system+in+endocrine+regulation+and+energy+balance&amp;amp;author=U+Pagotto&amp;amp;author=G+Marsicano&amp;amp;author=D+Cota&amp;amp;author=B+Lutz&amp;amp;author=R+Pasquali&amp;amp;volume=27&amp;amp;publication_year=2006&amp;amp;pages=73-100&amp;amp;pmid=16306385&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23672</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23673</code><code>]&lt;/span&gt;</code></p><p><code>23674</code><code>&lt;/span&gt;</code></p><p><code>23675</code><code>&lt;/li&gt;</code></p><p><code>23676</code><code>&lt;li id="R931"&gt;</code></p><p><code>23677</code><code>&lt;span class="citation"&gt;</code></p><p><code>23678</code><code>Panikashvili D, Mechoulam R, Beni SM, Alexandrovich A, Shohami E. CB&lt;sub&gt;</code></p><p><code>23679</code><code>1&lt;/sub&gt;</code></p><p><code>23680</code><code> cannabinoid receptors are involved in neuroprotection via NF-&lt;em&gt;</code></p><p><code>23681</code><code>&amp;#x003ba;&lt;/em&gt;</code></p><p><code>23682</code><code>B inhibition. &lt;span&gt;</code></p><p><code>23683</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23684</code><code>J Cereb Blood Flow Metab. &lt;/span&gt;</code></p><p><code>23685</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>23686</code><code>25&lt;/span&gt;</code></p><p><code>23687</code><code>:477–484.&lt;/span&gt;</code></p><p><code>23688</code><code> [&lt;a href="/pubmed/15729296" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23689</code><code>PubMed&lt;/a&gt;</code></p><p><code>23690</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23691</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Cereb+Blood+Flow+Metab&amp;amp;title=CB1+cannabinoid+receptors+are+involved+in+neuroprotection+via+NF-&amp;#x003ba;B+inhibition&amp;amp;author=D+Panikashvili&amp;amp;author=R+Mechoulam&amp;amp;author=SM+Beni&amp;amp;author=A+Alexandrovich&amp;amp;author=E+Shohami&amp;amp;volume=25&amp;amp;publication_year=2005&amp;amp;pages=477-484&amp;amp;pmid=15729296&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23692</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23693</code><code>]&lt;/span&gt;</code></p><p><code>23694</code><code>&lt;/span&gt;</code></p><p><code>23695</code><code>&lt;/li&gt;</code></p><p><code>23696</code><code>&lt;li id="R932"&gt;</code></p><p><code>23697</code><code>&lt;span class="citation"&gt;</code></p><p><code>23698</code><code>Panikashvili D, Shein NA, Mechoulam R, Trembovler V, Kohen R, Alexandrovich A, Shohami E. The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. &lt;span&gt;</code></p><p><code>23699</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23700</code><code>Neurobiol Dis. &lt;/span&gt;</code></p><p><code>23701</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>23702</code><code>22&lt;/span&gt;</code></p><p><code>23703</code><code>:257–264.&lt;/span&gt;</code></p><p><code>23704</code><code> [&lt;a href="/pubmed/16364651" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23705</code><code>PubMed&lt;/a&gt;</code></p><p><code>23706</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23707</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurobiol+Dis&amp;amp;title=The+endocannabinoid+2-AG+protects+the+blood-brain+barrier+after+closed+head+injury+and+inhibits+mRNA+expression+of+proinflammatory+cytokines&amp;amp;author=D+Panikashvili&amp;amp;author=NA+Shein&amp;amp;author=R+Mechoulam&amp;amp;author=V+Trembovler&amp;amp;author=R+Kohen&amp;amp;volume=22&amp;amp;publication_year=2006&amp;amp;pages=257-264&amp;amp;pmid=16364651&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23708</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23709</code><code>]&lt;/span&gt;</code></p><p><code>23710</code><code>&lt;/span&gt;</code></p><p><code>23711</code><code>&lt;/li&gt;</code></p><p><code>23712</code><code>&lt;li id="R933"&gt;</code></p><p><code>23713</code><code>&lt;span class="citation"&gt;</code></p><p><code>23714</code><code>Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, Shohami E. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. &lt;span&gt;</code></p><p><code>23715</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23716</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>23717</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>23718</code><code>413&lt;/span&gt;</code></p><p><code>23719</code><code>:527–531.&lt;/span&gt;</code></p><p><code>23720</code><code> [&lt;a href="/pubmed/11586361" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23721</code><code>PubMed&lt;/a&gt;</code></p><p><code>23722</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23723</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=An+endogenous+cannabinoid+(2-AG)+is+neuroprotective+after+brain+injury&amp;amp;author=D+Panikashvili&amp;amp;author=C+Simeonidou&amp;amp;author=S+Ben-Shabat&amp;amp;author=L+Hanus&amp;amp;author=A+Breuer&amp;amp;volume=413&amp;amp;publication_year=2001&amp;amp;pages=527-531&amp;amp;pmid=11586361&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23724</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23725</code><code>]&lt;/span&gt;</code></p><p><code>23726</code><code>&lt;/span&gt;</code></p><p><code>23727</code><code>&lt;/li&gt;</code></p><p><code>23728</code><code>&lt;li id="R934"&gt;</code></p><p><code>23729</code><code>&lt;span class="citation"&gt;</code></p><p><code>23730</code><code>Paria BC, Das SK, Dey SK. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. &lt;span&gt;</code></p><p><code>23731</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23732</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>23733</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>23734</code><code>92&lt;/span&gt;</code></p><p><code>23735</code><code>:9460–9464.&lt;/span&gt;</code></p><p><code>23736</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>23737</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC40821/"&gt;</code></p><p><code>23738</code><code>PMC free article&lt;/a&gt;</code></p><p><code>23739</code><code>]&lt;/span&gt;</code></p><p><code>23740</code><code> [&lt;a href="/pubmed/7568154" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23741</code><code>PubMed&lt;/a&gt;</code></p><p><code>23742</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23743</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=The+preimplantation+mouse+embryo+is+a+target+for+cannabinoid+ligand-receptor+signaling&amp;amp;author=BC+Paria&amp;amp;author=SK+Das&amp;amp;author=SK+Dey&amp;amp;volume=92&amp;amp;publication_year=1995&amp;amp;pages=9460-9464&amp;amp;pmid=7568154&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23744</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23745</code><code>]&lt;/span&gt;</code></p><p><code>23746</code><code>&lt;/span&gt;</code></p><p><code>23747</code><code>&lt;/li&gt;</code></p><p><code>23748</code><code>&lt;li id="R935"&gt;</code></p><p><code>23749</code><code>&lt;span class="citation"&gt;</code></p><p><code>23750</code><code>Paria BC, Song H, Wang X, Schmid PC, Krebsbach RJ, Schmid HH, Bonner TI, Zimmer A, Dey SK. Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. &lt;span&gt;</code></p><p><code>23751</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23752</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>23753</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>23754</code><code>276&lt;/span&gt;</code></p><p><code>23755</code><code>:20523–20528.&lt;/span&gt;</code></p><p><code>23756</code><code> [&lt;a href="/pubmed/11279117" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23757</code><code>PubMed&lt;/a&gt;</code></p><p><code>23758</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23759</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=Dysregulated+cannabinoid+signaling+disrupts+uterine+receptivity+for+embryo+implantation&amp;amp;author=BC+Paria&amp;amp;author=H+Song&amp;amp;author=X+Wang&amp;amp;author=PC+Schmid&amp;amp;author=RJ+Krebsbach&amp;amp;volume=276&amp;amp;publication_year=2001&amp;amp;pages=20523-20528&amp;amp;pmid=11279117&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23760</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23761</code><code>]&lt;/span&gt;</code></p><p><code>23762</code><code>&lt;/span&gt;</code></p><p><code>23763</code><code>&lt;/li&gt;</code></p><p><code>23764</code><code>&lt;li id="R936"&gt;</code></p><p><code>23765</code><code>&lt;span class="citation"&gt;</code></p><p><code>23766</code><code>Paria BC, Wang H, Dey SK. Endocannabinoid signaling in synchronizing embryo development and uterine receptivity for implantation. &lt;span&gt;</code></p><p><code>23767</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23768</code><code>Chem Phys Lipids. &lt;/span&gt;</code></p><p><code>23769</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>23770</code><code>121&lt;/span&gt;</code></p><p><code>23771</code><code>:201–210.&lt;/span&gt;</code></p><p><code>23772</code><code> [&lt;a href="/pubmed/12505701" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23773</code><code>PubMed&lt;/a&gt;</code></p><p><code>23774</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23775</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Chem+Phys+Lipids&amp;amp;title=Endocannabinoid+signaling+in+synchronizing+embryo+development+and+uterine+receptivity+for+implantation&amp;amp;author=BC+Paria&amp;amp;author=H+Wang&amp;amp;author=SK+Dey&amp;amp;volume=121&amp;amp;publication_year=2002&amp;amp;pages=201-210&amp;amp;pmid=12505701&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23776</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23777</code><code>]&lt;/span&gt;</code></p><p><code>23778</code><code>&lt;/span&gt;</code></p><p><code>23779</code><code>&lt;/li&gt;</code></p><p><code>23780</code><code>&lt;li id="R937"&gt;</code></p><p><code>23781</code><code>&lt;span class="citation"&gt;</code></p><p><code>23782</code><code>Paria BC, Zhao X, Wang J, Das SK, Dey SK. Fatty-acid amide hydrolase is expressed in the mouse uterus and embryo during the periimplantation period. &lt;span&gt;</code></p><p><code>23783</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23784</code><code>Biol Reprod. &lt;/span&gt;</code></p><p><code>23785</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>23786</code><code>60&lt;/span&gt;</code></p><p><code>23787</code><code>:1151–1157.&lt;/span&gt;</code></p><p><code>23788</code><code> [&lt;a href="/pubmed/10208977" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23789</code><code>PubMed&lt;/a&gt;</code></p><p><code>23790</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23791</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biol+Reprod&amp;amp;title=Fatty-acid+amide+hydrolase+is+expressed+in+the+mouse+uterus+and+embryo+during+the+periimplantation+period&amp;amp;author=BC+Paria&amp;amp;author=X+Zhao&amp;amp;author=J+Wang&amp;amp;author=SK+Das&amp;amp;author=SK+Dey&amp;amp;volume=60&amp;amp;publication_year=1999&amp;amp;pages=1151-1157&amp;amp;pmid=10208977&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23792</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23793</code><code>]&lt;/span&gt;</code></p><p><code>23794</code><code>&lt;/span&gt;</code></p><p><code>23795</code><code>&lt;/li&gt;</code></p><p><code>23796</code><code>&lt;li id="R938"&gt;</code></p><p><code>23797</code><code>&lt;span class="citation"&gt;</code></p><p><code>23798</code><code>Park B, Gibbons HM, Mitchell MD, Glass M. Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta. &lt;span&gt;</code></p><p><code>23799</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23800</code><code>Placenta. &lt;/span&gt;</code></p><p><code>23801</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>23802</code><code>24&lt;/span&gt;</code></p><p><code>23803</code><code>:990–995.&lt;/span&gt;</code></p><p><code>23804</code><code> [&lt;a href="/pubmed/14580383" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23805</code><code>PubMed&lt;/a&gt;</code></p><p><code>23806</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23807</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Placenta&amp;amp;title=Identification+of+the+CB1+cannabinoid+receptor+and+fatty+acid+amide+hydrolase+(FAAH)+in+the+human+placenta&amp;amp;author=B+Park&amp;amp;author=HM+Gibbons&amp;amp;author=MD+Mitchell&amp;amp;author=M+Glass&amp;amp;volume=24&amp;amp;publication_year=2003&amp;amp;pages=990-995&amp;amp;pmid=14580383&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23808</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23809</code><code>]&lt;/span&gt;</code></p><p><code>23810</code><code>&lt;/span&gt;</code></p><p><code>23811</code><code>&lt;/li&gt;</code></p><p><code>23812</code><code>&lt;li id="R939"&gt;</code></p><p><code>23813</code><code>&lt;span class="citation"&gt;</code></p><p><code>23814</code><code>Park B, McPartland JM, Glass M. Cannabis, cannabinoids and reproduction. &lt;span&gt;</code></p><p><code>23815</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23816</code><code>Prostaglandins Leukotrienes Essent Fatty Acids. &lt;/span&gt;</code></p><p><code>23817</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>23818</code><code>70&lt;/span&gt;</code></p><p><code>23819</code><code>:189–197.&lt;/span&gt;</code></p><p><code>23820</code><code> [&lt;a href="/pubmed/14683692" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23821</code><code>PubMed&lt;/a&gt;</code></p><p><code>23822</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23823</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Prostaglandins+Leukotrienes+Essent+Fatty+Acids&amp;amp;title=Cannabis,+cannabinoids+and+reproduction&amp;amp;author=B+Park&amp;amp;author=JM+McPartland&amp;amp;author=M+Glass&amp;amp;volume=70&amp;amp;publication_year=2004&amp;amp;pages=189-197&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23824</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23825</code><code>]&lt;/span&gt;</code></p><p><code>23826</code><code>&lt;/span&gt;</code></p><p><code>23827</code><code>&lt;/li&gt;</code></p><p><code>23828</code><code>&lt;li id="R940"&gt;</code></p><p><code>23829</code><code>&lt;span class="citation"&gt;</code></p><p><code>23830</code><code>Parker LA, Kwiatkowska M, Burton P, Mechoulam R. Effect of cannabinoids on lithium-induced vomiting in the &lt;em&gt;</code></p><p><code>23831</code><code>Suncus murinus&lt;/em&gt;</code></p><p><code>23832</code><code> (house musk shrew) &lt;span&gt;</code></p><p><code>23833</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23834</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>23835</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>23836</code><code>171&lt;/span&gt;</code></p><p><code>23837</code><code>:156–161.&lt;/span&gt;</code></p><p><code>23838</code><code> [&lt;a href="/pubmed/13680081" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23839</code><code>PubMed&lt;/a&gt;</code></p><p><code>23840</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23841</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Effect+of+cannabinoids+on+lithium-induced+vomiting+in+the+Suncus+murinus+(house+musk+shrew)&amp;amp;author=LA+Parker&amp;amp;author=M+Kwiatkowska&amp;amp;author=P+Burton&amp;amp;author=R+Mechoulam&amp;amp;volume=171&amp;amp;publication_year=2004&amp;amp;pages=156-161&amp;amp;pmid=13680081&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23842</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23843</code><code>]&lt;/span&gt;</code></p><p><code>23844</code><code>&lt;/span&gt;</code></p><p><code>23845</code><code>&lt;/li&gt;</code></p><p><code>23846</code><code>&lt;li id="R941"&gt;</code></p><p><code>23847</code><code>&lt;span class="citation"&gt;</code></p><p><code>23848</code><code>Parmentier-Batteur S, Jin K, Mao XO, Xie L, Greenberg DA. Increased severity of stroke in CB1 cannabinoid receptor knock-out mice. &lt;span&gt;</code></p><p><code>23849</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23850</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>23851</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>23852</code><code>22&lt;/span&gt;</code></p><p><code>23853</code><code>:9771–9775.&lt;/span&gt;</code></p><p><code>23854</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>23855</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6757835/"&gt;</code></p><p><code>23856</code><code>PMC free article&lt;/a&gt;</code></p><p><code>23857</code><code>]&lt;/span&gt;</code></p><p><code>23858</code><code> [&lt;a href="/pubmed/12427832" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23859</code><code>PubMed&lt;/a&gt;</code></p><p><code>23860</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23861</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Increased+severity+of+stroke+in+CB1+cannabinoid+receptor+knock-out+mice&amp;amp;author=S+Parmentier-Batteur&amp;amp;author=K+Jin&amp;amp;author=XO+Mao&amp;amp;author=L+Xie&amp;amp;author=DA+Greenberg&amp;amp;volume=22&amp;amp;publication_year=2002&amp;amp;pages=9771-9775&amp;amp;pmid=12427832&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23862</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23863</code><code>]&lt;/span&gt;</code></p><p><code>23864</code><code>&lt;/span&gt;</code></p><p><code>23865</code><code>&lt;/li&gt;</code></p><p><code>23866</code><code>&lt;li id="R942"&gt;</code></p><p><code>23867</code><code>&lt;span class="citation"&gt;</code></p><p><code>23868</code><code>Parolaro D, Massi P, Rubino T, Monti E. Endocannabinoids in the immune system and cancer: endocannabinoids in the immune system and cancer. &lt;span&gt;</code></p><p><code>23869</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23870</code><code>Prostaglandins Leukotrienes Essent Fatty Acids. &lt;/span&gt;</code></p><p><code>23871</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>23872</code><code>66&lt;/span&gt;</code></p><p><code>23873</code><code>:319–332.&lt;/span&gt;</code></p><p><code>23874</code><code> [&lt;a href="/pubmed/12052046" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23875</code><code>PubMed&lt;/a&gt;</code></p><p><code>23876</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23877</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Prostaglandins+Leukotrienes+Essent+Fatty+Acids&amp;amp;title=Endocannabinoids+in+the+immune+system+and+cancer:+endocannabinoids+in+the+immune+system+and+cancer&amp;amp;author=D+Parolaro&amp;amp;author=P+Massi&amp;amp;author=T+Rubino&amp;amp;author=E+Monti&amp;amp;volume=66&amp;amp;publication_year=2002&amp;amp;pages=319-332&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23878</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23879</code><code>]&lt;/span&gt;</code></p><p><code>23880</code><code>&lt;/span&gt;</code></p><p><code>23881</code><code>&lt;/li&gt;</code></p><p><code>23882</code><code>&lt;li id="R943"&gt;</code></p><p><code>23883</code><code>&lt;span class="citation"&gt;</code></p><p><code>23884</code><code>Pate DW, Jarvinen K, Urtti A, Jarho P, Fich M, Mahadevan V, Jarvinen T. Effects of topical anandamides on intraocular pressure in normotensive rabbits. &lt;span&gt;</code></p><p><code>23885</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23886</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>23887</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>23888</code><code>58&lt;/span&gt;</code></p><p><code>23889</code><code>:1849–1860.&lt;/span&gt;</code></p><p><code>23890</code><code> [&lt;a href="/pubmed/8637411" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23891</code><code>PubMed&lt;/a&gt;</code></p><p><code>23892</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23893</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Effects+of+topical+anandamides+on+intraocular+pressure+in+normotensive+rabbits&amp;amp;author=DW+Pate&amp;amp;author=K+Jarvinen&amp;amp;author=A+Urtti&amp;amp;author=P+Jarho&amp;amp;author=M+Fich&amp;amp;volume=58&amp;amp;publication_year=1996&amp;amp;pages=1849-1860&amp;amp;pmid=8637411&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23894</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23895</code><code>]&lt;/span&gt;</code></p><p><code>23896</code><code>&lt;/span&gt;</code></p><p><code>23897</code><code>&lt;/li&gt;</code></p><p><code>23898</code><code>&lt;li id="R944"&gt;</code></p><p><code>23899</code><code>&lt;span class="citation"&gt;</code></p><p><code>23900</code><code>Pate DW, Jarvinen K, Urtti A, Jarho P, Jarvinen T. Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits. &lt;span&gt;</code></p><p><code>23901</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23902</code><code>Curr Eye Res. &lt;/span&gt;</code></p><p><code>23903</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>23904</code><code>14&lt;/span&gt;</code></p><p><code>23905</code><code>:791–797.&lt;/span&gt;</code></p><p><code>23906</code><code> [&lt;a href="/pubmed/8529418" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23907</code><code>PubMed&lt;/a&gt;</code></p><p><code>23908</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23909</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Eye+Res&amp;amp;title=Ophthalmic+arachidonylethanolamide+decreases+intraocular+pressure+in+normotensive+rabbits&amp;amp;author=DW+Pate&amp;amp;author=K+Jarvinen&amp;amp;author=A+Urtti&amp;amp;author=P+Jarho&amp;amp;author=T+Jarvinen&amp;amp;volume=14&amp;amp;publication_year=1995&amp;amp;pages=791-797&amp;amp;pmid=8529418&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23910</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23911</code><code>]&lt;/span&gt;</code></p><p><code>23912</code><code>&lt;/span&gt;</code></p><p><code>23913</code><code>&lt;/li&gt;</code></p><p><code>23914</code><code>&lt;li id="R945"&gt;</code></p><p><code>23915</code><code>&lt;span class="citation"&gt;</code></p><p><code>23916</code><code>Pate DW, Jarvinen K, Urtti A, Mahadevan V, Jarvinen T. Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits. &lt;span&gt;</code></p><p><code>23917</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23918</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>23919</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>23920</code><code>63&lt;/span&gt;</code></p><p><code>23921</code><code>:2181–2188.&lt;/span&gt;</code></p><p><code>23922</code><code> [&lt;a href="/pubmed/9851310" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23923</code><code>PubMed&lt;/a&gt;</code></p><p><code>23924</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23925</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Effect+of+the+CB1+receptor+antagonist,+SR141716A,+on+cannabinoid-induced+ocular+hypotension+in+normotensive+rabbits&amp;amp;author=DW+Pate&amp;amp;author=K+Jarvinen&amp;amp;author=A+Urtti&amp;amp;author=V+Mahadevan&amp;amp;author=T+Jarvinen&amp;amp;volume=63&amp;amp;publication_year=1998&amp;amp;pages=2181-2188&amp;amp;pmid=9851310&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23926</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23927</code><code>]&lt;/span&gt;</code></p><p><code>23928</code><code>&lt;/span&gt;</code></p><p><code>23929</code><code>&lt;/li&gt;</code></p><p><code>23930</code><code>&lt;li id="R946"&gt;</code></p><p><code>23931</code><code>&lt;span class="citation"&gt;</code></p><p><code>23932</code><code>Patel S, Cravatt BF, Hillard CJ. Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala. &lt;span&gt;</code></p><p><code>23933</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23934</code><code>Neuropsychopharmacology. &lt;/span&gt;</code></p><p><code>23935</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>23936</code><code>30&lt;/span&gt;</code></p><p><code>23937</code><code>:497–507.&lt;/span&gt;</code></p><p><code>23938</code><code> [&lt;a href="/pubmed/15280883" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23939</code><code>PubMed&lt;/a&gt;</code></p><p><code>23940</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23941</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;amp;title=Synergistic+interactions+between+cannabinoids+and+environmental+stress+in+the+activation+of+the+central+amygdala&amp;amp;author=S+Patel&amp;amp;author=BF+Cravatt&amp;amp;author=CJ+Hillard&amp;amp;volume=30&amp;amp;publication_year=2005&amp;amp;pages=497-507&amp;amp;pmid=15280883&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23942</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23943</code><code>]&lt;/span&gt;</code></p><p><code>23944</code><code>&lt;/span&gt;</code></p><p><code>23945</code><code>&lt;/li&gt;</code></p><p><code>23946</code><code>&lt;li id="R947"&gt;</code></p><p><code>23947</code><code>&lt;span class="citation"&gt;</code></p><p><code>23948</code><code>Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. &lt;span&gt;</code></p><p><code>23949</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23950</code><code>Endocrinology. &lt;/span&gt;</code></p><p><code>23951</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>23952</code><code>145&lt;/span&gt;</code></p><p><code>23953</code><code>:5431–5438.&lt;/span&gt;</code></p><p><code>23954</code><code> [&lt;a href="/pubmed/15331569" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23955</code><code>PubMed&lt;/a&gt;</code></p><p><code>23956</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23957</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;amp;title=Endocannabinoid+signaling+negatively+modulates+stress-induced+activation+of+the+hypothalamic-pituitary-adrenal+axis&amp;amp;author=S+Patel&amp;amp;author=CT+Roelke&amp;amp;author=DJ+Rademacher&amp;amp;author=WE+Cullinan&amp;amp;author=CJ+Hillard&amp;amp;volume=145&amp;amp;publication_year=2004&amp;amp;pages=5431-5438&amp;amp;pmid=15331569&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23958</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23959</code><code>]&lt;/span&gt;</code></p><p><code>23960</code><code>&lt;/span&gt;</code></p><p><code>23961</code><code>&lt;/li&gt;</code></p><p><code>23962</code><code>&lt;li id="R948"&gt;</code></p><p><code>23963</code><code>&lt;span class="citation"&gt;</code></p><p><code>23964</code><code>Patel S, Wohlfeil ER, Rademacher DJ, Carrier EJ, Perry LJ, Kundu A, Falck JR, Nithipatikom K, Campbell WB, Hillard CJ. The general anesthetic propofol increases brain &lt;em&gt;</code></p><p><code>23965</code><code>N-&lt;/em&gt;</code></p><p><code>23966</code><code>arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. &lt;span&gt;</code></p><p><code>23967</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23968</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>23969</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>23970</code><code>139&lt;/span&gt;</code></p><p><code>23971</code><code>:1005–1013.&lt;/span&gt;</code></p><p><code>23972</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>23973</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1573928/"&gt;</code></p><p><code>23974</code><code>PMC free article&lt;/a&gt;</code></p><p><code>23975</code><code>]&lt;/span&gt;</code></p><p><code>23976</code><code> [&lt;a href="/pubmed/12839875" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>23977</code><code>PubMed&lt;/a&gt;</code></p><p><code>23978</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>23979</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=The+general+anesthetic+propofol+increases+brain+N-arachidonylethanolamine+(anandamide)+content+and+inhibits+fatty+acid+amide+hydrolase&amp;amp;author=S+Patel&amp;amp;author=ER+Wohlfeil&amp;amp;author=DJ+Rademacher&amp;amp;author=EJ+Carrier&amp;amp;author=LJ+Perry&amp;amp;volume=139&amp;amp;publication_year=2003&amp;amp;pages=1005-1013&amp;amp;pmid=12839875&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23980</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23981</code><code>]&lt;/span&gt;</code></p><p><code>23982</code><code>&lt;/span&gt;</code></p><p><code>23983</code><code>&lt;/li&gt;</code></p><p><code>23984</code><code>&lt;li id="R949"&gt;</code></p><p><code>23985</code><code>&lt;span class="citation"&gt;</code></p><p><code>23986</code><code>Paton WDM, Pertwee RG.  The actions of cannabis in man. In: Nahas GG, Paton WDM, editors. &lt;span class="ref-journal"&gt;</code></p><p><code>23987</code><code>Marijuana: Chemistry, Pharmacology, Metabolism and Clinical Effects.&lt;/span&gt;</code></p><p><code>23988</code><code> Pergamon Press; Oxford: 1973. pp. 735–738. &lt;span class="nowrap"&gt;</code></p><p><code>23989</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?title=Marijuana:+Chemistry,+Pharmacology,+Metabolism+and+Clinical+Effects&amp;amp;author=WDM+Paton&amp;amp;author=RG+Pertwee&amp;amp;publication_year=1973&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>23990</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>23991</code><code>]&lt;/span&gt;</code></p><p><code>23992</code><code>&lt;/span&gt;</code></p><p><code>23993</code><code>&lt;/li&gt;</code></p><p><code>23994</code><code>&lt;li id="R950"&gt;</code></p><p><code>23995</code><code>&lt;span class="citation"&gt;</code></p><p><code>23996</code><code>Patrick GB. Marijuana and the lung. &lt;span&gt;</code></p><p><code>23997</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>23998</code><code>Postgrad Med. &lt;/span&gt;</code></p><p><code>23999</code><code>1980;&lt;span class="ref-vol"&gt;</code></p><p><code>24000</code><code>67&lt;/span&gt;</code></p><p><code>24001</code><code>:110–113. 116–118.&lt;/span&gt;</code></p><p><code>24002</code><code> [&lt;a href="/pubmed/7375399" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24003</code><code>PubMed&lt;/a&gt;</code></p><p><code>24004</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24005</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Postgrad+Med&amp;amp;title=Marijuana+and+the+lung&amp;amp;author=GB+Patrick&amp;amp;volume=67&amp;amp;publication_year=1980&amp;amp;pages=110-113&amp;amp;pmid=7375399&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24006</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24007</code><code>]&lt;/span&gt;</code></p><p><code>24008</code><code>&lt;/span&gt;</code></p><p><code>24009</code><code>&lt;/li&gt;</code></p><p><code>24010</code><code>&lt;li id="R951"&gt;</code></p><p><code>24011</code><code>&lt;span class="citation"&gt;</code></p><p><code>24012</code><code>Patsos HA, Hicks DJ, Greenhough A, Williams AC, Paraskeva C. Cannabinoids and cancer: potential for colorectal cancer therapy. &lt;span&gt;</code></p><p><code>24013</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24014</code><code>Biochem Soc Trans. &lt;/span&gt;</code></p><p><code>24015</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>24016</code><code>33&lt;/span&gt;</code></p><p><code>24017</code><code>:712–714.&lt;/span&gt;</code></p><p><code>24018</code><code> [&lt;a href="/pubmed/16042581" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24019</code><code>PubMed&lt;/a&gt;</code></p><p><code>24020</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24021</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Soc+Trans&amp;amp;title=Cannabinoids+and+cancer:+potential+for+colorectal+cancer+therapy&amp;amp;author=HA+Patsos&amp;amp;author=DJ+Hicks&amp;amp;author=A+Greenhough&amp;amp;author=AC+Williams&amp;amp;author=C+Paraskeva&amp;amp;volume=33&amp;amp;publication_year=2005&amp;amp;pages=712-714&amp;amp;pmid=16042581&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24022</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24023</code><code>]&lt;/span&gt;</code></p><p><code>24024</code><code>&lt;/span&gt;</code></p><p><code>24025</code><code>&lt;/li&gt;</code></p><p><code>24026</code><code>&lt;li id="R952"&gt;</code></p><p><code>24027</code><code>&lt;span class="citation"&gt;</code></p><p><code>24028</code><code>Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M, Hall W. Cannabis use and mental health in young people: cohort study. &lt;span&gt;</code></p><p><code>24029</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24030</code><code>BMJ. &lt;/span&gt;</code></p><p><code>24031</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>24032</code><code>325&lt;/span&gt;</code></p><p><code>24033</code><code>:1195–1198.&lt;/span&gt;</code></p><p><code>24034</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>24035</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC135489/"&gt;</code></p><p><code>24036</code><code>PMC free article&lt;/a&gt;</code></p><p><code>24037</code><code>]&lt;/span&gt;</code></p><p><code>24038</code><code> [&lt;a href="/pubmed/12446533" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24039</code><code>PubMed&lt;/a&gt;</code></p><p><code>24040</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24041</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;amp;title=Cannabis+use+and+mental+health+in+young+people:+cohort+study&amp;amp;author=GC+Patton&amp;amp;author=C+Coffey&amp;amp;author=JB+Carlin&amp;amp;author=L+Degenhardt&amp;amp;author=M+Lynskey&amp;amp;volume=325&amp;amp;publication_year=2002&amp;amp;pages=1195-1198&amp;amp;pmid=12446533&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24042</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24043</code><code>]&lt;/span&gt;</code></p><p><code>24044</code><code>&lt;/span&gt;</code></p><p><code>24045</code><code>&lt;/li&gt;</code></p><p><code>24046</code><code>&lt;li id="R953"&gt;</code></p><p><code>24047</code><code>&lt;span class="citation"&gt;</code></p><p><code>24048</code><code>Paulaskis JD, Sul HS. Cloning and expression of mouse fatty acid synthase and other specific mRNA: developmental and hormonal regulation in 3T3&amp;#x02013;L1 cells. &lt;span&gt;</code></p><p><code>24049</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24050</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>24051</code><code>1988;&lt;span class="ref-vol"&gt;</code></p><p><code>24052</code><code>263&lt;/span&gt;</code></p><p><code>24053</code><code>:7049–7054.&lt;/span&gt;</code></p><p><code>24054</code><code> [&lt;a href="/pubmed/2452820" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24055</code><code>PubMed&lt;/a&gt;</code></p><p><code>24056</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24057</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=Cloning+and+expression+of+mouse+fatty+acid+synthase+and+other+specific+mRNA:+developmental+and+hormonal+regulation+in+3T3&amp;#x02013;L1+cells&amp;amp;author=JD+Paulaskis&amp;amp;author=HS+Sul&amp;amp;volume=263&amp;amp;publication_year=1988&amp;amp;pages=7049-7054&amp;amp;pmid=2452820&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24058</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24059</code><code>]&lt;/span&gt;</code></p><p><code>24060</code><code>&lt;/span&gt;</code></p><p><code>24061</code><code>&lt;/li&gt;</code></p><p><code>24062</code><code>&lt;li id="R954"&gt;</code></p><p><code>24063</code><code>&lt;span class="citation"&gt;</code></p><p><code>24064</code><code>Pazos MR, Nunez E, Benito C, Tolon RM, Romero J. Role of the endocannabinoid system in Alzheimer&amp;#x02019;s disease: new perspectives. &lt;span&gt;</code></p><p><code>24065</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24066</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>24067</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>24068</code><code>75&lt;/span&gt;</code></p><p><code>24069</code><code>:1907–1915.&lt;/span&gt;</code></p><p><code>24070</code><code> [&lt;a href="/pubmed/15306158" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24071</code><code>PubMed&lt;/a&gt;</code></p><p><code>24072</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24073</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Role+of+the+endocannabinoid+system+in+Alzheimer&amp;#x02019;s+disease:+new+perspectives&amp;amp;author=MR+Pazos&amp;amp;author=E+Nunez&amp;amp;author=C+Benito&amp;amp;author=RM+Tolon&amp;amp;author=J+Romero&amp;amp;volume=75&amp;amp;publication_year=2004&amp;amp;pages=1907-1915&amp;amp;pmid=15306158&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24074</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24075</code><code>]&lt;/span&gt;</code></p><p><code>24076</code><code>&lt;/span&gt;</code></p><p><code>24077</code><code>&lt;/li&gt;</code></p><p><code>24078</code><code>&lt;li id="R955"&gt;</code></p><p><code>24079</code><code>&lt;span class="citation"&gt;</code></p><p><code>24080</code><code>Pertwee RG. Cannabinoids and the gastrointestinal tract. &lt;span&gt;</code></p><p><code>24081</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24082</code><code>Gut. &lt;/span&gt;</code></p><p><code>24083</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>24084</code><code>48&lt;/span&gt;</code></p><p><code>24085</code><code>:859–867.&lt;/span&gt;</code></p><p><code>24086</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>24087</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1728337/"&gt;</code></p><p><code>24088</code><code>PMC free article&lt;/a&gt;</code></p><p><code>24089</code><code>]&lt;/span&gt;</code></p><p><code>24090</code><code> [&lt;a href="/pubmed/11358910" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24091</code><code>PubMed&lt;/a&gt;</code></p><p><code>24092</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24093</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;amp;title=Cannabinoids+and+the+gastrointestinal+tract&amp;amp;author=RG+Pertwee&amp;amp;volume=48&amp;amp;publication_year=2001&amp;amp;pages=859-867&amp;amp;pmid=11358910&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24094</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24095</code><code>]&lt;/span&gt;</code></p><p><code>24096</code><code>&lt;/span&gt;</code></p><p><code>24097</code><code>&lt;/li&gt;</code></p><p><code>24098</code><code>&lt;li id="R956"&gt;</code></p><p><code>24099</code><code>&lt;span class="citation"&gt;</code></p><p><code>24100</code><code>Pertwee RG. Cannabinoids and multiple sclerosis. &lt;span&gt;</code></p><p><code>24101</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24102</code><code>Pharmacol Ther. &lt;/span&gt;</code></p><p><code>24103</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>24104</code><code>95&lt;/span&gt;</code></p><p><code>24105</code><code>:165–174.&lt;/span&gt;</code></p><p><code>24106</code><code> [&lt;a href="/pubmed/12182963" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24107</code><code>PubMed&lt;/a&gt;</code></p><p><code>24108</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24109</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Ther&amp;amp;title=Cannabinoids+and+multiple+sclerosis&amp;amp;author=RG+Pertwee&amp;amp;volume=95&amp;amp;publication_year=2002&amp;amp;pages=165-174&amp;amp;pmid=12182963&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24110</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24111</code><code>]&lt;/span&gt;</code></p><p><code>24112</code><code>&lt;/span&gt;</code></p><p><code>24113</code><code>&lt;/li&gt;</code></p><p><code>24114</code><code>&lt;li id="R957"&gt;</code></p><p><code>24115</code><code>&lt;span class="citation"&gt;</code></p><p><code>24116</code><code>Pertwee RG. The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. &lt;span&gt;</code></p><p><code>24117</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24118</code><code>AAPS J. &lt;/span&gt;</code></p><p><code>24119</code><code>2005a;&lt;span class="ref-vol"&gt;</code></p><p><code>24120</code><code>7&lt;/span&gt;</code></p><p><code>24121</code><code>:E625–E654.&lt;/span&gt;</code></p><p><code>24122</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>24123</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC2751266/"&gt;</code></p><p><code>24124</code><code>PMC free article&lt;/a&gt;</code></p><p><code>24125</code><code>]&lt;/span&gt;</code></p><p><code>24126</code><code> [&lt;a href="/pubmed/16353941" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24127</code><code>PubMed&lt;/a&gt;</code></p><p><code>24128</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24129</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=AAPS+J&amp;amp;title=The+therapeutic+potential+of+drugs+that+target+cannabinoid+receptors+or+modulate+the+tissue+levels+or+actions+of+endocannabinoids&amp;amp;author=RG+Pertwee&amp;amp;volume=7&amp;amp;publication_year=2005a&amp;amp;pages=E625-E654&amp;amp;pmid=16353941&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24130</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24131</code><code>]&lt;/span&gt;</code></p><p><code>24132</code><code>&lt;/span&gt;</code></p><p><code>24133</code><code>&lt;/li&gt;</code></p><p><code>24134</code><code>&lt;li id="R958"&gt;</code></p><p><code>24135</code><code>&lt;span class="citation"&gt;</code></p><p><code>24136</code><code>Pertwee RG. Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. &lt;span&gt;</code></p><p><code>24137</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24138</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>24139</code><code>2005b;&lt;span class="ref-vol"&gt;</code></p><p><code>24140</code><code>76&lt;/span&gt;</code></p><p><code>24141</code><code>:1307–1324.&lt;/span&gt;</code></p><p><code>24142</code><code> [&lt;a href="/pubmed/15670612" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24143</code><code>PubMed&lt;/a&gt;</code></p><p><code>24144</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24145</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Inverse+agonism+and+neutral+antagonism+at+cannabinoid+CB1+receptors&amp;amp;author=RG+Pertwee&amp;amp;volume=76&amp;amp;publication_year=2005b&amp;amp;pages=1307-1324&amp;amp;pmid=15670612&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24146</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24147</code><code>]&lt;/span&gt;</code></p><p><code>24148</code><code>&lt;/span&gt;</code></p><p><code>24149</code><code>&lt;/li&gt;</code></p><p><code>24150</code><code>&lt;li id="R959"&gt;</code></p><p><code>24151</code><code>&lt;span class="citation"&gt;</code></p><p><code>24152</code><code>Pertwee RG.  Pharmacological actions of cannabinoids. In: Pertwee R, editor. &lt;span class="ref-journal"&gt;</code></p><p><code>24153</code><code>Cannabinoids.&lt;/span&gt;</code></p><p><code>24154</code><code> Springer; New York: 2005c. pp. 1–53. [&lt;a href="/pubmed/16596770" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24155</code><code>PubMed&lt;/a&gt;</code></p><p><code>24156</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24157</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?title=Cannabinoids&amp;amp;author=RG+Pertwee&amp;amp;publication_year=2005c&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24158</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24159</code><code>]&lt;/span&gt;</code></p><p><code>24160</code><code>&lt;/span&gt;</code></p><p><code>24161</code><code>&lt;/li&gt;</code></p><p><code>24162</code><code>&lt;li id="R960"&gt;</code></p><p><code>24163</code><code>&lt;span class="citation"&gt;</code></p><p><code>24164</code><code>Pertwee RG, Browne SE, Ross TM, Stretton CD. An investigation of the involvement of GABA in certain pharmacological effects of &amp;#x00394;-9-tetrahydrocannabinol. &lt;span&gt;</code></p><p><code>24165</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24166</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>24167</code><code>1991;&lt;span class="ref-vol"&gt;</code></p><p><code>24168</code><code>40&lt;/span&gt;</code></p><p><code>24169</code><code>:581–585.&lt;/span&gt;</code></p><p><code>24170</code><code> [&lt;a href="/pubmed/1666920" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24171</code><code>PubMed&lt;/a&gt;</code></p><p><code>24172</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24173</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=An+investigation+of+the+involvement+of+GABA+in+certain+pharmacological+effects+of+&amp;#x00394;-9-tetrahydrocannabinol&amp;amp;author=RG+Pertwee&amp;amp;author=SE+Browne&amp;amp;author=TM+Ross&amp;amp;author=CD+Stretton&amp;amp;volume=40&amp;amp;publication_year=1991&amp;amp;pages=581-585&amp;amp;pmid=1666920&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24174</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24175</code><code>]&lt;/span&gt;</code></p><p><code>24176</code><code>&lt;/span&gt;</code></p><p><code>24177</code><code>&lt;/li&gt;</code></p><p><code>24178</code><code>&lt;li id="R961"&gt;</code></p><p><code>24179</code><code>&lt;span class="citation"&gt;</code></p><p><code>24180</code><code>Pertwee RG, Fernando SR, Griffin G, Abadji V, Makriyannis A. Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. &lt;span&gt;</code></p><p><code>24181</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24182</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>24183</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>24184</code><code>272&lt;/span&gt;</code></p><p><code>24185</code><code>:73–78.&lt;/span&gt;</code></p><p><code>24186</code><code> [&lt;a href="/pubmed/7713152" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24187</code><code>PubMed&lt;/a&gt;</code></p><p><code>24188</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24189</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Effect+of+phenylmethylsulphonyl+fluoride+on+the+potency+of+anandamide+as+an+inhibitor+of+electrically+evoked+contractions+in+two+isolated+tissue+preparations&amp;amp;author=RG+Pertwee&amp;amp;author=SR+Fernando&amp;amp;author=G+Griffin&amp;amp;author=V+Abadji&amp;amp;author=A+Makriyannis&amp;amp;volume=272&amp;amp;publication_year=1995&amp;amp;pages=73-78&amp;amp;pmid=7713152&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24190</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24191</code><code>]&lt;/span&gt;</code></p><p><code>24192</code><code>&lt;/span&gt;</code></p><p><code>24193</code><code>&lt;/li&gt;</code></p><p><code>24194</code><code>&lt;li id="R962"&gt;</code></p><p><code>24195</code><code>&lt;span class="citation"&gt;</code></p><p><code>24196</code><code>Pertwee RG, Fernando SR, Nash JE, Coutts AA. Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine. &lt;span&gt;</code></p><p><code>24197</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24198</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>24199</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>24200</code><code>118&lt;/span&gt;</code></p><p><code>24201</code><code>:2199–2205.&lt;/span&gt;</code></p><p><code>24202</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>24203</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1909886/"&gt;</code></p><p><code>24204</code><code>PMC free article&lt;/a&gt;</code></p><p><code>24205</code><code>]&lt;/span&gt;</code></p><p><code>24206</code><code> [&lt;a href="/pubmed/8864562" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24207</code><code>PubMed&lt;/a&gt;</code></p><p><code>24208</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24209</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Further+evidence+for+the+presence+of+cannabinoid+CB1+receptors+in+guinea-pig+small+intestine&amp;amp;author=RG+Pertwee&amp;amp;author=SR+Fernando&amp;amp;author=JE+Nash&amp;amp;author=AA+Coutts&amp;amp;volume=118&amp;amp;publication_year=1996&amp;amp;pages=2199-2205&amp;amp;pmid=8864562&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24210</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24211</code><code>]&lt;/span&gt;</code></p><p><code>24212</code><code>&lt;/span&gt;</code></p><p><code>24213</code><code>&lt;/li&gt;</code></p><p><code>24214</code><code>&lt;li id="R963"&gt;</code></p><p><code>24215</code><code>&lt;span class="citation"&gt;</code></p><p><code>24216</code><code>Pertwee RG, Ross RA, Craib SJ, Thomas A. (&amp;#x02212;)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens. &lt;span&gt;</code></p><p><code>24217</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24218</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>24219</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>24220</code><code>456&lt;/span&gt;</code></p><p><code>24221</code><code>:99–106.&lt;/span&gt;</code></p><p><code>24222</code><code> [&lt;a href="/pubmed/12450575" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24223</code><code>PubMed&lt;/a&gt;</code></p><p><code>24224</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24225</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=(&amp;#x02212;)-Cannabidiol+antagonizes+cannabinoid+receptor+agonists+and+noradrenaline+in+the+mouse+vas+deferens&amp;amp;author=RG+Pertwee&amp;amp;author=RA+Ross&amp;amp;author=SJ+Craib&amp;amp;author=A+Thomas&amp;amp;volume=456&amp;amp;publication_year=2002&amp;amp;pages=99-106&amp;amp;pmid=12450575&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24226</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24227</code><code>]&lt;/span&gt;</code></p><p><code>24228</code><code>&lt;/span&gt;</code></p><p><code>24229</code><code>&lt;/li&gt;</code></p><p><code>24230</code><code>&lt;li id="R964"&gt;</code></p><p><code>24231</code><code>&lt;span class="citation"&gt;</code></p><p><code>24232</code><code>Perwitz N, Fasshauer M, Klein J. Cannabinoid receptor signaling directly inhibits thermogenesis and alters expression of adiponectin and visfatin. &lt;span&gt;</code></p><p><code>24233</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24234</code><code>Horm Metab Res. &lt;/span&gt;</code></p><p><code>24235</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>24236</code><code>38&lt;/span&gt;</code></p><p><code>24237</code><code>:356–358.&lt;/span&gt;</code></p><p><code>24238</code><code> [&lt;a href="/pubmed/16718635" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24239</code><code>PubMed&lt;/a&gt;</code></p><p><code>24240</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24241</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Horm+Metab+Res&amp;amp;title=Cannabinoid+receptor+signaling+directly+inhibits+thermogenesis+and+alters+expression+of+adiponectin+and+visfatin&amp;amp;author=N+Perwitz&amp;amp;author=M+Fasshauer&amp;amp;author=J+Klein&amp;amp;volume=38&amp;amp;publication_year=2006&amp;amp;pages=356-358&amp;amp;pmid=16718635&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24242</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24243</code><code>]&lt;/span&gt;</code></p><p><code>24244</code><code>&lt;/span&gt;</code></p><p><code>24245</code><code>&lt;/li&gt;</code></p><p><code>24246</code><code>&lt;li id="R965"&gt;</code></p><p><code>24247</code><code>&lt;span class="citation"&gt;</code></p><p><code>24248</code><code>Petro DJ. Marihuana as a therapeutic agent for muscle spasm or spasticity. &lt;span&gt;</code></p><p><code>24249</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24250</code><code>Psychosomatics. &lt;/span&gt;</code></p><p><code>24251</code><code>1980;&lt;span class="ref-vol"&gt;</code></p><p><code>24252</code><code>21&lt;/span&gt;</code></p><p><code>24253</code><code>:81–85.&lt;/span&gt;</code></p><p><code>24254</code><code> [&lt;a href="/pubmed/7360860" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24255</code><code>PubMed&lt;/a&gt;</code></p><p><code>24256</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24257</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychosomatics&amp;amp;title=Marihuana+as+a+therapeutic+agent+for+muscle+spasm+or+spasticity&amp;amp;author=DJ+Petro&amp;amp;volume=21&amp;amp;publication_year=1980&amp;amp;pages=81-85&amp;amp;pmid=7360860&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24258</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24259</code><code>]&lt;/span&gt;</code></p><p><code>24260</code><code>&lt;/span&gt;</code></p><p><code>24261</code><code>&lt;/li&gt;</code></p><p><code>24262</code><code>&lt;li id="R966"&gt;</code></p><p><code>24263</code><code>&lt;span class="citation"&gt;</code></p><p><code>24264</code><code>Petro DJ, Ellenberger C., Jr Treatment of human spasticity with &amp;#x00394;&lt;sup&gt;</code></p><p><code>24265</code><code>9&lt;/sup&gt;</code></p><p><code>24266</code><code>-tetrahydrocannabinol. &lt;span&gt;</code></p><p><code>24267</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24268</code><code>J Clin Pharmacol. &lt;/span&gt;</code></p><p><code>24269</code><code>1981;&lt;span class="ref-vol"&gt;</code></p><p><code>24270</code><code>21&lt;/span&gt;</code></p><p><code>24271</code><code>:413S–416S.&lt;/span&gt;</code></p><p><code>24272</code><code> [&lt;a href="/pubmed/6271839" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24273</code><code>PubMed&lt;/a&gt;</code></p><p><code>24274</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24275</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pharmacol&amp;amp;title=Treatment+of+human+spasticity+with+&amp;#x00394;9-tetrahydrocannabinol&amp;amp;author=DJ+Petro&amp;amp;author=C+Ellenberger&amp;amp;volume=21&amp;amp;publication_year=1981&amp;amp;pages=413S-416S&amp;amp;pmid=6271839&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24276</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24277</code><code>]&lt;/span&gt;</code></p><p><code>24278</code><code>&lt;/span&gt;</code></p><p><code>24279</code><code>&lt;/li&gt;</code></p><p><code>24280</code><code>&lt;li id="R967"&gt;</code></p><p><code>24281</code><code>&lt;span class="citation"&gt;</code></p><p><code>24282</code><code>Pfitzer T, Niederhoffer N, Szabo B. Central effects of the cannabinoid receptor agonist WIN55212-2 on respiratory and cardiovascular regulation in anaesthetised rats. &lt;span&gt;</code></p><p><code>24283</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24284</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>24285</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>24286</code><code>142&lt;/span&gt;</code></p><p><code>24287</code><code>:943–952.&lt;/span&gt;</code></p><p><code>24288</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>24289</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1575120/"&gt;</code></p><p><code>24290</code><code>PMC free article&lt;/a&gt;</code></p><p><code>24291</code><code>]&lt;/span&gt;</code></p><p><code>24292</code><code> [&lt;a href="/pubmed/15226190" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24293</code><code>PubMed&lt;/a&gt;</code></p><p><code>24294</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24295</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Central+effects+of+the+cannabinoid+receptor+agonist+WIN55212-2+on+respiratory+and+cardiovascular+regulation+in+anaesthetised+rats&amp;amp;author=T+Pfitzer&amp;amp;author=N+Niederhoffer&amp;amp;author=B+Szabo&amp;amp;volume=142&amp;amp;publication_year=2004&amp;amp;pages=943-952&amp;amp;pmid=15226190&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24296</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24297</code><code>]&lt;/span&gt;</code></p><p><code>24298</code><code>&lt;/span&gt;</code></p><p><code>24299</code><code>&lt;/li&gt;</code></p><p><code>24300</code><code>&lt;li id="R968"&gt;</code></p><p><code>24301</code><code>&lt;span class="citation"&gt;</code></p><p><code>24302</code><code>Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J for the RIO North America Group. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients. &lt;span&gt;</code></p><p><code>24303</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24304</code><code>J Am Med Assoc. &lt;/span&gt;</code></p><p><code>24305</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>24306</code><code>295&lt;/span&gt;</code></p><p><code>24307</code><code>:761–775.&lt;/span&gt;</code></p><p><code>24308</code><code> [&lt;a href="/pubmed/16478899" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24309</code><code>PubMed&lt;/a&gt;</code></p><p><code>24310</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24311</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Med+Assoc&amp;amp;title=Effect+of+rimonabant,+a+cannabinoid-1+receptor+blocker,+on+weight+and+cardiometabolic+risk+factors+in+overweight+or+obese+patients&amp;amp;author=FX+Pi-Sunyer&amp;amp;author=LJ+Aronne&amp;amp;author=HM+Heshmati&amp;amp;author=J+Devin&amp;amp;author=J+Rosenstock&amp;amp;volume=295&amp;amp;publication_year=2006&amp;amp;pages=761-775&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24312</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24313</code><code>]&lt;/span&gt;</code></p><p><code>24314</code><code>&lt;/span&gt;</code></p><p><code>24315</code><code>&lt;/li&gt;</code></p><p><code>24316</code><code>&lt;li id="R969"&gt;</code></p><p><code>24317</code><code>&lt;span class="citation"&gt;</code></p><p><code>24318</code><code>Pinto A, Tuttolomondo A, Di Raimondo D, Fernandez P, Licata G. Cerebrovascular risk factors and clinical classification of strokes. &lt;span&gt;</code></p><p><code>24319</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24320</code><code>Semin Vasc Med. &lt;/span&gt;</code></p><p><code>24321</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>24322</code><code>4&lt;/span&gt;</code></p><p><code>24323</code><code>:287–303.&lt;/span&gt;</code></p><p><code>24324</code><code> [&lt;a href="/pubmed/15630637" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24325</code><code>PubMed&lt;/a&gt;</code></p><p><code>24326</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24327</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Semin+Vasc+Med&amp;amp;title=Cerebrovascular+risk+factors+and+clinical+classification+of+strokes&amp;amp;author=A+Pinto&amp;amp;author=A+Tuttolomondo&amp;amp;author=D+Di+Raimondo&amp;amp;author=P+Fernandez&amp;amp;author=G+Licata&amp;amp;volume=4&amp;amp;publication_year=2004&amp;amp;pages=287-303&amp;amp;pmid=15630637&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24328</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24329</code><code>]&lt;/span&gt;</code></p><p><code>24330</code><code>&lt;/span&gt;</code></p><p><code>24331</code><code>&lt;/li&gt;</code></p><p><code>24332</code><code>&lt;li id="R970"&gt;</code></p><p><code>24333</code><code>&lt;span class="citation"&gt;</code></p><p><code>24334</code><code>Pinto L, Capasso R, Di Carlo G, Izzo AA. Endocannabinoids and the gut. &lt;span&gt;</code></p><p><code>24335</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24336</code><code>Prostaglandins Leukotrienes Essent Fatty Acids. &lt;/span&gt;</code></p><p><code>24337</code><code>2002a;&lt;span class="ref-vol"&gt;</code></p><p><code>24338</code><code>66&lt;/span&gt;</code></p><p><code>24339</code><code>:333–341.&lt;/span&gt;</code></p><p><code>24340</code><code> [&lt;a href="/pubmed/12052047" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24341</code><code>PubMed&lt;/a&gt;</code></p><p><code>24342</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24343</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Prostaglandins+Leukotrienes+Essent+Fatty+Acids&amp;amp;title=Endocannabinoids+and+the+gut&amp;amp;author=L+Pinto&amp;amp;author=R+Capasso&amp;amp;author=G+Di+Carlo&amp;amp;author=AA+Izzo&amp;amp;volume=66&amp;amp;publication_year=2002a&amp;amp;pages=333-341&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24344</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24345</code><code>]&lt;/span&gt;</code></p><p><code>24346</code><code>&lt;/span&gt;</code></p><p><code>24347</code><code>&lt;/li&gt;</code></p><p><code>24348</code><code>&lt;li id="R971"&gt;</code></p><p><code>24349</code><code>&lt;span class="citation"&gt;</code></p><p><code>24350</code><code>Pinto L, Izzo AA, Cascio MG, Bisogno T, Hospodar-Scott K, Brown DR, Mascolo N, Di Marzo V, Capasso F. Endocannabinoids as physiological regulators of colonic propulsion in mice. &lt;span&gt;</code></p><p><code>24351</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24352</code><code>Gastroenterology. &lt;/span&gt;</code></p><p><code>24353</code><code>2002b;&lt;span class="ref-vol"&gt;</code></p><p><code>24354</code><code>123&lt;/span&gt;</code></p><p><code>24355</code><code>:227–234.&lt;/span&gt;</code></p><p><code>24356</code><code> [&lt;a href="/pubmed/12105851" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24357</code><code>PubMed&lt;/a&gt;</code></p><p><code>24358</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24359</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;amp;title=Endocannabinoids+as+physiological+regulators+of+colonic+propulsion+in+mice&amp;amp;author=L+Pinto&amp;amp;author=AA+Izzo&amp;amp;author=MG+Cascio&amp;amp;author=T+Bisogno&amp;amp;author=K+Hospodar-Scott&amp;amp;volume=123&amp;amp;publication_year=2002b&amp;amp;pages=227-234&amp;amp;pmid=12105851&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24360</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24361</code><code>]&lt;/span&gt;</code></p><p><code>24362</code><code>&lt;/span&gt;</code></p><p><code>24363</code><code>&lt;/li&gt;</code></p><p><code>24364</code><code>&lt;li id="R972"&gt;</code></p><p><code>24365</code><code>&lt;span class="citation"&gt;</code></p><p><code>24366</code><code>Piomelli D. The molecular logic of endocannabinoid signaling. &lt;span&gt;</code></p><p><code>24367</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24368</code><code>Nat Rev Neurosci. &lt;/span&gt;</code></p><p><code>24369</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>24370</code><code>4&lt;/span&gt;</code></p><p><code>24371</code><code>:873–884.&lt;/span&gt;</code></p><p><code>24372</code><code> [&lt;a href="/pubmed/14595399" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24373</code><code>PubMed&lt;/a&gt;</code></p><p><code>24374</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24375</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Neurosci&amp;amp;title=The+molecular+logic+of+endocannabinoid+signaling&amp;amp;author=D+Piomelli&amp;amp;volume=4&amp;amp;publication_year=2003&amp;amp;pages=873-884&amp;amp;pmid=14595399&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24376</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24377</code><code>]&lt;/span&gt;</code></p><p><code>24378</code><code>&lt;/span&gt;</code></p><p><code>24379</code><code>&lt;/li&gt;</code></p><p><code>24380</code><code>&lt;li id="R973"&gt;</code></p><p><code>24381</code><code>&lt;span class="citation"&gt;</code></p><p><code>24382</code><code>Pistis M, Perra S, Pillolla G, Melis M, Gessa GL, Muntoni AL. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1-and non-CB1-mediated actions. &lt;span&gt;</code></p><p><code>24383</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24384</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>24385</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>24386</code><code>46&lt;/span&gt;</code></p><p><code>24387</code><code>:115–125.&lt;/span&gt;</code></p><p><code>24388</code><code> [&lt;a href="/pubmed/14654103" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24389</code><code>PubMed&lt;/a&gt;</code></p><p><code>24390</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24391</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=Cannabinoids+modulate+neuronal+firing+in+the+rat+basolateral+amygdala:+evidence+for+CB1-and+non-CB1-mediated+actions&amp;amp;author=M+Pistis&amp;amp;author=S+Perra&amp;amp;author=G+Pillolla&amp;amp;author=M+Melis&amp;amp;author=GL+Gessa&amp;amp;volume=46&amp;amp;publication_year=2004&amp;amp;pages=115-125&amp;amp;pmid=14654103&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24392</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24393</code><code>]&lt;/span&gt;</code></p><p><code>24394</code><code>&lt;/span&gt;</code></p><p><code>24395</code><code>&lt;/li&gt;</code></p><p><code>24396</code><code>&lt;li id="R974"&gt;</code></p><p><code>24397</code><code>&lt;span class="citation"&gt;</code></p><p><code>24398</code><code>Pivik RT, Zarcone V, Dement WC, Hollister LE. &amp;#x00394;-9-Tetrahydrocannabinol and synhexl: effects on human sleep patterns. &lt;span&gt;</code></p><p><code>24399</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24400</code><code>Clin Pharmacol Ther. &lt;/span&gt;</code></p><p><code>24401</code><code>1972;&lt;span class="ref-vol"&gt;</code></p><p><code>24402</code><code>13&lt;/span&gt;</code></p><p><code>24403</code><code>:426–435.&lt;/span&gt;</code></p><p><code>24404</code><code> [&lt;a href="/pubmed/4337346" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24405</code><code>PubMed&lt;/a&gt;</code></p><p><code>24406</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24407</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;amp;title=&amp;#x00394;-9-Tetrahydrocannabinol+and+synhexl:+effects+on+human+sleep+patterns&amp;amp;author=RT+Pivik&amp;amp;author=V+Zarcone&amp;amp;author=WC+Dement&amp;amp;author=LE+Hollister&amp;amp;volume=13&amp;amp;publication_year=1972&amp;amp;pages=426-435&amp;amp;pmid=4337346&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24408</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24409</code><code>]&lt;/span&gt;</code></p><p><code>24410</code><code>&lt;/span&gt;</code></p><p><code>24411</code><code>&lt;/li&gt;</code></p><p><code>24412</code><code>&lt;li id="R975"&gt;</code></p><p><code>24413</code><code>&lt;span class="citation"&gt;</code></p><p><code>24414</code><code>Poirier B, Bidouard J-P, Cadrouvele C, Marniquet X, Staels B, O&amp;#x02019;Connor SE, Janiak P, Herbert J-M. The anti-obesity effect of rimonabant is associated with an improved serum lipid profile. &lt;span&gt;</code></p><p><code>24415</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24416</code><code>Diabetes Obesity Metab. &lt;/span&gt;</code></p><p><code>24417</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>24418</code><code>7&lt;/span&gt;</code></p><p><code>24419</code><code>:65–72.&lt;/span&gt;</code></p><p><code>24420</code><code> [&lt;a href="/pubmed/15642077" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24421</code><code>PubMed&lt;/a&gt;</code></p><p><code>24422</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24423</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Diabetes+Obesity+Metab&amp;amp;title=The+anti-obesity+effect+of+rimonabant+is+associated+with+an+improved+serum+lipid+profile&amp;amp;author=B+Poirier&amp;amp;author=J-P+Bidouard&amp;amp;author=C+Cadrouvele&amp;amp;author=X+Marniquet&amp;amp;author=B+Staels&amp;amp;volume=7&amp;amp;publication_year=2005&amp;amp;pages=65-72&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24424</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24425</code><code>]&lt;/span&gt;</code></p><p><code>24426</code><code>&lt;/span&gt;</code></p><p><code>24427</code><code>&lt;/li&gt;</code></p><p><code>24428</code><code>&lt;li id="R976"&gt;</code></p><p><code>24429</code><code>&lt;span class="citation"&gt;</code></p><p><code>24430</code><code>Poncelet M, Maruani J, Calassi R, Soubri&amp;#x000e9; P. Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice. &lt;span&gt;</code></p><p><code>24431</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24432</code><code>Neurosci Lett. &lt;/span&gt;</code></p><p><code>24433</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>24434</code><code>343&lt;/span&gt;</code></p><p><code>24435</code><code>:216–218.&lt;/span&gt;</code></p><p><code>24436</code><code> [&lt;a href="/pubmed/12770700" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24437</code><code>PubMed&lt;/a&gt;</code></p><p><code>24438</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24439</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Lett&amp;amp;title=Overeating,+alcohol+and+sucrose+consumption+decrease+in+CB1+receptor+deleted+mice&amp;amp;author=M+Poncelet&amp;amp;author=J+Maruani&amp;amp;author=R+Calassi&amp;amp;author=P+Soubri&amp;#x000e9;&amp;amp;volume=343&amp;amp;publication_year=2003&amp;amp;pages=216-218&amp;amp;pmid=12770700&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24440</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24441</code><code>]&lt;/span&gt;</code></p><p><code>24442</code><code>&lt;/span&gt;</code></p><p><code>24443</code><code>&lt;/li&gt;</code></p><p><code>24444</code><code>&lt;li id="R977"&gt;</code></p><p><code>24445</code><code>&lt;span class="citation"&gt;</code></p><p><code>24446</code><code>Pontieri FE, Tanda G, Orzi F, Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. &lt;span&gt;</code></p><p><code>24447</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24448</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>24449</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>24450</code><code>382&lt;/span&gt;</code></p><p><code>24451</code><code>:255–257.&lt;/span&gt;</code></p><p><code>24452</code><code> [&lt;a href="/pubmed/8717040" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24453</code><code>PubMed&lt;/a&gt;</code></p><p><code>24454</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24455</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Effects+of+nicotine+on+the+nucleus+accumbens+and+similarity+to+those+of+addictive+drugs&amp;amp;author=FE+Pontieri&amp;amp;author=G+Tanda&amp;amp;author=F+Orzi&amp;amp;author=G+Di+Chiara&amp;amp;volume=382&amp;amp;publication_year=1996&amp;amp;pages=255-257&amp;amp;pmid=8717040&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24456</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24457</code><code>]&lt;/span&gt;</code></p><p><code>24458</code><code>&lt;/span&gt;</code></p><p><code>24459</code><code>&lt;/li&gt;</code></p><p><code>24460</code><code>&lt;li id="R978"&gt;</code></p><p><code>24461</code><code>&lt;span class="citation"&gt;</code></p><p><code>24462</code><code>Porcella A, Casellas P, Gessa GL, Pani L. Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana. &lt;span&gt;</code></p><p><code>24463</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24464</code><code>Brain Res Mol Brain Res. &lt;/span&gt;</code></p><p><code>24465</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>24466</code><code>58&lt;/span&gt;</code></p><p><code>24467</code><code>:240–245.&lt;/span&gt;</code></p><p><code>24468</code><code> [&lt;a href="/pubmed/9685662" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24469</code><code>PubMed&lt;/a&gt;</code></p><p><code>24470</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24471</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res+Mol+Brain+Res&amp;amp;title=Cannabinoid+receptor+CB1+mRNA+is+highly+expressed+in+the+rat+ciliary+body:+implications+for+the+antiglaucoma+properties+of+marihuana&amp;amp;author=A+Porcella&amp;amp;author=P+Casellas&amp;amp;author=GL+Gessa&amp;amp;author=L+Pani&amp;amp;volume=58&amp;amp;publication_year=1998&amp;amp;pages=240-245&amp;amp;pmid=9685662&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24472</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24473</code><code>]&lt;/span&gt;</code></p><p><code>24474</code><code>&lt;/span&gt;</code></p><p><code>24475</code><code>&lt;/li&gt;</code></p><p><code>24476</code><code>&lt;li id="R979"&gt;</code></p><p><code>24477</code><code>&lt;span class="citation"&gt;</code></p><p><code>24478</code><code>Porcella A, Marchese G, Casu MA, Rocchitta A, Lai ML, Gessa GL, Pani L. Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid. &lt;span&gt;</code></p><p><code>24479</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24480</code><code>Eur J Endocrinol. &lt;/span&gt;</code></p><p><code>24481</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>24482</code><code>147&lt;/span&gt;</code></p><p><code>24483</code><code>:255–261.&lt;/span&gt;</code></p><p><code>24484</code><code> [&lt;a href="/pubmed/12153749" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24485</code><code>PubMed&lt;/a&gt;</code></p><p><code>24486</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24487</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Endocrinol&amp;amp;title=Evidence+for+functional+CB1+cannabinoid+receptor+expressed+in+the+rat+thyroid&amp;amp;author=A+Porcella&amp;amp;author=G+Marchese&amp;amp;author=MA+Casu&amp;amp;author=A+Rocchitta&amp;amp;author=ML+Lai&amp;amp;volume=147&amp;amp;publication_year=2002&amp;amp;pages=255-261&amp;amp;pmid=12153749&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24488</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24489</code><code>]&lt;/span&gt;</code></p><p><code>24490</code><code>&lt;/span&gt;</code></p><p><code>24491</code><code>&lt;/li&gt;</code></p><p><code>24492</code><code>&lt;li id="R980"&gt;</code></p><p><code>24493</code><code>&lt;span class="citation"&gt;</code></p><p><code>24494</code><code>Porcella A, Maxia C, Gessa GL, Pani L. The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein. &lt;span&gt;</code></p><p><code>24495</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24496</code><code>Eur J Neurosci. &lt;/span&gt;</code></p><p><code>24497</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>24498</code><code>12&lt;/span&gt;</code></p><p><code>24499</code><code>:1123–1127.&lt;/span&gt;</code></p><p><code>24500</code><code> [&lt;a href="/pubmed/10762343" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24501</code><code>PubMed&lt;/a&gt;</code></p><p><code>24502</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24503</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurosci&amp;amp;title=The+human+eye+expresses+high+levels+of+CB1+cannabinoid+receptor+mRNA+and+protein&amp;amp;author=A+Porcella&amp;amp;author=C+Maxia&amp;amp;author=GL+Gessa&amp;amp;author=L+Pani&amp;amp;volume=12&amp;amp;publication_year=2000&amp;amp;pages=1123-1127&amp;amp;pmid=10762343&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24504</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24505</code><code>]&lt;/span&gt;</code></p><p><code>24506</code><code>&lt;/span&gt;</code></p><p><code>24507</code><code>&lt;/li&gt;</code></p><p><code>24508</code><code>&lt;li id="R981"&gt;</code></p><p><code>24509</code><code>&lt;span class="citation"&gt;</code></p><p><code>24510</code><code>Porcella A, Maxia C, Gessa GL, Pani L. The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies. &lt;span&gt;</code></p><p><code>24511</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24512</code><code>Eur J Neurosci. &lt;/span&gt;</code></p><p><code>24513</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>24514</code><code>13&lt;/span&gt;</code></p><p><code>24515</code><code>:409–412.&lt;/span&gt;</code></p><p><code>24516</code><code> [&lt;a href="/pubmed/11168547" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24517</code><code>PubMed&lt;/a&gt;</code></p><p><code>24518</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24519</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurosci&amp;amp;title=The+synthetic+cannabinoid+WIN55212-2+decreases+the+intraocular+pressure+in+human+glaucoma+resistant+to+conventional+therapies&amp;amp;author=A+Porcella&amp;amp;author=C+Maxia&amp;amp;author=GL+Gessa&amp;amp;author=L+Pani&amp;amp;volume=13&amp;amp;publication_year=2001&amp;amp;pages=409-412&amp;amp;pmid=11168547&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24520</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24521</code><code>]&lt;/span&gt;</code></p><p><code>24522</code><code>&lt;/span&gt;</code></p><p><code>24523</code><code>&lt;/li&gt;</code></p><p><code>24524</code><code>&lt;li id="R982"&gt;</code></p><p><code>24525</code><code>&lt;span class="citation"&gt;</code></p><p><code>24526</code><code>Portella G, Laezza C, Laccetti P, De Petrocellis L, Di Marzo V, Bifulco M. Inhibitory effects of cannabinoid CB&lt;sub&gt;</code></p><p><code>24527</code><code>1&lt;/sub&gt;</code></p><p><code>24528</code><code> receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis. &lt;span&gt;</code></p><p><code>24529</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24530</code><code>FASEB J. &lt;/span&gt;</code></p><p><code>24531</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>24532</code><code>17&lt;/span&gt;</code></p><p><code>24533</code><code>:1771–1773.&lt;/span&gt;</code></p><p><code>24534</code><code> [&lt;a href="/pubmed/12958205" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24535</code><code>PubMed&lt;/a&gt;</code></p><p><code>24536</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24537</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;amp;title=Inhibitory+effects+of+cannabinoid+CB1+receptor+stimulation+on+tumor+growth+and+metastatic+spreading:+actions+on+signals+involved+in+angiogenesis+and+metastasis&amp;amp;author=G+Portella&amp;amp;author=C+Laezza&amp;amp;author=P+Laccetti&amp;amp;author=L+De+Petrocellis&amp;amp;author=V+Di+Marzo&amp;amp;volume=17&amp;amp;publication_year=2003&amp;amp;pages=1771-1773&amp;amp;pmid=12958205&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24538</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24539</code><code>]&lt;/span&gt;</code></p><p><code>24540</code><code>&lt;/span&gt;</code></p><p><code>24541</code><code>&lt;/li&gt;</code></p><p><code>24542</code><code>&lt;li id="R983"&gt;</code></p><p><code>24543</code><code>&lt;span class="citation"&gt;</code></p><p><code>24544</code><code>Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J, Nomikos GG, Carter P, Bymaster FP, Leese AB, et al.  Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. &lt;span&gt;</code></p><p><code>24545</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24546</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>24547</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>24548</code><code>301&lt;/span&gt;</code></p><p><code>24549</code><code>:1020–1024.&lt;/span&gt;</code></p><p><code>24550</code><code> [&lt;a href="/pubmed/12023533" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24551</code><code>PubMed&lt;/a&gt;</code></p><p><code>24552</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24553</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Characterization+of+a+novel+endocannabinoid,+virodhamine,+with+antagonist+activity+at+the+CB1+receptor&amp;amp;author=AC+Porter&amp;amp;author=JM+Sauer&amp;amp;author=MD+Knierman&amp;amp;author=GW+Becker&amp;amp;author=MJ+Berna&amp;amp;volume=301&amp;amp;publication_year=2002&amp;amp;pages=1020-1024&amp;amp;pmid=12023533&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24554</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24555</code><code>]&lt;/span&gt;</code></p><p><code>24556</code><code>&lt;/span&gt;</code></p><p><code>24557</code><code>&lt;/li&gt;</code></p><p><code>24558</code><code>&lt;li id="R984"&gt;</code></p><p><code>24559</code><code>&lt;span class="citation"&gt;</code></p><p><code>24560</code><code>Powles T, te Poele R, Shamash J, Chaplin T, Propper D, Joel S, Oliver T, Liu WM. Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway. &lt;span&gt;</code></p><p><code>24561</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24562</code><code>Blood. &lt;/span&gt;</code></p><p><code>24563</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>24564</code><code>105&lt;/span&gt;</code></p><p><code>24565</code><code>:1214–1221.&lt;/span&gt;</code></p><p><code>24566</code><code> [&lt;a href="/pubmed/15454482" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24567</code><code>PubMed&lt;/a&gt;</code></p><p><code>24568</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24569</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;amp;title=Cannabis-induced+cytotoxicity+in+leukemic+cell+lines:+the+role+of+the+cannabinoid+receptors+and+the+MAPK+pathway&amp;amp;author=T+Powles&amp;amp;author=R+te+Poele&amp;amp;author=J+Shamash&amp;amp;author=T+Chaplin&amp;amp;author=D+Propper&amp;amp;volume=105&amp;amp;publication_year=2005&amp;amp;pages=1214-1221&amp;amp;pmid=15454482&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24570</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24571</code><code>]&lt;/span&gt;</code></p><p><code>24572</code><code>&lt;/span&gt;</code></p><p><code>24573</code><code>&lt;/li&gt;</code></p><p><code>24574</code><code>&lt;li id="R985"&gt;</code></p><p><code>24575</code><code>&lt;span class="citation"&gt;</code></p><p><code>24576</code><code>Prather PL, Martin NA, Breivogel CS, Childers SR. Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein &lt;em&gt;</code></p><p><code>24577</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>24578</code><code>-subunits with different potencies. &lt;span&gt;</code></p><p><code>24579</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24580</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>24581</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>24582</code><code>57&lt;/span&gt;</code></p><p><code>24583</code><code>:1000–1010.&lt;/span&gt;</code></p><p><code>24584</code><code> [&lt;a href="/pubmed/10779385" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24585</code><code>PubMed&lt;/a&gt;</code></p><p><code>24586</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24587</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=Activation+of+cannabinoid+receptors+in+rat+brain+by+WIN+55212-2+produces+coupling+to+multiple+G+protein+&amp;#x003b1;-subunits+with+different+potencies&amp;amp;author=PL+Prather&amp;amp;author=NA+Martin&amp;amp;author=CS+Breivogel&amp;amp;author=SR+Childers&amp;amp;volume=57&amp;amp;publication_year=2000&amp;amp;pages=1000-1010&amp;amp;pmid=10779385&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24588</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24589</code><code>]&lt;/span&gt;</code></p><p><code>24590</code><code>&lt;/span&gt;</code></p><p><code>24591</code><code>&lt;/li&gt;</code></p><p><code>24592</code><code>&lt;li id="R986"&gt;</code></p><p><code>24593</code><code>&lt;span class="citation"&gt;</code></p><p><code>24594</code><code>Pryce G, Baker D. Emerging properties of cannabinoid medicines in management of multiple sclerosis. &lt;span&gt;</code></p><p><code>24595</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24596</code><code>Trends Neurosci. &lt;/span&gt;</code></p><p><code>24597</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>24598</code><code>28&lt;/span&gt;</code></p><p><code>24599</code><code>:272–276.&lt;/span&gt;</code></p><p><code>24600</code><code> [&lt;a href="/pubmed/15866202" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24601</code><code>PubMed&lt;/a&gt;</code></p><p><code>24602</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24603</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Trends+Neurosci&amp;amp;title=Emerging+properties+of+cannabinoid+medicines+in+management+of+multiple+sclerosis&amp;amp;author=G+Pryce&amp;amp;author=D+Baker&amp;amp;volume=28&amp;amp;publication_year=2005&amp;amp;pages=272-276&amp;amp;pmid=15866202&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24604</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24605</code><code>]&lt;/span&gt;</code></p><p><code>24606</code><code>&lt;/span&gt;</code></p><p><code>24607</code><code>&lt;/li&gt;</code></p><p><code>24608</code><code>&lt;li id="R987"&gt;</code></p><p><code>24609</code><code>&lt;span class="citation"&gt;</code></p><p><code>24610</code><code>Pryce G, Ahmed Z, Hankey DJ, Jackson SJ, Croxford JL, Pocock JM, Ledent C, Petzold A, Thompson AJ, Giovannoni G, et al.  Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. &lt;span&gt;</code></p><p><code>24611</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24612</code><code>Brain. &lt;/span&gt;</code></p><p><code>24613</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>24614</code><code>126&lt;/span&gt;</code></p><p><code>24615</code><code>:2191–2202.&lt;/span&gt;</code></p><p><code>24616</code><code> [&lt;a href="/pubmed/12876144" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24617</code><code>PubMed&lt;/a&gt;</code></p><p><code>24618</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24619</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;amp;title=Cannabinoids+inhibit+neurodegeneration+in+models+of+multiple+sclerosis&amp;amp;author=G+Pryce&amp;amp;author=Z+Ahmed&amp;amp;author=DJ+Hankey&amp;amp;author=SJ+Jackson&amp;amp;author=JL+Croxford&amp;amp;volume=126&amp;amp;publication_year=2003&amp;amp;pages=2191-2202&amp;amp;pmid=12876144&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24620</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24621</code><code>]&lt;/span&gt;</code></p><p><code>24622</code><code>&lt;/span&gt;</code></p><p><code>24623</code><code>&lt;/li&gt;</code></p><p><code>24624</code><code>&lt;li id="R988"&gt;</code></p><p><code>24625</code><code>&lt;span class="citation"&gt;</code></p><p><code>24626</code><code>Pugh G, Jr, Mason DJ, Jr, Combs V, Welch SP. Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP55,940 in the spinal cord. &lt;span&gt;</code></p><p><code>24627</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24628</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>24629</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>24630</code><code>281&lt;/span&gt;</code></p><p><code>24631</code><code>:730–737.&lt;/span&gt;</code></p><p><code>24632</code><code> [&lt;a href="/pubmed/9152379" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24633</code><code>PubMed&lt;/a&gt;</code></p><p><code>24634</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24635</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Involvement+of+dynorphin+B+in+the+antinociceptive+effects+of+the+cannabinoid+CP55,940+in+the+spinal+cord&amp;amp;author=G+Pugh&amp;amp;author=DJ+Mason&amp;amp;author=V+Combs&amp;amp;author=SP+Welch&amp;amp;volume=281&amp;amp;publication_year=1997&amp;amp;pages=730-737&amp;amp;pmid=9152379&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24636</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24637</code><code>]&lt;/span&gt;</code></p><p><code>24638</code><code>&lt;/span&gt;</code></p><p><code>24639</code><code>&lt;/li&gt;</code></p><p><code>24640</code><code>&lt;li id="R989"&gt;</code></p><p><code>24641</code><code>&lt;span class="citation"&gt;</code></p><p><code>24642</code><code>Purnell WD, Gregg JM. &amp;#x00394;&lt;sup&gt;</code></p><p><code>24643</code><code>9&lt;/sup&gt;</code></p><p><code>24644</code><code>-Tetrahydrocannabinol, euphoria and intraocular pressure in man. &lt;span&gt;</code></p><p><code>24645</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24646</code><code>Ann Ophthalmol. &lt;/span&gt;</code></p><p><code>24647</code><code>1975;&lt;span class="ref-vol"&gt;</code></p><p><code>24648</code><code>7&lt;/span&gt;</code></p><p><code>24649</code><code>:921–923.&lt;/span&gt;</code></p><p><code>24650</code><code> [&lt;a href="/pubmed/1147519" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24651</code><code>PubMed&lt;/a&gt;</code></p><p><code>24652</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24653</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Ann+Ophthalmol&amp;amp;title=&amp;#x00394;9-Tetrahydrocannabinol,+euphoria+and+intraocular+pressure+in+man&amp;amp;author=WD+Purnell&amp;amp;author=JM+Gregg&amp;amp;volume=7&amp;amp;publication_year=1975&amp;amp;pages=921-923&amp;amp;pmid=1147519&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24654</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24655</code><code>]&lt;/span&gt;</code></p><p><code>24656</code><code>&lt;/span&gt;</code></p><p><code>24657</code><code>&lt;/li&gt;</code></p><p><code>24658</code><code>&lt;li id="R990"&gt;</code></p><p><code>24659</code><code>&lt;span class="citation"&gt;</code></p><p><code>24660</code><code>Quartilho A, Mata HP, Ibrahim MM, Vanderah TW, Porreca F, Makriyannis A, Malan TP., Jr Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. &lt;span&gt;</code></p><p><code>24661</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24662</code><code>Anesthesiology. &lt;/span&gt;</code></p><p><code>24663</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>24664</code><code>99&lt;/span&gt;</code></p><p><code>24665</code><code>:955–960.&lt;/span&gt;</code></p><p><code>24666</code><code> [&lt;a href="/pubmed/14508331" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24667</code><code>PubMed&lt;/a&gt;</code></p><p><code>24668</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24669</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Anesthesiology&amp;amp;title=Inhibition+of+inflammatory+hyperalgesia+by+activation+of+peripheral+CB2+cannabinoid+receptors&amp;amp;author=A+Quartilho&amp;amp;author=HP+Mata&amp;amp;author=MM+Ibrahim&amp;amp;author=TW+Vanderah&amp;amp;author=F+Porreca&amp;amp;volume=99&amp;amp;publication_year=2003&amp;amp;pages=955-960&amp;amp;pmid=14508331&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24670</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24671</code><code>]&lt;/span&gt;</code></p><p><code>24672</code><code>&lt;/span&gt;</code></p><p><code>24673</code><code>&lt;/li&gt;</code></p><p><code>24674</code><code>&lt;li id="R991"&gt;</code></p><p><code>24675</code><code>&lt;span class="citation"&gt;</code></p><p><code>24676</code><code>Racz I, Bilkei-Gorzo A, Toth ZE, Michel K, Palkovits M, Zimmer A. A critical role for the cannabinoid CB&lt;sub&gt;</code></p><p><code>24677</code><code>1&lt;/sub&gt;</code></p><p><code>24678</code><code> receptors in alcohol dependence and stress- stimulated ethanol drinking. &lt;span&gt;</code></p><p><code>24679</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24680</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>24681</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>24682</code><code>23&lt;/span&gt;</code></p><p><code>24683</code><code>:2453–2458.&lt;/span&gt;</code></p><p><code>24684</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>24685</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6742040/"&gt;</code></p><p><code>24686</code><code>PMC free article&lt;/a&gt;</code></p><p><code>24687</code><code>]&lt;/span&gt;</code></p><p><code>24688</code><code> [&lt;a href="/pubmed/12657705" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24689</code><code>PubMed&lt;/a&gt;</code></p><p><code>24690</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24691</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=A+critical+role+for+the+cannabinoid+CB1+receptors+in+alcohol+dependence+and+stress-+stimulated+ethanol+drinking&amp;amp;author=I+Racz&amp;amp;author=A+Bilkei-Gorzo&amp;amp;author=ZE+Toth&amp;amp;author=K+Michel&amp;amp;author=M+Palkovits&amp;amp;volume=23&amp;amp;publication_year=2003&amp;amp;pages=2453-2458&amp;amp;pmid=12657705&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24692</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24693</code><code>]&lt;/span&gt;</code></p><p><code>24694</code><code>&lt;/span&gt;</code></p><p><code>24695</code><code>&lt;/li&gt;</code></p><p><code>24696</code><code>&lt;li id="R992"&gt;</code></p><p><code>24697</code><code>&lt;span class="citation"&gt;</code></p><p><code>24698</code><code>Rademacher DJ, Patel S, Hopp FA, Dean C, Hillard CJ, Seagard JL. Microinjection of a cannabinoid receptor antagonist into the NTS increases baroreflex duration in dogs. &lt;span&gt;</code></p><p><code>24699</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24700</code><code>Am J Physiol. &lt;/span&gt;</code></p><p><code>24701</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>24702</code><code>284&lt;/span&gt;</code></p><p><code>24703</code><code>:H1570–H1576.&lt;/span&gt;</code></p><p><code>24704</code><code> [&lt;a href="/pubmed/12521935" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24705</code><code>PubMed&lt;/a&gt;</code></p><p><code>24706</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24707</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol&amp;amp;title=Microinjection+of+a+cannabinoid+receptor+antagonist+into+the+NTS+increases+baroreflex+duration+in+dogs&amp;amp;author=DJ+Rademacher&amp;amp;author=S+Patel&amp;amp;author=FA+Hopp&amp;amp;author=C+Dean&amp;amp;author=CJ+Hillard&amp;amp;volume=284&amp;amp;publication_year=2003&amp;amp;pages=H1570-H1576&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24708</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24709</code><code>]&lt;/span&gt;</code></p><p><code>24710</code><code>&lt;/span&gt;</code></p><p><code>24711</code><code>&lt;/li&gt;</code></p><p><code>24712</code><code>&lt;li id="R993"&gt;</code></p><p><code>24713</code><code>&lt;span class="citation"&gt;</code></p><p><code>24714</code><code>Raft D, Gregg J, Ghia J, Harris L. Effects of intravenous tetrahydrocannabinol on experimental and surgical pain: psychological correlates of the analgesic response. &lt;span&gt;</code></p><p><code>24715</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24716</code><code>Clin Pharmacol Ther. &lt;/span&gt;</code></p><p><code>24717</code><code>1977;&lt;span class="ref-vol"&gt;</code></p><p><code>24718</code><code>21&lt;/span&gt;</code></p><p><code>24719</code><code>:26–33.&lt;/span&gt;</code></p><p><code>24720</code><code> [&lt;a href="/pubmed/832447" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24721</code><code>PubMed&lt;/a&gt;</code></p><p><code>24722</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24723</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;amp;title=Effects+of+intravenous+tetrahydrocannabinol+on+experimental+and+surgical+pain:+psychological+correlates+of+the+analgesic+response&amp;amp;author=D+Raft&amp;amp;author=J+Gregg&amp;amp;author=J+Ghia&amp;amp;author=L+Harris&amp;amp;volume=21&amp;amp;publication_year=1977&amp;amp;pages=26-33&amp;amp;pmid=832447&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24724</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24725</code><code>]&lt;/span&gt;</code></p><p><code>24726</code><code>&lt;/span&gt;</code></p><p><code>24727</code><code>&lt;/li&gt;</code></p><p><code>24728</code><code>&lt;li id="R994"&gt;</code></p><p><code>24729</code><code>&lt;span class="citation"&gt;</code></p><p><code>24730</code><code>Ralevic V, Kendall DA, Randall MD, Smart D. Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function. &lt;span&gt;</code></p><p><code>24731</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24732</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>24733</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>24734</code><code>71&lt;/span&gt;</code></p><p><code>24735</code><code>:2577–2594.&lt;/span&gt;</code></p><p><code>24736</code><code> [&lt;a href="/pubmed/12354577" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24737</code><code>PubMed&lt;/a&gt;</code></p><p><code>24738</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24739</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Cannabinoid+modulation+of+sensory+neurotransmission+via+cannabinoid+and+vanilloid+receptors:+roles+in+regulation+of+cardiovascular+function&amp;amp;author=V+Ralevic&amp;amp;author=DA+Kendall&amp;amp;author=MD+Randall&amp;amp;author=D+Smart&amp;amp;volume=71&amp;amp;publication_year=2002&amp;amp;pages=2577-2594&amp;amp;pmid=12354577&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24740</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24741</code><code>]&lt;/span&gt;</code></p><p><code>24742</code><code>&lt;/span&gt;</code></p><p><code>24743</code><code>&lt;/li&gt;</code></p><p><code>24744</code><code>&lt;li id="R995"&gt;</code></p><p><code>24745</code><code>&lt;span class="citation"&gt;</code></p><p><code>24746</code><code>Raman C, McAllister SD, Rizvi G, Patel SG, Moore DH, Abood ME. Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid. &lt;span&gt;</code></p><p><code>24747</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24748</code><code>Amyotroph Lateral Scler Other Motor Neuron Disord. &lt;/span&gt;</code></p><p><code>24749</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>24750</code><code>5&lt;/span&gt;</code></p><p><code>24751</code><code>:33–39.&lt;/span&gt;</code></p><p><code>24752</code><code> [&lt;a href="/pubmed/15204022" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24753</code><code>PubMed&lt;/a&gt;</code></p><p><code>24754</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24755</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Amyotroph+Lateral+Scler+Other+Motor+Neuron+Disord&amp;amp;title=Amyotrophic+lateral+sclerosis:+delayed+disease+progression+in+mice+by+treatment+with+a+cannabinoid&amp;amp;author=C+Raman&amp;amp;author=SD+McAllister&amp;amp;author=G+Rizvi&amp;amp;author=SG+Patel&amp;amp;author=DH+Moore&amp;amp;volume=5&amp;amp;publication_year=2004&amp;amp;pages=33-39&amp;amp;pmid=15204022&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24756</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24757</code><code>]&lt;/span&gt;</code></p><p><code>24758</code><code>&lt;/span&gt;</code></p><p><code>24759</code><code>&lt;/li&gt;</code></p><p><code>24760</code><code>&lt;li id="R996"&gt;</code></p><p><code>24761</code><code>&lt;span class="citation"&gt;</code></p><p><code>24762</code><code>Ramirez BG, Blazquez C, G&amp;#x000f3;mez del Pulgar T, Guzman M, de Ceballos ML. Prevention of Alzheimer&amp;#x02019;s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. &lt;span&gt;</code></p><p><code>24763</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24764</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>24765</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>24766</code><code>25&lt;/span&gt;</code></p><p><code>24767</code><code>:1904–1913.&lt;/span&gt;</code></p><p><code>24768</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>24769</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6726060/"&gt;</code></p><p><code>24770</code><code>PMC free article&lt;/a&gt;</code></p><p><code>24771</code><code>]&lt;/span&gt;</code></p><p><code>24772</code><code> [&lt;a href="/pubmed/15728830" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24773</code><code>PubMed&lt;/a&gt;</code></p><p><code>24774</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24775</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Prevention+of+Alzheimer&amp;#x02019;s+disease+pathology+by+cannabinoids:+neuroprotection+mediated+by+blockade+of+microglial+activation&amp;amp;author=BG+Ramirez&amp;amp;author=C+Blazquez&amp;amp;author=T+G&amp;#x000f3;mez+del+Pulgar&amp;amp;author=M+Guzman&amp;amp;author=ML+de+Ceballos&amp;amp;volume=25&amp;amp;publication_year=2005&amp;amp;pages=1904-1913&amp;amp;pmid=15728830&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24776</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24777</code><code>]&lt;/span&gt;</code></p><p><code>24778</code><code>&lt;/span&gt;</code></p><p><code>24779</code><code>&lt;/li&gt;</code></p><p><code>24780</code><code>&lt;li id="R997"&gt;</code></p><p><code>24781</code><code>&lt;span class="citation"&gt;</code></p><p><code>24782</code><code>Ramos JA, Gonzalez S, Sagredo O, Gomez-Ruiz M, Fernandez-Ruiz J. Therapeutic potential of the endocannabinoid system in the brain. &lt;span&gt;</code></p><p><code>24783</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24784</code><code>Mini Rev Med Chem. &lt;/span&gt;</code></p><p><code>24785</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>24786</code><code>5&lt;/span&gt;</code></p><p><code>24787</code><code>:609–617.&lt;/span&gt;</code></p><p><code>24788</code><code> [&lt;a href="/pubmed/16026307" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24789</code><code>PubMed&lt;/a&gt;</code></p><p><code>24790</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24791</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mini+Rev+Med+Chem&amp;amp;title=Therapeutic+potential+of+the+endocannabinoid+system+in+the+brain&amp;amp;author=JA+Ramos&amp;amp;author=S+Gonzalez&amp;amp;author=O+Sagredo&amp;amp;author=M+Gomez-Ruiz&amp;amp;author=J+Fernandez-Ruiz&amp;amp;volume=5&amp;amp;publication_year=2005&amp;amp;pages=609-617&amp;amp;pmid=16026307&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24792</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24793</code><code>]&lt;/span&gt;</code></p><p><code>24794</code><code>&lt;/span&gt;</code></p><p><code>24795</code><code>&lt;/li&gt;</code></p><p><code>24796</code><code>&lt;li id="R998"&gt;</code></p><p><code>24797</code><code>&lt;span class="citation"&gt;</code></p><p><code>24798</code><code>Randall MD, Harris D, Kendall DA, Ralevic V. Cardiovascular effects of cannabinoids. &lt;span&gt;</code></p><p><code>24799</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24800</code><code>Pharmacol Ther. &lt;/span&gt;</code></p><p><code>24801</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>24802</code><code>95&lt;/span&gt;</code></p><p><code>24803</code><code>:191–202.&lt;/span&gt;</code></p><p><code>24804</code><code> [&lt;a href="/pubmed/12182966" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24805</code><code>PubMed&lt;/a&gt;</code></p><p><code>24806</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24807</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Ther&amp;amp;title=Cardiovascular+effects+of+cannabinoids&amp;amp;author=MD+Randall&amp;amp;author=D+Harris&amp;amp;author=DA+Kendall&amp;amp;author=V+Ralevic&amp;amp;volume=95&amp;amp;publication_year=2002&amp;amp;pages=191-202&amp;amp;pmid=12182966&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24808</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24809</code><code>]&lt;/span&gt;</code></p><p><code>24810</code><code>&lt;/span&gt;</code></p><p><code>24811</code><code>&lt;/li&gt;</code></p><p><code>24812</code><code>&lt;li id="R999"&gt;</code></p><p><code>24813</code><code>&lt;span class="citation"&gt;</code></p><p><code>24814</code><code>Randall MD, Kendall DA, O&amp;#x02019;Sullivan The complexities of the cardiovascular actions of cannabinoids. &lt;span&gt;</code></p><p><code>24815</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24816</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>24817</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>24818</code><code>142&lt;/span&gt;</code></p><p><code>24819</code><code>:20–26.&lt;/span&gt;</code></p><p><code>24820</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>24821</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1574918/"&gt;</code></p><p><code>24822</code><code>PMC free article&lt;/a&gt;</code></p><p><code>24823</code><code>]&lt;/span&gt;</code></p><p><code>24824</code><code> [&lt;a href="/pubmed/15131000" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24825</code><code>PubMed&lt;/a&gt;</code></p><p><code>24826</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24827</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=The+complexities+of+the+cardiovascular+actions+of+cannabinoids&amp;amp;author=MD+Randall&amp;amp;author=DA+Kendall&amp;amp;author=+O&amp;#x02019;Sullivan&amp;amp;volume=142&amp;amp;publication_year=2004&amp;amp;pages=20-26&amp;amp;pmid=15131000&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24828</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24829</code><code>]&lt;/span&gt;</code></p><p><code>24830</code><code>&lt;/span&gt;</code></p><p><code>24831</code><code>&lt;/li&gt;</code></p><p><code>24832</code><code>&lt;li id="R1000"&gt;</code></p><p><code>24833</code><code>&lt;span class="citation"&gt;</code></p><p><code>24834</code><code>Ravinet Trillou C, Arnone M, Delgorge C, Gonalons N, Keane P, Maffrand JP, Soubri&amp;#x000e9; P. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. &lt;span&gt;</code></p><p><code>24835</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24836</code><code>Am J Physiol. &lt;/span&gt;</code></p><p><code>24837</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>24838</code><code>284&lt;/span&gt;</code></p><p><code>24839</code><code>:R345–R353.&lt;/span&gt;</code></p><p><code>24840</code><code> [&lt;a href="/pubmed/12399252" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24841</code><code>PubMed&lt;/a&gt;</code></p><p><code>24842</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24843</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol&amp;amp;title=Anti-obesity+effect+of+SR141716,+a+CB1+receptor+antagonist,+in+diet-induced+obese+mice&amp;amp;author=C+Ravinet+Trillou&amp;amp;author=M+Arnone&amp;amp;author=C+Delgorge&amp;amp;author=N+Gonalons&amp;amp;author=P+Keane&amp;amp;volume=284&amp;amp;publication_year=2003&amp;amp;pages=R345-R353&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24844</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24845</code><code>]&lt;/span&gt;</code></p><p><code>24846</code><code>&lt;/span&gt;</code></p><p><code>24847</code><code>&lt;/li&gt;</code></p><p><code>24848</code><code>&lt;li id="R1001"&gt;</code></p><p><code>24849</code><code>&lt;span class="citation"&gt;</code></p><p><code>24850</code><code>Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubri&amp;#x000e9; P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. &lt;span&gt;</code></p><p><code>24851</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24852</code><code>Int J Obes. &lt;/span&gt;</code></p><p><code>24853</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>24854</code><code>24&lt;/span&gt;</code></p><p><code>24855</code><code>:640–648.&lt;/span&gt;</code></p><p><code>24856</code><code> [&lt;a href="/pubmed/14770190" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24857</code><code>PubMed&lt;/a&gt;</code></p><p><code>24858</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24859</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Obes&amp;amp;title=CB1+cannabinoid+receptor+knockout+in+mice+leads+to+leanness,+resistance+to+diet-induced+obesity+and+enhanced+leptin+sensitivity&amp;amp;author=C+Ravinet+Trillou&amp;amp;author=C+Delgorge&amp;amp;author=C+Menet&amp;amp;author=M+Arnone&amp;amp;author=P+Soubri&amp;#x000e9;&amp;amp;volume=24&amp;amp;publication_year=2004&amp;amp;pages=640-648&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24860</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24861</code><code>]&lt;/span&gt;</code></p><p><code>24862</code><code>&lt;/span&gt;</code></p><p><code>24863</code><code>&lt;/li&gt;</code></p><p><code>24864</code><code>&lt;li id="R1002"&gt;</code></p><p><code>24865</code><code>&lt;span class="citation"&gt;</code></p><p><code>24866</code><code>Rawson RA, Obert JL, McCann MJ, Mann AJ. Cocaine treatment outcome: cocaine use following inpatient, outpatient and no treatment. &lt;span&gt;</code></p><p><code>24867</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24868</code><code>NIDA Res Monogr. &lt;/span&gt;</code></p><p><code>24869</code><code>1986;&lt;span class="ref-vol"&gt;</code></p><p><code>24870</code><code>67&lt;/span&gt;</code></p><p><code>24871</code><code>:271–277.&lt;/span&gt;</code></p><p><code>24872</code><code> [&lt;a href="/pubmed/3092077" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24873</code><code>PubMed&lt;/a&gt;</code></p><p><code>24874</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24875</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=NIDA+Res+Monogr&amp;amp;title=Cocaine+treatment+outcome:+cocaine+use+following+inpatient,+outpatient+and+no+treatment&amp;amp;author=RA+Rawson&amp;amp;author=JL+Obert&amp;amp;author=MJ+McCann&amp;amp;author=AJ+Mann&amp;amp;volume=67&amp;amp;publication_year=1986&amp;amp;pages=271-277&amp;amp;pmid=3092077&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24876</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24877</code><code>]&lt;/span&gt;</code></p><p><code>24878</code><code>&lt;/span&gt;</code></p><p><code>24879</code><code>&lt;/li&gt;</code></p><p><code>24880</code><code>&lt;li id="R1003"&gt;</code></p><p><code>24881</code><code>&lt;span class="citation"&gt;</code></p><p><code>24882</code><code>Ray AM, Benham CD, Roberts JC, Gill CH, Lanneau C, Gitterman DP, Harries M, Davis JB, Davies CH. Capsazepine protects against neuronal injury caused by oxygen glucose deprivation by inhibiting &lt;em&gt;</code></p><p><code>24883</code><code>I&lt;sub&gt;</code></p><p><code>24884</code><code>h&lt;/sub&gt;</code></p><p><code>24885</code><code>&lt;/em&gt;</code></p><p><code>24886</code><code>. &lt;span&gt;</code></p><p><code>24887</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24888</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>24889</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>24890</code><code>23&lt;/span&gt;</code></p><p><code>24891</code><code>:10146–10153.&lt;/span&gt;</code></p><p><code>24892</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>24893</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6740864/"&gt;</code></p><p><code>24894</code><code>PMC free article&lt;/a&gt;</code></p><p><code>24895</code><code>]&lt;/span&gt;</code></p><p><code>24896</code><code> [&lt;a href="/pubmed/14602831" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24897</code><code>PubMed&lt;/a&gt;</code></p><p><code>24898</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24899</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Capsazepine+protects+against+neuronal+injury+caused+by+oxygen+glucose+deprivation+by+inhibiting+Ih&amp;amp;author=AM+Ray&amp;amp;author=CD+Benham&amp;amp;author=JC+Roberts&amp;amp;author=CH+Gill&amp;amp;author=C+Lanneau&amp;amp;volume=23&amp;amp;publication_year=2003&amp;amp;pages=10146-10153&amp;amp;pmid=14602831&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24900</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24901</code><code>]&lt;/span&gt;</code></p><p><code>24902</code><code>&lt;/span&gt;</code></p><p><code>24903</code><code>&lt;/li&gt;</code></p><p><code>24904</code><code>&lt;li id="R1004"&gt;</code></p><p><code>24905</code><code>&lt;span class="citation"&gt;</code></p><p><code>24906</code><code>Raza M, Pal S, Rafiq A, DeLorenzo RJ. Long-term alteration of calcium homeostatic mechanisms in the pilocarpine model of temporal lobe epilepsy. &lt;span&gt;</code></p><p><code>24907</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24908</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>24909</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>24910</code><code>903&lt;/span&gt;</code></p><p><code>24911</code><code>:1–12.&lt;/span&gt;</code></p><p><code>24912</code><code> [&lt;a href="/pubmed/11382382" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24913</code><code>PubMed&lt;/a&gt;</code></p><p><code>24914</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24915</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Long-term+alteration+of+calcium+homeostatic+mechanisms+in+the+pilocarpine+model+of+temporal+lobe+epilepsy&amp;amp;author=M+Raza&amp;amp;author=S+Pal&amp;amp;author=A+Rafiq&amp;amp;author=RJ+DeLorenzo&amp;amp;volume=903&amp;amp;publication_year=2001&amp;amp;pages=1-12&amp;amp;pmid=11382382&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24916</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24917</code><code>]&lt;/span&gt;</code></p><p><code>24918</code><code>&lt;/span&gt;</code></p><p><code>24919</code><code>&lt;/li&gt;</code></p><p><code>24920</code><code>&lt;li id="R1005"&gt;</code></p><p><code>24921</code><code>&lt;span class="citation"&gt;</code></p><p><code>24922</code><code>Regelson W, Butler JR, Schulz J, Kirk T, Peek L, Green ML, Zalis MO.  &amp;#x00394;-9-THC as an effective antidepressant and appetite-stimulating agent in advanced cancer patients. In: Braude MC, Szara S, editors. &lt;span class="ref-journal"&gt;</code></p><p><code>24923</code><code>The Pharmacology of Marijuana.&lt;/span&gt;</code></p><p><code>24924</code><code> Raven Press; New York: 1976. pp. 763–776. &lt;span class="nowrap"&gt;</code></p><p><code>24925</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?title=The+Pharmacology+of+Marijuana&amp;amp;author=W+Regelson&amp;amp;author=JR+Butler&amp;amp;author=J+Schulz&amp;amp;author=T+Kirk&amp;amp;author=L+Peek&amp;amp;publication_year=1976&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24926</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24927</code><code>]&lt;/span&gt;</code></p><p><code>24928</code><code>&lt;/span&gt;</code></p><p><code>24929</code><code>&lt;/li&gt;</code></p><p><code>24930</code><code>&lt;li id="R1006"&gt;</code></p><p><code>24931</code><code>&lt;span class="citation"&gt;</code></p><p><code>24932</code><code>Reggio PH. Pharmacophores for ligand recognition and activation/inactivation of the cannabinoid receptors. &lt;span&gt;</code></p><p><code>24933</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24934</code><code>Curr Pharm Des. &lt;/span&gt;</code></p><p><code>24935</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>24936</code><code>9&lt;/span&gt;</code></p><p><code>24937</code><code>:1607–1633.&lt;/span&gt;</code></p><p><code>24938</code><code> [&lt;a href="/pubmed/12871061" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24939</code><code>PubMed&lt;/a&gt;</code></p><p><code>24940</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24941</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Pharm+Des&amp;amp;title=Pharmacophores+for+ligand+recognition+and+activation/inactivation+of+the+cannabinoid+receptors&amp;amp;author=PH+Reggio&amp;amp;volume=9&amp;amp;publication_year=2003&amp;amp;pages=1607-1633&amp;amp;pmid=12871061&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24942</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24943</code><code>]&lt;/span&gt;</code></p><p><code>24944</code><code>&lt;/span&gt;</code></p><p><code>24945</code><code>&lt;/li&gt;</code></p><p><code>24946</code><code>&lt;li id="R1007"&gt;</code></p><p><code>24947</code><code>&lt;span class="citation"&gt;</code></p><p><code>24948</code><code>Reilly SM, Skuse DH, Wolke D, Stevenson J. Oral-motor dysfunction in children who fail to thrive: organic or non-organic? &lt;span&gt;</code></p><p><code>24949</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24950</code><code>Dev Med Child Neurol. &lt;/span&gt;</code></p><p><code>24951</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>24952</code><code>41&lt;/span&gt;</code></p><p><code>24953</code><code>:115–122.&lt;/span&gt;</code></p><p><code>24954</code><code> [&lt;a href="/pubmed/10075097" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24955</code><code>PubMed&lt;/a&gt;</code></p><p><code>24956</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24957</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Dev+Med+Child+Neurol&amp;amp;title=Oral-motor+dysfunction+in+children+who+fail+to+thrive:+organic+or+non-organic?&amp;amp;author=SM+Reilly&amp;amp;author=DH+Skuse&amp;amp;author=D+Wolke&amp;amp;author=J+Stevenson&amp;amp;volume=41&amp;amp;publication_year=1999&amp;amp;pages=115-122&amp;amp;pmid=10075097&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24958</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24959</code><code>]&lt;/span&gt;</code></p><p><code>24960</code><code>&lt;/span&gt;</code></p><p><code>24961</code><code>&lt;/li&gt;</code></p><p><code>24962</code><code>&lt;li id="R1008"&gt;</code></p><p><code>24963</code><code>&lt;span class="citation"&gt;</code></p><p><code>24964</code><code>Reynolds JR. On therapeutic uses and toxic effects of cannabis indica. &lt;span&gt;</code></p><p><code>24965</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24966</code><code>Lancet. &lt;/span&gt;</code></p><p><code>24967</code><code>1890;&lt;span class="ref-vol"&gt;</code></p><p><code>24968</code><code>1&lt;/span&gt;</code></p><p><code>24969</code><code>:637–638.&lt;/span&gt;</code></p><p><code>24970</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>24971</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;amp;title=On+therapeutic+uses+and+toxic+effects+of+cannabis+indica&amp;amp;author=JR+Reynolds&amp;amp;volume=1&amp;amp;publication_year=1890&amp;amp;pages=637-638&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24972</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24973</code><code>]&lt;/span&gt;</code></p><p><code>24974</code><code>&lt;/span&gt;</code></p><p><code>24975</code><code>&lt;/li&gt;</code></p><p><code>24976</code><code>&lt;li id="R1009"&gt;</code></p><p><code>24977</code><code>&lt;span class="citation"&gt;</code></p><p><code>24978</code><code>Rhee MH, Beywitch M, Avidor-Reiss T, Levy R, Vogel Z. Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes. &lt;span&gt;</code></p><p><code>24979</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24980</code><code>J Neurochem. &lt;/span&gt;</code></p><p><code>24981</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>24982</code><code>71&lt;/span&gt;</code></p><p><code>24983</code><code>:1525–1534.&lt;/span&gt;</code></p><p><code>24984</code><code> [&lt;a href="/pubmed/9751186" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>24985</code><code>PubMed&lt;/a&gt;</code></p><p><code>24986</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>24987</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;amp;title=Cannabinoid+receptor+activation+differentially+regulates+the+various+adenylyl+cyclase+isozymes&amp;amp;author=MH+Rhee&amp;amp;author=M+Beywitch&amp;amp;author=T+Avidor-Reiss&amp;amp;author=R+Levy&amp;amp;author=Z+Vogel&amp;amp;volume=71&amp;amp;publication_year=1998&amp;amp;pages=1525-1534&amp;amp;pmid=9751186&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>24988</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>24989</code><code>]&lt;/span&gt;</code></p><p><code>24990</code><code>&lt;/span&gt;</code></p><p><code>24991</code><code>&lt;/li&gt;</code></p><p><code>24992</code><code>&lt;li id="R1010"&gt;</code></p><p><code>24993</code><code>&lt;span class="citation"&gt;</code></p><p><code>24994</code><code>Rhee MH, Vogel Z, Barg J, Bayewitch M, Levy R, Hanus L, Breuer A, Mechoulam R. Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylyl cyclase. &lt;span&gt;</code></p><p><code>24995</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>24996</code><code>J Med Chem. &lt;/span&gt;</code></p><p><code>24997</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>24998</code><code>40&lt;/span&gt;</code></p><p><code>24999</code><code>:3228–3233.&lt;/span&gt;</code></p><p><code>25000</code><code> [&lt;a href="/pubmed/9379442" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25001</code><code>PubMed&lt;/a&gt;</code></p><p><code>25002</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25003</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;amp;title=Cannabinol+derivatives:+binding+to+cannabinoid+receptors+and+inhibition+of+adenylyl+cyclase&amp;amp;author=MH+Rhee&amp;amp;author=Z+Vogel&amp;amp;author=J+Barg&amp;amp;author=M+Bayewitch&amp;amp;author=R+Levy&amp;amp;volume=40&amp;amp;publication_year=1997&amp;amp;pages=3228-3233&amp;amp;pmid=9379442&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25004</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25005</code><code>]&lt;/span&gt;</code></p><p><code>25006</code><code>&lt;/span&gt;</code></p><p><code>25007</code><code>&lt;/li&gt;</code></p><p><code>25008</code><code>&lt;li id="R1011"&gt;</code></p><p><code>25009</code><code>&lt;span class="citation"&gt;</code></p><p><code>25010</code><code>Richardson JD, Aanonsen L, Hargreaves KM. SR141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice. &lt;span&gt;</code></p><p><code>25011</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25012</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>25013</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>25014</code><code>319&lt;/span&gt;</code></p><p><code>25015</code><code>:R3–R4.&lt;/span&gt;</code></p><p><code>25016</code><code> [&lt;a href="/pubmed/9042616" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25017</code><code>PubMed&lt;/a&gt;</code></p><p><code>25018</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25019</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=SR141716A,+a+cannabinoid+receptor+antagonist,+produces+hyperalgesia+in+untreated+mice&amp;amp;author=JD+Richardson&amp;amp;author=L+Aanonsen&amp;amp;author=KM+Hargreaves&amp;amp;volume=319&amp;amp;publication_year=1997&amp;amp;pages=R3-R4&amp;amp;pmid=9042616&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25020</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25021</code><code>]&lt;/span&gt;</code></p><p><code>25022</code><code>&lt;/span&gt;</code></p><p><code>25023</code><code>&lt;/li&gt;</code></p><p><code>25024</code><code>&lt;li id="R1012"&gt;</code></p><p><code>25025</code><code>&lt;span class="citation"&gt;</code></p><p><code>25026</code><code>Richardson JD, Aanonsen L, Hargreaves KM. Antihyperalgesic effects of spinal cannabinoids. &lt;span&gt;</code></p><p><code>25027</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25028</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>25029</code><code>1998a;&lt;span class="ref-vol"&gt;</code></p><p><code>25030</code><code>345&lt;/span&gt;</code></p><p><code>25031</code><code>:145–153.&lt;/span&gt;</code></p><p><code>25032</code><code> [&lt;a href="/pubmed/9600630" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25033</code><code>PubMed&lt;/a&gt;</code></p><p><code>25034</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25035</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Antihyperalgesic+effects+of+spinal+cannabinoids&amp;amp;author=JD+Richardson&amp;amp;author=L+Aanonsen&amp;amp;author=KM+Hargreaves&amp;amp;volume=345&amp;amp;publication_year=1998a&amp;amp;pages=145-153&amp;amp;pmid=9600630&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25036</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25037</code><code>]&lt;/span&gt;</code></p><p><code>25038</code><code>&lt;/span&gt;</code></p><p><code>25039</code><code>&lt;/li&gt;</code></p><p><code>25040</code><code>&lt;li id="R1013"&gt;</code></p><p><code>25041</code><code>&lt;span class="citation"&gt;</code></p><p><code>25042</code><code>Richardson JD, Aanonsen L, Hargreaves KM. Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia. &lt;span&gt;</code></p><p><code>25043</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25044</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>25045</code><code>1998b;&lt;span class="ref-vol"&gt;</code></p><p><code>25046</code><code>18&lt;/span&gt;</code></p><p><code>25047</code><code>:451–457.&lt;/span&gt;</code></p><p><code>25048</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>25049</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6793401/"&gt;</code></p><p><code>25050</code><code>PMC free article&lt;/a&gt;</code></p><p><code>25051</code><code>]&lt;/span&gt;</code></p><p><code>25052</code><code> [&lt;a href="/pubmed/9412521" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25053</code><code>PubMed&lt;/a&gt;</code></p><p><code>25054</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25055</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Hypoactivity+of+the+spinal+cannabinoid+system+results+in+NMDA-dependent+hyperalgesia&amp;amp;author=JD+Richardson&amp;amp;author=L+Aanonsen&amp;amp;author=KM+Hargreaves&amp;amp;volume=18&amp;amp;publication_year=1998b&amp;amp;pages=451-457&amp;amp;pmid=9412521&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25056</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25057</code><code>]&lt;/span&gt;</code></p><p><code>25058</code><code>&lt;/span&gt;</code></p><p><code>25059</code><code>&lt;/li&gt;</code></p><p><code>25060</code><code>&lt;li id="R1014"&gt;</code></p><p><code>25061</code><code>&lt;span class="citation"&gt;</code></p><p><code>25062</code><code>Richardson JD, Kilo S, Hargreaves KM. Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB&lt;sub&gt;</code></p><p><code>25063</code><code>1&lt;/sub&gt;</code></p><p><code>25064</code><code> receptors. &lt;span&gt;</code></p><p><code>25065</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25066</code><code>Pain. &lt;/span&gt;</code></p><p><code>25067</code><code>1998c;&lt;span class="ref-vol"&gt;</code></p><p><code>25068</code><code>75&lt;/span&gt;</code></p><p><code>25069</code><code>:111–119.&lt;/span&gt;</code></p><p><code>25070</code><code> [&lt;a href="/pubmed/9539680" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25071</code><code>PubMed&lt;/a&gt;</code></p><p><code>25072</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25073</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;amp;title=Cannabinoids+reduce+hyperalgesia+and+inflammation+via+interaction+with+peripheral+CB1+receptors&amp;amp;author=JD+Richardson&amp;amp;author=S+Kilo&amp;amp;author=KM+Hargreaves&amp;amp;volume=75&amp;amp;publication_year=1998c&amp;amp;pages=111-119&amp;amp;pmid=9539680&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25074</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25075</code><code>]&lt;/span&gt;</code></p><p><code>25076</code><code>&lt;/span&gt;</code></p><p><code>25077</code><code>&lt;/li&gt;</code></p><p><code>25078</code><code>&lt;li id="R1015"&gt;</code></p><p><code>25079</code><code>&lt;span class="citation"&gt;</code></p><p><code>25080</code><code>Richfield EK, Herkenham M. Selective vulnerability in Huntington&amp;#x02019;s disease: preferential loss of cannabinoid receptors in lateral globus pallidus. &lt;span&gt;</code></p><p><code>25081</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25082</code><code>Ann Neurol. &lt;/span&gt;</code></p><p><code>25083</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>25084</code><code>36&lt;/span&gt;</code></p><p><code>25085</code><code>:577–584.&lt;/span&gt;</code></p><p><code>25086</code><code> [&lt;a href="/pubmed/7944290" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25087</code><code>PubMed&lt;/a&gt;</code></p><p><code>25088</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25089</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Ann+Neurol&amp;amp;title=Selective+vulnerability+in+Huntington&amp;#x02019;s+disease:+preferential+loss+of+cannabinoid+receptors+in+lateral+globus+pallidus&amp;amp;author=EK+Richfield&amp;amp;author=M+Herkenham&amp;amp;volume=36&amp;amp;publication_year=1994&amp;amp;pages=577-584&amp;amp;pmid=7944290&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25090</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25091</code><code>]&lt;/span&gt;</code></p><p><code>25092</code><code>&lt;/span&gt;</code></p><p><code>25093</code><code>&lt;/li&gt;</code></p><p><code>25094</code><code>&lt;li id="R1016"&gt;</code></p><p><code>25095</code><code>&lt;span class="citation"&gt;</code></p><p><code>25096</code><code>Richter A, L&amp;#x000f6;scher W. (+)-WIN 55,212-2, a novel cannabinoid receptor agonist, exerts antidystonic effects in mutant dystonic hamsters. &lt;span&gt;</code></p><p><code>25097</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25098</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>25099</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>25100</code><code>264&lt;/span&gt;</code></p><p><code>25101</code><code>:371–377.&lt;/span&gt;</code></p><p><code>25102</code><code> [&lt;a href="/pubmed/7698178" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25103</code><code>PubMed&lt;/a&gt;</code></p><p><code>25104</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25105</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=(+)-WIN+55,212-2,+a+novel+cannabinoid+receptor+agonist,+exerts+antidystonic+effects+in+mutant+dystonic+hamsters&amp;amp;author=A+Richter&amp;amp;author=W+L&amp;#x000f6;scher&amp;amp;volume=264&amp;amp;publication_year=1994&amp;amp;pages=371-377&amp;amp;pmid=7698178&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25106</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25107</code><code>]&lt;/span&gt;</code></p><p><code>25108</code><code>&lt;/span&gt;</code></p><p><code>25109</code><code>&lt;/li&gt;</code></p><p><code>25110</code><code>&lt;li id="R1017"&gt;</code></p><p><code>25111</code><code>&lt;span class="citation"&gt;</code></p><p><code>25112</code><code>Richter A, L&amp;#x000f6;scher W. Effects of pharmacological manipulations of cannabinoid receptors on severity of dystonia in a genetic model of paroxysmal dyskinesia. &lt;span&gt;</code></p><p><code>25113</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25114</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>25115</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>25116</code><code>454&lt;/span&gt;</code></p><p><code>25117</code><code>:145–151.&lt;/span&gt;</code></p><p><code>25118</code><code> [&lt;a href="/pubmed/12421641" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25119</code><code>PubMed&lt;/a&gt;</code></p><p><code>25120</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25121</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Effects+of+pharmacological+manipulations+of+cannabinoid+receptors+on+severity+of+dystonia+in+a+genetic+model+of+paroxysmal+dyskinesia&amp;amp;author=A+Richter&amp;amp;author=W+L&amp;#x000f6;scher&amp;amp;volume=454&amp;amp;publication_year=2002&amp;amp;pages=145-151&amp;amp;pmid=12421641&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25122</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25123</code><code>]&lt;/span&gt;</code></p><p><code>25124</code><code>&lt;/span&gt;</code></p><p><code>25125</code><code>&lt;/li&gt;</code></p><p><code>25126</code><code>&lt;li id="R1018"&gt;</code></p><p><code>25127</code><code>&lt;span class="citation"&gt;</code></p><p><code>25128</code><code>Riegel AC, Lupica CR. Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. &lt;span&gt;</code></p><p><code>25129</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25130</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>25131</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>25132</code><code>24&lt;/span&gt;</code></p><p><code>25133</code><code>:11070–11078.&lt;/span&gt;</code></p><p><code>25134</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>25135</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC4857882/"&gt;</code></p><p><code>25136</code><code>PMC free article&lt;/a&gt;</code></p><p><code>25137</code><code>]&lt;/span&gt;</code></p><p><code>25138</code><code> [&lt;a href="/pubmed/15590923" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25139</code><code>PubMed&lt;/a&gt;</code></p><p><code>25140</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25141</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Independent+presynaptic+and+postsynaptic+mechanisms+regulate+endocannabinoid+signaling+at+multiple+synapses+in+the+ventral+tegmental+area&amp;amp;author=AC+Riegel&amp;amp;author=CR+Lupica&amp;amp;volume=24&amp;amp;publication_year=2004&amp;amp;pages=11070-11078&amp;amp;pmid=15590923&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25142</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25143</code><code>]&lt;/span&gt;</code></p><p><code>25144</code><code>&lt;/span&gt;</code></p><p><code>25145</code><code>&lt;/li&gt;</code></p><p><code>25146</code><code>&lt;li id="R1019"&gt;</code></p><p><code>25147</code><code>&lt;span class="citation"&gt;</code></p><p><code>25148</code><code>Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Matinez S, Marvani J, Neliat G, Caput D, et al.  SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. &lt;span&gt;</code></p><p><code>25149</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25150</code><code>FEBS Lett. &lt;/span&gt;</code></p><p><code>25151</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>25152</code><code>350&lt;/span&gt;</code></p><p><code>25153</code><code>:240–244.&lt;/span&gt;</code></p><p><code>25154</code><code> [&lt;a href="/pubmed/8070571" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25155</code><code>PubMed&lt;/a&gt;</code></p><p><code>25156</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25157</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;amp;title=SR141716A,+a+potent+and+selective+antagonist+of+the+brain+cannabinoid+receptor&amp;amp;author=M+Rinaldi-Carmona&amp;amp;author=F+Barth&amp;amp;author=M+Heaulme&amp;amp;author=D+Shire&amp;amp;author=B+Calandra&amp;amp;volume=350&amp;amp;publication_year=1994&amp;amp;pages=240-244&amp;amp;pmid=8070571&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25158</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25159</code><code>]&lt;/span&gt;</code></p><p><code>25160</code><code>&lt;/span&gt;</code></p><p><code>25161</code><code>&lt;/li&gt;</code></p><p><code>25162</code><code>&lt;li id="R1020"&gt;</code></p><p><code>25163</code><code>&lt;span class="citation"&gt;</code></p><p><code>25164</code><code>Rinaldi-Carmona M, Barth F, Millan J, Derocq JM, Casellas P, Congy C, Oustric D, Sarran M, Bouaboula M, Calandra B, et al.  SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. &lt;span&gt;</code></p><p><code>25165</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25166</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>25167</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>25168</code><code>284&lt;/span&gt;</code></p><p><code>25169</code><code>:644–650.&lt;/span&gt;</code></p><p><code>25170</code><code> [&lt;a href="/pubmed/9454810" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25171</code><code>PubMed&lt;/a&gt;</code></p><p><code>25172</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25173</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=SR+144528,+the+first+potent+and+selective+antagonist+of+the+CB2+cannabinoid+receptor&amp;amp;author=M+Rinaldi-Carmona&amp;amp;author=F+Barth&amp;amp;author=J+Millan&amp;amp;author=JM+Derocq&amp;amp;author=P+Casellas&amp;amp;volume=284&amp;amp;publication_year=1998&amp;amp;pages=644-650&amp;amp;pmid=9454810&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25174</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25175</code><code>]&lt;/span&gt;</code></p><p><code>25176</code><code>&lt;/span&gt;</code></p><p><code>25177</code><code>&lt;/li&gt;</code></p><p><code>25178</code><code>&lt;li id="R1021"&gt;</code></p><p><code>25179</code><code>&lt;span class="citation"&gt;</code></p><p><code>25180</code><code>Rios C, Gomes I, Devi LA. &lt;em&gt;</code></p><p><code>25181</code><code>&amp;#x003bc;&lt;/em&gt;</code></p><p><code>25182</code><code> Opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis. &lt;span&gt;</code></p><p><code>25183</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25184</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>25185</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>25186</code><code>148&lt;/span&gt;</code></p><p><code>25187</code><code>:387–395.&lt;/span&gt;</code></p><p><code>25188</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>25189</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1751792/"&gt;</code></p><p><code>25190</code><code>PMC free article&lt;/a&gt;</code></p><p><code>25191</code><code>]&lt;/span&gt;</code></p><p><code>25192</code><code> [&lt;a href="/pubmed/16682964" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25193</code><code>PubMed&lt;/a&gt;</code></p><p><code>25194</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25195</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=&amp;#x003bc;+Opioid+and+CB1+cannabinoid+receptor+interactions:+reciprocal+inhibition+of+receptor+signaling+and+neuritogenesis&amp;amp;author=C+Rios&amp;amp;author=I+Gomes&amp;amp;author=LA+Devi&amp;amp;volume=148&amp;amp;publication_year=2006&amp;amp;pages=387-395&amp;amp;pmid=16682964&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25196</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25197</code><code>]&lt;/span&gt;</code></p><p><code>25198</code><code>&lt;/span&gt;</code></p><p><code>25199</code><code>&lt;/li&gt;</code></p><p><code>25200</code><code>&lt;li id="R1022"&gt;</code></p><p><code>25201</code><code>&lt;span class="citation"&gt;</code></p><p><code>25202</code><code>Rivas-V JF, Garcia R. Inhibition of histamine-stimulated gastric acid secretion by &amp;#x02212;&lt;sup&gt;</code></p><p><code>25203</code><code>9&lt;/sup&gt;</code></p><p><code>25204</code><code>-tetrahydrocannabinol in rat isolated stomach. &lt;span&gt;</code></p><p><code>25205</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25206</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>25207</code><code>1980;&lt;span class="ref-vol"&gt;</code></p><p><code>25208</code><code>65&lt;/span&gt;</code></p><p><code>25209</code><code>:317–318.&lt;/span&gt;</code></p><p><code>25210</code><code> [&lt;a href="/pubmed/6105088" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25211</code><code>PubMed&lt;/a&gt;</code></p><p><code>25212</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25213</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Inhibition+of+histamine-stimulated+gastric+acid+secretion+by+&amp;#x02212;9-tetrahydrocannabinol+in+rat+isolated+stomach&amp;amp;author=JF+Rivas-V&amp;amp;author=R+Garcia&amp;amp;volume=65&amp;amp;publication_year=1980&amp;amp;pages=317-318&amp;amp;pmid=6105088&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25214</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25215</code><code>]&lt;/span&gt;</code></p><p><code>25216</code><code>&lt;/span&gt;</code></p><p><code>25217</code><code>&lt;/li&gt;</code></p><p><code>25218</code><code>&lt;li id="R1023"&gt;</code></p><p><code>25219</code><code>&lt;span class="citation"&gt;</code></p><p><code>25220</code><code>Robbe D, Alonso G, Duchamp F, Bockaert J, Manzoni OJ. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. &lt;span&gt;</code></p><p><code>25221</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25222</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>25223</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>25224</code><code>21&lt;/span&gt;</code></p><p><code>25225</code><code>:109–116.&lt;/span&gt;</code></p><p><code>25226</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>25227</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6762427/"&gt;</code></p><p><code>25228</code><code>PMC free article&lt;/a&gt;</code></p><p><code>25229</code><code>]&lt;/span&gt;</code></p><p><code>25230</code><code> [&lt;a href="/pubmed/11150326" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25231</code><code>PubMed&lt;/a&gt;</code></p><p><code>25232</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25233</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Localization+and+mechanisms+of+action+of+cannabinoid+receptors+at+the+glutamatergic+synapses+of+the+mouse+nucleus+accumbens&amp;amp;author=D+Robbe&amp;amp;author=G+Alonso&amp;amp;author=F+Duchamp&amp;amp;author=J+Bockaert&amp;amp;author=OJ+Manzoni&amp;amp;volume=21&amp;amp;publication_year=2001&amp;amp;pages=109-116&amp;amp;pmid=11150326&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25234</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25235</code><code>]&lt;/span&gt;</code></p><p><code>25236</code><code>&lt;/span&gt;</code></p><p><code>25237</code><code>&lt;/li&gt;</code></p><p><code>25238</code><code>&lt;li id="R1024"&gt;</code></p><p><code>25239</code><code>&lt;span class="citation"&gt;</code></p><p><code>25240</code><code>Robbe D, Kopf M, Remaury A, Bockaert J, Manzoni OJ. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. &lt;span&gt;</code></p><p><code>25241</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25242</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>25243</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>25244</code><code>99&lt;/span&gt;</code></p><p><code>25245</code><code>:8384–8388.&lt;/span&gt;</code></p><p><code>25246</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>25247</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC123076/"&gt;</code></p><p><code>25248</code><code>PMC free article&lt;/a&gt;</code></p><p><code>25249</code><code>]&lt;/span&gt;</code></p><p><code>25250</code><code> [&lt;a href="/pubmed/12060781" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25251</code><code>PubMed&lt;/a&gt;</code></p><p><code>25252</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25253</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Endogenous+cannabinoids+mediate+long-term+synaptic+depression+in+the+nucleus+accumbens&amp;amp;author=D+Robbe&amp;amp;author=M+Kopf&amp;amp;author=A+Remaury&amp;amp;author=J+Bockaert&amp;amp;author=OJ+Manzoni&amp;amp;volume=99&amp;amp;publication_year=2002&amp;amp;pages=8384-8388&amp;amp;pmid=12060781&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25254</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25255</code><code>]&lt;/span&gt;</code></p><p><code>25256</code><code>&lt;/span&gt;</code></p><p><code>25257</code><code>&lt;/li&gt;</code></p><p><code>25258</code><code>&lt;li id="R1025"&gt;</code></p><p><code>25259</code><code>&lt;span class="citation"&gt;</code></p><p><code>25260</code><code>Robson P.  Human studies of cannabinoids and medicinal cannabis. In: Pertwee R, editor. &lt;span class="ref-journal"&gt;</code></p><p><code>25261</code><code>Cannabinoids.&lt;/span&gt;</code></p><p><code>25262</code><code> Springer; New York: 2005. pp. 719–757. &lt;span class="nowrap"&gt;</code></p><p><code>25263</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?title=Cannabinoids&amp;amp;author=P+Robson&amp;amp;publication_year=2005&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25264</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25265</code><code>]&lt;/span&gt;</code></p><p><code>25266</code><code>&lt;/span&gt;</code></p><p><code>25267</code><code>&lt;/li&gt;</code></p><p><code>25268</code><code>&lt;li id="R1026"&gt;</code></p><p><code>25269</code><code>&lt;span class="citation"&gt;</code></p><p><code>25270</code><code>Rodriguez de Fonseca F, Carrera MRA, Navarro M, Koob GF, Weiss F. Activation of corticotrophin-releasing factor in the limbic system during cannabinoid withdrawal. &lt;span&gt;</code></p><p><code>25271</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25272</code><code>Science (Wash DC) &lt;/span&gt;</code></p><p><code>25273</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>25274</code><code>276&lt;/span&gt;</code></p><p><code>25275</code><code>:2050–2054.&lt;/span&gt;</code></p><p><code>25276</code><code> [&lt;a href="/pubmed/9197270" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25277</code><code>PubMed&lt;/a&gt;</code></p><p><code>25278</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25279</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Science+(Wash+DC)&amp;amp;title=Activation+of+corticotrophin-releasing+factor+in+the+limbic+system+during+cannabinoid+withdrawal&amp;amp;author=F+Rodriguez+de+Fonseca&amp;amp;author=MRA+Carrera&amp;amp;author=M+Navarro&amp;amp;author=GF+Koob&amp;amp;author=F+Weiss&amp;amp;volume=276&amp;amp;publication_year=1997&amp;amp;pages=2050-2054&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25280</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25281</code><code>]&lt;/span&gt;</code></p><p><code>25282</code><code>&lt;/span&gt;</code></p><p><code>25283</code><code>&lt;/li&gt;</code></p><p><code>25284</code><code>&lt;li id="R1027"&gt;</code></p><p><code>25285</code><code>&lt;span class="citation"&gt;</code></p><p><code>25286</code><code>Rodriguez De Fonseca F, Gorriti MA, Bilbao A, Escuredo L, Garcia-Segura LM, Piomelli D, Navarro M. Role of the endogenous cannabinoid system as a modulator of dopamine transmission: implications for Parkinson&amp;#x02019;s disease and schizophrenia. &lt;span&gt;</code></p><p><code>25287</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25288</code><code>Neurotox Res. &lt;/span&gt;</code></p><p><code>25289</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>25290</code><code>3&lt;/span&gt;</code></p><p><code>25291</code><code>:23–35.&lt;/span&gt;</code></p><p><code>25292</code><code> [&lt;a href="/pubmed/15111259" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25293</code><code>PubMed&lt;/a&gt;</code></p><p><code>25294</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25295</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurotox+Res&amp;amp;title=Role+of+the+endogenous+cannabinoid+system+as+a+modulator+of+dopamine+transmission:+implications+for+Parkinson&amp;#x02019;s+disease+and+schizophrenia&amp;amp;author=F+Rodriguez+De+Fonseca&amp;amp;author=MA+Gorriti&amp;amp;author=A+Bilbao&amp;amp;author=L+Escuredo&amp;amp;author=LM+Garcia-Segura&amp;amp;volume=3&amp;amp;publication_year=2001&amp;amp;pages=23-35&amp;amp;pmid=15111259&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25296</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25297</code><code>]&lt;/span&gt;</code></p><p><code>25298</code><code>&lt;/span&gt;</code></p><p><code>25299</code><code>&lt;/li&gt;</code></p><p><code>25300</code><code>&lt;li id="R1028"&gt;</code></p><p><code>25301</code><code>&lt;span class="citation"&gt;</code></p><p><code>25302</code><code>Rodriguez de Fonseca F, Rubio P, Menzaghi F, Merlo-Pich E, Rivier J, Koob GF, Navarro M. Corticotropin-releasing factor (CRF) antagonist [D-Phe&lt;sup&gt;</code></p><p><code>25303</code><code>12&lt;/sup&gt;</code></p><p><code>25304</code><code>,Nle&lt;sup&gt;</code></p><p><code>25305</code><code>21,38&lt;/sup&gt;</code></p><p><code>25306</code><code>y&lt;em&gt;</code></p><p><code>25307</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>25308</code><code>MeLeu&lt;sup&gt;</code></p><p><code>25309</code><code>37&lt;/sup&gt;</code></p><p><code>25310</code><code>]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats. &lt;span&gt;</code></p><p><code>25311</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25312</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>25313</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>25314</code><code>276&lt;/span&gt;</code></p><p><code>25315</code><code>:56–64.&lt;/span&gt;</code></p><p><code>25316</code><code> [&lt;a href="/pubmed/8558457" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25317</code><code>PubMed&lt;/a&gt;</code></p><p><code>25318</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25319</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Corticotropin-releasing+factor+(CRF)+antagonist+[D-Phe12,Nle21,38y&amp;#x003b1;MeLeu37]CRF+attenuates+the+acute+actions+of+the+highly+potent+cannabinoid+receptor+agonist+HU-210+on+defensive-withdrawal+behavior+in+rats&amp;amp;author=F+Rodriguez+de+Fonseca&amp;amp;author=P+Rubio&amp;amp;author=F+Menzaghi&amp;amp;author=E+Merlo-Pich&amp;amp;author=J+Rivier&amp;amp;volume=276&amp;amp;publication_year=1996&amp;amp;pages=56-64&amp;amp;pmid=8558457&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25320</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25321</code><code>]&lt;/span&gt;</code></p><p><code>25322</code><code>&lt;/span&gt;</code></p><p><code>25323</code><code>&lt;/li&gt;</code></p><p><code>25324</code><code>&lt;li id="R1029"&gt;</code></p><p><code>25325</code><code>&lt;span class="citation"&gt;</code></p><p><code>25326</code><code>Rog DJ, Nurmikko TF, Friede T, Young CA. Randomized, controlled trial of cannabisbased medicine in central pain in multiple sclerosis. &lt;span&gt;</code></p><p><code>25327</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25328</code><code>Neurology. &lt;/span&gt;</code></p><p><code>25329</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>25330</code><code>65&lt;/span&gt;</code></p><p><code>25331</code><code>:812–819.&lt;/span&gt;</code></p><p><code>25332</code><code> [&lt;a href="/pubmed/16186518" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25333</code><code>PubMed&lt;/a&gt;</code></p><p><code>25334</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25335</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;amp;title=Randomized,+controlled+trial+of+cannabisbased+medicine+in+central+pain+in+multiple+sclerosis&amp;amp;author=DJ+Rog&amp;amp;author=TF+Nurmikko&amp;amp;author=T+Friede&amp;amp;author=CA+Young&amp;amp;volume=65&amp;amp;publication_year=2005&amp;amp;pages=812-819&amp;amp;pmid=16186518&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25336</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25337</code><code>]&lt;/span&gt;</code></p><p><code>25338</code><code>&lt;/span&gt;</code></p><p><code>25339</code><code>&lt;/li&gt;</code></p><p><code>25340</code><code>&lt;li id="R1030"&gt;</code></p><p><code>25341</code><code>&lt;span class="citation"&gt;</code></p><p><code>25342</code><code>Romero EM, Fernandez B, Sagredo O, Gomez N, Uriguen L, Guaza C, De Miguel R, Ramos JA, Viveros MP. Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats. &lt;span&gt;</code></p><p><code>25343</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25344</code><code>Brain Res Dev Brain Res. &lt;/span&gt;</code></p><p><code>25345</code><code>2002a;&lt;span class="ref-vol"&gt;</code></p><p><code>25346</code><code>136&lt;/span&gt;</code></p><p><code>25347</code><code>:85–92.&lt;/span&gt;</code></p><p><code>25348</code><code> [&lt;a href="/pubmed/12101025" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25349</code><code>PubMed&lt;/a&gt;</code></p><p><code>25350</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25351</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res+Dev+Brain+Res&amp;amp;title=Antinociceptive,+behavioural+and+neuroendocrine+effects+of+CP+55,940+in+young+rats&amp;amp;author=EM+Romero&amp;amp;author=B+Fernandez&amp;amp;author=O+Sagredo&amp;amp;author=N+Gomez&amp;amp;author=L+Uriguen&amp;amp;volume=136&amp;amp;publication_year=2002a&amp;amp;pages=85-92&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25352</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25353</code><code>]&lt;/span&gt;</code></p><p><code>25354</code><code>&lt;/span&gt;</code></p><p><code>25355</code><code>&lt;/li&gt;</code></p><p><code>25356</code><code>&lt;li id="R1031"&gt;</code></p><p><code>25357</code><code>&lt;span class="citation"&gt;</code></p><p><code>25358</code><code>Romero J, Berrendero F, Garcia-Gil L, de la Cruz P, Ramos JA, Fernandez-Ruiz JJ. Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [&lt;sup&gt;</code></p><p><code>25359</code><code>35&lt;/sup&gt;</code></p><p><code>25360</code><code>S]guanylyl-5&amp;#x02032;&lt;em&gt;</code></p><p><code>25361</code><code>O&lt;/em&gt;</code></p><p><code>25362</code><code>-(thio)-triphosphate binding in the basal ganglia of aged rats. &lt;span&gt;</code></p><p><code>25363</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25364</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>25365</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>25366</code><code>84&lt;/span&gt;</code></p><p><code>25367</code><code>:1075–1083.&lt;/span&gt;</code></p><p><code>25368</code><code> [&lt;a href="/pubmed/9578396" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25369</code><code>PubMed&lt;/a&gt;</code></p><p><code>25370</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25371</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Loss+of+cannabinoid+receptor+binding+and+messenger+RNA+levels+and+cannabinoid+agonist-stimulated+[35S]guanylyl-5&amp;#x02032;O-(thio)-triphosphate+binding+in+the+basal+ganglia+of+aged+rats&amp;amp;author=J+Romero&amp;amp;author=F+Berrendero&amp;amp;author=L+Garcia-Gil&amp;amp;author=P+de+la+Cruz&amp;amp;author=JA+Ramos&amp;amp;volume=84&amp;amp;publication_year=1998&amp;amp;pages=1075-1083&amp;amp;pmid=9578396&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25372</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25373</code><code>]&lt;/span&gt;</code></p><p><code>25374</code><code>&lt;/span&gt;</code></p><p><code>25375</code><code>&lt;/li&gt;</code></p><p><code>25376</code><code>&lt;li id="R1032"&gt;</code></p><p><code>25377</code><code>&lt;span class="citation"&gt;</code></p><p><code>25378</code><code>Romero J, Berrendero F, Perez-Rosado A, Manzanares J, Rojo A, Fernandez-Ruiz JJ, de Yebenes JG, Ramos JA. Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB&lt;sub&gt;</code></p><p><code>25379</code><code>1&lt;/sub&gt;</code></p><p><code>25380</code><code> receptor mRNA levels in the caudate-putamen. &lt;span&gt;</code></p><p><code>25381</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25382</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>25383</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>25384</code><code>66&lt;/span&gt;</code></p><p><code>25385</code><code>:485–494.&lt;/span&gt;</code></p><p><code>25386</code><code> [&lt;a href="/pubmed/10794065" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25387</code><code>PubMed&lt;/a&gt;</code></p><p><code>25388</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25389</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Unilateral+6-hydroxydopamine+lesions+of+nigrostriatal+dopaminergic+neurons+increased+CB1+receptor+mRNA+levels+in+the+caudate-putamen&amp;amp;author=J+Romero&amp;amp;author=F+Berrendero&amp;amp;author=A+Perez-Rosado&amp;amp;author=J+Manzanares&amp;amp;author=A+Rojo&amp;amp;volume=66&amp;amp;publication_year=2000&amp;amp;pages=485-494&amp;amp;pmid=10794065&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25390</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25391</code><code>]&lt;/span&gt;</code></p><p><code>25392</code><code>&lt;/span&gt;</code></p><p><code>25393</code><code>&lt;/li&gt;</code></p><p><code>25394</code><code>&lt;li id="R1033"&gt;</code></p><p><code>25395</code><code>&lt;span class="citation"&gt;</code></p><p><code>25396</code><code>Romero J, de Miguel R, Garcia-Palomero E, Fernandez-Ruiz JJ, Ramos JA. Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function. &lt;span&gt;</code></p><p><code>25397</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25398</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>25399</code><code>1995a;&lt;span class="ref-vol"&gt;</code></p><p><code>25400</code><code>694&lt;/span&gt;</code></p><p><code>25401</code><code>:223–232.&lt;/span&gt;</code></p><p><code>25402</code><code> [&lt;a href="/pubmed/8974649" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25403</code><code>PubMed&lt;/a&gt;</code></p><p><code>25404</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25405</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Time-course+of+the+effects+of+anandamide,+the+putative+endogenous+cannabinoid+receptor+ligand,+on+extrapyramidal+function&amp;amp;author=J+Romero&amp;amp;author=R+de+Miguel&amp;amp;author=E+Garcia-Palomero&amp;amp;author=JJ+Fernandez-Ruiz&amp;amp;author=JA+Ramos&amp;amp;volume=694&amp;amp;publication_year=1995a&amp;amp;pages=223-232&amp;amp;pmid=8974649&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25406</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25407</code><code>]&lt;/span&gt;</code></p><p><code>25408</code><code>&lt;/span&gt;</code></p><p><code>25409</code><code>&lt;/li&gt;</code></p><p><code>25410</code><code>&lt;li id="R1034"&gt;</code></p><p><code>25411</code><code>&lt;span class="citation"&gt;</code></p><p><code>25412</code><code>Romero J, Garcia L, Cebeira M, Zadrozny D, Fernandez-Ruiz JJ, Ramos JA. The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons. &lt;span&gt;</code></p><p><code>25413</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25414</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>25415</code><code>1995b;&lt;span class="ref-vol"&gt;</code></p><p><code>25416</code><code>56&lt;/span&gt;</code></p><p><code>25417</code><code>:2033–2040.&lt;/span&gt;</code></p><p><code>25418</code><code> [&lt;a href="/pubmed/7776829" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25419</code><code>PubMed&lt;/a&gt;</code></p><p><code>25420</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25421</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=The+endogenous+cannabinoid+receptor+ligand,+anandamide,+inhibits+the+motor+behavior:+role+of+nigrostriatal+dopaminergic+neurons&amp;amp;author=J+Romero&amp;amp;author=L+Garcia&amp;amp;author=M+Cebeira&amp;amp;author=D+Zadrozny&amp;amp;author=JJ+Fernandez-Ruiz&amp;amp;volume=56&amp;amp;publication_year=1995b&amp;amp;pages=2033-2040&amp;amp;pmid=7776829&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25422</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25423</code><code>]&lt;/span&gt;</code></p><p><code>25424</code><code>&lt;/span&gt;</code></p><p><code>25425</code><code>&lt;/li&gt;</code></p><p><code>25426</code><code>&lt;li id="R1035"&gt;</code></p><p><code>25427</code><code>&lt;span class="citation"&gt;</code></p><p><code>25428</code><code>Romero J, Lastres-Becker I, de Miguel R, Berrendero F, Ramos JA, Fernandez-Ruiz J. The endogenous cannabinoid system and the basal ganglia. Biochemical, pharmacological, and therapeutic aspects. &lt;span&gt;</code></p><p><code>25429</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25430</code><code>Pharmacol Ther. &lt;/span&gt;</code></p><p><code>25431</code><code>2002b;&lt;span class="ref-vol"&gt;</code></p><p><code>25432</code><code>95&lt;/span&gt;</code></p><p><code>25433</code><code>:137–152.&lt;/span&gt;</code></p><p><code>25434</code><code> [&lt;a href="/pubmed/12182961" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25435</code><code>PubMed&lt;/a&gt;</code></p><p><code>25436</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25437</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Ther&amp;amp;title=The+endogenous+cannabinoid+system+and+the+basal+ganglia.+Biochemical,+pharmacological,+and+therapeutic+aspects&amp;amp;author=J+Romero&amp;amp;author=I+Lastres-Becker&amp;amp;author=R+de+Miguel&amp;amp;author=F+Berrendero&amp;amp;author=JA+Ramos&amp;amp;volume=95&amp;amp;publication_year=2002b&amp;amp;pages=137-152&amp;amp;pmid=12182961&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25438</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25439</code><code>]&lt;/span&gt;</code></p><p><code>25440</code><code>&lt;/span&gt;</code></p><p><code>25441</code><code>&lt;/li&gt;</code></p><p><code>25442</code><code>&lt;li id="R1036"&gt;</code></p><p><code>25443</code><code>&lt;span class="citation"&gt;</code></p><p><code>25444</code><code>Ros J, Claria J, To-Figueras J, Planaguma A, Cejudo-Martin P, Fernandez-Varo G, Martin-Ruiz R, Arroyo V, Rivera F, Rodes J, et al.  Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. &lt;span&gt;</code></p><p><code>25445</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25446</code><code>Gastroenterology. &lt;/span&gt;</code></p><p><code>25447</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>25448</code><code>122&lt;/span&gt;</code></p><p><code>25449</code><code>:85–93.&lt;/span&gt;</code></p><p><code>25450</code><code> [&lt;a href="/pubmed/11781284" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25451</code><code>PubMed&lt;/a&gt;</code></p><p><code>25452</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25453</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;amp;title=Endogenous+cannabinoids:+a+new+system+involved+in+the+homeostasis+of+arterial+pressure+in+experimental+cirrhosis+in+the+rat&amp;amp;author=J+Ros&amp;amp;author=J+Claria&amp;amp;author=J+To-Figueras&amp;amp;author=A+Planaguma&amp;amp;author=P+Cejudo-Martin&amp;amp;volume=122&amp;amp;publication_year=2002&amp;amp;pages=85-93&amp;amp;pmid=11781284&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25454</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25455</code><code>]&lt;/span&gt;</code></p><p><code>25456</code><code>&lt;/span&gt;</code></p><p><code>25457</code><code>&lt;/li&gt;</code></p><p><code>25458</code><code>&lt;li id="R1037"&gt;</code></p><p><code>25459</code><code>&lt;span class="citation"&gt;</code></p><p><code>25460</code><code>Rosch S, Ramer R, Brune K, Hinz B. &lt;em&gt;</code></p><p><code>25461</code><code>R&lt;/em&gt;</code></p><p><code>25462</code><code>(+)-Methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells. &lt;span&gt;</code></p><p><code>25463</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25464</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>25465</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>25466</code><code>316&lt;/span&gt;</code></p><p><code>25467</code><code>:1219–1228.&lt;/span&gt;</code></p><p><code>25468</code><code> [&lt;a href="/pubmed/16330497" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25469</code><code>PubMed&lt;/a&gt;</code></p><p><code>25470</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25471</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=R(+)-Methanandamide+and+other+cannabinoids+induce+the+expression+of+cyclooxygenase-2+and+matrix+metalloproteinases+in+human+nonpigmented+ciliary+epithelial+cells&amp;amp;author=S+Rosch&amp;amp;author=R+Ramer&amp;amp;author=K+Brune&amp;amp;author=B+Hinz&amp;amp;volume=316&amp;amp;publication_year=2006&amp;amp;pages=1219-1228&amp;amp;pmid=16330497&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25472</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25473</code><code>]&lt;/span&gt;</code></p><p><code>25474</code><code>&lt;/span&gt;</code></p><p><code>25475</code><code>&lt;/li&gt;</code></p><p><code>25476</code><code>&lt;li id="R1038"&gt;</code></p><p><code>25477</code><code>&lt;span class="citation"&gt;</code></p><p><code>25478</code><code>Rosenblatt KA, Daling JR, Chen C, Sherman KJ, Schwartz SM. Marijuana use and risk of oral squamous cell carcinoma. &lt;span&gt;</code></p><p><code>25479</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25480</code><code>Cancer Res. &lt;/span&gt;</code></p><p><code>25481</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>25482</code><code>64&lt;/span&gt;</code></p><p><code>25483</code><code>:4049–4054.&lt;/span&gt;</code></p><p><code>25484</code><code> [&lt;a href="/pubmed/15173020" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25485</code><code>PubMed&lt;/a&gt;</code></p><p><code>25486</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25487</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=Marijuana+use+and+risk+of+oral+squamous+cell+carcinoma&amp;amp;author=KA+Rosenblatt&amp;amp;author=JR+Daling&amp;amp;author=C+Chen&amp;amp;author=KJ+Sherman&amp;amp;author=SM+Schwartz&amp;amp;volume=64&amp;amp;publication_year=2004&amp;amp;pages=4049-4054&amp;amp;pmid=15173020&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25488</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25489</code><code>]&lt;/span&gt;</code></p><p><code>25490</code><code>&lt;/span&gt;</code></p><p><code>25491</code><code>&lt;/li&gt;</code></p><p><code>25492</code><code>&lt;li id="R1039"&gt;</code></p><p><code>25493</code><code>&lt;span class="citation"&gt;</code></p><p><code>25494</code><code>Rosenkrantz H, Braude M. Acute, subacute and 23-day chronic marihuana inhalation toxicities in the rat. &lt;span&gt;</code></p><p><code>25495</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25496</code><code>Taxicol Appl Pharmacol. &lt;/span&gt;</code></p><p><code>25497</code><code>1974;&lt;span class="ref-vol"&gt;</code></p><p><code>25498</code><code>28&lt;/span&gt;</code></p><p><code>25499</code><code>:428–441.&lt;/span&gt;</code></p><p><code>25500</code><code> [&lt;a href="/pubmed/4850426" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25501</code><code>PubMed&lt;/a&gt;</code></p><p><code>25502</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25503</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Taxicol+Appl+Pharmacol&amp;amp;title=Acute,+subacute+and+23-day+chronic+marihuana+inhalation+toxicities+in+the+rat&amp;amp;author=H+Rosenkrantz&amp;amp;author=M+Braude&amp;amp;volume=28&amp;amp;publication_year=1974&amp;amp;pages=428-441&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25504</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25505</code><code>]&lt;/span&gt;</code></p><p><code>25506</code><code>&lt;/span&gt;</code></p><p><code>25507</code><code>&lt;/li&gt;</code></p><p><code>25508</code><code>&lt;li id="R1040"&gt;</code></p><p><code>25509</code><code>&lt;span class="citation"&gt;</code></p><p><code>25510</code><code>Ross RA, Brockie HC, Stevenson LA, Murphy VL, Templeton F, Makriyannis A, Pertwee RG. Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630. &lt;span&gt;</code></p><p><code>25511</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25512</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>25513</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>25514</code><code>126&lt;/span&gt;</code></p><p><code>25515</code><code>:665–672.&lt;/span&gt;</code></p><p><code>25516</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>25517</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1565857/"&gt;</code></p><p><code>25518</code><code>PMC free article&lt;/a&gt;</code></p><p><code>25519</code><code>]&lt;/span&gt;</code></p><p><code>25520</code><code> [&lt;a href="/pubmed/10188977" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25521</code><code>PubMed&lt;/a&gt;</code></p><p><code>25522</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25523</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Agonist-inverse+agonist+characterization+at+CB1+and+CB2+cannabinoid+receptors+of+L759633,+L759656,+and+AM630&amp;amp;author=RA+Ross&amp;amp;author=HC+Brockie&amp;amp;author=LA+Stevenson&amp;amp;author=VL+Murphy&amp;amp;author=F+Templeton&amp;amp;volume=126&amp;amp;publication_year=1999&amp;amp;pages=665-672&amp;amp;pmid=10188977&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25524</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25525</code><code>]&lt;/span&gt;</code></p><p><code>25526</code><code>&lt;/span&gt;</code></p><p><code>25527</code><code>&lt;/li&gt;</code></p><p><code>25528</code><code>&lt;li id="R1041"&gt;</code></p><p><code>25529</code><code>&lt;span class="citation"&gt;</code></p><p><code>25530</code><code>Rossato M, Ion Popa F, Ferigo M, Clari G, Foresta C. Human sperm express cannabinoid receptor Cb&lt;sub&gt;</code></p><p><code>25531</code><code>1&lt;/sub&gt;</code></p><p><code>25532</code><code>, the activation of which inhibits motility, acrosome reaction, and mitochondrial function. &lt;span&gt;</code></p><p><code>25533</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25534</code><code>J Clin Endocrinol Metab. &lt;/span&gt;</code></p><p><code>25535</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>25536</code><code>90&lt;/span&gt;</code></p><p><code>25537</code><code>:984–991.&lt;/span&gt;</code></p><p><code>25538</code><code> [&lt;a href="/pubmed/15562018" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25539</code><code>PubMed&lt;/a&gt;</code></p><p><code>25540</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25541</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;amp;title=Human+sperm+express+cannabinoid+receptor+Cb1,+the+activation+of+which+inhibits+motility,+acrosome+reaction,+and+mitochondrial+function&amp;amp;author=M+Rossato&amp;amp;author=F+Ion+Popa&amp;amp;author=M+Ferigo&amp;amp;author=G+Clari&amp;amp;author=C+Foresta&amp;amp;volume=90&amp;amp;publication_year=2005&amp;amp;pages=984-991&amp;amp;pmid=15562018&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25542</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25543</code><code>]&lt;/span&gt;</code></p><p><code>25544</code><code>&lt;/span&gt;</code></p><p><code>25545</code><code>&lt;/li&gt;</code></p><p><code>25546</code><code>&lt;li id="R1042"&gt;</code></p><p><code>25547</code><code>&lt;span class="citation"&gt;</code></p><p><code>25548</code><code>Roth MD. Pharmacology: marijuana and your heart. &lt;span&gt;</code></p><p><code>25549</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25550</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>25551</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>25552</code><code>434&lt;/span&gt;</code></p><p><code>25553</code><code>:708–709.&lt;/span&gt;</code></p><p><code>25554</code><code> [&lt;a href="/pubmed/15815611" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25555</code><code>PubMed&lt;/a&gt;</code></p><p><code>25556</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25557</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Pharmacology:+marijuana+and+your+heart&amp;amp;author=MD+Roth&amp;amp;volume=434&amp;amp;publication_year=2005&amp;amp;pages=708-709&amp;amp;pmid=15815611&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25558</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25559</code><code>]&lt;/span&gt;</code></p><p><code>25560</code><code>&lt;/span&gt;</code></p><p><code>25561</code><code>&lt;/li&gt;</code></p><p><code>25562</code><code>&lt;li id="R1043"&gt;</code></p><p><code>25563</code><code>&lt;span class="citation"&gt;</code></p><p><code>25564</code><code>Rotzinger S, Vaccarino FJ. Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models. &lt;span&gt;</code></p><p><code>25565</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25566</code><code>J Psychiatry Neurosci. &lt;/span&gt;</code></p><p><code>25567</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>25568</code><code>28&lt;/span&gt;</code></p><p><code>25569</code><code>:171–181.&lt;/span&gt;</code></p><p><code>25570</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>25571</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC161741/"&gt;</code></p><p><code>25572</code><code>PMC free article&lt;/a&gt;</code></p><p><code>25573</code><code>]&lt;/span&gt;</code></p><p><code>25574</code><code> [&lt;a href="/pubmed/12790157" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25575</code><code>PubMed&lt;/a&gt;</code></p><p><code>25576</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25577</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Psychiatry+Neurosci&amp;amp;title=Cholecystokinin+receptor+subtypes:+role+in+the+modulation+of+anxiety-related+and+reward-related+behaviours+in+animal+models&amp;amp;author=S+Rotzinger&amp;amp;author=FJ+Vaccarino&amp;amp;volume=28&amp;amp;publication_year=2003&amp;amp;pages=171-181&amp;amp;pmid=12790157&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25578</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25579</code><code>]&lt;/span&gt;</code></p><p><code>25580</code><code>&lt;/span&gt;</code></p><p><code>25581</code><code>&lt;/li&gt;</code></p><p><code>25582</code><code>&lt;li id="R1044"&gt;</code></p><p><code>25583</code><code>&lt;span class="citation"&gt;</code></p><p><code>25584</code><code>Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. &lt;span&gt;</code></p><p><code>25585</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25586</code><code>N Engl J Med. &lt;/span&gt;</code></p><p><code>25587</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>25588</code><code>344&lt;/span&gt;</code></p><p><code>25589</code><code>:1688–1700.&lt;/span&gt;</code></p><p><code>25590</code><code> [&lt;a href="/pubmed/11386269" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25591</code><code>PubMed&lt;/a&gt;</code></p><p><code>25592</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25593</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;amp;title=Amyotrophic+lateral+sclerosis&amp;amp;author=LP+Rowland&amp;amp;author=NA+Shneider&amp;amp;volume=344&amp;amp;publication_year=2001&amp;amp;pages=1688-1700&amp;amp;pmid=11386269&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25594</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25595</code><code>]&lt;/span&gt;</code></p><p><code>25596</code><code>&lt;/span&gt;</code></p><p><code>25597</code><code>&lt;/li&gt;</code></p><p><code>25598</code><code>&lt;li id="R1045"&gt;</code></p><p><code>25599</code><code>&lt;span class="citation"&gt;</code></p><p><code>25600</code><code>Rowland NE, Mukherjee M, Roberston K. Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. &lt;span&gt;</code></p><p><code>25601</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25602</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>25603</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>25604</code><code>159&lt;/span&gt;</code></p><p><code>25605</code><code>:111–116.&lt;/span&gt;</code></p><p><code>25606</code><code> [&lt;a href="/pubmed/11797078" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25607</code><code>PubMed&lt;/a&gt;</code></p><p><code>25608</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25609</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Effects+of+the+cannabinoid+receptor+antagonist+SR+141716,+alone+and+in+combination+with+dexfenfluramine+or+naloxone,+on+food+intake+in+rats&amp;amp;author=NE+Rowland&amp;amp;author=M+Mukherjee&amp;amp;author=K+Roberston&amp;amp;volume=159&amp;amp;publication_year=2001&amp;amp;pages=111-116&amp;amp;pmid=11797078&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25610</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25611</code><code>]&lt;/span&gt;</code></p><p><code>25612</code><code>&lt;/span&gt;</code></p><p><code>25613</code><code>&lt;/li&gt;</code></p><p><code>25614</code><code>&lt;li id="R1046"&gt;</code></p><p><code>25615</code><code>&lt;span class="citation"&gt;</code></p><p><code>25616</code><code>Rubino T, Massi P, Vigano D, Fuzio D, Parolaro D. Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome. &lt;span&gt;</code></p><p><code>25617</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25618</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>25619</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>25620</code><code>66&lt;/span&gt;</code></p><p><code>25621</code><code>:2213–2219.&lt;/span&gt;</code></p><p><code>25622</code><code> [&lt;a href="/pubmed/10834304" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25623</code><code>PubMed&lt;/a&gt;</code></p><p><code>25624</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25625</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Long-term+treatment+with+SR141716A,+the+CB1+receptor+antagonist,+influences+morphine+withdrawal+syndrome&amp;amp;author=T+Rubino&amp;amp;author=P+Massi&amp;amp;author=D+Vigano&amp;amp;author=D+Fuzio&amp;amp;author=D+Parolaro&amp;amp;volume=66&amp;amp;publication_year=2000&amp;amp;pages=2213-2219&amp;amp;pmid=10834304&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25626</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25627</code><code>]&lt;/span&gt;</code></p><p><code>25628</code><code>&lt;/span&gt;</code></p><p><code>25629</code><code>&lt;/li&gt;</code></p><p><code>25630</code><code>&lt;li id="R1047"&gt;</code></p><p><code>25631</code><code>&lt;span class="citation"&gt;</code></p><p><code>25632</code><code>Rudich Z, Stinson J, Jeavons M, Brown SC. Treatment of chronic intractable neuropathic pain with dronabinol: case report of two adolescents. &lt;span&gt;</code></p><p><code>25633</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25634</code><code>Pain Res Manag. &lt;/span&gt;</code></p><p><code>25635</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>25636</code><code>8&lt;/span&gt;</code></p><p><code>25637</code><code>:221–224.&lt;/span&gt;</code></p><p><code>25638</code><code> [&lt;a href="/pubmed/14679417" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25639</code><code>PubMed&lt;/a&gt;</code></p><p><code>25640</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25641</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pain+Res+Manag&amp;amp;title=Treatment+of+chronic+intractable+neuropathic+pain+with+dronabinol:+case+report+of+two+adolescents&amp;amp;author=Z+Rudich&amp;amp;author=J+Stinson&amp;amp;author=M+Jeavons&amp;amp;author=SC+Brown&amp;amp;volume=8&amp;amp;publication_year=2003&amp;amp;pages=221-224&amp;amp;pmid=14679417&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25642</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25643</code><code>]&lt;/span&gt;</code></p><p><code>25644</code><code>&lt;/span&gt;</code></p><p><code>25645</code><code>&lt;/li&gt;</code></p><p><code>25646</code><code>&lt;li id="R1048"&gt;</code></p><p><code>25647</code><code>&lt;span class="citation"&gt;</code></p><p><code>25648</code><code>Rueda D, Galve-Roperh I, Haro A, Guzman M. The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. &lt;span&gt;</code></p><p><code>25649</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25650</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>25651</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>25652</code><code>58&lt;/span&gt;</code></p><p><code>25653</code><code>:814–820.&lt;/span&gt;</code></p><p><code>25654</code><code> [&lt;a href="/pubmed/10999952" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25655</code><code>PubMed&lt;/a&gt;</code></p><p><code>25656</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25657</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=The+CB(1)+cannabinoid+receptor+is+coupled+to+the+activation+of+c-Jun+N-terminal+kinase&amp;amp;author=D+Rueda&amp;amp;author=I+Galve-Roperh&amp;amp;author=A+Haro&amp;amp;author=M+Guzman&amp;amp;volume=58&amp;amp;publication_year=2000&amp;amp;pages=814-820&amp;amp;pmid=10999952&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25658</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25659</code><code>]&lt;/span&gt;</code></p><p><code>25660</code><code>&lt;/span&gt;</code></p><p><code>25661</code><code>&lt;/li&gt;</code></p><p><code>25662</code><code>&lt;li id="R1049"&gt;</code></p><p><code>25663</code><code>&lt;span class="citation"&gt;</code></p><p><code>25664</code><code>Ruiu S, Pinna GA, Marchese G, Mussinu JM, Saba P, Tambaro S, Casti P, Vargiu R, Pani L. Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB&lt;sub&gt;</code></p><p><code>25665</code><code>1&lt;/sub&gt;</code></p><p><code>25666</code><code> cannabinoid receptor. &lt;span&gt;</code></p><p><code>25667</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25668</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>25669</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>25670</code><code>306&lt;/span&gt;</code></p><p><code>25671</code><code>:363–370.&lt;/span&gt;</code></p><p><code>25672</code><code> [&lt;a href="/pubmed/12663689" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25673</code><code>PubMed&lt;/a&gt;</code></p><p><code>25674</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25675</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Synthesis+and+characterization+of+NESS+0327:+a+novel+putative+antagonist+of+the+CB1+cannabinoid+receptor&amp;amp;author=S+Ruiu&amp;amp;author=GA+Pinna&amp;amp;author=G+Marchese&amp;amp;author=JM+Mussinu&amp;amp;author=P+Saba&amp;amp;volume=306&amp;amp;publication_year=2003&amp;amp;pages=363-370&amp;amp;pmid=12663689&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25676</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25677</code><code>]&lt;/span&gt;</code></p><p><code>25678</code><code>&lt;/span&gt;</code></p><p><code>25679</code><code>&lt;/li&gt;</code></p><p><code>25680</code><code>&lt;li id="R1050"&gt;</code></p><p><code>25681</code><code>&lt;span class="citation"&gt;</code></p><p><code>25682</code><code>Russo E. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. &lt;span&gt;</code></p><p><code>25683</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25684</code><code>Med Hypotheses. &lt;/span&gt;</code></p><p><code>25685</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>25686</code><code>66&lt;/span&gt;</code></p><p><code>25687</code><code>:234–246.&lt;/span&gt;</code></p><p><code>25688</code><code> [&lt;a href="/pubmed/16209908" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25689</code><code>PubMed&lt;/a&gt;</code></p><p><code>25690</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25691</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Med+Hypotheses&amp;amp;title=A+tale+of+two+cannabinoids:+the+therapeutic+rationale+for+combining+tetrahydrocannabinol+and+cannabidiol&amp;amp;author=E+Russo&amp;amp;volume=66&amp;amp;publication_year=2006&amp;amp;pages=234-246&amp;amp;pmid=16209908&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25692</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25693</code><code>]&lt;/span&gt;</code></p><p><code>25694</code><code>&lt;/span&gt;</code></p><p><code>25695</code><code>&lt;/li&gt;</code></p><p><code>25696</code><code>&lt;li id="R1051"&gt;</code></p><p><code>25697</code><code>&lt;span class="citation"&gt;</code></p><p><code>25698</code><code>Russo EB. Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? &lt;span&gt;</code></p><p><code>25699</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25700</code><code>Neuro Endocrinol Lett. &lt;/span&gt;</code></p><p><code>25701</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>25702</code><code>25&lt;/span&gt;</code></p><p><code>25703</code><code>:31–39.&lt;/span&gt;</code></p><p><code>25704</code><code> [&lt;a href="/pubmed/15159679" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25705</code><code>PubMed&lt;/a&gt;</code></p><p><code>25706</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25707</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuro+Endocrinol+Lett&amp;amp;title=Clinical+endocannabinoid+deficiency+(CECD):+can+this+concept+explain+therapeutic+benefits+of+cannabis+in+migraine,+fibromyalgia,+irritable+bowel+syndrome+and+other+treatment-resistant+conditions?&amp;amp;author=EB+Russo&amp;amp;volume=25&amp;amp;publication_year=2004&amp;amp;pages=31-39&amp;amp;pmid=15159679&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25708</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25709</code><code>]&lt;/span&gt;</code></p><p><code>25710</code><code>&lt;/span&gt;</code></p><p><code>25711</code><code>&lt;/li&gt;</code></p><p><code>25712</code><code>&lt;li id="R1052"&gt;</code></p><p><code>25713</code><code>&lt;span class="citation"&gt;</code></p><p><code>25714</code><code>Rutkowska M, Fereniec-Goltbiewska L. ACEA (arachidonyl-2-chloroethylamide), the selective cannabinoid CB1 receptor agonist, protects against aspirin-induced gastric ulceration. &lt;span&gt;</code></p><p><code>25715</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25716</code><code>Pharmazie 2006. &lt;/span&gt;</code></p><p><code>25717</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>25718</code><code>61&lt;/span&gt;</code></p><p><code>25719</code><code>:341–342.&lt;/span&gt;</code></p><p><code>25720</code><code> [&lt;a href="/pubmed/16649551" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25721</code><code>PubMed&lt;/a&gt;</code></p><p><code>25722</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25723</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmazie+2006&amp;amp;title=ACEA+(arachidonyl-2-chloroethylamide),+the+selective+cannabinoid+CB1+receptor+agonist,+protects+against+aspirin-induced+gastric+ulceration&amp;amp;author=M+Rutkowska&amp;amp;author=L+Fereniec-Goltbiewska&amp;amp;volume=61&amp;amp;publication_year=2006&amp;amp;pages=341-342&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25724</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25725</code><code>]&lt;/span&gt;</code></p><p><code>25726</code><code>&lt;/span&gt;</code></p><p><code>25727</code><code>&lt;/li&gt;</code></p><p><code>25728</code><code>&lt;li id="R1053"&gt;</code></p><p><code>25729</code><code>&lt;span class="citation"&gt;</code></p><p><code>25730</code><code>Rutkowska M, Jamontt J, Gliniak H. Effects of cannabinoids on the anxiety-like response in mice. &lt;span&gt;</code></p><p><code>25731</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25732</code><code>Pharmacol Rep. &lt;/span&gt;</code></p><p><code>25733</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>25734</code><code>58&lt;/span&gt;</code></p><p><code>25735</code><code>:200–206.&lt;/span&gt;</code></p><p><code>25736</code><code> [&lt;a href="/pubmed/16702621" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25737</code><code>PubMed&lt;/a&gt;</code></p><p><code>25738</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25739</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Rep&amp;amp;title=Effects+of+cannabinoids+on+the+anxiety-like+response+in+mice&amp;amp;author=M+Rutkowska&amp;amp;author=J+Jamontt&amp;amp;author=H+Gliniak&amp;amp;volume=58&amp;amp;publication_year=2006&amp;amp;pages=200-206&amp;amp;pmid=16702621&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25740</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25741</code><code>]&lt;/span&gt;</code></p><p><code>25742</code><code>&lt;/span&gt;</code></p><p><code>25743</code><code>&lt;/li&gt;</code></p><p><code>25744</code><code>&lt;li id="R1054"&gt;</code></p><p><code>25745</code><code>&lt;span class="citation"&gt;</code></p><p><code>25746</code><code>Ryberg E, Vu HK, Larsson N, Groblewski T, Hjorth S, Elebring T, Sjogren S, Greasley PJ. Identification and characterisation of a novel splice variant of the human CB1 receptor. &lt;span&gt;</code></p><p><code>25747</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25748</code><code>FEBS Lett. &lt;/span&gt;</code></p><p><code>25749</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>25750</code><code>579&lt;/span&gt;</code></p><p><code>25751</code><code>:259–264.&lt;/span&gt;</code></p><p><code>25752</code><code> [&lt;a href="/pubmed/15620723" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25753</code><code>PubMed&lt;/a&gt;</code></p><p><code>25754</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25755</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;amp;title=Identification+and+characterisation+of+a+novel+splice+variant+of+the+human+CB1+receptor&amp;amp;author=E+Ryberg&amp;amp;author=HK+Vu&amp;amp;author=N+Larsson&amp;amp;author=T+Groblewski&amp;amp;author=S+Hjorth&amp;amp;volume=579&amp;amp;publication_year=2005&amp;amp;pages=259-264&amp;amp;pmid=15620723&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25756</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25757</code><code>]&lt;/span&gt;</code></p><p><code>25758</code><code>&lt;/span&gt;</code></p><p><code>25759</code><code>&lt;/li&gt;</code></p><p><code>25760</code><code>&lt;li id="R1055"&gt;</code></p><p><code>25761</code><code>&lt;span class="citation"&gt;</code></p><p><code>25762</code><code>Saario SM, Savinainen JR, Laitinen JT, Jarvinen T, Niemi R. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. &lt;span&gt;</code></p><p><code>25763</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25764</code><code>Biochem Pharmacol. &lt;/span&gt;</code></p><p><code>25765</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>25766</code><code>67&lt;/span&gt;</code></p><p><code>25767</code><code>:1381–1387.&lt;/span&gt;</code></p><p><code>25768</code><code> [&lt;a href="/pubmed/15013854" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25769</code><code>PubMed&lt;/a&gt;</code></p><p><code>25770</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25771</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;amp;title=Monoglyceride+lipase-like+enzymatic+activity+is+responsible+for+hydrolysis+of+2-arachidonoylglycerol+in+rat+cerebellar+membranes&amp;amp;author=SM+Saario&amp;amp;author=JR+Savinainen&amp;amp;author=JT+Laitinen&amp;amp;author=T+Jarvinen&amp;amp;author=R+Niemi&amp;amp;volume=67&amp;amp;publication_year=2004&amp;amp;pages=1381-1387&amp;amp;pmid=15013854&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25772</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25773</code><code>]&lt;/span&gt;</code></p><p><code>25774</code><code>&lt;/span&gt;</code></p><p><code>25775</code><code>&lt;/li&gt;</code></p><p><code>25776</code><code>&lt;li id="R1056"&gt;</code></p><p><code>25777</code><code>&lt;span class="citation"&gt;</code></p><p><code>25778</code><code>Salim K, Schneider U, Burstein S, Hoy L, Karst M. Pain measurements and side effect profile of the novel cannabinoid ajulemic acid. &lt;span&gt;</code></p><p><code>25779</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25780</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>25781</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>25782</code><code>48&lt;/span&gt;</code></p><p><code>25783</code><code>:1164–1171.&lt;/span&gt;</code></p><p><code>25784</code><code> [&lt;a href="/pubmed/15910892" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25785</code><code>PubMed&lt;/a&gt;</code></p><p><code>25786</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25787</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=Pain+measurements+and+side+effect+profile+of+the+novel+cannabinoid+ajulemic+acid&amp;amp;author=K+Salim&amp;amp;author=U+Schneider&amp;amp;author=S+Burstein&amp;amp;author=L+Hoy&amp;amp;author=M+Karst&amp;amp;volume=48&amp;amp;publication_year=2005&amp;amp;pages=1164-1171&amp;amp;pmid=15910892&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25788</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25789</code><code>]&lt;/span&gt;</code></p><p><code>25790</code><code>&lt;/span&gt;</code></p><p><code>25791</code><code>&lt;/li&gt;</code></p><p><code>25792</code><code>&lt;li id="R1057"&gt;</code></p><p><code>25793</code><code>&lt;span class="citation"&gt;</code></p><p><code>25794</code><code>S&amp;#x000e1;nchez C, de Ceballos ML, del Pulgar TG, Rueda D, Corbacho C, Velasco G, Galve-Roperh I, Huffman JW, Ramon y Cajal S, Guzman M. Inhibition of glioma growth in vivo by selective activation of the CB2 cannabinoid receptor. &lt;span&gt;</code></p><p><code>25795</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25796</code><code>Cancer Res. &lt;/span&gt;</code></p><p><code>25797</code><code>2001a;&lt;span class="ref-vol"&gt;</code></p><p><code>25798</code><code>61&lt;/span&gt;</code></p><p><code>25799</code><code>:5784–5789.&lt;/span&gt;</code></p><p><code>25800</code><code> [&lt;a href="/pubmed/11479216" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25801</code><code>PubMed&lt;/a&gt;</code></p><p><code>25802</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25803</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=Inhibition+of+glioma+growth+in+vivo+by+selective+activation+of+the+CB2+cannabinoid+receptor&amp;amp;author=C+S&amp;#x000e1;nchez&amp;amp;author=ML+de+Ceballos&amp;amp;author=TG+del+Pulgar&amp;amp;author=D+Rueda&amp;amp;author=C+Corbacho&amp;amp;volume=61&amp;amp;publication_year=2001a&amp;amp;pages=5784-5789&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25804</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25805</code><code>]&lt;/span&gt;</code></p><p><code>25806</code><code>&lt;/span&gt;</code></p><p><code>25807</code><code>&lt;/li&gt;</code></p><p><code>25808</code><code>&lt;li id="R1058"&gt;</code></p><p><code>25809</code><code>&lt;span class="citation"&gt;</code></p><p><code>25810</code><code>S&amp;#x000e1;nchez C, Galve-Roperh I, Canova C, Brachet P, Guzman M. &amp;#x00394;&lt;sup&gt;</code></p><p><code>25811</code><code>9&lt;/sup&gt;</code></p><p><code>25812</code><code>-Tetrahydrocannabinol induces apoptosis in C6 glioma cells. &lt;span&gt;</code></p><p><code>25813</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25814</code><code>FEBS Lett. &lt;/span&gt;</code></p><p><code>25815</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>25816</code><code>436&lt;/span&gt;</code></p><p><code>25817</code><code>:6–10.&lt;/span&gt;</code></p><p><code>25818</code><code> [&lt;a href="/pubmed/9771884" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25819</code><code>PubMed&lt;/a&gt;</code></p><p><code>25820</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25821</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;amp;title=&amp;#x00394;9-Tetrahydrocannabinol+induces+apoptosis+in+C6+glioma+cells&amp;amp;author=C+S&amp;#x000e1;nchez&amp;amp;author=I+Galve-Roperh&amp;amp;author=C+Canova&amp;amp;author=P+Brachet&amp;amp;author=M+Guzman&amp;amp;volume=436&amp;amp;publication_year=1998&amp;amp;pages=6-10&amp;amp;pmid=9771884&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25822</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25823</code><code>]&lt;/span&gt;</code></p><p><code>25824</code><code>&lt;/span&gt;</code></p><p><code>25825</code><code>&lt;/li&gt;</code></p><p><code>25826</code><code>&lt;li id="R1059"&gt;</code></p><p><code>25827</code><code>&lt;span class="citation"&gt;</code></p><p><code>25828</code><code>S&amp;#x000e1;nchez C, Rueda D, Segui B, Galve-Roperh I, Levade T, Guzman M. The CB&lt;sub&gt;</code></p><p><code>25829</code><code>1&lt;/sub&gt;</code></p><p><code>25830</code><code> cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan. &lt;span&gt;</code></p><p><code>25831</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25832</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>25833</code><code>2001b;&lt;span class="ref-vol"&gt;</code></p><p><code>25834</code><code>59&lt;/span&gt;</code></p><p><code>25835</code><code>:955–959.&lt;/span&gt;</code></p><p><code>25836</code><code> [&lt;a href="/pubmed/11306675" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25837</code><code>PubMed&lt;/a&gt;</code></p><p><code>25838</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25839</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=The+CB1+cannabinoid+receptor+of+astrocytes+is+coupled+to+sphingomyelin+hydrolysis+through+the+adaptor+protein+fan&amp;amp;author=C+S&amp;#x000e1;nchez&amp;amp;author=D+Rueda&amp;amp;author=B+Segui&amp;amp;author=I+Galve-Roperh&amp;amp;author=T+Levade&amp;amp;volume=59&amp;amp;publication_year=2001b&amp;amp;pages=955-959&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25840</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25841</code><code>]&lt;/span&gt;</code></p><p><code>25842</code><code>&lt;/span&gt;</code></p><p><code>25843</code><code>&lt;/li&gt;</code></p><p><code>25844</code><code>&lt;li id="R1060"&gt;</code></p><p><code>25845</code><code>&lt;span class="citation"&gt;</code></p><p><code>25846</code><code>S&amp;#x000e1;nchez MG, Ruiz-Llorente L, Sanchez AM, Diaz-Laviada I. Activation of phosphoinositide 3-kinase/PKB pathway by CB&lt;sub&gt;</code></p><p><code>25847</code><code>1&lt;/sub&gt;</code></p><p><code>25848</code><code> and CB&lt;sub&gt;</code></p><p><code>25849</code><code>2&lt;/sub&gt;</code></p><p><code>25850</code><code> cannabinoid receptors expressed in prostate PC-3 cells: involvement in Raf-1 stimulation and NGF induction. &lt;span&gt;</code></p><p><code>25851</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25852</code><code>Cell Signal. &lt;/span&gt;</code></p><p><code>25853</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>25854</code><code>15&lt;/span&gt;</code></p><p><code>25855</code><code>:851–859.&lt;/span&gt;</code></p><p><code>25856</code><code> [&lt;a href="/pubmed/12834810" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25857</code><code>PubMed&lt;/a&gt;</code></p><p><code>25858</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25859</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cell+Signal&amp;amp;title=Activation+of+phosphoinositide+3-kinase/PKB+pathway+by+CB1+and+CB2+cannabinoid+receptors+expressed+in+prostate+PC-3+cells:+involvement+in+Raf-1+stimulation+and+NGF+induction&amp;amp;author=MG+S&amp;#x000e1;nchez&amp;amp;author=L+Ruiz-Llorente&amp;amp;author=AM+Sanchez&amp;amp;author=I+Diaz-Laviada&amp;amp;volume=15&amp;amp;publication_year=2003&amp;amp;pages=851-859&amp;amp;pmid=12834810&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25860</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25861</code><code>]&lt;/span&gt;</code></p><p><code>25862</code><code>&lt;/span&gt;</code></p><p><code>25863</code><code>&lt;/li&gt;</code></p><p><code>25864</code><code>&lt;li id="R1061"&gt;</code></p><p><code>25865</code><code>&lt;span class="citation"&gt;</code></p><p><code>25866</code><code>Sa&amp;#x000f1;udo-Pe&amp;#x000f1;a MC, Patrick SL, Khen S, Patrick RL, Tsou K, Walker JM. Cannabinoid effects in basal ganglia in a rat model of Parkinson&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>25867</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25868</code><code>Neurosci Lett. &lt;/span&gt;</code></p><p><code>25869</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>25870</code><code>248&lt;/span&gt;</code></p><p><code>25871</code><code>:171–174.&lt;/span&gt;</code></p><p><code>25872</code><code> [&lt;a href="/pubmed/9654336" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25873</code><code>PubMed&lt;/a&gt;</code></p><p><code>25874</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25875</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Lett&amp;amp;title=Cannabinoid+effects+in+basal+ganglia+in+a+rat+model+of+Parkinson&amp;#x02019;s+disease&amp;amp;author=MC+Sa&amp;#x000f1;udo-Pe&amp;#x000f1;a&amp;amp;author=SL+Patrick&amp;amp;author=S+Khen&amp;amp;author=RL+Patrick&amp;amp;author=K+Tsou&amp;amp;volume=248&amp;amp;publication_year=1998&amp;amp;pages=171-174&amp;amp;pmid=9654336&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25876</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25877</code><code>]&lt;/span&gt;</code></p><p><code>25878</code><code>&lt;/span&gt;</code></p><p><code>25879</code><code>&lt;/li&gt;</code></p><p><code>25880</code><code>&lt;li id="R1062"&gt;</code></p><p><code>25881</code><code>&lt;span class="citation"&gt;</code></p><p><code>25882</code><code>Sa&amp;#x000f1;udo-Pe&amp;#x000f1;a MC, Strangman NM, Mackie K, Walker JM, Tsou K. CB&lt;sub&gt;</code></p><p><code>25883</code><code>1&lt;/sub&gt;</code></p><p><code>25884</code><code> receptor localization in spinal cord and roots, dorsal root ganglion, and peripheral nerve. &lt;span&gt;</code></p><p><code>25885</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25886</code><code>Acta Pharmacol Sin. &lt;/span&gt;</code></p><p><code>25887</code><code>1999a;&lt;span class="ref-vol"&gt;</code></p><p><code>25888</code><code>12&lt;/span&gt;</code></p><p><code>25889</code><code>:1115–1120.&lt;/span&gt;</code></p><p><code>25890</code><code> [&lt;a href="/pubmed/11216446" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25891</code><code>PubMed&lt;/a&gt;</code></p><p><code>25892</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25893</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Acta+Pharmacol+Sin&amp;amp;title=CB1+receptor+localization+in+spinal+cord+and+roots,+dorsal+root+ganglion,+and+peripheral+nerve&amp;amp;author=MC+Sa&amp;#x000f1;udo-Pe&amp;#x000f1;a&amp;amp;author=NM+Strangman&amp;amp;author=K+Mackie&amp;amp;author=JM+Walker&amp;amp;author=K+Tsou&amp;amp;volume=12&amp;amp;publication_year=1999a&amp;amp;pages=1115-1120&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25894</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25895</code><code>]&lt;/span&gt;</code></p><p><code>25896</code><code>&lt;/span&gt;</code></p><p><code>25897</code><code>&lt;/li&gt;</code></p><p><code>25898</code><code>&lt;li id="R1063"&gt;</code></p><p><code>25899</code><code>&lt;span class="citation"&gt;</code></p><p><code>25900</code><code>Sa&amp;#x000f1;udo-Pe&amp;#x000f1;a MC, Tsou K, Walker JM. Motor actions of cannabinoids in the basal ganglia output nuclei. &lt;span&gt;</code></p><p><code>25901</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25902</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>25903</code><code>1999b;&lt;span class="ref-vol"&gt;</code></p><p><code>25904</code><code>65&lt;/span&gt;</code></p><p><code>25905</code><code>:703–713.&lt;/span&gt;</code></p><p><code>25906</code><code> [&lt;a href="/pubmed/10462071" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25907</code><code>PubMed&lt;/a&gt;</code></p><p><code>25908</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25909</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Motor+actions+of+cannabinoids+in+the+basal+ganglia+output+nuclei&amp;amp;author=MC+Sa&amp;#x000f1;udo-Pe&amp;#x000f1;a&amp;amp;author=K+Tsou&amp;amp;author=JM+Walker&amp;amp;volume=65&amp;amp;publication_year=1999b&amp;amp;pages=703-713&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25910</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25911</code><code>]&lt;/span&gt;</code></p><p><code>25912</code><code>&lt;/span&gt;</code></p><p><code>25913</code><code>&lt;/li&gt;</code></p><p><code>25914</code><code>&lt;li id="R1064"&gt;</code></p><p><code>25915</code><code>&lt;span class="citation"&gt;</code></p><p><code>25916</code><code>Sa&amp;#x000f1;udo-Pe&amp;#x000f1;a MC, Walker JM. Effects of intrapallidal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system. &lt;span&gt;</code></p><p><code>25917</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25918</code><code>Synapse. &lt;/span&gt;</code></p><p><code>25919</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>25920</code><code>28&lt;/span&gt;</code></p><p><code>25921</code><code>:27–32.&lt;/span&gt;</code></p><p><code>25922</code><code> [&lt;a href="/pubmed/9414015" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25923</code><code>PubMed&lt;/a&gt;</code></p><p><code>25924</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25925</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Synapse&amp;amp;title=Effects+of+intrapallidal+cannabinoids+on+rotational+behavior+in+rats:+interactions+with+the+dopaminergic+system&amp;amp;author=MC+Sa&amp;#x000f1;udo-Pe&amp;#x000f1;a&amp;amp;author=JM+Walker&amp;amp;volume=28&amp;amp;publication_year=1998&amp;amp;pages=27-32&amp;amp;pmid=9414015&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25926</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25927</code><code>]&lt;/span&gt;</code></p><p><code>25928</code><code>&lt;/span&gt;</code></p><p><code>25929</code><code>&lt;/li&gt;</code></p><p><code>25930</code><code>&lt;li id="R1065"&gt;</code></p><p><code>25931</code><code>&lt;span class="citation"&gt;</code></p><p><code>25932</code><code>Saper CB. The central autonomic nervous system: conscious visceral perception and autonomic pattern generation. &lt;span&gt;</code></p><p><code>25933</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25934</code><code>Annu Rev Neurosci. &lt;/span&gt;</code></p><p><code>25935</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>25936</code><code>25&lt;/span&gt;</code></p><p><code>25937</code><code>:433–469.&lt;/span&gt;</code></p><p><code>25938</code><code> [&lt;a href="/pubmed/12052916" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25939</code><code>PubMed&lt;/a&gt;</code></p><p><code>25940</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25941</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Neurosci&amp;amp;title=The+central+autonomic+nervous+system:+conscious+visceral+perception+and+autonomic+pattern+generation&amp;amp;author=CB+Saper&amp;amp;volume=25&amp;amp;publication_year=2002&amp;amp;pages=433-469&amp;amp;pmid=12052916&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25942</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25943</code><code>]&lt;/span&gt;</code></p><p><code>25944</code><code>&lt;/span&gt;</code></p><p><code>25945</code><code>&lt;/li&gt;</code></p><p><code>25946</code><code>&lt;li id="R1066"&gt;</code></p><p><code>25947</code><code>&lt;span class="citation"&gt;</code></p><p><code>25948</code><code>Sarfaraz S, Afaq F, Adhami VM, Mukhtar H. Cannabinoid receptor as a novel target for the treatment of prostate cancer. &lt;span&gt;</code></p><p><code>25949</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25950</code><code>Cancer Res. &lt;/span&gt;</code></p><p><code>25951</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>25952</code><code>65&lt;/span&gt;</code></p><p><code>25953</code><code>:1635–1641.&lt;/span&gt;</code></p><p><code>25954</code><code> [&lt;a href="/pubmed/15753356" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25955</code><code>PubMed&lt;/a&gt;</code></p><p><code>25956</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25957</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=Cannabinoid+receptor+as+a+novel+target+for+the+treatment+of+prostate+cancer&amp;amp;author=S+Sarfaraz&amp;amp;author=F+Afaq&amp;amp;author=VM+Adhami&amp;amp;author=H+Mukhtar&amp;amp;volume=65&amp;amp;publication_year=2005&amp;amp;pages=1635-1641&amp;amp;pmid=15753356&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25958</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25959</code><code>]&lt;/span&gt;</code></p><p><code>25960</code><code>&lt;/span&gt;</code></p><p><code>25961</code><code>&lt;/li&gt;</code></p><p><code>25962</code><code>&lt;li id="R1067"&gt;</code></p><p><code>25963</code><code>&lt;span class="citation"&gt;</code></p><p><code>25964</code><code>Sarker KP, Biswas KK, Yamakuchi M, Lee KY, Hahiguchi T, Kracht M, Kitajima I, Maruyama I. ASK1&amp;#x02013;p38 MAPK/JNK signaling cascade mediates anandamide-induced PC12 cell death. &lt;span&gt;</code></p><p><code>25965</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25966</code><code>J Neurochem. &lt;/span&gt;</code></p><p><code>25967</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>25968</code><code>85&lt;/span&gt;</code></p><p><code>25969</code><code>:50–61.&lt;/span&gt;</code></p><p><code>25970</code><code> [&lt;a href="/pubmed/12641726" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25971</code><code>PubMed&lt;/a&gt;</code></p><p><code>25972</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25973</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;amp;title=ASK1&amp;#x02013;p38+MAPK/JNK+signaling+cascade+mediates+anandamide-induced+PC12+cell+death&amp;amp;author=KP+Sarker&amp;amp;author=KK+Biswas&amp;amp;author=M+Yamakuchi&amp;amp;author=KY+Lee&amp;amp;author=T+Hahiguchi&amp;amp;volume=85&amp;amp;publication_year=2003&amp;amp;pages=50-61&amp;amp;pmid=12641726&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25974</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25975</code><code>]&lt;/span&gt;</code></p><p><code>25976</code><code>&lt;/span&gt;</code></p><p><code>25977</code><code>&lt;/li&gt;</code></p><p><code>25978</code><code>&lt;li id="R1068"&gt;</code></p><p><code>25979</code><code>&lt;span class="citation"&gt;</code></p><p><code>25980</code><code>Sarker KP, Obara S, Nakata M, Kitajima I, Maruyama I. Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3. &lt;span&gt;</code></p><p><code>25981</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>25982</code><code>FEBS Lett. &lt;/span&gt;</code></p><p><code>25983</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>25984</code><code>472&lt;/span&gt;</code></p><p><code>25985</code><code>:1039–1044.&lt;/span&gt;</code></p><p><code>25986</code><code> [&lt;a href="/pubmed/10781801" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>25987</code><code>PubMed&lt;/a&gt;</code></p><p><code>25988</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>25989</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;amp;title=Anandamide+induces+apoptosis+of+PC-12+cells:+involvement+of+superoxide+and+caspase-3&amp;amp;author=KP+Sarker&amp;amp;author=S+Obara&amp;amp;author=M+Nakata&amp;amp;author=I+Kitajima&amp;amp;author=I+Maruyama&amp;amp;volume=472&amp;amp;publication_year=2000&amp;amp;pages=1039-1044&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>25990</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>25991</code><code>]&lt;/span&gt;</code></p><p><code>25992</code><code>&lt;/span&gt;</code></p><p><code>25993</code><code>&lt;/li&gt;</code></p><p><code>25994</code><code>&lt;li id="R1069"&gt;</code></p><p><code>25995</code><code>&lt;span class="citation"&gt;</code></p><p><code>25996</code><code>Savinainen JR, Laitinen JT. Detection of cannabinoid CB&lt;sub&gt;</code></p><p><code>25997</code><code>1&lt;/sub&gt;</code></p><p><code>25998</code><code>, adenosine A&lt;sub&gt;</code></p><p><code>25999</code><code>1&lt;/sub&gt;</code></p><p><code>26000</code><code>, muscarinic acetylcholine, and GABA&lt;sub&gt;</code></p><p><code>26001</code><code>B&lt;/sub&gt;</code></p><p><code>26002</code><code> receptor-dependent G protein activity in transducin-deactivated membranes and autoradiography sections of rat retina. &lt;span&gt;</code></p><p><code>26003</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26004</code><code>Cell Mol Neurobiol. &lt;/span&gt;</code></p><p><code>26005</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>26006</code><code>24&lt;/span&gt;</code></p><p><code>26007</code><code>:243–256.&lt;/span&gt;</code></p><p><code>26008</code><code> [&lt;a href="/pubmed/15176438" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26009</code><code>PubMed&lt;/a&gt;</code></p><p><code>26010</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26011</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cell+Mol+Neurobiol&amp;amp;title=Detection+of+cannabinoid+CB1,+adenosine+A1,+muscarinic+acetylcholine,+and+GABAB+receptor-dependent+G+protein+activity+in+transducin-deactivated+membranes+and+autoradiography+sections+of+rat+retina&amp;amp;author=JR+Savinainen&amp;amp;author=JT+Laitinen&amp;amp;volume=24&amp;amp;publication_year=2004&amp;amp;pages=243-256&amp;amp;pmid=15176438&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26012</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26013</code><code>]&lt;/span&gt;</code></p><p><code>26014</code><code>&lt;/span&gt;</code></p><p><code>26015</code><code>&lt;/li&gt;</code></p><p><code>26016</code><code>&lt;li id="R1070"&gt;</code></p><p><code>26017</code><code>&lt;span class="citation"&gt;</code></p><p><code>26018</code><code>Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, Heng HHQ, George SR, O&amp;#x02019;Dowd BF. Identification and cloning of three novel human G protein-coupled receptor genes GPR52, &amp;#x003a8;GPR53 and GPR55: GPR55 is extensively expressed in human brain. &lt;span&gt;</code></p><p><code>26019</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26020</code><code>Mol Brain Res. &lt;/span&gt;</code></p><p><code>26021</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>26022</code><code>64&lt;/span&gt;</code></p><p><code>26023</code><code>:193–198.&lt;/span&gt;</code></p><p><code>26024</code><code> [&lt;a href="/pubmed/9931487" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26025</code><code>PubMed&lt;/a&gt;</code></p><p><code>26026</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26027</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Brain+Res&amp;amp;title=Identification+and+cloning+of+three+novel+human+G+protein-coupled+receptor+genes+GPR52,+&amp;#x003a8;GPR53+and+GPR55:+GPR55+is+extensively+expressed+in+human+brain&amp;amp;author=M+Sawzdargo&amp;amp;author=T+Nguyen&amp;amp;author=DK+Lee&amp;amp;author=KR+Lynch&amp;amp;author=R+Cheng&amp;amp;volume=64&amp;amp;publication_year=1999&amp;amp;pages=193-198&amp;amp;pmid=9931487&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26028</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26029</code><code>]&lt;/span&gt;</code></p><p><code>26030</code><code>&lt;/span&gt;</code></p><p><code>26031</code><code>&lt;/li&gt;</code></p><p><code>26032</code><code>&lt;li id="R1071"&gt;</code></p><p><code>26033</code><code>&lt;span class="citation"&gt;</code></p><p><code>26034</code><code>Scadden DT. AIDS-related malignancies. &lt;span&gt;</code></p><p><code>26035</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26036</code><code>Annu Rev Med. &lt;/span&gt;</code></p><p><code>26037</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>26038</code><code>54&lt;/span&gt;</code></p><p><code>26039</code><code>:285–303.&lt;/span&gt;</code></p><p><code>26040</code><code> [&lt;a href="/pubmed/12525676" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26041</code><code>PubMed&lt;/a&gt;</code></p><p><code>26042</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26043</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Med&amp;amp;title=AIDS-related+malignancies&amp;amp;author=DT+Scadden&amp;amp;volume=54&amp;amp;publication_year=2003&amp;amp;pages=285-303&amp;amp;pmid=12525676&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26044</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26045</code><code>]&lt;/span&gt;</code></p><p><code>26046</code><code>&lt;/span&gt;</code></p><p><code>26047</code><code>&lt;/li&gt;</code></p><p><code>26048</code><code>&lt;li id="R1072"&gt;</code></p><p><code>26049</code><code>&lt;span class="citation"&gt;</code></p><p><code>26050</code><code>Schabitz WR, Giuffrida A, Berger C, Aschoff A, Schwaninger M, Schwab S, Piomelli D. Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. &lt;span&gt;</code></p><p><code>26051</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26052</code><code>Stroke. &lt;/span&gt;</code></p><p><code>26053</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>26054</code><code>33&lt;/span&gt;</code></p><p><code>26055</code><code>:2112–2114.&lt;/span&gt;</code></p><p><code>26056</code><code> [&lt;a href="/pubmed/12154273" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26057</code><code>PubMed&lt;/a&gt;</code></p><p><code>26058</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26059</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Stroke&amp;amp;title=Release+of+fatty+acid+amides+in+a+patient+with+hemispheric+stroke:+a+microdialysis+study&amp;amp;author=WR+Schabitz&amp;amp;author=A+Giuffrida&amp;amp;author=C+Berger&amp;amp;author=A+Aschoff&amp;amp;author=M+Schwaninger&amp;amp;volume=33&amp;amp;publication_year=2002&amp;amp;pages=2112-2114&amp;amp;pmid=12154273&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26060</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26061</code><code>]&lt;/span&gt;</code></p><p><code>26062</code><code>&lt;/span&gt;</code></p><p><code>26063</code><code>&lt;/li&gt;</code></p><p><code>26064</code><code>&lt;li id="R1073"&gt;</code></p><p><code>26065</code><code>&lt;span class="citation"&gt;</code></p><p><code>26066</code><code>Schelling G, Hauer D, Azad SC, Schmoelz M, Chouker A, Schmidt M, Hornuss C, Rippberger M, Briegel J, Thiel M, et al.  Effects of general anesthesia on anandamide blood levels in humans. &lt;span&gt;</code></p><p><code>26067</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26068</code><code>Anesthesiology. &lt;/span&gt;</code></p><p><code>26069</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>26070</code><code>104&lt;/span&gt;</code></p><p><code>26071</code><code>:273–277.&lt;/span&gt;</code></p><p><code>26072</code><code> [&lt;a href="/pubmed/16436846" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26073</code><code>PubMed&lt;/a&gt;</code></p><p><code>26074</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26075</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Anesthesiology&amp;amp;title=Effects+of+general+anesthesia+on+anandamide+blood+levels+in+humans&amp;amp;author=G+Schelling&amp;amp;author=D+Hauer&amp;amp;author=SC+Azad&amp;amp;author=M+Schmoelz&amp;amp;author=A+Chouker&amp;amp;volume=104&amp;amp;publication_year=2006&amp;amp;pages=273-277&amp;amp;pmid=16436846&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26076</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26077</code><code>]&lt;/span&gt;</code></p><p><code>26078</code><code>&lt;/span&gt;</code></p><p><code>26079</code><code>&lt;/li&gt;</code></p><p><code>26080</code><code>&lt;li id="R1074"&gt;</code></p><p><code>26081</code><code>&lt;span class="citation"&gt;</code></p><p><code>26082</code><code>Schmid K, Niederhoffer N, Szabo B. Analysis of the respiratory effects of cannabinoids in rats. &lt;span&gt;</code></p><p><code>26083</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26084</code><code>Naunyn-Schmiedeberg&amp;#x02019;s Arch Pharmacol. &lt;/span&gt;</code></p><p><code>26085</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>26086</code><code>368&lt;/span&gt;</code></p><p><code>26087</code><code>:301–308.&lt;/span&gt;</code></p><p><code>26088</code><code> [&lt;a href="/pubmed/13680088" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26089</code><code>PubMed&lt;/a&gt;</code></p><p><code>26090</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26091</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Naunyn-Schmiedeberg&amp;#x02019;s+Arch+Pharmacol&amp;amp;title=Analysis+of+the+respiratory+effects+of+cannabinoids+in+rats&amp;amp;author=K+Schmid&amp;amp;author=N+Niederhoffer&amp;amp;author=B+Szabo&amp;amp;volume=368&amp;amp;publication_year=2003&amp;amp;pages=301-308&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26092</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26093</code><code>]&lt;/span&gt;</code></p><p><code>26094</code><code>&lt;/span&gt;</code></p><p><code>26095</code><code>&lt;/li&gt;</code></p><p><code>26096</code><code>&lt;li id="R1075"&gt;</code></p><p><code>26097</code><code>&lt;span class="citation"&gt;</code></p><p><code>26098</code><code>Schmid PC, Krebsbach RJ, Perry SR, Dettmer TM, Maasson JL, Schmid HH. Occurrence and postmortem generation of anandamide and other long-chain &lt;em&gt;</code></p><p><code>26099</code><code>N-&lt;/em&gt;</code></p><p><code>26100</code><code>acylethanolamines in mammalian brain. &lt;span&gt;</code></p><p><code>26101</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26102</code><code>FEBS Lett. &lt;/span&gt;</code></p><p><code>26103</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>26104</code><code>375&lt;/span&gt;</code></p><p><code>26105</code><code>:117–120.&lt;/span&gt;</code></p><p><code>26106</code><code> [&lt;a href="/pubmed/7498458" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26107</code><code>PubMed&lt;/a&gt;</code></p><p><code>26108</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26109</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;amp;title=Occurrence+and+postmortem+generation+of+anandamide+and+other+long-chain+N-acylethanolamines+in+mammalian+brain&amp;amp;author=PC+Schmid&amp;amp;author=RJ+Krebsbach&amp;amp;author=SR+Perry&amp;amp;author=TM+Dettmer&amp;amp;author=JL+Maasson&amp;amp;volume=375&amp;amp;publication_year=1995&amp;amp;pages=117-120&amp;amp;pmid=7498458&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26110</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26111</code><code>]&lt;/span&gt;</code></p><p><code>26112</code><code>&lt;/span&gt;</code></p><p><code>26113</code><code>&lt;/li&gt;</code></p><p><code>26114</code><code>&lt;li id="R1076"&gt;</code></p><p><code>26115</code><code>&lt;span class="citation"&gt;</code></p><p><code>26116</code><code>Schmid PC, Paria BC, Krebsbach RJ, Schmid HH, Dey SK. Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. &lt;span&gt;</code></p><p><code>26117</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26118</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>26119</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>26120</code><code>94&lt;/span&gt;</code></p><p><code>26121</code><code>:4188–4192.&lt;/span&gt;</code></p><p><code>26122</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>26123</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC20598/"&gt;</code></p><p><code>26124</code><code>PMC free article&lt;/a&gt;</code></p><p><code>26125</code><code>]&lt;/span&gt;</code></p><p><code>26126</code><code> [&lt;a href="/pubmed/9108127" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26127</code><code>PubMed&lt;/a&gt;</code></p><p><code>26128</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26129</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Changes+in+anandamide+levels+in+mouse+uterus+are+associated+with+uterine+receptivity+for+embryo+implantation&amp;amp;author=PC+Schmid&amp;amp;author=BC+Paria&amp;amp;author=RJ+Krebsbach&amp;amp;author=HH+Schmid&amp;amp;author=SK+Dey&amp;amp;volume=94&amp;amp;publication_year=1997&amp;amp;pages=4188-4192&amp;amp;pmid=9108127&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26130</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26131</code><code>]&lt;/span&gt;</code></p><p><code>26132</code><code>&lt;/span&gt;</code></p><p><code>26133</code><code>&lt;/li&gt;</code></p><p><code>26134</code><code>&lt;li id="R1077"&gt;</code></p><p><code>26135</code><code>&lt;span class="citation"&gt;</code></p><p><code>26136</code><code>Schmid PC, Reddy PV, Natarajan V, Schmid HH. Metabolism on &lt;em&gt;</code></p><p><code>26137</code><code>N-&lt;/em&gt;</code></p><p><code>26138</code><code>acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type. &lt;span&gt;</code></p><p><code>26139</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26140</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>26141</code><code>1983;&lt;span class="ref-vol"&gt;</code></p><p><code>26142</code><code>258&lt;/span&gt;</code></p><p><code>26143</code><code>:9302–9306.&lt;/span&gt;</code></p><p><code>26144</code><code> [&lt;a href="/pubmed/6308001" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26145</code><code>PubMed&lt;/a&gt;</code></p><p><code>26146</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26147</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=Metabolism+on+N-acylethanolamine+phospholipids+by+a+mammalian+phosphodiesterase+of+the+phospholipase+D+type&amp;amp;author=PC+Schmid&amp;amp;author=PV+Reddy&amp;amp;author=V+Natarajan&amp;amp;author=HH+Schmid&amp;amp;volume=258&amp;amp;publication_year=1983&amp;amp;pages=9302-9306&amp;amp;pmid=6308001&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26148</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26149</code><code>]&lt;/span&gt;</code></p><p><code>26150</code><code>&lt;/span&gt;</code></p><p><code>26151</code><code>&lt;/li&gt;</code></p><p><code>26152</code><code>&lt;li id="R1078"&gt;</code></p><p><code>26153</code><code>&lt;span class="citation"&gt;</code></p><p><code>26154</code><code>Schmid PC, Zuzarte-Augustin ML, Schmid HH. Properties of rat liver &lt;em&gt;</code></p><p><code>26155</code><code>N&lt;/em&gt;</code></p><p><code>26156</code><code>-acylethanolamine amidohydrolase. &lt;span&gt;</code></p><p><code>26157</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26158</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>26159</code><code>1985;&lt;span class="ref-vol"&gt;</code></p><p><code>26160</code><code>260&lt;/span&gt;</code></p><p><code>26161</code><code>:14145–14149.&lt;/span&gt;</code></p><p><code>26162</code><code> [&lt;a href="/pubmed/4055775" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26163</code><code>PubMed&lt;/a&gt;</code></p><p><code>26164</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26165</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=Properties+of+rat+liver+N-acylethanolamine+amidohydrolase&amp;amp;author=PC+Schmid&amp;amp;author=ML+Zuzarte-Augustin&amp;amp;author=HH+Schmid&amp;amp;volume=260&amp;amp;publication_year=1985&amp;amp;pages=14145-14149&amp;amp;pmid=4055775&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26166</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26167</code><code>]&lt;/span&gt;</code></p><p><code>26168</code><code>&lt;/span&gt;</code></p><p><code>26169</code><code>&lt;/li&gt;</code></p><p><code>26170</code><code>&lt;li id="R1079"&gt;</code></p><p><code>26171</code><code>&lt;span class="citation"&gt;</code></p><p><code>26172</code><code>Schon F, Hart PE, Hodgson TL, Pambakian AL, Ruprah M, Williamson EM, Kennard C. Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis. &lt;span&gt;</code></p><p><code>26173</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26174</code><code>Neurology. &lt;/span&gt;</code></p><p><code>26175</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>26176</code><code>53&lt;/span&gt;</code></p><p><code>26177</code><code>:2209–2210.&lt;/span&gt;</code></p><p><code>26178</code><code> [&lt;a href="/pubmed/10599815" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26179</code><code>PubMed&lt;/a&gt;</code></p><p><code>26180</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26181</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;amp;title=Suppression+of+pendular+nystagmus+by+smoking+cannabis+in+a+patient+with+multiple+sclerosis&amp;amp;author=F+Schon&amp;amp;author=PE+Hart&amp;amp;author=TL+Hodgson&amp;amp;author=AL+Pambakian&amp;amp;author=M+Ruprah&amp;amp;volume=53&amp;amp;publication_year=1999&amp;amp;pages=2209-2210&amp;amp;pmid=10599815&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26182</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26183</code><code>]&lt;/span&gt;</code></p><p><code>26184</code><code>&lt;/span&gt;</code></p><p><code>26185</code><code>&lt;/li&gt;</code></p><p><code>26186</code><code>&lt;li id="R1080"&gt;</code></p><p><code>26187</code><code>&lt;span class="citation"&gt;</code></p><p><code>26188</code><code>Schuckit MA. Low level of response to alcohol as a predictor of future alcoholism. &lt;span&gt;</code></p><p><code>26189</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26190</code><code>Am J Psychiatry. &lt;/span&gt;</code></p><p><code>26191</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>26192</code><code>151&lt;/span&gt;</code></p><p><code>26193</code><code>:184–189.&lt;/span&gt;</code></p><p><code>26194</code><code> [&lt;a href="/pubmed/8296886" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26195</code><code>PubMed&lt;/a&gt;</code></p><p><code>26196</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26197</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Psychiatry&amp;amp;title=Low+level+of+response+to+alcohol+as+a+predictor+of+future+alcoholism&amp;amp;author=MA+Schuckit&amp;amp;volume=151&amp;amp;publication_year=1997&amp;amp;pages=184-189&amp;amp;pmid=8296886&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26198</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26199</code><code>]&lt;/span&gt;</code></p><p><code>26200</code><code>&lt;/span&gt;</code></p><p><code>26201</code><code>&lt;/li&gt;</code></p><p><code>26202</code><code>&lt;li id="R1081"&gt;</code></p><p><code>26203</code><code>&lt;span class="citation"&gt;</code></p><p><code>26204</code><code>Schuel H, Burkman LJ. A tale of two cells: endocannabinoid-signaling regulates functions of neurons and sperm. &lt;span&gt;</code></p><p><code>26205</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26206</code><code>Biol Reprod. &lt;/span&gt;</code></p><p><code>26207</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>26208</code><code>73&lt;/span&gt;</code></p><p><code>26209</code><code>:1078–1086.&lt;/span&gt;</code></p><p><code>26210</code><code> [&lt;a href="/pubmed/16120829" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26211</code><code>PubMed&lt;/a&gt;</code></p><p><code>26212</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26213</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biol+Reprod&amp;amp;title=A+tale+of+two+cells:+endocannabinoid-signaling+regulates+functions+of+neurons+and+sperm&amp;amp;author=H+Schuel&amp;amp;author=LJ+Burkman&amp;amp;volume=73&amp;amp;publication_year=2005&amp;amp;pages=1078-1086&amp;amp;pmid=16120829&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26214</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26215</code><code>]&lt;/span&gt;</code></p><p><code>26216</code><code>&lt;/span&gt;</code></p><p><code>26217</code><code>&lt;/li&gt;</code></p><p><code>26218</code><code>&lt;li id="R1082"&gt;</code></p><p><code>26219</code><code>&lt;span class="citation"&gt;</code></p><p><code>26220</code><code>Scorticati C, Fernandez-Solari J, De Laurentiis A, Mohn C, Prestifilippo JP, Lasaga M, Seilicovich A, Billi S, Franchi A, McCann SM, et al.  The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen. &lt;span&gt;</code></p><p><code>26221</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26222</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>26223</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>26224</code><code>101&lt;/span&gt;</code></p><p><code>26225</code><code>:11891–11896.&lt;/span&gt;</code></p><p><code>26226</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>26227</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC511070/"&gt;</code></p><p><code>26228</code><code>PMC free article&lt;/a&gt;</code></p><p><code>26229</code><code>]&lt;/span&gt;</code></p><p><code>26230</code><code> [&lt;a href="/pubmed/15280536" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26231</code><code>PubMed&lt;/a&gt;</code></p><p><code>26232</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26233</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=The+inhibitory+effect+of+anandamide+on+luteinizing+hormone-releasing+hormone+secretion+is+reversed+by+estrogen&amp;amp;author=C+Scorticati&amp;amp;author=J+Fernandez-Solari&amp;amp;author=A+De+Laurentiis&amp;amp;author=C+Mohn&amp;amp;author=JP+Prestifilippo&amp;amp;volume=101&amp;amp;publication_year=2004&amp;amp;pages=11891-11896&amp;amp;pmid=15280536&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26234</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26235</code><code>]&lt;/span&gt;</code></p><p><code>26236</code><code>&lt;/span&gt;</code></p><p><code>26237</code><code>&lt;/li&gt;</code></p><p><code>26238</code><code>&lt;li id="R1083"&gt;</code></p><p><code>26239</code><code>&lt;span class="citation"&gt;</code></p><p><code>26240</code><code>Scott DA, Wright CE, Angus JA. Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat. &lt;span&gt;</code></p><p><code>26241</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26242</code><code>Pain. &lt;/span&gt;</code></p><p><code>26243</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>26244</code><code>109&lt;/span&gt;</code></p><p><code>26245</code><code>:124–131.&lt;/span&gt;</code></p><p><code>26246</code><code> [&lt;a href="/pubmed/15082134" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26247</code><code>PubMed&lt;/a&gt;</code></p><p><code>26248</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26249</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;amp;title=Evidence+that+CB-1+and+CB-2+cannabinoid+receptors+mediate+antinociception+in+neuropathic+pain+in+the+rat&amp;amp;author=DA+Scott&amp;amp;author=CE+Wright&amp;amp;author=JA+Angus&amp;amp;volume=109&amp;amp;publication_year=2004&amp;amp;pages=124-131&amp;amp;pmid=15082134&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26250</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26251</code><code>]&lt;/span&gt;</code></p><p><code>26252</code><code>&lt;/span&gt;</code></p><p><code>26253</code><code>&lt;/li&gt;</code></p><p><code>26254</code><code>&lt;li id="R1084"&gt;</code></p><p><code>26255</code><code>&lt;span class="citation"&gt;</code></p><p><code>26256</code><code>Seeley RJ, Woods SC. Monitoring of stored and available fuel by the CNS: implications for obesity. &lt;span&gt;</code></p><p><code>26257</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26258</code><code>Nat Neurosci. &lt;/span&gt;</code></p><p><code>26259</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>26260</code><code>4&lt;/span&gt;</code></p><p><code>26261</code><code>:901–909.&lt;/span&gt;</code></p><p><code>26262</code><code> [&lt;a href="/pubmed/14595401" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26263</code><code>PubMed&lt;/a&gt;</code></p><p><code>26264</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26265</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Neurosci&amp;amp;title=Monitoring+of+stored+and+available+fuel+by+the+CNS:+implications+for+obesity&amp;amp;author=RJ+Seeley&amp;amp;author=SC+Woods&amp;amp;volume=4&amp;amp;publication_year=2003&amp;amp;pages=901-909&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26266</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26267</code><code>]&lt;/span&gt;</code></p><p><code>26268</code><code>&lt;/span&gt;</code></p><p><code>26269</code><code>&lt;/li&gt;</code></p><p><code>26270</code><code>&lt;li id="R1085"&gt;</code></p><p><code>26271</code><code>&lt;span class="citation"&gt;</code></p><p><code>26272</code><code>Selley DE, Rorrer WK, Breivogel CS, Zimmer AM, Zimmer A, Martin BR, Sim-Selley LJ. Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation. &lt;span&gt;</code></p><p><code>26273</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26274</code><code>J Neurochem. &lt;/span&gt;</code></p><p><code>26275</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>26276</code><code>77&lt;/span&gt;</code></p><p><code>26277</code><code>:1048–1057.&lt;/span&gt;</code></p><p><code>26278</code><code> [&lt;a href="/pubmed/11359870" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26279</code><code>PubMed&lt;/a&gt;</code></p><p><code>26280</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26281</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;amp;title=Agonist+efficacy+and+receptor+efficiency+in+heterozygous+CB1+knockout+mice:+relationship+of+reduced+CB1+receptor+density+to+G-protein+activation&amp;amp;author=DE+Selley&amp;amp;author=WK+Rorrer&amp;amp;author=CS+Breivogel&amp;amp;author=AM+Zimmer&amp;amp;author=A+Zimmer&amp;amp;volume=77&amp;amp;publication_year=2001&amp;amp;pages=1048-1057&amp;amp;pmid=11359870&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26282</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26283</code><code>]&lt;/span&gt;</code></p><p><code>26284</code><code>&lt;/span&gt;</code></p><p><code>26285</code><code>&lt;/li&gt;</code></p><p><code>26286</code><code>&lt;li id="R1086"&gt;</code></p><p><code>26287</code><code>&lt;span class="citation"&gt;</code></p><p><code>26288</code><code>Semple DM, McIntosh AM, Lawrie SM. Cannabis as a risk factor for psychosis: systematic review. &lt;span&gt;</code></p><p><code>26289</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26290</code><code>J Psychopharmacol. &lt;/span&gt;</code></p><p><code>26291</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>26292</code><code>19&lt;/span&gt;</code></p><p><code>26293</code><code>:187–194.&lt;/span&gt;</code></p><p><code>26294</code><code> [&lt;a href="/pubmed/15871146" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26295</code><code>PubMed&lt;/a&gt;</code></p><p><code>26296</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26297</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Psychopharmacol&amp;amp;title=Cannabis+as+a+risk+factor+for+psychosis:+systematic+review&amp;amp;author=DM+Semple&amp;amp;author=AM+McIntosh&amp;amp;author=SM+Lawrie&amp;amp;volume=19&amp;amp;publication_year=2005&amp;amp;pages=187-194&amp;amp;pmid=15871146&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26298</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26299</code><code>]&lt;/span&gt;</code></p><p><code>26300</code><code>&lt;/span&gt;</code></p><p><code>26301</code><code>&lt;/li&gt;</code></p><p><code>26302</code><code>&lt;li id="R1087"&gt;</code></p><p><code>26303</code><code>&lt;span class="citation"&gt;</code></p><p><code>26304</code><code>Shakespeare DT, Boggild M, Young C. Anti-spasticity agents for multiple sclerosis. &lt;span&gt;</code></p><p><code>26305</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26306</code><code>Cochrane Database Syst Rev. &lt;/span&gt;</code></p><p><code>26307</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>26308</code><code>4&lt;/span&gt;</code></p><p><code>26309</code><code>:CD001332.&lt;/span&gt;</code></p><p><code>26310</code><code> [&lt;a href="/pubmed/14583932" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26311</code><code>PubMed&lt;/a&gt;</code></p><p><code>26312</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26313</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cochrane+Database+Syst+Rev&amp;amp;title=Anti-spasticity+agents+for+multiple+sclerosis&amp;amp;author=DT+Shakespeare&amp;amp;author=M+Boggild&amp;amp;author=C+Young&amp;amp;volume=4&amp;amp;publication_year=2003&amp;amp;pages=CD001332&amp;amp;pmid=14583932&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26314</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26315</code><code>]&lt;/span&gt;</code></p><p><code>26316</code><code>&lt;/span&gt;</code></p><p><code>26317</code><code>&lt;/li&gt;</code></p><p><code>26318</code><code>&lt;li id="R1088"&gt;</code></p><p><code>26319</code><code>&lt;span class="citation"&gt;</code></p><p><code>26320</code><code>Shapiro BJ, Tashkin DP, Vachon L. Tetrahydrocannabinol as a bronchodilator: Why bother. &lt;span&gt;</code></p><p><code>26321</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26322</code><code>Chest. &lt;/span&gt;</code></p><p><code>26323</code><code>1977;&lt;span class="ref-vol"&gt;</code></p><p><code>26324</code><code>71&lt;/span&gt;</code></p><p><code>26325</code><code>:558–560.&lt;/span&gt;</code></p><p><code>26326</code><code> [&lt;a href="/pubmed/852329" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26327</code><code>PubMed&lt;/a&gt;</code></p><p><code>26328</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26329</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;amp;title=Tetrahydrocannabinol+as+a+bronchodilator:+Why+bother&amp;amp;author=BJ+Shapiro&amp;amp;author=DP+Tashkin&amp;amp;author=L+Vachon&amp;amp;volume=71&amp;amp;publication_year=1977&amp;amp;pages=558-560&amp;amp;pmid=852329&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26330</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26331</code><code>]&lt;/span&gt;</code></p><p><code>26332</code><code>&lt;/span&gt;</code></p><p><code>26333</code><code>&lt;/li&gt;</code></p><p><code>26334</code><code>&lt;li id="R1089"&gt;</code></p><p><code>26335</code><code>&lt;span class="citation"&gt;</code></p><p><code>26336</code><code>Shapiro D. The ocular manifestations of the cannabinols. &lt;span&gt;</code></p><p><code>26337</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26338</code><code>Ophthalmologica. &lt;/span&gt;</code></p><p><code>26339</code><code>1974;&lt;span class="ref-vol"&gt;</code></p><p><code>26340</code><code>168&lt;/span&gt;</code></p><p><code>26341</code><code>:366–369.&lt;/span&gt;</code></p><p><code>26342</code><code> [&lt;a href="/pubmed/4832043" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26343</code><code>PubMed&lt;/a&gt;</code></p><p><code>26344</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26345</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Ophthalmologica&amp;amp;title=The+ocular+manifestations+of+the+cannabinols&amp;amp;author=D+Shapiro&amp;amp;volume=168&amp;amp;publication_year=1974&amp;amp;pages=366-369&amp;amp;pmid=4832043&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26346</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26347</code><code>]&lt;/span&gt;</code></p><p><code>26348</code><code>&lt;/span&gt;</code></p><p><code>26349</code><code>&lt;/li&gt;</code></p><p><code>26350</code><code>&lt;li id="R1090"&gt;</code></p><p><code>26351</code><code>&lt;span class="citation"&gt;</code></p><p><code>26352</code><code>Sharkey KA, Pittman QJ. Central and peripheral signaling mechanisms involved in endocannabinoid regulation of feeding: a perspective on the munchies. &lt;span&gt;</code></p><p><code>26353</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26354</code><code>SciSTKE. &lt;/span&gt;</code></p><p><code>26355</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>26356</code><code>277&lt;/span&gt;</code></p><p><code>26357</code><code>:pe15.&lt;/span&gt;</code></p><p><code>26358</code><code> [&lt;a href="/pubmed/15798103" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26359</code><code>PubMed&lt;/a&gt;</code></p><p><code>26360</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26361</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=SciSTKE&amp;amp;title=Central+and+peripheral+signaling+mechanisms+involved+in+endocannabinoid+regulation+of+feeding:+a+perspective+on+the+munchies&amp;amp;author=KA+Sharkey&amp;amp;author=QJ+Pittman&amp;amp;volume=277&amp;amp;publication_year=2005&amp;amp;pages=pe15&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26362</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26363</code><code>]&lt;/span&gt;</code></p><p><code>26364</code><code>&lt;/span&gt;</code></p><p><code>26365</code><code>&lt;/li&gt;</code></p><p><code>26366</code><code>&lt;li id="R1091"&gt;</code></p><p><code>26367</code><code>&lt;span class="citation"&gt;</code></p><p><code>26368</code><code>Shearman LP, Rosko KM, Fleischer R, Wang J, Xu S, Tong XS, Rocha BA. Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice. &lt;span&gt;</code></p><p><code>26369</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26370</code><code>Behav Pharmacol. &lt;/span&gt;</code></p><p><code>26371</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>26372</code><code>14&lt;/span&gt;</code></p><p><code>26373</code><code>:573–582.&lt;/span&gt;</code></p><p><code>26374</code><code> [&lt;a href="/pubmed/14665974" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26375</code><code>PubMed&lt;/a&gt;</code></p><p><code>26376</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26377</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Behav+Pharmacol&amp;amp;title=Antidepressant-like+and+anorectic+effects+of+the+cannabinoid+CB1+receptor+inverse+agonist+AM251+in+mice&amp;amp;author=LP+Shearman&amp;amp;author=KM+Rosko&amp;amp;author=R+Fleischer&amp;amp;author=J+Wang&amp;amp;author=S+Xu&amp;amp;volume=14&amp;amp;publication_year=2003&amp;amp;pages=573-582&amp;amp;pmid=14665974&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26378</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26379</code><code>]&lt;/span&gt;</code></p><p><code>26380</code><code>&lt;/span&gt;</code></p><p><code>26381</code><code>&lt;/li&gt;</code></p><p><code>26382</code><code>&lt;li id="R1092"&gt;</code></p><p><code>26383</code><code>&lt;span class="citation"&gt;</code></p><p><code>26384</code><code>Shen M, Thayer SA. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. &lt;span&gt;</code></p><p><code>26385</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26386</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>26387</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>26388</code><code>54&lt;/span&gt;</code></p><p><code>26389</code><code>:459–462.&lt;/span&gt;</code></p><p><code>26390</code><code> [&lt;a href="/pubmed/9730904" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26391</code><code>PubMed&lt;/a&gt;</code></p><p><code>26392</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26393</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=Cannabinoid+receptor+agonists+protect+cultured+rat+hippocampal+neurons+from+excitotoxicity&amp;amp;author=M+Shen&amp;amp;author=SA+Thayer&amp;amp;volume=54&amp;amp;publication_year=1998&amp;amp;pages=459-462&amp;amp;pmid=9730904&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26394</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26395</code><code>]&lt;/span&gt;</code></p><p><code>26396</code><code>&lt;/span&gt;</code></p><p><code>26397</code><code>&lt;/li&gt;</code></p><p><code>26398</code><code>&lt;li id="R1093"&gt;</code></p><p><code>26399</code><code>&lt;span class="citation"&gt;</code></p><p><code>26400</code><code>Shen M, Thayer SA. &amp;#x00394;&lt;sup&gt;</code></p><p><code>26401</code><code>9&lt;/sup&gt;</code></p><p><code>26402</code><code>-Tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture. &lt;span&gt;</code></p><p><code>26403</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26404</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>26405</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>26406</code><code>55&lt;/span&gt;</code></p><p><code>26407</code><code>:8–13.&lt;/span&gt;</code></p><p><code>26408</code><code> [&lt;a href="/pubmed/9882692" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26409</code><code>PubMed&lt;/a&gt;</code></p><p><code>26410</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26411</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=&amp;#x00394;9-Tetrahydrocannabinol+acts+as+a+partial+agonist+to+modulate+glutamatergic+synaptic+transmission+between+rat+hippocampal+neurons+in+culture&amp;amp;author=M+Shen&amp;amp;author=SA+Thayer&amp;amp;volume=55&amp;amp;publication_year=1999&amp;amp;pages=8-13&amp;amp;pmid=9882692&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26412</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26413</code><code>]&lt;/span&gt;</code></p><p><code>26414</code><code>&lt;/span&gt;</code></p><p><code>26415</code><code>&lt;/li&gt;</code></p><p><code>26416</code><code>&lt;li id="R1094"&gt;</code></p><p><code>26417</code><code>&lt;span class="citation"&gt;</code></p><p><code>26418</code><code>Shire D, Carillon C, Kaghad M, Calandra B, Rinaldi-Carmona M, Le Fur G, Caput D, Ferara P. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. &lt;span&gt;</code></p><p><code>26419</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26420</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>26421</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>26422</code><code>270&lt;/span&gt;</code></p><p><code>26423</code><code>:3726–3731.&lt;/span&gt;</code></p><p><code>26424</code><code> [&lt;a href="/pubmed/7876112" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26425</code><code>PubMed&lt;/a&gt;</code></p><p><code>26426</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26427</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=An+amino-terminal+variant+of+the+central+cannabinoid+receptor+resulting+from+alternative+splicing&amp;amp;author=D+Shire&amp;amp;author=C+Carillon&amp;amp;author=M+Kaghad&amp;amp;author=B+Calandra&amp;amp;author=M+Rinaldi-Carmona&amp;amp;volume=270&amp;amp;publication_year=1995&amp;amp;pages=3726-3731&amp;amp;pmid=7876112&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26428</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26429</code><code>]&lt;/span&gt;</code></p><p><code>26430</code><code>&lt;/span&gt;</code></p><p><code>26431</code><code>&lt;/li&gt;</code></p><p><code>26432</code><code>&lt;li id="R1095"&gt;</code></p><p><code>26433</code><code>&lt;span class="citation"&gt;</code></p><p><code>26434</code><code>Shohami E, Gallily R, Mechoulam R, Bass R, Ben-Hur T. Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-&lt;em&gt;</code></p><p><code>26435</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>26436</code><code> inhibitor and an effective neuroprotectant. &lt;span&gt;</code></p><p><code>26437</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26438</code><code>J Neuroimmunol. &lt;/span&gt;</code></p><p><code>26439</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>26440</code><code>72&lt;/span&gt;</code></p><p><code>26441</code><code>:169–177.&lt;/span&gt;</code></p><p><code>26442</code><code> [&lt;a href="/pubmed/9042110" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26443</code><code>PubMed&lt;/a&gt;</code></p><p><code>26444</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26445</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neuroimmunol&amp;amp;title=Cytokine+production+in+the+brain+following+closed+head+injury:+dexanabinol+(HU-211)+is+a+novel+TNF-&amp;#x003b1;+inhibitor+and+an+effective+neuroprotectant&amp;amp;author=E+Shohami&amp;amp;author=R+Gallily&amp;amp;author=R+Mechoulam&amp;amp;author=R+Bass&amp;amp;author=T+Ben-Hur&amp;amp;volume=72&amp;amp;publication_year=1997&amp;amp;pages=169-177&amp;amp;pmid=9042110&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26446</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26447</code><code>]&lt;/span&gt;</code></p><p><code>26448</code><code>&lt;/span&gt;</code></p><p><code>26449</code><code>&lt;/li&gt;</code></p><p><code>26450</code><code>&lt;li id="R1096"&gt;</code></p><p><code>26451</code><code>&lt;span class="citation"&gt;</code></p><p><code>26452</code><code>Shohami E, Novikov M, Bass R. Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat. &lt;span&gt;</code></p><p><code>26453</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26454</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>26455</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>26456</code><code>674&lt;/span&gt;</code></p><p><code>26457</code><code>:55–62.&lt;/span&gt;</code></p><p><code>26458</code><code> [&lt;a href="/pubmed/7773695" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26459</code><code>PubMed&lt;/a&gt;</code></p><p><code>26460</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26461</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Long-term+effect+of+HU-211,+a+novel+non-competitive+NMDA+antagonist,+on+motor+and+memory+functions+after+closed+head+injury+in+the+rat&amp;amp;author=E+Shohami&amp;amp;author=M+Novikov&amp;amp;author=R+Bass&amp;amp;volume=674&amp;amp;publication_year=1995&amp;amp;pages=55-62&amp;amp;pmid=7773695&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26462</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26463</code><code>]&lt;/span&gt;</code></p><p><code>26464</code><code>&lt;/span&gt;</code></p><p><code>26465</code><code>&lt;/li&gt;</code></p><p><code>26466</code><code>&lt;li id="R1097"&gt;</code></p><p><code>26467</code><code>&lt;span class="citation"&gt;</code></p><p><code>26468</code><code>Shohami E, Novikov M, Mechoulam R. A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat. &lt;span&gt;</code></p><p><code>26469</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26470</code><code>J Neurotrauma. &lt;/span&gt;</code></p><p><code>26471</code><code>1993;&lt;span class="ref-vol"&gt;</code></p><p><code>26472</code><code>10&lt;/span&gt;</code></p><p><code>26473</code><code>:109–119.&lt;/span&gt;</code></p><p><code>26474</code><code> [&lt;a href="/pubmed/8411215" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26475</code><code>PubMed&lt;/a&gt;</code></p><p><code>26476</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26477</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurotrauma&amp;amp;title=A+nonpsychotropic+cannabinoid,+HU-211,+has+cerebroprotective+effects+after+closed+head+injury+in+the+rat&amp;amp;author=E+Shohami&amp;amp;author=M+Novikov&amp;amp;author=R+Mechoulam&amp;amp;volume=10&amp;amp;publication_year=1993&amp;amp;pages=109-119&amp;amp;pmid=8411215&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26478</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26479</code><code>]&lt;/span&gt;</code></p><p><code>26480</code><code>&lt;/span&gt;</code></p><p><code>26481</code><code>&lt;/li&gt;</code></p><p><code>26482</code><code>&lt;li id="R1098"&gt;</code></p><p><code>26483</code><code>&lt;span class="citation"&gt;</code></p><p><code>26484</code><code>Shook JE, Burks TF. Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents. &lt;span&gt;</code></p><p><code>26485</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26486</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>26487</code><code>1989;&lt;span class="ref-vol"&gt;</code></p><p><code>26488</code><code>249&lt;/span&gt;</code></p><p><code>26489</code><code>:444–449.&lt;/span&gt;</code></p><p><code>26490</code><code> [&lt;a href="/pubmed/2542532" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26491</code><code>PubMed&lt;/a&gt;</code></p><p><code>26492</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26493</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Psychoactive+cannabinoids+reduce+gastrointestinal+propulsion+and+motility+in+rodents&amp;amp;author=JE+Shook&amp;amp;author=TF+Burks&amp;amp;volume=249&amp;amp;publication_year=1989&amp;amp;pages=444-449&amp;amp;pmid=2542532&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26494</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26495</code><code>]&lt;/span&gt;</code></p><p><code>26496</code><code>&lt;/span&gt;</code></p><p><code>26497</code><code>&lt;/li&gt;</code></p><p><code>26498</code><code>&lt;li id="R1099"&gt;</code></p><p><code>26499</code><code>&lt;span class="citation"&gt;</code></p><p><code>26500</code><code>Shouman B, Fontaine RH, Baud O, Schwendimann L, Keller M, Spedding M, Lelievre V, Gressens P. Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage. &lt;span&gt;</code></p><p><code>26501</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26502</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>26503</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>26504</code><code>148&lt;/span&gt;</code></p><p><code>26505</code><code>:442–451.&lt;/span&gt;</code></p><p><code>26506</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>26507</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1751782/"&gt;</code></p><p><code>26508</code><code>PMC free article&lt;/a&gt;</code></p><p><code>26509</code><code>]&lt;/span&gt;</code></p><p><code>26510</code><code> [&lt;a href="/pubmed/16682966" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26511</code><code>PubMed&lt;/a&gt;</code></p><p><code>26512</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26513</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Endocannabinoids+potently+protect+the+newborn+brain+against+AMPA-kainate+receptor-mediated+excitotoxic+damage&amp;amp;author=B+Shouman&amp;amp;author=RH+Fontaine&amp;amp;author=O+Baud&amp;amp;author=L+Schwendimann&amp;amp;author=M+Keller&amp;amp;volume=148&amp;amp;publication_year=2006&amp;amp;pages=442-451&amp;amp;pmid=16682966&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26514</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26515</code><code>]&lt;/span&gt;</code></p><p><code>26516</code><code>&lt;/span&gt;</code></p><p><code>26517</code><code>&lt;/li&gt;</code></p><p><code>26518</code><code>&lt;li id="R1100"&gt;</code></p><p><code>26519</code><code>&lt;span class="citation"&gt;</code></p><p><code>26520</code><code>Showalter VM, Compton DR, Martin BR, Abood ME. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. &lt;span&gt;</code></p><p><code>26521</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26522</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>26523</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>26524</code><code>278&lt;/span&gt;</code></p><p><code>26525</code><code>:989–999.&lt;/span&gt;</code></p><p><code>26526</code><code> [&lt;a href="/pubmed/8819477" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26527</code><code>PubMed&lt;/a&gt;</code></p><p><code>26528</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26529</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Evaluation+of+binding+in+a+transfected+cell+line+expressing+a+peripheral+cannabinoid+receptor+(CB2):+identification+of+cannabinoid+receptor+subtype+selective+ligands&amp;amp;author=VM+Showalter&amp;amp;author=DR+Compton&amp;amp;author=BR+Martin&amp;amp;author=ME+Abood&amp;amp;volume=278&amp;amp;publication_year=1996&amp;amp;pages=989-999&amp;amp;pmid=8819477&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26530</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26531</code><code>]&lt;/span&gt;</code></p><p><code>26532</code><code>&lt;/span&gt;</code></p><p><code>26533</code><code>&lt;/li&gt;</code></p><p><code>26534</code><code>&lt;li id="R1101"&gt;</code></p><p><code>26535</code><code>&lt;span class="citation"&gt;</code></p><p><code>26536</code><code>Sidney S, Quesenberry CP, Jr, Friedman GD, Tekawa IS. Marijuana use and cancer incidence (California, United States) &lt;span&gt;</code></p><p><code>26537</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26538</code><code>Cancer Causes Control. &lt;/span&gt;</code></p><p><code>26539</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>26540</code><code>8&lt;/span&gt;</code></p><p><code>26541</code><code>:722–728.&lt;/span&gt;</code></p><p><code>26542</code><code> [&lt;a href="/pubmed/9328194" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26543</code><code>PubMed&lt;/a&gt;</code></p><p><code>26544</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26545</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Causes+Control&amp;amp;title=Marijuana+use+and+cancer+incidence+(California,+United+States)&amp;amp;author=S+Sidney&amp;amp;author=CP+Quesenberry&amp;amp;author=GD+Friedman&amp;amp;author=IS+Tekawa&amp;amp;volume=8&amp;amp;publication_year=1997&amp;amp;pages=722-728&amp;amp;pmid=9328194&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26546</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26547</code><code>]&lt;/span&gt;</code></p><p><code>26548</code><code>&lt;/span&gt;</code></p><p><code>26549</code><code>&lt;/li&gt;</code></p><p><code>26550</code><code>&lt;li id="R1102"&gt;</code></p><p><code>26551</code><code>&lt;span class="citation"&gt;</code></p><p><code>26552</code><code>Siegfried Z, Kanyas K, Latzer Y, Karni O, Bloch M, Lerer B, Berry EM. Association study of cannabinoid receptor gene (&lt;em&gt;</code></p><p><code>26553</code><code>CNR1&lt;/em&gt;</code></p><p><code>26554</code><code>) alleles and anorexia nervosa: differences between restricting and bingeing/purging subtypes. &lt;span&gt;</code></p><p><code>26555</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26556</code><code>Am J Med Genetics. &lt;/span&gt;</code></p><p><code>26557</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>26558</code><code>125B&lt;/span&gt;</code></p><p><code>26559</code><code>:126–130.&lt;/span&gt;</code></p><p><code>26560</code><code> [&lt;a href="/pubmed/14755457" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26561</code><code>PubMed&lt;/a&gt;</code></p><p><code>26562</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26563</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Med+Genetics&amp;amp;title=Association+study+of+cannabinoid+receptor+gene+(CNR1)+alleles+and+anorexia+nervosa:+differences+between+restricting+and+bingeing/purging+subtypes&amp;amp;author=Z+Siegfried&amp;amp;author=K+Kanyas&amp;amp;author=Y+Latzer&amp;amp;author=O+Karni&amp;amp;author=M+Bloch&amp;amp;volume=125B&amp;amp;publication_year=2004&amp;amp;pages=126-130&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26564</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26565</code><code>]&lt;/span&gt;</code></p><p><code>26566</code><code>&lt;/span&gt;</code></p><p><code>26567</code><code>&lt;/li&gt;</code></p><p><code>26568</code><code>&lt;li id="R1103"&gt;</code></p><p><code>26569</code><code>&lt;span class="citation"&gt;</code></p><p><code>26570</code><code>Siegmund SV, Uchinami H, Osawa Y, Brenner DA, Schwabe RF. Anandamide induces necrosis in primary hepatic stellate cells. &lt;span&gt;</code></p><p><code>26571</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26572</code><code>Hepatology. &lt;/span&gt;</code></p><p><code>26573</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>26574</code><code>41&lt;/span&gt;</code></p><p><code>26575</code><code>:1085–1095.&lt;/span&gt;</code></p><p><code>26576</code><code> [&lt;a href="/pubmed/15841466" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26577</code><code>PubMed&lt;/a&gt;</code></p><p><code>26578</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26579</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;amp;title=Anandamide+induces+necrosis+in+primary+hepatic+stellate+cells&amp;amp;author=SV+Siegmund&amp;amp;author=H+Uchinami&amp;amp;author=Y+Osawa&amp;amp;author=DA+Brenner&amp;amp;author=RF+Schwabe&amp;amp;volume=41&amp;amp;publication_year=2005&amp;amp;pages=1085-1095&amp;amp;pmid=15841466&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26580</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26581</code><code>]&lt;/span&gt;</code></p><p><code>26582</code><code>&lt;/span&gt;</code></p><p><code>26583</code><code>&lt;/li&gt;</code></p><p><code>26584</code><code>&lt;li id="R1104"&gt;</code></p><p><code>26585</code><code>&lt;span class="citation"&gt;</code></p><p><code>26586</code><code>Sieradzan KA, Fox SH, Hill M, Dick JP, Crossman AR, Brotchie JM. Cannabinoids reduce levodopa-induced dyskinesia in Parkinson&amp;#x02019;s disease: a pilot study. &lt;span&gt;</code></p><p><code>26587</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26588</code><code>Neurology. &lt;/span&gt;</code></p><p><code>26589</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>26590</code><code>57&lt;/span&gt;</code></p><p><code>26591</code><code>:2108–2111.&lt;/span&gt;</code></p><p><code>26592</code><code> [&lt;a href="/pubmed/11739835" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26593</code><code>PubMed&lt;/a&gt;</code></p><p><code>26594</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26595</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;amp;title=Cannabinoids+reduce+levodopa-induced+dyskinesia+in+Parkinson&amp;#x02019;s+disease:+a+pilot+study&amp;amp;author=KA+Sieradzan&amp;amp;author=SH+Fox&amp;amp;author=M+Hill&amp;amp;author=JP+Dick&amp;amp;author=AR+Crossman&amp;amp;volume=57&amp;amp;publication_year=2001&amp;amp;pages=2108-2111&amp;amp;pmid=11739835&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26596</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26597</code><code>]&lt;/span&gt;</code></p><p><code>26598</code><code>&lt;/span&gt;</code></p><p><code>26599</code><code>&lt;/li&gt;</code></p><p><code>26600</code><code>&lt;li id="R1105"&gt;</code></p><p><code>26601</code><code>&lt;span class="citation"&gt;</code></p><p><code>26602</code><code>Sieradzan KA, Mann DM. The selective vulnerability of nerve cells in Huntington&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>26603</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26604</code><code>Neuropathol Appl Neurobiol. &lt;/span&gt;</code></p><p><code>26605</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>26606</code><code>27&lt;/span&gt;</code></p><p><code>26607</code><code>:1–21.&lt;/span&gt;</code></p><p><code>26608</code><code> [&lt;a href="/pubmed/11298997" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26609</code><code>PubMed&lt;/a&gt;</code></p><p><code>26610</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26611</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropathol+Appl+Neurobiol&amp;amp;title=The+selective+vulnerability+of+nerve+cells+in+Huntington&amp;#x02019;s+disease&amp;amp;author=KA+Sieradzan&amp;amp;author=DM+Mann&amp;amp;volume=27&amp;amp;publication_year=2001&amp;amp;pages=1-21&amp;amp;pmid=11298997&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26612</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26613</code><code>]&lt;/span&gt;</code></p><p><code>26614</code><code>&lt;/span&gt;</code></p><p><code>26615</code><code>&lt;/li&gt;</code></p><p><code>26616</code><code>&lt;li id="R1106"&gt;</code></p><p><code>26617</code><code>&lt;span class="citation"&gt;</code></p><p><code>26618</code><code>Silber MH. Clinical practice: chronic insomnia. &lt;span&gt;</code></p><p><code>26619</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26620</code><code>N Engl J Med. &lt;/span&gt;</code></p><p><code>26621</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>26622</code><code>353&lt;/span&gt;</code></p><p><code>26623</code><code>:803–810.&lt;/span&gt;</code></p><p><code>26624</code><code> [&lt;a href="/pubmed/16120860" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26625</code><code>PubMed&lt;/a&gt;</code></p><p><code>26626</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26627</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;amp;title=Clinical+practice:+chronic+insomnia&amp;amp;author=MH+Silber&amp;amp;volume=353&amp;amp;publication_year=2005&amp;amp;pages=803-810&amp;amp;pmid=16120860&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26628</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26629</code><code>]&lt;/span&gt;</code></p><p><code>26630</code><code>&lt;/span&gt;</code></p><p><code>26631</code><code>&lt;/li&gt;</code></p><p><code>26632</code><code>&lt;li id="R1107"&gt;</code></p><p><code>26633</code><code>&lt;span class="citation"&gt;</code></p><p><code>26634</code><code>Silverdale MA, McGuire S, McInnes A, Crossman AR, Brotchie JM. Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>26635</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26636</code><code>Exp Neurol. &lt;/span&gt;</code></p><p><code>26637</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>26638</code><code>169&lt;/span&gt;</code></p><p><code>26639</code><code>:400–406.&lt;/span&gt;</code></p><p><code>26640</code><code> [&lt;a href="/pubmed/11358453" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26641</code><code>PubMed&lt;/a&gt;</code></p><p><code>26642</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26643</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Exp+Neurol&amp;amp;title=Striatal+cannabinoid+CB1+receptor+mRNA+expression+is+decreased+in+the+reserpine-treated+rat+model+of+Parkinson&amp;#x02019;s+disease&amp;amp;author=MA+Silverdale&amp;amp;author=S+McGuire&amp;amp;author=A+McInnes&amp;amp;author=AR+Crossman&amp;amp;author=JM+Brotchie&amp;amp;volume=169&amp;amp;publication_year=2001&amp;amp;pages=400-406&amp;amp;pmid=11358453&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26644</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26645</code><code>]&lt;/span&gt;</code></p><p><code>26646</code><code>&lt;/span&gt;</code></p><p><code>26647</code><code>&lt;/li&gt;</code></p><p><code>26648</code><code>&lt;li id="R1108"&gt;</code></p><p><code>26649</code><code>&lt;span class="citation"&gt;</code></p><p><code>26650</code><code>Simiand J, Keane M, Keane PE, Soubri&amp;#x000e9; P. SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. &lt;span&gt;</code></p><p><code>26651</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26652</code><code>Behav Pharmacol. &lt;/span&gt;</code></p><p><code>26653</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>26654</code><code>9&lt;/span&gt;</code></p><p><code>26655</code><code>:179–181.&lt;/span&gt;</code></p><p><code>26656</code><code> [&lt;a href="/pubmed/10065938" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26657</code><code>PubMed&lt;/a&gt;</code></p><p><code>26658</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26659</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Behav+Pharmacol&amp;amp;title=SR+141716,+a+CB1+cannabinoid+receptor+antagonist,+selectively+reduces+sweet+food+intake+in+marmoset&amp;amp;author=J+Simiand&amp;amp;author=M+Keane&amp;amp;author=PE+Keane&amp;amp;author=P+Soubri&amp;#x000e9;&amp;amp;volume=9&amp;amp;publication_year=1998&amp;amp;pages=179-181&amp;amp;pmid=10065938&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26660</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26661</code><code>]&lt;/span&gt;</code></p><p><code>26662</code><code>&lt;/span&gt;</code></p><p><code>26663</code><code>&lt;/li&gt;</code></p><p><code>26664</code><code>&lt;li id="R1109"&gt;</code></p><p><code>26665</code><code>&lt;span class="citation"&gt;</code></p><p><code>26666</code><code>Simons-Morton DG, Obarzanek E, Cutler JA. Obesity research&amp;#x02014;limitations of methods, measurements, and medications. &lt;span&gt;</code></p><p><code>26667</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26668</code><code>J Am Med Assoc. &lt;/span&gt;</code></p><p><code>26669</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>26670</code><code>295&lt;/span&gt;</code></p><p><code>26671</code><code>:826–828.&lt;/span&gt;</code></p><p><code>26672</code><code> [&lt;a href="/pubmed/16478906" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26673</code><code>PubMed&lt;/a&gt;</code></p><p><code>26674</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26675</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Med+Assoc&amp;amp;title=Obesity+research&amp;#x02014;limitations+of+methods,+measurements,+and+medications&amp;amp;author=DG+Simons-Morton&amp;amp;author=E+Obarzanek&amp;amp;author=JA+Cutler&amp;amp;volume=295&amp;amp;publication_year=2006&amp;amp;pages=826-828&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26676</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26677</code><code>]&lt;/span&gt;</code></p><p><code>26678</code><code>&lt;/span&gt;</code></p><p><code>26679</code><code>&lt;/li&gt;</code></p><p><code>26680</code><code>&lt;li id="R1110"&gt;</code></p><p><code>26681</code><code>&lt;span class="citation"&gt;</code></p><p><code>26682</code><code>Sinor AD, Irvin SM, Greenberg DA. Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. &lt;span&gt;</code></p><p><code>26683</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26684</code><code>Neurosci Lett. &lt;/span&gt;</code></p><p><code>26685</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>26686</code><code>278&lt;/span&gt;</code></p><p><code>26687</code><code>:157–160.&lt;/span&gt;</code></p><p><code>26688</code><code> [&lt;a href="/pubmed/10653017" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26689</code><code>PubMed&lt;/a&gt;</code></p><p><code>26690</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26691</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Lett&amp;amp;title=Endocannabinoids+protect+cerebral+cortical+neurons+from+in+vitro+ischemia+in+rats&amp;amp;author=AD+Sinor&amp;amp;author=SM+Irvin&amp;amp;author=DA+Greenberg&amp;amp;volume=278&amp;amp;publication_year=2000&amp;amp;pages=157-160&amp;amp;pmid=10653017&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26692</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26693</code><code>]&lt;/span&gt;</code></p><p><code>26694</code><code>&lt;/span&gt;</code></p><p><code>26695</code><code>&lt;/li&gt;</code></p><p><code>26696</code><code>&lt;li id="R1111"&gt;</code></p><p><code>26697</code><code>&lt;span class="citation"&gt;</code></p><p><code>26698</code><code>Sipe JC, Chiang K, Gerber AL, Beutler E, Cravatt BF. A missense mutation in human fatty acid amide hydrolase associated with problem drug use. &lt;span&gt;</code></p><p><code>26699</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26700</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>26701</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>26702</code><code>99&lt;/span&gt;</code></p><p><code>26703</code><code>:8394–8399.&lt;/span&gt;</code></p><p><code>26704</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>26705</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC123078/"&gt;</code></p><p><code>26706</code><code>PMC free article&lt;/a&gt;</code></p><p><code>26707</code><code>]&lt;/span&gt;</code></p><p><code>26708</code><code> [&lt;a href="/pubmed/12060782" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26709</code><code>PubMed&lt;/a&gt;</code></p><p><code>26710</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26711</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=A+missense+mutation+in+human+fatty+acid+amide+hydrolase+associated+with+problem+drug+use&amp;amp;author=JC+Sipe&amp;amp;author=K+Chiang&amp;amp;author=AL+Gerber&amp;amp;author=E+Beutler&amp;amp;author=BF+Cravatt&amp;amp;volume=99&amp;amp;publication_year=2002&amp;amp;pages=8394-8399&amp;amp;pmid=12060782&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26712</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26713</code><code>]&lt;/span&gt;</code></p><p><code>26714</code><code>&lt;/span&gt;</code></p><p><code>26715</code><code>&lt;/li&gt;</code></p><p><code>26716</code><code>&lt;li id="R1112"&gt;</code></p><p><code>26717</code><code>&lt;span class="citation"&gt;</code></p><p><code>26718</code><code>Sipe JC, Waalen J, Gerber A, Beutler E. Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH) &lt;span&gt;</code></p><p><code>26719</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26720</code><code>Int J Obes. &lt;/span&gt;</code></p><p><code>26721</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>26722</code><code>29&lt;/span&gt;</code></p><p><code>26723</code><code>:755–759.&lt;/span&gt;</code></p><p><code>26724</code><code> [&lt;a href="/pubmed/15809662" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26725</code><code>PubMed&lt;/a&gt;</code></p><p><code>26726</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26727</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Obes&amp;amp;title=Overweight+and+obesity+associated+with+a+missense+polymorphism+in+fatty+acid+amide+hydrolase+(FAAH)&amp;amp;author=JC+Sipe&amp;amp;author=J+Waalen&amp;amp;author=A+Gerber&amp;amp;author=E+Beutler&amp;amp;volume=29&amp;amp;publication_year=2005&amp;amp;pages=755-759&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26728</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26729</code><code>]&lt;/span&gt;</code></p><p><code>26730</code><code>&lt;/span&gt;</code></p><p><code>26731</code><code>&lt;/li&gt;</code></p><p><code>26732</code><code>&lt;li id="R1113"&gt;</code></p><p><code>26733</code><code>&lt;span class="citation"&gt;</code></p><p><code>26734</code><code>Sirven JI, Berg AT. Marijuana as a treatment for epilepsy and multiple sclerosis? A &amp;#x0201c;grass roots&amp;#x0201d; movement. &lt;span&gt;</code></p><p><code>26735</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26736</code><code>Neurology. &lt;/span&gt;</code></p><p><code>26737</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>26738</code><code>62&lt;/span&gt;</code></p><p><code>26739</code><code>:1924–1925.&lt;/span&gt;</code></p><p><code>26740</code><code> [&lt;a href="/pubmed/15184589" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26741</code><code>PubMed&lt;/a&gt;</code></p><p><code>26742</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26743</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;amp;title=Marijuana+as+a+treatment+for+epilepsy+and+multiple+sclerosis?+A+&amp;#x0201c;grass+roots&amp;#x0201d;+movement&amp;amp;author=JI+Sirven&amp;amp;author=AT+Berg&amp;amp;volume=62&amp;amp;publication_year=2004&amp;amp;pages=1924-1925&amp;amp;pmid=15184589&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26744</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26745</code><code>]&lt;/span&gt;</code></p><p><code>26746</code><code>&lt;/span&gt;</code></p><p><code>26747</code><code>&lt;/li&gt;</code></p><p><code>26748</code><code>&lt;li id="R1114"&gt;</code></p><p><code>26749</code><code>&lt;span class="citation"&gt;</code></p><p><code>26750</code><code>Skaper SD, Buriani A, Dal Toso R, Petrelli L, Romanello S, Facci L, Leon A. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. &lt;span&gt;</code></p><p><code>26751</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26752</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>26753</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>26754</code><code>93&lt;/span&gt;</code></p><p><code>26755</code><code>:3984–3989.&lt;/span&gt;</code></p><p><code>26756</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>26757</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC39472/"&gt;</code></p><p><code>26758</code><code>PMC free article&lt;/a&gt;</code></p><p><code>26759</code><code>]&lt;/span&gt;</code></p><p><code>26760</code><code> [&lt;a href="/pubmed/8633002" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26761</code><code>PubMed&lt;/a&gt;</code></p><p><code>26762</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26763</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=The+ALIAmide+palmitoylethanolamide+and+cannabinoids,+but+not+anandamide,+are+protective+in+a+delayed+postglutamate+paradigm+of+excitotoxic+death+in+cerebellar+granule+neurons&amp;amp;author=SD+Skaper&amp;amp;author=A+Buriani&amp;amp;author=R+Dal+Toso&amp;amp;author=L+Petrelli&amp;amp;author=S+Romanello&amp;amp;volume=93&amp;amp;publication_year=1996&amp;amp;pages=3984-3989&amp;amp;pmid=8633002&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26764</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26765</code><code>]&lt;/span&gt;</code></p><p><code>26766</code><code>&lt;/span&gt;</code></p><p><code>26767</code><code>&lt;/li&gt;</code></p><p><code>26768</code><code>&lt;li id="R1115"&gt;</code></p><p><code>26769</code><code>&lt;span class="citation"&gt;</code></p><p><code>26770</code><code>Smith CG, Asch RH. Drug abuse and reproduction. &lt;span&gt;</code></p><p><code>26771</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26772</code><code>Fertil Steril. &lt;/span&gt;</code></p><p><code>26773</code><code>1987;&lt;span class="ref-vol"&gt;</code></p><p><code>26774</code><code>48&lt;/span&gt;</code></p><p><code>26775</code><code>:355–373.&lt;/span&gt;</code></p><p><code>26776</code><code> [&lt;a href="/pubmed/3305084" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26777</code><code>PubMed&lt;/a&gt;</code></p><p><code>26778</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26779</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Fertil+Steril&amp;amp;title=Drug+abuse+and+reproduction&amp;amp;author=CG+Smith&amp;amp;author=RH+Asch&amp;amp;volume=48&amp;amp;publication_year=1987&amp;amp;pages=355-373&amp;amp;pmid=3305084&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26780</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26781</code><code>]&lt;/span&gt;</code></p><p><code>26782</code><code>&lt;/span&gt;</code></p><p><code>26783</code><code>&lt;/li&gt;</code></p><p><code>26784</code><code>&lt;li id="R1116"&gt;</code></p><p><code>26785</code><code>&lt;span class="citation"&gt;</code></p><p><code>26786</code><code>Smith FL, Fujimori K, Lowe J, Welch SP. Characterization of &amp;#x00394;&lt;sup&gt;</code></p><p><code>26787</code><code>9&lt;/sup&gt;</code></p><p><code>26788</code><code>-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats. &lt;span&gt;</code></p><p><code>26789</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26790</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>26791</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>26792</code><code>60&lt;/span&gt;</code></p><p><code>26793</code><code>:183–191.&lt;/span&gt;</code></p><p><code>26794</code><code> [&lt;a href="/pubmed/9610941" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26795</code><code>PubMed&lt;/a&gt;</code></p><p><code>26796</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26797</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Characterization+of+&amp;#x00394;9-tetrahydrocannabinol+and+anandamide+antinociception+in+nonarthritic+and+arthritic+rats&amp;amp;author=FL+Smith&amp;amp;author=K+Fujimori&amp;amp;author=J+Lowe&amp;amp;author=SP+Welch&amp;amp;volume=60&amp;amp;publication_year=1998&amp;amp;pages=183-191&amp;amp;pmid=9610941&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26798</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26799</code><code>]&lt;/span&gt;</code></p><p><code>26800</code><code>&lt;/span&gt;</code></p><p><code>26801</code><code>&lt;/li&gt;</code></p><p><code>26802</code><code>&lt;li id="R1117"&gt;</code></p><p><code>26803</code><code>&lt;span class="citation"&gt;</code></p><p><code>26804</code><code>Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R, Martin BR. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. &lt;span&gt;</code></p><p><code>26805</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26806</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>26807</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>26808</code><code>270&lt;/span&gt;</code></p><p><code>26809</code><code>:219–227.&lt;/span&gt;</code></p><p><code>26810</code><code> [&lt;a href="/pubmed/8035318" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26811</code><code>PubMed&lt;/a&gt;</code></p><p><code>26812</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26813</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=The+pharmacological+activity+of+anandamide,+a+putative+endogenous+cannabinoid,+in+mice&amp;amp;author=PB+Smith&amp;amp;author=DR+Compton&amp;amp;author=SP+Welch&amp;amp;author=RK+Razdan&amp;amp;author=R+Mechoulam&amp;amp;volume=270&amp;amp;publication_year=1994&amp;amp;pages=219-227&amp;amp;pmid=8035318&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26814</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26815</code><code>]&lt;/span&gt;</code></p><p><code>26816</code><code>&lt;/span&gt;</code></p><p><code>26817</code><code>&lt;/li&gt;</code></p><p><code>26818</code><code>&lt;li id="R1118"&gt;</code></p><p><code>26819</code><code>&lt;span class="citation"&gt;</code></p><p><code>26820</code><code>Smith PF. GW-1000: GW pharmaceuticals. &lt;span&gt;</code></p><p><code>26821</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26822</code><code>Curr Opin Investig Drugs. &lt;/span&gt;</code></p><p><code>26823</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>26824</code><code>5&lt;/span&gt;</code></p><p><code>26825</code><code>:748–754.&lt;/span&gt;</code></p><p><code>26826</code><code> [&lt;a href="/pubmed/15298072" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26827</code><code>PubMed&lt;/a&gt;</code></p><p><code>26828</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26829</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Investig+Drugs&amp;amp;title=GW-1000:+GW+pharmaceuticals&amp;amp;author=PF+Smith&amp;amp;volume=5&amp;amp;publication_year=2004&amp;amp;pages=748-754&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26830</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26831</code><code>]&lt;/span&gt;</code></p><p><code>26832</code><code>&lt;/span&gt;</code></p><p><code>26833</code><code>&lt;/li&gt;</code></p><p><code>26834</code><code>&lt;li id="R1119"&gt;</code></p><p><code>26835</code><code>&lt;span class="citation"&gt;</code></p><p><code>26836</code><code>Smith PF. The safety of cannabinoids for the treatment of multiple sclerosis. &lt;span&gt;</code></p><p><code>26837</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26838</code><code>Expert Opin Drug Saf. &lt;/span&gt;</code></p><p><code>26839</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>26840</code><code>4&lt;/span&gt;</code></p><p><code>26841</code><code>:443–456.&lt;/span&gt;</code></p><p><code>26842</code><code> [&lt;a href="/pubmed/15934852" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26843</code><code>PubMed&lt;/a&gt;</code></p><p><code>26844</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26845</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Expert+Opin+Drug+Saf&amp;amp;title=The+safety+of+cannabinoids+for+the+treatment+of+multiple+sclerosis&amp;amp;author=PF+Smith&amp;amp;volume=4&amp;amp;publication_year=2005&amp;amp;pages=443-456&amp;amp;pmid=15934852&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26846</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26847</code><code>]&lt;/span&gt;</code></p><p><code>26848</code><code>&lt;/span&gt;</code></p><p><code>26849</code><code>&lt;/li&gt;</code></p><p><code>26850</code><code>&lt;li id="R1120"&gt;</code></p><p><code>26851</code><code>&lt;span class="citation"&gt;</code></p><p><code>26852</code><code>Smith SR, Terminelli C, Denhardt G. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice. &lt;span&gt;</code></p><p><code>26853</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26854</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>26855</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>26856</code><code>293&lt;/span&gt;</code></p><p><code>26857</code><code>:136–150.&lt;/span&gt;</code></p><p><code>26858</code><code> [&lt;a href="/pubmed/10734163" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26859</code><code>PubMed&lt;/a&gt;</code></p><p><code>26860</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26861</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Effects+of+cannabinoid+receptor+agonist+and+antagonist+ligands+on+production+of+inflammatory+cytokines+and+anti-inflammatory+interleukin-10+in+endotoxemic+mice&amp;amp;author=SR+Smith&amp;amp;author=C+Terminelli&amp;amp;author=G+Denhardt&amp;amp;volume=293&amp;amp;publication_year=2000&amp;amp;pages=136-150&amp;amp;pmid=10734163&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26862</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26863</code><code>]&lt;/span&gt;</code></p><p><code>26864</code><code>&lt;/span&gt;</code></p><p><code>26865</code><code>&lt;/li&gt;</code></p><p><code>26866</code><code>&lt;li id="R1121"&gt;</code></p><p><code>26867</code><code>&lt;span class="citation"&gt;</code></p><p><code>26868</code><code>Smith SR, Terminelli C, Denhardt G. Modulation of cytokine responses in &lt;em&gt;</code></p><p><code>26869</code><code>Corynebacterium parvum&lt;/em&gt;</code></p><p><code>26870</code><code>-primed endotoxemic mice by centrally administered cannabinoid ligands. &lt;span&gt;</code></p><p><code>26871</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26872</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>26873</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>26874</code><code>425&lt;/span&gt;</code></p><p><code>26875</code><code>:73–83.&lt;/span&gt;</code></p><p><code>26876</code><code> [&lt;a href="/pubmed/11672577" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26877</code><code>PubMed&lt;/a&gt;</code></p><p><code>26878</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26879</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Modulation+of+cytokine+responses+in+Corynebacterium+parvum-primed+endotoxemic+mice+by+centrally+administered+cannabinoid+ligands&amp;amp;author=SR+Smith&amp;amp;author=C+Terminelli&amp;amp;author=G+Denhardt&amp;amp;volume=425&amp;amp;publication_year=2001&amp;amp;pages=73-83&amp;amp;pmid=11672577&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26880</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26881</code><code>]&lt;/span&gt;</code></p><p><code>26882</code><code>&lt;/span&gt;</code></p><p><code>26883</code><code>&lt;/li&gt;</code></p><p><code>26884</code><code>&lt;li id="R1122"&gt;</code></p><p><code>26885</code><code>&lt;span class="citation"&gt;</code></p><p><code>26886</code><code>Sofia RD, Diamantis W, Harrison JE, Melton J. Evaluation of antiulcer activity of &amp;#x00394;&lt;sup&gt;</code></p><p><code>26887</code><code>9&lt;/sup&gt;</code></p><p><code>26888</code><code>-tetrahydrocannabinol in the Shay rat test. &lt;span&gt;</code></p><p><code>26889</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26890</code><code>Pharmacology. &lt;/span&gt;</code></p><p><code>26891</code><code>1978;&lt;span class="ref-vol"&gt;</code></p><p><code>26892</code><code>17&lt;/span&gt;</code></p><p><code>26893</code><code>:173–177.&lt;/span&gt;</code></p><p><code>26894</code><code> [&lt;a href="/pubmed/704660" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26895</code><code>PubMed&lt;/a&gt;</code></p><p><code>26896</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26897</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology&amp;amp;title=Evaluation+of+antiulcer+activity+of+&amp;#x00394;9-tetrahydrocannabinol+in+the+Shay+rat+test&amp;amp;author=RD+Sofia&amp;amp;author=W+Diamantis&amp;amp;author=JE+Harrison&amp;amp;author=J+Melton&amp;amp;volume=17&amp;amp;publication_year=1978&amp;amp;pages=173-177&amp;amp;pmid=704660&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26898</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26899</code><code>]&lt;/span&gt;</code></p><p><code>26900</code><code>&lt;/span&gt;</code></p><p><code>26901</code><code>&lt;/li&gt;</code></p><p><code>26902</code><code>&lt;li id="R1123"&gt;</code></p><p><code>26903</code><code>&lt;span class="citation"&gt;</code></p><p><code>26904</code><code>Sofia RD, Nalepa SD, Harakal JJ, Vassar HB. Anti-edema and analgesic properties of &amp;#x00394;&lt;sup&gt;</code></p><p><code>26905</code><code>9&lt;/sup&gt;</code></p><p><code>26906</code><code>-tetrahydrocannabinol (THC) &lt;span&gt;</code></p><p><code>26907</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26908</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>26909</code><code>1973;&lt;span class="ref-vol"&gt;</code></p><p><code>26910</code><code>186&lt;/span&gt;</code></p><p><code>26911</code><code>:646–655.&lt;/span&gt;</code></p><p><code>26912</code><code> [&lt;a href="/pubmed/4728343" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26913</code><code>PubMed&lt;/a&gt;</code></p><p><code>26914</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26915</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Anti-edema+and+analgesic+properties+of+&amp;#x00394;9-tetrahydrocannabinol+(THC)&amp;amp;author=RD+Sofia&amp;amp;author=SD+Nalepa&amp;amp;author=JJ+Harakal&amp;amp;author=HB+Vassar&amp;amp;volume=186&amp;amp;publication_year=1973&amp;amp;pages=646-655&amp;amp;pmid=4728343&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26916</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26917</code><code>]&lt;/span&gt;</code></p><p><code>26918</code><code>&lt;/span&gt;</code></p><p><code>26919</code><code>&lt;/li&gt;</code></p><p><code>26920</code><code>&lt;li id="R1124"&gt;</code></p><p><code>26921</code><code>&lt;span class="citation"&gt;</code></p><p><code>26922</code><code>Solinas M, Goldberg SR. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems. &lt;span&gt;</code></p><p><code>26923</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26924</code><code>Neuropsychopharmacology. &lt;/span&gt;</code></p><p><code>26925</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>26926</code><code>30&lt;/span&gt;</code></p><p><code>26927</code><code>:2035–2045.&lt;/span&gt;</code></p><p><code>26928</code><code> [&lt;a href="/pubmed/15812567" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26929</code><code>PubMed&lt;/a&gt;</code></p><p><code>26930</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26931</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;amp;title=Motivational+effects+of+cannabinoids+and+opioids+on+food+reinforcement+depend+on+simultaneous+activation+of+cannabinoid+and+opioid+systems&amp;amp;author=M+Solinas&amp;amp;author=SR+Goldberg&amp;amp;volume=30&amp;amp;publication_year=2005&amp;amp;pages=2035-2045&amp;amp;pmid=15812567&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26932</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26933</code><code>]&lt;/span&gt;</code></p><p><code>26934</code><code>&lt;/span&gt;</code></p><p><code>26935</code><code>&lt;/li&gt;</code></p><p><code>26936</code><code>&lt;li id="R1125"&gt;</code></p><p><code>26937</code><code>&lt;span class="citation"&gt;</code></p><p><code>26938</code><code>Song ZH, Bonner TI. A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists bu not WIN55212-2. &lt;span&gt;</code></p><p><code>26939</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26940</code><code>Mol Pharmacol. &lt;/span&gt;</code></p><p><code>26941</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>26942</code><code>49&lt;/span&gt;</code></p><p><code>26943</code><code>:891–896.&lt;/span&gt;</code></p><p><code>26944</code><code> [&lt;a href="/pubmed/8622639" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26945</code><code>PubMed&lt;/a&gt;</code></p><p><code>26946</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26947</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pharmacol&amp;amp;title=A+lysine+residue+of+the+cannabinoid+receptor+is+critical+for+receptor+recognition+by+several+agonists+bu+not+WIN55212-2&amp;amp;author=ZH+Song&amp;amp;author=TI+Bonner&amp;amp;volume=49&amp;amp;publication_year=1996&amp;amp;pages=891-896&amp;amp;pmid=8622639&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26948</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26949</code><code>]&lt;/span&gt;</code></p><p><code>26950</code><code>&lt;/span&gt;</code></p><p><code>26951</code><code>&lt;/li&gt;</code></p><p><code>26952</code><code>&lt;li id="R1126"&gt;</code></p><p><code>26953</code><code>&lt;span class="citation"&gt;</code></p><p><code>26954</code><code>Song ZH, Slowey CA. Involvement of cannabinoid receptors in the intraocular pressure-lowering effects of WIN55212-2. &lt;span&gt;</code></p><p><code>26955</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26956</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>26957</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>26958</code><code>292&lt;/span&gt;</code></p><p><code>26959</code><code>:136–139.&lt;/span&gt;</code></p><p><code>26960</code><code> [&lt;a href="/pubmed/10604940" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26961</code><code>PubMed&lt;/a&gt;</code></p><p><code>26962</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26963</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Involvement+of+cannabinoid+receptors+in+the+intraocular+pressure-lowering+effects+of+WIN55212-2&amp;amp;author=ZH+Song&amp;amp;author=CA+Slowey&amp;amp;volume=292&amp;amp;publication_year=2000&amp;amp;pages=136-139&amp;amp;pmid=10604940&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26964</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26965</code><code>]&lt;/span&gt;</code></p><p><code>26966</code><code>&lt;/span&gt;</code></p><p><code>26967</code><code>&lt;/li&gt;</code></p><p><code>26968</code><code>&lt;li id="R1127"&gt;</code></p><p><code>26969</code><code>&lt;span class="citation"&gt;</code></p><p><code>26970</code><code>Soria G, Mendizabal V, Tourino C, Robledo P, Ledent C, Parmentier M, Maldonado R, Valverde O. Lack of CB1 cannabinoid receptor impairs cocaine self-administration. &lt;span&gt;</code></p><p><code>26971</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26972</code><code>Neuropsychopharmacology. &lt;/span&gt;</code></p><p><code>26973</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>26974</code><code>30&lt;/span&gt;</code></p><p><code>26975</code><code>:1670–1680.&lt;/span&gt;</code></p><p><code>26976</code><code> [&lt;a href="/pubmed/15742004" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26977</code><code>PubMed&lt;/a&gt;</code></p><p><code>26978</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26979</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;amp;title=Lack+of+CB1+cannabinoid+receptor+impairs+cocaine+self-administration&amp;amp;author=G+Soria&amp;amp;author=V+Mendizabal&amp;amp;author=C+Tourino&amp;amp;author=P+Robledo&amp;amp;author=C+Ledent&amp;amp;volume=30&amp;amp;publication_year=2005&amp;amp;pages=1670-1680&amp;amp;pmid=15742004&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26980</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26981</code><code>]&lt;/span&gt;</code></p><p><code>26982</code><code>&lt;/span&gt;</code></p><p><code>26983</code><code>&lt;/li&gt;</code></p><p><code>26984</code><code>&lt;li id="R1128"&gt;</code></p><p><code>26985</code><code>&lt;span class="citation"&gt;</code></p><p><code>26986</code><code>Sospedra M, Martin R. Immunology of multiple sclerosis. &lt;span&gt;</code></p><p><code>26987</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>26988</code><code>Annu Rev Immunol. &lt;/span&gt;</code></p><p><code>26989</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>26990</code><code>23&lt;/span&gt;</code></p><p><code>26991</code><code>:683–747.&lt;/span&gt;</code></p><p><code>26992</code><code> [&lt;a href="/pubmed/15771584" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>26993</code><code>PubMed&lt;/a&gt;</code></p><p><code>26994</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>26995</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Immunol&amp;amp;title=Immunology+of+multiple+sclerosis&amp;amp;author=M+Sospedra&amp;amp;author=R+Martin&amp;amp;volume=23&amp;amp;publication_year=2005&amp;amp;pages=683-747&amp;amp;pmid=15771584&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>26996</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>26997</code><code>]&lt;/span&gt;</code></p><p><code>26998</code><code>&lt;/span&gt;</code></p><p><code>26999</code><code>&lt;/li&gt;</code></p><p><code>27000</code><code>&lt;li id="R1129"&gt;</code></p><p><code>27001</code><code>&lt;span class="citation"&gt;</code></p><p><code>27002</code><code>Specter S, Lancz G, Westrich G, Friedman H. &amp;#x00394;-9-Tetrahydrocannabinol augments murine retroviral induced immunosuppression and infection. &lt;span&gt;</code></p><p><code>27003</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27004</code><code>Int J Immunopharmacol. &lt;/span&gt;</code></p><p><code>27005</code><code>1991;&lt;span class="ref-vol"&gt;</code></p><p><code>27006</code><code>13&lt;/span&gt;</code></p><p><code>27007</code><code>:411–417.&lt;/span&gt;</code></p><p><code>27008</code><code> [&lt;a href="/pubmed/1646773" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27009</code><code>PubMed&lt;/a&gt;</code></p><p><code>27010</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27011</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Immunopharmacol&amp;amp;title=&amp;#x00394;-9-Tetrahydrocannabinol+augments+murine+retroviral+induced+immunosuppression+and+infection&amp;amp;author=S+Specter&amp;amp;author=G+Lancz&amp;amp;author=G+Westrich&amp;amp;author=H+Friedman&amp;amp;volume=13&amp;amp;publication_year=1991&amp;amp;pages=411-417&amp;amp;pmid=1646773&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27012</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27013</code><code>]&lt;/span&gt;</code></p><p><code>27014</code><code>&lt;/span&gt;</code></p><p><code>27015</code><code>&lt;/li&gt;</code></p><p><code>27016</code><code>&lt;li id="R1130"&gt;</code></p><p><code>27017</code><code>&lt;span class="citation"&gt;</code></p><p><code>27018</code><code>Spencer DJ. Cannabis-induced psychosis. &lt;span&gt;</code></p><p><code>27019</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27020</code><code>Int J Addict. &lt;/span&gt;</code></p><p><code>27021</code><code>1971;&lt;span class="ref-vol"&gt;</code></p><p><code>27022</code><code>6&lt;/span&gt;</code></p><p><code>27023</code><code>:323–326.&lt;/span&gt;</code></p><p><code>27024</code><code> [&lt;a href="/pubmed/4150319" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27025</code><code>PubMed&lt;/a&gt;</code></p><p><code>27026</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27027</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Addict&amp;amp;title=Cannabis-induced+psychosis&amp;amp;author=DJ+Spencer&amp;amp;volume=6&amp;amp;publication_year=1971&amp;amp;pages=323-326&amp;amp;pmid=4150319&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27028</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27029</code><code>]&lt;/span&gt;</code></p><p><code>27030</code><code>&lt;/span&gt;</code></p><p><code>27031</code><code>&lt;/li&gt;</code></p><p><code>27032</code><code>&lt;li id="R1131"&gt;</code></p><p><code>27033</code><code>&lt;span class="citation"&gt;</code></p><p><code>27034</code><code>Spicuzza L, Haddad EB, Birrell M, Ling A, Clarke D, Venkatesan P, Barnes PJ, Belvisi MG. Characterization of the effects of cannabinoids on guinea-pig tracheal smooth muscle tone: role in the modulation of acetylcholine release from parasympathetic nerves. &lt;span&gt;</code></p><p><code>27035</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27036</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>27037</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>27038</code><code>130&lt;/span&gt;</code></p><p><code>27039</code><code>:1720–1726.&lt;/span&gt;</code></p><p><code>27040</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>27041</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1572241/"&gt;</code></p><p><code>27042</code><code>PMC free article&lt;/a&gt;</code></p><p><code>27043</code><code>]&lt;/span&gt;</code></p><p><code>27044</code><code> [&lt;a href="/pubmed/10928980" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27045</code><code>PubMed&lt;/a&gt;</code></p><p><code>27046</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27047</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Characterization+of+the+effects+of+cannabinoids+on+guinea-pig+tracheal+smooth+muscle+tone:+role+in+the+modulation+of+acetylcholine+release+from+parasympathetic+nerves&amp;amp;author=L+Spicuzza&amp;amp;author=EB+Haddad&amp;amp;author=M+Birrell&amp;amp;author=A+Ling&amp;amp;author=D+Clarke&amp;amp;volume=130&amp;amp;publication_year=2000&amp;amp;pages=1720-1726&amp;amp;pmid=10928980&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27048</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27049</code><code>]&lt;/span&gt;</code></p><p><code>27050</code><code>&lt;/span&gt;</code></p><p><code>27051</code><code>&lt;/li&gt;</code></p><p><code>27052</code><code>&lt;li id="R1132"&gt;</code></p><p><code>27053</code><code>&lt;span class="citation"&gt;</code></p><p><code>27054</code><code>Srivastava MD, Srivastava BI, Brouhard B. &amp;#x00394;&lt;sup&gt;</code></p><p><code>27055</code><code>9&lt;/sup&gt;</code></p><p><code>27056</code><code> Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. &lt;span&gt;</code></p><p><code>27057</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27058</code><code>Immunopharmacology. &lt;/span&gt;</code></p><p><code>27059</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>27060</code><code>40&lt;/span&gt;</code></p><p><code>27061</code><code>:179–185.&lt;/span&gt;</code></p><p><code>27062</code><code> [&lt;a href="/pubmed/9858061" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27063</code><code>PubMed&lt;/a&gt;</code></p><p><code>27064</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27065</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Immunopharmacology&amp;amp;title=&amp;#x00394;9+Tetrahydrocannabinol+and+cannabidiol+alter+cytokine+production+by+human+immune+cells&amp;amp;author=MD+Srivastava&amp;amp;author=BI+Srivastava&amp;amp;author=B+Brouhard&amp;amp;volume=40&amp;amp;publication_year=1998&amp;amp;pages=179-185&amp;amp;pmid=9858061&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27066</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27067</code><code>]&lt;/span&gt;</code></p><p><code>27068</code><code>&lt;/span&gt;</code></p><p><code>27069</code><code>&lt;/li&gt;</code></p><p><code>27070</code><code>&lt;li id="R1133"&gt;</code></p><p><code>27071</code><code>&lt;span class="citation"&gt;</code></p><p><code>27072</code><code>Stamer WD, Golightly SF, Hosohata Y, Ryan EP, Porter AC, Varga E, Noecker RJ, Felder CC, Yamamura HI. Cannabinoid CB&lt;sub&gt;</code></p><p><code>27073</code><code>1&lt;/sub&gt;</code></p><p><code>27074</code><code> receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues. &lt;span&gt;</code></p><p><code>27075</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27076</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>27077</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>27078</code><code>431&lt;/span&gt;</code></p><p><code>27079</code><code>:277–286.&lt;/span&gt;</code></p><p><code>27080</code><code> [&lt;a href="/pubmed/11730719" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27081</code><code>PubMed&lt;/a&gt;</code></p><p><code>27082</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27083</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Cannabinoid+CB1+receptor+expression,+activation+and+detection+of+endogenous+ligand+in+trabecular+meshwork+and+ciliary+process+tissues&amp;amp;author=WD+Stamer&amp;amp;author=SF+Golightly&amp;amp;author=Y+Hosohata&amp;amp;author=EP+Ryan&amp;amp;author=AC+Porter&amp;amp;volume=431&amp;amp;publication_year=2001&amp;amp;pages=277-286&amp;amp;pmid=11730719&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27084</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27085</code><code>]&lt;/span&gt;</code></p><p><code>27086</code><code>&lt;/span&gt;</code></p><p><code>27087</code><code>&lt;/li&gt;</code></p><p><code>27088</code><code>&lt;li id="R1134"&gt;</code></p><p><code>27089</code><code>&lt;span class="citation"&gt;</code></p><p><code>27090</code><code>Staquet M, Gantt C, Machin D. Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain. &lt;span&gt;</code></p><p><code>27091</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27092</code><code>Clin Pharmacol Ther. &lt;/span&gt;</code></p><p><code>27093</code><code>1978;&lt;span class="ref-vol"&gt;</code></p><p><code>27094</code><code>23&lt;/span&gt;</code></p><p><code>27095</code><code>:397–401.&lt;/span&gt;</code></p><p><code>27096</code><code> [&lt;a href="/pubmed/343969" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27097</code><code>PubMed&lt;/a&gt;</code></p><p><code>27098</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27099</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;amp;title=Effect+of+a+nitrogen+analog+of+tetrahydrocannabinol+on+cancer+pain&amp;amp;author=M+Staquet&amp;amp;author=C+Gantt&amp;amp;author=D+Machin&amp;amp;volume=23&amp;amp;publication_year=1978&amp;amp;pages=397-401&amp;amp;pmid=343969&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27100</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27101</code><code>]&lt;/span&gt;</code></p><p><code>27102</code><code>&lt;/span&gt;</code></p><p><code>27103</code><code>&lt;/li&gt;</code></p><p><code>27104</code><code>&lt;li id="R1135"&gt;</code></p><p><code>27105</code><code>&lt;span class="citation"&gt;</code></p><p><code>27106</code><code>Steffens M, Feuerstein TJ. Receptor-independent depression of DA and 5-HT uptake by cannabinoids in rat neocortex&amp;#x02013;involvement of Na&lt;sup&gt;</code></p><p><code>27107</code><code>+&lt;/sup&gt;</code></p><p><code>27108</code><code>/K&lt;sup&gt;</code></p><p><code>27109</code><code>+&lt;/sup&gt;</code></p><p><code>27110</code><code>-ATPase. &lt;span&gt;</code></p><p><code>27111</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27112</code><code>Neurochem Int. &lt;/span&gt;</code></p><p><code>27113</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>27114</code><code>44&lt;/span&gt;</code></p><p><code>27115</code><code>:529–538.&lt;/span&gt;</code></p><p><code>27116</code><code> [&lt;a href="/pubmed/15209421" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27117</code><code>PubMed&lt;/a&gt;</code></p><p><code>27118</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27119</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurochem+Int&amp;amp;title=Receptor-independent+depression+of+DA+and+5-HT+uptake+by+cannabinoids+in+rat+neocortex&amp;#x02013;involvement+of+Na+/K+-ATPase&amp;amp;author=M+Steffens&amp;amp;author=TJ+Feuerstein&amp;amp;volume=44&amp;amp;publication_year=2004&amp;amp;pages=529-538&amp;amp;pmid=15209421&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27120</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27121</code><code>]&lt;/span&gt;</code></p><p><code>27122</code><code>&lt;/span&gt;</code></p><p><code>27123</code><code>&lt;/li&gt;</code></p><p><code>27124</code><code>&lt;li id="R1136"&gt;</code></p><p><code>27125</code><code>&lt;span class="citation"&gt;</code></p><p><code>27126</code><code>Steffens S, Veillard NR, Arnaud C, Pelli G, Burger F, Staub C, Karsak M, Zimmer A, Frossard JL, Mach F. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. &lt;span&gt;</code></p><p><code>27127</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27128</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>27129</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>27130</code><code>434&lt;/span&gt;</code></p><p><code>27131</code><code>:782–786.&lt;/span&gt;</code></p><p><code>27132</code><code> [&lt;a href="/pubmed/15815632" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27133</code><code>PubMed&lt;/a&gt;</code></p><p><code>27134</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27135</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Low+dose+oral+cannabinoid+therapy+reduces+progression+of+atherosclerosis+in+mice&amp;amp;author=S+Steffens&amp;amp;author=NR+Veillard&amp;amp;author=C+Arnaud&amp;amp;author=G+Pelli&amp;amp;author=F+Burger&amp;amp;volume=434&amp;amp;publication_year=2005&amp;amp;pages=782-786&amp;amp;pmid=15815632&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27136</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27137</code><code>]&lt;/span&gt;</code></p><p><code>27138</code><code>&lt;/span&gt;</code></p><p><code>27139</code><code>&lt;/li&gt;</code></p><p><code>27140</code><code>&lt;li id="R1137"&gt;</code></p><p><code>27141</code><code>&lt;span class="citation"&gt;</code></p><p><code>27142</code><code>Stein EA, Fuller SA, Edgemond WS, Campbell WB. Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat. &lt;span&gt;</code></p><p><code>27143</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27144</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>27145</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>27146</code><code>119&lt;/span&gt;</code></p><p><code>27147</code><code>:107–114.&lt;/span&gt;</code></p><p><code>27148</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>27149</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1915721/"&gt;</code></p><p><code>27150</code><code>PMC free article&lt;/a&gt;</code></p><p><code>27151</code><code>]&lt;/span&gt;</code></p><p><code>27152</code><code> [&lt;a href="/pubmed/8872363" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27153</code><code>PubMed&lt;/a&gt;</code></p><p><code>27154</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27155</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Physiological+and+behavioural+effects+of+the+endogenous+cannabinoid,+arachidonylethanolamide+(anandamide),+in+the+rat&amp;amp;author=EA+Stein&amp;amp;author=SA+Fuller&amp;amp;author=WS+Edgemond&amp;amp;author=WB+Campbell&amp;amp;volume=119&amp;amp;publication_year=1996&amp;amp;pages=107-114&amp;amp;pmid=8872363&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27156</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27157</code><code>]&lt;/span&gt;</code></p><p><code>27158</code><code>&lt;/span&gt;</code></p><p><code>27159</code><code>&lt;/li&gt;</code></p><p><code>27160</code><code>&lt;li id="R1138"&gt;</code></p><p><code>27161</code><code>&lt;span class="citation"&gt;</code></p><p><code>27162</code><code>Stella N. Cannabinoid signaling in glial cells. &lt;span&gt;</code></p><p><code>27163</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27164</code><code>Glia. &lt;/span&gt;</code></p><p><code>27165</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>27166</code><code>48&lt;/span&gt;</code></p><p><code>27167</code><code>:267–277.&lt;/span&gt;</code></p><p><code>27168</code><code> [&lt;a href="/pubmed/15390110" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27169</code><code>PubMed&lt;/a&gt;</code></p><p><code>27170</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27171</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Glia&amp;amp;title=Cannabinoid+signaling+in+glial+cells&amp;amp;author=N+Stella&amp;amp;volume=48&amp;amp;publication_year=2004&amp;amp;pages=267-277&amp;amp;pmid=15390110&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27172</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27173</code><code>]&lt;/span&gt;</code></p><p><code>27174</code><code>&lt;/span&gt;</code></p><p><code>27175</code><code>&lt;/li&gt;</code></p><p><code>27176</code><code>&lt;li id="R1139"&gt;</code></p><p><code>27177</code><code>&lt;span class="citation"&gt;</code></p><p><code>27178</code><code>Stella N, Schweitzer P, Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. &lt;span&gt;</code></p><p><code>27179</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27180</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>27181</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>27182</code><code>388&lt;/span&gt;</code></p><p><code>27183</code><code>:773–778.&lt;/span&gt;</code></p><p><code>27184</code><code> [&lt;a href="/pubmed/9285589" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27185</code><code>PubMed&lt;/a&gt;</code></p><p><code>27186</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27187</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=A+second+endogenous+cannabinoid+that+modulates+long-term+potentiation&amp;amp;author=N+Stella&amp;amp;author=P+Schweitzer&amp;amp;author=D+Piomelli&amp;amp;volume=388&amp;amp;publication_year=1997&amp;amp;pages=773-778&amp;amp;pmid=9285589&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27188</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27189</code><code>]&lt;/span&gt;</code></p><p><code>27190</code><code>&lt;/span&gt;</code></p><p><code>27191</code><code>&lt;/li&gt;</code></p><p><code>27192</code><code>&lt;li id="R1140"&gt;</code></p><p><code>27193</code><code>&lt;span class="citation"&gt;</code></p><p><code>27194</code><code>Stengel PW, Rippy MK, Cockerham SL, Devane WA, Silbaugh SA. Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs. &lt;span&gt;</code></p><p><code>27195</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27196</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>27197</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>27198</code><code>355&lt;/span&gt;</code></p><p><code>27199</code><code>:57–66.&lt;/span&gt;</code></p><p><code>27200</code><code> [&lt;a href="/pubmed/9754939" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27201</code><code>PubMed&lt;/a&gt;</code></p><p><code>27202</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27203</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Pulmonary+actions+of+anandamide,+an+endogenous+cannabinoid+receptor+agonist,+in+guinea+pigs&amp;amp;author=PW+Stengel&amp;amp;author=MK+Rippy&amp;amp;author=SL+Cockerham&amp;amp;author=WA+Devane&amp;amp;author=SA+Silbaugh&amp;amp;volume=355&amp;amp;publication_year=1998&amp;amp;pages=57-66&amp;amp;pmid=9754939&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27204</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27205</code><code>]&lt;/span&gt;</code></p><p><code>27206</code><code>&lt;/span&gt;</code></p><p><code>27207</code><code>&lt;/li&gt;</code></p><p><code>27208</code><code>&lt;li id="R1141"&gt;</code></p><p><code>27209</code><code>&lt;span class="citation"&gt;</code></p><p><code>27210</code><code>Sterin-Borda L, Del Zar CF, Borda E. Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: endogenous signal transduction pathways. &lt;span&gt;</code></p><p><code>27211</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27212</code><code>Biochem Pharmacol. &lt;/span&gt;</code></p><p><code>27213</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>27214</code><code>69&lt;/span&gt;</code></p><p><code>27215</code><code>:1705–1713.&lt;/span&gt;</code></p><p><code>27216</code><code> [&lt;a href="/pubmed/15885656" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27217</code><code>PubMed&lt;/a&gt;</code></p><p><code>27218</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27219</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;amp;title=Differential+CB1+and+CB2+cannabinoid+receptor-inotropic+response+of+rat+isolated+atria:+endogenous+signal+transduction+pathways&amp;amp;author=L+Sterin-Borda&amp;amp;author=CF+Del+Zar&amp;amp;author=E+Borda&amp;amp;volume=69&amp;amp;publication_year=2005&amp;amp;pages=1705-1713&amp;amp;pmid=15885656&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27220</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27221</code><code>]&lt;/span&gt;</code></p><p><code>27222</code><code>&lt;/span&gt;</code></p><p><code>27223</code><code>&lt;/li&gt;</code></p><p><code>27224</code><code>&lt;li id="R1142"&gt;</code></p><p><code>27225</code><code>&lt;span class="citation"&gt;</code></p><p><code>27226</code><code>Storr M, Gaffal E, Saur D, Schusdziarra V, Allescher HD. Effect of cannabinoids on neural transmission in rat gastric fundus. &lt;span&gt;</code></p><p><code>27227</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27228</code><code>Can J Physiol Pharmacol. &lt;/span&gt;</code></p><p><code>27229</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>27230</code><code>80&lt;/span&gt;</code></p><p><code>27231</code><code>:67–76.&lt;/span&gt;</code></p><p><code>27232</code><code> [&lt;a href="/pubmed/11911227" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27233</code><code>PubMed&lt;/a&gt;</code></p><p><code>27234</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27235</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Can+J+Physiol+Pharmacol&amp;amp;title=Effect+of+cannabinoids+on+neural+transmission+in+rat+gastric+fundus&amp;amp;author=M+Storr&amp;amp;author=E+Gaffal&amp;amp;author=D+Saur&amp;amp;author=V+Schusdziarra&amp;amp;author=HD+Allescher&amp;amp;volume=80&amp;amp;publication_year=2002&amp;amp;pages=67-76&amp;amp;pmid=11911227&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27236</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27237</code><code>]&lt;/span&gt;</code></p><p><code>27238</code><code>&lt;/span&gt;</code></p><p><code>27239</code><code>&lt;/li&gt;</code></p><p><code>27240</code><code>&lt;li id="R1143"&gt;</code></p><p><code>27241</code><code>&lt;span class="citation"&gt;</code></p><p><code>27242</code><code>Storr M, Sibaev A, Marsicano G, Lutz B, Schusdziarra V, Timmermans JP, Allescher HD. Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon. &lt;span&gt;</code></p><p><code>27243</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27244</code><code>Am J Physiol. &lt;/span&gt;</code></p><p><code>27245</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>27246</code><code>286&lt;/span&gt;</code></p><p><code>27247</code><code>:G110–G117.&lt;/span&gt;</code></p><p><code>27248</code><code> [&lt;a href="/pubmed/12893627" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27249</code><code>PubMed&lt;/a&gt;</code></p><p><code>27250</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27251</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol&amp;amp;title=Cannabinoid+receptor+type+1+modulates+excitatory+and+inhibitory+neurotransmission+in+mouse+colon&amp;amp;author=M+Storr&amp;amp;author=A+Sibaev&amp;amp;author=G+Marsicano&amp;amp;author=B+Lutz&amp;amp;author=V+Schusdziarra&amp;amp;volume=286&amp;amp;publication_year=2004&amp;amp;pages=G110-G117&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27252</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27253</code><code>]&lt;/span&gt;</code></p><p><code>27254</code><code>&lt;/span&gt;</code></p><p><code>27255</code><code>&lt;/li&gt;</code></p><p><code>27256</code><code>&lt;li id="R1144"&gt;</code></p><p><code>27257</code><code>&lt;span class="citation"&gt;</code></p><p><code>27258</code><code>Straiker A, Stella N, Piomelli D, Mackie K, Karten HJ, Maguire G. Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system. &lt;span&gt;</code></p><p><code>27259</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27260</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>27261</code><code>1999a;&lt;span class="ref-vol"&gt;</code></p><p><code>27262</code><code>96&lt;/span&gt;</code></p><p><code>27263</code><code>:14565–14570.&lt;/span&gt;</code></p><p><code>27264</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>27265</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC24476/"&gt;</code></p><p><code>27266</code><code>PMC free article&lt;/a&gt;</code></p><p><code>27267</code><code>]&lt;/span&gt;</code></p><p><code>27268</code><code> [&lt;a href="/pubmed/10588745" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27269</code><code>PubMed&lt;/a&gt;</code></p><p><code>27270</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27271</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Cannabinoid+CB1+receptors+and+ligands+in+vertebrate+retina:+localization+and+function+of+an+endogenous+signaling+system&amp;amp;author=A+Straiker&amp;amp;author=N+Stella&amp;amp;author=D+Piomelli&amp;amp;author=K+Mackie&amp;amp;author=HJ+Karten&amp;amp;volume=96&amp;amp;publication_year=1999a&amp;amp;pages=14565-14570&amp;amp;pmid=10588745&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27272</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27273</code><code>]&lt;/span&gt;</code></p><p><code>27274</code><code>&lt;/span&gt;</code></p><p><code>27275</code><code>&lt;/li&gt;</code></p><p><code>27276</code><code>&lt;li id="R1145"&gt;</code></p><p><code>27277</code><code>&lt;span class="citation"&gt;</code></p><p><code>27278</code><code>Straiker AJ, Maguire G, Mackie K, Lindsey J. Localization of cannabinoid CB1 receptors in the human anterior eye and retina. &lt;span&gt;</code></p><p><code>27279</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27280</code><code>Investig Ophthalmol Vis Sci. &lt;/span&gt;</code></p><p><code>27281</code><code>1999b;&lt;span class="ref-vol"&gt;</code></p><p><code>27282</code><code>40&lt;/span&gt;</code></p><p><code>27283</code><code>:2442–2448.&lt;/span&gt;</code></p><p><code>27284</code><code> [&lt;a href="/pubmed/10476817" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27285</code><code>PubMed&lt;/a&gt;</code></p><p><code>27286</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27287</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Investig+Ophthalmol+Vis+Sci&amp;amp;title=Localization+of+cannabinoid+CB1+receptors+in+the+human+anterior+eye+and+retina&amp;amp;author=AJ+Straiker&amp;amp;author=G+Maguire&amp;amp;author=K+Mackie&amp;amp;author=J+Lindsey&amp;amp;volume=40&amp;amp;publication_year=1999b&amp;amp;pages=2442-2448&amp;amp;pmid=10476817&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27288</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27289</code><code>]&lt;/span&gt;</code></p><p><code>27290</code><code>&lt;/span&gt;</code></p><p><code>27291</code><code>&lt;/li&gt;</code></p><p><code>27292</code><code>&lt;li id="R1146"&gt;</code></p><p><code>27293</code><code>&lt;span class="citation"&gt;</code></p><p><code>27294</code><code>Strangman NM, Patrick SL, Hohmann AG, Tsou K, Walker JM. Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity. &lt;span&gt;</code></p><p><code>27295</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27296</code><code>Brain Res. &lt;/span&gt;</code></p><p><code>27297</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>27298</code><code>813&lt;/span&gt;</code></p><p><code>27299</code><code>:323–328.&lt;/span&gt;</code></p><p><code>27300</code><code> [&lt;a href="/pubmed/9838180" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27301</code><code>PubMed&lt;/a&gt;</code></p><p><code>27302</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27303</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res&amp;amp;title=Evidence+for+a+role+of+endogenous+cannabinoids+in+the+modulation+of+acute+and+tonic+pain+sensitivity&amp;amp;author=NM+Strangman&amp;amp;author=SL+Patrick&amp;amp;author=AG+Hohmann&amp;amp;author=K+Tsou&amp;amp;author=JM+Walker&amp;amp;volume=813&amp;amp;publication_year=1998&amp;amp;pages=323-328&amp;amp;pmid=9838180&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27304</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27305</code><code>]&lt;/span&gt;</code></p><p><code>27306</code><code>&lt;/span&gt;</code></p><p><code>27307</code><code>&lt;/li&gt;</code></p><p><code>27308</code><code>&lt;li id="R1147"&gt;</code></p><p><code>27309</code><code>&lt;span class="citation"&gt;</code></p><p><code>27310</code><code>Stumpff F, Boxberger M, Krauss A, Rosenthal R, Meissner S, Choritz L, Wiederholt M, Thieme H. Stimulation of cannabinoid (CB1) and prostanoid (EP2) receptors opens BKCa channels and relaxes ocular trabecular meshwork. &lt;span&gt;</code></p><p><code>27311</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27312</code><code>Exp Eye Res. &lt;/span&gt;</code></p><p><code>27313</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>27314</code><code>80&lt;/span&gt;</code></p><p><code>27315</code><code>:697–708.&lt;/span&gt;</code></p><p><code>27316</code><code> [&lt;a href="/pubmed/15862177" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27317</code><code>PubMed&lt;/a&gt;</code></p><p><code>27318</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27319</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Exp+Eye+Res&amp;amp;title=Stimulation+of+cannabinoid+(CB1)+and+prostanoid+(EP2)+receptors+opens+BKCa+channels+and+relaxes+ocular+trabecular+meshwork&amp;amp;author=F+Stumpff&amp;amp;author=M+Boxberger&amp;amp;author=A+Krauss&amp;amp;author=R+Rosenthal&amp;amp;author=S+Meissner&amp;amp;volume=80&amp;amp;publication_year=2005&amp;amp;pages=697-708&amp;amp;pmid=15862177&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27320</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27321</code><code>]&lt;/span&gt;</code></p><p><code>27322</code><code>&lt;/span&gt;</code></p><p><code>27323</code><code>&lt;/li&gt;</code></p><p><code>27324</code><code>&lt;li id="R1148"&gt;</code></p><p><code>27325</code><code>&lt;span class="citation"&gt;</code></p><p><code>27326</code><code>Sugiura T, Kodaka T, Nakane S, Miyashita T, Kondo S, Suhara Y, Takayama H, Waku K, Seki C, Baba N, et al.  Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor: structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. &lt;span&gt;</code></p><p><code>27327</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27328</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>27329</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>27330</code><code>274&lt;/span&gt;</code></p><p><code>27331</code><code>:2794–2801.&lt;/span&gt;</code></p><p><code>27332</code><code> [&lt;a href="/pubmed/9915812" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27333</code><code>PubMed&lt;/a&gt;</code></p><p><code>27334</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27335</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=Evidence+that+the+cannabinoid+CB1+receptor+is+a+2-arachidonoylglycerol+receptor:+structure-activity+relationship+of+2-arachidonoylglycerol,+ether-linked+analogues,+and+related+compounds&amp;amp;author=T+Sugiura&amp;amp;author=T+Kodaka&amp;amp;author=S+Nakane&amp;amp;author=T+Miyashita&amp;amp;author=S+Kondo&amp;amp;volume=274&amp;amp;publication_year=1999&amp;amp;pages=2794-2801&amp;amp;pmid=9915812&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27336</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27337</code><code>]&lt;/span&gt;</code></p><p><code>27338</code><code>&lt;/span&gt;</code></p><p><code>27339</code><code>&lt;/li&gt;</code></p><p><code>27340</code><code>&lt;li id="R1149"&gt;</code></p><p><code>27341</code><code>&lt;span class="citation"&gt;</code></p><p><code>27342</code><code>Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. &lt;span&gt;</code></p><p><code>27343</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27344</code><code>Biochem Biophys Res Commun. &lt;/span&gt;</code></p><p><code>27345</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>27346</code><code>215&lt;/span&gt;</code></p><p><code>27347</code><code>:89–97.&lt;/span&gt;</code></p><p><code>27348</code><code> [&lt;a href="/pubmed/7575630" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27349</code><code>PubMed&lt;/a&gt;</code></p><p><code>27350</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27351</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;amp;title=2-Arachidonoylglycerol:+a+possible+endogenous+cannabinoid+receptor+ligand+in+brain&amp;amp;author=T+Sugiura&amp;amp;author=S+Kondo&amp;amp;author=A+Sukagawa&amp;amp;author=S+Nakane&amp;amp;author=A+Shinoda&amp;amp;volume=215&amp;amp;publication_year=1995&amp;amp;pages=89-97&amp;amp;pmid=7575630&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27352</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27353</code><code>]&lt;/span&gt;</code></p><p><code>27354</code><code>&lt;/span&gt;</code></p><p><code>27355</code><code>&lt;/li&gt;</code></p><p><code>27356</code><code>&lt;li id="R1150"&gt;</code></p><p><code>27357</code><code>&lt;span class="citation"&gt;</code></p><p><code>27358</code><code>Sugiura T, Yoshinaga N, Kondo S, Waku K, Ishima Y. Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain. &lt;span&gt;</code></p><p><code>27359</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27360</code><code>Biochem Biophys Res Commun. &lt;/span&gt;</code></p><p><code>27361</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>27362</code><code>271&lt;/span&gt;</code></p><p><code>27363</code><code>:654–658.&lt;/span&gt;</code></p><p><code>27364</code><code> [&lt;a href="/pubmed/10814517" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27365</code><code>PubMed&lt;/a&gt;</code></p><p><code>27366</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27367</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;amp;title=Generation+of+2-arachidonoylglycerol,+an+endogenous+cannabinoid+receptor+ligand,+in+picrotoxinin-administered+rat+brain&amp;amp;author=T+Sugiura&amp;amp;author=N+Yoshinaga&amp;amp;author=S+Kondo&amp;amp;author=K+Waku&amp;amp;author=Y+Ishima&amp;amp;volume=271&amp;amp;publication_year=2000&amp;amp;pages=654-658&amp;amp;pmid=10814517&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27368</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27369</code><code>]&lt;/span&gt;</code></p><p><code>27370</code><code>&lt;/span&gt;</code></p><p><code>27371</code><code>&lt;/li&gt;</code></p><p><code>27372</code><code>&lt;li id="R1151"&gt;</code></p><p><code>27373</code><code>&lt;span class="citation"&gt;</code></p><p><code>27374</code><code>Sugrue MF. New approaches to antiglaucoma therapy. &lt;span&gt;</code></p><p><code>27375</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27376</code><code>J Med Chem. &lt;/span&gt;</code></p><p><code>27377</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>27378</code><code>40&lt;/span&gt;</code></p><p><code>27379</code><code>:2793–2809.&lt;/span&gt;</code></p><p><code>27380</code><code> [&lt;a href="/pubmed/9288160" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27381</code><code>PubMed&lt;/a&gt;</code></p><p><code>27382</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27383</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;amp;title=New+approaches+to+antiglaucoma+therapy&amp;amp;author=MF+Sugrue&amp;amp;volume=40&amp;amp;publication_year=1997&amp;amp;pages=2793-2809&amp;amp;pmid=9288160&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27384</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27385</code><code>]&lt;/span&gt;</code></p><p><code>27386</code><code>&lt;/span&gt;</code></p><p><code>27387</code><code>&lt;/li&gt;</code></p><p><code>27388</code><code>&lt;li id="R1152"&gt;</code></p><p><code>27389</code><code>&lt;span class="citation"&gt;</code></p><p><code>27390</code><code>Sumariwalla PF, Gallily R, Tchilibon S, Fride E, Mechoulam R, Feldmann M. A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with anti-inflammatory properties in murine collagen-induced arthritis. &lt;span&gt;</code></p><p><code>27391</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27392</code><code>Arthritis Rheum. &lt;/span&gt;</code></p><p><code>27393</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>27394</code><code>50&lt;/span&gt;</code></p><p><code>27395</code><code>:985–998.&lt;/span&gt;</code></p><p><code>27396</code><code> [&lt;a href="/pubmed/15022343" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27397</code><code>PubMed&lt;/a&gt;</code></p><p><code>27398</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27399</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheum&amp;amp;title=A+novel+synthetic,+nonpsychoactive+cannabinoid+acid+(HU-320)+with+anti-inflammatory+properties+in+murine+collagen-induced+arthritis&amp;amp;author=PF+Sumariwalla&amp;amp;author=R+Gallily&amp;amp;author=S+Tchilibon&amp;amp;author=E+Fride&amp;amp;author=R+Mechoulam&amp;amp;volume=50&amp;amp;publication_year=2004&amp;amp;pages=985-998&amp;amp;pmid=15022343&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27400</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27401</code><code>]&lt;/span&gt;</code></p><p><code>27402</code><code>&lt;/span&gt;</code></p><p><code>27403</code><code>&lt;/li&gt;</code></p><p><code>27404</code><code>&lt;li id="R1153"&gt;</code></p><p><code>27405</code><code>&lt;span class="citation"&gt;</code></p><p><code>27406</code><code>Sun YX, Tsuboi K, Okamoto Y, Tonai T, Murakami M, Kudo I, Ueda N. Biosynthesis of anandamide and &lt;em&gt;</code></p><p><code>27407</code><code>N-&lt;/em&gt;</code></p><p><code>27408</code><code>palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D. &lt;span&gt;</code></p><p><code>27409</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27410</code><code>Biochem J. &lt;/span&gt;</code></p><p><code>27411</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>27412</code><code>380&lt;/span&gt;</code></p><p><code>27413</code><code>:749–756.&lt;/span&gt;</code></p><p><code>27414</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>27415</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1224205/"&gt;</code></p><p><code>27416</code><code>PMC free article&lt;/a&gt;</code></p><p><code>27417</code><code>]&lt;/span&gt;</code></p><p><code>27418</code><code> [&lt;a href="/pubmed/14998370" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27419</code><code>PubMed&lt;/a&gt;</code></p><p><code>27420</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27421</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+J&amp;amp;title=Biosynthesis+of+anandamide+and+N-palmitoylethanolamine+by+sequential+actions+of+phospholipase+A2+and+lysophospholipase+D&amp;amp;author=YX+Sun&amp;amp;author=K+Tsuboi&amp;amp;author=Y+Okamoto&amp;amp;author=T+Tonai&amp;amp;author=M+Murakami&amp;amp;volume=380&amp;amp;publication_year=2004&amp;amp;pages=749-756&amp;amp;pmid=14998370&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27422</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27423</code><code>]&lt;/span&gt;</code></p><p><code>27424</code><code>&lt;/span&gt;</code></p><p><code>27425</code><code>&lt;/li&gt;</code></p><p><code>27426</code><code>&lt;li id="R1154"&gt;</code></p><p><code>27427</code><code>&lt;span class="citation"&gt;</code></p><p><code>27428</code><code>Sun YX, Tsuboi K, Zhao LY, Okamoto Y, Lambert DM, Ueda N. Involvement of &lt;em&gt;</code></p><p><code>27429</code><code>N-&lt;/em&gt;</code></p><p><code>27430</code><code>acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other &lt;em&gt;</code></p><p><code>27431</code><code>N-&lt;/em&gt;</code></p><p><code>27432</code><code>acylethanolamines in macrophages. &lt;span&gt;</code></p><p><code>27433</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27434</code><code>Biochim Biophys Acta. &lt;/span&gt;</code></p><p><code>27435</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>27436</code><code>1736&lt;/span&gt;</code></p><p><code>27437</code><code>:211–2120.&lt;/span&gt;</code></p><p><code>27438</code><code> [&lt;a href="/pubmed/16154384" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27439</code><code>PubMed&lt;/a&gt;</code></p><p><code>27440</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27441</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochim+Biophys+Acta&amp;amp;title=Involvement+of+N-acylethanolamine-hydrolyzing+acid+amidase+in+the+degradation+of+anandamide+and+other+N-acylethanolamines+in+macrophages&amp;amp;author=YX+Sun&amp;amp;author=K+Tsuboi&amp;amp;author=LY+Zhao&amp;amp;author=Y+Okamoto&amp;amp;author=DM+Lambert&amp;amp;volume=1736&amp;amp;publication_year=2005&amp;amp;pages=211-2120&amp;amp;pmid=16154384&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27442</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27443</code><code>]&lt;/span&gt;</code></p><p><code>27444</code><code>&lt;/span&gt;</code></p><p><code>27445</code><code>&lt;/li&gt;</code></p><p><code>27446</code><code>&lt;li id="R1155"&gt;</code></p><p><code>27447</code><code>&lt;span class="citation"&gt;</code></p><p><code>27448</code><code>Sundram S, Copolov D, Dean B. Clozapine decreases [&lt;sup&gt;</code></p><p><code>27449</code><code>3&lt;/sup&gt;</code></p><p><code>27450</code><code>H] CP 55940 binding to the cannabinoid&lt;sub&gt;</code></p><p><code>27451</code><code>1&lt;/sub&gt;</code></p><p><code>27452</code><code> receptor in the rat nucleus accumbens. &lt;span&gt;</code></p><p><code>27453</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27454</code><code>Naunyn-Schmiedeberg&amp;#x02019;s Arch Pharmacol. &lt;/span&gt;</code></p><p><code>27455</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>27456</code><code>371&lt;/span&gt;</code></p><p><code>27457</code><code>:428–433.&lt;/span&gt;</code></p><p><code>27458</code><code> [&lt;a href="/pubmed/15995876" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27459</code><code>PubMed&lt;/a&gt;</code></p><p><code>27460</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27461</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Naunyn-Schmiedeberg&amp;#x02019;s+Arch+Pharmacol&amp;amp;title=Clozapine+decreases+[3H]+CP+55940+binding+to+the+cannabinoid1+receptor+in+the+rat+nucleus+accumbens&amp;amp;author=S+Sundram&amp;amp;author=D+Copolov&amp;amp;author=B+Dean&amp;amp;volume=371&amp;amp;publication_year=2005&amp;amp;pages=428-433&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27462</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27463</code><code>]&lt;/span&gt;</code></p><p><code>27464</code><code>&lt;/span&gt;</code></p><p><code>27465</code><code>&lt;/li&gt;</code></p><p><code>27466</code><code>&lt;li id="R1156"&gt;</code></p><p><code>27467</code><code>&lt;span class="citation"&gt;</code></p><p><code>27468</code><code>Suplita RL, 2nd, Gutierrez T, Fegley D, Piomelli D, Hohmann AG. Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventrome-dial medulla. &lt;span&gt;</code></p><p><code>27469</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27470</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>27471</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>27472</code><code>50&lt;/span&gt;</code></p><p><code>27473</code><code>:372–379.&lt;/span&gt;</code></p><p><code>27474</code><code> [&lt;a href="/pubmed/16129456" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27475</code><code>PubMed&lt;/a&gt;</code></p><p><code>27476</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27477</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=Inhibition+of+fatty-acid+amide+hydrolase+enhances+cannabinoid+stress-induced+analgesia:+sites+of+action+in+the+dorsolateral+periaqueductal+gray+and+rostral+ventrome-dial+medulla&amp;amp;author=RL+Suplita&amp;amp;author=T+Gutierrez&amp;amp;author=D+Fegley&amp;amp;author=D+Piomelli&amp;amp;author=AG+Hohmann&amp;amp;volume=50&amp;amp;publication_year=2006&amp;amp;pages=372-379&amp;amp;pmid=16316669&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27478</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27479</code><code>]&lt;/span&gt;</code></p><p><code>27480</code><code>&lt;/span&gt;</code></p><p><code>27481</code><code>&lt;/li&gt;</code></p><p><code>27482</code><code>&lt;li id="R1157"&gt;</code></p><p><code>27483</code><code>&lt;span class="citation"&gt;</code></p><p><code>27484</code><code>Svendsen KB, Jensen TS, Bach FW. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. &lt;span&gt;</code></p><p><code>27485</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27486</code><code>BMJ. &lt;/span&gt;</code></p><p><code>27487</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>27488</code><code>329&lt;/span&gt;</code></p><p><code>27489</code><code>:253.&lt;/span&gt;</code></p><p><code>27490</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>27491</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC498019/"&gt;</code></p><p><code>27492</code><code>PMC free article&lt;/a&gt;</code></p><p><code>27493</code><code>]&lt;/span&gt;</code></p><p><code>27494</code><code> [&lt;a href="/pubmed/15258006" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27495</code><code>PubMed&lt;/a&gt;</code></p><p><code>27496</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27497</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;amp;title=Does+the+cannabinoid+dronabinol+reduce+central+pain+in+multiple+sclerosis?+Randomised+double+blind+placebo+controlled+crossover+trial&amp;amp;author=KB+Svendsen&amp;amp;author=TS+Jensen&amp;amp;author=FW+Bach&amp;amp;volume=329&amp;amp;publication_year=2004&amp;amp;pages=253&amp;amp;pmid=15258006&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27498</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27499</code><code>]&lt;/span&gt;</code></p><p><code>27500</code><code>&lt;/span&gt;</code></p><p><code>27501</code><code>&lt;/li&gt;</code></p><p><code>27502</code><code>&lt;li id="R1158"&gt;</code></p><p><code>27503</code><code>&lt;span class="citation"&gt;</code></p><p><code>27504</code><code>Szabo B, Nordheim U, Niederhoffer N. Effects of cannabinoids on sympathetic and parasympathetic neuroeffector transmission in the rabbit heart. &lt;span&gt;</code></p><p><code>27505</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27506</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>27507</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>27508</code><code>297&lt;/span&gt;</code></p><p><code>27509</code><code>:819–826.&lt;/span&gt;</code></p><p><code>27510</code><code> [&lt;a href="/pubmed/11303075" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27511</code><code>PubMed&lt;/a&gt;</code></p><p><code>27512</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27513</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Effects+of+cannabinoids+on+sympathetic+and+parasympathetic+neuroeffector+transmission+in+the+rabbit+heart&amp;amp;author=B+Szabo&amp;amp;author=U+Nordheim&amp;amp;author=N+Niederhoffer&amp;amp;volume=297&amp;amp;publication_year=2001&amp;amp;pages=819-826&amp;amp;pmid=11303075&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27514</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27515</code><code>]&lt;/span&gt;</code></p><p><code>27516</code><code>&lt;/span&gt;</code></p><p><code>27517</code><code>&lt;/li&gt;</code></p><p><code>27518</code><code>&lt;li id="R1159"&gt;</code></p><p><code>27519</code><code>&lt;span class="citation"&gt;</code></p><p><code>27520</code><code>Szabo B, Siemes S, Wallmichrath I. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. &lt;span&gt;</code></p><p><code>27521</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27522</code><code>Eur J Neurosci. &lt;/span&gt;</code></p><p><code>27523</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>27524</code><code>15&lt;/span&gt;</code></p><p><code>27525</code><code>:2057–2061.&lt;/span&gt;</code></p><p><code>27526</code><code> [&lt;a href="/pubmed/12099913" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27527</code><code>PubMed&lt;/a&gt;</code></p><p><code>27528</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27529</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurosci&amp;amp;title=Inhibition+of+GABAergic+neurotransmission+in+the+ventral+tegmental+area+by+cannabinoids&amp;amp;author=B+Szabo&amp;amp;author=S+Siemes&amp;amp;author=I+Wallmichrath&amp;amp;volume=15&amp;amp;publication_year=2002&amp;amp;pages=2057-2061&amp;amp;pmid=12099913&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27530</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27531</code><code>]&lt;/span&gt;</code></p><p><code>27532</code><code>&lt;/span&gt;</code></p><p><code>27533</code><code>&lt;/li&gt;</code></p><p><code>27534</code><code>&lt;li id="R1160"&gt;</code></p><p><code>27535</code><code>&lt;span class="citation"&gt;</code></p><p><code>27536</code><code>Tabarin A, Chaves YD, Carmona M del C, Catargi B, Zorrilla EP, Roberts AJ, Coscina DV, Rousset S, Redonnet A, Parker GC, et al.  Resistance to diet-induced obesity in &lt;em&gt;</code></p><p><code>27537</code><code>&amp;#x003bc;&lt;/em&gt;</code></p><p><code>27538</code><code>-opioid receptor-deficient mice: evidence for a &amp;#x0201c;thrifty gene&amp;#x0201d; &lt;span&gt;</code></p><p><code>27539</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27540</code><code>Diabetes. &lt;/span&gt;</code></p><p><code>27541</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>27542</code><code>54&lt;/span&gt;</code></p><p><code>27543</code><code>:3510–3516.&lt;/span&gt;</code></p><p><code>27544</code><code> [&lt;a href="/pubmed/16306369" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27545</code><code>PubMed&lt;/a&gt;</code></p><p><code>27546</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27547</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;amp;title=Resistance+to+diet-induced+obesity+in+&amp;#x003bc;-opioid+receptor-deficient+mice:+evidence+for+a+&amp;#x0201c;thrifty+gene&amp;#x0201d;&amp;amp;author=A+Tabarin&amp;amp;author=YD+Chaves&amp;amp;author=C+Carmona+M+del&amp;amp;author=B+Catargi&amp;amp;author=EP+Zorrilla&amp;amp;volume=54&amp;amp;publication_year=2005&amp;amp;pages=3510-3516&amp;amp;pmid=16306369&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27548</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27549</code><code>]&lt;/span&gt;</code></p><p><code>27550</code><code>&lt;/span&gt;</code></p><p><code>27551</code><code>&lt;/li&gt;</code></p><p><code>27552</code><code>&lt;li id="R1161"&gt;</code></p><p><code>27553</code><code>&lt;span class="citation"&gt;</code></p><p><code>27554</code><code>Takahashi KA, Castillo PE. The CB1 receptor mediates glutamatergic synaptic suppression in the hippocampus. &lt;span&gt;</code></p><p><code>27555</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27556</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>27557</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>27558</code><code>139&lt;/span&gt;</code></p><p><code>27559</code><code>:792–802.&lt;/span&gt;</code></p><p><code>27560</code><code> [&lt;a href="/pubmed/16527424" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27561</code><code>PubMed&lt;/a&gt;</code></p><p><code>27562</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27563</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=The+CB1+receptor+mediates+glutamatergic+synaptic+suppression+in+the+hippocampus&amp;amp;author=KA+Takahashi&amp;amp;author=PE+Castillo&amp;amp;volume=139&amp;amp;publication_year=2006&amp;amp;pages=792-802&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27564</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27565</code><code>]&lt;/span&gt;</code></p><p><code>27566</code><code>&lt;/span&gt;</code></p><p><code>27567</code><code>&lt;/li&gt;</code></p><p><code>27568</code><code>&lt;li id="R1162"&gt;</code></p><p><code>27569</code><code>&lt;span class="citation"&gt;</code></p><p><code>27570</code><code>Tanda G, Loddo P, Di Chiara G. Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol. &lt;span&gt;</code></p><p><code>27571</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27572</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>27573</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>27574</code><code>376&lt;/span&gt;</code></p><p><code>27575</code><code>:23–26.&lt;/span&gt;</code></p><p><code>27576</code><code> [&lt;a href="/pubmed/10440085" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27577</code><code>PubMed&lt;/a&gt;</code></p><p><code>27578</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27579</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Dependence+of+mesolimbic+dopamine+transmission+on+delta9-tetrahydrocannabinol&amp;amp;author=G+Tanda&amp;amp;author=P+Loddo&amp;amp;author=G+Di+Chiara&amp;amp;volume=376&amp;amp;publication_year=1999&amp;amp;pages=23-26&amp;amp;pmid=10440085&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27580</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27581</code><code>]&lt;/span&gt;</code></p><p><code>27582</code><code>&lt;/span&gt;</code></p><p><code>27583</code><code>&lt;/li&gt;</code></p><p><code>27584</code><code>&lt;li id="R1163"&gt;</code></p><p><code>27585</code><code>&lt;span class="citation"&gt;</code></p><p><code>27586</code><code>Tanda G, Munzar P, Goldberg SR. Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. &lt;span&gt;</code></p><p><code>27587</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27588</code><code>Nat Neurosci. &lt;/span&gt;</code></p><p><code>27589</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>27590</code><code>3&lt;/span&gt;</code></p><p><code>27591</code><code>:1073–1074.&lt;/span&gt;</code></p><p><code>27592</code><code> [&lt;a href="/pubmed/11036260" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27593</code><code>PubMed&lt;/a&gt;</code></p><p><code>27594</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27595</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Neurosci&amp;amp;title=Self-administration+behavior+is+maintained+by+the+psychoactive+ingredient+of+marijuana+in+squirrel+monkeys&amp;amp;author=G+Tanda&amp;amp;author=P+Munzar&amp;amp;author=SR+Goldberg&amp;amp;volume=3&amp;amp;publication_year=2000&amp;amp;pages=1073-1074&amp;amp;pmid=11036260&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27596</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27597</code><code>]&lt;/span&gt;</code></p><p><code>27598</code><code>&lt;/span&gt;</code></p><p><code>27599</code><code>&lt;/li&gt;</code></p><p><code>27600</code><code>&lt;li id="R1164"&gt;</code></p><p><code>27601</code><code>&lt;span class="citation"&gt;</code></p><p><code>27602</code><code>Tashkin DP, Baldwin GC, Sarafian T, Dubinett S, Roth MD. Respiratory and immunologic consequences of marijuana smoking. &lt;span&gt;</code></p><p><code>27603</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27604</code><code>J Clin Pharmacol. &lt;/span&gt;</code></p><p><code>27605</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>27606</code><code>42&lt;/span&gt;</code></p><p><code>27607</code><code>:71S–81S.&lt;/span&gt;</code></p><p><code>27608</code><code> [&lt;a href="/pubmed/12412839" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27609</code><code>PubMed&lt;/a&gt;</code></p><p><code>27610</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27611</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pharmacol&amp;amp;title=Respiratory+and+immunologic+consequences+of+marijuana+smoking&amp;amp;author=DP+Tashkin&amp;amp;author=GC+Baldwin&amp;amp;author=T+Sarafian&amp;amp;author=S+Dubinett&amp;amp;author=MD+Roth&amp;amp;volume=42&amp;amp;publication_year=2002&amp;amp;pages=71S-81S&amp;amp;pmid=12412839&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27612</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27613</code><code>]&lt;/span&gt;</code></p><p><code>27614</code><code>&lt;/span&gt;</code></p><p><code>27615</code><code>&lt;/li&gt;</code></p><p><code>27616</code><code>&lt;li id="R1165"&gt;</code></p><p><code>27617</code><code>&lt;span class="citation"&gt;</code></p><p><code>27618</code><code>Tashkin DP, Reiss S, Shapiro BJ, Calvarese B, Olsen JL, Lodge JW. Bronchial effects of aerosolized &amp;#x00394;&lt;sup&gt;</code></p><p><code>27619</code><code>9&lt;/sup&gt;</code></p><p><code>27620</code><code>-tetrahydrocannabinol in healthy and asthmatic subjects. &lt;span&gt;</code></p><p><code>27621</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27622</code><code>Am Rev Respir Dis. &lt;/span&gt;</code></p><p><code>27623</code><code>1977;&lt;span class="ref-vol"&gt;</code></p><p><code>27624</code><code>115&lt;/span&gt;</code></p><p><code>27625</code><code>:57–65.&lt;/span&gt;</code></p><p><code>27626</code><code> [&lt;a href="/pubmed/319717" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27627</code><code>PubMed&lt;/a&gt;</code></p><p><code>27628</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27629</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+Rev+Respir+Dis&amp;amp;title=Bronchial+effects+of+aerosolized+&amp;#x00394;9-tetrahydrocannabinol+in+healthy+and+asthmatic+subjects&amp;amp;author=DP+Tashkin&amp;amp;author=S+Reiss&amp;amp;author=BJ+Shapiro&amp;amp;author=B+Calvarese&amp;amp;author=JL+Olsen&amp;amp;volume=115&amp;amp;publication_year=1977&amp;amp;pages=57-65&amp;amp;pmid=319717&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27630</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27631</code><code>]&lt;/span&gt;</code></p><p><code>27632</code><code>&lt;/span&gt;</code></p><p><code>27633</code><code>&lt;/li&gt;</code></p><p><code>27634</code><code>&lt;li id="R1166"&gt;</code></p><p><code>27635</code><code>&lt;span class="citation"&gt;</code></p><p><code>27636</code><code>Tashkin DP, Shapiro BJ, Frank IM. Acute pulmonary physiologic effects of smoked marijuana and oral 9-tetrahydrocannabinol in healthy young men. &lt;span&gt;</code></p><p><code>27637</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27638</code><code>N Engl J Med. &lt;/span&gt;</code></p><p><code>27639</code><code>1973;&lt;span class="ref-vol"&gt;</code></p><p><code>27640</code><code>289&lt;/span&gt;</code></p><p><code>27641</code><code>:336–341.&lt;/span&gt;</code></p><p><code>27642</code><code> [&lt;a href="/pubmed/4718513" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27643</code><code>PubMed&lt;/a&gt;</code></p><p><code>27644</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27645</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;amp;title=Acute+pulmonary+physiologic+effects+of+smoked+marijuana+and+oral+9-tetrahydrocannabinol+in+healthy+young+men&amp;amp;author=DP+Tashkin&amp;amp;author=BJ+Shapiro&amp;amp;author=IM+Frank&amp;amp;volume=289&amp;amp;publication_year=1973&amp;amp;pages=336-341&amp;amp;pmid=4718513&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27646</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27647</code><code>]&lt;/span&gt;</code></p><p><code>27648</code><code>&lt;/span&gt;</code></p><p><code>27649</code><code>&lt;/li&gt;</code></p><p><code>27650</code><code>&lt;li id="R1167"&gt;</code></p><p><code>27651</code><code>&lt;span class="citation"&gt;</code></p><p><code>27652</code><code>Tashkin DP, Shapiro BJ, Frank IM. Acute effects of smoked marijuana and oral &amp;#x00394;&lt;sup&gt;</code></p><p><code>27653</code><code>9&lt;/sup&gt;</code></p><p><code>27654</code><code>-tetrahydrocannabinol on specific airway conductance in asthmatic subjects. &lt;span&gt;</code></p><p><code>27655</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27656</code><code>Am Rev Respir Dis. &lt;/span&gt;</code></p><p><code>27657</code><code>1974;&lt;span class="ref-vol"&gt;</code></p><p><code>27658</code><code>109&lt;/span&gt;</code></p><p><code>27659</code><code>:420–428.&lt;/span&gt;</code></p><p><code>27660</code><code> [&lt;a href="/pubmed/4816823" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27661</code><code>PubMed&lt;/a&gt;</code></p><p><code>27662</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27663</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+Rev+Respir+Dis&amp;amp;title=Acute+effects+of+smoked+marijuana+and+oral+&amp;#x00394;9-tetrahydrocannabinol+on+specific+airway+conductance+in+asthmatic+subjects&amp;amp;author=DP+Tashkin&amp;amp;author=BJ+Shapiro&amp;amp;author=IM+Frank&amp;amp;volume=109&amp;amp;publication_year=1974&amp;amp;pages=420-428&amp;amp;pmid=4816823&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27664</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27665</code><code>]&lt;/span&gt;</code></p><p><code>27666</code><code>&lt;/span&gt;</code></p><p><code>27667</code><code>&lt;/li&gt;</code></p><p><code>27668</code><code>&lt;li id="R1168"&gt;</code></p><p><code>27669</code><code>&lt;span class="citation"&gt;</code></p><p><code>27670</code><code>Tashkin DP, Shapiro BJ, Lee YE, Harper CE. Effects of smoked marijuana in experimentally induced asthma. &lt;span&gt;</code></p><p><code>27671</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27672</code><code>Am Rev Respir Dis. &lt;/span&gt;</code></p><p><code>27673</code><code>1975;&lt;span class="ref-vol"&gt;</code></p><p><code>27674</code><code>112&lt;/span&gt;</code></p><p><code>27675</code><code>:377–386.&lt;/span&gt;</code></p><p><code>27676</code><code> [&lt;a href="/pubmed/1099949" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27677</code><code>PubMed&lt;/a&gt;</code></p><p><code>27678</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27679</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+Rev+Respir+Dis&amp;amp;title=Effects+of+smoked+marijuana+in+experimentally+induced+asthma&amp;amp;author=DP+Tashkin&amp;amp;author=BJ+Shapiro&amp;amp;author=YE+Lee&amp;amp;author=CE+Harper&amp;amp;volume=112&amp;amp;publication_year=1975&amp;amp;pages=377-386&amp;amp;pmid=1099949&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27680</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27681</code><code>]&lt;/span&gt;</code></p><p><code>27682</code><code>&lt;/span&gt;</code></p><p><code>27683</code><code>&lt;/li&gt;</code></p><p><code>27684</code><code>&lt;li id="R1169"&gt;</code></p><p><code>27685</code><code>&lt;span class="citation"&gt;</code></p><p><code>27686</code><code>Taylor FM., 3rd Marijuana as a potential respiratory tract carcinogen: a retrospective analysis of a community hospital population. &lt;span&gt;</code></p><p><code>27687</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27688</code><code>South Med J. &lt;/span&gt;</code></p><p><code>27689</code><code>1988;&lt;span class="ref-vol"&gt;</code></p><p><code>27690</code><code>81&lt;/span&gt;</code></p><p><code>27691</code><code>:1213–1216.&lt;/span&gt;</code></p><p><code>27692</code><code> [&lt;a href="/pubmed/3175726" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27693</code><code>PubMed&lt;/a&gt;</code></p><p><code>27694</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27695</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=South+Med+J&amp;amp;title=Marijuana+as+a+potential+respiratory+tract+carcinogen:+a+retrospective+analysis+of+a+community+hospital+population&amp;amp;author=FM+Taylor&amp;amp;volume=81&amp;amp;publication_year=1988&amp;amp;pages=1213-1216&amp;amp;pmid=3175726&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27696</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27697</code><code>]&lt;/span&gt;</code></p><p><code>27698</code><code>&lt;/span&gt;</code></p><p><code>27699</code><code>&lt;/li&gt;</code></p><p><code>27700</code><code>&lt;li id="R1170"&gt;</code></p><p><code>27701</code><code>&lt;span class="citation"&gt;</code></p><p><code>27702</code><code>Teichner A, Ovadia H, Lavie G, Leker RR. Combination of dexanabinol and tempol in focal cerebral ischemia: is there a ceiling effect? &lt;span&gt;</code></p><p><code>27703</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27704</code><code>Exp Neurol. &lt;/span&gt;</code></p><p><code>27705</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>27706</code><code>182&lt;/span&gt;</code></p><p><code>27707</code><code>:353–360.&lt;/span&gt;</code></p><p><code>27708</code><code> [&lt;a href="/pubmed/12895446" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27709</code><code>PubMed&lt;/a&gt;</code></p><p><code>27710</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27711</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Exp+Neurol&amp;amp;title=Combination+of+dexanabinol+and+tempol+in+focal+cerebral+ischemia:+is+there+a+ceiling+effect?&amp;amp;author=A+Teichner&amp;amp;author=H+Ovadia&amp;amp;author=G+Lavie&amp;amp;author=RR+Leker&amp;amp;volume=182&amp;amp;publication_year=2003&amp;amp;pages=353-360&amp;amp;pmid=12895446&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27712</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27713</code><code>]&lt;/span&gt;</code></p><p><code>27714</code><code>&lt;/span&gt;</code></p><p><code>27715</code><code>&lt;/li&gt;</code></p><p><code>27716</code><code>&lt;li id="R1171"&gt;</code></p><p><code>27717</code><code>&lt;span class="citation"&gt;</code></p><p><code>27718</code><code>Teixeira-Clerc F, Julien B, Grenard P, Tran Van Nhieu J, Deveaux V, Li L, Serriere-Lanneau V, Ledent C, Mallat A, Lotersztajn S. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. &lt;span&gt;</code></p><p><code>27719</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27720</code><code>Nat Med. &lt;/span&gt;</code></p><p><code>27721</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>27722</code><code>12&lt;/span&gt;</code></p><p><code>27723</code><code>:671–676.&lt;/span&gt;</code></p><p><code>27724</code><code> [&lt;a href="/pubmed/16715087" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27725</code><code>PubMed&lt;/a&gt;</code></p><p><code>27726</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27727</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;amp;title=CB1+cannabinoid+receptor+antagonism:+a+new+strategy+for+the+treatment+of+liver+fibrosis&amp;amp;author=F+Teixeira-Clerc&amp;amp;author=B+Julien&amp;amp;author=P+Grenard&amp;amp;author=J+Tran+Van+Nhieu&amp;amp;author=V+Deveaux&amp;amp;volume=12&amp;amp;publication_year=2006&amp;amp;pages=671-676&amp;amp;pmid=16715087&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27728</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27729</code><code>]&lt;/span&gt;</code></p><p><code>27730</code><code>&lt;/span&gt;</code></p><p><code>27731</code><code>&lt;/li&gt;</code></p><p><code>27732</code><code>&lt;li id="R1172"&gt;</code></p><p><code>27733</code><code>&lt;span class="citation"&gt;</code></p><p><code>27734</code><code>Ten Ham M, Loskota WJ, Lomax P. Acute and chronic effects of &lt;em&gt;</code></p><p><code>27735</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>27736</code><code>9-tetrahydrocannabinol on seizures in the gerbil. &lt;span&gt;</code></p><p><code>27737</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27738</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>27739</code><code>1975;&lt;span class="ref-vol"&gt;</code></p><p><code>27740</code><code>31&lt;/span&gt;</code></p><p><code>27741</code><code>:148–152.&lt;/span&gt;</code></p><p><code>27742</code><code> [&lt;a href="/pubmed/1126373" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27743</code><code>PubMed&lt;/a&gt;</code></p><p><code>27744</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27745</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Acute+and+chronic+effects+of+&amp;#x003b2;9-tetrahydrocannabinol+on+seizures+in+the+gerbil&amp;amp;author=M+Ten+Ham&amp;amp;author=WJ+Loskota&amp;amp;author=P+Lomax&amp;amp;volume=31&amp;amp;publication_year=1975&amp;amp;pages=148-152&amp;amp;pmid=1126373&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27746</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27747</code><code>]&lt;/span&gt;</code></p><p><code>27748</code><code>&lt;/span&gt;</code></p><p><code>27749</code><code>&lt;/li&gt;</code></p><p><code>27750</code><code>&lt;li id="R1173"&gt;</code></p><p><code>27751</code><code>&lt;span class="citation"&gt;</code></p><p><code>27752</code><code>Thaker GK, Carpenter WT., Jr Advances in schizophrenia. &lt;span&gt;</code></p><p><code>27753</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27754</code><code>Nat Med. &lt;/span&gt;</code></p><p><code>27755</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>27756</code><code>7&lt;/span&gt;</code></p><p><code>27757</code><code>:667–671.&lt;/span&gt;</code></p><p><code>27758</code><code> [&lt;a href="/pubmed/11385502" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27759</code><code>PubMed&lt;/a&gt;</code></p><p><code>27760</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27761</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;amp;title=Advances+in+schizophrenia&amp;amp;author=GK+Thaker&amp;amp;author=WT+Carpenter&amp;amp;volume=7&amp;amp;publication_year=2001&amp;amp;pages=667-671&amp;amp;pmid=11385502&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27762</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27763</code><code>]&lt;/span&gt;</code></p><p><code>27764</code><code>&lt;/span&gt;</code></p><p><code>27765</code><code>&lt;/li&gt;</code></p><p><code>27766</code><code>&lt;li id="R1174"&gt;</code></p><p><code>27767</code><code>&lt;span class="citation"&gt;</code></p><p><code>27768</code><code>Tham SM, Angus JA, Tudor EM, Wright CE. Synergistic and additive interactions of the cannabinoid agonist CP55,940 with &lt;em&gt;</code></p><p><code>27769</code><code>&amp;#x003bc;&lt;/em&gt;</code></p><p><code>27770</code><code> opioid receptor and &lt;em&gt;</code></p><p><code>27771</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>27772</code><code>&lt;sub&gt;</code></p><p><code>27773</code><code>2&lt;/sub&gt;</code></p><p><code>27774</code><code>-adrenoceptor agonists in acute pain models in mice. &lt;span&gt;</code></p><p><code>27775</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27776</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>27777</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>27778</code><code>144&lt;/span&gt;</code></p><p><code>27779</code><code>:875–884.&lt;/span&gt;</code></p><p><code>27780</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>27781</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1576059/"&gt;</code></p><p><code>27782</code><code>PMC free article&lt;/a&gt;</code></p><p><code>27783</code><code>]&lt;/span&gt;</code></p><p><code>27784</code><code> [&lt;a href="/pubmed/15778704" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27785</code><code>PubMed&lt;/a&gt;</code></p><p><code>27786</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27787</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Synergistic+and+additive+interactions+of+the+cannabinoid+agonist+CP55,940+with+&amp;#x003bc;+opioid+receptor+and+&amp;#x003b1;2-adrenoceptor+agonists+in+acute+pain+models+in+mice&amp;amp;author=SM+Tham&amp;amp;author=JA+Angus&amp;amp;author=EM+Tudor&amp;amp;author=CE+Wright&amp;amp;volume=144&amp;amp;publication_year=2005&amp;amp;pages=875-884&amp;amp;pmid=15778704&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27788</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27789</code><code>]&lt;/span&gt;</code></p><p><code>27790</code><code>&lt;/span&gt;</code></p><p><code>27791</code><code>&lt;/li&gt;</code></p><p><code>27792</code><code>&lt;li id="R1175"&gt;</code></p><p><code>27793</code><code>&lt;span class="citation"&gt;</code></p><p><code>27794</code><code>Thanos PK, Dimitrakakis ES, Rice O, Gifford A, Volkow ND. Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors. &lt;span&gt;</code></p><p><code>27795</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27796</code><code>Behav Brain Res. &lt;/span&gt;</code></p><p><code>27797</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>27798</code><code>164&lt;/span&gt;</code></p><p><code>27799</code><code>:206–213.&lt;/span&gt;</code></p><p><code>27800</code><code> [&lt;a href="/pubmed/16140402" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27801</code><code>PubMed&lt;/a&gt;</code></p><p><code>27802</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27803</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Behav+Brain+Res&amp;amp;title=Ethanol+self-administration+and+ethanol+conditioned+place+preference+are+reduced+in+mice+lacking+cannabinoid+CB1+receptors&amp;amp;author=PK+Thanos&amp;amp;author=ES+Dimitrakakis&amp;amp;author=O+Rice&amp;amp;author=A+Gifford&amp;amp;author=ND+Volkow&amp;amp;volume=164&amp;amp;publication_year=2005&amp;amp;pages=206-213&amp;amp;pmid=16140402&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27804</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27805</code><code>]&lt;/span&gt;</code></p><p><code>27806</code><code>&lt;/span&gt;</code></p><p><code>27807</code><code>&lt;/li&gt;</code></p><p><code>27808</code><code>&lt;li id="R1176"&gt;</code></p><p><code>27809</code><code>&lt;span class="citation"&gt;</code></p><p><code>27810</code><code>Thiele TE, Marsh DJ, Ste Marie L, Bernstein IL, Palmiter RD. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. &lt;span&gt;</code></p><p><code>27811</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27812</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>27813</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>27814</code><code>396&lt;/span&gt;</code></p><p><code>27815</code><code>:366–369.&lt;/span&gt;</code></p><p><code>27816</code><code> [&lt;a href="/pubmed/9845072" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27817</code><code>PubMed&lt;/a&gt;</code></p><p><code>27818</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27819</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Ethanol+consumption+and+resistance+are+inversely+related+to+neuropeptide+Y+levels&amp;amp;author=TE+Thiele&amp;amp;author=DJ+Marsh&amp;amp;author=L+Ste+Marie&amp;amp;author=IL+Bernstein&amp;amp;author=RD+Palmiter&amp;amp;volume=396&amp;amp;publication_year=1998&amp;amp;pages=366-369&amp;amp;pmid=9845072&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27820</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27821</code><code>]&lt;/span&gt;</code></p><p><code>27822</code><code>&lt;/span&gt;</code></p><p><code>27823</code><code>&lt;/li&gt;</code></p><p><code>27824</code><code>&lt;li id="R1177"&gt;</code></p><p><code>27825</code><code>&lt;span class="citation"&gt;</code></p><p><code>27826</code><code>Thomas A, Stevenson LA, Wease KN, Price MR, Baillie G, Ross RA, Pertwee RG. Evidence that the plant cannabinoid &amp;#x00394;&lt;sup&gt;</code></p><p><code>27827</code><code>9&lt;/sup&gt;</code></p><p><code>27828</code><code>-tetrahydrocannabivarin is a cannabinoid CB&lt;sub&gt;</code></p><p><code>27829</code><code>1&lt;/sub&gt;</code></p><p><code>27830</code><code> and CB&lt;sub&gt;</code></p><p><code>27831</code><code>2&lt;/sub&gt;</code></p><p><code>27832</code><code> receptor antagonist. &lt;span&gt;</code></p><p><code>27833</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27834</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>27835</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>27836</code><code>146&lt;/span&gt;</code></p><p><code>27837</code><code>:917–926.&lt;/span&gt;</code></p><p><code>27838</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>27839</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1751228/"&gt;</code></p><p><code>27840</code><code>PMC free article&lt;/a&gt;</code></p><p><code>27841</code><code>]&lt;/span&gt;</code></p><p><code>27842</code><code> [&lt;a href="/pubmed/16205722" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27843</code><code>PubMed&lt;/a&gt;</code></p><p><code>27844</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27845</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Evidence+that+the+plant+cannabinoid+&amp;#x00394;9-tetrahydrocannabivarin+is+a+cannabinoid+CB1+and+CB2+receptor+antagonist&amp;amp;author=A+Thomas&amp;amp;author=LA+Stevenson&amp;amp;author=KN+Wease&amp;amp;author=MR+Price&amp;amp;author=G+Baillie&amp;amp;volume=146&amp;amp;publication_year=2005&amp;amp;pages=917-926&amp;amp;pmid=16205722&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27846</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27847</code><code>]&lt;/span&gt;</code></p><p><code>27848</code><code>&lt;/span&gt;</code></p><p><code>27849</code><code>&lt;/li&gt;</code></p><p><code>27850</code><code>&lt;li id="R1178"&gt;</code></p><p><code>27851</code><code>&lt;span class="citation"&gt;</code></p><p><code>27852</code><code>Thomas EA, Carson MJ, Neal MJ, Sutcliffe JG. Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide. &lt;span&gt;</code></p><p><code>27853</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27854</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>27855</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>27856</code><code>94&lt;/span&gt;</code></p><p><code>27857</code><code>:14115–14119.&lt;/span&gt;</code></p><p><code>27858</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>27859</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC28442/"&gt;</code></p><p><code>27860</code><code>PMC free article&lt;/a&gt;</code></p><p><code>27861</code><code>]&lt;/span&gt;</code></p><p><code>27862</code><code> [&lt;a href="/pubmed/9391162" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27863</code><code>PubMed&lt;/a&gt;</code></p><p><code>27864</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27865</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Unique+allosteric+regulation+of+5-hydroxytryptamine+receptor-mediated+signal+transduction+by+oleamide&amp;amp;author=EA+Thomas&amp;amp;author=MJ+Carson&amp;amp;author=MJ+Neal&amp;amp;author=JG+Sutcliffe&amp;amp;volume=94&amp;amp;publication_year=1997&amp;amp;pages=14115-14119&amp;amp;pmid=9391162&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27866</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27867</code><code>]&lt;/span&gt;</code></p><p><code>27868</code><code>&lt;/span&gt;</code></p><p><code>27869</code><code>&lt;/li&gt;</code></p><p><code>27870</code><code>&lt;li id="R1179"&gt;</code></p><p><code>27871</code><code>&lt;span class="citation"&gt;</code></p><p><code>27872</code><code>Thomas EA, Cravatt BF, Sutcliffe JG. The endogenous lipid oleamide activates serotonin 5-HT7 neurons in mouse thalamus and hypothalamus. &lt;span&gt;</code></p><p><code>27873</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27874</code><code>J Neurochem. &lt;/span&gt;</code></p><p><code>27875</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>27876</code><code>72&lt;/span&gt;</code></p><p><code>27877</code><code>:2370–2378.&lt;/span&gt;</code></p><p><code>27878</code><code> [&lt;a href="/pubmed/10349846" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27879</code><code>PubMed&lt;/a&gt;</code></p><p><code>27880</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27881</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurochem&amp;amp;title=The+endogenous+lipid+oleamide+activates+serotonin+5-HT7+neurons+in+mouse+thalamus+and+hypothalamus&amp;amp;author=EA+Thomas&amp;amp;author=BF+Cravatt&amp;amp;author=JG+Sutcliffe&amp;amp;volume=72&amp;amp;publication_year=1999&amp;amp;pages=2370-2378&amp;amp;pmid=10349846&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27882</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27883</code><code>]&lt;/span&gt;</code></p><p><code>27884</code><code>&lt;/span&gt;</code></p><p><code>27885</code><code>&lt;/li&gt;</code></p><p><code>27886</code><code>&lt;li id="R1180"&gt;</code></p><p><code>27887</code><code>&lt;span class="citation"&gt;</code></p><p><code>27888</code><code>Thomas MJ, Beurrier C, Bonci A, Malenka RC. Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. &lt;span&gt;</code></p><p><code>27889</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27890</code><code>Nat Neurosc. &lt;/span&gt;</code></p><p><code>27891</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>27892</code><code>4&lt;/span&gt;</code></p><p><code>27893</code><code>:1217–1223.&lt;/span&gt;</code></p><p><code>27894</code><code> [&lt;a href="/pubmed/11694884" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27895</code><code>PubMed&lt;/a&gt;</code></p><p><code>27896</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27897</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Neurosc&amp;amp;title=Long-term+depression+in+the+nucleus+accumbens:+a+neural+correlate+of+behavioral+sensitization+to+cocaine&amp;amp;author=MJ+Thomas&amp;amp;author=C+Beurrier&amp;amp;author=A+Bonci&amp;amp;author=RC+Malenka&amp;amp;volume=4&amp;amp;publication_year=2001&amp;amp;pages=1217-1223&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27898</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27899</code><code>]&lt;/span&gt;</code></p><p><code>27900</code><code>&lt;/span&gt;</code></p><p><code>27901</code><code>&lt;/li&gt;</code></p><p><code>27902</code><code>&lt;li id="R1181"&gt;</code></p><p><code>27903</code><code>&lt;span class="citation"&gt;</code></p><p><code>27904</code><code>Thompson AJ, Baker D. Cannabinoids in MS: potentially useful but not just yet! &lt;span&gt;</code></p><p><code>27905</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27906</code><code>Neurology. &lt;/span&gt;</code></p><p><code>27907</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>27908</code><code>58&lt;/span&gt;</code></p><p><code>27909</code><code>:1323–1324.&lt;/span&gt;</code></p><p><code>27910</code><code> [&lt;a href="/pubmed/12011274" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27911</code><code>PubMed&lt;/a&gt;</code></p><p><code>27912</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27913</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;amp;title=Cannabinoids+in+MS:+potentially+useful+but+not+just+yet!&amp;amp;author=AJ+Thompson&amp;amp;author=D+Baker&amp;amp;volume=58&amp;amp;publication_year=2002&amp;amp;pages=1323-1324&amp;amp;pmid=12011274&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27914</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27915</code><code>]&lt;/span&gt;</code></p><p><code>27916</code><code>&lt;/span&gt;</code></p><p><code>27917</code><code>&lt;/li&gt;</code></p><p><code>27918</code><code>&lt;li id="R1182"&gt;</code></p><p><code>27919</code><code>&lt;span class="citation"&gt;</code></p><p><code>27920</code><code>Thornton-Jones ZD, Vickers SP, Clifton PG. The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses to food. &lt;span&gt;</code></p><p><code>27921</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27922</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>27923</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>27924</code><code>179&lt;/span&gt;</code></p><p><code>27925</code><code>:452–460.&lt;/span&gt;</code></p><p><code>27926</code><code> [&lt;a href="/pubmed/15821957" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27927</code><code>PubMed&lt;/a&gt;</code></p><p><code>27928</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27929</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=The+cannabinoid+CB1+receptor+antagonist+SR141716A+reduces+appetitive+and+consummatory+responses+to+food&amp;amp;author=ZD+Thornton-Jones&amp;amp;author=SP+Vickers&amp;amp;author=PG+Clifton&amp;amp;volume=179&amp;amp;publication_year=2005&amp;amp;pages=452-460&amp;amp;pmid=15821957&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27930</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27931</code><code>]&lt;/span&gt;</code></p><p><code>27932</code><code>&lt;/span&gt;</code></p><p><code>27933</code><code>&lt;/li&gt;</code></p><p><code>27934</code><code>&lt;li id="R1183"&gt;</code></p><p><code>27935</code><code>&lt;span class="citation"&gt;</code></p><p><code>27936</code><code>Timpone JG, Wright DJ, Li N, Egorin MJ, Enama ME, Mayers J, Galetto G. The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome: the DATRI 004 Study Group. Division of AIDS Treatment Research Initiative. &lt;span&gt;</code></p><p><code>27937</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27938</code><code>AIDS Res Hum Retroviruses. &lt;/span&gt;</code></p><p><code>27939</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>27940</code><code>13&lt;/span&gt;</code></p><p><code>27941</code><code>:305–315.&lt;/span&gt;</code></p><p><code>27942</code><code> [&lt;a href="/pubmed/9071430" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27943</code><code>PubMed&lt;/a&gt;</code></p><p><code>27944</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27945</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=AIDS+Res+Hum+Retroviruses&amp;amp;title=The+safety+and+pharmacokinetics+of+single-agent+and+combination+therapy+with+megestrol+acetate+and+dronabinol+for+the+treatment+of+HIV+wasting+syndrome:+the+DATRI+004+Study+Group.+Division+of+AIDS+Treatment+Research+Initiative&amp;amp;author=JG+Timpone&amp;amp;author=DJ+Wright&amp;amp;author=N+Li&amp;amp;author=MJ+Egorin&amp;amp;author=ME+Enama&amp;amp;volume=13&amp;amp;publication_year=1997&amp;amp;pages=305-315&amp;amp;pmid=9071430&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27946</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27947</code><code>]&lt;/span&gt;</code></p><p><code>27948</code><code>&lt;/span&gt;</code></p><p><code>27949</code><code>&lt;/li&gt;</code></p><p><code>27950</code><code>&lt;li id="R1184"&gt;</code></p><p><code>27951</code><code>&lt;span class="citation"&gt;</code></p><p><code>27952</code><code>Tomida I, Pertwee RG, Azuara-Blanco A. Cannabinoids and glaucoma. &lt;span&gt;</code></p><p><code>27953</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27954</code><code>Br J Ophthalmol. &lt;/span&gt;</code></p><p><code>27955</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>27956</code><code>88&lt;/span&gt;</code></p><p><code>27957</code><code>:708–713.&lt;/span&gt;</code></p><p><code>27958</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>27959</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1772142/"&gt;</code></p><p><code>27960</code><code>PMC free article&lt;/a&gt;</code></p><p><code>27961</code><code>]&lt;/span&gt;</code></p><p><code>27962</code><code> [&lt;a href="/pubmed/15090428" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27963</code><code>PubMed&lt;/a&gt;</code></p><p><code>27964</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27965</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Ophthalmol&amp;amp;title=Cannabinoids+and+glaucoma&amp;amp;author=I+Tomida&amp;amp;author=RG+Pertwee&amp;amp;author=A+Azuara-Blanco&amp;amp;volume=88&amp;amp;publication_year=2004&amp;amp;pages=708-713&amp;amp;pmid=15090428&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27966</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27967</code><code>]&lt;/span&gt;</code></p><p><code>27968</code><code>&lt;/span&gt;</code></p><p><code>27969</code><code>&lt;/li&gt;</code></p><p><code>27970</code><code>&lt;li id="R1185"&gt;</code></p><p><code>27971</code><code>&lt;span class="citation"&gt;</code></p><p><code>27972</code><code>Tournier M, Sorbara F, Gindre C, Swendsen JD, Verdoux H. Cannabis use and anxiety in daily life: a naturalistic investigation in a non-clinical population. &lt;span&gt;</code></p><p><code>27973</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27974</code><code>Psychiatry Res. &lt;/span&gt;</code></p><p><code>27975</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>27976</code><code>118&lt;/span&gt;</code></p><p><code>27977</code><code>:1–8.&lt;/span&gt;</code></p><p><code>27978</code><code> [&lt;a href="/pubmed/12759155" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27979</code><code>PubMed&lt;/a&gt;</code></p><p><code>27980</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>27981</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychiatry+Res&amp;amp;title=Cannabis+use+and+anxiety+in+daily+life:+a+naturalistic+investigation+in+a+non-clinical+population&amp;amp;author=M+Tournier&amp;amp;author=F+Sorbara&amp;amp;author=C+Gindre&amp;amp;author=JD+Swendsen&amp;amp;author=H+Verdoux&amp;amp;volume=118&amp;amp;publication_year=2003&amp;amp;pages=1-8&amp;amp;pmid=12759155&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>27982</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>27983</code><code>]&lt;/span&gt;</code></p><p><code>27984</code><code>&lt;/span&gt;</code></p><p><code>27985</code><code>&lt;/li&gt;</code></p><p><code>27986</code><code>&lt;li id="R1186"&gt;</code></p><p><code>27987</code><code>&lt;span class="citation"&gt;</code></p><p><code>27988</code><code>Tram&amp;#x000e8;r MR, Carroll D, Campbell FA, Reynolds DJM, Moore RA, McQuay HJ. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. &lt;span&gt;</code></p><p><code>27989</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>27990</code><code>Br Med J. &lt;/span&gt;</code></p><p><code>27991</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>27992</code><code>323&lt;/span&gt;</code></p><p><code>27993</code><code>:1–8.&lt;/span&gt;</code></p><p><code>27994</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>27995</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC34325/"&gt;</code></p><p><code>27996</code><code>PMC free article&lt;/a&gt;</code></p><p><code>27997</code><code>]&lt;/span&gt;</code></p><p><code>27998</code><code> [&lt;a href="/pubmed/11440936" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>27999</code><code>PubMed&lt;/a&gt;</code></p><p><code>28000</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28001</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+Med+J&amp;amp;title=Cannabinoids+for+control+of+chemotherapy+induced+nausea+and+vomiting:+quantitative+systematic+review&amp;amp;author=MR+Tram&amp;#x000e8;r&amp;amp;author=D+Carroll&amp;amp;author=FA+Campbell&amp;amp;author=DJM+Reynolds&amp;amp;author=RA+Moore&amp;amp;volume=323&amp;amp;publication_year=2001&amp;amp;pages=1-8&amp;amp;pmid=11440920&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28002</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28003</code><code>]&lt;/span&gt;</code></p><p><code>28004</code><code>&lt;/span&gt;</code></p><p><code>28005</code><code>&lt;/li&gt;</code></p><p><code>28006</code><code>&lt;li id="R1187"&gt;</code></p><p><code>28007</code><code>&lt;span class="citation"&gt;</code></p><p><code>28008</code><code>Tranguch S, Daikoku T, Guo Y, Wang H, Dey SK. Molecular complexity in establishing uterine receptivity and implantation. &lt;span&gt;</code></p><p><code>28009</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28010</code><code>Cell Mol Life Sci. &lt;/span&gt;</code></p><p><code>28011</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>28012</code><code>62&lt;/span&gt;</code></p><p><code>28013</code><code>:1964–1973.&lt;/span&gt;</code></p><p><code>28014</code><code> [&lt;a href="/pubmed/16143898" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28015</code><code>PubMed&lt;/a&gt;</code></p><p><code>28016</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28017</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cell+Mol+Life+Sci&amp;amp;title=Molecular+complexity+in+establishing+uterine+receptivity+and+implantation&amp;amp;author=S+Tranguch&amp;amp;author=T+Daikoku&amp;amp;author=Y+Guo&amp;amp;author=H+Wang&amp;amp;author=SK+Dey&amp;amp;volume=62&amp;amp;publication_year=2005&amp;amp;pages=1964-1973&amp;amp;pmid=16143898&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28018</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28019</code><code>]&lt;/span&gt;</code></p><p><code>28020</code><code>&lt;/span&gt;</code></p><p><code>28021</code><code>&lt;/li&gt;</code></p><p><code>28022</code><code>&lt;li id="R1188"&gt;</code></p><p><code>28023</code><code>&lt;span class="citation"&gt;</code></p><p><code>28024</code><code>Treffert DA. Marijuana use in schizophrenia: a clear hazard. &lt;span&gt;</code></p><p><code>28025</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28026</code><code>Am J Psychiatry. &lt;/span&gt;</code></p><p><code>28027</code><code>1978;&lt;span class="ref-vol"&gt;</code></p><p><code>28028</code><code>135&lt;/span&gt;</code></p><p><code>28029</code><code>:1213–1215.&lt;/span&gt;</code></p><p><code>28030</code><code> [&lt;a href="/pubmed/29496" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28031</code><code>PubMed&lt;/a&gt;</code></p><p><code>28032</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28033</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Psychiatry&amp;amp;title=Marijuana+use+in+schizophrenia:+a+clear+hazard&amp;amp;author=DA+Treffert&amp;amp;volume=135&amp;amp;publication_year=1978&amp;amp;pages=1213-1215&amp;amp;pmid=29496&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28034</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28035</code><code>]&lt;/span&gt;</code></p><p><code>28036</code><code>&lt;/span&gt;</code></p><p><code>28037</code><code>&lt;/li&gt;</code></p><p><code>28038</code><code>&lt;li id="R1189"&gt;</code></p><p><code>28039</code><code>&lt;span class="citation"&gt;</code></p><p><code>28040</code><code>Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. &lt;span&gt;</code></p><p><code>28041</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28042</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>28043</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>28044</code><code>83&lt;/span&gt;</code></p><p><code>28045</code><code>:393–411.&lt;/span&gt;</code></p><p><code>28046</code><code> [&lt;a href="/pubmed/9460749" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28047</code><code>PubMed&lt;/a&gt;</code></p><p><code>28048</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28049</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Immunohistochemical+distribution+of+cannabinoid+CB1+receptors+in+the+rat+central+nervous+system&amp;amp;author=K+Tsou&amp;amp;author=S+Brown&amp;amp;author=MC+Sanudo-Pena&amp;amp;author=K+Mackie&amp;amp;author=JM+Walker&amp;amp;volume=83&amp;amp;publication_year=1998&amp;amp;pages=393-411&amp;amp;pmid=9460749&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28050</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28051</code><code>]&lt;/span&gt;</code></p><p><code>28052</code><code>&lt;/span&gt;</code></p><p><code>28053</code><code>&lt;/li&gt;</code></p><p><code>28054</code><code>&lt;li id="R1190"&gt;</code></p><p><code>28055</code><code>&lt;span class="citation"&gt;</code></p><p><code>28056</code><code>Tsou K, Lowitz KA, Hohmann AG, Martin WJ, Hathaway CB, Bereiter DA, Walker JM. Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist. &lt;span&gt;</code></p><p><code>28057</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28058</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>28059</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>28060</code><code>70&lt;/span&gt;</code></p><p><code>28061</code><code>:791–798.&lt;/span&gt;</code></p><p><code>28062</code><code> [&lt;a href="/pubmed/10627219" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28063</code><code>PubMed&lt;/a&gt;</code></p><p><code>28064</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28065</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Suppression+of+noxious+stimulus-evoked+expression+of+Fos+protein-like+immunoreactivity+in+rat+spinal+cord+by+a+selective+cannabinoid+agonist&amp;amp;author=K+Tsou&amp;amp;author=KA+Lowitz&amp;amp;author=AG+Hohmann&amp;amp;author=WJ+Martin&amp;amp;author=CB+Hathaway&amp;amp;volume=70&amp;amp;publication_year=1996&amp;amp;pages=791-798&amp;amp;pmid=10627219&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28066</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28067</code><code>]&lt;/span&gt;</code></p><p><code>28068</code><code>&lt;/span&gt;</code></p><p><code>28069</code><code>&lt;/li&gt;</code></p><p><code>28070</code><code>&lt;li id="R1191"&gt;</code></p><p><code>28071</code><code>&lt;span class="citation"&gt;</code></p><p><code>28072</code><code>Tsou K, Mackie K, Sanudo-Pena MC, Walker JM. Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic inter-neurons in the rat hippocampal formation. &lt;span&gt;</code></p><p><code>28073</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28074</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>28075</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>28076</code><code>93&lt;/span&gt;</code></p><p><code>28077</code><code>:969–975.&lt;/span&gt;</code></p><p><code>28078</code><code> [&lt;a href="/pubmed/10473261" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28079</code><code>PubMed&lt;/a&gt;</code></p><p><code>28080</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28081</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Cannabinoid+CB1+receptors+are+localized+primarily+on+cholecystokinin-containing+GABAergic+inter-neurons+in+the+rat+hippocampal+formation&amp;amp;author=K+Tsou&amp;amp;author=K+Mackie&amp;amp;author=MC+Sanudo-Pena&amp;amp;author=JM+Walker&amp;amp;volume=93&amp;amp;publication_year=1999&amp;amp;pages=969-975&amp;amp;pmid=10473261&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28082</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28083</code><code>]&lt;/span&gt;</code></p><p><code>28084</code><code>&lt;/span&gt;</code></p><p><code>28085</code><code>&lt;/li&gt;</code></p><p><code>28086</code><code>&lt;li id="R1192"&gt;</code></p><p><code>28087</code><code>&lt;span class="citation"&gt;</code></p><p><code>28088</code><code>Tsuboi K, Sun YX, Okamoto Y, Araki N, Tonai T, Ueda N. Molecular characterization of &lt;em&gt;</code></p><p><code>28089</code><code>N-&lt;/em&gt;</code></p><p><code>28090</code><code>acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. &lt;span&gt;</code></p><p><code>28091</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28092</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>28093</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>28094</code><code>280&lt;/span&gt;</code></p><p><code>28095</code><code>:11082–11092.&lt;/span&gt;</code></p><p><code>28096</code><code> [&lt;a href="/pubmed/15655246" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28097</code><code>PubMed&lt;/a&gt;</code></p><p><code>28098</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28099</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=Molecular+characterization+of+N-acylethanolamine-hydrolyzing+acid+amidase,+a+novel+member+of+the+choloylglycine+hydrolase+family+with+structural+and+functional+similarity+to+acid+ceramidase&amp;amp;author=K+Tsuboi&amp;amp;author=YX+Sun&amp;amp;author=Y+Okamoto&amp;amp;author=N+Araki&amp;amp;author=T+Tonai&amp;amp;volume=280&amp;amp;publication_year=2005&amp;amp;pages=11082-11092&amp;amp;pmid=15655246&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28100</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28101</code><code>]&lt;/span&gt;</code></p><p><code>28102</code><code>&lt;/span&gt;</code></p><p><code>28103</code><code>&lt;/li&gt;</code></p><p><code>28104</code><code>&lt;li id="R1193"&gt;</code></p><p><code>28105</code><code>&lt;span class="citation"&gt;</code></p><p><code>28106</code><code>Tucci SA, Rogers EK, Korbonits M, Kirkham TC. The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin. &lt;span&gt;</code></p><p><code>28107</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28108</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>28109</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>28110</code><code>143&lt;/span&gt;</code></p><p><code>28111</code><code>:520–523.&lt;/span&gt;</code></p><p><code>28112</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>28113</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1575431/"&gt;</code></p><p><code>28114</code><code>PMC free article&lt;/a&gt;</code></p><p><code>28115</code><code>]&lt;/span&gt;</code></p><p><code>28116</code><code> [&lt;a href="/pubmed/15381634" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28117</code><code>PubMed&lt;/a&gt;</code></p><p><code>28118</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28119</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=The+cannabinoid+CB1+receptor+antagonist+SR141716+blocks+the+orexigenic+effects+of+intrahypothalamic+ghrelin&amp;amp;author=SA+Tucci&amp;amp;author=EK+Rogers&amp;amp;author=M+Korbonits&amp;amp;author=TC+Kirkham&amp;amp;volume=143&amp;amp;publication_year=2004&amp;amp;pages=520-523&amp;amp;pmid=15381634&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28120</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28121</code><code>]&lt;/span&gt;</code></p><p><code>28122</code><code>&lt;/span&gt;</code></p><p><code>28123</code><code>&lt;/li&gt;</code></p><p><code>28124</code><code>&lt;li id="R1194"&gt;</code></p><p><code>28125</code><code>&lt;span class="citation"&gt;</code></p><p><code>28126</code><code>Turner WM, Tsuang MT. Impact of substance abuse on the course and outcome of schizophrenia. &lt;span&gt;</code></p><p><code>28127</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28128</code><code>Schizophr Bull. &lt;/span&gt;</code></p><p><code>28129</code><code>1990;&lt;span class="ref-vol"&gt;</code></p><p><code>28130</code><code>16&lt;/span&gt;</code></p><p><code>28131</code><code>:87–95.&lt;/span&gt;</code></p><p><code>28132</code><code> [&lt;a href="/pubmed/2185537" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28133</code><code>PubMed&lt;/a&gt;</code></p><p><code>28134</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28135</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Schizophr+Bull&amp;amp;title=Impact+of+substance+abuse+on+the+course+and+outcome+of+schizophrenia&amp;amp;author=WM+Turner&amp;amp;author=MT+Tsuang&amp;amp;volume=16&amp;amp;publication_year=1990&amp;amp;pages=87-95&amp;amp;pmid=2185537&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28136</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28137</code><code>]&lt;/span&gt;</code></p><p><code>28138</code><code>&lt;/span&gt;</code></p><p><code>28139</code><code>&lt;/li&gt;</code></p><p><code>28140</code><code>&lt;li id="R1195"&gt;</code></p><p><code>28141</code><code>&lt;span class="citation"&gt;</code></p><p><code>28142</code><code>Twelves D, Perkins KS, Counsell C. Systematic review of incidence studies of Parkinson&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>28143</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28144</code><code>Mov Disord. &lt;/span&gt;</code></p><p><code>28145</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>28146</code><code>18&lt;/span&gt;</code></p><p><code>28147</code><code>:19–31.&lt;/span&gt;</code></p><p><code>28148</code><code> [&lt;a href="/pubmed/12518297" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28149</code><code>PubMed&lt;/a&gt;</code></p><p><code>28150</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28151</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mov+Disord&amp;amp;title=Systematic+review+of+incidence+studies+of+Parkinson&amp;#x02019;s+disease&amp;amp;author=D+Twelves&amp;amp;author=KS+Perkins&amp;amp;author=C+Counsell&amp;amp;volume=18&amp;amp;publication_year=2003&amp;amp;pages=19-31&amp;amp;pmid=12518297&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28152</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28153</code><code>]&lt;/span&gt;</code></p><p><code>28154</code><code>&lt;/span&gt;</code></p><p><code>28155</code><code>&lt;/li&gt;</code></p><p><code>28156</code><code>&lt;li id="R1196"&gt;</code></p><p><code>28157</code><code>&lt;span class="citation"&gt;</code></p><p><code>28158</code><code>Tzavara ET, Wade M, Nomikos GG. Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: site and mechanism of action. &lt;span&gt;</code></p><p><code>28159</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28160</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>28161</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>28162</code><code>23&lt;/span&gt;</code></p><p><code>28163</code><code>:9374–9384.&lt;/span&gt;</code></p><p><code>28164</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>28165</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6740571/"&gt;</code></p><p><code>28166</code><code>PMC free article&lt;/a&gt;</code></p><p><code>28167</code><code>]&lt;/span&gt;</code></p><p><code>28168</code><code> [&lt;a href="/pubmed/14561865" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28169</code><code>PubMed&lt;/a&gt;</code></p><p><code>28170</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28171</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Biphasic+effects+of+cannabinoids+on+acetylcholine+release+in+the+hippocampus:+site+and+mechanism+of+action&amp;amp;author=ET+Tzavara&amp;amp;author=M+Wade&amp;amp;author=GG+Nomikos&amp;amp;volume=23&amp;amp;publication_year=2003&amp;amp;pages=9374-9384&amp;amp;pmid=14561865&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28172</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28173</code><code>]&lt;/span&gt;</code></p><p><code>28174</code><code>&lt;/span&gt;</code></p><p><code>28175</code><code>&lt;/li&gt;</code></p><p><code>28176</code><code>&lt;li id="R1197"&gt;</code></p><p><code>28177</code><code>&lt;span class="citation"&gt;</code></p><p><code>28178</code><code>Ueda N, Kurahashi Y, Yamamoto S, Tokunaga T. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. &lt;span&gt;</code></p><p><code>28179</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28180</code><code>J Biol Chem. &lt;/span&gt;</code></p><p><code>28181</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>28182</code><code>270&lt;/span&gt;</code></p><p><code>28183</code><code>:23823–23827.&lt;/span&gt;</code></p><p><code>28184</code><code> [&lt;a href="/pubmed/7559559" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28185</code><code>PubMed&lt;/a&gt;</code></p><p><code>28186</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28187</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=Partial+purification+and+characterization+of+the+porcine+brain+enzyme+hydrolyzing+and+synthesizing+anandamide&amp;amp;author=N+Ueda&amp;amp;author=Y+Kurahashi&amp;amp;author=S+Yamamoto&amp;amp;author=T+Tokunaga&amp;amp;volume=270&amp;amp;publication_year=1995&amp;amp;pages=23823-23827&amp;amp;pmid=7559559&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28188</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28189</code><code>]&lt;/span&gt;</code></p><p><code>28190</code><code>&lt;/span&gt;</code></p><p><code>28191</code><code>&lt;/li&gt;</code></p><p><code>28192</code><code>&lt;li id="R1198"&gt;</code></p><p><code>28193</code><code>&lt;span class="citation"&gt;</code></p><p><code>28194</code><code>Ugdyzhekova DS, Krylatov AV, Bernatskaya NA, Maslov LN, Mechoulam R, Pertwee RG. Activation of cannabinoid receptors decreases the area of ischemic myocardial necrosis. &lt;span&gt;</code></p><p><code>28195</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28196</code><code>Bull Exp Biol Med. &lt;/span&gt;</code></p><p><code>28197</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>28198</code><code>133&lt;/span&gt;</code></p><p><code>28199</code><code>:125–126.&lt;/span&gt;</code></p><p><code>28200</code><code> [&lt;a href="/pubmed/12428278" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28201</code><code>PubMed&lt;/a&gt;</code></p><p><code>28202</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28203</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Bull+Exp+Biol+Med&amp;amp;title=Activation+of+cannabinoid+receptors+decreases+the+area+of+ischemic+myocardial+necrosis&amp;amp;author=DS+Ugdyzhekova&amp;amp;author=AV+Krylatov&amp;amp;author=NA+Bernatskaya&amp;amp;author=LN+Maslov&amp;amp;author=R+Mechoulam&amp;amp;volume=133&amp;amp;publication_year=2002&amp;amp;pages=125-126&amp;amp;pmid=12428278&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28204</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28205</code><code>]&lt;/span&gt;</code></p><p><code>28206</code><code>&lt;/span&gt;</code></p><p><code>28207</code><code>&lt;/li&gt;</code></p><p><code>28208</code><code>&lt;li id="R1199"&gt;</code></p><p><code>28209</code><code>&lt;span class="citation"&gt;</code></p><p><code>28210</code><code>Ugdyzhekova DS, Maslov LN, Krylatov AV, Lishmanov IuB, Tam SV. Specificity of the anti-arrhythmic effect of &lt;em&gt;</code></p><p><code>28211</code><code>&amp;#x003ba;&lt;/em&gt;</code></p><p><code>28212</code><code>1-opioid receptor agonists. &lt;span&gt;</code></p><p><code>28213</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28214</code><code>Eksp Klin Farmakol. &lt;/span&gt;</code></p><p><code>28215</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>28216</code><code>64&lt;/span&gt;</code></p><p><code>28217</code><code>:17–20.&lt;/span&gt;</code></p><p><code>28218</code><code> [&lt;a href="/pubmed/11589101" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28219</code><code>PubMed&lt;/a&gt;</code></p><p><code>28220</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28221</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eksp+Klin+Farmakol&amp;amp;title=Specificity+of+the+anti-arrhythmic+effect+of+&amp;#x003ba;1-opioid+receptor+agonists&amp;amp;author=DS+Ugdyzhekova&amp;amp;author=LN+Maslov&amp;amp;author=AV+Krylatov&amp;amp;author=IuB+Lishmanov&amp;amp;author=SV+Tam&amp;amp;volume=64&amp;amp;publication_year=2001&amp;amp;pages=17-20&amp;amp;pmid=11589101&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28222</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28223</code><code>]&lt;/span&gt;</code></p><p><code>28224</code><code>&lt;/span&gt;</code></p><p><code>28225</code><code>&lt;/li&gt;</code></p><p><code>28226</code><code>&lt;li id="R1200"&gt;</code></p><p><code>28227</code><code>&lt;span class="citation"&gt;</code></p><p><code>28228</code><code>Ujike H, Morita Y. New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia. &lt;span&gt;</code></p><p><code>28229</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28230</code><code>J Pharmacol Sci. &lt;/span&gt;</code></p><p><code>28231</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>28232</code><code>96&lt;/span&gt;</code></p><p><code>28233</code><code>:376–381.&lt;/span&gt;</code></p><p><code>28234</code><code> [&lt;a href="/pubmed/15613777" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28235</code><code>PubMed&lt;/a&gt;</code></p><p><code>28236</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28237</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Sci&amp;amp;title=New+perspectives+in+the+studies+on+endocannabinoid+and+cannabis:+cannabinoid+receptors+and+schizophrenia&amp;amp;author=H+Ujike&amp;amp;author=Y+Morita&amp;amp;volume=96&amp;amp;publication_year=2004&amp;amp;pages=376-381&amp;amp;pmid=15613777&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28238</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28239</code><code>]&lt;/span&gt;</code></p><p><code>28240</code><code>&lt;/span&gt;</code></p><p><code>28241</code><code>&lt;/li&gt;</code></p><p><code>28242</code><code>&lt;li id="R1201"&gt;</code></p><p><code>28243</code><code>&lt;span class="citation"&gt;</code></p><p><code>28244</code><code>Ujike H, Takaki M, Nakata K, Tanaka Y, Takeda T, Kodama M, Fujiwara Y, Sakai A, Kuroda S. CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia. &lt;span&gt;</code></p><p><code>28245</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28246</code><code>Mol Psychiatry. &lt;/span&gt;</code></p><p><code>28247</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>28248</code><code>7&lt;/span&gt;</code></p><p><code>28249</code><code>:515–518.&lt;/span&gt;</code></p><p><code>28250</code><code> [&lt;a href="/pubmed/12082570" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28251</code><code>PubMed&lt;/a&gt;</code></p><p><code>28252</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28253</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mol+Psychiatry&amp;amp;title=CNR1,+central+cannabinoid+receptor+gene,+associated+with+susceptibility+to+hebephrenic+schizophrenia&amp;amp;author=H+Ujike&amp;amp;author=M+Takaki&amp;amp;author=K+Nakata&amp;amp;author=Y+Tanaka&amp;amp;author=T+Takeda&amp;amp;volume=7&amp;amp;publication_year=2002&amp;amp;pages=515-518&amp;amp;pmid=12082570&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28254</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28255</code><code>]&lt;/span&gt;</code></p><p><code>28256</code><code>&lt;/span&gt;</code></p><p><code>28257</code><code>&lt;/li&gt;</code></p><p><code>28258</code><code>&lt;li id="R1202"&gt;</code></p><p><code>28259</code><code>&lt;span class="citation"&gt;</code></p><p><code>28260</code><code>Ulugol A, Ozyigit F, Yesilyurt O, Dogrul A. The additive antinociceptive interaction between WIN 55,212-2, a cannabinoid agonist, and ketorolac. &lt;span&gt;</code></p><p><code>28261</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28262</code><code>Anesth Analg. &lt;/span&gt;</code></p><p><code>28263</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>28264</code><code>102&lt;/span&gt;</code></p><p><code>28265</code><code>:443–447.&lt;/span&gt;</code></p><p><code>28266</code><code> [&lt;a href="/pubmed/16428540" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28267</code><code>PubMed&lt;/a&gt;</code></p><p><code>28268</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28269</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Anesth+Analg&amp;amp;title=The+additive+antinociceptive+interaction+between+WIN+55,212-2,+a+cannabinoid+agonist,+and+ketorolac&amp;amp;author=A+Ulugol&amp;amp;author=F+Ozyigit&amp;amp;author=O+Yesilyurt&amp;amp;author=A+Dogrul&amp;amp;volume=102&amp;amp;publication_year=2006&amp;amp;pages=443-447&amp;amp;pmid=16428540&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28270</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28271</code><code>]&lt;/span&gt;</code></p><p><code>28272</code><code>&lt;/span&gt;</code></p><p><code>28273</code><code>&lt;/li&gt;</code></p><p><code>28274</code><code>&lt;li id="R1203"&gt;</code></p><p><code>28275</code><code>&lt;span class="citation"&gt;</code></p><p><code>28276</code><code>Underdown NJ, Hiley CR, Ford WR. Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. &lt;span&gt;</code></p><p><code>28277</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28278</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>28279</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>28280</code><code>146&lt;/span&gt;</code></p><p><code>28281</code><code>:809–816.&lt;/span&gt;</code></p><p><code>28282</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>28283</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1751211/"&gt;</code></p><p><code>28284</code><code>PMC free article&lt;/a&gt;</code></p><p><code>28285</code><code>]&lt;/span&gt;</code></p><p><code>28286</code><code> [&lt;a href="/pubmed/16158067" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28287</code><code>PubMed&lt;/a&gt;</code></p><p><code>28288</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28289</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Anandamide+reduces+infarct+size+in+rat+isolated+hearts+subjected+to+ischaemia-reperfusion+by+a+novel+cannabinoid+mechanism&amp;amp;author=NJ+Underdown&amp;amp;author=CR+Hiley&amp;amp;author=WR+Ford&amp;amp;volume=146&amp;amp;publication_year=2005&amp;amp;pages=809-816&amp;amp;pmid=16158067&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28290</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28291</code><code>]&lt;/span&gt;</code></p><p><code>28292</code><code>&lt;/span&gt;</code></p><p><code>28293</code><code>&lt;/li&gt;</code></p><p><code>28294</code><code>&lt;li id="R1204"&gt;</code></p><p><code>28295</code><code>&lt;span class="citation"&gt;</code></p><p><code>28296</code><code>Ungerleider JT, Andyrsiak T, Fairbanks L, Ellison GW, Myers LW. &amp;#x00394;-9-THC in the treatment of spasticity associated with multiple sclerosis. &lt;span&gt;</code></p><p><code>28297</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28298</code><code>Adv Alcohol Subst Abuse. &lt;/span&gt;</code></p><p><code>28299</code><code>1987;&lt;span class="ref-vol"&gt;</code></p><p><code>28300</code><code>7&lt;/span&gt;</code></p><p><code>28301</code><code>:39–50.&lt;/span&gt;</code></p><p><code>28302</code><code> [&lt;a href="/pubmed/2831701" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28303</code><code>PubMed&lt;/a&gt;</code></p><p><code>28304</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28305</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Adv+Alcohol+Subst+Abuse&amp;amp;title=&amp;#x00394;-9-THC+in+the+treatment+of+spasticity+associated+with+multiple+sclerosis&amp;amp;author=JT+Ungerleider&amp;amp;author=T+Andyrsiak&amp;amp;author=L+Fairbanks&amp;amp;author=GW+Ellison&amp;amp;author=LW+Myers&amp;amp;volume=7&amp;amp;publication_year=1987&amp;amp;pages=39-50&amp;amp;pmid=2831701&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28306</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28307</code><code>]&lt;/span&gt;</code></p><p><code>28308</code><code>&lt;/span&gt;</code></p><p><code>28309</code><code>&lt;/li&gt;</code></p><p><code>28310</code><code>&lt;li id="R1205"&gt;</code></p><p><code>28311</code><code>&lt;span class="citation"&gt;</code></p><p><code>28312</code><code>Urig&amp;#x000fc;en L, Perez-Rial S, Ledent C, Palomo T, Manzanares J. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. &lt;span&gt;</code></p><p><code>28313</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28314</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>28315</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>28316</code><code>46&lt;/span&gt;</code></p><p><code>28317</code><code>:966–973.&lt;/span&gt;</code></p><p><code>28318</code><code> [&lt;a href="/pubmed/15081793" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28319</code><code>PubMed&lt;/a&gt;</code></p><p><code>28320</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28321</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=Impaired+action+of+anxiolytic+drugs+in+mice+deficient+in+cannabinoid+CB1+receptors&amp;amp;author=L+Urig&amp;#x000fc;en&amp;amp;author=S+Perez-Rial&amp;amp;author=C+Ledent&amp;amp;author=T+Palomo&amp;amp;author=J+Manzanares&amp;amp;volume=46&amp;amp;publication_year=2004&amp;amp;pages=966-973&amp;amp;pmid=15081793&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28322</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28323</code><code>]&lt;/span&gt;</code></p><p><code>28324</code><code>&lt;/span&gt;</code></p><p><code>28325</code><code>&lt;/li&gt;</code></p><p><code>28326</code><code>&lt;li id="R1206"&gt;</code></p><p><code>28327</code><code>&lt;span class="citation"&gt;</code></p><p><code>28328</code><code>Vaccani A, Massi P, Colombo A, Rubino T, Parolaro D. Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism. &lt;span&gt;</code></p><p><code>28329</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28330</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>28331</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>28332</code><code>144&lt;/span&gt;</code></p><p><code>28333</code><code>:1032–1036.&lt;/span&gt;</code></p><p><code>28334</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>28335</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1576089/"&gt;</code></p><p><code>28336</code><code>PMC free article&lt;/a&gt;</code></p><p><code>28337</code><code>]&lt;/span&gt;</code></p><p><code>28338</code><code> [&lt;a href="/pubmed/15700028" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28339</code><code>PubMed&lt;/a&gt;</code></p><p><code>28340</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28341</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Cannabidiol+inhibits+human+glioma+cell+migration+through+a+cannabinoid+receptor-independent+mechanism&amp;amp;author=A+Vaccani&amp;amp;author=P+Massi&amp;amp;author=A+Colombo&amp;amp;author=T+Rubino&amp;amp;author=D+Parolaro&amp;amp;volume=144&amp;amp;publication_year=2005&amp;amp;pages=1032-1036&amp;amp;pmid=15700028&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28342</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28343</code><code>]&lt;/span&gt;</code></p><p><code>28344</code><code>&lt;/span&gt;</code></p><p><code>28345</code><code>&lt;/li&gt;</code></p><p><code>28346</code><code>&lt;li id="R1207"&gt;</code></p><p><code>28347</code><code>&lt;span class="citation"&gt;</code></p><p><code>28348</code><code>Vachon L, FitzGerald MX, Solliday NH, Gould IA, Gaensler EA. Single-dose effects of marihuana smoke: bronchial dynamics and respiratory-center sensitivity in normal subjects. &lt;span&gt;</code></p><p><code>28349</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28350</code><code>N Engl J Med. &lt;/span&gt;</code></p><p><code>28351</code><code>1973;&lt;span class="ref-vol"&gt;</code></p><p><code>28352</code><code>288&lt;/span&gt;</code></p><p><code>28353</code><code>:985–989.&lt;/span&gt;</code></p><p><code>28354</code><code> [&lt;a href="/pubmed/4696254" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28355</code><code>PubMed&lt;/a&gt;</code></p><p><code>28356</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28357</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;amp;title=Single-dose+effects+of+marihuana+smoke:+bronchial+dynamics+and+respiratory-center+sensitivity+in+normal+subjects&amp;amp;author=L+Vachon&amp;amp;author=MX+FitzGerald&amp;amp;author=NH+Solliday&amp;amp;author=IA+Gould&amp;amp;author=EA+Gaensler&amp;amp;volume=288&amp;amp;publication_year=1973&amp;amp;pages=985-989&amp;amp;pmid=4696254&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28358</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28359</code><code>]&lt;/span&gt;</code></p><p><code>28360</code><code>&lt;/span&gt;</code></p><p><code>28361</code><code>&lt;/li&gt;</code></p><p><code>28362</code><code>&lt;li id="R1208"&gt;</code></p><p><code>28363</code><code>&lt;span class="citation"&gt;</code></p><p><code>28364</code><code>Valjent E, Maldonado R. A behavioural model to reveal place preference to &amp;#x00394;&lt;sup&gt;</code></p><p><code>28365</code><code>9&lt;/sup&gt;</code></p><p><code>28366</code><code>-tetrahydrocannabinol in mice. &lt;span&gt;</code></p><p><code>28367</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28368</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>28369</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>28370</code><code>147&lt;/span&gt;</code></p><p><code>28371</code><code>:436–438.&lt;/span&gt;</code></p><p><code>28372</code><code> [&lt;a href="/pubmed/10672638" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28373</code><code>PubMed&lt;/a&gt;</code></p><p><code>28374</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28375</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=A+behavioural+model+to+reveal+place+preference+to+&amp;#x00394;9-tetrahydrocannabinol+in+mice&amp;amp;author=E+Valjent&amp;amp;author=R+Maldonado&amp;amp;volume=147&amp;amp;publication_year=2000&amp;amp;pages=436-438&amp;amp;pmid=10672638&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28376</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28377</code><code>]&lt;/span&gt;</code></p><p><code>28378</code><code>&lt;/span&gt;</code></p><p><code>28379</code><code>&lt;/li&gt;</code></p><p><code>28380</code><code>&lt;li id="R1209"&gt;</code></p><p><code>28381</code><code>&lt;span class="citation"&gt;</code></p><p><code>28382</code><code>Valverde O, Ledent C, Beslot F, Parmentier M, Roques BP. Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors. &lt;span&gt;</code></p><p><code>28383</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28384</code><code>Eur J Neurosci. &lt;/span&gt;</code></p><p><code>28385</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>28386</code><code>12&lt;/span&gt;</code></p><p><code>28387</code><code>:533–539.&lt;/span&gt;</code></p><p><code>28388</code><code> [&lt;a href="/pubmed/10712632" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28389</code><code>PubMed&lt;/a&gt;</code></p><p><code>28390</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28391</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurosci&amp;amp;title=Reduction+of+stress-induced+analgesia+but+not+of+exogenous+opioid+effects+in+mice+lacking+CB1+receptors&amp;amp;author=O+Valverde&amp;amp;author=C+Ledent&amp;amp;author=F+Beslot&amp;amp;author=M+Parmentier&amp;amp;author=BP+Roques&amp;amp;volume=12&amp;amp;publication_year=2000&amp;amp;pages=533-539&amp;amp;pmid=10712632&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28392</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28393</code><code>]&lt;/span&gt;</code></p><p><code>28394</code><code>&lt;/span&gt;</code></p><p><code>28395</code><code>&lt;/li&gt;</code></p><p><code>28396</code><code>&lt;li id="R1210"&gt;</code></p><p><code>28397</code><code>&lt;span class="citation"&gt;</code></p><p><code>28398</code><code>van der Stelt M, Di Marzo V. The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. &lt;span&gt;</code></p><p><code>28399</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28400</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>28401</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>28402</code><code>480&lt;/span&gt;</code></p><p><code>28403</code><code>:133–150.&lt;/span&gt;</code></p><p><code>28404</code><code> [&lt;a href="/pubmed/14623357" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28405</code><code>PubMed&lt;/a&gt;</code></p><p><code>28406</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28407</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=The+endocannabinoid+system+in+the+basal+ganglia+and+in+the+mesolimbic+reward+system:+implications+for+neurological+and+psychiatric+disorders&amp;amp;author=M+van+der+Stelt&amp;amp;author=V+Di+Marzo&amp;amp;volume=480&amp;amp;publication_year=2003&amp;amp;pages=133-150&amp;amp;pmid=14623357&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28408</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28409</code><code>]&lt;/span&gt;</code></p><p><code>28410</code><code>&lt;/span&gt;</code></p><p><code>28411</code><code>&lt;/li&gt;</code></p><p><code>28412</code><code>&lt;li id="R1211"&gt;</code></p><p><code>28413</code><code>&lt;span class="citation"&gt;</code></p><p><code>28414</code><code>van der Stelt M, Di Marzo V. Endovanilloids: putative endogenous ligands of transient receptor potential vanilloid 1 channels. &lt;span&gt;</code></p><p><code>28415</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28416</code><code>Eur J Biochem. &lt;/span&gt;</code></p><p><code>28417</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>28418</code><code>271&lt;/span&gt;</code></p><p><code>28419</code><code>:1827–1834.&lt;/span&gt;</code></p><p><code>28420</code><code> [&lt;a href="/pubmed/15128293" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28421</code><code>PubMed&lt;/a&gt;</code></p><p><code>28422</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28423</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Biochem&amp;amp;title=Endovanilloids:+putative+endogenous+ligands+of+transient+receptor+potential+vanilloid+1+channels&amp;amp;author=M+van+der+Stelt&amp;amp;author=V+Di+Marzo&amp;amp;volume=271&amp;amp;publication_year=2004&amp;amp;pages=1827-1834&amp;amp;pmid=15128293&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28424</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28425</code><code>]&lt;/span&gt;</code></p><p><code>28426</code><code>&lt;/span&gt;</code></p><p><code>28427</code><code>&lt;/li&gt;</code></p><p><code>28428</code><code>&lt;li id="R1212"&gt;</code></p><p><code>28429</code><code>&lt;span class="citation"&gt;</code></p><p><code>28430</code><code>van der Stelt M, Fox SH, Hill M, Crossman AR, Petrosino S, Di Marzo V, Brotchie JM. A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>28431</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28432</code><code>FASEB J. &lt;/span&gt;</code></p><p><code>28433</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>28434</code><code>19&lt;/span&gt;</code></p><p><code>28435</code><code>:1140–1142.&lt;/span&gt;</code></p><p><code>28436</code><code> [&lt;a href="/pubmed/15894565" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28437</code><code>PubMed&lt;/a&gt;</code></p><p><code>28438</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28439</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;amp;title=A+role+for+endocannabinoids+in+the+generation+of+parkinsonism+and+levodopa-induced+dyskinesia+in+MPTP-lesioned+non-human+primate+models+of+Parkinson&amp;#x02019;s+disease&amp;amp;author=M+van+der+Stelt&amp;amp;author=SH+Fox&amp;amp;author=M+Hill&amp;amp;author=AR+Crossman&amp;amp;author=S+Petrosino&amp;amp;volume=19&amp;amp;publication_year=2005&amp;amp;pages=1140-1142&amp;amp;pmid=15894565&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28440</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28441</code><code>]&lt;/span&gt;</code></p><p><code>28442</code><code>&lt;/span&gt;</code></p><p><code>28443</code><code>&lt;/li&gt;</code></p><p><code>28444</code><code>&lt;li id="R1213"&gt;</code></p><p><code>28445</code><code>&lt;span class="citation"&gt;</code></p><p><code>28446</code><code>van der Stelt M, Veldhuis WB, Bar PR, Veldink GA, Vliegenthart JF, Nicolay K. Neuroprotection by &amp;#x00394;9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity. &lt;span&gt;</code></p><p><code>28447</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28448</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>28449</code><code>2001a;&lt;span class="ref-vol"&gt;</code></p><p><code>28450</code><code>21&lt;/span&gt;</code></p><p><code>28451</code><code>:6475–6479.&lt;/span&gt;</code></p><p><code>28452</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>28453</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6763099/"&gt;</code></p><p><code>28454</code><code>PMC free article&lt;/a&gt;</code></p><p><code>28455</code><code>]&lt;/span&gt;</code></p><p><code>28456</code><code> [&lt;a href="/pubmed/11517236" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28457</code><code>PubMed&lt;/a&gt;</code></p><p><code>28458</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28459</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Neuroprotection+by+&amp;#x00394;9-tetrahydrocannabinol,+the+main+active+compound+in+marijuana,+against+ouabain-induced+in+vivo+excitotoxicity&amp;amp;author=M+van+der+Stelt&amp;amp;author=WB+Veldhuis&amp;amp;author=PR+Bar&amp;amp;author=GA+Veldink&amp;amp;author=JF+Vliegenthart&amp;amp;volume=21&amp;amp;publication_year=2001a&amp;amp;pages=6475-6479&amp;amp;pmid=11517236&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28460</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28461</code><code>]&lt;/span&gt;</code></p><p><code>28462</code><code>&lt;/span&gt;</code></p><p><code>28463</code><code>&lt;/li&gt;</code></p><p><code>28464</code><code>&lt;li id="R1214"&gt;</code></p><p><code>28465</code><code>&lt;span class="citation"&gt;</code></p><p><code>28466</code><code>van der Stelt M, Veldhuis WB, van Haaften GW, Fezza F, Bisogno T, Bar PR, Veldink GA, Vliegenthart JF, Di Marzo V, Nicolay K. Exogenous anandamide protects rat brain against acute neuronal injury in vivo. &lt;span&gt;</code></p><p><code>28467</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28468</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>28469</code><code>2001b;&lt;span class="ref-vol"&gt;</code></p><p><code>28470</code><code>21&lt;/span&gt;</code></p><p><code>28471</code><code>:8765–8771.&lt;/span&gt;</code></p><p><code>28472</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>28473</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6762287/"&gt;</code></p><p><code>28474</code><code>PMC free article&lt;/a&gt;</code></p><p><code>28475</code><code>]&lt;/span&gt;</code></p><p><code>28476</code><code> [&lt;a href="/pubmed/11698588" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28477</code><code>PubMed&lt;/a&gt;</code></p><p><code>28478</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28479</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Exogenous+anandamide+protects+rat+brain+against+acute+neuronal+injury+in+vivo&amp;amp;author=M+van+der+Stelt&amp;amp;author=WB+Veldhuis&amp;amp;author=GW+van+Haaften&amp;amp;author=F+Fezza&amp;amp;author=T+Bisogno&amp;amp;volume=21&amp;amp;publication_year=2001b&amp;amp;pages=8765-8771&amp;amp;pmid=11698588&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28480</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28481</code><code>]&lt;/span&gt;</code></p><p><code>28482</code><code>&lt;/span&gt;</code></p><p><code>28483</code><code>&lt;/li&gt;</code></p><p><code>28484</code><code>&lt;li id="R1215"&gt;</code></p><p><code>28485</code><code>&lt;span class="citation"&gt;</code></p><p><code>28486</code><code>Vaney C, Heinzel-Gutenbrunner M, Jobin P, Tschopp F, Gattlen B, Hagen U, Schnelle M, Reif M. Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study. &lt;span&gt;</code></p><p><code>28487</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28488</code><code>Mult Scler. &lt;/span&gt;</code></p><p><code>28489</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>28490</code><code>10&lt;/span&gt;</code></p><p><code>28491</code><code>:417–424.&lt;/span&gt;</code></p><p><code>28492</code><code> [&lt;a href="/pubmed/15327040" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28493</code><code>PubMed&lt;/a&gt;</code></p><p><code>28494</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28495</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mult+Scler&amp;amp;title=Efficacy,+safety+and+tolerability+of+an+orally+administered+cannabis+extract+in+the+treatment+of+spasticity+in+patients+with+multiple+sclerosis:+a+randomized,+double-blind,+placebo-controlled,+crossover+study&amp;amp;author=C+Vaney&amp;amp;author=M+Heinzel-Gutenbrunner&amp;amp;author=P+Jobin&amp;amp;author=F+Tschopp&amp;amp;author=B+Gattlen&amp;amp;volume=10&amp;amp;publication_year=2004&amp;amp;pages=417-424&amp;amp;pmid=15327040&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28496</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28497</code><code>]&lt;/span&gt;</code></p><p><code>28498</code><code>&lt;/span&gt;</code></p><p><code>28499</code><code>&lt;/li&gt;</code></p><p><code>28500</code><code>&lt;li id="R1216"&gt;</code></p><p><code>28501</code><code>&lt;span class="citation"&gt;</code></p><p><code>28502</code><code>Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rossner S for the RIO-Europe Study Group. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. &lt;span&gt;</code></p><p><code>28503</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28504</code><code>Lancet. &lt;/span&gt;</code></p><p><code>28505</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>28506</code><code>365&lt;/span&gt;</code></p><p><code>28507</code><code>:1389–1397.&lt;/span&gt;</code></p><p><code>28508</code><code> [&lt;a href="/pubmed/15836887" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28509</code><code>PubMed&lt;/a&gt;</code></p><p><code>28510</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28511</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;amp;title=Effects+of+the+cannabinoid-1+receptor+blocker+rimonabant+on+weight+reduction+and+cardiovascular+risk+factors+in+overweight+patients:+1-year+experience+from+the+RIO-Europe+study&amp;amp;author=LF+Van+Gaal&amp;amp;author=AM+Rissanen&amp;amp;author=AJ+Scheen&amp;amp;author=O+Ziegler&amp;amp;author=S+Rossner&amp;amp;volume=365&amp;amp;publication_year=2005&amp;amp;pages=1389-1397&amp;amp;pmid=15836887&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28512</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28513</code><code>]&lt;/span&gt;</code></p><p><code>28514</code><code>&lt;/span&gt;</code></p><p><code>28515</code><code>&lt;/li&gt;</code></p><p><code>28516</code><code>&lt;li id="R1217"&gt;</code></p><p><code>28517</code><code>&lt;span class="citation"&gt;</code></p><p><code>28518</code><code>van Oosten BW, Killestein J, Mathus-Vliegen EM, Polman CH. Multiple sclerosis following treatment with a cannabinoid receptor-1 antagonist. &lt;span&gt;</code></p><p><code>28519</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28520</code><code>Mult Scler. &lt;/span&gt;</code></p><p><code>28521</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>28522</code><code>10&lt;/span&gt;</code></p><p><code>28523</code><code>:330–331.&lt;/span&gt;</code></p><p><code>28524</code><code> [&lt;a href="/pubmed/15222701" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28525</code><code>PubMed&lt;/a&gt;</code></p><p><code>28526</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28527</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mult+Scler&amp;amp;title=Multiple+sclerosis+following+treatment+with+a+cannabinoid+receptor-1+antagonist&amp;amp;author=BW+van+Oosten&amp;amp;author=J+Killestein&amp;amp;author=EM+Mathus-Vliegen&amp;amp;author=CH+Polman&amp;amp;volume=10&amp;amp;publication_year=2004&amp;amp;pages=330-331&amp;amp;pmid=15222701&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28528</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28529</code><code>]&lt;/span&gt;</code></p><p><code>28530</code><code>&lt;/span&gt;</code></p><p><code>28531</code><code>&lt;/li&gt;</code></p><p><code>28532</code><code>&lt;li id="R1218"&gt;</code></p><p><code>28533</code><code>&lt;span class="citation"&gt;</code></p><p><code>28534</code><code>Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, Stella N, Makriyannis A, Piomelli D, Davison JS, et al.  Identification and functional characterization of brainstem cannabinoid CB2 receptors. &lt;span&gt;</code></p><p><code>28535</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28536</code><code>Science (Wash DC) &lt;/span&gt;</code></p><p><code>28537</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>28538</code><code>310&lt;/span&gt;</code></p><p><code>28539</code><code>:329–332.&lt;/span&gt;</code></p><p><code>28540</code><code> [&lt;a href="/pubmed/16224028" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28541</code><code>PubMed&lt;/a&gt;</code></p><p><code>28542</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28543</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Science+(Wash+DC)&amp;amp;title=Identification+and+functional+characterization+of+brainstem+cannabinoid+CB2+receptors&amp;amp;author=MD+Van+Sickle&amp;amp;author=M+Duncan&amp;amp;author=PJ+Kingsley&amp;amp;author=A+Mouihate&amp;amp;author=P+Urbani&amp;amp;volume=310&amp;amp;publication_year=2005&amp;amp;pages=329-332&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28544</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28545</code><code>]&lt;/span&gt;</code></p><p><code>28546</code><code>&lt;/span&gt;</code></p><p><code>28547</code><code>&lt;/li&gt;</code></p><p><code>28548</code><code>&lt;li id="R1219"&gt;</code></p><p><code>28549</code><code>&lt;span class="citation"&gt;</code></p><p><code>28550</code><code>Varga K, Lake K, Martin BR, Kunos G. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. &lt;span&gt;</code></p><p><code>28551</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28552</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>28553</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>28554</code><code>278&lt;/span&gt;</code></p><p><code>28555</code><code>:279–283.&lt;/span&gt;</code></p><p><code>28556</code><code> [&lt;a href="/pubmed/7589169" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28557</code><code>PubMed&lt;/a&gt;</code></p><p><code>28558</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28559</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Novel+antagonist+implicates+the+CB1+cannabinoid+receptor+in+the+hypotensive+action+of+anandamide&amp;amp;author=K+Varga&amp;amp;author=K+Lake&amp;amp;author=BR+Martin&amp;amp;author=G+Kunos&amp;amp;volume=278&amp;amp;publication_year=1995&amp;amp;pages=279-283&amp;amp;pmid=7589169&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28560</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28561</code><code>]&lt;/span&gt;</code></p><p><code>28562</code><code>&lt;/span&gt;</code></p><p><code>28563</code><code>&lt;/li&gt;</code></p><p><code>28564</code><code>&lt;li id="R1220"&gt;</code></p><p><code>28565</code><code>&lt;span class="citation"&gt;</code></p><p><code>28566</code><code>Varga K, Lake KD, Huangfu D, Guyenet PG, Kunos G. Mechanism of the hypotensive action of anandamide in anesthetized rats. &lt;span&gt;</code></p><p><code>28567</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28568</code><code>Hypertension. &lt;/span&gt;</code></p><p><code>28569</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>28570</code><code>28&lt;/span&gt;</code></p><p><code>28571</code><code>:682–686.&lt;/span&gt;</code></p><p><code>28572</code><code> [&lt;a href="/pubmed/8843898" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28573</code><code>PubMed&lt;/a&gt;</code></p><p><code>28574</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28575</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;amp;title=Mechanism+of+the+hypotensive+action+of+anandamide+in+anesthetized+rats&amp;amp;author=K+Varga&amp;amp;author=KD+Lake&amp;amp;author=D+Huangfu&amp;amp;author=PG+Guyenet&amp;amp;author=G+Kunos&amp;amp;volume=28&amp;amp;publication_year=1996&amp;amp;pages=682-686&amp;amp;pmid=8843898&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28576</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28577</code><code>]&lt;/span&gt;</code></p><p><code>28578</code><code>&lt;/span&gt;</code></p><p><code>28579</code><code>&lt;/li&gt;</code></p><p><code>28580</code><code>&lt;li id="R1221"&gt;</code></p><p><code>28581</code><code>&lt;span class="citation"&gt;</code></p><p><code>28582</code><code>Varga K, Wagner JA, Bridgen DT, Kunos G. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. &lt;span&gt;</code></p><p><code>28583</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28584</code><code>FASEB J. &lt;/span&gt;</code></p><p><code>28585</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>28586</code><code>12&lt;/span&gt;</code></p><p><code>28587</code><code>:1035–1044.&lt;/span&gt;</code></p><p><code>28588</code><code> [&lt;a href="/pubmed/9707176" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28589</code><code>PubMed&lt;/a&gt;</code></p><p><code>28590</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28591</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;amp;title=Platelet-+and+macrophage-derived+endogenous+cannabinoids+are+involved+in+endotoxin-induced+hypotension&amp;amp;author=K+Varga&amp;amp;author=JA+Wagner&amp;amp;author=DT+Bridgen&amp;amp;author=G+Kunos&amp;amp;volume=12&amp;amp;publication_year=1998&amp;amp;pages=1035-1044&amp;amp;pmid=9707176&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28592</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28593</code><code>]&lt;/span&gt;</code></p><p><code>28594</code><code>&lt;/span&gt;</code></p><p><code>28595</code><code>&lt;/li&gt;</code></p><p><code>28596</code><code>&lt;li id="R1222"&gt;</code></p><p><code>28597</code><code>&lt;span class="citation"&gt;</code></p><p><code>28598</code><code>Varma DR, Goldbaum D. Effect of &amp;#x00394;&lt;sup&gt;</code></p><p><code>28599</code><code>9&lt;/sup&gt;</code></p><p><code>28600</code><code>-tetrahydrocannabinol on experimental hypertension in rats. &lt;span&gt;</code></p><p><code>28601</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28602</code><code>J Pharm Pharmacol. &lt;/span&gt;</code></p><p><code>28603</code><code>1975;&lt;span class="ref-vol"&gt;</code></p><p><code>28604</code><code>27&lt;/span&gt;</code></p><p><code>28605</code><code>:790–791.&lt;/span&gt;</code></p><p><code>28606</code><code> [&lt;a href="/pubmed/241799" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28607</code><code>PubMed&lt;/a&gt;</code></p><p><code>28608</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28609</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Pharmacol&amp;amp;title=Effect+of+&amp;#x00394;9-tetrahydrocannabinol+on+experimental+hypertension+in+rats&amp;amp;author=DR+Varma&amp;amp;author=D+Goldbaum&amp;amp;volume=27&amp;amp;publication_year=1975&amp;amp;pages=790-791&amp;amp;pmid=241799&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28610</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28611</code><code>]&lt;/span&gt;</code></p><p><code>28612</code><code>&lt;/span&gt;</code></p><p><code>28613</code><code>&lt;/li&gt;</code></p><p><code>28614</code><code>&lt;li id="R1223"&gt;</code></p><p><code>28615</code><code>&lt;span class="citation"&gt;</code></p><p><code>28616</code><code>Varma N, Carlson GC, Ledent C, Alger BE. Metabotropic glutamate receptors drive the endocannabinoid system in the hippocampus. &lt;span&gt;</code></p><p><code>28617</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28618</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>28619</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>28620</code><code>21&lt;/span&gt;</code></p><p><code>28621</code><code>:RC188.&lt;/span&gt;</code></p><p><code>28622</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>28623</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6763031/"&gt;</code></p><p><code>28624</code><code>PMC free article&lt;/a&gt;</code></p><p><code>28625</code><code>]&lt;/span&gt;</code></p><p><code>28626</code><code> [&lt;a href="/pubmed/11734603" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28627</code><code>PubMed&lt;/a&gt;</code></p><p><code>28628</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28629</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Metabotropic+glutamate+receptors+drive+the+endocannabinoid+system+in+the+hippocampus&amp;amp;author=N+Varma&amp;amp;author=GC+Carlson&amp;amp;author=C+Ledent&amp;amp;author=BE+Alger&amp;amp;volume=21&amp;amp;publication_year=2001&amp;amp;pages=RC188&amp;amp;pmid=11734603&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28630</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28631</code><code>]&lt;/span&gt;</code></p><p><code>28632</code><code>&lt;/span&gt;</code></p><p><code>28633</code><code>&lt;/li&gt;</code></p><p><code>28634</code><code>&lt;li id="R1224"&gt;</code></p><p><code>28635</code><code>&lt;span class="citation"&gt;</code></p><p><code>28636</code><code>Velasco G, Galve-Roperh I, Sanchez C, Blazquez C, Guzman M. Hypothesis: cannabinoid therapy for the treatment of gliomas. &lt;span&gt;</code></p><p><code>28637</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28638</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>28639</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>28640</code><code>47&lt;/span&gt;</code></p><p><code>28641</code><code>:315–323.&lt;/span&gt;</code></p><p><code>28642</code><code> [&lt;a href="/pubmed/15275820" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28643</code><code>PubMed&lt;/a&gt;</code></p><p><code>28644</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28645</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=Hypothesis:+cannabinoid+therapy+for+the+treatment+of+gliomas&amp;amp;author=G+Velasco&amp;amp;author=I+Galve-Roperh&amp;amp;author=C+Sanchez&amp;amp;author=C+Blazquez&amp;amp;author=M+Guzman&amp;amp;volume=47&amp;amp;publication_year=2004&amp;amp;pages=315-323&amp;amp;pmid=15275820&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28646</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28647</code><code>]&lt;/span&gt;</code></p><p><code>28648</code><code>&lt;/span&gt;</code></p><p><code>28649</code><code>&lt;/li&gt;</code></p><p><code>28650</code><code>&lt;li id="R1225"&gt;</code></p><p><code>28651</code><code>&lt;span class="citation"&gt;</code></p><p><code>28652</code><code>Venance L, Piomelli D, Glowinski J, Giaume C. Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. &lt;span&gt;</code></p><p><code>28653</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28654</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>28655</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>28656</code><code>376&lt;/span&gt;</code></p><p><code>28657</code><code>:590–594.&lt;/span&gt;</code></p><p><code>28658</code><code> [&lt;a href="/pubmed/7637807" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28659</code><code>PubMed&lt;/a&gt;</code></p><p><code>28660</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28661</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Inhibition+by+anandamide+of+gap+junctions+and+intercellular+calcium+signalling+in+striatal+astrocytes&amp;amp;author=L+Venance&amp;amp;author=D+Piomelli&amp;amp;author=J+Glowinski&amp;amp;author=C+Giaume&amp;amp;volume=376&amp;amp;publication_year=1995&amp;amp;pages=590-594&amp;amp;pmid=7637807&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28662</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28663</code><code>]&lt;/span&gt;</code></p><p><code>28664</code><code>&lt;/span&gt;</code></p><p><code>28665</code><code>&lt;/li&gt;</code></p><p><code>28666</code><code>&lt;li id="R1226"&gt;</code></p><p><code>28667</code><code>&lt;span class="citation"&gt;</code></p><p><code>28668</code><code>Vered M, Bar-Joseph A, Belayev L, Berkovich Y, Biegon A. Anti-ischemia activity of HU-211, a non-psychotropic synthetic cannabinoid. &lt;span&gt;</code></p><p><code>28669</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28670</code><code>Acta Neurochir Suppl. &lt;/span&gt;</code></p><p><code>28671</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>28672</code><code>60&lt;/span&gt;</code></p><p><code>28673</code><code>:335–337.&lt;/span&gt;</code></p><p><code>28674</code><code> [&lt;a href="/pubmed/7976583" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28675</code><code>PubMed&lt;/a&gt;</code></p><p><code>28676</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28677</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Acta+Neurochir+Suppl&amp;amp;title=Anti-ischemia+activity+of+HU-211,+a+non-psychotropic+synthetic+cannabinoid&amp;amp;author=M+Vered&amp;amp;author=A+Bar-Joseph&amp;amp;author=L+Belayev&amp;amp;author=Y+Berkovich&amp;amp;author=A+Biegon&amp;amp;volume=60&amp;amp;publication_year=1994&amp;amp;pages=335-337&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28678</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28679</code><code>]&lt;/span&gt;</code></p><p><code>28680</code><code>&lt;/span&gt;</code></p><p><code>28681</code><code>&lt;/li&gt;</code></p><p><code>28682</code><code>&lt;li id="R1227"&gt;</code></p><p><code>28683</code><code>&lt;span class="citation"&gt;</code></p><p><code>28684</code><code>Verty ANA, McFarlane JR, McGregor IS, Mallet PE. Evidence for an interaction between CB&lt;sub&gt;</code></p><p><code>28685</code><code>1&lt;/sub&gt;</code></p><p><code>28686</code><code> cannabinoid and melanocortin NCR-4 receptors in regulating food intake. &lt;span&gt;</code></p><p><code>28687</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28688</code><code>Endocrinology. &lt;/span&gt;</code></p><p><code>28689</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>28690</code><code>145&lt;/span&gt;</code></p><p><code>28691</code><code>:3224–3231.&lt;/span&gt;</code></p><p><code>28692</code><code> [&lt;a href="/pubmed/15033920" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28693</code><code>PubMed&lt;/a&gt;</code></p><p><code>28694</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28695</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;amp;title=Evidence+for+an+interaction+between+CB1+cannabinoid+and+melanocortin+NCR-4+receptors+in+regulating+food+intake&amp;amp;author=ANA+Verty&amp;amp;author=JR+McFarlane&amp;amp;author=IS+McGregor&amp;amp;author=PE+Mallet&amp;amp;volume=145&amp;amp;publication_year=2004&amp;amp;pages=3224-3231&amp;amp;pmid=15033920&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28696</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28697</code><code>]&lt;/span&gt;</code></p><p><code>28698</code><code>&lt;/span&gt;</code></p><p><code>28699</code><code>&lt;/li&gt;</code></p><p><code>28700</code><code>&lt;li id="R1228"&gt;</code></p><p><code>28701</code><code>&lt;span class="citation"&gt;</code></p><p><code>28702</code><code>Verty ANA, Singh ME, McGregor IS, Mallet PE. The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine. &lt;span&gt;</code></p><p><code>28703</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28704</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>28705</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>28706</code><code>168&lt;/span&gt;</code></p><p><code>28707</code><code>:314–323.&lt;/span&gt;</code></p><p><code>28708</code><code> [&lt;a href="/pubmed/12700881" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28709</code><code>PubMed&lt;/a&gt;</code></p><p><code>28710</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28711</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=The+cannabinoid+receptor+antagonist+SR+141716+attenuates+overfeeding+induced+by+systemic+or+intracranial+morphine&amp;amp;author=ANA+Verty&amp;amp;author=ME+Singh&amp;amp;author=IS+McGregor&amp;amp;author=PE+Mallet&amp;amp;volume=168&amp;amp;publication_year=2003&amp;amp;pages=314-323&amp;amp;pmid=12700881&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28712</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28713</code><code>]&lt;/span&gt;</code></p><p><code>28714</code><code>&lt;/span&gt;</code></p><p><code>28715</code><code>&lt;/li&gt;</code></p><p><code>28716</code><code>&lt;li id="R1229"&gt;</code></p><p><code>28717</code><code>&lt;span class="citation"&gt;</code></p><p><code>28718</code><code>Vickers SP, Kennett GA. Cannabinoids and the regulation of ingestive behavior. &lt;span&gt;</code></p><p><code>28719</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28720</code><code>Curr Drug Targets. &lt;/span&gt;</code></p><p><code>28721</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>28722</code><code>6&lt;/span&gt;</code></p><p><code>28723</code><code>:215–223.&lt;/span&gt;</code></p><p><code>28724</code><code> [&lt;a href="/pubmed/15777191" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28725</code><code>PubMed&lt;/a&gt;</code></p><p><code>28726</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28727</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Curr+Drug+Targets&amp;amp;title=Cannabinoids+and+the+regulation+of+ingestive+behavior&amp;amp;author=SP+Vickers&amp;amp;author=GA+Kennett&amp;amp;volume=6&amp;amp;publication_year=2005&amp;amp;pages=215-223&amp;amp;pmid=15777191&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28728</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28729</code><code>]&lt;/span&gt;</code></p><p><code>28730</code><code>&lt;/span&gt;</code></p><p><code>28731</code><code>&lt;/li&gt;</code></p><p><code>28732</code><code>&lt;li id="R1230"&gt;</code></p><p><code>28733</code><code>&lt;span class="citation"&gt;</code></p><p><code>28734</code><code>Vickers SP, Webster LJ, Wyatt A, Dourish CT, Kennett GA. Preferential effects of the cannabinoid CB&lt;sub&gt;</code></p><p><code>28735</code><code>1&lt;/sub&gt;</code></p><p><code>28736</code><code> receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. &lt;span&gt;</code></p><p><code>28737</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28738</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>28739</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>28740</code><code>167&lt;/span&gt;</code></p><p><code>28741</code><code>:103–111.&lt;/span&gt;</code></p><p><code>28742</code><code> [&lt;a href="/pubmed/12632249" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28743</code><code>PubMed&lt;/a&gt;</code></p><p><code>28744</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28745</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Preferential+effects+of+the+cannabinoid+CB1+receptor+antagonist,+SR+141716,+on+food+intake+and+body+weight+gain+of+obese+(fa/fa)+compared+to+lean+Zucker+rats&amp;amp;author=SP+Vickers&amp;amp;author=LJ+Webster&amp;amp;author=A+Wyatt&amp;amp;author=CT+Dourish&amp;amp;author=GA+Kennett&amp;amp;volume=167&amp;amp;publication_year=2003&amp;amp;pages=103-111&amp;amp;pmid=12632249&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28746</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28747</code><code>]&lt;/span&gt;</code></p><p><code>28748</code><code>&lt;/span&gt;</code></p><p><code>28749</code><code>&lt;/li&gt;</code></p><p><code>28750</code><code>&lt;li id="R1231"&gt;</code></p><p><code>28751</code><code>&lt;span class="citation"&gt;</code></p><p><code>28752</code><code>Vidrio H, Sanchez-Salvatori MA, Medina M. Cardiovascular effects of (&amp;#x02212;)-11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl in rats. &lt;span&gt;</code></p><p><code>28753</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28754</code><code>J Cardiovasc Pharmacol. &lt;/span&gt;</code></p><p><code>28755</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>28756</code><code>28&lt;/span&gt;</code></p><p><code>28757</code><code>:332–336.&lt;/span&gt;</code></p><p><code>28758</code><code> [&lt;a href="/pubmed/8856492" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28759</code><code>PubMed&lt;/a&gt;</code></p><p><code>28760</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28761</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Cardiovasc+Pharmacol&amp;amp;title=Cardiovascular+effects+of+(&amp;#x02212;)-11-OH-delta+8-tetrahydrocannabinol-dimethylheptyl+in+rats&amp;amp;author=H+Vidrio&amp;amp;author=MA+Sanchez-Salvatori&amp;amp;author=M+Medina&amp;amp;volume=28&amp;amp;publication_year=1996&amp;amp;pages=332-336&amp;amp;pmid=8856492&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28762</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28763</code><code>]&lt;/span&gt;</code></p><p><code>28764</code><code>&lt;/span&gt;</code></p><p><code>28765</code><code>&lt;/li&gt;</code></p><p><code>28766</code><code>&lt;li id="R1232"&gt;</code></p><p><code>28767</code><code>&lt;span class="citation"&gt;</code></p><p><code>28768</code><code>Vigano D, Rubino T, Parolaro D. Molecular and cellular basis of cannabinoid and opioid interactions. &lt;span&gt;</code></p><p><code>28769</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28770</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>28771</code><code>2005a;&lt;span class="ref-vol"&gt;</code></p><p><code>28772</code><code>81&lt;/span&gt;</code></p><p><code>28773</code><code>:360–368.&lt;/span&gt;</code></p><p><code>28774</code><code> [&lt;a href="/pubmed/15927245" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28775</code><code>PubMed&lt;/a&gt;</code></p><p><code>28776</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28777</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Molecular+and+cellular+basis+of+cannabinoid+and+opioid+interactions&amp;amp;author=D+Vigano&amp;amp;author=T+Rubino&amp;amp;author=D+Parolaro&amp;amp;volume=81&amp;amp;publication_year=2005a&amp;amp;pages=360-368&amp;amp;pmid=15927245&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28778</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28779</code><code>]&lt;/span&gt;</code></p><p><code>28780</code><code>&lt;/span&gt;</code></p><p><code>28781</code><code>&lt;/li&gt;</code></p><p><code>28782</code><code>&lt;li id="R1233"&gt;</code></p><p><code>28783</code><code>&lt;span class="citation"&gt;</code></p><p><code>28784</code><code>Vigano D, Rubino T, Vaccani A, Bianchessi S, Marmorato P, Castiglioni C, Parolaro D. Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems. &lt;span&gt;</code></p><p><code>28785</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28786</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>28787</code><code>2005b;&lt;span class="ref-vol"&gt;</code></p><p><code>28788</code><code>182&lt;/span&gt;</code></p><p><code>28789</code><code>:527–536.&lt;/span&gt;</code></p><p><code>28790</code><code> [&lt;a href="/pubmed/16079992" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28791</code><code>PubMed&lt;/a&gt;</code></p><p><code>28792</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28793</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Molecular+mechanisms+involved+in+the+asymmetric+interaction+between+cannabinoid+and+opioid+systems&amp;amp;author=D+Vigano&amp;amp;author=T+Rubino&amp;amp;author=A+Vaccani&amp;amp;author=S+Bianchessi&amp;amp;author=P+Marmorato&amp;amp;volume=182&amp;amp;publication_year=2005b&amp;amp;pages=527-536&amp;amp;pmid=16079992&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28794</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28795</code><code>]&lt;/span&gt;</code></p><p><code>28796</code><code>&lt;/span&gt;</code></p><p><code>28797</code><code>&lt;/li&gt;</code></p><p><code>28798</code><code>&lt;li id="R1234"&gt;</code></p><p><code>28799</code><code>&lt;span class="citation"&gt;</code></p><p><code>28800</code><code>Vinod KY, Hungund BL. Endocannabinoid lipids and mediated system: Implications for alcoholism and neuropsychiatric disorders. &lt;span&gt;</code></p><p><code>28801</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28802</code><code>Life Sci. &lt;/span&gt;</code></p><p><code>28803</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>28804</code><code>77&lt;/span&gt;</code></p><p><code>28805</code><code>:1569–1583.&lt;/span&gt;</code></p><p><code>28806</code><code> [&lt;a href="/pubmed/16005471" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28807</code><code>PubMed&lt;/a&gt;</code></p><p><code>28808</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28809</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Life+Sci&amp;amp;title=Endocannabinoid+lipids+and+mediated+system:+Implications+for+alcoholism+and+neuropsychiatric+disorders&amp;amp;author=KY+Vinod&amp;amp;author=BL+Hungund&amp;amp;volume=77&amp;amp;publication_year=2005&amp;amp;pages=1569-1583&amp;amp;pmid=16005471&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28810</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28811</code><code>]&lt;/span&gt;</code></p><p><code>28812</code><code>&lt;/span&gt;</code></p><p><code>28813</code><code>&lt;/li&gt;</code></p><p><code>28814</code><code>&lt;li id="R1235"&gt;</code></p><p><code>28815</code><code>&lt;span class="citation"&gt;</code></p><p><code>28816</code><code>Viveros MP, Marco EM, File SE. Endocannabinoid system and stress and anxiety responses. &lt;span&gt;</code></p><p><code>28817</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28818</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>28819</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>28820</code><code>81&lt;/span&gt;</code></p><p><code>28821</code><code>:331–342.&lt;/span&gt;</code></p><p><code>28822</code><code> [&lt;a href="/pubmed/15927244" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28823</code><code>PubMed&lt;/a&gt;</code></p><p><code>28824</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28825</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Endocannabinoid+system+and+stress+and+anxiety+responses&amp;amp;author=MP+Viveros&amp;amp;author=EM+Marco&amp;amp;author=SE+File&amp;amp;volume=81&amp;amp;publication_year=2005&amp;amp;pages=331-342&amp;amp;pmid=15927244&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28826</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28827</code><code>]&lt;/span&gt;</code></p><p><code>28828</code><code>&lt;/span&gt;</code></p><p><code>28829</code><code>&lt;/li&gt;</code></p><p><code>28830</code><code>&lt;li id="R1236"&gt;</code></p><p><code>28831</code><code>&lt;span class="citation"&gt;</code></p><p><code>28832</code><code>Vizi ES, Katona I, Freund TF. Evidence for presynaptic cannabinoid CB&lt;sub&gt;</code></p><p><code>28833</code><code>1&lt;/sub&gt;</code></p><p><code>28834</code><code> receptor-mediated inhibition of noradrenaline release in the guinea pig lung. &lt;span&gt;</code></p><p><code>28835</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28836</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>28837</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>28838</code><code>431&lt;/span&gt;</code></p><p><code>28839</code><code>:237–244.&lt;/span&gt;</code></p><p><code>28840</code><code> [&lt;a href="/pubmed/11728431" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28841</code><code>PubMed&lt;/a&gt;</code></p><p><code>28842</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28843</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Evidence+for+presynaptic+cannabinoid+CB1+receptor-mediated+inhibition+of+noradrenaline+release+in+the+guinea+pig+lung&amp;amp;author=ES+Vizi&amp;amp;author=I+Katona&amp;amp;author=TF+Freund&amp;amp;volume=431&amp;amp;publication_year=2001&amp;amp;pages=237-244&amp;amp;pmid=11728431&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28844</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28845</code><code>]&lt;/span&gt;</code></p><p><code>28846</code><code>&lt;/span&gt;</code></p><p><code>28847</code><code>&lt;/li&gt;</code></p><p><code>28848</code><code>&lt;li id="R1237"&gt;</code></p><p><code>28849</code><code>&lt;span class="citation"&gt;</code></p><p><code>28850</code><code>Vlachou S, Nomikos GG, Panagis G. WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation. &lt;span&gt;</code></p><p><code>28851</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28852</code><code>Behav Brain Res. &lt;/span&gt;</code></p><p><code>28853</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>28854</code><code>141&lt;/span&gt;</code></p><p><code>28855</code><code>:215–222.&lt;/span&gt;</code></p><p><code>28856</code><code> [&lt;a href="/pubmed/12742258" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28857</code><code>PubMed&lt;/a&gt;</code></p><p><code>28858</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28859</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Behav+Brain+Res&amp;amp;title=WIN+55,212-2+decreases+the+reinforcing+actions+of+cocaine+through+CB1+cannabinoid+receptor+stimulation&amp;amp;author=S+Vlachou&amp;amp;author=GG+Nomikos&amp;amp;author=G+Panagis&amp;amp;volume=141&amp;amp;publication_year=2003&amp;amp;pages=215-222&amp;amp;pmid=12742258&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28860</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28861</code><code>]&lt;/span&gt;</code></p><p><code>28862</code><code>&lt;/span&gt;</code></p><p><code>28863</code><code>&lt;/li&gt;</code></p><p><code>28864</code><code>&lt;li id="R1238"&gt;</code></p><p><code>28865</code><code>&lt;span class="citation"&gt;</code></p><p><code>28866</code><code>Volicer L, Stelly M, Morris J, McLaughlin J, Volicer BJ. Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>28867</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28868</code><code>J Geriat Psychiatry. &lt;/span&gt;</code></p><p><code>28869</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>28870</code><code>12&lt;/span&gt;</code></p><p><code>28871</code><code>:913–919.&lt;/span&gt;</code></p><p><code>28872</code><code> [&lt;a href="/pubmed/9309469" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28873</code><code>PubMed&lt;/a&gt;</code></p><p><code>28874</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28875</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Geriat+Psychiatry&amp;amp;title=Effects+of+dronabinol+on+anorexia+and+disturbed+behavior+in+patients+with+Alzheimer&amp;#x02019;s+disease&amp;amp;author=L+Volicer&amp;amp;author=M+Stelly&amp;amp;author=J+Morris&amp;amp;author=J+McLaughlin&amp;amp;author=BJ+Volicer&amp;amp;volume=12&amp;amp;publication_year=1997&amp;amp;pages=913-919&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28876</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28877</code><code>]&lt;/span&gt;</code></p><p><code>28878</code><code>&lt;/span&gt;</code></p><p><code>28879</code><code>&lt;/li&gt;</code></p><p><code>28880</code><code>&lt;li id="R1239"&gt;</code></p><p><code>28881</code><code>&lt;span class="citation"&gt;</code></p><p><code>28882</code><code>Volkow ND, Wang G-J, Fowler JS, Logan J, Gatley SJ, Gifford A, Hitzemann R, Ding YS, Pappas N. Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D&lt;sub&gt;</code></p><p><code>28883</code><code>2&lt;/sub&gt;</code></p><p><code>28884</code><code> receptor levels. &lt;span&gt;</code></p><p><code>28885</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28886</code><code>Am J Psychiatry. &lt;/span&gt;</code></p><p><code>28887</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>28888</code><code>156&lt;/span&gt;</code></p><p><code>28889</code><code>:1440–1443.&lt;/span&gt;</code></p><p><code>28890</code><code> [&lt;a href="/pubmed/10484959" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28891</code><code>PubMed&lt;/a&gt;</code></p><p><code>28892</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28893</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Psychiatry&amp;amp;title=Prediction+of+reinforcing+responses+to+psychostimulants+in+humans+by+brain+dopamine+D2+receptor+levels&amp;amp;author=ND+Volkow&amp;amp;author=G-J+Wang&amp;amp;author=JS+Fowler&amp;amp;author=J+Logan&amp;amp;author=SJ+Gatley&amp;amp;volume=156&amp;amp;publication_year=1999&amp;amp;pages=1440-1443&amp;amp;pmid=10484959&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28894</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28895</code><code>]&lt;/span&gt;</code></p><p><code>28896</code><code>&lt;/span&gt;</code></p><p><code>28897</code><code>&lt;/li&gt;</code></p><p><code>28898</code><code>&lt;li id="R1240"&gt;</code></p><p><code>28899</code><code>&lt;span class="citation"&gt;</code></p><p><code>28900</code><code>Volkow ND, Wang G-J, Fowler JS, Logan J, Gatley SJ, Hitzemann R, Chen AD, Dewey SL, Pappas N. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. &lt;span&gt;</code></p><p><code>28901</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28902</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>28903</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>28904</code><code>386&lt;/span&gt;</code></p><p><code>28905</code><code>:830–833.&lt;/span&gt;</code></p><p><code>28906</code><code> [&lt;a href="/pubmed/9126741" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28907</code><code>PubMed&lt;/a&gt;</code></p><p><code>28908</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28909</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Decreased+striatal+dopaminergic+responsiveness+in+detoxified+cocaine-dependent+subjects&amp;amp;author=ND+Volkow&amp;amp;author=G-J+Wang&amp;amp;author=JS+Fowler&amp;amp;author=J+Logan&amp;amp;author=SJ+Gatley&amp;amp;volume=386&amp;amp;publication_year=1997&amp;amp;pages=830-833&amp;amp;pmid=9126741&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28910</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28911</code><code>]&lt;/span&gt;</code></p><p><code>28912</code><code>&lt;/span&gt;</code></p><p><code>28913</code><code>&lt;/li&gt;</code></p><p><code>28914</code><code>&lt;li id="R1241"&gt;</code></p><p><code>28915</code><code>&lt;span class="citation"&gt;</code></p><p><code>28916</code><code>Voruganti LN, Slomka P, Zabel P, Mattar A, Awad AG. Cannabis induced dopamine release: an in-vivo SPECT study. &lt;span&gt;</code></p><p><code>28917</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28918</code><code>Psychiatry Res. &lt;/span&gt;</code></p><p><code>28919</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>28920</code><code>107&lt;/span&gt;</code></p><p><code>28921</code><code>:173–177.&lt;/span&gt;</code></p><p><code>28922</code><code> [&lt;a href="/pubmed/11566433" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28923</code><code>PubMed&lt;/a&gt;</code></p><p><code>28924</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28925</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychiatry+Res&amp;amp;title=Cannabis+induced+dopamine+release:+an+in-vivo+SPECT+study&amp;amp;author=LN+Voruganti&amp;amp;author=P+Slomka&amp;amp;author=P+Zabel&amp;amp;author=A+Mattar&amp;amp;author=AG+Awad&amp;amp;volume=107&amp;amp;publication_year=2001&amp;amp;pages=173-177&amp;amp;pmid=11566433&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28926</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28927</code><code>]&lt;/span&gt;</code></p><p><code>28928</code><code>&lt;/span&gt;</code></p><p><code>28929</code><code>&lt;/li&gt;</code></p><p><code>28930</code><code>&lt;li id="R1242"&gt;</code></p><p><code>28931</code><code>&lt;span class="citation"&gt;</code></p><p><code>28932</code><code>Wada JA, Osawa T, Corcoran ME. Effects of tetrahydrocannabinols on kindled amygdaloid seizures and photogenic seizures in Senegalese baboons, &lt;em&gt;</code></p><p><code>28933</code><code>Papio papio&lt;/em&gt;</code></p><p><code>28934</code><code>. &lt;span&gt;</code></p><p><code>28935</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28936</code><code>Epilepsia. &lt;/span&gt;</code></p><p><code>28937</code><code>1975a;&lt;span class="ref-vol"&gt;</code></p><p><code>28938</code><code>16&lt;/span&gt;</code></p><p><code>28939</code><code>:439–448.&lt;/span&gt;</code></p><p><code>28940</code><code> [&lt;a href="/pubmed/810346" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28941</code><code>PubMed&lt;/a&gt;</code></p><p><code>28942</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28943</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Epilepsia&amp;amp;title=Effects+of+tetrahydrocannabinols+on+kindled+amygdaloid+seizures+and+photogenic+seizures+in+Senegalese+baboons,+Papio+papio&amp;amp;author=JA+Wada&amp;amp;author=T+Osawa&amp;amp;author=ME+Corcoran&amp;amp;volume=16&amp;amp;publication_year=1975a&amp;amp;pages=439-448&amp;amp;pmid=810346&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28944</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28945</code><code>]&lt;/span&gt;</code></p><p><code>28946</code><code>&lt;/span&gt;</code></p><p><code>28947</code><code>&lt;/li&gt;</code></p><p><code>28948</code><code>&lt;li id="R1243"&gt;</code></p><p><code>28949</code><code>&lt;span class="citation"&gt;</code></p><p><code>28950</code><code>Wada JA, Wake A, Sato M, Corcoran ME. Antiepileptic and prophylactic effects of tetrahydrocannabinols in amygdaloid kindled cats. &lt;span&gt;</code></p><p><code>28951</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28952</code><code>Epilepsia. &lt;/span&gt;</code></p><p><code>28953</code><code>1975b;&lt;span class="ref-vol"&gt;</code></p><p><code>28954</code><code>16&lt;/span&gt;</code></p><p><code>28955</code><code>:503–510.&lt;/span&gt;</code></p><p><code>28956</code><code> [&lt;a href="/pubmed/1183427" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28957</code><code>PubMed&lt;/a&gt;</code></p><p><code>28958</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28959</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Epilepsia&amp;amp;title=Antiepileptic+and+prophylactic+effects+of+tetrahydrocannabinols+in+amygdaloid+kindled+cats&amp;amp;author=JA+Wada&amp;amp;author=A+Wake&amp;amp;author=M+Sato&amp;amp;author=ME+Corcoran&amp;amp;volume=16&amp;amp;publication_year=1975b&amp;amp;pages=503-510&amp;amp;pmid=1183427&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28960</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28961</code><code>]&lt;/span&gt;</code></p><p><code>28962</code><code>&lt;/span&gt;</code></p><p><code>28963</code><code>&lt;/li&gt;</code></p><p><code>28964</code><code>&lt;li id="R1244"&gt;</code></p><p><code>28965</code><code>&lt;span class="citation"&gt;</code></p><p><code>28966</code><code>Wade DT, Makela P, Robson P, House H, Bateman C. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. &lt;span&gt;</code></p><p><code>28967</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28968</code><code>Mult Scler. &lt;/span&gt;</code></p><p><code>28969</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>28970</code><code>10&lt;/span&gt;</code></p><p><code>28971</code><code>:434–441.&lt;/span&gt;</code></p><p><code>28972</code><code> [&lt;a href="/pubmed/15327042" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28973</code><code>PubMed&lt;/a&gt;</code></p><p><code>28974</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28975</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mult+Scler&amp;amp;title=Do+cannabis-based+medicinal+extracts+have+general+or+specific+effects+on+symptoms+in+multiple+sclerosis?+A+double-blind,+randomized,+placebo-controlled+study+on+160+patients&amp;amp;author=DT+Wade&amp;amp;author=P+Makela&amp;amp;author=P+Robson&amp;amp;author=H+House&amp;amp;author=C+Bateman&amp;amp;volume=10&amp;amp;publication_year=2004&amp;amp;pages=434-441&amp;amp;pmid=15327042&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28976</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28977</code><code>]&lt;/span&gt;</code></p><p><code>28978</code><code>&lt;/span&gt;</code></p><p><code>28979</code><code>&lt;/li&gt;</code></p><p><code>28980</code><code>&lt;li id="R1245"&gt;</code></p><p><code>28981</code><code>&lt;span class="citation"&gt;</code></p><p><code>28982</code><code>Wade DT, Robson P, House H, Makela P, Aram J. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. &lt;span&gt;</code></p><p><code>28983</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>28984</code><code>Clin Rehabil. &lt;/span&gt;</code></p><p><code>28985</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>28986</code><code>17&lt;/span&gt;</code></p><p><code>28987</code><code>:21–29.&lt;/span&gt;</code></p><p><code>28988</code><code> [&lt;a href="/pubmed/12617376" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>28989</code><code>PubMed&lt;/a&gt;</code></p><p><code>28990</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>28991</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Clin+Rehabil&amp;amp;title=A+preliminary+controlled+study+to+determine+whether+whole-plant+cannabis+extracts+can+improve+intractable+neurogenic+symptoms&amp;amp;author=DT+Wade&amp;amp;author=P+Robson&amp;amp;author=H+House&amp;amp;author=P+Makela&amp;amp;author=J+Aram&amp;amp;volume=17&amp;amp;publication_year=2003&amp;amp;pages=21-29&amp;amp;pmid=12617376&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>28992</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>28993</code><code>]&lt;/span&gt;</code></p><p><code>28994</code><code>&lt;/span&gt;</code></p><p><code>28995</code><code>&lt;/li&gt;</code></p><p><code>28996</code><code>&lt;li id="R1246"&gt;</code></p><p><code>28997</code><code>&lt;span class="citation"&gt;</code></p><p><code>28998</code><code>Wagner JA, Abesser M, Karcher J, Laser M, Kunos G. Coronary vasodilator effects of endogenous cannabinoids in vasopressin-preconstricted unpaced rat isolated hearts. &lt;span&gt;</code></p><p><code>28999</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29000</code><code>J Cardiovasc Pharmacol. &lt;/span&gt;</code></p><p><code>29001</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>29002</code><code>46&lt;/span&gt;</code></p><p><code>29003</code><code>:348–355.&lt;/span&gt;</code></p><p><code>29004</code><code> [&lt;a href="/pubmed/16116341" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29005</code><code>PubMed&lt;/a&gt;</code></p><p><code>29006</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29007</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Cardiovasc+Pharmacol&amp;amp;title=Coronary+vasodilator+effects+of+endogenous+cannabinoids+in+vasopressin-preconstricted+unpaced+rat+isolated+hearts&amp;amp;author=JA+Wagner&amp;amp;author=M+Abesser&amp;amp;author=J+Karcher&amp;amp;author=M+Laser&amp;amp;author=G+Kunos&amp;amp;volume=46&amp;amp;publication_year=2005&amp;amp;pages=348-355&amp;amp;pmid=16116341&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29008</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29009</code><code>]&lt;/span&gt;</code></p><p><code>29010</code><code>&lt;/span&gt;</code></p><p><code>29011</code><code>&lt;/li&gt;</code></p><p><code>29012</code><code>&lt;li id="R1247"&gt;</code></p><p><code>29013</code><code>&lt;span class="citation"&gt;</code></p><p><code>29014</code><code>Wagner JA, Hu K, Bauersachs J, Karcher J, Wiesler M, Goparaju SK, Kunos G, Ertl G. Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. &lt;span&gt;</code></p><p><code>29015</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29016</code><code>J Am Coll Cardiol. &lt;/span&gt;</code></p><p><code>29017</code><code>2001a;&lt;span class="ref-vol"&gt;</code></p><p><code>29018</code><code>38&lt;/span&gt;</code></p><p><code>29019</code><code>:2048–2054.&lt;/span&gt;</code></p><p><code>29020</code><code> [&lt;a href="/pubmed/11738314" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29021</code><code>PubMed&lt;/a&gt;</code></p><p><code>29022</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29023</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Coll+Cardiol&amp;amp;title=Endogenous+cannabinoids+mediate+hypotension+after+experimental+myocardial+infarction&amp;amp;author=JA+Wagner&amp;amp;author=K+Hu&amp;amp;author=J+Bauersachs&amp;amp;author=J+Karcher&amp;amp;author=M+Wiesler&amp;amp;volume=38&amp;amp;publication_year=2001a&amp;amp;pages=2048-2054&amp;amp;pmid=11738314&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29024</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29025</code><code>]&lt;/span&gt;</code></p><p><code>29026</code><code>&lt;/span&gt;</code></p><p><code>29027</code><code>&lt;/li&gt;</code></p><p><code>29028</code><code>&lt;li id="R1248"&gt;</code></p><p><code>29029</code><code>&lt;span class="citation"&gt;</code></p><p><code>29030</code><code>Wagner JA, Hu K, Karcher J, Bauersachs J, Schafer A, Laser M, Han H, Ertl G. CB&lt;sub&gt;</code></p><p><code>29031</code><code>1&lt;/sub&gt;</code></p><p><code>29032</code><code> cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction. &lt;span&gt;</code></p><p><code>29033</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29034</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>29035</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>29036</code><code>138&lt;/span&gt;</code></p><p><code>29037</code><code>:1251–1258.&lt;/span&gt;</code></p><p><code>29038</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>29039</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1573770/"&gt;</code></p><p><code>29040</code><code>PMC free article&lt;/a&gt;</code></p><p><code>29041</code><code>]&lt;/span&gt;</code></p><p><code>29042</code><code> [&lt;a href="/pubmed/12711625" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29043</code><code>PubMed&lt;/a&gt;</code></p><p><code>29044</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29045</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=CB1+cannabinoid+receptor+antagonism+promotes+remodeling+and+cannabinoid+treatment+prevents+endothelial+dysfunction+and+hypotension+in+rats+with+myocardial+infarction&amp;amp;author=JA+Wagner&amp;amp;author=K+Hu&amp;amp;author=J+Karcher&amp;amp;author=J+Bauersachs&amp;amp;author=A+Schafer&amp;amp;volume=138&amp;amp;publication_year=2003&amp;amp;pages=1251-1258&amp;amp;pmid=12711625&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29046</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29047</code><code>]&lt;/span&gt;</code></p><p><code>29048</code><code>&lt;/span&gt;</code></p><p><code>29049</code><code>&lt;/li&gt;</code></p><p><code>29050</code><code>&lt;li id="R1249"&gt;</code></p><p><code>29051</code><code>&lt;span class="citation"&gt;</code></p><p><code>29052</code><code>Wagner JA, J&amp;#x000e1;rai Z, B&amp;#x000e1;tkai S, Kunos G. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB&lt;sub&gt;</code></p><p><code>29053</code><code>1&lt;/sub&gt;</code></p><p><code>29054</code><code> receptors. &lt;span&gt;</code></p><p><code>29055</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29056</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>29057</code><code>2001b;&lt;span class="ref-vol"&gt;</code></p><p><code>29058</code><code>423&lt;/span&gt;</code></p><p><code>29059</code><code>:203–210.&lt;/span&gt;</code></p><p><code>29060</code><code> [&lt;a href="/pubmed/11448486" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29061</code><code>PubMed&lt;/a&gt;</code></p><p><code>29062</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29063</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Hemodynamic+effects+of+cannabinoids:+coronary+and+cerebral+vasodilation+mediated+by+cannabinoid+CB1+receptors&amp;amp;author=JA+Wagner&amp;amp;author=Z+J&amp;#x000e1;rai&amp;amp;author=S+B&amp;#x000e1;tkai&amp;amp;author=G+Kunos&amp;amp;volume=423&amp;amp;publication_year=2001b&amp;amp;pages=203-210&amp;amp;pmid=11448486&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29064</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29065</code><code>]&lt;/span&gt;</code></p><p><code>29066</code><code>&lt;/span&gt;</code></p><p><code>29067</code><code>&lt;/li&gt;</code></p><p><code>29068</code><code>&lt;li id="R1250"&gt;</code></p><p><code>29069</code><code>&lt;span class="citation"&gt;</code></p><p><code>29070</code><code>Wagner JA, Varga K, Ellis EF, Rzigalinski BA, Martin BR, Kunos G. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. &lt;span&gt;</code></p><p><code>29071</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29072</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>29073</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>29074</code><code>390&lt;/span&gt;</code></p><p><code>29075</code><code>:518–521.&lt;/span&gt;</code></p><p><code>29076</code><code> [&lt;a href="/pubmed/9394002" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29077</code><code>PubMed&lt;/a&gt;</code></p><p><code>29078</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29079</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Activation+of+peripheral+CB1+cannabinoid+receptors+in+haemorrhagic+shock&amp;amp;author=JA+Wagner&amp;amp;author=K+Varga&amp;amp;author=EF+Ellis&amp;amp;author=BA+Rzigalinski&amp;amp;author=BR+Martin&amp;amp;volume=390&amp;amp;publication_year=1997&amp;amp;pages=518-521&amp;amp;pmid=9394002&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29080</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29081</code><code>]&lt;/span&gt;</code></p><p><code>29082</code><code>&lt;/span&gt;</code></p><p><code>29083</code><code>&lt;/li&gt;</code></p><p><code>29084</code><code>&lt;li id="R1251"&gt;</code></p><p><code>29085</code><code>&lt;span class="citation"&gt;</code></p><p><code>29086</code><code>Wagner JA, Varga K, J&amp;#x000e1;rai Z, Kunos G. Mesenteric vasodilation mediated by endothelial anandamide receptors. &lt;span&gt;</code></p><p><code>29087</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29088</code><code>Hypertension. &lt;/span&gt;</code></p><p><code>29089</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>29090</code><code>33&lt;/span&gt;</code></p><p><code>29091</code><code>:429–434.&lt;/span&gt;</code></p><p><code>29092</code><code> [&lt;a href="/pubmed/9931142" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29093</code><code>PubMed&lt;/a&gt;</code></p><p><code>29094</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29095</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;amp;title=Mesenteric+vasodilation+mediated+by+endothelial+anandamide+receptors&amp;amp;author=JA+Wagner&amp;amp;author=K+Varga&amp;amp;author=Z+J&amp;#x000e1;rai&amp;amp;author=G+Kunos&amp;amp;volume=33&amp;amp;publication_year=1999&amp;amp;pages=429-434&amp;amp;pmid=9931142&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29096</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29097</code><code>]&lt;/span&gt;</code></p><p><code>29098</code><code>&lt;/span&gt;</code></p><p><code>29099</code><code>&lt;/li&gt;</code></p><p><code>29100</code><code>&lt;li id="R1252"&gt;</code></p><p><code>29101</code><code>&lt;span class="citation"&gt;</code></p><p><code>29102</code><code>Wahn H, Wolf J, Kram F, Frantz S, Wagner JA. The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs. &lt;span&gt;</code></p><p><code>29103</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29104</code><code>Am J Physiol. &lt;/span&gt;</code></p><p><code>29105</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>29106</code><code>289&lt;/span&gt;</code></p><p><code>29107</code><code>:H2491–H2496.&lt;/span&gt;</code></p><p><code>29108</code><code> [&lt;a href="/pubmed/16055511" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29109</code><code>PubMed&lt;/a&gt;</code></p><p><code>29110</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29111</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol&amp;amp;title=The+endocannabinoid+arachidonyl+ethanolamide+(anandamide)+increases+pulmonary+arterial+pressure+via+cyclooxygenase-2+products+in+isolated+rabbit+lungs&amp;amp;author=H+Wahn&amp;amp;author=J+Wolf&amp;amp;author=F+Kram&amp;amp;author=S+Frantz&amp;amp;author=JA+Wagner&amp;amp;volume=289&amp;amp;publication_year=2005&amp;amp;pages=H2491-H2496&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29112</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29113</code><code>]&lt;/span&gt;</code></p><p><code>29114</code><code>&lt;/span&gt;</code></p><p><code>29115</code><code>&lt;/li&gt;</code></p><p><code>29116</code><code>&lt;li id="R1253"&gt;</code></p><p><code>29117</code><code>&lt;span class="citation"&gt;</code></p><p><code>29118</code><code>Waksman Y, Olson JM, Carlisle SJ, Cabral GA. The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. &lt;span&gt;</code></p><p><code>29119</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29120</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>29121</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>29122</code><code>288&lt;/span&gt;</code></p><p><code>29123</code><code>:1357–1366.&lt;/span&gt;</code></p><p><code>29124</code><code> [&lt;a href="/pubmed/10027878" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29125</code><code>PubMed&lt;/a&gt;</code></p><p><code>29126</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29127</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=The+central+cannabinoid+receptor+(CB1)+mediates+inhibition+of+nitric+oxide+production+by+rat+microglial+cells&amp;amp;author=Y+Waksman&amp;amp;author=JM+Olson&amp;amp;author=SJ+Carlisle&amp;amp;author=GA+Cabral&amp;amp;volume=288&amp;amp;publication_year=1999&amp;amp;pages=1357-1366&amp;amp;pmid=10027878&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29128</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29129</code><code>]&lt;/span&gt;</code></p><p><code>29130</code><code>&lt;/span&gt;</code></p><p><code>29131</code><code>&lt;/li&gt;</code></p><p><code>29132</code><code>&lt;li id="R1254"&gt;</code></p><p><code>29133</code><code>&lt;span class="citation"&gt;</code></p><p><code>29134</code><code>Walker JM, Huang SM. Cannabinoid analgesia. &lt;span&gt;</code></p><p><code>29135</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29136</code><code>Pharmacol Ther. &lt;/span&gt;</code></p><p><code>29137</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>29138</code><code>95&lt;/span&gt;</code></p><p><code>29139</code><code>:127–135.&lt;/span&gt;</code></p><p><code>29140</code><code> [&lt;a href="/pubmed/12182960" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29141</code><code>PubMed&lt;/a&gt;</code></p><p><code>29142</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29143</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Ther&amp;amp;title=Cannabinoid+analgesia&amp;amp;author=JM+Walker&amp;amp;author=SM+Huang&amp;amp;volume=95&amp;amp;publication_year=2002&amp;amp;pages=127-135&amp;amp;pmid=12182960&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29144</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29145</code><code>]&lt;/span&gt;</code></p><p><code>29146</code><code>&lt;/span&gt;</code></p><p><code>29147</code><code>&lt;/li&gt;</code></p><p><code>29148</code><code>&lt;li id="R1255"&gt;</code></p><p><code>29149</code><code>&lt;span class="citation"&gt;</code></p><p><code>29150</code><code>Walker JM, Huang SM, Strangman NM, Sa&amp;#x000f1;udo-Pe&amp;#x000f1;a MC. Identification of the role of endogenous cannabinoids in pain modulation: strategies and pitfalls. &lt;span&gt;</code></p><p><code>29151</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29152</code><code>J Pain. &lt;/span&gt;</code></p><p><code>29153</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>29154</code><code>1&lt;/span&gt;</code></p><p><code>29155</code><code>:20–32.&lt;/span&gt;</code></p><p><code>29156</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>29157</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pain&amp;amp;title=Identification+of+the+role+of+endogenous+cannabinoids+in+pain+modulation:+strategies+and+pitfalls&amp;amp;author=JM+Walker&amp;amp;author=SM+Huang&amp;amp;author=NM+Strangman&amp;amp;author=MC+Sa&amp;#x000f1;udo-Pe&amp;#x000f1;a&amp;amp;volume=1&amp;amp;publication_year=2000&amp;amp;pages=20-32&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29158</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29159</code><code>]&lt;/span&gt;</code></p><p><code>29160</code><code>&lt;/span&gt;</code></p><p><code>29161</code><code>&lt;/li&gt;</code></p><p><code>29162</code><code>&lt;li id="R1256"&gt;</code></p><p><code>29163</code><code>&lt;span class="citation"&gt;</code></p><p><code>29164</code><code>Walker JM, Huang SM, Strangman NM, Tsou K, Sa&amp;#x000f1;udo-Pe&amp;#x000f1;a MC. Pain modulation by release of the endogenous cannabinoid anandamide. &lt;span&gt;</code></p><p><code>29165</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29166</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>29167</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>29168</code><code>96&lt;/span&gt;</code></p><p><code>29169</code><code>:12198–12203.&lt;/span&gt;</code></p><p><code>29170</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>29171</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC18435/"&gt;</code></p><p><code>29172</code><code>PMC free article&lt;/a&gt;</code></p><p><code>29173</code><code>]&lt;/span&gt;</code></p><p><code>29174</code><code> [&lt;a href="/pubmed/10518599" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29175</code><code>PubMed&lt;/a&gt;</code></p><p><code>29176</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29177</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Pain+modulation+by+release+of+the+endogenous+cannabinoid+anandamide&amp;amp;author=JM+Walker&amp;amp;author=SM+Huang&amp;amp;author=NM+Strangman&amp;amp;author=K+Tsou&amp;amp;author=MC+Sa&amp;#x000f1;udo-Pe&amp;#x000f1;a&amp;amp;volume=96&amp;amp;publication_year=1999&amp;amp;pages=12198-12203&amp;amp;pmid=10518599&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29178</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29179</code><code>]&lt;/span&gt;</code></p><p><code>29180</code><code>&lt;/span&gt;</code></p><p><code>29181</code><code>&lt;/li&gt;</code></p><p><code>29182</code><code>&lt;li id="R1257"&gt;</code></p><p><code>29183</code><code>&lt;span class="citation"&gt;</code></p><p><code>29184</code><code>Walker JM, Krey JF, Chu CJ, Huang SM. Endocannabinoids and related fatty acid derivatives in pain modulation. &lt;span&gt;</code></p><p><code>29185</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29186</code><code>Chem Phys Lipids. &lt;/span&gt;</code></p><p><code>29187</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>29188</code><code>121&lt;/span&gt;</code></p><p><code>29189</code><code>:159–172.&lt;/span&gt;</code></p><p><code>29190</code><code> [&lt;a href="/pubmed/12505698" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29191</code><code>PubMed&lt;/a&gt;</code></p><p><code>29192</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29193</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Chem+Phys+Lipids&amp;amp;title=Endocannabinoids+and+related+fatty+acid+derivatives+in+pain+modulation&amp;amp;author=JM+Walker&amp;amp;author=JF+Krey&amp;amp;author=CJ+Chu&amp;amp;author=SM+Huang&amp;amp;volume=121&amp;amp;publication_year=2002&amp;amp;pages=159-172&amp;amp;pmid=12505698&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29194</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29195</code><code>]&lt;/span&gt;</code></p><p><code>29196</code><code>&lt;/span&gt;</code></p><p><code>29197</code><code>&lt;/li&gt;</code></p><p><code>29198</code><code>&lt;li id="R1258"&gt;</code></p><p><code>29199</code><code>&lt;span class="citation"&gt;</code></p><p><code>29200</code><code>Wallace MJ, Blair RE, Falenski KW, Martin BR, DeLorenzo RJ. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. &lt;span&gt;</code></p><p><code>29201</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29202</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>29203</code><code>2003a;&lt;span class="ref-vol"&gt;</code></p><p><code>29204</code><code>307&lt;/span&gt;</code></p><p><code>29205</code><code>:129–137.&lt;/span&gt;</code></p><p><code>29206</code><code> [&lt;a href="/pubmed/12954810" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29207</code><code>PubMed&lt;/a&gt;</code></p><p><code>29208</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29209</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=The+endogenous+cannabinoid+system+regulates+seizure+frequency+and+duration+in+a+model+of+temporal+lobe+epilepsy&amp;amp;author=MJ+Wallace&amp;amp;author=RE+Blair&amp;amp;author=KW+Falenski&amp;amp;author=BR+Martin&amp;amp;author=RJ+DeLorenzo&amp;amp;volume=307&amp;amp;publication_year=2003a&amp;amp;pages=129-137&amp;amp;pmid=12954810&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29210</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29211</code><code>]&lt;/span&gt;</code></p><p><code>29212</code><code>&lt;/span&gt;</code></p><p><code>29213</code><code>&lt;/li&gt;</code></p><p><code>29214</code><code>&lt;li id="R1259"&gt;</code></p><p><code>29215</code><code>&lt;span class="citation"&gt;</code></p><p><code>29216</code><code>Wallace MJ, Martin BR, DeLorenzo RJ. Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. &lt;span&gt;</code></p><p><code>29217</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29218</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>29219</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>29220</code><code>452&lt;/span&gt;</code></p><p><code>29221</code><code>:295–301.&lt;/span&gt;</code></p><p><code>29222</code><code> [&lt;a href="/pubmed/12359270" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29223</code><code>PubMed&lt;/a&gt;</code></p><p><code>29224</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29225</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Evidence+for+a+physiological+role+of+endocannabinoids+in+the+modulation+of+seizure+threshold+and+severity&amp;amp;author=MJ+Wallace&amp;amp;author=BR+Martin&amp;amp;author=RJ+DeLorenzo&amp;amp;volume=452&amp;amp;publication_year=2002&amp;amp;pages=295-301&amp;amp;pmid=12359270&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29226</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29227</code><code>]&lt;/span&gt;</code></p><p><code>29228</code><code>&lt;/span&gt;</code></p><p><code>29229</code><code>&lt;/li&gt;</code></p><p><code>29230</code><code>&lt;li id="R1260"&gt;</code></p><p><code>29231</code><code>&lt;span class="citation"&gt;</code></p><p><code>29232</code><code>Walsh D, Nelson KA, Mahmoud FA. Established and potential therapeutic applications of cannabinoids in oncology. &lt;span&gt;</code></p><p><code>29233</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29234</code><code>Support Care Cancer. &lt;/span&gt;</code></p><p><code>29235</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>29236</code><code>11&lt;/span&gt;</code></p><p><code>29237</code><code>:137–143.&lt;/span&gt;</code></p><p><code>29238</code><code> [&lt;a href="/pubmed/12618922" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29239</code><code>PubMed&lt;/a&gt;</code></p><p><code>29240</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29241</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Support+Care+Cancer&amp;amp;title=Established+and+potential+therapeutic+applications+of+cannabinoids+in+oncology&amp;amp;author=D+Walsh&amp;amp;author=KA+Nelson&amp;amp;author=FA+Mahmoud&amp;amp;volume=11&amp;amp;publication_year=2003&amp;amp;pages=137-143&amp;amp;pmid=12618922&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29242</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29243</code><code>]&lt;/span&gt;</code></p><p><code>29244</code><code>&lt;/span&gt;</code></p><p><code>29245</code><code>&lt;/li&gt;</code></p><p><code>29246</code><code>&lt;li id="R1261"&gt;</code></p><p><code>29247</code><code>&lt;span class="citation"&gt;</code></p><p><code>29248</code><code>Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, Mackie K, Stella N. Nonpsychotropic cannabinoid receptors regulate microglial cell migration. &lt;span&gt;</code></p><p><code>29249</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29250</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>29251</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>29252</code><code>23&lt;/span&gt;</code></p><p><code>29253</code><code>:1398–1405.&lt;/span&gt;</code></p><p><code>29254</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>29255</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6742252/"&gt;</code></p><p><code>29256</code><code>PMC free article&lt;/a&gt;</code></p><p><code>29257</code><code>]&lt;/span&gt;</code></p><p><code>29258</code><code> [&lt;a href="/pubmed/12598628" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29259</code><code>PubMed&lt;/a&gt;</code></p><p><code>29260</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29261</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Nonpsychotropic+cannabinoid+receptors+regulate+microglial+cell+migration&amp;amp;author=L+Walter&amp;amp;author=A+Franklin&amp;amp;author=A+Witting&amp;amp;author=C+Wade&amp;amp;author=Y+Xie&amp;amp;volume=23&amp;amp;publication_year=2003&amp;amp;pages=1398-1405&amp;amp;pmid=12598628&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29262</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29263</code><code>]&lt;/span&gt;</code></p><p><code>29264</code><code>&lt;/span&gt;</code></p><p><code>29265</code><code>&lt;/li&gt;</code></p><p><code>29266</code><code>&lt;li id="R1262"&gt;</code></p><p><code>29267</code><code>&lt;span class="citation"&gt;</code></p><p><code>29268</code><code>Walter L, Stella N. Cannabinoids and neuroinflammation. &lt;span&gt;</code></p><p><code>29269</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29270</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>29271</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>29272</code><code>141&lt;/span&gt;</code></p><p><code>29273</code><code>:775–785.&lt;/span&gt;</code></p><p><code>29274</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>29275</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1574256/"&gt;</code></p><p><code>29276</code><code>PMC free article&lt;/a&gt;</code></p><p><code>29277</code><code>]&lt;/span&gt;</code></p><p><code>29278</code><code> [&lt;a href="/pubmed/14757702" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29279</code><code>PubMed&lt;/a&gt;</code></p><p><code>29280</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29281</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=Cannabinoids+and+neuroinflammation&amp;amp;author=L+Walter&amp;amp;author=N+Stella&amp;amp;volume=141&amp;amp;publication_year=2004&amp;amp;pages=775-785&amp;amp;pmid=14757702&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29282</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29283</code><code>]&lt;/span&gt;</code></p><p><code>29284</code><code>&lt;/span&gt;</code></p><p><code>29285</code><code>&lt;/li&gt;</code></p><p><code>29286</code><code>&lt;li id="R1263"&gt;</code></p><p><code>29287</code><code>&lt;span class="citation"&gt;</code></p><p><code>29288</code><code>Walther S, Mahlberg R, Eichmann U, Kunz D. &amp;#x00394;-9-Tetrahydrocannabinol for nighttime agitation in severe dementia. &lt;span&gt;</code></p><p><code>29289</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29290</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>29291</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>29292</code><code>185&lt;/span&gt;</code></p><p><code>29293</code><code>:524–528.&lt;/span&gt;</code></p><p><code>29294</code><code> [&lt;a href="/pubmed/16521031" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29295</code><code>PubMed&lt;/a&gt;</code></p><p><code>29296</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29297</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=&amp;#x00394;-9-Tetrahydrocannabinol+for+nighttime+agitation+in+severe+dementia&amp;amp;author=S+Walther&amp;amp;author=R+Mahlberg&amp;amp;author=U+Eichmann&amp;amp;author=D+Kunz&amp;amp;volume=185&amp;amp;publication_year=2006&amp;amp;pages=524-528&amp;amp;pmid=16521031&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29298</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29299</code><code>]&lt;/span&gt;</code></p><p><code>29300</code><code>&lt;/span&gt;</code></p><p><code>29301</code><code>&lt;/li&gt;</code></p><p><code>29302</code><code>&lt;li id="R1264"&gt;</code></p><p><code>29303</code><code>&lt;span class="citation"&gt;</code></p><p><code>29304</code><code>Wang H, Dey SK, Maccarrone M. Jekyll and Hyde: two faces of cannabinoid signaling in male and female fertility. &lt;span&gt;</code></p><p><code>29305</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29306</code><code>Endocr Rev. &lt;/span&gt;</code></p><p><code>29307</code><code>2006&lt;/span&gt;</code></p><p><code>29308</code><code> in press. [&lt;a href="/pubmed/16682502" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29309</code><code>PubMed&lt;/a&gt;</code></p><p><code>29310</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29311</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Endocr+Rev&amp;amp;title=Jekyll+and+Hyde:+two+faces+of+cannabinoid+signaling+in+male+and+female+fertility&amp;amp;author=H+Wang&amp;amp;author=SK+Dey&amp;amp;author=M+Maccarrone&amp;amp;publication_year=2006&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29312</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29313</code><code>]&lt;/span&gt;</code></p><p><code>29314</code><code>&lt;/span&gt;</code></p><p><code>29315</code><code>&lt;/li&gt;</code></p><p><code>29316</code><code>&lt;li id="R1265"&gt;</code></p><p><code>29317</code><code>&lt;span class="citation"&gt;</code></p><p><code>29318</code><code>Wang H, Guo Y, Wang D, Kingsley PJ, Marnett LJ, Das SK, DuBois RN, Dey SK. Aberrant cannabinoid signaling impairs oviductal transport of embryos. &lt;span&gt;</code></p><p><code>29319</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29320</code><code>Nat Med. &lt;/span&gt;</code></p><p><code>29321</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>29322</code><code>10&lt;/span&gt;</code></p><p><code>29323</code><code>:1074–1079.&lt;/span&gt;</code></p><p><code>29324</code><code> [&lt;a href="/pubmed/15378054" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29325</code><code>PubMed&lt;/a&gt;</code></p><p><code>29326</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29327</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;amp;title=Aberrant+cannabinoid+signaling+impairs+oviductal+transport+of+embryos&amp;amp;author=H+Wang&amp;amp;author=Y+Guo&amp;amp;author=D+Wang&amp;amp;author=PJ+Kingsley&amp;amp;author=LJ+Marnett&amp;amp;volume=10&amp;amp;publication_year=2004&amp;amp;pages=1074-1079&amp;amp;pmid=15378054&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29328</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29329</code><code>]&lt;/span&gt;</code></p><p><code>29330</code><code>&lt;/span&gt;</code></p><p><code>29331</code><code>&lt;/li&gt;</code></p><p><code>29332</code><code>&lt;li id="R1266"&gt;</code></p><p><code>29333</code><code>&lt;span class="citation"&gt;</code></p><p><code>29334</code><code>Wang J, Paria BC, Dey SK, Armant DR. Stage-specific excitation of cannabinoid receptor exhibits differential effects on mouse embryonic development. &lt;span&gt;</code></p><p><code>29335</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29336</code><code>Biol Reprod. &lt;/span&gt;</code></p><p><code>29337</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>29338</code><code>60&lt;/span&gt;</code></p><p><code>29339</code><code>:839–844.&lt;/span&gt;</code></p><p><code>29340</code><code> [&lt;a href="/pubmed/10084956" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29341</code><code>PubMed&lt;/a&gt;</code></p><p><code>29342</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29343</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biol+Reprod&amp;amp;title=Stage-specific+excitation+of+cannabinoid+receptor+exhibits+differential+effects+on+mouse+embryonic+development&amp;amp;author=J+Wang&amp;amp;author=BC+Paria&amp;amp;author=SK+Dey&amp;amp;author=DR+Armant&amp;amp;volume=60&amp;amp;publication_year=1999&amp;amp;pages=839-844&amp;amp;pmid=10084956&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29344</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29345</code><code>]&lt;/span&gt;</code></p><p><code>29346</code><code>&lt;/span&gt;</code></p><p><code>29347</code><code>&lt;/li&gt;</code></p><p><code>29348</code><code>&lt;li id="R1267"&gt;</code></p><p><code>29349</code><code>&lt;span class="citation"&gt;</code></p><p><code>29350</code><code>Wang L, Liu J, Harvey-White J, Zimmer A, Kunos G. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. &lt;span&gt;</code></p><p><code>29351</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29352</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>29353</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>29354</code><code>100&lt;/span&gt;</code></p><p><code>29355</code><code>:1393–1398.&lt;/span&gt;</code></p><p><code>29356</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>29357</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC298783/"&gt;</code></p><p><code>29358</code><code>PMC free article&lt;/a&gt;</code></p><p><code>29359</code><code>]&lt;/span&gt;</code></p><p><code>29360</code><code> [&lt;a href="/pubmed/12538878" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29361</code><code>PubMed&lt;/a&gt;</code></p><p><code>29362</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29363</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Endocannabinoid+signaling+via+cannabinoid+receptor+1+is+involved+in+ethanol+preference+and+its+age-dependent+decline+in+mice&amp;amp;author=L+Wang&amp;amp;author=J+Liu&amp;amp;author=J+Harvey-White&amp;amp;author=A+Zimmer&amp;amp;author=G+Kunos&amp;amp;volume=100&amp;amp;publication_year=2003&amp;amp;pages=1393-1398&amp;amp;pmid=12538878&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29364</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29365</code><code>]&lt;/span&gt;</code></p><p><code>29366</code><code>&lt;/span&gt;</code></p><p><code>29367</code><code>&lt;/li&gt;</code></p><p><code>29368</code><code>&lt;li id="R1268"&gt;</code></p><p><code>29369</code><code>&lt;span class="citation"&gt;</code></p><p><code>29370</code><code>Wang X, Feuerstein GZ. Role of immune and inflammatory mediators in CNS injury. &lt;span&gt;</code></p><p><code>29371</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29372</code><code>Drug News Perspect. &lt;/span&gt;</code></p><p><code>29373</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>29374</code><code>13&lt;/span&gt;</code></p><p><code>29375</code><code>:133–140.&lt;/span&gt;</code></p><p><code>29376</code><code> [&lt;a href="/pubmed/12937603" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29377</code><code>PubMed&lt;/a&gt;</code></p><p><code>29378</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29379</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Drug+News+Perspect&amp;amp;title=Role+of+immune+and+inflammatory+mediators+in+CNS+injury&amp;amp;author=X+Wang&amp;amp;author=GZ+Feuerstein&amp;amp;volume=13&amp;amp;publication_year=2000&amp;amp;pages=133-140&amp;amp;pmid=12937603&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29380</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29381</code><code>]&lt;/span&gt;</code></p><p><code>29382</code><code>&lt;/span&gt;</code></p><p><code>29383</code><code>&lt;/li&gt;</code></p><p><code>29384</code><code>&lt;li id="R1269"&gt;</code></p><p><code>29385</code><code>&lt;span class="citation"&gt;</code></p><p><code>29386</code><code>Wang Y, Kaminski NE, Wang DH. VR1-mediated depressor effects during high-salt intake: role of anandamide. &lt;span&gt;</code></p><p><code>29387</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29388</code><code>Hypertension. &lt;/span&gt;</code></p><p><code>29389</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>29390</code><code>46&lt;/span&gt;</code></p><p><code>29391</code><code>:986–991.&lt;/span&gt;</code></p><p><code>29392</code><code> [&lt;a href="/pubmed/16144988" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29393</code><code>PubMed&lt;/a&gt;</code></p><p><code>29394</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29395</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;amp;title=VR1-mediated+depressor+effects+during+high-salt+intake:+role+of+anandamide&amp;amp;author=Y+Wang&amp;amp;author=NE+Kaminski&amp;amp;author=DH+Wang&amp;amp;volume=46&amp;amp;publication_year=2005&amp;amp;pages=986-991&amp;amp;pmid=16144988&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29396</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29397</code><code>]&lt;/span&gt;</code></p><p><code>29398</code><code>&lt;/span&gt;</code></p><p><code>29399</code><code>&lt;/li&gt;</code></p><p><code>29400</code><code>&lt;li id="R1270"&gt;</code></p><p><code>29401</code><code>&lt;span class="citation"&gt;</code></p><p><code>29402</code><code>Wang Y, Liu Y, Ito Y, Hashiguchi T, Kitajima I, Yamakuchi M, Shimizu H, Matsuo S, Imaizumi H, Maruyama I. Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock. &lt;span&gt;</code></p><p><code>29403</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29404</code><code>Anal Biochem. &lt;/span&gt;</code></p><p><code>29405</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>29406</code><code>294&lt;/span&gt;</code></p><p><code>29407</code><code>:73–82.&lt;/span&gt;</code></p><p><code>29408</code><code> [&lt;a href="/pubmed/11412008" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29409</code><code>PubMed&lt;/a&gt;</code></p><p><code>29410</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29411</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Anal+Biochem&amp;amp;title=Simultaneous+measurement+of+anandamide+and+2-arachidonoylglycerol+by+polymyxin+B-selective+adsorption+and+subsequent+high-performance+liquid+chromatography+analysis:+increase+in+endogenous+cannabinoids+in+the+sera+of+patients+with+endotoxic+shock&amp;amp;author=Y+Wang&amp;amp;author=Y+Liu&amp;amp;author=Y+Ito&amp;amp;author=T+Hashiguchi&amp;amp;author=I+Kitajima&amp;amp;volume=294&amp;amp;publication_year=2001&amp;amp;pages=73-82&amp;amp;pmid=11412008&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29412</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29413</code><code>]&lt;/span&gt;</code></p><p><code>29414</code><code>&lt;/span&gt;</code></p><p><code>29415</code><code>&lt;/li&gt;</code></p><p><code>29416</code><code>&lt;li id="R1271"&gt;</code></p><p><code>29417</code><code>&lt;span class="citation"&gt;</code></p><p><code>29418</code><code>Ward SJ, Dykstra LA. The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940) &lt;span&gt;</code></p><p><code>29419</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29420</code><code>Behav Pharmacol. &lt;/span&gt;</code></p><p><code>29421</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>29422</code><code>16&lt;/span&gt;</code></p><p><code>29423</code><code>:381–388.&lt;/span&gt;</code></p><p><code>29424</code><code> [&lt;a href="/pubmed/16148442" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29425</code><code>PubMed&lt;/a&gt;</code></p><p><code>29426</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29427</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Behav+Pharmacol&amp;amp;title=The+role+of+CB1+receptors+in+sweet+versus+fat+reinforcement:+effect+of+CB1+receptor+deletion,+CB1+receptor+antagonism+(SR141716A)+and+CB1+receptor+agonism+(CP-55940)&amp;amp;author=SJ+Ward&amp;amp;author=LA+Dykstra&amp;amp;volume=16&amp;amp;publication_year=2005&amp;amp;pages=381-388&amp;amp;pmid=16148442&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29428</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29429</code><code>]&lt;/span&gt;</code></p><p><code>29430</code><code>&lt;/span&gt;</code></p><p><code>29431</code><code>&lt;/li&gt;</code></p><p><code>29432</code><code>&lt;li id="R1272"&gt;</code></p><p><code>29433</code><code>&lt;span class="citation"&gt;</code></p><p><code>29434</code><code>Ware M, Beaulieu P. Cannabinoids for the treatment of pain: an update on recent clinical trials. &lt;span&gt;</code></p><p><code>29435</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29436</code><code>Pain Res Manag. &lt;/span&gt;</code></p><p><code>29437</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>29438</code><code>10&lt;/span&gt;</code></p><p><code>29439</code><code>:27A–30A.&lt;/span&gt;</code></p><p><code>29440</code><code> [&lt;a href="/pubmed/16237479" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29441</code><code>PubMed&lt;/a&gt;</code></p><p><code>29442</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29443</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pain+Res+Manag&amp;amp;title=Cannabinoids+for+the+treatment+of+pain:+an+update+on+recent+clinical+trials&amp;amp;author=M+Ware&amp;amp;author=P+Beaulieu&amp;amp;volume=10&amp;amp;publication_year=2005&amp;amp;pages=27A-30A&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29444</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29445</code><code>]&lt;/span&gt;</code></p><p><code>29446</code><code>&lt;/span&gt;</code></p><p><code>29447</code><code>&lt;/li&gt;</code></p><p><code>29448</code><code>&lt;li id="R1273"&gt;</code></p><p><code>29449</code><code>&lt;span class="citation"&gt;</code></p><p><code>29450</code><code>Ware MA, Adams H, Guy GW. The medicinal use of cannabis in the UK: results of a nationwide survey. &lt;span&gt;</code></p><p><code>29451</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29452</code><code>Int J Clin Pract. &lt;/span&gt;</code></p><p><code>29453</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>29454</code><code>59&lt;/span&gt;</code></p><p><code>29455</code><code>:291–295.&lt;/span&gt;</code></p><p><code>29456</code><code> [&lt;a href="/pubmed/15857325" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29457</code><code>PubMed&lt;/a&gt;</code></p><p><code>29458</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29459</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Clin+Pract&amp;amp;title=The+medicinal+use+of+cannabis+in+the+UK:+results+of+a+nationwide+survey&amp;amp;author=MA+Ware&amp;amp;author=H+Adams&amp;amp;author=GW+Guy&amp;amp;volume=59&amp;amp;publication_year=2005&amp;amp;pages=291-295&amp;amp;pmid=15857325&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29460</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29461</code><code>]&lt;/span&gt;</code></p><p><code>29462</code><code>&lt;/span&gt;</code></p><p><code>29463</code><code>&lt;/li&gt;</code></p><p><code>29464</code><code>&lt;li id="R1274"&gt;</code></p><p><code>29465</code><code>&lt;span class="citation"&gt;</code></p><p><code>29466</code><code>Ware MA, Doyle CR, Woods R, Lynch ME, Clark AJ. Cannabis use for chronic non-cancer pain: results of a prospective survey. &lt;span&gt;</code></p><p><code>29467</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29468</code><code>Pain. &lt;/span&gt;</code></p><p><code>29469</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>29470</code><code>102&lt;/span&gt;</code></p><p><code>29471</code><code>:211–216.&lt;/span&gt;</code></p><p><code>29472</code><code> [&lt;a href="/pubmed/12620613" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29473</code><code>PubMed&lt;/a&gt;</code></p><p><code>29474</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29475</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;amp;title=Cannabis+use+for+chronic+non-cancer+pain:+results+of+a+prospective+survey&amp;amp;author=MA+Ware&amp;amp;author=CR+Doyle&amp;amp;author=R+Woods&amp;amp;author=ME+Lynch&amp;amp;author=AJ+Clark&amp;amp;volume=102&amp;amp;publication_year=2003&amp;amp;pages=211-216&amp;amp;pmid=12620613&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29476</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29477</code><code>]&lt;/span&gt;</code></p><p><code>29478</code><code>&lt;/span&gt;</code></p><p><code>29479</code><code>&lt;/li&gt;</code></p><p><code>29480</code><code>&lt;li id="R1275"&gt;</code></p><p><code>29481</code><code>&lt;span class="citation"&gt;</code></p><p><code>29482</code><code>Wartmann M, Campbell D, Subramanian A, Burstein SH, Davis RJ. The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. &lt;span&gt;</code></p><p><code>29483</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29484</code><code>FEBS Lett. &lt;/span&gt;</code></p><p><code>29485</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>29486</code><code>359&lt;/span&gt;</code></p><p><code>29487</code><code>:133–136.&lt;/span&gt;</code></p><p><code>29488</code><code> [&lt;a href="/pubmed/7867785" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29489</code><code>PubMed&lt;/a&gt;</code></p><p><code>29490</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29491</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;amp;title=The+MAP+kinase+signal+transduction+pathway+is+activated+by+the+endogenous+cannabinoid+anandamide&amp;amp;author=M+Wartmann&amp;amp;author=D+Campbell&amp;amp;author=A+Subramanian&amp;amp;author=SH+Burstein&amp;amp;author=RJ+Davis&amp;amp;volume=359&amp;amp;publication_year=1995&amp;amp;pages=133-136&amp;amp;pmid=7867785&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29492</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29493</code><code>]&lt;/span&gt;</code></p><p><code>29494</code><code>&lt;/span&gt;</code></p><p><code>29495</code><code>&lt;/li&gt;</code></p><p><code>29496</code><code>&lt;li id="R1276"&gt;</code></p><p><code>29497</code><code>&lt;span class="citation"&gt;</code></p><p><code>29498</code><code>Watzl B, Scuderi P, Watson RR. Influence of marijuana components (THC and CBD) on human mononuclear cell cytokine secretion in vitro. &lt;span&gt;</code></p><p><code>29499</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29500</code><code>Adv Exp Med Biol. &lt;/span&gt;</code></p><p><code>29501</code><code>1991;&lt;span class="ref-vol"&gt;</code></p><p><code>29502</code><code>288&lt;/span&gt;</code></p><p><code>29503</code><code>:63–70.&lt;/span&gt;</code></p><p><code>29504</code><code> [&lt;a href="/pubmed/1659139" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29505</code><code>PubMed&lt;/a&gt;</code></p><p><code>29506</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29507</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Adv+Exp+Med+Biol&amp;amp;title=Influence+of+marijuana+components+(THC+and+CBD)+on+human+mononuclear+cell+cytokine+secretion+in+vitro&amp;amp;author=B+Watzl&amp;amp;author=P+Scuderi&amp;amp;author=RR+Watson&amp;amp;volume=288&amp;amp;publication_year=1991&amp;amp;pages=63-70&amp;amp;pmid=1659139&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29508</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29509</code><code>]&lt;/span&gt;</code></p><p><code>29510</code><code>&lt;/span&gt;</code></p><p><code>29511</code><code>&lt;/li&gt;</code></p><p><code>29512</code><code>&lt;li id="R1277"&gt;</code></p><p><code>29513</code><code>&lt;span class="citation"&gt;</code></p><p><code>29514</code><code>Weidenfeld J, Feldman S, Mechoulam R. Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat. &lt;span&gt;</code></p><p><code>29515</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29516</code><code>Neuroendocrinology. &lt;/span&gt;</code></p><p><code>29517</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>29518</code><code>59&lt;/span&gt;</code></p><p><code>29519</code><code>:110–112.&lt;/span&gt;</code></p><p><code>29520</code><code> [&lt;a href="/pubmed/8127398" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29521</code><code>PubMed&lt;/a&gt;</code></p><p><code>29522</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29523</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroendocrinology&amp;amp;title=Effect+of+the+brain+constituent+anandamide,+a+cannabinoid+receptor+agonist,+on+the+hypothalamo-pituitary-adrenal+axis+in+the+rat&amp;amp;author=J+Weidenfeld&amp;amp;author=S+Feldman&amp;amp;author=R+Mechoulam&amp;amp;volume=59&amp;amp;publication_year=1994&amp;amp;pages=110-112&amp;amp;pmid=8127398&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29524</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29525</code><code>]&lt;/span&gt;</code></p><p><code>29526</code><code>&lt;/span&gt;</code></p><p><code>29527</code><code>&lt;/li&gt;</code></p><p><code>29528</code><code>&lt;li id="R1278"&gt;</code></p><p><code>29529</code><code>&lt;span class="citation"&gt;</code></p><p><code>29530</code><code>Weiss F, Lorang MT, Bloom FE, Koob GF. Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. &lt;span&gt;</code></p><p><code>29531</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29532</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>29533</code><code>1993;&lt;span class="ref-vol"&gt;</code></p><p><code>29534</code><code>267&lt;/span&gt;</code></p><p><code>29535</code><code>:250–258.&lt;/span&gt;</code></p><p><code>29536</code><code> [&lt;a href="/pubmed/8229752" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29537</code><code>PubMed&lt;/a&gt;</code></p><p><code>29538</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29539</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Oral+alcohol+self-administration+stimulates+dopamine+release+in+the+rat+nucleus+accumbens:+genetic+and+motivational+determinants&amp;amp;author=F+Weiss&amp;amp;author=MT+Lorang&amp;amp;author=FE+Bloom&amp;amp;author=GF+Koob&amp;amp;volume=267&amp;amp;publication_year=1993&amp;amp;pages=250-258&amp;amp;pmid=8229752&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29540</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29541</code><code>]&lt;/span&gt;</code></p><p><code>29542</code><code>&lt;/span&gt;</code></p><p><code>29543</code><code>&lt;/li&gt;</code></p><p><code>29544</code><code>&lt;li id="R1279"&gt;</code></p><p><code>29545</code><code>&lt;span class="citation"&gt;</code></p><p><code>29546</code><code>Weksler ME, Gouras G, Relkin NR, Szabo P. The immune system, amyloid-&lt;em&gt;</code></p><p><code>29547</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>29548</code><code> peptide, and Alzheimer&amp;#x02019;s disease. &lt;span&gt;</code></p><p><code>29549</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29550</code><code>Immunol Rev. &lt;/span&gt;</code></p><p><code>29551</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>29552</code><code>205&lt;/span&gt;</code></p><p><code>29553</code><code>:244–256.&lt;/span&gt;</code></p><p><code>29554</code><code> [&lt;a href="/pubmed/15882358" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29555</code><code>PubMed&lt;/a&gt;</code></p><p><code>29556</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29557</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Immunol+Rev&amp;amp;title=The+immune+system,+amyloid-&amp;#x003b2;+peptide,+and+Alzheimer&amp;#x02019;s+disease&amp;amp;author=ME+Weksler&amp;amp;author=G+Gouras&amp;amp;author=NR+Relkin&amp;amp;author=P+Szabo&amp;amp;volume=205&amp;amp;publication_year=2005&amp;amp;pages=244-256&amp;amp;pmid=15882358&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29558</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29559</code><code>]&lt;/span&gt;</code></p><p><code>29560</code><code>&lt;/span&gt;</code></p><p><code>29561</code><code>&lt;/li&gt;</code></p><p><code>29562</code><code>&lt;li id="R1280"&gt;</code></p><p><code>29563</code><code>&lt;span class="citation"&gt;</code></p><p><code>29564</code><code>Welch SP, Stevens DL. Antinociceptive activity of intrathecally administered cannabinoids alone and in combination with morphine in mice. &lt;span&gt;</code></p><p><code>29565</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29566</code><code>J Pharmacol Exp Ther. &lt;/span&gt;</code></p><p><code>29567</code><code>1992;&lt;span class="ref-vol"&gt;</code></p><p><code>29568</code><code>262&lt;/span&gt;</code></p><p><code>29569</code><code>:10–18.&lt;/span&gt;</code></p><p><code>29570</code><code> [&lt;a href="/pubmed/1320680" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29571</code><code>PubMed&lt;/a&gt;</code></p><p><code>29572</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29573</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;amp;title=Antinociceptive+activity+of+intrathecally+administered+cannabinoids+alone+and+in+combination+with+morphine+in+mice&amp;amp;author=SP+Welch&amp;amp;author=DL+Stevens&amp;amp;volume=262&amp;amp;publication_year=1992&amp;amp;pages=10-18&amp;amp;pmid=1320680&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29574</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29575</code><code>]&lt;/span&gt;</code></p><p><code>29576</code><code>&lt;/span&gt;</code></p><p><code>29577</code><code>&lt;/li&gt;</code></p><p><code>29578</code><code>&lt;li id="R1281"&gt;</code></p><p><code>29579</code><code>&lt;span class="citation"&gt;</code></p><p><code>29580</code><code>Wenger T, Jamali KA, Juaneda C, Leonardelli J, Tramu G. Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus. &lt;span&gt;</code></p><p><code>29581</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29582</code><code>Biochem Biophys Res Commun. &lt;/span&gt;</code></p><p><code>29583</code><code>1997;&lt;span class="ref-vol"&gt;</code></p><p><code>29584</code><code>237&lt;/span&gt;</code></p><p><code>29585</code><code>:724–728.&lt;/span&gt;</code></p><p><code>29586</code><code> [&lt;a href="/pubmed/9299434" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29587</code><code>PubMed&lt;/a&gt;</code></p><p><code>29588</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29589</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;amp;title=Arachidonyl+ethanolamide+(anandamide)+activates+the+parvocellular+part+of+hypothalamic+paraventricular+nucleus&amp;amp;author=T+Wenger&amp;amp;author=KA+Jamali&amp;amp;author=C+Juaneda&amp;amp;author=J+Leonardelli&amp;amp;author=G+Tramu&amp;amp;volume=237&amp;amp;publication_year=1997&amp;amp;pages=724-728&amp;amp;pmid=9299434&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29590</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29591</code><code>]&lt;/span&gt;</code></p><p><code>29592</code><code>&lt;/span&gt;</code></p><p><code>29593</code><code>&lt;/li&gt;</code></p><p><code>29594</code><code>&lt;li id="R1282"&gt;</code></p><p><code>29595</code><code>&lt;span class="citation"&gt;</code></p><p><code>29596</code><code>Westlake TM, Howlett AC, Bonner TI, Matsuda LA, Herkenham M. Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer&amp;#x02019;s brains. &lt;span&gt;</code></p><p><code>29597</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29598</code><code>Neuroscience. &lt;/span&gt;</code></p><p><code>29599</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>29600</code><code>63&lt;/span&gt;</code></p><p><code>29601</code><code>:637–652.&lt;/span&gt;</code></p><p><code>29602</code><code> [&lt;a href="/pubmed/7898667" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29603</code><code>PubMed&lt;/a&gt;</code></p><p><code>29604</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29605</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;amp;title=Cannabinoid+receptor+binding+and+messenger+RNA+expression+in+human+brain:+an+in+vitro+receptor+autoradiography+and+in+situ+hybridization+histochemistry+study+of+normal+aged+and+Alzheimer&amp;#x02019;s+brains&amp;amp;author=TM+Westlake&amp;amp;author=AC+Howlett&amp;amp;author=TI+Bonner&amp;amp;author=LA+Matsuda&amp;amp;author=M+Herkenham&amp;amp;volume=63&amp;amp;publication_year=1994&amp;amp;pages=637-652&amp;amp;pmid=7898667&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29606</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29607</code><code>]&lt;/span&gt;</code></p><p><code>29608</code><code>&lt;/span&gt;</code></p><p><code>29609</code><code>&lt;/li&gt;</code></p><p><code>29610</code><code>&lt;li id="R1283"&gt;</code></p><p><code>29611</code><code>&lt;span class="citation"&gt;</code></p><p><code>29612</code><code>Whan LB, West MC, McClure N, Lewis SE. Effects of &amp;#x00394;-9-tetrahydrocannabinol, the primary psychoactive cannabinoid in marijuana, on human sperm function in vitro. &lt;span&gt;</code></p><p><code>29613</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29614</code><code>Fertil Steril. &lt;/span&gt;</code></p><p><code>29615</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>29616</code><code>85&lt;/span&gt;</code></p><p><code>29617</code><code>:653–660.&lt;/span&gt;</code></p><p><code>29618</code><code> [&lt;a href="/pubmed/16500334" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29619</code><code>PubMed&lt;/a&gt;</code></p><p><code>29620</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29621</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Fertil+Steril&amp;amp;title=Effects+of+&amp;#x00394;-9-tetrahydrocannabinol,+the+primary+psychoactive+cannabinoid+in+marijuana,+on+human+sperm+function+in+vitro&amp;amp;author=LB+Whan&amp;amp;author=MC+West&amp;amp;author=N+McClure&amp;amp;author=SE+Lewis&amp;amp;volume=85&amp;amp;publication_year=2006&amp;amp;pages=653-660&amp;amp;pmid=16500334&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29622</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29623</code><code>]&lt;/span&gt;</code></p><p><code>29624</code><code>&lt;/span&gt;</code></p><p><code>29625</code><code>&lt;/li&gt;</code></p><p><code>29626</code><code>&lt;li id="R1284"&gt;</code></p><p><code>29627</code><code>&lt;span class="citation"&gt;</code></p><p><code>29628</code><code>Whiteside GT, Gottshall SL, Boulet JM, Chaffer SM, Harrison JE, Pearson MS, Turchin PI, Mark L, Garrison AE, Valenzano KJ. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB&lt;sub&gt;</code></p><p><code>29629</code><code>2&lt;/sub&gt;</code></p><p><code>29630</code><code>-selective agonist, GW405833. &lt;span&gt;</code></p><p><code>29631</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29632</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>29633</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>29634</code><code>528&lt;/span&gt;</code></p><p><code>29635</code><code>:65–72.&lt;/span&gt;</code></p><p><code>29636</code><code> [&lt;a href="/pubmed/16316650" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29637</code><code>PubMed&lt;/a&gt;</code></p><p><code>29638</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29639</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=A+role+for+cannabinoid+receptors,+but+not+endogenous+opioids,+in+the+antinociceptive+activity+of+the+CB2-selective+agonist,+GW405833&amp;amp;author=GT+Whiteside&amp;amp;author=SL+Gottshall&amp;amp;author=JM+Boulet&amp;amp;author=SM+Chaffer&amp;amp;author=JE+Harrison&amp;amp;volume=528&amp;amp;publication_year=2005&amp;amp;pages=65-72&amp;amp;pmid=16316650&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29640</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29641</code><code>]&lt;/span&gt;</code></p><p><code>29642</code><code>&lt;/span&gt;</code></p><p><code>29643</code><code>&lt;/li&gt;</code></p><p><code>29644</code><code>&lt;li id="R1285"&gt;</code></p><p><code>29645</code><code>&lt;span class="citation"&gt;</code></p><p><code>29646</code><code>Wickens AP, Pertwee RG. &amp;#x00394;&lt;sup&gt;</code></p><p><code>29647</code><code>9&lt;/sup&gt;</code></p><p><code>29648</code><code>-Tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats. &lt;span&gt;</code></p><p><code>29649</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29650</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>29651</code><code>1993;&lt;span class="ref-vol"&gt;</code></p><p><code>29652</code><code>250&lt;/span&gt;</code></p><p><code>29653</code><code>:205–208.&lt;/span&gt;</code></p><p><code>29654</code><code> [&lt;a href="/pubmed/8119321" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29655</code><code>PubMed&lt;/a&gt;</code></p><p><code>29656</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29657</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=&amp;#x00394;9-Tetrahydrocannabinol+and+anandamide+enhance+the+ability+of+muscimol+to+induce+catalepsy+in+the+globus+pallidus+of+rats&amp;amp;author=AP+Wickens&amp;amp;author=RG+Pertwee&amp;amp;volume=250&amp;amp;publication_year=1993&amp;amp;pages=205-208&amp;amp;pmid=8119321&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29658</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29659</code><code>]&lt;/span&gt;</code></p><p><code>29660</code><code>&lt;/span&gt;</code></p><p><code>29661</code><code>&lt;/li&gt;</code></p><p><code>29662</code><code>&lt;li id="R1286"&gt;</code></p><p><code>29663</code><code>&lt;span class="citation"&gt;</code></p><p><code>29664</code><code>Wiley JL, Burston JJ, Leggett DC, Alekseeva OO, Razdan RK, Mahadevan A, Martin BR. CB1 cannabinoid receptor-mediated modulation of food intake in mice. &lt;span&gt;</code></p><p><code>29665</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29666</code><code>Br J Pharmacol. &lt;/span&gt;</code></p><p><code>29667</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>29668</code><code>145&lt;/span&gt;</code></p><p><code>29669</code><code>:293–300.&lt;/span&gt;</code></p><p><code>29670</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>29671</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1576140/"&gt;</code></p><p><code>29672</code><code>PMC free article&lt;/a&gt;</code></p><p><code>29673</code><code>]&lt;/span&gt;</code></p><p><code>29674</code><code> [&lt;a href="/pubmed/15778743" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29675</code><code>PubMed&lt;/a&gt;</code></p><p><code>29676</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29677</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;amp;title=CB1+cannabinoid+receptor-mediated+modulation+of+food+intake+in+mice&amp;amp;author=JL+Wiley&amp;amp;author=JJ+Burston&amp;amp;author=DC+Leggett&amp;amp;author=OO+Alekseeva&amp;amp;author=RK+Razdan&amp;amp;volume=145&amp;amp;publication_year=2005&amp;amp;pages=293-300&amp;amp;pmid=15778743&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29678</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29679</code><code>]&lt;/span&gt;</code></p><p><code>29680</code><code>&lt;/span&gt;</code></p><p><code>29681</code><code>&lt;/li&gt;</code></p><p><code>29682</code><code>&lt;li id="R1287"&gt;</code></p><p><code>29683</code><code>&lt;span class="citation"&gt;</code></p><p><code>29684</code><code>Williams CM, Kirkham TC. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. &lt;span&gt;</code></p><p><code>29685</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29686</code><code>Psychopharmacology (Berl) &lt;/span&gt;</code></p><p><code>29687</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>29688</code><code>143&lt;/span&gt;</code></p><p><code>29689</code><code>:315–317.&lt;/span&gt;</code></p><p><code>29690</code><code> [&lt;a href="/pubmed/10353436" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29691</code><code>PubMed&lt;/a&gt;</code></p><p><code>29692</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29693</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology+(Berl)&amp;amp;title=Anandamide+induces+overeating:+mediation+by+central+cannabinoid+(CB1)+receptors&amp;amp;author=CM+Williams&amp;amp;author=TC+Kirkham&amp;amp;volume=143&amp;amp;publication_year=1999&amp;amp;pages=315-317&amp;amp;pmid=10353436&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29694</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29695</code><code>]&lt;/span&gt;</code></p><p><code>29696</code><code>&lt;/span&gt;</code></p><p><code>29697</code><code>&lt;/li&gt;</code></p><p><code>29698</code><code>&lt;li id="R1288"&gt;</code></p><p><code>29699</code><code>&lt;span class="citation"&gt;</code></p><p><code>29700</code><code>Williams CM, Kirkham TC. Reversal of &amp;#x00394;&lt;sup&gt;</code></p><p><code>29701</code><code>9&lt;/sup&gt;</code></p><p><code>29702</code><code>-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. &lt;span&gt;</code></p><p><code>29703</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29704</code><code>Pharmacol Biochem Behav. &lt;/span&gt;</code></p><p><code>29705</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>29706</code><code>71&lt;/span&gt;</code></p><p><code>29707</code><code>:341–348.&lt;/span&gt;</code></p><p><code>29708</code><code> [&lt;a href="/pubmed/11812541" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29709</code><code>PubMed&lt;/a&gt;</code></p><p><code>29710</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29711</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Biochem+Behav&amp;amp;title=Reversal+of+&amp;#x00394;9-THC+hyperphagia+by+SR141716+and+naloxone+but+not+dexfenfluramine&amp;amp;author=CM+Williams&amp;amp;author=TC+Kirkham&amp;amp;volume=71&amp;amp;publication_year=2002&amp;amp;pages=341-348&amp;amp;pmid=11812542&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29712</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29713</code><code>]&lt;/span&gt;</code></p><p><code>29714</code><code>&lt;/span&gt;</code></p><p><code>29715</code><code>&lt;/li&gt;</code></p><p><code>29716</code><code>&lt;li id="R1289"&gt;</code></p><p><code>29717</code><code>&lt;span class="citation"&gt;</code></p><p><code>29718</code><code>Williams CM, Rogers PJ, Kirkham TC. Hyperphagia in prefed rats following oral &amp;#x00394;&lt;sup&gt;</code></p><p><code>29719</code><code>9&lt;/sup&gt;</code></p><p><code>29720</code><code>-THC. &lt;span&gt;</code></p><p><code>29721</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29722</code><code>Physiol Behav. &lt;/span&gt;</code></p><p><code>29723</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>29724</code><code>65&lt;/span&gt;</code></p><p><code>29725</code><code>:343–346.&lt;/span&gt;</code></p><p><code>29726</code><code> [&lt;a href="/pubmed/9855485" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29727</code><code>PubMed&lt;/a&gt;</code></p><p><code>29728</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29729</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Physiol+Behav&amp;amp;title=Hyperphagia+in+prefed+rats+following+oral+&amp;#x00394;9-THC&amp;amp;author=CM+Williams&amp;amp;author=PJ+Rogers&amp;amp;author=TC+Kirkham&amp;amp;volume=65&amp;amp;publication_year=1998&amp;amp;pages=343-346&amp;amp;pmid=9855485&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29730</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29731</code><code>]&lt;/span&gt;</code></p><p><code>29732</code><code>&lt;/span&gt;</code></p><p><code>29733</code><code>&lt;/li&gt;</code></p><p><code>29734</code><code>&lt;li id="R1290"&gt;</code></p><p><code>29735</code><code>&lt;span class="citation"&gt;</code></p><p><code>29736</code><code>Williams IJ, Edwards S, Rubo A, Haller VL, Stevens DL, Welch SP. Time course of the enhancement and restoration of the analgesic efficacy of codeine and morphine by delta(9)-tetrahydrocannabinol. &lt;span&gt;</code></p><p><code>29737</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29738</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>29739</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>29740</code><code>539&lt;/span&gt;</code></p><p><code>29741</code><code>:57–63.&lt;/span&gt;</code></p><p><code>29742</code><code> [&lt;a href="/pubmed/16687136" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29743</code><code>PubMed&lt;/a&gt;</code></p><p><code>29744</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29745</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=Time+course+of+the+enhancement+and+restoration+of+the+analgesic+efficacy+of+codeine+and+morphine+by+delta(9)-tetrahydrocannabinol&amp;amp;author=IJ+Williams&amp;amp;author=S+Edwards&amp;amp;author=A+Rubo&amp;amp;author=VL+Haller&amp;amp;author=DL+Stevens&amp;amp;volume=539&amp;amp;publication_year=2006&amp;amp;pages=57-63&amp;amp;pmid=16687136&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29746</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29747</code><code>]&lt;/span&gt;</code></p><p><code>29748</code><code>&lt;/span&gt;</code></p><p><code>29749</code><code>&lt;/li&gt;</code></p><p><code>29750</code><code>&lt;li id="R1291"&gt;</code></p><p><code>29751</code><code>&lt;span class="citation"&gt;</code></p><p><code>29752</code><code>Williams SJ, Hartley JP, Graham JD. Bronchodilator effect of &amp;#x00394;&lt;sup&gt;</code></p><p><code>29753</code><code>1&lt;/sup&gt;</code></p><p><code>29754</code><code>-tetrahydrocannabinol administered by aerosol of asthmatic patients. &lt;span&gt;</code></p><p><code>29755</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29756</code><code>Thorax. &lt;/span&gt;</code></p><p><code>29757</code><code>1976;&lt;span class="ref-vol"&gt;</code></p><p><code>29758</code><code>31&lt;/span&gt;</code></p><p><code>29759</code><code>:720–723.&lt;/span&gt;</code></p><p><code>29760</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>29761</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC470501/"&gt;</code></p><p><code>29762</code><code>PMC free article&lt;/a&gt;</code></p><p><code>29763</code><code>]&lt;/span&gt;</code></p><p><code>29764</code><code> [&lt;a href="/pubmed/797044" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29765</code><code>PubMed&lt;/a&gt;</code></p><p><code>29766</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29767</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Thorax&amp;amp;title=Bronchodilator+effect+of+&amp;#x00394;1-tetrahydrocannabinol+administered+by+aerosol+of+asthmatic+patients&amp;amp;author=SJ+Williams&amp;amp;author=JP+Hartley&amp;amp;author=JD+Graham&amp;amp;volume=31&amp;amp;publication_year=1976&amp;amp;pages=720-723&amp;amp;pmid=797044&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29768</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29769</code><code>]&lt;/span&gt;</code></p><p><code>29770</code><code>&lt;/span&gt;</code></p><p><code>29771</code><code>&lt;/li&gt;</code></p><p><code>29772</code><code>&lt;li id="R1292"&gt;</code></p><p><code>29773</code><code>&lt;span class="citation"&gt;</code></p><p><code>29774</code><code>Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. &lt;span&gt;</code></p><p><code>29775</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29776</code><code>Annu Rev Immunol. &lt;/span&gt;</code></p><p><code>29777</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>29778</code><code>17&lt;/span&gt;</code></p><p><code>29779</code><code>:255–281.&lt;/span&gt;</code></p><p><code>29780</code><code> [&lt;a href="/pubmed/10358759" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29781</code><code>PubMed&lt;/a&gt;</code></p><p><code>29782</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29783</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Immunol&amp;amp;title=Immunologic+basis+of+antigen-induced+airway+hyperresponsiveness&amp;amp;author=M+Wills-Karp&amp;amp;volume=17&amp;amp;publication_year=1999&amp;amp;pages=255-281&amp;amp;pmid=10358759&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29784</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29785</code><code>]&lt;/span&gt;</code></p><p><code>29786</code><code>&lt;/span&gt;</code></p><p><code>29787</code><code>&lt;/li&gt;</code></p><p><code>29788</code><code>&lt;li id="R1293"&gt;</code></p><p><code>29789</code><code>&lt;span class="citation"&gt;</code></p><p><code>29790</code><code>Wilson RI, Kunos G, Nicoll RA. Presynaptic specificity of endocannabinoid signalling in the hippocampus. &lt;span&gt;</code></p><p><code>29791</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29792</code><code>Neuron. &lt;/span&gt;</code></p><p><code>29793</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>29794</code><code>31&lt;/span&gt;</code></p><p><code>29795</code><code>:453–462.&lt;/span&gt;</code></p><p><code>29796</code><code> [&lt;a href="/pubmed/11516401" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29797</code><code>PubMed&lt;/a&gt;</code></p><p><code>29798</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29799</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;amp;title=Presynaptic+specificity+of+endocannabinoid+signalling+in+the+hippocampus&amp;amp;author=RI+Wilson&amp;amp;author=G+Kunos&amp;amp;author=RA+Nicoll&amp;amp;volume=31&amp;amp;publication_year=2001&amp;amp;pages=453-462&amp;amp;pmid=11516401&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29800</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29801</code><code>]&lt;/span&gt;</code></p><p><code>29802</code><code>&lt;/span&gt;</code></p><p><code>29803</code><code>&lt;/li&gt;</code></p><p><code>29804</code><code>&lt;li id="R1294"&gt;</code></p><p><code>29805</code><code>&lt;span class="citation"&gt;</code></p><p><code>29806</code><code>Wilson RI, Nicoll RA. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. &lt;span&gt;</code></p><p><code>29807</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29808</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>29809</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>29810</code><code>410&lt;/span&gt;</code></p><p><code>29811</code><code>:588–592.&lt;/span&gt;</code></p><p><code>29812</code><code> [&lt;a href="/pubmed/11279497" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29813</code><code>PubMed&lt;/a&gt;</code></p><p><code>29814</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29815</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Endogenous+cannabinoids+mediate+retrograde+signalling+at+hippocampal+synapses&amp;amp;author=RI+Wilson&amp;amp;author=RA+Nicoll&amp;amp;volume=410&amp;amp;publication_year=2001&amp;amp;pages=588-592&amp;amp;pmid=11279497&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29816</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29817</code><code>]&lt;/span&gt;</code></p><p><code>29818</code><code>&lt;/span&gt;</code></p><p><code>29819</code><code>&lt;/li&gt;</code></p><p><code>29820</code><code>&lt;li id="R1295"&gt;</code></p><p><code>29821</code><code>&lt;span class="citation"&gt;</code></p><p><code>29822</code><code>Wilson RI, Nicoll RA. Endocannabinoid signaling in the brain. &lt;span&gt;</code></p><p><code>29823</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29824</code><code>Science (Wash DC) &lt;/span&gt;</code></p><p><code>29825</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>29826</code><code>296&lt;/span&gt;</code></p><p><code>29827</code><code>:678–682.&lt;/span&gt;</code></p><p><code>29828</code><code> [&lt;a href="/pubmed/11976437" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29829</code><code>PubMed&lt;/a&gt;</code></p><p><code>29830</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29831</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Science+(Wash+DC)&amp;amp;title=Endocannabinoid+signaling+in+the+brain&amp;amp;author=RI+Wilson&amp;amp;author=RA+Nicoll&amp;amp;volume=296&amp;amp;publication_year=2002&amp;amp;pages=678-682&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29832</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29833</code><code>]&lt;/span&gt;</code></p><p><code>29834</code><code>&lt;/span&gt;</code></p><p><code>29835</code><code>&lt;/li&gt;</code></p><p><code>29836</code><code>&lt;li id="R1296"&gt;</code></p><p><code>29837</code><code>&lt;span class="citation"&gt;</code></p><p><code>29838</code><code>Wirguin I, Mechoulam R, Breuer A, Schezen E, Weidenfeld J, Brenner T. Suppression of experimental autoimmune encephalomyelitis by cannabinoids. &lt;span&gt;</code></p><p><code>29839</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29840</code><code>Immunopharmacology. &lt;/span&gt;</code></p><p><code>29841</code><code>1994;&lt;span class="ref-vol"&gt;</code></p><p><code>29842</code><code>28&lt;/span&gt;</code></p><p><code>29843</code><code>:209–214.&lt;/span&gt;</code></p><p><code>29844</code><code> [&lt;a href="/pubmed/7852052" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29845</code><code>PubMed&lt;/a&gt;</code></p><p><code>29846</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29847</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Immunopharmacology&amp;amp;title=Suppression+of+experimental+autoimmune+encephalomyelitis+by+cannabinoids&amp;amp;author=I+Wirguin&amp;amp;author=R+Mechoulam&amp;amp;author=A+Breuer&amp;amp;author=E+Schezen&amp;amp;author=J+Weidenfeld&amp;amp;volume=28&amp;amp;publication_year=1994&amp;amp;pages=209-214&amp;amp;pmid=7852052&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29848</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29849</code><code>]&lt;/span&gt;</code></p><p><code>29850</code><code>&lt;/span&gt;</code></p><p><code>29851</code><code>&lt;/li&gt;</code></p><p><code>29852</code><code>&lt;li id="R1297"&gt;</code></p><p><code>29853</code><code>&lt;span class="citation"&gt;</code></p><p><code>29854</code><code>Wise RA. Dopamine, learning and motivation. &lt;span&gt;</code></p><p><code>29855</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29856</code><code>Nat Rev Neurosci. &lt;/span&gt;</code></p><p><code>29857</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>29858</code><code>5&lt;/span&gt;</code></p><p><code>29859</code><code>:483–494.&lt;/span&gt;</code></p><p><code>29860</code><code> [&lt;a href="/pubmed/15152198" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29861</code><code>PubMed&lt;/a&gt;</code></p><p><code>29862</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29863</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Neurosci&amp;amp;title=Dopamine,+learning+and+motivation&amp;amp;author=RA+Wise&amp;amp;volume=5&amp;amp;publication_year=2004&amp;amp;pages=483-494&amp;amp;pmid=15152198&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29864</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29865</code><code>]&lt;/span&gt;</code></p><p><code>29866</code><code>&lt;/span&gt;</code></p><p><code>29867</code><code>&lt;/li&gt;</code></p><p><code>29868</code><code>&lt;li id="R1298"&gt;</code></p><p><code>29869</code><code>&lt;span class="citation"&gt;</code></p><p><code>29870</code><code>Witkin JM, Tzavara ET, Davis RJ, Li X, Nomikos GG. A therapeutic role for cannabinoid CB&lt;sub&gt;</code></p><p><code>29871</code><code>1&lt;/sub&gt;</code></p><p><code>29872</code><code> receptor antagonists in major depressive disorders. &lt;span&gt;</code></p><p><code>29873</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29874</code><code>Trends Pharmacol Sci. &lt;/span&gt;</code></p><p><code>29875</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>29876</code><code>26&lt;/span&gt;</code></p><p><code>29877</code><code>:609–617.&lt;/span&gt;</code></p><p><code>29878</code><code> [&lt;a href="/pubmed/16260047" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29879</code><code>PubMed&lt;/a&gt;</code></p><p><code>29880</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29881</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Trends+Pharmacol+Sci&amp;amp;title=A+therapeutic+role+for+cannabinoid+CB1+receptor+antagonists+in+major+depressive+disorders&amp;amp;author=JM+Witkin&amp;amp;author=ET+Tzavara&amp;amp;author=RJ+Davis&amp;amp;author=X+Li&amp;amp;author=GG+Nomikos&amp;amp;volume=26&amp;amp;publication_year=2005&amp;amp;pages=609-617&amp;amp;pmid=16260047&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29882</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29883</code><code>]&lt;/span&gt;</code></p><p><code>29884</code><code>&lt;/span&gt;</code></p><p><code>29885</code><code>&lt;/li&gt;</code></p><p><code>29886</code><code>&lt;li id="R1299"&gt;</code></p><p><code>29887</code><code>&lt;span class="citation"&gt;</code></p><p><code>29888</code><code>Witting A, Chen L, Cudaback E, Straiker A, Walter L, Rickman B, Moller T, Brosnan C, Stella N. Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection. &lt;span&gt;</code></p><p><code>29889</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29890</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>29891</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>29892</code><code>103&lt;/span&gt;</code></p><p><code>29893</code><code>:6362–6367.&lt;/span&gt;</code></p><p><code>29894</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>29895</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1458883/"&gt;</code></p><p><code>29896</code><code>PMC free article&lt;/a&gt;</code></p><p><code>29897</code><code>]&lt;/span&gt;</code></p><p><code>29898</code><code> [&lt;a href="/pubmed/16571660" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29899</code><code>PubMed&lt;/a&gt;</code></p><p><code>29900</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29901</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Experimental+autoimmune+encephalomyelitis+disrupts+endocannabinoid-mediated+neuroprotection&amp;amp;author=A+Witting&amp;amp;author=L+Chen&amp;amp;author=E+Cudaback&amp;amp;author=A+Straiker&amp;amp;author=L+Walter&amp;amp;volume=103&amp;amp;publication_year=2006&amp;amp;pages=6362-6367&amp;amp;pmid=16571660&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29902</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29903</code><code>]&lt;/span&gt;</code></p><p><code>29904</code><code>&lt;/span&gt;</code></p><p><code>29905</code><code>&lt;/li&gt;</code></p><p><code>29906</code><code>&lt;li id="R1300"&gt;</code></p><p><code>29907</code><code>&lt;span class="citation"&gt;</code></p><p><code>29908</code><code>Witting A, Walter L, Wacker J, Moller T, Stella N. P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. &lt;span&gt;</code></p><p><code>29909</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29910</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>29911</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>29912</code><code>101&lt;/span&gt;</code></p><p><code>29913</code><code>:3214–3219.&lt;/span&gt;</code></p><p><code>29914</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>29915</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC365769/"&gt;</code></p><p><code>29916</code><code>PMC free article&lt;/a&gt;</code></p><p><code>29917</code><code>]&lt;/span&gt;</code></p><p><code>29918</code><code> [&lt;a href="/pubmed/14976257" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29919</code><code>PubMed&lt;/a&gt;</code></p><p><code>29920</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29921</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=P2X7+receptors+control+2-arachidonoylglycerol+production+by+microglial+cells&amp;amp;author=A+Witting&amp;amp;author=L+Walter&amp;amp;author=J+Wacker&amp;amp;author=T+Moller&amp;amp;author=N+Stella&amp;amp;volume=101&amp;amp;publication_year=2004&amp;amp;pages=3214-3219&amp;amp;pmid=14976257&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29922</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29923</code><code>]&lt;/span&gt;</code></p><p><code>29924</code><code>&lt;/span&gt;</code></p><p><code>29925</code><code>&lt;/li&gt;</code></p><p><code>29926</code><code>&lt;li id="R1301"&gt;</code></p><p><code>29927</code><code>&lt;span class="citation"&gt;</code></p><p><code>29928</code><code>Woolridge E, Barton S, Samuel J, Osorio J, Dougherty A, Holdcroft A. Cannabis use in HIV for pain and other medical symptoms. &lt;span&gt;</code></p><p><code>29929</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29930</code><code>J Pain Symptom Manage. &lt;/span&gt;</code></p><p><code>29931</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>29932</code><code>29&lt;/span&gt;</code></p><p><code>29933</code><code>:358–367.&lt;/span&gt;</code></p><p><code>29934</code><code> [&lt;a href="/pubmed/15857739" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29935</code><code>PubMed&lt;/a&gt;</code></p><p><code>29936</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29937</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Pain+Symptom+Manage&amp;amp;title=Cannabis+use+in+HIV+for+pain+and+other+medical+symptoms&amp;amp;author=E+Woolridge&amp;amp;author=S+Barton&amp;amp;author=J+Samuel&amp;amp;author=J+Osorio&amp;amp;author=A+Dougherty&amp;amp;volume=29&amp;amp;publication_year=2005&amp;amp;pages=358-367&amp;amp;pmid=15857739&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29938</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29939</code><code>]&lt;/span&gt;</code></p><p><code>29940</code><code>&lt;/span&gt;</code></p><p><code>29941</code><code>&lt;/li&gt;</code></p><p><code>29942</code><code>&lt;li id="R1302"&gt;</code></p><p><code>29943</code><code>&lt;span class="citation"&gt;</code></p><p><code>29944</code><code>Wright K, Rooney N, Feeney M, Tate J, Robertson D, Welham M, Ward S. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. &lt;span&gt;</code></p><p><code>29945</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29946</code><code>Gastroenterology. &lt;/span&gt;</code></p><p><code>29947</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>29948</code><code>129&lt;/span&gt;</code></p><p><code>29949</code><code>:437–453.&lt;/span&gt;</code></p><p><code>29950</code><code> [&lt;a href="/pubmed/16083701" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29951</code><code>PubMed&lt;/a&gt;</code></p><p><code>29952</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29953</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;amp;title=Differential+expression+of+cannabinoid+receptors+in+the+human+colon:+cannabinoids+promote+epithelial+wound+healing&amp;amp;author=K+Wright&amp;amp;author=N+Rooney&amp;amp;author=M+Feeney&amp;amp;author=J+Tate&amp;amp;author=D+Robertson&amp;amp;volume=129&amp;amp;publication_year=2005&amp;amp;pages=437-453&amp;amp;pmid=16083701&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29954</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29955</code><code>]&lt;/span&gt;</code></p><p><code>29956</code><code>&lt;/span&gt;</code></p><p><code>29957</code><code>&lt;/li&gt;</code></p><p><code>29958</code><code>&lt;li id="R1303"&gt;</code></p><p><code>29959</code><code>&lt;span class="citation"&gt;</code></p><p><code>29960</code><code>Yaksh TL. The antinociceptive effects of intrathecally administered levonantradol and desacetyllevonantradol in the rat. &lt;span&gt;</code></p><p><code>29961</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29962</code><code>J Clin Pharmacol. &lt;/span&gt;</code></p><p><code>29963</code><code>1981;&lt;span class="ref-vol"&gt;</code></p><p><code>29964</code><code>21&lt;/span&gt;</code></p><p><code>29965</code><code>:334S–340S.&lt;/span&gt;</code></p><p><code>29966</code><code> [&lt;a href="/pubmed/6895380" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29967</code><code>PubMed&lt;/a&gt;</code></p><p><code>29968</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29969</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pharmacol&amp;amp;title=The+antinociceptive+effects+of+intrathecally+administered+levonantradol+and+desacetyllevonantradol+in+the+rat&amp;amp;author=TL+Yaksh&amp;amp;volume=21&amp;amp;publication_year=1981&amp;amp;pages=334S-340S&amp;amp;pmid=6895380&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29970</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29971</code><code>]&lt;/span&gt;</code></p><p><code>29972</code><code>&lt;/span&gt;</code></p><p><code>29973</code><code>&lt;/li&gt;</code></p><p><code>29974</code><code>&lt;li id="R1304"&gt;</code></p><p><code>29975</code><code>&lt;span class="citation"&gt;</code></p><p><code>29976</code><code>Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, et al.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. &lt;span&gt;</code></p><p><code>29977</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29978</code><code>Nat Med. &lt;/span&gt;</code></p><p><code>29979</code><code>2002;&lt;span class="ref-vol"&gt;</code></p><p><code>29980</code><code>8&lt;/span&gt;</code></p><p><code>29981</code><code>:1288–1295.&lt;/span&gt;</code></p><p><code>29982</code><code> [&lt;a href="/pubmed/12368907" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>29983</code><code>PubMed&lt;/a&gt;</code></p><p><code>29984</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>29985</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;amp;title=Adiponectin+stimulates+glucose+utilization+and+fatty-acid+oxidation+by+activating+AMP-activated+protein+kinase&amp;amp;author=T+Yamauchi&amp;amp;author=J+Kamon&amp;amp;author=Y+Minokoshi&amp;amp;author=Y+Ito&amp;amp;author=H+Waki&amp;amp;volume=8&amp;amp;publication_year=2002&amp;amp;pages=1288-1295&amp;amp;pmid=12368907&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>29986</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>29987</code><code>]&lt;/span&gt;</code></p><p><code>29988</code><code>&lt;/span&gt;</code></p><p><code>29989</code><code>&lt;/li&gt;</code></p><p><code>29990</code><code>&lt;li id="R1305"&gt;</code></p><p><code>29991</code><code>&lt;span class="citation"&gt;</code></p><p><code>29992</code><code>Yao L, McFarland K, Fan P, Jiang Z, Ueda T, Diamond I. Adenosine A2a blockade prevents synergy between &lt;em&gt;</code></p><p><code>29993</code><code>&amp;#x003bc;&lt;/em&gt;</code></p><p><code>29994</code><code>-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats. &lt;span&gt;</code></p><p><code>29995</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>29996</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>29997</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>29998</code><code>103&lt;/span&gt;</code></p><p><code>29999</code><code>:7877–7882.&lt;/span&gt;</code></p><p><code>30000</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>30001</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC1458620/"&gt;</code></p><p><code>30002</code><code>PMC free article&lt;/a&gt;</code></p><p><code>30003</code><code>]&lt;/span&gt;</code></p><p><code>30004</code><code> [&lt;a href="/pubmed/16684876" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30005</code><code>PubMed&lt;/a&gt;</code></p><p><code>30006</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30007</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Adenosine+A2a+blockade+prevents+synergy+between+&amp;#x003bc;-opiate+and+cannabinoid+CB1+receptors+and+eliminates+heroin-seeking+behavior+in+addicted+rats&amp;amp;author=L+Yao&amp;amp;author=K+McFarland&amp;amp;author=P+Fan&amp;amp;author=Z+Jiang&amp;amp;author=T+Ueda&amp;amp;volume=103&amp;amp;publication_year=2006&amp;amp;pages=7877-7882&amp;amp;pmid=16684876&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30008</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30009</code><code>]&lt;/span&gt;</code></p><p><code>30010</code><code>&lt;/span&gt;</code></p><p><code>30011</code><code>&lt;/li&gt;</code></p><p><code>30012</code><code>&lt;li id="R1306"&gt;</code></p><p><code>30013</code><code>&lt;span class="citation"&gt;</code></p><p><code>30014</code><code>Yazulla S, Studholme KM, McIntosh HH, Deutsch DG. Immunocytochemical localization of cannabinoid CB1 receptor and fatty acid amide hydrolase in rat retina. &lt;span&gt;</code></p><p><code>30015</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30016</code><code>J Comp Neurol. &lt;/span&gt;</code></p><p><code>30017</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>30018</code><code>415&lt;/span&gt;</code></p><p><code>30019</code><code>:80–90.&lt;/span&gt;</code></p><p><code>30020</code><code> [&lt;a href="/pubmed/10540359" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30021</code><code>PubMed&lt;/a&gt;</code></p><p><code>30022</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30023</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Comp+Neurol&amp;amp;title=Immunocytochemical+localization+of+cannabinoid+CB1+receptor+and+fatty+acid+amide+hydrolase+in+rat+retina&amp;amp;author=S+Yazulla&amp;amp;author=KM+Studholme&amp;amp;author=HH+McIntosh&amp;amp;author=DG+Deutsch&amp;amp;volume=415&amp;amp;publication_year=1999&amp;amp;pages=80-90&amp;amp;pmid=10540359&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30024</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30025</code><code>]&lt;/span&gt;</code></p><p><code>30026</code><code>&lt;/span&gt;</code></p><p><code>30027</code><code>&lt;/li&gt;</code></p><p><code>30028</code><code>&lt;li id="R1307"&gt;</code></p><p><code>30029</code><code>&lt;span class="citation"&gt;</code></p><p><code>30030</code><code>Yazulla S, Studholme KM, McIntosh HH, Fan SF. Cannabinoid receptors on goldfish retinal bipolar cells: electron-microscope immunocytochemistry and whole-cell recordings. &lt;span&gt;</code></p><p><code>30031</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30032</code><code>Vis Neurosci. &lt;/span&gt;</code></p><p><code>30033</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>30034</code><code>17&lt;/span&gt;</code></p><p><code>30035</code><code>:391–401.&lt;/span&gt;</code></p><p><code>30036</code><code> [&lt;a href="/pubmed/10910107" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30037</code><code>PubMed&lt;/a&gt;</code></p><p><code>30038</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30039</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Vis+Neurosci&amp;amp;title=Cannabinoid+receptors+on+goldfish+retinal+bipolar+cells:+electron-microscope+immunocytochemistry+and+whole-cell+recordings&amp;amp;author=S+Yazulla&amp;amp;author=KM+Studholme&amp;amp;author=HH+McIntosh&amp;amp;author=SF+Fan&amp;amp;volume=17&amp;amp;publication_year=2000&amp;amp;pages=391-401&amp;amp;pmid=10910107&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30040</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30041</code><code>]&lt;/span&gt;</code></p><p><code>30042</code><code>&lt;/span&gt;</code></p><p><code>30043</code><code>&lt;/li&gt;</code></p><p><code>30044</code><code>&lt;li id="R1308"&gt;</code></p><p><code>30045</code><code>&lt;span class="citation"&gt;</code></p><p><code>30046</code><code>Yoles E, Belkin M, Schwartz M. HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomy. &lt;span&gt;</code></p><p><code>30047</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30048</code><code>J Neurotrauma. &lt;/span&gt;</code></p><p><code>30049</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>30050</code><code>13&lt;/span&gt;</code></p><p><code>30051</code><code>:49–57.&lt;/span&gt;</code></p><p><code>30052</code><code> [&lt;a href="/pubmed/8714863" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30053</code><code>PubMed&lt;/a&gt;</code></p><p><code>30054</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30055</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurotrauma&amp;amp;title=HU-211,+a+nonpsychotropic+cannabinoid,+produces+short-+and+long-term+neuroprotection+after+optic+nerve+axotomy&amp;amp;author=E+Yoles&amp;amp;author=M+Belkin&amp;amp;author=M+Schwartz&amp;amp;volume=13&amp;amp;publication_year=1996&amp;amp;pages=49-57&amp;amp;pmid=8714863&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30056</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30057</code><code>]&lt;/span&gt;</code></p><p><code>30058</code><code>&lt;/span&gt;</code></p><p><code>30059</code><code>&lt;/li&gt;</code></p><p><code>30060</code><code>&lt;li id="R1309"&gt;</code></p><p><code>30061</code><code>&lt;span class="citation"&gt;</code></p><p><code>30062</code><code>Yoshida T, Fukaya M, Uchigashima M, Miura E, Kamiya H, Kano M, Watanabe M. Localization of diacylglycerol lipase-&lt;em&gt;</code></p><p><code>30063</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>30064</code><code> around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidinoyl-glycerol, and presynaptic cannabinoid CB1 receptor. &lt;span&gt;</code></p><p><code>30065</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30066</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>30067</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>30068</code><code>26&lt;/span&gt;</code></p><p><code>30069</code><code>:4740–4751.&lt;/span&gt;</code></p><p><code>30070</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>30071</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6674155/"&gt;</code></p><p><code>30072</code><code>PMC free article&lt;/a&gt;</code></p><p><code>30073</code><code>]&lt;/span&gt;</code></p><p><code>30074</code><code> [&lt;a href="/pubmed/16672646" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30075</code><code>PubMed&lt;/a&gt;</code></p><p><code>30076</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30077</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Localization+of+diacylglycerol+lipase-&amp;#x003b1;+around+postsynaptic+spine+suggests+close+proximity+between+production+site+of+an+endocannabinoid,+2-arachidinoyl-glycerol,+and+presynaptic+cannabinoid+CB1+receptor&amp;amp;author=T+Yoshida&amp;amp;author=M+Fukaya&amp;amp;author=M+Uchigashima&amp;amp;author=E+Miura&amp;amp;author=H+Kamiya&amp;amp;volume=26&amp;amp;publication_year=2006&amp;amp;pages=4740-4751&amp;amp;pmid=16672646&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30078</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30079</code><code>]&lt;/span&gt;</code></p><p><code>30080</code><code>&lt;/span&gt;</code></p><p><code>30081</code><code>&lt;/li&gt;</code></p><p><code>30082</code><code>&lt;li id="R1310"&gt;</code></p><p><code>30083</code><code>&lt;span class="citation"&gt;</code></p><p><code>30084</code><code>Yoshihara S, Morimoto H, Ohori M, Yamada Y, Abe T, Arisaka O. Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways. &lt;span&gt;</code></p><p><code>30085</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30086</code><code>Int Arch Allergy Immunol. &lt;/span&gt;</code></p><p><code>30087</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>30088</code><code>138&lt;/span&gt;</code></p><p><code>30089</code><code>:80–87.&lt;/span&gt;</code></p><p><code>30090</code><code> [&lt;a href="/pubmed/16103691" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30091</code><code>PubMed&lt;/a&gt;</code></p><p><code>30092</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30093</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Int+Arch+Allergy+Immunol&amp;amp;title=Endogenous+cannabinoid+receptor+agonists+inhibit+neurogenic+inflammations+in+guinea+pig+airways&amp;amp;author=S+Yoshihara&amp;amp;author=H+Morimoto&amp;amp;author=M+Ohori&amp;amp;author=Y+Yamada&amp;amp;author=T+Abe&amp;amp;volume=138&amp;amp;publication_year=2005&amp;amp;pages=80-87&amp;amp;pmid=16103691&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30094</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30095</code><code>]&lt;/span&gt;</code></p><p><code>30096</code><code>&lt;/span&gt;</code></p><p><code>30097</code><code>&lt;/li&gt;</code></p><p><code>30098</code><code>&lt;li id="R1311"&gt;</code></p><p><code>30099</code><code>&lt;span class="citation"&gt;</code></p><p><code>30100</code><code>Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A, Thompson A. The cannabinoids in MS study&amp;#x02014;final results from 12 months follow-up. &lt;span&gt;</code></p><p><code>30101</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30102</code><code>Mult Scler. &lt;/span&gt;</code></p><p><code>30103</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>30104</code><code>109&lt;/span&gt;</code></p><p><code>30105</code><code>:S115.&lt;/span&gt;</code></p><p><code>30106</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>30107</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Mult+Scler&amp;amp;title=The+cannabinoids+in+MS+study&amp;#x02014;final+results+from+12+months+follow-up&amp;amp;author=J+Zajicek&amp;amp;author=P+Fox&amp;amp;author=H+Sanders&amp;amp;author=D+Wright&amp;amp;author=J+Vickery&amp;amp;volume=109&amp;amp;publication_year=2004&amp;amp;pages=S115&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30108</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30109</code><code>]&lt;/span&gt;</code></p><p><code>30110</code><code>&lt;/span&gt;</code></p><p><code>30111</code><code>&lt;/li&gt;</code></p><p><code>30112</code><code>&lt;li id="R1312"&gt;</code></p><p><code>30113</code><code>&lt;span class="citation"&gt;</code></p><p><code>30114</code><code>Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A, Thompson A UK MS Research Group. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. &lt;span&gt;</code></p><p><code>30115</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30116</code><code>Lancet. &lt;/span&gt;</code></p><p><code>30117</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>30118</code><code>362&lt;/span&gt;</code></p><p><code>30119</code><code>:1517–1526.&lt;/span&gt;</code></p><p><code>30120</code><code> [&lt;a href="/pubmed/14615106" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30121</code><code>PubMed&lt;/a&gt;</code></p><p><code>30122</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30123</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;amp;title=Cannabinoids+for+treatment+of+spasticity+and+other+symptoms+related+to+multiple+sclerosis+(CAMS+study):+multicentre+randomised+placebo-controlled+trial&amp;amp;author=J+Zajicek&amp;amp;author=P+Fox&amp;amp;author=H+Sanders&amp;amp;author=D+Wright&amp;amp;author=J+Vickery&amp;amp;volume=362&amp;amp;publication_year=2003&amp;amp;pages=1517-1526&amp;amp;pmid=14615106&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30124</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30125</code><code>]&lt;/span&gt;</code></p><p><code>30126</code><code>&lt;/span&gt;</code></p><p><code>30127</code><code>&lt;/li&gt;</code></p><p><code>30128</code><code>&lt;li id="R1313"&gt;</code></p><p><code>30129</code><code>&lt;span class="citation"&gt;</code></p><p><code>30130</code><code>Zalish M, Lavie V. Dexanabinol (HU-211) has a beneficial effect on axonal sprouting and survival after rat optic nerve crush injury. &lt;span&gt;</code></p><p><code>30131</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30132</code><code>Vision Res. &lt;/span&gt;</code></p><p><code>30133</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>30134</code><code>43&lt;/span&gt;</code></p><p><code>30135</code><code>:237–242.&lt;/span&gt;</code></p><p><code>30136</code><code> [&lt;a href="/pubmed/12535983" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30137</code><code>PubMed&lt;/a&gt;</code></p><p><code>30138</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30139</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Vision+Res&amp;amp;title=Dexanabinol+(HU-211)+has+a+beneficial+effect+on+axonal+sprouting+and+survival+after+rat+optic+nerve+crush+injury&amp;amp;author=M+Zalish&amp;amp;author=V+Lavie&amp;amp;volume=43&amp;amp;publication_year=2003&amp;amp;pages=237-242&amp;amp;pmid=12535983&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30140</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30141</code><code>]&lt;/span&gt;</code></p><p><code>30142</code><code>&lt;/span&gt;</code></p><p><code>30143</code><code>&lt;/li&gt;</code></p><p><code>30144</code><code>&lt;li id="R1314"&gt;</code></p><p><code>30145</code><code>&lt;span class="citation"&gt;</code></p><p><code>30146</code><code>Zangen A, Solinas M, Ikemoto S, Goldberg SR, Wise RA. Two brain sites for cannabinoid reward. &lt;span&gt;</code></p><p><code>30147</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30148</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>30149</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>30150</code><code>26&lt;/span&gt;</code></p><p><code>30151</code><code>:4901–4907.&lt;/span&gt;</code></p><p><code>30152</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>30153</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6674153/"&gt;</code></p><p><code>30154</code><code>PMC free article&lt;/a&gt;</code></p><p><code>30155</code><code>]&lt;/span&gt;</code></p><p><code>30156</code><code> [&lt;a href="/pubmed/16672664" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30157</code><code>PubMed&lt;/a&gt;</code></p><p><code>30158</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30159</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Two+brain+sites+for+cannabinoid+reward&amp;amp;author=A+Zangen&amp;amp;author=M+Solinas&amp;amp;author=S+Ikemoto&amp;amp;author=SR+Goldberg&amp;amp;author=RA+Wise&amp;amp;volume=26&amp;amp;publication_year=2006&amp;amp;pages=4901-4907&amp;amp;pmid=16672664&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30160</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30161</code><code>]&lt;/span&gt;</code></p><p><code>30162</code><code>&lt;/span&gt;</code></p><p><code>30163</code><code>&lt;/li&gt;</code></p><p><code>30164</code><code>&lt;li id="R1315"&gt;</code></p><p><code>30165</code><code>&lt;span class="citation"&gt;</code></p><p><code>30166</code><code>Zaretsky A, Rector NA, Seeman MV, Fornazzari X. Current cannabis use and tardive dyskinesia. &lt;span&gt;</code></p><p><code>30167</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30168</code><code>Schizophr Res. &lt;/span&gt;</code></p><p><code>30169</code><code>1993;&lt;span class="ref-vol"&gt;</code></p><p><code>30170</code><code>11&lt;/span&gt;</code></p><p><code>30171</code><code>:3–8.&lt;/span&gt;</code></p><p><code>30172</code><code> [&lt;a href="/pubmed/7905284" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30173</code><code>PubMed&lt;/a&gt;</code></p><p><code>30174</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30175</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Schizophr+Res&amp;amp;title=Current+cannabis+use+and+tardive+dyskinesia&amp;amp;author=A+Zaretsky&amp;amp;author=NA+Rector&amp;amp;author=MV+Seeman&amp;amp;author=X+Fornazzari&amp;amp;volume=11&amp;amp;publication_year=1993&amp;amp;pages=3-8&amp;amp;pmid=7905284&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30176</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30177</code><code>]&lt;/span&gt;</code></p><p><code>30178</code><code>&lt;/span&gt;</code></p><p><code>30179</code><code>&lt;/li&gt;</code></p><p><code>30180</code><code>&lt;li id="R1316"&gt;</code></p><p><code>30181</code><code>&lt;span class="citation"&gt;</code></p><p><code>30182</code><code>Zaugg HE, Kyncl J. New antihypertensive cannabinoids. &lt;span&gt;</code></p><p><code>30183</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30184</code><code>J Med Chem. &lt;/span&gt;</code></p><p><code>30185</code><code>1983;&lt;span class="ref-vol"&gt;</code></p><p><code>30186</code><code>26&lt;/span&gt;</code></p><p><code>30187</code><code>:214–217.&lt;/span&gt;</code></p><p><code>30188</code><code> [&lt;a href="/pubmed/6827538" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30189</code><code>PubMed&lt;/a&gt;</code></p><p><code>30190</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30191</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;amp;title=New+antihypertensive+cannabinoids&amp;amp;author=HE+Zaugg&amp;amp;author=J+Kyncl&amp;amp;volume=26&amp;amp;publication_year=1983&amp;amp;pages=214-217&amp;amp;pmid=6827538&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30192</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30193</code><code>]&lt;/span&gt;</code></p><p><code>30194</code><code>&lt;/span&gt;</code></p><p><code>30195</code><code>&lt;/li&gt;</code></p><p><code>30196</code><code>&lt;li id="R1317"&gt;</code></p><p><code>30197</code><code>&lt;span class="citation"&gt;</code></p><p><code>30198</code><code>Zavitsanou K, Garrick T, Huang XF. Selective antagonist [&lt;sup&gt;</code></p><p><code>30199</code><code>3&lt;/sup&gt;</code></p><p><code>30200</code><code>H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia. &lt;span&gt;</code></p><p><code>30201</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30202</code><code>Prog Neuropsychopharmacol Biol Psychiatry. &lt;/span&gt;</code></p><p><code>30203</code><code>2004;&lt;span class="ref-vol"&gt;</code></p><p><code>30204</code><code>28&lt;/span&gt;</code></p><p><code>30205</code><code>:355–360.&lt;/span&gt;</code></p><p><code>30206</code><code> [&lt;a href="/pubmed/14751433" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30207</code><code>PubMed&lt;/a&gt;</code></p><p><code>30208</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30209</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Prog+Neuropsychopharmacol+Biol+Psychiatry&amp;amp;title=Selective+antagonist+[3H]SR141716A+binding+to+cannabinoid+CB1+receptors+is+increased+in+the+anterior+cingulate+cortex+in+schizophrenia&amp;amp;author=K+Zavitsanou&amp;amp;author=T+Garrick&amp;amp;author=XF+Huang&amp;amp;volume=28&amp;amp;publication_year=2004&amp;amp;pages=355-360&amp;amp;pmid=14751433&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30210</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30211</code><code>]&lt;/span&gt;</code></p><p><code>30212</code><code>&lt;/span&gt;</code></p><p><code>30213</code><code>&lt;/li&gt;</code></p><p><code>30214</code><code>&lt;li id="R1318"&gt;</code></p><p><code>30215</code><code>&lt;span class="citation"&gt;</code></p><p><code>30216</code><code>Zeng BY, Dass B, Owen A, Rose S, Cannizzaro C, Tel BC, Jenner P. Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats. &lt;span&gt;</code></p><p><code>30217</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30218</code><code>Neurosci Lett. &lt;/span&gt;</code></p><p><code>30219</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>30220</code><code>276&lt;/span&gt;</code></p><p><code>30221</code><code>:71–74.&lt;/span&gt;</code></p><p><code>30222</code><code> [&lt;a href="/pubmed/10624794" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30223</code><code>PubMed&lt;/a&gt;</code></p><p><code>30224</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30225</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Lett&amp;amp;title=Chronic+L-DOPA+treatment+increases+striatal+cannabinoid+CB1+receptor+mRNA+expression+in+6-hydroxydopamine-lesioned+rats&amp;amp;author=BY+Zeng&amp;amp;author=B+Dass&amp;amp;author=A+Owen&amp;amp;author=S+Rose&amp;amp;author=C+Cannizzaro&amp;amp;volume=276&amp;amp;publication_year=1999&amp;amp;pages=71-74&amp;amp;pmid=10624794&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30226</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30227</code><code>]&lt;/span&gt;</code></p><p><code>30228</code><code>&lt;/span&gt;</code></p><p><code>30229</code><code>&lt;/li&gt;</code></p><p><code>30230</code><code>&lt;li id="R1319"&gt;</code></p><p><code>30231</code><code>&lt;span class="citation"&gt;</code></p><p><code>30232</code><code>Zhang ZF, Morgenstern H, Spitz MR, Tashkin DP, Yu GP, Marshall JR, Hsu TC, Schantz SP. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. &lt;span&gt;</code></p><p><code>30233</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30234</code><code>Cancer Epidemiol Biomarkers Prev. &lt;/span&gt;</code></p><p><code>30235</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>30236</code><code>8&lt;/span&gt;</code></p><p><code>30237</code><code>:1071–1078.&lt;/span&gt;</code></p><p><code>30238</code><code> [&lt;a href="/pubmed/10613339" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30239</code><code>PubMed&lt;/a&gt;</code></p><p><code>30240</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30241</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Epidemiol+Biomarkers+Prev&amp;amp;title=Marijuana+use+and+increased+risk+of+squamous+cell+carcinoma+of+the+head+and+neck&amp;amp;author=ZF+Zhang&amp;amp;author=H+Morgenstern&amp;amp;author=MR+Spitz&amp;amp;author=DP+Tashkin&amp;amp;author=GP+Yu&amp;amp;volume=8&amp;amp;publication_year=1999&amp;amp;pages=1071-1078&amp;amp;pmid=10613339&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30242</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30243</code><code>]&lt;/span&gt;</code></p><p><code>30244</code><code>&lt;/span&gt;</code></p><p><code>30245</code><code>&lt;/li&gt;</code></p><p><code>30246</code><code>&lt;li id="R1320"&gt;</code></p><p><code>30247</code><code>&lt;span class="citation"&gt;</code></p><p><code>30248</code><code>Zheng ZM, Specter S, Friedman H. Inhibition by &amp;#x00394;-9-tetrahydrocannab-inol of tumor necrosis factor &lt;em&gt;</code></p><p><code>30249</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>30250</code><code> production by mouse and human macrophages. &lt;span&gt;</code></p><p><code>30251</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30252</code><code>Int J Immunopharmacol. &lt;/span&gt;</code></p><p><code>30253</code><code>1992;&lt;span class="ref-vol"&gt;</code></p><p><code>30254</code><code>14&lt;/span&gt;</code></p><p><code>30255</code><code>:1445–1452.&lt;/span&gt;</code></p><p><code>30256</code><code> [&lt;a href="/pubmed/1334476" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30257</code><code>PubMed&lt;/a&gt;</code></p><p><code>30258</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30259</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Immunopharmacol&amp;amp;title=Inhibition+by+&amp;#x00394;-9-tetrahydrocannab-inol+of+tumor+necrosis+factor+&amp;#x003b1;+production+by+mouse+and+human+macrophages&amp;amp;author=ZM+Zheng&amp;amp;author=S+Specter&amp;amp;author=H+Friedman&amp;amp;volume=14&amp;amp;publication_year=1992&amp;amp;pages=1445-1452&amp;amp;pmid=1334476&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30260</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30261</code><code>]&lt;/span&gt;</code></p><p><code>30262</code><code>&lt;/span&gt;</code></p><p><code>30263</code><code>&lt;/li&gt;</code></p><p><code>30264</code><code>&lt;li id="R1321"&gt;</code></p><p><code>30265</code><code>&lt;span class="citation"&gt;</code></p><p><code>30266</code><code>Zheng ZM, Specter SC. &amp;#x00394;-9-Tetrahydrocannabinol suppresses tumor necrosis factor &lt;em&gt;</code></p><p><code>30267</code><code>&amp;#x003b1;&lt;/em&gt;</code></p><p><code>30268</code><code> maturation and secretion but not its transcription in mouse macrophages. &lt;span&gt;</code></p><p><code>30269</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30270</code><code>Int J Immunopharmacol. &lt;/span&gt;</code></p><p><code>30271</code><code>1996;&lt;span class="ref-vol"&gt;</code></p><p><code>30272</code><code>18&lt;/span&gt;</code></p><p><code>30273</code><code>:53–68.&lt;/span&gt;</code></p><p><code>30274</code><code> [&lt;a href="/pubmed/8732433" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30275</code><code>PubMed&lt;/a&gt;</code></p><p><code>30276</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30277</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Immunopharmacol&amp;amp;title=&amp;#x00394;-9-Tetrahydrocannabinol+suppresses+tumor+necrosis+factor+&amp;#x003b1;+maturation+and+secretion+but+not+its+transcription+in+mouse+macrophages&amp;amp;author=ZM+Zheng&amp;amp;author=SC+Specter&amp;amp;volume=18&amp;amp;publication_year=1996&amp;amp;pages=53-68&amp;amp;pmid=8732433&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30278</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30279</code><code>]&lt;/span&gt;</code></p><p><code>30280</code><code>&lt;/span&gt;</code></p><p><code>30281</code><code>&lt;/li&gt;</code></p><p><code>30282</code><code>&lt;li id="R1322"&gt;</code></p><p><code>30283</code><code>&lt;span class="citation"&gt;</code></p><p><code>30284</code><code>Zhu LX, Sharma S, Stolina M, Gardner B, Roth MD, Tashkin DP, Dubinett SM. &amp;#x00394;-9-Tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. &lt;span&gt;</code></p><p><code>30285</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30286</code><code>J Immunol. &lt;/span&gt;</code></p><p><code>30287</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>30288</code><code>165&lt;/span&gt;</code></p><p><code>30289</code><code>:373–380.&lt;/span&gt;</code></p><p><code>30290</code><code> [&lt;a href="/pubmed/10861074" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30291</code><code>PubMed&lt;/a&gt;</code></p><p><code>30292</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30293</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;amp;title=&amp;#x00394;-9-Tetrahydrocannabinol+inhibits+antitumor+immunity+by+a+CB2+receptor-mediated,+cytokine-dependent+pathway&amp;amp;author=LX+Zhu&amp;amp;author=S+Sharma&amp;amp;author=M+Stolina&amp;amp;author=B+Gardner&amp;amp;author=MD+Roth&amp;amp;volume=165&amp;amp;publication_year=2000&amp;amp;pages=373-380&amp;amp;pmid=10861074&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30294</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30295</code><code>]&lt;/span&gt;</code></p><p><code>30296</code><code>&lt;/span&gt;</code></p><p><code>30297</code><code>&lt;/li&gt;</code></p><p><code>30298</code><code>&lt;li id="R1323"&gt;</code></p><p><code>30299</code><code>&lt;span class="citation"&gt;</code></p><p><code>30300</code><code>Zhuang SY, Bridges D, Grigorenko E, McCloud S, Boon A, Hampson RE, Deadwyler SA. Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores. &lt;span&gt;</code></p><p><code>30301</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30302</code><code>Neuropharmacology. &lt;/span&gt;</code></p><p><code>30303</code><code>2005;&lt;span class="ref-vol"&gt;</code></p><p><code>30304</code><code>48&lt;/span&gt;</code></p><p><code>30305</code><code>:1086–1096.&lt;/span&gt;</code></p><p><code>30306</code><code> [&lt;a href="/pubmed/15910885" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30307</code><code>PubMed&lt;/a&gt;</code></p><p><code>30308</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30309</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;amp;title=Cannabinoids+produce+neuroprotection+by+reducing+intracellular+calcium+release+from+ryanodine-sensitive+stores&amp;amp;author=SY+Zhuang&amp;amp;author=D+Bridges&amp;amp;author=E+Grigorenko&amp;amp;author=S+McCloud&amp;amp;author=A+Boon&amp;amp;volume=48&amp;amp;publication_year=2005&amp;amp;pages=1086-1096&amp;amp;pmid=15910885&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30310</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30311</code><code>]&lt;/span&gt;</code></p><p><code>30312</code><code>&lt;/span&gt;</code></p><p><code>30313</code><code>&lt;/li&gt;</code></p><p><code>30314</code><code>&lt;li id="R1324"&gt;</code></p><p><code>30315</code><code>&lt;span class="citation"&gt;</code></p><p><code>30316</code><code>Zimmer A, Valjent E, Konig M, Zimmer AM, Robledo P, Hahn H, Valverde O, Maldonado R. Absence of &amp;#x00394;-9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice. &lt;span&gt;</code></p><p><code>30317</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30318</code><code>J Neurosci. &lt;/span&gt;</code></p><p><code>30319</code><code>2001;&lt;span class="ref-vol"&gt;</code></p><p><code>30320</code><code>21&lt;/span&gt;</code></p><p><code>30321</code><code>:9499–9505.&lt;/span&gt;</code></p><p><code>30322</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>30323</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC6763924/"&gt;</code></p><p><code>30324</code><code>PMC free article&lt;/a&gt;</code></p><p><code>30325</code><code>]&lt;/span&gt;</code></p><p><code>30326</code><code> [&lt;a href="/pubmed/11717384" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30327</code><code>PubMed&lt;/a&gt;</code></p><p><code>30328</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30329</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci&amp;amp;title=Absence+of+&amp;#x00394;-9-tetrahydrocannabinol+dysphoric+effects+in+dynorphin-deficient+mice&amp;amp;author=A+Zimmer&amp;amp;author=E+Valjent&amp;amp;author=M+Konig&amp;amp;author=AM+Zimmer&amp;amp;author=P+Robledo&amp;amp;volume=21&amp;amp;publication_year=2001&amp;amp;pages=9499-9505&amp;amp;pmid=11717384&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30330</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30331</code><code>]&lt;/span&gt;</code></p><p><code>30332</code><code>&lt;/span&gt;</code></p><p><code>30333</code><code>&lt;/li&gt;</code></p><p><code>30334</code><code>&lt;li id="R1325"&gt;</code></p><p><code>30335</code><code>&lt;span class="citation"&gt;</code></p><p><code>30336</code><code>Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. &lt;span&gt;</code></p><p><code>30337</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30338</code><code>Proc Natl Acad Sci USA. &lt;/span&gt;</code></p><p><code>30339</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>30340</code><code>96&lt;/span&gt;</code></p><p><code>30341</code><code>:5780–5785.&lt;/span&gt;</code></p><p><code>30342</code><code> &lt;span class="nowrap"&gt;</code></p><p><code>30343</code><code>[&lt;a class="int-reflink" href="/pmc/articles/PMC21937/"&gt;</code></p><p><code>30344</code><code>PMC free article&lt;/a&gt;</code></p><p><code>30345</code><code>]&lt;/span&gt;</code></p><p><code>30346</code><code> [&lt;a href="/pubmed/10318961" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30347</code><code>PubMed&lt;/a&gt;</code></p><p><code>30348</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30349</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;amp;title=Increased+mortality,+hypoactivity,+and+hypoalgesia+in+cannabinoid+CB1+receptor+knockout+mice&amp;amp;author=A+Zimmer&amp;amp;author=AM+Zimmer&amp;amp;author=AG+Hohmann&amp;amp;author=M+Herkenham&amp;amp;author=TI+Bonner&amp;amp;volume=96&amp;amp;publication_year=1999&amp;amp;pages=5780-5785&amp;amp;pmid=10318961&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30350</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30351</code><code>]&lt;/span&gt;</code></p><p><code>30352</code><code>&lt;/span&gt;</code></p><p><code>30353</code><code>&lt;/li&gt;</code></p><p><code>30354</code><code>&lt;li id="R1326"&gt;</code></p><p><code>30355</code><code>&lt;span class="citation"&gt;</code></p><p><code>30356</code><code>Zuardi AW, Crippa JA, Hallak JE, Moreira FA, Guimaraes FS. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. &lt;span&gt;</code></p><p><code>30357</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30358</code><code>Braz J Med Biol Res. &lt;/span&gt;</code></p><p><code>30359</code><code>2006;&lt;span class="ref-vol"&gt;</code></p><p><code>30360</code><code>39&lt;/span&gt;</code></p><p><code>30361</code><code>:421–429.&lt;/span&gt;</code></p><p><code>30362</code><code> [&lt;a href="/pubmed/16612464" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30363</code><code>PubMed&lt;/a&gt;</code></p><p><code>30364</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30365</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Braz+J+Med+Biol+Res&amp;amp;title=Cannabidiol,+a+Cannabis+sativa+constituent,+as+an+antipsychotic+drug&amp;amp;author=AW+Zuardi&amp;amp;author=JA+Crippa&amp;amp;author=JE+Hallak&amp;amp;author=FA+Moreira&amp;amp;author=FS+Guimaraes&amp;amp;volume=39&amp;amp;publication_year=2006&amp;amp;pages=421-429&amp;amp;pmid=16612464&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30366</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30367</code><code>]&lt;/span&gt;</code></p><p><code>30368</code><code>&lt;/span&gt;</code></p><p><code>30369</code><code>&lt;/li&gt;</code></p><p><code>30370</code><code>&lt;li id="R1327"&gt;</code></p><p><code>30371</code><code>&lt;span class="citation"&gt;</code></p><p><code>30372</code><code>Zuardi AW, Morais SL, Guimaraes FS, Mechoulam R. Antipsychotic effect of cannabidiol. &lt;span&gt;</code></p><p><code>30373</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30374</code><code>J Clin Psychiatry. &lt;/span&gt;</code></p><p><code>30375</code><code>1995;&lt;span class="ref-vol"&gt;</code></p><p><code>30376</code><code>56&lt;/span&gt;</code></p><p><code>30377</code><code>:485–486.&lt;/span&gt;</code></p><p><code>30378</code><code> [&lt;a href="/pubmed/7559378" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30379</code><code>PubMed&lt;/a&gt;</code></p><p><code>30380</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30381</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Psychiatry&amp;amp;title=Antipsychotic+effect+of+cannabidiol&amp;amp;author=AW+Zuardi&amp;amp;author=SL+Morais&amp;amp;author=FS+Guimaraes&amp;amp;author=R+Mechoulam&amp;amp;volume=56&amp;amp;publication_year=1995&amp;amp;pages=485-486&amp;amp;pmid=7559378&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30382</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30383</code><code>]&lt;/span&gt;</code></p><p><code>30384</code><code>&lt;/span&gt;</code></p><p><code>30385</code><code>&lt;/li&gt;</code></p><p><code>30386</code><code>&lt;li id="R1328"&gt;</code></p><p><code>30387</code><code>&lt;span class="citation"&gt;</code></p><p><code>30388</code><code>Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG. Action of cannabidiol on the anxiety and other effects produced by &amp;#x00394;&lt;sup&gt;</code></p><p><code>30389</code><code>9&lt;/sup&gt;</code></p><p><code>30390</code><code>-THC in normal subjects. &lt;span&gt;</code></p><p><code>30391</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30392</code><code>Psychopharmacology. &lt;/span&gt;</code></p><p><code>30393</code><code>1982;&lt;span class="ref-vol"&gt;</code></p><p><code>30394</code><code>76&lt;/span&gt;</code></p><p><code>30395</code><code>:245–250.&lt;/span&gt;</code></p><p><code>30396</code><code> [&lt;a href="/pubmed/6285406" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30397</code><code>PubMed&lt;/a&gt;</code></p><p><code>30398</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30399</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology&amp;amp;title=Action+of+cannabidiol+on+the+anxiety+and+other+effects+produced+by+&amp;#x00394;9-THC+in+normal+subjects&amp;amp;author=AW+Zuardi&amp;amp;author=I+Shirakawa&amp;amp;author=E+Finkelfarb&amp;amp;author=IG+Karniol&amp;amp;volume=76&amp;amp;publication_year=1982&amp;amp;pages=245-250&amp;amp;pmid=6285406&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30400</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30401</code><code>]&lt;/span&gt;</code></p><p><code>30402</code><code>&lt;/span&gt;</code></p><p><code>30403</code><code>&lt;/li&gt;</code></p><p><code>30404</code><code>&lt;li id="R1329"&gt;</code></p><p><code>30405</code><code>&lt;span class="citation"&gt;</code></p><p><code>30406</code><code>Zurier RB, Rossetti RG, Burstein SH, Bidinger B. Suppression of human monocyte interleukin-1&lt;em&gt;</code></p><p><code>30407</code><code>&amp;#x003b2;&lt;/em&gt;</code></p><p><code>30408</code><code> production by ajulemic acid, a nonpsychoactive cannabinoid. &lt;span&gt;</code></p><p><code>30409</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30410</code><code>Biochem Pharmacol. &lt;/span&gt;</code></p><p><code>30411</code><code>2003;&lt;span class="ref-vol"&gt;</code></p><p><code>30412</code><code>65&lt;/span&gt;</code></p><p><code>30413</code><code>:649–655.&lt;/span&gt;</code></p><p><code>30414</code><code> [&lt;a href="/pubmed/12566094" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30415</code><code>PubMed&lt;/a&gt;</code></p><p><code>30416</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30417</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;amp;title=Suppression+of+human+monocyte+interleukin-1&amp;#x003b2;+production+by+ajulemic+acid,+a+nonpsychoactive+cannabinoid&amp;amp;author=RB+Zurier&amp;amp;author=RG+Rossetti&amp;amp;author=SH+Burstein&amp;amp;author=B+Bidinger&amp;amp;volume=65&amp;amp;publication_year=2003&amp;amp;pages=649-655&amp;amp;pmid=12566094&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30418</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30419</code><code>]&lt;/span&gt;</code></p><p><code>30420</code><code>&lt;/span&gt;</code></p><p><code>30421</code><code>&lt;/li&gt;</code></p><p><code>30422</code><code>&lt;li id="R1330"&gt;</code></p><p><code>30423</code><code>&lt;span class="citation"&gt;</code></p><p><code>30424</code><code>Zurier RB, Rossetti RG, Lane JH, Goldberg JM, Hunter SA, Burstein SH. Dimethylheptyl-THC-11 oic acid: a nonpsychoactive antiinflammatory agent with a cannabinoid template structure. &lt;span&gt;</code></p><p><code>30425</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30426</code><code>Arthritis Rheum. &lt;/span&gt;</code></p><p><code>30427</code><code>1998;&lt;span class="ref-vol"&gt;</code></p><p><code>30428</code><code>41&lt;/span&gt;</code></p><p><code>30429</code><code>:163–170.&lt;/span&gt;</code></p><p><code>30430</code><code> [&lt;a href="/pubmed/9433882" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30431</code><code>PubMed&lt;/a&gt;</code></p><p><code>30432</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30433</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheum&amp;amp;title=Dimethylheptyl-THC-11+oic+acid:+a+nonpsychoactive+antiinflammatory+agent+with+a+cannabinoid+template+structure&amp;amp;author=RB+Zurier&amp;amp;author=RG+Rossetti&amp;amp;author=JH+Lane&amp;amp;author=JM+Goldberg&amp;amp;author=SA+Hunter&amp;amp;volume=41&amp;amp;publication_year=1998&amp;amp;pages=163-170&amp;amp;pmid=9433882&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30434</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30435</code><code>]&lt;/span&gt;</code></p><p><code>30436</code><code>&lt;/span&gt;</code></p><p><code>30437</code><code>&lt;/li&gt;</code></p><p><code>30438</code><code>&lt;li id="R1331"&gt;</code></p><p><code>30439</code><code>&lt;span class="citation"&gt;</code></p><p><code>30440</code><code>Zygmunt PM, Chuang H, Movahed P, Julius D, Hogestatt ED. The anandamide transport inhibitor AM404 activates vanilloid receptors. &lt;span&gt;</code></p><p><code>30441</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30442</code><code>Eur J Pharmacol. &lt;/span&gt;</code></p><p><code>30443</code><code>2000;&lt;span class="ref-vol"&gt;</code></p><p><code>30444</code><code>396&lt;/span&gt;</code></p><p><code>30445</code><code>:39–42.&lt;/span&gt;</code></p><p><code>30446</code><code> [&lt;a href="/pubmed/10822052" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30447</code><code>PubMed&lt;/a&gt;</code></p><p><code>30448</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30449</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;amp;title=The+anandamide+transport+inhibitor+AM404+activates+vanilloid+receptors&amp;amp;author=PM+Zygmunt&amp;amp;author=H+Chuang&amp;amp;author=P+Movahed&amp;amp;author=D+Julius&amp;amp;author=ED+Hogestatt&amp;amp;volume=396&amp;amp;publication_year=2000&amp;amp;pages=39-42&amp;amp;pmid=10822052&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30450</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30451</code><code>]&lt;/span&gt;</code></p><p><code>30452</code><code>&lt;/span&gt;</code></p><p><code>30453</code><code>&lt;/li&gt;</code></p><p><code>30454</code><code>&lt;li id="R1332"&gt;</code></p><p><code>30455</code><code>&lt;span class="citation"&gt;</code></p><p><code>30456</code><code>Zygmunt PM, Petersson J, Andersson DA, Chuang HH, Sorgard M, Di Marzo V, Julius D, H&amp;#x000f6;gest&amp;#x000e4;tt ED. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. &lt;span&gt;</code></p><p><code>30457</code><code>&lt;span class="ref-journal"&gt;</code></p><p><code>30458</code><code>Nature (Lond) &lt;/span&gt;</code></p><p><code>30459</code><code>1999;&lt;span class="ref-vol"&gt;</code></p><p><code>30460</code><code>400&lt;/span&gt;</code></p><p><code>30461</code><code>:452–457.&lt;/span&gt;</code></p><p><code>30462</code><code> [&lt;a href="/pubmed/10440374" ref="reftype=pubmed&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord"&gt;</code></p><p><code>30463</code><code>PubMed&lt;/a&gt;</code></p><p><code>30464</code><code>] &lt;span class="nowrap"&gt;</code></p><p><code>30465</code><code>[&lt;a href="https://scholar.google.com/scholar_lookup?journal=Nature+(Lond)&amp;amp;title=Vanilloid+receptors+on+sensory+nerves+mediate+the+vasodilator+action+of+anandamide&amp;amp;author=PM+Zygmunt&amp;amp;author=J+Petersson&amp;amp;author=DA+Andersson&amp;amp;author=HH+Chuang&amp;amp;author=M+Sorgard&amp;amp;volume=400&amp;amp;publication_year=1999&amp;amp;pages=452-457&amp;amp;pmid=10440374&amp;amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;amp;article-id=2241751&amp;amp;issue-id=161221&amp;amp;journal-id=319&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar"&gt;</code></p><p><code>30466</code><code>Google Scholar&lt;/a&gt;</code></p><p><code>30467</code><code>]&lt;/span&gt;</code></p><p><code>30468</code><code>&lt;/span&gt;</code></p><p><code>30469</code><code>&lt;/li&gt;</code></p><p><code>30470</code><code>&lt;/ul&gt;</code></p><p><code>30471</code><code>&lt;/div&gt;</code></p><p><code>30472</code><code>&lt;/div&gt;</code></p><p><code>30473</code><code>&lt;/div&gt;</code></p><p><code>30474</code><code>&lt;!--post-content--&gt;</code></p><p><code>30475</code><code>&lt;/div&gt;</code></p><p><code>30476</code><code>          </code></p><p><code>30477</code><code>            </code></p><p><code>30478</code><code>            </code></p><p><code>30479</code><code>        </code></p><p><code>30480</code><code>            </code></p><p><code>30481</code><code>        &lt;/div&gt;</code></p><p><code>30482</code><code>          </code></p><p><code>30483</code><code>        &lt;!-- Book content --&gt;</code></p><p><code>30484</code><code>          </code></p><p><code>30485</code><code>    &lt;/div&gt;</code></p><p><code>30486</code><code>          </code></p><p><code>30487</code><code>    </code></p><p><code>30488</code><code>    &lt;div id="rightcolumn" class="four_col col last"&gt;</code></p><p><code>30489</code><code>          </code></p><p><code>30490</code><code>        &lt;!-- Custom content above discovery portlets --&gt;</code></p><p><code>30491</code><code>          </code></p><p><code>30492</code><code>        &lt;div class="col6"&gt;</code></p><p><code>30493</code><code>          </code></p><p><code>30494</code><code>            </code></p><p><code>30495</code><code>        &lt;/div&gt;</code></p><p><code>30496</code><code>          </code></p><p><code>30497</code><code>        </code></p><p><code>30498</code><code>        &lt;div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"&gt;</code></p><p><code>30499</code><code>&lt;div class="format-menu"&gt;</code></p><p><code>30500</code><code>&lt;h2&gt;</code></p><p><code>30501</code><code>Formats:&lt;/h2&gt;</code></p><p><code>30502</code><code>&lt;ul&gt;</code></p><p><code>30503</code><code>&lt;li class="selected"&gt;</code></p><p><code>30504</code><code>Article&lt;/li&gt;</code></p><p><code>30505</code><code> | &lt;li&gt;</code></p><p><code>30506</code><code>&lt;a href="/pmc/articles/PMC2241751/?report=reader"&gt;</code></p><p><code>30507</code><code>PubReader&lt;/a&gt;</code></p><p><code>30508</code><code>&lt;/li&gt;</code></p><p><code>30509</code><code> | &lt;li&gt;</code></p><p><code>30510</code><code>&lt;a href="/pmc/articles/PMC2241751/pdf/nihms38123.pdf"&gt;</code></p><p><code>30511</code><code>PDF (2.8M)&lt;/a&gt;</code></p><p><code>30512</code><code>&lt;/li&gt;</code></p><p><code>30513</code><code> | &lt;li&gt;</code></p><p><code>30514</code><code>&lt;a href="#" data-citationid="PMC2241751" class="citationexporter ctxp"&gt;</code></p><p><code>30515</code><code>Cite&lt;/a&gt;</code></p><p><code>30516</code><code>&lt;/li&gt;</code></p><p><code>30517</code><code>&lt;/ul&gt;</code></p><p><code>30518</code><code>&lt;/div&gt;</code></p><p><code>30519</code><code>&lt;/div&gt;</code></p><p><code>30520</code><code>&lt;div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"&gt;</code></p><p><code>30521</code><code>&lt;h2&gt;</code></p><p><code>30522</code><code>Share&lt;/h2&gt;</code></p><p><code>30523</code><code>&lt;ul&gt;</code></p><p><code>30524</code><code>&lt;li class="facebook"&gt;</code></p><p><code>30525</code><code>&lt;a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2241751%2F"&gt;</code></p><p><code>30526</code><code>&lt;img src="//static.pubmed.gov/portal/portal3rc.fcgi/4201310/img/4047626" alt="Share on Facebook" /&gt;</code></p><p><code>30527</code><code>          </code></p><p><code>30528</code><code>                             Facebook</code></p><p><code>30529</code><code>                        &lt;/a&gt;</code></p><p><code>30530</code><code>&lt;/li&gt;</code></p><p><code>30531</code><code>&lt;li class="twitter"&gt;</code></p><p><code>30532</code><code>&lt;a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2241751%2F&amp;amp;text=The%20Endocannabinoid%20System%20as%20an%20Emerging%20Target%20of%20Pharmacotherapy"&gt;</code></p><p><code>30533</code><code>&lt;img src="//static.pubmed.gov/portal/portal3rc.fcgi/4201310/img/4047627" alt="Share on Twitter" /&gt;</code></p><p><code>30534</code><code>          </code></p><p><code>30535</code><code>                             Twitter</code></p><p><code>30536</code><code>                        &lt;/a&gt;</code></p><p><code>30537</code><code>&lt;/li&gt;</code></p><p><code>30538</code><code>&lt;li class="gplus"&gt;</code></p><p><code>30539</code><code>&lt;a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2241751%2F"&gt;</code></p><p><code>30540</code><code>&lt;img src="//static.pubmed.gov/portal/portal3rc.fcgi/4201310/img/4047628" alt="Share on Google Plus" /&gt;</code></p><p><code>30541</code><code>          </code></p><p><code>30542</code><code>                             Google+</code></p><p><code>30543</code><code>                        &lt;/a&gt;</code></p><p><code>30544</code><code>&lt;/li&gt;</code></p><p><code>30545</code><code>&lt;/ul&gt;</code></p><p><code>30546</code><code>&lt;/div&gt;</code></p><p><code>30547</code><code>          </code></p><p><code>30548</code><code>        </code></p><p><code>30549</code><code>        &lt;div id="ajax-portlets" data-pmid="16968947" data-aiid="2241751" data-aid="2241751" data-iid="161221" data-domainid="319" data-domain="nihpa" data-accid="PMC2241751" data-md5="dbfecb7bca0cce6c8b20813818c631d1"&gt;</code></p><p><code>30550</code><code>&lt;/div&gt;</code></p><p><code>30551</code><code>          </code></p><p><code>30552</code><code>                </code></p><p><code>30553</code><code>        &lt;!-- Custom content below discovery portlets --&gt;</code></p><p><code>30554</code><code>          </code></p><p><code>30555</code><code>        &lt;div class="col7"&gt;</code></p><p><code>30556</code><code>          </code></p><p><code>30557</code><code>            </code></p><p><code>30558</code><code>        &lt;/div&gt;</code></p><p><code>30559</code><code>          </code></p><p><code>30560</code><code>    &lt;/div&gt;</code></p><p><code>30561</code><code>          </code></p><p><code>30562</code><code>&lt;/div&gt;</code></p><p><code>30563</code><code>          </code></p><p><code>30564</code><code>          </code></p><p><code>30565</code><code>&lt;!-- Custom content after all --&gt;</code></p><p><code>30566</code><code>          </code></p><p><code>30567</code><code>&lt;div class="col8"&gt;</code></p><p><code>30568</code><code>          </code></p><p><code>30569</code><code>    </code></p><p><code>30570</code><code>&lt;/div&gt;</code></p><p><code>30571</code><code>          </code></p><p><code>30572</code><code>&lt;div class="col9"&gt;</code></p><p><code>30573</code><code>          </code></p><p><code>30574</code><code>    </code></p><p><code>30575</code><code>&lt;/div&gt;</code></p><p><code>30576</code><code>          </code></p><p><code>30577</code><code>          </code></p><p><code>30578</code><code>&lt;script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"&gt;</code></p><p><code>30579</code><code>&lt;/script&gt;</code></p><p><code>30580</code><code>          </code></p><p><code>30581</code><code>&lt;script&gt;</code></p><p><code>30582</code><code>          </code></p><p><code>30583</code><code>    (function($){</code></p><p><code>30584</code><code>        $('.skiplink').each(function(i, item){</code></p><p><code>30585</code><code>            var href = $($(item).attr('href'));</code></p><p><code>30586</code><code>            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus</code></p><p><code>30587</code><code>            $(item).on('click', function(event){</code></p><p><code>30588</code><code>                event.preventDefault();</code></p><p><code>30589</code><code>                $.scrollTo(href, 0, {</code></p><p><code>30590</code><code>                    onAfter: function(){</code></p><p><code>30591</code><code>                        href.focus();</code></p><p><code>30592</code><code>                    }</code></p><p><code>30593</code><code>                });</code></p><p><code>30594</code><code>            });</code></p><p><code>30595</code><code>        });</code></p><p><code>30596</code><code>    })(jQuery);</code></p><p><code>30597</code><code>&lt;/script&gt;</code></p><p><code>30598</code><code>          </code></p><p><code>30599</code><code>          </code></p><p><code>30600</code><code>          </code></p><p><code>30601</code><code>          </code></p><p><code>30602</code><code>&lt;div id="body-link-poppers"&gt;</code></p><p><code>30603</code><code>&lt;/div&gt;</code></p><p><code>30604</code><code>          </code></p><p><code>30605</code><code>                        &lt;/div&gt;</code></p><p><code>30606</code><code>          </code></p><p><code>30607</code><code>                        &lt;div class="bottom"&gt;</code></p><p><code>30608</code><code>          </code></p><p><code>30609</code><code>                            </code></p><p><code>30610</code><code>                            &lt;div id="NCBIFooter_dynamic"&gt;</code></p><p><code>30611</code><code>          </code></p><p><code>30612</code><code>    &lt;a id="help-desk-link" class="help_desk" href="" target="_blank"&gt;</code></p><p><code>30613</code><code>Support Center&lt;/a&gt;</code></p><p><code>30614</code><code>          </code></p><p><code>30615</code><code>    &lt;a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2021-10-26T14:05:50-04:00&amp;amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.52&amp;amp;Host=ptpmc101&amp;amp;ncbi_phid=8A1AC5371782FE310000000008240822&amp;amp;ncbi_session=8A1AED4817306781_0453SID&amp;amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2241751%2F&amp;amp;Db=pmc&amp;amp;folderID=132&amp;amp;Ncbi_App=pmc&amp;amp;Page=literature&amp;amp;style=classic&amp;amp;deptID=28049" target="_blank"&gt;</code></p><p><code>30616</code><code>Support Center&lt;/a&gt;</code></p><p><code>30617</code><code>          </code></p><p><code>30618</code><code>    </code></p><p><code>30619</code><code>&lt;/div&gt;</code></p><p><code>30620</code><code>          </code></p><p><code>30621</code><code>          </code></p><p><code>30622</code><code>                            &lt;div class="footer" id="footer"&gt;</code></p><p><code>30623</code><code>          </code></p><p><code>30624</code><code>    </code></p><p><code>30625</code><code>    &lt;div class="subfooter"&gt;</code></p><p><code>30626</code><code> &lt;/div&gt;</code></p><p><code>30627</code><code>&lt;script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"&gt;</code></p><p><code>30628</code><code> &lt;/script&gt;</code></p><p><code>30629</code><code>          </code></p><p><code>30630</code><code>    &lt;div id="external-disclaimer" class="offscreen_noflow"&gt;</code></p><p><code>30631</code><code>          </code></p><p><code>30632</code><code>        External link. Please review our &lt;a href="https://www.nlm.nih.gov/privacy.html"&gt;</code></p><p><code>30633</code><code>privacy policy&lt;/a&gt;</code></p><p><code>30634</code><code>.</code></p><p><code>30635</code><code>    &lt;/div&gt;</code></p><p><code>30636</code><code>    </code></p><p><code>30637</code><code>    &lt;div id="ncbifooter" class="contact_info"&gt;</code></p><p><code>30638</code><code>      </code></p><p><code>30639</code><code>        &lt;div id="footer-contents-right"&gt;</code></p><p><code>30640</code><code>          </code></p><p><code>30641</code><code>            &lt;div id="nlm_thumb_logo"&gt;</code></p><p><code>30642</code><code>          </code></p><p><code>30643</code><code>                &lt;a href="https://www.nlm.nih.gov" title="NLM"&gt;</code></p><p><code>30644</code><code>NLM&lt;/a&gt;</code></p><p><code>30645</code><code>          </code></p><p><code>30646</code><code>            &lt;/div&gt;</code></p><p><code>30647</code><code>          </code></p><p><code>30648</code><code>            &lt;div id="nih_thumb_logo"&gt;</code></p><p><code>30649</code><code>          </code></p><p><code>30650</code><code>                &lt;a href="https://www.nih.gov" title="NIH"&gt;</code></p><p><code>30651</code><code>NIH&lt;/a&gt;</code></p><p><code>30652</code><code>          </code></p><p><code>30653</code><code>            &lt;/div&gt;</code></p><p><code>30654</code><code>          </code></p><p><code>30655</code><code>            &lt;div id="hhs_thumb_logo"&gt;</code></p><p><code>30656</code><code>          </code></p><p><code>30657</code><code>                &lt;a href="https://www.hhs.gov" title="DHHS"&gt;</code></p><p><code>30658</code><code>DHHS&lt;/a&gt;</code></p><p><code>30659</code><code>          </code></p><p><code>30660</code><code>            &lt;/div&gt;</code></p><p><code>30661</code><code>          </code></p><p><code>30662</code><code>            &lt;div id="usagov_thumb_logo"&gt;</code></p><p><code>30663</code><code>          </code></p><p><code>30664</code><code>                &lt;a href="https://www.usa.gov" title="USA.gov"&gt;</code></p><p><code>30665</code><code>USA.gov&lt;/a&gt;</code></p><p><code>30666</code><code>          </code></p><p><code>30667</code><code>            &lt;/div&gt;</code></p><p><code>30668</code><code>         </code></p><p><code>30669</code><code>        &lt;/div&gt;</code></p><p><code>30670</code><code>          </code></p><p><code>30671</code><code>        </code></p><p><code>30672</code><code>        &lt;div id="footer-contents-left"&gt;</code></p><p><code>30673</code><code>          </code></p><p><code>30674</code><code>            &lt;p class="address vcard"&gt;</code></p><p><code>30675</code><code>          </code></p><p><code>30676</code><code>                &lt;span class="url"&gt;</code></p><p><code>30677</code><code>          </code></p><p><code>30678</code><code>                    &lt;a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov"&gt;</code></p><p><code>30679</code><code>National Center for</code></p><p><code>30680</code><code>                        Biotechnology Information&lt;/a&gt;</code></p><p><code>30681</code><code>,</code></p><p><code>30682</code><code>                &lt;/span&gt;</code></p><p><code>30683</code><code> &lt;span class="org url newdomain"&gt;</code></p><p><code>30684</code><code>&lt;a href="https://www.nlm.nih.gov/"&gt;</code></p><p><code>30685</code><code>U.S. National Library of Medicine&lt;/a&gt;</code></p><p><code>30686</code><code>&lt;/span&gt;</code></p><p><code>30687</code><code>          </code></p><p><code>30688</code><code>                &lt;span class="adr"&gt;</code></p><p><code>30689</code><code>          </code></p><p><code>30690</code><code>                    &lt;span class="street-address"&gt;</code></p><p><code>30691</code><code>8600 Rockville Pike&lt;/span&gt;</code></p><p><code>30692</code><code>, &lt;span class="locality"&gt;</code></p><p><code>30693</code><code>Bethesda&lt;/span&gt;</code></p><p><code>30694</code><code>          </code></p><p><code>30695</code><code>                    &lt;span class="region"&gt;</code></p><p><code>30696</code><code>MD&lt;/span&gt;</code></p><p><code>30697</code><code>, &lt;span class="postal-code"&gt;</code></p><p><code>30698</code><code>20894&lt;/span&gt;</code></p><p><code>30699</code><code>          </code></p><p><code>30700</code><code>                    &lt;span class="country-name"&gt;</code></p><p><code>30701</code><code>USA&lt;/span&gt;</code></p><p><code>30702</code><code>          </code></p><p><code>30703</code><code>                &lt;/span&gt;</code></p><p><code>30704</code><code>          </code></p><p><code>30705</code><code>            &lt;/p&gt;</code></p><p><code>30706</code><code>          </code></p><p><code>30707</code><code>            </code></p><p><code>30708</code><code>            &lt;a href="/home/about/policies.shtml"&gt;</code></p><p><code>30709</code><code>Policies and Guidelines&lt;/a&gt;</code></p><p><code>30710</code><code> | &lt;a href="/home/about/contact.shtml"&gt;</code></p><p><code>30711</code><code>Contact&lt;/a&gt;</code></p><p><code>30712</code><code>          </code></p><p><code>30713</code><code>        &lt;/div&gt;</code></p><p><code>30714</code><code>          </code></p><p><code>30715</code><code>    &lt;/div&gt;</code></p><p><code>30716</code><code>          </code></p><p><code>30717</code><code>    &lt;script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"&gt;</code></p><p><code>30718</code><code> &lt;/script&gt;</code></p><p><code>30719</code><code>    </code></p><p><code>30720</code><code>    &lt;script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"&gt;</code></p><p><code>30721</code><code> &lt;/script&gt;</code></p><p><code>30722</code><code>          </code></p><p><code>30723</code><code>&lt;/div&gt;</code></p><p><code>30724</code><code>          </code></p><p><code>30725</code><code>                        &lt;/div&gt;</code></p><p><code>30726</code><code>          </code></p><p><code>30727</code><code>                    &lt;/div&gt;</code></p><p><code>30728</code><code>          </code></p><p><code>30729</code><code>                    &lt;!--/.page--&gt;</code></p><p><code>30730</code><code>          </code></p><p><code>30731</code><code>                &lt;/div&gt;</code></p><p><code>30732</code><code>          </code></p><p><code>30733</code><code>                &lt;!--/.wrap--&gt;</code></p><p><code>30734</code><code>          </code></p><p><code>30735</code><code>            &lt;/div&gt;</code></p><p><code>30736</code><code>&lt;!-- /.twelve_col --&gt;</code></p><p><code>30737</code><code>          </code></p><p><code>30738</code><code>        &lt;/div&gt;</code></p><p><code>30739</code><code>          </code></p><p><code>30740</code><code>        &lt;!-- /.grid --&gt;</code></p><p><code>30741</code><code>          </code></p><p><code>30742</code><code>          </code></p><p><code>30743</code><code>        &lt;span class="PAFAppResources"&gt;</code></p><p><code>30744</code><code>&lt;/span&gt;</code></p><p><code>30745</code><code>          </code></p><p><code>30746</code><code>        </code></p><p><code>30747</code><code>        &lt;!-- BESelector tab --&gt;</code></p><p><code>30748</code><code>          </code></p><p><code>30749</code><code>        </code></p><p><code>30750</code><code>        </code></p><p><code>30751</code><code>        </code></p><p><code>30752</code><code>        &lt;noscript&gt;</code></p><p><code>30753</code><code>&lt;img alt="statistics" src="/stat?jsdisabled=true&amp;amp;ncbi_db=pmc&amp;amp;ncbi_pdid=article&amp;amp;ncbi_acc=&amp;amp;ncbi_domain=nihpa&amp;amp;ncbi_report=record&amp;amp;ncbi_type=fulltext&amp;amp;ncbi_objectid=&amp;amp;ncbi_pcid=/articles/PMC2241751/&amp;amp;ncbi_app=pmc" /&gt;</code></p><p><code>30754</code><code>&lt;/noscript&gt;</code></p><p><code>30755</code><code>          </code></p><p><code>30756</code><code>        </code></p><p><code>30757</code><code>        </code></p><p><code>30758</code><code>        &lt;!-- usually for JS scripts at page bottom --&gt;</code></p><p><code>30759</code><code>          </code></p><p><code>30760</code><code>        &lt;!--&lt;component id="PageFixtures" label="styles"&gt;</code></p><p><code>30761</code><code>&lt;/component&gt;</code></p><p><code>30762</code><code>--&gt;</code></p><p><code>30763</code><code>          </code></p><p><code>30764</code><code>    </code></p><p><code>30765</code><code>          </code></p><p><code>30766</code><code>&lt;!-- 8A1AED4817306781_0453SID /projects/PMC/PMCViewer@4.52 ptpmc101 v4.1.r635708 Mon, Aug 09 2021 01:08:56 --&gt;</code></p><p><code>30767</code><code>          </code></p><p><code>30768</code><code>&lt;span id="portal-csrf-token" style="display:none" data-token="8A1AED4817306781_0453SID"&gt;</code></p><p><code>30769</code><code>&lt;/span&gt;</code></p><p><code>30770</code><code>          </code></p><p><code>30771</code><code>          </code></p><p><code>30772</code><code>&lt;script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4201310/js/3879255/4121861/3818874/3821238/4117325/4200673/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"&gt;</code></p><p><code>30773</code><code>&lt;/script&gt;</code></p><p><code>30774</code><code>&lt;/body&gt;</code></p><p><code>30775</code><code>          </code></p><p><code>30776</code><code>&lt;/html&gt;</code></p><div></div></main><iframe hidden="hidden" title="Hidden frame for spell checking" src="about:blank" id="iframeSpelling"></iframe></body></html>